<?xml version="1.0" encoding="iso-8859-1" ?>
<recordset>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>A visão atual da indicação cirúrgica das cardiopatias congênitas</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>01-02</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiologia baseada em evidências em foco: a prática cardiológica sólida e robusta</s1>
</fA08>
<fA11 dir="011000">
<s1>Álvaro Avezum</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>03-03</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiologia baseada em evidências I. Princípios, racionalidade e aplicações de uma nova prática cardiológica e análise crítica da literatura</s1>
</fA08>
<fA11 dir="011000">
<s1>Álvaro Avezum</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>05-13</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Insuficiência cardíaca em grande hospital terciário de São Paulo</s1>
</fA08>
<fA08 dir="en">
<s1>Heart failure in a large tertiary hospital of São Paulo</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Moacir Roberto Cuce Nobre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maurício Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Manoel Fernandes Canesin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Dalia Ballas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>João Batista Serro-Azul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>15-20</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar a incidência, principais causas, fatores desencadeantes ou de piora da insuficiência cardíaca (IC) no ano de 1995, no Instituto do Coração de São Paulo. MÉTODOS: Foram analisados os registros referentes a pacientes internados, obtidos do banco de dados da PRODESP. Analisaram-se nos pacientes com IC os dados: idade, sexo, diagnóstico principal e secundários, procedimentos executados e óbitos. Para fim de análise, construíram-se tabelas de distribuição conforme o sexo, idade e diagnóstico principal. Análise de variância e teste do qui-quadrado foram empregados para verificar diferença entre os grupos estudados. RESULTADOS: Dos pacientes internados (903 de 9620) 9,38% apresentaram IC. As idades variaram de 2 dias a 98 (média 52,6) anos e a maioria era do sexo masculino (60,4%). Miocardiopatia isquêmica (32,6%), miocardiopatia dilatada (25,8%) e valvopatias (22,0%) foram as principais causas de IC. Foram submetidos à cirurgia, angioplastia, ou implante de marcapasso, 32,1% dos pacientes, sendo os valvopatas na maioria submetidos à correção de sua cardiopatia de base (63,3%). Houve maior incidência de múltiplos diagnósticos secundários com o aumento da idade. A mortalidade foi maior nos com idade &lt;20 anos e nos &gt;80 anos. CONCLUSÃO: A incidência de IC foi de 9,38%, sendo miocardiopatia isquêmica a causa mais freqüente. Foi possível corrigir a causa da IC em 32,1%. A mortalidade foi maior nas crianças provavelmente pela maior complexidade de sua cardiopatia e nos mais idosos devido à maior associação de diagnósticos secundários ou fatores agravantes.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To study the incidence, main causes, aggravating factors and secondary diagnoses of heart failure (HF) during 1995 at the Instituto do Coração of São Paulo. METHODS: Data from hospitalized patients according to the PRODESP data base were analyzed. The following data were studied: age, sex, principal and secondary diagnoses, surgical procedures and mortality. To analyze the data, tables according to sex, age and main cause were built. Analysis of variance and t test were employed to verify differences between groups. RESULTS: In 1995, 903 out of 9620 patients were hospitalized due to HF. The majority were male (60.4%) and the patients' age was between two days and 98 years old (mean 52.6). Ischemic (32.6), dilated (25.8%) and valvar heart disease (22%) were the main causes of HF. 32.1% were submitted to correction of the HF main cause, specially those with valvar heart disease (62.3%). There was greater incidence of multiple diagnoses in aged patients. The mortality was greater in patients younger than 20 and in those older than 80 years old. CONCLUSION: The incidence of HF at INCOR during 1995 was 9.38%. Ischemic myocardiopathy was the most frequent HF cause. The mortality was greater among children, probably because of heart disease complexity and, in the above-80 group due to the greater comorbidity.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>diabetes mellitus</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fibrilação atrial</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diabetes</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Doenças cardiovasculares observadas durante o seguimento de um grupo de pacientes na forma indeterminada da doença de Chagas</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiovascular diseases observed during follow-up of a group of patients in undetermined form of Chagas' disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Barbara Maria Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fábio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>21-24</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Observar, num grupo de pacientes na forma indeterminada da doença de Chagas, o aparecimento de doenças cardiovasculares e sua possível relação com a doença de base. MÉTODOS: Foram seguidos, prospectivamente, 160 pacientes por até 177 meses com avaliações clínicas trimestrais. RESULTADOS: Tornaram-se hipertensos 23 (14,4%) pacientes, sendo 21 (13,2%) com pressão arterial diastólica &lt;110mmHg. Duas pacientes (1,2%) hipertensas tiveram acidente vascular cerebral isquêmico (AVCI). Uma (0,6%) paciente teve hemorragia meníngea por ruptura de aneurisma cerebral. Quatro (2,4%) pacientes apresentaram arritmia clinicamente, dois (1,2%) extra-sístoles ventriculares, um (0,6%) extra-sístoles supraventriculares e um (0,6%) fibrilação atrial aguda. Dois (1,2%) pacientes desenvolveram coronariopatia comprovada angiograficamente, um (0,6%) com infarto agudo do miocárdio, outro com angina estável. Um (0,6%) paciente desenvolveu sinais e sintomas de insuficiência cardíaca, juntamente com o aparecimento de hipertensão arterial sistêmica (HAS). CONCLUSÃO: A doença cardiovascular mais freqüente foi a HAS. Duas hipertensas apresentaram AVCI. As arritmias observadas não foram mais freqüentes que na população normal e a coronariopatia também ocorreu raramente, confirmando um bom prognóstico clínico a longo prazo desse grupo de pacientes.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: The aim of this study was to evaluate the cardiovascular outcome in patients with the undetermined form of Chagas' disease and whether or not it is related to the infectious disease in the long-term. METHODS: One hundred and sixty patients were prospectively followed-up at three month intervals for up to 177 months. RESULTS: Twenty and three (14.4%) patients developed hypertension complicated by ischemic stroke in two (1.2%) and symptomatic heart failure in one (0.6%). Cardiac arrhythmias occurred in four (2.4%) patients corresponding to isolated ventricular ectopic beats in two (1.2%), isolated supraventricular ectopic beats in one (0.6%) and an isolated episode of acute atrial fibrillation in another (0.6%). Two (1.2%) patients developed symptoms of coronary artery disease, one of them had one episode of acute chest pain diagnosed as myocardial infarction and the other had chronic chest pain diagnosed as angina. CONCLUSION: Hypertension is the most common cardiovascular disease occurring in the long-term follow-up of patients with the undetermined form of Chagas' disease. Cardiac rhythm disturbances and coronary artery disease were not more frequent than those generally found in a healthy population. These data confirm a favorable long-term prognosis in patients with the undetermined form of Chagas' disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença de Chagas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>forma indeterminada</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>alterações clínicas</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>undetermined form</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>clinical changes</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Comparação da aterosclerose coronária em pacientes com infarto do miocárdio e angina do peito</s1>
</fA08>
<fA08 dir="en">
<s1>Comparison of coronary heart disease extent and severity in patients with myocardial infarction and angina pectoris</s1>
</fA08>
<fA11 dir="011000">
<s1>Waldomiro Carlos Manfroi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alcides José Zago</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cristiane Bauermann Leitão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Karen Gomes Ordovás</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Letícia Weiss Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Josiane de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Luciana Kirschnick</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Rafael Henriques Candiago</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Rosana Cruz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Alexandre Goellner</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Ilza Dias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Rio Grande do Sul Hospital de Clínicas de Porto Alegre </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>25-29</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar a gravidade da doença coronária e a presença de fatores de risco cardiovasculares entre pacientes com angina e infarto do miocárdio (IM). MÉTODOS: Estudaram-se 62 pacientes com IM e 129 com angina, através de cineangiocoronariografia, avaliando-se a oclusão (lesão de 99% ou 100%), a severidade (escore de 0 a 5 de acordo com o número de vasos afetados) e a extensão (3 grupos com diferentes graus de estenose). Dois observadores experientes interpretaram cegamente os angiogramas. RESULTADOS: Os pacientes com IM tiveram maior oclusão (50% vs 13,2% [p&lt;0,01]), maior severidade (79% vs 54,3% com mais de 90% de estenose [p&lt;0,02]) e maior extensão (2,0 vs 0,87 [p&lt;0,001]), mesmo quando controlados para os fatores de risco coronários clássicos e para o tempo de doença. O tabagismo foi o único fator de risco independente correlacionado com IM (P&lt;0,01). CONCLUSÃO: Entre os pacientes estudados, a doença coronária foi maior no grupo IM, bem como a prevalência de tabagismo.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To compare the severity of the coronary heart disease and the presence of coronary risk factors between angina and myocardial infarction (MI) patients. METHODS: We studied 62 patients with MI and 129 with angina through coronary angiography to evaluate occlusion (lesion of 99% or 100%), extent (with a score of 0-5 derived by the number of vessels affected) and severity (3 groups of different stenosis degrees). Two experient observers blindly interpretated the angiograms. RESULTS: Patients with MI had more occlusions (50% vs 13.2% [p&lt;0.01]), more severity (79% vs 54.3% with &gt;90% stenosis [p&lt;0.02]) and more extent (2.0 vs 0.87 [p&lt;0.001]), even when controlled for current coronary risk factors and disease duration. Smoking was the only independent risk factor related to MI (p&lt;0.001). CONCLUSION: Among the studied patients, coronary heart disease extent and severity was greater in the MI group, as well as the prevalence smoking.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angina do peito</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cineangiocoronariografia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angina pectoris</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Correlação eletro-ecocardiográfica no diagnóstico da hipertrofia ventricular esquerda</s1>
</fA08>
<fA08 dir="en">
<s1>Electro-echocardiographic correlation in the diagnosis of left ventricular hypertrophy</s1>
</fA08>
<fA11 dir="011000">
<s1>Hamilton Domingos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Josane Couto Elias Luzio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gualberto Nogueira de Leles</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Leandro Sauer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz Alberto Ovando</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Mato Grosso do Sul  </s1>
<s2>Campo Grande MS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>31-35</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar a eficácia diagnóstica de 4 critérios eletrocardiográficos: índices de Sokolov, Gubner, Cornell e Romhilt, na detecção da hipertrofia ventricular esquerda (HVE) em pacientes hipertensos. MÉTODOS: Foram avaliados 30 pacientes ambulatoriais, com hipertensão arterial sistêmica leve, moderada ou grave, sendo considerado o diagnóstico de HVE quando os índices eram: Sokolov &gt;35mm, Gubner &gt;22mm, Romhilt &gt;5 pontos e Cornell &gt;20mm para mulheres e 28mm para homens. Determinaram-se, então, a sensibilidade, especificidade, eficácia diagnóstica e outras variáveis diagnósticas para cada um dos critérios, isoladamente, e para os 4 considerados simultaneamente, utilizando-se como padrão ouro para HVE o índice de massa do ventrículo esquerdo &gt;98g/m² para mulheres e &gt;120g/m² para homens, obtido ao ecocardiograma. RESULTADOS: Considerando cada critério eletrocardiográfico isolado, o índice de Sokolov apresentou a melhor eficácia, com sensibilidade = 40%, eficácia diagnóstica de 50% e especificidade 100%; o 2º critério mais eficaz foi o índice de Gubner e, em 3º lugar, empatados, os índices de Romhilt e Cornell. Quando considerados, simultaneamente, ou seja, a presença de pelo menos um dos quatro critérios, a sensibilidade foi 52% e a eficácia diagnóstica 57%. CONCLUSÃO: Os quatro critérios eletrocardiográficos considerados individualmente ou em conjunto foram pouco eficazes na detecção da HVE e, considerando a importância desta entidade patológica, concluímos que é imprescindível a utilização de método propedêutico mais sensível para tal diagnóstico.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To compare the efficacy of four electrocardiographic criteria: Sokolov, Gubner, Cornell and Romhilt indexes, in the diagnosis of left ventricular hypertrophy (LVH) in hypertensive patients. METHODS: LVH was analyzed in the eletrocardiogram of 30 ambulatory patients presenting with systemic arterial hypertension, classified as mild, moderate and severe, according to the following indexes: Sokolov &gt;35mm, Gubner &gt;22mm, Romhilt &gt;5 points and Cornell &gt;20mm for women and 28mm for men. Sensitivity, specificity, diagnostic accuracy and other diagnostic variables were determined. Mass index of the left ventricle, &gt;98g/m² for women and &gt;120g/m² for men, obtained by echocardiography, was considered the gold standard for the diagnosis of LVH. RESULTS: When electrocardiographic criteria were considered separately, the Sokolov index showed the highest accuracy, with a sensitivity of 40%, diagnostic accuracy of 50% and specificity of 100%; the second most accurate index was Gubner, and Romhilt and Cornell indexes followed. When at least one of the indexes was positive, the sensitivity was 52% and diagnostic accuracy was 57%. CONCLUSION: The four electrocardiographic indexes were not diagnostic of LVH, when analyzed either separately or together. Considering the high prevalence of this pathological condition, we conclude that a more accurate diagnostic method should be used in this diagnosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia ventricular esquerda</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>eletrocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Ablação por cateter do flutter atrial. Caracterização eletrofisiológica da interrupção da condução pelos istmos posterior e septal</s1>
</fA08>
<fA08 dir="en">
<s1>Catheter ablation of atrial flutter. Electrophysiological characterization of posterior and septal isthmus block</s1>
</fA08>
<fA11 dir="011000">
<s1>José Marcos Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sílvio Roberto Borges Alessi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>André Gustavo da Silva Rezende</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luis Alberto Renjel Prudêncio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Angelo Amato Vincenzo de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>37-47</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar os tipos de bloqueio obtidos nos istmos posterior (entre o anel tricuspídeo e veia cava inferior) e septal (entre o anel tricuspídeo e óstio do seio coronário), após ablação do flutter atrial (FLA). MÉTODOS: Foram submetidos à ablação por radiofreqüência (RF) 14 pacientes com FLA tipo I (9 homens) em 16 procedimentos. A ativação atrial ao redor do anel tricuspídeo foi avaliada em ritmo sinusal utilizando-se cateter &quot;Halo&quot; com 10 pares de eletrodos (H1-2 a H19-20), durante estimulação do seio coronário proximal (SCP) e região póstero-lateral do átrio direito (H1-2), antes e após ablações lineares. De acordo com a frente de programação do impulso definiu-se: ausência de bloqueio (condução bidirecional), bloqueio incompleto (condução bidirecional com retardo num dos sentidos) e bloqueio completo (ausência de condução pelo istmo). O intervalo desta ativação (deltaSCP/H1-2) foi analisado. RESULTADOS: Bloqueio completo foi obtido em 7 procedimentos (44%) e incompleto em 4 (25%). O deltaSCP/H1-2 foi de 74 ± 26ms no primeiro grupo e de 30,5 ± 7,5ms no segundo (p&lt;0,05). Em 5 casos não demonstrou-se bloqueio. Num seguimento médio de 12 meses, ocorreu recorrência do FLA nos 6 pacientes com bloqueio incompleto ou ausente e em nenhum com bloqueio completo (p&lt;0,001). CONCLUSÃO: A verificação de bloqueio completo pelo mapeamento multipolar atrial é uma estratégia eficaz para definir o sucesso e recorrência clínica na ablação do FLA tipo I.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: Evaluate the different types of conduction blocks obtained between inferior vena cava-tricuspid annulus (posterior isthmus) and between tricuspid annulus-coronary sinus ostium (septal isthmus) after radiofrequency (RF) catheter ablation of atrial flutter (AFL) METHODS: In 16 procedures, 14 patients (pts), 9 male, with type I AFL underwent RF ablation. Atrial activation around tricuspid annulus was performed with a 10-bipole &quot;Halo&quot; catheter (H1-2; H19-20). In sinus rhythm, isthmus conduction was evaluated during proximal coronary sinus (PCS) and low lateral right atrium (H1-2) pacing, before and after linear ablation. According to the wave front of impulse propagation we assessed absence of block (bidirectional conduction); incomplete block (bidirectional conduction with delay in one front of impulse propagation) and complete block (absence of conduction). The PCS/H1-2 interval was measured before and after ablation. RESULTS: Complete isthmus block was achieved in 7 (44%) and incomplete block in 4 (25%) procedures. Conduction block was not achieved in 5 procedures. At a mean follow-up of 12 months, there were no recurrences in the pts with complete block, whereas AFL recurred in the 6 pts with incomplete or no conduction block (p&lt;0.001). Pts with complete block had deltaPCS/H1-2 interval (74.0 ± 26.0ms) greater than incomplete (30.5 ± 7.5ms) or absent block (p&lt;0.05). CONCLUSION: The verification of complete isthmus conduction block with atrial multipolar mapping is an effective strategy to assess electrophysiological success and absence of late recurrence in common atrial flutter ablation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>flutter atrial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ablação por cateter</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>radiofreqüência</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial flutter</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>catheter ablation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>radiofrequency</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Contribuição de eletrocardiografia dinâmica pelo sistema Holter na avaliação de pacientes com a síndrome congênita do QT longo</s1>
</fA08>
<fA08 dir="en">
<s1>Contribution of the dynamic eletrocardiography by Holter monitoring in the evaluation of congenital long QT syndrome patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Ivan G. Maia</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcio L. A. Fagundes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando E. S. Cruz Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rosa Célia P. Barbosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo A. G. Alves</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>49-54</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar pelo Holter-24h a dinâmica da repolarização ventricular de pacientes com a síndrome congênita do QT longo. MÉTODOS: Foram incluídos seis pacientes, sendo os resultados confrontados com os observados em um grupo controle semelhante em número, idade e sexo. Analisaram-se nas gravações a morfologia da onda T e sua dinâmica, o intervalo QTc médio para as 24h, as relações entre QT e ciclo cardíaco, a variabilidade do QTc das 24h, bem como a sua dispersão (diferença entre o maior e menor QTc observado). Todas as variáveis foram definidas a partir da medida do intervalo QT obtida no 1º minuto de cada hora da gravação. RESULTADOS: Alterações morfológicas da onda T estiveram presentes em todos os pacientes, observando-se em cinco deles freqüentes episódios de alternância da onda T, achados ausentes no controle. QTc médio para as 24h - controle: 436,1±8,9ms; pacientes: 598,2±73,8ms (p=0,000). Correlação linear entre QT e ciclo cardíaco - controle: r= 0,967; pacientes: r= 0,812 (p=0,000). Variabilidade do QTc para as 24h - controle: 14,7±2,1ms; pacientes: 36,9±17,2ms (p=0,01). Dispersão do QTc - controle: 53,3±8,1ms; pacientes: 168,3±70,2ms (p=0,000). CONCLUSÃO: Os resultados apresentaram ampla variabilidade dos intervalos QTc nas 24h, menor adaptabilidade do intervalo QT às flutuações dos ciclos cardíacos e significativa dispersão da repolarização ventricular nas 24h, confirmando mais uma vez a existência de importante alteração da vulnerabilidade ventricular nesses pacientes.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: The purpose of this study was to evaluate the value of ambulatory electrocardiogram as a clinical tool to assess ventricular repolarization in patients with the congenital long QT syndrome. METHODS: The study population comprised six patients and their data were compared to a control group of six patients matched in age and gender. The QT interval (ms), corrected by the heart rate, was measured in the first minute of each hour using two monitoring leads, with the mean of six consecutives complexes. The data obtained include the morphologic pattern of T wave, the mean 24-h QTc interval, relation between QT and cardiac cycle, QTc variability (assessed calculating hourly standard deviation of the interval and then obtaining the global 24-h mean), QTc dispersion (difference between the longest and shortest QTc interval). RESULTS: In all patients abnormal patterns of T waves were detected with frequent episodes of T wave alternans. Mean 24-h QTc - patients: 598.2±73.8ms; controls: 436.1±8.9ms (p=0.000). Linear correlation and regression between QT and heart rate - patients: r= 0.812; controls: r= 0.967 (p=0.000). QTc variability - patients: 36.9±17.2ms; controls: 14.7±2.1ms (p=0.01). QTc dispersion - patients: 168.3±70.2ms; controls: 53.3±8.1ms (p=0.000). CONCLUSION: The data showed increased hourly QTc variability, QTc dispersion and worse correlation between QT and heart rate. This data may reflect an abnormally augmented ventricular vulnerability.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Holter</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>síndrome congênita do QT longo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>intervalo QT</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Holter</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital long QT syndrome</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>QT interval</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Tratamento anti-hipertensivo. Prescrição e custo de medicamentos. Pesquisa em hospital terciário</s1>
</fA08>
<fA08 dir="en">
<s1>Antihypertensive treatment. Prescription and cost of drugs. Survey in a tertiary care hospital</s1>
</fA08>
<fA11 dir="011000">
<s1>Daniela Akashi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Flávia K. Issa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alexandre C. Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Anna C. Tannuri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Daniele Q. Fucciolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maurício L. Lobato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Tatiana G. Galvão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Isabela M. Benseñor</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Paulo A. Lotufo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>55-57</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>7</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar os medicamentos anti-hipertensivos mais utilizados por pacientes que procuram atendimento em hospital público terciário, avaliando o impacto das diretrizes de atendimento (consensos) e custo de aquisição. MÉTODOS: Foram selecionados 141 pacientes (101 do sexo feminino) de 40 a 72 (média 53,3) anos, que procuraram de forma espontânea, atendimento em hospital terciário, com diagnóstico prévio de hipertensão arterial feito por médico e ausência de queixas relacionadas ao aparelho cardiovascular. RESULTADOS: Verificou-se que 75,9% (n=107) estavam em uso diário de anti-hipertensivos, sendo 60,7% (n=86) em monoterapia e os demais em terapia mista. Os medicamentos mais empregados em monoterapia eram: tiazídicos, metildopa, inibidores da ECA, bloqueadores de canal de cálcio e betabloqueadores. A combinação com tiazídicos (26,3% do total) seguiu a mesma preferência. O segundo medicamento mais prescrito, metildopa, era o de maior custo. Metade dos pacientes adquiriu os medicamentos por compra direta. CONCLUSÃO: Observou-se maior utilização de anti-hipertensivos de alto custo, conduta discordante das principais diretrizes das sociedades médicas, sobretudo do V-JNC, que preconizou tiazídicos e betabloqueadores, como anti-hipertensivos de primeira escolha em hipertensos sem complicações ou condições associadas.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To study the most prescribed anti-hypertensive drugs, evaluating their agreement with established guidelines and drug cost. METHODS: One hundred and forty one (101 women, mean age = 53.3 years) hypertensive patients who searched spontaneous attention were interviewed in a tertiary-care hospital. The inclusion criteria were previous diagnosis of hypertension and non cardiovascular complaints. RESULTS: The majority of the 107 (75.9%) patients were on medical treatment. In those receiving monotherapy, thiazides were the most utilized drugs, followed by methyldopa, ACE inhibitors, calcium channel-blockers, and beta-blockers. The association with thiazides (26.3%) followed the same preference. The second most prescribed drug, methyldopa, was the more expensive. Fifty percent of the patients purchased the drugs at their own expense. CONCLUSION: A preference for prescription of expensive drugs for hypertension was detected in this sample in Brazil. This does not agree with major guidelines, mainly the V-JNC, which suggest thiazides and betablockers as first choice drugs for hypertensives with no complications or associated comorbidity.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>terapêutica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>custo-benefício</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>therapy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cost-effectiveness</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Balão único versus balão de Inoue na valvoplastia mitral percutânea por balão. Resultados imediatos e complicações</s1>
</fA08>
<fA08 dir="en">
<s1>Single balloon versus Inoue balloon in percutaneous mitral balloon valvuloplasty. Short-term results and complications</s1>
</fA08>
<fA11 dir="011000">
<s1>Edison C. Sandoval Peixoto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Sérgio de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Mário Salles Netto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ivana Picone Borges</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ronaldo A. Villela</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Pierre Labrunie</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Cláudia Brum</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Rodrigo T. Sandoval Peixoto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Marcello A. Sena</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Marta Labrunie</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Ricardo T. Sandoval Peixoto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Daniela M. Burello</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>59-64</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>57</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100111</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar os resultados imediatos e complicações da valvoplastia mitral percutânea por balão (VMPB), com o balão de Inoue (BI) e com o balão único (BU). MÉTODOS: Dentre 390 procedimentos utilizaram-se o BI em 29 procedimentos e o BU de baixo perfil em 337. Não houve diferença na idade e sexo nos 2 grupos. O grupo BI era menos sintomático (p=0,0015). Não houve diferença na distribuição do escore ecocardiográfico e da área valvar mitral (AVM) pré-VMPB. RESULTADOS: Quando compararam-se os 2 grupos entre si, os resultados nos grupos BI e BU foram, respectivamente: pré-VMPB para pressão pulmonar média (PPM) 36±15 e 39±14mmHg, p=0,2033, para gradiente (GRAD) mitral médio 17±6 e 20±7mmHg, p=0,0396 e AVM 0,9±0,2 e 0,9±9,2cm², p=0,8043, enquanto os valores pós-VMPB foram PPM 25±8 e 28±10mmHg, p=0,2881, GRAD 5±3 e 5±4mmHg, p=0,2778 e AVM 2,2±0,2 e 2,0±0,4cm², p=0,0362. Pré-VMPB a válvula mitral era competente em 26 procedimentos com o BI e 280 dos com o BU e havia regurgitação mitral de +/4 em 3 do grupo BI e em 57 do BU, p=0,3591 e pós-VMPB tivemos, no grupo BI a valva mitral (VM) competente em 18, +/4 em 7 e 2+/4 em 4 e no grupo BU, a VM era competente em 218, +/4 em 80, 2+/4 em 25, 3+/4 em 5 e 4+/4 em 2, p=0,7439. Só houve complicações no grupo BU. CONCLUSÃO: As duas técnicas foram eficientes. Os resultados hemodinâmicos foram semelhantes, embora a AVM pós-VMPB do grupo do BI foi maior.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To assess short-term results and complications of percutaneous mitral balloon valvuloplasty (PMBV) performed with Inoue balloon (IB) and single low profile balloon (SB). METHODS: We performed 390 PMBV procedures, 29 with IB and 337 with SB . There were no differences in age, sex, echocardiographic score distribution and echocardiographic mitral valve area (MVA). RESULTS: We performed 29 complete procedures with IB and 330 of 337 in SB group. Comparing IB and pre and pos-PMBV data we obtained: mean pulmonary artery pressure (MPAP) 36±15 and 39±14mmHg, p=0.2033, mean mitral gradient 17±6 and 20±7mmHg, p=0.0396 and MVA 0.9±0.2 and 0.9±0.2cm², p=0.8043 and pos-PMBV: MPAP 25±8 and 28±10mmHg, p=0.2881, gradient 5±3 and 5±4mmHg, p=0.2778 and MVA 2.2±0.2 and 2.0±0.4cm², p=0.0362. Mitral valve (MV) was competent in 26 patients in IB and in 280 in SB group and we had +/4 mitral regurgitation in 3 patients in IB and in 57 in SB group (p=0.3591) pre-PMBV respectively and pos-PMBV there was also no difference in MV competence (p=0.7439). CONCLUSION: Both techniques were effective. Hemodynamic data were also similar although MVA was greater in IB group after PMBV.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvoplastia mitral percutânea por balão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>balão de Inoue</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>balão único</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous mitral balloon valvuloplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Inoue balloon technique</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>single balloon technique</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Aneurisma do ducto arterioso associado a interrupção do arco aórtico</s1>
</fA08>
<fA08 dir="en">
<s1>Aneurysm of the arterial duct associated to aortic arch interruption</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Zielinsky</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leandro Turra Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Cardiologia do Rio Grande do Sul Unidade de Cardiologia Fetal </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>65-67</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100112</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>É relatado um caso de aneurisma de ducto arterioso, com diagnóstico pré-natal, o que é muito raro, numa gestante com 33 semanas, onde o feto apresentou uma dilatação aneurismática do canal arterial, com calibre uniformemente aumentado, inserindo-se na aorta descendente, associado à interrupção do arco aórtico. A criança nasceu de parto cesáreo e manteve-se estável com o uso de prostaglandina até o 9º dia de vida, quando foi levada à cirurgia, tendo falecido durante o procedimento por falência biventricular. Este é o primeiro relato da associação desta anomalia com outra malformação cardiovascular intra-uterina, mostrando que este achado nem sempre é associado a uma evolução benigna.</s0>
</fC01>
<fC01 dir="en">
<s0>Aneurysm of the arterial duct is an infrequent finding, which is very rarely detected prenatally. A case of antenatal diagnosis in a pregnant patient (33 weeks) is reported. The fetus presented an aneurysmatic dilation of the arterial duct with uniformly enlarged diameter, inserting into the descending aorta, which was interrupted. The neonate was born by cesarean section and was kept on postaglandins till the 9th day of life, when he was sent to surgery. During the surgical procedure, the baby died as a result of biventricular failure. This is the first report of prenatal association of aneurysm of the ducts anteriosus with other cardiovascular malformations and emphasizes that this finding does not always have a benign course.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Hiper-homocisteinemia e doenças vaso-oclusivas</s1>
</fA08>
<fA11 dir="011000">
<s1>Sergio Paulo Bydlowski</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Carlos Magnanelli</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Dalton de Alencar F. Chamone</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>69-76</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>90</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100113</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Stents. Uma revisão da literatura</s1>
</fA08>
<fA11 dir="011000">
<s1>Ênio Eduardo Guérios</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ronaldo da Rocha Loures Bueno</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Maurício Piá de Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Deborah Christina Nercolini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alvaro Luiz Aranha Pacheco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Universitário Evangélico de Curitiba  </s1>
<s2>Curitiba PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>77-87</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>133</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100114</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Senhor Editor</s1>
</fA08>
<fA11 dir="011000">
<s1>Bruno Caramelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Raul Dias dos Santos Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Andrei de Carvalho Sposito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Tania Leme da Rocha Martinez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>89-91</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100115</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Coarctação de aorta. Do diagnóstico simples às complicações imprevisíveis</s1>
</fA08>
<fA11 dir="011000">
<s1>Munir Ebaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jorge Yussef Afiune</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>647-648</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiologia baseada em evidências - IV. Principais estratégias de pesquisa e níveis de recomendações em cardiologia</s1>
</fA08>
<fA11 dir="011000">
<s1>Álvaro Avezum</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>649-652</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>5</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Hipertensão arterial entre funcionários de banco estatal no Rio de Janeiro. Hábitos de vida e tratamento</s1>
</fA08>
<fA08 dir="en">
<s1>High blood pressure among bank employees. Life-style and treatment</s1>
</fA08>
<fA11 dir="011000">
<s1>Dóra Chor</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Oswaldo Cruz Escola Nacional de Saúde Pública Depto de Epidemiologia</s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>653-660</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>39</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estimar a freqüência de tratamento de hipertensão arterial e hábitos de vida relacionados à saúde, comparando-se hipertensos e não hipertensos. MÉTODOS: Estudo seccional em amostra sistemática de 1183 funcionários de banco estatal, no Rio de Janeiro, através de questionário autopreenchido. Medidas diretas da pressão arterial, peso e estatura foram tomadas em subamostra. Participantes informados por profissional de saúde, mais de uma vez, que eram hipertensos, foram classificados como hipertensos. RESULTADOS: Não houve diferença importante entre hipertensos e não hipertensos, quanto à prevalência de tabagismo, consumo de álcool e atividades físicas. Entre os hipertensos com sobrepeso/obesidade, a prática de dieta foi mais freqüente do que entre não hipertensos com sobrepeso/obesidade. Apenas 44,7% dos hipertensos estavam sob tratamento, condição associada à alta escolaridade, ser ex-fumante, ter sobrepeso/obesidade ou história familiar de doenças cerebrovasculares. CONCLUSÃO: A disponibilidade de serviços de saúde e o acesso à informação não foram suficientes para garantir o tratamento ou adoção de hábitos de vida que contribuem para o controle da pressão arterial, no conjunto dos hipertensos.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: This study estimates the frequency of treatment of high blood pressure and compares life-styles among hipertensives and non-hipertensives. METHODS: Cross-sectional study in a sistematic sample of 1183 employees in a government-owned bank in the State of Rio de Janeiro, through a self-administered questionnaire. Direct measurements of arterial pressure, weight and height were also taken in a sub-sample. Those who had been informed more than once as having high blood pressure, by a health professional, were classified as hipertensives. RESULTS: There were no important differences among hipertensives and non-hipertensives with respect to the prevalence of smoking, alcohol and physical activities. Dieting was more frequent among overweight/obese hipertensives than overweight/obese non-hipertensives. Only 44,7% were under treatment. Subjects with high level of education were more likely to be treated as were those who quit smoking, presented overweight/obesity or family history of cerebrovascular diseases. CONCLUSION: Access to information and health care was not sufficient to guarantee high blood pressure treatment or a healthy life-style which contributes to hypertension control.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>adesão ao tratamento</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estilo de vida</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>high blood pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treatment compliance</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>life style</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação hemodinâmica e evolução clínica de crianças portadoras de cardiomiopatia dilatada grave candidatas a transplante cardíaco</s1>
</fA08>
<fA08 dir="en">
<s1>Hemodynamic evaluation and clinical outcome of children candidates for heart transplantation with severe dilated cardiomyopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>Estela Azeka</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Miguel Barbero Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Roberto Camargo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Kajita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ana Cristina Aliman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Otávio C. Auler</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Munir Ebaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>661-666</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar o perfil dos parâmetros hemodinâmicos e a evolução clínica de crianças candidatas a transplante cardíaco, portadoras de cardiomiopatia grave. MÉTODOS: Foram 24 crianças, com idade entre 4 meses e 10 anos e 8 meses (média de 3,7±2,5 anos), no período de fevereiro/92 a maio/96, submetidas a estudo hemodinâmico e medidos os seguintes parâmetros: débito cardíaco, pressão média de artéria pulmonar (PMAP) e pressão capilar pulmonar. Foram calculados o índice de resistência vascular pulmonar (IRVP) e gradiente de pressão transpulmonar (GPT). RESULTADOS: Do ponto de vista evolutivo, 10 (41,6%) crianças foram transplantadas (grupo A), 5 (20,8%) aguardam o transplante (grupo B) e 9 (37,6%) faleceram (grupo C). Observou-se que a média das idades dos pacientes do grupo B foi significativamente menor que do grupo C. Dos dados hemodinâmicos, a PMAP, GTP e IRVP apresentaram médias significativamente menores no grupo A em relação ao grupo C. CONCLUSÃO: O perfil hemodinâmico de crianças candidatas ao transplante cardíaco mostrou-se compatível ao quadro clínico de insuficiência cardíaca grave. A idade foi o único fator que diferenciou o grupo B e C (p= 0,036). O IRVP, PMAP e o GTP foram fatores que diferenciaram de modo significativo o grupo A e o grupo C (p=0,010; p=0,044 e p=0,023, respectivamente). Quanto maior a idade no momento da indicação do transplante na criança, pior foi seu prognóstico.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate hemodynamic parameters and clinical outcome of children with severe cardiomyopathy who are candidates for heart transplantation. METHODS: Twenty four children aged from 4 months to 10 years and 8 months (mean 3.7±2.5 years) from February 1992 to May 1996, were submitted to hemodynamic study and the following parameters were measured: cardiac output, mean pulmonary artery pressure (MPAP) and capillary wedge pressure. The pulmonary vascular resistance index (PVRI) and transpulmonary pressure gradient (TGP) were calculated. RESULTS: Ten (41.6%) children were transplanted (group A), 5 (20.8%) are still waiting heart transplantation (group B) and 9 (37.6%) died (group C). The mean age of the B and C group were significantly different. The PVRI, MPAP and TPG were significant lower in group A than group C (p=0.01; p=0.044 and p=0.023 respectively). CONCLUSION: The profile of the hemodynamic parameters of children with severe dilated cardiomyopathy was compatible with the clinical findings. The age was the only difference comparing groups B and C. PVRI, MPAP and TPG were significant factors between group A and C. The older the patient, the worse was the prognosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>criança</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiomiopatia dilatada</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>transplante cardíaco</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>child</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dilated cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart transplantation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Fatores de risco para infarto do miocárdio no Brasil: estudo FRICAS</s1>
</fA08>
<fA08 dir="en">
<s1>Risk factors for acute myocardial infarction in Brazil (FRICAS study)</s1>
</fA08>
<fA11 dir="011000">
<s1>Marco Aurélio Dias da Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Amanda G. M. R. Sousa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Hernan Schargodsky</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>667-675</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar os fatores de risco para a ocorrência de infarto agudo do miocárdio (IAM) no Brasil. MÉTODOS: Estudo conduzido entre janeiro/94 e março/95, em 20 centros médicos no Brasil, constituído de casos, 299 pacientes com IAM e, controles, 292 indivíduos, identificados no mesmo centro que os casos, e admitidos com largo espectro de doenças agudas, não relacionadas a fatores de risco conhecidos ou suspeitos para IAM. Os dados foram colhidos por meio de um questionário estruturado, preenchido pelo próprio paciente. Os efeitos das variáveis pesquisadas sobre a ocorrência de IAM foram estudadas em abordagens univariadas, considerando-se significativo p&lt;=0,05. RESULTADOS: Os fatores relacionados ao risco de IAM foram, para os casos e controles, respectivamente: hipercolesterolemia: 210,93±46,74mg/dl e 185,71±45,45mg/dl (p= 0,000); tabagismo: 41,69% e 27,20% (p= 0,000); hipertensão arterial: 52,35% e 20,88% (p= 0,000); diabetes mellitus: 19,70% e 9,93% (p= 0,001); história familiar: positiva no pai dos indivíduos em 42,14 e 33,22% (p= 0,025) e na mãe em 42,14% e 30,82% (p= 0,007); situação socioeconômica: 88,99% e 60,20% proprietários de casa própria (p= 0,002) e 44,45% e 33,21% de automóvel (p= 0,010); atividade física: 56,83% e 48,28% haviam mantido o hábito de caminhar no ano que antecedeu à entrada no estudo (p= 0,029); hábitos alimentares: 38,79 e 28,42% consumiam habitualmente embutidos (p= 0,013). A média do peso corporal foi de 72,50±26,89kg e 69±12,26kg (p= 0,0271) e a altura média de 166,56±7,81cm e 166,66±8,47cm. CONCLUSÃO: O estudo confirmou a importância da hipercolesterolemia, hipertensão arterial sistêmica, diabetes, sobrepeso e história familiar positiva, como fatores de risco para ocorrência de IAM. Houve relação direta e significativa entre a ocorrência de IAM e a condição socioeconômica.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To determine risk factors related to acute myocardial infarction (AMI) in Brazil. METHODS: Five hundred ninety one patients were selected in 20 medical centers in Brazil, between January/94 and March/95. Two-hundred-ninety-nine patients were cases, and 292 controls with a variety of acute diseases not related to the suspected or known risk factors for acute myocardial infarction. All data were collected through a structured questionnaire filled by the patients. The evaluation of the variables was done through univariate analysis with a significance level of 5%. RESULTS: The factors related to acute myocardial infarction were respectively to cases and controls: Hypercholesterolemia - 210.93±46.74mg/dl and 185.71±45.45mg/dl, (p=0.000); smoking - 41.69% and 27.20% (p=0.000); hypertension - 52.35% and 20.88% (p=0.000); diabetes - 19.70% and 9.93% (p=0.001); family history - related to the patient's father in 42.14% and 33.22% (p=0.025) and to the mother in 42.14% and 30.82% (p=0.007); socioeconomic level - 88.99% and 60.20% owned house (p=0.002); 44.45% and 33.21% owned car (p=0.010); physical activity - 56.83% and 48.28% had the habit of walking in the year prior to study entry (p=0.029); diet - 38.79% and 28.42% consumed canned food (p=0.013). The mean weight was 72.50±26.89kg and 69±12.26kg (p=0.0271). The mean height was 166.56±8.81cm and 166.66±8.47cm. CONCLUSION: This study confirmed the importance of hypercholesterolemia, hypertension, diabetes mellitus, overweight and family history as risk factors for acute myocardial infarction. There was a significant relation between socioeconomic level and the prevalence of acute myocardial infarction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto agudo do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco coronário</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estudo caso-controle</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>case-control study</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo morfométrico do miocárdio em adultos com subnutrição protéico-energética</s1>
</fA08>
<fA08 dir="en">
<s1>Myocardial morphometry of protein-energy malnourished adults</s1>
</fA08>
<fA11 dir="011000">
<s1>Daniel Ferreira da Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cristiane Helena Pedrini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Júlio Cláudio Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marlene Antônia dos Reis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sidney Gonçalves Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Selma Freire de Carvalho da Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Vicente de Paula Antunes Teixeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina do Triângulo Mineiro Depto de Clínica Médica </s1>
<s2>Uberaba MG</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>667-680</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO:Comparar o tamanho das células musculares e a presença de lipofuscina no coração de adultos necropsiados, subnutridos e controles. MÉTODOS:De uma casuística inicial de 315 necropsias de adultos, foram excluídos casos com sinais de retenção hídrica, cardiopatias, hepatopatias, hipertensão e nefropatias. Subnutrição foi caracterizada pelo índice de massa corporal (IMC) &lt;17kg/m². Fragmentos de miocárdio foram processados para morfometria computadorizada, determinando-se a espessura dos miocardiócitos e a presença de lipofuscina. RESULTADOS:Subnutridos (n=8) e controles (n=4) foram estatisticamente diferentes, respectivamente, quanto ao IMC (14,86±1,13 vs 22,02±0,9kg/m²), relação peso cardíaco/peso corporal (0,68±0,09 vs 0,54±0,07%), espessura de miocardiócitos (10,91±0,77 vs 12,90±1,82µm) e presença de lipofuscina no miocárdio (39,1 vs 54,4%). CONCLUSÃO: Comparados aos controles, adultos subnutridos têm menores espessuras de miocardiócitos e presença de lipofuscina, fenômenos que refletiriam um distúrbio metabólico com repercussões clínicas danosas em pacientes terminais.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To compare cardiac muscle cells width and cardiomyocyte lipofuscin pigment presence between malnourished and non-malnourished necropsied adults. METHODS: Out of 315 necropsy protocols of adults randomly chosen, those with edema, ascitis, systemic arterial hypertension, chronic liver disease, and heart disease were excluded. Malnutrition was defined by body mass index (BMI) &lt;17kg/m². Cardiomyocytes morphometry study and lipofuscin pigment counts were performed. RESULTS: Malnourished (n=8) and controls (n=4), respectively, showed statistical differences in relation to BMI (14.86±1.13 vs 22.02±0.9kg/m²), heart weight/body weight ratio (0.68±0.09 vs 0.54±0.07%), cardiomyocytes width (10.91±0.77 vs 12.90±1.82µm) and lipofuscin pigment presence (39.1 vs 54.4%). CONCLUSION: When compared with controls, necropsied malnourished adults showed decreased myocardial fibers diameters and lower lipofuscin pigment presence. These findings might reflect altered metabolism, and would be associated with harmful clinical effects in terminally ill patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>subnutrição protéico-energética</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>morfometria miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lipofuscina</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>protein-energy malnutrition</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardium morphometry</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipofuscin</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação morfo-funcional cardíaca em jovens normotensos, filhos de hipertensos. Estudo Doppler-ecocardiográfico prospectivo</s1>
</fA08>
<fA08 dir="en">
<s1>Morpho-functional cardiac evaluation in young normotensive children of hypertensive patients. A prospective Doppler-echocardiographic study</s1>
</fA08>
<fA11 dir="011000">
<s1>Cristina Maria Sousa de Almeida</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Aristarco Gonçalves de Siqueira-Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maurício Bastos de Freitas Rachid</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jamil Rachid</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>César Selem Kamel</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>681-686</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>47</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar pelo Doppler-ecocardiograma alterações cardíacas, estrutural e/ou funcionais, que podem surgir nos jovens normotensos com história familiar de hipertensão arterial sistêmica (HAS). MÉTODOS: Estudo prospectivo realizado com 62 jovens normotensos entre 15 e 30 anos, sendo 32 filhos de hipertensos (grupo 1) e 30 filhos de normotensos (grupo 2) comparáveis quanto à pressão arterial, superfície corporal, freqüência cardíaca, idade e sexo. Após exame clínico, todos realizaram Doppler-ecocardiograma para avaliar as estruturas cardíacas e a função ventricular esquerda (sistólico e diastólica). RESULTADOS: A fração de encurtamento sistólico do ventrículo esquerdo (VE) foi significativamente maior no grupo 1 - valor médio de 38,03±4,95% - do que no grupo 2 - 34,7±4,48 % (p&lt;0,01). O tempo de desaceleração mitral (TD) variou de 85 a 160ms - médio de 116,47±16,99ms - no grupo 1 e de 100 a 220ms - médio de 126,73±26,66ms - no grupo 2 (p&lt;0,05). Houve correlação entre o índice de massa do VE e o diâmetro do átrio esquerdo (AE) no grupo 1 (r= 0,514, p&lt;0,01). CONCLUSÃO: Os filhos de hipertensos, quando comparados com filhos de normotensos, exibem exacerbação da função sistólica do VE, semelhante ao que ocorre na fase inicial da HAS ou na HAS &quot;borderline&quot;, mesmo que não haja hipertrofia do VE ou aumento dos níveis pressóricos. O TD mitral (mais curto no grupo 1) foi o único parâmetro de função diastólica do VE que diferiu nos 2 grupos analisados. A correlação entre o índice de massa do VE e o diâmetro do AE nos filhos de hipertensos sugere que o AE se modifica de acordo com as alterações funcionais e hemodinâmicas do VE.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: Evaluate functional and/or structural cardiac changes in young normotensive subjects with a family history of hypertension. METHODS: Prospective study was performed with 62 normotensive persons, ages 15 to 30 years, divided in 32 children of hypertensive patients (group 1) and 30 children of normotensive persons (group 2) comparable in blood pressure, body surface area, heart rate, age and sex. After clinical examination, all underwent Doppler-echocardiogram to evaluate cardiac structure and left ventricular (LV) systolic and diastolic function. RESULTS: Systolic LV fractional shortening was increased in group 1 when compared with group 2 (38.03±4.95% and 34.7±4.48%, respectively - p&lt;0.01). Mitral deceleration time (DT) ranged from 85 to 160ms - mean values 116.47±16.99ms - in group 1 and from 100 to 220ms - mean values 126.73±26.66ms - in group 2 (p&lt;0.05). A correlation between LV mass and left atrium (LA) diameter was noted in group 1 (r = 0.514, p&lt;0.01). COCLUSION: Children of hypertensive patients show increased LV function, similar to what occurs in early hypertension and in borderline hypertension, even when there is no evidence of LV hypertrophy or high blood pressure. Mitral DT (shorten in group 1) was the only diastolic parameter that differed in the groups. The correlation between LV mass and LA dimension suggests that LA size could be related to functional and hemodynamic LV changes.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Doppler-ecocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores genéticos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>normotensos</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Doppler-echocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>genetic factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>normotensive persons</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação de potenciais fragmentados em presença de bloqueio de ramo direito sem alterações estruturais miocárdicas ventriculares. Estudo pelo eletrocardiograma de alta resolução no domínio da freqüência</s1>
</fA08>
<fA08 dir="en">
<s1>Evaluation of fragmented potentials in the presence of right bundle branch block without structural myocardium abnormalities by using signal-averaged electrocardiogram on time and frequency domain</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Ginefra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eduardo C. Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz A. Christiani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria de Fátima M. P. Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo R. Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sílvia H. Boghossian</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Mônica Scott</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Isabela M. T. Rangel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Rosângela S. Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Francisco M. Albanesi Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro Faculdade de Ciências Médicas </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>687-694</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Em ausência de alterações estruturais miocárdicas (AEM), avaliar se o bloqueio de ramo direito (BRD) gera potenciais fragmentados (PF) e turbulência espectral (TE) no eletrocardiograma de alta resolução (ECGAR). MÉTODOS: Doze crianças com comunicação inter-atrial (CIA) e bloqueio incompleto do ramo direito (BIRD) sem AEM (Grupo I), foram comparadas com 17 crianças com tetralogia de Fallot (TF) operada, BCRD e AEM, 5 com extra sístoles ventriculares e 2 com taquicardia ventricular sustentada (Grupo II). Todas fizeram ECGAR nos domínios do tempo (DT) e da freqüência (DF), com cinco variáveis analisadas. RESULTADOS: Os pacientes do grupo I tiveram as variáveis normais apesar do BIRD. No grupo II, 4 das cinco variáveis foram anormais, sugerindo a presença de PF e TE atribuíveis a AEM inerentes à malformação e ao ato cirúrgico. CONCLUSÃO: Na CIA o BIRD não complicado de AEM não gera PF e TE, não constituindo fator de risco para taquicardia ventricular sustentada.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate if the presence of right bundle branch block (RBBB), without structural myocardial abnormalities (SMA) can generate fragmented potentials (FP) and spectral turbulence on signal-averaged electrocardiogram (SAECG). METHODS: Twelve children with atrial septal defect (ASD) and incomplete right bundle branch block (IRBBB without SMA (group I) were compared to 17 children with post-operative tetralogy of Fallot (TF) with CRBBB, all with SMA, 5 with ventricular premature beats and 2 with sustained ventricular tachycardia (group II). All had SAECG on time (TD) and frequency domain (FD) with 5 variables analysed. RESULTS: All patients of group I had normal variables, in contrast with group II which presented abnormal variables suggesting FP and ST. CONCLUSION: In ASD without SMA, the isolated IRBBB did not generate FP and ST.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>eletrocardiograma de alta resolução</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>turbulência espectral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>bloqueio do ramo direito</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>signal-averaged electrocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>spectral turbulence</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>right bundle branch block</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Uso de digital em idosos admitidos em unidade de geriatria de um hospital geral</s1>
</fA08>
<fA08 dir="en">
<s1>Use of digoxin in elderly patients admitted to a geriatric unit of a general hospital</s1>
</fA08>
<fA11 dir="011000">
<s1>Ulisses Gabriel de Vasconcelos Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maira Tonidandel Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Emylucy Martins Paiva Paradela</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Flávio Gomes Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Governador Israel Pinheiro Instituto de Previdência dos Servidores do Estado de Minas Gerais </s1>
<s2>Belo Horizonte MG</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>695-698</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETVO: Detectar a freqüência da prescrição do digital, assim como as suas indicações, em idosos admitidos em unidade de geriatria de um hospital geral. MÉTODOS: Foram investigados, consecutivamente, 130 pacientes não selecionados, de ambos os sexos (100 mulheres e 30 homens), com idades  &gt; ou = 65 (média 80±9) anos. Os pacientes foram avaliados através de exame clínico completo, rotina básica de sangue, radiografia simples de tórax, eletrocardiograma e ecocardiograma Doppler. Baseados na avaliação clínica e exames complementares, o uso do digital foi considerado adequado, questionável ou inadequado. RESULTADOS: Estavam em uso de digital 27,6% dos pacientes. A indicação foi considerada adequada em 36,1%, questionável em 11,1% e inadequada em 52,7%. CONCLUSÃO: Uma alta prevalência de prescrição do digital foi detectada nos idosos admitidos, sendo que a maior parte a adotava por razões consideradas inadequadas ou questionáveis. Devido ao risco aumentado de intoxicação digitálica nessa faixa etária, a droga deveria ser prescrita sob indicações mais criteriosas.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To determine the prevalence of digoxin use as well as its indications in elderly patients at the time of admission to a geriatric unit of a general hospital. METHODS: One hundred and thirty elderly patients aged 65 and over (mean age = 80±9 years), 100 women and 30 men were consecutively investigated. Each patient was submitted to a thorough clinical investigation, laboratory work-up, chest X-ray, electrocardiogram and doppler echocardiogram. The use of digoxin was considered appropriate, questionable or inappropriate. RESULTS: At the time of admission to the geriatric unit 27.6% of the patients were receiving digoxin. The indication was considered appropriate in 36.1%, questionable in 11,1% and inappropriate in 52.7%. CONCLUSION: We found a high prevalence of digoxin use in elderly patients admitted to a geriatric unit of a general hospital. In most cases its indications were considered inappropriate or questionable. Due to the increased risk of digitalis intoxication in this age group the drug should be prescribed under more strict indications.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>digital</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>idoso</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hospital</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>digoxin</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hospital</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Evolução dos níveis de colesterol na população adulta de São José do Rio Preto (1991-1997)</s1>
</fA08>
<fA08 dir="en">
<s1>Trends in cholesterol levels in the adult population of São José do Rio Preto (1991-1997)</s1>
</fA08>
<fA11 dir="011000">
<s1>José Carlos Nicolau</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cristiani Nogueira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Lília Nigro Maia</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>699-704</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Realizar levantamento de fatores de risco para aterosclerose na população  &gt; ou = 20 anos de São José do Rio Preto, e comparar os dados obtidos com os coletados, em levantamento similar, em 1991. MÉDOTOS: Pesquisa quantitativa com amostragem estratificada por sexo e idade. Os entrevistados (646 indivíduos, 303 homens) foram abordados em Postos de Saúde e outros pontos de afluxo da população, distribuídos por zona geográfica e por classe social dos bairros. A margem de erro foi de 4%, e o intervalo de confiança (IC) de 95%. RESULTADOS: A) Níveis médios de HDL-colesterol (apenas em 1997): homens 43,7±15mg/dL, mulheres 49,6±13,5mg/dL (p&lt;0,001, 95% IC 3,7 a 8,1); B) níveis médios de colesterol total em 1991 vs 1997: população global 192,5±48,9mg/dL vs 190,5±42,5mg/dL (p=NS); homens 187,6±53,3 vs 190,5±42,5mg/dL (p=NS); mulheres 196,8±40mg/dL vs 187,6±37,8mg/dL (p=0,008, 95% IC 2,4 a 15,9). C) Em análise de regressão, as variáveis que se correlacionaram significativamente com níveis de colesterol, em ambas as pesquisas, foram: idade (p&lt;0,001), pressão arterial sistólica (p&lt;0,001) e diastólica (p&lt;0,001), dieta (p&lt;0,001). Sexo feminino correlacionou-se apenas em 1991 (p=0,011) e sedentarismo apenas em 1997 (p=0,014). CONCLUSÃO: Os níveis de colesterol na população adulta de São José do Rio Preto são bastante aceitáveis, sendo que no sexo feminino diminuíram, de maneira significativa, na pesquisa atual, em relação à realizada em 1991.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To develop a survey about risk factors for atherosclerosis in a  &gt; or = 20-year-old population from São José do Rio Preto, and compare the results with those obtained in a similar survey in 1991. METHODS: Quantitative survey with sample stratified by sex and age. The individuals (a total of 646, 303 men) where contacted in outpatient facilities from the Health Secretary and other populated sites, distributed by geographic zone and social class of different neighborhoods. The standard error of the survey was 4%, and the confidence interval was 95%. RESULTS: A) Mean HDL-cholesterol (only in 1997): male gender 43.7±15mg/dL, female gender 49.6±13.5mg/dL (p&lt;0.001, 95% CI 3.7 a 8.1). B) Mean total cholesterol in 1991 vs 1997: for the global population 192.5±48.9mg/dL vs 190.5±42.5mg/dL (p=NS); for men 187.6±53.3mg/dL vs 190.5±42.5mg/dL (p=NS); for women 196.8±40mg/dL vs 187.6±37.8mg/dL (p=0.008, 95% CI 2.4 a 15.9). C) By regression analysis, the variables that correlated significantly with cholesterol levels, in both surveys, were: age (p&lt;0.001), systolic (p&lt;0.001) and diastolic (p&lt;0.001) arterial pressure, diet (p&lt;0.001). Female gender showed correlation only in the 1991 survey (p=0.011), and sedentarism only in 1997 (p=0.014). CONCLUSION: The mean cholesterol levels in the adult population of São José do Rio Preto are very favorable and, in female gender, showed a significant decrease in the 1997 survey, relatively to the 1991 survey.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>colesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>levantamento populacional</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cholesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>population survey</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Ablação com radiofreqüência do flutter atrial tipo I. Importância do bloqueio bidirecional do istmo entre a veia cava inferior e o anel da valva tricúspide</s1>
</fA08>
<fA08 dir="en">
<s1>Type I atrial flutter radiofrequency ablation. Importance of bidirectional line of block in the inferior vena cava tricuspide annulus isthmus</s1>
</fA08>
<fA11 dir="011000">
<s1>Mauricio Scanavacca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eduardo Sosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Luis Velarde</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>André D'Ávila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Denise Hachul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Basileu Reolão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Osvaldo Sanches</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Márcio Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Francisco Darrieux</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>705-711</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar a importância clínica da determinação eletrofisiológica da presença de bloqueio bidirecional na condução pelo istmo localizado entre a veia cava inferior e o anel da valva tricúspide (VCI - AT), após a ablação do flutter atrial tipo I (FL) com radiofreqüência (RF). MÉTODOS: Quarenta pacientes consecutivos (idade média 51±11 anos) com FL foram submetidos a ablação do istmo VCI-AT com RF. Em 30 pacientes (GI), o sucesso foi avaliado pela interrupção e não reindução do FL com estimulação atrial programada. Nos últimos 10 pacientes foi avaliada também a condução bidirecional pelo istmo, com cateteres posicionados na sua entrada e saída e em cada lado da linha de bloqueio. O bloqueio foi considerado bidirecional quando ocorrido nos dois sentidos e unidirecional quando ocorrido em um só sentido. RESULTADOS: Vinte e seis (86%) pacientes do GI e 10 (100%) do GII tiveram sucesso imediato (p= 0,5558). Durante o seguimento, 7 (30%) de 23 pacientes do GI e 3 (30%) de 9 do GII tiveram recorrência de FL (p= NS). Os três pacientes do GII que apresentaram recorrência tinham bloqueio unidirecional, enquanto os seis casos sem recorrência tinham bloqueio bidirecional (p=0,012). CONCLUSÃO: A demonstração de bloqueio bidirecional no istmo VCI-AT, obtida imediatamente após a ablação do FL com RF, relaciona-se a menor índice de recorrência clínica, devendo ser o critério preferencial para término do procedimento.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To determine the clinical importance of a bi-directional line of block demonstration in the inferior vena cava-tricuspid annulus isthmus as an end-point for radiofrequency (RF) atrial flutter (FL) ablation. METHODS: Forty consecutive patients (51±11 years) with type I FL were divided in 2 groups: GI (30 patients) anatomic, non-electrophysiologic isthmus ablation technique (interruption and non-induction FL criteria); and GII (10 patients) anatomic with electrophysiologic evaluation of bi-directional isthmus conduction. The isthmus activation was analyzed before and after anatomic RF ablation with a cateter exploring each side of the line of block, depending on the conduction evaluation (anterograde or retrograde). RESULTS: FL was interrupted and not reinduced in 26/30 (86.6%) GI patients and in 10 (100%) GII patients (p= 0.5558). During follow-up FL recurred in 30% of the patients in both groups. In GII, 6 patients with bi-directional block remained assymptomatic, whereas 3 patients with unidirectional block presented recurrence (p= 0.012). CONCLUSION: Electrophysiologic demonstration of bi-directional line of block in the isthmus is related to long-term success and should be the criterion for interruption of type I atrial FL RF ablation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>flutter atrial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ablação com radiofreqüência</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>taquicardias supraventriculares</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial flutter</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>radiofrequency catheter ablation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>supraventricular tachycardia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Captopril associado à hidroclorotiazida no tratamento da hipertensão leve e moderada. Estudo multicêntrico brasileiro</s1>
</fA08>
<fA08 dir="en">
<s1>Association of captopril and hydrochlorothiazide in mild and moderate hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>José Luiz Santello</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Décio Mion Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>713-716</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100512</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a eficácia e tolerabilidade da associação de captopril 50mg com hidroclorotiazida 25mg em hipertensos com pressão arterial diastólica (PAD) entre 95 e 115mmHg. MÉTODOS: Estudo aberto, multicêntrico, não comparativo. Na fase inicial, durante 2 semanas, os pacientes receberam placebo, seguida de ½ comprimido da associação. Os pacientes foram avaliados após 4, 8 e 12 semanas. Após 8 semanas de tratamento, naqueles em que a PAD foi &gt;90mmHg, foi prescrito um comprimido/dia. RESULTADOS: Foram analisados 433 pacientes, com idades de 47±10 anos, sendo 30% mulheres e 76% brancos. As pressões sistólica/diastólica iniciais foram de 156±16/103±11mmHg, após 14 dias de placebo, 156±15/103±9mmHg (p&gt;0,05) e, após 4, 8 e 12 semanas, mostraram progressiva redução (p&lt;0,05) para 143±14/95±11, 140±13/91±9 e 134±11/86±8mmHg. O controle pressórico foi observado em 45, 67 e 88% (p&lt;0,05), após 4, 8 e 12 semanas. Tosse foi o sintoma mais importante registrado em 7% dos pacientes em placebo e 12% nos que usavam a associação. A tolerabilidade foi considerada boa por 98% dos pacientes. CONCLUSÃO: A associação de captopril com hidroclorotiazida é eficaz e tem boa tolerabilidade, sendo prescrita em dose única diária em monoterapia, para hipertensos leves e moderados.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the effectiveness and tolerance of the association of captopril 50mg and hydrochlorithiazide 25mg in hypertensive patients with diastolic pressure between 95 and 115 mmHg. METHODS: An open, multicenter and non-comparative study was performed. After 2 weeks of placebo, the patients received ½ tablet of drug association. Patients were evaluated after 4, 8 and 12 weeks, and those who had diastolic pressure &gt;90mmHg after 8 weeks of therapy received 1 tablet/day. RESULTS: The results of 433 patients were analyzed: 47±10 years old, 30% female, 76% white. Initial systolic and diastolic pressures were 156±16 and 103±11mmHg and after 14 days of placebo were 156±15 and 103±9mmHg (p&gt;0.05). Systolic/diastolic pressure after 4, 8 and 12 weeks of treatment reduced progressively (p&lt;0.05) to 143±14/95±11, 140±13/91±9 and 134±11/86±8mmHg. Blood pressure control was observed in 45, 67 and 88% (p&lt;0.05) of patients after 4, 8 and 12 weeks. Cough was the most important symptom, registered in 7% of patients under placebo and 12% in patients under treatment. The tolerance was considered good for 98% of patients. CONCLUSION: The association of captopril with hydrochlorothiazide is effective with good tolerance, being indicated as a once a day monotherapy for mild and moderate hypertension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>captopril</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hidroclorotiazida</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>captopril</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hydrochlorothiazide</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Mixoma gigante de átrio esquerdo</s1>
</fA08>
<fA08 dir="en">
<s1>Giant left atrial myxoma</s1>
</fA08>
<fA11 dir="011000">
<s1>Juan Francisco Muñoz Cruz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leniel Bairral Dias</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>João Osório Rodrigues Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>717-718</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>6</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100513</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Homem de 65 anos, portador de miocardiopatia dilatada e hipertensão arterial de longa data, com antecedentes de acidente vascular cerebral e que, ao ecocardiograma, apresentou mixoma gigante de átrio esquerdo.</s0>
</fC01>
<fC01 dir="en">
<s0>A 65 year-old man with dilated cardiomiopathy and long history of high blood pressure and a previous cerebral vascular accident had a giant left atrial myxoma as an echocardiographic finding.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Ergoespirometria. Teste de esforço cardiopulmonar, metodologia e interpretação</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Yazbek Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo Tavares de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Lívia Maria dos Santos Sabbag</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Linamara Rizzo Battistella</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina Instituto do Coração Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>719-724</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100514</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Inibição do receptor plaquetário glicoproteína (GP) IIb/IIIa em síndromes isquêmicas agudas e intervenções coronárias</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo R. A. Caramori</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>José R. Casco</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alcides J. Zago</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Allan G. Adelman</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>725-734</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>113</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100515</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Detection of the viable myocardium. A perfusion scintigraphic study, before and after coronary bypass surgery in myocardial infarction patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Willliam A. Chalela</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo J. Moffa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José A. F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Aguinaldo P. Moraes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Soares Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José C. Meneghetti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>535-545</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To compare single-photon-emission computed tomography (SPECT) imaging scans using 201Tl and 99mTc-MIBI in detection of viable myocardium, in regions compromised by infarction. METHODS: Thirty-two (59.3±9.8 years old and 87% male) myocardial infarction patients were studied. All had Q waves on the ECG and left ventricle ejection fraction of &lt;50%. They underwent coronary and left ventricle angiographies and SPECT before (including 201Tl reinjection) and after coronary artery bypass surgery (CABG). Improvement in perfusion observed after surgery was considered the gold standard for myocardial viability. RESULTS: Among 102 studied regions of the heart, there were 40 (39.2%) areas of transient perfusion defects in the conventional protocol with 201Tl and 52 (51.0%) after reinjection. Therefore, 12/62 (19.4%) more viable regions were identified by reinjection. Using 99mTc-MIBI, only 14 (13.7%) regions with transient defects were identified, all of which were seen also in 201Tl protocols. After surgery, 49 of a total of 93 regions analyzed (52.7%) were viable. Sensitivity, specificity, accuracy, positive and negative prediction values were, respectively, 201Tl SPECT scans - 65.3%, 90.9%, 77.4%, 88.9% and 70.2%, reinjection protocol with 201Tl scans - 81.6%, 81.8%, 81.7%, 83.3% and 80.0%; 99mTc-MIBI SPECT scans - 20.4%, 90.9%, 53.8%, 71.4% and 50.6%. Logistic regression demonstrated that the reinjection protocol with 201Tl was the best predictor of viability (P&lt;0.001). CONCLUSION: Our data suggest the election of 201Tl for viability studies, especially when using the reinjection protocol.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial viability</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial perfusion scintigraphy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Myxoma of the mitral valve</s1>
</fA08>
<fA11 dir="011000">
<s1>Antônio Sérgio C. Rocha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Elizabeth Ferreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo R. Dutra</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Nazareth N. Rocha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Solange M. Tinoco</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cesar Nascimento</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Rosana Grandelle</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Rita C. Villela</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Marialda Coimbra</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Celso Garcia</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>624-626</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Only rarely do myxomas originate from the mitral valve. This is the report of a 49-year-old woman presenting with congestive heart failure. The diagnosis of an intracardiac tumor involving the anterior cuspid of the mitral valve was made by transesophageal echocardiography. The patient underwent surgery for tumor resection and plasty of the valve was made with reconstruction and preservation of the valve. The diagnosis of myxoma was confirmed by histology. This is the 23rd case of myxoma of the mitral valve reported in the literature.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Systemic hypertension in heart transplant recipients</s1>
</fA08>
<fA11 dir="011000">
<s1>Miguel Gus</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nádia Schiavo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Altamiro Reis da Costa</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>634-640</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>55</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Beta-adrenergic pathway in healthy and hypertrophied hearts</s1>
</fA08>
<fA11 dir="011000">
<s1>Reginaldo de Almeida Barros</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marina Politi Okoshi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Carlos Cicogna</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>649-656</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>70</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200512</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Brazilian multicenter study on efficacy and tolerability of trandolapril in mild-to-moderate essential arterial hypertension. EMBATHE substudy with ambulatory blood pressure monitoring</s1>
</fA08>
<fA11 dir="011000">
<s1>Osvaldo Kohlmann Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo César B. Veiga Jardim</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Wille Oigman</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>553-557</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: A double-blind, placebo-controlled multicenter study involving 34 centers from different Brazilian regions was performed to evaluate the antihypertensive efficacy and tolerability of trandolapril, an angiotensin I converting enzyme inhibitor, in the treatment of mild-to-moderate systemic arterial hypertension. METHODS: Of 262 patients enrolled in this study, 127 were treated with trandolapril 2 mg/day for 8 consecutive weeks, and the remaining 135 patients received placebo for the same period of time. Reduction in blood pressure (BP) and the occurrence of adverse events during this period were evaluated in both groups. RESULTS: Significant reductions in both systolic and diastolic pressures were observed in patients treated with trandolapril when compared with those on placebo. Antihypertensive efficacy was achieved in 57.5% of the patients on trandolapril and in 42% of these normal values of BP were obtained. The efficacy of trandolapril was similar in all centers, regardless of the area of the country. In a subset of 30 patients who underwent ABPM, responders showed a significant hypotensive effect to trandolapril throughout the 24 hour day. The adverse event profile was similar in both trandolapril and placebo groups. CONCLUSION: Our results demonstrate, for the first time in a large group of hypertensive patients from different regions in Brazil, good efficacy and tolerability of trandolapril during treatment of mild-to-moderate essential systemic hypertension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mild-to-moderate hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>trandolapril</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ACE inhibitor</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Dynamic three-dimensional reconstruction of the heart by transesophageal echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria de Fátima Veiga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mário G. Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fausto J. Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de Lisboa Hospital Universitário de Santa Maria </s1>
<s2>Lisbon </s2>
<s3>Portugal</s3>
</fA14>
<fA20 dir="000000">
<s1>564-568</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate echocardiography accuracy in performing and obtaining images for dynamical three-dimensional (3D) reconstruction. METHODS: Three-dimensional (3D) image reconstruction was obtained in 20 consecutive patients who underwent transesophageal echocardiography. A multiplanar 5 MHz transducer was used for 3D reconstruction. RESULTS: Twenty patients were studied consecutively. The following cardiac diseases were present: valvar prostheses&lt;FONT FACE=&quot;Symbol&quot;&gt;-&lt;/FONT&gt;6 (2 mitral, 2 aortic and 2 mitral and aortic); mitral valve prolapse&lt;FONT FACE=&quot;Symbol&quot;&gt;-&lt;/FONT&gt; 3; mitral and aortic disease &lt;FONT FACE=&quot;Symbol&quot;&gt;-&lt;/FONT&gt; 2; aortic valve disease&lt;FONT FACE=&quot;Symbol&quot;&gt;-&lt;/FONT&gt; 5; congenital heart disease&lt;FONT FACE=&quot;Symbol&quot;&gt;-&lt;/FONT&gt; 3 (2 atrial septal defect&lt;FONT FACE=&quot;Symbol&quot;&gt;-&lt;/FONT&gt; ASD - and 1 transposition of the great arteries -TGA); arteriovenous fistula&lt;FONT FACE=&quot;Symbol&quot;&gt;-&lt;/FONT&gt; 1. In 7 patients, color Doppler was also obtained and used for 3D flow reconstruction. Twenty five cardiac structures were acquired and 60 reconstructions generated (28 of mitral valves, 14 of aortic valves, 4 of mitral prostheses, 7 of aortic prostheses and 7 of the ASD). Fifty five of 60 (91.6%) reconstructions were considered of good quality by 2 independent observers. The 11 reconstructed mitral valves/prostheses and the 2 reconstructed ASDs provided more anatomical information than two dimensional echocardiography (2DE) alone. CONCLUSION: 3D echocardiography using a transesophageal transducer is a feasible technique, which improves detection of anatomical details of cardiac structures, particularly of the mitral valve and atrial septum.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>three-dimensional echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ultrasonography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>valvar disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Risk factors for atherosclerosis in students of a private university in São Paulo - Brazil</s1>
</fA08>
<fA11 dir="011000">
<s1>Lísia Marcílio Rabelo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Márcio Viana</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Arlete Schimith</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rose Vega Patin</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mara Andréa Valverde</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Regina Célia Denadai</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ana Paula Cleary</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Sandra Lemes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Caio Auriemo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Mauro Fisberg</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Tania Leme da Rocha Martinez</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>575-580</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>45</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To characterize the risk profile for atherosclerosis (AS) in adolescents and young adults of a private university in São Paulo. METHODS: Clinical, nutritional, and laboratory parameters were evaluated in 209 students of both genders aged 17 to 25 years. In addition to determination of the lipid profile, the association of its abnormal values with other risk factors for AS was also investigated. RESULTS: Increased levels of total cholesterol, LDL-C and triglycerides (TG) were observed in 9.1%, 7.6% and 16.3% of the students, respectively, and decreased levels of HDL-C in 8.6% of them. Prevalence of the remaining risk factors analyzed was elevated: sedentary life style (78.9%); high intake of total fat (77.5%); high cholesterol intake (35.9%); smoking, hypertension (15.8%) and obesity (7.2%). There was an association between elevated LDL-C and TG levels and sedentary life style and body mass index. CONCLUSION: The high prevalence of risk factors for AS in young individuals draws attention to the need for adopting preventive plans.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adolescents</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>young adults</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Comparison between right and left ventricular myocardia during the human fetal period. Stereological evaluation</s1>
</fA08>
<fA11 dir="011000">
<s1>Ricardo Xavier-Vidal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Kalil Madi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio de Janeiro Hospital Universitário Clementino Fraga Filho </s1>
<s2> RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>587-592</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>57</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: To develop a stereological comparison between right (RV) and left ventricle (LV) myocardium during the third human gestational trimester. METHODS: Five human fetal hearts of the third trimester provided representative samples of 5 RV myocardium and 4 LV myocardium. The material was fixed in 10% buffered formaldehyde, and processed through routine methods. Fifteen microscopic fields were randomly chosen and counted in each ventricular myocardium using an &quot;M-42&quot; test system. The following stereological parameters were assessed: Vv (%), Lv (µm²), Sv (µm²/µm³), Vp (µm³), Nv (1/mm³) and total N. RESULTS: No significant difference between the stereological parameters of the myocardial structures assessed was evidenced, when comparing RV and LV. CONCLUSION: Right and left human ventricular myocardium are very similar during the fetal period at least in regard to their structural aspects.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac development</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>morphology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>morphometry</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stereology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>biometry</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Surgical revascularization of posterior coronary arteries without cardiopulomonary bypass</s1>
</fA08>
<fA11 dir="011000">
<s1>J. Glauco Lobo Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>João Marcelo A. C. de Albuquerque</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Bellini G. Gomes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rafael P. de Siqueira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rodrigo M. Landim</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Ricardo R. M. de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Francisco M. de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Ciro Ciarline</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>J. Acácio Feitosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Maria Claudia Leitão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Francisca Elita B. Pinheiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Erirtonio Façanha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>J. Nogueira Paes Jr</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>597-600</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the results observed during the early postoperative period in patients who had the posterior coronary arteries revascularized without cardiopulmonary bypass (CPB), in regard to the following parameters: age, sex,bypass grafts types, morbidity and mortality. METHODS: From January 1995 to June 1998, 673 patients underwent myocardial revascularization (MR). Of this total, 607 (90.20%) MR procedures were performed without CPB. The posterior coronary arteries (PCA) were revascularized in 298 (44.27%) patients, 280 (93.95%) without CPB. The age of the patients ranged from 37 to 88 years (mean, 61 years). The male gender predominated, with 198 men (70.7%). The revascularization of the posterior coronary arteries had the following distribution: diagonalis artery (31 patients, 10%); marginal branches of the circumflex artery (243 patients, 78.7%); posterior ventricular artery (4 patients, 1.3%); and posterior descending artery (31 patients, 10%). RESULTS: Procedure-related complications without death occurred in 7 cases, giving a morbidity of 2.5%. There were 11 deaths in the early postoperative period (mortality of 3.9%). CONCLUSION: Similarly to the anterior coronary arteries, the posterior coronary arteries may benefit from myocardial revascularization without CPB.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiopulmonary bypass</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>minimally invasive surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Rheumatic carditis treated with high doses of pulsetherapy methylprednisolone. Results in 70 children over 12 years</s1>
</fA08>
<fA11 dir="011000">
<s1>Gesmar Volga Haddad Herdy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Alberto Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Cecilia Olivaes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Elisabeth Amabile Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Hsu Tchou</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Raquel Cosendey</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Raquel Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Fabiano Azeredo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Debora de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Artur H. Herdy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Vania Glória S. Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFF Hospital Universitário Antônio Pedro </s1>
<s2> RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>604-606</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: To report the result of patients treated with IV methylprednisolone divided into three groups and compare their follow-up during the last 12 years. METHODS: Seventy children with active rheumatic carditis (76 episodes) in heart failure Class III and IV (NYHA) were studied. The diagnosis was based on modified Jones' criteria. After ruling out infections and strongyloidiasis, treatment with IV methylprednisolone bolus was started three times a week until the laboratory tests became negative. Patients were divided into 3 groups, according to the time of hospital admittance: Groups 1, 2 and 3, comprising of 40, 18 and 12 children, respectively. RESULTS: Eighteen children in Group 1 (45%) were in their 1st attack: 2 series of pulsetherapy were used in 10 (25%), 3 in 9 (23%) and 4 in 21 (52%). In Group 2, 14 cases (77%) were in their 1st attack: 2 series were used in 7 (39%), 4 in 9 (50%) and 5 in 2 (11%). The echocardiogram showed a flail mitral valve in 12 (66%) of these patients (1 death occurred after mitral valvoplasty). In Group 3, 6 patients needed 5 or more series of pulsetherapy and a flail mitral valve was present in 5 (41%). One child underwent mitral valve replacement while still in the active phase, after 8 series of pulsetherapy, and another died. The number of patients who needed 5 or more series was significantly higher in Group 3. CONCLUSION: There were variations in the presentation and evolution of the cases during these 12 year. The established pulsetherapy protocol continues to be useful to treat severe cases.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rheumatic carditis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>methylprednisolone</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>children</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Evaluation of the heart rate and arrhythmias following the Maze procedure for chronic atrial fibrillation</s1>
</fA08>
<fA11 dir="011000">
<s1>Bartira Cunha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Renato A. K. Kalil</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Álvaro S. Albrecht</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Gustavo G. Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Cláudio L. Kruse</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>611-614</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: To assess the presence and the prevalence of arrhythmias and the variability of the heart rate in the medium-term postoperative period following the maze procedure for chronic atrial fibrillation (AF). METHODS: Seventeen patients with a mean age of 51.7±12.9 years, who previously underwent the maze procedure without cryoablation for chronic atrial fibrillation, were evaluated with the 24 hour electrocardiogram (ECG) - Holter monitoring from the 6th month after the operation. Valvular and coronary procedures were concomitantly performed. RESULTS: The mean heart rate during Holter monitoring was 82±8bpm; the maximal heart rate was 126 ± 23bpm and the minimal heart rate 57±7bpm. Sinus rhythm was found in 10 (59%) patients and atrial rhythm was found in 7 (41%). Supraventricular extrasystoles had a rate of 2.3±5.5% of the total number of heartbeats and occurred in 16 (94%) patients. Six (35%) patients showed nonsustained atrial tachycardia. Ventricular extrasystoles, with a rate of 0.8±0.5% of the total heartbeats, occurred in 14 (82%) patients. The chronotropic competence was normal in 9 (53%) patients and attenuated in 8 (47%). The atrioventricular conduction (AV) was unchanged in 13 (76%) patients and there were 4 (24%) cases of first degree atrioventricular block (AVB). CONCLUSION: After the maze procedure, the values for the mean heart rate, AV conduction and chronotropic competence approach the normal range, although some cases show attenuation of the chronotropic response, first degree AV block or benign arrhythmias.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arrhythmias</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Cutting balloon angioplasty for intrastent restenosis treatment</s1>
</fA08>
<fA11 dir="011000">
<s1>João Orávio de Freitas Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sérgio Luis Berti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Geraldo Bonfá</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Sílvia Martins Speranza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Pércio Primo Gandolphi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Hércules Lisboa Bongiovani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Irmandade da Santa Casa de Misericórdia de Araraquara  </s1>
<s2>Araraquara SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>618-620</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We describe here two patients with angiographic diagnosis of intrastent restenosis and regional myocardial ischemia. One stent restenosis was located in a native coronary artery and the other in a vein graft. Both were treated with cutting balloon angioplasty (CBA), inflated at low pressures. Angiographic success was obtained and both patients were discharged in the day after the procedure. Cutting balloon angioplasty using low inflation pressures achieved important luminal gains, in these two cases of intrastent restenosis. Further studies are necessary before the effectiveness of this procedure can be precisely defined.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Assessment of functional capacity through oxygen consumption in patients with asymptomatic probable heart disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Oswaldo Carneiro Rodrigues</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Emerson Silami-Garcia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria da Consolação Vieira Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Giane Amorim Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Minas Gerais  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>06-10</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: To compare peak exercise oxygen consumption (VO2peak) of healthy individuals with asymptomatic individuals with probable heart disease. METHODS: Ninety-eight men were evaluated. They were divided into two groups: 1) 39 healthy individuals (group N) with an age range of 50±4.6 years; and 2) 59 asymptomatic individuals with signs of atherosclerotic and/or hypertensive heart disease (group C) with an age range of 51.9±10.4 years. In regard to age, height, body surface area, percentage of fat, lean body mass, and daily physical activity, both groups were statistically similar. Environmental conditions during the ergometric test were also controlled. RESULTS: Maximal aerobic power (watts), VO2peak, maximal heart rate, and maximal pulmonary ventilation were lower in group C (p&lt;0.01) than in group N; weight, however, was lower in group N (p=0.031) than in group C. Differences in the respiratory gas exchange index, heart rate at rest, and the maximal double product of the two groups were not statistically significant. CONCLUSION: Signs of probable heart disease, even though asymptomatic, may reduce the functional capacity, perhaps due to the lower maximal cardiac output and/or muscle metabolic changes.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>functional capacity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>oxygen consumption</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Coronary artery disease, microalbuminuria and lipid profile in patients with non-insulin dependent diabetes mellitus</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciana Bahia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marília B. Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Pedro di Marco da Cruz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria de Fátima Gonçalves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>17-22</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>45</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: To determine the frequency of coronary artery disease, microalbuminuria and the relation to lipid profile disorders, blood pressure and clinical and metabolic features. METHODS: Fifty-five type 2 diabetic patients (32 females, 23 males), aged 59.9±9 years and with known diabetes duration of 11±7.3 years were studied. Coronary artery disease (CAD) was defined as a positive history of myocardial infarction, typical angina, myocardial revascularization or a positive stress testing. Microalbuminuria was defined when two out of three overnight urine samples had a urinary albumin excretion ranging 20 - 200µg/min. RESULTS: CAD was present in 24 patients (43,6%). High blood pressure (HBP) present in 32 patients (58.2%) and was more frequent in CAD group (p=0.05) HBP. Increased the risk of CAD 3.7 times (CI[1.14-12]). Microalbuminuria was present in 25 patients (45.5%) and tended to associate with higher systolic blood pressure (SBP) (p = 0.06), presence of hypertension (p = 0.06) and know diabetes duration (p = 0.08). In the stepwise multiple logistic regression the systolic blood pressure was the only variable that influenced UAE (r = 0.39, r² = 0.14, p = 0.01). The h ypertensive patients had higher cholesterol levels (p = 0.04). CONCLUSION: In our sample the frequency of microalbuminuria, hypertension, hypercholesterolemia and CHD was high. Since diabetes is an independent risk factor for cardiovascular disease, the association of others risk factors suggest the need for an intensive therapeutic intervention in primary and in secundary prevention.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>microalbuminuria</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipid disorders</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diabetes mellitus</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Safety and efficacy of coronary stent implantation. Acute and six month outcomes of 1,126 consecutive patients treated in 1996 and 1997</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Alberto Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ibraim Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alexandre Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Andrea Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Aurea Chaves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fausto Feres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Galo Maldonado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luiz Tanajura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Marinella Centemero</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Amanda G. M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>J. Eduardo Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo </s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>30-36</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: The authors analyzed the 30-day and 6-month outcomes of 1,126 consecutive patients who underwent coronary stent implantation in 1996 and 1997. METHODS: The 30-day results and 6-month angiographic follow-up were analyzed in patients treated with coronary stents in 1996 and 1997. All patients underwent coronary stenting with high-pressure implantation (&gt;12 atm) and antiplatelet drug regimen (aspirin plus ticlopidine). RESULTS: During the study period, 1,390 coronary stents were implanted in 1,200 vessels of 1,126 patients; 477 patients were treated in the year 1996 and 649 in 1997. The number of percutaneous procedures performed using stents increased significantly in 1997 compared to 1996 (64 % vs 48%, p=0.0001). The 30-day results were similar in both years; the success and stent thrombosis rates were equal (97% and 0.8%, respectively). The occurrence of new Q wave MI (1.3% vs 1.1%, 1996 vs 1997, p=NS), emergency coronary bypass surgery (1% vs 0.6%, 1996 vs 1997, p=NS) and 30-day death rates (0.2% vs 0.5%, 1996 vs 1997, p=NS) were similar. The 6-month restenosis rate was 25% in 1996 and 27% in 1997 (p= NS); the target vessel revascularization rate was 15% in 1996 and 16% in 1997 (p = NS). CONCLUSIONS: Intracoronary stenting showed a high success rate and a low incidence of 30-day occurrence of new major coronary events in both periods, despite the greater angiographic complexity of the patients treated with in 1997. These adverse variables did not have a negative influence at the 6-month clinical and angiographic follow-up, with similar rates of restenosis and ischemia-driven target lesion revascularization rates.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stents</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>restenosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Influence of the elevation of the left ventricular diastolic pressure on the values of the first temporal derivative of the ventricular pressure (dP/dt)</s1>
</fA08>
<fA11 dir="011000">
<s1>Katashi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Roberto Fioretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rossano César Bonatto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Teresinha Trovarelli Tornero</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo José Tucci</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de São Paulo Faculdade de Medicina de Botucatu </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>42-46</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>53</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: To assess the effects of the elevation of the left ventricular end-diastolic pressure (LVEDP) on the value of the 1st temporal derivative of the ventricular pressure (dP/dt). METHODS: Nineteen anesthetized dogs were studied. The dogs were mechanically ventilated and underwent thoracotomy with parasympathetic nervous system block. The LVEDP was controlled with the use of a perfusion circuit connected to the left atrium and adjusted to the height of a reservoir. The elevation of the LVEDP was achieved by a sudden increase in the height of a reservoir filled with blood. Continuous recordings of the electrocardiogram, the aortic and ventricular pressures and the dP/dt were performed. RESULTS: Elevation of the LVEDP did not result in any variation of the heart rate (167±16.0bpm, before the procedure; 167±15.5bpm, after the procedure). All the other variables assessed, including systolic blood pressure (128±18.3mmHg and 150±21.5mmHg), diastolic blood pressure (98±16.9mmHg and 115±19.8mmHg), LVEDP (5.5±2.49 and 9.3±3.60mmHg), and dP/dt (4,855 ± 1,082 mmHg/s and 5,149±1,242mmHg/s) showed significant increases following the expansion of the ventricular cavity. Although the elevation of the dP/dt was statistically significant, 6 dogs curiously showed a decrease in the values of dP/dt. CONCLUSION: Sudden elevation of the LVEDP resulted in increased values of dP/dt; however, in some dogs, this response was not uniform.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Frank-Starling mechanism</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dP/dt</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular function</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Natural course of subsequent pregnancy after peripartum cardiomyopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco Manes Albanesi Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Tatiana Tavares da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>53-57</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effect of subsequent pregnancy after peripartum cardiomyopathy (PPCM) on maternal and fetal outcome. METHODS: Prospective study of 34 patients with the diagnosis of PPCM (mean age= 26years). At the time of first diagnosis 5 were in NYHA functional class (FC) II for heart failure, one in FC III and 28 in FC IV. After clinical treatment, patients were advised to avoid new pregnancies and a follow-up was obtained. RESULTS: There were 12 (35.3%) subsequent pregnancies in patients (pt) aged 19 to 44 years (mean 32), divided into two groups: GI: 6 pts who had normalized their heart size and GII: 6 pts with persistent cardiomegaly. GI had initially mild clinical manifestations ( 3 were in FC II, 1 in FC II and 2 in FC IV) and complete recovery of cardiac function (FC I). A new pregnancy was well-tolerated in 5 (83.3%); 1 pt presented with preeclampsia, and progressed to FC II. Presently, 5 pt are in FC I and 1 in FC II. GII pts had more severe heart failure at the onset of PPCM (1 pt in FC II and 5 in FC IV); during follow-up, 4 pt were in FC I and 2 in FC II. A new pregnancy was well tolerated in all of them, but the eldest, who had had 2 pregnancies and had a progressive worsening of clinical status, dying 8 years after the last pregnancy and 13 years after the diagnosis of PPCM. The remaining 5 pt are still alive, 3 in FC I and 2 in FC II, with worsening of FC in 1. Subsequent pregnancies occurred 3-7 years after clinical treatment of PPCM and no fetal distress was observed. CONCLUSION: Subsequent pregnancies are well-tolerated after PPCM, but not devoid of risk. No fetal distress was observed. A minimum interval of 3 years after the recovery of function seems to be safe for subsequent pregnancies.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>peripartum cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>subsequent pregnancy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Aortopulmonary window. Clinical and surgical assessment of 18 cases</s1>
</fA08>
<fA11 dir="011000">
<s1>Andressa Mussi Soares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Tâmara Martins Cortêz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Angela Maria T. Albuquerque</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Claudia P. Castro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Miguel Barbero-Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Munir Ebaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>67-74</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>44</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Aortopulmonary window (APW) is an uncommon congenital malformation. Its clinical presentation is dependent on the size of the defect and on the associated lesions. We evaluated our experience with this anomaly and compared it with 296 cases reported in the literature. METHODS: Retrospective study of 18 patients diagnosed as having APW (age range from 13 days to 31 years, 13 (72.2%) females), divided into two groups: Group A (GA): 10 patients with isolated APW, and Group B (GB): 8 patients with associated lesions. RESULTS: Heart failure occurred in 14 patients, and cyanosis in 3: 2 from GB (tetralogy of Fallot - TF, and double outlet right ventricle - DORV), and one from GA with pulmonary hypertension. In 5 patients from GA the diagnosis of mitral regurgitation was made based on a systolic murmur and LV hypertrophy on the EKG. In GB, clinical findings were determined by the associated defect. Diagnosis was established by echocardiography in 11 (61.2%) of the patients. In 3 patients, a wrong diagnosis of mitral regurgitation was made, in 1 a patent ductus arteriosus was diagnosed and in 3 others, the diagnosis of APW was masked by other important associated defects (2 cases of DORV and 1 case of TF). The diagnosis was made by catheterization in 3 (16.6%) patients, by surgery in 3 (16.6%) and by necropsy in 1 (5.5%). Corrective surgery was performed in 14 (77.7%) patients, with one immediate death and good long-term follow-up in the remaining patients. CONCLUSION: APW can be confused with other defects. Clinical findings, associated with an adequate echocardiogram can provide the information for the correct diagnosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortopulmonary window</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diagnosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Aortic valve assessment. Anatomical study of 100 healthy human hearts</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo Biscegli Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rosangela Monteiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Helena Guimarães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Siomara Christina Veronezi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Márcia Kyiomi Koike</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fabio Biscegli Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Adib Domingos Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>81-86</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: To assess anatomical characteristics of the aortic valve, so that they may be useful in diagnostic situations and surgical treatment. METHODS: The study analyzed 100 healthy fixed human hearts; 84% of them obtained from males, 61% of them from Caucasian individuals. The ages of the individuals ranged from 9 to 86 years (mean 30±15.5 years). The characteristics assessed related to age, sex, and race were the following: number and height of the cusps, size of the lunulae, internal and external intercommissural distance, position of the coronary ostium in relation to the aortic valve, position of the ventricular septum in relation to the aortic valve, thickness of the cusps. RESULTS: All hearts assessed had a tricuspidal aortic valve. In regard to the height of the cusps and size of the lunula, the left coronary cusp was larger, followed by the right coronary cusp and the noncoronary cusp. The internal and external intercommissural distances had mean values of 24.6±5.7mm and 19.7±7mm, respectively. In regard to the position of the coronary ostia, in one heart two ostia emerged from the left coronary sinus, and in another, the ostium was supracommissural. The mean diameter of the aorta was 21.8±3.6mm, and there were no significant sexual or racial differences, but the diameter increased progressively with the increase in age. The thickness of the cusps did not show any significant difference in the 3 points assessed. CONCLUSION: The aortic valve annulus did not show a perfect circumference, with some variations in the measurements of the annulus, in the cusps and in the relation with the ventricular septum.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>anatomy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic valve</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Myocardial repair with long-term and low-dose administration of a nitric oxide synthesis inhibitor. Myofibroblasts, type III collagen and fibronectin</s1>
</fA08>
<fA11 dir="011000">
<s1>Mônica Gomes Pessanha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Myriam Dumas Hahn</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Alberto Mandarim-de-Lacerda</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro Instituto de Biologia Centro Biomédico</s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>92-96</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>64</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study the healing process of the myocardium in hypertensive rats undergoing inhibition of nitric oxide synthesis. METHODS: Two groups of animals were studied: one received L-NAME, 12mg/kg/day, and the other was a control group. The presence of type III collagen, fibronectin, and alpha-smooth muscle actin-positive cells was assessed by immunohistochemistry. RESULTS: Fibronectin was seen in both early and late lesions, while type III collagen was seen mainly in areas of incomplete healing, situated among myocytes and around the intramyocardial branches of the coronary arteries. Areas representing early and late lesions showed a population of spindle-shaped cells. Immunohistochemistry showed that these cells were positive for alpha-smooth muscle actin. CONCLUSION: In the myocardium of hypertensive rats, the alpha-smooth muscle actin-positive cells are related to the accumulation of type III collagen and fibronectin in the areas of myocardial damage.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myofibroblasts</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nitric oxide</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial remodeling</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>alpha-smooth muscle actin</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Essential thrombocythemia and acute myocardial infarction treated with rescue coronary angioplasty</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Esteves Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Francisco de Assis Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Augusto Guimarães Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Junya Kajita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eulógio Emílio Martinez Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>100-102</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A 48-year-old man with essential thrombocythemia suffered an extensive anterior acute myocardial infarction; this is a rare association. A pharmacological thrombolysis was performed, without success. He subsequently underwent successful rescue coronary angioplasty. To our knowledge, there is no other report in the literature relating the triad of essential thrombocythemia, acute myocardial infarction and rescue coronary angioplasty.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Left ventricular hypertrophy in systemic hypertension. Benefits of its reversal</s1>
</fA08>
<fA11 dir="011000">
<s1>J. Braz Nogueira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de Lisboa  </s1>
<s2>Lisbon </s2>
<s3>Portugal</s3>
</fA14>
<fA20 dir="000000">
<s1>108-112</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>44</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Physical activity at moderate and high altitudes. Cardiovascular and respiratory morbidit</s1>
</fA08>
<fA11 dir="011000">
<s1>Augusta L. Campos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo Vivacqua C. Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco  </s1>
<s2>Rio de Janeiro </s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>121-128</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>77</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300111</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Invasive hemodynamic monitoring in the postoperative period of cardiac surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Desanka Dragosavac</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sebastião Araújo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria do Carmo Monteiro Carieli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Renato G. G. Terzi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sanja Dragosavac</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Reinaldo Wilson Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNICAMP Faculdade de Ciências Médicas </s1>
<s2>Campinas </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>129-138</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJETIVE: To assess the hemodynamic profile of cardiac surgery patients with circulatory instability in the early postoperative period (POP). METHODS: Over a two-year period, 306 patients underwent cardiac surgery. Thirty had hemodynamic instability in the early POP and were monitored with the Swan-Ganz catheter. The following parameters were evaluated: cardiac index (CI), systemic and pulmonary vascular resistance, pulmonary shunt, central venous pressure (CVP), pulmonary capillary wedge pressure (PCWP), oxygen delivery and consumption, use of vasoactive drugs and of circulatory support. RESULTS: Twenty patients had low cardiac index (CI), and 10 had normal or high CI. Systemic vascular resistance was decreased in 11 patients. There was no correlation between oxygen delivery (DO2) and consumption (VO2), p=0.42, and no correlation between CVP and PCWP, p=0.065. Pulmonary vascular resistance was decreased in 15 patients and the pulmonary shunt was increased in 19. Two patients with CI &lt; 2L/min/m² received circulatory support. CONCLUSION: Patients in the POP of cardiac surgery frequently have a mixed shock due to the systemic inflammatory response syndrome (SIRS). Therefore, invasive hemodynamic monitoring is useful in handling blood volume, choice of vasoactive drugs, and indication for circulatory support.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Swan-Ganz catheter</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Results of the surgical treatment of chronic atrial fibrillation</s1>
</fA08>
<fA11 dir="011000">
<s1>Renato A. K. Kalil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Álvaro Albrecht</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gustavo G. Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Daniela Vasconcellos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Bartira Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Domingos Hatem</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Paulo Moreno</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Rogério Abrahão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>João R. M. Sant'Anna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Paulo R. Prates</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Ivo A. Nesralla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>139-148</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Report clinical experience in surgical treatment of atrial fibrillation (AF) by Cox-maze procedure. METHODS: 61 patients underwent surgical treatment for AF. Two had primary AF and 59 AF secondary to heart disease (2 atrial septal defects, 57 mitral). Ages ranged from 20 to 74 years (mean = 49). There were 44 females (72%). The surgical technique employed was Cox 3 without cryoablation. The patients were follow-up in specific at patient clinics and underwent periodical ECG, exercise tests, echocardiogram and Holter monitoring. RESULTS: In-hospital mortality was 4.9% and late mortality 1.6%. A temporary pacemaker was used in 28 (46%) and a definitive in 7 patients (11.4%). On hospital discharge, AF remained in 17%; 63.9% had sinus rhythm, 6.9% atrial rhythm, 1.7% junctional rhythm, and 10.3% had pacemaker rhythm. In the last evaluation, AF was present in 19.5%; (70.5% sinus rhythm, 4% atrial rhythm, 2% atrial tachycardia, and 4% pacemaker rhythm). There was no report of thromboembolic episodes. Chronotropic response was considered adequate in 19%, intermediate in 29%, and inadequate in 42%. In Holter monitoring, the mean heart rate was 82±8 bpm, with a minimum of 57±7 bpm and maximum of 126±23 bpm, with supraventricular extrasystoles in 2.3±5.5% of the total heartbeats and ventricular extrasystoles in 0.8±0.5%. In the echocardiogram, the A wave was present in the left atrium in 87.5%. CONCLUSION: Maze procedure is effective and has acceptable surgical risk. Atrial or sinus rhythms remain stable with a small but remarkable frequency of atrial and ventricular arrhythmias. Left atrial contraction is present, although attenuated, as well as the chronotropic response to exercise.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arrhythmias</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>In-stent restenosis. Acute and long-term outcomes after excimer laser coronary angioplasty</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Bejarano</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Edgardo Bermudez</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Pedro Diaz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Francesca Gallarello</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>James R. Margolis</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>149-156</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJETIVE: With the increased use of intracoronary stents, in-stent restenosis has become a clinically significant drawback in invasive cardiology. We retrospectively assessed the short- and long-term outcomes after excimer laser coronary angioplasty of in-stent restenosis. METHODS: Twenty-five patients with 33 incidents of in-stent restenosis treated with excimer laser coronary angioplasty (ELCA) were analyzed. Sixty-six percent were males, mean age of 73±11 years, and 83% were functional class III-IV (NYHA). ELCA was performed using 23 concentric and 10 eccentric catheters with a diameter of 1.6-2.2 mm, followed by balloon angioplasty (PTCA) and ultrasound monitoring. The procedure was performed in the following vessels: left anterior descending artery, 10; left circumflex artery, 8; right coronary artery, 6; left main coronary artery, 2; and venous bypass graft, 7. RESULTS: The ELCA was successful in 71% of the cases, and PTCA was 100% successful. The diameter of the treated vessels was 3.44±0.5mm; the minimal luminal diameter (MLD) increased from 0.30mm pre-ECLA to 1.97mm post-ELCA, and to 2.94mm post-PTCA (p&lt;0.001). The percent stenosis was reduced from 91.4±9.5% before ECLA to 42.3±14.9% after ELCA and to 14.6 ± 9.3% after PTCA (p&lt;0.001). Seventeen (68%) patients were asymptomatic at 6 months and 15 (60%) at 1 year. New restenosis rates were 8/33 (24.2%) at 6 months and 9 /33 (27.3%) at 12 months. CONCLUSION: ELCA is safe and effective for the treatment of in-stent restenosis. In the present sample, a slight increase in new restenotic lesions between 6 and 12 months was found.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>laser</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>restenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stents</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Doppler echocardiographic evaluation of HIV-positive patients in different stages of the disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Guilherme Lobosco Werneck</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz José Martins Romêo Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Mario Luiz Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense  </s1>
<s2>Rio de Janeiro </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>157-168</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>58</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJETIVE: To evaluate by Doppler echocardiography (DE) early abnormalities of ventricular function in HIV-positive patients, as well as other cardiac abnormalities that can be detected by this method, with special emphasis on mitral valve flow. METHODS: 84 HIV- positive patients, 59 with CD4 cell count &gt;500/mm³ (Group A) and 25 with CD4 cell count &lt;500/mm³ (Group B), were analyzed. CD4 cells were counted and matched with structural data and systolic and diastolic function of the left ventricle (LV), as analyzed by DE. The results were compared with those obtained in 47 healthy individuals (Group C). RESULTS: 8% of patients in Group B had mild pericardial effusion; 31.5% showed decreased systolic function of the LV, and 12% had moderate mitral regurgitation. A wave velocity from the mitral inflow was different among the 3 groups, being higher in Group B, where the deceleration time of the E wave of the mitral inflow and the E/A ratio were significantly lower with a normal value of the isovolumic relaxation time (IVRT). CONCLUSION: HIV-positive patients with a CD4 cell count &gt;500/mm³ had no abnormalities by DE. Patients with a more advanced infection (those with a CD4 cell count &lt;500/mm³), had a significantly abnormal LV systolic function and a higher incidence of pericardial effusion and mitral regurgitation. Mitral valve inflow by Doppler did not indicate diastolic dysfunction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Doppler echocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>AIDS</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral flow</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Ventricular evoked response in patients with hypertrophic obstructive cardiomyopathy treated with DDD pacing</s1>
</fA08>
<fA11 dir="011000">
<s1>João Ricardo M. Sant'Anna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Raquel Prati</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Helmut Hutten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Günter Schreier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Peter Kastner</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Renato A. K. Kalil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Paulo R. Prates</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Iran Castro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Paulo C. Azambuja</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Farid Faes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Ivo A. Nesralla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Max Schaldach</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>169-179</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the changes in ventricular evoked responses (VER) produced by the decrease in left ventricular outflow tract gradient (LVOTG) in patients with hypertrophic obstructive cardiomyopathy (HOCM) treated with dual-chamber (DDD) pacing. METHODS: A pulse generator Physios CTM (Biotronik, Germany) was implanted in 9 patients with severe drug-refractory HOCM. After implantation, the following conditions were assessed: 1) Baseline evaluation: different AV delay (ranging from 150ms to 50 ms) were sequentially programmed during 5 to 10 minutes, and the LVOTG (as determined by Doppler echocardiography) and VER recorded; 2) standard evaluation, when the best AV delay (resulting in the lowest LVOTG) programmed at the initial evaluation was maintained so that its effect on VER and LVOTG could be assessed during each chronic pacing evaluation. RESULTS: LVOTG decreased after DDD pacing, with a mean value of 59 ± 24 mmHg after dual chamber pacemaker, which was significantly less than the gradient before pacing (98 + 22mmHg). An AV delay &gt;100ms produced a significantly lower decrease in VER depolarization duration (VER DD) when compared to an AV delay &lt;=100ms. Linear regression analyses showed a significant correlation between the LVOTG values and the magnitude of VER (r=0.69; p&lt;0.05) in the 9 studied patients. CONCLUSION: The telemetry obtained intramyocardial electrogram is a sensitive means to assess left ventricular dynamics in patients with HOCM treated with DDD pacing.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>obstructive hypertrophic cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>DDD pacing intracardiac electrogram</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Anomalous origin of the left coronary artery from the right pulmonary artery with intramural aortic trajectory. Clinicosurgical diagnostic implications</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Miguel Barbero-Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carla Tanamati</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luis Kajita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Munir Ebaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Adib Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>181-190</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Anomalous origin of the left coronary artery from the right pulmonary artery (AOLCARPA), is a rare entity that is usually associated with other defects. Of the 20 cases of AOLCARPA reported in the literature, 14 (70%) had associations. We describe four patients with AOLCARPA without associated defects, but with a peculiar intramural aortic trajectory. METHODS: Fifty-five patients with anomalous origin of the left coronary artery were operated upon at INCOR-FMUSP. Four of the patients had the anomalous origin from the right pulmonary artery (RPA) without associated defects but with intramural aortic trajectory. Clinical and laboratory examinations were analyzed, as well as surgical findings. RESULTS: All patients had congestive heart failure (CHF) and 3 also had angina pectoris. Two patients had a murmur of mitral regurgitation, signs of myocardial infarction on the ECG and cardiomegaly. The shortening fraction varied from 9% to 23%. The hemodynamic study confirmed the diagnosis of anomalous origin of the coronary artery, but the intramural trajectory and the origin from the RPA were established only at surgery. In 3 patients, the technique of side-to-side anastomosis was performed with a good outcome. One patient, who underwent end-to-side anastomosis, died 6 months after the surgery. CONCLUSION: Association with other defects usually occurs in the AOLCARPA, and the intramural aortic trajectory is difficult to clinically diagnose but easy to surgically correct.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>anomalous origin of the left coronary artery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>right pulmonary artery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Intraaortic balloon pump support during coronary angioplasty. Initial experience</s1>
</fA08>
<fA11 dir="011000">
<s1>Evandro C.V. Osterne</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gustavo A. Alexim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vicente P. da Motta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rosaly M.M. Lins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eustáquio F. Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marcos V. Carneiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Elio Ribeiro de Morais</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Alexandre V. Brick</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital das Forças Armadas  </s1>
<s2>Brasília </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>191-200</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the use of the intraaortic balloon (IAoB) in association with coronary angioplasty in high-risk patients. METHODS: Fourteen high-risk patients unresponsive to clinical therapy and with formal contraindication to surgical revascularization were treated by coronary angioplasty, most of which was followed by stenting. All procedures were performed with circulatory support with the IAoB. This study reports the early results and the late findings after 12 months of follow-up. Six patients had multivessel coronary disease; of these, four had left main equivalent lesions and two had unprotected left main coronary artery disease, one of whom had severe &quot;end-vessel&quot; stenosis and the other was a patient with Chagas' disease with single-vessel lesion. Eleven patients had a left ventricular ejection fraction &lt;30%. RESULTS: In 100% of the patients, the procedures were initially successful. Two patients had severe bleeding during the withdrawal of the left femoral sheath. At the end of twelve months, 4 patients were asymptomatic and the others were clinically controlled. There were two late deaths in the 7th and 11th months. CONCLUSION: The combined use of the intraaortic balloon pump and percutaneous coronary angioplasty in high-risk patients with acute ischemic syndromes provides the necessary hemodynamic stability to successfully perform the procedures.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>circulatory support</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>intraaortic balloon pump</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Laboratory assessment of the hypertensive individual. Value of the main guidelines for high blood pressure</s1>
</fA08>
<fA11 dir="011000">
<s1>Rafael S. Reis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Isabela J. Benseñor</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo A. Lotufo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>201-210</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine if abnormal laboratory findings are more common in individuals with hypertension and in those with other risk factors, such as obesity, smoking and alcohol ingestion. METHODS: A study was carried out in the general outpatient clinics of a university hospital (145 individuals without previous diagnosis of hypertension) and the following variables were assessed: high blood pressure (as defined by the VI Joint National Committee on Prevention, Detection and Treatment of High Blood Pressure - VI JNC), obesity [calculated using body mass index (BMI)], tobacco use, and alcoholic ingestion. The laboratory examinations consisted of the following tests: hemogram, glycemia, uric acid, potassium, total/HDL-fraction cholesterol, triglycerides, calcium and creatinine. RESULTS: High blood pressure was not associated with a higher number of abnormal laboratory tests. Hypertensive individuals with a BMI  &gt; or = 25kg/m² or normotensive obese individuals, however, had a higher frequency of diabetes (12X), hypertriglyceridemia (3X), and hypercholesterolemia (2X), as compared with hypertensive individuals with BMI &lt;25kg/m² and preobese/normal weight normotensive individuals. CONCLUSION: High blood pressure is not associated with a higher frequency of abnormal laboratory tests. The association of high blood pressure and obesity, however, increases the detection of diabetes and dyslipidemias.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>laboratory examinations</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>high blood pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>obesity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>screening</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Recurrence of atrial septal defect in three generations</s1>
</fA08>
<fA11 dir="011000">
<s1>Celso Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leila M. S. Farah</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rui M. Póvoa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Bráulio Luna Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Andréa Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Celso Ferreira Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo EPM </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>211-218</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Beginning with a patient presenting with an atrial septal defect (ASD) of the secundum type, the genealogy was identified in four affected individuals who belonged to three successive generations of the same family. The defects were visually confirmed in all individuals and were found to be anatomically similar. No other congenital malformations were present in these individuals. The genealogy was identified in 1972, when ASD recurred in two generations, and it was concluded that the mechanism of transmission was autosomal recessive. The fifth individual, identified 21 years later, and having an anomaly identical to that of the others, was the child of a couple who had no consaguinity and whose mother was a member of the previously studied genealogy. Considering the absence of phenotype in the parents and the rarity of the ASD gene in the general population, the occurrence of the uniparental disomy for this family nucleus, and the same autosomal recessive mechanism of transmission by this affected individual is possible. This study reports the familial occurrence of ASD by genetic mechanisms of transmission, emphasizing the necessity for genetic-clinical studies in members of the familial nucleus in order to detect new carriers, who usually are asymptomatic, thereby allowing for early and adequate treatment of individuals who may be affected.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Ebstein's anomaly with coarctation of the aorta. An unusual association</s1>
</fA08>
<fA11 dir="011000">
<s1>Munir Ebaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Estela Azeka</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Nana Miura Ikari</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eduardo A. Sosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Miguel Barbero Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>219-224</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Ebstein's anomaly with coarctation of the aorta is an extremely unusual condition. In this report, the clinical and surgical features of 3 male patients, aged 7 months, 4 years and 14 years, are discussed. All patients were in situs solitus. The first 2 patients had atrioventricular and ventriculoarterial discordance and progressed to heart failure in the neonatal period. The third had atrioventricular and ventriculoarterial concordance, as well as Wolf-Parkinson-White syndrome, with frequent episodes of paroxysmal tachycardia. The 3 patients underwent surgery for correction of the coarctation of the aorta. The patient with atrioventricular and ventriculoarterial concordance underwent tricuspid valvuloplasty using a DeVega-like technique. In addition, ablation of 2 anomalous pathways (Kent bundle), which were detected by the electrophysiologic study, was also subsequently performed. The 3 patients showed a good postoperative outcome for 2 years, although, in those with discordance, the surgical procedure did not influence the dysplasia of the tricuspid valve, because this valve showed light to moderate dysfunction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>A 63-year-old man with heart failure 3 years after bioprosthetic replacement of mitral and aortic heart valves</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>225-236</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>The role of depression in coronary artery disease</s1>
</fA08>
<fA11 dir="011000">
<s1>André Luiz Langer Manica</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carolina Garcia Soares Leães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Benício Noronha Frey</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Mário Francisco Juruena</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Faculdade Federal de Ciências Médicas de Porto Alegre  </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>237-250</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>105</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300212</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Doppler echocardiographic study in adolescents and young adults with sickle cell anemia</s1>
</fA08>
<fA11 dir="011000">
<s1>Wolney de Andrade Martins</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Delma Maria da Cunha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Augusto de Freitas Pinheiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz José Martins Romêo Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Raul Carlos Pareto Jr</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>469-474</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>57</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Anatomical and functional assessment of the heart through Doppler and echocardiography in patients with cell anemia (SCA). METHODS: Twenty-five patients with SCA and ages ranging from 14 to 45 years were prospectively studied in a comparison with 25 healthy volunteers. All of them underwent clinical and laboratory evaluation and Doppler echocardiography as well.The measurements were converted into body surface indices. RESULTS: There were increases in all chamber diameters and left ventricle (LV) mass of the SCA patients. It was characterised an eccentric hypertrophy of the left ventricle. The preload was increased (left ventricle end-diastolic volume) and the afterload was decreased (diastolic blood pressure, peripheral vascular resistance and end-systolic parietal stress ESPS). The cardiac index was increased due to the stroke volume. The ejection fraction and the percentage of the systolic shortening , as well as the systolic time intervals of the LV were equivalent. The isovolumetric contraction period of the LV was increased. The mitral E-septum distance and the end-systolic volume index (ESVi) were increased. The ESPS/ESVi ratio,a loading independent parameter, was decreased in SCA, suggesting systolic dysfunction. No significant differences in the diastolic function or in the pulmonary pressure occurred. CONCLUSION: Chamber dilations, eccentric hypertrophy and systolic dysfunction confirm the evidence of the literature in characterizing a sickle cell anemia cardiomyopathy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sickle cell anemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiomyopathy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Primary coronary angioplasty and stent implantation in acute myocardial infarction. Comparative analysis of the in-hospital results in the CENIC/SBHCI registry</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Alberto Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Amanda G. M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cantídeo C. Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>André Labrunie</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Cláudia R. Alves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Jamil Saad</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>480-484</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Comparative analysis of the in-hospital results after primary implantation of stents or coronary balloon angioplasty in patients with acute myocardial infarction (MI). METHODS: CENIC (National Center of Cardiovascular Interventions) gathered data on 3,924 patients undergoing coronary angioplasty (in the primary form, without the previous use of thrombolytic agents) in the first 24 hours after a MI, during the period of 1996-1998. From these 3,924 patients, 1,337 (34%) underwent stent implantation. We analyzed the success of the procedure and the occurrence of adverse cardiac events. RESULTS: In patients undergoing stent implantation there were more males (77% vs 69%, p=0.001), previous by pass surgery (6.3% vs. 4.5%, p=0.01), anterior MI and stent implantation in left descending artery (55% vs. 48% vs. p=0.009), and saphenous vein bypass grafts (3.3% vs. 1.9%). the procedure was more succesful in the group of stents (97% vs. 84%, p=0.001) and reinfarction rate (2.5 vs. 4%, p=0.002). The need for emergency revascularization was similar (1% vs. 1.1%, NS). Total in-hospital mortality was lower in stent group (3.4% vs. 7. 2%, p=0.0001) and this effect was in patients Killip class III/V (19.5% vs. 32.5%, p= 0.002) because there was no difference in patients class I/II (1.7% vs. 2.8%, p=0.9). CONCLUSION: Primary stent implantation in acute myocardial infarction showed better early results than balloon angioplasty alome.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stents</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Right ventricular bifocal stimulation in the treatment of dilated cardiomyopathy with heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>José Carlos Pachón Mateos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Remy Nelson Albornoz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Enrique Indalécio Pachón Mateos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Vera Márcia Gimenez</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Juán Carlos Pachón Mateos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maria Zélia Cunha Pachón</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Eusebio Ramos dos Santos Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Paulo de Tarso Jorge Medeiros</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Marco Aurélio Dias da Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Paulo Paredes Paulista</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>José Eduardo Moraes Rêgo Sousa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Adib Domingos Jatene</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>492-498</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To describe a new more efficient method of endocardial cardiac stimulation, which produces a narrower QRS without using the coronary sinus or cardiac veins. METHODS: We studied 5 patients with severe dilated cardiomyopathy, chronic atrial fibrillation and AV block, who underwent definitive endocardial pacemaker implantation, with 2 leads, in the RV, one in the apex and the other in the interventricular septum (sub pulmonary), connected, respectively, to ventricular and atrial bicameral pacemaker outputs. Using Doppler echocardiography, we compared, in the same patient, conventional (VVI), high septal (&quot;AAI&quot;) and bifocal (&quot;DDT&quot; with AV interval ~ 0) stimulation. RESULTS: The RV bifocal stimulation had the best results with an increase in ejection fraction and cardiac output and reduction in QRS duration, mitral regurgitation and in the left atrium area (p &lt;= 0.01). The conventional method of stimulation showed the worst result. CONCLUSION: These results suggest that, when left ventricular stimulation is not possible, right ventricular bifocal stimulation should be used in patients with severe cardiomyopathy where a pacemaker is indicated.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pacemaker</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>multisite stimulation and heart failure</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Endomyocardial fibrosis associated with massive calcification of the left ventricle</s1>
</fA08>
<fA11 dir="011000">
<s1>Manoel Fernandes Canesin</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Renato Faria da Gama</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Débora Lee Smith</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Flávio Jun Kazuma</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Arlei Takiuchi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>503-506</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>08</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>This is the report of a rare case of endomyocardial fibrosis associated with massive calcification of the left ventricle in a male patient with dyspnea on great exertion, which began 5 years earlier and rapidly evolved. Due to lack of information and the absence of clinical signs that could characterize impairment of other organs, the case was initially managed as a disease with a pulmonary origin. With the evolution of the disease and in the presence of radiological images of heterogeneous opacification in the projection of the left ventricle, the diagnostic hypothesis of endomyocardial disease was established. This hypothesis was later confirmed on chest computed tomography. The patient died on the 16th day of the hospital stay, probably because of lack of myocardial reserve, with clinical findings of refractory heart failure, possibly aggravated by pulmonary infection. This shows that a rare disease such as endomyocardial fibrosis associated with massive calcification of the left ventricle may be suspected on a simple chest X-ray and confirmed by computed tomography.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>The patient is a 46-year-old female with marked myocardial hypertrophy and heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>511-514</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Use of sildenafil in patients with cardiovascular disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Armênio Costa Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcus Vinícius Bolívar Malachias</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Otávio Rizzi Coelho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Emílio Cesar Zilli</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rafael Leite Luna</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>521-526</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Evaluation of the treadmill stress testing for risk stratification after acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Celso Blacher</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Waldomiro Manfroi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Brisa Simões Fernandes</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>532-536</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Specialized computer support systems for medical diagnosis. Relationship with the Bayes' theorem and with logical diagnostic thinking</s1>
</fA08>
<fA11 dir="011000">
<s1>Pedro José Negreiros de Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFC Hospital Universitário Walter Cantídio </s1>
<s2>Fortaleza CE</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>545-552</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>52</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Univentricular atrioventricular connection. Review of the current therapeutical possibilities</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>03-04</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Permanent and temporary pacemaker implantation after orthotopic heart transplantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Bacal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Edimar A. Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcelo L. C. Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Neusa Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz Felipe Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Alfredo Fiorelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Roberto Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Martino Martinelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Noedir A. G. Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Giovanni Bellotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>José Antonio F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>09-12</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE:To determine the indication for and incidence and evolution of temporary and permanent pacemaker implantation in cardiac transplant recipients. METHODS: A retrospective review of 114 patients who underwent orthotopic heart transplantation InCor (Heart Institute USP BR) between March 1985 and May 1993. We studied the incidence of and indication for temporary pacing, the relationship between pacing and rejection, the need for pemanent pacing and the clinical follow-up. RESULTS: Fourteen of 114 (12%)heart transplant recipients required temporary pacing and 4 of 114 (3.5%) patients required permanent pacing. The indication for temporary pacing was sinus node dysfunction in 11 patients (78.5%) and atrioventricular (AV) block in 3 patients (21.4%). The indication for permanent pacemaker implantation was sinus node dysfunction in 3 patients (75%) and atrioventricular (AV) block in 1 patient (25%). We observed rejection in 3 patients (21.4%) who required temporary pacing and in 2 patients (50%) who required permanent pacing. The previous use of amiodarone was observed in 10 patients (71.4%) with temporary pacing. Seven of the 14 patients (50%) died during follow-up. CONCLUSION: Sinus node dysfunction was the principal indication for temporary and permanent pacemaker implantation in cardiac transplant recipients. The need for pacing was related to worse prognosis after cardiac transplantation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pacemaker</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac transplantation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Chest pain in the emergency room. Importance of a systematic approach</s1>
</fA08>
<fA11 dir="011000">
<s1>Roberto Bassan</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo Scofano</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Roberto Gamarski</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Hans Fernando Dohmann</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Lúcia Pimenta</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>André Volschan</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Mônica Araujo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Cristina Clare</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Marcelo Fabrício</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Carlos Henrique Sanmartin</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Kalil Mohallem</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Sergio Gaspar</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Renato Macaciel</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>22-29</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the efficiency of a systematic diagnostic approach in patients with chest pain in the emergency room in relation to the diagnosis of acute coronary syndrome (ACS) and the rate of hospitalization in high-cost units. METHODS: One thousand and three consecutive patients with chest pain were screened according to a pre-established process of diagnostic investigation based on the pre-test probability of ACS determinate by chest pain type and ECG changes. RESULTS: Of the 1003 patients, 224 were immediately discharged home because of no suspicion of ACS (route 5) and 119 were immediately transferred to the coronary care united because of ST elevation or left bundle-branch block (LBBB) (route 1) (74% of these had a final diagnosis of acute myocardial infarction [AMI]). Of the 660 patients that remained in the emergency room under observation, 77 (12%) had AMI without ST segment elevation and 202 (31%) had unstable angina (UA). In route 2 (high probability of ACS) 17% of patients had AMI and 43% had UA, whereas in route 3 (low probability) 2% had AMI and 7 % had UA. The admission ECG has been confirmed as a poor sensitivity test for the diagnosis of AMI ( 49%), with a positive predictive value considered only satisfactory (79%). CONCLUSION: A systematic diagnostic strategy, as used in this study, is essential in managing patients with chest pain in the emergency room in order to obtain high diagnostic accuracy, lower cost, and optimization of the use of coronary care unit beds.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chest pain</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>emergency room</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>unstable angina</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>The results of the Campaign for evaluating sphygmomanometers accuracy and their physical conditions</s1>
</fA08>
<fA11 dir="011000">
<s1>Décio Mion Jr</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Angela M. G. Pierin</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Débora Cristina Alavarce</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Henrique da Cunha Vasconcellos</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>35-38</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the sphygmomanometers calibration accuracy and the physical conditions of the cuff-bladder, bulb, pump, and valve. METHODS: Sixty hundred and forty five aneroid sphygmomanometers were evaluated, 521 used in private practice and 124 used in hospitals. Aneroid manometers were tested against a properly calibrated mercury manometer and were considered calibrated when the error was &lt;=3mm Hg. The physical conditions of the cuffs-bladder, bulb, pump, and valve were also evaluated. RESULTS: Of the aneroid sphygmomanometers tested, 51% of those used in private practice and 56% of those used in hospitals were found to be not accurately calibrated. Of these, the magnitude of inaccuracy ranged from 4 to 8mm Hg in 70% and 51% of the devices, respectively. The problems found in the cuffs - bladders, bulbs, pumps, and valves of the private practice and hospital devices were bladder damage (34% vs. 21%, respectively), holes/leaks in the bulbs (22% vs. 4%, respectively), and rubber aging (15% vs. 12%, respectively). Of the devices tested, 72% revealed at least one problem interfering with blood pressure measurement accuracy. CONCLUSION: Most of the manometers evaluated, whether used in private practice or in hospitals, were found to be inaccurate and unreliable, and their use may jeopardize the diagnosis and treatment of arterial hypertension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure measurement</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sphygmomanometers</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>calibration accuracy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Acute myocardial infarction in the Brazilian State of São Paulo. In-hospital deaths from 1979 to 1996 and hospital fatality from 1984 to 1998 in the public health system</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Francisco Marcopito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Artur Jaques Goldfeder</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Simone Schenkman</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>43-46</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the following parameters in the Brazilian State of São Paulo: 1) the percentage of deaths due to acute myocardial infarction (AMI) occurring in hospitals; 2) the percentage of deaths due to AMI occurring in public health system hospitals as compared with all in-hospital deaths due to AMI between 1979 and 1996; 3) the fatality due to AMI in public health system hospitals from 1984 to 1998. METHODS: Data were available on the Datasus Web site (the health information agency of the Brazilian Department of Health) that provided the following: a) number of deaths resulting from AMI in hospitals; b) number of deaths resulting from AMI in public health system hospitals; c) number of hospital admissions due to AMI in public health system hospitals. RESULTS: The percentage of in-hospital deaths due to AMI increased from 54.9 in 1979 to 68.6 in 1996. The percentage contribution of the public health system to total number of deaths due to AMI occurring in hospitals decreased from 22.9 in 1984 to 13.7 in 1996; fatality due to AMI occurring in public health system hospitals had an irregular evolution from 1984 to 1992 and showed a slight trend for increased frequency from 1993 to 1998. CONCLUSION: The percentage of in-hospital deaths due to AMI has been increasing. Deaths resulting from AMI in public health system hospitals have decreased when compared with the total number of deaths due to AMI in all hospitals. Fatality due to AMI in public health system hospitals did not decrease from 1992 to 1998.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemic heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Constrictive pericarditis in a 19-month-old child</s1>
</fA08>
<fA11 dir="011000">
<s1>José Carlos dos Santos Guitti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Londrina  </s1>
<s2>Londrina PR</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>51-54</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report a case of chronic nonspecific constrictive pericarditis with myocardial involvement in a 19-month-old infant. The patient underwent total pericardiectomy and had irreversible hemodynamic instability. Constrictive pericarditis is rare in childhood. It may follow several processes, most frequently an infectious disease. The natural course of the disease consists of progressive myocardial dysfunction with atrioventricular valvular involvement. When diagnosis is established early in the course of the disease and treatment started immediately, the evolution is favorable in most instances.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Lupus carditis</s1>
</fA08>
<fA11 dir="011000">
<s1>Creso A. Falcão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Norma Lucena</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Izabel C. Alves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ângela L. Pessoa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Emmanuelle T. Godoi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de Pernambuco Faculdade de Ciências Médicas </s1>
<s2>Recife PE</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>64-71</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>62</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Transmission of infectious diseases through mouth-to-mouth ventilation: evidence-based or emotion-based medicine?</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Frederico Arend</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Faculdade de Medicina Hospital de Clínicas de Porto Alegre</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>86-97</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>204</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Mário Rigatto, meu mestre (28/12/1928 -- 17/1/2000)</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos A. M. Gottschall</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Academia Sul-Rio-Grandense de Medicina  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>99-100</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan</s1>
</fA08>
<fA11 dir="011000">
<s1>Antônio Carlos Avanza Jr</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Lilian Mameri El Aouar</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Geraldo Mill</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Espírito Santo  </s1>
<s2>Vitória </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>111-117</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To compare the regression of left ventricular hypertrophy in patients with moderate hypertension treated with enalapril, losartan or a combination of the two drugs at lower doses. METHODS: Patients of both sexes with moderate hypertension confirmed by ambulatory monitoring of arte-rial blood pressure and with left ventricular hypertrophy on echocardiogram were assigned to three groups: enalapril (35 mg/day, n=15), losartan (175 mg/day, n=15) and enalapril+losartan (15 mg+100 mg/day, n=16). The patients received the drugs for 10 months. RESULTS: The three therapeutic regimens were equally effective in reducing blood pressure and left ventricular mass index (LVMI, g/m²): 141±3.9 to 123±3.6 in the enalapril group (p&lt;0.05), from 147±3.8 to 133±2.8 in the losartan group (p&lt;0.05), and from 146±3.0 to 116±4.0 in the enalapril+losartan group (p&lt;0.05). However, the percent reduction of LVMI was significantly greater (p&lt;0.01) in the enalapril+losartan group (20.5±5.0%) than in enalapril (12.4±3.2%) and the losartan (9.1±2.1%) groups. Normalization of LVMI was obtained in 10 out of the 16 patients who received enalapril+ losartan, in 6 out of the 15 patients who received only enalapril and in 4 out of the 15 patients treated with losartan. CONCLUSION: The combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist (AT1 receptor antagonist) in patients produced an additional effect on the reduction of left ventricular hypertrophy. This finding may depend on a more complete inhibition of the cardiac renin-angiotensin.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angiotensin-converting enzyme</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>losartan</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>renin-angiotensin system</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Chlamydia pneumoniae and atherosclerosis. Identification of bacterial DNA in the arterial wall</s1>
</fA08>
<fA11 dir="011000">
<s1>Mário Sérgio Soares de Azeredo Coutinho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernando Joo Daniel Nakamae</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Elizabeth Menezes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Santa Catarina  </s1>
<s2>Florianópolis SC</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>124-128</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>41</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: The intracellular Gram-negative bacterium Chlamydia pneumoniae has been associated with atherosclerosis. The presence of Chlamydia pneumoniae has been investigated in fragments of the arterial wall with a technique for DNA identification. METHODS: Arterial fragments obtained from vascular surgical procedures in 58 patients were analyzed. From these patients, 39 were males and the mean age was 65±6 years. The polymerase chain reaction was used to identify the bacterial DNA with a pair of primers that codify the major outer membrane protein (MOMP) of Chlamydia pneumoniae. The amplified product was visualized by electrophoresis in the 2% agarose gel stained with ethidium bromide, and it was considered positive when migrating in the band of molecular weight of the positive controls. RESULTS: Seven (12%) out of the 58 patients showed positive results for Chlamydia pneumoniae. CONCLUSION: DNA from Chlamydia pneumoniae was identified in the arterial wall of a substantial number of patients with atherosclerosis. This association, which has already been described in other countries, corroborates the evidence favoring a role played by Chlamydia pneumoniae in atherogenesis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chlamydia pneumoniae</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>polymerase chain reaction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>A new surgical approach for treating dilated cardiomyopathy with mitral regurgitation</s1>
</fA08>
<fA11 dir="011000">
<s1>Enio Buffolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ivan Antonio Machado de Paula</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Honório Palma</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>João Nelson Rodrigues Branco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>135-140</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the early outcome of mitral valve prostheses implantation and left ventricular remodeling in 23 patients with end-stage cardiomyopathy and secondary mitral regurgitation (NYHA class III and IV). METHODS: Mitral valvular prosthesis implantation with preservation of papillary muscles and chordae tendinae, and plasty of anteriun cuspid for remodeling of the left ventricle. RESULTS: The surgery was performed in 23 patients, preoperative ejection fraction (echocardiography) varied from 13% to 44% (median: 30%). In 13 patients associated procedures were performed: myocardial revascularization (9), left ventricle plicature repair (3) and aortic prosthese implantation (1). Early deaths (2) occurred on the 4th PO day (cardiogenic shock) and on the 20th PO day (upper gastrointestinal bleeding), and a late death in the second month PO (ventricular arrhythmia). Improvement occurred in NYHA class in 82.6% of the patients (P&lt;0.0001), with a survival rate of 86.9% (mean of 8.9 months of follow-up). CONCLUSION: This technique offers a promising therapeutic alternative for the treatment of patients in refractory heart failure with cardiomyopathy and secondary mitral regurgitation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral insufficiency</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dilated cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral implantation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Treatment of persistent rejection with methotrexate in stable patients submitted to heart transplantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Bacal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Viviane Cordeiro Veiga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alfredo Inácio Fiorelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Giovanni Bellotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Edimar Alcides Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Noedir Antonio Groppo Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>145-148</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE:&lt;FONT FACE=&quot;Symbol&quot;&gt;&lt;/FONT&gt;To evaluate the use of methotrexate for the treatment of recurrent rejection in heart transplant recipients. METHODS: We studied 6 patients submitted to heart transplantation that showed rejection grade  &gt; or =  3A (ISHLT) in two consecutives endomyocardial biopsy specimens. The dose was 11.26±3.75mg/week. The evaluated data were: ventricular function, endomyocardial biopsy, white cell count and number of rejection episodes before and after methotrexate administration. RESULTS: There was a reduction in the number of rejection episodes (5.17±1.47 before methotrexate; 2.33±1.75 after 6 months and 3.17±2.99 after 12 months of treatment, p=0.0193). The ventricular function was normal with ejection fraction of 76.5±4.80 before and 75.6±4.59 after methotrexate (p=0.4859). One patient did not finish the treatment because he showed signs of rejection associated with severe pericardial effusion. Five patients had a reduction in the white cell count (8,108±23.72 before and 5650±1350 after methotrexate, p=0.0961). One pulmonary infection with complete resolution after antibiotic treatment was observed. CONCLUSION: Methotrexate in low doses is an effective adjunct therapy in the treatment of recurrent rejection after heart transplantation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart transplantation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>methotrexate</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rejection</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Great amount of C.pneumoniae in ruptured plaque vessel segments at autopsy. A comparative study with stable plaques</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria de Lourdes Higuchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jussara Bianchi Castelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vera D. Aiello</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sueli Palomino</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marcia M. Reis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Nadia V. Sambiase</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Shizie Fukasawa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Hiram G. Bezerra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>José A. F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>University of São Paulo Medical School Heart Institute</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>149-151</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A possible relationship between C.pneumoniae (CP) infection, atherosclerosis and acute myocardial infarction is a debated matter. Now we performed the search of CP in histological segments of fatal ruptured plaques and of stable plaques by histochemistry (Macchiavello stain), immunohistochemistry and in situ hybridization techniques. Electron microscopy and confocal laser microscopy techniques were used in two additional cases. The semi-quantitification of CP + cells (0-4+) and quantification of lymphocytes demonstrated greater amount of CP + cells and more inflammation in the adventitia of vulnerable plaque vessel segments than of stable ones, larger amount of CP + cells in adventitia than in the plaque and high frequency of CP + cells in all groups studied. This preliminary study strongly suggests a direct pathogenetic involvement of adventitial CP in the rupture of the atheromatous plaque, development of acute myocardial infarction and also in the development of atherosclerosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Coronary bilateral ostial enlargement using the saphenous vein in a patient with syphilitic aortitis</s1>
</fA08>
<fA11 dir="011000">
<s1>Ulisses A. Croti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Francisco Gregori Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Miguel B. Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luís A. Dallan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Thelma Elisa F. Gregori</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Divina S. Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>S. Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>156-158</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A patient with tertiary syphilis presenting with bilateral coronary ostial lesions and aortic regurgitation underwent surgical reconstruction of the coronary ostia by the anterior approach with autogenous saphenous vein grafting and substitution of the aortic valve with a bovine bioprosthesis. The procedure was easily performed and had good outcomes both early and late. The rarity of the association of a lesion in both coronary ostia with aortic regurgitation in syphilis and the surgical technique employed are discussed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>The patient is a 65-year-old woman with heart failure and proteinuria</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>163-166</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Coarctation of the aorta corrected during childhood. Clinical aspects during follow-up</s1>
</fA08>
<fA11 dir="011000">
<s1>Margarida Maria da Costa Smith Maia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vera Demarchi Aiello</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Miguel Barbero-Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Munir Ebaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>174-180</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>89</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Ischemic heart disease. Hospitalization, length of stay and expenses in Brazil from 1993 to 1997</s1>
</fA08>
<fA11 dir="011000">
<s1>Ruy Laurenti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cassia Maria Buchalla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carla Vanessa de Sousa Caratin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Saúde Pública Departamento de Epidemiologia</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>488-492</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To identify characteristics of the hospitalizations due to ischemic heart disease (IHD) made by the Single Health System -- &quot;Sistema Único de Saúde (SUS) in Brazil from 1993 to 1997. METHODS: The information used came from records of permissions for hospitalization due to IHD (diseases codified from 410 to 414 by the International Disease Classification -- 9th Revision) furnished by the data bank DATASUS. The material studied was classified according to age, sex and length of hospitalization of the patients, and expenses to the system for IHD. RESULTS: IHD represents 1.0% of total hospitalizations. Angina pectoris was the most frequent type, occurring in 53.3% of the cases, followed by acute myocardial infarct (26.6%). This later was more frequent in men and angina in women . The majority of patients with IHD stayed hospitalized from 5 to 8 days. In the years of 1997 the expenses due to hospital treatment for IHD reach to 0.01% of Brazil's Gross Internal Product. In the studied period (1993-1997), IHD was responsible by 1.0% of hospitalizations, however it was 3.3% of the expenses of SUS. CONCLUSION: IHD is an important cause of hospitalization by the SUS; it has a rather high cost, indicating the need for preventive measures aimed at reducing exposure to risk factors and to decrease the incidence of this group of diseases in the nation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemic heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hospitalization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>espenses</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Trends in mortality due to ischemic heart disease in the municipality of Goiania, Brazil, during the years between 1980 and 1994</s1>
</fA08>
<fA11 dir="011000">
<s1>Suzana Alves de Moraes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Márcia Helena Vieira de Rezende</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Isabel Cristina Martins de Freitas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Escola de Enfermagem de Ribeirão Preto </s1>
<s2>Ribeirão Preto SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>498-502</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the trends of specific, standardized coefficients of mortality due to ischemic heart disease according to sex and age during the years 1980 and 1994 in the municipality of Goiania, GO, Brazil. METHODS: Data on deaths were retrieved from the Information on Mortality System of the Ministry of Health; population data were obtained from the Foundation of the Brazilian Institute for Geography and Statistics (IBGE). The trends of the specific coefficients were analyzed by triennia of the historical series, including individuals of both sexes from 25 years of age on, partitioned into 6 age groups of ten years intervals. The population data corresponding to the year 1980 were used as the standard for the calculation of each age group coefficient. Analyses were carried out by straight linear regression. RESULTS: Coefficients were greater for males in each triennium of the series and increased with age in both sexes. The study of the trends of the specific age coefficients of both sexes revealed a stable pattern of evolution up to the age of 65-74 years (P&gt;0.05). From 75 years on, a clear-cut decline in mortality due to ischemic heart disease was shown by both sexes. The standardized coefficients also showed a significant decline (p&lt;=0.05). CONCLUSION: The municipality of Goiânia is at present in a stage of epidemiological transition similar to that of developed countries, even though the observed decline is predominantly influenced by the mortality of older individuals (75 years of age or older).</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial ischemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>trend studies</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Safety and efficacy of angioplasty with intracoronary stenting in patients with unstable coronary syndromes. Comparison with stable coronary syndromes</s1>
</fA08>
<fA11 dir="011000">
<s1>Luís C. L. Correia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Carlos Brito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Andréa C. Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antônio M. Azevedo Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mário S. Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Heitor G. Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Péricles Esteves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Português  </s1>
<s2>Salvador BA</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>508-512</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess safety and efficacy of coronary angioplasty with stent implantation in unstable coronary syndromes. METHODS: Retrospective analysis of in-hospital and late evolution of 74 patients with unstable coronary syndromes (unstable angina or infarction without elevation of the ST segment) undergoing coronary angioplasty with stent placement. These 74 patients were compared with 31 patients with stable coronary syndromes (stable angina or stable silent ischemia) undergoing the same procedure. RESULTS: No death and no need for revascularization of the culprit artery occurred in the in-hospital phase. The incidences of acute non-Q-wave myocardial infarction were 1.4% and 3.2% (p=0.6) in the unstable and stable coronary syndrome groups, respectively. In the late follow-up (11.2±7.5 months), the incidences of these events combined were 5.7% in the unstable coronary syndrome group and 6.9% (p=0.8) in the stable coronary syndrome group. In the multivariate analysis, the only variable with a tendency to significance as an event predictor was diabetes mellitus (p=0.07; OR=5.2; 95% CI=0.9-29.9). CONCLUSION: The in-hospital and late evolutions of patients with unstable coronary syndrome undergoing angioplasty with intracoronary stent implantation are similar to those of the stable coronary syndrome group, suggesting that this procedure is safe and efficacious when performed in unstable coronary syndrome patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stent</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>unstable coronary syndromes</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Use of tandem stents for treatment of helicoidal dissection of the right coronary artery</s1>
</fA08>
<fA11 dir="011000">
<s1>Murillo K. Furukawa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Eduardo M. Domingues</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcos César V. de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Virgílio Ribeiro Franco Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Décio Salvadori Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Real e Benemérita Sociedade Portuguesa de Beneficência Hospital São Joaquim </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>516-518</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Coronary dissection occurs frequently and in several degrees during coronary angioplasty, which is one of the mechanisms for increasing the lumen diameter of a vessel. However the length of the dissection may affect the procedure, becoming the most frequent cause of total occlusion after coronary angioplasty. We report here a case of extensive dissection that occurred during the coronary angioplasty of a focused lesion, which we treated with two long stents.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Criteria for acceptance of records of ambulatory arterial pressure monitoring</s1>
</fA08>
<fA11 dir="011000">
<s1>Décio Mion Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Katia Coelho Ortega</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>519-519</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>03</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Right-sided heart failure in a 37-year-old man with systemic lupus erythematosus</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>526-530</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Analysis of the genetic component of coronary artery disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio de Padua Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>531-536</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>A review of the classification, diagnosis, and management of autonomic dysfunction syndromes associated with orthostatic intolerance</s1>
</fA08>
<fA11 dir="011000">
<s1>Blair P. Grubb</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sérgio do Carmo Jorge</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>The Medical College of Ohio  </s1>
<s2>Toledo Ohio</s2>
<s3>USA</s3>
</fA14>
<fA20 dir="000000">
<s1>545-552</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Management of chronic aortic regurgitation. From physician to surgeon</s1>
</fA08>
<fA11 dir="011000">
<s1>Flávio Tarasoutchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>266-268</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Myocardial revascularization with coronary endarterectomy. Stratification of risk factors for early mortality</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Antibas Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luís Alberto Oliveira Dallan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Augusto Ferreira Lisboa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fernando Platania</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Richard Halti Cabral</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Adib Domingos Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>275-280</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the risk factors for mortality related to myocardial revascularization when performed in association with coronary endarterectomy. METHODS: We assessed retrospectively 353 patients who underwent 373 coronary endarterectomies between January '89 and November '98, representing 3.73% of the myocardial revascularizations in this period of time. The arteries involved were as follows: right coronary artery in 218 patients (58.45%); left anterior descending in 102 patients (27.35%); circumflex artery in 39 patients (10.46%); and diagonal artery in 14 patients (3.74%). We used 320 (85.79%) venous grafts and 53 (14.21%) arterial grafts. RESULTS: In-hospital mortality among our patients was 9.3% as compared with 5.7% in patients with myocardial revascularizations without endarterectomy (p=0.003). Cause of death was related to acute myocardial infarction in 18 (54.55%) patients. The most significant risk factors for mortality identified were as follows: diabetes mellitus (p=0.001; odds ratio =7.168), left main disease (&lt;0.001; 9.283), female sex (0.01; 3.111), acute myocardial infarction (0.02; 3.546), ejection fraction &lt;35% (&lt;0.001; 5.89), and previous myocardial revascularization (&lt;0.001; 4.295). CONCLUSION: Coronary endarterectomy is related to higher mortality, and the risk factors involved are important elements of a poor outcome.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary endarterectomy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Response of blood pressure to maximum exercise in hypertensive patients under different therapeutic programs</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Angela Magalhães de Queiroz Carreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jamila Costa Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Antônio Caldas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Leandro Reis Tavares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eduardo Nani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense Hospital Universitário Antônio Pedro </s1>
<s2> RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>285-288</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the behavior of blood pressure during exercise in patients with hypertension controlled by frontline antihypertension drugs. METHODS: From 979ergometric tests we retrospectively selected 49 hipertensive patients (19 males). The age was 53±12 years old and normal range rest arterial pressure (&lt;=140/90 mmHg) all on pharmacological monotherapy. There were 12 on beta blockers; 14 on calcium antagonists, 13 on diuretics and 10 on angiotensin converting enzyme inhibitor. Abnormal exercise behhavior of blood pressure was diagnosed if anyone of the following criteria was detected: peak systolic pressure above 220 mmHg, raising of systolic pressure  &gt; or =  10 mmHg/MET; or increase of diastolic pressure greater than 15 mmHg. RESULTS: Physiologic response of arterial blood pressure occurred in 50% of patients on beta blockers, the best one (p&lt;0.05), in 36% and 31% on calcium antagonists and on diuretics, respectively, and in 20% on angiotensin converting enzyme inhibitor, the later the leastr one (p&lt;0.05). CONCLUSION: Beta-blockers were more effective than calcium antagonists, diuretics and angiotensin-converting enzyme inhibitors in controlling blood pressure during exercise, and angiotensin converting enzyme inhibitors the least effective drugs.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stress test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>antihypertension therapy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>PANDORA - Survey of Brazilian cardiologists about cholesterol reduction</s1>
</fA08>
<fA11 dir="011000">
<s1>Raul D. Santos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Andrei C. Spósito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Ernesto dos Santos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Francisco H. Fonseca</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Emílio H. Moriguchi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Tania L. R. Martinez</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Dikran Armaganijam</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Sérgio Timerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Ari Timerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>José C. Nicolau</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>José A. F. Ramires</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>296-302</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To report about a group of physicians' understanding of the recommendations of the II Brazilian Guidelines Conference on Dyslipidemias, and about the state of the art of primary and secondary prevention of atherosclerosis. METHODS: Through the use of a questionnaire on dyslipidemia, atherosclerosis prevention, and recommendations for lipid targets established by the II Brazilian Guidelines Conference on Dyslipidemias, 746 physicians, 98% cardiologists, were evaluated. RESULTS:Eighty-seven percent of the respondents stated that the treatment of dyslipidemia changes the natural history of coronary disease. Although most of the participants followed the total cholesterol recommendations (&lt;200mg/dL for atherosclerosis prevention), only 55.8% would adopt the target of LDL-C &lt;100 mg/dL for secondary prevention. Between 30.5 and 36.7% answered, in different questions, that the recommended level for HDL-C should be &lt;35mg/dL. Only 32.7% would treat their patients indefinitely with lipid- lowering drugs. If the drug treatment did not reach the proposed target, only 35.5% would increase the dosage, and 29.4% would change the medication. Participants did not know the targets proposed for diabetics. CONCLUSION: Although the participating physicians valued the role played by lipids in the prevention of atherosclerosis, serious deficiencies exist in their knowledge of the recommendations given during the II Brazilian Guidelines Conference on Dyslipidemias.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Hypercaulesterolomia atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Clinical and pathological assessment of 82 patients with cardiovascular diseases undergoing autopsy at the Hospital das Clínicas of the Faculdade de Medicina de Botucatu from 1988 to 1993</s1>
</fA08>
<fA11 dir="011000">
<s1>Reinaldo Ayer de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcos Augusto de Moraes Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rubens Ramos de Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Mário Rubens Guimarães Montenegro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual Paulista Faculdade de Medicina de Botucatu </s1>
<s2>Botucatu SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>308-312</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluated the clinical diagnostic, efficiency for basic death causes in patients dying of circulatory disease and de relative frequency of those diseases. METHODS: Analysis of medical record data of 82 patients, ages from 16 to 84 years old (68 over 40 years old), whose died of circulatory disease and had undergone necropsy in the period from 1988 to 1993 years in the University Hospital of Medicine Faculty of Botucatu-UNESP, Br. RESULTS: The functional class of patients were III or IV, in 78%, and 81.7% needed urgent hospitalization. By the clinical judgment the death were by ischemic heart disease in 32 (21 acute myocardial infarction), Chagas'disease in 12, valvopathy in 11, cardiomyopathy in 7, heart failure with no specification of cardiopathy in 11 and other causes in 9. At the necropsy the death cause was ischemic heart disease in 34 patients, valvopathy in 10, Chagas'disease in 10, cardiomyopathy in 5, and heart failure with no specification of cardiopathy in 2.The concordance taxes were in thhe same order: 94,6%, 90,0%, 83.3%, 71.4% and 28.5%. CONCLUSION: There was a great efficiency of clinical diagnosis for death cause in a general university hospital. The ischemic heart disease were the main causes of death.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>autopsy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Outcome of acute renal failure associated with cardiac surgery in infants</s1>
</fA08>
<fA11 dir="011000">
<s1>João Egídio Romão Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Miguel G. Fuzissima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Armando F. Vidonho Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Irene L. Noronha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Sérgio L. Quintaes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Hugo Abensur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Maria Regina T. Araújo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Ivanir Freitas Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Marcello Marcondes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Real e Benemérita Beneficência Portuguesa de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>318-321</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the impact of acute renal failure (ARF) on the evolution of infants undergoing cardiac surgery. METHODS: We assessed 15 infants undergoing cardiac surgery who developed (ARF). Their demographic, clinical and surgical data, and evolution were analyzed. RESULTS: Their mean age was 4.4±4.0 months (8 days to 24 months). Twelve infants were males, and 4 patients already had ARF at surgery. The primary cause of ARF was immediate acute cardiac dysfunction in 10 infants, cardiac dysfunction associated with sepsis in 2 infants, and isolated sepsis in 3 infants. All children depended on mechanical ventilation during their postoperative period, 14 infants used vasoactive drugs, and 11 had an infectious process associated with ARF. Thirteen infants required dialytic treatment. Eleven infants developed oluguric ARF, and all had to undergo peritoneal dialysis; of the 4 patients with non-oliguric, 2 required dialysis, the main indication being hypervolemia. Of these 13 dialyzed infants, 4 died in the first 24 hours because of the severity of the underlying cardiac disease (mean urea level of 49±20 mg/dl). The mortality rate for the entire group was 60% , and it was higher among the patients with oliguria ARF (73% vs 25%, p&lt;0.001). The cause of death was acute cardiac dysfunction in 6 infants (early type-1ARF) and sepsis in the 3 remaining infants (late type-2 ARF). CONCLUSION: The mortality rate of ARF associated with cardiac surgery in infants was hight, being higher among children with oliguria; peritoneal dialysis was indicated due to clinically uncontrolled hypervolemia and not to the uremic hypercatabolic state.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute renal failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>infants</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>peritoneal dialysis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Cantrell Syndrome. Case report of an adult</s1>
</fA08>
<fA11 dir="011000">
<s1>João Luiz Alencar Araripe Falcão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sandra Nívea dos Reis Saraiva Falcão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Wanda Cristina Sawicki</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Aroldo Walter Liberatori Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Carlos Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>326-328</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Cantrell syndrome is characterized by defects that involve the diaphragm, abdominal wall, pericardium, heart, and lower region of the sternum. It is a rare entity, usually diagnosed at birth and accompanied by high mortality due to the complexity and gravity of the anomalies. In this report, we present a 32-year-old male patient, who was diagnosed in infancy but who reached adult age asymptomatic.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>A 73-year-old woman with retrosternal pain but no obstructive coronary artery lesion on coronary angiography</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>334-338</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>08</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Beta-adrenergic blocking agents in heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Michel Batlouni</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Denilson Campos de Albuquerque</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>350-360</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>85</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Cardiac dysfunction in heart failure is widely recognized as a progressive process, regardless of the clinical signs and symptoms. An increase in cardiac sympathetic drive is one of the earliest neurohormonal responses occurring in patients with heart failure and may be one of the major causes of the progressive remodeling leading to the decline in myocardial function, and responsible for the poor prognosis of patients with heart failure. Therefore, recent data provided by several appropriately designed clinical trials clearly indicate the benefits of beta-adrenoceptor blocking agents, combined with diuretics, ACE inhibitors, and digoxin in chronic heart failure class II to IV due to systolic ventricular dysfunction. The benefits are related to symptoms, functional capacity, remodeling, and improvement in left ventricular function, reduction in cardiovascular hospitalization, a decrease in the overall and sudden cardiac death rate, and are similar in patients with ischemic or nonischemic cardiomyopathy, independent of age, gender, or functional class. In this review we describe the cardiovascular effects of the increase in sympathetic drive, the pharmacological properties of the beta-blockers most evaluated in heart failure therapy (metoprolol, bisoprolol, and carvedilol), the major clinical trials related to these agents in heart failure, the recommendations for their appropriate use in clinical practice, the precautions to be adopted, and how to handle the more common adverse reactions.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Coronary stent implantation in diabetic versus nondiabetic patients. Early and late outcomes</s1>
</fA08>
<fA11 dir="011000">
<s1>Denis Moulin Bayerl</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Erasmo Siqueira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Isaac Moscoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Elise Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alexandre Maeda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Oscar Bittencourt</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>M. Fernanda Mauro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Salvador Cristovão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Adnan Salman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Gustavo Sanches</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>José Armando Mangione</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital São Joaquim da Real e Benemérita Sociedade Portuguesa de Beneficência  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>365-368</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess whether coronary stenting in diabetic patients provides in-hospital results and clinical evolution similar to those in nondiabetic patients. METHODS: From July `97 to April '99 we performed coronary stent implantation in 386 patients with coronary heart disease, who were divided into two groups: diabetic patients and nondiabetic patients. The in-hospital results and the clinical evolution of each group were retrospectively analyzed. RESULTS: The nondiabetic group comprised 305 (79%) patients and the diabetic group 81 (21%) patients. Basic clinical and angiographic characteristics were similar. Angiographic success was in diabetics = 96.6% vs in nondiabetics = 97.9% (p=ns). Among the major complications in the in-hospital phase, the rate of myocardial infarction was higher in the diabetic group (7.4% vs 1.9%) (p=0.022). In the follow-up, a favorable and homogeneous evolution occurred in regard to asymptomatic patients, myocardial infarction, and death in the groups. A greater need for revascularization, however, existed in the diabetic patients (15% vs 2.4%, p&lt;0.001). CONCLUSION: Coronary stenting in diabetic patients is an efficient procedure, with a high angiographic and clinical success rate similar to that in nondiabetic patients. Diabetic patients, however, had a higher incidence of in-hospital myocardial infarction and a greater need for additional myocardial revascularization.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diabetes mellitus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary stent</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Mortality due to cardiovascular disease in women during the reproductive age (15 to 49 years), in the State of São Paulo, Brazil, from 1991 to 1995</s1>
</fA08>
<fA11 dir="011000">
<s1>Nagib Haddad</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Barbosa da Silva</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Secretaria de Estado da Saúde de São Paulo Instituto Dante Pazzanese de Cardiologia </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>375-379</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To describe mortality due to cardiovascular diseases in women during the reproductive age (15 to 49 years) in the state of São Paulo, Brazil, from 1991 to 1995. METHODS: A list of all deaths and their underlying causes, coded according to the International Classification of Diseases, 9th revision, multiple causes of death, and estimates of the female population according to age groups were provided by the SEADE Foundation. Specific coefficients for 100 thousand women for each year as well as the medians of these coefficients related to 5 years, and the percentage of death by subgroups were calculated. RESULTS: Cerebrovascular diseases have the highest coefficients (14.24 for 100 thousand females), followed by ischemic heart disease (7.37), other heart diseases (6.39), hypertensive disease (3.03), chronic rheumatic heart disease (1.58), pulmonary vascular diseases (1.29), and active rheumatic fever (0.05). Systemic arterial hypertension, as an associated cause, occurred in 55.3% to 57.8% of all the deaths due to intracerebral hemorrhage and in 30.4% to 30.8% due to subarachnoid hemorrhage. CONCLUSION: The significance of cerebrovascular diseases, coronary artery disease, and systemic arterial hypertension as causes of mortality suggests the need to emphasize preventive actions for young women who have the potential to reproduce to avoid possible complications in future pregnancies, and premature mortality.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>female mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cerebrovascular diseases</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Mitral valve repair with a malleable bovine pericardium ring</s1>
</fA08>
<fA11 dir="011000">
<s1>Marco Antônio Volpe</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Domingo Marcolino Braile</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Reinaldo Wilson Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Dorotéia Rossi Silva Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Campinas Faculdade de Ciências Médicas </s1>
<s2> SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>389-396</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>50</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To describe a surgical procedure utilizing a malleable bovine pericardium ring in mitral valve repair and clinical and echodopplercadiographic results. METHODS: Thirty-two (25 female and 7 male) patients, aged between 9 and 66 (M=36.4±17.2) years, were studied over a 16-month period, with 100% follow-up. In 23 (72%) of the patients, the mitral approach was the only one applied; 9 patients underwent associated operations. The technique applied consisted of measuring the perimeter of the anterior leaflet and implanting, according to this measurement, a flexible bovine pericardium prosthesis for reinforcement and conformation of the posterior mitral annulus, reducing it to the perimeter of the anterior leaflet with adjustment of the valve apparatus. RESULTS: The patient survival ratio was 93.8%, with 2 (6.2%) fatal outcomes, one from unknown causes, the other due to left ventricular failure. Only one reoperation was performed. On echodopplercardiography, 88% of the patients had functional recovery of the mitral valve (50% without and 38% with mild insufficiency and no hemodynamic repercussions). Of four (12%) of the remaining patients, 6% had moderate and 6% had seigre insufficiency. Twenty-eight percent of class II patients and 72% of class III patients passed into classes I (65%), II (32%), and III (3%), according to NYHA classification criteria. CONCLUSION: Being flexible, the bovine pericardium ring fit perfectly into the valve annulus, taking into account its geometry and contractility. Valve repair was shown to be reproducible, demonstrating significant advantages during patient evolution, which did not require anticoagulation measures.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valve surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>annuloplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>bovine pericardium</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Short-term follow-up of patients after aneurysmectomy of the left ventricle</s1>
</fA08>
<fA11 dir="011000">
<s1>Wilson Luiz da Silveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Adélio Ferreira Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Érica Coelho Garcia Soares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Max Weyler Nery</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antônio Fernando Carneiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Vilmondes Gonçalves de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Santa Genoveva Grupo CentroCardio </s1>
<s2>Goiânia GO</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>401-404</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>39</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Left ventricular aneurysm is a complication of myocardial infarction that can best be treated by reconstructive surgeries that can restore ventricular geometry. We analyzed immediate results in a group of consecutive patients who underwent surgical correction of left ventricular aneurysms. METHODS: From January '90 to August '99, 94 patients - mean age 58.4 (ranging from 36 to 73 years), 65 (69.1%) males and 9 ( 30.8%) females - were operated upon. Pre-operative ejection fraction ranged from 0.22 to 0.58 (mean = 0.52), and the aneurysm was located in the antero-lateral area in 90.4% of the cases. Functional class III and IV (NYHA) was present in 82 (87.2%) patients, and 12 (12.7%) were in functional class I and II. Congestive heart failure was the most frequent cause (77.6%), occurring in isolation in 24.4% or associated with coronary artery diseases in 53.2%. RESULTS: Short-term follow-up showed a 7.4% mortality, and low cardiac output was the main cause of death. Coming off pump was uneventful in 73 patients (77.6%), with a 3.2% mortality and with the use of inotropics in 20 (21.3%). One patient (1%) did not come off the pump. CONCLUSION: Surgical correction was adequate in the immediate follow-up of operated patients, and mortality was higher in patients with higher functional class.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular aneurysm</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Cardiac findings in 31 patients with Noonan's syndrome</s1>
</fA08>
<fA11 dir="011000">
<s1>Débora Romeo Bertola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ae Kim Chong</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sofia M. M. Sugayama</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Lilian Maria José Albano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Jaqueline Wagenführ</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Regina Lúcia Moysés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Claudette Hajaj Gonzalez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Instituto da Criança</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>409-412</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate cardiac findings in 31 Noonan syndrome patients. METHODS: Thirty-one (18 males and 13 females)patients from 26 families affected with Noonan's syndrome were evaluated from the cardiac point of view with electrocardiography and echodopplercardiography. RESULTS: Twenty patients had some type of cardiac abnormality. The most frequent was pulmonary valve stenosis followed by hypertrophic myocardiopathy, commonly associated with valve defects. Upper deviation of the QRS axis was observed in 80% of these patients. CONCLUSION: In view of the high frequency and diversity of cardiac abnormalities present in Noonan syndrome, cardiac evaluation with electrocardiography and echocardiography should be performed in all patients diagnostically suspected of having this disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Noonan syndrome</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary valve stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertrophic myocardiopathy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Bacal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Viviane Cordeiro Veiga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alfredo Inácio Fiorelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Giovanni Bellotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Edimar Alcides Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Noedir Antonio Groppo Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>421-428</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>46</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study the influence of immune and nonimmune risk factors on the development of allograft vasculopathy after cardiac transplantation. METHODS: We studied 39 patients with a mean age of 46±12 years. The following variables were analyzed: weight (kg), body mass index (kg/m²), donor's age and sex, rejection episodes in the first and second years after transplantation, systolic and diastolic blood pressures (mmHg), total cholesterol and fractions (mg/dL), triglycerides (mg/dL), diabetes, and cytomegalovirus infection. The presence of allograft vasculopathy was established through coronary angiography. RESULTS: Allograft vasculopathy was observed in 15 (38%) patients. No statistically significant difference was observed between the two groups in regard to hypertension, cytomegalovirus infection, diabetes, donor's sex and age, rejection episodes in the first and second years after transplantation, and cholesterol levels. We observed a tendency toward higher levels of triglycerides in the group with disease. Univariate and multivariate analyses showed statistically significant differences between the two groups when we analyzed the body mass index (24.53±4.3 versus 28.11±4.6; p=0.019). CONCLUSION: Body mass index was an important marker of allograft vasculopathy in the population studied.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac transplantation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>allograft vasculopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>body mass index</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Clinical significance of in-hospital reocclusion after mechanical reperfusion and percutaneous transluminal coronary angioplasty for acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Eva Cantalejo Munhoz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Franco de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Irmandade da Santa Casa de Misericórdia de Curitiba  </s1>
<s2>Curitiba PR</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>436-441</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>74</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the effects of in-hospital reocclusion of reperfused AMI culprit coronary arteries in mortality and to identify the predictors. METHODS: The present study comprises a sample of 155 patients with AMI who underwent successful mechanical reperfusion by direct coronary angioplasty and angiographic control during hospitalization or before discharge. Patients were classified into group A: reoccluded patients (n=30) and group B: non-reoccluded patients (n=125). RESULTS: We identified in-hospital reocclusion predictors and found a greater significance in mortality among reoccluded patients (23,3% x 1.6%; p=0.00004). Silent reocclusion or typical angina at reocclusion had a good prognosis. The independent predictors of in-hospital mortality were hypertension, multiarterial lesions, totally occluded AMI culprit lesions, failed redilatation, failed redilatation in comparison with no intention to redilate, no redilatation in comparison with no atempt to redilate, and reocclusion within the first 48 to 72 hours. The decision to redilate, independently of the result, led to a 50.0% reduction in hospital mortality (p=0.0366). CONCLUSION: In-hospital AMI culprit coronary artery reocclusion had an adverse effect similar to that reported in clinical studies with high mortality rates (23.3% x 1.6%; p=0.00004). The major contribution of this study is to recommend the reopening of reoccluded AMI culprit coronary arteries as a means for the management of coronary artery reocclusion.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary reocclusion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>reinfarction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Cardiac tamponade in systemic lupus erythematosus. Report of four cases</s1>
</fA08>
<fA11 dir="011000">
<s1>Márcia Bueno Castier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Elisa M. Neves Albuquerque</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Eduarda F. Costa Castro Menezes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Evandro Klumb</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Francisco Manes Albanesi Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual do Rio de Janeiro Hospital Universitário Pedro Ernesto </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>446-448</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>45</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To report and assess the incidence of cardiac tamponade in systemic lupus erythematosus as a cardiac manifestation of the disease. METHODS: We reviewed the medical records of 325 patients diagnosed with systemic lupus erythematosus according to the American Rheumatism Association and their complementary laboratory tests compatible with cardiac tamponade. RESULTS: In the 325 medical recors reviewed, we found 108 patients with pericardial effusions corresponding to 33.2% of the total and 54% of the patients studied in the active phase of the disease. Clinical assessment and transthoracic echocardiogram allowed the clinical diagnosis of cardiac tamponade in only 4 (1.23%) patients, 3 of whom were females, white, with ages ranging from 25 to 44 years. The pericardial fluid was hemorrhagic or serosanguineous with high levels of FAN and positivity for LE cells. In the treatment, we successfully used pericardicentesis associated with high doses of corticosteroids. In clinical and laboratory follow-up performed for a period of 3 years, neither recrudescence of the pericardial effusion nor evolution to constriction occurred. CONCLUSION: Even though rare (1.23%), cardiac tamponade in patients with systemic lupus erythematosus has a benign evolution when properly treated, according to our experience.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac tamponade</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>systemic lupus erythematosus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pericardial effusion</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>The degree of activation of cardiac muscle depends on muscle length</s1>
</fA08>
<fA11 dir="011000">
<s1>Dilson J. E. Rassier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Vale do Rio dos Sinos  </s1>
<s2>São Leopoldo RS</s2>
<s3>Brasil</s3>
</fA14>
<fA20 dir="000000">
<s1>454-457</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>37</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Critical analysis of diagnostic methods in pediatric cardiology</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>04-06</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Atrioventricular pacemaker. Incidence and causes of reprogramming in long-term follow-up</s1>
</fA08>
<fA11 dir="011000">
<s1>Martino Martinelli Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sylton de Arruda Melo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Silvana A. D. Nishióka</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Anísio A. A. Pedrosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sérgio Freitas de Siqueira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Roberto Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Eduardo Sosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>11-14</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the incidence of problems requiring reprogramming of atrioventricular pacemakers in a long-term follow-up, and also the causes for this procedure. METHODS: During the period from May '98 to December '99, 657 patients were retrospectively studied, An actuarial curve for the event reprogramming of the stimulation mode was drawn. RESULTS: The follow-up period ranged from 12 to 178 months (mean = 81 months). Eighty-two (12.4%) patients underwent reprogramming of the stimulation mode as follows: 63 (9.5%) changed to VVI,(R/C); 10 (1.5%) changed to DVI,C; 6 (0.9%) changed to VDD,C; and 3 (0.5%) changed to DOO. The causes for the reprogramming were as follows: arrhythmia conducted by the pacemaker in 39 (37.6%) patients; loss of atrial sensitivity or capture, or both, in 39 (38.6%) patients; and microfracture of atrial electrode in 5 (4.9%) patients. The stimulation mode reprogramming free probability after 15 years was 58%. CONCLUSION: In a long-term follow-up, the atrioventricular pacemaker provided a low incidence of complications, a high probability of permanence in the DDD,C mode, and the most common cause of reprogramming was arrhythmia conducted by the pacemaker.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrioventricular pacemaker</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>reprogramming</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>DDD,Cmode</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Echocardiographic assessment of the different left ventricular geometric patterns in hypertensive patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Delma Maria Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ademir Batista da Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Wolney de Andrade Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luís Augusto de Freitas Pinheiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luís José Martins Romêo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Álvaro Vilela de Moraes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Fernando Portugal Morcerf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense  </s1>
<s2>Niterói RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>22-28</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>37</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To identiy left ventricular geometric patterns in hypertensive patients on echocardiography, and to correlate those patterns with casual blood pressure measurements and with the parameters obtained on a 24-hour ambulatory blood pressure monitoring. METHODS: We studied sixty hypertensive patients, grouped according to the Joint National Committee stages of hypertension.. Using the single- and two-dimensional Doppler Echocardiography, we analyzed the left ventricular mass and the geometric patterns through the correlation of left ventricular mass index and relative wall thickness. On ambulatory blood pressure monitoring we assessed the means and pressure loads in the different geometric patterns detected on echocardiography RESULTS: We identified three left ventricular geometric patterns: 1) concentric hypertrophy, in 25% of the patients; 2) concentric remodeling, in 25%; and 3) normal geometry, in 50%. Casual systolic blood pressure was higher in the group with concentric hypertrophy than in the other groups (p=0.001). Mean systolic pressure in the 24h, daytime and nighttime periods was also higher in patients with concentric hypertrophy, as compared to the other groups (p=0.003, p=0.004 and p=0.007). Daytime systolic load and nighttime diastolic load were higher in patients with concentric hypertrophy ( p=0.004 and p=0.01, respectively). CONCLUSIONS: Left ventricular geometric patterns show significant correlation with casual systolic blood pressure, and with means and pressure loads on ambulatory blood pressure monitoring.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Noninvasive diagnosis of allograft vascular disease after heart transplantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Bacal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Noedir Antonio Groppo Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Viviane Cordeiro Veiga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>William A. Chalela</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Cesar Grupi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Ana Clara Rodrigues</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Eulógio E. Martinez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Alfredo Inácio Fiorelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Luiz Felipe Pinho Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Edimar Alcides Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Giovanni Bellotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Instituto do Coração do Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>36-42</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>47</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the predictive values of noninvasive tests for the detection of allograft vascular disease. METHODS: We studied 39 patients with mean ages of 48±13 years and a follow-up period of 86±13 months. The diagnosis of allograft vascular disease was made by cine-coronary arteriography, and it was considered as positive if lesions existed that caused  &gt; or = 50% obstruction of the lumen. Patients underwent 24h Holter monitoring, thallium scintigraphy, a treadmill stress test, and dobutamine stress echocardiography. Sensitivity, specificity, and positive and negative predictive values were determined in percentages for each method, as compared with the cine-coronary arteriography results. RESULTS: Allograft vascular disease was found in 15 (38%) patients. The Holter test showed 15.4% sensitivity, 95.5% specificity. For the treadmill stress test, sensitivity was 10%, specificity was 100%. When thallium scintigraphy was used, sensitivity was 40%, specificity 95.8%. On echocardiography with dobutamine, we found a 63.6% sensitivity, 91.3% specificity. When the dobutamine echocardiogram was associated with scintigraphy, sensitivity was 71.4%, specificity was 87%. CONCLUSION: In this group of patients, the combination of two noninvasive methods (dobutamine echocardiography and thallium scintigraphy) may be a good alternative for the detection of allograft vascular disease in asymptomatic patients with normal ventricular function.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart transplantation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>allograft vascular disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diagnostic methods</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Immunologic evaluation in infective endocarditis</s1>
</fA08>
<fA11 dir="011000">
<s1>Wilma C. Neves Forte</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Aline C. Mario</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Adilson da Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luciana S. Henriques</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Carla L. Gonzales</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Roberto A. Franken</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa de Misericórdia de São Paulo Faculdade de Ciências Médicas </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>48-52</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the immune response in peripheral blood of patients with infective endocarditis. METHODS: We studied 10 patients with infective endocarditis, age range from 20 to 50 years-old, males and females, and 20 healthy subjects in the same age range. The diagnosis of the disease was based on the clinical picture, echocardiogram, and hemoculture based upon samples drawn and tested before the treatment started. The were no history of atopy or malnutrition, no autoimmune disease, and they were not using any immunosuppressant or antibiotic medication. RESULTS: The patients with endocarditis had significantly higher T and B lymphocyte, CD4+ and CD8+ cell counts, IgM and IgG serum levels, and C4 component of the complement than the control group; no significant difference concerning serum IgA and neutrophil oxidative metabolism; a significant decrease in C3, chemotaxis, and monocyte phagocytosis;cryoglobulins were detected in 66.6% of patients and they were formed by IgG, IgM, IgA, C3, and C4. CONCLUSION: The patients with infective endocarditis were immunocompetent in most sectors of immune response and, at a certain moment, an autoimmune component may be present.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cryoglobulin</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endocarditis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>immune response</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>autoimmunity</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Acute myocardial infarction in progressively elderly patients. A comparative analysis of immediate results in patients who underwent primary percutaneous coronary intervention</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Alberto Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alexandre Zago</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Áurea Chaves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ibraim Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz Tanajura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rodolfo Staico</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Marinella Centemero</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Fausto Feres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Galo Maldonado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Manoel Cano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Andréa Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Alexandre Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="131000">
<s1>Amanda G.M.R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="141000">
<s1>J. Eduardo Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>58-62</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Analysis of the in-hospital results, in progressively elderly patients who undergo primary percutaneous coronary intervention (PCI) in the first 24 hours of AMI. METHODS: The patients were divided into three different age groups (60/69, 70/79, and  &gt; or = 80 years) and were treated from 7/95 until 12/99. The primary success rate and the occurrence of major clinical events were analyzed at the end of the in-hospital phase. Coronary stent implantation and abciximab use were employed at the intervencionist discretion. RESULTS: We analyzed 201 patients with age ranging from 60 to 93 years, who underwent primary PCI. Patients with ages above 70 were more often female (p=.015). Those with ages above 80 were treated later with PCI (p=.054), and all of them presented with total occlusion of the infarct-related artery. Coronary stents were implanted in 30% of the patients. Procedural success was lower in  &gt; or = 80 year old patients (p=.022), and the death rate was higher in  &gt; or = 70 years olds (p=.019). Reinfarction and coronary bypass surgery were uncommon events. A trend occurred toward a higher combined incidence of major in-hospital events according to increased age (p=.064). CONCLUSION: Elderly patients ( &gt; or = 70 years) presented with adverse clinical and angiographic profiles and patients  &gt; or = 80 years of age obtained reduced TIMI 3 flow success rates after primary PTCA, and those  &gt; or = 70 years had a higher death rate.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Catecholaminergic polymorphic ventricular tachycardia. An important diagnosis in children with syncope and normal heart</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Roberto Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Kleber R. Ponzi Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sílvio R. B. Alessi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Angelo A. V. de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>São Paulo Federal University Paulista School of Medicine </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>69-74</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Syncope in children is primarily related to vagal hyperreactivity, but ventricular tachycardia (VT) way rarely be seen. Catecholaminergic polymorphic VT is a rare entity that can occur in children without heart disease and with a normal QT interval, which may cause syncope and sudden cardiac death. In this report, we describe the clinical features, treatment, and clinical follow-up of three children with syncope associated with physical effort or emotion and cathecolaminergic polymorphic VT. Symptoms were controlled with beta-blockers, but one patient died suddenly in the fourth year of follow-up. Despite the rare occurrence, catecholaminergic polymorphic VT is an important cause of syncope and sudden death in children with no identified heart disease and normal QT interval.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Sudden death in Chagas' disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Anis Rassi Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sérgio Gabriel Rassi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Anis Rassi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital São Salvador  </s1>
<s2>Goiânia GO</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>86-96</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>114</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Correlação clínico-radiográfica</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>97-97</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>In Memoriam</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Monteiro</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>98-98</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Enhancing longevity of pacemakers through reprogramming. Underutilization and cost-effectiveness</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Luiz Pinho Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leonor Garcia Rincón</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Bruna Guimarães Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cleonice Carvalho Mota</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marco Túlio Bacarini Pires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Minas Gerais Faculdade de Medicina Hospital das Clínicas</s1>
<s2>Belo Horizonte MG</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>441-444</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: This study was performed to observe the number of pacemakers that had never been reprogrammed after implantation, and the effect of optimised output programming on estimated longevity of pulse generators in patients with pacemaker METHODS: Sixty patients with Teletronics Reflex pacemakers were evaluated in a pacemaker clinic, from the time of the beginning of its activities, in June 1998, until March 1999. Telemetry was performed during the first clinic visit, and we observed how many pulse generators retained nominal output settings of the manufactures indicating the absence of reprogramming until that date. After evaluation of the capture threshold, reprogramming of pacemakers was performed with a safety margin of 2 to 2.5:1, and we compared the estimated longevity based on battery current at the manufacturer's settings with that based on settings achieved after reprogramming. RESULTS: In 95% of the cases, the original programmed setting was never reprogrammed before the patients attended the pacemaker clinic. Reprogramming the pacemaker prolonged estimated pulse generator life by 19.7±15.6 months (35.5%). CONCLUSION: The majority of the pacemakers evaluated had never been reprogrammed. Estimated pulse generator longevity can be prolonged significantly, using this simple, safe, efficacious, and cost-effective procedure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>artificial cardiac stimulation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>telemetry</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cost-effectiveness</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Establishing the prevalence of hypertension. Influence of sampling criteria</s1>
</fA08>
<fA11 dir="011000">
<s1>Sandra Costa Fuchs</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Juliano G. Petter</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Melissa C. Accordi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Vanessa L. Zen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antônio D. Pizzol-Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Leila Beltrami Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Flávio Danni Fuchs</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Faculdade de Medicina Hospital de Clínicas de Porto Alegre</s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>449-452</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To compare the prevalence of systemic hypertension in two different populations: a representative sample of the adult urban population of Porto Alegre, and individuals who sought blood pressure measurement in a hypertension prevention and control campaign. METHODS: A cross-sectional study was carried out involving a representative sample of the adult urban population of Porto Alegre and a population sample obtained from a hypertension prevention and control campaign, which included all the individuals who sought the blood pressure assessment unit at the Hospital das Clínicas in Porto Alegre. The following parameters were investigated: history of hypertension, use of antihypertensive drugs, age, and sex. Adjustments for age and sex in the prevalence rates were performed to make them comparable. RESULTS: Hypertension prevalence, defined as values  &gt; or = 160/95mmHg or treatment with antihypertensive drugs, was higher in the campaign sample (42%) as compared with the population sample (24%). Among those who were aware of their hypertensive condition and were under medication, 54% of the campaign sample and 62% of the representative population sample maintained their pressure levels &lt;160/90mmHg. CONCLUSION: Prevalence rates of hypertension differed a lot in the campaign sample and in the representative population sample, showing that the sampling criterion may influence assessment of risk factors and bias the association between risk factors and health aggravations.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sampling</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prevalence</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Clinical impact of transesophageal echocardiography in patients with stroke without clinical evidence of cardiovascular sources of emboli</s1>
</fA08>
<fA11 dir="011000">
<s1>Solange Bernardes Tatani</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Márcia Maiumi Fukujima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>João Augusto Costa Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Darcy Cortez Ferreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Claudia G. Monaco Ghefter</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Gilmar Fernandes Prado</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Zara Babayan</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Lyamara Apostólico de Azevedo</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>458-461</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: The purpose of this study is to evaluate the impact of transeophageal echocardiography on management of patients at low-risk for cardiogenic embolism to prevent new potential cardiovascular sources of emboli. METHODS: We studied 69 patients with ischemic stroke at low-risk for cardiogenic embolism. Transeophageal echocardiography was performed to access: left atrium enlargement; communication or aneurysm of the interatrial septum; patent foramen ovale; spontaneous echo contrast or intracavitary thrombi; the presence of intraaortic atherosclerotic plaques or thrombi; significant valvar morphologic alteration or dysfunction; left ventricle enlargement, hypertrophy, or contractile abnormality. Transesophageal echocardiography altered clinical management, and we adopted anticoagulant therapy or another procedure apart from the use of acetylsalicylic acid. RESULTS: Transeophageal echocardiography detected at least one abnormality in 40 cases (58%). Clinical conduct was adjusted after the performance of transesophageal echocardiography in 11 patients (15.9%); anticoagulation was added in 10 cases and surgical correction in one patient. CONCLUSION: Transeophageal echocardiography was a very useful tool in the secondary prevention for stroke in patients at low risk for cardiogenic embolism.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>transeophageal echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stroke</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>embolism</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Diet and medication in the treatment of hyperuricemia in hypertensive patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria do Rosário Gondim Peixoto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Estelamaris Tronco Monego</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo César B. Veiga Jardim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Magna Maria Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ana Luiza Lima Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Jonivan Siqueira de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Otavio Balestra Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Goiás Faculdades de Medicina Enfermagem e Nutrição </s1>
<s2>Goiânia GO</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>468-472</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the effects of diet and medication, either isolated or associated, on serum levels of uric acid in patients with hyperuricemia. METHODS: We studied patients from the Hypertension Unit of the University of Goias who had hyperuricemia (men  &gt; or = 8.5mg/dL and women  &gt; or = 7.5mg/dL). We divided the patients into three groups: G1 (low purine diet), G2 (low purine diet + medication), and G3 (medication only). Patients received allopurinol, 150mg/day titrated up to 300mg/dL when necessary. Patients were evaluated with regards to their lifestyles (diet, smoking, physical, activity, alcohol consumption), uric acid, blood pressure, use of medication, body mass index, cholesterol, and triglyceride. Follow-up took place in weeks 0 (M1), 6 (M2), 12 (M3) during the intervention and in week 36(M4) after the study was completed. RESULTS: Fifty-five patients participated in the study, 31 women, mean age 54.4±10.6 years, body mass index 28.6±3.9kg/m². A similar reduction (p&lt;0.001) in uric acid levels occurred in the three intervention groups. In week 36 (M4), after 24 weeks without intervention, a tendency toward elevation of uricemia was noted in G2 and G3, and a continuous drop in uricemia was noted in G1. No significant modifications were observed in the other variables analyzed. CONCLUSION: Considering the cost x benefit relationship, a diet low in purine should be the 1st therapeutic option for controlling hyperuricemia in patients with similar characteristic to the ones presented in this study.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>uric acid</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>low-purine diet</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Influence of the echocardiographic score and not of the previous surgical mitral commissurotomy on the outcome of percutaneous mitral balloon valvuloplasty</s1>
</fA08>
<fA11 dir="011000">
<s1>Edison C. Sandoval Peixoto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rodrigo T. Sandoval Peixoto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ivana Picone Borges</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Sérgio de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marta Labrunie</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Mário Salles Netto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ronaldo A. Villela</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Pierre Labrunie</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Guilherme A. Xavier de Brito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Ricardo T. Sandoval Peixoto</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>478-482</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate prior mitral surgical commissurotomy and echocardiographic score influence on the outcomes and complications of percutaneous mitral balloon valvuloplasty. METHODS: We performed 459 complete mitral valvuloplasty procedures. Four hundred thirteen were primary valvuloplasty and 46 were in patients who had undergone prior surgical commissurotomy. The prior commissurotomy group was older, had higher echo scores, and a tendency toward a higher percentage of atrial fibrillation. RESULTS: When the groups were compared with each other, no differences were found in pre- and postprocedure mean pulmonary artery pressure, mean mitral gradient, mitral valve area, and mitral regurgitation . Because we found no significant differences, we subdivided the entire group based on echo scores, those with echo scores &lt;=8 and those with echo scores &gt;8 the mitral valve area being higher in the &lt;=8 echo score group 2.06±0.42 versus 1.90±0.40cm² (p=0.0090) in the &gt;8 echo score group. CONCLUSION: Dividing the groups based on echo score revealed that the higher echo score group had smaller mitral valve areas postvalvuloplasty.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous mitral balloon valvuloplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prior mitral commissurotomy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral stenosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>The use of primary stenting or balloon percutaneous transluminal coronary angioplasty for the treatment of acutely occluded saphenous vein grafts. Results from the Brazilian National Registry - CENIC</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Alberto Mattos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Amanda G.M.R. Sousa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cantídio de Moura Campos Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>André Labrunie</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Cláudia Rodrigues Alves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fausto Feres</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Milton Macedo Soares Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Jamil Saad</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>490-495</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: We conducted a comparative analysis of the in-hospital outcomes of patients who underwent primary percutaneous transluminal angioplasty (PTCA) or stent implantation because of an acute myocardial infarction (AMI) related to an acute vein graft occlusion. METHODS: Since 1991 the Brazilian Society of Hemodynamic and Interventional Cardiology has maintained a large database (CENIC). From these, we selected all consecutive patients, who underwent primary PTCA or stenting in the first 24 hours of AMI, with the target vessel being an occluded vein graft. Immediate results and major coronary events occurring up until hospital discharge were analyzed. RESULTS: During this period, 5,932 patients underwent primary PTCA or stenting; 158 (3%) of the procedures were performed because of an acute vein graft occlusion. Stenting was performed in 74 (47%) patients. Patients treated with stents had a higher success rate and lower mean residual stenosis compared with those who underwent primary balloon PTCA. The incidence of reinfarction and death were similar for stenting and balloon PTCA. CONCLUSION: Primary percutaneous treatment of AMI related to acute vein graft occlusion is still an uncommon practice. Primary stenting improved luminal diameter and offered higher rates of success; however, this strategy did not reduce the in-hospital reinfarction and death rate, compared with that occurring with PTCA treatment.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>bypass</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stents</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Trends in death from circulatory diseases in Brazil between 1979 and 1996</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio de Padua Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Desidério Favarato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria de Fátima Marinho de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Solange Desirée Avakian</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Mendes Aldrighi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luiz Antonio Machado César</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>504-510</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>45</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the trends in mortality due to circulatory diseases in men and women aged  &gt; or = 30 years in Brazil from 1979 to 1996. METHODS: We analyzed population count data obtained from the IBGE Foundation and mortality data obtained from the System of Information on Mortality of the DATASUS of the Ministry of Health. RESULTS: Circulatory diseases, ischemic heart disease, and cerebrovascular disease were the major causes of death in men and women in Brazil. The standardized age coefficient for circulatory disease in men aged  &gt; or = 30 years ranged from 620 to 506 deaths/100,000 inhabitants and in women from 483 to 383 deaths/100,000 inhabitants for the years 1979 and 1996, respectively. In men, the mean coefficient for the period was 586.25 deaths with a significant trend towards a decrease (P&lt;0.001) and a decline of 8.25 deaths/year. In women, the mean coefficient for the period was 439.58 deaths, a significant trend towards a decrease (P&lt;0.001) and a rate of decline of 7.53 deaths/year. The same significant trend towards a decrease in death (P&lt;0.001) was observed for ischemic heart disease and cerebrovascular disease. Risk of death from these causes was always higher for men of any age group (P&lt;0.001). Cerebrovascular disease was the primary cause of death in women. CONCLUSION: Although circulatory diseases have been the major cause of mortality in men and women in the Brazilian population, with a greater participation by cerebrovascular diseases, a trend towards a decrease in the risk of death from these causes is being observed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>circulatory disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemic heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cerebrovascular disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>trends</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Double-outlet left ventricle. Echocardiographic diagnosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Lilian Maria Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paula Iamac Nomura de Rangel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Angela Maria Broglio Soraggi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Beatriz Helena Sanches Furlanetto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Gláucio Furlanetto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Real e Benemérita Sociedade Portuguesa de Beneficência de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>514-516</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>This is a case report of a double-outlet left ventricle associated with tricuspid atresia and hypoplasia of the right ventricle, diagnosed during echocardiography with color-flow imaging, in a three-month-old child who presented with fatigue and cyanosis. The child underwent palliative pulmonary arterial banding without an invasive procedure, and showed sustained improvement during follow-up.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Twenty-year-old woman with pulmonary hypertension, syncope, and severe headache</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Bocayuva Cauduro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Moacyr Roberto Cucê Nobre</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Léa M. M. F. Demarchi</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>525-532</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Correlação Clínico-Radiográfica</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>533-533</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Noninvasive diagnostic evaluation for chest pain in women</s1>
</fA08>
<fA11 dir="011000">
<s1>William A. Chalela</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio P. Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José M. Aldrighi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>540-544</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600611</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Effectiveness of primary angioplasty in the treatment of acute myocardial infarction. Analysis of in-hospital and late outcomes in 135 consecutive cases</s1>
</fA08>
<fA11 dir="011000">
<s1>Rogério Sarmento Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ana Maria Krepsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos A.M. Gottschall</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>213-220</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>60</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Evaluate early and late evolution of patients submitted to primary coronary angioplasty for acute myocardial infarction. METHODS: A prospective study of 135 patients with acute myocardial infarction submitted to primary transcutaneous coronary angioplasty (PTCA). Success was defined as TIMI 3 flow and residual lesion &lt;50%. We performed statistical analyses by univariated, multivariated methods and survival analyze by Kaplan-Meier. RESULTS: PTCA success rate was 78% and early mortality 18,5%. Killip classes III and IV was associated to higher mortality, odds ratio 22.9 (95% CI: 5,7 to 91,8) and inversely related to age &lt;75 years (OR = 0,93; 95% CI: 0.88 to 0.98). If we had chosen success flow as TIMI 2 and had excluded patients in Killip III/IV classes, success rate would be 86% and mortality 8%. The survival probability at the end or study, follow-up time 142 ± 114 days, was 80% and event free survival 35%. Greater survival was associated to stenting (OR = 0.09; 0.01 to 0.75) and univessel disease (OR = 0.21; 0.07 to 0.61). CONCLUSION: The success rate was lower and mortality was higher than randomized trials, however similar to that of non randomized studies. This demonstrated the efficacy of primary PTCA in our local conditions.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemic heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>primary percutaneous transluminal coronary angioplasty</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Mini-sternotomy for the treatment of aortic valve lesions</s1>
</fA08>
<fA11 dir="011000">
<s1>Altamiro Ribeiro Dias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo Ribeiro Dias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fábio Gaiotto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Lima O. Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Filinto M.C.N. Cerqueira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Roney Sampaio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Paulo de Lara Lavitola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Nelson Elias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Flávio Tarasoutchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Luiz F. Cardoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Noedir A. G. Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>225-228</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>6</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To compare inverted-L mini-sternotomy performed above the sternal furcula with conventional sternotomy in patients with aortic valve diseases who undergo surgical treatment. METHODS: We operated upon 30 patients who had aortic valve lesions that had clinical and hemodynamic findings. All patients underwent inverted-L sternotomy, which extended from above the manubrium of the sternum to the 3rd right intercostal space, without opening the pleural cavity. Their ages ranged from 32 to 76 years, and 18 were males and 12 were females. We used negative pressure in a venous ¼-inch cannula, and the patients were maintained in Trendelemburg's position. Twenty-seven patients received bioprostheses with diameters ranging from 23 to 29mm. Three patients underwent only removal of the calcifications of the aortic valve leaflets and aortic commissurotomy. RESULTS: The mean duration of anoxic cardiac arrest was 63.11min. Access was considered good in all patients. One death was due to pulmonary and renal problems not related to the incision. All patients had a better recovery in the intensive care unit, got out of bed sooner, coughed more easily, and performed prophylactic physiotherapeutic maneuvers for respiratory problems more easily and with less pain in the incision. Early ambulation was more easily carried out by all patients. CONCLUSION: Mini-sternotomy proved to be better than the conventional sternotomy because it provided morecomfort for the patients in the early postoperative period, with less pain and greater desire for early ambulation and all its inherent advantages.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic valve disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic valve surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sternotomy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Morphofunctional study of the junction between the left atrium and the pulmonary veins in patient with pulmonary hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>Jennecy Sales Cavalcanti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Laura Patrícia Ferreira Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Pernambuco  </s1>
<s2>Recife </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>232-234</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study the arrangement of the myocardial fiber bundles at the pulmonary venous left atrial junction in patients with pulmonary hypertension, and to discuss the pathophysiological importance of this element in the etiology of acute pulmonary edema. METHODS: We obtained 12 hearts and their pulmonary vein extremities from postmortem examinations of patients with the anatomicopathological diagnosis of acute pulmonary edema. The specimens, which had no grossly visible morphological cardiac alterations, were fixed in 10% formalin, and the muscular arrangement of the pulmonary venous left atrial junctions was analyzed. This material was then isolated, embedded in paraffin, underwent serial cutting (50 µm of thickness), and was stained with Azam's trichrome. RESULTS: We observed in our specimens that: a) the myocardial fiber bundles that originate in the atrial wall and involve the openings of the pulmonary veins were fewer than those observed in healthy material; b) the myocardial fiber bundles that extend into the pulmonary veins were shorter than those found in material originating from individuals with no pulmonary hypertension. CONCLUSION: Anatomical changes that result in a reduction in the amount of myocardial fiber bundles in the pulmonary venous left atrial junction, isolated or associated with other factors, may be the cause of disorders in pulmonary circulation, leading to an increase in pulmonary venous pressure, and, consequently, to acute pulmonary edema.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary veins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left atrium</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Laser assisted extraction of pacemaker and implantable defibrillator leads</s1>
</fA08>
<fA11 dir="011000">
<s1>Roberto Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Martino Martinelli Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Elizabeth Sartori Crevelari</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Noedir Antonio Groppo Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>239-242</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>7</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the results of laser-assisted extraction of permanent pacemaker and defibrillator leads. METHODS: We operated upon 36 patients, whose mean age was 54.2 years, and extracted 56 leads. The reasons for extracting the leads were as follows: infection in 19 patients, elective replacement in 13, and other causes in 4 patients. The mean time of catheter placement was 7.5±5.5 years. Forty-seven leads were from pacemakers, and 9 were from defibrillators. Thirty-eight leads were in use, 14 had been abandoned in the pacemaker pocket, and 4 had been abandoned inside the venous system. RESULTS: We successfully extracted 54 catheters, obtaining a 96.4% rate of success and an 82.1% rate for complete extraction. The 2 unsuccessful cases were due to the presence of calcium in the trajectory of the lead. The mean duration of laser light application was 123.0±104.5 s, using 5,215.2±4,924.0 pulses, in a total of 24.4±24.2 cycles of application. Thirty-four leads were extracted from the myocardium with countertraction after complete progression of the laser sheath, 12 leads came loose during the progression of the laser sheath, and the remaining 10 were extracted with other maneuvers. One patient experienced cardiac tamponade after extraction of the defibrillator lead, requiring open emergency surgery. CONCLUSION: The use of the excimer laser allowed extraction of the leads with a 96% rate of success; it was not effective in 2 patients who had calcification on the lead. One patient (2.8%) had a complication that required cardiac surgery on an emergency basis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>artificial cardiac pacemaker</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lead extraction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>laser light</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Physical activity, cardiorespiratory fitness, dietary content, and risk factors that cause a predisposition towards cardiovascular disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Dartagnan Pinto Guedes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Joana Elisabete Ribeiro Pinto Guedes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Londrina  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>251-257</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>52</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze associations between levels of physical activity, cardiorespiratory fitness, dietary content, and risk factors that cause a predisposition towards cardiovascular disease. METHODS: Sixty-two individuals aged between 20 and 45 years were evaluated. Levels of physical activity were established by estimates of energy demand corresponding to everyday activity; indices for cardiorespiratory fitness were obtained from estimates of maximal oxygen consumption; information about dietary content was obtained from dietary records kept on seven consecutive days. To indicate risk factors that cause a predisposition towards cardiovascular disease, use was made of body mass indexes, waist-hip circumference relationships, levels of arterial pressure and of plasma lipid-lipoprotein concentration. To establish associations between the variables studied, multiple regression analysis was used. RESULTS: Physical activity levels and cardiorespiratory fitness levels were inversely correlated with the amount and distribution of body fat and arterial pressure. Taken together, the two variables were responsible for between 16% and 19% of the variation in arterial pressure. Total and saturated fat ingestion was associated with higher serum lipid levels. Both dietary components were responsible for between 49% and 61% of the variation in LDL-cholesterol. CONCLUSION: High ingestion of food rich in total and saturated fat and decreased levels of physical activity and of cardiorespiratory fitness are associated with an increased risk of cardiovascular disease, which supports previous data.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>body fat</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>plasma lipids</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipoproteins</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Arterial distensibility as a possible compensatory mechanism in chronic aortic regurgitation</s1>
</fA08>
<fA11 dir="011000">
<s1>Liliane Kopel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Flávio Tarasoutchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Caio Medeiros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ricardo T. Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Silvia G. Lage</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>University of São Paulo FM Clínicas Hospital</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>262-265</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate elastic properties of conduit arteries in asymptomatic patients who have severe chronic aortic regurgitation. METHODS: Twelve healthy volunteers aged 30±1 years (control group) and 14 asymptomatic patients with severe aortic regurgitation aged 29±2 years and left ventricular ejection fraction of 0.61±0.02 (radioisotope ventriculography) were studied. High-resolution ultrasonography was performed to measure the systolic and diastolic diameters of the common carotid artery. Simultaneous measurement of blood pressure enabled the calculation of arterial compliance and distensibility. RESULTS: No differences were observed between patients with aortic regurgitation and the control group concerning age, sex, body surface, and mean blood pressure. Pulse pressure was significantly higher in the aortic regurgitation group compared with that in the control group (78±3 versus 48±1mmHg, P&lt;0.01). Arterial compliance and distensibility were significantly greater in the aortic regurgitation group compared with that in the control group (11.0±0.8 versus 8.1±0.7 10-10 N-1 m4, P=0.01 e and 39.3±2.6 versus 31.1±2.0 10-6 N-1 m², P=0.02, respectively). CONCLUSION: Patients with chronic aortic regurgitation have increased arterial distensibility. Greater vascular compliance, to lessen the impact of systolic volume ejected into conduit arteries, represents a compensatory mechanism in left ventricular and arterial system coupling.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chronic aortic regurgitation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial distensibility</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elasticity</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Intracoronary brachytherapy in the treatment of in-stent restenosis. Initial experience in Brazil</s1>
</fA08>
<fA11 dir="011000">
<s1>Fábio Sândoli de Brito Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rodrigo Hanriot</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Breno Oliveira Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Miguel Antonio Neves Rati</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Nadia Sueli de Medeiros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Mônica Lagatta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Carlos da Cruz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>João Victor Salvajoli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Marco Antonio Perin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Israelita Albert Einstein  </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>270-273</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Intracoronary brachytherapy using beta or gamma radiation is currently the most efficient type of therapy for preventing the recurrence of coronary in-stent restenosis. Its implementation depends on the interaction among interventionists, radiotherapists, and physicists to assure the safety and quality of the method. The authors report the pioneering experience in Brazil of the treatment of 2 patients with coronary in-stent restenosis, in whom beta radiation was used as part of the international multicenter randomized PREVENT study (Proliferation REduction with Vascular ENergy Trial). The procedures were performed rapidly and did not require significant modifications in the traditional techniques used for conventional angioplasty. Alteration in the radiological protection devices of the hemodynamic laboratory were also not required, showing that intracoronary brachytherapy using beta radiation can be incorporated into the interventional tools of cardiology in our environment.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Diagnosis and therapeutics of pulmonary arteriovenous fistula in childhood. Case report and review of the literature</s1>
</fA08>
<fA11 dir="011000">
<s1>Roberto Bartolomeu Gianisella</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Raul Ivo Rossi Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>278-281</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the case of a 3-year-old female patient, who, since birth, had cyanosis difficult to explain with usual diagnostic tests. The only findings on physical examination were cyanosis and clubbing of her fingers. Chest computerized tomography showed images of excessive attenuation in the right lung, which resembled arteriovenous fistulae that were later confirmed on cardiac catheterization. The fistulous trajectories were then embolized with 7 Gianturco coils, which resulted in an immediate increase in the arterial saturation of blood oxygen.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 9/2001 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>282-282</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Saúde. Uma visão ampliada</s1>
</fA08>
<fA11 dir="011000">
<s1>Georg Tuppy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Cardioclínica Araçatuba  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>283-284</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700310</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Nódulos de Aschoff e fibrose miocárdica em músculo papilar do ventrículo esquerdo</s1>
</fA08>
<fA11 dir="011000">
<s1>Lurildo R. Saraiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Giordano Bruno Parente</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vital Lira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Pernambuco Disciplina de Cardiologia </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>285-285</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700311</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Plástica da valva mitral com a técnica de &quot;Duplo Teflon&quot;. Análise dos resultados imediatos e tardios</s1>
</fA08>
<fA11 dir="011000">
<s1>Pablo Pomerantzeff</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>286-286</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700312</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Ácidos Graxos n-3, n-6 e prevenção de doenças cardiovasculares</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>287-310</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700313</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST: PARTE I Estratificação de Risco e Condutas nas primeiras 12 horas após a chegada do paciente ao Hospital</s1>
</fA08>
<fA11 dir="011000">
<s1>José Carlos Nicolau</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Antonio Machado Cesar</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ari Timerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Leopoldo Soares Piegas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Antonio Marin-Neto</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>3-23</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>133</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST: PARTE II Condutas nos Pacientes de Risco Intermediário e Alto</s1>
</fA08>
<fA11 dir="011000">
<s1>José Carlos Nicolau</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Antonio Machado Cesar</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ari Timerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Leopoldo Soares Piegas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Antonio Marin-Neto</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>24-38</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>93</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700002</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>III Diretrizes Brasileiras Sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia</s1>
</fA08>
<fA11 dir="011000">
<s1>Raul D. Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Sociedade Brasileira de Cardiologia Departamento de Aterosclerose </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-48</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>206</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Em busca de novos paradigmas para o manejo da cardiopatia isquêmica</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Pinto Ribeiro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nadine Clausell</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital de Clínicas de Porto Alegre  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal do Rio Grande do Sul Faculdade de Medicina </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-12</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>127</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeito dos ácidos graxos ômega-3 sobre o relaxamento-dependente do endotélio em coelhos hipercolesterolêmicos</s1>
</fA08>
<fA08 dir="en">
<s1>Effects of omega-3 fatty acids on endothelium-dependent relaxation in hypercholesterolemic rabbits</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Afonso Ribeiro Jorge</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Lidia Cruz Neyra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Regina Michico Ozaki</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eros de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Campinas Núcleo de Medicina e Cirurgia Experimental </s1>
<s2>Campinas </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>13-18</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar o efeito dos ácidos graxos ômega-3 sobre o relaxamento-dependente do endotélio, o colesterol plasmático, as LDL, VLDL, HDL, triglicérides e a peroxidação lipídica das partículas de LDL-nativas, oxidadas e da parede arterial. MÉTODOS: Coelhos da raça Nova Zelândia foram submetidos a dieta enriquecida com colesterol (0,5%) e gordura de coco (2%), por 30 dias e separados em grupo hipercolesterolemia (H) e ômega-3 (O-3), sendo administrado ao O-3 ácidos graxos ômega-3 na dose de 300mg/kg/dia, durante 15 dias, através de gavagem. O colesterol plasmático, triglicérides, LDL-colesterol, VLDL e HDL-colesterol foram medidos através de kits enzimáticos e os resultados expressos em mg/dl. As LDL foram obtidas por ultracentrifugação e oxidadas através da exposição ao Cu++. A peroxidação lipídica das LDL e da parede da aorta foi mensurada pela dosagem do malondialdeido (MDA). A função endotelial foi avaliada por curvas de concentração-efeito obtidas pela acetilcolina e nitroprussiato, após contração com norepinefrina. RESULTADOS: Houve aumento do colesterol plasmático e das VLDL, sem interferência nos níveis de LDL e HDL, no O-3. Observou-se redução significante dos triglicérides. Verificou-se aumento significante do teor de MDA nas LDL-nativas e oxidadas, assim como na parede arterial. O relaxamento-dependente do endotélio foi significativamente menor no O-3. CONCLUSÃO: A administração de ácidos graxos ômega-3 na dosagem de 300/mg/kg/dia, a coelhos hipercolesterolêmicos aumentou o colesterol e as VLDL plasmáticas, enquanto reduziu os triglicérides. O relaxamento-dependente do endotélio foi menor que no grupo H.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To study the effect of omega-3 fatty acid on endothelium-dependent relaxation, total plasma cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides levels as well as, the malondialdehyde (MDA) content of the LDL particles and arterial wall. METHODS: Fourteen male rabbits were randomly assigned to hypercholesterolemic and omega-3 groups. The dose of omega-3 fatty acid utilized was 300g/kg/day during 15 days. All rabbits were fed a diet supplemented with cholesterol (0.5%) and coconut oil (2%) for four weeks. At the end of the experiment the animals were killed and the aorta removed for measurement of MDA content and the endothelium-dependent relaxation studies. Total plasma cholesterol, VLDL-cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides was measured by enzymatic kits. MDA was also measured in natives and oxidized LDL and arterial wall. RESULTS: Cholesterol and VLDL-cholesterol were increased significantly in the omega-3 treated animals. The triglyceride level was significantly reduced (p&lt;0.05). The MDA content was increased in the LDL particles and in the arterial wall (p&lt;0.05). Endothelium-dependent relaxation was significantly reduced (p&lt;0.05). CONCLUSION: Omega-3 fatty acid impairs the endothelium-dependent relaxation when administered to cholesterol fed rabbits, increases the cholesterol and reduces the triglycerides plasma levels. The lipid peroxidation of the LDL particles and arterial wall was increased.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>relaxamento-dependente do endotélio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ácidos graxos ômega-3</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipercolesterolemia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>malondialdeido</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endothelium-dependent relaxation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>omega-3 fatty acid</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypercholesterolemia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Defeito total do septo atrioventricular. Correlação anatomofuncional entre pacientes com e sem síndrome de Down</s1>
</fA08>
<fA08 dir="en">
<s1>Complete atrioventricular canal. Clinical-anatomic correlations between patients with and without Down's syndrome</s1>
</fA08>
<fA11 dir="011000">
<s1>Liliana María Ferrín</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Nana Miura Ikari</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Tâmara Cortez Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Miguel Barbero Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Munir Ebaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>19-23</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar o grau de repercussão, fatores responsáveis e época de aparecimento dos sintomas do defeito do septo atrioventricular (DSAV), em pacientes com e sem síndrome de Down. MÉTODOS: Foram estudados 80 pacientes com idade &lt;2 anos, sendo 55 (69%) com síndrome de Down - grupo I (GI) e 25 (31%) sem síndrome de Down - grupo II (GII). Avaliaram-se a idade de manifestação dos sintomas, sua intensidade, classe funcional (CF), repercussão clínica, tipo anatômico e grau de malformação da valva atrioventricular (VAV). RESULTADOS: A idade média de manifestação dos sintomas foi de 50 (±75) dias nos dois grupos. A CF II (NYHA) predominou no GI (31 casos - 56,5%) e a CF III-IV no GII (19 - 76%) p&lt;0,005. O quadro de insuficiência cardíaca esteve presente em 34 (62%) pacientes do GI e em 21 (84%) do GII e, o de hipertensão pulmonar em 21 (38%) do GI e em 4 (16%) do GII, p&lt;0,04. Pressão média da artéria pulmonar &gt;50mmHg ocorreu em 56% dos casos do GI em relação a 28% do GII p&lt;0,019. A evolução até a cirurgia foi instável (agravamentos da insuficiência cardíaca) em 33 (60%) do GI e em 21 (84%) do GII p&lt;0,03. O tipo A de Rastelli foi o mais encontrado nos dois grupos, 35 (67%) pacientes no GI e nos 25 (100%) do GII. A alteração anatômica da VAV foi importante em 8% no GI e em 38% no GII. CONCLUSÃO: Há sugestão de predominância de hiper-reatividade vascular pulmonar nas crianças com síndrome de Down e de manifestações de insuficiência cardíaca nas geneticamente normais.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To compare clinical course, causes and symptoms beginning enset time in children with complete atrioventricular canal with and without Down's syndrome. METHODS: Records of 80 patients &lt;2 years of age, were reviewed. There were 55 (69%) with Down's syndrome - group I (GI) and 25 (31%) without - group II (GII). Age at synpton enset intensity, functional class, clinical repercussion and anatomic variations in patients undergoing corrective surgery were evaluated. RESULTS: Mean age at symptoms onset was similar for the two groups (50 ±75 days). Class II (NYHA) was more frequent in GI (31 patients - 56.5%) and class III-IV (NYHA) in GII (19 patients - 76%) p&lt;0.005. Clinical repercussion evaluation showed that congestive heart failure was present in 34 (62%) patients of GI and 21 (84%) of GII; and, pulmonary hypertension was in 21 (38%) patients of GI and 4 (16%) patients of GII p&lt;0.04. Mean pulmonary arterial pressure of 50mmHg or more was present in 68% of children with Down's syndrome and in 35% of GII. Clinical course until surgical correction was down hill in 33 (60%) from GI and 21 (84%) from GII p&lt;0.03. Seventy seven patients underwent surgical correction. CAVC type A of the Rastelli classification was predominant in both groups, GI 37 (67%) - GII 25 (100%). There or more severe valvar morphologic lesions in group II (38%) than in group I (8%). CONCLUSION: There seems to be a pulmonary vascular hyperreactivity predominance in Down's children and cardiac insufficiency signs in the normal genetic group.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>defeito do septo atrioventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>síndrome de Down</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão pulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>complete atrioventricular canal</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Down's syndrome</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Valor diagnóstico do teste ergométrico na detecção da isquemia miocárdica silenciosa no paciente idoso com hipertensão sistólica</s1>
</fA08>
<fA08 dir="en">
<s1>Value of exercise testing for silent myocardial ischemia in elderly patients with systolic hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>João Joaquim de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sandra Regina A. S. Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Goiânia Faculdade de Medicina Hospital das Clínicas</s1>
<s2>Goiânia </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>25-29</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>60</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o valor diagnóstico do teste ergométrico (TE) na detecção da isquemia silenciosa no idoso com hipertensão sistólica isolada. MÉTODOS: Foram comparados, 110 pacientes com hipertensão sistólica (grupo A), com 104 pacientes sem hipertensão (grupo B). Eles foram submetidos a TE, conforme protocolo de Bruce, entre janeiro/91 a dezembro/94. O esforço era interrompido se a freqüência máxima fosse alcançada ou se desenvolvessem fadiga, dispnéia, arritmia severa, hipotensão e depressão significativa do segmento ST &gt;2mm (0,2mV). RESULTADOS: O TE mostrou depressão isquêmica de ST em 22 (20%) dos pacientes idosos com hipertensão sistólica e em 12 (11,5%) dos idosos-controle. O tempo de esforço foi mais curto nos hipertensos: 7,1±2,9min vs 8,8±2,5min. A depressão de ST foi maior nos hipertensos do que no grupo controle: 2,5±0,8mm vs 1,9±0,4mm. A duração isquêmica do ST foi também mais prolongada no grupo hipertenso do que no controle: 5,4±2,8min vs 3,4±1,9min. CONCLUSÃO: Pacientes idosos com hipertensão sistólica isolada têm mais isquemia miocárdica silenciosa do que idosos normotensos. Entre idosos hipertensos houve uma prevalência de isquemia silenciosa 1,7 vezes mais freqüente que idosos normotensos, de mesma faixa etária (20% vs 11,5%, p&lt;0,003).</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the diagnosis value of exercise testing for silent myocardial ischemia in systolic hypertension of the elderly. METHODS: We compared 110 patients with systolic hypertension (group A) with 104 patients without hypertension (group B). They were submitted to an exercise test according to the Bruce protocol, between January/91 to December/94. Exercise was discontinued if target heart rate was achieved, or fatigue, dyspnea, severe arrhythmia, hypotension or significant ST segment depression &gt;2mm/0.2mV developed. RESULTS: Exercise testing showed ischemic ST depression in 22 (20%) of the elderly patients with hypertension systolic and 12 (11.5%) of control elderly patients. The exercise time was shorter in the hypertensives 7.1±2.9min vs 8.8±2.5min. The ST depression was greater in the hypertensives than the control group: 2.5±0.8min vs 1.9±0.4min. Also the duration or ischemic ST depression was longer in the hypertensive patients than the control group 5.4±2.8min vs 3.4±1.9min. CONCLUSION: Elderly hypertensive patients with systolic hypertension have more silent myocardial ischemia than elderly without hypertension. Among the elderly hypertensive patients there was a prevalence of silent ischemia that was 1.7 times higher than in the normotensive elderlies (20% vs 11.5% P&lt;0.003).</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste de esforço</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>isquemia silenciosa</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão sistólica do idoso</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise testing</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>silent ischemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly systolic hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Segurança e exeqüibilidade da ecocardiografia com estresse pela dobutamina associada à atropina</s1>
</fA08>
<fA08 dir="en">
<s1>Safety and feasibility of dobutamine-atropine stress echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Wilson Mathias Jr</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Léa Paula Beneti</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fabio Cesar dos Santos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Renata Duprat</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ailton Beraldo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Manoel Adan Gil</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Lázaro Andrade</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Eulógio Martinez</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>31-34</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar a segurança e exeqüibilidade da ecocardiografia com estresse pela dobutamina associada à atropina (EEDA) em pacientes com doença arterial coronária (DAC) suspeita ou conhecida. MÉTODOS: Estudados 3000 testes consecutivos, pela EEDA, armazenados em formato de banco de dados. RESULTADOS: Observaram-se, como maiores complicações relacionadas ao teste, a ocorrência de 1 caso de infarto agudo do miocárdio, 4 de taquicardia ventricular sustentada e 5 de intoxicação atropínica. Um dos objetivos do teste foi atingido em 95% dos exames. CONCLUSÃO: A EEDA é um método seguro e exeqüível para o diagnóstico de DAC.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To study the safety and feasibility of dobutamine-atropine stress echocardiography (DASE) in patients with known or suspected coronary artery disease. METHODS: There were 3,000 DASE that were studied in a prospective fashion. All symptons and side effects were stored in a data base format. RESULTS: Major test-related complications observed included one case of myocardial infarction, four cases of sustained ventricular tachycardia and five cases of atropine intoxication. There was no death or ventricular fibrillation as a direct or indirect consequence of the test. The infusion protocol allowed to us to examine patients using beta blockers, and led to 95% feasibility. CONCLUSION: DASE is a safe and feasible method for the study of patients with suspected or known coronary artery disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coronariopatia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dobutamina</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dobutamine</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Enalaprilato na prevenção da hipertrofia ventricular esquerda induzida pelo isoproterenol</s1>
</fA08>
<fA08 dir="en">
<s1>Enalaprilat prevents the left ventricular hypertrophy induced by isoproterenol</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo A. S. Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Bráulio Luna Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rui Póvoa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Celso Ferreira Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Neif Murad</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marcelo Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Celso Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>35-39</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar se o enalaprilato, droga inibidora da enzima de conversão da angiotensina I, previne a hipertrofia ventricular esquerda (HVE) induzida pelo isoproterenol. MÉTODOS: Foram divididos em 4 grupos, 72 ratos Wistar-EPM: CON controle; ENA, tratados com enalaprilato (1mg/kg via subcutânea (sc) por 8 dias); ISO, tratados com isoproterenol (0,3mg/kg via sc/8 dias) e ENA+ISO, tratados simultaneamente com ambas as drogas. Em 10 animais de cada grupo foram determinadas a freqüência cardíaca (FC) e a pressão arterial (PA) e verificado o peso de ventrículo esquerdo (VE). Em 8 animais de cada grupo, fragmento do VE foi corado com hematoxilina-eosina e picro-sírius e preparado para estudo morfométrico e ultra-estrutural, respectivamente, com microscópio de luz e eletrônico. RESULTADOS: Nos grupos estudados (CON, ENA, ISO e ISO+ENA) não ocorreram variações na PA. Os grupos ISO e ISO+ENA exibiram aumentos significantes na FC. O grupo ISO apresentou aumento significativo do peso do VE (PU= 0,821g e PS= 0,204g), quando comparado ao grupo CON. O grupo ENA não exibiu modificação de peso do VE quando comparado ao grupo CON (PU= 0,590g e PS= 0,139g). No grupo ENA+ISO (PU= 0,737g e PS= 0,177g) constatou-se diferença de peso ao ser comparado aos grupos ISO e CON. A análise morfométrica e ultra-estrutural mostraram que o ISO induziu hipertrofia dos cardiomiócitos e aumento do tecido conjuntivo com depósito de fibras colágenas do tipo I. O enalaprilato associado com isoproterenol atenuou importantemente aquela manifestação. CONCLUSÃO: O enalaprilato inibiu a ação do isoproterenol sobre os cardiomiócitos, evitando parcialmente, na dose utilizada, a HVE e diminuindo também a quantidade de fibras colágenas.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate whether the enalaprilat, angiotensin I enzyme conversion inhibitor, could prevent the left ventricular hypertrophy (LVH) induced by isoproterenol. METHODS: Seventy two adult Wistar-EPM rats were divided into four groups: CON, control; ENA, treated with enalaprilat (1mg/kg via subcutaneous (sc) for 8 days); ISO, treated with isoproterenol (0.3mg via sc for 8 days) e ENA+ISO, treated with both drugs simultaneously. Each group had the arterial blood pressure, cardiac rate and the left ventricle (LV) weight determined in 10 animals. In 8 animals from each group a small sample was taken from the LV and stained with hematoxyline-eosine and picrosirius for morphometric and ultra-structural studies with optic and transmission electronic microscopy. RESULTS: The ISO group showed that the LV weight increased 47% in comparison with control. On the other hand the ENA+ISO group showed only 22.1% increase (p&lt;0.05). The morphometric and ultra-structural analyses revealed that isoproterenol induced cardiomyocite hypertrophy and augmented the content of the type I collagen in the cardiac interstitium. CONCLUSION: Enalaprilat inhibited the isoproterenol action on the cardiomyocite, avoiding partially the LVH and decreasing the content of collagen fibers.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>isoproterenol</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>enalaprilato</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>isoproterenol</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>enalaprilat</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Monitorização ambulatorial da pressão arterial em adolescentes normais</s1>
</fA08>
<fA08 dir="en">
<s1>Ambulatory blood pressure monitoring in normal adolescents</s1>
</fA08>
<fA11 dir="011000">
<s1>Vera H. Koch</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Anita Colli</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Ignez Saito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Patricia Ruffo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rita Cardoso</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Edna C. Ignes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Yassuhiko Okay</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Décio Mion Jr</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>41-46</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar tecnicamente a monitorização ambulatorial de pressão arterial (MAPA) em adolescentes normais. MÉTODOS: Quarenta e cinco adolescentes eutróficos, entre 10-18 anos de idade, sendo 27 do sexo feminino. RESULTADOS: Verificaram-se, em média, 90% de medidas bem sucedidas: incômodo relacionado ao funcionamento do monitor em 30% dos casos; valores médios de descenso sistólico, diastólico e de diminuição de freqüência cardíaca, no sono noturno, respectivamente iguais a 13%, 23% e 24%; carga pressórica na vigília, no sexo masculino, de 25,4±27,7% e 11,8±14,6% e, no feminino, de 17,5±18,7% e 11,8±11,4% para pressão arterial sistólica (PAS) e diastólica (PAD), respectivamente; carga pressórica no sono, no sexo masculino, de 15,4±22,9% e 2,8±4,9% e, no feminino, de 10,5±18,2% e 1,8±2,7% para PAS e PAD; medidas diastólicas mais elevadas nas duas primeiras horas de monitorização; diferenças entre sono noturno e vespertino quanto aos parâmetros cardiovasculares estudados. CONCLUSÃO: A MAPA mostrou-se bem tolerada pela população adolescente. Os registros obtidos apresentaram-se tecnicamente adequados para análise.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate technical aspects of ambulatory blood pressure monitoring (ABPM) in normal adolescents. METHODS: Forty five normal adolescents (27 female), 10-18 years old. RESULTS: ABPM recordings showed a mean of 90% successful readings; 30% of the patients complained of sleep disruption related to the functioning of the ABPM monitor; the mean systolic, diastolic and heart rate fall during sleep was 13%, 23% and 24% respectively; the mean systolic and diastolic blood pressure load, while awake, was in male adolescents 25.4±27.7% and 11.8±14.6%, and in female adolescents, 17.5±18.7% and 11.8±11.4%, respectively; the mean systolic and diastolic blood pressure load, while asleep, was in male adolescents 15.4±22.9% and 2.8±4.9% and, in female adolescents, 10.5±18.2% and 1.8±2.7%, respectively; the mean diastolic values of the first two hours of recording were higher than the ones obtained during the rest of the hours of recording while awake; different mean systolic, diastolic and heart rate values were found during the afternoon and nocturnal sleep periods. CONCLUSION: ABPM was well accepted by the adolescent population, with good technical results.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>pressão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>monitorização ambulatorial de pressão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>adolescente</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ambulatory blood pressure monitoring</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adolescent</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Implante de stent em bifurcação coronária</s1>
</fA08>
<fA08 dir="en">
<s1>Stents for bifurcational coronary lesion</s1>
</fA08>
<fA11 dir="011000">
<s1>Cyro Vargues Rodrigues</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>André Pessanha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Valério Fuks</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Augusto Neno</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Nestor Augusto C. Garcia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Munir Murad</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital São Vicente de Paulo  </s1>
<s2>Rio de Janeiro </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>47-50</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Descrevem-se dois casos de angioplastia transluminal coronária (ATC) com implante de stents em bifurcação de coronária descendente anterior (DA) com artéria diagonal (DI), destacando-se as técnicas utilizadas. No caso 1, implantou-se na DA um flexistent Gianturco-Roubin (GR) e através de suas hastes, um Palmaz-Schatz (PS) no óstio de DI, com sucesso. O reestudo angiográfico em sete meses mostrou ausência de reestenose. No caso 2, implantou-se metade de um stent PS em DA e outro PS em DI, nesta ordem, também com sucesso. No seguimento clínico de seis meses, paciente encontra-se assintomático.</s0>
</fC01>
<fC01 dir="en">
<s0>We describe two cases of coronary angioplasty with stents implantation in bifurcational lesion of the left anterior descending artery and the diagonal branch using new techniques successfully performed. Angiographic reestenosis was not present after seven months in one case and the patient was asymptomatic after six months of clinical follow-up in the other.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Valvoplastia mitral percutânea de urgência em gestante</s1>
</fA08>
<fA08 dir="en">
<s1>Emergency percutaneous balloon mitral valvoplasty in a pregnant woman</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz A. Gubolino</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernando Amaral</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antoninha M. L. de A. Bragalha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ronaldo Moschini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luis Henrique F. Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Amir M. Kalafe</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital dos Fornecedores de Cana de Piracicaba Instituto do Coração </s1>
<s2>Piracicaba SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>51-53</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Gestante com 33 anos na 28ª semana e sinais de óbito fetal foi admitida em caráter de urgência com quadro de edema pulmonar agudo secundário à estenose mitral grave. Com o insucesso do tratamento medicamentoso intensivo, a paciente foi submetida à valvoplastia mitral percutânea de emergência com melhora imediata. O agravamento subseqüente do quadro, atribuído ao óbito fetal, foi tratado através parto cesáreo com melhora clínica considerável. A paciente teve alta hospitalar no 10º dia, e 11 meses após o procedimento, encontra-se em classe funcional I, sem uso de medicação e com sinais ecocardiográficos de estenose mitral leve (área valvar: 2,0 cm²).</s0>
</fC01>
<fC01 dir="en">
<s0>We report the case of a 33-year-old woman in the 28th week of pregnancy and with signs of fetal death, admitted to hospital in an emergency due to pulmonary edema secondary to severe mitral valve stenosis. Intensive medical treatment was unsuccessful and the patient was submitted to an emergency percutaneous balloon mitral valvoplasty with prompt clinical improvement. Subsequent clinical deterioration secondary to fetal death was managed by cesarean section resulting in clinical estabilization. The patient was discharged 10 days after admission and at 11 months after the procedure she had mild symptons without drug therapy and echocardiographic signs of mild residual mitral stenosis (mitral valve area: 2,0cm²).</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Valvuloplastia aórtica por balão como ponte para o tratamento definitivo na estenose aórtica grave</s1>
</fA08>
<fA08 dir="en">
<s1>Aortic balloon valvuloplasty as a bridge to definitive therapy of severe aortic stenosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Henrique Patrus Mundim Pena</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sérgio Lopes da Costa Teixeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ari Mandil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Charles Simão Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria da Consolação V. Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Felício Rocho  </s1>
<s2>Belo Horizonte MG</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>55-57</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Homem de 36 anos, com quadro de estenose aórtica crítica e choque cardiogênico refratário, foi submetido a valvuloplastia aórtica por balão como procedimento de salvamento, seguindo-se compensação clínica, o que possibilitou a realização de cirurgia de troca valvar aórtica no 48º dia após esse procedimento. O acompanhamento clínico e ecocardiográfico demonstrou melhora funcional significativa até o presente, oito meses após a cirurgia. A valvuloplastia aórtica por balão constitui opção terapêutica de salvamento em pacientes com estenose aórtica grave e elevado risco cirúrgico, servindo como ponte para a cirurgia de troca aórtica ou transplante cardíaco. A cirurgia de troca aórtica deve ser considerada, mesmo em pacientes com disfunção ventricular grave, reservando-se o transplante cardíaco aos pacientes em que se supõe depressão muito acentuada e irreversível da contratilidade miocárdica.</s0>
</fC01>
<fC01 dir="en">
<s0>In a 36-year-old man with severe aortic stenosis and refractory cardiogenic shock, an emergency percutaneous balloon aortic valvuloplasty was performed, followed by clinical improvement, allowing elective aortic valve replacement at the 48th day post-valvuloplasty. Clinical follow-up for eight months after surgery showed significant functional improvement. Aortic balloon valvuloplasty is a life-saving approach to patients with severe aortic stenosis and high surgical risk and should be considered as a bridge to planned valve replacement or cardiac transplantation. Aortic valve replacement should be considered even in patients with severe ventricular dysfunction, while the cardiac transplantation should be indicated for patients with a very marked and irreverssible depression of myocardial contractility.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Medicina ortomolecular baseada em evidência</s1>
</fA08>
<fA11 dir="011000">
<s1>Luís Beck da Silva Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jorge Pinto Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>59-60</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900111</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 4/97 - Instituto do Coração do Hospital das Clínicas - FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>61-68</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900112</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Doença reumática</s1>
</fA08>
<fA11 dir="011000">
<s1>João Joaquim de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sandra Regina A. S. Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>João Dhoria Vijle</s1>
<afiliation>A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Goiás Faculdade de Medicina </s1>
<s2>Goiânia GO</s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Mayo Clinic and Foundation Rochester  </s1>
<s2> </s2>
<s3>EUA</s3>
</fA14>
<fA20 dir="000000">
<s1>69-77</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>53</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900113</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="">
<s1></s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>79-81</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900114</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Antibioticoprofilaxia da endocardite infecciosa. Necessidade de mais longa observação?</s1>
</fA08>
<fA11 dir="011000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>83-85</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Hipertensão arterial sistêmica. Uma doença programada no útero?</s1>
</fA08>
<fA11 dir="011000">
<s1>Sandra S. Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Real Hospital Português Instituto do Coração de Pernambuco </s1>
<s2>Recife PE</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>87-88</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Amilóidose cardíaca. Uma doença de muitas faces e diferentes prognósticos</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiac amyloidosis. A disease with many faces and different prognoses</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dalton Precoma</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>João Batista Serro-Azul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Mauricio Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Humberto Pierri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Ligia Pivotto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Amit Nussbacher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Otavio Celso Eluf Gebara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Giovanni Bellotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>89-93</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar as formas de apresentação da amilóidose cardíaca em hospital terciário. MÉTODOS: Nos últimos 15 anos, foram identificados 8 pacientes com amilóidose, sendo 5 mulheres , com idades entre 23 e 83 (média 62) anos. Após anamnese e exame físico foram submetidos a eletrocardiograma (ECG), ecocardiograma (ECO), estudo com pirofosfato de tecnécio e biópsia endomiocárdica, cujos resultados permitiram caracterizar suas formas clínicas. RESULTADOS: Sete pacientes apresentavam dispnéia aos esforços, 6 quadro de insuficiência cardíaca congestiva (ICC), 1 síncopes. O ECG identificou bloqueio atrioventricular total (BAVT) em 4 casos e área eletricamente inativa ântero-septal em outros 4. O ECO mostrou diâmetros normais em todos e fração de ejeção discretamente reduzida em 6. Hipertrofia do septo e parede posterior em todos, sendo em 7 com aspecto sugestivo de doença de depósito (aspecto granuloso). Os dados clínicos caracterizam dois grupos, um com BAVT e outro com cardiomiopatia restritiva. A evolução foi diferente com melhora clínica após o implante de marcapasso no primeiro grupo e má evolução no grupo com cardiomiopatia restritiva que evoluiu de maneira refratária, 3 falecendo em menos de 6 meses após diagnóstico. CONCLUSÃO: A presença de aumento da espessura das paredes ao ECO, discreta disfunção sistólica e aspecto de doença de depósito identificaram a quase totalidade dos casos. Cardiomiopatia restritiva e distúrbio de condução foram as formas de apresentação, sendo o prognóstico muito reservado nos pacientes com forma restritiva, evoluindo para ICC refratária.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To identify the principal forms of cardiac amiloydosis presentation in a terciary hospital. METHODS: Eight cases whith cardiac amyloidosis were identified. Five were woman, their ages ranged from 23 to 83 years (mean 62). After a medical history and clinical examination the patients, were submitted to complementary tests: electrocardiogram (EKG), echocardiogram (ECHO), scintigraphy with technecium pirophosfate and cardiac biopsy these results allowed the identification of their clinical situation. RESULTS: Seven patients refered dyspnea, 6 were in heart failure, 1 patient had syncope. The EKG identified complete atrioventricular (AV) block in 4 patients, and antero septal inactive area in the other 4. The ECHO showed normal cardiac diameter in all (mean left ventricular diastolic diameter of 46.8) and slight reduction of left ventricular ejection fraction; hypertrophy of the left ventricular septal and posterior walls in all cases, in 7 cases there was a hyper refractile granular sparkling ECHO. Two different groups were identified: one with complete AV block and the second with restrictive cardiomyopathy. The prognosis was different in these two groups. Those with complete AV block evolved better after pacemaker implantation and those with restrictive cardiomyopathy had refractary heart failure and 3 of them died. CONCLUSION: The increased free wall and septal thickness, the slight systolic dysfunction and the infiltration aspect at ECHO allow us to identify the great majority of the cases. Those patients with restrictive cardiomyopathy evolve with refractory heart failure and most of them die in a few months.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>amilóidose cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>bloqueio atrioventricular total</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac amyloidosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>complete atrioventricular block</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Valor prognóstico da ecocardiografia com estresse pela dobutamina associada à atropina</s1>
</fA08>
<fA08 dir="en">
<s1>Prognostic value of dobutamine-atropine stress echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Mathias Jr Wilson</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ulisses Stella</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Flávio Baruta</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Adriana Cordovil</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Lázaro Andrade</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Expedito Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Renata Duprat</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Eulógio Martinez</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>95-99</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o valor prognóstico para eventos cardíacos maiores da ecocardiografia com estresse pela dobutamina associada à atropina (EEDA). MÉTODOS: Estudados 452 pacientes consecutivos, com alto risco para presença de doença arterial coronária, acompanhados por um período médio de 23 meses. RESULTADOS: Houve 9 mortes cardíacas e 2 infartos agudos do miocárdio em pacientes com EEDA positiva e 2 infartos e 1 morte cardíaca em pacientes com EEDA negativa. CONCLUSÃO: A EEDA é capaz de identificar pacientes de alto risco para eventos maiores.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To determine the prognostic value of dobutamine-atropine stress echocardiography (DASE). METHODS: We studied 452 consecutive patients at high risk for coronary artery disease, using DASE. They were followed during a mean period of 23 months. RESULTS: There were 9 cardiac deaths and 2 acute myocardial infarctions in the group of patients with positive tests, and there were 2 myocardial infarctions and 1 cardiac death in patients with negative DASE. CONCLUSION: We conclude that DASE reliably identifies patients at high risk for hard cardiac events.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coronariopatia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dobutamina</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dobutamine</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Ativação da enzima conversora de angiotensina no coração após infarto do miocárdio e suas repercussões no remodelamento ventricular</s1>
</fA08>
<fA08 dir="en">
<s1>Activation of the cardiac angiotensin-converting enzime after infarction in rats and its role in ventricular remodeling</s1>
</fA08>
<fA11 dir="011000">
<s1>José Geraldo Mill</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria da Conceição Milanez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vera Cristina W. Busatto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Andréa Cruz de Moraes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria da Glória S. Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFES Centro Biomédico Depto de Ciências Fisiológicas</s1>
<s2>Vitória ES</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>101-110</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>44</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar as alterações de atividade da enzima conversora de angiotensina (ECA) no coração com infarto do miocárdio (IM) e comparar os efeitos do captopril e losartan em parâmetros morfológicos e funcionais de ratos com IM. MÉTODOS: O IM foi produzido em ratos Wistar por ligadura de ramos da artéria coronária esquerda. Os controles (Con) foram submetidos a uma cirurgia fictícia. Animais com IM e Con foram tratados com captopril (30mg/kg/dia) ou losartan (15mg/kg/dia) e estudados 30 dias após, determinando-se a atividade da ECA nos ventrículos direito (VD) e esquerdo (VE), as alterações hemodinâmicas e as concentrações de hidroxiprolina (OH-Pro) e proteína total no VD e VE. RESULTADOS: A atividade da ECA aumentou no VD (+25%) e VE (+70%) após IM. A maior atividade foi observada na cicatriz fibrótica, onde atingiu cerca de 4,5 vezes a do músculo do VE que sobreviveu ao IM (420±68 vs 94±8nmoles/g/min; P&lt;0,01). O IM determinou aumento da pressão diastólica final e hipertrofia do VD e VE. Captopril e losartan foram igualmente eficazes em atenuar a hipertrofia e o aumento da pré-carga. O captopril também atenuou o aumento de OH-Pro no VD e VE após IM. O IM reduziu a concentração de proteína principalmente no músculo de VE, efeito esse acentuado pelo captopril. CONCLUSÃO: A grande atividade da ECA na cicatriz deve produzir altas concentrações de angiotensina II (AII) no sangue que drena da cicatriz. Os efeitos dos inibidores da ECA seriam decorrentes, principalmente, da redução de geração local de AII, e não de aumento de cininas, uma vez que captopril e losartan exerceram efeitos similares no remodelamento pós-infarto.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To determine angiotensin converting enzyme (ACE) activity in the heart of infarcted rats and to investigate the effects of captopril and losartan on the post- infarction remodeling process. METHODS: Myocardial infarction (MI) was produced in Wistar rats by ligature of the left coronary artery. Control rats (Con) underwent a sham surgery. MI and Con rats remained untreated or were treated with captopril (30mg/kg/day) or losartan (15mg/kg/day) for 30 days. ACE activity was determined in right (RV) and left ventricular (LV) muscles and in the scar tissue. The effects of captopril therapy was also investigated in the hydroxiproline (OH-Pro) and protein in RV and LV . RESULTS: ACE activity increased 25% in the RV and 70% in the remaining LV muscle. The highest ACE activity was found in the scar tissue, where it was 4.5 times the value of the LV muscle (420±68 vs 94±8nmoles/g/min; P&lt;0.01). An increase of the end-diastolic pressure and of the muscle mass was found in the RV and LV of MI rats. Captopril and losartan treatments were equally efficient to attenuate these parameters in both ventricles. Captopril also reduced the total OH-Pro content in the RV and LV muscles. The Prot concentration was significantly reduced in the myocardium of MI rats, an effect enhanced by captopril therapy. CONCLUSION: The AII concentration in the blood draining from the scar to the surrounding muscle is probably high. It is likely that this elevated local generation of AII contributes to hypertrophy and to collagen deposition. The effects of ACE inhibitors on remodeling are likely to depend on the reduction of the locally generated AII.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>remodelamento ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>inibidores da enzima conversora de angiotensina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angiotensina II</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular remodeling</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angiotensin converting enzyme inhibitors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angiotensin II</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação tardia por tomografia computadorizada espiral de enxertos de pericárdio bovino liso como substitutos aórticos</s1>
</fA08>
<fA08 dir="en">
<s1>Late evaluation of bovine pericardium grafts as aortic substitutes by spiral computed tomography</s1>
</fA08>
<fA11 dir="011000">
<s1>Renato A. K. Kalil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Jader Feldman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando W. B. Ludwig</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alessandro D'Avila da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Roberto Prates</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>João R. M. Sant'Anna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ivo A. Nesralla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>111-115</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar, morfologicamente, por tomografia computadorizada espiral, enxertos de pericárdio bovino liso empregados como substitutos aórticos. MÉTODOS: Dez pacientes foram submetidos a exame por tomografia computadorizada espiral para reconstituição da imagem dos enxertos. Os critérios de seleção foram tempo de seguimento superior a 2 anos, enxertos de pericárdio liso não revestido, implantados na aorta ascendente ou descendente. RESULTADOS: Os exames demonstraram bom resultado cirúrgico em todos os casos, persistindo em alguns, a imagem de dissecção aórtica distal à anastomose. Um caso apresentava hematoma entre o enxerto e a parede aórtica, em 5 não foram encontradas alterações estruturais no pericárdio e, nos demais, foi detectada dilatação de grau leve, em relação ao diâmetro descrito do enxerto implantado. Não foram vistos sinais de calcificação ou pseudoaneurismas. CONCLUSÃO: Os enxertos tubulares de pericárdio bovino liso, não revestido, apresentam resultados satisfatórios quando empregados como substitutos aórticos. A médio prazo, não foram detectadas anormalidades estruturais relacionadas ao material empregado, pela tomografia computadorizada espiral, exceto dilatação em alguns casos.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate morphologically by spiral computed tomography (SCT) bovine pericardial grafts as aortic substitutes. METHODS: Ten patients were submitted to aortic graft evaluation with SCT. There were 8 ascending and 2 descending grafts. Examination was done after 2 to 7 years post operative. Ages ranged from 49 to 67 years, with 6 male and 4 female patients. All had implanted smooth surface naked pericardial grafts. RESULTS: Surgical result was good in all. Distal dissection persisted in some cases. One had a peri-graft hematoma, 5 had no structural changes and 4 presented mild graft dilatation. There were no graft calcification or pseudoaneurysm. CONCLUSION: Glutaraldehyde preserved naked smooth surface bovine pericardial aortic grafts present satisfactory structural aspect, as seen by SCT, at medium term follow-up. Mild dilatation may be seen in some cases.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tomografia computadorizada</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aorta</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>enxertos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>pericárdio bovino</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>heteroenxertos</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic grafts</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>bovine pericardium</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>computed tomography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>É a cardiomiopatia hipertrófica apical vista em uma amostra na cidade do Rio de Janeiro similar à encontrada no oriente?</s1>
</fA08>
<fA08 dir="en">
<s1>Is the apical hypertrophic cardiomyopathy seen in one population in Rio de Janeiro city similar to that found in the east?</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco Manes Albanesi Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcia Bueno Castier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alberto Siqueira Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Ginefra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UERJ Hospital Universitário Pedro Ernesto </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>117-123</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Investigar a existência de diferença na forma de apresentação clínica e evolutiva da cardiomiopatia hipertrófica apical (CMHA), vista em uma amostra na cidade do Rio de Janeiro e a observada no oriente, onde foi descrita. MÉTODOS: Entre 156 pacientes com cardiomiopatia hipertrófica diagnosticados em nossa instituição, foram identificados 13 (8,34%) com a forma apical, sendo estudadas as suas manifestações clínicas, os meios de diagnóstico e a sua evolução. RESULTADOS: Eram 8 homens e 5 mulheres, com idades entre 19 a 75 anos, todos da raça branca, a maioria sintomática. O eletrocardiograma revelou ondas T gigantes em precordiais em 10 pacientes (76,92%), o ecocardiograma (ECO), a presença de hipertrofia apical em todos os casos, sendo em 10 (76,92%) restrita a ponta do ventrículo esquerdo (VE), em dois (15,4%) a ponta do ventrículo direito (VD) e, em 1 (7,68%), acometendo ambos os ventrículos. A cineventriculografia confirmou os achados do ECO. A evolução variou de 6 a 264 meses (x=95,4). Ocorreram dois óbitos (15,4%) em pacientes com o comprometimento associado ao VD, devido ao aumento significativo da dimensão dos átrios, ocorrência de fibrilação atrial, insuficiência valvar mitral e/ou tricúspide e tromboembolismo. Entre os vivos, a paciente com acometimento do VD evolui com restrição diastólica, e os restantes com lesão localizada do VE , 9 estão assintomáticos em uso de propranolol (8) ou amiodarona (1) e um permanece assintomático sem medicação. CONCLUSÃO: presentação, diagnóstico e evolução, porém notamos em 3 pacientes ( 23,08%) o acometimento da ponta do VD, não descrito no oriente, mas com péssimo prognóstico evolutivo.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To investigate the differences between clinical aspects and evolution of apical hypertrophic cardiomyopathy (AHCM) seen in Rio de Janeiro and the Oriental form, which was the first described. METHODS: In 156 patients with AHCM diagnosed in our institution, there were 13 (8.34%) with the apical form of the disease, whose clinical settings, diagnostic procedures and evolution were studied. RESULTS: There were 8 males and 5 females, between 19 and 75 years old, all white. Electrocardiogram (EKG) showed giant T waves in precordial leads in 10 (76.92%), echocardiogram (ECHO) demonstrated apical hypertrophy in all, 10 (76.92%) had only in the left ventricle, 2 in right ventricle and one involving both. Cineangiography corroborated ECHO findings. Follow-up ranged from 6 to 294 months (x= 95.4). Two deaths occurred in patients with RV involvement, due to large atria, atrial fibrillation, tricuspid or mitral insufficiency and thromboembolism. Among the survivors, the patient with RV disease has diastolic restriction and the ones with LV involvement, 9 are asymptomatic using either propranolol (8) or amiodarone (1), and one uses no medication. CONCLUSION: A HCM seen in Rio de Janeiro is similar to that found in the Orient (Japan) regarding presentation, diagnosis and evolution; but in 3 patients we have found RV disease, not described in Japan, characterizing a distinct group with a worse evolution.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiomiopatia hipertrófica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>apical</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>evolução</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertrophic cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>apical</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>evolution</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Hematoma retroesofágico com grave disfagia após estreptoquinase para tratamento da trombose venosa axilo-subclávia</s1>
</fA08>
<fA08 dir="en">
<s1>Severe dysfagia due to retroesophageal hematoma after thrombolytic therapy for right axillosubclavian vein thrombosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Claudio do Amaral Baruzzi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Emília Cardoso Gadelha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Claudio Cirenza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Elias Knobel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Israelita Albert Einstein  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>125-127</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>6</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Homem de 72 anos, portador de neoplasia de próstata estádio IV, submetido à osteossíntese da coluna cervical para descompressão metastática da raiz nervosa, responsável por dor intensa no membro superior direito. Após três meses da internação, apresentou trombose total da veia axilo-subclávia direita, complicação da cateterização prolongada da veia subclávia direita para controle de septicemia secundária a pneumonia hospitalar. Foi submetido a terapia trombolítica com estreptoquinase por via venosa, no membro superior contra-lateral, na dose de 250.000UI em 15min, seguida de 100.000UI/h durante cinco dias, com total recanalização do trombo e redução do edema. Após 24h do término da trombólise, apresentou disfagia a líquidos e o esofagograma mostrou extensa compressão extrínseca do esôfago, por provável hematoma retroesofágico. Necessitou de nutrição enteral durante três meses, quando ocorreu normalização da deglutição, reabsorção do hematoma retroesofágico e passagem adequada do contraste pelo esôfago. No seguimento evolutivo não apresentou seqüelas da trombose venosa profunda, não tem disfagia e permaneceu em uso profilático de meias elásticas e heparina de baixo peso molecular.</s0>
</fC01>
<fC01 dir="en">
<s0>We report the case of a 72 year-old man with advanced, stage IV, prostate cancer who underwent osteosynthesis of the cervical spine for nerve root decompression due to metastasis which was causing severe pain in his right upper limb. After three months in the hospital, he developed occlusive thrombosis of the right axillosubclavian vein as a complication of prolonged catheterization of the right subclavian vein for treatment of septicemia secondary to a hospital acquired pneumonia. The patient received thrombolytic therapy with IV streptokinase in the contralateral arm in the following dosage: 250,000 units in 15 minutes followed by 100,000 units per hour during five days. This led to total recanalization of the thrombus, with significant reduction of the arm edema. Twenty-four hours after the end of the thrombolytic therapy, the patient started to complain of dysfagia to solids and liquids and a contrasted esophagogram revealed extensive extrinsic compression of the esophagus due to a probable retroesophageal hematoma. The patient required enteral nutrition via nasoenteral tube during three months after which swallowing returned to normal and a repeat upper GI series confirmed that the hematoma had been reabsorbed, with normal passage of contrast through the esophagus. On late follow-up, the patient did not show evidence of any sequelae of deep venous thrombosis nor any residual dysfagia and is currently in use of elastic stockings and low molecular weight heparin.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Angina instável devida a comunicação entre artéria coronária e artéria pulmonar direita em paciente com arterite de Takayasu</s1>
</fA08>
<fA08 dir="en">
<s1>Coronary steal due to collateral circulation from circumflex coronary to right pulmonary artery leading to unstable angina in Takayasu's arteritis</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo R. Viecili</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>David Pamplona</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando H. Y. Cesena</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Protásio L. da Luz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>129-132</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Mulher de 63 anos com arterite de Takayasu, envolvendo arco aórtico, artérias subclávias e artéria pulmonar direita, com dor precordial progressiva. O eletrocardiograma de esforço revelou depressão do segmento ST. A cineangiocoronariografia não mostrou lesões estenóticas ostiais e nem epicárdicas e, sim, comunicação entre a artéria coronária circunflexa e o ramo do lobo superior da artéria pulmonar direita. O fluxo sangüíneo através da comunicação arterial foi considerado de grau importante, provocando, provavelmente, síndrome do roubo de fluxo coronário e, conseqüentemente, o quadro de angina de peito com caráter progressivo.</s0>
</fC01>
<fC01 dir="en">
<s0>A sixty three year old woman suffering from Takayasu's arteritis with involvement of the aortic arch, subclavia arteries and occlusion of the right pulmonary artery, developed progressive precordial pain. Exercise electrocardiogram disclosed ST segment depression. Coronary arteriograms demonstrated no coronary stenosis, but collateral circulation arising from circumflex coronary artery to right pulmonary artery. The collateral blood flow was considered to be of great importance, and causing the coronary steal syndrome, leading to angina pectoris.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Ventriculectomia parcial em criança - técnica de Batista</s1>
</fA08>
<fA08 dir="en">
<s1>Partial ventriculectomy in a child - the Batista operation</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiza Mara Elias</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Raynold Monteiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rosângela Fittaroni</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcelo Zaninotto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eduardo Coelho de Souza</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maria Alejandra Rivero</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Daniela Chaves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Randas José Vilela Batista</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Magnus Coelho de Souza</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>133-135</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>7</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Criança com dois anos e seis meses de idade, apresentando cardiomiopatia dilatada idiopática, classe funcional III-IV (New York Heart Association - NYHA) e indicação de transplante cardíaco, foi submetida à ventriculectomia parcial, pela técnica de Batista. A avaliação pré-operatória com ecocardiograma (ECO) e ventriculografia radioisotópica (Gated Blood Pool) revelaram fração de ejeção de ventrículo esquerdo (FEVE) de 13% e 20%, respectivamente. Após a cirurgia, que consistiu na remoção de uma parte do músculo da parede lateral do ventrículo esquerdo, a FEVE foi para 50% pelo ECO e 30% pela ventriculografia radioisotópica. A criança recebeu alta hospitalar no 16º pós-operatório em classe funcional I (NYHA).</s0>
</fC01>
<fC01 dir="en">
<s0>We present the case of a two and a half year old child with idiopatic dilated cardiomyopathy and end-stage congestive heart failure (NYHA III-IV) who underwent &quot;partial ventriculectomy&quot;. The operation was performed under normothermic cardiopulmorary bypass and normothermic oxygenated blood cardioplegia and consisted of removal of a large wedge of muscle from the lateral wall of the left ventricle beginning at the apex and extending between the papillary muscles, ending proximal to the mitral annulus. Pre-operative the left ventricular ejection fraction (EF) was 13% by echocardiography and 20% by radionuclide ventriculography. Postoperative avaliation showed improvement of EF to 50% and 30%, respectively. The child was in functional class I (NYHA) on discharge from hospital (16th postoperative day).</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 5/97 - Instituto do Coração do Hospital das Clínicas - FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>137-140</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Reestenose pós-angioplastia. Fisiopatogenia</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Ricardo Avancini Caramori</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Germán Iturry Yamamoto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alcides José Zago</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFRGS Hospital de Clínicas de Porto Alegre </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>141-150</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>127</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900212</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="">
<s1></s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>151-151</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900213</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Bioprótese cardíaca de dura-máter</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Boro Puig</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>153-154</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Disfunção arterial como possível mecanismo de agressão cardíaca em pacientes com diabetes mellitus tipo II. Estudo Doppler-ecocardiográfico</s1>
</fA08>
<fA08 dir="en">
<s1>Arterial dysfunction as a possible mechanism of cardiac injury in type II diabetic patients. A Doppler-echocardiographic study</s1>
</fA08>
<fA11 dir="011000">
<s1>Beatriz Bojikian Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Katashi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marina Politi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Shiguero Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Walkyria P. Pimenta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José C. Christovan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Carlos R. Padovani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Antonio Carlos Cicogna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNESP Faculdade de Medicina de Botucatu </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>155-159</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>37</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a estrutura e função do ventrículo esquerdo (VE) e a rigidez arterial em portadores de diabetes mellitus tipo II. MÉTODOS: Foram estudados 13 doentes diabéticos de ambos os sexos (55±8 anos) sem outras doenças. A estrutura e função do VE foram avaliadas por meio de ecodopplercardiografia associada à monitorização não invasiva da pressão arterial (PA). Os resultados foram comparados aos obtidos em grupo de indivíduos normais de mesma idade (n=12). RESULTADOS: Não houve diferenças entre os grupos quanto a PA diastólica, dimensões das câmaras esquerdas e índices de função sistólica e diastólica. Os pacientes diabéticos apresentaram índice de massa do VE (101±10 vs 80±14g/m²; p&lt;0,001) e índice de rigidez arterial sistêmica (0,86±0,26 vs 0,69±0,19mmHg/mL; p&lt;0,05) significantemente maiores que os controles. CONCLUSÃO: O diabetes mellitus está associado a aumento da rigidez arterial sistêmica e esse fator poderia contribuir para seus efeitos adversos sobre o VE.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the left ventricular structure and function and the arterial stiffness in type II diabetic patients. METHODS: Thirteen diabetic patients, men and women (age 55±8 years) were included in the study. None of the patients had any other clinical disorders. Doppler-echocardiography and non-invasive monitoring of arterial blood pressure were performed. All the results were compared to an age and sex matched control group (n=12). RESULTS: There were no differences between the groups for diastolic blood pressure, dimensions of cardiac chambers and ventricular systolic and diastolic function indexes. Diabetic patients had increased left ventricular mass index (101±10 vs 80±14g/m²; p&lt;0.001) and increased arterial stiffness (0.86±0.26 vs 0.69±0.19mmHg/mL; p&lt;0.05), when compared to control group. CONCLUSION: Diabetes mellitus is associated to increased systemic arterial stiffness and this may contribute to the adverse effects of diabetes on left ventricular morphology.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>massa miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>rigidez arterial sistêmica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial mass</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>systemic arterial stiffness</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Sintomas, complicações e alterações hemodinâmicas associadas a ecocardiografia de estresse com dobutamina</s1>
</fA08>
<fA08 dir="en">
<s1>Symptoms, complications and hemodynamic effects related to dobutamine stress echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Rita Pinton</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Walmor Lemke</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Lazaro G. Garcia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa de Misericórdia de Curitiba  </s1>
<s2>Curitiba PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>161-164</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a segurança e efeitos hemodinâmicos da ecocardiografia de estresse com dobutamina. MÉTODOS: Estudo prospectivo de 735 pacientes consecutivos, submetidos a ecocardiografia de estresse com dobutamina, para avaliar doença coronária e ou miocardiopatia. Inicialmente, a dobutamina foi administrada via endovenosa com doses progressivas de 5, 10, 20, 30µg/kg/min a intervalos de 3min. O protocolo foi modificado para atingir a dose máxima de 40µg/kg/min, e, finalmente, até o limite de 50µg/kg/min. RESULTADOS: A dobutamina aumentou significantemente a freqüência cardíaca (FC) (de 72±12bpm para 117±23bpm, p&lt;0,0005), a pressão sistólica (de 133±21bpm para 157±29mmHg, p&lt;0,0005) e o duplo produto (de 9,635±2,100 para 18,400±4,050, p&lt;0,0001) do estado basal para o pico de infusão, respectivamente. Observou-se aumento significativo (p&lt;0,05) da FC em cada estágio de infusão de dobutamina até dose de 40µg/kg/min, além do qual se mantém inalterado. Não ocorreram morte, infarto do miocárdio ou episódios de taquicardia ventricular. Os efeitos colaterais mais comuns foram náusea, ansiedade, tremor, apreensão e cefaléia em 55 (7,4%) pacientes. Angina de peito ocorreu em 10 (1,4%). As arritmias mais comum foram extra-sístoles ventriculares em 138 (18,7%) pacientes e extra-sistolia supraventricular 36 (4,9%). Houve 4 pacientes que apresentaram taquicardia ventricular não sustentada, sem repercussão hemodinâmica. CONCLUSÃO: Ecocardiografia de estresse com dobutamina é um método seguro e bem tolerado. Doses de infusão de dobutamina &gt;40µg/kg/min não provocam resposta cronotrópica adicional, o que torna questionável a validade do protocolo de ecocardiografia de estresse com doses de dobutamina &gt;40µg/kg/min.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: This study focuses on the safety and hemodynamic effects of dobutamine stress echocardiography. METHODS: Seven hundred and thirty five consecutive patients underwent dobutamine stress echocardiography for the evaluation of coronary artery disease and or cardiomyopathy. Dobutamine was administered intravenously at incremental doses of 5, 10, 20, 30µg/kg/min, at 3min intervals. The maximal dose was 40 or 50µg/kg/min. RESULTS: Dobutamine significantly (p&lt;0.0005) increased the heart rate (from 72±12bpm to 117±23bpm), systolic blood pressure (from 133±21 to 157±29mmHg) and the rate-pressure product (from 9.635±2.100 to 18.400±4.050, p&lt;0.0001) from baseline to peak infusion rate, respectively. There was a significant increase in heart rate (p&lt;0.05) at each infusion step, except for the 50µg/kg/min dose, when the heart became stable. There were no deaths myocardial infarctions, or episodes of sustained ventricular tachycardia. Common non cardiac side effects included nausea, anxiety, headache, tremors and urgency in 55 (7.4%) of the patients. Angina pectoris occured in 10 (1.4%) of the patients. The most common arrhytmias were usually mild. CONCLUSION: Dobutamine stress echocardiography is safe, and well tolerated. In this study complications such as myocardial infarction, death, ventricular tachycardia or fibrillation did not occur. There was no additional increase in heart rate with doses greater than 40µg/kg/min. The advantage of stress echocardiography protocol with peak doses of 50µg/kg/min is questionable.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste de esforço</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>catecolaminas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>efeitos adversos</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>catecholamines</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adverse effects</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Tratamento medicamentoso da doença arterial coronária estável em centros de atendimento primário e terciário</s1>
</fA08>
<fA08 dir="en">
<s1>Clinical therapeutics for stable coronary artery disease. Differences between primary and tertiary medical care centers</s1>
</fA08>
<fA11 dir="011000">
<s1>Antônio P. Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Everli P. S. Gonçalves Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Desidério Favarato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Angela Raineri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Renato M. Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José A. F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>165-168</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Observar a distribuição das drogas em pacientes com doença arterial coronária (DAC) estável, em centros de atendimento (CA) primário e terciário. MÉTODOS: Foram analisados, 300 pacientes, consecutivos, no ambulatório do Grupo de Coronariopatias do INCOR com diagnóstico de DAC, idades entre 31 a 80 (58,5±8,0) anos, sendo 205 (68%) do sexo masculino e 95 (32%) do feminino e estudadas as características clínicas e hemodinâmicas. Avaliaram-se as drogas utilizadas, inicialmente, nos CA primários (comunitários) e, posteriormente, no CA terciário. RESULTADOS: As drogas mais utilizadas nos CA primários foram os b-bloqueadores (50% dos pacientes), nitratos (48%), bloqueadores dos canais de cálcio (46%), ácido acetil-salicílico (44%), diuréticos (30%) e os inibidores da enzima de conversão de angiotensina (ECA), em 11% dos pacientes. No CA terciário as drogas mais utilizadas foram o ácido acetil-salicílico (76% dos casos), nitratos (55%), diuréticos (49%), inibidores da ECA (42%), os antagonistas dos canais de cálcio (37%) e os betabloqueadores (35% dos pacientes). Os b-bloqueadores foram mais prescritos em CA primário, p= 0,02, já os inibidores da ECA, p&lt;0,0001, o ácido acetil-salicílico, p&lt;0,0001 e os diuréticos, p= 0,002, foram mais prescritos no CA terciário. CONCLUSÃO: O tratamento farmacológico preconizado para a DAC estável deve ser otimizado em ambos os CA, dando prioridade às drogas que modificam a história natural da doença, como os betabloqueadores, antiagregantes plaquetários, e os inibidores da ECA nos pacientes com disfunção ventricular esquerda.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To observe the distribution of the main drugs used in patients with stable coronary heart disease, in primary and tertiary medical care centers (MCC). METHODS: We studied 300 consecutive out patients at the Hetat Institute with the diagnosis of stable coronary artery disease, 205 (68%) males and 95 (32%) female, aged from 31 to 80 (mean 58±8.0) years old. Drug intake was evaluated. RESULTS: We observed that the use of nitrates (48% vs 55%; p=NS) and calcium antagonists (46% vs 37%; p=NS), respectively in both primary and tertiary MCC was similar. The beta blockers were used more often in the primary MCC (50% vs 35%; p= 0,02). Angiotensin coverting enzyme inhibitors (11% vs 42%; p&lt; 0.001), diuretics (30% vs 49%; p= 0.002) and aspirin (44% vs 76%; p= 0.0001) were more frequently used in the tertiary MCC. CONCLUSION: We observed similar frequency of use of nitrates and calcium antagonists in both centers. There was a higher use of beta blockers in primary MCC. The angiotensin coverting enzyme inhibitors and antiplatelet agents were more used in the tertiary MCC. In relation to the updated literature, the best pharmacotherapy to coronary artery disease should be optimized in both centers.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aterosclerose coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>terapêutica clínica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>centros médicos primários e terciários</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>medical therapeutics</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>community and reference medical centers</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeito do treinamento físico de membros superiores aeróbio de curta duração no deficiente físico com hipertensão leve</s1>
</fA08>
<fA08 dir="en">
<s1>The effect of short term Aerobic physical training using upper limbs in paraplegic persons with mild to moderate hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>Sandra Haddad</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Roberto Santos Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ivan Ferraretto</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>169-173</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar as alterações provocadas pelo treinamento físico (TF), com membros superiores (MMSS), em condição aeróbia de curta duração, sobre variáveis dos sistemas cardiovascular e metabólico. MÉTODOS: Foram estudados 11 deficientes físicos (DF) paraplégicos, com média de idade de 59 anos, sendo 7 homens e 4 mulheres, com lesão de T9 a T11 e grau leve de hipertensão arterial sistêmica (HAS). Os DF foram avaliados antes e após 12 semanas de um programa de TF supervisionado de MMSS, por meio de teste ergométrico (TE) em cicloergômetro mecânico adaptado para MMSS, utilizando-se protocolo intermitente com incremento de carga de 125kgm/min (20w) para mulheres e 140kgm/min (25w) para homens a cada 3min., em velocidade que variou de 83 a 95rpm. O consumo de oxigênio (VO2) foi calculado de acordo com a equação para MMSS do American College of Sports Medicine. A intensidade do exercício durante o programa de TF foi estabelecida pela reserva de freqüência cardíaca (RFC) de Karvonen, com variação de 65% a 85% e escala de percepção subjetiva ao esforço de Borg obtida pelo TE. RESULTADOS: A capacidade aeróbia máxima estimada aumentou 22% (930±349 vs 1138±290mL/min; p=0,003); a pressão arterial sistólica (PAS) e diastólica (PAD) em repouso e no exercício submáximo diminuíram em 4%, 15% e 5%, 5%, respectivamente. CONCLUSÃO: O TF aeróbio de intensidade leve a moderada com MMSS, além de melhorar a aptidão funcional exerce também papel importante como modelo terapêutico não medicamentoso na resposta hipertensiva observada em DF paraplégicos.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To study the modifications induced by physical training (PT) using upper limbs in aerobic condition of short duration on cardiovascular and metabolic variables. METHODS: Eleven paraplegic persons, with a mean age of 59 years, 7 men and 4 women with lesions at T9 through T11 and mild hypertension (HAS) were studied. The patients were studied before and after 12 weeks of a supervised program of PT, through exercise tests in a mechanic ergometer (ST) adapted for the arms. We emploied an intermittent protocol with stress increments of 125 (20w) and 140kgm/min (25w) for women and men, respectively every 3min. The ergometric speed ranged from 83 to 95rpm. The oxygen consumption (VO2) was estimated according to American College of Sports Medicine equation for arms. The exercise intensity during the TF program was estimated through the Karvonen cardiac frequency reserve, with a variation of 65% to 85% and the Borg stress scale of subjetive perception during the stress test. RESULTS: The mean maximal aerobic capacity increased in 22% (930+349 vs 1138+290mL/min; p=0.003); there was a reduction of systolic and diastolic pressures at rest and after submaximal exercise of 4%,15% and 5% and 5%, respectively. CONCLUSION: Physical training of mild to moderate intensity using the upper limbs in paraplegic persons, besides inducing functional capacity increment , is an important model of non drug control of the hypertensive response.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial sistêmica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>exercício físico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>deficiente físico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>paraplegia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>physic exercise</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>physical deficient</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>paraplegia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>A perda precoce do diâmetro luminal após angioplastia coronária e sua influência no fenômeno da reestenose</s1>
</fA08>
<fA08 dir="en">
<s1>Early luminal diameter loss after percutaneous transluminal coronary angioplasty and its relation to the restenosis phenomenon</s1>
</fA08>
<fA11 dir="011000">
<s1>Adriano Mendes Caixeta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fábio Sândoli de Brito Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Pedro Eduardo Horta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Miguel Rati</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mauro Fonseca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Júlia Tizue Fukushima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Siguemituzo Arie</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Fúlvio Pileggi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>175-179</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar a perda do diâmetro luminal mínimo (DLM) nos primeiros 15min após angioplastia coronária por balão (AC), quantificando sua influência na reestenose coronária. MÉTODOS: Foram estudadas, prospectivamente, 86 AC em 86 pacientes. Os pacientes foram divididos em dois subgrupos de acordo com a presença ou ausência de reestenose; o 1º grupo compreendendo as 31 lesões com reestenose e o 2º, as 55 lesões sem reestenose. RESULTADOS: A análise univariada mostrou que a relação balão/artéria foi menor no grupo com reestenose (0,92±0,01 vs 1,00±0,11, P= .003). O grupo com reestenose apresentou maior recolhimento elástico absoluto e relativo no 1°min (0,79±0,54 vs 0,68±0,59mm; P= 0,007 e 32,04±14,27 vs 22,15±16,65%; P= 0,006.) e no controle angiográfico do 15°min (1,25±0,59 vs 0,90±0,65mm, P= 0,017 e 46,75±15,69 vs 29,18±17,84%, P&lt;0,00001) do que o grupo sem reestenose. O DLM no 1°min foi menor no grupo com reestenose (2,15±0,42 vs 2,43±0,58mm; P=0,022). O grupo com reestenose apresentou uma maior perda precoce no DLM (0,46±0,34 vs 0,22±0,35mm, P= 0,004). Este decréscimo na luz do vaso determinou que o DLM do 15°min fosse ainda menor no grupo com reestenose (1,69±0,48 vs 2,20±0,61; P= 0,0001). Da análise multivariada, entretanto, identificou-se apenas a relação balão/artéria e o DLM do 15°min como os dois fatores independentes mais relacionados à reestenose. CONCLUSÃO: O recolhimento elástico e a perda do DLM ao longo dos 15min são fatores diretamente relacionados à reestenose. Entretanto, a análise multivariada mostrou que a relação balão/artéria e o DLM de 15min são os dois fatores independentes mais fortemente preditores de reestenose.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the early luminal diameter loss in the first 15min after percutaneous transluminal coronary angioplasty (PTCA) and its influence on coronary restenosis. METHODS: In a prospective study, we evaluated 86 patients. The patients were divided in two groups based on the presence or absence of coronary restenosis. Thirty one lesions developed restenosis and 55 lesions did not. RESULTS: Univariate analysis showed that balloon/artery ratio was lower in the group of restenosis (0.92±0,01 vs 1.00±0,11, P= .003). Absolute and relative elastic recoil at 1 min was greater in the group that developed restenosis (0.79±0.54 vs 0.68±0.59mm; P= .007 and 32.04±14.27 vs 22.15±16.65%; P= .006). Similarly, absolute and relative elastic recoil at 15 min were greater in the group with restenosis (1.25±0.59 vs 0.90±0.65mm, P= .017 e 46.75±15.69 vs 29.18±17.84%, P&lt; .00001). Minimal luminal diameter( MLD) at 1min was lower in the group with restenosis (2.15±0.42 vs 2.43±0.58mm; P= .022). The very early loss was greater in the group with restenosis (0.46±0.34 vs 0.22±0.35mm, P= .004). MLD at 15 min was lower in the group of restenosis than in the group without restenosis (1.69±0.48 vs 2.20±0.61; P= .0001). Multivariate analisys revealed balloon/artery ratio and MLD at 15 min as independent correlates of the late outcome. CONCLUSION: The late outcome of PTCA is influenced by elastic recoil and the early MLD loss after PTCA. However, the strongest and most important predictors of late outcome by multivariate analysis were balloon/artery ratio and MLD at 15 min.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous transluminal coronary angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elastic recoil</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>restenosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Isquemia miocárdica intermitente após angioplastia cirúrgica do tronco de coronária esquerda</s1>
</fA08>
<fA08 dir="en">
<s1>Intermittent myocardial isquemia after surgical angioplasty of the left main coronary artery</s1>
</fA08>
<fA11 dir="011000">
<s1>Luís Roberto Gerola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ivana Delamônica Freire Eckert</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Alfredo Sejópolis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alberto Najjar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luís Cesar N. Scala</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Ronaldo D. Fontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Santa Cruz - Cuiabá  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>181-184</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Dois pacientes do sexo masculino (38 e 53 anos) com angina instável, com estudo hemodinâmico revelando grave lesão de óstio de tronco de coronária esquerda (TCE), foram submetidos a angioplastia cirúrgica do TCE com patch de veia safena. Ao final da operação os pacientes apresentaram isquemia miocárdica intermitente, um deles com choque cardiogênico e, em ambos, reversão completa do quadro. O estudo hemodinâmico pós-operatório revelou adequada ampliação do TCE com função ventricular esquerda preservada nos dois pacientes. Embora a angioplastia cirúrgica do TCE seja uma alternativa técnica para os doentes com lesões ostiais, chamamos a atenção para esta grave morbidade operatória, tendo como uma das possíveis causas o espasmo do TCE.</s0>
</fC01>
<fC01 dir="en">
<s0>Two 38 and 53-year old male patients with unstable angina, whose hemodynamic study showed an isolated stenosis of the left coronary artery ostium, were submitted to a surgical angioplasty of the left main coronary artery (LMCA) with saphenous vein patch. At the end of the operation, the patients presented intermitent myocardial isquemia. One of them led to abrupt cardiogenic shock which reversed completely. The postoperative hemodynamic study demonstrated excellent left main coronary artery patency and normal left ventricular . of LMCA has been proposed as an alternative technique to the treatment of ostial lesions, the surgical team should be prepared to face severe operative morbidity. The LMCA spasm has been considered as a possible etiology of that event.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Trombose em artérias coronárias normais causando infarto agudo do miocárdio em paciente alcoólatra</s1>
</fA08>
<fA08 dir="en">
<s1>Thrombosis in normal coronary arteries causing acute myocardial infarction in an alcoholic patient</s1>
</fA08>
<fA11 dir="011000">
<s1>David Pamplona</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcello Barduco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcelo Luis C. Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luciano Forlenza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz Antonio Machado César</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>185-188</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Paciente jovem, etilista, que sofreu infarto agudo do miocárdio. Após terapêutica trombolítica sem sucesso, a cineangiocoronariografia na fase aguda evidenciava trombos em múltiplas artérias. Um 2º CATE, realizado no 7º dia de internação revelou coronárias normais. Não havia nenhum distúrbio do metabolismo lipídico, assim como outro fator de risco de doença arterial coronária, a não ser o fato de ser tabagista de oito a 10 cigarros ao dia, há dois anos, o que nos levou a acreditar que o abuso de álcool etílico possa ter contribuído para esse evento.</s0>
</fC01>
<fC01 dir="en">
<s0>A case of a young patient, heavy drinker, who suffered an acute myocardial infarction (AMI), and whose cinecoronariography, early post unsuccessful intravenous thrombolysis, showed the presence of thrombi in multiple arteries is reported. A second cinecoronariography performed on the 7th day post AMI revealed normal coronary arteries. There were no plasmatic lipid or coagulation abnormalities, nor other risk factors for coronary artery disease. We speculate about the role of the heavy alcohol ingestion in this particular case.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Ergometria de membros superiores. Um método importante na avaliação cardiocirculatória ao exercício</s1>
</fA08>
<fA11 dir="011000">
<s1>Sandra Haddad</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Associação de Assistência à Criança Defeituosa  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>189-193</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>47</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Ecocardiografia fetal. Apresentando o método</s1>
</fA08>
<fA11 dir="011000">
<s1>Solange Bernardes Tatani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Centro de Cardiologia Não Invasiva  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>197-201</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900311</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Ecocardiografia fetal. Novas fronteiras</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>203-204</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900312</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Fisiologia da circulação fetal e diagnóstico das alterações funcionais do coração do feto</s1>
</fA08>
<fA11 dir="011000">
<s1>Sandra S. Mattos</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Português Unidade de Cardiologia e Medicina Fetal </s1>
<s2>Recife PE</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>205-207</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900313</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Malformações cardíacas fetais. Diagnóstico e conduta</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Zielinsky</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul Unidade de Cardiologia Fetal</s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>209-218</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900314</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Arritmias fetais</s1>
</fA08>
<fA11 dir="011000">
<s1>Lilian Maria Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo Zugaib</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>219-222</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900315</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Ecocardiografia fetal</s1>
</fA08>
<fA11 dir="011000">
<s1>Solange Bernardes Tatani</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Centro de Cardiologia Não Invasiva  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>195-196</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900310</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação dos efeitos a curto prazo de programas de conscientização e de terapia com pravastatina em indivíduos de alto risco para doença cardiovascular provenientes de consultórios particulares</s1>
</fA08>
<fA08 dir="en">
<s1>The evaluation of short term effects of awareness programs and pravastatin therapy on subjects from private clinics at high risk for cardiovascular disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Raul D. Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz O. do Nascimento</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Raul C. Maranhão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>225-230</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a eficácia de programas de conscientização (PC) sobre o controle de fatores de risco (FR) para doença cardiovascular (DCV). MÉTODOS: Pacientes hipercolesterolêmicos de alto risco para DCV foram divididos em 2 grupos durante 16 semanas. O grupo A (n=417, 54,3±10,0 anos, 55% homens) recebeu orientação verbal e escrita sobre controle de FR, e o grupo B (n=180, 54,4±10,9 anos, 45% homens) apenas orientação verbal. Todos os participantes receberam 10mg/dia de pravastatina por 12 semanas. Avaliaram-se o peso, pressão arterial, o colesterol total (CT) e frações, triglicérides, índices I e II de Castelli (CT/HDL-C e LDL-C/HDL-C) e escores de Framingham. RESULTADOS: No basal, A diferiu de B no HDL-C (40,0±11,0 vs 43,0±11,0mg/dl, p=0,013) e no índice I (8,2±3,0 vs 7,6±2,3, p=0,008). Após 16 semanas as variações % foram maiores em A do que B no CT (-28,0 vs -25,0, p&lt;0,05), LDL-C (-29,0 vs -27,6, p&lt;0,05), HDL-C (+13,7 vs. + 10,8, p&lt;0,05) e índice I (-39,0 vs -33,0; p&lt;0,05). A pravastatina potencializou os efeitos da dieta sobre os lípides. CONCLUSÃO: O PC parece ser mais eficaz a curto prazo, em reduzir os FR para DCV do que a orientação apenas verbal.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate short-term efficacy of awareness programs (AP) in reducing coronary heart disease risk factors (CHDRF). METHODS: High risk hypercholesterolemic patients were divided in 2 groups during 16 weeks. Group A (n=417, 54.3±10.0 years, 55% males) received verbal and written orientation on CHDRF control, and group B (n=180, 54.4±10.9 years, 45% males) received only verbal orientation. All participants received pravastatin 10mg q.d. for 12 weeks. The evolution of body weight, arterial pressure, lipid profile, Castelli's I and II indexes (TC/HDL and LDL/HDL), and Framingham scores were evaluated. RESULTS: At baseline, A had a lower HDL-C (40.0±11.0 vs 43.0±11.0mg/dl, p=0.013) and a higher index I (8.2±3.0 vs 7.6±2.3, p=0.008) than B. After 16 weeks, A had greater change than B in TC (-28.0 vs -25.0, p&lt;0.05), LDL-C (-29.0 vs -27.6, p&lt;0.05), HDL-C levels (+13.7 vs +10.8, p&lt;0.05) and in the Castelli's Index (-39.0 vs -33.0; p&lt;0.05). In both groups pravastatin use potentialized the effects of diet on the lipid profile. CONCLUSION: The AP seemed to be more effective than verbal orientation alone in CHDRF reduction at short-term.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipercolesterolemia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença cardiovascular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>pravastatina</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypercholesterolemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pravastatin</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Fatores de risco de aterosclerose na infância. Um estudo epidemiológico</s1>
</fA08>
<fA08 dir="en">
<s1>Risk factors of atherosclerosis in children. An epidemiologic study</s1>
</fA08>
<fA11 dir="011000">
<s1>Zoffi Roberto S. Gerber</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>231-236</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Obter um perfil dos fatores de risco coronário em uma amostra populacional pediátrica da cidade de Bento Gonçalves, RS, no período de maio/90 a junho/91. MÉTODOS: Foram estudados 1501 escolares de 6 a 16 anos incompletos, visando a detecção dos níveis séricos de colesterol total, lipoproteínas, triglicerídeos, bem como a avaliação da pressão arterial e da história familiar de doença cardiovascular isquêmica e obesidade. RESULTADOS: Foram detectadas 420 (27,98%) crianças com hipercolesterolemia, sendo que 75 (5%) apresentavam hipertensão arterial sistólica e 48 (3,20%) hipertensão arterial diastólica. A história familiar foi importante quando positiva, porém, sua ausência não excluia a presença de fatores de risco para a aterosclerose. A hipertrigliceridemia foi encontrada em 136 (9,06%) escolares e a LDL-colesterol elevada em 155 (10,33%), mostrando forte associação com hipercolesterolemia. Apresentaram índice de massa corporal acima de percentil 95, não mostrando uma maior prevalência de hipercolesterolemia, 111 crianças. CONCLUSÃO: Os fatores de risco para a aterosclerose estão presentes na infância e deveriam ser pesquisados independentemente do nível socioeconômico, da história familiar, da idade e do sexo, devendo o pediatra ser um dos responsáveis por esta investigação.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To obtain a profile of risk factors for coronary atherosclerosis in a pediatric population from Bento Gonçalves, Rio Grande do Sul, from May 1990 to June 1991. METHODS: One thousand five hundred and one children with ages from 6 to 15 years were studied to assess serum cholesterol levels and their association with other risk factors, such as arterial hypertension, obesity and family history of cardiovascular disease. RESULTS: Four hundred and twenty (27.98%) children showed cholesterol levels over 180mg%; 75 (5%) had systolic hypertension and 48 (3.20%) diastolic hypertension. The family history was important to search for risk factors such as hypercholesterolemia, but did not exclude risk factors when negative. One hundred and thirty six (9.06%) children showed hipetriglyceridemia; 155 (10.33%) presented LDL-cholesterol above 130mg% and showed a strong association with hypercholesterolemia. Obesity was present in 111 children, but none showed a major prevalence of hypercholesterolemia. CONCLUSION: Risk factors for atherosclerosis are present in children and their search should be performed, independent of family income, family history, age and sex. The pediatrician must have a significant role in this setting.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doenças cardiovasculares</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>arteriosclerose coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>criança</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>child</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Capacidade funcional máxima e função diastólica em portadores de cardiomiopatia chagásica sem insuficiência cardíaca congestiva</s1>
</fA08>
<fA08 dir="en">
<s1>Maximal functional capacity and diastolic function in patients with cardiomyopathy due to Chagas' disease without congestive heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Barbara M. Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Vera Maria Cury Salemi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo R. Santos Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rita Helena A. Cardoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Dalia Ballas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>237-241</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Identificar disfunções cardíacas precoces em pacientes assintomáticos com cardiomiopatia chagásica. MÉTODOS: Foram estudados 38 indivíduos masculinos, sendo o grupo controle constituído de 20 indivíduos sedentários normais e o grupo Chagas de 18 pacientes assintomáticos, portadores da doença de Chagas, com eletrocardiograma alterado e fração de encurtamento (DD) normal ao ecocardiograma. Ambos os grupos foram submetidos à avaliação da capacidade funcional máxima, com medidas do consumo máximo de oxigênio (VO2max), índice de pulso de oxigênio (PO2max), ventilação máxima (VE max), freqüência cardíaca máxima (FC max), e limiar anaeróbio do VO2max (LA-VO2). A função diastólica do ventrículo esquerdo foi avaliada pelo ecocardiograma convencional (ondas E e A além da relação E/A). RESULTADOS: Não ocorreram diferenças significativas entre os dois grupos em relação ao DD (p=0,212) e a idade média (p=0,060). Houve diferença significativa (p&lt;0,001) em relação aos parâmetros VO2max, PO2max, VE max, FC max, LA-VO2, onda E e relação E/A. Não houve significância (p=0,520) em relação a onda A. CONCLUSÃO: O comprometimento na função ventricular pode contribuir para as diferenças acima mencionadas, como conseqüência de disfunção sistólica e diastólica.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To identify early cardiac dysfunctions in asymptomatic patients with Chagas' cardiomyopathy. METHODS: We studied 38 male individuals: control group consisting of 20 sedentary normal individuals and Chagas' group, of 18 asymptomatic patients with Chagas' disease, with suggestive electrocardiographic alterations and normal fractional shortening (FS) on echocardiogram. Both groups were submitted to evaluation of the maximal functional capacity, with measurements of maximal O2 consumption (VO2max), O2-pulse rate (PO2max), maximal ventilation (VEmax), maximal heart rate (HRmax), and anaerobic threshold of the VO2max(VO2-AT). Left ventricular diastolic function was evaluated by conventional echocardiography (E wave, A wave and E/A ratio). RESULTS: No significant differences occurred between the two groups with regard to FS (p=0.212) and age means (p=0.060). The 2 groups were significantly different (p&lt;0.001) regarding the parameters VO2max, PO2max, VEmax, HRmax and VO2-AT, E wave and E/A ratio. There was no difference (p=0.520) in A wave. CONCLUSION: Impaired ventricular function may account for the above mentioned differences, a consequence of both systolic and diastolic dysfunctions.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença de Chagas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>capacidade funcional máxima</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função diastólica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>maximal functional capacity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diastolic function</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo mesoscópico da valva mitral e do seu anel fibroso</s1>
</fA08>
<fA08 dir="en">
<s1>Mesoscopic study of the mitral valve and its fibrous ring</s1>
</fA08>
<fA11 dir="011000">
<s1>Jennecy Sales Cavalcanti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eveline de Lucena Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Emanuelle Tenório A. M. Godoi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Laura Patrícia Ferreira Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Viviane Xavier de Lima e Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Micheline de Lucena Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Centro de Ciências Biológicas Universidade Federal de Pernambuco </s1>
<s2>Recife PE</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>243-246</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar o arranjo espacial dos elementos fibrosos que constituem os folhetos da valva mitral e do seu anel fibroso. MÉTODOS: Foram utilizados 20 corações adultos, de ambos os sexos, fixados em formol a 10%. Isolaram-se a valva mitral, juntamente com o anel fibroso, e uma pequena quantidade de tecido muscular ao seu redor. Parte desse material foi incluído em parafina, submetido a cortes seriados de 40µm de espessura e corados pelo tricrômio de Azan e pela resorcina-fucsina, e o restante das peças dissecadas sob lupa estereoscópica, com ajuda de delicadas pinças e agulhas, para se observar a disposição dos feixes miocárdicos ao nível do anel mitral. RESULTADOS: Observou-se que o anel fibroso mitral era constituído por feixes colágenos de trajetória semicircular, envolvendo de forma incompleta o óstio atrioventricular, uma vez que era ausente na região ântero-medial do óstio. Verificou-se que os feixes miocárdicos ventriculares inseriam-se de forma oblíqua, na borda externa do anel, sendo que na região ântero-medial assumiam uma trajetória semicircular. Os folhetos da valva mitral eram constituídos de feixes colágenos dispostos, paralelamente, no sentido do maior eixo da válvula, recobertos pelo endocárdio atrial e ventricular. Os feixes colágenos, presentes na base dos folhetos valvares, praticamente se continuavam com os do anel fibroso. Observou-se, em alguns casos, a existência de delgados feixes miocárdios atriais no folheto valvar anterior, que praticamente eram restritos à região central das válvulas. CONCLUSÃO: Os folhetos da valva mitral e seu anel fibroso possuem uma continuidade estrutural, que demonstra que estes elementos funcionam de forma integrada no fechamento do óstio atrioventricular esquerdo durante a sístole ventricular, no que seria auxiliado pela redução do diâmetro do anel fibroso, através da contração dos feixes miocárdicos semicirculares que nele se inserem.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To study the spatial arrangement of the fibrous elements that form the leaflets of the mitral valve and its fibrous ring. METHODS: The study of 20 human adult hearts, of both sexes, fixed in 10% formaldehyde solution was made. The mitral valves with their fibrous rings and small parts of the adjacent atrial and ventricular muscles were removed. Part of this material was embedded in paraffin and cut serially at a thickness of 40µm and stained by Azan's trichrome and by resorcin-fuccin and another was dissected under stereoscope in order to verify the arrangement of the myocardial bundles at the level of the fibrous ring. RESULTS: It was observed that the fibrous ring is consisted of collagenous fibers which involved in an incomplete form the atrioventricular ostium, as they were absent in the anteromedial region of the ostium. The leaflets were made of collagenous fibers disposed parallel to the long axis of the valve. This collagenous fibers were covered by atrial and ventricular endocardium. The collagenous fibers of the leaflets were continuous, by their base, into the fibrous ring. It was observed, in a few cases, the presence of atrial muscle fibers into the anterior leaflet of the mitral, mainly in its central area. CONCLUSION: The leaflets of the mitral valve and its fibrous ring have a structural continuity suggesting that elements would act synchronously in the closure of the atrioventricular ostium during ventricular systole. The contraction of the myocardial bundles fixed in the fibrous ring contributes to decrease the diameter of the mitral ring.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valva mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>anel fibroso</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coração</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valve</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fibrous ring</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Ação do mononitrato-5 de isossorbida sublingual durante cinecoronariografia. Comparação com o uso de nitroglicerina sublingual</s1>
</fA08>
<fA08 dir="en">
<s1>Sublingual isosorbide-5 mononitrate during coronary arteriography. Comparison with sublingual nitroglycerin</s1>
</fA08>
<fA11 dir="011000">
<s1>Anellys E. L. C. Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Siguemituzo Arie</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Evandro L. Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luís F. A. Campos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo R. Soares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Donaldo P. Garcia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>247-250</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>7</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o efeito sublingual do mononitrato-5 de isossorbida (MN5IS) e nitroglicerina (NTG) sobre o diâmetro luminal de artérias coronárias epicárdicas, pressão arterial média e efeitos colaterais. MÉTODOS: Cinqüenta pacientes foram submetidos a cateterismo cardíaco e cinecoronariografia, na condição inicial e 5min após administração sublingual de MN5IS grupo A (GA) ou NTG grupo B (GB). RESULTADOS: O diâmetro coronário de referência aumentou em ambos os grupos, sem significância estatística entre os mesmos. Nos GA e GB foram demonstrados uma diminuição (1,66mmHg) e um aumento (0,79mmHg) na pressão arterial média, respectivamente (p=0,123). Não foram observados efeitos colaterais com o uso destas drogas. CONCLUSÃO: MN5IS sublingual é uma alternativa à administração de NTG durante cinecoronariografia e representa uma alternativa terapêutica para o tratamento de doença cardíaca isquêmica.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the effect of sublingual isosorbide-5 mononitrate (ISMN) and nitroglycerin (NTG) on luminal diameter of epicardial coronary arteries, mean arterial pressure and deleterious effects. METHODS: Fifty patients were submitted to cardiac catheterization and coronary arteriography, at baseline, and 5min after sublingual administration of ISMN, group A (GA) or NTG, group B (GB). RESULTS: Reference vessel diameter increased in both groups, without statistical significance. In GA and GB, a decrease (1.66mmHg) and an increase (0.79mmHg) in mean arterial pressure, respectively, were demonstrated (p=0.123). There were no deleterious effects with the use of these drugs. CONCLUSION: Sublingual ISMN is an alternative to administration of NTG during coronary arteriography, and represents a therapeutic alternative to ischemic heart disease treatment.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mononitrato-5 de isossorbida</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>nitroglicerina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angiografia quantitativa</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>isosorbide-5 mononitrate</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nitroglycerin</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>quantitative angiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Ressonância nuclear magnética no diagnóstico de pseudoaneurisma de ventrículo esquerdo. Antigo problema, nova opção</s1>
</fA08>
<fA08 dir="en">
<s1>Nuclear magnetic resonance imaging in the diagnosis of left ventricular pseudoaneurysm. An old problem, a new option</s1>
</fA08>
<fA11 dir="011000">
<s1>Glaura S. Alvarenga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Liliane Kopel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luís Alberto Oliveira Dallan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Francisco Avila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maristela C. Monachini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Silvia G. Lage</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>251-254</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Paciente feminina, 67 anos, internada por infarto agudo do miocárdio de parede lateral, com edema agudo de pulmão e evolução para choque cardiogênico nas primeiras horas. Ecocardiograma transesofágico e ressonância nuclear magnética confirmaram o diagnóstico de pseudoaneurisma de ventrículo esquerdo. A paciente foi submetida a tratamento cirúrgico com sucesso.</s0>
</fC01>
<fC01 dir="en">
<s0>We describe the case of a 61 year-old female patient admitted to the hospital with acute lateral myocardial infarction, in pulmonary edema, who evolved to cardiogenic shock in the first hours. Transesophageal echodopplercardiogram and nuclear magnetic resonance imaging showed the diagnosis of a left ventricular pseudoaneurysm. Surgical repair was successfully undertaken.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Inotrópicos, não devem ser prescritos?</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Guilherme Velloso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>255-256</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 6/97 - Instituto do Coração do Hospital das Clínicas - FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>257-261</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Aplicação clínica do ultra-som intracoronário</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gary S. Mintz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Andrea S. Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Lowell F. Satler</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Jeffrey J. Popma</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Augusto D. Pichard</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Roxana Mehran</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Kenneth M. Kent</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Martin B. Leon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Washington Hospital Center  </s1>
<s2>Washington DC</s2>
<s3>USA</s3>
</fA14>
<fA20 dir="000000">
<s1>263-265</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>I Consenso Nacional de Reabilitação Cardiovascular</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>267-291</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>127</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Cartas ao Editor</s1>
</fA08>
<fA11 dir="011000">
<s1>Luís Alberto Oliveira Dallan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>293-293</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Ventriculectomia parcial esquerda. Resultados atuais, possíveis indicações e perspectivas futuras</s1>
</fA08>
<fA11 dir="011000">
<s1>Reinaldo B. Bestetti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Carlos F. Brasil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rubio Bombonato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital do Coração de Ribeirão Preto  </s1>
<s2>Ribeirão Preto SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>295-297</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiomiopatias. Uma visão crítica do conceito da classificação</s1>
</fA08>
<fA11 dir="011000">
<s1>Mady Charles</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fábio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>299-300</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Indicações clínico-epidemiológicas para investigação ecocardiográfica no período neonatal. Valor dos grupos de risco</s1>
</fA08>
<fA08 dir="en">
<s1>Clinical-epidemiologic indications for echocardiographic investigation in the neonatal period. Value of risk groups</s1>
</fA08>
<fA11 dir="011000">
<s1>Lilian dos Santos Rodrigues Sadeck</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Renato Azevedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alfonso Julio Guedes Barbato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Valdenise M. L. T. Calil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria do Rosário Dias de Oliveira Latorre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cléa Rodrigues Leone</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Lauro Araújo Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto da Criança Prof. Pedro de Alcântara</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>301-307</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>42</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudo ecocardiográfico em recém-nascidos (RN) de grupos de risco para cardiopatia congênita, a fim de se determinar a prevalência que justifique esse exame no período neonatal. MÉTODOS: Estudaram-se, de novembro/91 a abril/93, 156 RN do berçário anexo à Maternidade do HC-FMUSP, sendo RN de mães com cardiopatia congênita ou com diabetes mellitus, crianças de muito baixo peso, com malformações extracardíacas ou presença de sinais cardíacos, caracterizados por sopro, cianose ou arritmia, todos submetidos ao ecocardiograma. RESULTADOS: A prevalência encontrada foi de 21,8%, superior ao da população geral (0,8 a 1,2%), sendo que a maior entre os grupos, de 40,7%, ocorreu no grupo de malformações extracardíacas. CONCLUSÃO: Nossos dados justificam a realização de ecocardiograma em RN pertencentes a um destes grupos de risco para cardiopatia congênita.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: An echocardiographic study was performed in newborns from risk groups, with the aim of to determining prevalence and to evaluate the indications for this test in the neonatal period. METHODS: One hundred fifty six newborns were studied . They were admitted to the Newborn ward of the Department of Obstetric of the HC-FMUSP, in the period of November 91 to April 93, from mothers with congenital heart disease or diabetes, low birth weight newborns, with extracardiac malformations, cardiac signs and/or congenital infections. RESULTS: The observed prevalence was 21.8%, greater than that of the general population (0.8-1.2%). The group composed by 27 children with extracardiac abnormalities presented the largest prevalence when compared with the other groups (40.7%). These data justify the use of echocardiography in high risk newborns for the detection of congenital heart disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatias congênitas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>recém-nascidos</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>newborn/infant</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>O acometimento isquêmico obstrutivo na cardiomiopatia hipertrófica do tipo septal assimétrico com envolvimento da artéria descendente anterior</s1>
</fA08>
<fA08 dir="en">
<s1>Obstructive ischemic involvement of the left anterior descending coronary artery in asymmetrical septal form of hypertrophic cardiomyopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco Manes Albanesi Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcia Bueno Castier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Tatiana Tavares da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Silvia Helena Cardoso Boghossian</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Ginefra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>309-315</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>41</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o papel da doença arterial coronária (DAC) com comprometimento da artéria descendente anterior (ADA) na cardiomiopatia hipertrófica (CMH) e sua repercussão na evolução, visto ser controverso o significado da necrose e fibrose do septo interventricular (SIV) nesta cardiomiopatia. MÉTODOS: Entre 158 pacientes com CMH, selecionamos 6 (3,79%) com CMH e DAC com lesão obrigatória de ADA, sendo 4 homens, entre 52 e 70 (x= 65,16) nos, 4 com a forma obstrutiva da CMH. O tempo de diagnóstico da CMH foi de 78 a 182 (x=141) meses e da DAC de 1 dia a 106 (x= 42) meses. Os pacientes foram acompanhados com avaliações clínicas e exames complementares periódicos. RESULTADOS: A forma de apresentação da DAC foi em 5 com angina instável e um com infarto do miocárdio. A ADA estava comprometida entre 60 a 100%, sendo em um lesão única e nos 5 restantes com lesão em 2 ou mais vasos. Na evolução, 3 foram submetidos a revascularização miocárdica (RM), um associada a miomectomia septal, um a angioplastia e 2 somente a tratamento clínico. No período de observação de 76 a 124 meses após o diagnóstico da DAC, ocorreu um óbito. No fim do estudo observamos redução nos valores médios do SIV de 1,53 para 1,40cm, gradiente de pressão entre o corpo e a via de saída do ventrículo esquerdo (VE) de 56 para 15,75mmHg, com discreto aumento no diâmetro diastólico do VE de 4,55 para 4,85cm e do diâmetro sistólico de 2,83 para 3,13cm, sem alterar a dimensão do átrio esquerdo (4,13cm). CONCLUSÃO: A DAC da ADA é bem tolerada na CMH septal assimétrica, participando do processo fibrótico septal e melhorando o desempenho cardíaco, não representando problema adverso na evolução da CMH.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: The significance of necrosis and fibrosis of the interventricular septum in hypethrophic cardiomyopathy (HCM) is controversial. The purpose of this study was then to evaluate the clinical impact of left anterior descending artery (LAD) disease in HCM. METHODS: Among 158 patients presenting with HCM, 6 (3.79%) had LAD disease. Mean age was 65.16 years (52 to 70), 4 were men and 4 had the obstructive form of HCM. All patients were submitted to complete clinical and laboratory evaluation. Mean time of the diagnosis was 141 months (ranging from 78 to 182) for HCM and 42 months (ranging from one day to 106 months) for LAD disease. RESULTS: Five patients had unstable angina and one had myocardial infarction. LAD disease (60 to 100% coronary narrowing) was present in all patients; one patient had single vessel disease and 5 multivessel disease. During follow-up, 3 patients had coronary artery bypass grafting (CABG), one with associated septal myectomy; one was submitted to coronary angioplasty and 2 were submitted to medical treatment. During a follow-up period ranging from 76 to 124 months after LAD disease diagnosis, one patient died. At the end of the study, a reduction of the thickness of the interventricular septum from 1.53 to 1.40cm was observed and left ventricular outflow pressure gradient decreased from 56 to 16mmHg. Left ventricular diastolic diameter increased from 4.55 to 4.85cm and systolic diameter from 2.83 to 3.13cm. Left atrium diameter was unchanged. CONCLUSION: LAD disease is well tolerated in the asymmetrical form of HCM and may contribute to septal fibrosis, improving cardiac function. It does not represent an adverse factor in the evolution of HCM.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiomiopatia hipertrófica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatia isquêmica obstrutiva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lesão da artéria descendente anterior</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertrophic cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerotic coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left anterior descending coronary artery lesion</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Evolução a longo prazo e complicações da hipertensão arterial após transplante cardíaco</s1>
</fA08>
<fA08 dir="en">
<s1>Long-term follow-up and complications of arterial hypertension after cardiac transplantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Aparecido Bortolotto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Hélio Bernardes Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Edmar A. Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Giovanni Bellotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Noedir Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Adib D. Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>317-321</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a evolução da hipertensão arterial (HA), e suas consequências, em pacientes submetidos a transplante cardíaco (TC) em uso de ciclosporina (CL). MÉTODOS: Em 65 pacientes submetidos a TC ortotópico, avaliamos a pressão arterial, creatinina sérica e níveis sangüíneos de CL nos períodos pré-operatório (15 dias antes do TC), pós-operatório precoce (15 e 30 dias) e tardio (6, 12, 24, 48 e 60 meses); em 20 pacientes analisamos índice cardíaco e resistência vascular no pré, 15 e 30 dias, 6 e 12 meses após TC; em 33 pacientes, estudamos estrutura e função ventricular ao ecocardiograma, 24±13 meses após TC. RESULTADOS: Após 30 dias, a HA estava presente em 58,5% dos pacientes (50% leve), enquanto na evolução tardia, a incidência da HA aumentou significativamente para 93% após um ano (85% moderada a grave). A creatinina sérica aumentou progressivamente do pré-TC (1,43±0,5mg/dl) até após um ano (1,83± 0,9 mg/dl), mantendo leve incremento até os 60 meses (2,4± 0,8mg/dl). Não houve correlação entre a HA, creatinina sérica e níveis de CL. O índice cardíaco aumentou na fase precoce, enquanto a resistência periférica diminuiu no início e aumentou significativamente aos 12 meses. Ao ecocardiograma, 54% dos pacientes apresentavam hipertrofia de ventrículo esquerdo com função normal. Dos 31 pacientes que faleceram durante a evolução, dois tiveram a causa mortis diretamente relacionada a HA. CONCLUSÃO: A HA em pacientes submetidos a TC em uso de CL ocorre precocemente, aumenta em prevalência e gravidade com o tempo e é mediada por aumento da resistência periférica, não se correlacionando com a nefrotoxicidade e com os níveis sangüíneos da CL, podendo agravar a insuficiência renal ou comprometer a longevidade do transplante, induzindo hipertrofia ventricular.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the progression of arterial hypertension (AH) and its consequences , in patients submitted to cardiac transplantation (CT) in use of cyclosporine (CY). METHODS: In 65 patients submitted to orthotopic CT, we evaluated blood pressure, serum creatinine and blood levels of CY before, 15 and 30 days, and 6, 12, 24, 48 and 60 months after CT; in 20 patients we analyzed cardiac index and systemic vascular resistance pre-CT, 15 and 30 days, 6 and 12 months after CT; in 33 patients, we studied anatomic and functional modifications by echocardiography, 24±13 months after CT. RESULTS: Thirty days after CT, AH was present in 58.5% (50% mild), and after one year, 93% of patients were hypertensives (85% moderate-to-severe), remaining unchanged during the rest of follow-up. The serum creatinine progressively increased, reaching values significantly higher than those pre-CT after one year, persisting with a mild increment until 60 months. Echocardiography showed left ventricle hypertrophy in 54% of patients, all of which had normal function. Two patients died as a direct consequence of hypertensive complications. CONCLUSION: AH in patients submitted to CT on CY use occurs early, increases in prevalence and severity during the follow-up and is mediated by an increase in vascular resistance. Also, the AH does not correlate to CY blood levels or nefrotoxicity, but it can impair renal function and compromise longevity of transplantation by inducing ventricular hypertrophy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ciclosporina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>transplante cardíaco</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cyclosporine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart transplantation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Comportamento da pressão arterial em filhos de normotensos e filhos de hipertensos submetidos a estímulos pressóricos</s1>
</fA08>
<fA08 dir="en">
<s1>Arterial blood pressure responses in children of normotensive and hypertensive parents submitted to pressor tests</s1>
</fA08>
<fA11 dir="011000">
<s1>José Wilson S. Cavalcante</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leonardo P. Cavalcante</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Walewska S. Pacheco</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcus G. F. de Menezes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Carlos G. Gama Fº</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>323-326</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar a pressão arterial (PA) basal e as respostas a estímulos pressóricos de filhos de normotensos e filhos de hipertensos. MÉTODOS: Foram examinados 32 adolescentes, do sexo masculino, brancos, na faixa etária entre 13 e 18 anos, sendo que 16 eram filhos de hipertensos e 16 filhos de normotensos. Para cada indivíduo foi aferida a PA basal seguida da aplicação de três testes pressóricos: teste do exercício isométrico com o handgrip, teste pressor ao frio e teste do exercício aritmético mental. Para a aferição da PA foi utilizado um dispositivo oscilométrico, digital, previamente calibrado. RESULTADOS: Os filhos de hipertensos exibiram valores basais de PA, tanto sistólica quanto diastólica, maiores que os filhos de normotensos (p&lt;0,10). Quanto aos testes pressóricos, as respostas foram maiores nos filhos de hipertensos, porém, somente a resposta da PA diastólica ao teste do exercício aritmético mental alcançou significância estatística (p&lt;0,10). CONCLUSÃO: Os resultados obtidos indicam a necessidade de atenção especial às crianças e adolescentes com antecedentes familiares de hipertensão.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To compare cardiovascular reactivity in adolescents with and without family history of hypertension. METHODS: Thirty two subjects, males, students, aging between 13 to 18 years old were examined. One half of them had no family history of hypertension and the other half had at least one hypertensive parent. Basal blood pressure level was obtained before the application of the following selected tests: isometric handgrip exercise test, cold pressor test and arithmetic mental stress test. The blood pressure values were obtained by a digital, oscilometric device, previously calibrated. RESULTS: The subjects with family history of hypertension exhibited higher basal levels of both systolic and diastolic blood pressure (p&lt;0,10). Concerning the tests applied, the subjects with family history of hypertension also exhibited higher responses, but only the response of the diastolic blood pressure to the mental stress test was statistically significant (p&lt;0,10). CONCLUSION: Our findings point to the need of a special follow-up of children with a family history of hypertension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>testes pressóricos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>adolescentes</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fator genético</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pressor tests</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adolescents</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>genetic factor</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo multicêntrico de idosos atendidos em ambulatórios de cardiologia e geriatria de instituições brasileiras</s1>
</fA08>
<fA08 dir="en">
<s1>Multicenter study of elderly patients in outpatient clinics of cardiology and geriatric brazilian institutions</s1>
</fA08>
<fA11 dir="011000">
<s1>Cláudia F. Gravina Taddei</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Roberto Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Cássio de Moraes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maurício Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alberto Libberman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Silvio Carlos Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Felício Savioli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Giuseppe Dioguardi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Roberto Franken</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>327-333</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar aspectos epidemiológicos, clínicos e terapêuticos de idosos com doenças cardiovasculares (DCV), no Brasil. MÉTODOS: Idosos com DCV, atendidos em 36 serviços de Cardiologia e Geriatria do Brasil, foram investigados através de questionário aplicado aos que tinham consulta marcada para o período analisado (um mês). RESULTADOS: Estudados 2196 idosos de 65 a 96 anos, sendo 60% mulheres e analisados os fatores de risco: sedentarismo (74%), pressão arterial (PA) elevada (53%), LDL colesterol aumentado (33%), colesterol total aumentado (30%), obesidade (30%), HDL-colesterol diminuído (15%), diabetes (13%) e tabagismo (6%). Observou-se maior prevalência nas mulheres, com três ou mais fatores de risco. O principal motivo de consulta foi a PA elevada (48%). Teste ergométrico e cinecoronariografia, foram mais solicitados para os homens. Os diagnósticos mais comuns foram hipertensão arterial sistêmica (HAS) (67%) e insuficiência coronária (ICo) (29%). Os medicamentos mais utilizados foram diuréticos (42%). CONCLUSÃO: Foi observada alta prevalência de fatores de risco (93%), principalmente nas mulheres; sedentarismo, como fator de risco mais freqüente, aumentando de prevalência com a idade; HAS, como principal motivo de consulta e diagnóstico; menor investigação e diagnóstico de ICo em mulheres; diuréticos, como os fármacos mais freqüentemente prescritos; insuficiência cardíaca como principal doença associada a internação (31%) e atendimento de emergência (10%).</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate epidemiological, clinical and therapeutic aspects of elderly patients with cardiovascular disease in Brazil. METHODS: Elderly patients with cardiovascular disease treated in 36 centers of cardiology and geriatrics were investigated through a questionnaire applied to those who had an appointment during the analyzed period . RESULTS: 2196 elderly patients ranging from 65 to 96 years of age were analyzed, 60% of which were females. The main risk factors were: sedentarism (74%); high blood pressure (53%), high LDL-cholesterol (33%), high total cholesterol (30%), obesity (30%), low HDL-cholesterol (15%), diabetes (13%) and smoking (6%). A higher prevalence of females existed among those with &gt; 3 risk factors. The main reason for the medical appointment was high blood pressure (48%). Stress test and coronariography were requested more often in males. The most common diagnoses were hypertension (67%), and coronary disease (29%). The most often used medications were diuretics (42%). CONCLUSION: There was high prevalence of risk factors (93%), mainly in females; sedentarism was the most common risk factor and prevalence increased with age; hypertension was the most common reason for a medical appointment . Diuretics were the most used drugs; congestive heart failure was the main disease associated to hospitalization (31%) and emergencies (10%).</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>idoso</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estudo multicêntrico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença cardiovascular</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>multicenter study</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Persistência do canal arterial e endarterite da artéria pulmonar</s1>
</fA08>
<fA08 dir="en">
<s1>Patent ductus arteriosus and pulmonary artery endarteritis</s1>
</fA08>
<fA11 dir="011000">
<s1>Ivan Romero Rivera</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valdir Ambrósio Moisés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Anselmo Cotrim Brandão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Celia Camelo Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Lázaro Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>335-338</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>8</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Descrevemos uma paciente de sete anos com diagnóstico ecocardiográfico e confirmação cirúrgica de endarterite de artéria pulmonar, citada como complicação da persistência do canal arterial e ilustramos a necessidade de ressecção cirúrgica completa do processo infeccioso para evitar outras complicações, como embolia pulmonar.</s0>
</fC01>
<fC01 dir="en">
<s0>We describe a seven year old girl with echocardiographic diagnosis of pulmonary artery endarteritis as a complication of a patent ductus arteriosus, confirmed at surgery. This case illustrates the necessity of complete surgical resection of the infectious source as a way to avoid other complications such as pulmonary embolism</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Tratamento cirúrgico de tomboembolismo plmonar cônico</s1>
</fA08>
<fA11 dir="011000">
<s1>Gabriel Lorier Taranto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Moreno</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Renato A. K. Kalil</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>339-348</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Propriedades anti-aterogênicas do fator relaxante derivado do endotélio (óxido nítrico)</s1>
</fA08>
<fA11 dir="011000">
<s1>Germán Iturry-Yamamoto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alexandre Alderete Alves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Dornelles Picon</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>349-357</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>157</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>II Consenso Brasileiro para o uso da monitorização ambulatorial da pressão arterial</s1>
</fA08>
<fA11 dir="011000">
<s1>Celso Amodeo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dante M. A. Giorgi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Décio Mion Jr</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fernando Nobre</s1>
<afiliation>A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Sociedade Brasileira de Cardiologia Departamento de Hipertensão Arterial </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Sociedade Brasileira de Hipertensão  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Sociedade Brasileira de Nefrologia Departamento de Hipertensão Arterial </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>359-367</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Senhor Editor</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>369-372</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900512</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Fidelidade ao Bom Senso</s1>
</fA08>
<fA11 dir="011000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Instituto do Coração do Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>373-374</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Tratamento medicamentoso da insuficiência cardíaca em hospital terciário de São Paulo</s1>
</fA08>
<fA08 dir="en">
<s1>Heart failure medical treatment in a tertiary hospital of São Paulo</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mauricio Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>João Batista Serro-Azul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Humberto Pierri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Amit Nussbacher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Otávio Celso Eluf Gebara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Instituto do Coração do Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>375-379</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar como são tratados pacientes com insuficiência cardíaca (IC) em hospital terciário de São Paulo. MÉTODOS: Analisados 100 pacientes com IC, em tratamento ambulatorial, com idade média de 56,8 anos, sendo 76 homens. Todos realizaram estudo ecocardiográfico, que identificou diâmetros ventriculares entre 48 e 89mm (média 65,9) e fração de ejeção (FE) entre 0,22 e 0,59 (média 0,43). A etiologia da disfunção ventricular (DV) foi isquêmica em 42 casos, cardiomiopatia dilatada em 28, secundária à valvopatia em 12, doença de Chagas em 10 e cardiomiopatia hipertensiva em 8. Analisou-se a terapêutica prescrita, se continha inibidores da enzima conversora de angiotensina (IECA) e qual a sua dosagem. Foi analisado, também, se a etiologia ou o grau de DV tinha influência na prescrição. RESULTADOS: Oitenta e sete pacientes receberam IECA, sendo que em 31 a dose foi inferior à preconizada nos grandes estudos. Digoxina foi prescrita em 69 casos, diuréticos em 85 e ácido acetilsalicílico em 33. Dividindo os pacientes em dois grupos, com FE maior e menor que 0,45, observamos que, no último, foi maior a prescrição de IECA (91,5% vs 80,4%) e maior o uso de doses adequadas (61% vs 48,7%). CONCLUSÃO: A maioria dos pacientes foi tratada conforme recomendações atuais, apresentando boa tolerabilidade para IECA, contudo 1/3 deles não usou IECA em dose considerada adequada. Esquemas terapêuticos com betabloqueadores e inibidores da angiotensina II não fizeram parte da prática clínica rotineira.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To study how patients with heart failure (HF) are treated in a tertiary hospital in São Paulo. METHODS: One hundred patients with HF during ambulatory care were analyzed. Seventy-six were men, and the average population age was 56.8 years old. All patients were submitted to echocardiogram, which identified ventricular diameters ranging between 48 and 89mm (average 65.9) and ejection fraction (EF) between 0.22 and 0.59 (average 0.43). The cause of HF was ischemic in 42 cases, dilated cardiomyopathy in 28, valvular heart disease in 12, Chagas' disease in 10 and systemic hypertension in 8 patients. The prescribed treatment was analyzed, with attention to the prescription and dosage of angiotensin converting enzyme (ACE) inhibitors. We also analyzed whether the cause and/or the degree of HF influenced the treatment chosen. RESULTS: Eighty-seven patients received ACE inhibitors, 31 received doses below those recommended in the large trials. Digoxin was prescribed in 69 cases, diuretics in 85, and aspirin in 33. When dividing the patients according to EF, the group with EF below 0.45 was prescribed more often ACE inhibitors (91.5% vs 80.4%) and had more often usage of adequate doses (61% vs 48.7%). CONCLUSION:In this sample the majority of the patients were treated according to modern recommendations and tolerated well ACE inhibitors, however 1/3 did not receive ACE inhibitors in the recommended doses. Treatment based on betablockers or angiotensin II inhibitors were not routinely employed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>disfunção ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>inibidores da enzima conversora de angiotensina</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular systolic dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ACE inhibitors</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Participação do estado contrátil e do relaxamento miocárdico na disfunção ventricular durante a transição hipertrofia-falência cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Myocardial function during the transition from compensated left ventricular hypertrophy to failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Cicogna</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Kathleen G. Robinson</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Chester H. Conrad</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Robin Squire</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marina P. Okoshi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Oscar H. L. Bing</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>381-384</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a participação do estado contrátil e do relaxamento miocárdico na disfunção do músculo cardíaco durante a transição hipertrofia-falência cardíaca em ratos espontaneamente hipertensos (SHR). MÉTODOS: Músculos papilares isolados do ventrículo esquerdo de SHR com insuficiência cardíaca (SHR-IC) e sem falência cardíaca (SHR) e de ratos normotensos controle Wistar-Kyoto (WKY) foram estudados em contrações isométrica e isotônica, em solução de Krebs-Henseleit (1,25 mM Ca2+, 28ºC). RESULTADOS: Os valores da tensão máxima desenvolvida (TD) e da velocidade máxima de encurtamento (Vmáx) foram menores nos SHR-IC e SHR, em relação aos WKY (p&lt;0,05). TD e Vmáx foram semelhantes nos SHR-IC e SHR (p&gt;0,05). A rigidez passiva do músculo aumentou significantemente nos SHR-IC (p&lt;0,05 vs WKY e SHR); esta variável não diferiu entre WKY e SHR (p&gt;0,05). CONCLUSÃO: Os dados obtidos mostram que a transição da fase de hipertrofia estável para insuficiência cardíaca nos ratos espontaneamente hipertensos está associada ao aumento da rigidez passiva do miocárdio e não à piora da função contrátil do músculo cardíaco.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To investigate the participation of contractile state and relaxation in cardiac muscle dysfunction during the transition from stable hypertrophy to cardiac decompensation in aging spontaneously hypertensive rats (SHR). METHODS: Isolated left ventricular papillary muscle function was studied in SHR with heart failure (SHR-F), in age-matched SHR without evidence of heart failure (SHR-NF), and in nonhypertensive controls Wistar-Kyoto rats (WKY). Muscles were analised in isometric and isotonic contractions in Krebs-Henseleit solution with calcium concentration of 1.25mM at 28ºC. RESULTS: Papillary muscles from SHR-F and SHR-NF demonstrated decreased active tension development and shortening velocity relative to normotensive WKY (p&lt;0.05). SHR-F and SHR-NF did not differ. Compared with SHR-NF and WKY, muscle passive stiffness was increased in the failing SHR (p&lt;0.05 versus WKY and SHR-NF). This parameter did not differ between SHR-NF and WKY (p&gt;0.05). CONCLUSION: These data suggest that the progression from stable hypertrophy to heart failure is associated with changes in the passive stiffness and is not related to depression of myocardial contractile function.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial function</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Coração de atleta em desportistas deficientes de elite</s1>
</fA08>
<fA08 dir="en">
<s1>Athlete's heart in elite disabled athletes</s1>
</fA08>
<fA11 dir="011000">
<s1>Japy Angelini Oliveira Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Carlos Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Edgar Lira Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Bráulio Luna Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Silvia Helena Covre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Flávio Antônio Ascânio Lauro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Marcelo Aria Dias Danucalov</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Wagner Aparecido Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Sérgio Tuffik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>José Lázaro Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Angelo Amato Vincenzo de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Eulógio Martinez Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>385-388</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar a prevalência de sinais de &quot;coração de atleta&quot; em desportistas deficientes para-olímpicos. MÉTODOS: Avaliação clínica, eletrocardiográfica, ecocardiográfica, vetorcardiográfica, ergométrica em 75 atletas, 27,8±6,7 anos, 56 homens, várias modalidades; com deficiência física (47), visual (12) e paralisia cerebral (16). RESULTADOS: Sinais de coração de atleta ocorreram em 33% dos exames clínicos (sopros e estalidos), em 55% dos eletrocardiogramas (bradicardia, bloqueio incompleto de ramo direito, sobrecargas, alterações de onda T), em 15% dos vetorcardiograma (sobrecargas), em 5% dos ecocardiogramas (dimensões cavitárias acima do habitual). Os sinais ocorreram em 51% dos atletas, sendo que em 46% dos casos havia 2 ou mais sinais e, em 12%, 4 ou mais sinais. O TE foi normal em 77% dos atletas; não houve ST isquêmico. Em 23% dos casos houve bloqueio divisional direito. CONCLUSÃO: Foram encontrados dois ou mais sinais de coração de atleta em 46% dos atletas deficientes para-olímpicos.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To assess the prevalence of the athlete's, heart syndrome in elite disabled Brazilians athletes. METHODS: Seventy-five athletes, age 27.8±6.7 years, 56 men, with various disabilities (47 physical, 12 visual and 16 cerebral paralysis) underwent clinical, electrocardiographic, vectorcardiographic, ergometric and echocardiographic evaluations. RESULTS: Athlete's heart signs occurred in 33% of the clinical evaluations, in 55% of the electrocardiograms, in 15% of the vectorcardiograms, and in 5% of the echocardiograms. At least one of these signs was presented in 51% of the athletes. There were 2 or more abnormalities in 46% of the athletes and 4 or more signs in 12%. Exercise test was considered not ischemic in 77% of the subjects. There was right bundle branch block in 23% of the tests. CONCLUSION: There were two or more athlete's heart syndrome signs in 46% of Brazilian disabled athletes.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coração de atleta</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>atleta deficiente</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>eletrocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste ergométrico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>athlete's heart</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>disabled athletes</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise test</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo da história natural da hipertrofia miocárdica e sua associação com hiperinsulinismo em filhos de mães diabéticas</s1>
</fA08>
<fA08 dir="en">
<s1>Study of the natural history of myocardial hypertrophy and its association with hyperinsulinism in infants of diabetic mothers</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Martha H. Leal da Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Leandro Turra Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fernanda Paiva Bonow</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Nilza Iracema Telles da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Lauro Luís Hagemann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Cardiologia do Rio Grande do Sul Fundação Universitária de Cardiologia </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>389-394</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>44</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Testar a hipótese de associação entre hipertrofia miocárdica e níveis aumentados de insulina no soro de filhos de mães diabéticas, além de determinar a freqüência de regressão espontânea e o momento de sua ocorrência. MÉTODOS: Foram estudados 72 pacientes (54 filhos de mães diabéticas e 18 controles). O diagnóstico de hipertrofia miocárdica foi realizado por ecocardiografia pré-natal, uni e bidimensional. Os registros da insulina amniótica foram obtidos de um estudo pré-natal prévio sobre hipertrofia miocárdica, pois a participação das gestantes era comum aos dois projetos. RESULTADOS: Houve 10 (18,52%) casos de hipertrofia miocárdica entre os filhos de mães diabéticas. As medidas do septo foram significantemente diferentes entre os grupos (filhos de mães diabéticas e controles) na avaliação com 1 mês (p=0,04). A insulina manteve-se elevada nos filhos de diabéticas até 3 meses de idade, período em que era significativamente diferente em relação aos controles (p=0,003 e p=0,001, com 1 mês e 3 meses, respectivamente). A associação entre a regressão do septo interventricular e a regressão dos níveis de insulina ocorreu até 1 mês de idade. CONCLUSÃO: Houve regressão espontânea das medidas do septo interventricular até 6 meses de idade e a associação entre hiperinsulinismo e hipertrofia miocárdica esteve presente até 1 mês de idade.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To test the hypothesis that myocardial hypertrophy is associated with increased serum insulin levels in children of diabetic mothers and to determine the frequency and timing of this spontaneous regression. METHODS: Seventy-two patients were studied (54 children of diabetic mothers and 18 controls). Diagnosis of myocardial hypertrophy was made by fetal echocardiography. Amniotic fluid insulin levels were obtained from a previous prenatal study on hypertrophic cardiomyopathy, since the participation of the mothers was common to both projects. RESULTS: There were 10 cases of myocardial hypertrophy among children of diabetic mothers (18.52%). Septal thickness was significantly different between the 2 groups (children of diabetic mothers and controls) in the evaluation performed at the age of 1 month (p=0.04). Insulin levels were still increased in children of diabetic mothers until the age of 3 months. During this period insulin levels were significantly higher than those of controls (p=0.003 and p=0.001, at 1 and 3 months, respectively). The association between regression of ventricular septum thickness and the decrease of insulin levels occurred up to the age of 1 month. CONCLUSION: There was spontaneous regression of ventricular septum thickness in children of diabetic mothers during the first 6 months of life. The association between hyperinsulinism and hypertrophic cardiomyopathy was present up to the first month of life.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>feto</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hiperinsulinismo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>diabetes mellitus</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hyperinsulinism</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diabetes mellitus</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Prevalência de dislipidemias em adultos da demanda laboratorial de Salvador, Brasil</s1>
</fA08>
<fA08 dir="en">
<s1>Prevalence of dyslipidemias in non-hospital laboratory tests of adults from Salvador, Brazil</s1>
</fA08>
<fA11 dir="011000">
<s1>Ines Lessa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João Lycio Conceição</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Mirabeau Levi Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Viviane Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Joabe Carneiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Joamar Melo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Joel Pinheiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Fábio Meireles</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Joaquim Netto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Felipe Reis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Rogério Gouvêa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Marcelo Couto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="131000">
<s1>Silvânia Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="141000">
<s1>Marlene Rosa Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia Salvador </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>395-400</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a prevalência das dislipidemias em adultos da demanda laboratorial não-hospitalar da cidade de Salvador (BA). MÉTODOS: Casuística procedente de amostra probabilística de 25% dos laboratórios não-hospitalares da cidade que usavam o método enzimático para dosagem dos lípides séricos e controle de qualidade da Sociedade Brasileira de Patologia Clínica (93% do total); LDL estimado pela fórmula de Friedewald. Sorteados os meses ímpares de 1995 para o estudo. Critérios para dislipidemias, em mg/dl: colesterol &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt;240; LDL &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt;160; HDL &lt;35 e triglicérides &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt;200. Análise: prevalências, seus intervalos de confiança (IC) a 95% e qui-quadrado (chi²). RESULTADOS: Excluídos uma recusa e um laboratório que arquivava laudos só por 3 meses, foram analisados dados de 24 dos 26 laboratórios amostrados. Dos 7392 adultos, 65,5% eram mulheres. Prevalências estimadas e valores dos IC a 95% para homens, foram: hipercolesterolemia =24,0% (20,5; 27,5); LDL elevado =26,1 (22,4; 29,3); HDL baixo =15,9 (14,2; 17,8) e hipertrigliceridemia =27,6 (25,7; 29,5). Para mulheres: hipercolesterolemia =30,0 (27,8; 32,2), LDL elevado =33,1 (30,8; 35,4); HDL baixo =8,0 (7,1; 8,9) e hipertrigliceridemia =30,4 (29,0; 31,4). Todas as prevalências diferiram significantemente inter-gênero (p, 0,05 a p&lt;0,001). Também foram mais freqüentes nas mulheres os níveis indesejáveis do colesterol e LDL. CONCLUSÃO: As dislipidemias são importante fator de risco para aterosclerose na demanda laboratorial de Salvador em ambos os gêneros. Os resultados subsidiam os médicos para incentivar mudanças no estilo de vida que conduzam seus pacientes a níveis lipídicos desejáveis.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To determine the prevalence of dyslipidemia in non-hospital laboratory tests of adults from Salvador, Brazil. METHODS: The study was carried out in subjects from a probabilistic sample of 25% of a total of 104 local laboratories that used the same enzymatic method for lipid analysis with the quality control as recommended by the Brazilian Society of Clinical Analyses. These represented 93% of all non-hospital laboratories of Salvador in 1995. The odd months of 1995 were selected for sampling in the present study. Criteria for dyslipidemias were: total cholesterol &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt;240; LDL &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt;160; HDL &lt;35 and triglycerides &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt;200mg/dl. Prevalence rates and their 95% confidence intervals (CI) and chi² test were used in the analyses. RESULTS: Tests from two of the 26 laboratories were not used in the analyses due to file problems or refusal. 7,392 adults were screened, 65% female. We observed prevalence (95% CI) of hypercholesterolemia in 30.0 (27.8; 32.2)%, high LDL in 30.1 (30.8; 35.4)% and hypertriglyceridemia in 30.4 (29.0; 31.4)% of the females. As to the male subjects, prevalences were: 24.0 (20.5; 27.5)% for hypercholesterolemia, 26.1 (22.4; 29.3)% for high LDL, 27.6 (25.7; 29.5)% for hypertriglyceridemia. All gender differences were significant. Low HDL occurred in 15.9 (14.2; 17.8)% of males and in 8.0 (7.1; 8.9)% of females. CONCLUSION: Dyslipidemia is an important risk factor observed in non-hospital laboratory tests of men and women in Salvador. Our data may provide physicians and other health care professionals with objective information to encourage life-style changes.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dislipidemias</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>colesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>triglicérides</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dyslipidemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hyperlipidemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cholesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>HDL</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>LDL</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Emprego de altas doses de amiodarona via oral na reversão da fibrilação atrial no pós-operatório de cirurgia cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>High dose amiodarone for the reversion of atrial fibrillation during the postoperative period of cardiac surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>João Carlos Vieira da Costa Guaragna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valério Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Tatiana Marlowe Cunha Brunini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Luis Linhatti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fábio Branco de Araújo Brauner</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Renan Canibal Pires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Luiz Carlos Bodanese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Católica do Rio Grande do Sul Faculdade de Medicina da Pontifícia Hospital São Lucas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>401-405</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Relatar a experiência no emprego de altas doses de amiodarona via oral (1800mg/d) na reversão da fibrilação atrial (FA) em pacientes submetidos à cirurgia cardíaca. MÉTODOS: Analisados, retrospectivamente, 80 pacientes que apresentaram FA no pós operatório de cirurgia cardíaca, constituindo 2 grupos: grupo A com 28 pacientes em uso de amiodarona e grupo B recebendo digital, sendo que este grupo foi subdividido no grupo C com 21 pacientes onde foi associada amiodarona, quando não houvesse reversão da arritmia em 48h. As diferenças foram consideradas significativas para um valor de P&lt;0,05. RESULTADOS: A FA esteve presente em 19,4% dos pacientes operados, com predomínio no sexo masculino e entre 60-69 anos. No grupo A, a reversão ocorreu em 78,6% dos casos, grupo B, o digital obteve sucesso em 60% das vezes e no grupo C, a taxa de sucesso foi de 90%. CONCLUSÃO: O uso de altas doses de amiodarona via oral, isolada ou em combinação com digital pode ser segura e eficaz no tratamento da FA em pós operatório de cirurgia cardíaca.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To report our experience using high dose oral amiodarone (1,800mg/day) for the reversion of atrial fibrillation to sinus rhythm in patients submitted to cardiac surgery. METHODS: We retrospectively analyzed the records of 80 patients who had atrial fibrillation during the postoperative period after cardiac surgery, initially divided in two groups: group A, 28 patients that used amiodarone, and group B composed of patients receiving digoxin. The latter group was divided further in a third group (C), with 21 patients in which amiodarone was associated with digoxin if there was no reversion of the arrhythmia after 48 hours of treatment. The observed differences were considered significant at P&lt;0.05. RESULTS: Atrial fibrillation occurred in 19.4% of the patients submitted to surgery, predominating in males, 60 to 69 years-old. In group A there was reversion to sinus rhythm in 78.6% of the cases. In group B digoxin succeeded in 60%, and in group C 90% of the patients reverted to sinus rhythm. CONCLUSION: High dose oral amiodarone, alone or combined to digoxin, can be safe and effective for the treatment of atrial fibrillation after cardiac surgery.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>amiodarona</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fibrilação atrial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>amiodarone</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Endocardite infecciosa em adolescentes. Análise dos fatores de risco de mortalidade intra-hospitalar</s1>
</fA08>
<fA08 dir="en">
<s1>Infective endocarditis in adolescents. analysis of risk factors for in-hospital mortality</s1>
</fA08>
<fA11 dir="011000">
<s1>Nádia Barreto Tenório Aoun</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Francisco Manes Albanesi Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maurício Bastos de Freitas Rachid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luíz André Vieira Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Augusto da Silva Messias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UERJ Hospital Universitário Pedro Ernesto </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>407-412</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar os aspectos epidemiológicos, clínicos, terapêuticos e evolutivos da endocardite infecciosa (EI) em grupo de pacientes com idade entre 12 e 20 (média de 15,5) anos. MÉTODOS: Foram estudados, retrospectivamente, 33 pacientes consecutivos (14 do sexo masculino e 19 do feminino), admitidos com diagnóstico de EI. RESULTADOS: A mortalidade da EI foi de 42%. A cardiopatia reumática predominou como condição predisponente (63% dos casos), seguida das cardiopatias congênitas (24%) e próteses cardíacas (12%). A maioria dos pacientes (78%) encontrava-se na admissão em CF III e IV e apresentava mortalidade significativamente maior do que os que se encontravam na CF I e II (p=0,01). Complicações embólicas foram detectadas em 51% e determinaram maior mortalidade (p=0,05). O agente etiológico mais isolado foi o Staphylococcus aureus (em 42% das hemoculturas positivas), seguido do Staphylococcus viridans (em 21%). A análise multivariada mostrou que a contagem global de leucócitos acima de 10.000/mm ³, e a CF referidos na admissão (p=0,01 e p=0,04), e a ocorrência de embolias (p=0,03) eram preditores independentes de mortalidade intra-hospitalar. CONCLUSÃO: A cardiopatia reumática permanece, semelhante à população adulta, como principal fator predisponente da EI nos adolescentes, tendo como principal agente etiológico o S.aureus, semelhante à população pediátrica. A mortalidade é elevada e representam preditores de mortalidade intra-hospitalar a CF na admissão, a ocorrência da fenômenos embólicos e a leucocitose.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To study the epidemiological, clinical, therapeutic and evolutive aspects of endocarditis in a group of patients aging 12 to 20 years-old ( mean 15.5). METHODS: Thirty-three consecutive patients (14 males, 19 females) admitted with infective endocarditis were retrospectively studied. RESULTS: Infective endocarditismortality was 42%. Rheumatic heart disease was the predominant underlying condition in 63% of patients. Congenital heart disease (24%) and cardiac prosthesis (12%) were the other affections involved. The majority of patients (78%) were in functional class III and IV, with more deaths than the 22% who were in functional class I and II (p=0.01). Staphylococcus aureus was the most frequently isolated agent (42% of the positive blood cultures, followed by Staphylococcus viridans, 21%). Multivariate analysis identified total leukocyte count above 10,000/mm³ and functional class, both at admission (p=0.01 and p=0.004, respectively), and the occurrence of embolic complications (p=0.03) as independent predictors of in-hospital mortality. CONCLUSION: Rheumatic heart disease remains, as in adults, the main predisposing factor for infective endocarditis in adolescents, and S.aureus is, like in children, the leading agent. Mortality is high and functional class at hospital admission, embolic complications and leukocytosis are independent predictors of in-hospital mortality.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>endocardite infecciosa</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>adolescente</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>infective endocarditis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adolescent</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação da anastomose de artéria torácica interna esquerda com artéria interventricular anterior pela ecodopplercardiografia</s1>
</fA08>
<fA08 dir="en">
<s1>Evaluation of left internal thoracic artery anastomosis with left anterior descending coronary artery by Doppler echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Adelaide Arruda</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Orlando Campos Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Expedito Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antônia Petrizzo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Lázaro Andrade</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antônio Carlos C. Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Enio Buffolo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Eulógio Martinez</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Wilson Mathias Jr</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>413-419</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o valor do ecocardiograma Doppler(ECO) transtorácico na identificação de perviabilidade da anastomose entre artéria torácica interna esquerda (ATIE) e interventricular anterior, realizada pela técnica de revascularização miocárdica pela minitoracotomia sem circulação extracorpórea. MÉTODOS: Estudaram-se os primeiros 12 pacientes, consecutivos, no período de pós-operatório intra-hospitalar pelo ECO, utilizando-se transdutores de 5MHz, pela via paraesternal esquerda, preferencialmente. Foram analisadas velocidades máximas e integrais de velocidade dos componentes sistólico e diastólico das curvas espectrais de fluxo Doppler. Todos pacientes foram submetidos à cinecoronariografia, enquanto hospitalizados. RESULTADOS: O ECO foi exeqüível em 93% dos pacientes. Nos com anastomose pérvia (6/7), observou-se ao estudo Doppler amplo componente diastólico (padrão A). Naqueles com anastomose obstruída (4/4) o padrão observado foi de predomínio sistólico (padrão B) (p=0,003*). CONCLUSÃO: O ECO da ATIE anastomosada com a artéria interventricular anterior, após cirurgia de revascularização miocárdica pela técnica de minitoracotomia, permitiu caracterizar precocemente, com precisão, a perviabilidade da anastomose.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To study the value of Doppler echocardiography as a tool for the evaluation of left internal thoracic artery graft (LITAG) patency in patients who underwent coronary revascularization using minimally invasive bypass surgery without extracorporeal circulation. METHODS: The first 12 consecutive patients were studied after coronary artery bypass surgery using a 5MHz Doppler transducer. Doppler signals for the systolic and diastolic flow velocities were preferably obtained in the second intercostal space. All patients underwent coronary angiography while hospitalized. RESULTS: The exam was feasible in 93% of patients. Doppler flow pattern was predominantly diastolic (pattern A) in patients with patent anastomoses (6/7). In patients with occluded anastomoses (4/4) Doppler flow pattern was predominantly systolic (pattern B) (p=0.003). CONCLUSION: Internal thoracic artery flow pattern as measured by Doppler echocardiography after minimally invasive coronary artery bypass graft surgery is an accurate method for identifying LITAG patency.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>artérias torácicas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>revascularização</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Doppler echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thoracic artery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>bypass surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Disfunção sistólica aguda de ventrículo esquerdo após drenagem de derrame pericárdico</s1>
</fA08>
<fA08 dir="en">
<s1>Transient left ventricular systolic dysfunction after pericardial effusion drainage</s1>
</fA08>
<fA11 dir="011000">
<s1>Fábio Branco de Araújo Brauner</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cristine Erdmann Nunes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rogério Fabra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alberto Riesgo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz Gustavo Thomé</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital de Caridade Dr. Astrogildo de Azevedo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>421-423</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>5</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Paciente com timoma e função sistólica normal do ventrículo esquerdo desenvolveu tamponamento cardíaco, revertido por pericardiocentese. Após quatro dias, foi submetida à exérese do tumor e, em aproximadamente uma semana da drenagem, apresentou disfunção sistólica aguda e grave do ventrículo esquerdo, que melhorou com terapia venosa, normalizando o quadro em três dias.</s0>
</fC01>
<fC01 dir="en">
<s0>A patient with a thymoma and initially normal ventricular systolic function developed cardiac tamponade, which was relieved by pericardiocentesis. After four days, the tumor was removed and, one week after the relief of tamponade, she developed severe left ventricular systolic dysfunction, that recovered in three days with venous therapy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 7/97 - Hospital Santa Isabel - Cenprecor - Salvador, BA</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>425-428</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900611</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="">
<s1></s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>429-429</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900612</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>69</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Declaração de desfibrilação precoce</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando E. S. Cruz Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sérgio Timerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Epotamênides Maria Good God</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>431-431</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1997</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(97)06900613</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Cinqüenta anos de monitorização da qualidade cardiológica brasileira</s1>
</fA08>
<fA11 dir="011000">
<s1>Angelo A. V. de Paola</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcia Barbosa</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-1</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Arteriografia coronária com cateter de muito baixo perfil. Eficácia e segurança do procedimento e da alta hospitalar aos 60 minutos</s1>
</fA08>
<fA08 dir="en">
<s1>Coronary arteriography with a very low profile catheter. Efficacy and safety of the procedure and of the 60 minute hospital discharge</s1>
</fA08>
<fA11 dir="011000">
<s1>Sergio Berti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fausto Feres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Danilo Castro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcos Gusmão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rodolfo Staico</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rone Padilha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Aurea Chaves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Marinella Centemero</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Luiz A. Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Amanda Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>J. Eduardo Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>3-7</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a eficiência, a segurança e a praticidade da angiografia coronária com cateteres 4 French (F), pela técnica de Judkins. MÉTODOS: De agosto/95 a janeiro/96, 70 pacientes com suspeita de insuficiência coronária submeteram-se à cinecoronariografia , utilizando introdutores e cateteres 4F. Após o exame, realizava-se compressão local por 15min e, 60min após, os pacientes eram orientados a caminhar, sob vigilância , sendo dada a alta hospitalar após 4h, . RESULTADOS: A idade variou de 31 a 83 (m = 57) anos, sendo 39 (56%) homens, com peso entre 43 a 101 (m = 69) kg. Obteve-se ótima qualidade de imagem em 62 casos (88%), havendo a necessidade de substituição por cateteres de maior calibre (6 a 8F) em 8 (12%) pacientes. Não ocorreram complicações vasculares ou sangramentos maiores. Em apenas 2 (3%) casos, houve discreto sangramento, resolvido com nova compressão local. Sessenta pacientes (85%) deambularam aos 60±5min e tiveram alta hospitalar com 4h, em média. CONCLUSÃO: A utilização de cateteres 4F por via femoral, para realização de cinecoronariografia permite a deambulação muito precoce (média = 60±5min) e sem complicações hemorrágicas. Verificaram-se pequena utilização de contraste (média = 60ml) e redução da permanência hospitalar. Esta técnica torna o exame cinecoronariográfico mais simples, menos traumático e menos invasivo.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the feasibility, efficacy and safety of the use of 4F Judkins catheters for coronary angiography. METHODS: From August/95 to January/96, 70 patients with suspected coronary artery disease underwent coronary cineangiography by the Judkins technique, with 4F catheters. Following punture of the right femoral artery, 4F sheaths were introduced. At the end of the procedure, the sheath was removed and manual compression was applied for 15min. Patients were oriented to walk under specialized supervision, 60min after the procedure, and discharged after 4h. RESULTS: Thirty nine (56%) patients were male, the age ranged from 31 to 83 (mean 57) years and weight from 43 to 101 (mean 69) kg. Optimal quality images were obtained in 62 patients (88%). It was necessary to use larger caliber catheters (6 and 8F) in 8 patients, due to femoral tortuosity or inadequate opacification of coronary arteries. There were no vascular complications nor major bleedings. In only 2 cases (3%) there was a minor bleeding, treated by new local compression. Sixty (85%) patients walked after 60±5min and were discharged after 4h. CONCLUSION: The use of 4F catheters for coronary angiography by femoral approach allowed early deambulation with no major bleeding. Image quality was good, with little contrast used and short hospital stay. This technique may lead to a simpler less traumatic and less invasive coronary angiography,.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cateterismo cardíaco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angiografia coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>deambulação precoce</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart catheterization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>early deambulation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Tratamento da superdosagem de anticoagulantes orais</s1>
</fA08>
<fA08 dir="en">
<s1>Reversal of excessive oral anticoagulation</s1>
</fA08>
<fA11 dir="011000">
<s1>Dayse Maria Lourenço</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vânia Maria Morelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carla Valadares Vignal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>9-13</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar a resposta de 73 pacientes com superdosagem de droga anti-vitamina K (AVK) a 3 esquemas de tratamento. MÉTODOS: Os 73 pacientes foram avaliados em 94 ocasiões e divididos em 3 grupos: grupo A (N=32) , suspensão do AVK por 2 dias e introdução de dose menor; grupo B (N=37), suspensão do AVK e reavaliação em 4 dias; grupo C (N=25), vitamina K por via oral. A razão normalizada internacional (RNI) final foi considerada adequada quando entre 2,0 e 4,0. RESULTADOS: Não houve diferença entre os tratamentos (chi²=2,352, p=0,671) para 61 pacientes com RNI inicial &lt;8. Houve mais pacientes com RNI &lt;2 no grupo C (chi²=9,998, p=0,007) entre 33 pacientes com RNI inicial &gt;8. Cinco dos 7 pacientes do grupo B que continuaram com superdosagem tinham RNI &lt;4,5 e pequeno risco de hemorragia. Entretanto, 6 dos 10 pacientes do grupo C com anticoagulação insuficiente tinham RNI &lt;1,6 e risco de trombose. Treze pacientes sangraram, mas sem necessidade de transfusão. CONCLUSÃO: A reversão da superdosagem de AVK pode ser feita pela suspensão da droga Administração de vitamina K, por via oral, deve se restringir a pacientes com RNI mais elevado para se evitar anticoagulação insuficiente.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the response of 73 patients with antivitamin K (AVK) overdose to 3 different therapeutic regimens. METHODS: Seventy three patients were evaluated in 94 occasions: group A (N=32), consisted of drug withdrawal for 2 days followed by reduced dosage; group B (N=37), drug withdrawal and reassessment within 4 days; group C (N=25), oral administration of vitamin K. Therapeutic range was set between INR-values of 2 and 4. RESULTS: Reversal regimens did not result in differences among 61 patients who had initial INR &lt;8 (chi²=2.352, p=0.671). There were more patients bellow therapeutic range in group C (N=14) than group B (N=19) (chi² =9.998, p=0.007). After intervention, 7 patients in group B still had INR &gt;4, but 5 of them were bellow 4.5, without increased bleeding risk. There were 10 patients in group C bellow therapeutic range, 6 of them with INR &lt; 1.6, with risk of thromboembolism. Thirteen patients bled, but none required transfusion. CONCLUSION: Reversal of excessive oral anticoagulation can be safely performed by initial withdrawal of the drug, followed by lower doses. Vitamin K administration may lead to INR bellow the therapeutic range. This should be reserved for patients with high INR or in the presence of bleeding.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>anticoagulação oral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>vitamina K</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sangramento</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tromboembolismo</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>oral anticoagulation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>vitamin K</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>bleeding</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>throboembolism</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Respostas cardiorrespiratórias durante exercício em portadores de transplante cardíaco. Análise ergoespirométrica comparativa com indivíduos normais</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiorespiratory response during exercise in heart transplant recipients comparated to normal healthy subjects</s1>
</fA08>
<fA11 dir="011000">
<s1>Ana Fátima Salles</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Japy Angelini Oliveira Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Turíbio Leite de Barros Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Dirceu Rodrigues de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Carlos de Camargo Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Yara Juliano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ênio Buffolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Eulógio Emílio Martinez Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>15-18</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>40</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar as respostas cardiorrespiratórias dos portadores de transplante cardíaco (TxC). MÉTODOS: Submeteram-se a testes ergoespirométricos 9 portadores de TxC (GI), pareados por sexo, idade, peso e altura, com 9 indivíduos sedentários, aparentemente sadios (GII). Os pacientes eram do sexo masculino, com idade de 48±12 anos, com TFI (NYHA) após 23±21 meses TxC. Faziam uso regular de ciclosporina, azatioprina, prednisona, dipiridamol e anti-hipertensivos. Os testes foram limitados por sintomas e interrompidos por exaustão. RESULTADOS: No pico do exercício, o GI apresentou desempenho significativamente inferior ao GII quanto ao VO2, VE, VEO2, FC, tempo de endurance e potência. No limiar anaeróbio, o GI apresentou VO2, tempo de endurance e potência significativamente inferior a do GII. Na potência de 40W o desempenho dos dois grupos foi similar. CONCLUSÃO: O GI apresentou desempenho cardiorrespiratório significativamente inferior no pico do exercício e similar na potência de 40W em relação ao GII, evidenciando os benefícios do TxC para cardiopatas em atividades habituais</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the cardiorespiratory response of heart transplant (HT) recipients. METHODS: Nine HT recipients (GI) underwent ergospirometric tests and were compared to 9 apparently healthy, sedentary subjects with similar sex, age, weight and height (GII). All were male patients aging 48±12 years, in functional class I (NYHA) an average of 23±21 months after HT. They were receiving cyclosporin, azathioprine, prednisone, dipyridamole and antihypertensive drugs. The tests were symptom-limited and they were interrupted due to exhaustion. RESULTS: During peak exercise, GI had a significantly lower physical performance related to lower VO2, VE, VEO2, HR, endurance time and work load. At the anaerobic threshold, VO2, endurance time and work load levels were also significantly lower in GI. The physical performance was similar between the groups in the 40W load. CONCLUSION: The cardiorespiratory performance in GI was significantly lower at peak exercise and similar to GII in the 40W load, showing the HT benefits cardiac patients during usual activities.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>transplante cardíaco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ergoespirometria</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>exercício físico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart transplant</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ergoespirometry</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>physical performance</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Alterações morfológicas na parede de artéria muscular em pacientes hipertensas</s1>
</fA08>
<fA08 dir="en">
<s1>Morphological changes of muscular arteries in hypertensive patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Mario Fritsch Toros Neves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Julia Fernandes Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Wille Oigman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro FAPERJ </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>19-23</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Identificar lesões estruturais na parede arterial uterina em mulheres com hipertensão arterial (HA). MÉTODOS: Vinte e seis pacientes com indicação de histerectomia eletiva foram divididas em dois grupos. O grupo 1, constituído por mulheres normotensas e, o grupo 2, por hipertensas sem tratamento regular. Foram obtidos dois segmentos da artéria uterina de cada paciente imediatamente após a cirurgia. Os fragmentos foram preparados em lâminas e submetidos ao estudo morfológico à microscopia óptica. RESULTADOS: Os grupos foram homogêneos em relação à idade, com média de 46,8+7,6 e 46,7+6,4 anos nos grupos 1 e 2, respectivamente. As médias de pressão arterial sistólica e diastólica máximas durante o período de internação foram de 130,0+3,4 x 83,8+6,5mmHg no grupo 1 e de 163,8+4,3 x 105,8+9,9mmHg no grupo 2 (p&lt;0,0001). As pacientes hipertensas apresentaram espessamentos maiores da camada íntima (p&lt;0,05). As fibras do complexo elástico encontravam-se mais numerosas e homogêneas no grupo com pressão arterial elevada e a hipertrofia celular mais freqüente (53,8%) que no das normotensas (23,1 %). CONCLUSÃO: HA parece acelerar o espessamento intimal relacionado à idade. As pacientes hipertensas apresentam elevada tendência para um aumento quantitativo e maior homogeneidade das fibras elásticas intimais na parede arterial uterina, indicando que a HA pode determinar alterações estruturais semelhantes ao processo de envelhecimento vascular.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To identify structural lesions in the wall of uterine arteries in hypertensive women. METHODS: Twenty six patients who underwent an elective hysterectomy were selected and separated in two groups. Group 1 was formed by women with normal blood pressure and group 2 consisted of hypertensive patients without regular treatment. Two segments of the uterine artery were obtained from every patient shortly after surgery. The fragments were fixed, sliced and stained. The morphological study was carried out using optical microscopy. RESULTS: Age was similar in both groups with means of 46.8+7.6 and 46.7+6.4 years-old in groups 1 and 2, respectively. The average maximal systolic and diastolic blood pressure during hospital admition were 130.0+3.4 and 83.8+6.5mmHg in the control group and 163.8+4.3 and 105.8+9.9mmHg in the hypertensive group (p&lt;0.0001). Hypertensive women had larger intimal thickness (p&lt;0.05). Elastic fibers were also more numerous and homogeneous in group 2. Cellular hypertrophy was more common in this group than in control patients (53.8% vs 23.1%). CONCLUSION: Hypertension seems to accelerate the age-related increase in intima thickness. Hypertensive women have more numerous and homogeneous elastic fibers in the wall of the uterine artery. These findings indicate that hypertension may determine structural changes similar to vascular aging.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>alterações vasculares</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>morfologia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>vascular changes</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>morphology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Tratamento de estenose subaórtica em membrana por cateter balão</s1>
</fA08>
<fA08 dir="en">
<s1>Balloon dilatation for the treatment of membranous subaortic stenosis</s1>
</fA08>
<fA11 dir="011000">
<s1>José Luiz B. Jacob</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nilton Carlos S. Machado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Wilson Miguel C. Coelho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sérgio Aloisio C. Garzon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Moléstias Cardiovasculares de São José do Rio Preto  </s1>
<s2>São José do Rio Preto SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>25-28</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar os resultados imediatos e a médio prazo do tratamento da estenose subaórtica em membrana através da dilatação percutânea por cateter balão. MÉTODOS: Os 14 pacientes, com idade média de 11,4+5,2 anos, foram selecionados pelo estudo ecodopplercardiográfico, mediante evidência de membrana subaórtica de fina espessura e distante das válvulas aórticas, ausência de componente muscular associado ou insuficiência aórtica (IAo) importante. Após a medida do gradiente e comprovação dos achados pela cineangiocardiografia, as dilatações eram feitas por insuflação manual e rápida até o desaparecimento da constricção do balão. O diâmetro do balão era no máximo igual ao da via de saída de ventrículo esquerdo, medida logo abaixo da valva aórtica. Manometria, ventriculografia esquerda e aortograma eram repetidos. Ecodopplercardiograma era realizado no dia seguinte, após 3 meses e a cada 6 meses após o procedimento. RESULTADOS: Os 17 procedimentos foram realizados com sucesso. O gradiente médio da amostra foi 76,1± 21,2mmHg (41-115) pré dilatação e 29,8±8,8mmHg (13-45) pós dilatação (p&lt;0,01). Não houve aumento da IAo pós procedimento. Doze pacientes receberam alta em 24h e 2 apresentaram oclusão de artéria femoral, tratados cirurgicamente. Não houve óbito imediato ou tardio. No acompanhamento de 33,3+23,6 meses (1-75) ocorreu reestenose em quatro pacientes, sendo três deles redilatados com sucesso. CONCLUSÃO: Em casos selecionados, o procedimento é seguro e eficaz e a ocorrência de reestenose pode ser tratada com nova dilatação percutânea.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: This study sought to evaluate the immediate and follow-up results of percutaneous balloon dilatation for the treatment of membranous subaortic stenoses. METHODS: Fourteen patients with mean age 11.4± 5.2 years, were submitted to the procedure. They were selected when the echocardiogram showed a thin subaortic membrane that was far from the aortic valve, no fibro-muscular obstruction and only mild or moderate aortic regurgitation. After measuring the pressure gradient and analysis of the angiographic features, the balloon dilatation was made by applying a fast manual inflation until the balloon waist disappeared. The balloon diameter was the same as that of the outflow tract of left ventricle, immediately bellow the aortic valve. Pressure measurement, left ventriculogram and aortogram were repeated. Doppler echocardiogram was repeated in the following day, after 3 months and every 6 months thereafter. RESULTS: All 17 procedures were successful. The mean gradient was 76.1±21.2mmHg before and 29.8±8.8mmHg after dilatation (p&lt;0.01). There was no increase in aortic regurgitation or death after the procedure or during the follow-up. Twelve patients were discharged 24h after the procedure. Surgical treatment for femoral artery thrombosis was performed in 2 patients. In the follow-up of 33.3±23.6 months, 4 patients developed restenosis and 3 of them were submitted to successful redilatation. CONCLUSION: We conclude that in selected cases, the procedure is safe and effective, and restenosis may be treated by percutaneous balloon redilatation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tratamento percutâneo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dilatação percutânea</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose subaórtica fixa</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous treatment</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous dilatation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>discrete subaortic stenosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Alterações da hemostasia em crianças submetidas a cirurgia cardíaca com circulação extracorpórea</s1>
</fA08>
<fA08 dir="en">
<s1>Hemostatic changes in children undergoing heart surgery with cardiopulmonary bypass</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernanda Maria Rebouças da Costa Silveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dayse Maria Lourenço</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Miguel Maluf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Werther B. Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Enio Buffolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>29-35</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar as alterações de hemostasia encontradas em crianças submetidas a cirurgia cardíaca com circulação extracorpórea (CEC). MÉTODOS: Estudamos 17 crianças no pré e pós-operatório (PO) imediato, no 1° PO e entre o 4º e 7º PO, analisando o hematócrito, tempo de protrombina (TP), tempo de tromboplastina parcial ativado, fibrinogênio, contagem de plaquetas, fator V e tempo de lise de euglobulina (TLE). Os pacientes foram divididos em grupos com e sem sangramento excessivo no PO. RESULTADOS: Houve alterações significantes no intra-operatório com aumento do TP e tempo de tromboplastina parcial ativado e redução do fibrinogênio, fator V e do TLE. Seis (35%) crianças sangraram excessivamente. A contagem de plaquetas foi significantemente menor no intra-operatório; neste grupo o tempo de CEC foi maior. CONCLUSÃO: Alterações de hemostasia no intra e PO ocorrem como conseqüência da ativação da cascata de coagulação e fibrinólise. A incidência de sangramento excessivo é alta nesta faixa etária. Os grupos com e sem sangramento excessivo diferenciaram-se pelo maior tempo de CEC e contagem reduzida de plaquetas.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: We evaluated hemostasic changes in children undergoing open heart surgery with cardiopulmonary bypass (CPB). METHODS: We studied 17 children before, during surgery, in the immediate, first and between the 4th and 7th postoperative days, measuring hematocrit, prothrombin time, activated partial thromboplastin time, fibrinogen, platelet count, factor V and euglobulin lysis time. Children were divided in those with and without excessive bleeding in the postoperative period. RESULTS: We observed significant prolongation of prothrombin time and activated partial thromboplastin time, reduction of fibrinogen and factor V, and shortening of euglobulin lysis time. Six (35%) children bled excessively. Platelet count reduction was greater in the intra operative period in these cases and the duration of CPB was longer in this group. CONCLUSION: Changes in hemostasis during open heart surgery are due to coagulation cascade disorders as well as fibrinolysis. The incidence of excessive bleeding is higher in the pediatric group. Prolonged CPB time and greater reduction in platelet count differentiated both groups.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hemostasia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>circulação extracorpórea</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hemostasis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiopulmonary bypass</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo multicêntrico do implante de stent intracoronário no Rio de Janeiro</s1>
</fA08>
<fA08 dir="en">
<s1>Multicenter study of intracoronary stent implantation in Rio de Janeiro</s1>
</fA08>
<fA11 dir="011000">
<s1>Norival Romão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Esmeralci Ferreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cláudio A. Feldman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Renato Vilella</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Noé Costa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cyro V. Rodrigues</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>André Pessanha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Valério Fuks</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Sérgio M. Leandro</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>37-42</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar retrospectivamente, implante de stent (IS) em paciente com doença arterial coronária (DAC), realizado em 7 hospitais do Rio de Janeiro. MÉTODOS: De junho/94 a dezembro/96, foram realizados 2.220 procedimentos, e desses, analisados 783 IS em 660 (29,7%) pacientes, através da coronariografia sem subtração digital. Os diversos tipos de stent, mais freqüentemente, usados foram: Palmaz-Schatz (40,9%), Gianturco-Roubin (29,1%) e NIR (22,0%). As indicações para o IS foram: lesão de novo, 67,9%; lesão reestenótica, 16,0%; lesão com resultado subótimo da angioplastia transluminal coronária (ATC), 8,2%; oclusão aguda ou provável pós-ATC, 4,9%; oclusão crônica, 3,0%. Todos os stents foram implantados com alta pressão, sem controle pelo ultra-som intracoronário. A prevenção da trombose subaguda, na maioria dos pacientes (87,8%), foi feita com o uso de ticlopidina e ácido acetil-salicílico. RESULTADOS: Evolução imediata: a) sucesso no IS em 770 lesões: 98,0% em 646 (97,9%) pacientes; b) sucesso clínico em 634 (96,0%) casos; c) complicações maiores: infarto agudo do miocárdio (IAM) - 1,1%; cirurgia de revascularização miocárdica (CRM) - 1,4% e óbito - 0,8%; d) complicações vasculares com correção cirúrgica e/ou sangramento - 3,0%. Evolução tardia: a) dos 399 (60,4%) pacientes acompanhados clinicamente, a coronariografia de 121 (30,3%) mostrou retorno da lesão no IS em 79 (19,8%) casos; b) freqüência de outros eventos: IAM - 1,5%; CRM - 2,3%; óbito -1,0% e outra ATC ou procedimento similar - 12,5%. CONCLUSÃO: O estudo multicêntrico mostrou que o IS na DAC pode ser realizado com segurança, alto índice de sucesso imediato, poucas complicações e baixa taxa de eventos cardíacos na evolução tardia.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate retrospectively stent implantation (SI) in patients with coronary artery disease (CAD) performed in 7 hospitals in Rio de Janeiro. METHODS: From June/94 to December/96 2,220 procedures were performed among which we analyzed 783 SI in 660 (29.7%) patients using coronary angiography without digital subtraction. Several types of stents were used: Palmaz-Schatz (40.9%), Gianturco-Roubin (29.1%) e NIR (22.0%). Indications for SI: 1- de novo lesion (67.9%); 2) restenotic lesion (16.0%); 3) sub-optimal results after PTCA (8.2%); 4) abrupt or threatened closure after PTCA (4.9%); 5) chronic occlusion (3.0%). All stents were implanted using high pressure balloon inflation without intracoronary ultrasound guidance. Sub-acute stent thrombosis prevention, in the majority of patients (87.8%) was done with ticlopidine and aspirin. RESULTS: Early outcome: a) the success rate of SI in 770 lesions was 98.0% in 646 (97.9%) patients; b) the clinical success rate in 634 patients was 96.0%; c) the major complications were acute myocardial infarction (1.1%); coronary artery bypass graft (1.4%) and death (0.8%); d) vascular complications with surgical correction and/or bleeding occurred in 3.0%. Late outcome: a) the clinical follow-up of 399 (60.4%) and the coronary angiographies of 121 patients (30.3%) showed in-stent lesion in 79 (19.8%); b) other event rates: myocardial infarction (1.5%); coronary bypass (2.3%); death: 1.0% and other PTCA or similar procedure (12.5%). CONCLUSION: This multicentric study showed that SI for CAD can be performed with safety, high early success rate, few complications and low rate of cardiac events during the late follow-up.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>implante de stent</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença arterial coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>reestenose coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stents implantation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary restenosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Análise da recorrência de fibrilação atrial durante terapia com sotalol ou quinidina</s1>
</fA08>
<fA08 dir="en">
<s1>Analysis of atrial fibrillation recurrence during therapy with sotalol or quinidine</s1>
</fA08>
<fA11 dir="011000">
<s1>Henrique Horta Veloso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Angelo Amato Vincenzo de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>43-49</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar a incidência e as características das crises de recorrência de fibrilação atrial (FA) em pacientes sob terapia com sotalol ou quinidina. MÉTODOS: Cento e vinte e um pacientes receberam de forma randômica sotalol (58 pacientes) ou quinidina (63 pacientes) após reversão de FA paroxística e foram acompanhados, ambulatorialmente, por 6 meses. As sintomatologias e as freqüências ventriculares ao eletrocardiograma de 12 derivações da crise inicial e da recorrência foram comparadas entre os grupos de drogas. As características clínicas e os dados do ecocardiograma foram analisados como preditores de recorrência. RESULTADOS: Dezessete (14%) pacientes apresentaram recorrência da arritmia, 7 (12%) em uso de sotalol e 10 (16%) em uso de quinidina. A recorrência ocorreu mais tardiamente no grupo tratado com sotalol (mediana de 69 dias) em comparação ao grupo tratado com quinidina (mediana de 10 dias) (p=0,04). A sintomatologia esteve presente em 14 (82%) pacientes na crise inicial e em 8 (47%) pacientes na recorrência. O tratamento antiarrítmico proporcionou recorrências menos sintomáticas (p&lt;0,04), não sendo possível demonstrar diferença significante entre as terapias. Somente os pacientes tratados com sotalol apresentaram menor freqüência ventricular na recorrência em comparação à crise inicial (p&lt;0,02). Todas as variáveis falharam em predizer recorrência da FA. CONCLUSÃO: Não foi possível demonstrar diferença entre o sotalol e a quinidina na prevenção de FA. O tratamento antiarrítmico proporcionou a ocorrência de recorrências menos sintomáticas. Os pacientes tratados com sotalol apresentaram recorrência mais tardiamente e freqüência ventricular significantemente menor na recorrência em comparação à crise inicial.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To analyze the recurrences of atrial fibrillation in patients treated with sotalol or quinidine. METHODS: After conversion to sinus rhythm, 121 patients with paroxysmal atrial fibrillation were randomized to sotalol (58 patients) or quinidine (63 patients) and followed-up during 6 months. Symptoms and ventricular rates on the 12 lead electrocardiogram of the arrhythmic events were compared between the two groups. Clinical and echocardiographic characteristics were analyzed as predictors of atrial fibrillation recurrence. RESULTS: Seventeen (14%) patients relapsed into atrial fibrillation; 7 (12%) were treated with sotalol and 10 (16%) with quinidine. Recurrence occurred later in the sotalol group (median 69 days) in comparison with the quinidine group (median 10 days) (p=0.04). Symptoms were present in 14 (82%) patients during the initial crisis and in 10 (47%) during recurrence. Recurrence was less symptomatic during antiarrhythmic therapy (p&lt;0.04), with no statistical differences between the two groups. Only patients treated with sotalol had ventricular rates during the recurrences lower than during initial crisis (p&lt;0.02). All variables failed to predict recurrence of atrial fibrillation. CONCLUSIONS: evention of atrial fibrillation. Recurrence was less symptomatic during antiarrhythmic therapy. Patients treated with sotalol relapsed to atrial fibrillation later and had ventricular rates during recurrences significantly lower than during the initial crisis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fibrilação atrial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>recorrência</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sotalol</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>quinidina</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>recurrence</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sotalol</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>quinidine</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Insuficiência cardíaca de alto débito devida a fístula coronária</s1>
</fA08>
<fA08 dir="en">
<s1>High output heart failure due to a coronary fistula</s1>
</fA08>
<fA11 dir="011000">
<s1>Orlando Petrucci Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Pedro Paulo M. de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cid de Abreu Leme Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Otávio Rizzi Coelho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fernando A. Barca Schellini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Eduardo Arantes Nogueira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Reinaldo W. Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Domingo Marcolino Braile</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Campinas  </s1>
<s2>Campinas SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>51-53</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>5</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Em mulher de 45 anos, apresentando quadro de insuficiência cardíaca classe funcional III e dor torácica atípica, foi evidenciada dilatação importante da coronária direita e sua drenagem para o átrio direito, demonstrada na ecocardiografia transtorácica e confirmada pela angiografia coronária. A paciente foi submetida a cirurgia, encontrando-se um ramo único desembocando no átrio direito, que foi ligado. Sua evolução pós-operatória foi boa estando, há três anos, livre de qualquer sintomatologia.</s0>
</fC01>
<fC01 dir="en">
<s0>A 45 year-old woman complaining of heart failure symptoms (New York Heart Association -class III) and a non typical thoracic pain was submitted to a transthoracic echocardiogram which showed a very dilated coronary artery and a fistula to the right atrium. The angiograms confirmed the same findings. She underwent open heart surgery which confirmed the diagnosis. Fistula ligation was then undertaken. She remains symptom-free three years after the operation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Utilização de stent para tratamento de dissecção coronária iatrogênica</s1>
</fA08>
<fA08 dir="en">
<s1>Stenting for iatrogenic coronary dissection</s1>
</fA08>
<fA11 dir="011000">
<s1>Ronaldo Tadeu Copini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Claudia Maria Rodrigues Alves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Francisco de Assis Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Augusto Marcondes de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>João Lourenço Villari Herrmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>55-57</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>6</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000111</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>A dissecção coronária iatrogênica é rara, entretanto, apresenta alta mortalidade e morbidade. Diante de uma oclusão coronária aguda é fundamental a restauração imediata da perviabilidade do vaso e, com isso, limitar a extensão e a duração da isquemia. Neste contexto o procedimento usual tem sido a revascularização miocárdica de emergência, precedido pela colocação de um balão intra-aórtico. A principal desvantagem desta abordagem é o tempo necessário para reunir uma equipe cirúrgica. Os autores apresentam caso de uma paciente com dissecção iatrogênica da artéria circunflexa durante o cateterismo diagnóstico, que foi solucionada através da implantação de um stent coronário, com ótimo resultado. Esta técnica apresenta vantagens em termos de velocidade de reperfusão e disponibilidade em centros que realizarão o cateterismo diagnóstico sem cobertura cirúrgica local.</s0>
</fC01>
<fC01 dir="en">
<s0>Catheter-induced coronary dissection is rare but has a significant mortality and morbidity. The ideal management of acute coronary occlusion, whatever the cause, is the prompt restoration of the vessel patency to limit the extent and duration of ischemia. In the setting of dissection during angiography the usual approach to myocardial salvage has been emergency aortocoronary bypass surgery preceded by insertion of an intra-aortic balloon. The main disadvantages of this approach is the delay in performing emergency surgery, mainly in centers without surgical back-up on site. The authors present a case of an elderly woman with left circumflex artery dissection caused by the catheter during coronary angiography. This problem was successfully managed using an intracoronary stent. This technique has potential advantages in terms of the speed of reperfusion and availability in centers performing diagnostic angiography without surgical back-up on site.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Terapêutica da forma crônica da doença de chagas. É eficaz o tratamento etiológico?</s1>
</fA08>
<fA11 dir="011000">
<s1>Barbara Maria Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>59-61</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000112</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Terapêutica da forma crônica da doença de Chagas. Tratamento específico da infecção pelo Trypanosoma cruzi</s1>
</fA08>
<fA11 dir="011000">
<s1>Vicente Amato Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>63-64</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000113</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Apoptose miocárdica. Um novo mecanismo de morte celular</s1>
</fA08>
<fA11 dir="011000">
<s1>Roberto Vieira Haendchen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica Hospital Universitário Cajuru </s1>
<s2>Curitiba PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>65-68</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000114</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="">
<s1></s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>69-70</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000115</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Esternotomia parcial mediana em H. Um novo acesso para a cirurgia cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Partial sternotomy in H. A new approach for cardiac surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Danton R. Loures</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leonardo A. Mulinari</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>André L. Tyszka</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edison Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Roberto G. Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rui Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Paraná Hospital de Clínicas </s1>
<s2>Curitiba PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>71-73</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Apresentar a nossa experiência com a toracotomia minimamente invasiva (TMI) em pacientes com doença valvar e descrever um novo tipo de toracotomia. MÉTODOS: Vinte e cinco pacientes com doença valvar, como maior problema cardíaco, foram submetidos a operação em um período de 5 meses. A incisão utilizada foi uma TMI em duas formas, uma em T invertido e outra em H. Nesta série, as reoperações constituíram 24%. RESULTADOS: O tamanho da incisão de pele variou de 7,5 a 11,0cm (média = 9,1cm). O tempo de permanência médio na UTI foi de 31h e hospitalar de 4,8 dias. Em todos os pacientes a cirurgia pôde ser realizada apropriadamente através deste acesso, sendo que em apenas um, foi necessária esternotomia total. CONCLUSÃO: A TMI apresenta algumas vantagens, como melhor resultado estético, menos dor e maior estabilidade torácica. Estes fatores possibilitam uma extubação precoce, diminuindo o tempo de internação hospitalar. A esternotomia em H apresenta como grande benefício a exposição da parte mais central do tórax, permitindo um melhor acesso a todas as valvas cardíacas. Esta técnica não apresentou complicações nas reoperações, o que nos faz acreditar que seja tão segura quanto a esternotomia total.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To present our results with the minimally invasive thoracotomy (MIT) in patients with valve disease and to describe a new type of thoracotomy. METHODS: Twenty-five patients with valve disease as the major cardiac problem were operated during a five month period. Two types of incisions were used: one in an inverted-T fashion and another in a H fashion. Fourteen patients were submitted to an inverted-T incision and eleven to a H incision. In 24% of the patients reoperation was being performed. RESULTS: The incisions ranged from 7.5 to 11cm (mean 9.1cm), mean ICU stay was 31h and hospital stay 4.8 days. In all but one patient the operation could be adequately in performed through the MIT, in only one patient total sternotomy had to be performed. CONCLUSION: The MIT may have some advantages such as, better aesthetic results, less pain and more sternal stability. These factors may improve early extubation and decrease hospital stay. The H type incision allows an adequate exposition of the most central part of the chest and all heart valves with adequate exposure. This technique led to no complications during reoperations and we believe it to be as safe as the total sternotomy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>esternotomia parcial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia minimamente invasiva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvopatias</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sternotomy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>minimally invasive surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart valve surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Diagnóstico do infarto agudo do miocárdio. Valor da dosagem de mioglobina sérica comparada com a creatinofosfoquinase e sua fração MB</s1>
</fA08>
<fA08 dir="en">
<s1>Acute myocardial infarction diagnosis. The value of serum myoglobin levels, compared with creatine kinase and MB fraction</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre Biasi Cavalcanti</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Henrique Heinisch</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Evandro de Campos Albino</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>João Nilson Zunino</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>75-80</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar o desempenho, em termos de teste diagnóstico, da dosagem sérica de mioglobina (Mgb) com a creatinofosfoquinase (CK) e a sua fração MB (CK-MB), para o diagnóstico de infarto agudo do miocárdio (IAM). MÉTODOS: Estudo observacional, contemporâneo e não controlado de 64 pacientes, admitidos entre setembro/94 e fevereiro/95, em uma emergência especializada em cardiologia, com dor torácica não traumática. Excluíram-se pacientes com sintomas há mais de 6h, trauma muscular, ressuscitação cardiopulmonar e insuficiência renal. O diagnóstico de IAM foi estabelecido quando ao menos dois dos seguintes critérios estavam presentes: dor torácica típica há mais de 20min, alterações eletrocardiográficas compatíveis com necrose (ondas Q), ou elevações tardias de CK e CK-MB. RESULTADOS: Na amostra estudada, 18 tiveram diagnóstico de IAM. A sensibilidade (S) encontrada para CK, CK-MB e Mgb foi de 33%, 22% e 61% e a especificidade (E) de 85%, 96% e 98%, respectivamente. A diferença entre a S de Mgb e a de CK foi de 28%, com um intervalo de confiança de 95% (IC 95%) de -4% a 59%, e a diferença entre a S de Mgb e a de CK-MB foi de 39%, IC 95% de 9% a 69%. A diferença entre a E de Mgb e a de CK foi de 13%, IC 95% de 12% a 14%, e a diferença entre a E de Mgb e a de CK-MB foi de 2%, IC 95% de -5% a 9%. CONCLUSÃO: A mioglobina mostrou ser um marcador mais sensível e tão específico quanto a CK-MB, para o diagnóstico de IAM na população estudada. Em relação a CK, a Mgb foi mais específica e com igual sensibilidade.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To compare the diagnostic performance of two traditional plasma markers of myocardial infarction (MI), creatine kinase (CK) and its MB fraction (CK-MB), with plasma myoglobin (Mgb) levels, for the diagnosis of MI. METHODS: From September of 94 to February of 95, in an observational, prospective, and non-controlled fashion, 64 patients admitted to a cardiology emergency room (ER), with non-traumatic chest pain were studied. Patients presenting with more than 6h after the onset of symptoms, muscular trauma, cardiopulmonary resuscitation and renal insufficiency were not included. Definitive MI diagnosis was established if the patient had at least two of the three classic MI findings: ischemic chest discomfort longer than 20min, electrocardiogram with necrosis (Q waves) and elevated CK and CK-MB levels. RESULTS: There were 18 patients with MI. The sensitivity for CK, CK-MB and Mgb were respectively 33%, 22% and 61%. The specificity was 85%, for CK ,95% for CK-MB and 97% for Mgb. The difference between Mgb and CK sensitivities was 28%, with a 95% confidence interval (CI) from -4% to 59%, the difference between Mgb and CK-MB sensitivities was 39%, (CI 9% to 69%). The difference between Mgb and CK especificities was 13%, (CI 12% to 14%) and the difference between Mgb and CK-MB specificities was 2%, (CI -5% to 9%). CONCLUSION: In the studied population, Mgb was more sensitive than CK-MB for the diagnosis of MI with similar specificity and Mgb was more specific than CK for this diagnosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>diagnóstico do infarto agudo do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mioglobina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>creatinofosfoquinase</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction diagnosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myoglobin</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>creatine kinase</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Adaptações fisiológicas precoces e tardias após valvotomia mitral por cateter balão</s1>
</fA08>
<fA08 dir="en">
<s1>Early and late physiological effects of balloon mitral valvuloplasty</s1>
</fA08>
<fA11 dir="011000">
<s1>Japy Angelini Oliveira Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo Regazzini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Orlando Campos Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ana Fátima Salles</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Turíbio Leite Barros Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Neil Ferreira Novo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Bocanegra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Eulógio Martinez Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Dirceu Vieira Santos Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>81-86</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliação não invasiva das respostas cardiopulmonares ao exercício a curto e longo prazo após valvotomia mitral por cateter balão. MÉTODOS: Estudaram-se 9 pacientes do sexo feminino, 35±9 anos, com estenose mitral, tipo funcional II ou III, em uso de digitálicos e diuréticos, através de teste ergoespirométrico, eletrocardiograma e ecocardiograma, antes e após valvotomia em fase precoce (3 a 5 dias) e tardia (8 a 12 meses). RESULTADOS: Os pacientes evoluíram para tipo funcional II (44%) ou I (56%), na fase tardia. Houve redução da freqüência cardíaca de repouso (87±11bpm vs 85±7bpm vs 75±9bpm) e elevação do número de estágios (4±1 estágios vs 5±2 estágios vs 6±1 estágios); a capacidade aeróbia máxima aumentou apenas na fase tardia (16±3mL/kg/min vs 18±4mL/kg/min vs 22±7mL/kg/min). O limiar anaeróbio, a ventilação pulmonar e o equivalente ventilatório do O2 permaneceram inalterados. Nas cargas submáximas de exercício ocorreu redução da freqüência cardíaca (estágio I: 124±18bpm vs 112±13bpm vs 87±15bpm), consumo de O2 (estágio I: 10±2mL/kg/min vs 8±2mL/kg/min vs 8±mL/kg/min) e ventilação pulmonar, nas fases precoce e tardia. A área valvar mitral mostrou reduções na fase tardia (0,94cm² vs 1,66cm² vs 1,20cm² ). CONCLUSÃO: Apesar da tendência à reestenose parcial, houve melhora no tipo funcional e no desempenho cardiopulmonar com diminuição da sobrecarga circulatória no exercício submáximo.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the early and late cardiorespiratory responses after balloon mitral valvuloplasty. METHODS: Nine female patients aged 35±9 years, with mitral stenosis, in class II or III (NYHA) underwent upright ergoespirometric test, resting electrocardiogram and echocardiogram before, 3 to 5 days (early evaluation) and 8 to 12 months (late evaluation) after mitral valvuloplasty. All patients were treated with digitalis and diuretics. RESULTS: During late evaluation, 44% patients were in class II and 56% were in class I (NYHA). The resting heart rate decreased (87±11bpm vs 85±7bpm vs 75±9bpm) and the number of steps increased (4±1 steps vs 5±2 steps vs 6±1 steps); the peak oxygen uptake improved only in the late evaluation (16±3mL/kg/min vs 18±4mL/kg/min vs 22±7mL/kg/min). The anaerobic threshold, minute ventilation (VE) and ventilatory equivalent for oxygen showed no change. The heart rate (1st step: 124±18bpm vs 112±13bpm vs 87±15bpm), O2 uptake (1st step: 10±2mL/kg/min vs 8±2mL/kg/min vs 8±2mL/kg/min) and VE decreased during submaximal exercise in early and late phases. The mitral valve area decreased in the late evaluation (0.94cm² vs 1.66cm² vs 1.20cm²). CONCLUSION: Although partial restenosis tended to occur in these patients, they improved the functional class and cardiorespiratory performance and cardiocirculatory load during submaximal exercise.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvoplastia mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste ergométrico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valvuloplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiogram</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeito da berinjela sobre os lípides plasmáticos, a peroxidação lipídica e a reversão da disfunção endotelial na hipercolesterolemia experimental</s1>
</fA08>
<fA08 dir="en">
<s1>Effect of eggplant on plasma lipid levels, lipidic peroxidation and reversion of endothelial dysfunction in experimental hypercholesterolemia</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Afonso Ribeiro Jorge</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Lidia C. Neyra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Regina M. Osaki</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eros de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Neura Bragagnolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Campinas Faculdades de Ciências Médicas </s1>
<s2>Campinas SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>87-91</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar o efeito do suco da berinjela sobre os lípides plasmáticos, o colesterol tecidual, a peroxidação lipídica das LDL nativas, oxidadas e da parede arterial e o relaxamento dependente do endotélio, em coelhos hipercolesterolêmicos. MÉTODOS: Coelhos foram separados em grupos controle (GC), hipercolesterolêmico (GH) e berinjela (GB), (n=10). Os animais do GC foram alimentados com ração normal, o GH e o GB com ração acrescentada de colesterol (0,5%) e gordura de babaçu (10%) durante 30 dias. Ao GB acrescentou-se suco de berinjela, nos últimos 15 dias do experimento. Os lípides plasmáticos foram medidos através de kits enzimáticos, a peroxidação lipídica pela dosagem do malondialdeído (MDA) e o relaxamento dependente do endotélio, por curvas de concentração efeito pela acetilcolina e nitroprussiato. RESULTADOS: O peso dos animais foi menor no GB em relação ao GC e GH (p&lt;0,05). O colesterol total plasmático, as LDL e os triglicérides que se elevaram no GH, reduziram-se em 19%, 29% e 38%, respectivamente no GB (p&lt;0,05). O colesterol tecidual foi menor no GB (50%) em relação ao GH (p&lt;0,05). Nos animais do GB ocorreu redução significante do teor de MDA nas LDL nativas (56%) e oxidadas (22%), assim como na parede arterial (30%) (p&lt;0,05). O relaxamento máximo dependente do endotélio, , elevou-se significantemente em 28% no GB em relação ao GH (p&lt;0,05). CONCLUSÃO: O suco de berinjela administrado a coelhos hipercolesterolêmicos reduziu significantemente o peso corpóreo, o colesterol total, as LDL plasmáticas, os triglicérides, o colesterol tecidual, a peroxidação lipídica das LDL nativas, oxidadas e da parede arterial, assim como aumentou o relaxamento dependente do endotélio.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To study the effect of egg plant on endothelium-dependent relaxation, and plasma lipids in hypercholesterolemic rabbits, and to assess influence of this plant on the malondialdehyde (MDA) content of LDL particles and the arterial wall. METHODS: Thirteen male rabbits were randomly assigned to control (C), hypercholesterolemic (H) and egg plant (E) treated groups (n=10 each). The H and E rabbits were fed a diet supplemented with cholesterol (0.5%) and coconut oil (10%) for 4 weeks. In addition, group E received 10mL of the fruit juice/day during the last 2 weeks.The animals were killed and the aorta removed to measure MDA content and the endothelium dependent relaxation responses. Total plasma cholesterol, VLDL, LDL, HDL and triglyceride levels were determined using commercial kits. MDA was quantified in native and oxidized LDL and in the arterial wall. RESULTS: After 4 weeks, the E group rabbits had a significantly lower weight , plasma cholesterol, LDL, triglyceride and aortic cholesterol contentthan group H(p&lt;0.05). The MDA content that was significantly increased in the LDL particles and in the arterial wall of H rabbits was reduced in the E group (p&lt;0.05). Endothelium-dependent relaxation were significantly higher in the E group compared H group rabbits (p&lt;0.05). CONCLUSION: In hypercholesterolemic rabbits egg plant juice significantly reduced weight, plasma cholesterol levels, aortic cholesterol content and the MDA concentrations in native-oxidized LDL and in the arterial wall and increased the endothelium-dependent relaxations.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>berinjela (solanum melongena)</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>LDL</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lípides plasmáticos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>colesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>eggplant</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cholesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>oxidized LDL</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Distribuição de gordura corporal, pressão arterial e níveis de lipídios-lipoproteínas plasmáticas</s1>
</fA08>
<fA08 dir="en">
<s1>Body fat distribution, blood pressure and plasma lipids and lipoprotein levels</s1>
</fA08>
<fA11 dir="011000">
<s1>Dartagnan Pinto Guedes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Joana Elisabete Ribeiro Pinto Guedes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Londrina Centro de Educação Física e Desporto </s1>
<s2>Londrina PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>93-98</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Investigar associações entre distribuição do tecido adiposo e níveis de pressão arterial e concentrações de lipídios-lipoproteínas plasmáticas, mediante controle de indicadores, quanto à quantidade de gordura corporal e à prática da atividade física. MÉTODOS: Estudo de 62 indivíduos com idades entre 20 e 45 anos. A distribuição do tecido adiposo foi determinada baseando-se na relação circunferência de cintura/quadril (CCQ), e como indicador da quantidade de gordura corporal recorreu-se às informações do índice de massa corporal (IMC), enquanto o nível de prática da atividade física foi estabelecido mediante estimativas do consumo máximo de oxigênio (VO2max). As associações entre CCQ e níveis de pressão arterial e de lipídios-lipoproteínas plasmáticas, com os efeitos do IMC e do VO2max controlados estatisticamente, foram estabelecidas pelo coeficiente de correlação parcial. RESULTADOS: Após correção pelo IMC verificou-se significativa correlação parcial entre a distribuição centrípeta do tecido adiposo e os níveis de pressão arterial, LDL-C e triglicerídios plasmáticos. Entretanto, controlando-se o VO2max, não foram constatadas associações significativas entre CCQ e qualquer variável sangüínea e pressão arterial.CONCLUSÃO: A distribuição centrípeta do tecido adiposo, independente da quantidade de gordura corporal, foi relacionada com concentrações de lipídios-lipoproteínas plasmáticas e níveis de pressão arterial em ambos os sexos. A prática da atividade física parece ser um importante modulador dessa associação, enfatizando seu papel no controle dos fatores de risco predisponentes às doenças cardiovasculares.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To study associations between FAT distribution and blood pressure levels and concentrations of lipids and lipoproteins, irrespective of body fat content and physical activity. METHODS: A sample of 62 subjects of both genders aging 20-45 years-old was used in the study. The adipose tissue distribution was based on the waist-to-hip ratio (WHR). Body fat content was estimated by the body mass index (BMI), and physical activity was assessed by maximal oxygen uptake (VO2max). Partial correlation analyses were used to determine the strength of the associations. RESULTS: After correction for BMI there was a significant partial correlation between centripetal adipose tissue distribution and serum triglyceride, LDL-cholesterol levels, and blood pressure. However, controlling for VO2max, there was no significant association between WHR and any serum variable and blood pressure. CONCLUSION: The centripetal adipose tissue distribution, independent of body fat content, was related to lipid and lipoprotein plasma concentrations and to blood pressure levels in both sexes. Physical activity seems to be an important modifier of this relationship, emphasizing its role in the control of cardiovascular risk factors.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>gordura corporal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>atividade física</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>body fat</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>physical activity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>A duração do exercício determina a magnitude e a duração da hipotensão pós-exercício</s1>
</fA08>
<fA08 dir="en">
<s1>Exercise duration determines the magnitude and duration of post-exercise hypotension</s1>
</fA08>
<fA11 dir="011000">
<s1>Cláudia Lúcia de Moraes Forjaz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Danilo Forghieri Santaella</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Liliane Onda Rezende</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Carlos Eduardo Negrão</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>99-104</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Considerando-se que a duração do exercício físico possa influenciar a hipotensão pós-exercício, testamos a hipótese de que o exercício submáximo mais prolongado provoca queda pressórica de maior magnitude e duração que o exercício mais curto.MÉTODOS: Protocolo experimental - 10 indivíduos realizaram duas sessões de exercício (25 e 45min) no cicloergômetro em 50%VO2 pico. Protocolo controle - 12 indivíduos permaneceram em repouso por 45min. A pressão arterial (PA) foi aferida antes (20min) e após (90min) o exercício ou o repouso. RESULTADOS: Protocolo experimental - a PA sistólica diminuiu significantemente pós-exercício e essa queda foi maior e mais prolongada após 45min de exercício. A PA média e diastólica diminuíram significantemente pós-exercício e foram significantemente menores na sessão de 45min. Protocolo controle - a PA não se alterou durante a sessão controle. CONCLUSÃO: O exercício físico de maior duração provoca hipotensão pós-exercício maior e mais prolongada.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: Considering that exercise duration may play a role in post-exercise hypotension, we tested the hypothesis that a prolonged submaximal exercise would lead to a greater and longer blood pressure fall after exercise than a shorter exercise bout. METHODS: Experimental protocol - 10 subjects were submitted to two cycle ergometer exercise trials (25 and 45min) at 50% of VO2 peak. Control protocol - 12 subjects rested in the sitting position for 45min. Blood pressure (BP) was measured before (20min) and after (90min) rest or exercise bouts. RESULTS: Systolic BP decreased significantly after exercise and this reduction was greater and lasted longer after 45min of exercise. Mean and diastolic BP decreased after exercise and they were significantly lower during the 45min session. Control protocol - no change in BP was observed after resting condition. CONCLUSION: A longer exercise bout leads to a greater and longer post-exercise hypotension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipotensão pós-exercício</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>duração do exercício</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>post-exercise hypotension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise duration</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Estereologia do miocárdio de ratos jovens e idosos</s1>
</fA08>
<fA08 dir="en">
<s1>Stereology of the myocytes in young and aged rats</s1>
</fA08>
<fA11 dir="011000">
<s1>Márcia Barbosa Águila</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Alberto Mandarim-de-Lacerda</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Mara Ibis Rodrigues Apfel</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>105-109</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar as diferenças quantitativas na composição e estrutura do miocárdio de ratos jovens e idosos utilizando a estereologia. MÉTODOS: Foram estudados 30 ratos machos da raça Wistar (15 animais jovens de 3 meses de idade e 15 animais idosos de 15 meses). Os corações foram retirados, pesados, perfundidos com solução de Bouin e posteriormente fixados em formol tamponado a 10% por 24h, processados por técnica histológica, incluídos em parafina, seccionados e corados pelo HE e picro-sirius. Foram analisados 15 campos aleatórios por grupo e foram determinados os seguintes parâmetros estereológicos: densidade de volume do miócito (Vv[miócito]) e densidade de volume do interstício cardíaco (Vv[interstício]) e densidade numérica dos miócitos (Nv[miócito]) (1/mm³), estimados pelo método disector. O número total de miócitos (N[miócitos]) e a média do volume do miócito (Vol[miócito]) dos corações dos dois grupos também foram determinados. As diferenças estatísticas entre os animais jovens e idosos foram testadas pelo teste não paramétrico de Mann-Whitney. RESULTADOS: Comparando os animais dos grupos jovem e idoso temos, respectivamente, os seguintes dados: o peso cardíaco aumentou de 1,1 para 1,7g, o Vv(miócito) diminuiu de 76,7 para 72,2%, Vv(interstício) aumentou de 23,3 para 27,8%, enquanto o Nv(miócito) diminuiu de 14,76x10(4) para 6,19x10(4)/mm³. O Vol(miócito) aumentou de 5,42x10³ para 13,26x10³mm³ e o N(miócito) diminuiu de 15,64x10(4) para 10,72x10(4) miócitos. Estas diferenças foram estatisticamente significativas (p&lt;0,05). CONCLUSÃO: Os resultados obtidos mostram que no envelhecimento ocorre perda de miócitos cardíacos e hipertrofia das células remanescentes.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To determine the myocardial quantitative changes comparing young and aged animals by using the stereology. METHODS: Thirty rat hearts were studied (15 rats aged 3 months and 15 other rats aging 15 months). The hearts were removed, weighed, fixed in 10% buffered formaldehyde solution, embedded in paraffin, cut in 7µm thick slices and stained with HE and picro-sirius stains. In each group we counted 15 random microscopic fields. The following parameters were studied: Vv(myocyte) and Vv(interstitium)(%) (the volume densities of the cardiac myocyte and interstitium, determined by the point-counting method), and Nv(myocyte) (1/mm³) (the numerical density of the cardiac myocytes, determined with the disector method). The total number of myocytes (N[myocyte]) and the mean volume of the myocytes (V[myocytes]) were also determined. The differences were tested by the Mann-Whitney test.RESULTS: Cardiac weight increased from 1.1 to 1.7g, the Vv(myocyte) decreased from 76.7 to 72.2%, the Vv(interstitium) increased from 23.3 to 27.8%. The Nv(myocyte) and the N(myocyte) decreased from 14.76x10(4) to 6.19x10(4)/mm³ and 15.64x10(4) to 10.72x10(4) myocytes, respectively. Simultaneously, the V(myocyte) increased from 5.42x10³ to 13.26x10³mm³. These differences were statistically significant (p&lt;0.05). CONCLUSION: Myocardial changes, comparing young rats with aged ones suggest loss of myocytes (increased apoptosis?) with simultaneous myocyte hypertrophy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>miócito</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>envelhecimento</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estereologia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocyte</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aging</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stereology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Associação entre diferentes indicadores de obesidade e prevalência de hipertensão arterial</s1>
</fA08>
<fA08 dir="en">
<s1>The association between different measurements of obesity and the prevalence of hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>Miguel Gus</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leila B. Moreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maurício Pimentel</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ana Luiza M. Gleisener</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Renan S. Moraes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Flávio D. Fuchs</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>111-114</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a associação entre índice de massa corporal (IMC), índice cintura-quadril e cintura com a prevalência de hipertensão arterial (HAS) em amostra representativa de 1088 adultos de Porto Alegre, Brasil. MÉTODOS: Foram considerados hipertensos indivíduos com pressão sistólica (PAS)  &gt; ou = 160mmHg ou diastólica (PAD)  &gt; ou =  95mmHg e definidos como obesos aqueles com IMC  &gt; ou = 27kg/m², ou com razão cintura/quadril  &gt; ou = 0,95 (homens) e  &gt; ou = 0,80 (mulheres) ou com cintura  &gt; ou = 96cm (homens) e  &gt; ou = 92cm (mulheres). RESULTADOS: A obesidade aferida pelo IMC associou-se com a prevalência de HAS em ambos sexos (RR 1,9, IC 1,0 - 3,2 masculino; RR 2,2, IC 1,3 - 3,8 feminino). Os outros índices associaram-se, significativamente, apenas nas mulheres. CONCLUSÃO: IMC  &gt; ou = 27,0kg/m² associou-se mais, consistentemente, com o risco de HAS. A magnitude similar das associações dos demais indicadores demonstram sua utilidade na avaliação do risco para hipertensão.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the association between body mass index (BMI), waist-hip ratio and waist circumference with the prevalence of hypertension in a representative sample of 1088 adults of Porto Alegre (RS), Brazil. METHODS: In this cross-sectional survey, subjects were considered as having hypertension if they had systolic blood pressure  &gt; or = 160mmHg or diastolic &gt; or = 90mmHg, and were considered obese if they had BMI  &gt; or = 27kg/m², or had a waist-hip-ratio  &gt; or = 0.95cm (men) or 0.80 (women) or had a waist circumference  &gt; or = 96 (men) or 92 (women). RESULTS: Obesity defined by the BMI was associated with hypertension in both genders (RR 1.9, CI 1.0 - 3.2 in men; RR 2.2, CI 1.3 - 3.8 in women). The other indices were significantly associated with hypertension just in women. CONCLUSION: BMI  &gt; or =  27.0kg/m² was strongly associated with increased odds to have hypertension. Similar magnitude of the association with the other indices indicate their utility to estimate the risk of hypertension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>obesidade</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prevalência</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>obesity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prevalence</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Meningococcemia complicada por miocardite</s1>
</fA08>
<fA08 dir="en">
<s1>Meningococcemia complicated by myocarditis</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco Manes Albanesi Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo Mourilhe Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rui Alves Barros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro Serviço de Cardiologia </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>115-118</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Homem de 26 anos com meningococcemia (meningite), complicada por miocardite (disfunção ventricular e isquemia miocárdica), requereu tratamento para insuficiência cardíaca e evolui com regressão da disfunção miocárdica, seis meses após o quadro infeccioso.</s0>
</fC01>
<fC01 dir="en">
<s0>We report a case of a 26-year old man with meningococcemia complicated with myocarditis (ventricular dysfunction and myocardial ischemia), that required treatment for heart failure. Regression of myocardial dysfunction was observed six months after the infection.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Comprometimento cardíaco na amiloidose sistêmica. Diagnóstico in vivo</s1>
</fA08>
<fA08 dir="en">
<s1>Heart disease and systemic amyloidosis. In vivo diagnosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Rosana G. G. Mendes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Roberto B. Evora</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Antonio Mansur Mendes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jorge Haddad</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Simone Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>119-123</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Descrevemos o caso de um paciente masculino de 42 anos, com amiloidose sistêmica, provavelmente primária, comprometendo o coração. Ressaltam-se os aspectos fisiopatológicos, clínicos e a relativa raridade do diagnóstico in vivo. Discutem-se, ainda que limitados, os aspectos terapêuticos relacionados aos problemas cardíacos.</s0>
</fC01>
<fC01 dir="en">
<s0>This is the case of a 42year-old male with systemic amyloidosis, probably primary, and heart involvement. Physiopathological and clinical aspects are described as well as the rarity of the diagnosis in vivo. The limited aspects of therapy are also described.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 1/ 98 - Instituto do Coração do Hospital das Clínicas - FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>125-130</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Uso do ecocardiograma transesofágico na cardioversão de fibrilação atrial</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Roberto Schvartzman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Waldomiro C. Manfroi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Pinotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFRGS Hospital de Clínicas de Porto Alegre </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>131-134</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000212</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Resumos dos Temas-Livres apresentados ao IV Congresso Brasileiro de Ergometria e Reabilitação Cardiovascular - 30/10 a 1/11/97 - Ribeirão Preto-SP</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>135-139</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000213</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Fator von Willebrand e disfunção endotelial pulmonar. Implicações prognósticas</s1>
</fA08>
<fA08 dir="en">
<s1>von Willebrand factor and pulmonary vascular endothelial cell dysfunction. Prognostic implications</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Augusto B. Lopes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nair Yukie Maeda</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sérgio Paulo Bydlowski</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Fundação Pró-Sangue Hemocentro de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>141-145</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar alterações quantitativas e estruturais do fator von Willebrand (fvW) circulante em 40 pacientes com hipertensão pulmonar pré-capilar e verificar possíveis implicações prognósticas dos resultados iniciais, em um ano de seguimento. MÉTODOS: A atividade antigênica plasmática do fator von Willebrand (vWF:Ag) foi analisada por imunoeletroforese. A concentração de multímeros de baixo peso molecular em relação ao total de multímeros do fvW (MBPM%) e o grau de fragmentação de sua subunidade principal foram analisados por Western immunoblotting. RESULTADOS: Em 40 pacientes, observamos aumento significativo de vWF:Ag em relação aos controles (p&lt;0,001). Também foi observado aumento de MBPM% (p&lt;0,001), além de degradação patológica da subunidade do fvW (p&lt;0,05). Em 11 pacientes que evoluíram para óbito no 1º ano, os valores iniciais de vWF:Ag foram 95% superiores em relação aos sobreviventes (p&lt;0,001). Os não sobreviventes tiveram ainda 31% de aumento em MBPM% (p&lt;0,005). A variável MBPM% foi selecionada por regressão logística (p&lt;0,05), como preditor de óbito no primeiro ano de evolução. CONCLUSÃO: As alterações do fvW circulante, consideradas como índices de lesão endotelial, têm valor prognóstico em hipertensão arterial pulmonar, com potencial impacto em decisões terapêuticas, como a indicação de transplante cardiopulmonar.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To analyze quantitative and structural changes in circulating von Willebrand factor (vWF) in 40 precapillary pulmonary hypertensive patients, as an attempt to identify possible correlations between endothelial cell dysfunction and patient short-term (one year) survival. METHODS: Plasma antigenic activity of vWF (vWF:Ag) was analyzed by immunoelectrophoresis. The relative concentration of vWF low molecular weight multimers (LMWM%) and the composition of vWF subunit were determined by densitometric analysis of Western blots. RESULTS: vWF:Ag was importantly increased in patients in comparison with normals (p&lt;0.001). Patients also had increased LMWM% (p&lt;0.001) and increased degradation of vWF main subunit (p&lt;0.05). At the beginning of the study, nonsurvivors (N=11) had higher vWF:Ag (p&lt;0.001) and LMWM% (p&lt;0.005) values in comparison with survivors. LMWM% was selected by logistic regression analysis as a predictor of death during the first year of follow-up (p&lt;0.05). CONCLUSION: Marked changes in circulating vWF likely reflect extensive pulmonary vascular endothelial cell dysfunction and are associated with poor short-term prognosis in pulmonary hypertension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fator von Willebrand</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão pulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>célula endotelial</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>von Willebrand factor</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endothelial cell</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Experiência inicial no fechamento percutâneo da comunicação interatrial com a prótese de Amplatzer</s1>
</fA08>
<fA08 dir="en">
<s1>Initial experience in percutaneous occlusion of atrial septal defects with the Amplatzer device</s1>
</fA08>
<fA11 dir="011000">
<s1>Valmir F. Fontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos A. C. Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Simone R. F. Fontes Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>César A. Esteves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sérgio L. N. Braga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Jorge E. Assef</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Sérgio C. Pontes Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Maria Virgínia T. Santana</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Ziyad M. Hijazi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>J. Eduardo M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>147-153</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar a experiência inicial no fechamento percutâneo da comunicação interatrial ostium secundum (CIA OS) com a prótese de Amplatzer. MÉTODOS: Sete pacientes foram submetidos ao procedimento através da via venosa anterógrada, orientados pela ecocardiografia transesofágica (ETE) e sob anestesia geral. Uma criança era portadora de 2 CIA e de canal arterial (CA). As CIA medidas pelo ETE variaram de 8,7 a 20mm. Um ecocardiograma transtorácico foi realizado na manhã seguinte do procedimento. RESULTADOS: Oito próteses foram implantadas nos 7 pacientes com sucesso. Em um paciente, o CA foi ocluído na mesma sessão com mola de Gianturco, tendo surgido taquicardia supraventricular durante a oclusão de uma das CIA, controlada com adenosina. Todos receberam alta hospitalar na manhã seguinte, com oclusão total dos defeitos. CONCLUSÃO: O procedimento mostrou-se seguro, eficaz e versátil, podendo ser considerado como uma alternativa terapêutica inicial em pacientes selecionados com CIA OS.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate our initial experience with percutaneous closure of secundum type atrial septal defects (ASD) with the Amplatzer septal occluder. METHODS: Seven patients underwent occlusion by anterograde approach, under general anesthesia and transesophageal echocardiography (TEE) guidance. One child had 2 ASD and a patent ductus arteriosus (PDA). The ASD size ranged from 8,7 to 20mm as measured by TEE. A transthoracic echocardiogram was performed in the morning after the procedure. RESULTS: Eight devices were successfully implanted in 7 patients and the PDA was occluded with a Gianturco coil at the same session. In this patient, there was an episode of supraventricular tachycardia during the occlusion of one ASD which was reverted with adenosin. All patients were discharged the day after, with complete occlusion of all defects. CONCLUSION: The procedure is safe, effective and versatile. It can be applied as an initial alternative to the treatment of selected patients with ASD.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>comunicação interatrial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tratamento percutâneo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prótese de Amplatzer</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial septal defects</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous treatment</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Amplatzer device</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Terapia combinada de colestiramina e inibidores da HMG-CoA redutase na prevenção secundária da doença coronária</s1>
</fA08>
<fA08 dir="en">
<s1>Combined therapy with cholestyramine and HMG-CoA reductase inihibtors in secondary prevention of coronary disease</s1>
</fA08>
<fA11 dir="011000">
<s1>José Paulo Novazzi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leonor do Espírito Santo de Almeida Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Caio Auriemo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Tania Leme da Rocha Martinez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina Hospital São Paulo</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>155-158</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar as alterações obtidas no perfil lipídico de coronariopatas dislipidêmicos, após a adição de colestiramina, em pacientes tratados com inibidores da HMG-CoA redutase, e que não atingiram os valores ideais de LDL-colesterol. MÉTODOS: Vinte coronariopatas (12 submetidos à revascularização do miocárdio, 3 à angioplastia coronária e 5 mantidos sob tratamento clínico), com média de idade de 60,78 anos, que já realizavam dieta hipolipemiante e eram medicados com lovastatina 20mg/dia ou sinvastatina 10mg/dia, receberam também colestiramina na dose de 8 a 16g/dia durante 8 semanas, com o objetivo de reduzir LDL-colesterol para valores inferiores a 100mg/dl. RESULTADOS: Houve significante redução do colesterol total (valor médio inicial 239,52mg/dL e ao final 199,00mg/dL), obtendo-se um decréscimo percentual médio de 16,92%. O valor médio de LDL-colesterol também se reduziu, significantemente, de 172,73mg/dL para 118,26mg/dL, com decréscimo percentual médio de 31,53%. A trigliceridemia média aumentou, ainda dentro da faixa de referência normal, de 145,05mg/dL para 162,00mg/dL, (diferença percentual média de 11,69%). Houve significante aumento da fração HDL-colesterol de um valor médio inicial de 38,00mg/dL para um valor médio final de 48,21mg/dL (diferença média percentual 26,87%). Não houve efeitos adversos que impedissem a continuidade do tratamento. CONCLUSÃO: A associação de colestiramina a doses baixas de vastatinas em pacientes com hipercolesterolemia primária e de alto risco coronário é uma boa opção terapêutica, podendo atingir benefícios sobre o perfil lipídico semelhantes àqueles obtidos quando esses fármacos são utilizados, isoladamente, ou em associação, e em doses mais elevadas.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate lipid profile changes associated with cholestyramine addition in hypercholesterolemic patients with established coronary heart disease under treatment with HMG-CoA reductase inihibtors that had not achieved the ideal value of LDL-cholesterol. METHODS: Twenty patients with coronary heart disease, (12 submitted to coronary artery bypass grafts, 3 to coronary angioplasty and 5 maintened under clinical management) with mean age of 60.78 years old, who were under hypolipemic diet and were medicated with lovastatin 20mg/d or simvastatin 10mg/d, received cholestyramine, doses ranging from 8 to 16g/day during 8 weeks, aiming to reduce LDL-cholesterol to values less than 100mg/dL. RESULTS: There was a significant reduction of total cholesterol, from initial mean value of 239.52mg/dL to final mean value of 199.00mg/dL, with a mean reduction of 16.92%. The mean value of LDL-cholesterol was also reduced significantly from 172.73mg/dL to 118.26mg/dL, with a mean reduction of 31.53%. Mean triglyceridemia increased, still within the normal reference values, from 145.05mg/dL to 162.00mg/dL, and the mean difference was 11.69%. There was a significant increase of HDL-cholesterol fraction from an initial mean value of 38.00mg/dL to a final mean value of 48.21mg/dL, mean difference of 26.87%. Side effects were not frequent, and did not interfere in the duration of the study. CONCLUSION: The association of cholestyramine to HMG-CoA reductase inihibtors, both in low doses, in patients with primary hypercholesterolemia and high coronary risk is a good therapeutic option that can reach benefits on the lipid profile similar to those obtained when these drugs are used in association or separately in higher doses.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>colestiramina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>inibidores da HMG-CoA redutase</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prevenção secundária</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cholestyramine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>HMG-CoA reductase inihibtors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>secondary prevention</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Comparação entre a prescrição de intensidade de treinamento físico baseada na avaliação ergométrica convencional e na ergoespirométrica</s1>
</fA08>
<fA08 dir="en">
<s1>Comparison between exercise intensity prescription based on a standard exercise test and cardiopulmonary exercise test</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Urbana Pinto Brandão Rondon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cláudia Lúcia de Moraes Forjaz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Newton Nunes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sandra Lia do Amaral</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Carlos Eduardo Negrão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>159-166</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar os limites inferiores (L.inf.) e superiores (L.sup.) da prescrição de treinamento físico aeróbio determinada pelo teste ergométrico convencional (60-70% do VO2máx estimado ou 70-85% da FCmáx atingida), com a prescrição obtida pelo teste ergoespirométrico [limiar anaeróbio (LA) e ponto de compensação respiratória (PCR)]. MÉTODOS: Realizaram teste ergoespirométrico progressivo até a exaustão 47 homens (30±5 anos), divididos em subgrupos, de acordo com a velocidade da esteira durante o teste (4 ou 5mph) e a capacidade física medida [baixa (BCF) e moderada (MCF)]. RESULTADOS: Os L.inf. de prescrição indireta apresentaram valores de VO2 e FC significantemente maiores que os valores de VO2 e FC no LA (4mph= 34,4±4,5 vs 19,6±4,6 e 5mph= 28,9±2 vs 18,9±5,4, e BCF= 32,0±4,1 vs 17,2±2,8 e MCF= 31,6±4,9 vs 21,1±5,7(mlO2.kg-1.min-1) e (4mph = 128,9±7,8 vs 113,1± 15,6 e 5mph= 130,3±5,2 vs 114,1± 18,9, e BCF= 127,6±7,2 vs 109,3±13,2 e MCF= 131,2± 5,7 vs 117,4± 19,2bpm). Os L.sup. de prescrição indireta no grupo de 4mph e BCF apresentaram valores de VO2 significantemente maiores que os valores medidos no PCR (40,1±5,3 vs 32,2±4,3 e 37,4±4,8 vs 30,6±2,5 mlO2.kg-1.min-1, respectivamente), e valores de FC semelhantes aos medidos no PCR. CONCLUSÃO: Os L.inf. da prescrição indireta de treinamento físico superestimam o LA, enquanto os L.sup. parecem adequados somente para indivíduos ativos com MCF.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To compare the lower (LL) and upper limits (UL) of exercise intensity prescription based on standard exercise test (60-70% of estimated VO2max or 70-85% of HRmax measured) with exercise intensity prescription based on cardiopulmonary exercise test [anaerobic threshold (AT) and respiratory compensation point (RCP)]. METHODS: Fourty seven men (30±5 years) who were submitted to a progressive cardiopulmonary exercise test until exhaustion were divided in subgroups according to treadmill speed during exercise test (4 or 5mph) and the physical capacity [lower (LPC) and moderate physical capacity (MPC)]. RESULTS: The LL of the indirect exercise intensity prescription showed VO2 and HR values significantly higher than VO2 and HR values measured at AT (4mph= 34.4±4.5 vs 19.6±4.6 and 5mph= 28.9±2 vs 18.9±5.4, and LPC= 32.0±4.1 vs 17.2±2.8 and MPC= 31.6±4.9 vs 21.1± 5.7mlO2.kg-1.min-1 ) and (4mph= 128.9±7.8 vs 113.1±15.6 and 5mph= 130.3±5.2 vs 114.1±18.9, and LPC= 127.6±7.2 vs 109.3±13.2 and MPC= 131.2±5.7 vs 117.4±19.2bpm) The UL of the indirect exercise intensity prescription in 4mph and LPC group showed VO2 values significantly higher than those measured at RCP (40.1±5.3 vs 32.2±4.3 and 37.4±4.8 vs 30.6±2.5mlO2.kg-1.min-1, respectively), but similar HR values to those obtained at RCP. CONCLUSION: The LL of prescription based on standard exercise test overestimate the AT, whereas the UL seem adequate only for subjects with moderate physical capacity.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prescrição de exercício</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>freqüência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>consumo de oxigênio máximo</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise prescription</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart rate</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>maximal oxygen uptake</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Evolução intra-hospitalar e seguimento pós-alta de pacientes idosos atendidos com insuficiência cardíaca congestiva na unidade de emergência</s1>
</fA08>
<fA08 dir="en">
<s1>Hospital outcome and short-term follow-up of predominatly elderly patients presenting to the emergency department with congestive heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Humberto Villacorta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nazareth Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rosana Cardoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sérgio Gaspar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eduardo Reis Maia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Therezil Bonates</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Daniel Kopiler</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Hans J. F. Dohmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>167-171</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Conhecer a evolução intra-hospitalar (IH) e pós-alta (PA) de uma população predominantemente idosa, com insuficiência cardíaca congestiva (ICC) na unidade de emergência (UE). MÉTODOS: Durante 11 meses, foram selecionados 57 pacientes consecutivos com ICC, atendidos em EU, com idade média de 69+15 (27 a 94) anos, sendo 39 (68,4%) homens. O diagnóstico de ICC baseou-se nos critérios de Boston. Avaliou-se a evolução IH e PA num período médio de 5,7+2,7 (1 a 12) meses, procurando-se identificar variáveis que se correlacionassem com a mortalidade e o mecanismo de morte, avaliado pelo sistema ACME . RESULTADOS: Oito (14%) pacientes faleceram na fase IH, sendo 7 por falência circulatória (FC), e 1 em pós-operatório (PO). Durante o seguimento ocorreram 9 (18,4%) óbitos, sendo 5 por FC, 2 mortes súbitas e 2 em PO (troca valvar mitral e ventriculectomia). A sobrevida dos pacientes que tiveram alta foi de 82% e 66%, aos 6 meses e 1 ano, respectivamente. Sódio sérico &lt;135mEq/l (p= 0,004) e sexo feminino (p= 0,038) foram preditores independentes de mortalidade. CONCLUSÃO: Pacientes idosos com ICC atendidos em UE apresentam mortalidade IH e PA elevadas e alta taxa de reinternação hospitalar. A maioria morre por falência circulatória decorrente da progressão da ICC.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the in-hospital (IH) outcome and the short-term follow-up of predominantly elderly patients presenting to an emergency room (ER) with congestive heart failure (CHF). METHODS: In an 11 month period, 57 patients presenting to the ER with CHF were included. Mean age was 69+15 years (27 to 94) and 39 (68,4%) were male. CHF diagnosis was based on the Boston criteria. We evaluated IH outcome and prognosis in a mean follow-up of 5,7+2,7 months (1 to 12). In addition, some mortality predictors and mechanisms of death according on the ACME system were identified. RESULTS: Eight patients (14%) died in the IH period. Modes of death were circulatory failure (CF) in 7, and peri-operative (PO) in one (aortic valve replacement). During follow-up 9 deaths ocurred. Five were due to CF, 2 were sudden and 2 were PO (mitral valve replacement and ventriculectomy). Six-months and 1-year survival rates of the patients who were discharged were 82% and 66%, respectively. Sodium lower than 135mEq/l (p= 0.004) and female gender (p= 0.038) were independent predictors of mortality. CONCLUSION: Elderly patients with CHF admitted to the ER have high in-hospital and short-term follow up mortalities. The majority die from CF due to worsening heart failure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca congestiva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>unidade de emergência</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prognóstico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congestive heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>emergency department</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Modificação do nódulo sinusal via cateter por energia de radiofreqüência em paciente com taquicardia sinusal inapropriada. Avaliação dos resultados imediatos e tardios</s1>
</fA08>
<fA08 dir="en">
<s1>Sinus node modification by catheter using radiofrequency current in a patient with inappropriate sinus tachycardia. Evaluation of early and late results</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando E. S. Cruz Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ivan G. Maia</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcio L. A. Fagundes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Silvia Boghossian</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Carlos Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>173-176</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>São apresentados os resultados imediatos e tardios, observados com a modificação do nódulo sinusal via cateter, usando-se energia de radiofreqüência, em portadora de taquicardia sinusal inapropriada. O procedimento normalizou os níveis de freqüência cardíaca nas 24h seguintes e após seis meses, mostrando-se, portanto, efetivo e seguro. Apesar da redução da freqüência cardíaca a níveis normais, houve manutenção dos sintomas apresentados pela paciente, sugerindo que não são decorridos, exclusivamente, do processo taquicárdico.</s0>
</fC01>
<fC01 dir="en">
<s0>This article reports the early and late results of a patient in whom radiofrequency current was used to ablate an incessant inappropriate sinus tachycardia. During successful radiofrequency application there was a sudden change of rate and subsequent emergence of a stable rhythm with the same sinus node P wave characteristics. During follow-up, normal cardiac cycles were still present after six months of the procedure, although the patient still complained of palpitations, suggesting no correlation with the heart rate.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Implante de stent dentro de stent recém-implantado em ponte de veia safena para otimização do resultado angiográfico</s1>
</fA08>
<fA08 dir="en">
<s1>Stenting a stent in saphenous vein graft to optimize the angiographic result</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Esteves Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Celso Kiyochi Takimura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Evandro Costa Lira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Junya Kajita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Siguemituzo Arie</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Giovanni Bellotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Fulvio Pileggi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>177-179</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Mulher de 60 anos, com angina progressiva e revascularização do miocárdio, há oito anos, com ponte de veia safena para coronária direita e anastomose de artéria mamaria esquerda para artéria descendente anterior. Submetida a implante de stent Gianturco-Roubin II em terço proximal da ponte de veia safena para artéria coronária direita, com resultado insatisfatório pela persistência de lesão residual, provavelmente, decorrente de prolapso para dentro da luz de material aterosclerótico através dos coils. Foi implantado outro stent (Palmaz-Schatz biliar) dentro do stent GRII com sucesso e ótimo resultado angiográfico. Um 2º stent Palmaz-Schatz biliar foi implantado em lesão distal no corpo da ponte, ultrapassando os dois stents, anteriormente implantados, com sucesso. Em algumas situações, implante de stent dentro de outro stent é recurso útil para otimização de resultado angiográfico do implante de um stent.</s0>
</fC01>
<fC01 dir="en">
<s0>A 60 year-old woman with progressive angina who had been submitted to saphenous bypass-graft to right coronary artery and a left mammary artery graft to anterior descending artery eight years previously, underwent implantation of a Gianturco Roubin II stent in the proximal third of the saphenous vein graft. The result was suboptimal by persistence of a residual stenosis probably due to prolapse of atherosclerotic material through the coil spaces. Another stent (Palmaz-Schatz biliar stent) was implanted at the previously stented site with no residual stenosis. Another Palmaz-Schatz biliar stent was successfully implanted in the distal body of the graft to treat another lesion (passing through the previously stents without difficulty). Stenting a stent, in selected situations, is a useful tool to optimize the angiographic result of stent implantation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>O vínculo droga valvopatia</s1>
</fA08>
<fA11 dir="011000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alfredo Halpern</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Eduardo Giusti Rossi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cláudia Cozer Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>João Cesar Nunes Sbano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>181-183</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Riscos e benefícios da biópsia endomiocárdica de ventrículo direito</s1>
</fA08>
<fA11 dir="011000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>185-186</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Registradores de eventos. Uma alternativa para esclarecimento de sintomas de provável origem cardíaca</s1>
</fA08>
<fA11 dir="011000">
<s1>Leandro Ioschpe Zimerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Claudio Meirelles Medeiros</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Jorge Pinto Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>187-191</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>42</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000310</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Disfunção parassimpática, variabilidade da freqüência cardíaca e estimulação colinérgica após infarto agudo do miocárdico</s1>
</fA08>
<fA11 dir="011000">
<s1>Amália Faria dos Reis</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Bianca Gouvêa Bastos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz José Martins Romêo Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Claudio Lucas da Nóbrega</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>193-199</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>88</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000311</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Resumos dos Temas Livres apresentados no XIV Congresso Brasileiro de Arritmias Cardíacas do DAEC, IV Simpósio da Solaece e I Simpósio de Eletrocardiografia Não Invasiva</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>201-235</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000312</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação do perfil arritmogênico ventricular de pacientes com miocardiopatia dilatada e fração de ejeção diminuída</s1>
</fA08>
<fA08 dir="en">
<s1>Evaluation of the arrhythmogenic profile of patients with dilated cardiomyopathy and reduced ejection fraction</s1>
</fA08>
<fA11 dir="011000">
<s1>Ivan G. Maia</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cantidio Drumond Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcelo Montera</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Lilian Soares da Costa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo A. G. Alves</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>237-241</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o perfil arritmogênico ventricular de pacientes com miocardiopatia dilatada e fração de ejeção diminuída. MÉTODOS: Estudo prospectivo em 40 pacientes com fração de ejeção média ao ecocardiograma de 32,5±2,1%, obtida pela análise do Holter de 24h, do balanço autonômico cardíaco, determinado por índices de variabilidade da freqüência cardíaca (rMSSD e pNN50), do eletrocardiograma (ECG) de alta resolução (ECGAR) e do grau de dispersão da repolarização ventricular determinado no ECG de superfície. Por regressão logística determinaram-se, a partir dos resultados, os preditores de risco para morte cardíaca e morte súbita. RESULTADOS: Observou-se na população envolvida uma elevada incidência de ectopias ventriculares isoladas, pareadas e de surtos não sustentados de taquicardia ventricular. Pela análise do balanço autonômico notou-se depressão da atividade vagal cardíaca em mais da metade dos pacientes, sendo que apenas 30% apresentaram ECGAR positivo. O grau de dispersão temporal da repolarização ventricular variou de 20 a 100ms. A presença de &gt;30 extra-sístoles isoladas por hora e de taquicardia ventricular não sustentada ao Holter foram os preditores de risco com valores mais elevados para a morte cardíaca e morte súbita, com uma razão de risco respectiva de 1,9 e 3,2 (p= 0,01 e 0,000). CONCLUSÃO: Foram observadas importantes alterações no comportamento elétrico e autonômico cardíaco, constituindo-se fatores de risco para a ocorrência de eventos arrítmicos graves ou fatais.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the arrhythmogenic profile of patients with dilated cardiomyopathy of low ejection fraction and its prognostic significance. METHODS: Data from 40 patients (30 males; mean age: 52±13 years) were analysed including ventricular arrhythmias (24h - Holter monitoring), autonomic balance from heart rate variability in time domain (rMSSD and pNN50 indexes), ventricular late potentials (signal averaged electrocardiogram (ECG)) and dispersion of ventricular repolarization measured from 12-lead ECG. RESULTS: There was a high prevalence of ventricular arrhythmias with at least one episode of nonsustained ventricular tachycardia (VT) in 60% of the patients. Depressed vagal activity was observed in more than half of the patients. In only 30% of the patients the signal-averaged ECG was positive. The dispersion of ventricular repolarization ranged from 20 to 100ms. The presence of &gt;30 ventricular premature beats or nonsustained VT on Holter monitoring was the most significant predictor of cardiac death and sudden cardiac death with a relative risk of 1.9 and 3.2, respectively (p= 0.01 and 0.000). CONCLUSION: In this study population it was noted that patients with dilated cardiomyopathy and low ejection fraction had an abnormal electrical and autonomic cardiac behaviour. These findings could represent risk factors for the ocurrence of life-threatening arrhythmias or fatal events.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>miocardiopatia dilatada</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>perfil arritmogênico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dilated cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arrhythmogenic profile</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Monitorização ambulatorial da pressão arterial em indivíduos com resposta exagerada dos níveis pressóricos em esforço. Influência do condicionamento físico</s1>
</fA08>
<fA08 dir="en">
<s1>Ambulatory blood pressure monitoring in individuals with exaggerated blood pressure response to exercise, influence of exercise training</s1>
</fA08>
<fA11 dir="011000">
<s1>Eliudem Galvão Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernando Herkenhoff</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Elisardo Corral Vasquez</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>243-249</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>55</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar em indivíduos hiper-reatores ao teste ergométrico (TE), a influência de um programa regular de exercícios sobre os parâmetros ergométricos e da MAPA. MÉTODOS: Estudaram-se 22 indivíduos (44±1 anos), sedentários, assintomáticos, normotensos e que apresentavam elevação exagerada da pressão sistólica (PAS &gt;220mmHg) durante o TE, divididos, através de amostragem casual simples, em dois grupos: grupo hiper-reator sedentário (GHS) e grupo hiper-reator condicionado (GHC). Os indivíduos do GHS foram orientados a não realizar qualquer tipo de exercício físico regular durante o período de 4 meses e o GHC composto de 10 indivíduos submetidos a programa de condicionamento físico aeróbico durante o mesmo período. RESULTADOS: Um programa de exercícios aeróbicos de moderada intensidade não promove redução significativa dos níveis pressóricos durante a monitorização (P&gt;0,05); mas, durante a realização do TE nesses indivíduos, verificamos redução (p&lt;0,05) dos níveis sistólicos e da freqüência cardíaca em cargas submáximas de trabalho. CONCLUSÃO: Um programa de condicionamento aeróbico em hiper-reatores não apresentou alterações significantes nos valores de PA de 24h e nos sub-períodos; entretanto, durante o TE, observamos redução da atividade inotrópica e cronotrópica em cargas sub-máximas de trabalho, sugerindo o envolvimento do sistema nervoso simpático nas respostas pressóricas exageradas observadas nesses indivíduos durante o exercício dinâmico, e uma redução correspondente do tônus simpático após o treinamento. Este efeito, aparentemente, não se estendeu às suas atividades diárias.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the effects of exercise training on ergometric test and Ambulatory Blood Pressure Monitoring (ABPM) in normotensive individuals with exaggerated blood pressure response to exercise. METHODS: We studied 22 sedentary and normotensive subjects (mean 44±1 years old) showing an exaggerated systolic blood pressure response (SBP&gt;220mmHg) during a cycloergometric test. These individuals were divided in two groups: sedentary hyperreactive group (SHG) and trained hyperreactive group (THG). The THG was submitted to a 4 month aerobic exercise training program. RESULTS: A program of moderate aerobic exercise did not reduce (P&gt;0.05) ABPM blood pressure levels. However, in the submaximal loads of dynamic exercise we observed a significant fall in the SBP and heart rate (P&lt;0.05). CONCLUSION: Normotensive individuals with exaggerated blood pressure response to dynamical exercise submitted to physical training presented a reduction in their systolic blood pressure and heart rate response during the submaximal loads of the cycloergometric test. The ABPM blood pressure values, however, did not change in both groups. These results suggest the involvement of the sympathetic nervous system in the exaggerated blood pressure response observed in these individuals during dynamic exercise and a corresponding reduction of the sympathetic tonus after training. This effect, apparently, did not extend to their daily activities.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste ergométrico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão reativa</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>MAPA</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ABPM</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hyperreactive response</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ergometric test</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Prognóstico da estenose valvar aórtica assintomática pelo teste de esforço</s1>
</fA08>
<fA08 dir="en">
<s1>The value of exercise test in the prognosis of asymptomatic patients with significant aortic valve stenosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Marisa Campos Moraes Amato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Jorge Moffa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>251-255</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>42</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o teste de esforço (TE) como fator preditivo do prognóstico do paciente assintomático com estenose valvar aórtica. MÉTODOS: Foram acompanhados, por 60 meses, 70 pacientes com área valvar &lt;1cm², sem outra lesão cardíaca, e estudados pelo ecocardiograma Doppler, TE (considerado positivo por alterações eletrocardiográficas ou pela presença de sintomas) e acompanhamento clinico, a fim de ser constatada a morte súbita ou o aparecimento de sintomas. RESULTADOS: A probabilidade de sobrevida livre de eventos em 16 meses foi de 50%. Não houve associação, estatisticamente significativa de eventos, com sexo nem com gradiente transvalvar, mas sim, com a idade &lt; e &gt;50 anos (p=0,0124), com a área valvar &lt; e &gt;0,7cm² (p=0,0003) e com a resposta positiva ou negativa do TE (p=0,0001). CONCLUSÃO: Pacientes assintomáticos com estenose importante apresentam baixa sobrevida livre de eventos e o TE é um bom fator preditivo de seu prognóstico.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the exercise test as a prognostic factor for asymptomatic patients with aortic valve stenosis. METHODS: During 60 months 70 patients with aortic valve area &lt;1cm² without any other heart lesion were studied. The patients underwent Dopplerechocardiograms exercise tests (considered positive in the presence of electrocardiographic changes or symptoms) and clinical follow-up in order to determine the onset of symptoms or sudden death. RESULTS: The event-free probability was 50% after 16 months of follow-up. There was no relationship between the occurence of events and the sex or to the transvalvar gradient. However, there was a statistically significant association between the incidence of events (p= 0.0124), valvar area (p= 0.0003) and exercise test results (p= 0.0001). CONCLUSION: Patients with significant aortic stenosis even without symptoms, have a low survival rate and the exercise test is a good prognostic factor during follow-up.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose valvar aórtica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste de esforço</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia Doppler</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic valve stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ergometric test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Doppler echocardiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Hemograma, sódio, potássio, cálcio, osmolalidade e viscosidade durante angiocardiografia pediátrica com ioxaglato</s1>
</fA08>
<fA08 dir="en">
<s1>Blood cell count, sodium, potassium, calcium, osmolality and viscosity, during pediatric angiocardiography with ioxaglate</s1>
</fA08>
<fA11 dir="011000">
<s1>Mauro Regis Silva Moura</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Flávio Leboute</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Antonio Mascia Gottschall</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>257-264</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Os meios de contraste (MC) introduzem alterações em alguns parâmetros sangüíneos, adquirindo, assim, mais importância na angiocardiografia pediátrica. MÉTODOS: Estudamos a presença e a severidade das mudanças no hematócrito, hemoglobina, leucócitos, sódio, potássio, cálcio, osmolalidade e viscosidade, em 35 crianças submetidas a angiocardiografia com ioxaglato, identificando, também, as variáveis independentes responsáveis por essas alterações. As amostras sangüíneas foram colhidas no início do procedimento (S1), no fim (S2) e 2h após (S3). RESULTADOS: Hematócrito: S1= 47,3±6,9%; S2= 40,7±7,4% (p&lt;0,001) (relacionado com o ioxaglato r=0,37, p&lt;0,05). Hemoglobina: S1= 15±2,1g%; S2= 13,2±2,4g% (p&lt;0,001). Leucócitos: S1= 7940±3040 leucócitos/mm³; S2= 6950± 2700/mm³ (NS); S3= 10830± 4690, (p&lt;0,001). Identificamos a duração do procedimento (r=0,38, p&lt;0,05) e o volume total de soro glicosado (r=0,49, p&lt;0,05). Sódio: S1= 134,5±0,4mEq/L; S2= 130,7±0,4mEq/L (p&lt;0,001) relacionado à solução glicosada (r=0,61, p&lt;0,01). Potássio: S1= 4,22± 0,45mEq/L; S2= 3,83±0,4mEq/L (p&lt;0,001). Nenhuma variável foi isolada. Cálcio; S1= 9,13±1,03mg%; S2= 8,4±0,91mg% (relacionado ao ioxaglato r=0,43, p&lt;0,01). Osmolalidade: S1= 293,3±12,5mOsm/kg; S2= 300,6±13,3mOsm/kg (p&lt;0,001). Nenhuma das variáveis independentes foi isolada. Viscosidade: S1= 3,36±0,81; S2= 3,09±0,74 (p&lt;0,01); S3= 3,87±0,89, p&lt;0,001 (devido a uma regressão linear indireta com o MC). CONCLUSÃO: Variações significativas nas variáveis dependentes medidas foram observadas durante e após o procedimento. O uso do ioxaglato foi parcialmente relacionado a mudanças no hematócrito/hemoglobina, cálcio total e viscosidade mas não as das variáveis restantes.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: Children's blood changes during angiocardiography may not be only due to the contrast media (CM). METHODS: We studied the presence and severity of changes in those parameters in 35 pediatric patients undergoing angiocardiography with ioxaglate aiming to identify independent variables responsible for those changes. Blood samples were taken at the beginning of the procedure (S1), at the end (S2) and two hours later (S3). RESULTS: Hematocrit: S1= 47.3±6.9%; S2= 40.7± 7.4% (p&lt;0.001), (related to the CM volume r=0.37, p&lt;0.05). Hemoglobin: S1= 15±2.1g%; S2= 13.2±2.4g% (p&lt;0.001), and S3= 12.7±2.5g% (NS). White blood cell count: S1= 7940±3040 leukocytes/mm³; S2= 6950± 2700/mm³ (NS); S3= 10830±4690 leukocytes/mm³, (p&lt;0.001). Procedure duration (r=0.38, p&lt;0.05) and 5% glucose fluid given between S2 and S3 (r=0.49, p&lt;0.05) were isolated. Sodium: S1= 134.5±0.4mEq/L; S2= 130.7±0.4mEq/L (p&lt;0.001) (due to 5% glucose fluid injected, r=0.61, p&lt;0.01). Potassium: S1= 4.22±0.45mEq/L, S2= 3.83±0.4mEq/L (p&lt;0.001). Calcium: S1= 9.13± 1.03mg%; S2= 8.4±0.91mg/dL. (related to the CM, r=0.43, p&lt;0.01.) Osmolality: S1= 293.3±12.5mOsm/kg; S2= 300.6±13.3mOsm/kg (p&lt;0.001). Viscosity: S1= 3.36±0.81; S2= 3.09±0.74 (p&lt;0.01); S3= 3.87±0.89, p&lt;0.001. There was an indirect linear regression with the CM. CONCLUSION: There were profound differences among the dependent variables observed but the ioxaglate was partially related to changes in hematocrit/ hemoglobin, total calcium and viscosity. We failed to demonstrate significant regression coefficient between CM and changes in leukocytes, sodium, potassium, and osmolality.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>meios de contraste</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angiocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiologia pediátrica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>contrast media</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angiocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart catheterization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pediatric cardiology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeito da cirurgia de revascularização miocárdica sobre os episódios isquêmicos assintomáticos</s1>
</fA08>
<fA08 dir="en">
<s1>Effect of coronary artery bypass graft surgery on ischemic asymptomatic episodes</s1>
</fA08>
<fA11 dir="011000">
<s1>Humberto Pierri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mauricio Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>João Batista Serro-Azul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ligia Pivotto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Amit Nusbacher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Otavio Gebara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luiz Gastão Serro-Azul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>José Antonio F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>265-269</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>46</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o efeito da cirurgia de revascularização miocárdica (CRM) sobre episódios isquêmicos assintomáticos (EIA). MÉTODOS: Foram estudados 28 homens, com angina estável (idade média 57,3±9,6) anos sem condições relacionadas a alterações de microcirculação e que, após retirada da medicação, apresentaram EIA à eletrocardiografia ambulatorial (ECGA). No pré-operatório e 4 meses após a cirurgia foram analisados os comportamentos dos EIA, segundo sua freqüência, e o de suas freqüências cardíacas (FC). A revascularização miocárdica foi completa em 75% dos casos. RESULTADOS: O número dos EIA foi reduzido de 162 (9 sintomáticos) no pré-operatório para, apenas, 4 no pós-operatório (p&lt;0,05). Nos dois pacientes com EIA no operatório, estudo cinecoronariográfico confirmou obstrução de enxertos aortocoronários. A análise das FC no início e pico dos EIA sugeriram envolvimento de mecanismo de redução de oferta e aumento de consumo de oxigênio pelo miocárdio. CONCLUSÃO: A CRM eliminou os episódios isquêmicos relacionados ou não ao aumento da FC. Quando os EIA encontram-se presentes após CRM, devemos considerar a possibilidade de oclusão de enxerto.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the effect of coronary artery bypass graft surgery (CABG) on ischemic asymptomatic episodes (IAE). METHODS: Twenty eight males (mean age 57.3±9.6 years) with stable angina and no microcirculation abnormalities, who presented with IAE after medication withdrawal, were studied using ambulatory electrocardiography monitoring. Presence of IEA was analyzed before and 4 months after CABG according to its frequency and heart rate (HR) response. CAGB was considered complete in 75% of the cases. RESULTS: The number of IAE was reduced from 162 (9 symptomatic) in the preoperative period to 4 after surgery (p&lt;0.05). In two patients with IAE in the postoperative period, coronariography confirmed obstruction of aortocoronary grafts. Analysis of HR at the beginning and peak of IAE suggested as mechanisms both reduced blood flow and increased oxygen consumption by the myocardium. CONCLUSION: CABC eliminated IAE regardless of HR. When IAE is present after surgery, graft occlusion should be suspected.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia de revascularização</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>episódios isquêmicos assintomáticos</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery bypass graft surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemic asymptomatic episodes</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Intervenção sobre tabagismo realizada por cardiologista em rotina ambulatorial</s1>
</fA08>
<fA08 dir="en">
<s1>Anti-smoking intervention performed by cardiologist during ambulatory care</s1>
</fA08>
<fA11 dir="011000">
<s1>Jaqueline Scholz Issa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Neusa Forti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sergio D. Giannini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jayme Diament</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>271-274</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a efetividade da intervenção sobre o tabagismo, realizada por médico cardiologista em rotina de ambulatório, utilizando a prescrição de adesivos de nicotina. MÉTODOS: Foram avaliados, consecutivamente, 100 pacientes (50 homens e 50 mulheres), incluindo consulta médica, aplicação de escore para definição do grau de dependência à nicotina, determinação da concentração de monóxido de carbono expirado e peso corpóreo. Os adesivos foram utilizados entre 8 e 12 semanas, com redução progressiva da concentração até a suspensão (concentrações de 21, 14 e 7mg) RESULTADOS: A taxa de abstinência um ano após o início do tratamento foi de 41%, confirmada pela concentração do monóxido de carbono. CONCLUSÃO: A intervenção sobre o tabagismo pode ser realizada em rotina de atendimento cardiológico com resultados satisfatórios. Os adesivos de nicotina são seguros, bem tolerados, e devem ser utilizados, mais freqüentemente, no auxílio aos fumantes, para deixarem de fumar.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: The aim of this study was to evaluate the effectiveness of nicotine patches as a strategy to help patients quit smoking in the cardiovascular clinic. METHODS: The population studied was composed of 100 patients (50 women and 50 men). The strategy included medical consultation, Fangerstron escore application and prescription of nicotine patches. Nicotine patches were continuously used for 8 to 12 weeks, with progressive concentration reduction releasing 21, 14, and 7mg/day. RESULTS: The abstinence rate one year later was 41% confirmed by carbon monoxide exhaled air concentration. CONCLUSION: Nicotine patches are safe, and well tolerated and, for these reasons, should be more frenquently prescribed by cardiologists to help patients quit smoking.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>abordagem tabagismo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prevenção tabagismo</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>smoking cessation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>smoking prevention</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Paraplegia aguda. Uma complicação rara da dissecção aórtica</s1>
</fA08>
<fA08 dir="en">
<s1>Acute paraplegia. A rare complication of aortic dissection</s1>
</fA08>
<fA11 dir="011000">
<s1>Renato Côrtes de Lacerda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Patrícia Bernard Andrea</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Evaristo Machado Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Baptista de Figueiredo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alfredo Brasil Teixeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paulo Cézar Monteiro de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Geral de Bonsucesso  </s1>
<s2>Rio de Janeiro </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>275-278</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Mulher normotensa de 67 anos desenvolveu síncope, seguida de choque, e, mesmo após estabilização hemodinâmica, permaneceu anúrica. Observaram-se paraplegia e paresia do membro superior direito, além de isquemia das extremidades distais dos membros inferiores. A hipótese de dissecção aórtica aguda foi considerada e confirmada através de tomografia computadorizada, tendo sido a paraplegia atribuída a infarto isquêmico da medula espinhal. Óbito ocorreu no 4º dia de evolução, conseqüente a tamponamento pericárdico. São revistas as dificuldades diagnósticas relacionadas a manifestações pouco conhecidas da dissecção aórtica, enfatizando-se, como complicação rara, a paraplegia aguda.</s0>
</fC01>
<fC01 dir="en">
<s0>A 67 year-old normotensive woman had a syncope followed by shock and remained anuric after hemodynamic stabilization. Paraplegia and paresis of the right upper limb, as well as signs of ischemia of the distal lower limbs were noted. The possibility of acute aortic dissection was raised and confirmed by computed tomography. The paraplegia was attributed to an ischemic infarction of the spinal cord. The patient died on the fourth hospital day due to a pericardial tamponade. This rare and not well recognized complication of aortic dissection is briefly reviewed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiomiopatia periparto. Análise crítica da imunossupressão</s1>
</fA08>
<fA08 dir="en">
<s1>Peripartum cardiomyopathy. A critical analysis of immunosupression</s1>
</fA08>
<fA11 dir="011000">
<s1>Heron Rached</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto de Cleva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ronaldo Pinheiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Pedro Gregório Mekhitarian</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ricardo Mazzieri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital da Beneficência Portuguesa  </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>279-281</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>É feita uma revisão da literatura a respeito da cardiomiopatia periparto, descrevendo o caso de paciente do sexo feminino, branca, 31 anos, primípara, que apresentou quadro de falência miocárdica 6h pós-cesárea, com boa resposta após tratamento imunossupressor.</s0>
</fC01>
<fC01 dir="en">
<s0>The authors review the literature about peripartum cardiomyopathy and describe a case of a white woman, 31 years old, primipara, who developed myocardial failure six hours after caesarian operation, with good results after immunossupressive therapy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 2/ 98 - Instituto do Coração do Hospital das Clínicas - FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>283-288</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>6</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Eficácia clínica de bloqueadores cardiosseletivos combinados com doses mínimas de diuréticos como monoterapia em hipertensão arterial</s1>
</fA08>
<fA11 dir="011000">
<s1>Celso Amodeo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>289-290</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>3</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Insuficiência cardíaca diastólica no idoso</s1>
</fA08>
<fA11 dir="011000">
<s1>Eurico Thomaz de Carvalho Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Romeu Rodrigues de Souza</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Luiz Figueira</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>291-299</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>81</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Miocardiopatia hipertrófica. Papel da ecocardiografia doppler no diagnóstico e na orientação terapêutica</s1>
</fA08>
<fA11 dir="011000">
<s1>Airton José Hoss</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Henrique Purper Petterson</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Leonora Scherer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Centro de Diagnóstico Cardiovascular  </s1>
<s2>Santa Cruz do Sul RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>301-306</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>52</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000412</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="">
<s1></s1>
</fA08>
<fA11 dir="011000">
<s1>José Carlos Pachón Mateos</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>307-307</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000413</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Contribuição do monitor de eventos no diagnóstico de sintomas</s1>
</fA08>
<fA08 dir="en">
<s1>The contribution of the loop memory ECG recorder to the diagnosis of symptoms</s1>
</fA08>
<fA11 dir="011000">
<s1>Cesar J. Grupi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Silvio A. Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Célia R. Sampaio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo J. Moffa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>309-314</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o poder de contribuição do monitor de eventos sintomáticos no esclarecimento de sintomas. MÉTODOS: Foram estudados 64 pacientes encaminhados para esclarecimento de sintomas e que já haviam sido submetidos à gravação com Holter. Foram monitorizados, durante 15 dias, com gravador com memória circular com capacidade de registrar uma derivação do ECG (CM5), antes e após ativado pelo paciente. Na vigência de sintomas, o paciente acionava um comando do gravador que provocava a retenção do sinal do ECG, que era, posteriormente, transmitido a uma central via telefone. RESULTADOS: Em dois pacientes não foi possível a realização completa da monitorização, nos restantes, sintomas que motivaram a indicação do exame foram: palpitações (67,7%), tonturas (32,3%), síncopes (29%) e outros (30,6%). Em 85,5% dos pacientes houve relato de sintomas, sendo que em 62,2% houve registro de alterações eletrocardiográficas, relacionadas aos sintomas: taquicardia sinusal, 45,5%; extra-sístoles, 30,3%; taquiarritmia supraventricular, 21,2%; taquicardia ventricular, 3% e bloqueio atrioventricular, 3%. A 1ª transmissão motivada por sintoma ocorreu: 35,5% no 1º dia, 33,9% do 2° ao 5º, 12,9% do 6º ao 10º e 3,2% do 11º ao 15º. Nos pacientes onde a gravação com Holter não permitiu esclarecimento, o gravador de eventos registrou sintomas em 35,5%. CONCLUSÃO: Trata-se de método bem aceito pelos pacientes e capaz de produzir aumento significativo no esclarecimento de sintomas em relação ao Holter.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the contribution of the loop memory recorder in improving the diagnosis of symptoms related to cardiac arrhythmias. METHODS: The study population was 64 patients whose Holter monitorization was inconclusive as to the diagnosis of symptoms related to cardiac arrhythmias. Each wore a patient-activated ambulatory electrocardiogram device for 15 days. The ECG recordings during the occurrence of symptoms were sent to the ECG receiving center by phone. RESULTS: Two patients did not conclude the study. The majority of the patients (85.5%) experienced symptoms in the fifteen days of monitorization, and in 62.2% of these patients electrocardiographic events were observed. The main symptoms experienced by these patients were: palpitation (67.7%), dizziness (32.3%), and syncope (29%). Other symptoms like breast pain, fatigue, indisposition and dyspnea were also noted in 30.6% of the patients. The main electrocardiographic disturbances observed were: sinus tachycardia (45.5%), isolated premature beats (30.3%), supraventricular tachycardia (21.2%), ventricular tachycardia (3%) and third degree AV block (3%). We also observed that the first symptomatic recording occurred mainly in the initial days of monitorization (69.4% in the first 5 days). The percentage of diagnoses was 35.5% in patients whose Holter monitoring had been inconclusive. CONCLUSION: The cardiac loop ECG recorder therefore achieved an important incremental diagnostic yield.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>gravador de eventos sintomáticos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>arritmias cardíacas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>monitorização cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>loop ECG recorder</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac arrhythmias</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac monitorization</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Diuréticos melhoram a capacidade funcional em pacientes com insuficiência cardíaca congestiva</s1>
</fA08>
<fA08 dir="en">
<s1>Diuretics improve functional capacity in patients with congestive heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Francesca Tadeu Eterno</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Múcio Tavares de Oliveira Jr</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>315-320</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Quantificar a influência do diurético na capacidade funcional em portadores de insuficiência cardíaca congestiva (ICC) descompensada, através do teste de caminhada. MÉTODOS: Estudamos 10 pacientes internados, com idade média de 47 anos, sendo cinco do sexo masculino, com ICC descompensada, em classe funcional III e IV (NYHA), submetidos ao teste de caminhada de 6 e 9min na admissão e alta. Foram obtidos registros na admissão e alta, do peso, do ecocardiograma, sódio, potássio, uréia, creatinina séricos, hematócrito e hemoglobina. O tratamento instituído foi o aumento da dose prévia de furosemida EV e/ou VO, associado ou não a diurético tiazídico, tendo sido mantidas as doses prévias de digital, captopril ou da associação de nitrato e hidralazina. RESULTADOS: O período de compensação variou entre 4 a 30 dias (média 8,7±7,8 dias). Ao ecocardiograma bidimensional apresentaram diâmetro do ventrículo esquerdo que variou de 47 a 81mm e a fração de ejeção de 0,26 a 0,74. A distância caminhada em 6min passou de 193,4±71,5m para 341,8±67,7m (p&lt;0,00002 ) e em 9min passou de 268,1±119,6m para 518,0±114,8m (p&lt;0,00005 ). Não houve diferença estatística entre os valores, na admissão e alta, do hematócrito, hemoglobina, uréia, creatinina e sódio. O potássio sérico médio à admissão era de 4,0±0,91mEq/l e na alta 4,69±1,00mEq/l (p= 0,01) e o peso dos pacientes na admissão e na alta foi de 58,9±6,42kg para 52,9±5,31kg, respectivamente (p&lt;0,0006 ). CONCLUSÃO: A compensação da ICC com o uso de diurético induziu a uma melhora importante, a curto prazo, da capacidade física dos pacientes, demonstrada pelo aumento da distância caminhada em 6 e 9min. O diurético melhorou significativamente o desempenho físico.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: The 6-9 minute walking test was used in this study to evaluate the impact of these drugs on functional capacity of patients admitted to the Hospital because of Heart Failure (CHF). METHODS: Ten patients (5 males and 5 females) with mean age of 47 years and NYHA CHF functional class III or IV underwent a 6-9 minute walking test at admission and on the day of discharge from the Hospital. The following parameters were evaluated both at admission and discharge: body weight, echocardiography-derived LV dimensions and function, plasmatic levels of sodium, potassium, BUN, creatinine, hemoglobin and hematocrit. Treatment consisted of increasing outpatient dose of furosemide (IV and/or PO) plus the association of thiazide if necessary. The previous dose regimen of digitalis, ACE inhibitors or the association nitrate and hydralazine was kept unchanged. RESULTS: Time to compensation of CHF varied from 4 to 30 days (mean 8.7±7.8 days). LV end diastolic dimension varied from 47 to 81mm. LV EF spanned from 0.26 to 0.74. The 6min walking distance improved from 193.4± 71.5m to 341.8±67.7m (p&lt;0.00002) and the 9min walking distance from 268.1±119.6m to 518.0±114.8m (p&lt;0.00005). Hemoglobin, hematocrit, BUN, creatinine and sodium levels were unchanged from admission to discharge, whereas plasma potassium level increased from 4.0±0.91mEq/l to 4.69±1.00mEq/l (p=0.01), and body weight was reduced from 58.9±6.42kg to 52.9±5.31kg (p&lt;0.0006). CONCLUSION: Compensating CHF with diuretics leads to a significant improvement in physical capacity. This benefit is already evident in the in-hospital phase.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>diuréticos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste de caminhada</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diuretics</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>six minute walk test</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Mortalidade precoce por doenças do coração no brasil. Comparação com outros países</s1>
</fA08>
<fA08 dir="en">
<s1>Premature mortality from heart diseases in Brazil. An international comparison</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Andrade Lotufo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>321-325</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar a mortalidade por doenças do coração e pela doença coronária (DC) nas faixas etárias dos 45 aos 64 anos, no período 1984-87, em capitais brasileiras com outros países. MÉTODOS: Foram utilizadas as estatísticas oficiais de mortalidade de 8 capitais com boa qualidade de informação: Belém, Recife, Salvador, Belo Horizonte, Rio de Janeiro, São Paulo, Curitiba e Porto Alegre e analisadas as doenças do coração [DC (410-414), mais insuficiência cardíaca (428), mais hipertensão (401-404)] e, isoladamente, a DC. A população foi a determinada nos Censos Demográficos de 1980 e 1991. RESULTADOS: A comparação com outros países mostrou que: a) as taxas de mortalidade por doenças do coração situam algumas cidades brasileiras na posição intermediária (Hungria, Rio de Janeiro, Finlândia, Porto Alegre e Polônia) e entre as mulheres no topo (Rio de Janeiro, Curitiba, Hungria, Porto Alegre, Inglaterra e Gales); b) DC apresentou o mesmo padrão (intermediário alto) das doenças do coração entre os homens (Finlândia, Hungria, Inglaterra e Gales, Porto Alegre e Rio de Janeiro). Entre as mulheres, repetiu-se a situação das doenças do coração (Rio de Janeiro, Curitiba, Hungria, Porto Alegre, Inglaterra e Gales). CONCLUSÃO: A comparação com outros países das taxas de mortalidade ajustadas por idade na faixa etária dos 45-64 anos no período 1984-87 mostrou que as cidades brasileiras estudadas têm altas taxas de mortalidade para as doenças do coração, principalmente entre as mulheres, em valores tão ou mais elevados do que os da Europa e dos Estados Unidos.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: Chronic diseases have been the main cause of mortality in the Brazilian metropolitan areas since 1960. Circulatory diseases are the main causes of chronic diseases. The aim was to compare the heart disease related premature deaths in Brazil with other countries in 1984-87. METHODS: We studied the deaths from the official mortality statistics from eight metropolitan areas with good assurance of information: Belém, Recife, Salvador, Belo Horizonte, Rio de Janeiro, São Paulo, Curitiba, Porto Alegre. Death causes analyzed were coronary heart disease (410-414); and heart diseases [ischemic heart disease (410-414) plus heart failure (428) plus, hypertension (401-404)]. The population was determined from the National Brazilian Census in 1980 and 1991, in other years it was determined by linear interpolation. RESULTS: The international comparison showed that: a) heart disease mortality rates for Brazilian men was ranked (Hungary, Rio de Janeiro, Finland, Porto Alegre and Poland) in the medium and among women (Rio de Janeiro, Curitiba, Hungary, Porto Alegre and England and Wales) in the top; b) coronary heart diseases showed the same pattern of heart diseases for men (Finland, Hungary, England and Wales, Porto Alegre, Rio de Janeiro) and for women (Rio de Janeiro, Curitiba, Hungary, Porto Alegre, England and Wales). CONCLUSIONS: The international comparison of age-adjusted mortality rates in the age strata 45-years-old to 64-years-old during the period 1984-87 showed that Brazilian cities had a high mortality pattern of heart diseases, similar or greater than Europe or United States, mainly among women.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>epidemiologia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doenças do coração</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mortalidade</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mortality</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Por que a letalidade hospitalar do infarto agudo do miocárdio é maior nas mulheres?</s1>
</fA08>
<fA08 dir="en">
<s1>Why is the in-hospital case-fatality rate of acute myocardial infarction higher in women?</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Carlos Santana Passos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Alberto Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Amine Amorim Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rogério Santos Jesus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia Faculdade de Medicina </s1>
<s2>Salvador BA</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>327-330</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a influência da idade, da gravidade da doença e das intervenções terapêuticas na maior letalidade hospitalar do infarto agudo do miocárdio (IAM) em mulheres. MÉTODOS: Estudo de coorte retrospectivo, envolvendo 388 pacientes com IAM (50 óbitos). Foram avaliadas, como possíveis explicações para a associação entre sexo e letalidade hospitalar do IAM, as variáveis: idade (&lt;60 vs  &gt; ou =  60 anos), duração de sintomas, classe de Killip, tipo de IAM (com ou sem ondas Q), comorbidades, história de acidente vascular cerebral e intervenções terapêuticas para o IAM (ácido acetil-salicílico, betabloqueadores e agentes trombolíticos). Modelos de regressão logística foram usados para avaliar a influência de potenciais variáveis confundidoras na associação entre sexo e letalidade hospitalar do IAM. RESULTADOS: A letalidade hospitalar do IAM foi mais alta em mulheres (19,5% vs 9,4%) do que em homens (odds ratio (OR)= 2,34; IC 95%= 1,12-4,47). Embora as mulheres fossem significantemente (p&lt;0,01) mais idosas, a associação entre sexo e morte reduziu-se em apenas 15% após ajuste para idade (OR= 1,99; IC 95 %= 1,07-3,67). Esta associação tornou-se mais fraca ao se considerar a gravidade da doença na admissão (OR= 1,84; IC 95%= 0,90-3,74) e intervenções terapêuticas para o IAM (OR= 1,50; IC= 0,67-3,38). CONCLUSÃO: Diferenças de idade não podem explicar completamente a maior letalidade do IAM em mulheres. A gravidade da doença na admissão e diferenças de abordagem terapêutica devem desempenhar importante papel na maior letalidade hospitalar do IAM em mulheres.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To assess the influence of age, disease severity at admission and therapeutic interventions on the higher in-hospital case-fatality rate of acute myocardial infarction (MI) in women. METHODS: A retrospective cohort study involving a total of 388 acute MI patients (50 deaths). The following variables were treated as possible explanatory factors for the association between gender and case-fatality rate of acute MI: age (&lt;60 vs  &gt; or = 60 years), duration of symptoms, Killip class, type of infarction (Q wave vs non-Q wave), comorbidities, previous history of stroke and specific therapeutic interventions for acute MI (aspirin, beta-blocking drugs, and thrombolytic agents). Logistic regression models were used to assess the influence of potential confounders on the association between gender and in-hospital death. RESULTS: The in-hospital case-fatality rate of acute MI was higher in women (19.5% vs 9.4%) than in men (odds ratio (OR) = 2.34; 95% CI= 1.12-4.47). Although women were significantly older than men (p&lt;0.01), the association between gender and death was reduced only by 15 percent after adjusting for age (OR=1.99; 95% CI= 1.07-3.67). This association became weaker after taking into account disease severity at admission (OR=1.84; 95% CI= 0.90-3.74) and therapeutic interventions for acute MI (OR=1.50; 95% CI= 0.67-3.38). CONCLUSION: Differences in age cannot fully explain the higher case-fatality rate in women than in men with acute MI. Severity of disease at admission and differences in therapeutic interventions might play an important role in the higher case-fatality rate of acute MI among women.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto agudo do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>letalidade hospitalar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mulheres</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>in-hospital case-fatality rate</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>women</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Prevalência de dislipidemias na demanda laboratorial de três diferentes prestadores de assistência</s1>
</fA08>
<fA08 dir="en">
<s1>Prevalence of dyslipidemias in adult ambulatory laboratory tests from different health care providers</s1>
</fA08>
<fA11 dir="011000">
<s1>Ines Lessa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João Lycio Conceição</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Levi Mirabeau</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Joabe Carneiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Joamar Melo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Viviane Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Joel Pinheiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Fábio Meireles</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Joaquim Reis Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Felipe Reis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Rogério Gouvea</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Marcelo Couto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="131000">
<s1>Marlene Rosa Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="141000">
<s1>Silvânia Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia  </s1>
<s2>Salvador BA</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>331-335</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Detectar diferenças nas prevalências das dislipidemias em adultos da demanda laboratorial de três diferentes prestadores de assistência médica, em Salvador, 1995. MÉTODOS: Estudo seccional, clínico epidemiológico, baseado em resultados das dosagens de lípides séricos de uma amostra probabilística de 25% dos 104 laboratórios que usavam o mesmo método de dosagem e o mesmo padrão para controle de qualidade. O critério de dislipidemia foi o do II Consenso Brasileiro de Dislipidemias para adultos. Os resultados foram agrupados conforme procedência: Sistema Único de Saúde (SUS), convênios (C) e seguros privados + particulares (SP). Análise: prevalência com intervalos de confiança (IC) a 95%, e teste do chi². RESULTADOS: Dos 5.464 adultos com menção da procedência, 14,8% foram do SUS, 31,6% dos C e 53,6% dos S+P. As mais elevadas prevalências de hipercolesterolemia - 28,0% (IC 24,0; 32,0) e de LDL-c elevado - 30,4% (IC 27,6; 33,2) foram detectadas no grupo C. No grupo S+P concentraram-se as maiores prevalências de HDL-c anormal - 12,3% (IC 10,0; 13,8) e hipertrigliceridemia - 17,8% (IC 16,3; 19,3). Quase todas as diferenças entre as prevalências foram estatisticamente significantes, favoráveis às taxas mais baixas do SUS. CONCLUSÃO: O melhor perfil lipídico do grupo SUS sugere diferenças sociais nas prevalências das dislipidemias. Para os três prestadores de assistência, a prevalência do HDL-c &lt;35mg/dL foi baixa quando comparada às das demais dislipidemias. Os resultados podem ser inferidos para a prática médica dos respectivos prestadores de assistência e indicam a necessidade de informação e de orientação dos usuários para redução das dislipidemias e melhoria do estilo de vida.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To detect differences in the prevalence of dyslipidemia in adult ambulatory laboratory tests from three different health care providers, in Salvador-Brazil, 1995. METHODS: The study was carried out using a probabilistic sample of 24 out of 104 laboratories (&lt;FONT FACE=Symbol&gt;@&lt;/FONT&gt;25%) which performed the same enzymatic method for lipid tests with the same quality control. Laboratory tests results were separated into three groups, according to health care provider: Sistema Único de Saúde (SUS, governamental), Health Maintenance Organizations (HMO), and Private or Patients Health Insurance (PHI). Criteria for dyslipidemias in mg/dL were: total cholesterol  &gt; or = 240; LDL-c  &gt; or = 160; HDL-c &lt;35 and triglycerides  &gt; or = 200. Prevalence rates, 95% confidence intervals (CI) and chi² test were used in the analysis. RESULTS: From the 5464 adult subjects, 14.8% were from SUS, 31.6%. from HMO and 53.6% PHI. The highest prevalence for hypercholesterolemia - 28.0% (CI 24.0; 32.0) and for LDL-c  &gt; or = 160mg/dL - 30.4% (CI 27.6; 33.2), were found in the HMO group. PHI had the highest prevalence for HDL-c &lt;35mg/dL - 12.3% (CI 10.0; 13.8), and for hypertrygliceridemia - 17.8% (CI 16.3; 19.3). Most of the differences among health providers were statistically significant. CONCLUSION: The best lypid profile observed in subjects from SUS suggests social differences in the prevalence of dyslipidemias. As compared to other dyslipidemias, HDL-c &lt;35mg/dL prevalence was lower than expected in all three groups. The data may provide insights to medical doctors and other health care professionals regarding the questions of dyslipidemias. It can also provide objective information to the patients and encourage them to change their life styles.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dislipidemia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prevalência</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prestadores de assistência</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dyslipidemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>health care</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Taquiarritmias supraventriculares no feto. Experiência de uma unidade de referência em cardiologia fetal</s1>
</fA08>
<fA08 dir="en">
<s1>Fetal supraventricular tachyarrhythmias. Experience of a fetal cardiology reference center</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rejane F. Dillenburg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gustavo G. de Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Lúcia P. Zimmer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Cardiologia do Rio Grande do Sul Unidade de Cardiologia Fetal </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>337-340</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a forma de apresentação, diagnóstico e tratamento das taquiarritmias supraventriculares fetais, através do relato de uma série de casos acompanhados em um centro terciário de cardiologia fetal. MÉTODOS: São descritos 25 casos de taquiarritmia supraventricular diagnosticados intra-útero, no período de janeiro/89 a outubro/97, em uma população compreendendo 3117 gestantes. RESULTADOS: Foram diagnosticados 17 casos de taquiarritmia supraventricular e 8 casos de flutter atrial fetal. As idades gestacionais variaram de 26 a 40 semanas. Doze fetos apresentavam hidropisia no momento do diagnóstico (6 com taquicardia supraventricular (TSV) e 6 com flutter atrial). Quatro fetos com TSV apresentavam cardiopatias estruturais (dois casos de anomalia de Ebstein e dois com comunicação interventricular). Todos os fetos foram internados na Unidade de Cardiologia Fetal para monitorização e tratamento. Entre os 17 fetos com TSV, 12 apresentaram reversão da arritmia após administração de digoxina, mas esta medida não foi eficaz em nenhum paciente com flutter. Dois pacientes com TSV e seis com flutter necessitaram interrupção da gestação para cardioversão elétrica pós-natal. A mortalidade foi de 3/17 no grupo da TSV (incluindo dois pacientes com anomalia de Ebstein) e de 0/8 no grupo com flutter. CONCLUSÃO: As taquiarritmias supraventriculares fetais são eventos raros na população geral. Entretanto, podem provocar insuficiência cardíaca e óbito intra-uterino. Como a resposta ao tratamento é satisfatória, tornam-se de extrema importância o diagnóstico precoce e o tratamento adequado.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To describe the presentation, diagnosis and treatment of fetal supraventricular tachyarrhythmias in a series of fetuses followed in a tertiary Fetal Cardiology Center. METHODS: Twenty-five fetuses with diagnosis of supraventricular tachyarrhytmia were reported from January 1989 to October 1997, among 3117 pregnant women referred for fetal cardiac evaluation. RESULTS: There were 17 fetuses with the diagnosis of supraventricular tachycardia (SVT) and 8 patients with atrial flutter (AF). Gestational age ranged from 26 to 40 weeks. Twelve patients were hydropic at presentation (6 with SVT and 6 AF). Four fetuses with SVT showed structural abnormalities (two with Ebsten's anomaly and two with VSD). All patients were admitted to the Fetal Cardiology Unit for monitoring and treatment. Among 17 fetuses with SVT, twelve showed good response to digoxin administration, but this drug was not useful in any of the patients with flutter. In two patients with SVT and in six with AF, the pregnancy was interrupted to perform post-natal cardioversion. The mortality rate was 3/17 in the SVT group (including 2 patients with ebstein's anomaly and 0/8 in the flutter group) CONCLUSION: Fetal supraventricular tachyarrithmias are rare in the general population. Nevertheless, the fetus may present with severe heart failure and death. Considering the satisfactory therapeutic response, accurate diagnosis and early treatment of these conditions are extremely important.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>arritmias</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coração fetal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetal heart</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arrhythmias</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Origem anômala da artéria pulmonar direita em aorta ascendente (hemitruncus)</s1>
</fA08>
<fA08 dir="en">
<s1>Anomalous origin of right pulmonary artery from ascending aorta (hemitruncus)</s1>
</fA08>
<fA11 dir="011000">
<s1>Ivan Romero Rivera</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valdir Ambrósio Moisés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Celia Camelo Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Samira Borges Leal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Miguel Angel Maluf</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Lázaro Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>341-344</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>A origem da artéria pulmonar direita em aorta ascendente é uma anomalia congênita rara, com poucos casos descritos na literatura. Descrevemos dois casos desta malformação, um associado à interrupção de arco aórtico tipo B. Em ambos, o diagnóstico foi realizado mediante ecocardiografia bidimensional, com confirmação angiográfica em um. A origem da artéria pulmonar direita era próxima à valva aórtica, anomalia patogeneticamente diferente da origem perto da artéria inominada.</s0>
</fC01>
<fC01 dir="en">
<s0>The origin of the right pulmonary artery from the ascending aorta is a rare congenital anomaly, with very few reports in the literature. We describe two cases of this rare malformation, one of them, associated with interruption of the aortic arch (type B). In both cases, the diagnosis was made by two-dimensional echocardiography, with angiographic confirmation in one of them. The origin of the right pulmonary artery was close to the aortic valve, anomaly pathogenetically distinct from the type that arises close to the innominate artery.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiomiopatia hipertrófica tratada por técnica intervencionista de redução septal</s1>
</fA08>
<fA11 dir="011000">
<s1>José Antonio Marin-Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Moysés O. Lima Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>André Schmidt</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Benedito C. Maciel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rogério Tumelero</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto Hospital das Cínicas</s1>
<s2>Ribeirão Preto SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>345-350</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Mulher de 75 anos com cardiomiopatia hipertrófica obstrutiva, com dispnéia classe IV, refratária ao tratamento clínico, apresentava contra-indicações relativas para abordagens cirúrgica e de implante de marcapasso. Realizou-se procedimento intervencionista para injeção seletiva de álcool absoluto no 1º ramo septal da artéria interventricular anterior. O infarto septal provocado acompanhou-se de liberação enzimática, elevação de ST e bloqueio de ramo direito do feixe de His. Não houve complicações inesperadas, e o gradiente da via ejetiva de ventrículo esquerdo, de 66mmHg, foi imediatamente abolido. Controle ecocardiográfico evidencia manutenção desse resultado, até o momento, dois meses após o procedimento, em correspondência a marcante alívio sintomático.</s0>
</fC01>
<fC01 dir="en">
<s0>A 75 year-old woman with obstructive hypertrophic cardiomyopathy and class IV dyspnea refractory to medical management had relative contraindications for both pacemaker implantation and surgical approach. Percutaneous intervention was devised to perform the selective injection of absolute alcohol in the first septal branch of the left anterior descending coronary artery. This led to a limited septal infarction documented by ST elevation, enzymatic elevation and the appearance of complete right bundle branch block on the electrocardiogram. A baseline left ventricular outflow tract pressure gradient of 66mmHg was immediately abolished and no unexpected complications supervened. Currently, two months after the procedure, marked symptomatic relief is present and associated with the absence of obstructive outflow gradient, as documented by echocardiography.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Prevenção da cardiopatia isquêmica. O investimento na saúde</s1>
</fA08>
<fA11 dir="011000">
<s1>Iseu Gus</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Cardiolgia do RS  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Fundação Universitária de Cardiologia  </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>351-353</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Autotransplante da valva pulmonar na posição aórtica (cirurgia de Ross)</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Amaral</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Francisco F. Moreira Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ricardo N. Sgarbieri</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>355-359</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>46</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Hipertensão de consultório</s1>
</fA08>
<fA11 dir="011000">
<s1>Eliandra Aparecida Marsaro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eliudem Galvão Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Espírito Santo Santa Casa de Misericórdia de Vitória Escola de Medicina</s1>
<s2>Vitória ES</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>361-364</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>53</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Alterações cardiovasculares na anemia falciforme</s1>
</fA08>
<fA11 dir="011000">
<s1>Wolney de Andrade Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Delma Maria da Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Anelise Hagen Ferrari</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz Augusto de Freitas Pinheiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luiz José Martins Romêo Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Raul Carlos Pareto Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense  </s1>
<s2>Niterói RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>365-370</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>88</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000512</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Suporte de vida em pediatria</s1>
</fA08>
<fA11 dir="011000">
<s1>Vinay Nadkarni</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mary Fran Hazinski</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>David Zideman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>John Kattwinkel</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Linda Quan</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Robert Bingham</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Arno Zarittsky</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Jon Bland</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Efraim Kramer</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>James Tiballs</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>371-381</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>68</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000513</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Comparação entre homens e mulheres hipercolesterolêmicos de alto risco de desenvolvimento de aterosclerose. Estudo dos fatores de risco e da resposta ao tratamento com pravastatina</s1>
</fA08>
<fA08 dir="en">
<s1>Comparison of hypercholesterolemic men and women at high risk for atherosclerosis. Study of risk factors and response to pravastatin treatment</s1>
</fA08>
<fA11 dir="011000">
<s1>Raul D. Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Raul C. Maranhão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>383-387</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar, entre homens e mulheres hipercolesterolêmicos, a prevalência dos fatores de risco e a resposta ao tratamento com pravastatina. MÉTODOS: Avaliados 486 homens e 368 mulheres, sendo 230 homens e 187 mulheres, que receberam 10mg de pravastatina por 3 meses. RESULTADOS: Houve diferença respectivamente entre mulheres e homens em relação a: hipertensão arterial (45,5% vs 40,8%; p=0,0012), hipertrofia ventricular esquerda (33,0% vs 22,0%; p=0,0041), sedentarismo (94,8% vs 87,8%; p=0,0005), tabagismo (43,0% vs 61,8%; p&lt;0,0001), escores de Framingham (20,0±7,1 vs 16,0±7,6 p&lt;0,001), HDL-C (43,0±11,0 vs 38,0±9,0mg/dL; p&lt;0,001), triglicérides-TG (216,0±115,0 vs 271,0± 172,0mg/dL; p&lt;0,001) e índices de Castelli (IC) I e II (7,7±2,6 vs 8,6±3,2; p=0,002 e 5,0±1,5 vs 5,5±2,0; p=0,015). Sob ação da pravastatina, houve maior redução nos TG (32,0 vs 21,0% p&lt;0,05) e IC I (-41,0% vs -37,0%; p&lt;0,05) e II (-40,0 vs -38,0%; p&lt;0,05) nos homens. CONCLUSÃO: Homens e mulheres diferiram nos fatores de risco e resposta ao tratamento com a pravastatina.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To compare the prevalence of risk factors, and the response to pravastatin treatment between men and women. METHODS: We evaluated 486 men and 386 women, of these 230 men and 187 women received 10mg of pravastatin for three months. RESULTS: There were differences between women and men in respectively: arterial hypertension (45.5% vs 40.8%; p=0.0012), left ventricular hypertrophy (33.0% vs 22.0%; p=0.0041), sedentarism (94.8% vs 87.8%; p=0.0005), smoking (43.0% vs 61.8%; p&lt;0.0001), Framingham scores (20.0±7.1 vs 16.0±7.6 p&lt;0.001), HDL-C (43.0±11.0 vs 38.0±9.0mg/dL; p&lt;0.001), triglycerides- TG (216.0±115.0 vs 271.0±172.0mg/dL; p&lt;0.001) and Castelli's indexes (CI) I and II (7.7±2.6 vs 8.6±3.2; p=0.002 and 5.0±1.5 vs 5.5±2.0; p=0.015). In men under pravastatin treatment there was a greater reduction in TG (32.0 vs 21.0% p&lt;0.05) and CI I (-41.0% vs -37.0%; p&lt;0.05) and II (-40.0 vs -38.0%; p&lt;0.05). CONCLUSION: Men and women differed in risk factors prevalence and response to treatment with pravastatin.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipercolesterolemia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aterosclerose</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypercholesterolemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Utilização de endoprótese auto-expansível (Stent) introduzida através da artéria femoral para tratamento de dissecção da aorta descendente</s1>
</fA08>
<fA08 dir="en">
<s1>Utilization of self-expandable prosthesis (Stent) introduced through the femoral artery for treatment of dissection of the descending aorta</s1>
</fA08>
<fA11 dir="011000">
<s1>José Honório Palma da Fonseca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Enio Buffolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Nikolaus Geisthovel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Dirceu Rodrigues Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Augusto Marcondes de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ivan Paula Machado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Cláudia Maria Rodrigues Alves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>389-392</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Apresentar a correção de dissecção da aorta descendente, utilizando stent recoberto com dácron® introduzido através da artéria femoral na sala de hemodinâmica. MÉTODOS: Quatro pacientes foram submetidos à sedação, anestesia local de ambas regiões inguinais e a heparinização sistêmica, com cateter contendo o stent introduzido, através da artéria femoral comum, previamente dissecada, até a aorta descendente no seu terço médio. RESULTADOS: A expansão do stent foi realizada no local onde existia a lesão da íntima, diagnosticada por arteriografia e ecocardiograma. A oclusão da falsa luz foi imediata. O tempo do procedimento foi em média de 1h e 30min. A alta hospitalar ocorreu sem complicações. CONCLUSÃO: Este procedimento poderá proporcionar uma melhora substancial nos resultados do tratamento das dissecções da aorta descendente.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: We present four cases of dissection of the thoracic descending aorta that underwent treatment with an auto expandable dácron®-covered stent. METHODS: The stent was deployed through the femoral artery in the hemodinamic laboratory after sedation, local anesthesia in both inguinal areas and systemic heparinization. The catheter with the stent was introduced through a cutdown in the left femoral artery until the area in the thoracic aorta with the previously diagnosed tear. RESULTS: The stent was expanded with immediate occlusion of the false lumen. The whole proccedure took 90 minutes and the patients were discharged without complications. CONCLUSION: Stent utilization is an important step to improve treatment results in type B aortic dissection.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aneurisma da aorta</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dissecção da aorta</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>stent</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aorta aneurysm</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aorta dissection</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stent</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Valor da biópsia de pericárdio no diagnóstico etiológico das pericardiopatias</s1>
</fA08>
<fA08 dir="en">
<s1>Value of pericardial biopsy in the etiologic diagnosis of pericarditis</s1>
</fA08>
<fA11 dir="011000">
<s1>Fábio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Barbara Maria Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luis Benvenutti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>393-395</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar o valor da biópsia no diagnóstico etiológico de derrames pericárdicos. MÉTODOS: Foram analisados, retrospectivamente, de 1990 a 1997, 38 pacientes com derrame pericárdico, com idades variando de 3 meses a 79 anos (média 41,15± 21,78 anos). Todos os pacientes foram submetidos a biópsia pericárdica, tendo como acesso a via subxifóide. RESULTADOS: A biópsia foi positiva em quatro (10,5%) casos, dois de etiologia tuberculosa e dois neoplásica (um adenocarcinoma indeterminado e um mesotelioma); no restante o diagnóstico foi de pericardite crônica inespecífica. CONCLUSÃO: Em nossa casuística a biópsia não foi um método eficaz para o diagnóstico etiológico dos derrames pericárdicos. Acreditamos que a indicação de biópsia pericárdica deva ser individualizada, especificamente nos casos de suspeita de etiologia neoplásica ou tuberculosa.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To determine the value of pericardial biopsy as a complementary exam in the etiology of pericardial effusion. METHODS: We analyzed retrospectively (from 1990 to 1997) 38 patients with pericardial effusion. The age ranged between 3 months and 79 years (mean 41.15± 21.78 years). Pericardial biopsy was perfomed in all cases through a subxiphoid incision. RESULTS: In 4 patients (10.5%) the biopsy was able to define etiology, 2 had tuberculosis and 2 neoplasias (1 undetermined adenocarcinoma, 1 mesotelioma). In 34 patients the biopsy showed inespecific chronic pericarditis. CONCLUSION: Pericardial biopsy was not an effective method to determine the etiological diagnosis in pericardial effusion patients. We believe that we have to individualise the indication of pericardial biopsy especially if tuberculosis or neoplasia are suspected.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>pericardite</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>biópsia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>etiologia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pericarditis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>biopsy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>etiology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Morfologia e estereologia do miocárdio em ratos hipertensos. Correlação com o tempo de inibição da síntese do óxido nítrico</s1>
</fA08>
<fA08 dir="en">
<s1>Morphology and stereology of the myocardium in hypertensive rats. Correlation with the time of nitric oxide synthesis inhibition</s1>
</fA08>
<fA11 dir="011000">
<s1>Leila Maria Meirelles Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Glória Maria Moraes Vianna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Alberto Mandarim-de-Lacerda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UERJ Instituto de Biologia Roberto Alcântara Gomes Laboratório de Morfometria e Morfologia Cardiovascular</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>397-402</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>44</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar mudanças estruturais do miocárdio decorrentes do tempo de inibição da síntese do óxido nítrico. MÉTODOS: Estudaram-se 4 grupos de 10 ratos: controle e L-Name (50mg/kg/dia) com 25 e 40 dias de experimentação. Os animais foram sacrificados e os corações processados tecnicamente para estudo em microscopia de luz, onde cortes corados pelo picro-sirius foram estudados com e sem luz polarizada para análise do colágeno do interstício cardíaco. Determinaram-se densidades de volume de miócitos (Vv[m]) e interstício cardíaco (Vv[int]), densidade numérica de miócitos (Nv[m]) e área transversal dos miócitos (A[m]). RESULTADOS: Compararam-se os animais L-Name com os respectivos controles. Nos L-Name a pressão da cauda aumentou 74,5 e 90,2% aos 25 e 40 dias, respectivamente. O peso cardíaco aumentou 50% e 28% aos 25 e 40 dias, respectivamente. O miocárdio dos animais L-Name apresentou hipertrofia de miócitos com aumento da A(m), fibrose perivascular e intersticial, espessamento das túnicas íntima e média das artérias intramiocárdicas. Aos 40 dias diminuíram Vv(m) e Nv(m) e aumentou Vv(int). CONCLUSÃO: Inibição da síntese do óxido nítrico provoca modificações miocárdicas que progridem com o tempo de administração de L-Name. A estereologia é uma metodologia útil para determinar e avaliar as modificações miocárdicas decorrentes deste modelo experimental de hipertensão arterial.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To study structural changes of the myocardium in relation to the time of nitric oxide synthesis inhibition. METHODS: Four groups of 10 rats each were studied: 2 control groups and 2 groups with administration of L-Name (50mg/kg/day), one during 25 days and the other during 40 days. The animals were then sacrificed and the hearts were prepared for study in light microscopy, where sections stained by picro-sirius were studied with and without polarized light for analysis of the cardiac interstitium collagen. Volume densities of myocytes (Vv[m]) and interstitium (Vv[int]), the numerical density of myocytes (Nv[m]) and the mean cross-sectional area of myocytes were (A[m]) also determined. RESULTS: The L-Name animals were compared with the respective controls. In the L-Name rats, the tail arterial pressure increased 74.5 and 90.2% in the 25 days group and in the 40 days group, respectively. The heart weight increased 50% in the 25 days group and 28.6% in the 40 days group. The myocardium of the L-Name animals presented myocyte hypertrophy with increased A(m), perivascular and interstitial fibrosis, thickness of the tunica intima and tunica media of the intramyocardial arteries. In the 40 days group the L-Name animals had decreased Vv(m) and Nv(m) and increased Vv(int). CONCLUSION: Inhibition of nitric oxide synthesis provokes myocardial changes that progress with the time of L-Name administration. The stereology is useful to determine and to evaluate the myocardial changes in this model of arterial hypertension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>óxido nítrico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>miocárdico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estereologia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nitric oxide</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardium</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stereology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Cirurgia valvar em gestantes. Experiência em oito casos</s1>
</fA08>
<fA08 dir="en">
<s1>Valve cardiac surgery during pregnancy. Experience of eight cases</s1>
</fA08>
<fA11 dir="011000">
<s1>Pablo Maria Alberto Pomerantzeff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Anderson Benício</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Manuel de Almeida Brandão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Walkiria Samuel Ávila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Cesar Luiz Bueno</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Maria Rita Lemos Bortolotto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Noedir Antonio Groppo Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Adib Domingos Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>403-408</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar, em gestantes, os resultados da cirurgia cardíaca e as conseqüências da circulação extracorpórea (CEC) nas gestantes e fetos. MÉTODOS: Estudo de 8 gestantes submetidas à cirurgia cardíaca valvar entre janeiro/86 e dezembro/96. Idade média de 31,4±8,9 anos, e idade gestacional entre 12 a 31 (média de 26,6±7,1) semanas. Em todas as pacientes foi realizada monitorização fetal. Durante a CEC manteve-se sempre o fluxo elevado e a temperatura acima de 34°C. Foram realizadas 4 cirurgias da valva aórtica e 4 da valva mitral, sendo duas reoperações. RESULTADOS: Não houve mortalidade materna. Ocorreram dois partos prematuros e em uma criança houve comprometimento neurológico. As demais crianças não apresentaram nenhum comprometimento em seu desenvolvimento. CONCLUSÃO: Os cuidados com o fluxo durante a CEC e a monitorização fetal no intra-operatório foram fundamentais para a obtenção de resultados bastante satisfatórios.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To analyze the results of the valve cardiac surgery in pregnant women and cardiopulmonary bypass consequences to the patients and their fetuses. METHODS: Study of 8 pregnant women who underwent cardiac surgery between January of 1986 and December of 1996. Patients' average age was 31.4±8.9 years and the gestation age ranged from 12 to 31 (average of 26,6±7,1) weeks . Fetus monitorization was performed in all patients. The temperature was always higher than 34°C, as well as high flow rates during the cardiopulmonary bypass. Four surgeries of aortic valve and four of mitral valve were performed, in which two were reoperations. RESULTS: There was no mortality. There were two premature births and in one child there was neurological damage. The other children did not have growth problems. CONCLUSION: Valve cardiac surgery in pregnant women may have good results as long as care in the cardiopulmonary bypass and fetus monitorization are undertaken.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>gravidez</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>circulação extracorpórea</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiopulmonary bypass</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pregnancy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Anatomia angiográfica do sistema venoso coronário. Aplicações em eletrofisiologia clínica</s1>
</fA08>
<fA08 dir="en">
<s1>Angiography of the coronary venous system. Usefulness in clinical cardiac electrophysiology</s1>
</fA08>
<fA11 dir="011000">
<s1>Wesley Duílio S. Melo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luis A. Renjel Prudencio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cássia E. Kusnir</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ana Lucia N. Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Vera Marques</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Magno C. Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Angelo Amato V. de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP EPM Escola Paulista de Medicina</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>409-413</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar as possibilidades diagnósticas e terapêuticas, através de microcateteres introduzidos nas veias do coração, em estudo angiográfico da circulação venosa coronária. MÉTODOS: Foram realizadas venografias superseletivas do coração em 30 portadores de taquicardia ventricular sustentada, utilizando-se cateter específico que providenciava a oclusão temporária do óstio do seio coronário. A idade média foi de 52,7 (variação de 24 a 76) anos, sendo 25 do sexo masculino e cinco do feminino. As veias foram analisadas de acordo com o número, calibre e distribuição nas paredes anterior e posterior do ventrículo esquerdo (VE). RESULTADOS: O seio coronário foi cateterizado em todos os pacientes, não havendo desconforto adicional ou complicações em nenhum caso. O número de veias da parede posterior do ventrículo esquerdo foi 3,1 e na parede anterior, 1,9 p&lt;0,05. Calibres das veias coronárias observados: veia interventricular anterior (segmento distal = 1,19±0,22mm, segmento médio = 1,65±0,35mm); veia interventricular posterior (segmento distal = 1,83±0,47mm, segmento médio = 2,00±0,52mm); veia posterior do VE (segmento distal = 1,45±0,25mm, segmento médio = 2,49±0,92mm); p&lt;0,05. CONCLUSÃO: A técnica de oclusão para o estudo das veias coronárias é exeqüível e segura. O número e o calibre (segmentos médio e distal) das veias da parede posterior do VE são significantemente maiores do que da parede anterior, sugerindo que condições anatômicas para o mapeamento elétrico epicárdico, através das veias coronárias, são mais adequadas na parede posterior do VE.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To study the angiographic anatomy of human coronary veins and the possibility of epicardial venous mapping through microelectrode catheters. METHODS: We evaluated 30 patients with sustained ventricular tachycardia using a catheter which provided occlusion of the coronary sinus ostium during venous angiography. They were 25 males, 5 females, ages ranging from 24 to 76 years (mean=52.7). The veins were studied according to their number, caliber and distribution in the anterior and posterior wall of the left ventricle. RESULTS: Coronary sinus was catheterized in all patients. No discomfort or complications were observed. The number of veins from posterior wall of the left ventricle was 3.1 and anterior wall, 1.9, p&lt;0.05. The caliber of the coronary veins were: anterior interventricular vein (distal segment = 1.19±0.22mm, midle segment = 1.65±0.35mm), posterior interventricular vein (distal segment = 1.83±0.47mm, midle segment = 2.00±0.52mm), left posterior vein (distal segment = 1.45±0.25mm, midle segment = 2.49±0.92mm); p&lt;0.05. CONCLUSION: The balloon occlusion technique for coronary venous angiography is feasible and safe. The number and the caliber (distal and midle) of the veins from the posterior wall of the left ventricle were significantly greater than those from the anterior wall. Anatomic conditions for venous epicardial mapping are more adequate in the posterior wall of the left ventricle.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angiografia coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>veia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>taquicardia ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>vein</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular tachycardia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação comparativa entre valvoplastia percutânea e comissurotomia a céu aberto na estenose mitral</s1>
</fA08>
<fA08 dir="en">
<s1>Comparison between percutaneous balloon valvuloplasty and open commissurotomy for mitral stenosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Francisco Cardoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Miguel Antonio Neves Rati</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Pablo Maria Alberto Pomerantzeff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Caio Cesar Jorge Medeiros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Flávio Tarasoutchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Eduardo Giusti Rossi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Walkiria Samuel Ávila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>415-421</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar resultados imediatos e após 12 meses de seguimento entre valvoplastia por balão e comissurotomia na estenose mitral. MÉTODOS: Oitenta e oito portadores de estenose mitral sintomáticos com anatomia favorável foram randomizados nos dois grupos. Todos os pacientes submeteram-se a avaliação clínica e Doppler ecocardiográfica antes, imediatamente após e 12 meses depois do procedimento. RESULTADOS: Gradiente médio mitral (mmHg) diminuiu (p&lt;0,001) de 12,18±5,84 para 5,80±2,66 no grupo comissurotomia (GC) e de 11,66±6,13 para 4,98±2,40 (p&lt;0,001) no grupo valvuloplastia (GV). Área valvar mitral (cm²) aumentou de 0,98±0,21 para 2,52±0,46 no GC e de 1,05±0,25 para 2,18±0,40 no GV (p&lt;0,001). Em ambos os grupos ocorreu uma diminuição discreta na área valvar mitral ao final do acompanhamento. Não ocorreram óbitos. Um paciente do GV apresentou insuficiência mitral significativa e necessitou tratamento cirúrgico. Aos 12 meses de acompanhamento todos os pacientes do GC e 97,7% dos pacientes do GV estavam em classe funcional I ou II (NYHA). CONCLUSÃO: Os procedimentos foram seguros e mostraram melhora semelhante no gradiente mitral e classe funcional. A área valvar mitral aumentou expressivamente mais no GC, e apresentou, também, uma redução mais significativa após 12 meses. A maioria dos pacientes não alterou a classe funcional no acompanhamento.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To compare immediate and late (12 months) follow up of clinical and Doppler echocardiographic results between percutaneous mitral balloon valvuloplasty and open commissurotomy in a prospective and randomized trial. METHODS: Eighty eight symptomatic patients with severe mitral stenosis and favorable anatomy were randomized in a prospective trial comparing the two procedures. All patients were submitted to clinical and Doppler echocardiographic evaluation before the procedures and immediate and twelve months thereafter. RESULTS: Mean mitral gradient (mmHg) decreased from 12.2±5.8 to 5.80±2.7 (p&lt;0.001) in commissurotomy group (CG) and from 11.7±6.1 to 5.0±2.4 (p&lt;0.001) in the balloon valvuloplasty group (VG). Mitral valve area (cm²) increased from 0.98±0.21 to 2.52±0.46 in CG and from 1.05±0.25 to 2.18±0.40 in VG (p&lt;0.001). In both groups there was a slight decrease in mitral valve area at 12 month follow-up. There was no death in either group. One patient in the VG had moderate mitral regurgitation and underwent surgery. At the 12 month follow-up, all patients in CG and 97.7% of patients in VG were in New York Heart Association functional class I or II. CONCLUSION: Both procedures were safe and showed similar immediate improvement in mitral gradient and functional class. Mitral valve area had a greater increase immediately after commissurotomy, however there was a significantly greater reduction in the CG after 12 months of follow-up, when compared to balloon valvuloplasty. In both groups, mitral gradient remained reduced and most patients did not change functional class during the follow-up.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvuloplastia por balão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>comissurotomia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valve stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>balloon valvuloplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>commissurotomy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Intervenções percutâneas para revascularização do miocárdio no Brasil em 1996 e 1997 comparadas às do biênio 1992 e 1993. Relatório do registro CENIC (Central Nacional de Intervenções Cardiovasculares)</s1>
</fA08>
<fA08 dir="en">
<s1>Percutaneous myocardial revascularization procedures in Brazil during 1996-1997 compared to the 1992-1993 period. A report from the Brazilian national registry -- CENIC</s1>
</fA08>
<fA11 dir="011000">
<s1>Amanda G. M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Alberto P. Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cantídio de Moura Campos Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Heitor G. Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Francisco P. Stella</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Gilberto Nunes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>423-430</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Relatar os resultados das intervenções coronárias percutâneas, no Brasil, no biênio 1996-97, comparando-os com os do biênio 1992-93. MÉTODOS: Foram coletados dados relativos a angioplastia com balão (ATC), aterectomia direcionada (AD), aterectomia rotacional (AR), angioplastia com laser (L) e stents coronários (ST). Estes dados foram comparados aos equivalentes, do Registro 1992-93. RESULTADOS: Participaram do registro atual 79% dos sócios titulares da SBHCI, de 127 hospitais, em 1996-97. Foram incluídos 22.025 pacientes, sendo 60,67% submetidos à ATC; 36,57% a ST; 2,3% a AR; 0,06% à AD e 0,4% ao L. A ATC foi o procedimento mais executado, observando-se um aumento relativo do implante de ST, de 1996 para 1997 de 35% (31,1 para 42,1%, p= 0,0001), com concomitante queda na utilização do balão (65,7% para 55,8%, p= 0,0001). A despeito da população de coronarianos tratados, em 1996-97 ser de maior complexidade clínica e anatômica, que a de 1992-93, verificaram-se maiores índices de sucesso do procedimento (89,7% x 92,8%, p= 0,000001), com menor lesão residual (22% x 19%, p= 0,001). Além disto, houve menores índices de complicações maiores: infarto agudo (2,5% x 1,2%, p&lt;0,01), cirurgia de emergência (0,8% x 0,5%, p= 0,002) e óbito (1,8% x 1,4%, p= 0,0003). CONCLUSÃO: Os procedimentos mais executados no último biênio foram: o balão (60,67%) e os stents coronários (36,57%); verificam-se elevados índices de sucesso (92,3%) e baixas taxas de complicações maiores, confirmando o desempenho de excelência da Cardiologia Intervencionista brasileira.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To report the results of percutaneous coronary interventions, in Brazil, in the years 1996-97, comparing them to those of 1992-93. METHODS: Data were collected in a standard form and the 1996-97 results were compared to those of 1992-93. RESULTS: The current Registry received data from 79% effective members of the SBHCI in 127 hospitals, including 22,025 patients, 60.67% of whom underwent PTCA, 36.57% stent implantation, 2.3% PTRA, 0.06% DCA and 0.4% laser angioplasty. Balloon angioplasty was the most frequent procedure in 1996-97, but its overall rate fell from 65.7% to 55.8% (p=0.0001) concomitantly, there was a 35% relative increase in the use of stents from 1992-93 to 1996-97. The success rate of the later period was higher (89.7% vs 92.8%, p=0.000001), with lower residual stenosis (22% vs 19%, p=0.001). Besides, there were lower major complications rates: acute myocardial infarction (2.5% vs 1.2%, p=0.002) and death (1.8% vs 1.4%, p=0,0003). CONCLUSION: The procedures most often carried out in both periods were balloon angioplasty (60.67%) and implantation of stents (36.57%); the success rate high, abrupt closure rate was low (1.5%). These favorable results corroborate the high standards of the Brazilian Interventional Cardiology.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>registro brasileiro</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angioplastia coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Brazilian registry</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous transluminal coronary angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stents</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Interação clínica entre moléstia de Chagas e hipertensão arterial primária em um serviço de referência ambulatorial</s1>
</fA08>
<fA08 dir="en">
<s1>Clinical relationship between Chagas' disease and primary arterial hypertension in an outpatient reference service</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Elena Guariento</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Eduardo Bagnara Orosz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Antonio Rocha Gontijo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNICAMP Faculdade de Ciências Médicas </s1>
<s2>Campinas SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>431-434</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Caracterizar a associação entre doença de Chagas e hipertensão arterial primária. MÉTODOS: Estudaram-se os chagásicos crônicos acompanhados pelo Grupo de Estudos em Doença de Chagas (Unicamp), no período de 15 anos, considerando-se: hipertensão arterial, forma clínica da doença, sexo, idade e raça. Confrontaram-se dados dos chagásicos hipertensos com os dos não hipertensos. RESULTADOS: Constatou-se que entre 878 chagásicos, 37% eram também hipertensos, dos quais 65% tinham cardiopatia, contra 49% do grupo normotenso; 31% dos chagásicos hipertensos apresentavam descompensação hemodinâmica, contra 24% dos não hipertensos. Entre os chagásicos hipertensos 41% eram negróides e 35% caucasóides; 50% dos chagásicos hipertensos tinham mais de 45 anos contra 29% dos não hipertensos. CONCLUSÃO: A associação entre moléstia de Chagas e hipertensão arterial primária cursou com um freqüente e mais grave comprometimento cardíaco, sendo esta mais prevalente nas faixas etárias mais elevadas.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the clinical relationship between Chagas' disease and primary arterial hypertension. METHODS: The study involved 878 chronic chagasic outpatients followed by the Chagas' Disease Study Group of the University Hospital (Unicamp), over a 15-year period. Initially, the age, gender, race, clinical form of Chagas' disease and the presence of hypertension were noted for each patient. Subsequently, the data for matched hypertensive and normotensive chagasic patients were compared. RESULTS: Of the chagasic patients 37% were hypertensive, of those, 65% had some form of heart disease compared to 49% in the normotensive group. Of those patients with Chagas' disease and arterial hypertension, 41% were blacks and 35% were caucasians. Fifty percent of the hypertensive chagasic patients were over 45 years old compared to only 29% of the non-hypertensive patients. CONCLUSION: Most of the hypertensive chagasic patients were 45 or more years old and showed some degree of heart failure compared to the normotensive group.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença de Chagas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial primária</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>primary arterial hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiopathy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Assistolia durante ecocardiograma de estresse com dobutamina</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiac asystole during dobutamine stress echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Rita Pinton</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Hermínio Haggi Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Walmor Lemke</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Olimpio R. França Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa de Misericórdia de Curitiba  </s1>
<s2>Curitiba PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>435-436</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>8</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Caso de assistolia, durante a realização de ecocardiografia de estresse com dobutamina, em mulher de 59 anos, com queixa de dor precordial. A complicação não foi associada com isquemia miocárdica e deve ter sido causada pela estimulação dos receptores cárdio-inibidores cardíacos à ação da dobutamina. A assistolia cardíaca foi revertida após administração de atropina, sem seqüelas.</s0>
</fC01>
<fC01 dir="en">
<s0>We report a case of cardiac asystole during dobutamine stress echocardiography in a 59 year-old woman presenting with chest pain and a positive treadmill test for ischemia. Cardiac asystole was not associated with myocardial ischaemia and was probably related to a powerful cardioinhibitory reflex caused by dobutamine stimulation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Correlação anatomoclínica: Caso 3/98 - Instituto do Coração do Hospital das Clínicas - FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>437-442</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000611</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Moxonidina. Um novo anti-hipertensivo de ação central</s1>
</fA08>
<fA11 dir="011000">
<s1>Carolina Garcia Soares Leães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Guido Aranha Rosito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Faculdade Federal de Ciências Médicas de Porto Alegre  </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>443-448</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>39</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000612</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Displasia arritmogênica do ventrículo direito</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Elias</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Joelci Tonet</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Robert Frank</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Guy Fontaine</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>449-456</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>58</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000613</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>70</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Parecer da Comissão Técnica designada pelo Departamento de Arritmias e Eletrofisiologia Clínica da Sociedade Brasileira de Cardiologia (DAEC/SBC)</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando E. S. Cruz Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Adalberto Lorga</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Angelo A. V. de Paola</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ayrton K. Peres</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Cídio Halperin</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Claudio Medeiros</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Eduardo B. Sternick</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Eduardo Sosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Jacob Atié</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Marcio L. A Fagundes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Reynaldo de Castro Miranda</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Sergio Rassi</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>457-458</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07000614</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>ESTADO DA ARTE: uma forma especial de educação médica continuada</s1>
</fA08>
<fA11 dir="011000">
<s1>Angelo A. V. de Paola</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcia Barbosa</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>93-93</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiomiopatias</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco Manes Albanesi Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>95-107</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>94</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Princípios de epidemiologia clínica aplicada à cardiologia</s1>
</fA08>
<fA11 dir="011000">
<s1>Mário Coutinho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Santa Catarina  </s1>
<s2>Florianópolis SC</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>109-116</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Relação entre a persistência da condução pela via lenta nodal após ablação de taquicardia por reentrada nodal e a recorrência clínica</s1>
</fA08>
<fA08 dir="en">
<s1>Persistence of AV conduction over the slow pathway after AVRNT radiofrequency ablation and its relation to the recurrences</s1>
</fA08>
<fA11 dir="011000">
<s1>Márcio A. Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maurício I. Scanavacca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>André D'Avila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ricardo Kuniyoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eduardo A. Sosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>117-120</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar se a persistência de salto nodal relaciona-se à taxa de recorrência de taquicardia por reentrada nodal (TRN) após ablação com radiofreqüência (RF) da via lenta do nó atrioventricular. MÉTODOS: Num seguimento de 20±12 meses, foi analisada a recorrência de TRN em 126 pacientes consecutivos submetidos a ablação com RF da via lenta nodal. O critério de interrupção do procedimento foi a não reindução da TRN, após estimulação atrial programada, com e sem isoproterenol intravenoso. Ao final do procedimento, 98 pacientes não apresentavam salto nodal, e em 28 persistia o salto nodal e/ou o eco atrial. RESULTADOS: Houve recorrência clínica de TRN em 15 (11%) pacientes: 9 no grupo sem salto nodal e/ou eco atrial e em 6 do grupo que persistiu com salto e/ou eco atrial. A recorrência tendeu a ser maior no 2º grupo (9% vs 21%), mas não houve significância estatística entre os resultados (p=0,09). CONCLUSÃO: Desde que a TRN não possa ser induzida após a infusão de isoproterenol, a recorrência espontânea da arritmia após a ablação por RF da via lenta nodal não é diferente entre pacientes que persistem ou não com salto nodal e/ou eco atrial.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: The aim of this study is to verify whether the persistence of conduction over the slow pathway is related to an increased trend for recurrence. METHODS: Recurrence rate was retrospectively analyzed in 126 patients who underwent slow pathway radiofrequency (RF) catheter ablation during a follow-up of 20±12 months. The ablative procedure was interrupted when AVNRT was no longer induced by atrial stimulation after intravenous infusion of isoproterenol. Ninety-eight patients had no evidence of slow pathway whereas 28 patients persisted with AV node jump and atrial echo beat. RESULTS: There were 15 recurrences: 9% of those who had no evidence of slow pathway (9 of 98 patients) and 21% of those with AV node jump and/or atrial echo beat but this difference was not statistically significant. CONCLUSION: As long as AVNRT cannot be induced by atrial pacing and isoproterenol infusion after slow pathway RF catheter ablation, the presence of AV node jump and/or atrial echo beat does not increase the risk of recurrence of AVNRT.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>taquicardia por reentrada nodal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ablação por cateter</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>via lenta</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrioventricular reentrant tachycardia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>catheter ablation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>slow pathway</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Asfixia perinatal e problemas cardíacos</s1>
</fA08>
<fA08 dir="en">
<s1>Perinatal asphyxia and heart problems</s1>
</fA08>
<fA11 dir="011000">
<s1>Gesmar Volga H. Herdy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vânia Glória S. Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Luiza S. Aragão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Alberto M. Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Plínio A. Tavares Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fabiano B. Azeredo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Pablo M. C. Nascimento</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Universitário Antônio Pedro  </s1>
<s2>Niterói RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>121-126</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a gravidade das complicações cardíacas na asfixia neonatal, sua evolução e correlacioná-las com o grau e duração do processo hipóxico. MÉTODOS: Foram estudados 90 bebês nos últimos 7 anos com grau de Apgar &lt;6 no 5°min de vida. Pelo protocolo, após o exame físico e os cuidados intensivos, eram submetidos a dosagem do pH arterial, CPK-MB, DHL, glicemia, além da realização de radiografia de tórax, eletrocardiograma (ECG), ecocardiograma, seriados e repetidos a cada semana. Aqueles que faleceram eram levados à necropsia. RESULTADOS: Dos 90, 73 (81%) eram prematuros, 30 (41%) eram apropriados para a idade gestacional (AIG) e 43 (59%) eram pequenos(PIG). Em 21 (23%) casos havia pH arterial &lt;7,2. Os quadros clínicos mais observados foram: pneumonia em 28 (31%), anemia 24 (26%) e icterícia moderada 12 (5%), entre outros. Ao exame físico observaram-se: sopro sistólico em 46 (50%), ictus propulsivo 18 (20%) e ICC em 8 (9%). No ECG, os sinais mais freqüentes foram alterações de repolarização (ST e T) em 44 (49%). No ecocardiograma, observou-se persistência do canal arterial (PCA) em 20 (22%), regurgitação tricúspide em 6 (7%), hipertensão pulmonar em 6 (8%), hipocontratilidade de VE e dilatação de VD em 4 (5%). Dos 23 óbitos, 14 foram estudados e as alterações mais freqüentes foram necrose de fibras em 8 (68%) casos e em 4 (29%) congestão, vacuolização e perda de estriação. CONCLUSÃO: A maioria teve evolução favorável mesmo naqueles que tiveram acidemia importante. Muitas alterações de ECG e ecocardiograma se normalizaram. Daqueles que evoluíram para o óbito, as lesões mais graves ocorreram nos que sofreram, por mais tempo, processo anóxico.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the severity of cardiac complications of neonatal asphyxia in relation to the length and degree of hipoxia. METHODS: Ninety babies with an Apgar score &lt;6 were examined in the intensive care unit at our institution during seven years. Arterial blood for measuring pH, glucose, LDH and MB fraction of CK, together with serial electrocardiogram (ECG), echocardiogram and chest X rays was obtained. The fatal cases were studied with macro and microscopic examination. RESULTS: From a total of 90 cases, 73 were premature: 30 (41%) appropriate for gestation age (AGA) and 43 (59%) small for gestation age (SGA). Twenty one (23%) cases had arterial pH &lt;7.2. The most common clinical conditions were: pneumonia 28 (31%), anemia 24 (26%) and jaundice 12 (13%). The main cardiological findings were: systolic murmur in 46 (50%), signs of heart hypertrophy in 18 (20%) and heart failure in 8 (9%). On ECG the main findings were ST and T abnormalities. The echocardiogram showed a patent ductus arteriosus (PDA) in 20 (22%), tricuspid regurgitation in 6 (7%), pulmonary hypertension in 6 (7%), dyskinesia and ventricular dilatation in 4 (5%). Necropsy was performed in 23 cases and macro and microscopy obtained in 14; the most frequent findings were: myocite necrosis in 8 (54%), congestion, vacuolization and loss of striae in 4 (29%). CONCLUSION: In the majority of cases, patients had a benign course, even those presenting with severe acidemia. Many abnormal EKGs and echocardiograms became normal after a few weeks. Among those who had a fatal outcome, the severity of histological lesions was observed in babies who had suffered asphyxia for more prolonged periods.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>asfixia perinatal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coração</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>perinatal asphyxia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Prevalência da hipertensão arterial sistêmica na população urbana de Passo Fundo (RS)</s1>
</fA08>
<fA08 dir="en">
<s1>Prevalence of hypertension in the Passo Fundo (Brazil) metropolitan area</s1>
</fA08>
<fA11 dir="011000">
<s1>Ibsen S. Trindade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gilberto Heineck</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Josemar Roberto Machado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Henrique Ayzemberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maurice Formighieri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Mosara Crestani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Jefferson Gusso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de Passo Fundo Faculdade de Medicina </s1>
<s2>Passo Fundo RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>127-130</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a prevalência de hipertensão arterial sistêmica (HAS) na população urbana da cidade de Passo Fundo (RS). MÉTODOS: Estudo observacional, descritivo e transversal de base populacional de uma amostra aleatória significativa da população em estudo. O critério para HAS foi 160/95mmHg. A média das últimas três aferições da pressão arterial (PA) foi utilizada nas análises. A amostra foi composta por 206 indivíduos. Houve correção dos níveis pressóricos em relação ao diâmetro do braço. A entrevista foi feita com questionários estandardizados. RESULTADO: A prevalência da HAS foi de 21,9% (IC=19,3 a 24,5) utilizando o critério de 160/95 somado aos pacientes normotensos em uso regular de medicação anti-hipertensiva. Dos 45 indivíduos hipertensos, 53,3% tomavam medicação anti-hipertensiva regularmente, sendo que 20% estavam com a PA controlada. Da população em estudo, 4,4% eram diabéticos, 33,0% fumantes, 31,4% mulheres usando anticoncepcional oral, 2,9% abusando de álcool, 29,6% obesos. Encontramos associação significativa com a HAS, em relação à idade, obesidade e diabetes mellitus e não a encontramos com referência ao sexo, cor, abuso de álcool, fumo e uso de anticoncepcional oral. CONCLUSÃO: A prevalência da HAS em Passo Fundo está dentro dos limites esperados para tal; no entanto, o grau de controle desta população está em um nível muito aquém do satisfatório.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the present prevalence of hypertension in the Passo Fundo metropolitan area. METHODS: This is an observational, descriptive, crossectional design with populational base, of a representative random sample of the adults of this urban region. The criteria for hypertension were blood pressure &gt;160/95mmHg or antihypertensive treatment. The average of the last three measurements was used in the analysis. Two hundred and six subjects were selected. The interview was made with standardized questionnaires. Blood pressure was corrected for arm diameter. RESULTS: The prevalence of hypertension was 21.9% (CI=19.3 to 24.5) of 45 hypertensive subjects, 53.3% were using anti-hypertensive drugs regularly, however only 20% had normal BP levels. Among the study population 4.4% were diabetics, 33.0% were smokers, 31.4% of the women were using contraceptives, 2.9% were heavy alcohol users, 29.6% were obese. The following conditions of interest were significatively associated with hypertension: age, obesity and diabetes; there was no association with sex, color, heavy alcohol use, smoking and contraceptive use. CONCLUSION: The prevalence of hypertension in the Passo Fundo metropolitan area is within the expected range, however the level of control in this population is not acceptable.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial sistêmica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>epidemiologia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Quilopericárdio idiopático</s1>
</fA08>
<fA08 dir="en">
<s1>Idiopathic chylopericardium</s1>
</fA08>
<fA11 dir="011000">
<s1>Fábio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Mauro Sérgio Stateri Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Barbara Maria Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Pego Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>131-134</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Descrevemos um caso de derrame pericárdico idiopático em que, durante investigação diagnóstica, foi constatado ser um quilopericárdio. A linfografia mostrou aplasia parcial do ducto torácico. Realizamos uma breve revisão da etiopatogenia, quadro clínico, métodos diagnósticos complementares e possibilidades terapêuticas do quilopericárdio.</s0>
</fC01>
<fC01 dir="en">
<s0>We describe a case of a patient with idiopathic pericardial effusion that during investigation proved to be a chylopericardium. Lymphangiography showed the chylopericardium to be due to partial aplasia of the thoracic duct. A brief review the etiology, clinical feature, diagnostic procedures and therapeutic possibilities of chylopericardium is presented.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Mixoma atrial esquerdo com acidente vascular cerebral isquêmico em criança</s1>
</fA08>
<fA08 dir="en">
<s1>Left atrial myxoma and isquemic stroke in a child</s1>
</fA08>
<fA11 dir="011000">
<s1>Isabela Thomaz Takakura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Moacir Fernandes de Godoy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcelo José Soares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Airton Camacho Moscardini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Domingo Marcolino Braile</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de São José do Rio Preto  </s1>
<s2>São José do Rio Preto SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>135-137</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>É apresentado um caso de mixoma atrial esquerdo associado a acidente vascular cerebral embólico em paciente do sexo feminino, com oito anos de idade. Feita a exérese do tumor, a criança apresentava, dois meses após cirurgia, presença de massa septoatrial esquerda, sugerindo recidiva, mantendo-se, porém, assintomática. A revisão da literatura enfatiza a raridade e a agressividade com que este tumor acomete esta faixa etária, além de salientar baixas taxas de recidiva após sua retirada.</s0>
</fC01>
<fC01 dir="en">
<s0>The authors present a case of left atrial myxoma with stroke in an 8-year-old female child. The tumor was removed and two months after the surgery a left atrial septum mass was observed suggesting recurrence. The child was asymptomatic. Literature review emphasizes the rarity and clinically aggressive behavior of this tumor at this age group and demonstrates rare recurrence rates after surgery.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiomiopatia hipertrófica apical associada a doença arterial coronária</s1>
</fA08>
<fA08 dir="en">
<s1>Apical hypertrophic cardiomyopathy associated with coronary artery disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco Manes Albanesi Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Justiniano Simões Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José David Aron Diamant</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcia Bueno Castier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>João Alexandre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rezende Assad</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Rosangela Cruz Lyra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>139-142</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Homem de 59 anos, portador de cardiomiopatia hipertrófica apical há 12 anos, apresentou agudização de quadro anginoso. Foi detectada doença arterial coronária com lesão trivascular, e indicada cirurgia de revascularização, com anastomose de artéria mamária e a colocação de duas pontes de veia safena, tendo evoluído com melhora do quadro anginoso e redução da dimensão do átrio esquerdo.</s0>
</fC01>
<fC01 dir="en">
<s0>A fifty-nine year old man, known to have hypertrophic cardiomyopathy, presented worsening of angina. Multivessel coronary artery disease was diagnosed, and he underwent myocardial revascularization (mammary and two safenous grafts were implanted) with good evolution and reduction of left atrium dimension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Circulação coronária dependente do ventrículo direito na atresia pulmonar com septo interventricular íntegro. Ausência da origem das artérias coronárias da aorta</s1>
</fA08>
<fA08 dir="en">
<s1>Right ventricle-dependent coronary circulation in pulmonary atresia with intact ventricular septum. Absence of origin of the coronary arteries from the aorta</s1>
</fA08>
<fA11 dir="011000">
<s1>Ivan Romero Rivera</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valdir Ambrósio Moises</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Celia Camelo Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Pedro Abujamra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Lázaro Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Estado de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>143-146</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>São descritos os aspectos clínicos, ecocardiográficos e angiográficos de um neonato de sexo masculino, com cinco dias de vida e diagnóstico de atresia pulmonar com septo interventricular íntegro. Tanto o ecocardiograma como a aortografia mostraram ausência da origem das artérias coronárias da aorta. O ecocardiograma bidimensional e, posteriormente, a ventriculografia direita identificaram as artérias coronárias, originando-se no ventrículo direito. Não houve contrastação retrógrada da aorta ou do tronco pulmonar quando contrastadas as artérias coronárias. Este é o primeiro caso relatado com diagnóstico ecocardiográfico pré angiografia, e é um exemplo da necessidade de se avaliar as artérias coronárias em pacientes com atresia pulmonar e septo ventricular íntegro.</s0>
</fC01>
<fC01 dir="en">
<s0>This report describes the clinical, echocardiographic and angiographic aspects of a five-day old boy with pulmonary atresia and intact ventricular septum. Both the echocardiogram and the aortography did not show any coronary arteries arising from the aorta. Two-dimensional echocardiography was able to identify the coronary arteries originating from the right ventricle and so did the right ventricular angiogram. No retrograde flow into the aorta or pulmonary trunk was identified after opacification of the coronary arteries. As far as we know this is the first case diagnosed by echocardiography, and is a vivid example of the necessity of identifying the coronary arteries in patients with pulmonary atresia and intact ventricular septum.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 4/98 - Instituto Dante Pazzanese de Cardiologia</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>147-152</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>O impacto dos inibidores da HMG-CoA redutase na modificação da história natural da doença coronária</s1>
</fA08>
<fA11 dir="011000">
<s1>Sergio Emanuel Kaiser</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Monica Luiza de Alcantara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>153-162</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>75</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100212</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Análise da utilização dos novos inibidores da trombina na prática médica</s1>
</fA08>
<fA11 dir="011000">
<s1>Carolina Blaya</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Clarissa Prati</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cristiano Boneti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Daniela Rezende Bonamigo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rita Carolina Pozzer Krumenauer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Guido Aranha Rosito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade Federal de Ciências Médicas de Porto Alegre  </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>163-167</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100213</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeitos do carvedilol (bloqueador &lt;FONT FACE=Symbol&gt;b1,b2,a&lt;/FONT&gt;1) na insuficiência cardíaca refratária</s1>
</fA08>
<fA08 dir="en">
<s1>Effects of carvedilol (beta1,beta2,alpha1-blocker) on refractory congestive heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Edimar Alcides Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernando Bacal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Giovanni Bellotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Dirceu Carrara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>169-173</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100214</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Os efeitos dos beta-bloqueadores na insuficiência cardíaca (IC) refratária não têm sido adequadamente estudados. Investigamos os efeitos do carvedilol (bloqueador &lt;FONT FACE=Symbol&gt;b1,b2,a1&lt;/FONT&gt;) nos sintomas e na função ventricular de portadores de IC refratária. MÉTODOS: Foram estudados 21 pacientes, idade média de 56±10 anos, 9 em classe funcional (CF) IV, e 12 em CF III intermitente com IV. A dose inicial de carvedilol foi de 6,25mg e, se tolerada, aumentada progressivamente. A dose média final foi 42±11mg. Os pacientes foram submetidos a avaliações clínicas e eletrocardiográficas seriadas. Realizaram-se, antes e com 196±60 dias de evolução, ecocardiograma e ventriculografia radioisotópica. RESULTADOS: O medicamento foi tolerado em 16 (76%) pacientes. Um paciente está em fase de titulação em CF II. Com 196±60 dias de evolução observaram-se 8 pacientes em CF I e 7 em II; redução da freqüência cardíaca de 96±15 para 67±10bpm (p&lt;0,0001); redução do diâmetro diastólico final de ventrículo esquerdo (VE) de 73±13 para 66±12mm (ecocardiograma) (p&lt;0,009); e aumento da fração de ejeção de VE de 0,21±0,06 para 0,34±0,12 (p&lt;0,0003). CONCLUSÃO: O carvedilol devido aos seus efeitos benéficos na função ventricular, remodelamento e CF é, se tolerado, uma potencial alternativa terapêutica no tratamento medicamentoso da IC refratária. Entretanto, estudos adicionais são necessários para definição do efeito a longo prazo neste específico subgrupo de pacientes.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: The effects of beta-blockers on severe heart failure are not well known. We investigated the effects of carvedilol (&lt;FONT FACE=Symbol&gt;b1,b2,a1&lt;/FONT&gt;-blocker) on symptoms, functional class (FC), and left ventricular function in patients with refractory heart failure. METHODS: We studied 21 patients, mean age 56±10 years, 9 in FC IV, e 12 in FC III (intermittently with class IV). The initial dosage was 6.25mg, and it was increased progressively as tolerated. The mean dose was 42±11mg. The patients were submitted to routine clinical evaluation, and electrocardiogram. We determined after 196±60 days of follow-up the left ventricular end diastolic dimension (by echocardiogram), and left ventricular ejection fraction (using MUGA). RESULTS: Carvedilol was well tolerated by 16 (76%) patients. One patient is in FC II during increment of the dosage. Eight patients were in FC I, and 7 in FC II at 196±60 days of follow-up. Heart rate decreased from 96±15 to 67±10bpm (p&lt;0.0001), left ventricular end diastolic diameter from 73±13 to 66±12mm (p&lt;0.009), and the left ventricular ejection fraction increased from 0.21±0.06 to 0.34±0.12 (p&lt;0.0003). CONCLUSION: Carvedilol may have beneficial effects on cardiac function, remodeling process, and FC. If tolerated, it seems to be a potential alternative option in the medical treatment of refractory heart failure. However, investigations are still necessary to clarify the long-term effects of carvedilol on this specific subgroup of patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca congestiva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>antagonistas beta-adrenérgicos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>transplante</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congestive heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adrenergic beta-antagonists</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>transplantation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Insuficiência cardíaca no Brasil</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco Manes Albanesi Fº</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>561-562</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Em busca de novos paradigmas para o manejo da insuficiência cardíaca</s1>
</fA08>
<fA11 dir="011000">
<s1>Nadine Clausell</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jorge Pinto Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>563-574</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>118</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Itens essenciais em bioestatística</s1>
</fA08>
<fA11 dir="011000">
<s1>Ângela Tavares Paes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>575-580</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Monitorização residencial da pressão arterial e monitorização ambulatorial da pressão arterial versus medida de pressão arterial no consultório</s1>
</fA08>
<fA08 dir="en">
<s1>Home blood pressure measurement and ambulatory blood pressure measurement versus office blood pressure measurement</s1>
</fA08>
<fA11 dir="011000">
<s1>Marco A. M. Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Angela M.G. Pierin</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos A. Segre</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Décio Mion Jr</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>581-585</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVOS: Comparar a monitorização residencial da pressão arterial (MRPA) e monitorização ambulatorial da pressão arterial (MAPA) com os registros de consultório e correlacionar o índice de massa de ventrículo esquerdo (IMVE) com a MRPA e medida de consultório. MÉTODOS: Protocolo 1 - Sessenta e oito hipertensos (58±12 anos, 37 mulheres) realizaram: a) MRPA durante 7 dias; b) MAPA de 24h; e c) medida da pressão arterial no consultório, pelo médico. Protocolo 2 - 41 hipertensos (48 ± 14 anos, 25 mulheres) além de MRPA e medida no consultório, realizaram ecocardiograma bi-dimensional. RESULTADOS: Protocolo 1 - a medida de consultório (153±24/96±13mmHg) foi maior (p&lt;0,05) do que a obtida pela MAPA diurna (137±17/87±12mmHg) e pela MRPA (133±18/84±12mmHg). Protocolo 2 - o IMVE mostrou correlação com as médias de pressão sistólica/diastólica da MRPA (r= 0,39/0,49, p&lt;0,05) mas não com as de consultório (r= 0,02/0,22, p&gt;0,05). CONCLUSÃO: A MRPA apresentou valores menores do que a medida de consultório e semelhantes aos da MAPA, além de melhor correlação com IMVE do que a medida de consultório.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To compare both home blood pressure measurement (HBPM) and ambulatory blood pressure monitoring (ABPM) with office blood pressure measurement (OBP); and also to compare the correlation between HBPM and OBP with LVMI (left ventricular mass index). METHODS: Protocol 1 - 68 hypertensive patients (58±12 years, 37 females): a) self recorded blood pressure at home in the 7 days; b) recorded the ABPM during 24 hours; and c) the physician recorded blood pressure in the office. Protocol 2- 41 hypertensive patients underwent the HBPM, OBP, and BI-dimensional echocardiogram. RESULTS: Protocol 1 - OBP (153±24/96±13mmHg) was higher (p&lt;0.05) than HBPM (133±18/84±12mmHg) and ABPM (137±17/87±12mmHg); Protocol 2 - LVMI correlated better with HBPM (r= 0.39 / 0.49, p&lt;0.05, systolic and diastolic, respectively) than OBP (r= 0.02/0.22, p&gt;0.05, systolic and diastolic, respectively). CONCLUSION: This study showed that HBPM has a better correlation with LVMI than OBP.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>medida residencial da pressão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>medida da pressão arterial no consultório</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>monitorização ambulatorial da pressão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>home blood pressure measurement</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>office blood pressure measurement</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ambulatory blood pressure measurement</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Diferença de letalidade hospitalar do infarto agudo do miocárdio entre homens e mulheres submetidos a angioplastia primária</s1>
</fA08>
<fA08 dir="en">
<s1>Difference in the case-fatality rate of acute myocardial infarction between men and women submitted to primary angioplasty</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Carlos Santana Passos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Alberto Lopes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fábio Peroba Esteves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fabiano Marins de Oliveira Santos</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>587-590</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar a letalidade hospitalar (LH) de homens e mulheres submetidos a angioplastia transluminal coronária primária (ATCP) como estratégia de reperfusão no infarto agudo do miocárdio (IAM). MÉTODOS: Estudo de coorte retrospectivo baseado em informações de prontuários médicos de pacientes hospitalizados devido a IAM em hospital de referência para doença coronária, utilizando preferencialmente a ATCP como técnica de reperfusão miocárdica precoce. Foram incluídos 83 pacientes, 35 (42%) mulheres e 48 (58%) homens, que preencheram critérios para reperfusão miocárdica precoce. RESULTADOS: A média de idade das mulheres foi superior a dos homens (66±10 vs 58±11 anos; p&lt;0,001). As mulheres também apresentaram uma maior freqüência de diabetes mellitus (37,1% vs 6,4%; p&lt;0,001). Apesar destas diferenças na idade e na freqüência de diabetes mellitus, os percentuais de pacientes em que a ATCP foi considerada sucesso foram similares entre homens (83,3%) e mulheres (82,3%). A LH foi também bastante semelhante entre homens e mulheres; 14,6% vs 14,3%, respectivamente. CONCLUSÃO: A possibilidade de que o excesso de risco de morrer entre as mulheres com IAM em relação aos homens possa ser reduzido ou até eliminado com o uso da ATCP apóia a necessidade de que se desenvolva um ensaio clínico a fim de avaliar esta questão.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To compare the in-hospital case-fatality rate of men and women submitted to percutaneous transluminal coronary angioplasty (PTCA) as a strategy of reperfusion in acute myocardial infarction (MI). METHODS: A retrospective cohort study based on information abstracted from medical records of MI patients admitted to a hospital where PTCA is used as the prefered method for early myocardial reperfusion. A total of 83 patients, 35 (42%) women and 48 (58%) men, who met the criteria for early myocardial reperfusion was included in the analysis. RESULTS: The mean age of women was higher than that of men (66±10 vs 58±11 years; p&lt;0.001). The women also had a higher frequency of diabetes mellitus (37.1% vs 6.4%; p&lt;0.001). Despite these differences in age and in the frequency of diabetes mellitus, the percentage of patients in whom the PTCA was considered successful was similar between men (83.3%) and women (82.3%). The case-fatality rate was also similar between men and women; 14.6% and 14.3%, respectively. CONCLUSION: The possibility that the excess risk of death in women with MI may be reduced and even eliminated with the use of PTCA, supports to the need for the development of a clinical trial to assess this question.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto agudo do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>letalidade hospitalar e angioplastia coronária primária</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>case-fatality rate</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>primary coronary angioplasty</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Intervenção coronária em hospital geral no Piauí</s1>
</fA08>
<fA08 dir="en">
<s1>Coronary intervention perfomed in a general hospital in the State of Piauí</s1>
</fA08>
<fA11 dir="011000">
<s1>Antenor Portela</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Linhares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Raldir Bastos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jayro Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital São Marcos  </s1>
<s2>Teresina </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>591-594</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar o índice de sucesso e complicações das intervenções coronárias realizadas em hospital geral do Piauí, em um laboratório de hemodinâmica com baixo volume de procedimentos por ano. MÉTODOS: Cento e vinte e dois pacientes, submetidos a 146 procedimentos de intervenção coronária, de agosto/91 a janeiro/98 tiveram seus dados clínicos e angiográficos analisados retrospectivamente. As cineangiocoronariografias e as intervenções foram realizadas em aparelho com sistema de fluoroscopia com câmara e monitor de TV de 525 linhas. As variáveis analisadas foram o sucesso inicial do procedimento (estenose residual &lt;50% e fluxo TIMI III) e as complicações maiores (oclusão aguda, infarto, cirurgia de urgência e óbito). Foram revisados os dados clínicos e as características morfológicas das lesões (ACC/AHA Task Force). RESULTADOS: A média etária foi de 61 anos, variando de 25 a 85, 67% dos pacientes eram do sexo masculino, 85% apresentavam síndrome isquêmica aguda (infarto agudo do miocárdio, angina pós infarto ou angina de repouso), 5% apresentavam-se em choque cardiogênico. 88% das lesões eram tipo B. O índice de sucesso imediato foi de 93%. A taxa de complicações maiores (oclusão aguda, cirurgia de urgência, infarto e óbito) foi de 3,5%. CONCLUSÃO: A despeito de um baixo volume de procedimentos por ano e um equipamento de cineangiocoronariografia convencional, o índice de sucesso desta instituição foi excelente em uma população de pacientes diversa e complexa com taxa de complicações semelhante à encontrada na literatura.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate retrospectively success and complication rates of coronary interventions performed in a general hospital with no digital equipment in the State of Piauí with a small annual number of procedures. METHODS: From August/91 to January/98, 122 patients underwent 146 procedures using a fluoroscope with camera and TV monitor of 525 lines. The variables analyzed included the initial success of procedures (residual stenosis less than fifty percent and TIMI III flow) and more serious complications (acute occlusion, infarcts, emergency surgeries and death). The clinical data and the morphological characteristics of the lesions (ACC/AHA Task Force) were also analyzed. RESULTS: Eighty five percent of the patients presented with an acute ischemic syndrome (acute myocardial infarction, post infarction angina, rest angina), 5% were in cardiogenic shock and 88% had type B lesions. The initial success rate was 93% while the more serious complications occurred in 3.5% of the cases. CONCLUSION: In spite of the small annual procedural volume and the use of conventional equipment, the initial success rate in our institution was excellent in a diverse and complex patient population while the complication rates were similar to that of the literature.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença arterial coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiologia intervencionista</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angioplatia coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>interventional cardiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angioplasty</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>O eletrocardiograma de alta resolução no domínio da freqüência. Utilização de técnicas estatísticas de correlação espectral para identificação de pacientes com taquicardia ventricular monomórfica sustentada</s1>
</fA08>
<fA08 dir="en">
<s1>Frequency domain analysis of the signal-averaged electrocardiogram. Application of statistical techniques of spectral correlation for identification of patients with sustained monomorphic ventricular tachycardia</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo Corrêa Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Roberto Benchimol Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Ginefra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Francisco Manes Albanesi Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>595-599</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar uma melhoria da acurácia diagnóstica da taquicardia ventricular monomórfica (TVM), através do eletrocardiograma de alta resolução (ECGAR), adicionando à análise no domínio do tempo (DT), técnicas estatísticas de correlação espectral no domínio da freqüência (DF). MÉTODOS: Foram estudados pelo ECGAR 137 indivíduos sendo 27 com cardiopatia e TVM sustentada, 30 com cardiopatia e sem TVM e 80 sem evidências de cardiopatia. Os parâmetros analisados no ECGAR no DT foram: duração do QRS filtrado, RMS40 e LAS40 e, no DF, as médias e os devios padrões da correlação espectral intersegmentar do sinal e da banda de freqüência delimitadora da concentração do sinal. RESULTADOS: A sensibilidade (Sb) e o valor preditivo positivo (VPP) do ECGAR no DT, DF e análise combinada de ambos os domínios foram, na detecção de TVM, respectivamente: Sb = 59,3%, 63% e 81,5% e VPP = 80,0%, 81,0% e 84,6%. CONCLUSÃO: A análise combinada do ECGAR nos DT e DF aumenta a acurácia diagnóstica de pacientes com apresentação clínica de TVM sustentada.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the diagnostic accuracy of monomorphic ventricular tachycardia (MVT), in patients with structural heart diseases and episodes of sustained MVT, using the signal-averaged ECG (SAECG) in the time (TD) and the frequency domain (FD) with statistical techniques of spectral correlation. METHODS: Twenty seven patients with at least one episode of sustained MVT, 30 patients with structural heart diseases and no evidence of ventricular arrhythmias and 80 subjects with no evidence of heart disease have been studied. SAECG was performed in all patients with the following parameters: duration of the filtered QRS, RMS 40 and LAS40 in TD and the mean and the standard deviation of both signal energy intersegmentar spectral correlation and energy frequency edge track in FD. RESULTS: The sensitivity(S) and positive predict value (PPV) of the SAECG in TD, in FD and combined analysis of both domains were: S = 59.3%, 63.0%, 81.5% and PPV = 80.0%, 81.0%, 84.6%, respectively. CONCLUSION: The combined analysis of SAECG in TD and in FD improves the diagnostic accuracy in patients with S sustained MVT.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>eletrocardiograma de alta resolução</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>taquicardia ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>processamento de sinal</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>high resolution electrocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular tachycardia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>signal processing</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Eficácia e tolerabilidade da associação bisoprolol/hidroclorotiazida na hipertensão arterial</s1>
</fA08>
<fA08 dir="en">
<s1>Efficacy and tolerability of the bisoprolol/hydrochlorothiazide combination in the treatment of arterial hypertension.</s1>
</fA08>
<fA11 dir="011000">
<s1>Rafael Leite Luna</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Wille Oigman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Antônio Ramirez</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Décio Mion</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Michel Batlouni</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>João Carlos da Rocha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Gilson Soares Feitosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Iran Castro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Hilton de Castro Chaves Júnior</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Epotaménides Maria Good God</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Lilia Nigro Maia</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Kátia Coelho Ortega</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Angela Maria de O. Raineri</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>601-608</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudo multicêntrico, aberto e não comparativo, para avaliar a eficácia e a tolerabilidade de dois agentes anti-hipertensivos combinados em doses baixas: o beta-bloqueador cardiosseletivo bisoprolol (2,5 e 5,0mg) com 6,25mg de hidroclorotiazida. MÉTODOS: Cento e seis pacientes com hipertensão arterial nos estágios I e II (leve a moderada) receberam a combinação bisoprolol/hidroclorotiazida, em uma única dose diária, e foram submetidos a uma avaliação da pressão arterial sistólica (PAS) e pressão arterial diastólica (PAD), durante 8 semanas. RESULTADOS: A combinação bisoprolol/hidroclorotiazida reduziu significativamente os valores médios iniciais da PAS (157,4mmHg para 137,3mmHg) e da PAD (98,8mmHg para 87,4mmHg). Ao final do estudo, 61% haviam normalizado a PA (&lt;90mmHg) e 22,9% deles foram responsivos ao tratamento, resultando em elevada taxa de resposta terapêutica (normalizados + responsivos) - total de 83.9% dos casos. Eventos adversos foram descritos em 18,9% dos pacientes, sendo os mais freqüentes: tontura e cefaléia. Não se observaram alterações clinicamente significativas nos níveis plasmáticos de glicose, potássio, ácido úrico e perfil lipídico. CONCLUSÃO: A combinação bisoprolol/hidroclorotiazida em baixas doses pode ser considerada uma alternativa racional, eficaz e bem tolerada para o tratamento inicial da hipertensão arterial leve ou moderada.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: Multicenter, open and non-controlled study to evaluated the efficacy and the tolerability of a low-dose combination of two anti-hypertensive agents: a cardioselective beta-blocker, bisoprolol (2.5 and 5.0mg) with 6.25mg of hydrochlorothiazide. METHODS: One hundred and six patients in the stage I and stage II of the systemic hypertension (mild to moderate) were given the bisoprolol/hydrochlorothiazide combination once daily and the diastolic and systolic blood pressures were monitored during the 8-week trial. RESULTS: The bisoprolol/hydrochlorothiazide combination reduced the initial mean values of systolic and diastolic blood pressures, respectively, from the 157.4mmHg and 98.8mmHg to 137.3mmHg and 87.4mmHg. At the end of the treatment period, 61% of the patients normalized blood pressure values (&lt;90mmHg) and 22.9% of them had responded to the treatment, resulting in a total response rate (normalized + responsive) of 83.9% of cases. Adverse events were described only in 18.9% of the patients and dizziness and headache were the most common. There were no clinically significant changes on plasma levels of potassium, uric acid, glucose, or in the lipid profile. CONCLUSION: The combination of low dosages of bisoprolol and hydrochlorothiazide may be considered an effective, well tolerated and rational alternative for the initial treatment of the patients with mild to moderate hypertension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>agentes anti-hipertensivos em baixas doses</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>combinação bisoprolol/hidroclorotiazida</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>low dosage of antihypertensive agents</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>bisoprolol/hydrochlorothiazide combination</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Massa intracardíaca em provável caso de granulomatose de Wegener</s1>
</fA08>
<fA08 dir="en">
<s1>Wegener's granulomatosis in a patient with intracardiac mass</s1>
</fA08>
<fA11 dir="011000">
<s1>Thelma L. Skare</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dimitri M. Zappi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade Evangélica de Medicina do Paraná  </s1>
<s2>Curitiba </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>609-611</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>7</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>A granulomatose de Wegener, doença conhecida há aproximadamente 65 anos, continua sendo um dilema para a classe médica, talvez pelo seu polimorfismo clínico, talvez pela carência de métodos diagnósticos. Seu diagnóstico laboratorial repousa no binômio: dosagem do anticorpo anti-neutrófilo em sua fração citoplasmática (ANCA-c) e na obtenção de material para análise anatomopatológica. Descrevemos aqui, o caso de um paciente, em cuja evolução clínica pôde ser observada todo aspecto proteiforme desta doença, chamando atenção para o envolvimento cardíaco. Este último considerado por muitos como pouco usual, manifestou-se clinicamente sob a forma de miocardite, pericardite e de uma massa intracardíaca.</s0>
</fC01>
<fC01 dir="en">
<s0>Although Wegener's granulomatosis is known for almost 65 years, the disease is still a dilemma for physicians. This is probably due to its different clinical presentations or to the lack of diagnostic methods. The laboratorial diagnosis is supported on the presence of antineutrophil cytoplasmic antibodies (ANCA-c) and on histological analysis of tissues from affected organs. This paper describes a case report of a patient whose clinical history presented all protean aspects of the disease, including cardiac involvement such as myocarditis, pericarditis and, surprisingly, intracardiac mass.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Comunicação interatrial do tipo seio coronário, comunicação interventricular e ausência de veia cava superior esquerda</s1>
</fA08>
<fA08 dir="en">
<s1>Coronary sinus atrial septal defect and ventricular septal defect with no left superior vena cava</s1>
</fA08>
<fA11 dir="011000">
<s1>Fábio Alves Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Augusto Cardoso Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Augusto de Jesus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Simone Rolim Fernandes Fontes Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Valmir Fernandes Fontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luís Carlos Bento de Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>613-617</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>08</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Relatamos um caso raro de um paciente de 21 meses, portador de comunicação interatrial do tipo seio coronário, associada a comunicação interventricular perimembranosa, e ausência de veia cava superior esquerda. O diagnóstico foi realizado através da ecocardiografia e confirmado pela angiografia. O paciente foi operado sem intercorrências, ambos os defeitos foram fechados com patch de pericárdio bovino e o fluxo das veias coronárias ficou direcionado para o átrio esquerdo. Um ecocardiograma mostrou ausência de shunt residual através dos defeitos.</s0>
</fC01>
<fC01 dir="en">
<s0>We report a rare case of a 21 month old child with a coronary sinus atrial septal defect associated with perimembranous ventricular septal defect and no left superior vena cava. The diagnosis was made by transthoracic echocardiogram and confirmed by angiography. The patient was operated on uneventfully, both defects were closed with bovine pericardial patches and the flow from the coronary veins was directed towards the left atrium. An echocardiogram revealed complete closure of both defects.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 5/98 - Instituto do Coração do Hospital das Clínicas - FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>619-623</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Ventriculectomia esquerda parcial. Paradigmas esquecidos</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos A. M. Gottschall</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>625-627</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100412</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>A troponina como marcador de injúria celular miocárdica</s1>
</fA08>
<fA11 dir="011000">
<s1>Moacir Fernandes de Godoy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Domingo Marcolino Braile</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Purini Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Português de Beneficência de São José do Rio Preto  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>629-633</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100413</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Insuficiência cardíaca</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Instituto do Coração do Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>635-642</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>67</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100414</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="">
<s1></s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>643-646</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100415</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Seqüência básica na elaboração de protocolos de pesquisa</s1>
</fA08>
<fA11 dir="011000">
<s1>Bráulio Luna Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Estado de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>735-740</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Quantificação de insuficiência protética mitral por diferentes métodos de avaliação pela ecocardiografia transesofágica</s1>
</fA08>
<fA08 dir="en">
<s1>Quantification of mitral prosthesis regurgitation by transesophageal echocardiography. Evaluation of different methods</s1>
</fA08>
<fA11 dir="011000">
<s1>Cláudio Henrique Fischer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Orlando Campos Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Valdir Ambrósio Moisés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Marconi Almeida Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Cristiano Vieira Machado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Edgar Bezerra de Lira Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Lázaro de Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Antonio Carlos de Camargo Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Dirceu Vieira Santos Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>741-750</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar os diferentes métodos de quantificação de insuficiência mitral (IM) ao ecocardiograma transesofágico (ETE) em pacientes com suspeita clínica de disfunção de prótese mitral. MÉTODOS: Foram estudados 15 pacientes, divididos em dois grupos, conforme a presença ou não de IM expressiva (grau importante) ao cateterismo cardíaco (Cate). A IM foi quantificada ao ETE pelos seguintes métodos, habitualmente empregados para IM de valvas nativas: avaliação subjetiva do jato regurgitante ao mapeamento de fluxo a cores, avaliação objetiva com base na área absoluta do jato regurgitante e na sua área relativa (área do jato/área do átrio esquerdo (AE)), e avaliação baseada na presença de fluxo sistólico reverso em veia pulmonar. RESULTADOS: A IM foi predominantemente de origem transprotética (14 pacientes) e de distribuição excêntrica (11 pacientes). Observou-se concordância estatisticamente significante (p&lt;0,05) entre IM expressiva ao Cate (8 pacientes) e ao ETE pela avaliação subjetiva e presença de fluxo sistólico reverso em veia pulmonar. As avaliações pelas áreas absoluta (área de jato &gt;7cm²) e relativa (área de jato &gt;35% da área do AE) não mostraram concordância significante com o Cate, com nítida subestimação ao ETE pela área relativa. Houve, porém, concordância significante, quando considerado como IM expressiva, jato cuja área relativa foi &gt;30% da área do AE. CONCLUSÃO: O ETE identificou adequadamente as IM protéticas angiograficamente expressivas, particularmente pelos métodos subjetivo e de fluxo sistólico reverso em veia pulmonar. É necessário cautela na utilização de critérios baseados na área do jato regurgitante, em virtude da subestimação da área na presença de jato excêntrico, freqüente em disfunção de prótese mitral.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the different methods for grading mitral regurgitation (MR) by transesophageal echocardiography (TEE) in patients with clinical suspicion of mitral prosthesis dysfunction. METHODS: Cardiac catheterization (Cath) was performed in 15 patients for grading the severity of prosthetic MR, divided in two groups based on the presence or absence of severe MR. Prosthetic MR was quantified by TEE using methods commonly used for MR of native valves: subjective assessment by color Doppler, objective assessment based on absolute jet area and on its relative area (jet area/left atrial area) and assessment based on the presence of systolic flow reversal in pulmonary vein. RESULTS: Prosthetic MR was mostly transprosthetic (14 patients) and eccentric (11 patients). There was significant correlation (p&lt;0.05) between Cath and TEE for identification of severe MR based on subjective assessment and on the presence of systolic flow reversal in pulmonary vein. Identification based on absolute (jet area &gt;7cm²) and relative (jet area &gt;35% of left atrial area) jet areas did not reveal significant correlation with the angiographic grade and showed clear underestimation by TEE when the last method was used. However, there was good correlation (p&lt;0.05) if relative jet areas &gt;30% were considered as cut point. CONCLUSION: TEE correctly identified angiographic severe mitral prosthesis regurgitation, mainly by the presence of systolic flow reversal in pulmonary vein and subjective assessment. The estimation of severity of the prosthetic MR by absolute or relative jet area seems to be limited and should be used with caution due to eccentricity of the regurgitant jet, frequently seen in mitral prosthesis dysfunction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma transesofágico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>disfunção de prótese</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>transesophageal echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prosthesis dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral regurgitation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Cirurgia de revascularização do miocárdio através de minitoracotomia esquerda</s1>
</fA08>
<fA08 dir="en">
<s1>Myocardial revascularization surgery through a left minithoracotomy</s1>
</fA08>
<fA11 dir="011000">
<s1>Wilson Luiz da Silveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Adélio Ferreira Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ersival Pereira Artiaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fernando César Queiroz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Keyla Alves Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maria Cristina de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Márcio Alves da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Marcus Abdulmassih del Papa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Lincoln Henrique Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Olympia M. B. Rodrigues da Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Hernando Nazzeta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Vilmondes Gonçalves de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Santa Genoveva  </s1>
<s2>Goiânia GO</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>747-750</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Atualmente existe uma tendência mundial para a realização de cirurgias através de incisões mínimas, denominadas minimamente invasivas, tornando o ato operatório cada vez menos agressivo. A introdução desta nova técnica possibilita a dissecção da artéria torácica interna esquerda (ATIE) e sua anastomose com a artéria interventricular anterior (AIA), através de uma minitoracotomia esquerda. MÉTODOS: De maio/96 a outubro/97, 11 portadores de insuficiência coronária, com lesão única e proximal da AIA, foram submetidos a revascularização do miocárdio (RM). A abordagem cirúrgica consistiu de uma toracotomia ântero-lateral esquerda, de aproximadamente 10cm, através do 4º espaço intercostal esquerdo, e nos últimos 6 casos com ressecção de parte da cartilagem da 4ª e 5ª costelas, dissecção da ATIE, abertura e reparo do pericárdio adjacente à AIA. Todos pacientes receberam ponte única para AIA com enxerto da ATIE, sem auxílio de circulação extracorpórea (CEC). RESULTADOS: A idade variou de 46 a 76 (média = 58,55) anos, sendo 10 (90,90%) pacientes do sexo masculino e 1 (9,09%) feminino. O tempo de permanência hospitalar variou de 4 a 8 (média de 5,2) dias. Nenhum paciente apresentou alteração eletrocardiográfica no pós-operatório imediato. Um paciente apresentou no controle, trombose no 1/3 distal da ATIE com comprometimento importante de fluxo e, outro, estenose ao nível da anastomose, sendo ambos submetidos a angioplastia com sucesso. Não houve mortalidade no grupo estudado. CONCLUSÃO: A ausência de mortalidade, sugere que a cirurgia de RM através de cirurgia minimamente invasiva, em grupos selecionados, é uma excelente alternativa de revascularização da AIA.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: There is, today, a global tendency towards a surgical approach privileging very small incisions, the so-called minimally invasive intervention, which results in a less aggressive action. The introduction of this new technique makes it possible to dissect the left internal thoracic artery (LITA) and to perform in the anastomosis with the anterior interventricular artery (AIA) through a left minithoracotomy. METHODS: From May of 1996 to october of 1997, 11 patients with ischemic heart disease and a single proximal lesion of the AIA were submitted to a myocardial revascularization (MR). The surgical approach consisted of a left anterolateral thoracotomy through the 4th left intercostal space, of approximatly 10cm, and in the last 6 cases, resection of part of the cartilage of the 4th and 5th ribs, dissection of the LITA, as well as opening and repair of the pericardium adjacent to the AIA was done. All patients received a single bypass to the AIA with a graft of the LITA, without extracorporeal circulation. RESULTS: The patients' age varied between 46 and 76 years (mean = 58,55). Ten patients (90,90%) were males and 1 (9,09%) was a female. Hospital stay ranged from 4 to 8 days, with the average of 5,2 days. None of the patients presented any electrocardiographic change in the immediate post-operatory period. During the control period one patient developed a clot in the distal LITA, with important compromise of the flow. In another patient the stenosis was at the level of the anastomosis. Both were successfully submitted to angioplasty. There were no deaths in the groups studied. CONCLUSION: The absence of deaths suggests to us that MR surgery carried out with this minimally invasive technique, in selected groups and is an excellent alternative to the revascularization of the AIA.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>minitoracotomia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>revascularização do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia minimamente invasiva</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>minithoracotomy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>minimally invasive surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Marcapasso com sensor de contratilidade regulado pelas variações do sistema nervoso autônomo na miocardiopatia chagásica crônica</s1>
</fA08>
<fA08 dir="en">
<s1>Chagas heart disease and contractility rate responsive pacing controlled by autonomic nervous system variations</s1>
</fA08>
<fA11 dir="011000">
<s1>Oswaldo Tadeu Greco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Vito Ardito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Dorotéia Rossi Silva Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Max Schaldach</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Moléstias Cardiovasculares  </s1>
<s2>São José do Rio Preto SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>751-761</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar o desempenho da estimulação cardíaca artificial com marcapasso do tipo VVIR cujo sensor é regulado pelas variações do sistema nervoso autônomo em pacientes chagásicos com distúrbio no sistema de condução. MÉTODOS: Estudados 47 chagásicos, 28 do sexo masculino, com idades entre 24 e 68 anos, 36 tinham bloqueio atrioventricular (AV) total; 8, bloqueio AV de 2º grau 2; e 3 doença do nódulo sinusal, e encontravam-se, de acordo com a NYHA, em classe I (4), II (15), III (16) e IV (12). Após o implante de marcapasso do tipo VVIR os pacientes foram acompanhados durante 12 meses. A resposta de freqüência foi registrada em gravações de Holter de 24h e divididos em dois grupos de acordo com a FC em repouso - grupo 1: &gt;65bpm e grupo 2: &lt;=65bpm, para estudo comparativo, considerando: 1) FC em exercício no período de pós-implante; 2) PA em repouso após o implante e 3) avaliação dos grupos de eletrodos identificados como TIR-60-UP e outros eletrodos. RESULTADOS: O grupo 1 teve em exercício menor variação entre seus valores, do que o grupo 2, indicando que esse tipo de sistema de estimulação permite controlar individualmente cada paciente. Os valores de PA em repouso e em exercício não foram diferentes entre os grupos. O eletrodo do tipo TIR-60-UP, comportou-se como os demais eletrodos. CONCLUSÃO: O marcapasso do tipo VVIR cujo sensor é regulado pelas variações do SNA propicia o restabelecimento dos mecanismos fisiológicos em chagásicos, sendo que 74% deles tiveram melhora de uma ou duas classes funcionais da NYHA.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To analyse the performance of the artificial cardiac stimulation with the VVIR pacemaker whose sensor is adjusted by the variations of the autonomic nervous system in Chagas disease patients with deficiency of the conduction system. METHODS: Forty-seven Chagas disease patients have been studied, 28 male between 24 and 68 years old, 36 patients had complete AV block, 8 had 2nd degree AV block and the other 3 had sinus node disease. The patients were in class I (4), II (15), III (16) and IV (12) according to the NYHA. A 12-month-follow-up with constant clinical evaluations was carried out after pacemaker implantation. Patients were divided in 2 different groups according to the HR at rest - group 1: &gt;65 beats per minute (bpm) and group 2: &lt;=65bpm, for a comparative study considering: 1) HR at stress test after the implantation; 2) arterial blood pressure at rest after the implantation and, 3) evaluation of the identified electrodes such as TIR-60-UP and others. RESULTS: The group 1 had greater HR at rest, and a smaller variation of values at stress than group 2. This shows that with this type of stimulation system it is possible to control each patient separately. The values of blood pressure at rest and during stress were not different between groups. According to the factors analysed the TIR-60-UP electrode had the same performance as the others. CONCLUSION: The VVIR pacemaker with the sensor adjusted by the ANS variations has provided the Chagas patients with a restoration of their physiological mechanisms. 74% of them had the improvement of either one or 2 functional classes.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>marcapasso</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença de Chagas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>marcapasso com resposta de freqüência</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sistema nervoso autônomo</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pacing</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rate responsive pacing</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>autonomic nervous system</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Diagnóstico pela ecocardiografia transesofágica e evolução de 35 pacientes portadores de flail mitral valve</s1>
</fA08>
<fA08 dir="en">
<s1>Flail mitral valve leaflet diagnosed by transesophageal echocardiography. Report and evolution of 35 cases</s1>
</fA08>
<fA11 dir="011000">
<s1>Mônica M. C. Caldas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Lúcia M. A. Fenelon</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>William A. M. Esteves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Tamara Katina</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Nilson Maia</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Márcia M. Barbosa</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>763-767</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Descrever os achados ao ecocardiograma transesofágico e evolução clínica de portadores de flail mitral valve. MÉTODOS: No período de janeiro/93 a março/97, 1675 pacientes foram submetidos, em nossa instituição, a ecocardiograma transesofágico, sendo que em 35 casos foi feito o diagnóstico de flail mitral valve e, posteriormente, obtida sua evolução clínica. RESULTADOS: A idade dos pacientes variou 12 a 87 anos (média 65±15) e 27 (77%) eram do sexo masculino. O folheto posterior foi o mais acometido (25 pacientes, 71%). O mecanismo do flail foi ruptura de cordoalha tendínea em todos os casos, exceto um, que apresentava importante alongamento e redundância de cordoalha. A etiologia foi prolapso e/ou degeneração mixomatosa em 15 pacientes, degenerativa em 9, isquêmica em 5, reumática em 4 e endocardite em 3. Regurgitação mitral de grau importante ocorreu em 25 (71%) pacientes e moderada em 10 (29%). O tempo médio de acompanhamento foi de 375±395 dias (1 a 1380). Foram submetidos a tratamento clínico 19 pacientes e a tratamento cirúrgico 16, sendo que em todos foi confirmado o diagnóstico transesofágico. O número total de óbitos (hospitalar e pós-hospitalar) foi alto (34%), tanto em pacientes submetidos a tratamento clínico quanto cirúrgico. Entre os sobreviventes, 17 estão em classe funcional (CF) I e 6 em CF II da NYHA. CONCLUSÃO: O diagnóstico de flail mitral valve ao ecocardiograma transesofágico é acurado, permitindo a definição de sua etiologia e mecanismo. A alta mortalidade à época do diagnóstico, provavelmente, se relaciona à gravidade da doença subjacente. Embora os pacientes não operados estejam evoluindo bem, a baixa CF observada nestes pacientes pode ser atribuída ao curto período de seguimento.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To describe transesophageal echocardiographic findings in patients presenting with flail mitral valve and to obtain their clinical follow-up. METHODS: From January/93 to March/97, 1675 patients were submitted to transesophageal echocardiogram at our institution; 35 of them were diagnosed as having flail mitral valve and their clinical follow-up was obtained. RESULTS: Thirty-five patients with the diagnosis of flail mitral valve were studied. Mean age was 65±15 years (12-87) and 27 (77%) were male. The posterior leaflet was involved in 25 (71%) patients. Ruptured chordae tendineae was present in all but one patient in whom flail mitral valve was due to a very elongated and redundant chordae. The etiology was prolapse and/or mixomatous degeneration in 16 patients, degenerative in 10, ischemic in 5, rheumatic in 4 and endocarditis in 3. Mitral regurgitation was severe in 25 (71%) patients and moderate in 10 (29%). The mean follow-up was 375±395 days (1 to 1380). Nineteen patients were followed clinically and 16 were submitted to surgery (transesophageal echocardiogram findings were confirmed in all 16). Overall mortality was high (34%). Among the survivors, 17 are in NYHA class I and 6 in class II. CONCLUSION: The diagnosis of flail mitral valve by transesophageal echocardiography is accurate, allowing for the definition of its mechanism and etiology, as well as the evaluation of hemodynamic compromise. The observed high mortality at the time of diagnosis may be related to the severity of the disease causing the flail mitral valve. Although non-operated survivors are doing well, the observed low functional class in these patients may be related to the short period of follow-up.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ruptura de cordoalha</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>regurgitação mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma transesofágico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>flail mitral valve</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral regurgitation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>transesophageal echocardiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Experiência global no fechamento percutâneo do canal arterial</s1>
</fA08>
<fA08 dir="en">
<s1>Overall experience with percutaneous occlusion of the patent ductus arteriosus</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Augusto Cardoso Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Simone Rolim Fenandes Fontes Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>César Augusto Esteves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sérgio Luís Navarro Braga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria Aparecida Paula Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Tarcísio Luís Valle de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Maria Virgínia Tavares Santana</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>José Eduardo Moraes Rego Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Valmir Fernandes Fontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>769-780</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>54</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a experiência global da nossa instituição com o fechamento percutâneo do canal arterial. MÉTODOS: Desde dezembro/92, 150 pacientes foram submetidos a 178 procedimentos (85 - técnica de Rashkind; 87 - coils de Gianturco; 6 - coils Duct Occlud). A mediana de idade foi de 6,5 anos (1 a 57). A média do diâmetro mínimo do canal foi de 3,05±1,24mm (1 a 8). Avaliações clínicas e ecocardiográficas foram realizadas seriadamente. RESULTADOS: Implantes adequados ocorreram em 143 (95,3%) pacientes. A prevalência de shunt residual imediato foi de 52,1%, decrescendo para 15,9% no seguimento. Esta taxa caiu para 5,2% após a realização de procedimentos adicionais. Embolização de coils ocorreu em 12 procedimentos e de umbrella em 1. Um paciente apresentou hemólise e outro estenose discreta da artéria pulmonar esquerda. Não houve mortalidade. CONCLUSÃO: Esta modalidade terapêutica é segura e eficaz, proporcionando bons resultados a longo prazo.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the overall experience of our institution with percutaneous occlusion of the patent ductus arteriosus. METHODS: Since December/92, 150 patients underwent 178 procedures (85 - Rashkind technique; 87 - Gianturco coils; 6 - Duct Occlud). Median age was 6.5 years (1 to 57). Mean minimum ductal diameter was 3.05±1.24mm (1 to 8). Clinical and echocardiographic evaluations were performed periodically. RESULTS: Adequate implantation was achieved in 143 (95.3%) patients. Prevalence of immediate residual shunting was 52.1%, falling to 15.9% during follow-up. This figure decreased to 5.2% after new additional procedures. Umbrella and coil embolization occurred in 1 and 12 procedures, respectively. Hemolysis and mild stenosis of left pulmonary artery were observed in one patient each. There was no mortality. CONCLUSION: This therapeutic modality is safe and efficacious with good follow-up results.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>persistência do canal arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiologia intervencionista</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatias congênitas</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>patent ductus arteriosus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>interventional cardiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart diseases</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>O significado da abstinência do álcool na cardiomiopatia alcoólica com disfunção ventricular moderada</s1>
</fA08>
<fA08 dir="en">
<s1>The significance of alcohol abstinence in alcoholic cardiomyopathy with moderate left ventricular dysfunction</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco Manes Albanesi Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Márcia Bueno Castier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Silvia Helena Cardoso Boghossian</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Tatiana Tavares da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro Faculdade de Ciências Médicas </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>781-785</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o papel da abstenção alcoólica, no período de 12 meses, na cardiomiopatia alcoólica (CMA) com disfunção ventricular de grau moderado, em pacientes tratados com esquema anticongestivo. MÉTODOS: Estudo observacional prospectivo com 20 pacientes com CMA, 9 (45%) na classe funcional (CF) II e 11(55%) na CF III, 16 (80%) homens, predomínio de negros (55%), de 35 a 56 (x=45) anos, com consumo pesado de álcool (&gt;80g etanol/dia), por período de 51 a 112 (x=85) meses, que concordaram, inicialmente, em participar de programa de apoio, com psicoterapia de grupo, além do acompanhamento clínico com realização de exames não invasivos, antes do início do programa e após 12 meses da terapia, e foram divididos em dois grupos, o 1 (G-I) constituído pelos que atingiram a abstinência e o 2 (G-II) pelos não abstêmios. RESULTADOS: Após 12 meses, 11 (55%) pacientes permaneciam em terapia de apoio, 8 (72,72%) no G-I, enquanto os 9 (45%) que não se mantiveram no programa, apenas 2 (22,22%) tinham logrado abstinência (G-I). Ao fim da avaliação, alcançamos número igual de pacientes entre os grupos. Comparando os grupos observamos: a) menores valores médios dos diâmetros sistólico (DSVE) e diastólico (DDVE) do ventrículo esquerdo no G-I; b) maior número de internações no G-II (3) em relação ao G-I (1); c) na evolução clínica, maior número de pacientes do G-I, entre os que apresentaram melhoras (3 G-I e 1 G-II) e que permaneceram inalterados (6 G-I e 3 G-II), além do maior número de pioras entre o G-II (1 G-I e 5 G-II). CONCLUSÃO: Apesar do desejo inicial favorável, a abstinência só foi obtida em 50% dos pacientes com CMA e disfunção ventricular moderada, porém, quando alcançada, apresentou melhor evolução (melhoras + inalterados = 90%), com maior redução do DSVE e do DDVE (p&lt;0,001), devendo sempre ser perseguida mesmo na presença de moderada disfunção ventricular.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the role of a 12 month alcohol abstinence period in patients with moderate left ventricular dysfunction treated with anticongestive therapy. METHODS: Prospective observational study with 20 patients with alcoholic cardiomyopathy (ACM), 9 (45%) in functional class (FC) II and 11 (55%) in FC III, 16 (80%) men, mostly black (55%), from 35 to 56 (x=45) years old, heavy alcohol users (&gt;80g ethanol for 51 to 112 (x=88) months. At the beginning, all agreed to participate with psychotherapy and clinical evaluation. After 12 months, they were divided in G-I, formed by those who remained abstemious and G-II of non-abstemious. RESULTS: After 12 months, among the 11(55%) who remained in psychotherapy, 8 were in G-I, among those who did not 9 (45%), only 2 (22,22%) remained abstemious (G-I). At the end of the evaluation period, both groups had the same number of patients. Comparing them, we observed: a) lower mean systolic and diastolic left ventricular diameters in G-I; b) more hospitalizations in G-II (3); c) more patients with stable or better clinical evolution in G-I. CONCLUSION: Despite the initial will, only 50% reached abstinence. When it was reached, patients had a better evolution in left ventricular systolic diameter and abstinence should always be tried even in the presence of moderate left ventricular dysfunction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiomiopatia alcoólica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>abstinência</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>evolução</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>alcoholic cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>abstinence</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>evolution</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Comportamento da freqüência cardíaca e da sua variabilidade durante as diferentes fases do exercício físico progressivo máximo</s1>
</fA08>
<fA08 dir="en">
<s1>Heart rate response and its variability during different phases of maximal graded exercise</s1>
</fA08>
<fA11 dir="011000">
<s1>Denise de Oliveira Alonso</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Claudia Lucia de Moraes Forjaz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Liliane Onda Rezende</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ana Maria F. W. Braga</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Carlos Eduardo Negrão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Maria Urbana Pinto Brandão Rondon</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>787-792</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: A variabilidade da freqüência cardíaca (VFC) tem sido estudada em repouso, como meio não-invasivo para avaliação da regulação autonômica cardíaca, sendo que sua diminuição está relacionada a maior risco cardiovascular. Entretanto, durante o exercício, quando ocorrem importantes alterações neurais, seu comportamento deve ser melhor documentado. Estudamos o comportamento da freqüência cardíaca (FC) e da sua variabilidade durante as diferentes fases metabólicas do exercício físico progressivo máximo, em jovens. MÉTODOS: Dezessete homens (28±6 anos) realizaram teste ergoespirométrico máximo em cicloergômetro (30W/3min), determinando-se a FC e a VFC (desvio-padrão) através da onda eletrocardiográfica, amplificada e gravada batimento a batimento em computador, numa freqüência da 125Hz (AT/Codas). RESULTADO: A FC aumentou concomitantemente ao aumento da intensidade do exercício. A VFC diminuiu progressivamente, atingindo níveis significantes em relação ao repouso a partir de 60% do consumo de oxigênio do pico do exercício, a partir de 45-60% da potência máxima e a partir da intensidade do limiar anaeróbio, estabilizando-se nos períodos subseqüentes. CONCLUSÃO: Nossos resultados sugerem que a VFC medida pelo desvio-padrão da FC diminui em fases do exercício nas quais o aumento da FC é determinado, principalmente, por retirada vagal.</s0>
</fC01>
<fC01 dir="en">
<s0>PURPOSE: Heart rate variability (HRV) has been studied at rest as a non-invasive tool for the assessment of cardiac autonomic control and, its attenuation is related to cardiovascular risk. However, during exercise, when important neural changes take place, HRV behaviour is not well established. The aim of this investigation was to study the heart rate (HR) and HRV responses during the different metabolic phases of maximal graded exercise in young men. METHODS: Seventeen men (age 28±6 years) were submitted to a graded cardiopulmonary exercise test in a cycloergometer (30W/3min). To study HR and HRV (standard-deviation), the eletrocardiographic signal was amplified and acquired beat-to-beat in a computer at a frequency of 125 Hz (AT/Codas). RESULTS: The HR increases concomitantly to the increase in exercise intensity. The HRV was significantly lower than rest values after exercise intensities of 60% of peak exercise oxygen uptake, 45-60% of maximal power and, after anaerobic threshold intensity. CONCLUSION: This results suggest that HRV measured by standard deviation of HR decreases during exercise phases when HR increment is determined mainly due to vagal withdrawal.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>freqüência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>variabilidade da freqüência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>exercício</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart rate</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart rate variability</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Ausência de conexão atrioventricular à direita. Apresentação morfológica e clínica quando o ventrículo principal é morfologicamente direito</s1>
</fA08>
<fA08 dir="en">
<s1>Absence of the right atrioventricular connection. Morphological and clinical presentation when the dominant ventricle is morphologically right</s1>
</fA08>
<fA11 dir="011000">
<s1>José Fernando Cavalini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vera Demarchi Aiello</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Munir Ebaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>793-796</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Ausência de conexão atrioventricular à direita com o ventrículo dominante, morfologicamente direito, colocado à esquerda, em conexão com o átrio esquerdo, é uma rara situação. Os autores apresentam cinco casos com esta disposição morfológica, salientando os aspectos anatômicos e clínicos, bem como a importância da nomenclatura baseada na análise segmentar seqüencial.</s0>
</fC01>
<fC01 dir="en">
<s0>Absent right atrioventricular connection, with the left atrium connected to a dominant left-sided morphologically right ventricle is a rare situation. We report five cases with these anatomical features, with emphasis on the morphological and clinical aspects. Although this combination of lesions is very uncommon, the sequential segmental analysis can easily provide an accurate description of the anomaly.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso nº 6/98 - Instituto Dante Pazzanese de Cardiologia - São Paulo</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>797-800</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Insuficiência cardíaca nos idosos. Diferenças e semelhanças com os mais jovens</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maurício Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>801-806</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>44</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100611</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Dislipidemias em crianças e adolescentes. Bases para a terapêutica</s1>
</fA08>
<fA11 dir="011000">
<s1>Neusa Forti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jaqueline Issa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Jayme Diament</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sergio Diogo Giannini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>807-810</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100612</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>71</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="">
<s1></s1>
</fA08>
<fA11 dir="011000">
<s1>Sergio Emanuel Kaiser</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>811-811</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1998</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(98)07100613</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Goals for the next millennium</s1>
</fA08>
<fA11 dir="011000">
<s1>Ângelo A. V. de Paola</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Márcia de Melo Barbosa</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>03-04</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Chronic coronary artery disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Protásio Lemos da Luz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Desidério Favarato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>University of São Paulo Medical School Instituto do Coração </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>22-38</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>162</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Rational utilization of diagnostic tests in cardiology</s1>
</fA08>
<fA11 dir="011000">
<s1>Bráulio Luna Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Federal University of the State of São Paulo Escola Paulista de Medicina </s1>
<s2>Sao Paulo SP</s2>
<s3>Brasil</s3>
</fA14>
<fA20 dir="000000">
<s1>45-50</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>08</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Neoplastic pericardial disease. Analysis of 26 patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Helena Nogueira Soufen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fábio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Barbara Maria Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Sampaio Gutierrez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paulo Pego-Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>55-58</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: To characterize patients with neoplastic pericardial disease diagnosed by clinical presentation, complementary test findings, and the histological type of tumor. METHODS: Twenty-six patients with neoplastic pericardial disease were retrospectively analyzed. RESULTS: Clinical manifestations and abnormalities in chest roentgenograms and electrocardiograms were frequent, but were not specific. Most patients underwent surgery. There was a high positivity of the pericardial biopsy when associated with the cytological analysis of the pericardial liquid used to determine the histological type of the tumor, particularly when the procedure was performed with the aid of pericardioscopy. CONCLUSION: The correct diagnosis of neoplastic pericardial disease involves suspicious but nonspecific findings during clinical examination and in screen tests. The suspicious findings must be confirmed through more invasive diagnostic approaches, in particular pericardioscopy with biopsy and cytological study.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>malignancy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pericardial disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pericardioscopy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Percutaneous closure of atrial septal defects. The role of transesophageal echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Simone R. F. Fontes Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Augusto Cardoso Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Jorge Eduardo Assef</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Renata de Sá Cassar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>César Augusto Esteves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sérgio N. Braga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Sérgio Pontes Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Valmir Fernandes Fontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>65-69</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: Evaluation of the role of transesophageal echocardiography in percutaneous closure of atrial septal defects (ASD) with the Amplatzer septal occluder. METHODS: Patients were selected for percutaneous closure of ASD by transesophageal echocardiography (TEE), which was also used to monitor the procedure, helping to select the appropriate size of the Amplatzer device, to verify its position, and to access the immediate results of the procedure. During the follow-up, TEE was used to evaluate the presence and magnitude of residual shunt (RS), device position, and right cardiac chamber diameters. RESULTS: Twenty-two (40%) of a total of 55 studied patients were selected. Thirteen underwent Amplatzer device implantation, eight are still waiting for it, and one preferred the conventional surgical treatment. All procedures were successful, which was mainly due to proper patient selection. Six (23%) patients acutely developed RS, which spontaneously disapeared at the three-month follow-up examination in three patients. There was a significant reduction in the right ventricle diastolic diameter, from 27mm (average) to 24mm and 20mm, one and three months after the procedure, respectively (p&lt;0.0076). CONCLUSION: With the aid of TEE, percutaneous closure of ASD can be successfully, safely, and effectively performed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial septal defects</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>interventional cardiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Relapsing pulmonary embolism in a patient with a spinal cord-injure</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciano J. Vacanti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João J. Rodrigues</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cláudio H. Fisher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sandra F. Delsin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Hermes T. Xavier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pronto Socorro Cardiológico de Santos  </s1>
<s2>Santos SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>75-78</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Tetralogy of fallot and aortic coarctation. A rare association</s1>
</fA08>
<fA11 dir="011000">
<s1>Renata Cristina de Santana</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vitor Coimbra Guerra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Nana Miura Ikari</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Munir Ebaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Instituto do Coração do Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>82-84</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Cardiovascular changes and cardiac morbidity of menopause. Effects of hormone replacement therapy</s1>
</fA08>
<fA11 dir="011000">
<s1>Roberto Bassan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>92-98</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>89</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>The &quot;no-reflow&quot; phenomenon in the coronary arteries</s1>
</fA08>
<fA11 dir="011000">
<s1>Antônio Esteves Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Donaldo Pereira Garcia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Eulógio Emílio Martinez Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>104-108</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Acute ischemic syndromes</s1>
</fA08>
<fA11 dir="011000">
<s1>Valter Correia de Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Escola Paulista de Medicina Hospital São Paulo </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>109-137</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>182</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Methodological and statistical topics in randomized controlled clinical trials</s1>
</fA08>
<fA11 dir="011000">
<s1>Claudia Caminha Escosteguy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital dos Servidores do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>139-143</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Edson Antonio Bregagnollo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Adjair Humberto Fortes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Carlos Cicogna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNESP Faculdade de Medicina de Botucatu </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>149-160</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the hemodynamic and vasodilating effects of milrinone lactate (ML) in patients with dilated cardiomyopathy (DCM) and New York Heart Association (NYHA) class III and IV heart failure. METHODS: Twenty patients with DCM and NYHA class III and IV heart failure were studied. The hemodynamic and vasodilating effects of ML, administered intravenously, were evaluated. The following variables were compared before and during drug infusion: cardiac output (CO) and cardiac index (CI); pulmonary capillary wedge pressure (PCWP); mean aortic pressure (MAP); mean pulmonary artery pressure (MPAP); mean right atrial pressure (MRAP); left ventricular systolic and end-diastolic pressures (LVSP and LVEDP, respectively); peak rate of left ventricular pressure rise (dP/dt); systemic vascular resistance (SVR); pulmonary vascular resistance (PVR); and heart rate (HR). RESULTS: All patients showed a significant improvement of the analysed parameters of cardiac performance with an increase of CO and CI; a significant improvement in myocardial contractility (dP/dt) and reduction of the LVEDP; PCWP; PAP; MAP; MRAP; SVR; PVR. Were observed no significant increase in HR occurred. CONCLUSION: Milrinone lactate is an inotropic dilating drug that, when administered intravenously, has beneficial effects on cardiac performance and myocardial contractility. It also promotes reduction of SVR and PVR in patients with DCM and NYHA class III and IV of heart failure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>inotropic agents</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>milrinone</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Protective effect of left ventricular hypertrophy in right coronary artery occlusions</s1>
</fA08>
<fA11 dir="011000">
<s1>Marne de Freitas Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Antônio Mascia Gottschall</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>161-170</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To test the hypothesis that left ventricular hypertrophy (LVH) reduces the electrocardiographic and functional effects of right coronary artery occlusion. METHODS: We analysed 215 patients (166 males and 49 women,age of 58.9±10.6 years), with occlusion of the right coronary artery without other associated lesions. There was no significant difference (p&gt;0.05) in age and gender distribution between the 78 patients with LVH (left ventricular mass &gt;100g/m²) (Group A) when compared with the 137 patients without LVH (left ventricular mass &lt;100g/m²) (Group B). RESULTS: The electrocardiographic finding of transmural necrosis was more often found in group B patients than in group A patients (56.9% and 30.8%, respectively; p&lt;0.05). The left ventricular function parameters of group A were better than those of group B: the ratio end-diastolic pressure/systolic pressure (EDP/SP) (A: 0.108±0.036; B: 0.121±0.050; p&lt;0.05); the end-diastolic volume index (A: 75.9±31.3ml/m²; B: 88.0±31.0ml/m²; p&lt;0.01); the end-systolic volume index (A: 16.0±10.0ml/m²; B: 27.0 ±20.0ml/m²; p&lt;0.001); the ejection fraction (A 78.6±10.8%; B 67.7±17.9%; p&lt;0.001); the anteroinferior shortening (A: 43.9±10.3%; B: 35.1±12.8%; p&lt;0.001). A higher degree of coronary tortuosity was observed in group A than in group B (78.2% and 24.1%; p&lt;0.001) and also a more frequent absent or minimal diaphragmatic hypokinetic area (A: 80.8%; B: 54.0%; p&lt;0.05). CONCLUSION: LVH reduces the effects of myocardial sequela and protects LV function when right coronary occlusion develops.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemic cardiopathy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Comparative study for the identification of myocardial ischemia by contrast ventriculography under the effect of isosorbide mononitrate and by perfusional myocardial scintigraphy in patients with ischemic heart disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Waldomiro Carlos Manfroi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Ludwig</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luciana Schmidt Kirschnick</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Josiane Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Letícia Weiss Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Karen Ordovás</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Cristiane Leitão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Rosana Cruz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Rafael Candiago</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Faculdade de Medicina </s1>
<s2>Porto Alegre </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>171-183</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>49</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate and compare the usefulness of cineventriculographies, before and after nitrate use, to technetium-99m sestamibi scintigraphy for the identification of myocardial ischemia. METHODS: Twenty-six patients were studied at basal conditions and 5 minutes after intravenous administration of isosorbide mononitrate (0.3mg/kg), to evaluate the performance and regional wall motion of the left ventricle (LV). The results were compared to those obtained with technetium-99m sestamibi scintigraphy. RESULTS: Before nitrate, contrast ventriculography identified 30 normal segments, 62 hypokinetic segments, 28 dyskinetic segments, and 14 akinetic segments. After drug administration, 99 segments were normal, 11 hypokinetic, 11 dyskinetic, and 13 akinetic. Myocardial scintigraphy revealed 110 ischemic segments and 18 fibrotic segments (p&lt;0.005). After drug administration, the ventriculography showed increase in the velocity of circumferential fiber shortening (p=0.0142), the ejection fraction (p=0.0462), decrease in the end-systolic volume (p=0.0031) and no change in end-diastolic volume. CONCLUSION: Contrast ventriculography using nitrate proved to be similar to perfusional myocardial scintigraphy in the identification of myocardial ischemia.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial ischemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial scintigraphy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>contrast ventriculography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Rescue coronary angioplasty in a patient with acute myocardial infarction and myocardial bridge</s1>
</fA08>
<fA11 dir="011000">
<s1>José Augusto Rocha Araújo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nilson Moura Fé Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Flávio José Rocha de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Aluísio Cruz Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sandro Salgueiro Rodrigues</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Frederico Augusto de Lima e Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital de Messejana  </s1>
<s2>Fortaleza </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>185-190</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Myocardial bridge in a patient with sickle cell anemia</s1>
</fA08>
<fA11 dir="011000">
<s1>Marco Aurélio de Seixas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Alberto Franchin Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Eduardo Suaide Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Samira Morhy Borges Leal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Juarez Ortiz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Centro de Cardiologia Não Invasiva  </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>191-200</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Case report 1/99 - Instituto do Coração do Hospital das Clínicas - FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>201-208</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>6</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>The role of G-proteins in the pathophysiology of the cardiovascular diseases</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Roberto B. Evora</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernando Nobre</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>209-229</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>43</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Monophasic action potential. New uses for an old technique</s1>
</fA08>
<fA11 dir="011000">
<s1>Adolfo A. Leirner</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Idágene A. Cestari</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Instituto do Coração do Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>231-242</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>41</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Letters to the editor</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>243-246</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Chagas' heart disease</s1>
</fA08>
<fA11 dir="011000">
<s1>José Antonio Marin-Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcus Vinícius Simões</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Álvaro V. Lima Sarabanda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto Hospital das Clínicas</s1>
<s2>Ribeirão Preto SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>247-280</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>200</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Why do we need randomized and epidemiological studies on cardiovascular disease? Evidence-based cardiology VII</s1>
</fA08>
<fA11 dir="011000">
<s1>Álvaro Avezum</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João Manoel Rossi Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Leopoldo Piegas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>281-296</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Over the last two decades the results of randomized clinical studies, which are powerful aids for correctly assessing therapeutical strategies, have consolidated cardiological practice. In addition, scientifically interesting hypotheses have been generated through the results of epidemiological studies. Properly conducted randomized studies without systematic errors and with statistical power adequate for demonstrating moderate and reasonable benefits in relevant clinical outcomes have provided reliable and strong results altering clinical practice, thus providing adequate treatment for patients with cardiovascular disease (CVD). The dissemination and use of evidence-based medicine in treating coronary artery disease (CAD), heart failure (HF), and in prevention will prevent hundreds of thousands of deaths annually in developed and developing countries. CVD is responsible for approximately 12 million deaths annually throughout the world, and approximately 60% of these deaths occur in developing countries. During recent years, an increase in mortality and morbidity rates due to CVD has occurred in developing countries. This increase is an indication that an epidemiological (demographic, economical, and health-related) transition is taking place in developing countries and this transition implies a global epidemic of CVD, which will require wide-ranging and globally effective strategies for prevention. The identification of conventional and emerging risk factors for CVD, as well as their management in high-risk individuals, has contributed to the decrease in the mortality rate due to CVD. Through a national collaboration, several multi-center and multinational randomized and epidemiological studies have been carried out throughout Brazil, thus contributing not only to a generalized scientific growth in different Brazilian hospitals but also to the consolidation of an increasingly evidence-based clinical practice.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Cholinergic stimulation with pyridostigmine, hemodynamic and echocardiographic analysis in healthy subjects</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Vasconcellos de Pontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Bianca Gouveia Bastos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz José Martins Romêo F°</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Claudio Lucas da Nóbrega</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense Hospital Universitário Antônio Pedro </s1>
<s2> RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>297-306</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>60</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Growing evidence suggests that sudden death after an acute myocardial infarction (AMI) correlates with autonomic nervous system imbalance. Parasympathomimetic drugs have been tested to reverse these changes. However, their effects on ventricular function need specific evaluation. Our objective was to analyze pyridostigmine's (PYR) effect on hemodynamic and echocardiographic variables of ventricular function. METHODS: Twenty healthy volunteers underwent Doppler echocardiographic evaluations, blood pressure (BP), and heart rate (HR) assessment at rest, before and 120 min after ingestion of 30 mg PYR or placebo, according to a double-blind, placebo-controlled, crossed and randomized protocol, on different days. RESULTS: PYR was well tolerated and did not cause alterations in BP or in ventricular systolic function. A reduction in HR of 10.9±1.3% occurred (p&lt;0,00001). There was an A wave reduction in the mitral flow (p&lt;0.01) and an E/A ratio increase (p&lt;0.001) without changes in the other diastolic function parameters (p&gt;0.05). CONCLUSION: PYR reduces HR and increases E/A ratio, without hemodynamic impairment or ventricular function change.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pyridostigmine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>autonomic nervous system</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary arterial disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Anomalous origin of the left coronary artery from the pulmonary trunk. Clinical features and midterm results after surgical treatment</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Amaral</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Julene S. Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>João A. Granzotti</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Elliot A. Shinebourne</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>307-320</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>48</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To report the authors' experience with the anomalous origin of the left coronary artery (AOLCA) from the pulmonary trunk, emphasizing preoperative data, surgical aspects and midterm results of the follow-up. METHODS: Retrospective analysis of 11 patients operated upon at the Royal Brompton Hospital from October, 84 to April, 97. RESULTS: Nine infants had heart failure (HF) and two other children presented with dyspnea and chest pain. All had ECG changes. The echocardiogram identified the anomalous origin of the coronary artery in 7 (64%) patients and hemodynamic studies were performed in 7 patients. All infants were operated upon between the 2nd and 10th month of life. Six patients were treated with aortic reimplantation of the left coronary artery, whereas five were operated upon according to the Takeuchi technique. All patients are alive, with clear improvement of the ECG changes and ventricular function, as evaluated by echocardiography. Two patients operated upon according to the Takeuchi technique required additional surgery due to severe supravalvular pulmonary stenosis. CONCLUSION: AOLCA is a rare disease. Most patients show early signs of severe HF associated with ECG findings. Surgical therapy must be instituted early in the disease, preferentially through aortic implantation of the anomalous coronary artery, with a high possibility of success. Shortly after surgery, clinical and ECG improvement, as well as normalization of left ventricular function, should be expected.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>anomalous left coronary artery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Bland-White-Garland syndrome</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular function</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Therapeutic approach to patients complaining of high blood pressure in a cardiological emergency room</s1>
</fA08>
<fA11 dir="011000">
<s1>Miguel Gus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>André G. Andrighetto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vanessa R. Balle</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marco B. Pilla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>321-326</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the management of patients complaining of high blood pressure (BP) in a cardiological emergency room. METHODS: Patients referred to the cardiological emergency room with the main complaint of high blood pressure were consecutively selected. The prescriptions and the choice of antihypertensive drugs were assessed. The classification of these patients as hypertensive emergencies or pseudoemergencies, according to the physician who provided initial care, was recorded. RESULTS: From a total of 858 patients presenting to the emergency room, 80 (9.3%) complained of high BP, and 61 (76.3%) received antihypertensive drugs. Sublingual nifedipine was the most commonly used drug (59%). One patient received intravenous medication, one patient was hospitalized and 6 patients (7.5%) were classified as hypertensive emergencies or pseudoemergencies. CONCLUSION: High BP could seldom be classified as a hypertensive emergency or pseudoemergency, even though it was a frequent complaint (9.3% of visits). Currently, the therapeutic approach is not recommended, even in specialized clinics.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertensive emergency and pseudoemergency</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nifedipine</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Mitral valve disease with rheumatic appearance in the presence of left ventricular endomyocardial fibrosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Lurildo R. Saraiva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Regina W. Carneiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Mauro B. Arruda</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Djair Brindeiro F°</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Vital Lira</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>327-332</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>This is a report of a nine-year-old boy with both mitral stenosis and regurgitation and extensive endomyocardial fibrosis of the left ventricle. Focus is given to the singularity of the fibrotic process, with an emphasis on the etiopathogenic aspects.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Atrial infarction is a unique and often unrecognized clinical entity</s1>
</fA08>
<fA11 dir="011000">
<s1>Rosana G. G. Mendes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Roberto B. Evora</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Waldemar Pessoa Hospital do Coração de Ribeirão Preto </s1>
<s2>Ribeirão Preto SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>333-342</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A patient with heart failure and acute atrial fibrillation received the final diagnosis of atrial infarction associated with ventricular infarction based on clinical findings of ischemia in association with atrial fibrillation and heart failure (mechanisms probably involved: contractile dysfunction and loss of atrial contribution). Although a transesophageal echocardiography, which could refine the diagnosis of anatomic abnormalities, was not performed, all evidence led to the diagnosis of atrial involvement. Electrocardiographic findings were consistent with Liu's major criterion 3. Therapy with digitalis, quinidine and angiotensin-converting enzyme inhibitors was chosen, as the patient had acute pulmonary edema. The use of beta-blockers and verapamil was restricted. No other complications, such as thrombo-embolism or atrial rupture, were noted.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Prognostic factors in patients with congestive heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Humberto Villacorta</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco  </s1>
<s2>Rio de Janeiro </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal Fluminense  </s1>
<s2>Niterói RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>343-362</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>154</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Cardiopulmonary resuscitation: update, controversies and new advances</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre C. Zago</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cristine E. Nunes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Viviane R. da Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Euler Manenti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luís Carlos Bodanese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica do Rio Grande do Sul Hospital São Lucas </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>363-386</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>94</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Cardiopulmonary arrest is a medical emergency in which the lapse of time between event onset and the initiation of measures of basic and advanced support, as well as the correct care based on specific protocols for each clinical situation, constitute decisive factors for a successful therapy. Cardiopulmonary arrest care cannot be restricted to the hospital setting because of its fulminant nature. This necessitates the creation of new concepts, strategies and structures, such as the concept of life chain, cardio-pulmonary resuscitation courses for professionals who work in emergency medical services, the automated external defibrillator, the implantable cardioverter-defibrillator, and mobile intensive care units, among others. New concepts, strategies and structures motivated by new advances have also modified the treatment and improved the results of cardiopulmonary resuscitation in the hospital setting. Among them, we can cite the concept of cerebral resuscitation, the application of the life chain, the creation of the universal life support algorithm, the adjustment of drug doses, new techniques - measure of the end-tidal carbon dioxide levels and of the coronary perfusion pressure - and new drugs under research.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Continuing medical education in cardiology. Proposal for a national program. Committee of medical residency and training in cardiology - SBC/FUNCOR</s1>
</fA08>
<fA11 dir="011000">
<s1>Bráulio Luna Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valter C. Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Celso Ferreira Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Gun</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Orlando Campos Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rui Póvoa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ângelo A. V. de Paola</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Celso Ferreira</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>387-392</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200310</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Preliminary sketch of medical residency in cardiology. Committee of medical residency and training in cardiology SBC/FUNCOR</s1>
</fA08>
<fA11 dir="011000">
<s1>Bráulio Luna Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valter C. Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Celso Ferreira Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Gun</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Orlando Campos Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rui Póvoa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ângelo A. V. de Paola</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Celso Ferreira</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>393-398</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>05</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200311</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="">
<s1></s1>
</fA08>
<fA11 dir="011000">
<s1>José Fernando Cavalini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>400-400</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200312</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Pregnancy does not cause structural bioprosthesis alteration</s1>
</fA08>
<fA11 dir="011000">
<s1>Walkiria Samuel Avila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>403-404</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Cardiogenic shock</s1>
</fA08>
<fA11 dir="011000">
<s1>Elias Knobel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Israelita Albert Einstein  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>414-422</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>67</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Systematic overviews and meta-analyses in cardiology. Evidence-based cardiology VIII</s1>
</fA08>
<fA11 dir="011000">
<s1>Alvaro Avezum</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>427-430</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Effects of protein-calorie restriction on mechanical function of hypertrophied cardiac muscle</s1>
</fA08>
<fA11 dir="011000">
<s1>Antônio Carlos Cicogna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Roberto Padovani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Carlos Georgette</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Flávio Ferrari Aragon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marina Politi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual Paulista Instituto de Biociências Faculdade de Medicina de Botucatu</s1>
<s2>Botucatu SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>436-440</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effect of food restriction (FR) on hypertrophied cardiac muscle in spontaneously hypertensive rats (SHR). METHODS: Isolated papillary muscle preparations of the left ventricle (LV) of 60-day-old SHR and of normotensive Wistar-Kyoto (WKY) rats were studied. The rats were fed either an unrestricted diet or FR diet (50% of the intake of the control diet) for 30 days. The mechanical function of the muscles was evaluated through monitoring isometric and isotonic contractions. RESULTS: FR caused: 1) reduction in the body weight and LV weight of SHR and WKY rats; 2) increase in the time to peak shortening and the time to peak developed tension (DT) in the hypertrophied myocardium of the SHR; 3) diverging changes in the mechanical function of the normal cardiac muscles of WKY rats with reduction in maximum velocity of isotonic shortening and of the time for DT to decrease 50% of its maximum value, and increase of the resting tension and of the rate of tension decline. CONCLUSION: Short-term FR causes prolongation of the contraction time of hypertrophied muscles and paradoxal changes in mechanical performance of normal cardiac fibers, with worsening of the shortening indices and of the resting tension, and improvement of the isometric relaxation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>food restriction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>spontaneously hypertensive rat</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Transmyocardial laser revascularization. Early clinical experience</s1>
</fA08>
<fA11 dir="011000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luis Alberto Oliveira Dallan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz Augusto F. Lisboa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Cristina Chavantes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luis Antonio Machado Cesar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Miriam J. Pardi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Adib D. Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>University of São Paulo Medical School Heart Institute</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>446-450</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the initial clinical experience of transmyocardial laser revascularization (TMLR) in patients with severe diffuse coronary artery disease. METHODS: Between February, 1998 and February, 1999, 20 patients were submitted to TMLR at the Heart Institute (InCor), University of São Paulo Medical School, Brazil, isolated or in association with conventional coronary artery bypass graft (CABG). All patients had severe diffuse coronary artery disease, with angina functional class III/IV (Canadian Cardiovascular Society score) unresponsive to medical therapy. Fourteen patients were submitted to TMLR as the sole therapy, whereas 6 underwent concomitant CABG. Fifty per cent of the patients had either been previously submitted to a CABG or to a percutaneous transluminal coronary angioplasty (PTCA). Mean age was 60 years, ranging from 45 to 74 years. RESULTS: All patients had three-vessel disease, with normal or mildly impaired left ventricular global function. Follow-up ranged from 1 to 13 months (mean 6.6 months), with no postoperative short or long term mortality. There was significant symptom improvement after the procedure, with 85% of the patients free of angina, and the remaining 15 % of the patients showing improvement in functional class, as well as in exercise tolerance. CONCLUSION: This novel technique can be considered a low risk alternative for a highly selected group of patients not suitable for conventional revascularization procedures.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>laser surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial ischemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Characteristics and identification of sites of chagasic ventricular tachycardia by endocardial mapping</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Zildany P. Távora</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Niraj Mehta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rose M. F. L. Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fernando A. A. Gondim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Vanderlei M. Hara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Angelo A. V. de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>463-474</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>39</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study electrophysiological characteristics that enable the identification and ablation of sites of chagasic tachycardia. METHODS: Thirty-one patients with chronic Chagas' heart disease and sustained ventricular tachycardia (SVT) underwent electrophysiological study to map and ablate that arrhythmia. Fifteen patients had hemodinamically stable SVT reproducible by programmed ventricular stimulation, 9 men and 6 women with ages ranging from 37 to 67 years and ejection fraction varying from 0.17 to 0.64. Endocardial mapping was performed during SVT in all patients. Radiofrequency (RF) current was applied to sites of presystolic activity of at least 30 ms. Entrainment was used to identify reentrant circuits. In both successful and unsuccessful sites of RF current application, electrogram and entrainment were analyzed. RESULTS: Entrainment was obtained during all mapped SVT. In 70.5% of the sites we observed concealed entrainment and ventricular tachycardia termination in the first 15 seconds of RF current application. In the unsuccessful sites, significantly earlier electrical activity was seen than in the successful ones. Concealed entrainment was significantly associated with ventricular tachycardia termination. Bystander areas were not observed. CONCLUSION: The reentrant mechanism was responsible for the genesis of all tachycardias. In 70.5% of the studied sites, the endocardial participation of the slow conducting zone of reentrant circuits was shown. Concealed entrainment was the main electrophysiological parameter associated with successful RF current application. There was no electrophysiological evidence of bystander regions in the mapped circuits of SVT.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chagasic cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular tachycardia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>catheter ablation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Aortic stenosis. Gender influence on left ventricular geometry and function in patients under 70 years of age</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Sérgio Cordeiro da Rocha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Auxiliadora Vellasco Pereira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Nazareth de Novaes Rocha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rita de Cássia Villela Soares</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Celso Garcia, Rosana Grandelle</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paulo Roberto Dutra da Silva</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>479-482</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To verify if adaptive left ventricle (LV) characteristics are also present in individuals under 70 years of age with severe aortic stenosis (AS). METHODS: The study comprised 40 consecutive patients under 70 years of age with AS and no associated coronary artery disease, referred for valve surgery. Out of the 40 patients, 22 were men and 18 women, and the mean age was 49.8±14.3 years. Cardiac symptoms, presence of systemic hypertension (SH), functional class according to the New York Heart Association (NYHA), and valve lesion etiology were considered. LV cavity dimensions, ejection fraction (EF), fractional shortening (FS), mass (MS), and relative diastolic thickness (RDT) were examined by Doppler echocardiography. RESULTS: Fourteen (63.6%) men and 11 (61.6%) women were classified as NYHA class III/IV (p=0.70). There was no difference in the frequency of angina, syncope or dyspnea between genders. The incidence of SH was greater in women than in men (10 versus 2, p=0.0044). Women had a smaller LV end-diastolic diameter index (32.1±6.5 x 36.5±5.3mm/m², p=0.027), LV end-systolic diameter index (19.9±5.9 x 26.5±6.4mm/m², p=0.0022) and LV mass index (MS) (211.4±71.1 x 270.9±74.9g/m², p=0.017) when compared with men. EF (66.2±13.4 x 52.0±14.6%, p=0.0032), FS (37.6±10.7 x 27.9±9.6%, p=0.0046) and RDT (0.58±0.22 x 0.44±0.09, p=0.0095) were significantly greater in women than in men. CONCLUSION: It is the patient gender rather than age that influences left ventricular adaptive response to AS.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>gender</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Mitral restenosis in the early postoperative period of a patient with systemic lupus erythematosus</s1>
</fA08>
<fA11 dir="011000">
<s1>Pablo Maria Alberto Pomerantzeff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jeanne D'Arc Honória Corrêa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Manuel de Almeida Brandão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Raimunda Violante Campos de Assis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Adib Domingos Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>485-486</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>6</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A forty eight year old woman, who had undergone mitral comissurotomy and subsequently developed early restenosis, presented with major comissural fusion and verrucous lesions on the cuspid edges of the mitral valve, with normal subvalvar apparatus. Patient did well for the first six months after surgery when she began to present dyspnea on light exertion. A clinical diagnosis of restenosis was made, which was confirmed by an echocardiogram and cardiac catheterization. She underwent surgery, and a stenotic mitral valve with verrucous lesions suggesting Libman-Sacks' endocarditis was found. Because the diagnosis of systemic lupus erythematosus (SLE) had not been confirmed at that time, a bovine pericardium bioprosthesis (FISICS-INCOR) was implanted. The patient did well in the late follow-up and is now in NYHA Class I .</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Paraplegia following intraaortic balloon circulatory assistance</s1>
</fA08>
<fA11 dir="011000">
<s1>Anderson Benício</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Felipe P. Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Otávio Costa Auler Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Noedir Antônio Groppo Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Adib Domingos Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>490-495</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>6</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Intraaortic balloon counterpulsation is frequently used in patients experiencing severe ventricular dysfunction following maximal drug therapy. However, even with the improvement of percutaneous insertion techniques, the procedure has always been followed by vascular, infectious, and neurological complications. This article describes a case of paraplegia due to intraaortic balloon counterpulsation in the postoperative period of cardiac surgery.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>A 40-year-old woman with a pericardial effusion</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>500-505</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>37</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Cellular and biomolecular mechanisms in dilated cardiomyopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>Beatriz Piva e Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre Serviço de Cardiologia</s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>512-515</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>51</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Familial hypertrophic cardiomyopathy. Genetic characterization</s1>
</fA08>
<fA11 dir="011000">
<s1>Adriana Paula Tirone</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>520-522</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200412</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?</s1>
</fA08>
<fA11 dir="011000">
<s1>Waldomiro Carlos Manfroi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alcides José Zago</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcelo Campos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alexandre Alves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria Lúcia Brisolara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Josiane de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Rafael Henriques Candiago</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luciana Kirschnick</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Letícia Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Kárem Ordovás</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Cristiane Leitão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Rosana Cruz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Faculdade de Medicina </s1>
<s2>Porto Alegre </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>663-667</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>67</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate whether apolipoproteins A-I (Apo A-I) and B (Apo B) have, higher ensitivity (SN), specificity (SP) and positive predictive value (PPV) than lipoproteins (LP), total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL), and triglycerides (TGL) in assessing the risk of coronary heart disease (CHD). METHODS: This is a transversal case-control study of 241 patients, who were divided into two groups: 1) 145 patients with CHD, and 2) 96 patients without coronary disease. A model of logistic regression to evaluate the relation between the LPs and CHD was developed in which variables with a p-alpha &lt;0.1 were included. RESULTS: Apo A-I levels were higher in the patients without CHD, (OR 2.08, CI 1.20-3.57). There were no statistical differences between the values of Apo A-I and the remaining lipid fractions (Apo A-I: 67%; Apo B: 100%; PPV: TC= 71%; TGC=71%; HDL=71%; LDL=71%). The costs of the tests in Reais were as follows: Apo A-I: R$ 56.60; Apo B-100: R$ 56.60; TC: R$ 9.94; HDL: R$ 21.30; LDL: R$ 28.40; TGL: R$ 14.20. CONCLUSION: Levels of Apo A-I and Apo B have no advantage over conventional lipoproteins in predicting the risk of CHD, despite the statistical association between Apo A-I and CHD; in addition, their costs are higher than those of the conventional lipoproteins.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipoproteins</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Difference in the in-hospital mortality of unstable angina pectoris between men and women</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Carlos Santana Passos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Alberto Lopes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Úrsula Costa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Nelson Lobo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alvaro Rabelo Jr</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>673-676</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: To assess differences in the in-hospital mortality (HM) rate between men and women with unstable angina pectoris (UA) according to age, depression of the ST segment, history of previous acute myocardial infarction (AMI), and risk factors for coronary heart disease. METHODS: From October 96 to March 98, 261 patients with UA were selected. Logistic regression models were developed to adjust the association between sex and HM for possible influence of covariables, such as hypertension, diabetes mellitus, dyslipidemia, sedentary lifestyle, smoking, and familial history of early coronary heart disease. RESULTS: HM due to UA was approximately three times higher in women (9.3%; 12/129) than in men (3.0%; 4/132) accounting for a relative risk of 3.07; 95% confidence interval (CI) =1.02-9.27. In logistic regression models, the association between sex and death was not significantly altered when the following parameters were considered: age, depression of the ST segment, history of previous AMI and risk factors for coronary heart disease. The nonadjusted and adjusted odds ratio (OR) for the distinct covariables were 3.28 (CI 95%=1.03-10.45) and 3.14 (CI = 95% = 0.88-11.20), respectively. CONCLUSION: Similarly to AMI, HM in UA is higher in women than in men. Age, risk factors for coronary heart disease, and depression of the ST segment in the electrocardiogram on patients' admission to the hospital did not significantly influence the association between sex and death.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>unstable angina pectoris</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>women</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>in-hospital mortality</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Myocardial perfusion by contrast echocardiography. Establishment of normal pattern of intracoronary injection and safety in humans</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Morcerf</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Armando Luiz Cantisano</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Flavia Salek</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Alberto Mendonça</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Guilherme Paulino</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Flavio Cure Palheiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antonio Carlos Nogueira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Wanderley Quarte Pereira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Álvaro Moraes</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>682-686</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To establish the normal pattern and safety of echocardiographic contrast in patients with no significant obstruction of epicardial coronary arteries. METHODS: 67 patients with normal coronary arteries or obstructions &lt; 50% were selected from 277 patients who underwent coronary angiography (CA). Mean age was 56 ± 11years and 36 were males. At the end CA, echocardiographic contrast was selectively injected into each coronary artery. The parasternal short axis of the left ventricle (LV) was divided into six segments: anterior (A), antero-lateral (AL), postero-lateral (PL), posterior (P), infero-septal (IS) and antero-septal (AS). Anterolateral (ALPM) and posteromedial papillary muscles (PMPM) were also considered. The pattern and intensity of the appearance of the myocardial contrast was visually analyzed. RESULTS: The right coronary artery (RCA) was dominant in 60 patients. Contrast appearance was sudden and simultaneous in the 3 muscle layers. All segments could be contrasted after the injection in both coronary arteries. 100% of the AS, A and AL segments, 97% of the PL and 98% of the ALPM were perfused by the left coronary artery (LCA). P and IS segments were perfused by the RCA in 85% and 82%, respectively, and by a dominant LCA in 71% of the cases. The PMPM was perfused by a dominant RCA in 77% and by a dominant LCA in 86%. There were no symptoms. CONCLUSION: Intracoronary injection of the sonicated solution is a safe procedure that allows for an excellent opacification of the myocardium and can potentially be used during routine CA.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial perfusion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial contrast echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>microbubbles</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Signal averaged electrocardiogram in top deficient athletes</s1>
</fA08>
<fA11 dir="011000">
<s1>Japy Angelini Oliveira Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Bráulio Luna Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Silvia Helena Covre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edgar Lira Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marcelo Regazzini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Greco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antônio Carlos Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Dirceu Vieira Santos Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Ângelo Amato Vincenzo de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>690-692</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Radiofrequency catheter ablation in patients with atrial fibrillation</s1>
</fA08>
<fA11 dir="011000">
<s1>Mauricio Scanavacca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eduardo Sosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>André D'Ávila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fernando Tondato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Francisco Darrieux</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Denise Hachul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antonio Bahia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Paulo Cavalcanti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Flávio Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>701-708</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Catheter-induced 3:1 second degree atrioventricular nodal block during atrioventricular nodal reentrant tachycardia</s1>
</fA08>
<fA11 dir="011000">
<s1>Leandro Zimerman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Claudio Medeiros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gustavo Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital de Clínicas de Porto Alegre Division of Cardiology </s1>
<s2> RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>713-715</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Hypoperfusion of the left ventricle in the absence of changes in segmental contractility as observed through echocardiography by using microbubbles during dobutamine infusion</s1>
</fA08>
<fA11 dir="011000">
<s1>Ana Lúcia Martins Arruda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Altamiro Ozório</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Eloisa Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Lázaro de Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Thomas Porter</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Wilson Mathias Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>722-726</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>A 45 - year-old woman with hypertrophic cardiomyopathy and cardiogenic shock</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>733-737</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Detection of functional changes of the fetal heart in the first trimester of gestation</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Geraldo Viana Murta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antônio Fernandes Moron</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Márcio Augusto Pinto de Ávila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>745-750</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>The authors consider the possibility of using color Doppler of the ductus venosus and the measurement of nuchal translucency as a screening test for alterations in fetal cardiac functions in the first trimester of gestation. Review of the literature suggests that the combination of the ultrasonographic measurement of nuchal translucency and Doppler at 10 and 14 weeks of gestation can be effective in detecting certain cardiac abnormalities. This conclusion, however, is preliminary and needs to be further investigated.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>72</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Medically unexplained syncope and its relationship to psychiatric disorders</s1>
</fA08>
<fA11 dir="011000">
<s1>André Gomes Andrighetto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ângela Beatriz John</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Juarez Neuhaus Barbisan</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Geraldo Vernet Taborda</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>756-760</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07200610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Fatal pulmonary embolism in hospitalized patients. Clinical diagnosis versus pathological confirmation</s1>
</fA08>
<fA11 dir="011000">
<s1>Cláudio Tinoco Mesquita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Laerte Boechat Morandi Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Flávia Teixeira Perrone</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cláudia da Silva Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Lavínia J. Barreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sônia Santos C. A Nascimento</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Raul Carlos Pareto Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense Hospital Universitário Antônio Pedro </s1>
<s2> RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>255-258</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To assess the incidence of fatal pulmonary embolism (FPE), the accuracy of clinical diagnosis, and the profile of patients who suffered an FPE in a tertiary University Hospital. METHODS - Analysis of the records of 3,890 autopsies performed at the Department of General Pathology from January 1980 to December 1990. RESULTS - Among the 3,980 autopsies, 109 were cases of clinically suspected FPE; of these, 28 cases of FPE were confirmed. FPE accounted for 114 deaths, with clinical suspicion in 28 cases. The incidence of FPE was 2.86%. No difference in sex distribution was noted. Patients in the 6th decade of life were most affected. The following conditions were more commonly related to FPE: neoplasias (20%) and heart failure (18.5%). The conditions most commonly misdiagnosed as FPE were pulmonary edema (16%), pneumonia (15%) and myocardial infarction (10%). The clinical diagnosis of FPE showed a sensitivity of 25.6%, a specificity of 97.9%, and an accuracy of 95.6%. CONCLUSION - The diagnosis of pulmonary embolism made on clinical grounds still has considerable limitations.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary embolism</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>clinical diagnosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Analysis of the effects of the continuous electrode paste band on precordial leads of the electrocardiogram</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Henrique Purper Petterson</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nelson Rudi Koehler</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ronaldo Passos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Iuri Christmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>PUCRS Hospital São Lucas </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>266-272</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>7</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To determine if the application of a continuous electrode paste band on precordial leads results in alteration of the electrocardiographic tracing as compared with an adequate amount of electrode paste, and if the former condition does not cause uniform morphologies from V1 to V6. METHODS - The amplitude and morphology of the electrocardiographic waves on the precordial leads in electrocardiographic tracings, which were performed with standard (control group) or excessive (continuous band) application of the electrode paste, were compared. RESULTS - None of the 106 patients studied showed uniformity of the QRS morphology from V1 to V6. The eletrocardiographic alterations identified in the tracings performed with a continuous electrode paste band that showed statistical significance in relation to the control group were the following: inversion of the P wave in V1; inversion of the T wave in V1, V2, and V3; appearance of R' waves in V1 and V2; disappearance of S waves in V1; appearance of S waves in V5 and V6; alterations in the amplitude of almost all waves, in all leads. CONCLUSION - Application of a continuous electrode paste band in the precordial leads may cause significant alterations in the electrocardiographic tracing obtained.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrocardiographic technique</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrodes</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrode paste</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>precordial leads</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Mitral valve repair. Quadrangular resection of the posterior leaflet in patients with myxomatous degeneration</s1>
</fA08>
<fA11 dir="011000">
<s1>Pablo Maria Alberto Pomerantzeff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Manuel de Almeida Brandão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Eduardo Giusti Rossi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luís Francisco Cardoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Flávio Tarasoutchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Noedir Antonio Groppo Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luiz Boro Puig</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Geraldo Verginelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Adib Domingos Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>277-280</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To analyze the immediate and late results of mitral valve repair with quadrangular resection of the posterior leaflet without the use of a prosthetic ring annuloplasty. METHODS - Using this technique, 118 patients with mitral valve prolapse who underwent mitral repair from January '84 through December '96 were studied. Age ranged from 30 to 86 (mean = 59.1±11.8) years and 62.7% were males. An associated surgery was performed in 22% of the patients, and coronary artery bypass graft was the most frequently performed surgery (15 patients - 12.7%). In 20 (16.9%) patients other associated techniques of mitral valve repair were used and shortening of elongated chordae tendineae was the most frequent one (6 patients). RESULTS - Immediate mortality was 0.9% (one patient). Long-term rates for thromboembolism, endocarditis, re-operation and death in the late postoperative period were 0.4%, 0.4%, 1.7% and 2.2% patients/year, respectively. The actuarial curve of survival was 83.8±8.6% over 12 years; survival free from re-operation was 91.8±4.3%, free from endocarditis was 99.2±0.8% and free from thromboembolism was 99.2±0.8%. In the late postoperative period, 93.8% of the patients were in functional class 1 (NYHA), with a complete follow-up in 89.7% of the patients. CONCLUSION - Patients with mitral valve prolapse who undergo mitral valve repair using this technique have a satisfactory prognosis over 12 years.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valve repair</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>valvular surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral annuloplasty</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Cardiac abnormalities in the acquired immunodeficiency syndrome. A prospective study with a clinical-pathological correlation in twenty-one adult patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Gesmar Volga Haddad Herdy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Artur Haddad Herdy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Pedro Savio Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Roberto de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fabiano B. Azevedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Kátia Azevedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Márcia Cláudia Vasconcelos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Raquel Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Hsu Y. Tchou</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Pablo Nascimento</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Rachel Cosendey</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Analise Ferrari</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="131000">
<s1>Vania S. Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense Hospital Universitário Antonio Pedro </s1>
<s2>Niterói RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>286-290</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To evaluate the cardiac abnormalities and their evolution during the course of the acquired immunodeficiency syndrome, as well as to correlate clinical and pathological data. METHODS - Twenty-one patients, admitted to the hospital with the diagnosis of acquired immunodeficiency syndrome, were prospectively studied and followed until their death. Age ranged from 19 to 42 years (17 males). ECG and echocardiogram were also obtained every six months. After death, macro- and microscopic examinations were also performed. RESULTS - The most frequent causes of referral to the hospital were: diarrhea or repeated pneumonias, tuberculosis, toxoplasmosis or Kaposi sarcoma. The most frequent findings were acute or chronic pericarditis (42%) and dilated cardiomyopathy (19%). Four patients died of cardiac problems: infective endocarditis, pericarditis with pericardial effusion, bacterial myocarditis and infection by Toxoplasma gondii. CONCLUSION - Severe cardiac abnormalities were the cause of death in some patients. In the majority of the patients, a good correlation existed between clinical and anatomical-pathological data. Cardiac evaluation was important to detect early manifestations and treat them accordingly, even in asymptomatic patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acquired immunodeficiency syndrome (AIDS)</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>clinical-pathological correlation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Effects of propranolol on the QT dispersion in congestive heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Flávia Cristina Carvalho de Deus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cassia Regina Guedes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eduardo Reis Maia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>César Gerson Pereira Subieta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Humberto Villacorta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Patrice Alessandra dos Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Helena Cramer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Valeria Battistella Amado dos Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Luis José Martins Romeo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Universitário Antônio Pedro  </s1>
<s2>Niterói RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>295-298</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - Studies have shown that therapy with beta-blockers reduces mortality in patients with heart failure. However, there are no studies describing the effects of propranolol on the QT dispersion in this population. The objective of this study was to assess the electrophysiological profile, mainly QT dispersion, of patients with heart failure regularly using propranolol. METHODS - Fifteen patients with heart failure and using propranolol were assessed over a period of 12 months. Twelve-lead electrocardiograms (ECG) were recorded prior to the onset of beta-blocker therapy and after 3 months of drug use. RESULTS - A significant reduction in heart rate, in QT dispersion and in QTc dispersion was observed, as was also an increase in the PR interval and in the QT interval, after the use of propranolol in an average dosage of 100 mg/day. CONCLUSION - Reduction in QT dispersion in patients with heart failure using propranolol may explain the reduction in the risk of sudden cardiac death with beta-blocker therapy, in this specific group of patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congestive heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>beta-blocker</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Stenting of unprotected left main coronary artery in a patient with cardiogenic shock</s1>
</fA08>
<fA11 dir="011000">
<s1>Bedson José Lopes de Sá</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mary Jane Martins Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Bonifácio Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Gama</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Raimundo João Costa Furtado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital - São Luís  </s1>
<s2>São Luís MA</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>302-304</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>6</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A 64-year-old female presented with pulmonary edema and cardiogenic shock after coronary arteriography that showed severe suboclusive lesion in the left main coronary artery (LMCA) in a dominant left coronary system. The patient succesfully underwent urgent angioplasty with stent deployment in the LMCA. After an uneventful period, the patient was discharged at day six.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Total agenesis of the left pericardium</s1>
</fA08>
<fA11 dir="011000">
<s1>J. Glauco Lobo Fº</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo R. Maia Oliveira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rafael Pontes de Siqueira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rodrigo M. Landim</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>João Marcelo A.C. de Albuquerque</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Carlos Bellini G. Gomes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Elita Borges</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Maria Claúdia Leitão</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>J. Nogueira Paes Jr</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto do Coração e Pulmão-ICORP  </s1>
<s2>Fortaleza CE</s2>
<s3>Brazil</s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital Prontocárdio  </s1>
<s2>Fortaleza CE</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>307-308</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>5</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>This is the report of a 46-year-old patient with the preoperative diagnosis of an atrial septal defect (ASD) of the ostium secudum type. After sternectomy, partial agenesis of the left pericardium was diagnosed. It is our opinion that, if the radiographic picture is suggestive of this entity, a clinical search for cardiopulmonary anomalies should be performed, because the majority of these associated anomalies can and should be surgically corrected.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>The greatest medical discovery of the millennium (Fundamental steps to the understanding of cardiac performance)</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Antonio Mascia Gottschall</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>320-330</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>39</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Percutaneous handling of coronary lesions &gt;20mm through stents. Is there a first choice strategy?</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Fernando L. Tanajura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ibraim M. F. Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz Alberto P. Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fausto Feres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alexandre Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rodolfo Staico</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Marinella P. Centemero</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Áurea J. Chaves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Andrea C. Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Amanda G. M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>J. Eduardo M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>335-338</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - This study compared the early and late results of the use of one single stent with those of the use of multiple stents in patients with lesions longer than 20mm. METHODS - Prospective assessment of patients electively treated with stents, with optimal stent deployment and followed-up for more than 3 months. From February '94 to January '98, 215 patients with lesions &gt;20mm were treated. These patients were divided into 2 groups as follows: Group A - 105 patients (49%) with one stent implanted; Group B - 110 patients (51%) with multiple stents implanted. RESULTS - The mean length of the lesions was 26mm in group A (21-48mm) versus 29mm in group B (21-52mm) (p=0.01). Major complications occurred in one patient (0.9%) in group A (subacute thrombosis, myocardial infarctionand death) and in 2 patients (1.8%) in group B (one emergency surgery and one myocardial infarction) (p=NS). The results of the late follow-up period (&gt;6 months) were similar for both groups (group A = 82% vs group B = 76%; p=NS), and we observed an event-free survical in 89% of the patients in group A and in 91% of the patients in group B (p=NS). Angina (group A = 11% vs group B = 7%) and lesion revascularization (group A = 5% vs group B = 6%; p=NS) also occurred in a similar percentage. No infarction or death was observed in the late follow-up period; restenosis was identified in 33% and 29% of the patients in groups A and B, respectively (p=NS). CONCLUSION - The results obtained using one stent and using multiple stents were similar; the greater cost-effectiveness of one stent implantation, however, seems to make this strategy the first choice.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary stents</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>complex lesions</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angioplasty</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Exercise and heart failure. Relation of the severity of the disease to the anaerobic threshold and the respiratory compensation point</s1>
</fA08>
<fA11 dir="011000">
<s1>Guilherme Veiga Guimarães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Giovanni Bellotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Mauricio Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luzimar Teixeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Edimar Alcides Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>344-348</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To identify, the anaerobic threshold and respiratory compensation point in patients with heart failure. METHODS - The study comprised 42 Men,divided according to the functional class (FC) as follows: group I (GI) - 15 patients in FC I; group II (GII) - 15 patients in FC II; and group III (GIII) - 12 patients in FC III. Patients underwent a treadmill cardiopulmonary exercise test, where the expired gases were analyzed. RESULTS - The values for the heart rate (in bpm) at the anaerobic threshold were the following: GI, 122±27; GII, 117±17; GIII, 114±22. At the respiratory compensation point, the heart rates (in bpm) were as follows: GI, 145±33; GII, 133±14; GIII 123±22. The values for the heart rates at the respiratory compensation point in GI and GIII showed statistical difference. The values of oxygen consumption (VO2) at the anaerobic threshold were the following (in ml/kg/min): GI, 13.6±3.25; GII, 10.77±1.89; GIII, 8.7±1.44 and, at the respiratory compensation point, they were as follows: GI, 19.1±2.2; GII, 14.22±2.63; GIII, 10.27±1.85. CONCLUSION - Patients with stable functional class I, II, and III heart failure reached the anaerobic threshold and the respiratory compensation point at different levels of oxygen consumption and heart rate. The role played by these thresholds in physical activity for this group of patients needs to be better clarified.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>oxygen consumption</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Critical aortic stenosis in the neonate. Clinical assessment and surgical outcome in 18 patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Miguel Barbero-Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Elisa R. Iwahashi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jorge Y. Afiune</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Munir Ebaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>354-358</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To assess neonates with aortic stenosis with early decompensation operated upon. (LCO) (CHF). METHODS - A and retrospective study analyzing 6 neonates with LCO, group I (GI), and 12 neonates with CHF, group II (GII). Clinical radiographic, electrocardiographic and echocardiographic findings also provided comparative bases for the study, as did surgical and evolutional findings. RESULTS - The mean ages at hospitalization and surgery (p = 0.0031) were 14.3 and 14.8 days in GI and 35.4 and 42.8 days in GII, respectively. Cardiac murmurs were more intense in GII (p = 0.0220). The aortic ring was smaller in GI (8.0 ± 2.5mm) as compared to GII (11.4±1.4mm) (p = 0.2882). Ventricular function was reduced to 18±5.5% and 33.3±7.6% in GI and GII, respectively (p = 0.0162). Aortic atresia, however, was present only in 2 neonates in GI. Five of 6 patients in GI died but all patients in GII survived (p=0.0007). In the latter group, 84.6% of the patients were in functional class I (FC-I) in the long-term follow-up, with moderate residual lesions in 6 neonates, discrete residual lesions in 4, and reoperation in 2. CONCLUSION - Aortic stenosis is a severe anomaly of the neonate, whose immediate evolution depends on the pre-operative anatomic and functional findings, and the late evolution essentially depends on the anatomic features of the valve.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>neonate</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Effects of lisinopril on experimental ischemia in rats. Influence of infarct size</s1>
</fA08>
<fA11 dir="011000">
<s1>Leonardo A. M. Zornoff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Beatriz B. Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz S. Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sérgio A. R. Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria T. T. Tornero</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Joel Spadaro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual Paulista Faculdade de Medicina de Botucatu </s1>
<s2>Botucatu SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>366-372</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - Angiotensin-converting enzyme inhibitors (ACEIs) have gained importance in preventing or attenuating the process of ventricular remodeling after myocardial infarction. The significance of infarct size in regard to the response to ACEIs, however, is controversial. This study aimed to analyze the effects of lisinopril on mortality rate, cardiac function, degree of cardiac hypertrophy and fibrosis in rats with different infarct sizes. METHODS - Lisinopril (20 mg/kg/day) dissolved in drinking water was administered to rats immediately after coronary artery occlusion. After being sacrificed, the infarcted animals were divided into two groups: one group of animals with small infarcts (&lt; 40% of the left ventricle) and another group of animals with large infarcts (&gt; 40% of the left ventricle). RESULTS - The mortality rate was 31.7% in treated rats and 47% in the untreated rats. There was no statistical difference between the groups with small and large infarcts in regard to myocardial concentration of hydroxyproline. In small infarcts, the treatment attenuated the heart dysfunction characterized by lower levels of blood pressure and lower values of the first derivative of pressure and of the negative derivative of pressure. The degree of hypertrophy was also attenuated in small infarcts. In regard to large infarcts, no differences between the groups were observed. CONCLUSION - Treatment with the ACEIs had no effect on mortality rate and on the amount of fibrosis. The protective effect of lisinopril on heart function and on the degree of hypertrophy could only be detected in small infarcts</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rat</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lisinopril</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Percutaneous mitral valvotomy in patients eighteen years old and younger. Immediate and late results</s1>
</fA08>
<fA11 dir="011000">
<s1>Cláudia Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sérgio Luiz Navarro Braga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>César Augusto Esteves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Matos Brito Castello Branco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Nisia Lira Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Mercedes Maldonado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Valmir Fernandes Fontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>378-381</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To analyze immediate and late results of percutaneous mitral valvotomy (PMV) in patients &lt;= 18 year. METHODS - Between August '87 and July '97, 48 procedures were performed on 40 patients. The mean age was 15.6 years; 68.7% were females four of whom were pregnant. RESULTS - Success was obtained in 91.7% of the procedures. Immediate complications were severe mitral regurgitation (6.3%) and cardiac tamponade (2.0%). Late follow-up was obtained in 88.8% of the patients (mean value=43.2±33.9 months). NYHA functional class (FC) I or II was observed in 96.2% of the patients and restenosis developed in five patients, at a mean follow-up of 29.7±11.9 months. Three patients presented with severe mitral insufficiency and underwent surgery. Two patients died. CONCLUSION - PMV represents a valid therapeutic option in young patients. In these patients, maybe because of subclinical rheumatic activity, restenosis may have a higher incidence and occur at an earlier stage than in others persons.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valvotomy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>restenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>teenagers</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Chylothorax after myocardial revascularization with the left internal thoracic artery</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Manuel Pêgo-Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gustavo Xavier Ebaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gustavo Henrique Nouer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Robinson Tadeu Munhoz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fábio Biscegli Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Adib Domingos Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto do Coração  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>387-390</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A 38-year-old male underwent coronary artery bypass grafting (CABG). A saphenous vein graft was attached to the left marginal branch. The left internal thoracic artery was anastomosed to the left anterior descending artery (LAD). The early recovery was uneventful and the patient was discharged on the 5th postoperative day. After three months, he came back to the hospital complaining of weight loss, weakness, and dyspnea on mild exertion. Chest X-rays showed left pleural effusion. On physical examination, a decreased vesicular murmur was detected. After six days, the diagnosis of chylothorax was made after a milky fluid was detected in the plural cavity and total pulmonary expansion did not occur. On the next day, both anterior and posterior pleural drainage were performed by videothoracoscopy, and prolonged parenteral nutrition (PPN) was instituted for ten days. After seven days the patient was put on a low-fat diet for 8 days. The fluid accumulation ceased, the drains were removed and the patient was discharged with normal pulmonary expansion.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Growth hormone for optimization of refractory heart failure treatment</s1>
</fA08>
<fA11 dir="011000">
<s1>Edimar Alcides Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Zyun Massuda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Guimarães Guilherme</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Dirceu Carrara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Giovanni Bellotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Amilcar Mocelin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Carlos Roberto Martins Rodrigues Sobrinho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>José Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>395-398</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>It has been reported that growth hormone may benefit selected patients with congestive heart failure. A 63-year-old man with refractory congestive heart failure waiting for heart transplantation, depending on intravenous drugs (dobutamine) and presenting with progressive worsening of the clinical status and cachexia, despite standard treatment, received growth hormone replacement (8 units per day) for optimization of congestive heart failure management. Increase in both serum growth hormone levels (from 0.3 to 0.8 mg/l) and serum IGF-1 levels (from 130 to 300ng/ml) was noted, in association with clinical status improvement, better optimization of heart failure treatment and discontinuation of dobutamine infusion. Left ventricular ejection fraction (by MUGA) increased from 13 % to 18 % and to 28 % later, in association with reduction of pulmonary pressures and increase in exercise capacity (rise in peak VO2 to 13.4 and to 16.2ml/kg/min later). The patient was &quot;de-listed&quot; for heart transplantation. Growth hormone may benefit selected patients with refractory heart failure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Syncope in a twenty-three-year-old male</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>403-406</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Quantitative study of myocardial microcirculation in arterial hypertension due to progressive inhibition of NO synthesis</s1>
</fA08>
<fA11 dir="011000">
<s1>Leila Maria Meirelles Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Alberto Mandarim-de-Lacerda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Rio de Janeiro State University  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>413-418</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study the quantitative changes in intramyocardial blood vessels in rats in whom nitric oxide synthesis was inhibited. METHODS: Four groups of 10 rats were studied: control (C25 and C40) and L-NAME (L25 and L40). The animals L25 and L40 received L-NAME in the dosage of 50mg/kg/day for 25 and 40 days, respectively. On days 26 and 41 the animals in groups 25 and 40 were sacrificed. Analysis of the myocardium was performed using light microscopy and stereology. RESULTS: Arterial blood pressure and heart weight increased 74.5 and 57.8% after 25 days and 90.2 and 34.6% after 40 days, respectively. Comparing the L-NAME rats with the respective controls revealed that vessel volume density decreased 31.3% after 40 days, and the vessel length-density decreased 53.5% after 25 days and 25.7% after 40 days. The mean cross-sectional area of the vessels showed an important reduction of 154.6% after 25 days. The intramyocardial vessels decreased significantly in length- density in the L-NAME animals. The mean cross-sectional area of the vessels, which normally increases during heart growth between 25 and 40 days, showed a precocious increase by the 25th day in the L-NAME rats. This suggests an increase of the size of the heart, including blood vessels. CONCLUSION: The inhibition of the NO synthesis provokes rarefaction in the intramyocardial vessels that progresses with the time of administration of L-NAME.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nitric oxide</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardium</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Immediate and long term evolution of valve replacement in children less than 12 years old</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Antibas Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Altamiro Ribeiro Dias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Pablo M. A. Pomerantzeff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Miguel Barbero-Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Noedir Antonio Groppo Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Adib Domingos Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>424-428</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: The aim of this work was the follow-up and evaluation of valve replacement in children under 12 years of age. METHODS: Forty-four children less than 12 years old were underwent valve replacement at INCOR-HCFMUSP between January 1986 and December 1992. Forty (91%) were rheumatic, 39 (88.7%) were in functional classes II or IV, 19 (43.2%) were operated upon on an emergency basis, and 6 (13.6%) had atrial fibrillation. Biological prostheses (BP) were employed in 26 patients (59.1%), and mechanical prostheses (MP) in 18 (40.9%). Mitral valves were replaced in 30 (68.7%), aortic valves in 8 (18.2%), a tricuspid valve in 1 (2.3%), and double (aortic and mitral) valves in 5 (11.4) of the patients. RESULTS: Hospital mortality was of 4.5% (2 cases). The mean follow-up period was 5.8 years. Re-operations occurred in 63.3% of the patients with BP and in 12.5% of those with MP (p=0.002). Infectious endocarditis was present in 26.3% of the BP, but in none of the cases of MP (p=0.049). Thrombosis occurred in 2 (12.5%) and hemorrhage in one (6.5%) of the patients with a MP. Delayed mortality occurred in 5 (11.9%) of the patients over a mean period of 2.6 years; four had had BP and one had a MP (NS). Actuarial survival and re-operation-free curves after 10 years were respectively, 82.5±7.7 (SD)% and 20.6±15.9%. CONCLUSION: Patients with MP required fewer re-operation, had less infectious endocarditis and lower late mortality rates compared with patients with bioprostheses. The former, therefore, appear to be the best valve replacement for pediatric patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac valve replacement</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rheumatic fever</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>children</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Holt-Oram syndrome revisited. Two patients in the same family</s1>
</fA08>
<fA11 dir="011000">
<s1>José Dario Frota Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Wagner Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Tiago Luiz Luz Leiria</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Mario Vallenas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo E. Leães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Celso Blacher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Eraldo Lúcio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Fernando A. Lucchese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital São Francisco da Santa Casa de Porto Alegre  </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>432-434</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Holt-Oram syndrome was first described in 1960 as an association of familial heart disease and musculoskeletal abnormalities. The most important findings include atrial septal defects, atrioventricular conduction abnormalities, vascular hypoplasia, and upper limb musculoskeletal deformities. We report two patients with this syndrome in the same family and discuss the variability of the musculoskeletal abnormalities and their association with the cardiac morphologic defects. Both patients in this study had associated eosinophilia, which has not been reported in the literature.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Pompe's disease or type IIa glycogenosis</s1>
</fA08>
<fA11 dir="011000">
<s1>José Luiz Balthazar Jacob</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rosiene Lisboa Leandro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Adelino Parro Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Moléstias Cardiovasculares  </s1>
<s2>São José do Rio Preto SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>438-440</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>This is the report of a five-month-old child presenting clinical evidence of Pompe's disease: severe hypotonicity, hyporeflexia and congestive heart failure. The ECG showed a short PR interval, the chest radiography disclosed marked cardiomegaly, and the echocardiogram revealed marked left ventricular hypertrophy - the most typical finding of this disease. A skeletal muscle biopsy led to final diagnosis, because in the histopathologic study marked increased glycogen accumulation was evident. Death occurred two months after symptom onset.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Double outlet right ventricle with anterior and left-sided aorta and subpulmonary ventricular septal defect</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciana Braz Peixoto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Samira Morhy Borges Leal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Eduardo Suaide Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sandra Maria Lima Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Juarez Ortiz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Centro de Cardiologia Não Invasiva de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>446-450</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>05</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Double outlet right ventricle (DORV) is a heterogeneous group of abnormal ventriculoarterial connections where, by definition, both great arteries (pulmonary artery and aorta) arise primarily from the morphologically right ventricle. This condition affects 1-1.5% of the patients with congenital heart diseases, with a frequency of 1 in each 10,000 live births. We report the case of an 18-day-old infant with DORV and extremely rare anatomical features, such as anterior and left-sided aorta and subpulmonary ventricular septal defect (VSD). In addition to the anatomic features, the role of the echocardiogram for guiding the diagnosis and the surgical therapy of this congenital heart disease are discussed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Prevention of acute coronary events through the Mediterranean diet</s1>
</fA08>
<fA11 dir="011000">
<s1>Arthur de Carvalho Azevedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>453-454</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>73</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Infectious agents in coronary atherosclerosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Luís Beck da Silva Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jorge Pinto Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>459-462</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>1999</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(99)07300507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Risk factors for atherosclerosis in an elderly out patient population in the City of São Paulo</s1>
</fA08>
<fA11 dir="011000">
<s1>Yolanda Maria Garcia Alencar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eurico Thomaz de Carvalho Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sérgio Márcio Pacheco Paschoal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Antonio Esper Curiati</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Chiu Ping Wong</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Júlio Litvoc</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>189-196</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>50</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze in out clinic elderly patients of both sexes for the prevalence of risk factors for atherosclerosis and study their association with the complications of atherosclerosis. METHODS: Five hundred and sixteen outpatients, 152 men and 364 women, 60 years or older, were studied. The prevalences of hypertension, dyslipidemia, diabetes mellitus, cigarette smoking and obesity were determined in both sexes and compared using the chi-square test. The association between these factors and the presence of atherosclerotic complications was analyzed by logistic regression. RESULTS: The comparative analysis of the factors in both sexes showed that hypertension, total cholesterol  &gt; or = 240mg/dL, LDL-cholesterol  &gt; or = 160mg/dL, and body mass index &gt;27.5 were more frequent among women, but HDL-cholesterol &lt;35mg/dL and cigarette smoking were more frequent among men, and no difference occurred between sexes in relation to the frequency of triglycerides  &gt; or = 250mg/dL and diabetes mellitus. After adjustment of the variables in the regression model, we observed that in the total of elderly patients, risk factors for complications of atherosclerosis were: triglycerides  &gt; or = 250mg/dL, hypertension, and male sex. Among men, the risk factors were: LDL-cholesterol  &gt; or = 160mg/dL, diabetes mellitus, HDL-cholesterol &lt;35mg/dL and hypertension. Among women, the risk factors were: tryglicerides  &gt; or = 250mg/dL and hypertension. CONCLUSION: The results showed that, in the elderly, the risk factors for atherosclerosis persist, but with different behaviors between men and women. The study suggests that the relative importance of the risk factors can change with the aging process.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Heart transplantation in neonates and children. Intermediate-term results</s1>
</fA08>
<fA11 dir="011000">
<s1>Estela Azeka</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Miguel Barbero-Marcial</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcelo Jatene</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Roberto Camargo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Otávio C. Auler</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Antonio F. Ramires</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Munir Ebaid</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>203-208</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess intermediate-term outcome in children who have undergone orthotopic heart transplantation. METHODS: We carried out a longitudinal and prospective study between October '92 and June '99 comprising 20 patients with ages ranging from 12 days to 7 years (mean of 2.8 years). We employed a double immunosuppression protocol with cyclosporine and azathioprine and induction therapy with polyclonal antithymocyte serum. Survival and complications resulting from the immunosuppression protocol were analyzed. RESULTS:&lt;FONT FACE=Symbol&gt;&lt;/FONT&gt;The double immunosuppression protocol and the induction therapy with polyclonal antithymocyte serum resulted in an actuarial survival curve of 90% and 78.2% at 1 and 6 years, respectively, with a mean follow-up period of 3.6 years. One patient died due to acute rejection 40 days after transplantation; another patient died 2 years after transplantation due to lymphoproliferative disorder; a third patient died because of primary failure of the graft; and a fourth patient died due to bronchopneumonia. The major complications were as follows: acute rejection, infection, nephrotoxicity, and systemic hypertension. The means of rejection and infection episodes per patient were 2.9 and 3.4, respectively. After one year of transplantation, a slight reduction in the creatinine clearance and systemic hypertension were observed in 7 (38.9%) patients. CONCLUSION: Heart transplantation made life possible for those patients with complex congenital heart diseases and cardiomyopathies in refractory congestive heart failure constituting a therapeutical option for this group of patients in the terminal phase.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart transplantation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>neonates</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>children</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Effects of a novel fermented soy product on the serum lipids of hypercholesterolemic rabbits</s1>
</fA08>
<fA11 dir="011000">
<s1>Elizeu A. Rossi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Regina C. Vendramini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Iracilda Z. Carlos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Igor S. Ueiji</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Márcio M. Squinzari</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sinézio I. Silva Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Graciela F. Valdez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual Paulista Faculdade de Ciências Farmacêuticas de Araraquara </s1>
<s2>Araraquara SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>213-216</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effect of a new feed soy product fermented by Enterococcus faecium and Lactobacillus jugurti on the serum lipid levels of rabbits with induced hypercholesterolemia. METHODS: Thirty-two rabbits were divided into 4 groups as follows: 1) control (C); 2) hypercholesterolemic (H); 3) hypercholesterolemic + fermented product (HPF); and 4) control + fermented product (CPF). The H and HPF groups were fed with a diet with 0.15% (p/p) cholesterol in the first 15 days. C and CPF groups received regular food preparation. The HPF and CPF groups received 10 mL daily of the fermented 30 days. Blood samples were drawn at the beginning of the study and at the 15th and 30th days. Concentrations of total cholesterol, HDL-cholesterol, and triglycerides were analyzed. RESULTS: After 15 days, the HPF group showed a total cholesterol concentration lower (18.4%) than that of the H group (p=0.05), but this difference disappeared after 30 days. No change was observed in total cholesterol levels of C and CPF groups. After 15 days, the HDL-cholesterol was higher (17.8%) in the HPF group, but the triglyceride levels remained unchanged in all groups during the same period of time. CONCLUSION: The soy fermented product caused an 18.4% reduction in total cholesterol and a 17.8% increase in the HDL-fraction. It may, therefore, be a possible coadjutor in the treatment of hypercholesterolemia.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fermented soy product</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Enterococcus faecium</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cholesterol</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>A study of infectious endocarditis in Ribeirão Preto, SP - Brazil. Analysis of cases occurring between 1992 and 1997</s1>
</fA08>
<fA11 dir="011000">
<s1>Everaldo Ruiz Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Tarciso Schirmbeck</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz Tadeu Moraes Figueiredo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto </s1>
<s2>Ribeirão Preto SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>225-231</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the epidemiology, diagnosis, clinical aspects causes and evolution of infectious endocarditis. METHODS: The patients analyzed were treated at the University Hospital of the Faculdade de Medicina of Ribeirão Preto-USP and had a diagnosis of infectious endocarditis defined by Duke's criteria, which classifies infectious endocarditis as native, prosthetic valve or that occurring in intravenous drug users. RESULTS: One hundred and eighty episodes of infectious endocarditis in 168 patients were observed. Echocardiograms in 132 (73.3%) provided a diagnosis of infectious endocarditis in 111 (84%) patients; mitral valves were affected in 55 (30.5%), tricuspid valves in 30 (16.6%) and the aortic valve in 28 (15.5%) patients. Hemocultures were performed in 148 (93.8%) episodes of IE. The most commonly isolated infectious organisms were Staphylococcus aureus in 46 (27.2%) patients and Streptococcus viridans in 27 (15.9%). Complications occurred in 116 (64.4%) patients and 73 (40.5%) of the patients died. CONCLUSION: The general profile of the observed infectious endocarditis was similar to that reported in studies performed in other countries and included users of intravenous drugs. The high degree of mortality observed is not compatible with progress in diagnosis and treatment of infectious endocarditis and is probably due to the absence of diagnostic suspicion. The high frequency of fatal cases of septicemia (45.1% of deaths) in the patients studied indicates that unnoticed cases of infectious endocarditis had only been diagnosed at necropsy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>infectious endocarditis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endocarditis in Brazil</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>bacterial endocarditis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Effects of carvedilol in heart failure due to dilated cardiomyopathy. Results of a double-blind randomized placebo-controlled study (CARIBE study)</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Roberto Chizzola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Humberto Felício Gonçalves Freitas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Márcia Azevedo Caldas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Joicely Melo da Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Cláudio Meneghetti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Norma Vasconcelos Saldanha Marinho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Alfredo José Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Edimar Alcides Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>238-242</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effects of carvedilol in patients with idiopathic dilated cardiomyopathy. METHODS: In a double-blind randomized placebo-controlled study, 30 patients (7 women) with functional class II and III heart failure were assessed. Their ages ranged from 28 to 66 years (mean of 43±9 years), and their left ventricular ejection fraction varied from 8% to 35%. Carvedilol was added to the usual therapy of 20 patients; placebo was added to the usual therapy of 10 patients. The initial dose of carvedilol was 12.5 mg, which was increased weekly until it reached 75 mg/day, according to the patient's tolerance. Clinical assessment, electrocardiogram, echocardiogram, and radionuclide ventriculography were performed in the pretreatment phase, being repeated after 2 and 6 months of medication use. RESULTS: A reduction in heart rate (p=0.016) as well as an increase in left ventricular shortening fraction (p=0.02) and in left ventricular ejection fraction (p=0.017) occurred in the group using carvedilol as compared with that using placebo. CONCLUSION: Carvedilol added to the usual therapy for heart failure resulted in better heart function.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>beta-blocker</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dilated cardiomyopathy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Right coronary artery fistula with congestive heart failure in the neonate. Doppler echocardiographic diagnosis and closure with detachable balloon</s1>
</fA08>
<fA11 dir="011000">
<s1>Ivan Romero Rivera</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valdir Ambrósio Moises</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Sergio Tebexreni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Celia Camelo Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Lázaro Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Orlando Campos Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>248-252</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report here a case of coronary artery fistula in a neonate with clinical signs of heart failure. The electrocardiogram showed signs of left ventricular hypertrophy and diffuse alterations in ventricular repolarization. Chest X-ray showed an enlargement of the cardiac silhouette with an increase in pulmonary flow. After echocardiographic diagnosis and angiographic confirmation, closure of the fistulous trajectory was performed with a detachable balloon with an early and late successful outcome.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Isolated noncompaction of the myocardium</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Elias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Wilson Valadão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ricardo Kuniyoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Aloir Queiroz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Carlos André Peixoto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Cardiologia do Espírito Santo Clínica do Ritmo </s1>
<s2>Vitória ES</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>258-261</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the case of a 42-year-old female with fatigue on exertion and palpitation consequent to the existence of isolated noncompaction of the myocardium. We discuss clinical and familial findings, diagnostic possibilities, and prognostic and therapeutical implications of this rare disorder of endomyocardial morphogenesis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Valvular regurgitation by color doppler echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>André Schmidt</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Oswaldo C. Almeida Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Pazin Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José A. Marin-Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Benedito C. Maciel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto </s1>
<s2>Ribeirão Preto SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>273-281</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>101</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Verapamil COER-24 180/240mg na hipertensão arterial leve a moderada em dose única diária avaliado pela monitorização ambulatorial da pressão arterial</s1>
</fA08>
<fA08 dir="en">
<s1>Single daily dose of verapamil (COER-24 180/240mg) in mild and moderate hypertension evaluated by ambulatory blood pressure monitoring</s1>
</fA08>
<fA11 dir="011000">
<s1>Katia Coelho Ortega</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Luis Santello</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando Nobre</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Oswaldo Kohlman Jr</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo César B. Veiga Jardim</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Lilian Soares da Costa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Guido Aranha Rosito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>José Joaquim Fernandes Raposo Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Wille Oigman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Décio Mion Jr</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>283-290</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a eficácia terapêutica do verapamil COER-24 180/240 mg, em dose única, ao deitar, como monoterapia para a hipertensão arterial leve a moderada. MÉTODOS: Estudo multicêntrico, aberto, não comparativo com 81 pacientes de ambos os sexos, com idade &gt;20 anos e hipertensão arterial essencial leve e moderada. Medimos a pressão arterial no consultório e com a monitorização ambulatorial (MAPA) durante 24h antes e ao final de 8 semanas do uso da medicação. RESULTADOS: Verificou-se diminuição (p&lt;0,0001) das pressões sistólicas e diastólicas medidas no consultório às semanas 3 e 8. A MAPA demonstrou que tanto a pressão sistólica, diastólica, média e freqüência cardíaca, quando as cargas pressóricas médias de 24h apresentaram reduções após 8 semanas de tratamento, além da redução do duplo-produto, especialmente pela manhã. A tolerabilidade foi boa, 68% dos pacientes não apresentaram eventos adversos. CONCLUSÃO: A monoterapia com o verapamil COER-24 180/240mg em dose única é eficaz para o controle da pressão arterial em hipertensos leves e moderados, com redução tanto na pressão casual quanto na MAPA/24h, além de apresentar boa tolerabilidade.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the anti-hypertensive effecft of verapamil COER-24 180/240 mg in a single dose at bedtime as single therapy in mild to moderate hypertensives. METHODS: A multicentric, open, placebo controlled study of 81 hypertensive patients older than 20 years-old followed to 8 weeks. Blood pressure was measured in doctor's office and by 24h ambulatory monitoring (ABPM). RESULTS: We observed a decreased in systolic and diastolic blood pressure in doctor's office at 4th and 8th weeks. ABPM showed that both systolic, diastolic and mean blood pressure, heart rate and the mean 24-hour blood pressure load decreased after the 8-week treatment. In addition, there was a reduction of the double-product, especially in the morning and 68% of the patients didn't have any adverse events. CONCLUSION: The theraphy verapamil COER-24 180/240mg in a single dose is useful for mild and moderate hypertensive patients, with significant pressure decrease in both office blood pressure measurements and in the ABPM/24 hours, as well as showing good tolerability.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>verapamil</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>MAPA</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>verapamil</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ABPM</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Reliability of the interpretation of coronary angiography by the simple visual method</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Augusto Nunes Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Edgar Guimarães Victor</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria do Rosário de Britto Leite</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Maria Pereira Gomes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Edgar Victor Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Jesus Reyes Liveras</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>300-308</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Evaluation of inter and intraobserver reproducibility of by the visual method interpretation of cineangiogram in a clinically based context. METHODS: Five interventional cardiologists analyzed 11 segments of 8 coronary cineangiograms at a two month apart sessions. The percent luminal reduction by the lesions were analyzed by two different classifications: in one (A) the lesions were graded in 0% = absent, 1-50% = mild, 51 - 69 = moderate, and  &gt; or =  70% = severe; the other classification (B) was a dichotomic one : &lt;70% = nonsignificant and  &gt; or =  70%=significant lesions. The agreement were measured by the kappa (k) index. RESULTS: Interobserver agreement was moderate for classification A (1st measurement, k = 0.36 -- 0.63, k m = 0.49; 2nd measurement, k = 0.39-0.68, k m = 0.52) and good for classification B (1st measurement, k = 0.55-0.73, k m = 0.63; 2nd measurement, k = 0.37-0.82, k m = 0.61). Intraobserver levels of agreement were k = 0.57-0.95 for classification A and 0.62-1.0 for classification B. CONCLUSION: The higher level of reproducibility obtained by adopting the dichotomous criteria usually considered for ischemic limits demonstrates that in the present clinical context, the reliability of the simple visual method is adequate for the identification of patients with clinically significant lesions and candidates for myocardial revascularization procedures.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>observer variation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>kappa statistic</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>The effect of siesta in parameters of cardiac structure and in interpretation of ambulatory arterial blood pressure monitoring</s1>
</fA08>
<fA11 dir="011000">
<s1>Marco A.M. Gomes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Angela M.G. Pierin</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Décio Mion Jr</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>314-318</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the influence of the siesta in ambulatory blood pressure (BP) monitoring and in cardiac structure parameters. METHODS: 1940 ambulatory arterial blood pressure monitoring tests were analyzed (Spacelabs 90207, 15/15 minutes from 7:00 to 22:00 hours and 20/20 minutes from 22:01 to 6.59hours) and 21% of the records indicated that the person had taken a siesta (263 woman, 52±14 years). The average duration of the siesta was 118±58 minutes. RESULTS: (average ± standard deviation) The average of systolic/diastolic pressures during wakefulness, including the napping period, was less than the average for the period not including the siesta (138±16/85±11 vs 139±16/86±11 mmHg, p&lt;0.05); 2) pressure loads during wakefulness including the siesta, were less than those observed without the siesta); 3) the averages of nocturnal sleep blood pressures were similar to those of the siesta, 4) nocturnal sleep pressure drops were similar to those in the siesta including wakefulness with and without the siesta; 5) the averages of BP in men were higher (p&lt;0.05) during wakefulness with and without the siesta, during the siesta and nocturnal sleep in relation to the average obtained in women; 6) patients with a reduction of 0- 5% during the siesta had thickening of the interventricular septum and a larger posterior wall than those with a reduction during the siesta &gt;5%. CONCLUSION: The siesta influenced the heart structure parameters and from a statistical point of view the average of systolic and diastolic pressures and the respective pressure loads of the wakeful period.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>siesta</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ambulatory arterial blood pressure monitoring</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sleep</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Peripheral arterial embolism. Report of hospitalized cases</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Moacyr Roberto Cuce Nobre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alfredo José Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Aírton Scipioni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>324-328</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: We analyzed the frequency of peripheral embolisms, the underlying heart disease,triggering factors, the sites of the emboli, and evolution of the patients. METHODS: We analyzed 29 cases of peripheral arterial embolism out of a total of 20,211 hospitalizations in a cardiology center in the city of São Paulo. The age was 51.89±18.66 years, and 15 were males. RESULTS: Embolism in the right lower limb occurred in 18 patients (62.0%),in the left lower 11(37.9%) and right upper 3 (10.3%) limbs, and in the left arm (1). Four patients had embolism in two limbs. The heart disease, mitral valvar heart disease (9 patients - 31.0%); infective endocarditis (7- 24.1%); dilated cardiomyopathy (6 - 20.6%); ischemic coronary heart disease (6 patients - 20.6%); and one patient with cor pulmonale. Atrial fibrillation was observed in 20 patients (68.9%), chronic in 12 patients (41.3% ) and acute in 8 (27.5%). All patients with mitral valvar heart disease had atrial fibrillation, chronic in 8 patients (88.8%); patients with cardiomyopathy and coronary heart disease, 4 in each group had atrial fibrillation, acute in 60% of the patients.Patients with infective endocarditis, 3 had staphylococcus and 2 Gram-negative bacteria. In the follow-up, 2 patients (6.8%) required limbs amputation, and 5 (17.2%) died due to embolism. CONCLUSION: Most of the time, embolism does not cause permanent complications. Our data highlight the importance of anticoagulation for patients acute atrial fibrillation in myocardial dysfunction and for patients with chronic atrial fibrillation in cases of mitral valvar heart disease to prevent peripheral embolism.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>valvar heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>peripheral arterial embolism</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Mortality attributed to myocardial infarction in the male and female population of Salvador, BA, between 1981 and 1996</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Carlos Santana Passos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Alberto Lopes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ines Lessa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Adelina Sanches</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rogério Santos-Jesus</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>332-334</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To describe according to gender the trend in mortality attributed to myocardial infarction (MI) in the population of Salvador, Bahia between 1981 and 1996. METHODS: This study was on mortality due to MI estimates by period and gender of the city of Salvador, Bahia. Data from 1981 to 1996 were stratified by quadrienia, and the percentage reduction in death rate due to MI relative to the preceding period (PRR) was determined. Comparisons between genders were expressed by the male/female death ratio (DR) based on the gender-related PPR. RESULTS: An overall increase of approximately 8% was observed in the death rate attributed to MI for the period 1985-1988 (89.2/10 5 individuals / year) versus the period 1981-1984 (82.1/10(5)/ year). In the subsequent periods, overall reductions of 10% and 20.3% were observed for the periods 1989-1992 and 1993-1996, respectively. For men, the PPRs were 11.1 in the period 1989-1992 and 22.7% in the period 1993-1996. The PPRs in women were lower: 8.6% and 17.4% between 1989 and 1992, and 1993 and 1996, respectively. Death rate reduction was greater for men than women, then the male/female DR decreased from 1.66 in 1981-1984 to 1.35 in 1993-1996. CONCLUSION: The results indicate a trend towards a reduction in the death rate attributed to myocardial infarction in the city of Salvador from the second half of the 1980s onwards, striking in men.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>trend</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>gender</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Congenital atresia of the ostium of the left coronary artery. Diagnostic difficulty and successful surgical revascularization in two patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Amaral</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carla Tanamati</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>João A Granzotti</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jorge L Haddad</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>João Ronaldo A Leite</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Miguel Barbero-Marcial</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>339-342</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report two cases of congenital atresia of the ostium of the left coronary artery. Case 1: a six-month-old infant presenting with serious cardiac insufficiency. A noninvasive diagnosis of dilated myocardiopathy was established and the clinical picture was pharmacologically compensated. When the patient was nine months of age, a hemodynamic study was performed that revealed congenital atresia of the ostium of the left coronary artery; the infant immediately underwent a successful anastomosis of the internal mammary artery with the left coronary artery. Case 2: an eleven-year-old asymptomatic boy with a history of heart murmur from the age of six months on, was refered for surgery with a diagnosis of anomalous origin of the left coronary artery from pulmonary trunk. A definitive diagnosis of atresia of the left coronary ostium was only established during surgery. Successful surgical revascularization with the left internal mammary artery, and left ventricular aneurysmectomy were performed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Myocardial infarction and subsequent pregnancy</s1>
</fA08>
<fA11 dir="011000">
<s1>Citânia Lúcia Tedoldi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Waldomiro Carlos Manfroi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Nossa Senhora da Conceição  </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>347-350</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the case of a 40-year-old woman with 2 previous myocardial infarctions, revascularization surgery, and an ongoing pregnancy complicated with preeclampsia and fetal hypoxia. Her follow-up performed by a multidisciplinary team made possible the birth through cesarean section of a premature infant of the female sex with a very low birth weight, but without severe respiratory distress of the hyaline membrane disease type. Three months after the delivery, mother and daughter were healthy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Bilateral carotid endarterectomy combined with myocardial revascularization during the same surgical act</s1>
</fA08>
<fA11 dir="011000">
<s1>Leonardo Andrade Mulinari</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>André Luiz Tyszka</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Arleto Zacarias Silva Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fábio Binhara Navarro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Roberto Gomes de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Nossa Senhora das Graças  </s1>
<s2>Curitiba PR</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>353-354</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>The best surgical approach for the treatment of patients with severe cerebral artery disease and simultaneous serious coronary artery disease still remains controversial. In this report we present a case of a 72-year-old female patient admitted to the hospital with unstable angina. Triple coronary artery obstructive disease and severe bilateral carotid artery stenosis were diagnosed. A combined, simultaneous surgical procedure was performed. After total circulatory by-pass with a membrane oxygenator, the patient's body temperature was lowered to 32°C. During the cool-down period, three proximal anastomoses of segments of autologous saphenous veins were performed in the ascending aorta. Immediately afterwards, bilateral carotid endarterectomy was performed, followed by three distal anastomoses to coronary arteries. The patient showed a satisfactory post-operative outcome. It was concluded that the combination of moderate hypothermia, hemodilution with appropriate hemodynamic control, as used in this patient, was an effective method of cerebral protection. The simultaneous approach of carotid endarterectomy and coronary artery by-pass surgery should be seen as a safe option for the treatment of this type of patient.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>A 15-year-old male with progressive muscular dystrophy of the Becker type and severe heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>360-364</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Expression of nitric oxide synthases in the pathophysiology of cardiovascular diseases</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernanda Viaro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernando Nobre</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Roberto B. Evora</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>380-393</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>71</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Epidemiological characteristics of congenital heart diseases in Londrina, Paraná South Brazil</s1>
</fA08>
<fA11 dir="011000">
<s1>José Carlos dos Santos Guitti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Londrina Centro de Ciências da Saúde </s1>
<s2>Londrina PR</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>400-404</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the prevalence and other epidemiological characteristics of congenital heart diseases. METHODS: A retrospective population based study of children who were born in Londrina, from January '89 to December '98 (80,262 live births). Diagnoses were confirmed through autopsy, surgery, catheterization, or echocardiography. RESULTS: A total of 441 patients was as certained what corresponds to a prevalence of 5.494:1,000 live births. Ventricular septal defect was the commonest lesion. A small number of transpositions of the great vessels and of left ventricular hypoplasia was observed. A high propation of ventricular septal defect (28.3%) and atrioventricular septal defects (8.1%) occurred. Fifty-one (11.35%) affected children had syndromic diseases and 52 (12.01%) children had nonsyndromic anomalies. CONCLUSION: The prevalence of congenital heart diseases in Londrina is in accordance with that of other regions of the globe. This prevalence also may reflect the reality in the southern region of Brazil, because population characteristics are very similar in the 3 southernmost Brazilian states.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Brazil</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Efficacy of a diagnostic strategy for patients with chest pain and no ST-segment elevation in the emergency room</s1>
</fA08>
<fA11 dir="011000">
<s1>Roberto Bassan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Gamarski</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Lúcia Pimenta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>André Volschan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marcelo Scofano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Hans Fernando Dohmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Monica Araujo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Cristina Clare</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Marcelo Fabrício</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Carlos Henrique Sanmartin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Kalil Mohallem</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Renato Macaciel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="131000">
<s1>Sergio Gaspar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pró-Cardíaco Hospital Teaching and Research Center </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>412-417</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: To evaluate the efficacy of a systematic model of care for patients with chest pain and no ST segment elevation in the emergency room. METHODS: From 1003 patients submitted to an algorithm diagnostic investigation by probability of acute ischemic syndrome. We analyzed 600 ones with no elevation of ST segment, then enrolled to diagnostic routes of median (route 2) and low probability (route 3) to ischemic syndrome. RESULTS: In route 2 we found 17% acute myocardial infarction and 43% unstable angina, whereas in route 3 the rates were 2% and 7%, respectively. Patients with normal/non--specific ECG had 6% probability of AMI whereas in those with negative first CKMB it was 7%; the association of the 2 data only reduced it to 4%. In patients in route 2 the diagnosis of AMI could only be ruled out with serial CKMB measurement up to 9 hours, while in route 3 it could be done in up to 3 hours. Thus, sensitivity and negative predictive value of admission CKMB for AMI were 52% and 93%, respectively. About one-half of patients with unstable angina did not disclose objective ischemic changes on admission. CONCLUSION: The use of a systematic model of care in patients with chest pain offers the opportunity of hindering inappropriate release of patients with ACI and reduces unnecessary admissions. However some patients even with normal ECG should not be released based on a negative first CKMB. Serial measurement of CKMB up to 9 hours is necessary in patients with medium probability of AMI.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chest pain</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>emergency room</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>unstable angina</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Mediastinitis after cardiac transplantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Noedir A. G. Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alfredo I. Fiorelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando Bacal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz F. Camargo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Edimar A. Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Andréa Freitas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>André Nicoletti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Daniela Meira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>425-430</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Assessment of incidence and behavior of mediastinitis after cardiac transplantation. METHODS: From 1985 to 1999, 214 cardiac transplantations were performed, 12 (5.6%) of the transplanted patients developed confirmed mediastinitis. Patient's ages ranged from 42 to 66 years (mean of 52.3±10.0 years) and 10 (83.3%) patients were males. Seven (58.3%) patients showed sternal stability on palpation, 4 (33.3%) patients had pleural empyema, and 2 (16.7%) patients did not show purulent secretion draining through the wound. RESULTS: Staphylococcus aureus was the infectious agent identified in the wound secretion or in the mediastinum, or both, in 8 (66.7%) patients. Staphylococcus epidermidis was identified in 2 (16.7%) patients, Enterococcus faecalis in 1 (8.3%) patient, and the cause of mediastinitis could not be determined in 1 (8.3%) patient. Surgical treatment was performed on an emergency basis, and the extension of the débridement varied with local conditions. In 2 (16.7%) patients, we chose to leave the surgical wound open and performed daily dressings with granulated sugar. Total sternal resection was performed in only 1 (8.3%) patient. Out of this series, 5 (41.7%) patients died, and the causes of death were related to the infection. Autopsy revealed persistence of mediastinitis in 1 (8.3%) patient. CONCLUSION: Promptness in diagnosing mediastinitis and precocious surgical drainage have changed the natural evolution of this disease. Nevertheless, observance of the basic precepts of prophylaxis of infection is still the best way to treat mediastinitis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mediastinitis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac transplantation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>immunosuppression</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Absence of the aortic valve associated with hypoplastic left-sided heart syndrome</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Alberto Benvenuti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Tamara Cortez Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Miguel Barbero-Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>434-436</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>In this report we describe the twelveth case in the literature of absence of the aortic valve cusps, associated with hypoplastic left-sided heart syndrome in a neonate. Clinical and hemodynamic conditions in our patient resemble the classical features of this syndrome except for a greater development of the ascending aorta and the left ventricular cavity, due to aortic insufficiency. A patch was unsuccessfully inserted at the aortic annulus to exclude the left ventricle from the circulation. In addition the Norwood operation was performed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>The Brugada syndrome. Outcome of one case</s1>
</fA08>
<fA11 dir="011000">
<s1>Ivan G. Maia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Magda Wanderley Soares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Silvia H. Boghossian</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Roberto Sá</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco - Hospital de Cardiologia de Laranjeiras  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>442-445</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>8</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>The Brugada syndrome is a rare condition, and due to its mutating manner of presentation it may be difficult to diagnose. We report one case and discuss the diagnostic aspects and the clinical outcome of one patient with characteristic findings of this syndrome. These findings are especially defined by J-ST elevation in the right leads of serial electrocardiographic records, wide oscillations of J points and ST segments during 24-hour Holter monitoring, and nocturnal sudden death. We stress the importance of the Holter monitor findings for diagnostic complementation. Through this method it is possible to establish a correlation between vigil activities and sleep and the variability of the degree of impairment in ventricular repolarization.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Association of pulmonary atresia with intact ventricular septum and aortic valve stenosis. Prenatal diagnosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Ivan Romero Rivera</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valdir Ambrósio Moises</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Celia Camelo Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Lázaro Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>450-452</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>6</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A rare association of pulmonary atresia with an intact septum was diagnosed through echocardiography in a fetus 32 weeks of gestational age. The diagnosis was later confirmed by echocardiography of the newborn infant and further on autopsy. The aortic valve was bicuspid with a pressure gradient of 81mmHg, and the right ventricle was hypoplastic, as were the pulmonary trunk and arteries, and the blood flow was totally dependent on the ductus arteriosus.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>An interpretation - mitral valve prolapse syndrome</s1>
</fA08>
<fA11 dir="011000">
<s1>Hudson Hübner França</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>PUC Faculdade de Medicina de Sorocaba </s1>
<s2>Sorocaba SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>456-458</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>43</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Reconstructive surgery for aortic valve disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo José F. Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Roberto B. Évora</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Walter V. A. Vicente</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Carlos Menardi</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>467-474</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>49</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Diretrizes para o implante de marcapasso cardíaco permanente</s1>
</fA08>
<fA11 dir="011000">
<s1>José Carlos S. Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vicente Ávila Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Domingo M. Braile</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo R. S. Brofman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alvaro R. B. Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Roberto Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Silas S. Galvão Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Paulo R. A. Gauch</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Fernando A. Lucchese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Martino Martinelli Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Paulo T. J. Medeiros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>José C. P. Mateos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="131000">
<s1>João Pimenta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="141000">
<s1>Roberto T. Takeda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Sociedade Brasileira de Cirurgia Cardiovascular Departamento de Estimulação Cardíaca Artificial </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>475-480</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>74</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Diretrizes para o implante de cardioversor desfibrilador implantável</s1>
</fA08>
<fA11 dir="011000">
<s1>José Carlos S. Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vicente Ávila Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Domingo M. Braile</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo R. S. Brofman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alvaro R. B. Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Roberto Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Silas S. Galvão Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Paulo R. A. Gauch</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Fernando A. Lucchese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Martino Martinelli Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Paulo T. J. Medeiros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>José C. P. Mateos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="131000">
<s1>João Pimenta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="141000">
<s1>Roberto T. Takeda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Sociedade Brasileira de Cirurgia Cardiovascular Departamento de Estimulação Cardíaca Artificial </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>481-482</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07400510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Tendências das publicações nas fases trimestral, bimestral e mensal das cinco décadas dos Arquivos Brasileiros de Cardiologia</s1>
</fA08>
<fA08 dir="en">
<s1>Publication trends in the quartely, bimonthly and monthly cycles of publication in the Brazilian Archives of Cardiology over five decades</s1>
</fA08>
<fA11 dir="011000">
<s1>Alfredo José Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Adriana Salatini Abud</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cícero Piva de Albuquerque</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>01-07</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>53</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar tendências das publicações nos Arquivos Brasileiros de Cardiologia de março de 1948 a fevereiro de 1998, nas fases trimestral, bimestral e mensal de publicação. MÉTODOS: Foram sorteados aleatoriamente 25% dos fascículos de cada fase e constituída amostra de 98 fascículos: 13 (11,5%) da fase trimestral, 27 (23,5%) da fase bimestral e 58 (65%) da fase mensal. Foram estudados o tipo de texto, o número de autores, a procedência, o idioma, e as referências bibliográficas. RESULTADOS: Foram estudados 1.204 textos, 90 (7,5%) da fase trimestral, 238 (19,8%) da fase bimestral e 876 (72,8%) da fase mensal. Os textos mais freqüentes foram artigos originais (353), revisões de tema (350) e relatos de caso (205). Nas três fases de periodicidade: não houve diferença significativa das proporções de artigos originais, revisões e relatos de caso; houve maior número de autores na fase mensal; verificou-se concentração geográfica das contribuições [864 de 1204 (72%) de três Estados], diminuíram as contribuições internacionais (20,8%, 4,4% e 4,9%), houve redução de publicações em outras línguas; a média de referências internacionais superou 16,7 e de nacionais foi inferior a 4,7. CONCLUSÃO: A análise da tendência evolutiva em cinco décadas de publicação revelou hiatos que podem ser preenchidos pelos Arquivos Brasileiros de Cardiologia, para melhor acompanhar as tendências internacionais de editoração de periódicos médicos, das expectativas dos autores e dos leitores.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study trends in selected manuscript characteristics of articles published in the Brazilian Archives of Cardiology from March 1948, to February 1998, in the quarterly, bimonthly and monthly cycles of publication. METHODS: A random sample of 25% of all issues of the journal comprised the study sample: 13 issues (11.5%) from the quarterly, 27 (23,5%) from the bimonthly, and 58 (65%) from the monthly publication cycle. We studied the type of manuscript, number of authors, geographical distribution, language of publication and references. RESULTS: A total of 1204 articles were studied, 90 (7.5%) from the quarterly, 238 (19,8%) from the bimonthly, and 876 (72.8%) from the monthly publication cycle. The most frequent published articles were original contributions (353), reviews (350) and case reports (205). No significant difference occurred in the proportion of original articles, reviews and case reports; the number of authors was higher in the monthly period;a geographical concentration of the contributions occurred (72% from three Brazilian States); manuscripts in languages other than Portuguese decreased. The mean number of Brazilian references cited was less than 4.7 and the mean number of international references cited was greater than 16.7. CONCLUSION: The analysis of the trends over five decades of publication revealed the need for further steps to be taken by the Brazilian Archives of Cardiology, to meet international publication standards for biomedical journals as well as authors' and readers' demands.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Periódicos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Publicação</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Periodicals</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Publishing</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Does a circadian variation occur in myocardial ischemia over 48 hours in patients with unstable angina?</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Antônio Machado César</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João Fernando Monteiro Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>César J. Grupi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>David Pamplona</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Miguel A. Moretti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Elcio Pferfmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José A. F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>14-18</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study the incidence of and variation in myocardial ischemia over 48 hours in patients with unstable angina. METHODS: Thirty-nine patients with unstable angina underwent long-term electrocardiography for 48 hours. The number of events and the period of time of ischemia (in minutes) were analyzed for the 48 hours, in two periods of 24 hours, and in periods of 4 hours. RESULTS: We analyzed 1755.8 hours of monitoring tapes, and ischemic episodes were detected in 18 (46.2%) patients, corresponding to 173 ischemic episodes, allowing the evaluation of 1304 minutes of ischemia.only 4 of which were (2.2%) symptomatic, Considering the entire period of time of recording and the predetermined time intervals, we observed a higher number of ischemic episodes (38) and a longer duration of ischemia (315.4 minutes) between 11:00 am and 3:00 pm. However, no significant differences occurred among the values in the different intervals. CONCLUSION: Long-term electrocardiography over 48 hours showed a high incidence (97.8%) of silent ischemic episodes in patients with unstable angina. No evidence of a circadian variation of myocardial ischemia in unstable angina was observed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial ischemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Holter monitoring</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>unstable angina</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>End-systolic pressure-diameter relation of the left ventricle during transient and sustained elevations of blood pressure</s1>
</fA08>
<fA11 dir="011000">
<s1>Edson Antonio Bregagnollo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Katashi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Beatriz Bojikian Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo José Ferreira Tucci</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de São Paulo Faculdade de Medicina de Botucatu </s1>
<s2>Botucatu SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>26-32</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>60</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effect of transient and sustained variations in cardiac load on the values of the end-systolic pressure-diameter relation (ESPDR) of the left ventricle. METHODS: We studied 13 dogs under general anesthesia and autonomic blockade. Variations of cardiac loads were done by elevation of blood pressure by mechanical constriction of the aorta. Two protocols were used in each animal: gradual peaking and decreasing pressure variation, the &quot;transient arterial hypertension protocol&quot; (TAH), and a quick and 10 min sustained elevation, the &quot;sustained arterial hypertension protocol&quot;(SAH). Then, we compared the ESDR in these two situations. RESULTS: Acute elevation of arterial pressure, being it &quot;transitory&quot; or &quot;sustained&quot;, did not alter the heart frequency and increased similarly the preload and after load. However, they acted differently in end systolic pressure-diameter relation. It was greater in the SAH than TAH protocol, 21.0±7.3mmHg/mm vs. 9.2±1.2mmHg/mm (p&lt;0.05). CONCLUSION: The left ventricular ESPDR values determined during sustained pressure elevations were higher than those found during transient pressure elevations. The time-dependent activation of myocardial contractility associated with the Frank-Starling mechanism is the major factor in inotropic stimulation during sustained elevations of blood pressure, determining an increase in the ESPDR values.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>end-systolic pressure-diameter relations</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac inotropism</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Predictive value of clinical and electrophysiological variables in patients with chronic chagasic cardiomyopathy and nonsustained ventricular tachycardia</s1>
</fA08>
<fA11 dir="011000">
<s1>Rose Mary Ferreira Lisboa da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Zildany Pinheiro Távora</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando Antônio Aquino Gondim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Niraj Metha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Vanderlei Mitsuo Hara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Angelo Amato Vincenzo de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>41-47</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>68</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Risk stratification of patients with nonsustained ventricular tachycardia (NSVT) and chronic chagasic cardiomyopathy (CCC). METHODS: Seventy eight patients with CCC and NSVT were consecutively and prospectively studied. All patients underwent to 24-hour Holter monitoring, radioisotopic ventriculography, left ventricular angiography, and electrophysiologic study. With programmed ventricular stimulation. RESULTS: Sustained monomorphic ventricular tachycardia (SMVT) was induced in 25 patients (32%), NSVT in 20 (25.6%) and ventricular fibrillation in 4 (5.1%). In 29 patients (37.2%) no arrhythmia was inducible. During a 55.7-month-follow-up, 22 (28.2%) patients died, 16 due to sudden death, 2 due to nonsudden cardiac death and 4 due to noncardiac death. Logistic regression analysis showed that induction was the independent and main variable that predicted the occurrence of subsequent events and cardiac death (probability of 2.56 and 2.17, respectively). The Mantel-Haenszel chi-square test showed that survival probability was significantly lower in the inducible group than in the noninductible group. The percentage of patients free of events was significantly higher in the noninducible group. CONCLUSION: Induction of SMVT during programmed ventricular stimulation was a predictor of arrhythmia occurrence cardiac death and general mortality in patients with CCC and NSVT.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagasic heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nonsustained ventricular tachycardia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrophysiologic study</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Clinical outcome of patients with familial hypercholesterolemia and coronary artery disease undergoing partial ileal bypass surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Jaqueline Scholz Issa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Artur Garrido Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sérgio Diogo Giannini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Neusa Forti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Jayme Diament</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Henrique Walter Pinotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>54-58</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>08</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Familial hypercholesterolemia is characterized by high serum levels of total cholesterol and LDL-cholesterol. It may be homozygous or heterozygous. In homozygous patients, LDL-cholesterol levels range from 500 to 1000mg/dL and coronary artery disease is precocious, usually manifesting itself between the 2nd and 3rd decades of life. The diagnosis is often made by the presence of xanthoma tuberosum and tendinous xanthomas that appear between the 1st and 2nd decades of life. The use of high doses of statins or even unusual procedures (apheresis, partial ileal bypass surgery, liver transplantation, gene therapy), or both, is necessary for increasing survival and improving quality of life, because a reduction in cholesterol levels is essential for stabilizing the coronary artery disease and reducing xanthomas. We report our experience with 3 patients with xanthomatous familial hypercholesterolemia and coronary artery disease, who underwent partial ileal bypass surgery. Their follow-up over the years (approximately 8 years) showed a mean 30% reduction in total cholesterol, with a significant reduction in the xanthomas and stabilization of the coronary artery disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Ebstein's anomaly with imperforate tricuspid valve. Prenatal diagnosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlo B. Pilla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>62-64</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Ebstein's anomaly is an uncommon congenital heart defect, with a prevalence of 0.3-0.5%. Its association with an imperforate tricuspid valve is an even more rare situation (less than 10% of cases). Prenatal diagnosis of this association by means of fetal echocardiography has not been reported. We describe here this association diagnosed before birth and confirmed after birth. The diagnostic potential and importance of fetal echocardiography during prenatal evaluation of cardiac malformations allows for adequate perinatal planning and management, with an obvious impact on morbidity and mortality.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Fetal tachyarrhythmia with 1:1 atrioventricular conduction. Adenosine infusion in the umbilical vein as a diagnostic test</s1>
</fA08>
<fA11 dir="011000">
<s1>Tiago L. L. Leiria</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gustavo G. de Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rejane F. Dillenburg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>67-68</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>08</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>This is the report of a case of fetal tachyarrhythmia with 1:1 atrioventricular conduction detected by pre-natal echocardiography in a fetus at 25-weeks gestation. Adenosine infusion via cordocentesis was performed as a diagnostic test to differentiate between atrioventricular nodal reentrant supraventricular tachyarrhythmia and atrial flutter. After infusion, transient 2:1 atrioventricular dissociation was obtained and the diagnosis of atrial flutter was made. Transplacental therapy with digoxin and amiodarone was then successfully used.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Mortality from acute myocardial infarction and other ischemic heart diseases in the State of São Paulo from 1980 to 1996</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz F. Marcopito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mírian M. Shirassu</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>72-74</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Iatrogenia em cardiologia</s1>
</fA08>
<fA08 dir="en">
<s1>Iatrogeny in cardiology</s1>
</fA08>
<fA11 dir="011000">
<s1>Afonso Celso Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Alexandre Franken</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sandra Regina Schwarzwalder Sprovieri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Valdir Golin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa de Misericórdia de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>75-78</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>O termo iatrogenia vem do grego e refere-se a qualquer alteração patológica provocada no paciente pela má prática médica. Infelizmente, o risco de sua ocorrência convive constantemente no manuseio das doenças cardíacas. Podem ser considerados dois tipos de iatrogenia: iatrogenia de ação, ou decorrente da ação médica, e iatrogenia de omissão, relacionada à falta de ação do médico. As iatrogenias ocorrem em todas as fases do ato médico, desde a relação com o paciente, passando pelo diagnóstico, tratamento, até a prevenção das doenças. O presente artigo comenta as iatrogenias no campo das doenças cardíacas e cita alguns exemplos de como ocorrem.</s0>
</fC01>
<fC01 dir="en">
<s0>The word iatrogeny derives from the Greek and concerns any disorder caused to the patient by inaproppriate medical practice. Unfortunately, the rise of an iatrogenic disease is related to the daily handline of cardiac disease. There are two types of iatrogeny: that caused by a medical action and omission iatrogeny, caused by the lack of a medical action. Iatrogeny occurs in all steps of medical practice starting with the patient-doctor relationship including diagnosis treatment and finally prevention of diseases. This article makes a brief commentary about iatrogenic heart disease and mentions some examples of it.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Adaptation to exercise following cardiac transplantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Ana Fátima Salles</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Japy Angelini Oliveira Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>85-90</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>88</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Transposition of the great arteries. Evaluation of the results and current management</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>94-96</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Influence of caffeine on blood pressure and platelet aggregation</s1>
</fA08>
<fA11 dir="011000">
<s1>José Wilson S. Cavalcante</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Roberto M. Santos Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcus G. F. de Menezes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Hedylamar Oliveira Marques</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Leonardo Pessoa Cavalcante</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Walewska S. Pacheco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Amazonas  </s1>
<s2>Manaus AM</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>102-105</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Studies have demonstrated that methylxanthines, such as caffeine, are A1 and A2 adenosine receptor antagonists found in the brain, heart, lungs, peripheral vessels, and platelets. Considering the high consumption of products with caffeine in their composition, in Brazil and throughout the rest of the world, the authors proposed to observe the effects of this substance on blood pressure and platelet aggregation. METHODS: Thirteen young adults, ranging from 21 to 27 years of age, participated in this study. Each individual took 750mg/day of caffeine (250mg tid), over a period of seven days. The effects on blood pressure were analyzed through the pressor test with handgrip, and platelet aggregation was analyzed using adenosine diphosphate, collagen, and adrenaline. RESULTS: Diastolic pressure showed a significant increase 24 hours after the first intake (p&lt;0.05). This effect, however, disappeared in the subsequent days. The platelet aggregation tests did not reveal statistically significant alterations, at any time during the study. CONCLUSION: The data suggest that caffeine increases diastolic blood pressure at the beginning of caffeine intake. This hypertensive effect disappears with chronic use. The absence of alterations in platelet aggregation indicates the need for larger randomized studies.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>caffeine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adenosine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Normal values of echocardiographic measurements. A population-based study</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Roberto Schvartzman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Flávio Danni Fuchs</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alex Gules Mello</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maikel Coli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mario Schvartzman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Leila Beltrami Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>111-114</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To describe echocardiographic measurements and left ventricular mass in a population sample of healthy adults inhabitants of the urban region of Porto Alegre. METHODS: An analytical, observational, population-based, cross-sectional study was done. Through a multi-stage probability sample, 114 individuals were selected to be submitted to a M-mode and two-dimensional echocardiogram with color Doppler. The analyses were restricted to healthy participants. Echocardiographic measurements were described by mean, standard deviation, 95 percentile and 95% confidence limits. RESULTS: A total of 100 healthy participants, with several characteristics similar to those from the original population, had a complete and reliable echocardiographic examination. The measurements of aorta, left atrium, interventricular septum, left ventricle in systole and diastole, left posterior wall and left ventricular mass, adjusted or not for body surface area or height, were significantly higher in males. The right ventricle size was similar among the genders. Several echocardiographic measurements were within standard normal limits. Interventricular septum, left posterior wall and left ventricular mass, adjusted or not for anthropometric measurements, and aortic dimensions had lower mean and range than the reference limits. CONCLUSION: The means and estimates of distribution for the measurements of interventricular septum, left posterior wall and left ventricular mass found in this survey were lower than those indicated by the international literature and accepted as normal limits.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>normal values</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Arrhythmogenic cardiomyopathy of the right ventricle. Predictive value of QT interval dispersion to assess arrhythmogenic risk and sudden death</s1>
</fA08>
<fA11 dir="011000">
<s1>Márcio L. A. Fagundes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ivan G. Maia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando E. S. Cruz Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo A. G. Alves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Silvia H. Boghossian</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Carlos Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Roberto Sá</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital PróCardíaco  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>120-124</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine in arrhythmogenic right ventricular cardiomyopathy the value of QT interval dispersion for identifying the induction of sustained ventricular tachycardia in the electrophysiological study or the risk of sudden cardiac death. METHODS: We assessed QT interval dispersion in the 12-lead electrocardiogram of 26 patients with arrhythmogenic right ventricular cardiomyopathy. We analyzed its association with sustained ventricular tachycardia and sudden cardiac death, and in 16 controls similar in age and sex. RESULTS: (mean ± SD). QT interval dispersion: patients = 53.8±14.1ms; control group = 35.0±10.6ms, p=0.001. Patients with induction of ventricular tachycardia: 52.5±13.8ms; without induction of ventricular tachycardia: 57.5±12.8ms, p=0.420. In a mean follow-up period of 41±11 months, five sudden cardiac deaths occurred. QT interval dispersion in this group was 62.0±17.8, and in the others it was 51.9±12.8ms, p=0.852. Using a cutoff  &gt; or = 60ms to define an increase in the degree of the QT interval dispersion, we were able to identify patients at risk of sudden cardiac death with a sensitivity of 60%, a specificity of 57%, and positive and negative predictive values of 25% and 85%, respectively. CONCLUSION: Patients with arrhythmogenic right ventricular cardiomyopathy have a significant increase in the degree of QT interval dispersion when compared with the healthy population. However it, did not identify patients with induction of ventricular tachycardia in the electrophysiological study, showing a very low predictive value for defining the risk of sudden cardiac death in the population studied.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sudden death</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arrhythmogenic dysplasia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>QT interval dispersion</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Structural and functional characteristics of rat hearts with and without myocardial infarct. Initial experience with doppler echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Valdir A. Moisés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo L. Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Emília Nozawa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rosemeire M. Kanashiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Orlando Campos Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Lázaro de Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antonio Carlos C. Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Paulo J. F. Tucci</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>131-136</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess by Doppler echocardiography the structural and functional alterations of rat heart with surgical induced extensive myocardial infarction. METHODS: Five weeks after surgical ligature of the left coronary artery, 38 Wistar-EPM rats of both sexes, 10 of them with extensive infarction, undergone anatomical and functional evaluation by Doppler echocardiography and then euthanized for anatomopathological analysis. RESULTS: Echocardiography was 100% sensible and specific to anatomopathological confirmed extensive miocardial infarction. Extensive infarction lead to dilatation of left ventricle (diastolic diameter: 0.89cm vs.0.64cm; systolic: 0.72cm vs. 0.33cm) and left atrium (0.55cm vs. 0.33cm); thinning of left ventricular anterior wall (systolic: 0.14cm vs. 0.23cm, diastolic: 0.11cm vs. 0.14cm); increased mitral E/ A wave relation (6.45 vs. 1.95). Signals of increased end diastolic ventricle pressure, B point in mitral valve tracing in 62.5% and signs of pulmonary hypertension straightening of pulmonary valve (90%) and notching of pulmonary systolic flow (60%) were observed in animals with extensive infarction. CONCLUSION: Doppler echocardiography has a high sensitivity and specificity for detection of chronic extensive infarction. Extensive infarction caused dilatation of left cardiac chambers and showed in Doppler signals of increased end diastolic left ventricular pressure and pulmonary artery pressure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarct</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rat hearts</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Doppler echocardiogram</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Multiple arterial anomalies in the newborn infant. Echocardiographic and angiographic diagnosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Ivan Romero Rivera</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Lourdes Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Valdir Ambrósio Moisés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Celia Camelo Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Lázaro Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>141-144</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Multiple arterial anomalies characterized by tortuosity and rolling of the pulmonary arteries and aorta were diagnosed on echocardiography in an asymptomatic newborn infant with a phenotype suggesting Ehlers-Danlos syndrome. These changes were later confirmed on angiography, which also showed peripheral vascular abnormalities. The electrocardiogram showed a probable hemiblock of the left anterosuperior branch, and the chest x-ray showed an excavated pulmonary trunk with normal pulmonary flow.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Apical aneurysm and left ventricular hypertrophy</s1>
</fA08>
<fA11 dir="011000">
<s1>Helena Nogueira Soufen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Clovis de Carvalho Frimm</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz Alberto Benvenuti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brasil</s3>
</fA14>
<fA20 dir="000000">
<s1>148-150</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>6</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A 59-year-old woman presented with an embolic transient ischemic attack and a history of controlled hypertension for 16 years. Both echocardiogram and MRI showed severe biventricular hypertrophy and an apical aneurysm with a thrombus. The occurrence of an apical aneurysm in the presence of cardiac hypertrophy is a rare finding and has been described in patients with hypertrophic cardiomyopathy. However, it has not been reported in patients with systemic arterial hypertension. In this patient the lack of a relationship between the severity of the hypertrophy and the levels of blood pressure, together with the presence of histologic disorganization of myocardial cardiac muscle cells by endomyocardial biopsy suggested the diagnosis of hypertrophic cardiomyopathy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Heart failure in a 9-year-old child after treatment with anthracycline for Wilms' tumor</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>157-162</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Endothelial dysfunction and coronary artery disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo R. A. Caramori</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alcides J. Zago</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Hospital das Clínicas </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>173-182</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>113</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Ambulatory blood pressure monitoring and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus</s1>
</fA08>
<fA11 dir="011000">
<s1>Cesar Nissan Cohen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Francisco Manes Albanesi Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria de Fátima Gonçalves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marília de Brito Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro Hospital Universitário Pedro Ernesto </s1>
<s2> RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>200-204</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the association between microalbuminuria with ambulatory blood pressure monitoring in normotensive individuals with insulin-dependent diabetes mellitus. METHODS: Thirty-seven patients underwent determination of the rate of urinary excretion of albumin through radioimmunoassay and ambulatory blood pressure monitoring. Their mean age was 26.5±6.7 years, and the mean duration of their disease was 8 (1-34) years. Microalbuminuria was defined as urinary excretion of albumin  &gt; or =  20 and &lt;200µg/min in at least 2 out of 3 urine samples. RESULTS: Nine (24.3%) patients were microalbuminuric. Ambulatory blood pressure monitoring in the microalbuminuric patients had higher mean pressure values, mainly the systolic pressure, during sleep as compared with that in the normoalbuminuric patients (120.1±8.3 vs 110.8±7.1 mmHg; p=0.007). The pressure load was higher in the microalbuminuric individuals, mainly the systolic pressure load during wakefulness [6.3 (2.9-45.9) vs 1.6 (0-16%); p=0.001]. This was the variable that better correlated with the urinary excretion of albumin (rS=0.61; p&lt;0.001). Systolic pressure load &gt;50% and diastolic pressure load &gt; 30% during sleep was associated with microalbuminuria (p=0.008). The pressure drop during sleep did not differ between the groups. CONCLUSION: Microalbuminuric normotensive insulin-dependent diabetic patients show greater mean pressure value and pressure load during ambulatory blood pressure monitoring, and these variables correlate with urinary excretion of albumin.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ambulatory blood pressure monitoring</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>insulin-dependent diabetes mellitus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diabetic nephropathy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Reduction of QTc interval dispersion. Potential mechanism of cardiac protection of pyridostigmine bromide</s1>
</fA08>
<fA11 dir="011000">
<s1>Renata Rodrigues Teixeira de Castro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Salvador Manoel Serra</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Claudio Lucas da Nóbrega</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense  </s1>
<s2>Niterói </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital Pró-Cardíaco  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>210-213</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>39</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Parasympathetic dysfunction is an independent risk factor in individuals with coronary artery disease, and cholinergic stimulation is a potential therapeutical option. We determined the effects of pyridostigmine bromide, a reversible anticholinesterase agent, on electrocardiographic variables of healthy individuals. METHODS: We carried out a cross-sectional, double blind, randomized, placebo-controlled study. We obtained electrocardiographic tracings in 12 simultaneous leads of 10 healthy young individuals at rest before and after oral administration of 45 mg of pyridostigmine or placebo. RESULTS: Pyridostigmine increased RR intervals (before: 886±27 ms vs after: 1054±37 ms) and decreased QTc dispersion (before: 72±9ms vs after: 45±3ms), without changing other electrocardiographic variables (PR segment, QT interval, QTc, and QT dispersion). CONCLUSION: Bradycardia and the reduction in QTc dispersion induced by pyridostigmine may effectively represent a protective mechanism if these results can be reproduced in individuals with cardiovascular diseases.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>autonomic nervous system</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>QTc dispersion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pyridostigmine</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Prognostic factors of rheumatic mitral stenosis during pregnancy and puerperium</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo José Bastos Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antônio Alberto Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gilson Soares Feitosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rosângela Vasconcelos de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rosenbert Mamédio da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Carlos Brito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Maria Lúcia Duarte</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Augusto José Gonçalves Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa de Misericórdia da Bahia Hospital Santa Izabel </s1>
<s2> BA</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>220-224</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To identifity characteristics associated with complications during pregnancy and puerperium in patients with rheumatic mitral stenosis. METHODS: Forty-one pregnant women (forty-five pregnancies) with mitral stenosis, followed-up from 1991 to 1999 were retrospectively evaluated. Predictor variables: the mitral valve area (MVA), measured by echocardiogram, and functional class (FC) before pregnancy (NYHA criteria).Maternal events: progression of heart failure, need for cardiac surgery or balloon mitral valvulotomy, death, and thromboembolism. Fetal/neonatal events: abortion, fetal or neonatal death, prematurity or low birth weight (&lt;2,500g), and extended stay in the nursery or hospitalization in newborn ICU. RESULTS: The mean ± SD of age of the patients was 28.8±4.6 years. The eventful and uneventful patients were similar in age and percentage of first pregnancies. As compared with the level 1 MVA, the relative risk (RR) of maternal events was 5.5 (95% confidence interval (CI) =0.8-39.7) for level 2 MVA and 11.4 (95% CI=1.7-74.5) for level 3 MVA. The prepregnancy FC (FC  &gt; or =  II and III versus I) was also associated with a risk for maternal events (RR=2.7; 95% CI=1.4-5.3).MVA and FC were not importantly associated with these events, although a smaller frequency of fetal/neonatal events was observed in patients who had undergone balloon valvulotomy. CONCLUSION: In pregnant women with mitral stenosis, the MVA and the FC are strongly associated with maternal complications but are not associated with fetal/neonatal events. Balloon mitral valvulotomy could have contributed to reducing the risks of fetal/neonatal events in the more symptomatic patients who had to undergo this procedure during pregnancy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pregnancy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognostic factors</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>The bussola study. Final results, conclusions and proposals</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Luiz da Silva Brasileiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>230-234</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the use of thrombolytic and acetylsalicylic acid therapies in acute myocardial infarct patients as well as the availability of technical and human resources for the care of these patients in the emergency units of the city of Rio de Janeiro. Additional objectives were the evaluation of the use of primary angioplasty and the level of acceptance of SBC /RJ as an entity responsible for programs of continued medical education. METHODS: Interviews with physicians at 46 emergency units in the city of Rio de Janeiro. RESULTS: Of the 46 emergency units inspected, a policy of encouragement to use thrombolytic therapy was only prescribed in 6.5%. In 1/3 of the public wards no thrombolytic agents were available, and in none of them was access to primary angioplasty regularly available; 45.9% did not offer the minimal conditions required for the handling of cases of acute myocardial infarction; 60% of the physicians on-call (at both public and private emergency units), appeared not to know the importance of the use of acetylsalicylic acid in acute myocardial infarct patients; all physicians interviewed would participate in programs of continued medical education organized by the SBC/RJ. CONCLUSION: The study suggests there was: 1) the low probability of the use of thrombolytic therapy in the majority of the emergency units in of the city of Rio de Janeiro due to the inadequate policy of waiting for the transfer of the patient to coronary or intensive care unit; 2) a low awareness to the importance of early use of acetylsalic acid in acute myocardial infarct; 3) half of the emergency units of the public net do not have the minimal conditions required for the handling of cases of acute myocardial infarction; 4) a high level of credibility exists that would enable the SBC/RJ to set up programs for continued medical education to change the mentality regarding the use of thrombolytic therapy and of acetylsalicylic acid.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarct</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thrombolysis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>emergencies</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Hormonal and cardiovascular reflex assessment in a female patient with pure autonomic failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Heno Ferreira Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernanda Marciano Consolim-Colombo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Denise Hachul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Elisa do Amaral Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fúlvio Pileggi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Hélio Bernardes Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>239-242</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the case of a 72-year-old female with pure autonomic failure, a rare entity, whose diagnosis of autonomic dysfunction was determined with a series of complementary tests. For approximately 2 years, the patient has been experiencing dizziness and a tendency to fall, a significant weight loss, generalized weakness, dysphagia, intestinal constipation, blurred vision, dry mouth, and changes in her voice. She underwent clinical assessment and laboratory tests (biochemical tests, chest X-ray, digestive endoscopy, colonoscopy, chest computed tomography, abdomen and pelvis computed tomography, abdominal ultrasound, and ambulatory blood pressure monitoring). Measurements of catecholamine and plasmatic renin activity were performed at rest and after physical exercise. Finally the patient underwent physiological and pharmacological autonomic tests that better diagnosed dysautonomia.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Cardiac involvement in total generalized lipodystrophy (Berardinelli- Seip syndrome)</s1>
</fA08>
<fA11 dir="011000">
<s1>Ruy Felipe Melo Viégas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rosiane Viana Zuza Diniz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Taciana Mara Rezende Fortes Viégas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edgar Bezerra Lira Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Dirceu Rodrigues de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>246-248</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>08</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Total generalized lipodystrophy (Berardinelli--Seip Syndrome) is a rare hereditary disease characterized by insulin-resistant diabetes mellitus and a small quantity of adipose tissue and is of unknown origin. Common cardiovascular alterations related to this syndrome are cardiac hypertrophy and arterial hypertension. This article reports a case of Berardinelli--Seip syndrome and reviews the literature with special emphasis on the cardiovascular manifestations of this syndrome.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Heart transplant in a patient with complete absence of the pericardium</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco Gregori Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Celso Otaviano Cordeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ulisses Alexandre Croti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Thelma Eliza Ferreira Gregori</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Osney Moure</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Londrina  </s1>
<s2>Londrina PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>251-252</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>04</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the case of a heart transplant in which the recipient patient had a total congenital absence of the pericardium. Associated with this, we found a major disproportion between the size of the recipient's mediastinal cavity and the size of the donor's heart. To prevent twisting of the great arteries, we placed the graft on the left diaphragm muscle and beneath the left lung, which resulted in an uneventful early and late postoperative course.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Why are calcium antagonists still being used in heart failure in the era of calcium sensitizers?</s1>
</fA08>
<fA11 dir="011000">
<s1>Wolney de Andrade Martins</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Humberto Villacorta</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Charles Mady</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Faculdade de Medicina de Teresópolis  </s1>
<s2> RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>258-261</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>52</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Effects of losartan on ventricular remodeling in experimental infarction in rats</s1>
</fA08>
<fA11 dir="011000">
<s1>Leonardo A. M. Zornoff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz S. Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Beatriz B. Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sergio A. R. Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Joel Spadaro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNESP Faculdade de Medicina de Botucatu </s1>
<s2>Botucatu SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>465-470</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the effects of losartan on ventricular remodeling and on survival after myocardial infarction in rats. METHODS: After surgical occlusion of left coronary artery, 84 surviving male Wistar rats were divided into two groups: LO treated with losartan (20mg/kg/day, n=33) and NT (n=51), without medication. After 3 months, we analyzed mortality; ventricular to body mass ratio (VM /BM); myocardial hydroxyproline concentration (HOP); isovolumetric pressure, +dp/dt, -dp/dt, and diastolic volume/left ventricle mass ratio (VO/LV). RESULTS: Mortality was: LO = 22%, and NT = 47% (p&lt;0.05). Ventricular mass,(VM/BM, mg/g) was 4.14 ± 0.76 and 3.54±0.48, in the NT and LO groups, respectively (p&lt;0.05). HOP (median) was 4.92 upsilong/mg in the LO and 5.54 upsilong/g in the NT group (p&gt;0.05). The V0/LV values (median) were 0.24 mL/g in group LO and 0.31 mL/g in group NT (p&lt;0.05) compared to NT group. There were no differences between the groups for +dp/dt and -dp/dt parameters. CONCLUSION: 1- The use of losartan myocardial infarction causes an attenuation of ventricular remodeling, bringing about an increased survival, an attenuation of ventricular hypertrophy and dilation, and an improvement of the isovolumetric pressure; 2- the treatment does not modify the myocardial collagen concentration.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fibrosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angiotensin II</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Detection of coronary artery disease based on the calcification index obtained by helical computed tomography</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Jader Feldman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Domingos Vitola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Nádia Schiavo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>476-480</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the relation between coronary artery disease and the calcification index on helical computed tomography. METHOD: We studied 22 patients (ages ranging from 40 to 70 years) who underwent coronary angiography because of chest pain suggestive of angina pectoris. Findings on coronary angiography were classified as follows: significant obstructive disease (stenosis  &gt; or = 50%), nonobstructive disease (stenosis &lt;50%), and no disease. With no previous knowledge of the results of the coronary angiography and within 7 days, helical computed tomography of the chest was performed. Then, data of the coronary angiography were correlated with the calcification index obtained by helical computed tomography. RESULTS: The sensitivity of helical computed tomography to the presence of significant obstructive lesions on coronary angiography was 87.5%, specificity was 100%, and negative and positive predictive values were 75% and 100%, respectively. The mean calcification index was greater in patients with severe coronary lesions, mainly when involvement of 2 or 3 vessels occurred, than that in patients with no coronary artery disease or with nonobstructive coronary artery lesions (p&lt;0.05). CONCLUSION: Helical computed tomography is an effective method for detecting and quantifying coronary artery calcification, and it has proved to be sensitive to and specific for the noninvasive diagnosis of coronary artery stenosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary arteries</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>calcification</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>computed tomography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Gas exchange during exercise in different evolutional stages of chronic Chagas' heart disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Fátima Palha de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Coury Pedrosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Giannella-Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio de Janeiro Hospital Universitário Clementino Fraga Fº </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>490-498</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To compare gas exchange at rest and during exercise in patients with chronic Chagas' heart disease grouped according to the Los Andes clinical/hemodynamic classification. METHODS: We studied 15 healthy volunteers and 52 patients grouped according to the Los Andes clinical/hemodynamic classification as follows: 17 patients in group IA (normal electrocardiogram/echocardiogram), 9 patients in group IB (normal electrocardiogram and abnormal echocardiogram), 14 patients in group II (abnormal electrocardiogram/echocardiogram, without congestive heart failure), and 12 patients in group III (abnormal electrocardiogram/echocardiogram with congestive heart failure). The following variables were analyzed: oxygen consumption (V O2), carbon dioxide production (V CO2), gas exchange rate (R), inspiratory current volume (V IC), expiratory current volume (V EC), respiratory frequency, minute volume (V E), heart rate (HR), maximum load, O2 pulse, and ventilatory anaerobic threshold (AT). RESULTS: When compared with the healthy group, patients in groups II and III showed significant changes in the following variables: V O2peak, V CO2peak, V ICpeak, V ECpeak, E, HR, and maximum load. Group IA showed significantly better results for these same variables as compared with group III. CONCLUSION: The functional capacity of patients in the initial phase of chronic Chagas' heart disease is higher than that of patients in an advanced phase and shows a decrease that follows the loss in cardiac-hemodynamic performance.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chronic Chagas' heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiopulmonary exercise test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>oxygen consumption</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>A comparative analysis of primary stenting and optimal balloon coronary angioplasty in acute myocardial infarction. Six month results from the STENT PAMI trial</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Alberto Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cindy L. Grines</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>David Cox</s1>
<afiliation>A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>J. Eduardo Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Costantino Costantini</s1>
<afiliation>A04</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Gregg Stone</s1>
<afiliation>A07</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Marie C. Morice</s1>
<afiliation>A05</afiliation>
</fA11>
<fA11 dir="081000">
<s1>William O'Neill</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Eulógio Garcia</s1>
<afiliation>A06</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Judith Boura</s1>
<afiliation>A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia Division of Interventional Cardiology </s1>
<s2>São Paulo </s2>
<s3>Brazil</s3>
</fA14>
<fA14 dir="020000">
<s1>William Beaumont Hospital  </s1>
<s2>Royal Oak MI</s2>
<s3>USA</s3>
</fA14>
<fA14 dir="030000">
<s1>Presbyterian Hospital  </s1>
<s2>Charlotte NC</s2>
<s3>USA</s3>
</fA14>
<fA14 dir="040000">
<s1>Clínica Cardiológica Costantino Costantini  </s1>
<s2>Curitiba </s2>
<s3>Brazil</s3>
</fA14>
<fA14 dir="050000">
<s1>Washington Hospital Center  </s1>
<s2>Washington DC</s2>
<s3>USA</s3>
</fA14>
<fA14 dir="060000">
<s1>L'Institut Cardiovasculaire Paris Sud  </s1>
<s2>Antony </s2>
<s3>France</s3>
</fA14>
<fA14 dir="070000">
<s1>Hospital Gregório Maranon  </s1>
<s2>Madrid </s2>
<s3>Spain</s3>
</fA14>
<fA20 dir="000000">
<s1>508-514</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To compare the outcome of balloon PTCA with final coronary stenosis diameter (SD) &lt;=30%, with elective coronary stenting. METHODS: We performed a comparative analysis of the 6 month outcomes in patients treated with primary stenting and those who obtained an optimal balloon PTCA result treated during the first 12 hours of AMI onset included in the STENT PAMI randomized trial. RESULTS: The results were analysed into 3 groups: primary stenting (441 patients, SD=22±6%), optimal PTCA (245 patients), and nonoptimal PTCA (182 patients, SD= 37±5%). At the end of the 6 months primary stent group presented with the lowest restenosis(23 vs. 31 vs. 45%, p=0.001, respectively). Ischemia-driven target vessel revascularization rate (TVR) (7 vs. 15.5 vs. 19%, p=0.001, respectively). CONCLUSION: At the 6 month follow-up, primary stenting offered the lowest restenosis and ischemia-driven TVR rates. Compared to optimal balloon PTCA. Nonoptimal primary balloon PTCA pts (SD=31-50%), had the worst late angiographic outcomes and should be treated more actively with coronary stent implantation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stent</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>restenosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Pregnancy after cardiac transplantation. Report of one case and review</s1>
</fA08>
<fA11 dir="011000">
<s1>Solange Bordignon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Anna Marcela Aramayo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Daniel Nunes e Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cíntia Gründler</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ivo Nesralla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>519-522</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A 14-year-old female patient became pregnant 6 years after heart transplantation. The pregnancy evolved uneventfully, and the newborn infant was healthy. Five months after delivery, the mother was in good condition with preserved ventricular function, and the baby had normal neuro-psychomotor development. Even though the case reported here was a success, pregnancy following cardiac transplantation is considered a high-risk condition and remains contraindicated.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Pseudo-myocardial infarction during an episode of herpes zoster</s1>
</fA08>
<fA11 dir="011000">
<s1>Roberto A. Franken</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo Franken</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa de São Paulo Faculdade de Ciências Médicas </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>527-530</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>The patient arrived at the emergency unit with a history of acute myocardial infarction, for which she was treated. Without improvement in the pain, the patient developed heart failure and underwent a hemodynamic study, which showed normal coronary arteries and extensive ventricular impairment. During evolution, the clinical findings improved and herpes zoster appeared on the right shoulder. In a few months the clinical findings subsided, and the findings of the electrocardiogram, chest X-ray, and ventricular function were normal. The patient is currently asymptomatic.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Aneurysm of the left main coronary artery</s1>
</fA08>
<fA11 dir="011000">
<s1>Ênio E. Guérios</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ronaldo R. L. Bueno</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo M. P. Andrade</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Deborah C. Nercolini</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Álvaro L. A. Pacheco</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José C. E. Tarastchuk</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Luiz F. Kubrusly</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Universitário Evangélico de Curitiba  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital Erasmo de Rotterdam  </s1>
<s2>Curitiba PR</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>534-536</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Aneurysm of the left main coronary artery is a rare angiographic finding, with few cases described in the international literature. We report the case of a 42-year-old male with a previous history of acute myocardial infarction, whose coronariography indicated triple vessel coronary disease and an aneurysm of the left main coronary artery. A review of the etiology, clinical aspects, and surgical management of coronary arterial aneurysm is presented.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>75</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Dyspnea and pain in the left lower limb in a 52-year-old male patient</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>544-550</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2000</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(00)07500608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Myths about cardiovascular diseases</s1>
</fA08>
<fA11 dir="011000">
<s1>Ruy Laurenti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cassia Maria Buchalla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Saúde Pública </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>105-110</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Prescription and adherence to statins of patients with coronary artery disease and hypercholesterolemia</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio P. Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>André P. L. Mattar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cristiane E. Tsubo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Danielle T. Simão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fábio R. Yoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Kuang Daci</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>115-118</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Statins have proved to be safe and effective in the secondary prevention of coronary artery disease, but the level of prescription and the reasons for nonadherence to treatment in many coronariopathy treatment centers has not been determined. The purpose of this study was to identify reasons for nonadherence to statin therapy. METHODS: We analyzed 207 consecutive patients with coronary artery disease and hypercholesterolemia (total cholesterol  &gt; or = 200mg/dL or LDL - cholesterol  &gt; or = 130mg/dL). Patients' average age was 61.7±10 year; 111 (53.6%) male were and 94 (46.6%) were female. We analyzed the level of prescription and adherence to treatment with statins. RESULTS: Statins were prescribed for 139 (67%) patients, but only 85 (41%) used the drug. In spite of being indicated, statins were not prescribed in 68 (33%) patients. Of 54 (26%) patients, nonadherent to statins, 67% did not use the drug due to its high cost, 31% due to the lack of instruction, and only 2% due to side effects. Total cholesterol (260.3±42.2 vs 226.4±51.9; p&lt;0.0001) and LDL cholesterol (174.6±38.1 vs 149.6±36.1; p&lt;0.0001) were lower in patients on medication. HDL-cholesterol increased from 37.6±9.6 to 41.5±12.9mg/dL (p=0.02), and triglycerides were not modified in patients using statins. CONCLUSION: The prescription of statins in patients with coronary artery disease and dyslipidemia is high; however, its adherence is far from satisfactory, due to the high cost of the medication. Reduction in total cholesterol and LDL cholesterol levels did not reach the targets recommended by the Brazilian Consensus on Dyslipidemia.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypercholesterolemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>statins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adherence</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Clinical and laboratory evaluation of hyperlipemic and hypothyroid patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Ana Valéria Barros de Castro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alexandra Procópio Bononi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Flávio Aragon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Roberto Padovani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Célia Regina Nogueira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Gláucia M. F. da Silva Mazeto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Walkyria de Paula Pimenta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNESP School of Medicine of Botucatu </s1>
<s2>Botucatu SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>123-126</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the frequency of hypothyroidism in a sample of hyperlipemic patients and evaluate clinical and laboratory factors indicative of thyropathy among them. METHODS: Fifty-one hyperlipemic patients, grouped according to an earlier or recent diagnosis of their thyroid function into euthyroid and hypothyroid, were evaluated with clinical and laboratory examinations of blood levels of free T4 and TSH (by radioimmunoassay). Patients were on average 46.8±11.7 years old, predominantly of the female sex (62.5%); 31% had a previous diagnosis of hypothyroidism and were under treatment with thyroxin. RESULTS: Fourteen three percent of patients analyzed had hypothyroidism, which had not been detected before. Differentiating attributes of the groups analyzed were: a predominance of females among the hypothyroid patients and a higher HDL serum concentration among those recently diagnosed. CONCLUSION: In the present study, new cases of hypothyroidism in hyperlipemic patients were a frequent occurrence, yet few clinical and laboratory data except tests evaluating free T4 and TSH in the blood indicated which patients had thyroid dysfunction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypothyroidism</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hyperlipemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dyslipemia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Congestive heart failure. Correlation between functional class and systolic and diastolic functions assessed by Doppler echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Cesar Selem Kamel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Aristarco G. Siqueira-Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz Felipe Mena Barreto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcos Benchimol</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFRJ University Hospital Clementino Fraga Filho </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>132-135</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the influence of systolic or diastolic dysfunction, or both on congestive heart failure functional class. METHODS: Thirty-six consecutive patients with a clinical diagnosis of congestive heart failure with sinus rhythm, who were seen between September and November of 1998 answered an adapted questionnaire about tolerance to physical activity for the determination of NYHA functional class. The patients were studied with transthoracic Doppler echocardiography. Two groups were compared: group 1 (19 patients in functional classes I and II) and group 2 (17 patients in functional classes III and IV). RESULTS: The average ejection fraction was significantly higher in group 1 (44.84%±8.04% vs. 32.59%±11.48% with p=0.0007). The mean ratio of the initial/final maximum diastolic filling velocity (E/A) of the left ventricle was significantly smaller in group 1 (1.07±0.72 vs. 1.98±1.49 with p=0.03). The average maximum systolic pulmonary venous velocity (S) was significantly higher in group 1 (53.53cm/s ± 12.02cm/s vs. 43.41cm/s ± 13.55cm/s with p=0.02). The mean ratio of maximum systolic/diastolic pulmonary venous velocity was significantly higher in group 1 (1.52±0.48 vs. 1.08±0.48 with p=0.01). A predominance of pseudo-normal and restrictive diastolic patterns existed in group 2 (58.83% in group 2 vs. 21.06% in group 1 with p=0.03). CONCLUSION: Both the systolic dysfunction index and the patterns of diastolic dysfunction evaluated by Doppler echocardiography worsened with the evolution of congestive heart failure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congestive heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>functional class</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>systolic function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diastolic function</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Lipid profile of nutrition students and its association with cardiovascular disease risk factors</s1>
</fA08>
<fA11 dir="011000">
<s1>Regina Mara Fisberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberta Horschutz Stella</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Juliana Masami Morimoto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luciana Sicca Pasquali</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sonia Tucunduva Philippi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maria do Rosário D. O. Latorre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>University of São Paulo School of Public Health </s1>
<s2> SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>143-147</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>40</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To describe the lipid profile and to verify its relationship with cardiovascular disease risk factors in students at a public university in São Paulo. METHODS: After obtaining clinical, anthropomorphic, and lipid profile data from 118 students, variables of the lipid profile were related to other risk factors. RESULTS: The mean age of the students was 20.3 years (SD=1.5). The risk of cardiovascular disease was characterized by a positive family history of ischemic heart disease in 38.9%; sedentariness in 35.6%; limiting and increased total and LDL-C cholesterol levels in 17.7% and 10.2%, respectively; decreased HDL-C levels in 11.1%; increased triglyceride levels in 11.1%; body mass index &gt;25 in 8.5%, and smoking in 6.7% of the subjects. Students' diet was found to be inadequate regarding protein, total fat, saturated fat, sodium, and fiber contents. A statistically significant association between cholesterol and contraceptive use, between HDL-C and contraceptive use, age and percent body fat, and triglycerides and percent lean weight was observed. CONCLUSION: A high prevalence of some risk factors of cardiovascular disease as well as the association between these factors with altered lipid profiles was observed in the young population studied.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipid profile</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerotic disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Cardiac extension of primary mediastinal seminoma compressing the right ventricular outflow tract</s1>
</fA08>
<fA11 dir="011000">
<s1>Lurildo R. Saraiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Djair Brindeiro Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Thiago B. Saraiva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Mauro B. Arruda</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Vital Lira</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Pernambuco  </s1>
<s2> PE</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>152-154</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the case of a 33-year-old male with primary seminoma of the anterior mediastinum with initial clinical manifestations suggestive of heart disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>A 54-year-old male with chronic myeloproliferative disorder and pulmonary thrombotic arteriopathy</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>159-162</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Correlação clínico-radiográfica</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>163-163</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Alcohol and atherosclerosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Murilo Foppa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Flávio Danni Fuchs</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Bruce B. Duncan</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>171-176</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>86</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Observational studies have attributed a protective effect to alcohol consumption on the development of atherosclerosis and cardiovascular morbidity and mortality. Alcohol intake in the amount of one to two drinks per day results in an estimated 20-40% reduction in cardiovascular events. An additional protective effect, according to major cohort studies, has been attributed to wine, probably due to antioxidant effects and platelet antiaggregation agents. On the other hand, the influence of different patterns of alcohol consumption and environmental factors may explain a great part of the additional effect of wine. Protection may be mediated by modulation of other risk factors, because alcohol increases HDL-C, produces a biphasic response on blood pressure, and modulates the endothelial function, while it neither increases body weight nor impairs glucose-insulin homeostasis. Alcohol may also have a direct effect on atherogenesis. Despite these favorable effects, the current evidence is not enough to justify prescribing alcohol to prevent cardiovascular disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Changes in the profile of lipoprotein subfractions associated with hormone replacement therapy</s1>
</fA08>
<fA11 dir="011000">
<s1>José Luiz da Costa Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcos Emanuel W. Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Áurea Beltrão de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Emílio H. Moriguchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>183-188</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To report the effects of 2 regimens of hormone replacement therapy during the postmenopausal period on the profile of the major lipoprotein subfractions (HDL, LDL, and VLDL). METHODS: We carried out a cohort study in 38 postmenopausal patients who were starting their hormone replacement therapy due to gynecological indications, for a period of 12 weeks. Analysis of lipoprotein subclasses was performed through nuclear magnetic resonance spectroscopy. RESULTS: Hormone replacement therapy cause an increase in the proportion of larger subfractions of VLDL and HDL (p=0.008 and 0.03, respectively) and in the proportion of larger particles of VLDL due to a 36% increase in the levels of larger particles (p=0.004), concomitantly with a 15% reduction in the levels of smaller particles (p=0.04). In regard to HDL, the increase occurred only a 17% increase in the levels of larger particles (p=0.002). No significant change occurred in the distribution pattern of LDL subfractions. CONCLUSION: The proportion of larger subfractions of VLDL and HDL increases after hormone replacement therapy. The increase in the proportion of larger particles of VLDL occurs due to an increase in the levels of the larger subclasses concomitantly with a reduction in the smaller particles. However, an increase in the proportion of larger particles of HDL occurs only due to an increase in the levels of the larger subfractions.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipoproteins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hormone replacement therapy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary heart disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Contribution of Doppler echocardiography to the evaluation of systolic and diastolic function of obese women versus a control group</s1>
</fA08>
<fA11 dir="011000">
<s1>Nathan Herszkowicz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alfonso Barbato</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Waldir Salvi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Daniel Pinheiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Denise Pantaleão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Alfredo Halpern</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Giovani G. Cerri</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>193-196</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study by doppler echocardiography the cardiac systolic and diastolic functions of health, uncomplicated obese subjects. METHODS: Fifty-nine obese women with an average body mass index (BMI) of 35 kg/m² were evaluated and compared with 19 subjects with an average BMI of 23 kg/m² (control group). RESULTS: In the obese group, a clear tendency was observed toward higher systolic pressure, increased wall thickness and, consequently, myocardial mass, elevation on the circumference stress of the left ventricular wall, and an indisputable presence of diastolic abnormalities. Filling abnormalities were observed with impaired relaxation, with prolonged isovolumic relaxation time (IVRT) and augmented atrium contribution representing early indexes of cardiac dysfunction when systolic performance is still normal. CONCLUSION: Obesity is generally a chronic condition, and doppler echocardiography can be used as a noninvasive instrument for early evaluation of left ventricular diastolic indexes.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>obesity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiopathy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Hypertension in a female nursing staff-pattern of occurrence, diagnosis, and treatment</s1>
</fA08>
<fA11 dir="011000">
<s1>Estela Maria Motta Lima Leão de Aquino</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Lucélia Batista Neves Cunha Magalhães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Jenny Araújo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria da Conceição Chagas de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Jackline Pereira Leto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia Instituto de Saúde Coletiva </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>203-208</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>57</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To report the pattern of occurrence, diagnosis, and treatment of hypertension in a female nursing staff of an emergency hospital. METHODS: We carried out a cross-sectional study that included interviews and blood pressure measurements of 494 nursing professionals at an emergency hospital in the city of Salvador, in the state of Bahia, Brazil. We considered hypertensive all individual with blood pressure  &gt; or =  140/90 mmHg or normal pressure if on regular treatment. RESULTS: We found a prevalence of hypertension of 36.4%. Only 18.3% of the individuals ignored their hypertensive condition, and 64.2% admitted not being having regular treatment. Of those individuals who were having treatment, 69.4% had elevated blood pressure on examination. The major reasons for not being on treatment was the occasional elevation of blood pressure (22.2%) and medical counseling (20.0%). CONCLUSION: The results point to the need to introduce hypertension control measures in this occupational group, because of the magnitude of the disease and the potential impact on diffusion of knowledge and measures to control hypertension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>female health</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>occupational health</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Unsupported valvuloplasty in children with congenital mitral valve anomalies. Late clinical results</s1>
</fA08>
<fA11 dir="011000">
<s1>Gabriel Lorier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Renato A.K. Kalil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gustavo R. Hoppen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Christiano Barcellos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Nicolas Teleo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Abud Homsi Netto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Javier Gonzalez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Paulo R. L. Prates</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Paulo R. Prates</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>João R. M. Sant'Anna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Ivo A. Nesralla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>215-220</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>43</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze late clinical evolution after surgical treatment of children, with reparative and reconstructive techniques without annular support. METHODS: We evaluated 21 patients operated upon between 1975 and 1998. Age 4.67±3.44 years; 47.6% girls; mitral insufficiency 57.1% (12 cases), stenosis 28.6% (6 cases), and double lesion 14.3% (3 cases). The perfusion 43.10±9.50min, and ischemia time were 29.40±10.50min. The average clinical follow-up in mitral insufficiency was 41.52±53.61 months. In the stenosis group (4 patients) was 46.39±32.02 months, and in the double lesion group (3 patients), 39.41±37.5 months. The echocardiographic follow-up was in mitral insufficiency 37.17±39.51 months, stenosis 42.61±30.59 months, and in the double lesion 39.41±37.51 months. RESULTS: Operative mortality was 9.5% (2 cases). No late deaths occurred. In the group with mitral insufficiency, 10 (83.3%) patients were asymptomatic (p=0.04). The majorit y with mild reflux (p=0.002). In the follow-up of the stenosis group, all were in functional class I (NYHA); and the mean transvalve gradient varied between 8 and 12mmHg, average of 10.7mmHg. In the double lesion group, 1 patient was reoperated at 43 months. No endocarditis or thromboembolism were reported. CONCLUSION: Mitral stenosis repair has worse late results, related to the valve abnormalities and associated lesions. The correction of mitral insufficiency without annular support showed good long-term results.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital cardiopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>valvuloplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral insufficiency</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo Park</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Geraldo Lorenzi-Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Inês Feltrim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Ricardo Nazário Viecili</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Márcia Cristina Sangean</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Márcia Volpe</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Paulo Ferreira Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Alfredo José Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>226-230</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To compare the effects of 3 types of noninvasive respiratory support systems in the treatment of acute pulmonary edema: oxygen therapy (O2), continuous positive airway pressure, and bilevel positive pressure ventilation. METHODS: We studied prospectively 26 patients with acute pulmonary edema, who were randomized into 1 of 3 types of respiratory support groups. Age was 69±7 years. Ten patients were treated with oxygen, 9 with continuous positive airway pressure, and 7 with noninvasive bilevel positive pressure ventilation. All patients received medicamentous therapy according to the Advanced Cardiac Life Support protocol. Our primary aim was to assess the need for orotracheal intubation. We also assessed the following: heart and respiration rates, blood pressure, PaO2, PaCO2, and pH at begining, and at 10 and 60 minutes after starting the protocol. RESULTS: At 10 minutes, the patients in the bilevel positive pressure ventilation group had the highest PaO2 and the lowest respiration rates; the patients in the O2 group had the highest PaCO2 and the lowest pH (p&lt;0.05). Four patients in the O2 group, 3 patients in the continuous positive pressure group, and none in the bilevel positive pressure ventilation group were intubated (p&lt;0.05). CONCLUSION: Noninvasive bilevel positive pressure ventilation was effective in the treatment of acute cardiogenic pulmonary edema, accelerated the recovery of vital signs and blood gas data, and avoided intubation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute pulmonary edema</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>noninvasive ventilation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>respiratory failure</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Primary neoplasms of the heart. Clinical and histological presentation of 50 cases</s1>
</fA08>
<fA11 dir="011000">
<s1>Fábio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Helena N. Soufen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Barbara M. Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Félix J. A. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>235-237</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze clinical and histologic findings of 50 patients with primary neoplams of the heart in a tertiary referral center. METHODS: From 1980 to 1998, we retrospectively analyzed 50 patients, 32 of whom were females, whose ages ranged from 9 to 73 years (mean age = 44.16±18 years). RESULTS: Most tumors were located in the left side of the heart (72%), myxoma being the most common (84%) histologic type. The other histologic types found were as follows: fibroma (4%), lipoma (2%), rhabdomyosarcoma (2%), hemangioma (2%), sarcoma (2%), angiosarcoma (2%), and lymphoma (2%). Diagnosis was established by echocardiography in 94% of the cases. Clinical findings were as follows: dyspnea (36%), weight loss (20%), palpitations (18%), chest pain (16%), fever (8%), and arthralgia (6%). All patients with thromboembolic phenomena (10%) had left atrial myxoma. Approximately 20% of the patients were asymptomatic at the initial clinical assessment. CONCLUSION: Primary cardiac tumors are a rare entity with diverse clinical and histologic findings, requiring, therefore, a high level of clinical suspicion.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac tumor</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myxoma</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Remission of heart failure through endoluminal repair of femoral arteriovenous fistula with the use of a covered stent</s1>
</fA08>
<fA11 dir="011000">
<s1>Antenor Portela</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Raldir Bastos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Benjamim Pessoa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Renato Duarte</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marcos Medeiros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Jayro Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital São Marcos  </s1>
<s2>Teresina PI</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>242-244</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the case of a 21-year-old male with high-output heart failure due to a femoral arteriovenous fistula caused by a firearm wound. A new balloon expandable stent covered with polytetrafluorethylene was implanted in the artery to occlude the arteriovenous fistula. The fistula was immediately occluded and the artery remained patent. On the following day, the patient felt much better, with no symptoms of heart failure. Additional follow-up is required to assure the usefulness of this less invasive procedure in the treatment of arteriovenous fistulas.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Postoperative necrotizing fasciitis of the thorax in cardiac surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>José Dario Frota Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Drews</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Leães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Celso Blacher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Francisco Tostes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Nilton Delatorre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Mariana Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Eraldo Lúcio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Wagner Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Marcela Sales</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Roberto Lobo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Ralf Stuermer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="131000">
<s1>Nicasio Tanaka</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="141000">
<s1>Luis Portugal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="151000">
<s1>Fernando Lucchese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa de Porto Alegre Hospital São Francisco </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>250-254</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Necrotizing fasciitis is a rare soft tissue infection and a life-threatening emergency, often fatal. Its incidence and management are described plentifully in the medical literature regarding the most common anatomical sites involved like the abdomen, lower and upper limbs, and perineum. However, available data and case reports of chest wall necrotizing fasciitis after thoracic procedures are scarce, mainly after major cardiac operations. We report and discuss a case of necrotizing fasciitis of the chest wall occurring in the immediate postoperative period of a cardiac procedure, and include a brief review of the concepts, pathophysiology, and treatment reported in the medical literature. We emphasize the need for early diagnosis and urgent and effective surgical debridement. Of importance is the fact that we have not found any references in the literature to cases similar or equal to the one we describe here, which occurred in the postoperative period of a cardiac procedure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Calcified aneurysms in coronary arteries of a 48-year-old patient</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo Kuhn Momolli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Luis de Castro e Silva Pretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Daniel Sato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cristiane Pereira Seibel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Norberto Duda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Roque Paulo Falleiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Luis Sérgio de Moura Fragomeni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de Passo Fundo Faculdade de Medicina </s1>
<s2>Passo fundo RS</s2>
<s3>Brasil</s3>
</fA14>
<fA20 dir="000000">
<s1>258-260</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>This is a case report of a 48-year-old female patient with a compatible history of Kawasaki disease during childhood, who was admitted to the emergency coronary unit with unstable angina pectoris. Coronary angiography identified two coronary aneurysms, one causing right coronary occlusion and the other causing severe obstruction of the left anterior descending coronary artery. Coronary artery bypass surgery was indicated.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Correlação clínico-radiográfica</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>InCor  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>261-261</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600310</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Effects of chlorthalidone and diltiazem on myocardial ischemia in elderly patients with hypertension and coronary artery disease</s1>
</fA08>
<fA11 dir="011000">
<s1>João Batista Serro-Azul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rogério Silva de Paula</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>César Gruppi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Lígia Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Humberto Pierri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Amit Nussbacher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Otávio Gebara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Paulo Moffa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Antônio Carlos Pereira-Barreto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Maurício Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>268-272</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJETIVE: Antihypertensive therapy with thiazides decreases coronary events in elderly patients. However, the influence of diuretics on myocardial ischemia has not been fully investigated. The aim of this study was to compare the effect of chlorthalidone and diltiazem on myocardial ischemia. METHODS: Following a randomized, double-blind, crossover protocol, we studied 15 elderly hypertensive patients aged 73.6±4.6 years with myocardial ischemia. All patients had angiographically documented coronary artery disease. We measured patients using 48- hour ambulatory electrocardiogram monitoring and exercise testing. After a 2-week period using placebo, patients received chlorthalidone or diltiazem for 4 weeks. RESULTS: Both treatments lowered systolic and diastolic blood pressures. The number of ischemic episodes on ambulatory electrocardiogram recordings was reduced with the use of chlorthalidone (2.5±3.8) and diltiazem (3.2±4.2) when compared with placebo (7.9±8.8; p&lt;0.05). The total duration of ischemic episodes was reduced in both treatments when compared with placebo (chlorthalidone: 19.2±31.9min; diltiazem: 19.3±29.6min; placebo: 46.1±55.3min; p&lt;0.05). CONCLUSION: In elderly hypertensive patients with coronary artery disease, chlorthalidone reduced myocardial ischemia similarly to diltiazem. This result is consistent with epidemiological studies and suggests that reduction of arterial blood pressure with thiazide therapy plays an important role in decreasing myocardial ischemia.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diuretics</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine</s1>
</fA08>
<fA11 dir="011000">
<s1>Salvador M. Serra</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo Vivacqua C. Costa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Bianca Gouvêa Bastos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Kelb Bousquet Santos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sérgio Henrique Rodolpho Ramalho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antonio Claudio Lucas da Nóbrega</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>279-284</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>52</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJETIVE: The evaluation, by exercise stress testing, of the cardiorespiratory effects of pyridostigmine (PYR), a reversible acetylcholinesterase inhibitor. METHODS: A double-blind, randomized, cross-over, placebo-controlled comparison of hemodynamic and ventilation variables of 10 healthy subjects who underwent three exercise stress tests (the first for adaptation and determination of tolerance to exercise, the other two after administration of placebo or 45mg of PYR). RESULTS: Heart rate at rest was: 68±3 vs 68±3bpm before and after placebo, respectively (P=0.38); 70±2 vs 59±2bpm, before and after pyridostigmine, respectively (P&lt;0.01). During exercise, relative to placebo: a significantly lower heart rate after PYR at, respectively, 20% (P=0.02), 40% (P=0.03), 80% (P=0.05) and 100% (P=0.02) of peak effort was observed. No significant differences were observed in arterial blood pressure, oxygen consumption at submaximal and maximal effort, exercise duration, respiratory ratio, CO2 production, ventilation threshold, minute ventilation, and oxygen pulse. CONCLUSION: Pyridostigmine, at a dose of 45mg, decreases heart rate at rest and during exercise, with minimal side effects and without interfering with exercise tolerance and ventilation variables.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>autonomic nervous system</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pyridostigmine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise stress testing</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Bundle branch and atrioventricular block as complications of acute myocardial infarction in the thrombolytic era</s1>
</fA08>
<fA11 dir="011000">
<s1>Claudia Caminha Escosteguy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marciano de Almeida Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Roberto de Andrade Medronho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Maurino Abreu</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mario Ypiranga Monteiro Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital dos Servidores do Estado do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>291-296</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the incidence of intraventricular and atrioventricular conduction defects associated with acute myocardial infarction and the degree of in hospital mortality resulting from this condition during the era of thrombolytic therapy. METHODS: Observational study of a cohort of 929 consecutive patients with acute myocardial infarction. Multivariate analysis by logistic regression. Was used. RESULTS: Logistic regression showed a greater incidence of bundle branch block in male sex (odds ratio = 1.87, 95% CI = 1.02-3.42), age over 70 years (odds ratio = 2.31, 95% CI = 1.68-5.00), anterior localization of the infarction (odds ratio = 1.93, 95% CI = 1.03-3.65). There was a greater incidence of complete atrioventricular block in inferior infarcts (odds ratio = 2.59, 95% CI 1.30-5.18) and the presence of cardiogenic shock (odds ratio = 3.90, 95% CI = 1.43-10.65). Use of a thrombolytic agent was associated with a tendency toward a lower occurrence of bundle branch block (odds ratio = 0.68) and a greater occurrence of complete atrioventricular block (odds ratio = 1.44). The presence of bundle branch block (odds ratio = 2.45 95% , CI = 1.14-5.28) and of complete atrioventricular block (odds ratio = 13.59, 95% CI = 5.43-33.98) was associated with a high and independent probability of inhospital death. CONCLUSION: During the current era of thrombolytic therapy and in this population, intraventricular disturbances of electrical conduction and complete atrioventricular block were associated with a high and independent risk of inhospital death during acute myocardial infarction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Bundle branch block</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>complete atrioventricular block</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thrombolysis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Reliability of the information about the history of diagnosis and treatment of hypertension. Differences in regard to sex, age, and educational level. The pró-saúde study</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo Faerstein</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dóra Chor</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Claudia de S. Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual do Rio de Janeiro Instituto de Medicina Social </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>301-304</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the intraobserver reliability of the information about the history of diagnosis and treatment of hypertension. METHODS: A multidimensional health questionnaire, which was filled out by the interviewees, was applied twice with an interval of 2 weeks, in July '99, to 192 employees of the University of the State of Rio de Janeiro (UERJ), stratified by sex, age, and educational level. The intraobserver reliability of the answers provided was estimated by the kappa statistic and by the coefficient of intraclass correlation (CICC). RESULTS: The general kappa (k) statistic was 0.75 (95% CI=0.73-0.77). Reliability was higher among females (k=0.88, 95% CI=0.85-0.91) than among males (k=0.62, 95% CI=0.59-0.65).The reliability was higher among individuals 40 years of age or older (k=0.79; 95% CI=0.73-0.84) than those from 18 to 39 years (k=0.52; 95% CI=0.45-0.57). Finally, the kappa statistic was higher among individuals with a university educational level (k=0.86; 95% CI=0.81-0.91) than among those with high school educational level (k=0.61; 95% CI=0.53-0.70) or those with middle school educational level (k=0.68; 95% CI=0.64-0.72). The coefficient of intraclass correlation estimated by the intraobserver agreement in regard to age at the time of the diagnosis of hypertension was 0.74. A perfect agreement between the 2 answers (k=1.00) was observed for 22 interviewees who reported prior prescription of antihypertensive medication. CONCLUSION: In the population studied, estimates of the reliability of the history of medical diagnosis of hypertension and its treatment ranged from substantial to almost perfect reliability.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>reliability of results</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>questionnaires</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Use of automated external defibrillators in a Brazilian airline. A 1-year experience</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Magalhães Alves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ênio João Jensen de Freitas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Heber Antunes Mathias</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Eduardo Amorim da Motta</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rita de Cássia Azevedo Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marina Müller</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Suzana Fátima B. Almeida</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Edward Stapleton</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Sergio Timerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>José Antonio F. Ramires</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>310-314</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>After the incorporation of automated external defibrilators by other airlines and the support of the Brazilian Society of cardiology, Varig Airlines Began the onboard defibrilation program with the initial purpose of equiping wide-body aircrafts frequently used in international flights and that airplanes use in the Rio - São Paulo route. With all fight attendants trained, the automated. External defibrilation devides were incorporated to 34 airplanes of a total pleet of 80 aircrats. The devices were intalled in the bagage compartments secured with velero straps and 2 pairs of electrods, one or which pre-conected to the device to minimize application time. Later, a portable monitor was addres to the ressocitation kit in the long flights. The expansion of the knowledge of the basic life support fundamentors and the correted implantation of the survival chain and of the automated external defibrilators will increase the extense of recovery of cardiorespiratory arrest victins in aircrafts.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Pneumococcal endocarditis of subacute evolution</s1>
</fA08>
<fA11 dir="011000">
<s1>Laercio Uemura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Newton César Grassi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luciane Cazarin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Londrina Hospital Universitário Regional do Norte do Paraná </s1>
<s2>Londrina PR</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>319-322</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>With the development of penicillin, Streptococcus pneumoniae has become an uncommon cause of bacterial endocarditis in adults. Subacute manifestation of pneumococcal endocarditis has been reported a few times in the literature, but most reports define the disease as acute, severe, and having a high mortality rate. We report the case of a 58-year-old male with subacute bacterial endocarditis due to Streptococcus pneumoniae. We stress the low frequency of this agent as a cause of endocarditis and the atypical evolution of this case. The pathophysiology, clinical manifestations and evolution, and the therapeutical options for this type of infection are also discussed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Surgical repair of a pseudoaneurysm of the ascending aorta after aortic valve replacement</s1>
</fA08>
<fA11 dir="011000">
<s1>Rui Manuel Sequeira de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Dantas Lima Jr</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Thomas Kahrbek</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maurício Tanomaru</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Policlínica de Cascavel Instituto de Moléstias Cardiovasculares de Cascavel </s1>
<s2>Cascavel PR</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>326-328</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the case of a patient with a pseudoaneurysm of the ascending aortic clinically diagnosed 5 months after surgical replacement of the aortic valve. Diagnosis was confirmed with the aid of two-dimensional echocardiography and helicoidal angiotomography. The corrective surgery, which consisted of a reinforced suture of the communication with the ascending aorta after opening and aspiration of the cavity of the pseudoaneurysm, was successfully performed through a complete sternotomy using extracorporeal circulation, femorofemoral cannulation, and moderate hypothermia, with no aortic clamping.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>An 18-year-old male with dyspnea and pulmonary arterial hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Aparecida Barne Teixeira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sandrigo Mangini</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vera Demarchi Aiello</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>333-336</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Correlação Clínico-Radiográfica</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>337-337</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Application of the principles of evidence-based medicine in programs to assess high-cost procedures and medications</s1>
</fA08>
<fA11 dir="011000">
<s1>Edimar Alcides Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Antonio Marin Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo  </s1>
<s2> SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>343-346</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="">
<s1></s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>347-347</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Characteristics associated with the dropout of hypertensive patients followed up in an outpatient referral clinic</s1>
</fA08>
<fA11 dir="011000">
<s1>Renné Gusmão Busnello</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Raquel Melchior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlo Faccin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Daniela Vettori</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Juliano Petter</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Leila Beltrami Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Flávio Danni Fuchs</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>352-354</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the characteristics associated with the dropout of patients followed up in a Brazilian out patient clinic specializing in hypertension. METHODS: Planned prospective cohort study of patients who were prescribed an antihypertensive treatment after an extensive initial evaluation. The following parameters were analyzed: sex, age, educational level, duration of disease, pressure level used for classifying the patient, previous treatment, physical activity, smoking, alcohol consumption, familial history of hypertension, and lesion in a target organ. RESULTS: We studied 945 hypertensive patients, 533 (56%) of whom dropped out of the follow-up. The mean age was 52.3±12.9 years. The highest probabilities of dropout of the follow-up were associated with current smoking, relative risk of 1.46 (1.04-2.06); educational level equal to or below 5 years of schooling, relative risk of 1.52 (1.11-2.08); and hypertension duration below 5 years, relative risk of 1.78 (1.28-2.48). Age increase was associated with a higher probability of follow-up with a relative risk of 0.98 (0.97-0.99). CONCLUSION: We identified a group at risk for dropping out the follow-up, which comprised patients with a lower educational level, a recent diagnosis of hypertension, and who were smokers. We think that measures assuring adherence to treatment should be directed to this group of patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>systemic hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dropout</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treatment</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Distribution of cardiac geometric patterns on echocardiography in essential hypertension. Impact of two criteria of stratification</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo Cantoni Rosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valdir Ambrósio Moisés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ricardo Cintra Sesso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Nárcia E. B. Kohlmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Frida Liane Plavnik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maria Teresa Zanella</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Artur Beltrame Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Osvaldo Kohlmann Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital do Rim e Hipertensão  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>362-368</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>43</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: To evaluate 2 left ventricular mass index (LVMI) normality criteria for the prevalence of left ventricular geometric patterns in a hypertensive population ( HT ) . METHODS: 544 essential hypertensive patients, were evaluated by echocardiography, and different left ventricular hypertrophy criteria were applied: 1 - classic : men - 134 g/m² and women - 110 g/m² ; 2- obtained from the 95th percentil of LVMI from a normotensive population (NT). RESULTS: The prevalence of 4 left ventricular geometric patterns, respectively for criteria 1 and 2, were: normal geometry - 47.7% and 39.3%; concentric remodelying - 25.4% and 14.3%; concentric hypertrophy - 18.4% and 27.7% and excentric hypertrophy - 8.8% and 16.7%, which confered abnormal geometry to 52.6% and 60.7% of hypertensive. The comparative analysis between NT and normal geometry hypertensive group according to criteria 1, detected significative stuctural differences,&quot;( *p &lt; 0.05):LVMI- 78.4 ± 1.50 vs 85.9 ±0.95 g/m² *; posterior wall thickness -8.5 ± 0.1 vs 8.9 ± 0.05 mm*; left atrium - 33.3 ± 0.41 vs 34.7 ± 0.30 mm *. With criteria 2, significative structural differences between the 2 groups were not observed. CONCLUSION: The use of a reference population based criteria, increased the abnormal left ventricular geometry prevalence in hypertensive patients and seemed more appropriate for left ventricular hypertrophy detection and risk stratification.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>essential hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>criteria of hypertrophy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Transradial approach for coronary interventions</s1>
</fA08>
<fA11 dir="011000">
<s1>José Carlos Brito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antônio Azevedo Júnior</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Adriano Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Roberto Von Sohsten</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ademar Santos Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Heitor Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>374-378</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the feasibility and safety of coronary interventions performed through the radial artery. METHODS: We studied 103 patients with ages from 38 to 86 years (57±8.7), 90 (87%) males, and: radial pulse with a good amplitude, presence of ulnar pulse, a good collateral flow through the palmar arch assessed with the Allen's test. RESULTS: The vascular approach was obtained in 97 (94%) patients, 88 (91%) treated electively and 9 (9%) during acute myocardial infarction, for primary angioplasty; 56 (64%) unstable angina; 22 (25%) stable angina; 10 (11%) were asymptomatic, 6 referred for recanalization of chronic occlusion and 4 silent ischemia in the first week after acute myocardial infarction. We approached 107 arteries: anterior descending artery, 49 (46%); right coronary artery, 27 (25%); circumflex artery, 25 (23%); diagonal artery, 6 (6%); and 2 saphenous vein bypass grafts. We treated 129 lesions: 80 (62%) B2 type; 23 (18%) B1 type; 17 (13%) C type; and 9 (7%). A type. There were 70 stents , and 59 balloon angioplasties performed. Thirty-two (33%) patients used GP IIb/IIIa inhibitors. The mean duration of the elective procedure was 42.3±12.8 min. Success, correct stent deployment and residual lesion &lt;20%, was reached in 100% of the lesions treated with stent implantation; arterial dilation with residual lesion &lt;50% was obtained in 96% of the lesions treated with transluminal coronary angioplasty (TCA). Complications, were: 1 (1.0%) non-Q-wave acute myocardial infarction; 2 (2%) hematomas in the forearm; and 2 losses of radial pulse. CONCLUSION: Radial artery aproach is practical and safe for percutaneous coronary interventions there was a low incidence of complications.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>radial artery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous interventions</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Plasma levels of immunoinflammatory markers in De Novo coronary atherosclerosis and coronary restenosis postangioplasty</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre Schaan de Quadros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jorge Pinto Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Waldomiro Carlos Manfroi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cristiane Leitão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Karen Ordovás</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Letícia Weiss</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Nadine Clausell</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Federal University of Rio Grande do Sul Hospital de Clínicas de Porto Alegre </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>385-389</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To compare circulating plasma levels of immunoinflammatory markers in patients with known de novo coronary artery disease and patients with postangioplasty restenosis. METHODS: Using enzymatic immunoabsorbent assay, we measured plasma levels of soluble interleukin-2 receptosr, tumor necrosis factor alpha, and soluble tumor necrosis alpha receptors I and II in 11 patients with restenosis postcoronary angioplasty (restenosis group), in 10 patients with primary atherosclerosis (de novo group) who were referred for coronary angiography because of stable or unstable angina, and in 9 healthy volunteers (control group). Levels of soluble interleukin-2 receptors were significantly higher in the de novo group compared with that in the restenosis and control groups. Levels were also higher in the restenosis group compared with that in the control group. Plasma levels of tumor necrosis alpha and receptor levels were significantly higher in the de novo group compared to with that in the restenosis and control groups, but levels in the restenosis group were not different from that in the controls. CONCLUSION: Coronary artery disease, either primary or secondary to restenosis, is associated with significant immunoinflammatory activity, which can be assessed by examining the extent of circulating plasma levels of inflammatory markers. Moreover, patients with de novo lesions appear to have increased inflammatory activity compared with patients with restenosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>inflammation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tumor necrosis factor alpha</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>interleukin-2</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Cholesterol pericarditis. A specific but rare cause of pericardial disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Fábio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Glacy Sabra Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Barbara Maria Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Pêgo- Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>393-394</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>During a diagnostic investigation in a 40-year-old male with pericardial effusion associated with hypothyroidism, cholesterol pericarditis was detected. We report a brief review on the etiopathogeny, clinical findings, and therapeutical possibilities of this entity.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Submitral left ventricular aneurysm. Case report and review of published Brazilian cases</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo José de Freitas Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rosana G. G. Mendes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Walter Vilella de A. Vicente</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Carlos Menardi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Roberto Barbosa Evora</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNAERP Faculdade de Medicina Fundação Waldemar B. Pessoa CECORP - Centro especializado do Coração e Pulmão de Ribeirão Preto</s1>
<s2>Ribeirão Preto SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>399-402</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Submitral left ventricular aneurysm is a cardiac pathology widely recognized, but relatively unknown, occurred almost exclusively in African black patients. Although still this idea of racial prevalence exists, cases have been described in patients of all the races. Ten Brazilian cases were reported. One of them was presented inside an Italian paper that refers the surgical treatment of a Brazilian patient of black race. We reported one more submitral left ventricular aneurysm case in a brown female patient, with antecedents of peripheral thromboembolism initially not identified as consequence of the cardiac pathology.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Histoplasmosis as a late infectious complication following heart transplantation in a patient with Chagas' disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Bacal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ana Cristina Magalhães Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Bruno Cupertino Migueletto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edimar Alcides Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Noedir A. G. Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Alfredo Inácio Fiorelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Tânia Mara V. Strabelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luis Alberto Benvenuti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Carlos Manuel Brandão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Giovanni Bellotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>José Antônio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>406-408</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Infectious complications following heart transplantation are an important cause of morbidity and mortality. Generally, bacterial infections are predominant; however, fungal infections can be responsible for up to 25% of infectious events. We report the case of a patient who presented with histoplasmosis as an infectious complication five years after heart transplantation due to a chagasic cardiopathy. This association has rarely been reported in the international literature.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>How much do we pay for a benefit? A descriptive cost analysis of the use of statins. The need for a national cost-effectiveness analysis</s1>
</fA08>
<fA11 dir="011000">
<s1>José Luiz da Costa Vieira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vera Lúcia Portal</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Emílio H. Moriguchi</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>414-418</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>A medicina baseada nos brasileiros</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Andrade Lotufo</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>419-420</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>03</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Correlação Clínico-Radiográfica</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>421-421</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>76</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Congenital heart disease in adults. Considerations about evolution, natural and in operated patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernando Antibas Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>430-436</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07600511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Use of transesophageal echocardiography during implantation of aortic endoprosthesis (stent). Initial experience</s1>
</fA08>
<fA11 dir="011000">
<s1>Cláudio Henrique Fischer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Orlando Campos Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Honório de Almeida Palma da Fonseca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cláudia Maria Rodrigues Alves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Augusto Marcondes Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Edgar Bezerra de Lira Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antonio Carlos de Camargo Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Ângelo Amato Vicenzo de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Ênio Buffolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>05-08</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To report the role played by transesophageal echocardiography during implantation of self-expanding aortic endoprostheses (stent) at a hemodynamics laboratory. METHODS: Thirteen patients underwent stent implantation in the descending thoracic aorta with the aid of transesophageal echocardiography during the entire procedure. Indications for stenting were as follows: 8 aortic dissections, 2 true aneurysms, 2 penetrating atherosclerotic ulcers, and 1 traumatic pseudoaneurysm. RESULTS: No complications resulting from the use of transesophageal echocardiography were observed. In 12 patients, the initial result was considered appropriate, with total or partial resolution of the major lesion confirmed by a posterior examination. In 1 patient, the procedure was suspended after transesophageal echocardiography and angiography showed that the proximal aortic diameter was inappropriate. Transesophageal echocardiography contributed to clarifying relevant points, such as aortic diameter, anatomic detail of the intimal lesion, and location and size of the communicating orifice. In addition, it facilitated placing the stent in the target lesion, reduced the time of exposure to radiation and the use of contrast medium, and provided rapid identification of intercurrent events, possibly reducing the total duration of the procedure. CONCLUSION: The use of transesophageal echocardiography during placement of aortic stents seems appropriate. The actual advantages of the procedure will be defined in a comparative prospective study.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>transesophageal echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stents</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortopathies</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Prevalence of hypertension in the urban population of Catanduva, in the State of São Paulo, Brazil</s1>
</fA08>
<fA11 dir="011000">
<s1>Olavo de Carvalho Freitas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fabiano Resende de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Juliana Marques Neves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paula Karine Veludo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ricardo Silva Parreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rodrigo Marafiotti Gonçalves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Simone Arenales de Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Reinaldo Bulgarelli Bestetti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de Catanduva  </s1>
<s2>Catanduva SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>16-21</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study the prevalence of systemic hypertension and its control in the population of Catanduva, in the state of São Paulo, Brazil. METHODS: We carried out a randomized cross-sectional population-based study of the urban population of Catanduva with individuals above 18 years of age (688 individuals accounting for 0.9% of the referred population). We interviewed study participants to analyze the major qualitative and quantitative variables that could influence the hypertensive scenario and the risk for systemic hypertension. Blood pressure was measured through the indirect method according to the III Consenso Brasileiro de Hipertensão (III Brazilian Consensus on Hypertension), which established blood pressure levels  &gt; or =  140/90 mm Hg as hypertensive. RESULTS: The prevalence of systemic hypertension was higher in individuals with: (1) history of hypertension (p&lt;0.0001); (2) diabetes mellitus (p=0.05); (3) body mass index (B. M. I)  &gt; or =  25 kg/m² (p&lt;0.001); (4) low educational level (p&lt;0.0001); (5) familial income ranging from 1 to 5 minimum wages (p&lt;0.05); (6) unmarried status (divorced/separated and widow(er)s) (p&lt;0.0001). Of the interviewed individuals, 27.6% (p=0.05) had blood pressure levels under control. CONCLUSION: Our study showed that the prevalence of systemic hypertension was 31.5%, and that 27.6% of the individuals interviewed had blood pressure levels under control at the time of the interview.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>antihypertensive treatment</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiological study of hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Do cardiologists at a university hospital adopt the guidelines for the treatment of heart failure?</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Moacyr Roberto Cucê Nobre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Inês Lancarotte</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Airton Roberto Scipioni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>30-36</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To verify whether the guidelines for the treatment of heart failure have been adopted at a university hospital. The guidelines recommend the following: use of angiotensin-converting enzyme inhibitors for all patients with systolic ventricular dysfunction, use of digitalis and diuretics for symptomatic patients, use of beta-blockers for patients in functional classes II or III, use of spironolactone for patients in functional classes III or IV. METHODS: We analyzed the prescriptions of 199 patients. All these patients had ejection fraction (EF) &lt;=0.50, their ages ranged from 25 to 86 years, and 142 were males. Cardiomyopathy was the most frequent diagnosis: 67 (33.6%) patients had dilated cardiomyopathy, 65 (32.6%) had ischemic cardiomyopathy. RESULTS: Angiotensin-converting enzyme inhibitors were prescribed for 93% of the patients. 71.8% also had a prescription for digitalis, 86.9% for diuretics, 27.6% for spironolactone, 12% for beta-blockers, 37.2% for acetylsalicylic acid, 6.5% for calcium channel antagonists, and 12.5% for anticoagulants. In regard to vasodilators, 71% of the patients were using captopril (85.2mg/day), 20% enalapril (21.4mg/day), 3% hydralazine and nitrates. In 71.8% of the cases, the dosages prescribed were in accordance with those recommended in the large studies. CONCLUSION: Most patients were prescribed the same doses as those recommended in the large studies. Brazilian patients tolerate well the doses recommended in the studies, and that not using these doses may be a consequence of the physician's fear of prescribing them and not of the patient's intolerance.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angiotensin-converting enzyme inhibitor</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>beta-blockers</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>anticoagulation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Is female sex an independent predictor of in-hospital mortality in acute myocardial infarction?</s1>
</fA08>
<fA11 dir="011000">
<s1>Lúcia Pimenta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Bassan</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alfredo Potsch</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Francisco Soares</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Francisco Manes Albanesi Filho</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>44-50</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>44</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess whether female sex is a factor independently related to in-hospital mortality in acute myocardial infarction. METHODS: Of 600 consecutive patients (435 males and 165 females) with acute myocardial infarction, we studied 13 demographic and clinical variables obtained at the time of hospital admission through uni- and multivariate analysis, and analyzed their relation to in-hospital death. RESULTS: Females were older (p&lt;0.001) and had a higher incidence of hypertension (p&lt;0.001). Males were more frequently smokers (p&lt;0.001). The remaining risk factors had a similar incidence among both sexes. All variables underwent uni- and multivariate analysis. Through univariate analysis, the following variables were found to be associated with in-hospital death: female sex (p&lt;0.001), age &gt;70 years (p&lt;0.001), the presence of previous coronary artery disease (p=0.0004), previous myocardial infarction (p&lt;0.001), infarction in the anterior wall (p=0.007), presence of left ventricular dysfunction (p&lt;0.001), and the absence of thrombolytic therapy (p=0.04). Through the multivariate analysis of logistic regression, the following variables were associated with in-hospital mortality: female sex (p=0.001), age (p=0.008), the presence of previous myocardial infarction (p=0.02), and left ventricular dysfunction (p&lt;0.001). CONCLUSION: After adjusting for all risk variables, female sex proved to be a variable independently related to in-hospital mortality in acute myocardial infarction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>female sex</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>in-hospital mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Caracterização funcional da hipertrofia miocárdica induzida pelo isoproterenol e de sua regressão</s1>
</fA08>
<fA11 dir="011000">
<s1>Neif Murad</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo Fabiano de Franco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo J. F. Tucci</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Laboratório de Fisiologia Cardíaca </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>51-58</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>42</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar as disfunções da hipertrofia miocárdica induzida pelo isoproterenol e de sua regressão. Corações isolados hipertrofiados por isoproterenol (ISO) (8 dias) e após 22 dias de sua suspensão (regressão) foram distendidos. MÉTODOS: Até pressão de repouso (Pr) de 60mmHg, analisaram-se: pressão desenvolvida máxima (PDmáx.); estresse sistólico (sigmamáx); inclinação da reta estresses/deformações; constante de relaxamento; rigidez da câmara e rigidez miocárdica. RESULTADOS: Nos corações hipertrofiados (H) as variações de volume (deltaV) necessárias para Pr=60mmHg foram heterogêneas. Em alguns (H1; n=10) deltaV equivaleu à dos controle (C) enquanto em outros (H2; n=10) foi inferior, e também diferiram quanto ao peso seco, complacência ventricular, rigidez miocárdica, constante de relaxamento,e sigmamáx. PDmáx dos grupos H1 e H2 foram superiores às de C (n=8) e Regressão (R) (n=8). Contudo, sigmamáx de H2 foi menor que C, H1 e R. O mecanismo de Frank-Starling foi deprimido nos corações hipertrofiados. A constante de relaxamento de H2 indicou retardo no decaimento da pressão associado a menor complacência ventricular e rigidez miocárdica acentuada. CONCLUSÃO: Hipertrofia miocárdica induzida pelo ISO não é homogênea. Alguns corações têm alterações pouco expressivas; outros têm comprometimento das funções sistólica e diastólica. A hipertrofia miocárdica reduz a capacidade de gerar força e aprimora a capacidade em variar pressão por aumento da relação massa/volume. Há, também, comprometimento da complacência ventricular e da rigidez muscular.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>isoproterenol</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função sistólica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função diastólica</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Chagas' heart disease: evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form</s1>
</fA08>
<fA11 dir="011000">
<s1>Barbara Maria Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Clovis de Carvalho Frimm</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>University of São Paulo Medical School HC</s1>
<s2>São Paulo </s2>
<s3>Brasil</s3>
</fA14>
<fA20 dir="000000">
<s1>59-62</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To identify and associate potential electrocardiographic and echocardiographic changes in patients with the indeterminate form of Chagas' disease during long-term follow-up. METHODS: One hundred sixty patients underwent standard electrocardiography and two-dimensional guided M-mode echocardiography for left ventricular ejection fraction determination. Patients were followed up for 98.6±30.4 months, undergoing repeat electrocardiographic studies at 6-month intervals and echocardiographic studies at 12-month intervals. RESULTS: Based on the electrocardiographic findings, the patients were divided into group I, 125 patients (78.6%) with normal electrocardiograms throughout follow-up, and group II, 34 patients (21.3%) who developed electrocardiographic changes. Group II was further divided into group IIA (9 patients, 5.6%) with permanent electrocardiographic changes, group IIB (14 patients, 8.8%) with transitory electrocardiographic changes, and group IIC (11 patients, 6.9%) with changes appearing only on the final electrocardiogram. Left ventricular ejection fractions remained normal in the entire population studied and did not differ among groups. CONCLUSION: The indeterminate form of Chagas' disease clearly represents a benign condition with a favorable long-term prognosis. Although some patients develop electrocardiographic changes, left ventricular systolic function is well preserved.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrocardiographic changes</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ejection fraction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Echocardiographic diagnosis of transposition of the great arteries associated with anomalous pulmonary venous connection</s1>
</fA08>
<fA11 dir="011000">
<s1>Lilian Maria Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gláucia Maria Penha Tavares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fred Luiz Mailho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Vicente de Paulo Cavalcante de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Armando Mangione</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Real e Benemérita Sociedade Portuguesa de Beneficência  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>66-68</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report 2 cases of transposition of the great arteries associated with anomalous pulmonary venous connection emphasizing the clinical findings, the diagnosis, and the evolution of the association. One of the patients had the anomalous pulmonary venous connection in its total infradiaphragmatic form, in the portal system, and the other patient had a partial form, in which an anomalous connection of the left superior lobar vein with the innominate vein existed. At the time of hospital admission, the patients had cyanosis and respiratory distress with clinical findings suggesting transposition of the great arteries. The diagnosis in 1 of the cases, in which the anomalous connection was partial, was established only with echocardiography, without invasive procedures that would represent risk for the patient; in the other case, in which the anomalous connection was total, the malformation was only evidenced with catheterization. The patients underwent surgery for anatomical correction of the heart disease. Only 1 patient had a good outcome.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Uhl's anomaly. Differential diagnosis and indication for cardiac transplantation in an infant</s1>
</fA08>
<fA11 dir="011000">
<s1>Nana Miura Ikari</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Estela Azeka</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vera Demarchi Aiello</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Miguel Barbero-Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Munir Ebaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>73-76</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the case of an 8-month-old female infant with Uhl's anomaly, who underwent successful cardiac transplantation. The clinical findings, complementary laboratory tests, anatomic findings, and differential diagnosis of the anomaly are discussed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Fibroelastoma of the mitral valve as a cause of transient ischemic stroke</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre Alessi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Gomes de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Dalton Bertolin Précoma</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Débora Fontoura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luciano Rodrigo Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Zanis Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Marcello Zapparoli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Nossa Senhora das Graças  </s1>
<s2>Curitiba PR</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>81-84</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A 44-year-old woman had a transient ischemic stroke, fibroelastoma of the mitral valve being the source of the embolus. The patient evolved with neutropenia induced by ticlopidine after 10 days of treatment. We report the major clinical features, therapeutical options, and medicamentous toxicity resulting from the use of antiplatelet drugs.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Correlação clínico-radiográfica</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>85-85</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>O uso do ultra-som intravascular na cardiologia intervencionista</s1>
</fA08>
<fA11 dir="011000">
<s1>Cesar Rocha Medeiros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Adriano Mendes Caixeta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cláudia Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Miguel Antônio Neves Rati</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Rede D´Or  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>87-94</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>63</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700111</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Cellular transplantation for the treatment of heart failure. State of the art</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcio Scorsin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Cesar Guarita Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Clínica Cardiológyca C. Costantini  </s1>
<s2>Curitiba PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>103-106</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Cytokines and troponin-I in cardiac dysfunction after coronary artery grafting with cardiopulmonary bypass</s1>
</fA08>
<fA11 dir="011000">
<s1>Neverton Savaris</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carisi Polanczyk</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Nadine Clausell</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Federal University of Rio Grande do Sul Hospital de Clínicas de Porto Alegre </s1>
<s2>Porto Alegre </s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>114-119</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: The association between cytokines and troponin-I with cardiac function after cardiac surgery with cardiopulmonary bypass remains a topic of continued investigation. METHODS: Serial measurements, within 24h following surgery, of tumor necrosis factor-alpha, its soluble receptors, and troponin-I were performed in patients with normal ejection fraction undergoing coronary artery bypass grafting. Ejection fraction was measured by radioisotopic ventriculography preoperatively, at 24h and at day 7 postoperatively. RESULTS: Of 19 patients studied (59±8.5 years), 10 (group 1) showed no changes in ejection fraction, 53±8% to 55±7%, and 9 (group 2) had a decrease in ejection fraction, 60±11% to 47±11% (p=0.015) before and 24h after coronary artery bypass grafting, respectively. All immunological variables, except tumor necrosis factor-alpha soluble receptor I at 3h postoperation (5.5± 0.5 in group 1 versus 5.9±0.2 pg/ml in group 2; p=0.048), were similar between groups. Postoperative troponin-I had an inverse correlation with ejection fraction at 24h (r= -0.44). CONCLUSIONS: Inflammatory activity, assessed based on tumor necrosis factor-alpha and its receptors, appears to play a minor role in cardiac dysfunction after cardiac surgery. Troponin I levels are inversely associated with early postoperative ejection fraction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cytokines</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>troponin-I</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>inflammatory response</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Percutaneous mechanical mitral commissurotomy performed with a Cribier's metallic valvulotome. Initial results</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Dias de Azeredo Bastos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>César A. Esteves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>David Araújo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luciene Ap. M. A. Bastos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Magno Eistein</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Geraldo Paulino Santana</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Gilson José de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luiz Brasil</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Antônio Calzada</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Delzirene Botelho Calzada</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>José Pereira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Rômulo Sales</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Nivaldo Gomes de Olivera</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>126-131</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the immediate results of percutaneous mechanical mitral commissurotomy. METHODS: Thirty patients underwent percutaneous mechanical mitral commissurotomy performed with a Cribier's metallic valvulotome from 8/11/99 to 2/4/00. Mean age was 30.7 years, and 73.3% were women. With regards to functional class, 63.3% were class III, and 36.7% were class IV. The echocardiographic score had a mean value of 7.5± 1.8. RESULTS: The mitral valve area increased from 0.97±0.15cm² to 2.16±0.50cm² (p&gt;0.0001). The mean diastolic gradient decreased from 17.9±5.0mmHg to 3.2±1.4mmHg. The mean left atrial pressure decreased from 23.6±5.4mmHg to 8.6±3.1mmHg, (p&gt;0.0001). Systolic pressure in the pulmonary artery decreased from 52.7±18.3mmHg to 32.2±7.4mmHg. Twenty-nine cases were successful. One patient developed severe mitral regurgitation. Interatrial septal defect was observed and one patient. One patient had cardiac tamponade due to left ventricular perforation. No deaths occurred. CONCLUSION: This method has proven to be safe and efficient in the treatment of rheumatic mitral stenosis. The potential advantage is that it can be used multiple times after sterilization, which decreases procedural costs significantly.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>commissurotomy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valve</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>metallic valvulotome</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Reduction in diastolic blood pressure and cardiovascular mortality in nondiabetic hypertensive patients. A reanalysis of the HOT study</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Alberto Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jadelson Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Carlos Beisl Noblat</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marco Antonio Silveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia Hospital Universitário Professor Edgar Santos </s1>
<s2>Salvador BA</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>135-137</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To use published Hypertension Optimal Treatment (HOT) Study data to evaluate changes in cardiovascular mortality in nondiabetic hypertensive patients according to the degree of reduction in their diastolic blood pressure. METHODS: In the HOT Study, 18,700 patients from various centers were allocated at random to groups having different objectives of for diastolic blood pressure: &lt;=90 (n=6264); &lt;=85 (n=6264); &lt;=80mmHg (n=6262). Felodipine was the basic drug used. Other antihypertensive drugs were administered in a sequential manner, aiming at the objectives of diastolic blood pressure reduction. RESULTS: The group of nondiabetic hypertensive subjects with diastolic pressure&lt;=80mmHg had a cardiovascular mortality ratio of 4.1/1000 patients/year, 35.5% higher than the group with diastolic pressure &lt;=90mmHg (cardiovascular mortality ratio, 3.1/1000 patients/year). In contrast, diabetic patients allocated to the diastolic pressure objective group of &lt;=80mmHg had a 66.7% reduction in cardiovascular mortality (3.7/1000 patients/year) when compared with the diastolic pressure group of &lt;=90mmHg (cardiovascular mortality ratio, 11.1/1000 patients/year). CONCLUSION: The results indicate that in hypertensive diabetic patients reduction in diastolic blood pressure to levels &lt;=80mmHg decreases the risk of fatal cardiovascular events. It remains necessary to define the level of diastolic blood pressure &lt;=90mmHg at which maximal reduction in cardiovascular mortality is obtained for nondiabetics.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>HOT Study</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diabetes mellitus</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Application of receptive music therapy in internal medicine and cardiology</s1>
</fA08>
<fA11 dir="011000">
<s1>Cyntia Marconato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eva Cantalejo Munhoz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcia Maria Menim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Thereza Albach</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Artes do Paraná  </s1>
<s2>Curitiba PR</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>140-141</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To investigate the effects of receptive music therapy in clinical practice. METHODS: Receptive music therapy was individually applied via musical auditions, including five stages: musical stimulation, sensation, situation, reflection, and behavioral alteration. Following anamnesis and obtainment of consent, patients answered a first questionnaire on health risk evaluation (Q1), and after participating in 16 weekly music therapy sessions, answered a second one (Q2). RESULTS: Two men and 8 women, aged above 18 years, referred to us due to symptoms of stress, emotional suffering, and the need to change lifestyles (health risk behavior) were studied between August 1998 and December 1999. Comparison between answers to Q1 and Q2, showed a trend (P=0.059) for reduction of ingestion of cholesterol-rich foods and for increased prospects in life with a tendency towards improvement, and also of increased intake of fiber-rich food (55.6%), increased levels of personal satisfaction (44.5%), and decreased levels of stress (66.7%). CONCLUSION: The study demonstrated decreased stress levels and increased personal satisfaction, higher consumption of fiber-rich food, lower cholesterol intake, and a better perspective on life, suggesting that receptive music therapy may be applied in clinical practice as an auxiliary therapeutic intervention for the treatment of behavioral health risks.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>receptive music therapy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>behavior alteration</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>music therapy in cardiology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Prognostic factors of the results of cardiopulmonary resuscitation in a cardiology hospital</s1>
</fA08>
<fA11 dir="011000">
<s1>Ari Timerman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Naim Sauaia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Leopoldo Soares Piegas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rui F. Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Carlos Gun</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Elizabeth Silva Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antonio C. Mugayar Bianco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>J. Eduardo M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>152-160</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>96</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the early and late results of cardiopulmonary resuscitation in a cardiology hospital and to try to detect prognostic determinants of both short- and long-term survival. METHODS: A series of 557 patients who suffered cardiorespiratory arrest (CRA) at the Dante Pazzanese Cardiology Institute over a period of 5 years was analyzed to examine factors predicting successful resuscitation and long-term survival. RESULTS: Ressuscitation maneuvers were tried in 536 patients; 281 patients (52.4%) died immediately, and 164 patients (30.6%) survived for than 24 hours. The 87 patients who survived for more than 1 month after CRA were compared with nonsurvivors. Coronary disease, cardiomyopathy, and valvular disease had a better prognosis. Primary arrhythmia occurred in 73.5% of the &gt;1-month survivor group and heart failure occurred in 12.6% of this group. In those patients in whom the initial mechanism of CRA was ventricular fibrillation, 33.3% survived for more than 1 month, but of those with ventricular asystole only 4.3% survived. None of the 10 patients with electromechanical dissociation survived. There was worse prognosis in patients included in the extreme age groups (zero to 10 years and 70 years or more). The best results occurred when the cardiac arrest took place in the catheterization laboratories. The worst results occurred in the intensive care unit and the hemodialysis room. CONCLUSION: The results in our series may serve as a helpful guide to physicians with the difficult task of deciding when not to resuscitate or when to stop resuscitation efforts.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiorespiratory arrest</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Multiple recurrences of cardiac myxomas with acute tumoral pulmonary embolism</s1>
</fA08>
<fA11 dir="011000">
<s1>Waldomiro Manfroi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Silvia R. R. Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Eduardo K. Saadi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jair Saadi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Carolina Alboim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>164-166</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the case of a 42-year-old female with a second recurrence of cardiac myxoma. Her first diagnosis was at the age of 24 years, when cardiac tumors were withdrawn from her right ventricle and left atrium. Her first recurrence was at the age of 36 years, when tumors were removed from the left and right atria, and the right ventricle. Six years later, the patient was admitted to the Hospital das Clínicas de Porto Alegre complaining of sudden dyspnea, dry cough, and pain in the right hypochondrium, which bore no relation to breathing. The transesophageal echocardiography showed a small tumor in the interatrial septum, close to the superior vena cava, and 2 larger tumors in the right ventricle, 1 close to the outflow tract and the other almost completely obstructing the right branch of the pulmonary artery. The patient was referred to surgery, in which myxomas were removed from the right atrium and ventricle with extension to the right pulmonary artery. The postoperative period was uneventful.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>A sixty-four-year-old woman with Chagas' disease, who underwent implantation of a permanent cardiac pacemaker and evolved with rapidly progressive heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Medeiros</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Alberto Benvenuti</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Roberto Costa</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>175-182</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Correlação clínico-radiográfica</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>183-183</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Pharmacological and clinical evidence for the use of low-molecular-weight heparins in acute coronary syndromes</s1>
</fA08>
<fA11 dir="011000">
<s1>Guido Aranha Rosito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Otávio Berwanger da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Jorge Pinto Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Faculdade de Medicina Hospital de Clínicas de Porto Alegre</s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>190-195</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>50</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="">
<s1></s1>
</fA08>
<fA11 dir="011000">
<s1>Manoel Fernandes Canesin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cintia M. Carvalho Grion</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Londrina HURNP Comissão de Ressuscitação Cardiopulmonar</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>196-197</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>VII Congresso Nacional do Departamento de Ergometria e Reabilitação Cardiovascular da SBC</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>199-203</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700212</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Influence of ischemic preconditioning in myocardial protection in patients undergoing myocardial revascularization with intermittent crossclamping of the aorta. Analysis of ions and blood gases</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Manuel Pêgo Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fabio Biscegli Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>André Felix Gentil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fabrício Ferreira Coelho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Karina Kwasnicka</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Noedir Antonio Groppo Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>318-323</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To test the hypothesis that short periods of ischemia may increase the myocardial protection obtained with intermittent crossclamping of the aorta. METHODS: In the control group (18 patients), surgery was performed with systemic hypothermia at 32ºC and intermittent crossclamping of the aorta. Extracorporeal circulation was used. In the preconditioning group (17 patients), 2 crossclampings of the aorta lasting 3min each were added prior to the intermittent crossclamping of the conventional technique with an interval of 2min of reperfusion between them. Blood samples for analyses of pH, pCO2, pO2, sodium, potassium, calcium, and magnesium were obtained from the coronary sinus at the beginning of extracorporeal circulation (time 1), at the end of the first anastomosis (time 2), and at the end of extracorporeal circulation (time 3). RESULTS: No difference was observed in the results of the 2 groups, except for a variation in the ionic values in the different times of blood withdrawal; sodium values, however, remained stable. All patients had a good clinical outcome. CONCLUSION: The results of intermittent crossclamping of the aorta with moderate hypothermia were not altered by the use of ischemic preconditioning.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial preconditioning</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ions</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Use of oral antihypertensive medication preceding blood pressure elevation in hospitalized patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Cristiano Ricardo Bastos de Macedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Carlos Beisl Noblat</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Lúcia de Araújo Costa Beisl Noblat</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jeane Meire Sales de Macedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Alberto Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia Hospital Universitário Professor Edgard Santos </s1>
<s2>Salvador BA</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>328-331</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the frequency of oral antihypertensive medication preceding the increase in blood pressure in patients in a university hospital, the drug of choice, and the maintained use of antihypertensive medication. METHODS: Data from January to June 1997 from the University Hospital Professor Edgard Santos Pharmacy concerning the prescriptions of all inpatients were used. Variables included in the analysis were: antihypertensive medication prescription preceding increase in blood pressure, type of antihypertensive medication, gender, clinical or surgical wards, and the presence of maintained antihypertensive medication. RESULTS: The hospital admitted 2,532 patients, 1,468 in surgical wards and 818 in medical wards. Antihypertensive medication prescription preceding pressure increase was observed in 578 patients (22.8%). Nifedipine was used in 553 (95.7%) and captopril in 25 (4.3%). In 50.7% of patients, prescription of antihypertensive medication was not associated with maintained antihypertensive medication. Prescription of antihypertensive drugs preceding elevation of blood pressure was significantly (p&lt;0.001) more frequent on the surgical floor (27.5%; 405/1468) than on the medical floor (14.3%; 117/818). The frequency of prescription of antihypertensive drugs preceding elevation of blood pressure without maintained antihypertensive drugs and the ratio between the number of prescriptions of nifedipine and captopril were greater in surgical wards. CONCLUSION: The use of antihypertensive medication, preceding elevation of blood pressure (22.8%) observed in admitted patients is not supported by scientific evidence. The high frequency of this practice may be even greater in nonuniversity hospitals.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nifedipine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>captopril</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Food consumption of adolescents. A simplified questionnaire for evaluating cardiovascular risk</s1>
</fA08>
<fA11 dir="011000">
<s1>Vera Lucia Chiara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rosely Sichieri</s1>
<afiliation>A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Estadual do Rio de Janeiro Instituto de Medicina Social </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>337-341</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To develop a simplified questionnaire for self-evaluation by adolescents of foods associated with the risk of coronary diseases. METHODS: Frequency questionnaires about 80 foods were answered by representative samples of 256 adolescents aged 12 to 19 from Rio de Janeiro as part of the Nutrition and Health Research project. The dependent variable was the serum cholesterol predicting equation as influenced by diet, and the independent variables were the foods. The variables were normalized and, using Pearson's correlation coefficient, those with r&gt;0.10 were selected for the regression model. The model was analyzed for sex, age, random sample, and total calories. Those food products that explained 85% of the cholesterol variation equation were present in the caloric model, and contained trans fatty acids were selected for the questionnaire. RESULTS: Sixty-five food products had a statistically significant correlation (P&lt;0.001) with the dependent variable. The simplified questionnaire included 9 food products present in all tested models: steak or broiled meat, hamburger, full-fat cheese, French fries or potato chips, whole milk, pies or cakes, cookies, sausages, butter or margarine. The limit of the added food points for self-evaluation was 100, and over 120 points was considered excessive. CONCLUSION: The scores given to the food products and the criteria for the evaluation of the consumption limits enabled the adolescents to get to know and to balance their intake.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nutritional evaluation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adolescents</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Some predictors of cardiovascular mortality among the elderly population of Botucatu (SP)</s1>
</fA08>
<fA11 dir="011000">
<s1>Tania Ruiz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mirela D. Sanchís</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ana Maria Fioravante</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Xavier C. Piqué</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual Paulista Faculdade de Medicina de Botucatu Departmento de Saúde Pública</s1>
<s2>Botucatu SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>349-354</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To detect factors associated with cardiovascular mortality in the elderly of Botucatu. METHODS: We evaluated 29 variables of interest in a cohort of patients aged ³60 using data from a survey conducted between 1983/84. The elderly cohort was analyzed in 1992 to detect the occurrence of cardiovascular deaths. Survival analysis was performed using the Kaplan-Meier method, the log-rank test, and Cox regression analysis. Three models were adapted for each group of variables, and a final model was chosen from those variables selected from each group. RESULTS: We identified predictor for cardiovascular death according to age for elderly males not supporting the family, not possessing a vehicle, and previous cardiovascular disease. In elderly females, the predictor variables were previous cardiovascular disease and diabetes mellitus. CONCLUSION: Socioeconomic indicators (family heading and vehicle ownerrship) may be added to well stabilished medical factors (diabete mellitus and hypertension to select target groups for programs intended to reduce deaths due to cardiovascular diseases in elderly people.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>survival</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Corrected transposition of the great arteries with several associated anomalies in a 68-year-old patient</s1>
</fA08>
<fA11 dir="011000">
<s1>José Luiz Balthazar Jacob</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Moléstias Cardiovasculares de São José do Rio Preto  </s1>
<s2>São José do Rio Preto SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>358-360</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>8</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Few patients with corrected transposition of the great arteries survive past 50 years of age because of the association with congenital defects, development of total atrioventricular block, and right ventricular dysfunction. We report the case of a male patient with dextrocardia in situs solitus and corrected transposition of the great arteries associated with a wide atrial septal defect and severe pulmonary valvar and subvalvar stenoses. The patient also developed a large aneurysm on the pulmonary artery, total atrioventricular block diagnosed 8 years earlier, symptoms of dysfunction of the systemic ventricle in the previous 2 years, insufficiency of the left atrioventricular valve, and aortic regurgitation. Despite all these associated anomalies, the patient developed class III cardiac decompensation only at the age of 68 years, which makes this case a rarity. The patient was clinically treated, and was discharged from the hospital in good condition.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Lipoma of the right atrium</s1>
</fA08>
<fA11 dir="011000">
<s1>Wilson Luiz da Silveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Max Weyler Nery</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Erica Coelho Garcia Soares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Adélio Ferreira Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Hernando Nazzetta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Márcia Andery Ludovico Batista</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Cacilda Pedrosa de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Vilmondes Gonçalves de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Santa Genoveva Grupo CentroCárdio </s1>
<s2>Goiânia GO</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>365-368</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>The patient is a 54-year-old asymptomatic male with a tumor in the right atrium that was diagnosed on transesophageal echocardiography and confirmed as a lipoma of the right atrium on computerized tomography. The patient underwent surgical repair with extracorporeal circulation. The tumor was resected, and its base of implantation in the atrium was repaired with a flap of bovine pericardium. The diagnosis of lipoma was confirmed on histopathological examination. Locating of the tumor with the aid of transesophageal echocardiography was very useful in the strategy of cannulation of the venae cava for installation of the circuit of extracorporeal circulation. The patient had a good postoperative evolution.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Case 5/2001 - Heart failure and insufficiency of the aortic and mitral valves in a 68-year-old woman with rheumatoid arthritis</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciano Campos Killinger</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Sampaio Gutierrez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clinicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>373-376</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>3</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 10/2001 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clinicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>377-377</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>The surgeon</s1>
</fA08>
<fA11 dir="011000">
<s1>Domingo M. Braile</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>378-378</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>A necessidade mais urgente: adquirir nossa própria experiência</s1>
</fA08>
<fA11 dir="011000">
<s1>Protásio L. da Luz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>379-380</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>4</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Apresentação</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>381-383</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>I Diretrizes para o Uso da Monitorização Residencial da Pressão Arterial</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>390-393</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>66</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700413</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>III Diretrizes para Uso da Monitorização Ambulatorial da Pressão Arterial - monitorização ambulatorial da pressão arterial</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>384-389</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700412</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Mechanical versus biological aortic valve implants in the elderly. A comparison of early and mid-term results</s1>
</fA08>
<fA11 dir="011000">
<s1>Lars I. Thulin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Johan L. Sjögren</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>University Hospital of Lund Division of Heart and Lung Diseases Heart Valve Section</s1>
<s2>Lund </s2>
<s3>Sweden</s3>
</fA14>
<fA20 dir="000000">
<s1>395-398</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Our aim was to compare, in a non randomized study, the surgical outcome in elderly patients with mechanical (Group 1; n=83) and bioprosthetic valve implants (Group 2; n=136). METHODS: During a three year period, 219 patients &gt;75 years underwent Aortic Valve Replacement. The groups matched according to age, sex, comorbidity, valve pathology and concomitant Coronary Artery Bypass Surgery. Follow-up was a total of 469 patient-years (mean follow-up 2.1 years, maximum 4,4 years). RESULTS: Operative mortality was zero and the overall early mortality was 2.3 % (within 30 days). Actuarial survival was 87.5 ± 4.0% and 66.1 ± 7.7% (NS) at 4 years in Group 1 and Group 2, respectively. Freedom from valve-related death was 88.9 ± 3.8% in Group 1 and 69.9±7.9% (NS) in Group 2 at 4 years. CONCLUSION: Aortic Valve Replacement in the elderly (&gt;75 years) is a safe procedure even in cases where concomitant coronary artery revascularization is performed. Only a few anticoagulant-related complications were reported and this may indicate that selected groups of elderly patients with significant life expectancy may benefit from mechanical implants .</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic valve</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart valve prosthesis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Video-assisted pericardioscopy. How to improve diagnostic efficacy in pericardial effusions</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo M. Pêgo-Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fabio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Barbara M. Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sandra Serson Rohr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Isabela Miranda Bernardelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fabio B. Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Sérgio A. Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>403-406</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess, in a prospective way, the experience with video-assisted pericardioscopy obtained in patients with pericardial effusion of unclear etiology in the preoperative period. METHODS: From January 1998 to June 2000, 20 patients were operated upon with the aid of video-assisted pericardioscopy. On echocardiography, 17 of these patients had significant pericardial effusion, and 3 had moderate pericardial effusion. Video-assisted pericardioscopy was performed through a small incision of the Marfan type. RESULTS: The diagnosis of pericardial effusion was established as follows: idiopathic in 9 (45%) patients, neoplastic in 4 (20%), resulting from hypothyroidism in 3 (15%), tuberculous in 2 (10%), due to cholesterol in 1 (5%), and chylopericardial in 1 (5%). The biopsy was positive in 30% of the patients, and the etiology could not be defined in 45% of the patients. CONCLUSION: Video-assisted pericardioscopy proved to be a method with low morbidity and a high index of diagnostic positivity. A high percentage of pericardial effusions are caused by viral infections, which are not diagnosed through current methods, being, therefore, classified as idiopathic.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>video-assisted thoracoscopy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>biopsy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>etiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pericardial effusion</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Treatment of atrial fibrillation with radiofrequency ablation and simultaneous multipolar mapping of the pulmonary veins</s1>
</fA08>
<fA11 dir="011000">
<s1>Almino C. Rocha Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Lima Farias</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Angelo A. V. de Paola</s1>
<afiliation>A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina Section of Clinical Electrophysiology</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>418-428</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>49</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To demonstrate the feasibility and safety of simultaneous catheterization and mapping of the 4 pulmonary veins for ablation of atrial fibrillation. METHODS: Ten patients, 8 with paroxysmal atrial fibrillation and 2 with persistent atrial fibrillation, refractory to at least 2 antiarrhythmic drugs and without structural cardiopathy, were consecutively studied. Through the transseptal insertion of 2 long sheaths, 4 pulmonary veins were simultaneously catheterized with octapolar microcatheters. After identification of arrhythmogenic foci radiofrequency was applied under angiographic or ultrasonographic control. RESULTS: During 17 procedures, 40 pulmonary veins were mapped, 16 of which had local ectopic activity, related or not with the triggering of atrial fibrillation paroxysms. At the end of each procedure, suppression of arrhythmias was obtained in 8 patients, and elimination of pulmonary vein potentials was accomplished in 4. During the clinical follow-up of 9.6±3 months, 7 patients remained in sinus rhythm, 5 of whom were using antiarrhythmic drugs that had previously been ineffective. None of the patients had pulmonary hypertension or evidence of stenosis in the pulmonary veins. CONCLUSION: Selective and simultaneous catheterization of the 4 pulmonary veins with microcatheters for simultaneous recording of their electrical activity is a feasible and safe procedure that may help ablation of atrial fibrillation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary veins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>radiofrequency catheter ablation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Atrial activation during sinus rhythm in patients with rheumatic and non-rheumatic paroxysmal atrial fibrillation. Frequency-domain analysis using signal-averaged electrocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Rogério Carregoza Dantas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eduardo Corrêa Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Roberto Benchimol Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alfredo de Souza Bomfim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Ginefra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>434-438</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Using P-wave signal-averaged electrocardiography, we assessed the patterns of atrial electrical activation in patients with idiopathic atrial fibrillation as compared with patterns in patients with atrial fibrillation associated with structural heart disease. METHODS: Eighty patients with recurrent paroxysmal atrial fibrillation were divided into 3 groups as follows: group I - 40 patients with atrial fibrillation associated with non-rheumatic heart disease; group II - 25 patients with rheumatic atrial fibrillation; and group III - 15 patients with idiopathic atrial fibrillation. All patients underwent P-wave signal-averaged electrocardiography for frequency-domain analysis using spectrotemporal mapping and statistical techniques for detecting and quantifying intraatrial conduction disturbances. RESULTS: We observed an important fragmentation in atrial electrical conduction in 27% of the patients in group I, 64% of the patients in group II, and 67% of the patients in group III (p=0.003). CONCLUSION: Idiopathic atrial fibrillation has important intraatrial conduction disturbances. These alterations are similar to those observed in individuals with rheumatic atrial fibrillation, suggesting the existence of some degree of structural involvement of the atrial myocardium that cannot be detected with conventional electrocardiography and echocardiography.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>signal-averaged</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>idiopathic atrial fibrillation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>The impact of syncope during clinical presentation of sustained ventricular tachycardia on total and cardiac mortality in patients with chronic Chagasic heart disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Roberto Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Guilherme Fenelon</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ângela Tavares Paes</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Angelo Amato Vincenzo de Paola</s1>
<afiliation>A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina Setor de Eletrofisiologia Clínica</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>446-452</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the impact of syncope during sustained ventricular tachycardia on total and cardiac mortality in patients with chronic chagasic heart disease. METHODS: We assessed 78 patients with sustained ventricular tachycardia and chronic Chagas' heart disease. The mean age was 53±10 years, 45 were males, and the mean ejection fraction was 49.6±13%. The patients were divided into 2 groups according to the presence (GI=45) or absence (GII=33) of syncope during sustained ventricular tachycardia. RESULTS: After a mean follow-up of 49 months, total mortality was 35% (28 deaths), 22 deaths having a cardiac cause (78.6%). No difference was observed in total (33.3% x 39.4%) and cardiac (26.7% x 30.3%) mortality, or in nonfatal sustained ventricular tachycardia between GI and GII patients (57.6% x 54.4%, respectively). However, the presence of syncope during recurrences was significantly greater in those patients who had had the symptom from the beginning (65.4% x 18.1%, p&lt;0.01). CONCLUSION: Syncope during the presentation of sustained ventricular tachycardia is not associated with an increase in total or cardiac mortality in patients with chronic Chagas' heart disease. However, syncope during the recurrence ventricular tachycardia is greater in patients experiencing syncope in the first episode, of sustained ventricular tachycardia.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>syncope</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sustained ventricular tachycardia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chronic Chagas' heart disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>The Bambuí health and aging study (BHAS). Prevalence of intermittent claudication in the aged population of the community of Bambuí and its associated factors</s1>
</fA08>
<fA11 dir="011000">
<s1>Valéria Maria de Azeredo Passos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sandhi Maria Barreto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Henrique Leonardo Guerra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Josélia Oliveira Araújo Firmo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Pedro Guatimosim Vidigal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maria Fernanda Furtado Lima-Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Minas Gerais Faculdade de Medicina </s1>
<s2>Belo Horizonte MG</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>458-462</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the prevalence of intermittent claudication in the aged population of Bambuí, Brazil, and to identify the factors associated with this disease. METHODS: Population-based cross-sectional study of the aged population ( &gt; or =  60 years of age) of Bambuí. Participants were interviewed and examined, after written consent. Intermittent claudication was defined based on a standardized questionnaire. Analysis was performed using multiple logistic regression. RESULTS: Of the 1,742 elderly living in Bambuí, 1,485 (85.2%) were enrolled in the study. Thirty-seven individuals (2.5%) with intermittent claudication were identified: 28 (1.9%) males and 9 (0.6%) females. Their age brackets were: 16 (1.08%) individuals between 60 and 69 years of age, 17 (1.15%) between 70 and 79 years, and 4 (0.27%)  &gt; or =  80 years. A significant association between intermittent claudication and the following characteristics was found: male sex (OR=5.1; CI 2.4-11.0), smokers (OR=3.1; CI 1.2-8.5), ex-smokers (OR=3.4; CI 1.3-8.7), and more than 2 hospital admissions in the last 12 months (OR=2.8; CI 1.1-7.2). CONCLUSION: Disease prevalence was similar to that of other countries. The association between intermittent claudication and smoking strengthens the significance of tobacco in peripheral artery disease pathogenesis. The association of intermittent claudication and a higher number of hospital admissions suggests greater morbidity in the elderly affected.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>peripheral obstructive arterial disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>intermittent claudication</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prevalence</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Manidipina no tratamento da hipertensão arterial essencial estágio I e II do paciente com sobrepeso ou obesidade andróide. Estudo multicêntrico brasileiro de eficácia, tolerabilidade e efeitos metabólicos</s1>
</fA08>
<fA08 dir="en">
<s1>Manidipine in the treatment of stage I and II essential hypertensive patients with overweight or android obesity. A brazilian multicentre study of efficacy, tolerability and metabolic effects</s1>
</fA08>
<fA11 dir="011000">
<s1>Osvaldo Kohlmann Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Artur Beltrame Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina Hospital do Rim e Hipertensão</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>463-470</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a eficácia anti-hipertensiva, efeitos metabólicos e tolerabilidade da manidipina no tratamento de hipertensos essenciais estágio I e II com sobrepeso ou obesidade do tipo andróide. MÉTODOS: Em estudo aberto, não comparativo, realizado em 11 centros brasileiros de pesquisa, 102 pacientes de ambos os sexos com sobrepeso ou obesidade central, foram tratados por 12 semanas com manidipina em dose única diária de 10 a 20mg e avaliadas pressão arterial, freqüência cardíaca e a presença de eventos adversos. Ao final dos períodos placebo e de droga ativa foram obtidos os valores plasmáticos da glicemia de jejum, colesterol total e frações e triglicérides. Em 12 pacientes foi avaliada a sensibilidade à insulina. RESULTADOS: A manidipina reduziu a pressão arterial de 159±15 / 102±5mmHg para 141±15 / 90±8mmHg sem acarretar aumento da freqüência cardíaca. A taxa de eficácia foi de 71,9% com 51,1% de normalização pressórica. Não foram observadas alterações significativas dos parâmetros metabólicos. A tolerabilidade da manidipina foi muito boa e no final do estudo 87,1% estavam livres de qualquer reação adversa. CONCLUSÃO: A manidipina constitui opção adequada, altamente eficaz, livre de efeitos metabólicos e segura para tratamento de hipertensos estágios I e II com sobrepeso ou obesidade andróide.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the efficacy, metabolic effects and tolerability of manidipine used in the treatment of stage I and II essential hypertensive patients with overweight or android obesity. METHODS: By an open-label, non comparative protocol in 11 Brazilian clinical research centers 102 hypertensive patients of both sexes with over weight or central obesity were treated with manidipine 10 to 20mg once daily for 12 weeks. Blood pressure, heart rate and adverse events were monitored. Fasting plasma glucose, total, HDL and LDL-cholesterol and triglicerides were determined at both placebo period and end of active treatment. Also in 12 patients, insulin sensitivity index was evaluated during placebo and manidipine treatment. RESULTS: Blood pressure was reduced from 159±15 / 102±5mmHg to 141±15 / 90±8mmHg with the treatment without any noticeable change in heart rate. Manidipine-efficacy rate was 71.9% with 51.1% of blood pressure normalization. No significant changes in metabolic parameters were noticed. Tolerability to manidipine was very high and at the last visit 87.1% of the treated patients were free of any adverse event. CONCLUSION: Manidipine is an adequate, highly effective, exempt of metabolic effects and safe option for treatment of stage I and II essential hypertensive patients with overweight or android obesity.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>manidipina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial essencial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>obesidade andróide</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>manidipine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>essential hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>android obesity</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>New percutaneous techniques for perforating the pulmonary valve in pulmonary atresia with intact ventricular septum</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos A. C. Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luciano N. L. de Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Simone R. F. F. Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Waldinai P. Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sérgio L. N. Braga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>César A. Esteves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Maria Virgínia T. Santana</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>J. Eduardo Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Valmir F. Fontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>479-486</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report new percutaneous techniques for perforating the pulmonary valve in pulmonary atresia with intact ventricular septum, in 3 newborns who had this birth defect. There was mild to moderate hypoplastic right ventricle, a patent infundibulum, and no coronary-cavitary communications. We succeeded in all cases, and no complications related to the procedure occurred. The new coaxial radiofrequency system was easy to handle, which simplified the procedure. Two patients required an additional source of pulmonary flow (Blalock-Taussig shunt) in the first week after catheterization. All patients had a satisfactory short-term clinical evolution and will undergo recatheterization within 1 year to define the next therapeutic strategy. We conclude that this technique may be safely and efficiently performed, especially when the new coaxial radiofrequency system is used, and it may become the initial treatment of choice in select neonates with pulmonary atresia and intact ventricular septum.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Aortopulmonary window and double aortic arch. A rare association</s1>
</fA08>
<fA11 dir="011000">
<s1>Evander Moraes Botura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo Piazzalunga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Flavio Barutta Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Douglas S. Grion</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Milton F. Neves Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Ricardo Ueda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>ULTRAMED MEDTAC Imagem em Medicina </s1>
<s2>Londrina PR</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>490-492</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the case of a 27-year-old male patient with dyspnea on physical exertion. Clinical assessment and various tests led to the diagnosis of aortopulmonary window and double aortic arch. According to a literature search, this may be the first report on such association.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 11/2001 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>493-493</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Management of mild aortic stenosis in patients undergoing coronary bypass surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Fábio Cañellas Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Waldomiro C. Manfroi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gustavo Werutsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Augusto Ferreira Bittencourt</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul  </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>497-499</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Diagnostic value of the tilt-table test for the assessment of syncope in children and adolescents</s1>
</fA08>
<fA11 dir="011000">
<s1>Tan Chen Wu</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Denise Hachul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Mauricio Scanavacca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eduardo Sosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital de Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>505-508</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To assess the diagnostic value, the characteristics, and feasibility of tilt-table testing in children and adolescents. METHODS - From August 1991 to June 1997, we retrospectively assessed 94 patients under the age of 18 years who had a history of recurring syncope and presyncope of unknown origin and who were referred for tilt-table testing. These patients were divided into 2 groups: group I (children) - 36 patients with ages ranging from 3 to 12 (mean of 9.19±2.31) years; group II (adolescents) - 58 patients with ages ranging from 13 to 18 (mean of 16.05±1.40) years. We compared the positivity rate, the type of hemodynamic response, and the time period required for the test to become positive in the 2 groups. RESULTS - The positivity rates were 41.6 % and 50% for groups I and II, respectively. The pattern of positive hemodynamic response that predominated in both groups was the mixed response. The mean time period required for the test to become positive was shorter in group I (11.0±7.23 min) than in group II (18.44±7.83 min). No patient experienced technical difficulty or complications. CONCLUSION - No difference was observed in regard to feasibility, positivity rate, and pattern of positive response for the tilt-table test in children and adolescents. Pediatric patients had earlier positive responses.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tilt-table test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>neurocardiogenic syncope</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>children and adolescents</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Assessment of splanchnic perfusion with gastric tonometry in the immediate postoperative period of cardiac surgery in children</s1>
</fA08>
<fA11 dir="011000">
<s1>Renato Lopes de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Werther Brunow de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Miguel Angel Maluf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>515-519</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - A prospective, nonrandomized clinical study to assess splanchnic perfusion based on intramucosal pH in the postoperative period of cardiac surgery and to check the evolution of patients during hospitalization. METHODS - We studied 10 children, during the immediate postoperative period after elective cardiac surgery. Sequential intramucosal pH measurements were taken, without dobutamine (T0) and with 5mcg/kg/min (T1) and 10 (T2) mcg/kg/min. In the pediatric intensive care unit, intramucosal pH measurements were made on admission and 4, 8, 12, and 24 hours thereafter. RESULTS - The patients had an increase in intramucosal pH values with dobutamine 10mcg/kg/min [7.19± 0.09 (T0), 7.16±0.13(T1), and 7.32±0.16(T2)], (p=0.103). During the hospitalization period, the intramucosal pH values were the following: 7.20±0.13 (upon admission), 7.27±0.16 (after 4 hours), 7.26±0.07 (after 8 hours), 7.32±0.12 (after 12 hours), and 7.38±0.08 (after 24 hours), (p=0.045). No deaths occurred, and none of the patients developed multiple organ and systems dysfunction. CONCLUSION - An increase in and normalization of intramucosal pH was observed after dobutamine use. Measurement of intramucosal pH is a type of monitoring that is easy to perform and free of complications in children during the postoperative period of cardiac surgery.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pH</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>splanchnic perfusion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dobutamine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>gastric tonometry</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pediatric cardiac surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Percutaneous closure of ductus arteriosus with the amplatzer prosthesis. The Brazilian experience</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Carlos Simões</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos A. C. Pedra</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>César A. Esteves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ronaldo Camargo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sérgio L.N. Braga</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Pedro Loureiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Marco Aurélio Santos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Valmir Fernandes Fontes</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>526-531</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To report the results of percutaneous occlusion of persistent ductus arteriosus with the Amplatzer prosthesis in 2 Brazilian cardiological centers. METHODS - From May 1998 to July 2000, 33 patients with clinical and laboratory diagnosis of persistent ductus arteriosus underwent attempts at percutaneous implantation of the Amplatzer prosthesis. The median age was 36 months (from 6 months to 38 years), and the median weight was 14kg (from 6 to 92kg). Sixteen patients (48.5%) were under 2 years of age at the time of the procedure. All patients were followed up with periodical clinical and echocardiographic evaluations to assess the presence and degree of residual shunt and possible complications, such as pseudocoarctation of the aorta and left pulmonary artery stenosis. RESULTS - The minimum diameter of the arterial ducts ranged from 2.5 to 7.0mm (mean of 4.0±1.0, median of 3.9). The rate of success for implantation of the prosthesis was 100%. Femoral pulse was lost in 1 patient. The echocardiogram revealed total closure prior to hospital discharge in 30 patients, and in the follow-up visit 3 months later in the 3 remaining patients. The mean follow-up duration was 6.4±3.4 months. All patients were clinically well, asymptomatic, and did not need medication. No patient had narrowing of the left pulmonary artery or of the aorta. No early or late embolic events occurred, nor did infectious endarteritis. A new hospital admission was not required for any patient. CONCLUSION - The Amplatzer prosthesis for persistent ductus arteriosus is safe and highly effective for occlusion of ductus arteriosus of varied diameters, including large ones in small symptomatic infants.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>persistent ductus arteriosus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous occlusion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Amplatzer prosthesis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Validation study of an automated wrist monitor, omron model HEM-608, compared with the standard methods for blood pressure measurement</s1>
</fA08>
<fA11 dir="011000">
<s1>Frida Liane Plavnik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Teresa Zanella</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Estado de São Paulo Escola Paulista de Medicina Fundação Oswaldo Ramos</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>537-540</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - The aim of our study was to assess the profile of a wrist monitor, the Omron Model HEM-608, compared with the indirect method for blood pressure measurement. METHODS - Our study population consisted of 100 subjects, 29 being normotensive and 71 being hypertensive. Participants had their blood pressure checked 8 times with alternate techniques, 4 by the indirect method and 4 with the Omron wrist monitor. The validation criteria used to test this device were based on the internationally recognized protocols. RESULTS - Our data showed that the Omron HEM-608 reached a classification B for systolic and A for diastolic blood pressure, according to the one protocol. The mean differences between blood pressure values obtained with each of the methods were -2.3 +7.9mmHg for systolic and 0.97+5.5mmHg for diastolic blood pressure. Therefore, we considered this type of device approved according to the criteria selected. CONCLUSION - Our study leads us to conclude that this wrist monitor is not only easy to use, but also produces results very similar to those obtained by the standard indirect method.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>automated blood pressure device</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>wrist monitor</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension and normotension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Reversibility of ventricular dysfunction: clinical experience in a medical office</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brasil</s3>
</fA14>
<fA20 dir="000000">
<s1>545-548</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To describe clinical observations of marked improvement in ventricular dysfunction in a medical office environment under circumstances differing from those in study protocols and multicenter studies performed in hospital or with outpatient cohorts. METHODS - Eleven cardiac failure patients with marked ventricular dysfunction receiving treatment at a doctors office between 1994 and 1999 were studied. Their ages ranged from 20 and 66 years (mean 39.42±14.05 years); 7 patients were men, 4 were women. Cardiopathic etiologies were arterial hypertension in 5 patients, peripartum cardiomyopathy in 2, nondefined myocarditis in 2, and alcoholic cardiomyopathy in 4. Initial echocardiograms revealed left ventricular dilatation (average diastolic diameter, 69.45±8.15mm), reduced left ventricular ejection fraction (0.38±0.08) and left atrial dilatation (43.36±5.16mm). The therapeutic approach followed consisted of patient orientation, elimination of etiological or causal factors of cardiac failure, and prescription of digitalis, diuretics, and angiotensinconverting enzyme inhibitors. RESULTS - Following treatment, left ventricular ejection fraction changed to 0.63±0.09; left ventricular diameters changed to 57.18±8.13mm, and left atrium diameters changed to 37.27±8.05mm. Maximum improvement was noted after 16.9±8.63 (6 to 36) months. CONCLUSION - Patients with serious cardiac failure and ventricular dysfunction caused by hypertension, alcoholism, or myocarditis can experience marked improvement in ventricular dysfunction after undergoing appropriate therapy within the venue of the doctor's office.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular remodeling</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dilated cardiomyopathy ventricular dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac failure</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Alberto Mattos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cindy L. Grines</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>J. Eduardo de Sousa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Amanda G. M. R. Sousa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Gregg W. Stone</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>David Cox</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Eulogio Garcia</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Marie-Claude Morice</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>William O'Neill</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Lorelei Grines</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Judith Boura</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>556-561</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - This analysis was undertaken to determine the composite incidence of cumulative adverse events (death, reinfarction, disabling stroke, and target vessel revascularization) at the end of the first year after acute myocardial infarction, in diabetic patients who underwent coronary stenting or primary coronary balloon angioplasty. METHODS - From the STENT PAMI trial, we analyzed the 6-month angiographic and 1-year clinical outcomes of 135 diabetic (112, noninsulin dependent) patients who underwent the randomization process of the trial and compared them with 758 nondiabetic patients. RESULTS - Coronary stenting did not significantly reduce the primary composite clinical end point when compared with PTCA (20 vs. 30%, p=0.2). A significant benefit from stenting was observed in patients with noninsulin dependent diabetes, with a trend toward a lesser need for new revascularization procedures (10 vs. 21%, p&lt;.001), with a significant reduction in the primary composite clinical end point at 1 year (12 vs. 28%, p=. 04). At 6 months, the restenosis rate were significantly reduced only in nondiabetic patients (18 vs. 33%, p&lt;. 001). Diabetic patients had the same restenosis rate (38%) either with stenting or balloon PTCA. CONCLUSIONS - Coronary Stenting in diabetics noninsulin dependent offered a significant reduction in the composite incidence of major clinical adverse events compared with balloon PTCA.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stents</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diabetes mellitus</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Trends in the risk of mortality due to cardiovascular diseases in five Brazilian geographic regions from 1979 to 1996</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria de Fátima Marinho de Souza</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ari Timerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Vicente Serrano Jr</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Raul D. Santos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio de Pádua Mansur</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>569-575</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To analyze the trends in risk of death due to cardiovascular diseases in the northern, northeastern, southern, southeastern, and central western Brazilian geographic regions from 1979 to 1996. METHODS - Data on mortality due to cardiovascular, cardiac ischemic, and cerebrovascular diseases in 5 Brazilian geographic regions were obtained from the Ministry of Health. Population estimates for the time period from 1978 to 1996 in the 5 Brazilian geographic regions were calculated by interpolation with the Lagrange method, based on the census data from 1970, 1980, 1991, and the population count of 1996, for each age bracket and sex. Trends were analyzed with the multiple linear regression model. RESULTS - Cardiovascular diseases showed a declining trend in the southern, southeastern, and northern Brazilian geographic regions in all age brackets and for both sexes. In the northeastern and central western regions, an increasing trend in the risk of death due to cardiovascular diseases occurred, except for the age bracket from 30 to 39 years, which showed a slight reduction. This resulted from the trends of cardiac ischemic and cerebrovascular diseases. The analysis of the trend in the northeastern and northern regions was impaired by the great proportion of poorly defined causes of death. CONCLUSION - The risk of death due to cardiovascular, cerebrovascular, and cardiac ischemic diseases decreased in the southern and southeastern regions, which are the most developed regions in the country, and increased in the least developed regions, mainly in the central western region.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac ischemic diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cerebrovascular diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Hypertension and clustering of cardiovascular risk factors in a community in Southeast Brazil: the Bambuí Health and Ageing Study</s1>
</fA08>
<fA11 dir="011000">
<s1>Sandhi Maria Barreto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valéria Maria Azeredo Passos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Josélia Oliveira Araújo Firmo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Henrique Leonardo Guerra</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Pedro Guatimosim Vidigal</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maria Fernanda Furtado Lima-Costa</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>576-581</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - A population-based prospective study was analysed to: a) determine the prevalence of hypertension; b) investigate the clustering of other cardiovascular risk factors and c) verify whether older differed from younger adults in the pattern of clustering. METHODS - The data comprised a representative sample of the population of Bambuí, Brazil. Multiple logistic regression was used to investigate the independent association between hypertension and selected factors. RESULTS - A total of 820 younger adults (82.5%) and 1494 older adults (85.9%) participated in this study. The overall prevalence of hypertension was 24.8% (SE=1.4 %), being higher in women (26.9±1.5%) than in men (22.0± 1.7%) (p=0.033). Hypertension was positively and significantly associated with physical inactivity, overweight, hypercholesterolemia hyperglycemia and hypertriglyceridemia. The coexistence of hypertension with 4 or more of these risk factors occurred 6 times more than expected by chance, after adjusting for age and sex (OR=6.3; 95%CI: 3.4-11.9). The pattern of risk factor clustering in hypertensive individuals differed with age. CONCLUSION - Our results reinforce the need to increase detection and treatment of hypertension and to approach patients' global risk profiles.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prevalence</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Case 6/2001 - The patient is an 11-year-old girl with Takayasu's arteritis and heart failure (Instituto do Coração do Hospital das Clínicas - FMUSP - São Paulo)</s1>
</fA08>
<fA11 dir="011000">
<s1>Fabio Gazelato de Mello Franco</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dante Marcelo Artigas Giorgi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Clementina Pinto Giorgi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Sampaio Gutierrez</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>587-591</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 12/2001 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>592-592</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Acute myocardial infarction: one century of history</s1>
</fA08>
<fA11 dir="011000">
<s1>Rogério Sarmento-Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ana Maria Krepsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos A. M. Gottschall</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>602-610</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0>78</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700611</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Cartas</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>611-613</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700612</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>77</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Errata</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>0-0</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2001</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(01)07700613</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Useful clinical features for the selection of ideal patients with strial fibrillation for mapping and catheter ablation</s1>
</fA08>
<fA11 dir="011000">
<s1>Niraj Mehta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Zildany Pinheiro Távora</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Noriaki Takeschita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edilberto Figueiredo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ricardo M. Lourenço</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Hélio Germiniani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Dalton Précoma</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Angelina Caron  </s1>
<s2>Campina Grande do Sul PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>9-16</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To identify useful clinical characteristics for selecting patients eligible for mapping and ablation of atrial fibrillation. METHODS: We studied 9 patients with atrial fibrillation, without structural heart disease, associated with: 1) antiarrhythmic drugs, 2) symptoms of low cardiac output, and 3) intention to treat. Seven patients had paroxysmal atrial fibrillation and 2 had recurrent atrial fibrillation. RESULTS: In the 6 patients who underwent mapping (all had paroxysmal atrial fibrillation), catheter ablation was successfully carried out in superior pulmonary veins in 5 patients (the first 3 in the left superior pulmonary vein and the last 2 in the right superior pulmonary vein). One patient experienced a recurrence of atrial fibrillation after 10 days. We observed that patients who had short episodes of atrial fibrillation on 24-hour Holter monitoring before the procedure were those in whom mapping the focus of tachycardia was possible. Tachycardia was successfully suppressed in 4 of 6 patients. The cause of failure was due to the impossibility of maintaining sinus rhythm long enough for efficient mapping. CONCLUSION: Patients experiencing short episodes of atrial fibrillation during 24-hour Holter monitoring were the most eligible for mapping and ablation, with a final success rate of 66%, versus the global success rate of 44%. Patients with persistent atrial fibrillation were not good candidates for focal ablation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>radiofrequency catheter ablation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mapping</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Epworth's sleepiness scale in outpatients with different values of arterial blood pressure</s1>
</fA08>
<fA11 dir="011000">
<s1>Miguel Gus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Daniel Nunes e Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Juliana Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Caroline P. Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Geraldo Druck Sant'Anna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul Unidade de Pesquisa</s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>21-24</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To compare sleepiness scores of the Epworth scale in patients with different levels of arterial pressure when undergoing outpatient monitoring within the context of clinical evaluation. METHODS: A total of 157 patients selected for outpatient monitoring of arterial pressure during hypertension evaluation were divided into 3 groups: group 1 - normotensive; group 2 - hypertensive; group 3 - resistant hypertensive. For analysis, values  &gt; or = 11 were considered as associated with respiratory disturbances during sleep. RESULTS: Seventeen (10.8%) patients in group 1, 112 (71.3%) in group 2, and 28 (17.8%) in group 3, which was composed of aged, more severely hypertensive individuals, were analyzed. Groups were similar relative to sex and body mass index, but different in relation to systolic and diastolic pressure levels and age. Despite an absolute difference, no statistically significant difference occurred between Epworth scores and in the proportion of patients with values  &gt; or = 11 (5.9% vs. 18.8% vs. 212.4%; P=0.37). Despite the positive association between degree of sleepiness measured with the scale and the severity of the hypertension, no statistical significance occurred following control by age (p=0.18). CONCLUSION: A positive correlation exists between degree of sleepiness and hypertension severity. The absence of a statistical significance shown in the present study could be due to a beta type of error. Instruments that render this complaint into an objective finding could help in the pursuit of an investigation of respiratory disturbances during sleep in more severely hypertensive patients, and should therefore be studied better.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sleep apnea syndrome</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Epworth sleepiness scale</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Lipid metabolism in rats fed diets containing different types of lipids</s1>
</fA08>
<fA11 dir="011000">
<s1>Márcia Barbosa Águila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carla Cota Loureiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alessandra da Rocha Pinheiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Alberto Mandarim-de-Lacerda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual do Rio de Janeiro Instituto de Biologia Centro Biomédico</s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>32-38</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>40</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effect of different types of lipid diets on the lipid metabolism of aging rats. METHODS: Fifty male Wistar rats were studied from the time of weaning to 12 and 18 months of age. Their diets were supplemented as follows: with soybean oil (S), canola oil (CA), lard and egg yolk (LE), and canola oil + lard and egg yolk (CA + LE). Blood pressure (BP) was measured every month, and the heart/body ratio (H/BR) was determined. The rats were euthanized at the age of 12 and 18 months, and blood samples were collected for lipid analysis as follows: total cholesterol (TC), LDL-C, VLDL-C, HDL-C, triglycerides (TG), and glucose. RESULTS: The type of oil ingested by the animals significantly altered BP, H/BR, and serum lipid levels in rats at 12 and 18 months. No difference was observed in the survival curve of the animals in the different groups. The LE group had the highest BP, and the CA group was the only one in which BP did not change with aging. A reduction in the H/BR was observed in the LE and CA+LE animals. At the age of 12 months, differences in TC, HDL-C, LDL-C, VLDL-C, TG, and glucose were observed. At the age of 18 months, a significant difference in TC, HDL-C, and glucose was observed. The highest TC value was found in the CA group and the lowest in the S group. CONCLUSION: No increase in BP occurred, and an improvement was evident in the lipid profile of rats fed a diet supplemented with CA, in which an elevation in HDL-C levels was observed, as compared with levels with the other types of diet.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>canola oil</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipoproteins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rats</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Ventricular resynchronization through biventricular cardiac pacing for the treatment of refractory heart failure in dilated cardiomyopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>Silas S. Galvão Fº</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cecília M. B. Barcellos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>J. Tarcísio M. Vasconcelos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jaime G. M. Arnez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Kátia N. Couceiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Leudo Campos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Evandro Sbaraini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Maurício G. Lyra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Fernando S. O. Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Real e Benemérita Beneficência Portuguesa de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>45-50</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: The biventricular pacing (BVP) approach has good results in the treatment of congestive heart failure (CHF) in patients (pts) with disorders of intraventricular conduction. METHODS: We have applied BVP to 28 pts, with left ventricular pacing using minitoracotomy in 3 pts and the transvenous aproach via coronary sinus in 25 pts. The mean duration of the QRS complexes was 187 ms, in the presence of the left branch block in 22 pts, and right branch block + divisional hemiblock in 6 pts. All pts had been considerated candidates to cardiac transplantation, and were under optimized drug therapy. Sixteen pts were in Functional Class (NYHA) IV, and 12 in class III. The ejection fraction varied from 22 to 46% (average = 34%). The pacing mode employed was biventricular triple-chamber in 22 pts, and bi-ventricular dual-chamber in 6 pts (one with ICD). RESULTS: The pts were followed up for a period that ranged from 10 days to 14 months (mean 5 months). All pts presented clinical improvement after implant, chaging the NYHA Functional Class at the end of follow-up to Class I (9pts), Class II (10 pts) and Class III (6 pts). The initial mean ejection fraction have-raised to 37%. Two pts died suddenly. One patient died due to a pulmonary fungal infection. CONCLUSION: Ventricular resynchronization through BVP, improved significantly the Functional Class and, therefore, the quality of life. Assessments of myocardial function acutely performed do not reflect the clinical improvement observed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>biventricular pacing</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular resynchronization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Cardiovascular assessment of patients with Ullrich-Turner's Syndrome on Doppler echocardiography and magnetic resonance imaging</s1>
</fA08>
<fA11 dir="011000">
<s1>Ana Valéria Barros de Castro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Katashi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sérgio Marrone Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maurício Fregonesi Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Patricia Ferreira Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luciana Pagliare</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Nancy Figueiredo Bueno</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Débora Aparecida Rodrigueiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Adriana Lúcia Mendes Haddad</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual Paulista Faculdade de Medicina de Botucatu Departamento de Clínica Médica</s1>
<s2>Botucatu SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>55-58</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the cardiovascular features of Ullrich-Turner's syndrome using echocardiography and magnetic resonance imaging, and to correlate them with the phenotype and karyotype of the patients. The diagnostic concordance between the 2 methods was also assessed. METHODS: Fifteen patients with the syndrome were assessed by echocardiography and magnetic resonance imaging (cardiac chambers, valves, and aorta). Their ages ranged from 10 to 28 (mean of 16.7) years. The karyotype was analyzed in 11 or 25 metaphases of peripheral blood lymphocytes, or both. RESULTS: The most common phenotypic changes were short stature and spontaneous absence of puberal development (100%); 1 patient had a cardiac murmur. The karyotypes detected were as follows: 45,X (n=7), mosaics (n=5), and deletions (n=3). No echocardiographic changes were observed. In regard to magnetic resonance imaging, coarctation and dilation of the aorta were found in 1 patient, and isolated dilation of the aorta was found in 4 patients. CONCLUSION: The frequencies of coarctation and dilation of the aorta detected on magnetic resonance imaging were similar to those reported in the literature (5.5% to 20%, and 6.3% to 29%, respectively). This confirmed the adjuvant role of magnetic resonance imaging to Doppler echocardiography for diagnosing cardiovascular alterations in patients with Ullrich-Turner's syndrome.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Doppler echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>magnetic resonance imaging</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Turner's syndrome</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>An analysis of electrocardiographic criteria for determining left ventricular hypertrophy</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Alberto Gasperin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Helio Germiniani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Roberto Facin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Admar Moraes de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Cláudio Leinig Pereira da Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Paraná Hospital de Clínicas de Curitiba </s1>
<s2>Curitiba PR</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>72-82</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>65</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the most sensitive criterion for the detection of left ventricular hypertrophy according to echocardiographically defined left ventricular mass. METHODS: The Sokolow-Lyon voltage, Sokolow-Lyon-Rappaport, Cornell voltage duration product, White-Bock, and Romhilt-Estes point scoring criteria were compared with left ventricular mass index, corrected for body surface, obtained from the echocardiograms of 306 outpatients (176 females, 130 males), of all age groups. RESULTS: The Cornell voltage duration product criteria index had the greatest sensitivity in women (54.90%), and the Sokolow-Lyon-Rappaport index was most sensitive in men (73.53%). When applied to men at the same voltage amplitude (20mm) as that in women, the Cornell index showed increased sensitivity relative to the conventional index (28mm) of 67.65% (P&lt;=0.01) and a sensitivity similar to that of the Sokolow-Lyon-Rappaport index, with higher specificity (P&lt;=0.01). The White-Bock and Romhilt-Estes criteria were the least sensitive in men and women, despite their high specificity. The electrocardiographic criteria were more efficient when dilatation predominated over left ventricular hypertrophy. CONCLUSION: The Cornell index had greater sensitivity in women, and the Sokolow-Lyon-Rappaport index was more sensitive in men. When applied to men at the same voltage amplitude as that of women, the Cornell index had an increase in sensitivity similar to that of the Sokolow-Lyon-Rappaport index.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrocardiogram</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Ambulatory blood pressure monitoring of patients with heart failure: a new prognosis marker</s1>
</fA08>
<fA11 dir="011000">
<s1>Manoel F. Canesin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dante Giorgi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Múcio T. de Oliveira Jr.</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maurício Wajngarten</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alfredo J. Mansur</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Antonio F. Ramires</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Londrina Hospital Universitário Regional do Norte do Paraná </s1>
<s2>Londrina PR</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>83-89</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>39</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the relationship between 24-hour ambulatory arterial blood pressure monitoring and the prognosis of patients with advanced congestive heart failure. METHODS: We studied 38 patients with NYHA functional class IV congestive heart failure, and analyzed left ventricular ejection fraction, diastolic diameter, and ambulatory blood pressure monitoring data. RESULTS: Twelve deaths occurred. Left ventricular ejection fraction (35.2±7.3%) and diastolic diameter (72.2±7.8mm) were not correlated with the survival. The mean 24-hour (SBP24), waking (SBPw), and sleeping (SBPs) systolic pressures of the living patients were higher than those of the deceased patients and were significant for predicting survival. Patients with mean SBP24, SBPv, and SBPs  &gt; or = 105mmHg had longer survival (p=0.002, p=0.01 and p=0.0007, respectively). Patients with diastolic blood pressure sleep decrements (dip) and patients with mean blood pressure dip &lt;=6mmHg had longer survival (p=0.04 and p=0.01, respectively). In the multivariate analysis, SBPs was the only variable with an odds ratio of 7.61 (CI: 1.56; 3704) (p=0.01). Patients with mean SBP&lt;105mmHg were 7.6 times more likely to die than those with SBP  &gt; or =  105 mmHg CONCLUSION: Ambulatory blood pressure monitoring appears to be a useful method for evaluating patients with congestive heart failure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure ambulatory monitorization</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>The use of abciximab associated with primary angioplasty for treating acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Manuel Lisandro Hernández Brito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Newton F. Stadler de Souza Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Álvaro Vieira Moura</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Augusto Lavalle</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rubens Zenobio Darwich</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marisa Leal</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Eva Cantalejo Munhoz</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>98-105</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>41</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the benefit resulting from the use of abciximab associated with primary angioplasty. The following parameters were analyzed in-hospital, at 30 days, and 6 months: (a) flow in the culprit artery; (b) ventricular function; (c) combined outcome of death, acute myocardial infarction, and aditional revascularization. METHODS: From November 1997 to June 1999, a longitudinal nonrandomized study with historical data of 137 patients with acute myocardial infarction within the first 12 hours. Patients undergoing primary angioplasty and were divided into 2 groups: those receiving (A) abciximab (26) or (B) conventional therapy (111). TIMI flow and regional ventricular function estimated by the standard deviation (SD)/chordis index were analyzed. RESULTS: At the end of angioplasty, TIMI 3 flow was observed in 76.9% and 83.8% of the patients in groups A and B, respectively (P=0.58). In the reevaluation, patients with TIMI flow &lt;3 showed a 100% improvement in group A and a 33% in group B (P&lt;0.0001). A significant improvement (P&lt;0.0001) in regional ventricular function, by SD/chordis index, occurred in each group; no significant difference between groups however, was observed (29.9% x 20.2%; P=0.58). A nonsignificant reduction in the combined outcome in the in-hospital phase (3.85% A x 9.0% B; P=0.34) and on the 30th day (4.0% x 12.0%; P=0.22) was observed in group A. CONCLUSION: Abciximab improved blood flow. Primary angioplasty improved regional ventricular function independent of antithrombotic therapy. Abciximab showed a trend toward reducing the combined outcome in the in-hospital phase and on the 30th day.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>primary angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>abciximab</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Increase in mortality due to myocardial infarction in the Brazilian city of São Paulo during winter</s1>
</fA08>
<fA11 dir="011000">
<s1>Rodolfo Sharovsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Antônio Machado César</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Univerisdade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>106-109</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study the seasonal variation in mortality due to myocardial infarction in the city of São Paulo. METHODS: We analyzed the database of PROAIM (Programa de Aprimoramento de Informações de Mortalidade) containing the registrations of the certificates of deaths due to myocardial infarction (International Classification of Diseases, 10th edition, classification I21) of the residents of the municipality of São Paulo during 12 months (from December 1996 to November 1997). The number of deaths was corrected for a standard period of 90 days and then it was divided by the corresponding population to obtain the event rate per 10 thousand inhabitants. The magnitude of the seasonal variation, which was defined by the difference of the relative risks between the seasons with higher and lower mortality, was estimated. RESULTS: A total of 5,615 deaths due to myocardial infarction were included in the study. Sixty-one per cent occurred in the male sex, and the mean age was 68 years. The mortality rate during winter was always higher and that during summer was lower than that during the other seasons (P&lt;0.01), independent from age and sex. Seasonal variations in deaths due to myocardial infarction was 30% in the general group, being 23% in individuals who died younger than 75 years, and 44% in the older ones. CONCLUSION: A marked seasonal variation in mortality due to myocardial infarction was observed in the city of São Paulo, with a significant increase in its magnitude and age distribution during the winter, similar to those reported in regions of North America and Europe with temperate climates.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>seasons</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Biventricular pacing improves clinical behavior and reduces prevalence of ventricular srrhythmia in patients with heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Martino Martinelli Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Anísio A. A. Pedrosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Roberto Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Silvana A. D. Nishioka</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sérgio F. Siqueira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Wagner T. Tamaki</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Eduardo Sosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>University of São Paulo Medical School Heart Institute</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>110-113</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>08</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: To analyze the influence of biventricular pacing (BP) on clinical behavior, ventricular arrhythmia (VA) prevalence, and left ventricular ejection fraction (LV EF) by gated ventriculography. METHODS: Twenty-four patients with left bundle branch block (LBBB) and NYHA class III and IV underwent pacemaker implantation and were randomized either to the conventional or BP group, all receiving BP after 6 months. RESULTS: Sixteen patients were in NYHA class IV (66.6%) and 8 were in class III (33.4%). After 1-year follow-up, 14 patients were in class II (70%) and 5 were in class III (25%). Two sudden cardiac deaths occurred. A significant reduction in QRS length was found with BP (p=0.006). A significant statistical increase, from a mean of 19.13 ± 5.19% (at baseline) to 25.33 ± 5.90% (with BP) was observed in LVEF Premature ventricular contraction prevalence decreased from a mean of 10,670.00 ± 12,595.39 SD or to a mean of 3,007.00 ± 3,216.63 SD PVC/24 h with BP (p&lt;0.05). Regarding the hospital admission rate over 1 year, we observed a significant reduction from 60. To 16 admissions with BP (p&lt;0.05). CONCLUSION: Patients with LBBB and severe heart failure experienced, with BP, a significant NYHA class and LVEF improvement. A reduction in the hospital admission rate and VA prevalence also occurred.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>biventricular pacing</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular arrhythmias</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Primary coronary angioplasty in a nonagenarian</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciano M. Baracioli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos V. Serrano Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antônio Esteves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jean Pierre Ciporkin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Carlos Nicolau</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>118-121</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800111</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A woman aged 98 years entered the tertiary hospital service with a picture of acute myocardial infarction of the extensive anterior wall, which began 4 hours earlier. Due to the large myocardial risk area suggested by the electrocardiogram, the patient was taken to the hemodynamics laboratory for the performance of emergency coronary arteriography, which revealed occlusion in the proximal third of the anterior descending artery. Primary angioplasty followed by stent grafting was successfully performed. The patient had a satisfactory evolution (Killip I) and was discharged from the hospital on the seventh postinfarction day. We discuss here aspects of thrombolysis and coronary percutaneous interventions in the aged.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Obstruction of the left ventricular outflow tract after mitral valvuloplasty with implantation of Gregori's ring</s1>
</fA08>
<fA11 dir="011000">
<s1>Roberto G. de Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gustavo K. Pimentel</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luciano de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Márcia M. da Silveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alexandre Alessi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Dalton B. Precoma</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>126-129</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800112</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Mitral valvuloplasty is efficient for repairing mitral valve disease with few complications. In some cases, obstruction of the left ventricular outflow tract may occur due to systolic anterior motion of the mitral valve. We report the case of a patient with this complication and a pressure gradient between the left ventricle and the aorta of 130 mm Hg after mitral valvuloplasty with implantation of a Gregori's ring. The management was clinical with suspension of the vasoactive drugs and introduction of a beta-blocker. Two years after the surgery, the patient is asymptomatic and has a normal life.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 1/2002: Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>130-130</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800113</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Anatomicopathological evidence of the beginning of atherosclerosis in infancy and adolescence</s1>
</fA08>
<fA11 dir="011000">
<s1>Lucimar Aparecida Françoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Veronica Coates</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa de São Paulo Faculdade de Ciências Médicas </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>137-142</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>51</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800114</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Therapeutic Angiogenesis: The Present and the Future</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre Cesar Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>University of Miami Department of Medicine Division of Cardiology</s1>
<s2>Miami FL</s2>
<s3>USA</s3>
</fA14>
<fA20 dir="000000">
<s1>145-147</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Acute Effects of Maternal Smoking on Fetal-Placental-Maternal System Hemodynamics</s1>
</fA08>
<fA11 dir="011000">
<s1>Janine Santos Müller</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo Antunes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ivo Behle</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Lucas Teixeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul</s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>152-155</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study acute hemodynamic alterations in the fetal-placental maternal system immediately after maternal exposure to nicotine. METHODS: This is a noncontrolled experimental study involving 21 pregnant smoking women, randomly selected, with uncomplicated pregnancies and without risk factors for fetal heart disease. Patients underwent ultrasound and fetal echocardiography before and after smoking a cigarette. They were asked to abstain from smoking for 12 hours before the study. The mean nicotine content of the cigarettes used in the study was 0.5mg of nicotine and 6mg of carbon monoxide. RESULTS: The average number of cigarettes smoked per a day prior to the study was 9.67. Gestational age ranged between 18 and 36 weeks. The mean maternal heart rate was elevated (P&lt;0.001) as was the mean fetal heart rate (P=0.044). Maternal systolic blood pressure (P=0.004) and diastolic blood pressure (P=0.033) were also elevated after smoking. A decrease occurred in the systolic/diastolic ratio in the right uterine artery (P=0.014) and in the left uterine artery (P=0.039). The other hemodynamic variables remained unchanged. CONCLUSION: Cigarette smoking can cause changes in physiologic variables of fetal-placental circulation, but it does not change fetal cardiac function, in the dose of nicotine and its components used in this study. The decrease in systolic/diastolic ratio in the uterine arteries is probably related to a dose-dependent nicotine pattern.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>smoking</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetal echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>obstetric ultrasound</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Evaluation of the Medical Care of Patients with Hypertension in an Emergency Department and in Ambulatory Hypertension Unit</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Nobre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fause Chauchar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Jaciara Machado Viana</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Gustavo José Veras Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Nereida Kilza da Costa Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto Hospital das Clínicas</s1>
<s2>Ribeirão Preto SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>159-161</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>8</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the characteristics of the patients receiving medical care in the Ambulatory of Hypertension of the Emergency Department, Division of Cardiology, and in the Emergency Unit of the Clinical Hospital of the Ribeirão Preto Medical School. METHODS: Using a protocol, we compared the care of the same hypertensive patients in on different occasions in the 2 different places. The characteristics of 62 patients, 29 men with a mean age of 57 years, were analyzed between January 1996 and December 1997. RESULTS: The care of these patients resulted in different medical treatment regardless of their clinical features and blood pressure levels. Thus, in the Emergency Unit, 97% presented with symptoms, and 64.5% received medication to rapidly reduce blood pressure. In 50% of the cases, nifedipine SL was the elected medication. Patients who applied to the Ambulatory of Hypertension presenting with similar features, or, in some cases, presenting with similar clinically higher levels of blood pressure, were not prescribed medication for a rapid reduction of blood pressure at any of the appointments. CONCLUSION: The therapeutic approach to patients with high blood pressure levels, symptomatic or asymptomatic, was dependent on the place of treatment. In the Emergency Unit, the conduct was, in the majority of cases, to decrease blood pressure immediately, whereas in the Ambulatory of Hypertension, the same levels of blood pressure, in the same individuals, resulted in therapeutic adjustment with nonpharmacological management. These results show the need to reconsider the concept of hypertensive crises and their therapeutical implications.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertensive crises</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>antihypertensive therapeutics</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Fontan Operation and the Cavopulmonary Technique: Immediate and Late Results According to the Presence of Atrial Fenestration</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nana Miura Ikari</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Tamara Cortez Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Miguel Barbero-Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>162-166</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To compare immediate and late results in patients with or without fenestration who underwent cavopulmonary anastomosis so that we could assess the efficiency of the technique. METHODS: Sixty-two patients underwent surgery between 1988 and 1999, 41 with fenestration (group I -G I) and 21 without fenestration (group II -G II). Tricuspid atresia was prevalent in group I (23-56%) and single ventricle was prevalent in group II (14-66%). Mean ages at the time of operation were 7.3 years in group I and 7.6 in group II. At late follow-up, mean ages were 10.6 years in group I and 12.8 years in group II. RESULTS: Immediate and late mortality were 7.3% in G-I and 4.7% in G-II. Significant pleural effusion occurred in 41.4% of G-I patients and in 23.8% of G-II patients. Significant pericardial effusion occurred in 29.2% and 14.2%, respectively, in groups I and II. Central venous pressure was greater in G-II, 17.7 cm in H2O, as opposed to 15 cm in G-I. Hospital stay was similar between the groups, 26.3 and 21.8 days, respectively. Cyanosis and arterial insaturation occurred in 5 patients, and 4 patients were in functional class II, all from G-I. At late follow-up, 58 (93.5%) were in functional class I. Sinus rhythm was present in 94%, and pulmonary perfusion was similar in both groups. Eleven patients who underwent spirometry had good tolerance to physical effort. CONCLUSION: Atrial fenestration did not improve the immediate or late follow-up of patients who underwent cavopulmonary anastomosis, and is, therefore, dispensable.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Fontan technique</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cavopulmonary anastomosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fenestration</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Does a Role Exist for Tilting-Guided Therapy in the Management of Neurocardiogenic Syncope?</s1>
</fA08>
<fA11 dir="011000">
<s1>Denise Hachul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mauricio Scanavacca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Eduardo Sosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>São Paulo University Heart Institute </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>167-171</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: Upright tilt-table testing (UTT) is an useful method for identifying patients with neurocardiogenic syncope, but its role in the evaluation of therapeutic efficacy is controversial. The aim of this study was to determine the correlation between negative UTT after therapy introduction (acute efficacy) and symptom recurrence during follow-up (chronic efficacy). METHODS: We studied 56 severely symptomatic patients (age 27±19 years) with recurrent (7±12 episodes) neurocardiogenic syncope (positive UTT). Once empirical pharmacological therapy was initiated, all patients underwent another UTT (therapeutic evaluation test - TET). Therapy was not modified after TET results. The probability of symptom recurrence was analyzed with the Kaplan-Meier method and compared by log-rank test in patients with negative and positive TET. RESULTS: Negative UTT after therapy was related to a significantly lower probability of recurrence during follow-up (4.9 versus 52.4% in 12 months, P&lt;0.0001). CONCLUSION: A good correlation exists between acute and long-term efficacy of pharmacological therapy for neurocardiogenic syncope, so that serial UTT may be considered a good method for identifying an effective therapeutic strategy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tilt-table test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>therapy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>neurocardiogenic syncope</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Effects of Sibutramine on the Treatment of Obesity in Patients with Arterial Hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>Alessandra Nunes Faria</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernando Flexa Ribeiro Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Daniel Diniz G. Lerário</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Nárcia Kohlmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sandra Roberta Gouvea Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maria Teresa Zanella</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Hospital do Rim e Hipertensão </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>176-180</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pressure during 24 hours (ambulatory blood pressure monitoring), on left ventricular mass, and on antihypertensive therapy in 86 obese and hypertensive patients for 6 months. METHODS: The patients underwent echocardiography, ambulatory blood pressure monitoring, and measurement of the levels of hepatic enzymes prior to and after treatment with sibutramine or placebo. RESULTS: The group using sibutramine had a greater weight loss than that using placebo (6.7% versus 2.5%; p&lt;0.001), an increase in heart rate (78.3±7.3 to 82±7.9 bpm; p=0.02), and a reduction in the left ventricular mass/height index (105±29.3 versus 96.6±28.58 g/m; p=0.002). Both groups showed similar increases in the levels of alkaline phosphatase and comparable adjustments in antihypertensive therapy; blood pressure, however, did not change. CONCLUSION: The use of sibutramine caused weight loss and a reduction in left ventricular mass in obese and hypertensive patients with no interference with blood pressure or with antihypertensive therapy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sibutramine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>obesity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Autonomic Modulation of the Heart in Systemic Arterial Hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>José Barbosa Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Roberto B. Barbosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ivan Cordovil</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>189-195</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the heart rate variability in patients with mild to moderate systemic arterial hypertension. METHODS: Thirty-two healthy (group I) and 70 systemic arterial hypertensive (group II) individuals, divided according to age (40 to 59 and 60 to 80 years old, respectively) and with a similar distribution by sex were studied. Thirty-one had left ventricular hypertrophy (LVH), 22 were overweight, and 16 had Type II diabetes mellitus. Smoking, alcohol ingestion, and sedentary habits were the same between groups. Variability in heart rate was analyzed in the time domain, using standard deviations of normal RR intervals (SDNN) and the differences between maximal brady- and tachycardia (D-BTmax) during sustained inspiration. Analysis of the frequency band of the power spectrum between 0.05 and 0.40 Hz at rest and during controlled respiration was chosen for analysis of the frequency domain. RESULTS: In both time and frequency domains, variables were lower in group II than in group I. Within groups, statistically significant variables were only found for individuals in the 40 to 59 year old group. The presence of LVH, overweight, or diabetes mellitus did not influence the variability in heart rate to a significant extent. CONCLUSION: Variability in heart rate was a valuable instrument for analyzing autonomic modulation of the heart in arterial hypertension. The autonomic system undergoes significant losses in cardio-modulatory capacity, more evident in subjects between 40 and 59 years old. In those over 60 years old, reduced variability in heart rate imposed by aging was not significantly influenced by the presence of systemic arterial hypertension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>autonomic cardiac modulation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>systemic arterial hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart rate variability</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Clinical Meaning of Ascites in Patients with Endomyocardial Fibrosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sergio Almeida Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Creusa Dal Bó</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>196-199</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the clinical meaning of ascites and the main features of patients with ascites and endomyocardial fibrosis. METHODS: We studied 166 patients with endomyocardial fibrosis (mean age 37 years, 114 women) treated over the last 20 years. Ventriculography findings, surgery or necropsy confirmed the diagnosis in all patients. Most patients belonged to New York Heart Association Functional Class III/IV (134, 83.7%). Eighty-one (50.6%) had biventricular, 28 (17.5%) had right ventricular, and 51 (31.8%) had left ventricular involvement. During follow-up, 56 patients died. RESULTS: Ascites was present in 67 (41.8%) patients, and right ventricular involvement was present in 59 (88%). In the comparison between patients with or without ascites, those with ascites had higher mortality (49.2% and 24.7%, respectively). Patients with ascites had a higher incidence of edema (95% vs. 43%), hepatomegaly (5.8cm vs. 4.1cm), mean right atrium pressure (19.3 vs. 12mmHg), and final right ventricle diastolic pressure (18.7 vs. 12.9mmHg). Also, patients with ascites had a longer history of illness (5.1 and 3.9 years, respectively) and had atrial fibrillation more frequently (44.7% vs. 30.1%). CONCLUSION: Ascites was observed in less than 50% of cases of endomyocardial fibrosis and was associated with greater involvement of the right ventricle and with a longer duration of the disease, thus being a characteristic of a worse prognosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ascites</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endomyocardial fibrosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>restrictive cardiomiopathy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Study of the Myocardial Contraction and Relaxation Velocities through Doppler Tissue Imaging Echocardiography: A New Alternative in the Assessment of the Segmental Ventricular Function</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Eduardo Suaide Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Darcy Cortez Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luciana Braz Peixoto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Claudia Gianini Monaco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Manuel Adán Gil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Juarez Ortiz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Noninvasive Heart Division  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>206-211</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Doppler tissue imaging (DTI) enables the study of the velocity of contraction and relaxation of myocardial segments. We established standards for the peak velocity of the different myocardial segments of the left ventricle in systole and diastole, and correlated them with the electrocardiogram. METHODS: We studied 35 healthy individuals (27 were male) with ages ranging from 12 to 59 years (32.9 ± 10.6). Systolic and diastolic peak velocities were assessed by Doppler tissue imaging in 12 segments of the left ventricle, establishing their mean values and the temporal correlation with the cardiac cycle. RESULTS: The means (and standard deviation) of the peak velocities in the basal, medial, and apical regions (of the septal, anterior, lateral, and posterior left ventricle walls) were respectively, in cm/s, 7.35(1.64), 5.26(1.88), and 3.33(1.58) in systole and 10.56(2.34), 7.92(2.37), and 3.98(1.64) in diastole. The mean time in which systolic peak velocity was recorded was 131.59ms (±19.12ms), and diastolic was 459.18ms (±18.13ms) based on the peak of the R wave of the electrocardiogram. CONCLUSION: In healthy individuals, maximum left ventricle segment velocities decreased from the bases to the ventricular apex, with certain proportionality between contraction and relaxation (P&lt;0.05). The use of Doppler tissue imaging may be very helpful in detecting early alterations in ventricular contraction and relaxation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Doppler tissue imaging</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Influence of Quality of Sleep on the Nocturnal Decline in Blood Pressure During Ambulatory Blood Pressure Monitoring</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre Alessi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cristiane Rodrigues Alessi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Edson Rogério Piana</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Márcia Assis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luciano Rodrigo Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cláudio L. Pereira da Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Paraná  </s1>
<s2>Curitiba PR</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>218-223</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>51</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the influence of the quality of sleep on the nocturnal physiological drop in blood pressure during ambulatory blood pressure monitoring. METHODS: We consecutively assessed ambulatory blood pressure monitoring, the degree of tolerance for the examination, and the quality of sleep in 168 patients with hypertension or with the suspected &quot;white-coat&quot; effect. Blood pressure fall during sleep associated with a specific questionnaire and an analogical visual scale of tolerance for ambulatory blood pressure monitoring were used to assess usual sleep and sleep on the day of examination. Two specialists in sleep disturbances classified the patients into 2 groups: those with normal sleep and those with abnormal sleep. RESULTS: Fifty-nine (35 %) patients comprised the abnormal sleep group. Findings regarding the quality of sleep on the day of ambulatory blood pressure monitoring as compared with those regarding the quality of sleep on a usual day were different and were as follows, respectively: total duration of sleep (-12.4±4.7 versus -42.2±14.9 minutes, P=0.02), latency of sleep (0.4±2.7 versus 17±5.1 minutes, P&lt;0.001), number of awakenings (0.1±0.1 versus 1.35±0.3 times, P&lt;0.001), and tolerance for ambulatory blood pressure monitoring (8±0.2 versus 6.7±0.35, P=0.035). An abnormal drop in blood pressure during sleep occurred in 20 (18%) patients in the normal sleep group and in 14 (24%) patients in the abnormal sleep group, P=0.53. CONCLUSION: Ambulatory blood pressure monitoring causes sleep disturbances in some patients, and a positive association between quality of sleep and tolerance for the examination was observed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ambulatory blood pressure monitoring</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sleep disturbances</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Mitral Valve Replacement and Remodeling of the Left Ventricle in Dilated Cardiomyopathy with Mitral Regurgitation: Initial Results</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Boro Puig</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fábio Antonio Gaiotto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José de Lima Oliveira Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Mirian Magalhães Pardi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fernando Bacal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Fábio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Giovanni Bellotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>224-229</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: This study evaluated the effects of a new method of mitral valve replacement on left ventricular (LV) remodeling and heart failure functional class. METHODS: Eight patients (6 men) with severe mitral regurgitation from end-stage dilated cardiomyopathy underwent surgery. Five patients were in functional class (FC) IV, 2 were in FC III and 1 was in FC III/IV. Age ranged from 33 to 63 years. Both the anterior and posterior leaflets of the mitral valve were divided into hemileaflets. The resultant 4 pedicles were displaced under traction toward the left atrium and anchored between the mitral annulus and an implanted valvular prosthesis. The beating heart facilitated ideal chordae tendineae positioning. RESULTS: All patients survived and were discharged from the hospital. After a mean follow-up period of 6.5 months (1-12 m), 5 patients were in FC I; 2 in FC I/II; and 1 in FC II. The preoperative ejection fraction ranged from 19% to 30% (mean: 25.7±3.4 %), and the postoperative ejection fraction ranged from 21% to 40% (mean: 31.1± 5.8%). Doppler echocardiography showed evidence of LV remodeling in 4 patients, including lateral wall changes and a tendency of the LV cavity to return to its elliptical shape. CONCLUSION: This technique of mitral valve replacement, involving new positioning of the chordae tendineae, allowed LV remodeling and improvement in FC during this brief follow-up period.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dilated cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular remodeling</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valve replacement</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Low Back Pain During Streptokinase Infusion</s1>
</fA08>
<fA11 dir="011000">
<s1>Ronald Feitosa Pinheiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Adriana Sanches Pedrolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcelo Nigri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Carlos de Camargo Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>233-235</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800212</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the case of a 57-year-old male patient with severe low back pain during streptokinase infusion administered to treat typical chest pain and elevation of the ST segment in the inferior wall. We reviewed the literature, emphasizing the differential diagnosis, the pathophysiology, and management of the event.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Aneurysm of the Right Atrial Appendage</s1>
</fA08>
<fA11 dir="011000">
<s1>Silvio Henrique Barberato</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Márcia Ferreira Alves Barberato</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Bianca Milanese Ávila</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sonia Perretto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Liliam do Rocio Gavazzoni Blume</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Miguel Chamma Neto</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>239-241</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800213</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Atrial aneurysms involving the free wall or atrial appendage are rare entities in cardiology practice and may be associated with atrial arrhythmias or embolic phenomena. We review the literature and report a case of aneurysm of the right atrial appendage in a young adult, whose diagnosis was established with echocardiography after an episode of paroxysmal atrial flutter.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 1/2002 - Descompensação de insuficiência cardíaca e ascite em mulher de 51 anos portadora de prótese biológica em posição mitral (Instituto do Coração do Hospital das Clínicas - FMUSP, São Paulo)</s1>
</fA08>
<fA11 dir="011000">
<s1>Guilherme Urpia Monte</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Renata Bacic Palhares</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Eduardo Vieira da Motta</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>242-248</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800214</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 2/2002 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>249-249</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800215</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Evolução da Intervenção Percutânea para o Tratamento da Doença Coronária Multiarterial</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre C. Zago</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Amanda G.M.R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Eduardo Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>250-260</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>45</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800216</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Implications of the Hemodynamic Optimization Approach Guided by Right Heart Catheterization in Patients with Severe Heart Failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Luís E. Rohde</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Thiago Furian</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Candice Campos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Andreia Biolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eneida Rabelo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Murilo Foppa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Nadine Clausell</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>261-266</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To report the hemodynamic and functional responses obtained with clinical optimization guided by hemodynamic parameters in patients with severe and refractory heart failure. METHODS: Invasive hemodynamic monitoring using right heart catheterization aimed to reach low filling pressures and peripheral resistance. Frequent adjustments of intravenous diuretics and vasodilators were performed according to the hemodynamic measurements. RESULTS: We assessed 19 patients (age = 48±12 years and ejection fraction = 21±5%) with severe heart failure. The intravenous use of diuretics and vasodilators reduced by 12 mm Hg (relative reduction of 43%) pulmonary artery occlusion pressure (P&lt;0.001), with a concomitant increment of 6 mL per beat in stroke volume (relative increment of 24%, P&lt;0.001). We observed significant associations between pulmonary artery occlusion pressure and mean pulmonary artery pressure (r=0.76; P&lt;0.001) and central venous pressure (r=0.63; P&lt;0.001). After clinical optimization, improvement in functional class occurred (P&lt; 0.001), with a tendency towards improvement in ejection fraction and no impairment to renal function. CONCLUSION: Optimization guided by hemodynamic parameters in patients with refractory heart failure provides a significant improvement in the hemodynamic profile with concomitant improvement in functional class. This study emphasizes that adjustments in blood volume result in imme-diate benefits for patients with severe heart failure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treatment</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hemodynamic optimization</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Electrocardiographic Alterations in Patients Hospitalized with Leptospirosis in the Brazilian City of Salvador</s1>
</fA08>
<fA11 dir="011000">
<s1>Edilson Sacramento</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Alberto Lopes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Everaldo Costa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Olaivio Lima Passos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Yara Aragão Costa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Eliana Dias Matos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia Faculdade de Medicina Hospital Universitário Professor Edgard Santos</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>State Health Care Authority of Bahia Hospital Couto Maia </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>267-270</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To report the frequency and types of electrocardiographic alterations in patients with leptospirosis in the first 24 hours of hospitalization. METHODS: We analyzed the electrocardiograms of 157 patients admitted to the Hospital Couto Maia in the city of Salvador, in the State of Bahia, Brazil, from March 1998 to June 1999. The electrocardiograms were performed in the first 24 hours after hospital admission, independent of the clinical manifestations of the patients. RESULTS: The mean ± SD for patients' age was 35.5± 13.7 (median = 32) years, and jaundice was present in 95.5% of them. Alterations in the electrocardiogram were detected in 68.2% (107/157) of the patients (95% confidence interval = 60.6% - 75.1%). Atrial fibrillation was the most frequent arrhythmia, occurring in 10.8% (17/157) of the patients. Other frequent findings were alterations in ventricular repolarization detected in 38.9% (61/157) of patients and first-degree atrioventricular block in 10.2% (16/157). The patients with atrial fibrillation were older and had higher levels of creatinine and aminotransferases. CONCLUSION: In this sample, approximately 2/3 of the patients had electrocardiographic alterations after hospital admission. Of the major arrhythmias, atrial fibrillation was the most frequent, and the patients with this arrhythmia had evidence of more severe disease. The relation between the presence and type of electrocardiographic alteration and the prognosis of leptospirosis is yet to be assessed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>leptospirosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>The Need for Pedagogical Qualifications for Teaching Cardiology to Undergraduate Students</s1>
</fA08>
<fA11 dir="011000">
<s1>Waldomiro Carlos Manfroi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carmen Lúcia Bezerra Machado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ana Maria Petersen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Júlia P. Spina</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Faculdade de Medicina Hospital de Clínicas de Porto Alegre</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>276-280</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To report a training program in cardiology emphasizing changes in its pedagogical practice. These changes were put into practice by some teachers at the Medical School of Porto Alegre of the University of Rio Grande do Sul (FAMED/UFRGS) aiming to make faculty and student activities more dynamic and to promote more efficacious learning. The training program is directed at 5th semester medical students and aims at a behavioral change in teachers and students to promote more interaction, to favor exchanges, and to make the teaching-learning process easier, always maintaining the patient in the center of the medical activity. METHODS: The program emphasizes the definition of general and specific objectives for each activity to be developed by the students, with training in the area of admission to the cardiology service, with special emphasis on behavioral change in the cognitive, motor, affective, and attitudinal areas. Knowledge was developed by means of interactive seminars with initial and final assessment tests to identify students' and teachers' performance. The students were evaluated in an immediate, continuous, and progressive way in their daily activities and through comparison of the results of 2 tests, one applied at the beginning of the training and the other at its end. These 2 tests contained the same questions. RESULTS: We systematically assessed 560 students over 4 years. The mean grades of the tests performed prior to and after the 244 seminars were 7.38±1.66 and 9.17± 0.82, respectively (p&lt;0.0001). For the tests applied at the beginning and at the end of the training, the mean grades were 5.61±1.61 and 9.37±0.90, respectively (p&lt;0.0001). CONCLUSION: The program proved to be efficient both for the students' learning and for assessing their performance in a systematic and objective way.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>teaching</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pedagogical references</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Study of Coronary Flow Reserve with Intravenous Use of Microbubbles (Contrast Echocardiography) and Adenosine: Protocol for Clinical Application in Patients Suspected of Having Coronary Heart Disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Morcerf</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alvaro Moraes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcia Carrinho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Hans J. F. Dohmann</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco Serviço de Ecocardiografia </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Centro de Diagnóstico Cardiovascular  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>290-298</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>80</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To test the feasibility, safety and accuracy of the adenosine protocol in the study of myocardial perfusion with microbubbles contrast echocardiography. METHODS: 81 pts (64 male, 60+11 years) were submitted to contrast echocardiography with PESDA (sonicated solution of albumin 20%-1ml, dextrose 5%-12ml and deca-fluorobutane gas-8ml) to study the myocardial perfusion at rest and after bolus injection of adenosine (6 to 18mg) and to coronary angiography within 1 month each other. For each patient 3 left ventricle perfusion beds were considered (total of 243 territories). 208 territories were analyzed and 35 territories were excluded. PESDA was continuously infused (1-2ml/min), titrated for best myocardial contrast. Triggered (1:1) second harmonic imaging was used. RESULTS: Coronary angiography showed 70 flow limiting (&gt; 75%) lesions and 138 no flow limiting lesions. At rest an obvious myocardium contrast enhancement was seen in at least 1 segment of a territory in all patients. After adenosine injection an unquestionable further increase in myocardial contrast was observed in 136 territories (99%) related to no flow limiting lesions, lasting &lt; 10 s, and a myocardial perfusion defect was detected in 68 territories (97%) related to flow limiting lesions. It was observed only 4 false results. There were no serious complications. CONCLUSION: Myocardial perfusion study with PESDA and adenosine protocol is a practical, safe and accurate method to analyze the coronary flow reserve.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial perfusion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiographic contrast</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Effect of Propafenone on the Contractile Activity of Latissimus Dorsi Muscle Isolated in an Organ Chamber: Experimental Study in Rats</s1>
</fA08>
<fA11 dir="011000">
<s1>Ricardo Simões</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eduardo Luis Guimarães Machado</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Odilon Gariglio de Alvarenga Freitas</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria da Consolação Vieira Moreira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Otoni Moreira Gomes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Cardiovascular São Francisco de Assis  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital São Francisco de Assis  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>304-308</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>51</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study the effect of propafenone on the contractile function of latissimus dorsi muscle isolated from rats in an organ chamber. METHODS: We studied 20 latissimus dorsi muscles of Wistar rats and divided them into 2 groups: group I (n=10), or control group - we studied the feasibility of muscle contractility; group II (n=10), in which the contralateral muscles were grouped - we analyzed the effect of propafenone on muscle contractility. After building a muscle ring, 8 periods of sequential 2-minute baths were performed, with intervals of preprogrammed electrical stimulation using a pacemaker of 50 stimuli/min. In group II, propafenone, at the concentration of 9.8 µg/mL, was added to the bath in period 2 and withdrawn in period 4. RESULTS: In group I, no significant depression in muscle contraction occurred up to period 5 (p&gt;0.05). In group II, a significant depression occurred in all periods, except between the last 2 periods (p&lt;0.05). Comparing groups I and II only in period 1, which was a standard period for both groups, we found no significant difference (p&gt;0.05). CONCLUSION: Propafenone had a depressing effect on the contractile function of latissimus dorsi muscle isolated from rats and studied in an organ chamber.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>skeletal muscle</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>propafenone</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiomyoplasty</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery: Report of an Adult Case</s1>
</fA08>
<fA11 dir="011000">
<s1>Celso K. Takimura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Allyson Nakamoto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Viviane T. Hotta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Monica F. Campos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mário Málamo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Roberto Otsubo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Santa Cruz  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>312-314</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the clinical findings, pathophysiology, diagnostic characteristics, and surgical repair of anomalous origin of the left coronary artery from the pulmonary artery in a 26-year-old female patient with a clinical diagnosis of coronary heart disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>A New Use for the Amplatzer Duct Occluder Device</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos A. C. Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luciano N. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlo B. Pilla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Valmir F. Fontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>318-321</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report a case in which the Amplatzer device for percutaneous occlusion of ductus arteriosus was successfully used for occluding a large systemic-pulmonary collateral vessel in a patient who had previously undergone surgery for correction of pulmonary atresia and ventricular septal defect (Rastelli technique), and was awaiting the change of a cardiac tube. In the first attempt, the device embolized to the distal pulmonary bed and, after being rescued with a Bitome, it was appropriately repositioned with no complications and with total occlusion of the vessel.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 3/2002 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>322-322</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Genetic Bases of Hypertrophic Cardiomyopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>Beatriz Piva e Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Faculdade de Medicina Hospital de Clínicas de Porto Alegre</s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>332-340</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>78</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Left Ventricular Hypertrophy Evaluation in Obese Hypertensive Patients: Effect of Left Ventricular Mass Index Criteria</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo Cantoni Rosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valdir Ambrósio Moysés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ricardo Cintra Sesso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Frida Liane Plavnik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fernando Flexa Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Nárcia E. B. Kohlmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Artur Beltrame Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Maria Tereza Zanella</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Osvaldo Kohlmann Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Kidney and Hypertension Hospital Division of Nephrology</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>347-351</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>46</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE: To evaluate left ventricular mass (LVM) index in hypertensive and normotensive obese individuals. METHODS: Using M mode echocardiography, 544 essential hypertensive and 106 normotensive patients were evaluated, and LVM was indexed for body surface area (LVM/BSA) and for height² (LVM/h²). The 2 indexes were then compared in both populations, in subgroups stratified according to body mass index (BMI): &lt;27; 27-30;  &gt; or =  30kg/m². RESULTS: The BSA index does not allow identification of significant differences between BMI subgroups. Indexing by height² provides significantly increased values for high BMI subgroups in normotensive and hypertensive populations. CONCLUSION: Left ventricular hypertrophy (LVH) has been underestimated in the obese with the use of LVM/BSA because this index considers obesity as a physiological variable. Indexing by height² allows differences between BMI subgroups to become apparent and seems to be more appropriate for detecting LVH in obese populations.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>essential hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>obesity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular mass index</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Pharmacological Therapy for Myocardial Infarction in the Elderly: An 8-year Analysis</s1>
</fA08>
<fA11 dir="011000">
<s1>Márcia Regina Pinho Makdisse</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Andrea de M. Matsushita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Iran Gonçalves Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Odete Miranda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ana Cristina Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Monica M. Cartocci</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Silvia Covre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Antonio Carlos de Camargo Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>369-373</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>50</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE :To assess the changes in the medicamentous treatment of elderly patients hospitalized with acute myocardial infarction occurring over an 8-year period. METHODS :We retrospectively analyzed 379 patients above the age of 65 years with acute myocardial infarction who were admitted to the coronary unit of a university-affiliated hospital from 1990 to 1997. The patients were divided into 2 groups, according to the period of time of hospital admission as follows: group 1 - from 1990 to 1993; and group 2 - from 1994 to 1997. RESULTS :The use of beta-blockers (40.8%chi 75.2%, p&lt;0.0001) and angiotensin-converting enzyme inhibitors (42% chi59.5%, p=0.001) was significantly greater in group 2, while the use of calcium antagonists (42% chi 18.5%, p&lt;0.0001) and general antiarrhythmic drugs (19.1% chi 10.8%, p=0.03) was significantly lower. No significant difference was observed in regard to the use of acetylsalicylic acid, thrombolytic agents, nitrate, and digitalis in the period studied. The length of hospitalization was shorter in group 2 (13.4&amp;plusmn;8.9 days chi 10.5&amp;plusmn;7.5 days, p&lt;0.001). The in-hospital mortality was 35.7% in group 1 and 26.6% in group 2 (p=0.07). CONCLUSION : Significant changes were observed in the treatment of elderly patients with acute myocardial infarction, with a greater use of beta-blockers and angiotensin-converting enzyme inhibitors and a lower use of calcium antagonists and antiarrhythmic drugs in group 2. The length of hospitalization and the mortality rate were also lower in group 2, even though the reduction in mortality was not statistically significant.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treatment</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Assessment of Thromboembolism After the Cox-Maze Procedure for Chronic Atrial Fibrillation Secondary to Mitral Valve Lesion</s1>
</fA08>
<fA11 dir="011000">
<s1>Renato A. K. Kalil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paula L. M. Nesralla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gustavo G. Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Tiago L. Leiria</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rogério Abrahão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paulo Moreno</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Paulo R. Prates</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>João R. M. Sant'Anna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Ivo A. Nesralla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>378-381</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the occurrence of late thromboembolism after surgical repair of chronic atrial fibrillation (AF) simultaneously with repair of mitral valve using the Cox-Maze procedure. METHODS: 69 patients underwent Cox 3 procedure, with no cryoablation simultaneously with mitral valvuloplasty or prosthesis. Mean age was 49.9&amp;plusmn;13.2 years. Mean follow-up was of 31.7&amp;plusmn;19 months. Types of lesion were as follows: 33 (48%) stenoses, 23 (33%) insufficiencies, and 13 (19%) double lesions. Procedures were: 64 (93%) valvuloplasties, 3 (4%) biological and 2 (3%) mechanical prosthesis placement. There were 9 (13%) patients with previous systemic embolism and 2 (3%) had left atrial thrombi. RESULTS: Early mortality was 7% and late 1%. 2 patients (3%) were reoperated for mitral placement. At last evaluation, 10 patients (15%), were in AF. The remaining 59 (85%) were either in sinus / atrial rythm (74%) or under pacing (12%). There were no occurrence of early or late, systemic or pulmonary embolism. Permanent anticoagulation was employed in 16 cases, 10 in regular rythm and 6 in AF. The remaining 47 (75%), 2 in AF and 45 in regular rythm, did not receive anticoagulants. CONCLUSIONS: These results are in accordance with others series, where the occurrence of embolism was rare after maze procedure. Permanent systemic anticoagulation seems to be unnecessary in those cases.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thromboembolism</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valve surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Heart Weight and Heart Weight/Body Weight Coefficient in Malnourished Adults</s1>
</fA08>
<fA11 dir="011000">
<s1>Daniel Ferreira da Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Selma Freire de Carvalho da Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marlene Antônia dos Reis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Vicente de Paula Antunes Teixeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina do Triângulo Mineiro  </s1>
<s2>Uberaba </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>385-387</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To compare the heart weight and the heart weight/body weight coefficient of adults with and without chronic malnutrition. METHODS: In an initial case series of 210 autopsies performed in adults, we recorded body and heart weights and calculated the heart weight/body weight coefficients (HW/BW x 100). The exclusion criteria were as follows: positive serology for Chagas' disease, edema, obesity, heart diseases, hepatopathies, nephropathies, and systemic arterial hypertension. Malnutrition was characterized as a body mass index &lt;18.5kg/m². Differences with p&lt;0.05 were considered significant. RESULTS: Individuals in the malnourished (n=15) and control (n=21) groups were statistically different, respectively, in regard to body mass index (15.9&amp;plusmn;1.7 versus 21.3&amp;plusmn;2.5kg/m²), heart weight (267.3&amp;plusmn;59.8 versus 329.1&amp;plusmn;50.4g), and the HW/BW coefficient (0.64&amp;plusmn;0.12 versus 0.57&amp;plusmn;0.09%). A positive and significant correlation was observed between heart weight and body mass index (r=0.52), and between heart weight and body weight (r=0.65). CONCLUSION: Malnourished individuals have lighter hearts and a greater HW/BW coefficient than non-malnourished individuals do. These findings indicate a possible preservation of the myocardium in relation to the intensity of weight loss associated with the probable relative increase in cardiac connective tissue and heart blood vessels.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac hypotrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nutrition</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>protein-calorie malnutrition</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Acute Myocardial Infarction: The First Manifestation of Ischemic Heart Disease and Relation to Risk Factors</s1>
</fA08>
<fA11 dir="011000">
<s1>Waldomiro Carlos Manfroi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carolina Peukert</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Clarissa Bacha Berti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Clarissa Noer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Danielle de Ávila Gutierres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Felipe Theodoro Bezerra Gaspar Carvalho da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>392-395</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the association between cardiovascular risk factors and acute myocardial infarction as the first manifestation of ischemic heart disease, correlating them with coronary angiographic findings. METHODS: We carried out a cross-sectional study of 104 patients with previous acute myocardial infarction, who were divided into 2 groups according to the presence or absence of angina prior to acute myocardial infarction. We assessed the presence of angina preceding acute myocardial infarction and risk factors, such as age &gt;55 years, male sex, smoking, systemic arterial hypertension, lipid profile, diabetes mellitus, obesity, sedentary lifestyle, and familial history of ischemic heart disease. On coronary angiography, the severity of coronary heart disease and presence of left ventricular hypertrophy were assessed. RESULTS: Of the 104 patients studied, 72.1% were males, 90.4% were white, 73.1% were older than 55 years, and 53.8% were hypertensive. Acute myocardial infarction was the first manifestation of ischemic heart disease in 49% of the patients. The associated risk factors were systemic arterial hypertension (RR=0.19; 95% CI=0.06-0.59; P=0.04) and left ventricular hypertrophy (RR=0.27; 95% CI=0,.8-0.88; P=0.03). The remaining risk factors were not statistically significant. CONCLUSION: Prevalence of acute myocardial infarction as the first manifestation of ischemic heart disease is high, approximately 50%. Hypertensive individuals more frequently have symptoms preceding acute myocardial infarction, probably due to ventricular hypertrophy associated with high blood pressure levels.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Clinical Profile, Predictors of Mortality, and Treatment of Patients after Myocardial Infarction, in an Academic Medical Center Hospital</s1>
</fA08>
<fA11 dir="011000">
<s1>Leonardo A. M. Zornoff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sérgio A. R. Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vanessa M. Assalin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Patrícia M. S. Pola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luís E. Becker</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marina P. Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Luiz S. Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Roberto M. T. Inoue</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Joel Spadaro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual Paulista Faculdade de Medicina de Botucatu </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>401-405</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate clinical profiles, predictors of 30-day mortality, and the adherence to international recommendations for the treatment of myocardial infarction in an academic medical center hospital. METHODS: We retrospectively studied 172 patients with acute myocardial infarction, admitted in the intensive care unit from January 1992 to December 1997. RESULTS: Most patients were male (68%), white (97%), and over 60 years old (59%). The main risk factor for coronary atherosclerotic disease was systemic blood hypertension (63%). Among all the variables studied, reperfusion therapy, smoking, hypertension, cardiogenic shock, and age were the predictors of 30-day mortality. Most commonly used medications were: acetylsalicylic acid (71%), nitrates (61%), diuretics (51%), angiotensin-converting enzyme inhibitors (46%), thrombolytic therapy (39%), and beta-blockers (35%). CONCLUSION: The absence of reperfusion therapy, smoking status, hypertension, cardiogenic shock, and advanced age are predictors of 30-day mortality in patients with acute myocardial infarction. In addition, some medications that are undoubtedly beneficial have been under-used after acute myocardial infarction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treatment</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Nonrespiratory Sinus Arrhythmia</s1>
</fA08>
<fA11 dir="011000">
<s1>José Barbosa Filho</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Roberto B. Barbosa</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ivan Cordovil</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Nacional de Cardiologia Laranjeiras  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Ministério da Saúde  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Universidade Gama Filho  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>409-411</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>5</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report here 2 cases of sinus arrhythmia considered to be a form of nonrespiratory sinus arrhythmia because they did not have variances in the RR interval sequence within the oscillations modulated by respiration. Because the patients had pulsus alternans similar that observed in bigeminy, and because they did not have signs or symptoms of heart failure, we believe the arrhythmias represent intrinsic alterations of the electric activity of the sinus node</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Concomitant Use of Glycoprotein IIb/IIIa Inhibitor and Streptokinase after Unsuccessful Rescue Angioplasty</s1>
</fA08>
<fA11 dir="011000">
<s1>José Marconi Almeida de Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leonardo Severino</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ederlon de Carvalho Rezende</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jairon Nascimento Alencar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Valter Correia de Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>João Lourenço V. Hermann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>416-419</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A 38-year-old man with acute myocardial infarction in the lower wall affecting the right ventricle underwent thrombolytic treatment with streptokinase. Approximately 2 hours after the thrombolytic treatment started, he presented with signs of coronary reocclusion. He underwent emergency cineangiocoronariography that revealed that his right coronary artery was completely occluded by a clot. He unsuccessfully underwent angioplasty and stent implantation. After the concomitant use of glycoprotein IIb/IIIa inhibitor, coronary TIMI III flow was achieved without additional dilations, and he was discharged from the hospital 5 days later with no further complications.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 2/2002 - Homem de 60 anos, normotenso, apresentando confusão mental, dor torácica e alargamento de mediastino</s1>
</fA08>
<fA11 dir="011000">
<s1>Otavio Martucci</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gustavo Loureiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Osvaldo Teixeira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Aparecida Barone Teixeira</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>420-423</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 4/2002 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>424-424</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Alternate Angiotensin II-Forming Pathways and Their Importance in Physiological or Physiopathological Conditions</s1>
</fA08>
<fA11 dir="011000">
<s1>Micheline Monteiro de Resende</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Geraldo Mill</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Espírito Santo Centro Biomédico Department of Physiological Sciences</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>432-438</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>67</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800412</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Letter to the Editor</s1>
</fA08>
<fA11 dir="011000">
<s1>Hurkan Kursaklioglu</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Atila Iyisoy</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ertan Demirtas</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>439-439</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800413</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Analysis of the Prevalence of Ventricular Late Potentials in the Late Phase of Myocardial Infarction Based on the Site of Infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Roberto Benchimol Barbosa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcos Oliveira de Sousa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Eduardo Correa Barbosa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alfredo de Souza Bomfim</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Ginefra</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Jurandir Nadal</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual do Rio de Janeiro Hospital Universitário Pedro Ernesto </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal do Rio de Janeiro Instituto Luiz Alberto Coimbra de Pós-Graduação em Engenharia </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>358-363</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: The initial site of myocardial infarction (MI) may influence the prevalence of ventricular late potentials (VLP), high-frequency signals, due to the time course of ventricular activation. The prevalence of VLP in a period of more than 2 years after acute MI was assessed focusing on the initially injured wall . METHODS: The prevalence of VLP in a late phase after MI (median of 924 days) in anterior/antero-septal and inferior/infero-dorsal wall lesion was analyzed using signal-averaged electrocardiogram in time domain. The diagnostic performance of the filters employed for analysis on was tested at high-pass cut-off frequencies of 25 Hz, 40 Hz and 80 Hz. RESULTS: The duration of the ventricular activation and its terminal portion were larger in inferior than anterior infarction, at high-pass cut-off frequencies of 40 Hz and 80 Hz. In patients with ventricular tachycardia, these differences were more remarked. The prevalence of ventricular late potentials was three times greater in inferior than anterior infarction. CONCLUSION: Late after myocardial infarction, the prevalence and the duration of ventricular late potentials are greater in lesions of inferior/infero-dorsal than anterior/antero-septal wall confirming their temporal process, reflecting their high-frequency content.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>signal-averaged electrocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular arrhythmia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Dear Dr. Kursaklioglu and colleagues</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz A. Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>440-440</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800414</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretrizes para Cardiologistas sobre Excesso de Peso e Doença Cardiovascular dos Departamentos de Aterosclerose, Cardiologia Clínica e FUNCOR da Sociedade Brasileira de Cardiologia</s1>
</fA08>
<fA11 dir="011000">
<s1>Raul D. Santos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sérgio Timerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Andrei C. Spósito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alfredo Halpern</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Adriano Segal</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Artur Beltrame Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Artur Garrido</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Charles Mady</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Fábio Fernandes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Geraldo Lorenzi Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>José Antônio F. Ramires</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Maria Teresa Zanela</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Max Grinberg</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Márcio Mancini</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>01-13</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>II Diretrizes da Sociedade Brasileira de Cardiologia Sobre Teste Ergométrico</s1>
</fA08>
<fA11 dir="011000">
<s1>Jadelson Andrade</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fábio Sândoli de Brito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fábio Vilas-Boas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Iran Castro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Japy Angelin de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ricardo Stein</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Álvaro Bellini</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Antônio Felipe Simão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Artur Herdy</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Fábio Vilas-Boas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Japy Angelin Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Paulo Toscano</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Ricardo Coutinho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Ricardo Stein</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>Augusto Heitor Xavier de Brito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>Heloísa Borges</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>Luís Eduardo Mastrocolla</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>Nabyl Ghorayeb</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="201000">
<s1>Ricardo Vivacqua</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="211000">
<s1>Maurício Nunes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="221000">
<s1>Milton Godoy</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="231000">
<s1>Salvador Serra</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="241000">
<s1>Roberto Alfieri</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="251000">
<s1>Jorge Pinto Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="261000">
<s1>Salvador Ramos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="271000">
<s1>Washington Araújo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="281000">
<s1>José Nolasco</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="291000">
<s1>Romeu Sérgio Meneghello</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="301000">
<s1>William Chalela</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="311000">
<s1>Claudio Gil S. Araújo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="321000">
<s1>Paulo Yazbeck</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="331000">
<s1>Claudio Gil Soares Araújo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="341000">
<s1>Marianna Andrade</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>01-17</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>I Diretrizes do Grupo de Estudos em Cardiogeriatria da Sociedade Brasileira de Cardiologia</s1>
</fA08>
<fA11 dir="011000">
<s1>Roberto Alexandre Franken</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cláudia F. Gravina Taddei</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ivan Gonçalves Maia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Michel Batlouni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>J.Eduardo Moraes Rego Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maurício Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Gilson Soares Feitosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Adalberto Lorga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Angelo de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Argemiro Scatolini Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Cidio Halperin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Dalmo Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="131000">
<s1>Denise Hachul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="141000">
<s1>Felicio Savioli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="151000">
<s1>Jacob Atiê</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="161000">
<s1>Rubens Gagliardi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="171000">
<s1>Alvaro Avezum</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="181000">
<s1>Edimar A. Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="191000">
<s1>Hans J. F. Dohmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="201000">
<s1>Ilnei Pereira Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="211000">
<s1>J. Francisco Kerr Saraiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="221000">
<s1>Luis C. Bodanese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="231000">
<s1>Marcelo Garcia Leal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="241000">
<s1>Abrahão Afiune Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="251000">
<s1>Alberto Libberman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="261000">
<s1>Amanda G. M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="271000">
<s1>Antonio Carlos S. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="281000">
<s1>Bruno Caramelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="291000">
<s1>Roberto R.C. Geraldez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="301000">
<s1>Airton P. Brandão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="311000">
<s1>Brivaldo Markman Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="321000">
<s1>Celso Amodeo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="331000">
<s1>Celso Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="341000">
<s1>João Souza Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="351000">
<s1>J Eduardo Siqueira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="361000">
<s1>Iran Gonçalves Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="371000">
<s1>Marcia P. Makdisse</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="381000">
<s1>Rafael L Luna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="391000">
<s1>Ronaldo F. Rosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="401000">
<s1>Carlos de Camargo Luis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="411000">
<s1>Elizabete Viana Freitas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="421000">
<s1>Flávio Tarasoutchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="431000">
<s1>Humberto Pierri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="441000">
<s1>Silvio Carlos de M. Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="451000">
<s1>Zilda M. Meneghello</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="461000">
<s1>Carlos C. Magalhães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="471000">
<s1>Fabio Nasri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="481000">
<s1>Iseu Gus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="491000">
<s1>Jairo Borges</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="501000">
<s1>João Batista Serro Azul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="511000">
<s1>José M. Aldrighi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="521000">
<s1>Nabil Ghorayeb</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="531000">
<s1>Stela Maris Grespan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Sociedade Brasileira de Cardiologia Grupo de Estudos em Cardiogeriatria </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-46</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Prevalence of Cardiac Arrhythmias During and After Pregnancy in Women with Chagas' Disease without Apparent Heart Disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Renato Enrique Sologuren Achá</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marco Túlio Oliveira Rezende</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rimmel Amador Guzmán Heredia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Aguinaldo Coelho da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Elmiro Santos Rezende</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cleber Augusto Oliveira Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Uberlândia Hospital de Clínicas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>5-9</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate cardiac arrhythmias during and after pregnancy in women with Chagas' disease without apparent heart disease using dynamic electrocardiography. METHODS: Twenty pregnant women with Chagas' disease without apparent heart disease aged 19 to 42 years (26.96 ± 3.6) and a control group of 20 non-chagasic pregnant patients aged 16 to 34 years (22.5 ± 4.8). The patients were submitted to passive hemagglutination and indirect immunofluorescence for the detection of Trypanosoma cruzi evaluation, and electrocardiography, echocardiography and 24-h dynamic electrocardiography. RESULTS: Supraventricular premature depolarizations were observed in 18 (90%) patients and ventricular premature depolarization in 11 (55%) patients of both groups during pregnancy. After delivery, supraventricular premature depolarizations were present in 13 (60%) chagasic patients and in 16 (89.4%) control patients (P&lt;=0.05). Ventricular premature depolarization were observed in 9 (45%) chagasic patients and 11 (57.8%) control patients. CONCLUSION: The prevalence of ventricular premature depolarization was similar for the chagasic and control groups during and after pregnancy. The incidence of supraventricular premature depolarizations was similar in the two groups during pregnancy, while after delivery a predominance was observed in the control group compared to the chagasic group.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas'disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pregnancy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arrhythmia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Correlations Between the Collagen Content of the Human Left Ventricular Myocardium, Measured by Biochemical and Morphometric Methods</s1>
</fA08>
<fA11 dir="011000">
<s1>José Duarte de Morais Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roseli Aparecida da Silva Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Valdemar Hial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Isabel Cristina Rezende Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marlene Antônia dos Reis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Vicente de Paula Antunes Teixeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina do Triângulo Mineiro  </s1>
<s2>Uberaba </s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>15-19</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess, in myocardium specimens obtained from necropsies, the correlation between the concentration of hydroxyproline, measured with the photocolorimetric method, and the intensity of fibrosis, determined with the morphometric method. METHODS: Left ventricle myocardium samples were obtained from 45 patients who had undergone necropsy, some of them with a variety of cardiopathies and others without any heart disease. The concentrations of hydroxyproline were determined with the photocolorimetric method. In the histologic sections from each heart, the myocardial fibrosis was quantified by using a light microscope with an integrating ocular lens. RESULTS: A median of, respectively, 4.5 and 4.3 mug of hydroxyproline/mg of dry weight was found in fixed and nonfixed left ventricle myocardium fragments. A positive correlation occurred between the hydroxyproline concentrations and the intensity of fibrosis, both in the fixed (Sr=+0.25; p=0.099) and in the nonfixed (Sr=+0.32; p=0.03) specimens. CONCLUSION: The biochemical methodology was proven to be adequate, and manual morphometry was shown to have limitations that may interfere with the statistical significance of correlations for the estimate of fibrosis intensity in the human myocardium.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hydroxyproline</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>morphometry</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Comparison between Adventitial and Intimal Inflammation of Ruptured and Nonruptured Atherosclerotic Plaques in Human Coronary Arteries</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria L. Higuchi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo S. Gutierrez</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Hiram G. Bezerra</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Suely A. Palomino</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Vera D. Aiello</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Júlia M. L. Silvestre</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Peter Libby</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>José A. F. Ramires</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>University of São Paulo Medical School Heart Institute</s1>
<s2>São Paulo </s2>
<s3>Brazil</s3>
</fA14>
<fA14 dir="020000">
<s1>Brigham and Women's Hospital Cardiovascular Division </s1>
<s2>Boston MA</s2>
<s3>USA</s3>
</fA14>
<fA20 dir="000000">
<s1>20-24</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To verify the possible role of adventitial inflammation in atherosclerotic plaque vulnerability and coronary artery remodelling. METHODS: We compared the mean numbers of lymphocytes in the adventitia and in the plaque of ruptured thrombosed and stable equi-stenotic coronary segments of 34 patients who died due to acute myocardial infarction. We also analysed adventitial microvessels, adventitial fibrosis and the external elastic membrane. RESULTS: In the adventitia, the numbers of lymphocytes and microvessels/mm² were 69.5±88.3 and 60.9± 32.1 in culprit lesions and 16.4 ± 21.1 and 44.3±16.1 in stable lesions (p&lt;0.05); within the plaques, the mean number of lymphocytes was 24±40.8 in culprit lesions and 10.9±13.2 in stable ones (p=0.17). The mean percent area of adventitial fibrosis/cross-sectional area of the vessel was significantly lower in unstable plaques (p&lt;0.001). The confocal images showed holes in the external elastic membrane. CONCLUSION: Unstable plaques exhibit chronic pan-arteritis, accompanied by enlargement, medial thinning, and less fibrosis than in stable lesions, which is compatible with vessel aneurysm. Adventitial inflammation may contribute significantly to atheroma instability.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>unstable plaques</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arteritis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aneurysm</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adventitial inflammation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Percutaneous Stent Implantation for Treating Multivessel Coronary Disease in Patients with and without Involvement of the Proximal Segment of the Anterior Descending Coronary Artery</s1>
</fA08>
<fA11 dir="011000">
<s1>Sandro Salgueiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Augusto Daige da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ricardo José Tofano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Vinicius Carvalho da Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Karina Pizarro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Adnan Ali Salman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Armando Mangione</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Real e Benemérita Sociedade Portuguesa de Beneficência de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>30-34</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess coronary stent placement in patients with multivessel coronary disease and involvement of the proximal portion of the anterior descending coronary artery. METHODS: We retrospectively analyzed the in-hospital and late evolution of 189 patients with multivessel coronary disease, who underwent percutaneous coronary stent placement. These patients were divided into 2 groups as follows: group I (GI) - 59 patients with involvement of the proximal segment of the anterior descending coronary artery; and group II (GII) - 130 patients without involvement of the proximal segment of the anterior descending coronary artery. RESULTS: No significant difference was observed in the success rate of the procedure (91.5% versus 97.6%, p=0.86), nor in the occurrence of major adverse cardiac events (5.1% versus 1.5%, p=0.38), nor in the occurrence of major vascular complications (1.7% versus 0%, p=0.69) in the in-hospital phase. In the late follow-up, the incidence of major adverse cardiac events (15.4% versus 13.7%, p=0.73) and the need for new revascularization (13.5% versus 10.3%, p=0.71) were similar for both groups. CONCLUSION: The in-hospital and late evolution of patients with multivessel coronary disease with and without involvement of the proximal segment of the anterior descending coronary artery treated with coronary stent placement did not differ. This suggests that this revascularization method is an effective procedure and a valuable option for treating these types of patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>multivessel coronary disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stent</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>anterior descending coronary artery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Assessment of the Cardiovascular Risk and Physical Activity of Individuals Exercising at a Public Park in the City of São Paulo</s1>
</fA08>
<fA11 dir="011000">
<s1>Cláudia L. M. Forjaz</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Taís Tinucci</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Teresa Bartholomeu</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Tiago E. M. Fernandes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Vivian Casagrande</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Geraldo Massucato</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Escola de Educação Física e Esporte </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Parque Fernando Costa  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>43-50</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Physical exercise helps to prevent cardiovascular disorders. Campaigns promoting exercise have taken many people to the parks of our city. The most appropriate exercise for preventing cardiovascular disorders is the aerobic modality; inappropriate exercise acutely increases cardiovascular risk, especially in individuals at higher risk. Therefore, assessing the cardiovascular risk of these individuals and their physical activities is of practical value. METHODS: In the Parque Fernando Costa, we carried out the project &quot;Exercício e Coração&quot; (Exercise and Heart) involving 226 individuals. Assessment of the cardiovascular risk and of the physical activity practiced by the individuals exercising at that park was performed with a questionnaire and measurement of the following parameters: blood pressure, weight, height, and waist/hip ratio. The individuals were lectured on the benefits provided by exercise and how to correctly exercise. Each participant received a customized exercise prescription. RESULTS: In regard to risk, 43% of the individuals had health problems and 7% of the healthy individuals had symptoms that could be attributed to heart disorders. High blood pressure was observed in a large amount of the population. In regard to the adequacy of the physical activity, the individuals exercised properly. The project was well accepted, because the participants not only appreciated the initiative, but also reported altering their exercise habits after taking part in the project. CONCLUSION: Data obtained in the current study point to the need to be more careful in assessing the health of individuals who exercise at parks, suggesting that city parks should have a sector designated for assessing and guiding physical activity.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular risk</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>public park</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Late Clinical Outcomes of the Fontan Operation in Patients with Tricuspid Atresia</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo T. Mastalir</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Renato A. K. Kalil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Estela S. K. Horowitz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Orlando Wender</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>João R. Sant'Anna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paulo R. Prates</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ivo A. Nesralla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>56-60</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Evaluation of the long-term clinical results of the Fontan operation in patients with tricuspid atresia. METHODS: A retrospective analysis was made at the Instituto de Cardiologia do Rio Grande do Sul (Institute of Cardiology of Rio Grande do Sul), from August 1980 through January 2000, of 25 patients with a long-term follow-up, out of a series of 36 patients who underwent the Fontan operation or one of its variants due to tricuspid atresia. Their mean age at surgery was 5.4±3.1 years, and their mean weight was 15.8±6.1 kg, the majority of them (63.9%) being males. Four patients underwent the classical Fontan operation, 12 the Kreutzer variant, 6 the Björk variant, 9 total cavopulmonary shunt with a fenestrated tube, and 5 total cavopulmonary shunt with a nonfenestrated tube. RESULTS: The patients were followed-up on an outpatient basis, with a mean long-term survival time of 5.5±4.2 years (50 days to 17.8 years) and a late mortality rate of 8%. Arterial saturation increased from 77.2±18.8% in the preoperative period to 91±6.7% upon the last outpatient visit (p&gt;0.05). At the final check, most (67%) patients were asymptomatic and 87% could tolerate exercise. Ten (40%) patients experienced some kind of complication during the long-term follow-up, such as cardiac arrhythmia, cyanosis, protein-losing enteropathy, neurological events, right heart failure, intolerance to exercise and reoperation. CONCLUSION: The results indicate that, once the immediate postoperative period is over, during which the adaptations to the new circulatory physiology occur, the evolution of patients with tricuspid atresia who underwent the Fontan operation is satisfactory, in spite of a low, yet significant, morbidity.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Fontan</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tricuspid atresia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cavopulmonary shunt</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Body Mass Index: A Scientific Evidence-Based Inquiry</s1>
</fA08>
<fA11 dir="011000">
<s1>Djalma Rabelo Ricardo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Claudio Gil Soares de Araújo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Gama Filho  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Clínica de Medicina do Exercício  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>70-78</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>66</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTVE: To objectively and critically assess body mass index and to propose alternatives for relating body weight and height that are evidence-based and that eliminate or reduce the limitations of the body mass index. METHODS: To analyze the relations involving weight and height, we used 2 databases as follows: 1) children and adolescents from Brazil, the United States, and Switzerland; and 2) 538 university students. We performed mathematical simulations with height data ranging from 115 to 190 cm and weight data ranging from 25 to 105 kg. We selected 3 methods to analyze the relation of weight and height as follows: body mass index - weight (kg)/height (m²); reciprocal of the ponderal index - height (cm)/weight1/3 (kg); and ectomorphy. Using the normal range from 20 to 25 kg/m² for the body mass index in the reference height of 170 cm, we identified the corresponding ranges of 41 to 44 cm/kg1/3 for the reciprocal of the ponderal index, and of 1.45 to 3.60 for ectomorphy. RESULTS: The mathematical simulations showed a strong association among the 3 methods with an absolute concordance to a height of 170 cm, but with a tendency towards discrepancy in the normal ranges, which had already been observed for the heights of 165 and 175 cm. This made the direct convertibility between the indices unfeasible. The reciprocal of the ponderal index and ectomorphy with their cut points comprised a larger age range in children and adolescents and a wider and more central range in the university students, both for the reported (current) and desired weights. CONCLUSION: The reciprocal of the ponderal index and ectomorphy are stronger and are more mathematically logical than body mass index; in addition, they may be applied with the same cut points for normal from the age of 5 ½ years on.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>body mass index</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ectomorphy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>reciprocal of the ponderal index</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Supravalvular Congenital Mitral Stenosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Moraes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cleuza Lapa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cristina Ventura</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rejane Santana</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Euclides Tenório</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Claudio Gomes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Carlos R. Moraes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Real Hospital Português Instituto do Coração de Pernambuco </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>InstitutoMaterno Infantil de Pernambuco  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>82-84</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Congenital supravalvular mitral stenosis is a rare malformation characterized by the presence of a shelf-like fibrous membrane, with 1 or 2 small orifices, covering and obstructing the mitral valve. The membrane is positioned closely to the mitral valve (and sometimes it is attached to it); therefore, a preoperative diagnosis is inevitably difficult, even with the use of biplane echocardiography. Two patients with supravalvular mitral stenosis aged 3 years and 3 months are described. In 1 patient, a preoperative diagnosis was made, and both successfully underwent correction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Cardiac Damage from Chronic Use of Chloroquine: A Case Report and Review of the Literature</s1>
</fA08>
<fA11 dir="011000">
<s1>Ricardo Alkmim Teixeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Martino Martinelli Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz Alberto Benvenuti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Roberto Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Anísio A. Pedrosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Silvana A. D. Nishióka</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>University of São Paulo Medical School Heart Institute</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>85-88</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Chloroquine has been widely used in rheumatological treatment, but potential severe side effects require careful follow-up. Cardiac damage is not a common consequence, but its clinical relevance has not yet been described. We report the case of a 58-year-old woman with rheumatoid arthritis, in whom chronic chloroquine use resulted in major irreversible cardiac damage. She presented with syncopal episodes due to complete atrioventricular block confirmed by electrophysiological study whose changes were concluded to be irreversible and a permanent pacemaker was indicated. Endomyocardial biopsy was also performed to search for histopathological and ultrastructural cardiac damage. We also reviewed the 22 cases of chloroquine-induced cardiopathy described to date as well as its pathophysiology.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>O Coração</s1>
</fA08>
<fA11 dir="011000">
<s1>Marina Politi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vitalino Dal Pai</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNESP Faculdade de Medicina de Botucatu </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>89-89</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="">
<s1></s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>90-90</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900111</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Teste Ergométrico Imediato em Pacientes com Dor Torácica na Sala de Emergência</s1>
</fA08>
<fA11 dir="011000">
<s1>Josiane de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Waldomiro Carlos Manfroi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carisi Anne Polanczyk</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>91-96</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900112</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Prevalence of Chagas' Disease in Mulungu do Morro Northeastern Brazil</s1>
</fA08>
<fA11 dir="011000">
<s1>Roque Aras</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marielza Veiga</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Irênio Gomes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Gildo Mota</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Bernardo Rodrigues</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rosângela Rabelo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Carmen Guzman-Bracho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Ailton Melo</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>441-443</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - The aim of this paper is to describe the prevalence of T. Cruzi infection in patients of from Mulungu do Morro, a rural tropical region of Northeastern Brazil. METHODS - A cross-sectional study was performed. After randomly selecting samples of the population, and obtaining their consents , patients completed pretested epidemiological and clinical questionnaires. Serum samples from all patients were collected and screened for the presence of T. cruzi antibodies. RESULTS - Of 694 patients examined, 174 patients (25.1%) tested had a positive serology for Chagas' disease. Of the study population, 341 patients were male with 27% Chagas' disease prevalence, without a statistical difference. Illiteracy was the only variable related to T. cruzi infection in our population. CONCLUSION - In conclusion, our study points to the high prevalence of Chagas' disease among patients in Mulungu do Morro, suggesting that this region has a high frequency of infection and probably active vectorial transmission.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prevalence</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>trypanosomiasis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Friedreich's Ataxia: Cardiac Evaluation of 25 Patients with Clinical Diagnosis and Literature Review</s1>
</fA08>
<fA11 dir="011000">
<s1>Lilian Maria José Albano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Silvana Angelina Dório Nishioka</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Regina Lucia Moysés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jaqueline Wagenführ</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Débora Bertola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sofia Mizuho Miura Sugayama</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>A. Kim Chong</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>448-451</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - Cardiac evaluation (clinical, electrocardiographic and echocardiographic) of 25 Brazilian patients with clinical diagnosis of Friedreich's ataxia (FA) related to the frequency and the size of GAA repeats (unstable expansion of trinucleotide repeats that results in the disease). METHODS - Clinical and cardiac study including electrocardiogram and echocardiogram of all patients and molecular analysis to detect the frequency and the size of GAA expansion, by polymerase chain reaction analysis. RESULTS - Homozygous GAA expansion was detected in 17 patients (68%) -- all typical cases. In 8 (32%) cases (6 atypical and 2 typical), no GAA expansion was observed, therefore it was not considered Friedreich's ataxia. All patients with GAA expansion (100%) had electrocardiographic abnormalities, and only 25% of the cases without GAA expansion had some abnormality on this exam. However, only 6% of all patients revealed some signals/symptoms suggestive of cardiac involvement. CONCLUSION - A molecular analysis is essential to confirm the diagnosis of Friedreich's ataxia; however, an adequate cardiac evaluation, including an electrocardiogram, was extremely useful to better screening the patients which should perform these molecular analysis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Friedreich's ataxia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac abnormalities</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertrophic cardiomyopathy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Consequences of the Prolonged Waiting Time for Patients Candidates for Heart Surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Nagib Haddad</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Olímpio J. N. V. Bittar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ana A. M. Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Barbosa da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Vivian L. Amato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Pedro S. Farsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Auristela I. O. Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Marcelo Sampaio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Tarcísio L. V. Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Dikran Armaganijan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>José Eduardo M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Secretaria de Saúde do Estado de São Paulo Instituto Dante Pazzanese de Cardiologia </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>459-465</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To assess mortality and the psychological repercussions of the prolonged waiting time for candidates for heart surgery. METHODS - From July 1999 to May 2000, using a standardized questionnaire, we carried out standardized interviews and semi-structured psychological interviews with 484 patients with coronary heart disease, 121 patients with valvular heart diseases, and 100 patients with congenital heart diseases. RESULTS - The coefficients of mortality (deaths per 100 patients/year) were as follows: patients with coronary heart disease, 5.6; patients with valvular heart diseases, 12.8; and patients with congenital heart diseases, 3.1 (p&lt;0.0001). The survival curve was lower in patients with valvular heart diseases than in patients with coronary heart disease and congenital heart diseases (p&lt;0.001). The accumulated probability of not undergoing surgery was higher in patients with valvular heart diseases than in the other patients (p&lt;0.001), and, among the patients with valvular heart diseases, this probability was higher in females than in males (p&lt;0.01). Several patients experienced intense anxiety and attributed their adaptive problems in the scope of love, professional, and social lives, to not undergoing surgery. CONCLUSION - Mortality was high, and even higher among the patients with valvular heart diseases, with negative psychological and social repercussions.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>waiting lists for heart surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>valvular heart surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Left Ventricular Diastolic Function in Essential Hypertensive Patients: Influence of Age and Left Ventricular Geometry</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo Cantoni Rosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valdir Ambrósio Moysés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ivan Rivera</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ricardo da Cintra Sesso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Nárcia Kohlmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maria Tereza Zanella</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Artur Beltrame Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Osvaldo Kohlmann Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Kidney and Hypertension Hospital Division of Nephrology</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>472-477</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>PURPOSE - To evaluate diastolic dysfunction (DD) in essential hypertension and the influence of age and cardiac geometry on this parameter. METHODS - Four hundred sixty essential hypertensive patients (HT) underwent Doppler echocardiography to obtain E/A wave ratio (E/A), atrial deceleration time (ADT), and isovolumetric relaxation time (IRT). All patients were grouped according to cardiac geometric patterns (NG - normal geometry; CR - concentric remodeling; CH- concentric hypertrophy; EH - eccentric hypertrophy) and to age (&lt;40; 40 - 60; &gt;60 years). One hundred six normotensives (NT) persons were also evaluated. RESULTS - A worsening of diastolic function in the HT compared with the NT, including HT with NG (E/A: NT - 1.38±0.03 vs HT - 1.27±0.02, p&lt;0.01), was observed. A higher prevalence of DD occurred parallel to age and cardiac geometry also in the prehypertrophic groups (CR). Multiple regression analysis identified age as the most important predictor of DD (r²=0.30, p&lt;0.01). CONCLUSION - DD was prevalent in this hypertensive population, being highly affected by age and less by heart structural parameters. DD is observed in incipient stages of hypertensive heart disease, and thus its early detection may help in the risk stratification of hypertensive patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>essential hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diastolic function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>age</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac geometry</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Prevalence of Risk Factors for Coronary Artery Disease in the Brazilian State of Rio Grande do Sul</s1>
</fA08>
<fA11 dir="011000">
<s1>Iseu Gus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Airton Fischmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cláudio Medina</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>484-490</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>64</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To determine the risk factors prevalence for coronary artery disease in the State of Rio Grande do Sul, Brazil and to identify their relation with the age bracket. METHODS - We carried out an observational, cross-sectional study of 1,066 adults older than 20 years in the Brazilian State of Rio Grande do Sul. We investigated the risk factors: familial antecedents, systemic arterial hypertension, high levels of cholesterol and glycemia, overweight/obesity, smoking and sedentary lifestyle. A standardized questionnaire completed at the patients' dwellings by health agents were used; the data were stored in an EPI-INFO software database. The results were expressed with a 95% confidence interval. RESULTS - The sample composition was of 51.8% females. The risk factors prevalences were: 1) sedentary lifestyle 71.3%; 2) familial antecedents: 57.3%; 3) overweight/obesity (body mass index &gt;25): 54.7%; 4) smokers: 33.9%; 5) hypertension: 31.6% (considering &gt;140/90mmHg) and 14.4% (considering &gt;160/95mmHg); 6) high glycemia (&gt;126 mg/dL): 7%; 7) high cholesterol &gt;240 mg/dL): 5.6%. CONCLUSION - The prevalence of the major risk factors for coronary artery disease in the Brazilian state of Rio Grande do Sul could be determined in a study that integrated public and private institutions.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Repair of an Atherosclerotic Coronary Artery Aneurysm by Implantation of a Coronary Covered Stent</s1>
</fA08>
<fA11 dir="011000">
<s1>Antenor Portela</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Raldir Bastos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Itamar Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jayro Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>São Marcos Hospital  </s1>
<s2>Teresina </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>494-496</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>An atherosclerotic aneurysm of the right coronary artery complicated by a recent myocardial infarction was successfully treated with coronary artery stenting, using a device consisting of 2 stents with a layer of expandable polytetrafluorethylene (PTFE) placed between them. A follow-up angiograph 5 months after the procedure showed sustained initial results.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Block of the Mitral-pulmonary Isthmus During Ablation of a Single Left-sided Accessory Pathway Causing Different Patterns of Retrograde Atrial Activation</s1>
</fA08>
<fA11 dir="011000">
<s1>José Tarcísio Medeiros de Vasconcelos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eduardo Rodrigues Bento Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Silas dos Santos Galvão Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cecília Monteiro Boya Barcellos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Jaime Giovany Arnez Maldonado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Beneficência Portuguesa de São Paulo Clínica de Ritmologia Cardíaca </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>504-509</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>The case of a 16-year-old patient with atrioventricular tachycardia caused by a single left anterolateral accessory pathway is reported. When the patient underwent radiofrequency ablation, a lesion on the mitral annulus lateral wall produced changes in the retrograde atrial activation pattern determined by that pathway; changes ranged from a delay in depolarization of the annulus posterior portions to full left atrium counterclockwise activation. Such phenomena were probably caused by a block in the isthmus between the annulus and the lower left pulmonary vein ostium. This case illustrates the importance of the mitral-pulmonary isthmus in the process of left atrium activation, an alert to changes induced by its unintentional block during accessory pathway ablation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Glossopharyngeal Neuralgia Associated with Cardiac Syncope</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Elias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo Kuniyoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Wilson Valadão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Hermes Carloni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mauricio Rocha Borges</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Carlos Alberto Peixoto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Derval Pimentel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Cardiologia do Espírito Santo Clínica do Ritmo </s1>
<s2>Vitória </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>515-519</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Glossopharyngeal neuralgia is an uncommon condition that has rarely been described in association with syncope. We report here 2 cases of glossopharyngeal neuralgia in elderly patients. Both were male and underwent temporary pacemaker insertion to prevent syncopal episodes. We discuss the clinical and surgical treatment of glossopharyngeal neuralgia, the role of cardiac stimulation, and the possible physiopathological mechanism of the associated cardiac disturbances.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Bloqueios Divisionais do Ramo Esquerdo na Miocardite Reumática</s1>
</fA08>
<fA11 dir="011000">
<s1>Lurildo R. Saraiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Inês Remígio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Simone Brandão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Thiago B. Saraiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Pernambuco  </s1>
<s2>Recife </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>520-520</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Atresia Pulmonar com Comunicação Interventricular</s1>
</fA08>
<fA11 dir="011000">
<s1>Ulisses Alexandre Croti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Miguel L. Barbero</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sergio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Instituto do Coração do Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>521-523</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>03</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 5/2002 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>524-524</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Estresse Mental e Sistema Cardiovascular</s1>
</fA08>
<fA11 dir="011000">
<s1>Débora Lopes Loures</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Isis Sant'Anna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Clarissa Seródio da Rocha Baldotto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eduardo Branco de Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Claudio Lucas da Nóbrega</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense Departamento de Fisiologia e Farmacologia </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>525-530</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>41</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800512</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Síndrome da Apnéia Obstrutiva do Sono e sua Relação com a Hipertensão Arterial Sistêmica: Evidências Atuais</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciano Ferreira Drager</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Renata Teixeira Ladeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rodrigo Antônio Brandão-Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Geraldo Lorenzi-Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Isabela Martins Benseñor</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>531-536</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>83</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800513</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Study of Coronary Sinus Flow Reserve Through Transesophageal Doppler Echocardiography in Normal Subjects</s1>
</fA08>
<fA11 dir="011000">
<s1>José Ramos Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>José A. F. Ramires</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marko Turina</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Caio J. Medeiros</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mário Lachat</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Jeane Tsutsui</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>102-106</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To evaluate the Coronary Flow Reserve in the Coronary Sinus through transesophageal Doppler echocardiography in normal subjects. METHODS - We obtained technically adequate flow samples for analysis in 10 healthy volunteers (37±8 years, 5 men) with no history of heart or systemic disease and with mean left ventricular mass index by transthoracic echocardiography of 87±18 g/m². Coronary sinus flow velocity was recorded within the coronary sinus with the patient in a resting condition and during intravenous adenosine infusion at a dose of 140 µg/kg/min for 4 minutes. Recording of coronary sinus blood flow was possible in all cases with measurement of peak systolic, diastolic, and retrograde velocities (PSV, PDV, and PRV, cm/sec), mean systolic and diastolic velocities (MSV and MDV, cm/sec), and systolic and diastolic velocity time integral (VTI S and VTI D, cm/sec). RESULTS - The coronary flow reserve was calculated as the ratio between the blood flow in the basal state and the maximum measured hyperemic blood flow with adenosine infusion. Results are shown as mean and standard deviations. (CFR = PSV + PDV -- PRV/basal PSV): 1st min = 2.2±0.21; 2nd min = 3±0.3; 3rd min = 3.4±0.37; 4th min = 3.6 ± 0.33. CONCLUSION - Although coronary sinus flow had significantly increased in the first minute, higher velocities were seen at third and fourth minutes, indicating that these should be the best times to study coronary sinus flow with intravenous adenosine in continuous infusion.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>transesophageal Doppler echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary sinus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary reserve</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Late Results of Endoventricular Patch Plasty Repair in Akinetic and Dyskinetic Areas After Acute Myocardial Infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo R. Prates</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Abud Homsi Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Lucas Maynard Lovato</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Guaracy F. Teixeira Fº</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>João R. M. Sant'Anna</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luiz M. Yordi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Renato A. K. Kalil</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Ivo A. Nesralla</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>112-116</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To assess the surgical results of endoventricular patch plasty repair in akinetic and dyskinetic left ventricular areas. METHODS - We studied 52 patients who had undergone endoventricular patch plasty repair associated with myocardial revascularization. The preoperative functional class distribution was as follows: class I in 1 (1.9%) patient; class II in 2 (3.8%) patients; class III in 23 (44.2%) patients; and class IV in 26 (50%) patients. RESULTS - The immediate mortality rate was 7.6% (4 patients). The clinical outcome of 44 patients followed up within a mean postoperative time of 29±25 months was as follows: class I in 33 (75%) patients; class II in 7 (15.9%) patients; class III in 2 (4.5%) patients; and class IV in 2 (4.5%) patients. Comparison between pre- and postoperative catheterization in 21 patients showed that the ejection fraction increased from 46.3% to 51.3% (p=0. 17); the left ventricular systolic volume decreased from 76.4 mL to 57.5 mL, (p=0.078); and the left ventricular diastolic volume decreased from 141.2 mL to 105.8 mL (p=0.0 73). These findings showed the tendency toward improvement, but with nonsignificant results. CONCLUSION - The technique proved to be effective, to have a low mortality rate, to cause significant clinical improvement, an increase in ejection fraction, and a reduction in left ventricular volumes.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular aneurysm</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hemodynamic assessment</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Cross-sectional Study on Blood Pressure Control in the Department of Nephrology of the Escola Paulista de Medicina - UNIFESP</s1>
</fA08>
<fA11 dir="011000">
<s1>João Batista de Freitas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Agostinho Tavares</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Osvaldo Kohlmann Jr</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Tereza Zanella</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Artur Beltrame Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>123-128</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To assess hypertension control rates in a specialized university-affiliated medical department, the influence of sex, diabetes, and obesity on that control, and the strategies for the treatment of hypertension. METHODS - We carried out a cross-sectional study with 1,210 patients followed up for at least 6 months. Information was gathered from medical and nursing records and comprised the following data: sex, age, weight, height, abdominal and hip circumferences, blood pressure, and class and number of the antihypertensive drugs prescribed. To assess obesity, we used body mass index and waist/hip ratio. Blood pressure was considered under control when its levels were below 140/90 mmHg. RESULTS - The study consisted of 73% females and 27% males. Most females (31.7%) were 50 to 59 years of age, and most males (28.3%) were 60 to 69 years. The blood pressure control rate found was 20.9% for the 1,210 patients and 23.4% for the hypertensive diabetic patients (n=290). Despite the low control rates found, 70% of the patients used 1 or 2 antihypertensive medications. A high prevalence of obesity (38%) was observed, and females had a greater abdominal obesity index than males did (90% vs 82%, p&lt;0.05). Patients with a greater body mass index had less control of blood pressure. CONCLUSION - The percentage of hypertensive patients with controlled blood pressure levels was low and was associated with a high prevalence of obesity. These data indicate the need for reviewing the strategies of global treatment for hypertension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure control</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treatment</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Initial Energy for External Electrical Cardioversion of Atrial Fibrillation</s1>
</fA08>
<fA11 dir="011000">
<s1>Edilberto Figueiredo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Henrique Horta Veloso</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Angelo Amato Vincenzo de Paola</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>134-138</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To investigate the initial energy level required for electrical cardioversion of atrial fibrillation (AF). METHODS - We studied patients undergoing electrical cardioversion in the 1st Multicenter Trial of SOCESP. Patients were divided into 2 groups according to the initial energy level of electrical cardioversion: 100J and  &gt; or = 150J. We compared the efficacy of the initial and final shock of the procedure, the number of shocks administered, and the cumulative energy levels. RESULTS - Eight-six patients underwent electrical cardioversion. In 53 patients (62%), cardioversion was started with 100J, and in 33 patients (38%), cardioversion was started with  &gt; or = 150J. Groups did not differ regarding clinical features and therapeutical interventions. A tendency existed towards greater efficacy of the initial shock in patients who received  &gt; or = 150J (61% vs. 42% in the 100J group, p=0.08). The number of shocks was smaller in the  &gt; or = 150J group (1.5±0.7 vs. 2.1±1.3, p=0.04). No difference existed regarding the final efficacy of electrical cardioversion and total cumulative energy levels in both groups. In the subgroup of patients with recent-onset AF (&lt;=48h), the cumulative energy level was lower in the 100J group (240±227J vs. 324±225J, p=0.03). CONCLUSION - Patients who were given initial energy of  &gt; or = 150J received fewer counter shocks with a tendency toward greater success than those patients who were given 100J; however, in patients with recent-onset AF, the average cumulative energy level was lower in the 100J group. These data suggest that electrical cardioversion should be initiated with energy levels  &gt; or = 150J in patients with chronic AF.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arrhythmia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrical cardioversion</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Eficiência dos Ésteres de Fitoesteróis Alimentares na Redução dos Lípides Plasmáticos em Hipercolesterolêmicos Moderados</s1>
</fA08>
<fA08 dir="en">
<s1>Plant sterol ester Efficiency on the Plasma Lipid Reduction in Moderate Hipercholesterolemic Subjects</s1>
</fA08>
<fA11 dir="011000">
<s1>Ana M. P. Lottenberg</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valéria S. Nunes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Edna R. Nakandakare</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Mônica Neves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Márcia Bernik</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>José E. Santos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Eder C. R. Quintão</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>139-142</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO - Avaliar o efeito dos ésteres de fitoesteróis (FE) da dieta, em função dos diferentes genótipos de apo E, sobre os lípides plasmáticos em indivíduos moderadamente hipercolesterolêmicos. MÉTODOS - Pacientes moderadamente hipercolesterolêmicos (20 a 60 anos de idade; 50 mulheres e 10 homens), mantidos em dieta habitual, receberam margarina (20g/dia) enriquecida com fitoesteróis (2,8g/dia=1,68g de FE), ou margarina normal (placebo), por dois períodos de quatro semanas cada, em estudo duplo cego e cruzado. RESULTADOS - Fitoesteróis reduziram significativamente o colesterol total e o LDL-colesterol, respectivamente, em 10% e 12% quando comparado à fase basal de admissão ao programa, e 6% e 8% quando comparado à fase placebo. O HDL-colesterol e a trigliceridemia não se modificaram. CONCLUSÃO - Ésteres de fitoesteróis da dieta reduziram a colesterolemia e a redução do LDL-colesterol foi mais pronunciada nos indivíduos que apresentavam valores maiores de LDL-colesterol, quando admitidos no estudo. Em relação ao sinótipo de apo E não houve diferença significativa entre apo E 3/3 e apo E 3/4.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE - This study aimed at relating the pattern of response to dietary plant sterol ester (PSE) treatment of plasma lipids concentrations and apo E polymorphisms. METHODS - Patients (20-60y old: 50 women; 10 men) with primary moderate hypercholesterolemia were fed margarine (20g/d), received no treatment (placebo), and were fed PSE (2.8g/d = 1.68 phytosterols), during 3 periods of 4 weeks each, in a crossover, double-blind study. DNA was extracted from white blood cells for the apo E polymorphisms. RESULTS - PSE treatment significantly lowered TC and LDL-C 10% and 12%, respectively, in relation to the baseline, and 6% and 8% in relation to the placebo phase, but HDL-C and TG levels were not modified. In regard to the apo E genotyping, no significant difference occurred between apo E 3/3 and apo E 3/4. CONCLUSION - Dietary plant sterol ester (PSE) treatment reduced cholesterolemia, and the reduction of LDL-C in absolute values was more pronounced when the initial LDL - C concentration were elevated.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ésteres de fitoesteróis</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>colesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>LDL-colesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>plant sterol ester</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cholesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>LDL-colesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>apo E</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>QRS Voltage-Duration Product in the Identification of Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats</s1>
</fA08>
<fA11 dir="011000">
<s1>Ljuba Bacharova</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jan Kyselovic</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Jan Klimas</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>143-148</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>48</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - Evaluation of the performance of the QRS voltage-duration product (VDP) for detection of left ventricular hypertrophy (LVH) in spontaneously hypertensive rats (SHR). METHODS - Orthogonal electrocardiograms (ECG) were recorded in male SHR at the age of 12 and 20 weeks, when systolic blood pressure (sBP) reached the average values of 165±3 mmHg and 195±12 mmHg, respectively. Age- and sex- matched normotensive Wistar Kyoto (WKY) rats were used as controls. VDP was calculated as a product of maximum QRS spatial vector magnitude and QRS duration. Left ventricular mass (LVM) was weighed after rats were sacrificed. RESULTS - LVM in SHR at 12 and 20 weeks of age (0.86±0.05 g and 1.05±0.07 g, respectively) was significantly higher as compared with that in WKY (0.65±0.07 g and 0.70±0.02 g). The increase in LVM closely correlated with the sBP increase. VDP did not reflect the increase in LVM in SHR. VDP was lower in SHR as compared with that in WKY, and the difference was significant at the age of 20 weeks (18.2mVms compared with 10.7mVms, p&lt;0.01). On the contrary, a significant increase in the VDP was observed in the control WKY at the age of 20 weeks without changes in LVM. The changes in VDP were influenced mainly by the changes in QRSmax. CONCLUSION - LVM was not the major determinant of QRS voltage changes and consequently of the VDP. These data point to the importance of the nonspatial determinants of the recorded QRS voltage in terms of the solid angle theory.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>QRS voltage-duration product</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>spontaneously hypertensive rat</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Electrocardiographic and Blood Pressure Alterations During Electroconvulsive Therapy in Young Adults</s1>
</fA08>
<fA11 dir="011000">
<s1>Demetrio Ortega Rumi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Cecília Solimene</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Júlio Yoshio Takada</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>César José Grupi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Dante Marcelo Giorgi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sérgio Paulo Rigonatti</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Protásio Lemos da Luz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>155-160</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To study cardiovascular alterations in young patients with no apparent organic disease who underwent electroconvulsive therapy. METHODS - The study comprised 47 healthy patients (22 males and 25 females) with a mean age of 30.3 years, who underwent electroconvulsive therapy. Ambulatory blood pressure monitoring and continuous electrocardiographic monitoring (Holter monitor) were performed during 24 hours. Blood pressure and heart rate were assessed 4 hours prior to electric shock administration, during electric shock administration, and 3 hours after electric shock administration. Arrhythmias and alterations in the ST segment in 24 hours were recorded. RESULTS - On electroconvulsive therapy, a significant increase in blood pressure and heart rate was observed and the measurements returned to basal values after 25 minutes. Three females had tracings with depression of the ST segment suggesting myocardial ischemia prior to and after electroconvulsive therapy. Coronary angiography was normal. No severe cardiac arrhythmias were diagnosed. CONCLUSION - 1) Electroconvulsive therapy is a safe therapeutic modality in psychiatry; 2) it causes a significant increase in blood pressure and heart rate; 3) it may be associated with myocardial ischemia in the absence of coronary obstructive disease; 4) electroconvulsive therapy was not associated with the occurrence of severe cardiac arrhythmias.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electroconvulsive therapy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart rate</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arrhythmias</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial ischemia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Analysis of Plasma Homocysteine Levels in Patients with Unstable Angina</s1>
</fA08>
<fA11 dir="011000">
<s1>José Roberto Tavares</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vânia D'Almeida</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Daniela C. Diniz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carolina A. Terzi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Edison N. Cruz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Edson Stefanini</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Adagmar Andriollo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Angelo A.V. de Paola</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Antonio C. Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>167-172</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>46</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE - To determine the prevalence of hyperhomocystinemia in patients with acute ischemic syndrome of the unstable angina type. METHODS - We prospectively studied 46 patients (24 females) with unstable angina and 46 control patients (19 males), paired by sex and age, blinded to the laboratory data. Details of diets, smoking habits, medication used, body mass index, and the presence of hypertension and diabetes were recorded, as were plasma lipid and glucose levels, C-reactive protein, and lipoperoxidation in all participants. Patients with renal disease were excluded. Plasma homocysteine was estimated using high-pressure liquid chromatography. RESULTS - Plasma homocysteine levels were significantly higher in the group of patients with unstable angina (12.7±6.7 µmol/L) than in the control group (8.7±4.4 µmol/L) (p&lt;0.05). Among males, homocystinemia was higher in the group with unstable angina than in the control group, but this difference was not statistically significant (14.1±5.9 µmol/L versus 11.9±4.2 µmol/L). Among females, however, a statistically significant difference was observed between the 2 groups: 11.0±7.4 µmol/L versus 6.4±2.9 µmol/L (p&lt;0.05) in the unstable angina and control groups, respectively. Approximately 24% of the patients had unstable angina at homocysteine levels above 15 µmol/L. CONCLUSION - High homocysteine levels seem to be a relevant prevalent factor in the population with unstable angina, particularly among females.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute ischemic syndrome</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>unstable angina</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>homocysteine</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Arterial Hypertension in a Child with Williams-Beuren Syndrome (7q11.23 Chromosomal Deletion)</s1>
</fA08>
<fA11 dir="011000">
<s1>Cristina de Sylos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alexandre C. Pereira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Estela Azeka</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Nana Miura</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sônia Maria Ferreira Mesquita</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Munir Ebaid</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>177-180</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the case of a 7-year-old male child diagnosed with Williams-Beuren syndrome and arterial hypertension refractory to clinical treatment. The diagnosis was confirmed by genetic study. Narrowing of the descending aorta and stenosis of the renal arteries were also diagnosed. Systemic vascular alterations caused by deletion of the elastin gene may occur early in individuals with Williams-Beuren syndrome, leading to the clinical manifestation of systemic arterial hypertension refractory to drug treatment.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Internal Mammary to Pulmonary Artery Fistula Presenting as Early Recurrent Angina after Coronary Bypass</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre C. Ferreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eduardo de Marchena</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Michelle Liester</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Afolabi O. Sangosanya</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>181-182</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A 50-year-old man developed recurrent angina 1 year after coronary artery bypass surgery. The patient was found to have a large fistula involving branches of the internal mammary artery graft and the left pulmonary artery. In the absence of another clear cause for the patient's symptoms, we speculated that our patient's angina and abnormal stress nuclear study were due to coronary steal. In patients with a history of coronary bypass grafting, fistula formation between graft and native vessels should be considered as a possible cause of early recurrent angina.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Retinal Detachment in Preeclampsia</s1>
</fA08>
<fA11 dir="011000">
<s1>Renata Silva do Prado</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Estêvão Lanna Figueiredo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Télcia Vasconcelos Barros Magalhães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>185-186</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Preeclampsia is an obstetric disease of unknown cause that affects approximately 5% of pregnant women. The visual system may be affected with variable intensity, being the retinal detachment a rare complication. The retinal detachment in preeclampsia is usually bilateral and serous, and its pathogenesis is related to the choroidal ischemia secondary to an intense arteriolar vasospasm. The majority of patients have complete recovery of vision with clinical management, and surgery is unnecessary. This is a case report of a 27 year old patient who developed the severe form of preeclampsia on her first pregnancy. She had progressive blurred vision, until she could see only shadows. Ophthalmic examination diagnosed spread and bilateral retinal detachment. With blood pressure control at postpartum, the patient had her retina reattached, and recovery of vision.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Por que sistematizar a nomenclatura dos defeitos congênitos do coração?</s1>
</fA08>
<fA11 dir="011000">
<s1>Vera Demarchi Aiello</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>187-189</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900212</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Mulher de 69 anos de idade com infarto do miocárdio e choque no período pós-operatório de revascularização do miocárdio</s1>
</fA08>
<fA11 dir="011000">
<s1>Ivan Ruiz Peralta</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Alberto Benvenuti</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>190-194</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900213</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="">
<s1></s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>195-195</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900214</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Chest Pain Units: A Modern Way of Managing Patients with Chest Pain in the Emergency Department</s1>
</fA08>
<fA11 dir="011000">
<s1>Roberto Bassan</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>203-209</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>69</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900215</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>It is estimated that 5 to 8 million individuals with chest pain or other symptoms suggestive of myocardial ischemia are seen each year in emergency departments (ED) in the United States 1,2, which corresponds to 5 to 10% of all visits 3,4. Most of these patients are hospitalized for evaluation of possible acute coronary syndrome (ACS). This generates an estimated cost of 3 - 6 thousand dollars per patient 5,6. From this evaluation process, about 1.2 million patients receive the diagnosis of acute myocardial infarction (AMI), and just about the same number have unstable angina. Therefore, about one half to two thirds of these patients with chest pain do not have a cardiac cause for their symptoms 2,3. Thus, the emergency physician is faced with the difficult challenge of identifying those with ACS - a life-threatening disease - to treat them properly, and to discharge the others to suitable outpatient investigation and management.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Echocardiographic Assessment of the Pulmonary Venous Flow: An Indicator of Increased Pulmonary Flow in Congenital Cardiac Malformations</s1>
</fA08>
<fA11 dir="011000">
<s1>Ivan Romero Rivera</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valdir Ambrósio Moisés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Angelo Amato V. de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>541-544</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>08</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To identify the left inferior pulmonary vein as an indirect marker of increased pulmonary flow in congenital heart diseases.METHODS: We carried out a prospective consecutive study on 40 patients divided into 2 groups as follows: G1 - 20 patients diagnosed with congenital heart disease and increased pulmonary flow; G2 (control group) - 20 patients who were either healthy or had congenital heart disease with decreased or normal pulmonary flow. We obtained the velocity-time integral of the left inferior pulmonary vein flow, excluding the &quot;reverse A&quot; wave, with pulsed Doppler echocardiography.RESULTS: In G1, 19 out of the 20 patients had well-identified dilation of the left inferior pulmonary vein. No G2 patient had dilation of the left inferior pulmonary vein. Dilation of the left inferior pulmonary vein in conditions of increased pulmonary flow had sensitivity of 95%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 95% (1 false-negative case). The integral of time and velocity of the pulmonary venous flow obtained with pulsed Doppler echocardiography was greater in the G1 patients (G1=25.0±4.6 cm versus G2=14.8±2.1 cm, p=0.0001).CONCLUSION: The identification of dilation of the left inferior pulmonary vein suggests the presence of congenital heart disease with increased pulmonary flow. This may be used as an indirect sign of increased flow, mainly in malformations of difficult diagnosis, such as atrial septal defects of the venous sinus or coronary sinus type.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary veins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart diseases</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Retrospective Study of the Survival of Patients who Underwent Cardiopulmonary Resuscitation in an Intensive Care Unit</s1>
</fA08>
<fA11 dir="011000">
<s1>Daniel Martins Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Guilherme Mariante Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcelo Wierzynski Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Letícia Biscaino Alves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luís Carlos Chorazje Adamatti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Eliana de Andrade Trotta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Sílvia Regina Rios Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFRGS Faculdade de Medicina Hospital de Clínicas de Porto Alegre</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>549-552</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate clinical and evolutive characteristics of patients admitted in an intensive care unit after cardiopulmonary resuscitation, identifying prognostic survival factors.METHODS: A retrospective study of 136 patients admitted between 1995 and 1999 to an intensive care unit, evaluating clinical conditions, mechanisms and causes of cardiopulmonary arrest, and their relation to hospital mortality.RESULTS: A 76% mortality rate independent of age and sex was observed. Asystole was the most frequent mechanism of death, and seen in isolation pulmonary arrest was the least frequent. Cardiac failure, need for mechanical ventilation, cirrhosis and previous stroke were clinically significant (p&lt;0.01) death factors.CONCLUSION: Prognostic factors supplement the doctor's decision as to whether or not a patient will benefit from cardiopulmonary resuscitation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiopulmonary resuscitation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiopulmonary arrest</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>intensive care unit</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Can the Cardiopulmonary 6-Minute Walk Test Reproduce the Usual Activities of Patients with Heart Failure?</s1>
</fA08>
<fA11 dir="011000">
<s1>Guilherme Veiga Guimarães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Giovanni Bellotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando Bacal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Amilcar Mocelin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Edimar Alcides Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>557-560</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: The 6-minute walk test is an way of assessing exercise capacity and predicting survival in heart failure. The 6-minute walk test was suggested to be similar to that of daily activities. We investigated the effect of motivation during the 6-minute walk test in heart failure. METHODS: We studied 12 males, age 45±12 years, ejection fraction 23±7%, and functional class III. Patients underwent the following tests: maximal cardiopulmonary exercise test on the treadmill (max), cardiopulmonary 6-minute walk test with the walking rhythm maintained between relatively easy and slightly tiring (levels 11 and 13 on the Borg scale) (6EB), and cardiopulmonary 6-minute walk test using the usual recommendations (6RU). The 6EB and 6RU tests were performed on a treadmill with zero inclination and control of the velocity by the patient. RESULTS: The values obtained in the max, 6EB, and 6RU tests were, respectively, as follows: O2 consumption (ml.kg-1.min-1) 15.4±1.8, 9.8±1.9 (60±10%), and 13.3±2.2 (90±10%); heart rate (bpm) 142±12, 110±13 (77±9%), and 126±11 (89±7%); distance walked (m) 733±147, 332±66, and 470±48; and respiratory exchange ratio (R) 1.13±0.06, 0.9±0.06, and 1.06±0.12. Significant differences were observed in the values of the variables cited between the max and 6EB tests, the max and 6RU tests, and the 6EB and 6RU tests (p&lt;0.05). CONCLUSION: Patients, who undergo the cardiopulmonary 6-minute walk test and are motivated to walk as much as they possibly can, usually walk almost to their maximum capacity, which may not correspond to that of their daily activities. The use of the Borg scale during the cardiopulmonary 6-minute walk test seems to better correspond to the metabolic demand of the usual activities in this group of patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>oxygen consumption</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Analysis of the Association Between Apolipoprotein E Polymorphism and Cardiovascular Risk Factors in an Elderly Population with Longevity</s1>
</fA08>
<fA11 dir="011000">
<s1>Carla Helena Augustin Schwanke</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ivana Beatrice Mânica da Cruz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ney Furhmann Leal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rosane Scheibe</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Yukio Moriguchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Emílio Hideyuki Moriguchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica do Rio Grande do Sul Faculdade de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>571-579</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To establish the allelic and genotypic frequencies related to apolipoprotein E (ApoE) polymorphism and association of the genotypes with risk factors and cardiovascular morbidity in an elderly population with longevity. METHODS: We analyzed 70 elderly patients aged 80 years or more who were part of the Projeto Veranópolis. We used the gene amplification technique through the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and cleavage with the restriction enzyme Hha I to identify the ApoE genotypes. The most frequent genotypes were compared considering biological variables and cardiovascular risks and morbidity. RESULTS: The frequencies of the E2, E3, and E4 alleles were 0.05, 0.84, and 0.11, respectively, and of the genotypes were as follows: E3E3 (0.70), E3E4 (0.22), E2E3 (0.06), and E2E2 (0.02). Individuals with the E3E4 had a mean age greater than those with the E3E3. No association was observed between the genotypes and the variables analyzed, except for obesity, which was associated with the E3E3 genotype. Individuals with the E3E4 genotype had high levels of LDL-cholesterol and fibrinogen as compared with those with the E3E3 genotype. CONCLUSION: The results suggest that the E4E4 genotype may be associated with early mortality. A balance between the protective or neutral factors and the cardiovascular risk factors may occur among the individuals with different genotypes, attenuating the negative effects of the E4 allele.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>apolipoprotein E</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly population with longevity</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Pericardial Effusion with Cardiac Tamponade as a Form of Presentation of Primary Hypothyroidism</s1>
</fA08>
<fA11 dir="011000">
<s1>Acir Rachid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leiber C. Caum</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ana Paula Trentini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos A. Fischer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Dênis A. J. Antonelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rafael P. Hagemann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Paraná Hospital das Clínicas de Curitiba </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>583-585</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>The authors describe a case of pericardial effusion accompanied by cardiac tamponade caused by primary hypothyroidism. Diagnosis was made by exclusion, because other causes of cardiac tamponade are more frequent. Emergency treatment of cardiac tamponade is pericardiocentesis (with possible pericardial window), and, after stabilization, performance of hormonal reposition therapy with L-thyroxin.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Primary Cardiac Angiosarcoma: A Therapeutical Dilemma</s1>
</fA08>
<fA11 dir="011000">
<s1>José Dario Frota Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernando A. Lucchese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Leães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luís Antônio Valente</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mariana S. Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Celso Blacher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa de Porto Alegre Hospital São Francisco </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>589-591</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Cardiac angiosarcomas are malignant tumors that almost invariably have a short and fatal evolution. The therapeutic approach includes surgery, chemotherapy, and radiation therapy, alone or in combination. Heart transplantation is an attractive option in nonresectable tumors, even though the current experience is still limited. However, in most patients, the diagnosis is still established late, and survival is only slightly altered by the proposed treatments, mainly due to previously existing and undetected metastases. We report a case that illustrates the therapeutic dilemma faced with this neoplasia, and we discuss the case based on a literature review.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Multiple Embolism in a Female Patient with Infective Endocarditis: Low Back Pain and Hematuria as the Initial Clinical Manifestations</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo Luiz Campos Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mônica Luisa Rappi Schmidt</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcos Valério Coimbra de Resende</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luis Sérgio Afonso de André Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital e Maternidade São Luiz  </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>595-597</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A 59-year-old female patient with mitral valve prolapse and a previous history of lumbosacral spondyloarthrosis and lumbar disk hernia had an episode of infective endocarditis due to Streptococcus viridans, which evolved with peripheral embolism to the left kidney, spleen, and left iliac artery, and intraventricular cerebral hemorrhage. Her clinical manifestations were low back pain and hematuria, which were initially attributed to an osteoarticular condition. Infective endocarditis is a severe polymorphic disease with multiple clinical manifestations and it should always be included in the differential diagnosis by clinicians.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Consultar, Diagnosticar e Tratar</s1>
</fA08>
<fA11 dir="011000">
<s1>Georg Tuppy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Cardioclínica Araçatuba S/C Ltda  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>598-599</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Febre, Convulsão e Coma em Mulher de 60 Anos Portadora de Doença Reumática Crônica</s1>
</fA08>
<fA11 dir="011000">
<s1>Margleicia Maria Vasconcelos Coutinho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Léa Maria Macruz Ferreira Demarchi</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>600-606</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 6/2002 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>607-607</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Intervenções Percutâneas em Cardiopatias Congênitas</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco de Assis Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Junya Kajita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Eulógio Emílio Martinez Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>608-617</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>139</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800611</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>A Participação do Tecido Adiposo Visceral na Gênese da Hipertensão e Doença Cardiovascular Aterogênica: Um Conceito Emergente</s1>
</fA08>
<fA11 dir="011000">
<s1>Sergio Girão Barroso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Virgínia Genelhu de Abreu</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Emílio Antonio Francischetti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UERJ Faculdade de Ciências Médicas Laboratório de Fisiopatologia Clínica e Experimental</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>618-630</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>170</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800612</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Do Vasodilators Interfere with Left Ventricular Remodeling in Chronic Mitral Regurgitation?</s1>
</fA08>
<fA11 dir="011000">
<s1>Roney Orismar Sampaio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>213-214</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Myocardial Bridges and their Relationship to the Anterior Interventricular Branch of the Left Coronary Artery</s1>
</fA08>
<fA11 dir="011000">
<s1>Vanildo Júnior de Melo Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jennecy Sales Cavalcanti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Tetsuo Tashiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFPE Centro de Ciências Biológicas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>219-222</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the relationship between myocardial bridges and the anterior interventricular branch (anterior descending) of the left coronary artery. METHODS: The study was carried out with postmortem material, and methods of dissection and observation were used. We assessed the perimeter of the anterior interventricular branch of the left coronary artery using a pachymeter, calculated its proximal and distal diameters in relation to the myocardial bridge, and also its diameter under the myocardial bridge in 30 hearts. We also observed the position of the myocardial bridge in relation to the origin of the anterior interventricular branch. RESULTS: The diameters of the anterior interventricular branch were as follows: the mean proximal diameter was 2.76±0.76 mm; the mean diameter under the myocardial bridge was 2.08±0.54 mm; and the mean distal diameter was 1.98±0.59 mm. In 33.33% (10/30) of the cases, the diameter of the anterior interventricular branch under the myocardial bridge was lower than the diameter of the anterior interventricular branch distal to the myocardial bridge. In 3.33% (1/30) of the cases, an atherosclerotic plaque was found in the segment under the myocardial bridge. The myocardial bridge was located in the middle third of the anterior interventricular branch in 86.66% (26/30) of the cases. CONCLUSION: Myocardial bridges are more frequently found in the middle third of the anterior interventricular branch of the left coronary artery. The diameter of the anterior interventricular branch of the left coronary artery under the myocardial bridge may be smaller than after the bridge. Myocardial bridges may not provide protection against the formation of atherosclerotic plaque inside the anterior interventricular branch of the left coronary artery.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial bridge</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary arteries</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>morphometry</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Experimental Model of Gene Transfection in Healthy Canine Myocardium: Perspectives of Gene Therapy for Ischemic Heart Disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Renato A. K. Kalil</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leonardo A. K. Teixeira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Eduardo T. Mastalir</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Moreno</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Cecília H. Fricke</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Nance B. Nardi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal do Rio Grande do Sul  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>228-232</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the transfection of the gene that encodes green fluorescent protein (GFP) through direct intramyocardial injection. METHODS: The pREGFP plasmid vector was used. The EGFP gene was inserted downstream from the constitutive promoter of the Rous sarcoma virus. Five male dogs were used (mean weight 13.5 kg), in which 0.5 mL of saline solution (n=1) or 0.5 mL of plasmid solution containing 0.5 µg of pREGFP/dog (n=4) were injected into the myocardium of the left ventricular lateral wall. The dogs were euthanized 1 week later, and cardiac biopsies were obtained. RESULTS: Fluorescence microscopy showed differences between the cells transfected and not transfected with pREGFP plasmid. Mild fluorescence was observed in the cardiac fibers that received saline solution; however, the myocardial cells transfected with pREGFP had overt EGFP expression. CONCLUSION: Transfection with the EGFP gene in healthy canine myocardium was effective. The reproduction of this efficacy using vascular endothelial growth factor (VEGF) instead of EGFP aims at developing gene therapy for ischemic heart disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>gene therapy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>gene transfection</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemic heart disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Unsupervised Rehabilitation: effects of Exercise Training over the Long Run</s1>
</fA08>
<fA11 dir="011000">
<s1>Japy Angelini Oliveira Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ana Cristina Leal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Valter Correia Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Dirceu Vieira Santos Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Bráulio Luna Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>239-244</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>40</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the safety and efficacy of unsupervised rehabilitation (USR) in the long run in low-risk patients with coronary artery disease. METHODS: We carried out a retrospective study with 30 patients divided into: group I (GI) - 15 patients from private clinics undergoing unsupervised rehabilitation; group II (GII) - control group, 15 patients from ambulatory clinic basis, paired by age, sex, and clinical findings. GI was stimulated to exercise under indirect supervision (jogging, treadmill, and sports). GII received the usual clinical treatment. RESULTS: The pre- and postobservation values in GI were, respectively: VO2peak (mL/kg/min), 24±5 and 31± 9; VO2 peak/peak HR: 0.18±0.05 and 0.28±0.13; peak double product (DP peak):26,800±7,000 and 29,000 ± 6,500; % peak HR/predicted HRmax: 89.5±9 and 89.3±9. The pre- and post- values in GII were: VO2 peak (mL/kg/min), 27± 7 and 28±5; VO2 peak/peak HR: 0.2±0.06 and 0.2± 0.05; DP peak: 24,900±8,000 and 25,600± 8,000, and % peak HR/predicted HRmax: 91.3±9 and 91.1± 11. The following values were significant: preobservation VO2peak versus postobservation VO2peak in GI (p=0.0 063); postobservation VO2peak in GI versus postobservation VO2peak in GII (p=0.0045); postobservation VO2 peak/peak HR GI versus postobservation peak VO2/peak HR in GII (p=0.0000). The follow-up periods in GI and GII were, respectively, 41.33± 20.19 months and 20.60±8.16 months (p&lt;0.05). No difference between the groups was observed in coronary risk factors, therapeutic management, or evolution of ischemia. No cardiovascular events secondary to USR were observed in 620 patient-months. CONCLUSION: USR was safe and efficient, in low-risk patients with coronary artery disease and provided benefits at the peripheral level.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerotic coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>unsupervised rehabilitation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Detection of Altered Risk Factors in Hospitalized Patients with Coronary Artery Disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Avany Fernandes Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Dorotéia Borges dos Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antônio Carlos Cicogna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Roberto Padovani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eliane de Abreu Soares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Roberto Carlos Burini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNESP Faculdade de Medicina de Botucatu </s1>
<s2>Botucatu SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>263-268</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>59</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess biochemical, anthropometric, and dietary variables considered risk factors for coronary artery disease. METHODS: Using anthropometrics, dietary allowance, and blood biochemistry, we assessed 84 patients [54 males (mean age of 55± 8 years) and 30 females (mean age of 57±7 years)], who had severe ( &gt; or =  70% coronary artery obstruction) and nonsevere forms of coronary artery disease determined by cardiac catheterization. The severe form of the disease prevailed in 70% of the males and 64% of the females, and a high frequency of familial antecedents (92% ' 88%) and history of acute myocardial infarction (80% ' 70%) were observed. Smoking predominated among males (65%) and diabetes mellitus among females (43%). RESULTS: Males and females had body mass index and body fat above the normal values. Females with nonsevere lesions had HDL &gt; 35 mg/dL, and this constituted a discriminating intergroup indicator. Regardless of the severity of the disease, hyperglycemia and hypertriglyceridemia were found among females, and cholesterolemia &gt; 200 mg/dL in both sexes, but only males had LDL fraction &gt; 160 mg/dL and homocysteine &gt; 11.7 mmol/L. The male dietary allowance was inadequate in nutrients for homocysteine metabolism and in nutrients with an antioxidant action, such as the vitamins B6, C, and folate. Individuals of both sexes had a higher lipid and cholesterol intake and an inadequate consumption of fiber. The diet was classified as high-protein, high-fat, and low-carbohydrate. CONCLUSION: The alterations found had no association with the severity of lesions, indicating the need for more effective nutritional intervention.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>individuals with coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hospitalization</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Trends of the Risk of Death due to Circulatory, Cerebrovascular, and Ischemic Heart Diseases in 11 Brazilian Capitals from 1980 to 1998</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio de Padua Mansur</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria de Fátima M. Souza</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ari Timermann</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Antonio F. Ramires</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>FMUSP Department of Preventive Medicine </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Sociedade Brasileira de Cardiologia FUNCOR </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>277-284</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the trends of the risk of death due to circulatory (CD), cerebrovascular (CVD), and ischemic heart diseases (IHD) in 11 Brazilian capitals from 1980 to 1998. METHODS: Data on mortality due to CD, CVD and IHD were obtained from the Brazilian Health Ministry, and the population estimates were calculated by interpolation with the Lagrange method based on census data from 1980 and 1991 and the population count of 1996. The trends were analyzed with the multiple linear regression method. RESULTS: CD showed a trend towards a decrease in most capitals, except for Brasília, where a mild increase was observed. The cities of Porto Alegre, Curitiba, Rio de Janeiro, Cuiabá, Goiânia, Belém, and Manaus showed a decrease in the risk of death due to CVD and IHD, while the city of Brasília showed an increase in CVD and IHD. The city of São Paulo showed a mild increase in IHD for individuals of both sexes aged 30 to 39 years and for females aged 40 to 59 years. In the cities of Recife and Salvador, a reduction in CD was observed for all ages and both sexes. In the city of Recife, however, an increase in IHD was observed at younger ages (30 to 49 years), and this trend decreased until a mild reduction (-4%) was observed in males &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt; 70 years. CONCLUSION: In general, a reduction in the risk of death due to CD and an increase in IHD were observed, mainly in the cities of Recife and Brasília.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>circulatory diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mortality</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Echocardiographic Abnormalities and Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus</s1>
</fA08>
<fA11 dir="011000">
<s1>Creso Abreu Falcão</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Izabel Cristina Alves</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Wiliam Habib Chahade</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ângela Luzia Branco Pinto Duarte</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Norma Lucena-Silva</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FESP Universidade de Pernambuco </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>FESP Hospital dos Servidores do Estado de Pernambuco </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>FESP Hospital do Servidor Público Estadual de São Paulo </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="040000">
<s1>Universidade Federal de Pernambuco  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="050000">
<s1>Fundação Oswaldo Cruz Centro de Pesquisas Aggeu Magalhães </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>285-291</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>51</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Lupus anticoagulant and anticardiolipin antibodies (aCL) have been associated with thrombosis, recurrent abortion, and thrombocytopenia in patients with systemic lupus erythematosus (SLE), but their relationship with cardiac disease is less clear. The purpose of this study was to evaluate the association between antiphospholipid antibodies (aPL) and echocardiographic abnormalities in patients with SLE. METHODS: A total of 70 consecutive patients and 42 control subjects underwent M-mode, 2-dimensional and Doppler echocardiography and tests for lupus anticoagulant, aCL IgG, IgM, and IgA. Lupus anticoagulant was assayed with the dilute Russell viper venom time, and aCL IgG, IgM, and IgA were measured by an enzyme-linked immunosorbent assay (ELISA). RESULTS: Lupus anticoagulant showed a prevalence of 10%. As a whole, aCL had a prevalence of 44.3% and aPL had a prevalence of 50%. Patients with echocardiographic abnormalities had a prevalence of 54.3% and showed a trend towards an association with aCL IgG (P=0.06). The presence of pulmonary hypertension (PH) was significantly associated with aCL IgG (p=0.02). CONCLUSION: aCL IgG was significantly associated with PH and showed a strong trend towards an association with echocardiographic abnormalities taken together. These findings suggest a role for aCL IgG in the development of lupus cardiovascular disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lupus erythematosus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>antiphospholipid syndrome</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lupus coagulation inhibitor</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Myocardial Revascularization Surgery with Regional Anesthesia Without an Endotracheal Tube in Conscious Patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Gladyston Luiz Lima Souto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Celme da Silva Caetano Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ary Getúlio de Paula Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marco Antonio Teixeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Márcio Roberto Moraes de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antonio Carlos Botelho da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital São José do Avaí  </s1>
<s2>Itaperuna RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>297-301</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To report initial experience with myocardial revascularization surgery (MRS) performed on patients who were totally awake and without an endotracheal tube.METHODS: Between January 1994 and May 2001, 272 patients underwent MRS without extracorporeal circulation. In 24, the operations were performed without the use of an endotracheal tube and with the patients totally awake and breathing normally. The age ranged from 51-75 years with the predominant male sex. Epidural thoracic administratios of the anesthesia was performed. Surgery was performed through a habitual anterolateral thoracotomy. During the entire procedure, the left lung remained partially collapsed.RESULTS: The 24 patients progressed well through the surgery. Pneumothorax time ranged from 70-190 minutes. No electrocardiographic, echocardiographic, or enzymatic alterations occurred that characterized pre- and postoperative infarcts. Twenty-three patients were stable enough to be released after 24 hours.CONCLUSION: This technique could be performed on an large number of selected patients. However, more experience is necessary.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery leypass graft</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidural thoracic anesthesia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Silent Patent Ductus Arteriosus Aneurysm</s1>
</fA08>
<fA11 dir="011000">
<s1>Aline Medeiros Botta</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Flávio Aquino</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carla Pereira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alberto Fin</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Aldemir Nogueira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cláudia Ricachinewsky</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Fernando Lucchese</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Silvana Molossi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Irmandade da Santa Casa de Misericórdia de Porto Alegre  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>UFRGS Hospital de Clínicas de Porto Alegre </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>305-307</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900310</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Ductus arteriosus aneurysm, a rare and potentially fatal condition, has been reported as a complication after surgical ductus arteriosus closure. Its spontaneous appearance as a septic complication, which was common in the presurgical and preantibiotic era, has been rarely reported in the contemporary literature. Persistence of silent ductus arteriosus in healthy children and adults is a frequent condition that currently has an increasing diagnostic possibility due to the availability of more accurate investigative methods, especially echocardiography. We report the case of a 1-year-old child, in whom no previous heart disease was known, who developed a giant aneurysm of the ductus arteriosus during a staphylococcal infection. This complication appeared after craniotomy for emptying an accidental subdural hematoma. This report associates the persistence of ductus arteriosus with a complication considered rare, which has a rapidly fatal evolution.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>É Imperiosa a Indicação de Estudo Eletrofisiológico Invasivo em Pacientes Sobreviventes de Parada Cardíaca?</s1>
</fA08>
<fA11 dir="011000">
<s1>José Tarcísio Medeiros de Vasconcelos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Silas dos Santos Galvão Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cecília Monteiro Boya Barcellos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Beneficência Portuguesa de São Paulo Clínica de Ritmologia Cardíaca </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>308-311</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900311</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 9/2002 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>312-312</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900312</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Fechamento Percutâneo da Comunicação Interatrial</s1>
</fA08>
<fA11 dir="011000">
<s1>Valmir Fernandes Fontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Augusto Cardoso Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>319-322</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900314</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Cursos, pré-requisitos e critérios para obtenção do Certificado de Habilitação em Ergometria</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>323-325</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900315</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Normatização dos Equipamentos e Técnicas de Exame para Realização de Implante de Marcapassos</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>326-326</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900316</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>O Ventrículo Direito e a Hipertensão Arterial: Aspectos Ecocardiográficos</s1>
</fA08>
<fA11 dir="011000">
<s1>Ricardo Pereira Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Celso Amodeo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Antônio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFCE Hospital Universitário Walter Cantídio </s1>
<s2>Fortaleza </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>313-318</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>42</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900313</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Neonate Aortic Stenosis: Importance of Myocardial Perfusion in Prognosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Marco Aurélio Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vitor Manuel Pereira Azevedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Nacional de Cardiologia Laranjeiras  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>251-255</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze our experience with percutaneous aortic balloon valvuloplasty in newborn infants with aortic stenosis, emphasizing the extraordinary importance of myocardial perfusion.METHODS: Over a 10-year-period, 21 neonates underwent percutaneous aortic balloon valvuloplasty. Age ranged from 2 to 27 days, weight ranged from 2.2 to 4.1 kg and 19 were males. All patients presented with congestive heart failure that could not be treated clinically. The onset of symptoms in the first week of life occurred in 9 patients considered as having critical aortic stenosis. Severe aortic stenosis occurred in 12 patients with the onset of symptoms in the second week of life.RESULTS: Mortality reached 100% in the patients with critical aortic stenosis. The procedure was considered effective in the 12 patients with severe aortic stenosis. Vascular complications included the loss of pulse in 12 patients and rupture of the femoral artery in 2 patients. Cardiac complications included acute aortic regurgitation in 2 patients and myocardial perforation in one. In an 8.2&lt;FONT FACE=Symbol&gt;&amp;plusmn;&lt;/FONT&gt;1.3-year follow-up, 5 of the 12 patients died (2 patients due to septicemia and 3 patients due to congestive heart failure). Five of the other 7 patients underwent a new procedure and 2 required surgery.CONCLUSION: Percutaneous aortic valvuloplasty in neonates is not an effective procedure in the 1st week of life, because at this age the common presentation is cardiogenic shock. It is possible that, in those patients with critical aortic stenosis, dilation of the aortic valve during fetal life may change the prognosis of its clinical outcome.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endocardial fibroelastosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial ischemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>valvuloplasty through balloon catheter</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic stenosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>I Diretriz de Dor Torácica na Sala de Emergência</s1>
</fA08>
<fA11 dir="011000">
<s1>Roberto Bassan</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Lúcia Pimenta</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Ernesto Leães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ari Timerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>André Volschan</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Carisi Polanczyk</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Cristina Clare</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Delcio Gonçalves da Silva Júnior</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Flávio Berriel Abreu</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Francisco das Chagas Monteiro Júnior</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Gilmar Valdir Greque</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Gustavo Luis Gouvea de Almeida</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Harry Correa Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Luis Eduardo de Magalhães Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>Maria das Graças Sousa de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>Olímpio Ribeiro França Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>Roberto Gamarski</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>Sergio Gouveia de Araújo Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="201000">
<s1>Sidney Campodonico Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="211000">
<s1>Waldomiro Barbosa Filho</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-22</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Prospective assessment of different indices of cardiac risk for patients undergoing noncardiac surgeries</s1>
</fA08>
<fA11 dir="011000">
<s1>Roberto Henrique Heinisch</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Caroline Ferrari Barbieri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>João Rogério Nunes Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Glauce Lippi de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Liana Miriam Miranda Heinisch</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Santa Catarina  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>333-338</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To compare the accuracy of 4 different indices of cardiac risk currently used for predicting perioperative cardiac complications. METHODS: We studied 119 patients at a university-affiliated hospital whose cardiac assessment had been required for noncardiac surgery. Predictive factors of high risk for perioperative cardiac complications were assessed through clinical history and physical examination, and the patients were followed up after surgery until the 4th postoperative day to assess the occurrence of cardiac events. All patients were classified according to 4 indices of cardiac risk: the Goldman risk-factor index, Detsky modified risk index, Larsen index, and the American Society of Anesthesiologists' physical status classification and their compared accuracies, examining the areas under their respective receiver operating characteristic (ROC) curves. RESULTS: Cardiac complications occurred in 16% of the patients. The areas under the ROC curves were equal for the Goldman risk-factor index, the Larsen index, and the American Society of Anesthesiologists' physical status classification: 0.48 (SEM &amp;plusmn; 0.03). For the Detsky index, the value found was 0.38 (SEM &amp;plusmn; 0.03). This difference in the values was not statistically significant. CONCLUSION: The cardiac risk indices currently used did not show a better accuracy than that obtained randomly. None of the indices proved to be significantly better than the others. Studies to improve our ability to predict such complications are still required.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac complications</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>noncardiac surgeries</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>indices of risk</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>A multicenter, open-label study of the efficacy and safety of telmisartan in mild to moderate hypertensive patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Frida Liane Plavnik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Artur Beltrame Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Osvaldo Ramos Hospital do Rim e Hipertensão </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>345-350</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the efficacy and tolerability of telmisartan, given once a day to patients with mild to moderate hypertension, as well as to assess the 24-hour blood pressure profile with ABPM. METHODS: Initially, 163 patients over 18 were selected, regardless of sex, with blood pressure levels &gt;140/90mmHg at visit 1, which was confirmed at visit 2. One hundred thirty-four patients completed the study. After a 4-week placebo run-in phase, telmisartan 40mg/daily was given for 6 weeks. In those patients whose blood pressure (BP) levels were lower than 140/90mmHg, the same dosage was kept for an additional period of 6 weeks. For those who had BP higher than 140/90mmHg, the dosage was increased to 80mg/daily. Sixty-two patients were included in a subgroup that underwent ABPM 3 different times during the study. RESULTS: In the overall group, blood pressure reduction ranged from 162.3±14.5/101.3±5.75 mmHg (baseline) to 147.3±20.1/90.8±10.9 mmHg (week 12) (p&lt;0.05). Mean blood pressure decreases were 14.4mmHg for systolic BP and 10.3mmHg for diastolic BP, after 12 weeks of active treatment. A subanalysis showed that 47 (35%) patients took telmisartan 40mg throughout the study and 81 (65%) had the dosage increased to 80mg daily. Using ABPM, an 8-mmHg reduction in systolic BP as well as a 5-mmHg reduction in diastolic BP were observed, when compared with baseline values in the final 6 hours (18-24 hours after the last dose of study medication). CONCLUSION: Our results confirm that telmisartan given once a day is effective in reducing blood pressure levels in mild to moderate hypertensive patients. This reduction occurs in a sustained and gradual manner during a 24-hour period confirmed by ABPM.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>telmisartan</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ABPM</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Benefits of exercise training in the treatment of heart failure: study with a control group</s1>
</fA08>
<fA11 dir="011000">
<s1>Mário Sérgio Vaz da Silva</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Edimar Alcides Bocchi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Guilherme Veiga Guimarães</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Roberto Padovani</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria Helena Gaíva G. da Silva</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Shirley Ferreira Pereira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ronaldo Ducchesi Fontes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Mato Grosso Instituto de Saúde Coletiva </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>357-362</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>40</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Exercise training programs have been proposed as adjuncts to treatment of heart failure. The effects of a 3-month-exercise-training-program with 3 exercise sessions per week were assessed in patients with stable systolic chronic heart failure. METHODS: We studied 24 patients with final left ventricle diastolic diameter of 70±10mm and left ventricular ejection fraction of 37±4%. Mean age was 52±16 years. Twelve patients were assigned to an exercise training group (G1), and 12 patients were assigned to a control group (G2). Patients underwent treadmill testing, before and after exercise training, to assess distance walked, heart rate, systolic blood pressure, and double product. RESULTS: In G2 group, before and after 3 months, we observed, respectively distance walked, 623±553 and 561± 460m (ns); peak heart rate, 142±23 and 146± 33b/min (ns); systolic blood pressure, 154±36 and 164±26 mmHg (ns); and double product, 22211± 6454 and 24293±7373 (ns). In G1 group, before and after exercise, we observed: distance walked, 615±394 and 970± 537m (p&lt;0.003) peak heart rate, 143±24 and 143±29b/min (ns); systolic blood pressure, 136±33 and 133±24 mmHg (ns); and double product, 19907± 7323 and 19115±5776, respectively. Comparing the groups, a significant difference existed regarding the variation in the double product, and in distance walked. CONCLUSION: Exercise training programs in patients with heart failure can bring about an improvement in physical capacity.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise training</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Acute myocardial infarction in elderly patients: comparative analysis of the predictors of mortality. The elderly versus the young</s1>
</fA08>
<fA11 dir="011000">
<s1>Marisa F. Leal</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Newton Fernando Stadler de Souza Filho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Hermínio Haggi Filho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Estela Regina Klosoviski</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eva Cantalejo Munhoz</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>PUCPR Aliança Saúde Centro de Diagnose Cardiovascular</s1>
<s2>Curitiba </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal do Rio Grande do Sul  </s1>
<s2>Rio Grande do Sul Porto Alegre</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>369-374</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study the in-hospital evolution of patients aged 65 years and older, with acute myocardial infarction, who were treated by direct coronary angioplasty with no fibrinolytic therapy. METHODS: We studied 885 patients divided into 2 groups as follows: group I (GI) - 293 (33.4%) patients aged &amp;sup3; 65 years (72&amp;plusmn;5 years), and group II (GII) - 592 patients aged &lt; 65 years (57&amp;plusmn;9 years). Multivessel disease was more frequent in GI (63.5% x 49.7%; p=0.001). A greater number of GII patients were class I or II of the clinical Killip-Kimball classification (K) (80.2% x 67.2%; p=0.00002), while a significant number of GI patients were KIII and KIV (24.3% x 12.8%; p=0.00003). RESULTS: Group I had a lower index of success (84.6% x 94%; p=0.0002) and a greater in-hospital mortality (12.2% x 4.7%; p=0.00007). The predictors of mortality in GI were as follows: previous infarction (20.5% x 6.3%; p=0.02), anterior location (13.4% x 6.4%; p=0.03), and male sex (10.4% x 4.4%; p=0.007). CONCLUSION: Elderly patients had more severe acute myocardial infarction and more extensive disease, a lower index of success, and greater in-hospital mortality. Previous infarction, anterior location and male sex were identified as predictors of mortality in the elderly group (GI).</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>the elderly</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Epidemiological aspects of adherence to the treatment of hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>Jadelson P. Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fábio Vilas-Boas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Hildenizia Chagas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marianna Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Escola Bahiana de Medicina e Saúde Pública  </s1>
<s2>Salvador </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>380-384</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the reasons given by patients for interrupting their pharmacological treatment of hypertension. METHODS: We carried out an observational cross-sectional study, in which a questionnaire was applied and blood pressure was measured in 401 patients in different centers of the state of Bahia. The patients selected had been diagnosed with hypertension and were not on antihypertensive treatment for at least 60 days. Clinical and epidemiological characteristics of the groups were analyzed. RESULTS: Of the 401 patients, 58.4% were females, 55.6% of whom white; 60.5% of the males were white. The major reasons alleged for not adhering to treatment were as follows (for males and females respectively): normalization of blood pressure (41.3% and 42.3%); side effects of the medications (31.7% and 24.8%); forgetting to use the medication (25.2% and 20.1%); cost of medication (21.6% and 20.1%); fear of mixing alcohol and medication (23.4% and 3.8%); ignoring the need for continuing the treatment (15% and 21.8%); use of an alternative treatment (11.4% and 17.1%); fear of intoxication (9.6% and 12.4%); fear of hypotension (9.6% and 12%); and fear of mixing the medication with other drugs (8.4% and 6.1%). CONCLUSION: Our data suggest that most factors concerning the abandonment of the treatment of hypertension are related to lack of information, and that, despite the advancement in antihypertensive drugs, side effects still account for most abandonments of treatment.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>systemic arterial hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treatment</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adherence</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Comparison between tilt-table testing results performed during different periods of the day</s1>
</fA08>
<fA11 dir="011000">
<s1>Tan Chen Wu</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Denise Hachul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Mauricio Scanavacca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eduardo Sosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>São Paulo University Heart Institute </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>390-394</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>44</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the influences of circadian variations on tilt-table testing (TTT) results by comparing the positivity rate of the test performed during the morning with that of the test performed in the afternoon and to evaluate the reproducibility of the results in different periods of the day. METHODS: One hundred twenty-three patients with recurrent unexplained syncope or near-syncope referred for TTT were randomized into 2 groups. In group I, 68 patients, TTT was performed first in the afternoon and then in the morning. In group II, 55 patients, the test was performed first in the morning and then in the afternoon. RESULTS: The TTT protocol was the prolonged passive test, without drug sensitization. Twenty-nine (23.5%) patients had a positive result in at least one of the periods. The positivity rate for each period was similar: 20 (16.2%) patients in the afternoon and 19 (15.4%) in the morning (p=1.000). Total reproducibility (positive/positive and negative/negative) was observed in 49 (89%) patients in group I and in 55 (81%) in group II. Reproducibility of the results was obtained in 94 (90.4%) patients with first negative tests but in 10 (34%) patients with first positive tests. CONCLUSION: TTT could be performed during any period of the day, and even in the 2 periods to enhance positivity. Considering the low reproducibility rate of the positive tests, serial TTT to evaluate therapeutic efficacy should be performed during the same period of the day.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tilt-table testing</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>circadian variation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>vasovagal syncope</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Metabolic and hemodynamic effects of saline infusion to maintain volemia on temporary abdominal aortic occlusion</s1>
</fA08>
<fA11 dir="011000">
<s1>Fábio Ferreira Amorim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Bruno do Vale Pinheiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Hélio Romaldini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>400-404</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze hemodynamic and metabolic effects of saline solution infusion in the maintenance of blood volume in ischemia-reperfusion syndrome during temporary abdominal aortic occlusion in dogs. METHODS: We studied 20 dogs divided into 2 groups: the ischemia-reperfusion group (IRG, n=10) and the ischemia-reperfusion group with saline solution infusion aiming at maintaining mean pulmonary arterial wedge pressure between 10 and 20 mmHg (IRG-SS, n=10). All animals were anesthetized with sodium thiopental and maintained on spontaneous ventilation. Occlusion of the supraceliac aorta was obtained with inflation of a Fogarty catheter inserted through the femoral artery. After 60 minutes of ischemia, the balloon was deflated, and the animals were observed for another 60 minutes of reperfusion. RESULTS: IRG-SS dogs did not have hemodynamic instability after aortic unclamping, and the mean systemic blood pressure and heart rate were maintained. However, acidosis worsened, which was documented by a greater reduction of arterial pH that occurred especially due to the absence of a respiratory response to metabolic acidosis that was greater with the adoption of this procedure. CONCLUSION: Saline solution infusion to maintain blood volume avoided hemodynamic instability after aortic unclamping. This procedure, however, caused worsening in metabolic acidosis in this experimental model.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>reperfusion lesion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hemodynamic</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>volemia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Primary coronary angioplasty in 9,434 patients during acute myocardial infarction: predictors of major in- hospital adverse events from 1996 to 2000 in Brazil</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Alberto Mattos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Amanda G.M.R. Sousa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ibraim M. F. Pinto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cantídio de Moura Campos Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>André Labrunie</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cláudia Rodrigues Alves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Jamil Saad</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>412-418</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To verify the results after the performance of primary coronary angioplasty in Brazil in the last 4 years. METHODS: During the first 24 hours of acute myocardial infarction onset, 9,434 (12.2%) patients underwent primary PTCA. We analyzed the success and occurrence of major in-hospital events, comparing them over the 4-year period. RESULTS: Primary PTCA use increased compared with that of all percutaneous interventions (1996=10.6% vs. 2000=13.1%; p&lt;0.001). Coronary stent implantation increased (1996=20% vs. 2000=71.9%; p&lt;0.001). Success was greater (1998=89.5% vs. 1999=92.5%; p&lt;0.001). Reinfarction decreased (1998=3.9% vs. 99=2.4% vs. 2000=1.5%; p&lt;0.001) as did emergency bypass surgery (1996=0.5% vs. 2000=0.2%; p=0.01). In-hospital deaths remained unchanged (1996=5.7% vs. 2000=5.1%, p=0.53). Balloon PTCA was one of the independent predictors of a higher rate of unsuccessful procedures (odds ratio 12.01 [CI=95%] 1.58-22.94), and stent implantation of lower mortality rates (odds ratio 4.62 [CI=95%] 3.19-6.08). CONCLUSION: The success rate has become progressively higher with a significant reduction in reinfarction and urgent bypass surgery, but in-hospital death remains nearly unchanged. Coronary stenting was a predictor of a lower death rate, and balloon PTCA was associated with greater procedural failure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stents</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>O paradoxo da doença coronariana</s1>
</fA08>
<fA11 dir="011000">
<s1>Hudson Hübner França</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>419-421</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 10/2002 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>427-427</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeitos dos exercícios físicos aeróbio e de força nas lipoproteínas HDL, LDL e lipoproteína(a)</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo Seixas Prado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Estélio Henrique Martin Dantas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>429-433</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>45</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900413</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Do bastão de Esculápio ao caduceu de Mercúrio</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo R. Prates</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>434-436</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900414</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Interpretação de um teste sob a visão epidemiológica: eficiência de um teste</s1>
</fA08>
<fA11 dir="011000">
<s1>Takao Kawamura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Cardioclínica Araçatuba  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>437-441</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>4</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900415</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Homem de 73 anos com tamponamento cardíaco três dias após angioplastia coronariana (Instituto do Coração do Hospital das Clínicas da FMUSP, São Paulo)</s1>
</fA08>
<fA11 dir="011000">
<s1>Daniela Calderaro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Renato Scotti Bagnatori</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Renata Bacic Palhares</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>422-426</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Trombectomia intracoronária: uma alternativa no manejo das síndromes isquêmicas agudas</s1>
</fA08>
<fA11 dir="011000">
<s1>Rogério Sarmento-Leite</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo R. M. Machado</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sinara L. Garcia</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antônio Satyro Neto</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Jorge P. Ribeiro</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Cardiosinos  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Hospital Regina  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="040000">
<s1>Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>428-428</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900412</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Normatização dos equipamentos e técnicas para realização de exames de teste de inclinação ortostática (tilt table test)</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>442-442</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900416</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Cateterismo cardíaco intervencionista na cardiologia pediátrica: o posicionamento médico quanto às aplicações atuais e perspectivas</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>443-445</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Surgical treatment of partial atrioventricular septal defect: functional analysis of the mitral valve in the postoperative period</s1>
</fA08>
<fA11 dir="011000">
<s1>Josué Viana Castro Neto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Chaccur</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cláudio Leo Gelape</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eliseu de Sousa Santos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Hélio Carlos Falcão</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Mário Issa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antoninho Sanfins Arnoni</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Flávio Sanches Almeida</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Camilo Abdulmassih Neto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Jarbas Jackson Dinkhuysen</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Luís Carlos Bento Souza</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Paulo Paredes Paulista</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Associação do Sanatório Sírio Hospital do Coração </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>450-453</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study mitral valve function in the postoperative period after correction of the partial form of atrioventricular septal defect. METHODS: Fifty patients underwent surgical correction of the partial form of atrioventricular septal defect. Their mean age was 11.8 years and 62% of the patients were males. Preoperative echocardiography showed moderate and severe mitral insufficiency in 44% of the patients. The mitral valve cleft was sutured in 45 (90%) patients (group II - GII). Echocardiographies were performed in the early postoperative period, and 6 and 12 months after hospital discharge. RESULTS: The patients who had some type of arrhythmia in the postoperative period had ostium primum atrial septal defect of a larger size (2.74 x 2.08 cm). All 5 patients in group I (GI), who did not undergo closure of the cleft, had a competent mitral valve or mild mitral insufficiency in the preoperative period. One of these patients began to have moderate mitral insufficiency in the postoperative period. On the other hand, in GII, 88.8% and 82.2% of the patients had competent mitral valve or mild mitral insufficiency in the early and late postoperative periods, respectively. CONCLUSION: The mitral valve cleft was repaired in 90% of cases. Echocardiography revealed competent mitral valve or mild mitral insufficiency in 88.8% and 82.2% of GII patients in the early and late postoperative periods, respectively.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>partial atrioventricular septal defect</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valve</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular surgical procedures</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Thiamin, selenium, and copper levels in patients with idiopathic dilated cardiomyopathy taking diuretics</s1>
</fA08>
<fA11 dir="011000">
<s1>Sérgio da Cunha</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Francisco Manes Albanesi Filho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vera Lúcia Freire da Cunha Bastos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Domingos Senra Antelo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mário Miranda de Souza</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UERJ Hospital Universitário Pedro Ernesto </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>UERJ IBRAG </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>460-465</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the association of thiamin, selenium, and copper serum levels with cardiac function in patients with idiopathic dilated cardiomyopathy using diuretics, and also to compare them with levels in control patients with no evidence of disease. METHODS: The study comprised 30 patients with heart disease and 30 healthy control individuals. Thiamin was analyzed by measuring the activity of erythrocytic transketolase and the effect of thiamin pyrophosphate. Selenium and copper serum levels were measured by hydride generation and flame atomic absorption spectrophotometry, respectively. RESULTS: Thiamin deficiency was observed in 10% of the control individuals and in 33% of the patients with heart disease (p=0.02). The mean selenium and copper serum levels in control individuals and patients with heart disease were, respectively, 73.2&amp;plusmn;9.9 &amp;micro;g/L (56.5 to 94.5 &amp;micro;g/L) and 72.3&amp;plusmn;14.3 &amp;micro;g/L (35.5 to 94 &amp;micro;g/L) (p=0.77); 1.1&amp;plusmn;0.4mg/L (0.6 to 1.8mg/L) and 1.2&amp;plusmn; 0.4mg/L (0.6 to 2.2mg/L) (p=0.27). No association between the levels of these nutrients and cardiac function was observed. CONCLUSION: Thiamin deficiency was significantly more frequent in patients with heart disease. No significant difference was observed between the mean selenium and copper serum levels in control individuals and in patients with heart disease. The results suggest possible benefits with thiamin replacement in patients taking diuretics.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thiamin</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>selenium</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>copper</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diuretics</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiomyopathy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Vector electrocardiographic alterations after percutaneous septal ablation in obstructive hypertrophic cardiomyopathy: possible anatomic causes</s1>
</fA08>
<fA11 dir="011000">
<s1>Andrés Ricardo Pérez Riera</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Silvia Judith Fortunato de Cano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Manuel Nicolás Cano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Vera Márcia L. Gimenez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luciano Augusto de Padua Fleury Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Eduardo M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>471-475</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Analyze the dromotropic disturbances (vector-electrocardiographic), and the possible anatomic causes, provoked by selective alcohol injection in the septal branch, for percutaneous treatment, of obstructive hypertrophic cardiomyopathy. METHODS: Ten patients with a mean age of 52.7 years underwent percutaneous septal ablation (PTSA) from october 1998; all in functional class III/IV). Twelve-lead electrocardiogram was performed prior to and during PTSA, and later electrocardiogram and vectorcardiogram according to Frank's method. The patients were followed up for 32 months. RESULTS: On electrocardiogram (ECG) prior to PTSA all patients had sinus rhythm and left atrial enlargement, 8 left ventricular hypertrophy of systolic pattern. On ECG immediately after PTSA, 8 had complete right bundle-branch block; 1 transient total atrioventricular block; 1 alternating transient bundle-branch block either right or hemiblock. On late ECG 8 had complete right bundle-branch block confirmed by vectorcardiogram, type 1 or Grishman. CONCLUSION: Septal fibrosis following alcohol injection caused a predominance of complete right bundle-branch block, different from surgery of myotomy/myectomy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous septal ablation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>obstructive hypertrophic cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>vector electrocardiographic alterations</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Myocardial revascularization in renal transplant patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Daniel de Souza Delgado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luís Roberto Gerola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Nelson Américo Hossne Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>João Nelson R. Branco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Enio Buffolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>480-483</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the results of surgical myocardial revascularization in renal transplant patients. METHODS: From 1991 to 2000, 11 renal transplant patients, whose ages ranged from 36 to 59 (47.5&amp;plusmn;8) years, 8 males and 3 females, underwent myocardial revascularization. The time interval between renal transplantation and myocardial revascularization ranged from 25 to 120 (mean of 63.8&amp;plusmn;32.7) months. RESULTS: The in-hospital mortality rate was 9%. One patient died on the 4th postoperative day from septicemia and respiratory failure. The mean graft/patient ratio was 2.7&amp;plusmn;0.8. Only 1 patient required slow hemodialysis during 24 hours in the postoperative period, and no patient had a definitive renal lesion or lost the transplanted kidney. The actuarial survival curves after 1, 2, and 3 years were, respectively, 90.9%, 56.8%, and 56.8%. CONCLUSION: Renal transplant patients may undergo myocardial revascularization with no lesion in or loss of the transplanted kidney.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>renal transplantation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Pregnancy and peripartum cardiomyopathy: a comparative and prospective study</s1>
</fA08>
<fA11 dir="011000">
<s1>Walkiria Samuel Avila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Elisa Carneiro de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cleide K. Tschaen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eduardo Giusti Rossi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>489-493</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess pregnancy outcome in women with peripartum cardiomyopathy and to compare it with idiopathic cardiomyopathy. METHODS: Twenty-six pregnant women, aged 28.4&amp;plusmn;6.1 years, with dilated cardiomyopathy were followed. Eighteen patients had peripartum cardiomyopathy [11 with persistent left ventricular systolic dysfunction (EF=45.2&amp;plusmn;2) and 7 with recovered ventricular function (EF=62.3&amp;plusmn;3.6)]. The 8 remaining patients had idiopathic cardiomyopathy (EF= 43.5&amp;plusmn;4.1). During the prenatal period, limited physical activity and a low-sodium diet were recommended, and hospitalization was recommended when complications occurred. RESULTS: Of the 26 patients, 11 (42.3%) had a normal delivery; 9(35.5%) had cardiac complications, 6 (22.2%) had obstetric complications. Two patients (7.7%) died. Two preterm pregnancies occurred, with 26 health newborns (2 sets of twins). Two miscarriages took place. The cardiac complication rate during pregnancy was lower (p&lt;0.009) in the peripartum cardiomyopathy group without ventricular dysfunction and greater (p=0.01) in the idiopathic group when compared with the peripartum group with ventricular dysfunction. Changes in left ventricular ejection fraction were not observed (p&lt;0.05) in the postpartum period, when compared with that during pregnancy in the 3 groups. CONCLUSION: Pregnancy in patients with dilated cardiomyopathy is associated with maternal morbidity. Left ventricular function is a prognostic factor and must be the most parameter when counseling patients with peripartum cardiomyopathy about a new pregnancy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>peripartum cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pregnancy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>maternal complication</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetal complication</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Relation between the behaviors of P-wave and QT dispersions in elderly patients with heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Cláudia Szlejf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jairo Rays</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Otávio Celso Eluf Gebara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Núbia Welerson Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Humberto Pierri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Amit Nussbacher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>João Batista Serro-Azul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Nelson Samesima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Carlos Alberto Pastore</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Maurício Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>497-499</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the relation between P-wave and QT dispersions in elderly patients with heart failure. METHODS: Forty-seven elderly patients (75.6±6 years) with stable heart failure in NYHA functional classes II or III and with ejection fractions of 37±6% underwent body surface mapping to analyze P-wave and QT dispersions. The degree of correlation between P-wave and QT dispersions was assessed, and P-wave dispersion values in patients with QT dispersion greater than and smaller than 100 ms were compared. RESULTS: The mean values of P-wave and QT dispersions were 54±14 ms and 68±27 ms, respectively. The correlation between the 2 variables was R=0.41 (p=0.04). In patients with QT dispersion values &gt; 100 ms, P-wave dispersion was significantly greater than in those with QT dispersion values &lt; 100 ms (58±16 vs 53±12 ms, p=0.04 ). CONCLUSION: Our results suggest that, in elderly patients with heart failure, a correlation between the values of P-wave and QT dispersions exists. These findings may have etiopathogenic, pathophysiologic, prognostic, and therapeutic implications, which should be investigated in other studies.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>P-wave dispersion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>QT dispersion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Evaluation of the marker of hypercoagulability prothrombin fragment F 1+2 in patients with mechanical or biological heart valve prostheses</s1>
</fA08>
<fA11 dir="011000">
<s1>Claudia Natália Ferreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Lauro Mello Vieira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luci Maria Sant'Ana Dusse</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Faria Santos Amaral</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>William Antônio de Magalhães Esteves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Lúcia Maria Amorim Fenelon</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Maria das Graças Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFMG Faculdade de Farmácia Depto de Análises Clínicas e Toxicológicas</s1>
<s2>Belo Horizonte MG</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>505-509</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To investigate whether patients with heart valve prostheses and similar International Normalized Ratios (INR) have the same level of protection against thromboembolic events, that is, whether the anticoagulation intensity is related to the intensity of hypercoagulability supression. METHODS: INR and plasma levels of prothrombin fragment 1+2 (F1+2) were assessed in blood samples of 27 patients (7 with mechanical heart valves and 20 with biological heart valves) and 27 blood samples from healthy donors that were not taking any medication. RESULTS: Increased levels of F1+2 were observed in blood samples of 5 patients with heart valve prostheses taking warfarin. These findings reinforce the idea that even though patients may have INRs, within the therapeutic spectrum, they are not free from new thromboembolic events. CONCLUSION: Determination of the hypercoagulability marker F1+2 might result in greater efficacy and safety for the use of oral anticoagulants, resulting in improved quality of life for patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart valve prostheses</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>warfarin</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prothrombin fragment 1+2</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Comparison between young males and females with acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Ricardo Augusto Slaibi Conti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Cecília Solimene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Protásio Lemos da Luz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alexandre Miguel Benjó</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Pedro Alves Lemos Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Antônio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>518-525</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>78</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the differences between young males and females after acute myocardial infarction. METHODS: We retrospectively studied 236 patients (54 females and 182 males) after acute myocardial infarction and during hospital stay assessed the following parameters: risk factors; the treatment used; the pattern of coronary artery obstruction; left ventricular ejection fraction; complications; and, using a logistic regression model, the factors related to the occurrence of reinfarction and death. RESULTS: No significant difference was observed between the sexes in risk factors, pattern of coronary artery obstruction, and left ventricular function. The time interval between symptom onset and treatment was longer in females (p=0.03), who underwent thrombolysis (p=0.01) and angioplasty (p=0.03) less frequently than males did, but not myocardial revascularization. Female sex (OR = 5.98) and diabetes (OR = 14.52) were independent factors related to the occurrence of reinfarction and death. CONCLUSION: Young males and females after acute myocardial infarction did not differ in coronary risk factors, and clinical and hemodynamic characteristics. Females had their treatment started later, and they underwent chemical thrombolysis and angioplasty less frequently than males did. Female sex and diabetes were related to the occurrence of reinfarction and death.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>young</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sex</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>clinical evolution</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Intra-His bundle block: clinical, electrocardiographic, and electrophysiologic characteristics</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo M. Andréa</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jacob Atié</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Washington A. Maciel</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Nilson A. de Oliveira Jr</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz Eduardo Camanho</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luís Gustavo Belo</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Hecio Affonso de Carvalho</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Leonardo Siqueira</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Eduardo Saad</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Ana Claudia Venancio</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFRJ Hospital Universitário Clementino Fraga Filho </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Instituto Estadual de Cardiologia Aloysio de Castro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Clínica São Vicente  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>532-537</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the clinical, electrocardiographic, and electrophysiologic characteristics of patients (pt) with intra-His bundle block undergoing an electrophysiologic study (EPS). METHODS: We analyzed the characteristics of 16 pt with second-degree atrioventricular block and symptoms of syncope or dyspnea, or both, undergoing conventional EPS. RESULTS: Intra-His bundle block was documented in 16 pt during an EPS. In 15 (94%) pt, the atrioventricular block was recorded in sinus rhythm; 4 (25%) pt had intra-His Wenckebach phenomenon, which correlated with Mobitz I (MI) atrioventricular block on the electrocardiogram. Seven (44%) pt had 2:1 atrioventricular block, 2 of whom were asymptomatic (12.5%). One (6%) pt had intra- and infra-His bundle block. Clinically, 11 (68%) pt had syncope or presyncope, 3 (18%) had dyspnea on exertion, and 2 (12.5%) were asymptomatic. Eight (50%) pt had bundle-branch block as follows: 4 (25%) pt had left bundle-branch block, and 4 (25%) had right bundle-branch block. Left anterosuperior divisional block was observed in 3 pt (19%), 2 of whom with associated right bundle-branch block. CONCLUSION: Intra-His bundle block was observed in 11% of the pt with second-degree atrioventricular block, syncope or presyncope, or both, it being the most frequent clinical presentation. Intra-His bundle block was more common in the elderly (&gt; 60 years) and among females. The most frequent electrocardiographic presentations were second-degree Mobitz I or type 2:1 atrioventricular block.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>intra-His</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrioventricular block</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>syncope</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Anomalous origin of the left pulmonary artery from the ascending aorta: successful surgical correction in an infant with fallot's tetralogy</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Amaral</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mônica A. C. Teixeira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>João A. Granzotti</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Henrique Manso</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Walter V. A. Vicente</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina de Ribeirão Preto Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>UNAERP Faculdade de Medicina </s1>
<s2>Ribeirão Preto </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>541-543</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>7</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We describe the case of a 40-day-old female patient with a history of breathlessness since birth who was referred to our hospital for surgical correction of common arterial trunk. The invasive investigation disclosed a Fallot¢s tetralogy anatomy associated with an anomalous origin of the left pulmonary artery from the ascending aorta. Immediately after diagnosis, the patient underwent a successful total surgical correction of the defect, including simultaneous anastomosis of the left pulmonary artery to the pulmonary trunk.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Treatment of delayed rupture of the left ventricle after mitral valve replacement</s1>
</fA08>
<fA11 dir="011000">
<s1>Walter J. Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Malcolm Underwood</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Raimondo Ascione</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Clinton T. Lloyd</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Gianni D. Angelini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>University of Bristol Bristol Heart Institute Bristol Royal Infirmary</s1>
<s2>Bristol </s2>
<s3>United Kingdom</s3>
</fA14>
<fA20 dir="000000">
<s1>547-549</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>8</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900512</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Rupture of the left ventricle following mitral valve replacement is a catastrophic complication with deadly consequences. We report here the case of a 75-year-old man who underwent elective mitral valve replacement for severe mitral regurgitation. Delayed type 1 rupture of the left ventricle developed 3 hours postoperatively in the intensive care unit. A salvaging maneuver was used, which gained time, allowing reoperation and successful intraventricular repair.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Valva ou válvula?</s1>
</fA08>
<fA11 dir="011000">
<s1>Aloir Queiroz de Araujo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Espírito Santo Hospital das Clínicas </s1>
<s2> Espírito Santo</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>550-551</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>8</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900513</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 11/2002 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>552-552</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900514</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Angina pós-cirurgia de revascularização miocárdica secundária à estenose de artéria subclávia esquerda: causa incomum, tratamento comum</s1>
</fA08>
<fA11 dir="011000">
<s1>Rogério Sarmento-Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luis Maria Yordi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gilberto Heineck</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Ortiz Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Carlos A. M. Gottschall</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>553-554</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900515</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Valvas cardíacas obtidas por engenharia de tecidos: a mais nova geração de próteses biológicas</s1>
</fA08>
<fA11 dir="011000">
<s1>Pascal M. Dohmen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Francisco Diniz Affonso da Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Iseu de Santo Elias Affonso da Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Wolfgang Konertz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Humboldt Hospital Charité </s1>
<s2>Berlim </s2>
<s3>Alemanha</s3>
</fA14>
<fA14 dir="020000">
<s1>Pontifícia Universidade Católica do Paraná Santa Casa de Misericórdia </s1>
<s2> Paraná</s2>
<s3>Curitiba</s3>
</fA14>
<fA20 dir="000000">
<s1>555-559</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900516</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Normatização dos equipamentos e técnicas de exame para realização de implante de desfibriladores</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>560-560</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900517</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>78</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>I Diretriz da Sociedade Brasileira de Cardiologia Sobre Cardiologia Nuclear</s1>
</fA08>
<fA11 dir="011000">
<s1>Gilson Soares Feitosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Carlos Nicolau</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>William Azem Chalela</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Cláudio Meneghetti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antônio Augusto Brito Ximenes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cristiana Altino de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>João Vicente Vítola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luiz Eduardo Mastrocolla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Adelanir Antonio Barroso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Dalton Bertolim Précoma</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Fernando Salis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>José Antonio Marin-Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="131000">
<s1>Carlos Alberto Buchpieguel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="141000">
<s1>Fernando Salis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="151000">
<s1>Romeu Sérgio Meneghelo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="161000">
<s1>Fábio Sândoli de Brito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Sociedade Brasileira de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>InCor  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-42</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07800001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Tratamento Farmacológico na Cardiologia Pediátrica: Os Avanços e o Manejo Específico em cada Síndrome</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>561-563</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>The Role of B-Type Natriuretic Peptide in the Diagnosis of Congestive Heart Failure in Patients Presenting to an Emergency Department with Dyspnea</s1>
</fA08>
<fA11 dir="011000">
<s1>Humberto Villacorta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Adriana Duarte</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Neison Marques Duarte</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ângela Carrano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Hans J. F. Dohmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Francisco Eduardo G. Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco Unidade de Emergência </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>569-572</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the utility of B-type natriuretic peptide (BNP) in the diagnosis of congestive heart failure (CHF) in patients presenting with dyspnea to an emergency department (ED). METHODS: Seventy patients presenting with dyspnea to an ED from April to July 2001 were included in the study. Mean age was 72&amp;plusmn;16 years and 33 (47%) were male. BNP was measured in all patients at the moment of admission to the ED. Emergency-care physicians, blinded to BNP values, were required to assign a probable initial diagnosis. A cardiologist retrospectively reviewed the data (blinded to BNP measurements) and assigned a definite diagnosis, which was considered the gold standard for assessing the diagnostic performance of BNP. RESULTS: The mean BNP concentration was higher in patients with CHF (n=36) than in those with other diagnoses (990&amp;plusmn;550 vs 80&amp;plusmn;67 pg/mL, p&lt;0.0001). Patients with systolic dysfunction had higher BNP levels than those with preserved systolic function (1,180&amp;plusmn;641 vs 753&amp;plusmn;437 pg/mL, p=0.03). At a blood concentration of 200 pg/mL, BNP showed a sensitivity of 100%, specificity of 97.1%, positive predictive value of 97.3%, and negative predictive value of 100%. The application of BNP could have potentially corrected all 16 cases in which the diagnosis was missed by the emergency department physician. CONCLUSION: BNP measurement is a useful tool in the diagnosis of CHF in patients presenting to the ED with dyspnea.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>natriuretic peptides</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>emergency medicine</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Doppler Echocardiographic Assessment of Pregnant Women with Chronic Arterial Hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>Nádia Cristiane de Mattia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Regina Lúcia Barbin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vera Therezinha M. Borges</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Carlos Peraçoli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Beatriz B. Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNESP Faculdade de Medicina de Botucatu </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>579-584</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess structural and functional cardiac changes in asymptomatic pregnant women with chronic arterial hypertension (CAH). METHODS: One hundred pregnant women with CAH underwent conventional Doppler echocardiography. The Student t test was used to compare them with 29 normotensive pregnant women (NT) in their third gestational trimester. RESULTS: Systolic (SBP; mmHg) and diastolic (DBP; mmHg) blood pressure values were higher (p&lt;0.001) in the CAH pregnant women (SBP: 139&amp;plusmn;19 and DBP: 92&amp;plusmn; 18) as compared with those of the NT group (SBP: 112&amp;plusmn;10 and DBP: 74&amp;plusmn;9). A significant enlargement of the left atrium (4.10&amp;plusmn;0.48 cm vs 3.6&amp;plusmn;0.3 cm; p&lt;0.001) and of the left ventricular normalized mass (59.6&amp;plusmn;19.7 g/cm2,7 vs 41.9&amp;plusmn;3.4 g/cm2,7; p&lt;0.001) was observed. Cardiac output (CO, L/min) and systolic volume (SV, mL) were significantly higher in the CAH group (CO: 6.0&amp;plusmn;1.54 vs 4.9&amp;plusmn;2.1, p&lt;0.01; SV: 77.3&amp;plusmn;19.8 vs 56.5&amp;plusmn;25.8, p&lt;0.001). CONCLUSION: Chronic hypertensive pregnant women have structural and functional cardiac changes that justify routine cardiologic assessment, even in the absence of cardiopulmonary symptoms.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>volume overload</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Stress During ACLS Courses: Is it Important for Learning Skills?</s1>
</fA08>
<fA11 dir="011000">
<s1>Emilton Lima Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Knopfholz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carla M. Menini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifical Catholic University of Paraná  </s1>
<s2> </s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>589-592</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the influence of stress on teaching medical emergencies in an Advanced Cardiac Life Support (ACLS) course and to verify this influence on learning, and the efficiency of emergency care training. METHODS: Seventeen physicians signed up for an ACLS course. Their pulses were taken and blood pressure (BP) verified on the first day, before the beginning of the course, and on the second day, during the theoretical and practical test (TPT). Variations in pulse rates and BP were compared with students' test grades. Then, students answered a questionnaire of variables (QV) about the amount of sleep they had during the course, the quantity of study material and the time spent studying for the course, and a stress scale graphic. RESULTS: Seven students had a pulse variation less than 10% between the 2 periods and 10 had a 10% or more variation. Grades on TPT were, respectively, 91.4&amp;plusmn;2.4 and 87.3&amp;plusmn;5.2 (p&lt;0.05). Six students had a BP variation less than 20 mmHg, and in 11 it varied more than 21 mmHg. Grades on the TPT were 92.3&amp;plusmn;3.3 and 86.2&amp;plusmn; 8.1, respectively (p&lt;0.05). The QV dates did not significantly influence grades. CONCLUSION: Stress, as an isolated variable, had a negative influence on the learning process and on the efficiency of emergency training in this situation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stress</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ACLS</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>medical education</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Devices and Techniques for Blood Pressure Measurement and Criteria for Hypertension Adopted by Brazilian Physicians: Exploratory Study</s1>
</fA08>
<fA11 dir="011000">
<s1>Décio Mion Júnior</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Angela Maria Geraldo Pierin</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ines Lessa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fernando Nobre</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>597-600</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine technical procedures and criteria used by Brazilian physicians for measuring blood pressure and diagnosing hypertension. METHODS: A questionnaire with 5 questions about practices and behaviors regarding blood pressure measurement and the diagnosis of hypertension was sent to 25,606 physicians in all Brazilian regions through a mailing list. The responses were compared with the recommendations of a specific consensus and descriptive analysis. RESULTS: Of the 3,621 (14.1%) responses obtained, 57% were from the southeastern region of Brazil. The following items were reported: use of an aneroid device by 67.8%; use of a mercury column device by 14.6%; 11.9% of the participants never calibrated the devices; 35.7% calibrated the devices at intervals &lt; 1 year; 85.8% measured blood pressure in 100% of the medical visits; 86.9% measured blood pressure more than once and on more than one occasion. For hypertension diagnosis, 55.7% considered the patient's age, and only 1/3 relied on consensus statements. CONCLUSION: Despite the adequate frequency of both practices, it was far from that expected, and some contradictions between the diagnostic criterion for hypertension and the number of blood pressure measurements were found. The results suggest that, to include the great majority of the medical professionals, disclosure of consensus statements and techniques for blood pressure measurement should go beyond the boundaries of medical events and specialized journals.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure measurement</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>calibration</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Assessment of the DIXTAL DX-2710 Automated Oscillometric Device for Blood Pressure Measurement with the Validation Protocols of the British Hypertension Society (BHS) and the Association for the Advancement of Medical Instrumentation (AAMI)</s1>
</fA08>
<fA11 dir="011000">
<s1>Gisele M. P. Mano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Viviane F. Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Angela M. G. Pierin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Josiane C. Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Edna C. Ignes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Kátia C. Ortega</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Décio Mion Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>606-610</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the Dixtal DX2710 automated oscillometric device used for blood pressure measurement according to the protocols of the BHS and the AAMI. METHODS: Three blood pressure measurements were taken in 94 patients (53 females 15 to 80 years). The measurements were taken randomly by 2 observers trained to measure blood pressure with a mercury column device connected with an automated device. The device was classified according to the protocols of the BHS and AAMI. RESULT: The mean of blood pressure levels obtained by the observers was 148&amp;plusmn;38/93&amp;plusmn;25 mmHg and that obtained with the device was 148&amp;plusmn;37/89&amp;plusmn;26 mmHg. Considering the differences between the measurements obtained by the observer and those obtained with the automated device according to the criteria of the BHS, the following classification was adopted: &quot;A&quot; for systolic pressure (69% of the differences &lt; 5; 90% &lt; 10; and 97% &lt; 15 mmHg); and &quot;B&quot; for diastolic pressure (63% of the differences &lt; 5; 83% &lt; 10; and 93% &lt; 15 mmHg). The mean and standard deviation of the differences were 0&amp;plusmn;6.27 mmHg for systolic pressure and 3.82&amp;plusmn;6.21 mmHg for diastolic pressure. CONCLUSION: The Dixtal DX2710 device was approved according to the international recommendations.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>validation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>automated</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>oscillometric blood pressure measuring device</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Trends in Productive Years of Life Lost to Premature Mortality Due to Coronary Heart Disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Ines Lessa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia Instituto de Saúde Coletiva </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>617-622</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To estimate the number of productive years of life lost to premature death due to coronary heart disease in Brazil and to report their trends over a 20-year period. METHODS: The Brazilian Ministry of Health raw database on death due to coronary heart disease from 1979-1998 was used. The productive years of life lost to premature death were estimated using 20 and 59 years of age as the cut points for the productive years, replacing the potential years of 1 and 70 of the original formula. A descriptive analysis was provided with adjustments, means, proportions, ratios, percentages of increase or reduction, and mobile means. RESULTS: A 35.8% increase in death for males and 51.3% for females was observed, +43.3% being the relative difference for females. The annual means of the productive years of life prematurely lost were analyzed in 140,865 males and 58,559 females, with the differential ratio between the age groups ranging from 2.3 to 2.5. The annual means were less favorable for males. Within each group (intragroup), the ratios decreased with the increase in age, and the age means at the time of death remained constant. The raw tendencies decreased in the 20- to 29-year age group and increased in the 40- to 59-year age group for females and the 40- to 49-year age group for males. When adjusted, the raw tendencies decreased. CONCLUSION: The 43.3% increase in the number of female deaths as compared with that of males and the ascending tendency in the productive years of life lost in the 40- to 59-year age group point to the influence of unfavorable changes in female lifestyles and suggest a deficiency in programs for prevention and control of risk factors and in their treatment in both sexes.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>premature mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>productive years of life</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>age</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Forma Indeterminada da Moléstia de Chagas: Proposta de Novos Critérios de Caracterização e Perspectivas de Tratamento Precoce da Cardiomiopatia</s1>
</fA08>
<fA11 dir="011000">
<s1>José Antonio Marin-Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Oswaldo César de Almeida Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Pazin-Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Benedito Carlos Maciel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina de Ribeirão Preto Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>623-627</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>56</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Paciente masculino de 35 anos com insuficiência cardíaca rapidamente progressiva, episódio isquêmico transitório cerebral, insuficiência aórtica e dissecção de aorta</s1>
</fA08>
<fA11 dir="011000">
<s1>Joaquim Serra</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Sampaio Gutierrez</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>628-633</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 12/2002 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>634-634</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Idoso: Doença Cardíaca e Comorbidades</s1>
</fA08>
<fA11 dir="011000">
<s1>Cláudio Zaslavsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Iseu Gus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>635-639</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900611</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>O Feto e a Hermenêutica da Diástole</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>640-643</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>47</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900612</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeitos Cardiovasculares da Testosterona</s1>
</fA08>
<fA11 dir="011000">
<s1>Otavio C. E. Gebara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Núbia W. Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Jayson W. Meyer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ana Luisa G. Calich</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eun J. Tai</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Humberto Pierri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Mauricio Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>José M. Aldrighi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>644-649</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0>40</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900613</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Requisitos e Normas para obtenção do Certificado de Habilitação em Eletrofisiologia</s1>
</fA08>
<fA11 dir="011000">
<s1>Sérgio G. Rassi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Márcio Fagundes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maurício Scanavacca</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>650-650</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900614</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Desafios terapêuticos da insuficiência coronariana obstrutiva crônica</s1>
</fA08>
<fA11 dir="011000">
<s1>Whady A. Hueb</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Antonio F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-6</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Improvement in left ventricular dysfunction after surgical correction of mitral regurgitation</s1>
</fA08>
<fA11 dir="011000">
<s1>Antônio Sérgio Cordeiro da Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nazareth de Novaes da Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rita de Cássia Villela Soares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marialda Coimbra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rosana Grandelle Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Clara Weksler</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Fernando Eugênio Cruz Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Celso Garcia da Silveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Paulo Roberto Dutra da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Health Ministery National Institute of Cardiology Laranjeiras Division of Cardiac Surgery</s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>13-18</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate whether left ventricular end-systolic (ESD) diameters &lt;FONT FACE=Symbol&gt;&amp;pound;&lt;/FONT&gt; 51mm in patients (pt) with severe chronic mitral regurgitation (MR) are predictors of a poor prognosis after mitral valve surgery (MVS). METHODS: Eleven pt (aged 36&amp;plusmn;13 years) were studied in the preoperative period (pre), median of 36 days; in the early postoperative period (post1), median of 9 days; and in the late postoperative period (post2), mean of 38.5&amp;plusmn;37.6 months. Clinical and echocardiographic data were gathered from each pt with MR and systolic diameter &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt;51mm (mean = 57&amp;plusmn;4mm) to evaluate the result of MVS. Ten patients were in NYHA Class III/IV. RESULTS: All but 2 pt improved in functional class. Two pt died from heart failure and infectious endocarditis 14 and 11 months, respectively, after valve replacement. According to ejection fraction (EF) in post2, we identified 2 groups: group 1 (n=6), whose EF decreased in post1, but increased in post2 (p=0.01) and group 2 (n=5), whose EF decreased progressively from post1 to post2 (p=0.10). All pt with symptoms lasting &lt;FONT FACE=Symbol&gt;&amp;pound;&lt;/FONT&gt; 48 months had improvement in EF in post2 (p=0.01). CONCLUSION: ESD &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt;51mm are not always associated with a poor prognosis after MVS in patients with MR. Symptoms lasting up to 48 months are associated with improvement in left ventricular function.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral regurgitation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgical correction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valvar correction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Prognostic value of technetium-99m-labeled single-photon emission computerized tomography in the follow-up of patients after their first myocardial revascularization surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Márcia Maria Sales dos Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eduardo Cwajg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Mauricio da Rocha Pantoja</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio de Janeiro Cintilab </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>25-30</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the prognostic value of Technetium-99m-labeled single-photon emission computerized tomography (SPECT) in the follow-up of patients who had undergone their first myocardial revascularization. METHODS: We carried out a retrospective study of 280 revascularized patients undergoing myocardial scintigraphy under stress (exercise or pharmacological stress with dipyridamole) and at rest according to a 2-day protocol. A set of clinical, stress electrocardiographic and scintigraphic variables was assessed. Cardiac events were classified as &quot;major&quot; (death, infarction, unstable angina) and &quot;any&quot; (major event or coronary angioplasty or new myocardial revascularization surgery). RESULTS: Thirty-six major events occurred as follows: 3 deaths, 11 infarctions, and 22 unstable anginas. In regard to any event, 22 angioplasties and 7 new surgeries occurred in addition to major events, resulting a total of 65 events. The sensitivity of scintigraphy in prognosticating a major event or any event was, respectively, 55% and 58%, showing a negative predictive value of 90% and 83%, respectively. Diabetes mellitus, inconclusive stress electrocardiography, and a scintigraphic visualization of left ventricular enlargement were significant variables for the occurrence of a major event. On multivariate analysis, abnormal myocardial scintigraphy was a predictor of any event. CONCLUSION: Myocardial perfusion tomography with Technetium-99m may be used to identify high-risk patients after their first myocardial revascularization surgery.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>single-photon emission computerized tomography (SPECT)</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Predictive factors of in-hospital mortality and of severe perioperative complications in myocardial revascularization surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernanda Fuscaldi Almeida</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sandhi Maria Barreto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Bráulio Roberto G. M. Couto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos E. F. Starling</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Minas Gerais  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>FIOCRUZ Centro de Pesquisa René Rachou </s1>
<s2>Belo Horizonte MG</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>51-60</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To investigate preoperative predictive factors of severe perioperative intercurrent events and in-hospital mortality in coronary artery bypass graft (CABG) surgery and to develop specific models of risk prediction for these events, mainly those that can undergo changes in the preoperative period. METHODS: We prospectively studied 453 patients who had undergone CABG. Factors independently associated with the events of interest were determined with multiple logistic regression and Cox proportional hazards regression model. RESULTS: The mortality rate was 11.3% (51/453), and 21.2% of the patients had 1 or more perioperative intercurrent events. In the final model, the following variables remained associated with the risk of intercurrent events: age &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt; 70 years, female sex, hospitalization via SUS (Sistema Único de Saúde - the Brazilian public health system), cardiogenic shock, ischemia, and dependence on dialysis. Using multiple logistic regression for in-hospital mortality, the following variables participated in the model of risk prediction: age &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt; 70 years, female sex, hospitalization via SUS, diabetes, renal dysfunction, and cardiogenic shock. According to the Cox regression model for death within the 7 days following surgery, the following variables remained associated with mortality: age &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt; 70 years, female sex, cardiogenic shock, and hospitalization via SUS. CONCLUSION: The aspects linked to the structure of the Brazilian health system, such as factors of great impact on the results obtained, indicate that the events investigated also depend on factors that do not relate to the patient's intrinsic condition.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>in-hospital mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>perioperative complications</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Catheter ablation of atriofascicular Mahaim fibers guided by the activation potential</s1>
</fA08>
<fA11 dir="011000">
<s1>Márcio Augusto Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gel Berardi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alessandro Kraemer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Elenir Nadalin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Carlos Moura Jorge</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>PUC/PR Hospital Universitário Cajuru </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>66-70</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine whether recording of the activation potential may be used as an isolated criterion to guide catheter ablation of atriofascicular Mahaim fibers. METHODS: We studied 6 patients (5 females, mean age of 26&amp;plusmn;7.3 years) with paroxysmal tachycardias with a wide QRS complex, whose electrophysiological study diagnosed atriofascicular Mahaim fibers. Mapping and catheter ablation were performed in sinus rhythm, guided only by the recording of the activation potential of the fiber. RESULTS: Efficacy in ablation was achieved in all patients. The fibers were located in the right lateral region of the tricuspid ring in 3 patients, right posterolateral region in 2, and right anterolateral region in 1. A mean of 5.3&amp;plusmn;3 radiofrequency applications was performed. The mean fluoroscopy time was 46.6&amp;plusmn;25 minutes, and the mean duration of the procedure was 178.6&amp;plusmn;108 minutes. No complication occurred. In a mean 20-month follow-up, all patients were asymptomatic and receiving no antiarrhythmic drugs. CONCLUSION: Catheter ablation of Mahaim fibers may be performed with good safety and efficacy by mapping the activation potential of the tricuspid ring in sinus rhythm.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Mahaim fibers</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>catheter ablation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atriofascicular accessory pathways</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Percutaneous implantation of endoprostheses in the carotid arteries</s1>
</fA08>
<fA11 dir="011000">
<s1>José Ribamar Costa Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Manuel N. Cano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Dinaldo C. Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio M. Kambara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Adriana C. Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rogério Queiroz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Silvia Cano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Amanda G.M.R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>J. Eduardo M.R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia Hospital do Coração </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>77-82</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the in-hospital evolution of patients undergoing percutaneous stent placement in the carotid arteries. METHODS: From August 1996 to April 2001, we studied 86 patients with carotid arterial obliterative lesions &gt; 70% who were treated with percutaneous stent placement in the carotid arteries. We assessed the rate of success of the implantation and of the procedure, the types of stents used, mortality rate, and neurological complications. RESULTS: Successful implantation was obtained in 98.9% of the cases, and the procedure was successful in 91.8%. The Wallstent was the most frequently used stent (73 patients - 77%). Cerebral strokes occurred as follows: 3 (3.2%) transient ischemic attacks, 1 (1.1%) minor stroke, and 3 (3.1%) major strokes. One (1.1%) patient died during hospitalization. CONCLUSION: The high rate of success of stent implantation (98.9%) in addition to the low rate of cerebral stroke/death (4.2%) showed the efficiency and safety of percutaneous stent placement in carotid arteries.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>placement</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stent</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>carotid arteries</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Assessment of the techniques of blood pressure measurement by health professionals</s1>
</fA08>
<fA11 dir="011000">
<s1>Eugenia Velludo Veiga</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Suely Nogueira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Evelin Capellari Cárnio</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sueli Marques</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marco Aurélio S. Lavrador</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Suzana Alves de Moraes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Luciana A. C. Souza</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Nereida K. C. Lima</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Fernando Nobre</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Escola de Enfermagem de Ribeirão Preto </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>USP FM Hospital das Clínicas de Ribeirão Preto</s1>
<s2>Ribeirão Preto SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>89-93</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess blood pressure measurement by health professionals of a public hospital in São Paulo State. METHODS: Semi-structured interviews and direct observation were performed with a verification list according to the criteria reported by Perloff et al. One hundred and five health professionals took part in the study. After measuring blood pressure, the level of concordance between the way the procedure was performed and the recommended one was assessed. RESULTS: Nurses and nurse's aides abided by 40% of the recommended procedures for adequate blood pressure measurement. The other categories of health professionals (nursing and medicine teachers, physicians, residents, and nursing students) abided by approximately 70%. CONCLUSION: Permanent educational activities aiming at standardizing blood pressure measurement should be implemented among the different categories of health professionals.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure measurement</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>methods of blood pressure measurement</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Right atrial lipoma</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo M. Pêgo-Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Pedro Luiz Guimarães Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fábio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Alberto Benvenuti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sérgio Almeida Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>97-99</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Benign cardiac tumors are rare, and lipomas are among those less frequently found. We report the case of a 48-year-old male complaining of high blood pressure and epistaxis in the last 2 months, with a diagnosis of right atrial lipoma established on echocardiography, magnetic resonance imaging, and anatomicopathological examination. The tumor was successfully removed, and up to 42 months after surgical excision, no evidence of tumor relapse was observed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 1/2003 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>InCor  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>100-100</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Valor prognóstico da resolução da elevação do segmento ST na reperfusão miocárdica</s1>
</fA08>
<fA11 dir="011000">
<s1>Pablo Balbuena Nery</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Carlos Bodanese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Euler Manenti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>PUCRS Hospital São Lucas </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>101-104</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000111</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeitos cardiovasculares agudos da exposição ao ambiente microgravitacional</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Eustáquio de Brito Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Martin Hernán Bonamino</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFRJ  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>105-115</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>78</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000112</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Normatização dos equipamentos e técnicas para a realização de avaliação eletrofisiológica invasiva de pacientes com arritmias cardíacas</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eduardo Sosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fábio Sândoli de Brito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ivan Maia</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Carlos Pachón Mateos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Júlio Gizzi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Márcio Fagundes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Martino Martinelli Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Roberto Costa</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>116-116</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000113</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Doppler tissue imaging to assess systolic function in Chagas' disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Márcio Vinícius Lins Barros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Luiz Pinho Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando Santana Machado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Manoel Otávio da Costa Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFMG Faculdade de Medicina </s1>
<s2>Belo Horizonte MG</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>36-40</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the usefulness of Doppler tissue imaging (DTI) for evaluating the systolic function of chagasic patients with and without electrocardiographic abnormalities, in comparision with echocardiographic study. METHODS: We studied 77 patients divided into 3 groups as follows: group 1 - control; group 2 - chagasic patients with normal electrocardiographic findings; and group 3 - chagasic patients with abnormal electrocardiographic findings. The following parameters were assessed: left ventricular dimensions and ejection fraction, left atrial dimensions and diastolic function on echocardiography. Systolic velocity and regional isovolumic contraction time (IVCTr) of the septal, anterior, lateral, posterior and inferior left ventricular walls were assessed on DTI. RESULTS: Left ventricular cavitary dimensions, ejection fraction and DTI systolic wave showed significant differences between groups 1 and 3 and between groups 2 and 3, which were not found between groups 1 and 2. IVCTr allowed a statistically significant discrimination among the 3 groups. CONCLUSION: DTI allowed discrimination among the different groups assessed, being superior to echocardiography in identifying early abnormalities of contractility, and, therefore, potentially useful for detecting incipient myocardial alterations in chagasic patients with normal electrocardiographic findings.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Doppler tissue imaging</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretriz de Indicações e Utilizações das Intervenções Percutâneas e Stent Intracoronariano na Prática Clínica</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Ilha Guimaraes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>J. Eduardo Sousa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Expedito Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Alberto Mattos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Amanda GRM Sousa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Gilberto Lahorgue Nunes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Rogério Gomes Sarmento Leite</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Álvaro Vieira Moura</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Carlos A. Mascia Gottschall</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Eduardo A. da Silva Costa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Francisco C. Couto Falcão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Mauricio Lopes Prudente</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Raimundo João Costa Furtado</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-14</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretriz de interpretação de eletrocardiograma de repouso</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Carlos Nicolau</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carisi A. Polanczyk</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Alberto Pastore</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Alves Pinho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Mario Sérgio de Carvalho Bacellar</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Demostenes G. Lima Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Rubens Nassar Darwich</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Antonio Luiz Pinho Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Marcelo Marcos Eloy Dunda</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Hélio Germiniani</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Francisco Faustino França</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Laurindo Saraiva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Clébia Maria Rios Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Paulo Ginefra</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>Iseu Gus</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>Eney Fernandes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>Andres Riera</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>Anisio Pedrosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="201000">
<s1>Antonio Américo Friedman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="211000">
<s1>Antonio Carlos Firmiani</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="221000">
<s1>Cesar Grupi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="231000">
<s1>Claudio Pinho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="241000">
<s1>Eduardo Vilaça Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="251000">
<s1>Elisabeth Kaiser</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="261000">
<s1>Fábio Sandoli Brito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="271000">
<s1>Gilberto Luiz Castro Vinhas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="281000">
<s1>Hélio Schwartz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="291000">
<s1>José Grindler</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="301000">
<s1>José Luiz Aziz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="311000">
<s1>Marcio Figueiredo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="321000">
<s1>Marcos S. Molina</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="331000">
<s1>Martino Martinelli</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="341000">
<s1>Nancy Tobias</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="351000">
<s1>Paulo Cesar R. Sanches</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="361000">
<s1>Paulo Jorge Moffa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="371000">
<s1>Severino Attanes Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="381000">
<s1>Silvana Nishioka</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-18</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Revisão das II Diretrizes da Sociedade Brasileira de Cardiologia para o Diagnóstico e Tratamento da Insuficiência Cardíaca</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Edimar Alcides Bocchi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fábio Vilas-Boas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marcelo Westerlund Montera</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maria da Consolação Vieira Moreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Michel Batlouni</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Cantídio Drumond Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Charles Mady</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Denílson Campos de Albuquerque</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Djair Falcão Brindeiro Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Domingo Marcolino Braile</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Francisco Manes Albanesi Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Gilson Soares Feitosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>Hans Fernando Rocha Dohmann</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>Humberto Villacorta Júnior</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>Jacob Atié</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>José Antônio Marin Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="201000">
<s1>José Carlos Pachon Mateos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="211000">
<s1>Luiz Carlos Bodanese</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="221000">
<s1>Maria da Consolação Vieira Moreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="231000">
<s1>Nadine Oliveira Clausell</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="241000">
<s1>Paulo Roberto Slud Brofman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="251000">
<s1>Ricardo Mourilhe Rocha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="261000">
<s1>Salvador Rassi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="271000">
<s1>Wilson Mathias Júnior</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-30</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>79</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretrizes para Avaliação e Tratamento de Pacientes com Arritmias Cardíacas</s1>
</fA08>
<fA11 dir="011000">
<s1>Gilson Soares Feitosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Carlos Nicolau</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Adalberto Lorga</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Adalberto Lorga Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>André D'Ávila</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Anis Rassi Jr</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Angelo A. V. de Paola</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Anísio Pedrosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Álvaro Barros da Costa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Ayrton Peres</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>César Grupi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Cláudio Cirenza</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Dalmo Moreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Dário Sobral</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Denise Hachul</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>Eduardo D'Andréa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>Eduardo Sosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>Epotamênides M. Good God</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>Fábio Sândoli de Brito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="201000">
<s1>Fernando Cruz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="211000">
<s1>Guilherme Fenelon</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="221000">
<s1>Gustavo Glotz Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="231000">
<s1>Hélio Brito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="241000">
<s1>Ivan G. Maia</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="251000">
<s1>Jacob Atié</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="261000">
<s1>José Carlos Moura Jorge</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="271000">
<s1>José Carlos de Andrade</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="281000">
<s1>José Carlos Pachón Mateos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="291000">
<s1>José Carlos Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="301000">
<s1>João Pimenta</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="311000">
<s1>José Tarcísio de Vasconcelos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="321000">
<s1>Júlio Gizzi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="331000">
<s1>Leandro Zimerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="341000">
<s1>Luiz Antonio Teno Castilho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="351000">
<s1>Márcio Fagundes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="361000">
<s1>Márcio Figueiredo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="371000">
<s1>Martino Martinelli Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="381000">
<s1>Maurício I. Scanavacca</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="391000">
<s1>Ney Valente</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="401000">
<s1>Paulo Medeiros</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="411000">
<s1>Paulo Brofman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="421000">
<s1>Reynaldo Castro Miranda</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="431000">
<s1>Roberto Costa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="441000">
<s1>Ricardo Kunyioshi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="451000">
<s1>Roberto Sá</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="461000">
<s1>Sérgio G. Rassi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="471000">
<s1>Sérgio Siqueira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="481000">
<s1>Silas Galvão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="491000">
<s1>Silvana Nishioka</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="501000">
<s1>Tereza Grillo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="511000">
<s1>Thiago da Rocha Rodrigues</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="521000">
<s1>Washington Maciel</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-50</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2002</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(02)07900001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>White-coat hypertension and normotension in the League of Hypertension of the Hospital das Clínicas, FMUSP: prevalence, clinical and demographic characteristics</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos A. Segre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rubens K. Ueno</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Karim R. J. Warde</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Tarso A. D. Accorsi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Márcio H. Miname</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Chang K. Chi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Angela M. G. Pierin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Décio Mion Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>122-126</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the prevalence of white-coat normortension, white-coat hypertension, and white-coat effect. METHODS: We assessed 670 medical records of patients from the League of Hypertension of the Hospital das Clínicas of the Medical School of the University of São Paulo. White-coat hypertension (blood pressure at the medical office: mean of 3 measurements with the oscillometric device &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt;140 or &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt;90 mmHg, or both, and ambulatory blood pressure monitoring mean during wakefulness &lt; 135/85) and white-coat normotension (office blood pressure &lt; 140/90 and blood pressure during wakefulness on ambulatory blood pressure monitoring &lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt; 135/85) were analyzed in 183 patients taking no medication. The white-coat effect (difference between office and ambulatory blood pressure &gt; 20 mmHg for systolic and 10 mmHg for diastolic) was analyzed in 487 patients on treatment, 374 of whom underwent multivariate analysis to identify the variables that better explain the white-coat effect. RESULTS: Prevalence of white-coat normotension was 12%, prevalence of white-coat hypertension was 20%, and prevalence of the white-coat effect was 27%. A significant correlation (p&lt;0.05) was observed between white-coat hypertension and familial history of hypertension, and between the white-coat effect and sex, severity of the office diastolic blood pressure, and thickness of left ventricular posterior wall. CONCLUSION: White-coat hypertension, white-coat normotension, and white-coat effect should be considered in the diagnosis of hypertension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>white-coat effect</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>white-coat hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>white-coat normotension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Exercise testing in hypertensive patients taking different angiotensin-converting enzyme inhibitors</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Angela M. Q. Carreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leandro R. Tavares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rafaela F. Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jamila C. Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antônio C. Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Karla G. Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Guilhermo C. Velarde</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Antonio Claudio L. Nóbrega</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense  </s1>
<s2>Niterói RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>133-137</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To compare blood pressure response to dynamic exercise in hypertensive patients taking trandolapril or captopril. METHODS: We carried out a prospective, randomized, blinded study with 40 patients with primary hypertension and no other associated disease. The patients were divided into 2 groups (n=20), paired by age, sex, race, and body mass index, and underwent 2 symptom-limited exercise tests on a treadmill before and after 30 days of treatment with captopril (75 to 150 mg/day) or trandolapril (2 to 4 mg/day). RESULTS: The groups were similar prior to treatment (p&lt;0.05), and both drugs reduced blood pressure at rest (p&lt;0.001). During treatment, trandolapril caused a greater increase in functional capacity (+31%) than captopril (+17%; p=0.01) did, and provided better blood pressure control during exercise, observed as a reduction in the variation of systolic blood pressure/MET (trandolapril: 10.7±1.9 mmHg/U vs 7.4±1.2 mmHg/U, p=0.02; captopril: 9.1±1.4 mmHg/U vs 11.4±2.5 mmHg/U, p=0.35), a reduction in peak diastolic blood pressure (trandolapril: 116.8±3.1 mmHg vs 108.1±2.5 mmHg, p=0.003; captopril: 118.2±3.1 mmHg vs 115.8±3.3 mmHg, p=0.35), and a reduction in the interruption of the tests due to excessive elevation in blood pressure (trandolapril: 50% vs 15%, p=0.009; captopril: 50% vs 45%, p=0.32). CONCLUSION: Monotherapy with trandolapril is more effective than that with captopril to control blood pressure during exercise in hypertensive patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>antihypertensive therapy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Mildly symptomatic chronic mitral regurgitation. Analysis of left ventricular systolic function and mitral regurgitant fraction under pharmacological influence: echocardiographic study</s1>
</fA08>
<fA11 dir="011000">
<s1>Ivan Romero Rivera</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valdir Ambrósio Moisés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Angelo Amato V. de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>144-149</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study echocardiographic parameters of left ventricular systolic function and valvar regurgitation under pharmacological influence in mildly symptomatic patients with chronic mitral regurgitation (MR). METHODS: We carried out a double-blind placebo controlled study in 12 patients with MR, mean aged 12.5 years old, who were randomized in 4 phases: A) digoxin; B) enalapril; C) digoxin + enalapril; D) placebo. The medication was administered for 30 days in each phase, and the following variables were analyzed: shortening and ejection fractions, wall stress index of left ventricle, left ventricular meridional end-systolic wall stress, Doppler-derived mean rate of left ventricular pressure rise (mean dP/dt), stroke volume and MR jet area. The clinical variables analysed were heart rate and systemic arterial pressure. RESULTS: No significant variation was observed in the clinical variables analysed. The shortening and ejection fraction, the mean dP/dt and stroke volume significantly increased and the wall stress index of left ventricle, the meridional left ventricular end systolic wall stress and the mitral regurgitation jet area decreased in the phases with medication as compared with that in the placebo phase. CONCLUSION: The parameters of left ventricular systolic function improved significantly and the degree of MR decreased with the isolated administration of digoxin or enalapril in mildly symptomatic patients with chronic MR. The combination of the drugs, however, did not show better results.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral regurgitation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Comparison of the effect of two HMG CoA reductase inhibitors on LDL susceptibility to oxidation</s1>
</fA08>
<fA11 dir="011000">
<s1>Vera Lúcia Portal</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Emílio H. Moriguchi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Luiz da Costa Vieira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sadi Schio</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eduardo T. Mastalir</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fabiana Buffé</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Eleni Borges Bortolini</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Ricardo Santalucia Brüch</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Rubem Rodrigues</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>156-161</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>53</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study the differences between fluvastatin and pravastatin regarding LDL susceptibility to oxidation, plasma levels of total cholesterol (TC), HDL-C, LDL-C and triglycerides (TG) in hypercholesterolemic patients with established coronary heart disease (CHD). METHODS: A double-blind randomized parallel study was conducted that included 41 hypercholesterolemic outpatients with CHD treated at the Instituto de Cardiologia do Rio Grande do Sul. The inclusion criteria were LDL-C above 100 mg/dL and triglycerides below 400 mg/dL based on 2 measures. After 4 weeks on a low cholesterol diet, those patients that fullfilled the inclusion criteria were randomized into 2 groups: the fluvastatin group (fluvastatin 40 mg/day) and the pravastatin group (pravastatin 20 mg/day), for 24 weeks of treatment. LDL susceptibility to oxidation was analyzed with copper-induced production of conjugated dienes (Cu2+) and water-soluble free radical initiator azo-bis (2'-2'amidinopropanil) HCl (AAPH). Spectroscopy nuclear magnetic resonance was used for determination of lipids. RESULTS: After 24 weeks of drug therapy, fluvastatin and pravastatin significantly reduced LDL susceptibility to oxidation as demonstrated by the reduced rate of oxidation (azo and Cu) and by prolonged azo-induced lag time (azo lag). The TC, LDL-C, and TG reduced significantly and HDL-C increased significantly. No differences between the drugs were observed. CONCLUSION: In hypercholesterolemic patients with CHD, both fluvastatin and pravastatin reduced LDL susceptibility to oxidation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>LDL oxidation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>statins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypercholesterolemia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Impact of nutritional counseling in reducing serum cholesterol in public health service patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria da Conceição Rosado Batista</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sylvia do Carmo Castro Franceschini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Viçosa  </s1>
<s2>Viçosa MG</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>167-170</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the impact of nutritional attention on the lipid profile and nutritional status of hypercholesterolemic patients attended in health centers of Belo Horizonte. METHODS: Using nutritional attendance patient record cards from two health units, the evolution of the lipid profile and the nutritional state (BMI) was monitored of 96 hypercholesterolemic patients who received diet. The patients were appraised at the following moments: initial (1st consultation), after 3 months (2nd consultation) and last consultation (variable for each patient). RESULTS: On the first attendance, 44,4% of the patients presented not only high total cholesterol and LDL-c, but also hypertriglyceridemia and 70.3% were overweight or obese, but most patients (75.6%) presented adequate HDL-c levels. There was significant reduction in the BMI, total cholesterol, LDL-c values (p &lt; 0.01) and also in the triglyceride levels (p &lt; 0.05) in the first three months, without alteration in the HDL-c levels. A significant reduction (p &lt; 0.01) was observed in the frequency of individuals with high cholesterol (from 89.6% down to 47.9%), high and very high LDL-c (from 82.6% down to 45.7%), as well as high and very high triglyceride (from 43.6% down to 16.7%). The observed reduction in frequency of the low HDL-c was statistically meaningless. CONCLUSION: This study evidences the effect of the nutritional attention on lipid profile in hypercholesterolemic patients, reinforcing the need for a multiprofessional team to attend them at the public health services.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypercholesterolemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nutritional status</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diet</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Socioeconomic aspects of spousal concordance for hypertension, obesity, and smoking in a community of Rio de Janeiro, Brazil</s1>
</fA08>
<fA11 dir="011000">
<s1>Katia Vergetti Bloch</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Henrique Klein</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Nelson Albuquerque de Souza e Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Armando da Rocha Nogueira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Lucia Helena Alvares Salis</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>179-186</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>50</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: The present study aims to evaluate the environmental role in the distribution of hypertension, obesity, and smoking and spousal concordance for the presence/absence of these 3 cardiovascular risk factors. METHODS: A cross-sectional study was conducted in a community in Rio de Janeiro, Brazil. The households were randomly selected. Odds ratios were estimated to measure spousal concordance, across socioeconomic levels.. RESULTS: Overall a significant aggregation of all 3 risk factors was present. The crude odds ratio for hypertension was 1.78 (95%CI=1.02-3.08); for obesity, it was 1.80 (95%CI=1.09-2.96); and for smoking, it was 3.40 (95% CI=2.07-5.61). The spousal concordance for hypertension decreased significantly (p&lt;0.001) from the lower to the higher educational level. In the case of obesity and smoking, the opposite was observed, although p-values for the linear trend were 0.10 and 0.08, respectively. CONCLUSION: In lower socioeconomic levels, couples are more concordant for hypertension and discordant for smoking. For hypertension and smoking, education seems to be a discriminant stronger than income, but for obesity the 2 socioeconomic indicators seem to represent different aspects of the environmental determinants of risk factor distribution.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>obesity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>smoking</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>spouse concordance</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Can patients with left main coronary artery disease wait for myocardial revascularization surgery?</s1>
</fA08>
<fA11 dir="011000">
<s1>Antônio Sérgio Cordeiro da Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Roberto Dutra da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Ministério da Saúde Instituto Nacional de Cardiologia Laranjeiras </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>191-203</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the occurrence of cardiac events in patients diagnosed with left main coronary artery disease on diagnostic cardiac catheterization and waiting for myocardial revascularization surgery. METHODS: All patients diagnosed with left main coronary artery disease (stenosis  &gt; or = 50%) consecutively identified on diagnostic cardiac catheterization during an 8-month period were selected for the study. The group comprised 56 patients (40 males and 16 females) with a mean age of 61±10 years. The cardiac events included death, nonfatal acute myocardial infarction, acute left ventricular failure, unstable angina, and emergency surgery. RESULTS: While waiting for surgery, patients experienced the following cardiac events: 7 acute myocardial infarctions and 1 death. All events occurred within the first 60 days after the diagnostic cardiac catheterization. More patients, whose indication for diagnostic cardiac catheterization was unstable angina, experienced events as compared with those with other indications [p=0.03, relative risk (RR) = 5.25, 95% confidence interval = 1.47 - 18.7]. In the multivariate analysis of logistic regression, unstable angina was also the only factor that independently contributed to a greater number of events (p = 0.02, OR = 8.43, 95% CI =1.37 - 51.7). CONCLUSION: Unstable angina in patients with left main coronary artery disease acts as a high risk factor for cardiac events, emergency surgery being recommended in these cases.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left main coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgical indication</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cinecoronary arteriography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Right ventricular diastolic dysfunction in the postoperative period of tetralogy of Fallot</s1>
</fA08>
<fA11 dir="011000">
<s1>Silvia Meyer Cardoso</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nelson Itiro Miyague</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>198-201</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess right ventricular diastolic function in the intermediate postoperative period of repair of tetralogy of Fallot. METHODS: We carried out a case-control study with 60 patients divided into 2 groups as follows: 1) group I - 30 patients who had undergone repair of tetralogy of Fallot and 2) group II - 30 healthy children. The 2 groups were paired for age, sex, and body surface. The flows in the pulmonary and tricuspid valves were analyzed with Doppler echocardiography. The presence of anterograde flow at the end of diastole in the pulmonary artery defined restrictive right ventricular physiology. Surgical, radiological, electrocardiographic, and echocardiographic variables were analized in the group I. RESULTS: The velocity of the A wave and the E/A ratio for the tricuspid valve showed significant differences between the groups. Cases with E/A &lt; 1.30 predominated in inspiration (group I - 19/30, and group II - 5/30). The duration of the QRS complex on the electrocardiogram was significantly increased in patients with E/A &lt;1.30. Nineteen (63.3%) patients had restrictive right ventricular physiology, which had a longer postoperative period, longer duration of the QRS complex, and a lower E/A ratio in inspiration. The surgical and radiological variables showed no statistical difference. CONCLUSION: Restrictive right ventricular physiology was detected on the intermediate follow-up of most patients undergoing repair of tetralogy of Fallot. The postoperative period and QRS duration were increased in patients with impairment in diastolic function.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tetralogy of Fallot</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diastolic function</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Value of the radiological study of the thorax for diagnosing left ventricular dysfunction in Chagas' disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Amanda Arantes Perez</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Luiz Pinho Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Márcio Vinícius Lins Barros</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcos Roberto de Sousa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Roberto José Bittencourt</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fernando Santana Machado</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Manoel Otávio Costa Rocha</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>208-213</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the value of the radiological study of the thorax for diagnosing left ventricular dilation and left ventricular systolic dysfunction in patients with Chagas' disease. METHODS: A cross-sectional study of 166 consecutive patients with Chagas' disease and no other associated diseases. The patients underwent cardiac assessment with chest radiography and Doppler echocardiography. Sensitivity, specificity, and positive and negative predictive values of chest radiography were calculated to detect left ventricular dysfunction and the accuracy of the cardiothoracic ratio in the diagnosis of left ventricular dysfunction with the area below the ROC curve. The cardiothoracic ratio was correlated with the left ventricular ejection fraction and the left ventricular diastolic diameter. RESULTS: The abnormal chest radiogram had a sensitivity of 50%, specificity of 80.5%, and positive and negative predictive values of 51.2% and 79.8%, respectively, in the diagnosis of left ventricular dysfunction. The cardiothoracic ratio showed a weak correlation with left ventricular ejection fraction (r=-0.23) and left ventricular diastolic diameter (r=0.30). The area calculated under the ROC curve was 0.734. CONCLUSION: The radiological study of the thorax is not an accurate indicator of left ventricular dysfunction; its use as a screening method to initially approach the patient with Chagas' disease should be reevaluated.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chest radiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Tetralogy of Fallot and hypertrophic cardiomyopathy: a rare association</s1>
</fA08>
<fA11 dir="011000">
<s1>Angela Maria Férrer Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Tereza Cristina Pinheiro Diógenes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Eduardo Régis Monte Jucá</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>André Férrer Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Clarissa Férrer Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Nogueira Paes Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Infantil Albert Sabin  </s1>
<s2>Fortaleza CE</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>217-219</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Tetralogy of Fallot is known as the most common cyanotic congenital heart disease and has a prevalence of 10% of all congenital heart diseases. Although many other heart anomalies may coexist, the association of tetralogy of Fallot and hypertrophic cardiomyopathy is extremely rare. We report this association in a 15-month-old female, cyanotic since birth, in her first hospital admission for diagnosis and treatment of recurring cyanotic crises. In addition, a review of the literature and of the problems related to the treatment is provided.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 1/03 - Homem, 27 anos, com sorologia reagente para doença de Chagas e antecedente de febre reumática há 11 anos</s1>
</fA08>
<fA11 dir="011000">
<s1>Carolina Bonet</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Tiago Pugliese Branco</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>André Fernando Gemente Larrubia</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Osvaldo Teixeira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria Aparecida Barone Teixeira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Silvio dos Santos Carvalhal</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>220-223</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 2/2003 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>224-224</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000212</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Normatização dos equipamentos e técnicas para realização de exames de mapeamento ambulatorial de pressão arterial (MAPA) e de monitorização residencial da pressão arterial (MRPA)</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marco Antônio Mota Gomes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Décio Mion Jr</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fernando Nobre</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria Alayde Mendonça</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Ludenulfo Lacet Cruz</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>225-233</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>66</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000213</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Electrocardiographic abnormalities in neurological diseases</s1>
</fA08>
<fA11 dir="011000">
<s1>Rui Póvoa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luciano Cavichio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ana Lúcia de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Danielle Viotti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Celso Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luciane Galvão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>João Pimenta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital do Servidor Público Estadual  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>355-358</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate electrocardiographic abnormalities in patients with neurologic diseases. METHODS: We studied 161 patients with neurologic disorders by analyzing the 12-lead electrocardiogram during the pathological process. An expert who did not know anything about the patients evaluated the traces. RESULTS: Neurological process included brain tumor (41%), stroke (27.3%), cerebral aneurysm (15.5%), subarachnoid hemorrhage (6.8%), subdural hemorrhage (5%), and head injury (4.4%). Electrocardiograms were normal in 61% of cases, and the most frequent abnormality was ventricular repolarization (23.7%). The presence of T waves (4.6%) and prolonged QT intervals (8.8%) was the most characteristic of brain injuries. CONCLUSION: We observed a lower incidence of electrocardiographic abnormalities than that described in the literature.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>neurologic diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>QT interval</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Percutaneous transluminal septal alcoholization for the treatment of refractory hypertrophic obstructive cardiomyopathy: initial experience in the Federal District</s1>
</fA08>
<fA11 dir="011000">
<s1>Evandro César Vidal Osterne</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Tamer Najar Seixas</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Walter Paulo Filho</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ernesto Misael Cintra Osterne</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Otoni Moreira Gomes</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital das Forças Armadas  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Instituto do Coração de Taguatinga  </s1>
<s2>Brasília </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Fundação Cardiovascular São Francisco de Assis  </s1>
<s2>Belo Horizonte </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>369-378</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>55</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the efficacy of percutaneous transluminal septal alcoholization in the treatment of refractory obstructive hypertrophic cardiomyopathy (HOC). METHODS: The patients were referred for alcoholization after Doppler echocardiography. Before and after alcoholization, the intraventricular pressure gradient was recorded. Alcoholization was performed with a 3mL injection of absolute alcohol through a coronary angioplasty balloon catheter. The procedure was concluded after a significant reduction or abolition of the pressure gradient. RESULTS: Of 22 patients, 18 (81.8%) successfully concluded the procedure with a reduction in intraventricular pressure gradient at baseline (from 67.6&amp;plusmn;24.2 mmHg to 3.8&amp;plusmn; 1.9 mmHg, p&lt;0.005) and after extrasystole (from 110.4&amp;plusmn; 24.2 mmHg to 9.6&amp;plusmn;2.6 mm Hg, p&lt;0.005). A significant reduction in mean interventricular septal thickness (from 2&amp;plusmn; 0.3 mm to 1.7&amp;plusmn;0.2 mm, p&lt;0.005) and in peak pressure gradient (from 90.7&amp;plusmn;23.5 mmHg to 6.1&amp;plusmn;1.4 mmHg, p&lt;0.005) was observed on Doppler echocardiography after 6 months, when all patients were in functional class I. The most frequent acute complication, present in 11% of the patients, was the need for definitive pacing implantation. Relapse of the symptoms and reappearance of the pressure gradient occurred in 16.6% of the patients. One patient (5.5%) died probably due to a diffuse coronary spasm prior to the procedure, and another died suddenly on late follow-up. CONCLUSION: Percutaneous transluminal septal alcoholization is effective and safe in the treatment of HOC.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous septal alcoholization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous septal ablation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertrophic obstructive cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ablation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Risk factors, biochemical markers, and genetic polymorphisms in early coronary artery disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Cristina Izar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Francisco Antonio Helfenstein Fonseca</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sílvia Saiuli Miki Ihara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Nelson Kasinski</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Won Han Sang</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Ieda Edite Lanzarini Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Leonor do Espírito Santo de Almeida Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Waldir Gabriel Miranda Relvas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Daisy Lourenço</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Sérgio Tufik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Angelo Amato Vincenzo de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Antonio Carlos Camargo Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo EPM </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>388-395</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>44</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the risk factors, lipid and apolipoprotein profile, hemostasis variables, and polymorphisms of the apolipoprotein AI-CIII gene in early coronary artery disease (CAD). METHODS: Case-control study with 112 patients in each group controlled by sex and age. After clinical evaluation and nutritional instruction, blood samples were collected for biochemical assays and genetic study. RESULTS: Familial history of early CAD (64 vs 39%), arterial hypertension (69 vs 36%), diabetes mellitus (25 vs 3%), and previous smoking (71 vs 46%) were more prevalent in the case group (p&lt;0.001). Hypertension and diabetes were independent risk factors. Early CAD was characterized by higher serum levels of total cholesterol (235 &amp;plusmn; 6 vs 209 &amp;plusmn; 4 mg/dL), of LDL-c (154 &amp;plusmn; 5 vs 135 &amp;plusmn; 4 mg/dL), triglycerides (205 &amp;plusmn; 12 vs 143 &amp;plusmn; 9 mg/dL), and apolipoprotein B (129 &amp;plusmn; 3 vs 105 &amp;plusmn; 3 mg/dL), and lower serum levels of HDL-c (40 &amp;plusmn; 1 vs 46 &amp;plusmn; 1 mg/dL) and apolipoprotein AI (134 &amp;plusmn; 2 vs 146 &amp;plusmn; 2mg/dL) [p&lt;0.01], in addition to an elevation in fibrinogen and D-dimer (p&lt;0.02). The simultaneous presence of the rare alleles of the APO AI-CIII genes in early CAD are associated with hypertriglyceridemia (p=0.03). CONCLUSION: Of the classical risk factors, hypertension and diabetes mellitus were independently associated with early CAD. In addition to an unfavorable lipid profile, an increase in the thrombotic risk was identified in this population. An additive effect of the APO AI-CIII genes was observed in triglyceride levels.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>genetic polymorphisms</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Influence of angiotensin II receptor subtypes of the paraventricular nucleus on the physiological responses induced by angiotensin II injection into the medial septal area</s1>
</fA08>
<fA11 dir="011000">
<s1>Wilson Abrão Saad</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Antonio de Arruda Camargo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Paulista State University School of Dentistry Department of Physiology</s1>
<s2>Araraquara </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Taubaté University Department of Medicine and Dentistry </s1>
<s2>Taubaté </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>401-405</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: We determined the effects of losartan and PD 123319 (antagonists of the AT1 and AT2 angiotensin receptors, respectively), and [Sar¹, Ala8] ANG II (a relatively peptide antagonist of angiotensin receptors) injected into the paraventricular nucleus (PVN) on water and 3% NaCl intake, and the diuretic, natriuretic, and pressor effects induced by administration of angiotensin II (ANG II) into the medial septal area (MSA) of conscious rats. METHODS: Holtzman rats were used . Animals were anesthetized with tribromoethanol (20 mg) per 100 grams of body weight, ip. A stainless steel guide cannula was implanted into the MSA and PVN. All drugs were injected in 0.5-mul volumes for 10-15 seconds. Seven days after brain surgery, water and 3% NaCl intake, urine and sodium excretion, and arterial blood pressure were measured. RESULTS: Losartan (40 nmol) and [Sar¹, Ala8] ANG II (40 nmol) completely eliminated whereas PD 123319 (40 nmol) partially blocked the increase in water and sodium intake and the increase in arterial blood pressure induced by ANG II (10 nmol) injected into the MSA. The PVN administration of PD 123319 and [Sar¹, Ala8] ANG II blocked whereas losartan attenuated the diuresis and natriuresis induced by MSA administration of ANG II. CONCLUSION: MSA involvement with PVN on water and sodium homeostasis and arterial pressure modulation utilizing ANGII receptors is suggested.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>central nervous system</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sodium balance</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Lipid peroxidation and nitric oxide inactivation in postmenopausal women</s1>
</fA08>
<fA11 dir="011000">
<s1>Isabela Rosier Olimpio Pereira</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo Chiara Bertolami</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>André Arpad Faludi</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Fernanda Campos</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Simone Ferderbar</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Emersom Silva Lima</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Mendes Aldrighi</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Dulcineia Saes Parra Abdalla</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Faculdade de Ciências Farmacêuticas  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>USP Faculdade de Saúde Pública </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>415-423</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>70</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effect of endogenous estrogens on the bioavailability of nitric oxide (&amp;middot;NO) and in the formation of lipid peroxidation products in pre- and postmenopausal women. METHODS: NOx and S-nitrosothiols were determined by gaseous phase chemiluminescence, nitrotyrosine was determined by ELISA, COx (cholesterol oxides) by gas chromatography, and cholesteryl linoleate hydroperoxides (CE18:2-OOH), trilinolein (TG18:2-OOH), and phospholipids (PC-OOH) by HPLC in samples of plasma. RESULTS: The concentrations of NOx, nitrotyrosine, COx, CE18:2-OOH, and PC-OOH were higher in the postmenopausal period (33.8&amp;plusmn;22.3 mM; 230&amp;plusmn;130 nM; 55&amp;plusmn;19 ng/mL; 17&amp;plusmn;8.7 nM; 2775&amp;plusmn;460 nM, respectively) as compared with those in the premenopausal period (21.1&amp;plusmn;7.3 mM; 114&amp;plusmn;41 nM; 31&amp;plusmn;13 ng/mL; 6&amp;plusmn;1.4 nM; 1635&amp;plusmn;373 nM). In contrast, the concentration of S-nitrosothiols was lower in the postmenopausal period (91&amp;plusmn;55 nM) as compared with that in the premenopausal p in the premenopausal period (237&amp;plusmn;197 nM). CONCLUSION: In the postmenopausal period, an increase in nitrotyrosine and a reduction of S-nitrosothiol formation, as well as an increase of COx, CE18:2-OOH and PC-OOH formation occurs. Therefore, ·NO inactivation and the increase in lipid peroxidation may contribute to endothelial dysfunction and to the greater risk for atherosclerosis in postmenopausal women.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>menopause</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nitric oxide</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipid peroxidation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Infective endocarditis: surgical therapy</s1>
</fA08>
<fA11 dir="011000">
<s1>Luís Sérgio de Moura Fragomeni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fabiano Fernandes Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Júlio Cesar de Mello Bajerski</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Roque Paulo Falleiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Gustavo Hoppen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Iselso Sartori</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de Passo Fundo Hospital São Vicente de Paulo </s1>
<s2>Passo Fundo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>431-437</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the major causes of surgical morbidity and mortality in patients with infective endocarditis operated upon in a regional cardiology center. METHODS: Thirty-four patients underwent surgical treatment for infective endocarditis. Their ages ranged from 20 to 68 years (mean of 40.6) and 79% were males. Their NYHA functional classes were as follows: IV - 19 (55.8%) patients; III - 12 (35.2%) patients; II - 3 (8.8%) patients. Blood cultures were positive in only 32% of the cases. Eight patients had already undergone previous cardiac surgery, whose major indication (82.3%) was heart failure refractory to clinical treatment. RESULTS: Four (11.7%) patients died at the hospital. Follow-up was complete in 26 (86%) patients. Five (14.7%) patients died later, 12, 36, 48, 60, and 89 months after hospital discharge. Of the 21 patients being currently followed up, 1 is in NYHA functional class III, and 5 in NYHA functional class II. CONCLUSION: A high degree of clinical suspicion, at an early diagnosis, and indication of surgical treatment prior to deterioration of left ventricular function and installation of generalized sepsis may improve prognosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endocarditis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>valvular surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Endomyocardial fibrosis in infancy</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo Biscegli Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ivan Salvador Bonillo Contreras</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Laura C. Riera Lameda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José de Lima Oliveira Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Munir Ebaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Elisa Rumiko Iwahashi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Deipara Monteiro Abellan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Vera Demarchi Aiello</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Miguel Barbero Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>442-445</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>The patient was a 4-month-old infant, who underwent persistent ductus arteriosus interruption with titanium clips at the age of 13 days and, since the age of 2 months, had crises of hypoxia and hypertonicity. After clinical investigation, the presence of pulmonary hypertension was confirmed and left ventricular inflow tract obstruction was suspected. The patient underwent surgical treatment at the age of 4 months, during which right and left ventricular endocardial fibrosis was identified. The fibrosis was resected, but the infant had an unfavorable clinical evolution with significant diastolic restriction and died on the sixth postoperative day. Anatomicopathological and surgical findings suggested endomyocardial fibrosis, although that pathology is very rare at the patient's age.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 2/03 - Paciente do sexo feminino, 73 anos, portadora de diabetes mellitus, com dor torácica há 2 dias</s1>
</fA08>
<fA11 dir="011000">
<s1>Tiago Pugliese Branco</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Osvaldo Teixeira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Aparecida Barone Teixeira</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>446-450</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 4/2003 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>451-451</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Proteína-C-reativa e doença cardiovascular: as bases da evidência científica</s1>
</fA08>
<fA11 dir="011000">
<s1>Wellington Bruno Santos</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rosa Maria R. Vieira</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Beni Olej</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mário Coutinho</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Alvaro Avezum</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal de Santa Catarina  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>452-456</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>90</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Normatização de técnicas e equipamentos para realização de exames em ergometria e ergoespirometria</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo Stein</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fábio Vilas-Boas</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>457-464</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Regional myocardial function in healthy adults: assessment through tissue Doppler echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Nuno Cardim</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antônio Gouveia Oliveira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Susana Longo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Teresa Ferreira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Amadeu Pereira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Roberto Palma Reis</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>João Martins Correia</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pulido Valente Serviço de Cardiologia </s1>
<s2>Lisboa </s2>
<s3>Portugal</s3>
</fA14>
<fA14 dir="020000">
<s1>Medical University of South Carolina Departamento de Biometria e Epidemiologia </s1>
<s2>Charlston South Carolina</s2>
<s3>United States of America</s3>
</fA14>
<fA20 dir="000000">
<s1>474-482</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>76</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To characterize left ventricular regional myocardial function through tissue Doppler echocardiography in healthy adults and to assess the influence of aging in this function. METHODS: In 45 healthy volunteers divided in two groups (&lt; 45 and &gt; 45 years old) we assessed longitudinal and radial regional function (velocities, times intervals and velocity-time integrals). Data were compared in each group and between groups. RESULTS: Systolic function: a) longitudinal: higher velocities and integrals in lateral and inferior walls and in basal segments, with a trend to reduction of these parameters with aging; b) radial: higher basal velocities, no significant change with aging. Diastolic function: a) longitudinal: higher velocities in lateral and inferior walls and in basal segments. With aging e and e/a velocities and integrals decreased, a increased and older individuals showed lower percentage of segments with e/a &gt;1; b) radial: aging was associated with lower e and higher a velocities. CONCLUSION: 1) Tissue Doppler echocardiography detects physiological differences between regional myocardial function of different ventricular segments, in velocities, times intervals and integrals, with physiological heterogeneity and asynchrony; 2) Many of these data are age dependent; 3) Our data contribute to define normal values, and may become useful when compared with data from populations with heart diseases.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>longitudinal and radial regional myocardial function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tissue Doppler echocardiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Effect of arginine vasopressin on the canine epicardial coronary artery: experiments on V1-receptor-mediated production of nitric oxide</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Roberto B. Evora</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paul J. Pearson</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alfredo J. Rodrigues</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fernanda Viaro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Hartzell V. Schaff</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Mayo Foundation Mayo Clinic </s1>
<s2>Rochester MN</s2>
<s3>USA</s3>
</fA14>
<fA14 dir="020000">
<s1>USP Faculdade de Medicina de Ribeirão Preto </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>489-494</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>39</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine whether arginine vasopressin releases endothelium-derived nitric oxide (EDNO) from the epicardial coronary artery. METHODS: We studied segments of canine left circumflex coronary arteries suspended in organ chambers to measure isometric force. The coronary artery segments were contracted with prostaglandin F2alpha (2 x 10-6M) and exposed to a unique, strong arginine vasopressin concentration (10-6M) or titrated concentrations (10-9 a 10-5 M). RESULTS: The unique dose of arginine vasopressin concentration (10-6M) induced transient, but significant (p&lt;0.05), relaxation in arterial segments with endothelium, and an increase, not significant, in tension in arteries without endothelium. Endothelium-dependent relaxation to arginine vasopressin was inhibited by Ng-monomethyl-L-arginine (L-NMMA, 10-5M) or N G-nitro-L-arginine (L-NOARG) (10-4M), 2 inhibitors of nitric oxide synthesis from L-arginine. Exogenous L-arginine (10-4M), but not D-arginine (10-4M), reversed the inhibitory effect of L-NMMA on vasopressin-mediated vasorelaxation. Endothelium dependent relaxation to vasopressin was also reversibly inhibited by the vasopressin V1-receptor blocker d(CH2)5Try(Me) arginine vasopressin (10-6M) (n=6, P&lt;0.05). CONCLUSION: Vasopressin acts through V1 endothelial receptors to stimulate nitric oxide release from L-arginine.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>vasopressin</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endothelium</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nitric oxide</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Surgical myocardial revascularization without extracorporeal circulation</s1>
</fA08>
<fA11 dir="011000">
<s1>Salomón Soriano Ordinola Rojas</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Viviane C. Veiga</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Januario M. Souza</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcos S. Berlinck</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Alberto Iasbech</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luiz Alberto Magna</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Reinaldo W. Vieira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Sergio A. Oliveira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Real e Benemérita Sociedade Portuguesa de Beneficência  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Estadual de Campinas  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>502-508</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>40</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the immediate postoperative period of patients undergoing myocardial revascularization without extracorporeal circulation with different types of grafts. METHODS: One hundred and twelve patients, 89 (79.5%) of whom were males, were revascularized without extracorporeal circulation. Their ages ranged from 39 to 85 years. The criteria for indicating myocardial revascularization without extracorporeal circulation were as follows: revascularized coronary artery caliber &gt; 1.5 mm, lack of intramyocardial trajectory on coronary angiography, noncalcified coronary arteries, and tolerance of the heart to the different rotation maneuvers. RESULTS: Myocardial revascularization without extracorporeal circulation was performed in 112 patients. Three were converted to extracorporeal circulation, which required a longer hospital stay but did not impact mortality. During the procedure, the following events were observed: atrial fibrillation in 10 patients, ventricular fibrillation in 4, total transient atrioventricular block in 2, ventricular extrasystoles in 58, use of a device to retrieve red blood cells in 53, blood transfusion in 8, and arterial hypotension in 89 patients. Coronary angiography was performed in 20 patients on the seventh postoperative day when the grafts were patent. CONCLUSION: Myocardial revascularization without extracorporeal circulation is a reproducible technique that is an alternative for treating ischemic heart disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Subendocardial fibrosis in remote myocardium results from reduction of coronary driving pressure during acute infarction in rats</s1>
</fA08>
<fA11 dir="011000">
<s1>Clovis de Carvalho Frimm</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcia Kiyomi Koike</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Mariana Cúri</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>University of São Paulo Medical School </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>University of São Paulo Institute of Mathematics and Statistics </s1>
<s2>São Paulo </s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>515-520</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To investigate the role of hemodynamic changes occurring during acute MI in subsequent fibrosis deposition within non-MI. METHODS: By using the rat model of MI, 3 groups of 7 rats each [sham, SMI (MI &lt;30%), and LMI (MI &gt;30%)] were compared. Systemic and left ventricular (LV) hemodynamics were recorded 10 minutes before and after coronary artery ligature. Collagen volume fraction (CVF) was calculated in picrosirius red-stained heart tissue sections 4 weeks later. RESULTS: Before surgery, all hemodynamic variables were comparable among groups. After surgery, LV end-diastolic pressure increased and coronary driving pressure decreased significantly in the LMI compared with the sham group. LV dP/dt max and dP/dt min of both the SMI and LMI groups were statistically different from those of the sham group. CVF within non-MI interventricular septum and right ventricle did not differ between each MI group and the sham group. Otherwise, subendocardial (SE) CVF was statistically greater in the LMI group. SE CVF correlated negatively with post-MI systemic blood pressure and coronary driving pressure, and positively with post-MI LV dP/dt min. Stepwise regression analysis identified post-MI coronary driving pressure as an independent predictor of SE CVF. CONCLUSION: LV remodeling in rats with MI is characterized by predominant SE collagen deposition in non-MI and results from a reduction in myocardial perfusion pressure occurring early on in the setting of MI.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary driving pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>subendocardial fibrosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hemodynamic</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular remodeling</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>New auxiliary indicators for the differential diagnosis of functional cardiorespiratory limitation in patients with chronic obstructive pulmonary disease and congestive heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo de Castro Cesar</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Aquiles Camelier</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Roberto Jardim</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fábio Tadeu Montesano</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Sérgio Tebexreni</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Turíbio Leite de Barros</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Centro de Medicina da Atividade Física e do Esporte  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>UNIFESP EPM Centro de Reabilitação Pulmonar</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>526-530</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To differentiate the nature of functional cardiorespiratory limitations during exercise in individuals with chronic obstructive pulmonary disease (COPD) or congestive heart failure (CHF) and to determine indicators that may help their classifications. METHODS: The study comprised 40 patients: 23 with COPD and 17 with CHF. All individuals underwent maximal cardiopulmonary exercise testing on a treadmill. RESULTS: The values of peak gas exchange ratio (R peak), peak carbon dioxide production (VCO2 peak), and peak oxygen ventilatory equivalent (V E O2 peak) were higher in the patients with CHF than in those with COPD, and, therefore, those were the variables that characterized the differences between the groups. For group classification, the differentiating functions with the R peak, VCO2 peak (L/min), and V E O2 peak variables were used as follows: group COPD: - 44.886 + 78.832 x R peak + 5.442 x VCO2 peak + 0.336 x V E O2 peak; group CHF: - 69.251 + 89.740 x R peak + 8.461 x VCO2 peak + 0.574 x V E O2 peak. The differentiating function, whose result is greater, correctly classifies the patient's group as 90%. CONCLUSION: The R peak, VCO2 peak, and V E O2 peak values may be used to identify the cause of the functional cardiorespiratory limitations in patients with COPD and CHF.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>obstructive pulmonary diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congestive heart failure</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Predictive factors of complications after coronary stent implantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre Schaan de Quadros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos A. M. Gottschall</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rogério Sarmento-Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Miguel Gus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rodrigo Wainstein</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>André Bussmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> Rio Grande do Sul</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>538-543</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the predictive factors of complications after implantation of coronary stents in a consecutive cohort study. METHODS: Clinical and angiographic characteristics related to the procedure were analyzed, and the incidence of major cardiovascular complications (myocardial infarction, urgent surgery, new angioplasty, death) in the in-hospital phase were recorded. Data were stored in an Access database and analyzed by using the SPSS 6.0 statistical program and a stepwise backwards multiple logistic regression model. RESULTS: One thousand eighteen (mean age of 61&amp;plusmn;11 years, 29% females) patients underwent 1,070 stent implantations. The rate of angiographic success was 96.8%, the rate of clinical success was 91%, and the incidence of major cardiovascular complications was 7.9%. The variables independently associated with major cardiovascular complications, with their respective odds ratio (OR) were: rescue stent, OR = 5.1 (2.7-9.6); filamentary stent, OR = 4.5 (2.2-9.1); first-generation tubular stent, OR = 2.4 (1.2-4.6); multiple stents, OR = 3 (1.6-5.6); complexity of the lesion, OR = 2.4 (1.1-5.1); thrombus, OR = 2 (1.1-3.5). CONCLUSION: The results stress the importance of angiographic variables and techniques in the risk of complications and draw attention to the influence of the stent's design on the result of the procedure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>interventional cardiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stents</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>predictive value</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>complications</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Effect of oscillatory breathing on the variability of the RR Intervals and its prognostic importance in individuals with left ventricular global systolic dysfunction</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Roberto Benchimol Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Barbosa Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ivan Cordovil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Nacional de Cardiologia Laranjeiras Universidade Gama Filho </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>551-557</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effect of the oscillatory breathing on the variability of RR intervals (VRR) and on prognostic significance after one year follow-up in subjects with left ventricular global systolic dysfunction. METHODS: We studied 76 subjects, whose age ranged from 40 to 80 years, paired for age and gender, divided into two groups: group I - 34 healthy subjects; group II - 42 subjects with left ventricular global systolic dysfunction (ejection fraction &lt; 0.40). The ECG signals were acquired during 600s in supine position, and analyzed the variation of the thoracic amplitude and the VRR. Clinical and V-RR variables were applied into a logistic multivariate model to foretell survival after one year follow-up. RESULTS: Oscillatory breathing was detected in 35.7% of subjects in vigil state of group II, with a concentration of the spectral power in the very low frequency band, and was independent of the presence of diabetes, functional class, ejection fraction, cause of ventricular dysfunction and survival after one year follow-up. In the logistic regression model, ejection fraction was the only independent variable to predict survival. CONCLUSION: 1) Oscillatory breathing pattern is frequent during wakefulness in the left ventricular global systolic dysfunction and concentrates spectral power in the very low band of V-RR; 2) it does not relate to severity and cause of left ventricular dysfunction; 3) ejection fraction is the only independent predictive variable for survival in this group of subjects.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>oscillatory breathing</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>variability in the RR intervals</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Dual anterior descending coronary artery associated with coronary artery disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciane da L. V. Siqueira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ronaldo R. L. Bueno</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ênio E. Guérios</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo M. P. de Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Deborah C. Nercolini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Stefan W. Negrão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Álvaro L. A. Pacheco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>José C. E. Tarastchuck</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Universitário Evangélico  </s1>
<s2>Curitiba </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>561-563</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>The patient is a male with risk factors for coronary artery disease, who was referred for cardiac catheterization after acute myocardial infarction in the inferior wall. The patient underwent transluminal coronary angioplasty in the right coronary artery with successful stent implantation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 5/2003 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM HC</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>564-564</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Alterações genéticas e colesterolemia: recentes estudos brasileiros</s1>
</fA08>
<fA11 dir="011000">
<s1>Neusa Forti</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luis A. Salazar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Jayme Diament</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sergio D. Giannini</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mario H. Hirata</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rosario D.C. Hirata</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidad de La Frontera Faculdad de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>USP Faculdade de Ciências Farmacêuticas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="040000">
<s1>USP Faculdade de Medicina HC</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>565-571</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>71</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Normatização dos equipamentos e técnicas para a realização de exames de eletrocardiografia e eletrocardiografia de alta resolução</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo J. Moffa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Augusto H. Uchida</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>572-578</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Distribution of risk factors in parents and siblings of patients with early coronary artery disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio de Padua Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>André P. L. Mattar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Anderson L. Rolim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fábio R. Yoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José F.G. Marin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luíz Antonio M. César</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Antonio F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>582-584</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Early coronary artery disease (CAD) is associated with risk factors (RF). Offspring of parents with a RF have a greater prevalence of them. However, the distribution of RF in parents and siblings of patients with early CAD is unknown. METHODS: The study comprised the parents and siblings of 42 patients with early CAD (&lt; 45 years), 29 males. Their mean age was 39.5&amp;plusmn;3.7 years. The following major RF were analyzed: smoking (&gt; 5 cigarretes/day), hypercholesterolemia (total cholesterol &gt; 200 mg/dL), hypertension (diastolic blood pressure &gt; 90 mmHg), and diabetes (glycemia &gt; 126 mg/dL). RESULTS: Of a total of 102 RF, 4, 3, 2, and 1 were observed in, respectively, 5, 15, 15, and 7 patients with early CAD, the most prevalent being smoking (86%) and hypercholesterolemia (83%). Diabetes was observed in 15 (36%) and hypertension in 16 (38%) patients. Smoking was more prevalent in the fathers (76%) and hypercholesterolemia in the mothers (30%). In 183 siblings, 131 RF were observed (1 patient with the disease had a mean of 4.7 siblings). The prevalences of smoking, hypertension, hypercholesterolemia, and diabetes in the siblings were, respectively, 32%, 18%, 14%, and 9%. The incidence of RF was as follows: 72 (39%) siblings had 1 RF, 25 (14%) siblings had 2 RF, and 3 (2%) siblings had 3 RF. In parents and their offspring, smoking was moderately correlated (r=0.43; P=0.02) with CAD. CONCLUSION: Smoking habit of parents is passed on to offspring, and, in association with hypercholesterolemia, it was the major cause of early CAD in offspring. High prevalence of smoking in offspring shows the potential responsibility of parents in the incidence of the disease in offspring.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>familial history</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>smoking</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Association between coronary artery atherosclerosis and the intima-media thickness of the common carotid artery measured on ultrasonography</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo Maffini da Rosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Caroline Kramer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Iran Castro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>589-592</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess whether the intima-media thickness of the common carotid artery of patients with coronary artery disease is greater than that of individuals without that disease. METHODS: Case-control prospective study of prevalence assessing the thickness of the intima and media layers of 29 patients with coronary artery disease and 29 individuals without that disease by using ultrasonography of the carotid arteries. Diabetic patients and those with peripheral artery and cerebral vasculopathies were excluded from the study. RESULTS: The mean age was 51&amp;plusmn;7.5 years. Fifty-five per cent of the patients were males. Acute myocardial infarction was present in 62%; cardiac catheterization in 72%; saphenous bypass in 5%; and coronary angioplasty in 24%. The intima-media thickness of the common carotid artery in case patients and in control patients was, respectively, 0.81&amp;plusmn;0.25 mm and 0.62&amp;plusmn;0.18 mm (P=0.001). CONCLUSION: Intima-media thickness of the common carotid artery was significantly greater in patients with coronary artery disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>intima-media thickness</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>common carotid artery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Acute myocardial infarction: clinical and epidemiological profile and factors associated with in-hospital death in the municipality of Rio de Janeiro</s1>
</fA08>
<fA11 dir="011000">
<s1>Claudia Caminha Escosteguy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Margareth Crisóstomo Portela</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Roberto de Andrade Medronho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maurício Teixeira Leite de Vasconcellos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>SUS Hospital dos Servidores do Estado </s1>
<s2> RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>600-606</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study the factors associated with the risk of in-hospital death in acute myocardial infarction in the Brazilian public health system in Rio de Janeiro, Brazil. METHODS: Sectional study of a sample with 391 randomly drawn medical records of the hospitalizations due to acute myocardial infarction recorded in the hospital information system in 1997. RESULTS: The diagnosis was confirmed in 91.7% of the cases; 61.5% males; age = 60.2 &amp;plusmn; 2.4 years; delta time until hospitalization of 11 hours; 25.3% were diabetic; 58.1% were hypertensive; 82.6% were in Killip I class. In-hospital mortality was 20.6%. Thrombolysis was used in 19.5%; acetylsalicylic acid (ASA) 86.5%; beta-blockers 49%; angiotensin-converting enzyme (ACE) inhibitors 63.3%; calcium channel blockers 30.5%. Factors associated with increased death: age (61-80 years: OR=2.5; &gt; 80 years: OR=9.6); Killip class (II: OR=1.9; III: OR=6; IV: OR=26.5); diabetes (OR=2.4); ventricular tachycardia (OR=8.5); ventricular fibrillation (OR=34); recurrent ischemia (OR=2.7). The use of ASA (OR=0.3), beta-blockers (OR=0.3), and ACE inhibitors (OR=0.4) was associated with a reduction in the chance of death. CONCLUSION: General lethality was high and some interventions of confirmed efficacy were underutilizated. The logistic model showed the beneficial effect of beta-blockers, and ACE inhibitors on the risk of in-hospital death.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>in-hospital mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>multivariate analysis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Acute myocardial infarction: predictors of mortality at a public hospital in the city of Fortaleza, Ceará state</s1>
</fA08>
<fA11 dir="011000">
<s1>Demóstenes Gonçalves Lima Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Pedro José Negreiros de Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Nogueira Paes Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Lurildo Ribeiro Saraiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Secretaria de Saúde do Estado do Ceará Hospital de Messejana </s1>
<s2>Recife PE</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>614-620</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>44</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To identify the clinical and demographic predictors of in-hospital mortality in acute myocardial infarction with elevation of the ST segment in a public hospital, in the city of Fortaleza, Ceará state, Brazil. METHODS: A retrospective study of 373 patients experiencing their first episode of acute myocardial infarction was carried out. Of the study patients, 289 were discharged from the hospital (group A) and 84 died (group B). Both groups were analyzed regarding: sex; age; time elapsed from the beginning of the symptoms of myocardial infarction to assistance at the hospital; use of streptokinase; risk factors for atherosclerosis; electrocardiographic location of myocardial infarct; and Killip functional class. RESULTS: In a univariate analysis, group B had a greater proportion of the following parameters as compared with group A: non-Killip I functional class; diabetes; age &gt;70 years; infarction of the inferior wall associated with right ventricular impairment; time between symptom onset and treatment at the hospital &gt;12 h; anteroseptal or extensive anterior infarction; no use of streptokinase; and no tobacco use. In a multivariate logistic regression analysis, only non-Killip I functional class, diabetes, and age &gt;70 years persisted as independent factors for death. CONCLUSION: Non-Killip I functional class, diabetes, and age &gt;70 years were independent predictors of mortality in acute myocardial infarction with elevation of the ST segment.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>in-hospital mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Killip functional class</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diabetes mellitus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Endothelium-dependent relaxation in response to poly-L-arginine in canine coronary arteries: implications about hyperpolarization as a mechanism of vasodilatation</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo R. B. Evora</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paul J. Pearson</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alfredo José Rodrigues</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fernanda Viaro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Hartzell V. Schaff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto Divisão de Cirurgia Experimental</s1>
<s2>Ribeirão Preto SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>626-630</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study the mechanism by which poly-L-arginine mediates endothelium-dependent relaxation. METHODS: Vascular segments with and without endothelium were suspended in organ chambers filled with control solution maintained at 37ºC and bubbled with 95% O2 / 5% CO2. Used drugs: indomethacin, acetycholine, EGTA, glybenclamide, ouabain, poly-L-arginine, methylene blue, N G-nitro-L-arginine, and verapamil and N G-monomethyl-L-arginine. Prostaglandin F2á and potassium chloride were used to contract the vascular rings. RESULTS: Poly-L-arginine (10-11 to 10-7 M) induced concentration-dependent relaxation in coronary artery segments with endothelium. The relaxation to poly-L-arginine was attenuated by ouabain, but was unaffected by glybenclamide. L-NOARG and oxyhemoglobin caused attenuation, but did not abolish this relaxation. Also, the relaxations was unaffected by methylene blue, verapamil, or the presence of a calcium-free bathing medium. The endothelium-dependent to poly-L-arginine relaxation was abolished only in vessels contracted with potassium chloride (40 mM) in the presence of L-NOARG and indomethacin. CONCLUSION: These experiments indicate that poly-L-arginine induces relaxation independent of nitric oxide.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>poly-L-arginine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>polycations</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nitric oxide</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>EDHF</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endothelium</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>National alert campaign about increased cholesterol: determination of cholesterol levels in 81,262 Brazilians</s1>
</fA08>
<fA11 dir="011000">
<s1>Tania L. Rocha Martinez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Raul D. Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Dikran Armaganijan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Kerginaldo P Torres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Andréia Loures-Vale</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maria Eliane Magalhães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Carlos Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Emilio Moriguchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Celso Amodeo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Juarez Ortiz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Sociedade Brasileira de Cardiologia  </s1>
<s2> SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>635-638</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the levels of total cholesterol in a significant sample of the Brazilian population. METHODS: Blood cholesterol was determined in 81.262 individuals &gt; 18 years old (51% male, 44.7 &amp;plusmn; 15.7 years), using Accutrend equipment, in the cities São Paulo, Campinas, Campos do Jordão, São José dos Campos, Santos, Santo André, Ribeirão Preto, Porto Alegre, Rio de Janeiro, Belo Horizonte, Curitiba, Brasília, Salvador and documented in the presence of other risk factors (RF) for coronary artery disease (CAD) (systemic hypertension, CAD in the family, smoking, and diabetes). Participants were classified according to sex, age, and the presence or absence of RF, respectively, as 0 RF, 1 RF and &gt; 2 RF. The percentage of individuals with cholesterol &gt; 200 mg/dL and &gt; 240 mg/dL was evaluated. RESULTS: The prevalence of individuals with 0, 1, and &gt; 2 risk factors was 30% (n = 24,589), 36% (n =29,324), and 34% (n = 27,349) respectively, (P=0.657), and the mean total cholesterol of the population was 199.0 &amp;plusmn; 35.0 mg/dL. Cholesterol levels above 200 and 240 mg/dL were found, respectively, in 40% (n = 32,515) and 13% (10.942) of individuals. The greater the number of risk factors the higher the levels of cholesterol (P&lt;0.0001) and the greater the proportion of individuals with cholesterol &gt; 200 mg/dL (P=0.032). No difference existed in the proportion of individuals with cholesterol &gt; 240 mg/dL (P=0.11). CONCLUSION: A great percentage of individuals with cholesterol levels above those recommended to prevent coronary artery disease was found.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cholesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Hemarthrosis of the knees following streptokinase therapy for acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo Pimenta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sônia M. A. Anti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina do ABC  </s1>
<s2>Santo André SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>641-642</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A sixty-four-year-old male patient was studied who had acute coronary syndrome with ST segment elevation experienced bilateral hemarthrosis of the knees after administration of streptokinase and acetylsalicylic acid.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 3/2002 - Mulher de 82 anos, portadora de hipertensão arterial sistêmica, fibrilação atrial e que apresentou acidente vascular cerebral recorrente e fatal (Instituto do Coração do Hospital das Clínicas da FMUSP, São Paulo)</s1>
</fA08>
<fA11 dir="011000">
<s1>Jaime Freitas Bastos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Alberto Benvenuti</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>643-648</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 6/2003 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>649-649</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Comunicação interatrial do tipo ostium secundum: Do tratamento cirúrgico ao percutâneo e os dinossauros do futuro</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos A. C. Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Simone R. F. Fontes Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Valmir Fernandes Fontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>650-655</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Cirurgia de revascularização miocárdica sem circulação extracorpórea: uma técnica em busca de evidências</s1>
</fA08>
<fA11 dir="011000">
<s1>Celso Blacher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jorge Pinto Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Faculdade de Medicina Hospital de Clínicas de Porto Alegre</s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>656-662</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000611</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Errata</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>00-00</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000612</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Coinfection with Mycoplasma Pneumoniae and Chlamydia Pneumoniae in ruptured plaques associated with acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria de Lourdes Higuchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcia Martins Reis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Nádia Vieira Sambiase</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Suely Aparecida Pinheiro Palomino</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Jussara Bianchi Castelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paulo Sampaio Gutierrez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Vera Demarchi Aiello</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>12-22</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>78</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study atheromas, Mycoplasma pneumoniae (M. pneumoniae), and Chlamydia pneumoniae (C. pneumoniae). METHODS: C. pneumoniae was studied with immunohistochemistry and M. pneumoniae with in situ hybridization (ISH), in segments of coronary arteries (SCA) as follows: group A - thrombosed ruptured plaques (TRP) of 23 patients who died due to acute myocardial infarction (AMI); group B - 23 nonruptured plaques (NRP) of group A patients; group C - NRP of 11 coronary patients who did not die due to AMI; and group D - 11 SCA from patients with dilated cardiomyopathy or Chagas' disease without atherosclerosis. RESULTS: The mean number of C. pneumoniae+ cells/400x in groups A, B, C, and D was, respectively, 3.3±3.6; 1.0±1.3; 1.2±2.4; and 0.4±0.3; and the percentage of M. pneumoniae area was, respectively, 3.9±3.5; 1.5± 1.6; 0.9±0.9; and 0.4±0.2. More M. pneumoniae and C. pneumoniae were found in of group A than in group B (P&lt;0.01). Good correlation was seen between the area of the vessel and the M. pneumoniae area in the plaque (r = 0.46; P=0.001) and between C. pneumoniae+ cells and CD4+ T lymphocytes (r = 0.42; P&lt;0.01). The number of C. pneumoniae+ cells correlated with CD20+ B cells (r=0.48; P&lt;0.01). CONCLUSION: M. pneumoniae and C. pneumoniae are more frequently found in TRP correlate with the intensity of the inflammation and diameter of the vessel (positive remodeling).</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Mycoplasma pneumoniae</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chlamydia pneumoniae</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>A new proposal to guide velocity and inclination in the ramp protocol for the treadmill ergometer</s1>
</fA08>
<fA11 dir="011000">
<s1>Odwaldo Barbosa e Silva</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dário C. Sobral Filho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital do Coração Prontocor </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Medicina do Exercício Atleticor </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>48-53</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To suggest criteria to guide protocol prescription in ramp treadmill testing, according to sex and age, based on velocity, inclination, and max VO2 reached by the population studied. METHODS: Prospective study describing heart rate (HR), time, velocity, inclination, and VO2 estimated at maximum effort of 1840 individuals from 4 to 79 years old, who performed a treadmill test (TT) according to the ramp protocol. A paired Student t test was used to assess the difference between predicted and reached max VO2, calculated according to the formulas of the &quot;American College of Sports Medicine&quot;. RESULTS: Submaximal HR was surpassed in 90.1% of the examinations, with a mean time of 10.0±2.0 minute. Initial and peak inclination velocity of the exercise and max VO2 were inversely proportional to age and were greater in male patients. Predicted Max VO2 was significantly lower than that reached in all patients, except for female children and adolescents (age &lt; 20 years old). CONCLUSION: Use of velocity, inclination, and maximum VO2 actually reached, as a criterion in prescribing the ramp protocol may help in the performance of exercise in treadmill testing. The ramp protocol was well accepted in all age groups and sexes with exercise time within the programmed 8 to 12 minutes.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treadmill test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise tolerance</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ramp protocol</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Comparative study of the use of diltiazem as an antispasmodic drug in coronary angiography via the transradial approach</s1>
</fA08>
<fA11 dir="011000">
<s1>José Ronaldo Mont'Alverne Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João Alexandre Rezende Assad</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alexandre do Canto Zago</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ricardo Leite Vieira da Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Guarany Mont'Alverne Pierre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Mohamed Hassan Saleh</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Rodrigo Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Sérgio Luiz Navarro Braga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Fausto Feres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Amanda Guerra Moraes Rego Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>José Eduardo Moraes Rego Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>59-63</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the impact of the use, prior to the procedure, of injectable diltiazem to prevent complications. METHODS: Between September 2000 and July 2001, 50 patients underwent transradial coronary angiography and were randomized to receive placebo (GI) or diltiazem (GII) through a catheter inserted into the radial artery. All patients received isosorbide mononitrate. Ultrasound analyses of the radial artery were performed before examination, 30 minutes afterwards, and 7 days afterwards to evaluate the flow, the diameter, and the artery output. RESULTS: The radial artery diameter of GI was 2.4± 0.5 mm before the procedure and 2.3±0.5 mm after 30 minutes (NS), whereas in GII the diameter was 2.2±0.3 mm before the examination and 2.5±0.4 mm 30 minutes after it (P&lt;0.001). Radial artery output in group 1 was 7.3±5.l2 mL/min before the examination and 6.1±3.5 mL/min 30 minutes after the examination (NS), and GII had an increase of 5.9±2.5 mL/min before examination to 9.05± 7.78 mL/min after the examination (P=0.04). Complications (spasm, occlusion, and partial obstruction) occurred in 4 patients (17.4%) in GI and did not occur in GII (P=0.04). CONCLUSION: The study suggests a decrease in vascular complications through the transradial access for coronary angiography with the use of diltiazem as an antispasmodic drug, resulting in the significant increase in the diameter of the radial artery and radial artery output.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>radial</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Enalapril alters the formation of the collagen matrix in spontaneously hypertensive rats</s1>
</fA08>
<fA11 dir="011000">
<s1>Alfredo de Souza Bomfim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Alberto Mandarim-de-Lacerda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UERJ Instituto de Biologia Roberto Alcântara Gomes </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>69-72</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effect of the inhibition of the angiotensin-converting enzyme on the collagen matrix (CM) of the heart of newborn spontaneously hypertensive rats (SHR) during embryonic development. METHODS: The study comprised the 2 following groups of SHR (n=5 each): treated group - rats conceived from SHR females treated with enalapril maleate (15 mg. kg-1.day-1) during gestation; and nontreated group - offspring of nontreated females. The newborns were euthanized within the first 24 hours after birth and their hearts were removed and processed for histological study. Three fields per animal were considered for computer-assisted digital analysis and determination of the volume densities (Vv) of the nuclei and CM. The images were segmented with the aid of Image Pro Plus® 4.5.029 software (Media Cybernetics). RESULTS: No difference was observed between the treated and nontreated groups in regard to body mass, cardiac mass, and the relation between cardiac and body mass. A significant reduction in the Vv[matrix] and a concomitant increase in the Vv[nuclei] were observed in the treated group as compared with those in the nontreated group. CONCLUSION: The treatment with enalapril of hypertensive rats during pregnancy alters the collagen content and structure of the myocardium of newborns.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angiotensin</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>enalapril</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>collagen matrix</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>spontaneously hypertensive rats</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Detection of incipient left ventricular hypertrophy in mild to moderate arterial hypertension with normal electrocardiogram and echocardiogram: a new use for signal-averaged electrocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Ginefra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eduardo C. Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo R. Benchimol Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alfredo S. Bomfim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sílvia H. Boghossian</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Angelo A. Salgado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Flávia G. Brasil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Elizabete A. Freitas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Francisco M. Albanesi Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UERJ Hospital Universitário Pedro Ernesto </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>79-84</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess signal-averaged electrocardiogram (SAECG) for diagnosing incipient left ventricular hypertrophy (LVH). METHODS: A study with 115 individuals was carried out. The individuals were divided as follows: GI - 38 healthy individuals; GII - 47 individuals with mild to moderate hypertension and normal findings on echocardiogram and ECG; and GIII - 30 individuals with hypertension and documented LVH. The magnitude vector of the SAECG was analyzed with the high-pass cutoff frequency of 40 Hz through the bidirectional four-pole Butterworth high-pass digital filter. The mean quadratic root of the total QRS voltage (RMST) and the two-dimensional integral of the QRS area of the spectro-temporal map were analyzed between 0 and 30 Hz for the frequency domain (Int FD), and between 40 and 250 Hz for the time domain (Int TD). The electrocardiographic criterion for LVH was based on the Cornell Product. Left ventricular mass was calculated with the Devereux formula. RESULTS: All parameters analyzed increased from GI to GIII, except for Int FD (GII vs GIII) and RMST log (GII vs GIII). Int TD showed greater accuracy for detecting LVH with an appropriate cutoff &gt; 8 (sensitivity of 55%, specificity of 81%). Positive values (&gt; 8) were found in 56.5% of the G II patients and in 18.4% of the GI patients (p&lt; 0.0005). CONCLUSION: SAECG can be used in the early diagnosis of LVH in hypertensive patients with normal ECG and echocardiogram.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>signal-averaged electrocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Malignant hypertension and hypertensive encephalopathy in primary aldosteronism caused by adrenal adenoma</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Aparecido Bortolotto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernando Henpin Yue Cesena</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fabio Biscegli Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Hélio Bernardes Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>97-100</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>6</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Two cases are reported as follows: 1) 1 female patient with accelerated-malignant hypertension secondary to an aldosterone-producing adrenal adenoma; and 2) 1 female patient with adrenal adenoma, severe hypertension, and hypertensive encephalopathy. This association is a rare clinical finding, and malignant hypertension may modify the hormonal characteristic of primary aldosteronism, making its diagnosis more difficult. The diagnosis of primary aldosteronism should be considered in patients with malignant hypertension or hypertensive encephalopathy if persistent hypokalemia occurs. Identification of primary aldosteronism is of paramount importance for the patient's evolution, because the surgical treatment makes the prognosis more favorable.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 7/2003 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>101-101</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Errata</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>0-0</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100112</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Characterization of the in vivo cardiac electrophysiologic effects of high-dose cocaine in closed-chest, anesthetized dogs with normal hearts</s1>
</fA08>
<fA11 dir="011000">
<s1>Guilherme Fenelon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Júlio Uchoa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Roberto Otobone</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcos Reis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Luiz Gomes do Amaral</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Angelo A. V. De Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Federal University of São Paulo Paulista School of Medicine </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>29-34</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To characterize the cardiac electrophysiologic effects of cocaine. METHODS: In 8 dogs (9-13 kg), electrophysiologic parameters and programmed stimulation were undertaken using transvenous catheters at baseline, and after cocaine intravenous infusion (12 mg/kg bolus followed by 0.22 mg/kg/min for 25 minutes). RESULTS: Cocaine plasma levels (n=5) rose to 6.73± 0.56 mg/mL. Cocaine did not affect sinus cycle length and arterial pressure. Cocaine prolonged P wave duration (54±6 vs 73±4 ms, P&lt;0.001), PR interval (115±17 vs 164±15 ms, P&lt;0.001), QRS duration (62±10 vs 88±14 ms, P&lt;0.001), and QTc interval (344±28 vs 403±62 ms, P=0.03) but not JT interval (193±35 vs 226±53 ms, NS). Cocaine prolonged PA (9±6 vs 23±8 ms, P&lt;0.001), AH (73±16 vs 92±15 ms; P=0.03), and HV (35±5 vs 45±3ms; P&lt;0.001) intervals and Wenckebach point (247±26 vs 280±28 ms, P=0.04). An increase occurred in atrial (138±8 vs 184± 20 ms; P&lt;0.001) and ventricular (160±15 vs 187±25 ms; P=0.03) refractoriness at a cycle length of 300 ms. Atrial arrhythmias were not induced in any dog. Ventricular fibrillation (VF) was induced in 2/8 dogs at baseline and 4/8 dogs after cocaine. CONCLUSION: High doses of cocaine exert significant class I effects and seem to enhance inducibility of VF but not of atrial arrhythmias.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cocaine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrophysiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular fibrillation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Cellular cholesterol efflux mediated by HDL isolated from subjects with low HDL levels and coronary artery disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciana Uint</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Andrei Sposito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Laura Ines Ventura Brandizzi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Vanda Mitie Yoshida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Raul Cavalcante Maranhão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Protásio Lemos da Luz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>University of São Paulo Medical School Heart Institute </s1>
<s2> </s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>39-41</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: The aim of this study was to verify whether HDL particles isolated from patients with coronary artery disease (CAD) and low HDL-C had diminished ability to promote cholesterol efflux from cultured cells compared with HDL isolated from subjects without CAD and with normal HDL-C. METHODS: Smooth muscle cells isolated from human aortas cultured and radiolabeled with ³H-cholesterol were loaded with cholesterol and incubated with increasing concentrations of HDL isolated from 13 CAD patients with low HDL-C (CAD group) or from 5 controls without CAD (C group). Efflux of cellular cholesterol was measured by cellular depletion of radiolabeled cholesterol and by the appearance of ³H-cholesterol into experimental medium expressed as a percentage of total labeled cholesterol. RESULTS: Cholesterol efflux increased with the amount of HDL present in the medium, and no difference was found between groups at various HDL protein concentrations: efflux was 28 ± 6.3% (C) and 25.5 ± 8.9% (CAD) with 25 mg/mL; 34 ± 4.3% (C) and 31.9 ± 6.6% (CD) with 50 mg/mL and 39.5 ± 3.5% (C) and 37.1 ± 4.4% (CAD) with 100 mg/mL, HDL. CONCLUSION: Because the HDL fraction of CAD patients with low HDL-C have normal ability to extract cholesterol from cells of the vessel wall, it is suggested that low HDL-C atherogenicity should be ascribed to diminished concentrations of HDL particles rather than to the qualitative properties of the HDL fraction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cholesterol efflux</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>high density lipoprotein</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Marfan's syndrome: early and severe form in siblings</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria de Fátima M. P. Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nadia Barreto Tenorio Aoun</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Monica Scott Borges</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Eliane Campos Magalhães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz A. Christiani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro Hospital Universitário Pedro Ernesto </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>89-92</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Marfan's syndrome is an inherited disorder of the connective tissue. Cardiologic manifestations, especially aortic dilation, are important causes of morbidity and mortality in the clinical course of the disease in adults and teenagers. In children, the presence of aortic aneurysm and its dissection or rupture is rare, occurring in patients with genetic mutation of the fibrillin gene but not in those who have the familial form of the disease. We describe here 2 patients, from the same family (siblings), diagnosed with gigantic aortic aneurysm early in infancy, one of them successfully undergoing surgery.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="en">
<s1>Evidence-based medicine. A lesson for electrocardiography?</s1>
</fA08>
<fA11 dir="011000">
<s1>Ljuba Bacharova</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>International Laser Center  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>102-110</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100111</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Self-perception and dissatisfaction with weight does not depend on the frequency of physical activity</s1>
</fA08>
<fA11 dir="011000">
<s1>Denise Sardinha Mendes Soares de Araújo</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Claudio Gil Soares de Araújo</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Gama Filho Educação Física </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade do Rio de Janeiro Escola de Educação </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Clínica de Medicina do Exercício  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>243-249</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>39</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the level of satisfaction with body weight and the self-perception of the weight/height ratio and to verify the influence of the frequency of present and past physical activity on these variables. METHODS: Using questionnaires or interviews, we obtained height data, reported and desired weight, self-perception of the weight/height ratio, and the frequency of current physical activity in 844 adults (489 women). Of these, evaluated the frequency of physical activity during high school of 193 individuals,and we measured their height and weight. RESULTS: Less than 2/3 of the individuals had body mass index between 20 and 24.9 kg/m2. A tendency existed to overestimate height by less than 1 cm and to underestimate weight by less than 1kg. Desired weight was less than that reported (p&lt;0.001), and only 20% were satisfied with their current weight. Only 42% of men and 25% of women exercised regularly. No association was found between the frequency of physical activity and the variables height, weight, and body mass index, and the level of satisfaction with current weight. CONCLUSION: Height and weight reported seem to be valid for epidemological studies, and great dissatisfaction with body weight and a distorted self-perception of height/weight ratio exists, especially in women, regardless of the frequency of physical activity.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>body mass index</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>physical activity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>self-perception</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>self-reported</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>height</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>weight</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Influence of balloon pressure inflation in patients undergoing primary coronary stent implantation during acute myocardial infarction: a quantitative coronary angiography analysis</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Alberto Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Amanda G.M.R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Áurea Chaves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fausto Feres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ibraim Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luiz Tanajura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Marinella Centemero</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Alexandre Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Ana C. Seixas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Andréa Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Galo Maldonado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Rodolfo Staico</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="131000">
<s1>J. Eduardo M.R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>260-268</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>44</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE:To verify the influence of moderate- or high-pressure balloon inflation during primary coronary stent implantation for acute myocardial infarction. METHODS: After successful coronary stent implantation, 82 patients were divided into 2 groups according to the last balloon inflation pressure: group 1 (&lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt;12 to &lt;16 atm) and group 2 (&lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt;16 to 20 atm), each with 41 cases. All patients underwent late coronary angiography. RESULTS: In group 1, the mean stent deployment pressure was 13.58±0.92 atm, and in the group 2 it was 18.15±1.66 atm. Stents implanted with moderate pressures (&lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt;12 to &lt;16 atm) had a significantly smaller postprocedural minimal lumen diameter, compared to with those with higher pressure, with lesser acute gain (2.7± 0.4 mm vs 2.9±04 mm; p=0.004), but the late lumen loss (0,9±0,8 mm vs 0,9±0,6 mm) and the restenosis (22% vs. 17.1%) and target-vessel revascularization rates (9.8% vs 7.3%) were similar between the groups. CONCLUSION: During AMI stenting, the use of high pressures (&lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt;16 atm) did not cause a measurable improvement in late outcome, either in the late loss, its index, and the net gain, or in clinical and angiographic restenosis rates.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stents</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>restenosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Epidemiological study of congenital heart defects in children and adolescents: analysis of 4,538 cases</s1>
</fA08>
<fA11 dir="011000">
<s1>Nelson Itiro Miyague</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Silvia Meyer Cardoso</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fabrício Meyer</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Frederico Thomaz Ultramari</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fábio Henrique Araújo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Igor Rozkowisk</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Alisson Parrilha Toschi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Infantil Pequeno Príncipe  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Associação de Proteção à Infância Dr. Raul Carneiro  </s1>
<s2>Curitiba </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>274-278</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the frequency and prevalence of congenital heart defects in a tertiary care center for children with heart diseases. METHODS: We carried out an epidemiological assessment of the first medical visit of 4,538 children in a pediatric hospital from January 1995 to December 1997. All patients with congenital heart defects had their diagnoses confirmed at least on echocardiography. The frequency and prevalence of the anomalies were computed according to the classification of sequential analysis. Age, weight, and sex were compared between the groups of healthy individuals and those with congenital heart defects after distribution according to the age group. RESULTS: Of all the children assessed, 2,017 (44.4%) were diagnosed with congenital heart disease, 201 (4.4%) with acquired heart disease, 52 (1.2%) with arrhythmias, and 2,268 (50%) were healthy children. Congenital heart diseases predominated in neonates and infants, corresponding to 71.5% of the cases. Weight and age were significantly lower in children with congenital heart defects. Ventricular septal defect was the most frequent acyanotic anomaly, and tetralogy of Fallot was the most frequent cyanotic anomaly. CONCLUSION: Children with congenital heart defects are mainly referred during the neonatal period and infancy with impairment in gaining weight. Ventricular septal defect is the most frequent heart defect.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prevalence</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Risk stratification with troponin I in patients undergoing myocardial revascularization surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>João Carlos Ferreira Leal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alfredo de Paula Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luis Ernesto Avanci</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Cristiane Valéria Braga Braile</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Moacir Fernandes de Godoy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Domingo Marcolino Braile</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Sociedade Portuguesa de Beneficência Hospital Infante Dom Henrique Braile Cardiocirurgia</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>284-288</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>7</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the immediate behavior and the prognostic value in terms of late survival of serum troponin I measurement in patients undergoing myocardial revascularization surgery with extracorporeal circulation. METHODS: We studied 88 random patients, 65 (73.8%) of the male sex, who underwent myocardial revascularization surgery with extracorporeal circulation. Troponin measurements were performed as follows: in the preoperative period, right after intensive care unit admission, and on the first and second postoperative days. Values below 0.1 nanogram per milliliter (ng/mL) were considered normal. The cut points for late prognostic assessment were 0.5 ng/mL; 1 ng/mL; 2.5 ng/mL; and 5 ng/mL. RESULTS: The serum troponin I levels were elevated on the first postoperative day, suggesting the occurrence of specific myocardial damage. Patients with a poor prognosis could be identified, because the serum levels above 2.5 ng/mL and 5 ng/mL in the postoperative period resulted, respectively, in mortality rates of 33% and 50% in a maximum 6-month follow-up. CONCLUSION: Troponin I values around 2.5 ng/mL in the postoperative period should call attention to the need for more aggressive diagnostic or therapeutical measures.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>troponin I</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac marker</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>The Yanomami indians in the INTERSALT study</s1>
</fA08>
<fA11 dir="011000">
<s1>Jairo de Jesus Mancilha-Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nelson Albuquerque de Souza e Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio de Janeiro FM Hospital Universitário Clementino Fraga Filho</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>295-300</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>40</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To study the distribution and inter-relationship among constitutional and biochemical variables with blood pressure (BP) in an population of Yanomami indians. To compare these findings with those of other populations. METHODS: The Yanomami indians were part of the INTERSALT, a study comprising 10,079 males and females, aged from 20 to 59 years, belonging to 52 populations in 32 countries in Africa, the Americas, Asia, and Europe. Each of the 52 centers was required to accrue 200 individuals, 25 participants in each age group. The variables analyzed were as follows: age, sex, arterial BP, urinary sodium and potassium excretion (24-hour urine), body mass index, and alcohol ingestion. RESULTS: The findings in the Yanomami population were as follows: a very low urinary sodium excretion (0.9 mmol/24h); mean systolic and diastolic BP levels of 95.4 mmHg and 61.4 mmHg, respectively; no cases of hypertension or obesity; and they have no knowledge of alcoholic beverages. Their BP levels do not elevate with age. The urinary sodium excretion relates positively and the urinary potassium excretion relates negatively to systolic BP. This correlation was maintained even when controlled for age and body mass index. CONCLUSION: A positive relation between salt intake and blood pressure was detected in the analysis of a set of diverse populations participating in the INTERSALT Study, including populations such as the Yanomami Indians. The qualitative observation of their lifestyle provided additional information.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dietary salt</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Assessment of factors that influence weaning from long-term mechanical ventilation after cardiac surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Emília Nozawa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eliane Kobayashi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marta Erika Matsumoto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Ignêz Zanetti Feltrim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria José Carvalho Carmona</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Otávio Costa Auler Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>306-310</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze parameters of respiratory system mechanics and oxygenation and cardiovascular alterations involved in weaning tracheostomized patients from long-term mechanical ventilation after cardiac surgery. METHODS: We studied 45 patients in their postoperative period of cardiac surgery, who required long-term mechanical ventilation for more than 10 days and had to undergo tracheostomy due to unsuccessful weaning from mechanical ventilation. The parameters of respiratory system mechanics, oxigenation and the following factors were analyzed: type of surgical procedure, presence of cardiac dysfunction, time of extracorporeal circulation, and presence of neurologic lesions. RESULTS: Of the 45 patients studied, successful weaning from mechanical ventilation was achieved in 22 patients, while the procedure was unsuccessful in 23 patients. No statistically significant difference was observed between the groups in regard to static pulmonary compliance (p=0.23), airway resistance (p=0.21), and the dead space/tidal volume ratio (p=0.54). No difference was also observed in regard to the variables PaO2/FiO2 ratio (p=0.86), rapid and superficial respiration index (p=0.48), and carbon dioxide arterial pressure (p=0.86). Cardiac dysfunction and time of extracorporeal circulation showed a significant difference. CONCLUSION: Data on respiratory system mechanics and oxygenation were not parameters for assessing the success or failure. Cardiac dysfunction and time of cardiopulmonary bypass, however, significantly interfered with the success in weaning patients from mechanical ventilation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>weaning</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>long-term mechanical ventilation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Study of the cardiac alterations in HIV-infected children consequent to the antiretroviral therapy: prospective study of 47 cases</s1>
</fA08>
<fA11 dir="011000">
<s1>Gesmar Volga Haddad Herdy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Alberto M. Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vania Gloria S. Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Raquel P. Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ivete Martins Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Hsu Y. Tchou</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Renata Melo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Bedros Kurdian</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Plínio de Assis Tavares Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFF Hospital Universitário Antônio Pedro </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>316-320</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Detect of cardiac alterations in children with AIDS and compare their evolution with the administration of only one anti-retroviral and the recent cases who received drugs in combination. METHODS: We prospectively studied 47 children in 3 groups: group 1, 20 cases treated only with zidovudine; group 2, 10 patients treated initially with zidovudine and later with a combination of drugs and in group 3, 17 patients, who receiced two or three since the beginning. In all patients it was done chest X-ray, EKG and echocardiography every 6 months and after death complete pathological study. RESULTS: Among the 45 patients cases 26 (57%) were index cases. Malnutrition, diarrhea tachycardia, signs of congestive heart failure, pericardial effusion, abnormal ventricular repolarization and arrhythmias were more frequent in group 1. Echocardiographic abnormalities were present in 10 (50%) children of group 1. They were less frequent in the others two groups. In regard to the outcome in group 1, two patients had worsening of sings of cardiomyopaty and 4 died. Cardiac dysfunction in all cases of group 2 and 3 improved with the medication. CONCLUSION:- The children who received combination and their cardiac alterations had more favorable outcome than those who received only one drug.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>children</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>AIDS</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Risk factors for acute myocardial infarction during the postoperative period of myocardial revascularization</s1>
</fA08>
<fA11 dir="011000">
<s1>José Ribamar Costa Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dinaldo C. Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alexei DerBedrossian</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Enilton T. Egito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Edson R. Romano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marcos O. Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ieda M. Liguori</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Jorge Fahran</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Luis C. B. Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Adib D. Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Leopoldo S. Piegas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>ASS Hospital do Coração </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>325-328</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To identify risk factors for acute myocardial infarction during the postoperative period after myocardial revascularization. METHODS: This was a case-control study paired for sex, age, number, type of graft used, coronary endarterectomy, type of myocardial protection, and use of extracorporeal circulation. We assessed 178 patients (89 patients in each group) undergoing myocardial revascularization, and the following variables were considered: dyslipidemia, systemic hypertension, smoking, diabetes mellitus, previous myocardial revascularization surgery, previous coronary angioplasty, and acute myocardial infarction. RESULTS: Baseline clinical characteristics did not differ in the groups, except for previous myocardial revascularization surgery, prevalent in the case group (34 patients vs. 12 patients; p = 0.0002). This was the only independent predictor of risk for acute myocardial infarction in the postoperative period, based on a multivariate logistic regression analysis (p=0.0001). Mortality and the time of hospital stay of the case group were significantly higher (19.1% vs. 1.1%; p&lt;0.001 and 15.7 days vs. 10.6 days; p&lt;0.05 respectively) than those of the control. CONCLUSION: Only previous myocardial revascularization was an independent predictor of acute myocardial infarction in the postoperative period, based on multivariate logistic regression analysis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>extracorporeal circulation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Symptomatic myocardial bridging or cardiac Whipple's Diseas</s1>
</fA08>
<fA11 dir="011000">
<s1>Virgínia L. Ribeiro Cabral</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Daniella Knecht</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Regina Célia Pego</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Nuno C. Figueiredo Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Heliópolis  </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>332-334</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>This report concerns a patient with articular and cardiac manifestations of Whipple's disease. The disease was diagnosed only when gastrointestinal symptoms had appeared, because all cardiac symptoms were attributed exclusively to myocardial bridging. After 18 months of treatment with trimethoprim-sulfamethoxazole, the patient is fully asymptomatic with a normal echocardiogram.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 3/2003 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>InCor  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>335-335</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000310</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Interação entre drogas antiarrítmicas e limiares de desfibrilação em pacientes portadores de cardioversor desfibrilador implantável</s1>
</fA08>
<fA11 dir="011000">
<s1>José Tarcísio Medeiros de Vasconcelos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Silas dos Santos Galvão Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cecília Monteiro Boya Barcellos</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Beneficência Portuguesa de São Paulo  </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>336-338</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>41</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000311</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Coarctação da aorta: anomalia congênita com novas perspectivas de tratamento</s1>
</fA08>
<fA11 dir="011000">
<s1>Marco Aurélio Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vitor Manuel Pereira Azevedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Nacional de Cardiologia Laranjeiras  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>340-346</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>66</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000312</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Normatização dos cursos, pré-requisitos e critérios para obtenção do certificado de atuação na área de ecocardiografia pediátrica da sociedade brasileira de cardiologia</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>347-350</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000313</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>80</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Errata</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>339-339</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08000314</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Short- and midterm follow-up results of valvuloplasty with balloon catheter for congenital aortic stenosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos A. C. Pedra</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Simone R. F. Pedra</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sérgio L. N. Braga</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>César A. Esteves</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Samuel M. Moreira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Magali A. dos Santos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ieda J. Bosisio</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Maria Aparecida P. Silva</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Patrícia F. Elias</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Maria Virgínia T. Santana</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Valmir F. Fontes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital do Coração da Associação Sanatório Sírio  </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>120-128</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>53</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To report short and midtem follow-up results of balloon aortic valvuloplasty to treat congenital aortic stenosis. METHODS: Seventy-five patients (median age: 8 years) underwent the procedure through the retrograde femoral or carotid route. RESULTS: The procedure was completed in 74 patients (98.6%). The peak-to-peak systolic gradient dropped from 79.6±27.7 to 22.3±17.8 mmHg (P&lt;0.001), the left ventricular systolic pressure dropped from 164±39.1 to 110±24.8 mmHg (P&lt;0.001), and the left ventricular end diastolic pressure dropped from 13.3±5.5 to 8.5±8.3 mmHg (P&lt; 0.01). Four patients (5.3%) died due to the procedure. Aortic regurgitation (AoR) appeared or worsened in 27/71 (38%) patients, and no immediate surgical intervention was required. A mean follow-up of 50±38 months was obtained in 37 patients. Restenosis and significant AoR were observed in 16.6% of the patients. The estimates for being restenosis-free and for having significant AoR in 90 months were 60% and 50%, respectively. CONCLUSION: Aortic valvuloplasty was considered the initial palliative method of choice in managing congenital aortic stenosis, with satisfactory short- and midterm results.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital aortic stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic valvuloplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>interventional catheterization</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Hypertensive diabetic patients: guidelines for conduct and their difficulties</s1>
</fA08>
<fA11 dir="011000">
<s1>Weimar K. S. Barroso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo César B. V. Jardim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Thiago S. V. Jardim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cláudio T. S. Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alessandro L. A. Magalhães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fuad M. Ibrahim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Priscila V. O. Couto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Andrea Silveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Estelamaris T. Monego</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFG Hospital das Clínicas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>143-147</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effect of blood pressure (BP) control and other cardiovascular risk factors in patients with diabetes mellitus in a referral service for the treatment of hypertension. METHODS: A retrospective study where diabetic patients (at least 2 fasting glucose levels above 126 mg/dL, use of hypoglycemic agents or insulin, or both of these) were included. They were evaluated at the first appointment (M1) and at the last appointment (M2), regarding blood pressure, body mass index (BMI), use of hypertensive drugs, glycemia, total cholesterol (TC), creatinine, and potassium. RESULTS: Of 1,032 patients studied, 146 patients with a mean age of 61.6 years had diabetes, and 27 were men (18.5%). Mean follow-up was 5.5 years. BP values were 161.6 x 99.9 mmHg in M1 and 146.3 x 89.5 mmHg in M2. In M1, 10.4% of the patients did not use medications, 50.6% used just 1 drug, 30.8% used 2 drugs, and 8.2% used 3 or more drugs. In M2, these values were 10.9%, 39%, 39.7%, and 10.4%, respectively. Diuretics were the most commonly used medication, whereas angiotensin-converting enzyme inhibitors (ACE inhibitors) were those drugs which presented greater increase when comparing M1 to M2 (24.6% and 41.7%, respectively). Only 17,1% reached the recommended goal (BP&lt;130x85 mmhg). The other cardiovascular risk factors did not change significantly. CONCLUSION: Our data reinforce the necessity of a more aggressive approach in the treatment of these patients, despite the social and economic difficulties in adhering to treatment.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diabetes</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treatment</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Safety, feasibility, and results of exercise testing for stratifying patients with chest pain in the emergency room</s1>
</fA08>
<fA11 dir="011000">
<s1>Renato Machado Macaciel</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ricardo Vivacqua</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Salvador Serra</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Augusta Campos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marcelo Miranda</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Roberto Gamarski</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Hans Dohman</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Roberto Bassan</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal Fluminense  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>174-181</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess safety, feasibility, and the results of early exercise testing in patients with chest pain admitted to the emergency room of the chest pain unit, in whom acute myocardial infarction and high-risk unstable angina had been ruled out. METHODS: A study including 1060 consecutive patients with chest pain admitted to the emergency room of the chest pain unit was carried out. Of them, 677 (64%) patients were eligible for exercise testing, but only 268 (40%) underwent the test. RESULTS: The mean age of the patients studied was 51.7±12.1 years, and 188 (70%) were males. Twenty-eight (10%) patients had a previous history of coronary artery disease, 244 (91%) had a normal or unspecific electrocardiogram, and 150 (56%) underwent exercise testing within a 12-hour interval. The results of the exercise test in the latter group were as follows: 34 (13%) were positive, 191 (71%) were negative, and 43 (16%) were inconclusive. In the group of patients with a positive exercise test, 21 (62%) underwent coronary angiography, 11 underwent angioplasty, and 2 underwent myocardial revascularization. In a univariate analysis, type A/B chest pain (definitely/probably anginal) (p&lt;0.0001), previous coronary artery disease (p&lt;0.0001), and route 2 (patients at higher risk) correlated with a positive or inconclusive test (p&lt;0.0001). CONCLUSION: In patients with chest pain and in whom acute myocardial infarction and high-risk unstable angina had been ruled out, the exercise test proved to be feasible, safe, and well tolerated.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chest pain</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>emergency room</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chest pain unit</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 4/2003 - Paciente de 61 anos, portadora de cardiopatia da doença de Chagas, com disfunção ventricular, taquicardia ventricular recorrente e marcapasso cardíaco, que apresentou morte em assistolia após ressecção cirúrgica de aneurisma de ponta</s1>
</fA08>
<fA11 dir="011000">
<s1>Fábio Gazelato Franco</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Jorge Moffa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria de Lourdes Higuchi</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>210-215</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A 61 year-old Chagasic woman, with previous left ventricular systolic disfunction, ventricular tachychardia and cardiac pacemaker, presented cardiac arrest in asystolia after surgical ressection of apical aneurysm.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 8/2003: Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>216-216</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Normatização do ensino de cardiologia no curso de graduação em medicina</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>217-218</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100212</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Initial diagnostic errors in children suspected of having heart disease: prevalence and long-term consequences</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Amaral</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João A. Granzotti</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina de Ribeirão Preto </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital do Coração de Ribeirão Preto  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>UNAERP  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>152-155</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To access the incidence of diagnostic errors in the initial evaluation of children with cardiac murmurs. METHODS: We evaluated our 7-years of experience in a public pediatric cardiology outpatient clinic. Of 3692 patients who were sent to the hospital, 2603 presented with a heart murmur and were investigated. Patients for whom a disagreement existed between the initial and final diagnoses were divided into the following 2 groups: G1 (n=17) with an initial diagnosis of an innocent murmur and a final diagnosis of cardiopathy, and G2 (n=161) with an initial diagnosis of cardiopathy and a final diagnosis of a normal heart. RESULTS: In G1, the great majority of patients had cardiac defects with mild hemodynamic repercussions, such as small ventricular septal defect and mild pulmonary stenosis. In G2, the great majority of structural defects were interventricular communication, atrial septal defect and pulmonary valve stenosis. CONCLUSION: A global analysis demonstrated that diagnostic error in the initial evaluation of children with cardiac murmurs is real, reaching approximately 6% of cases. The majority of these misdiagnoses were in patients with an initial diagnosis of cardiopathy, which was not confirmed through later complementary examinations. Clinical cardiovascular examination is an excellent resource in the evaluation of children suspected of having cardiopathy. Immediate outpatient discharge of children with an initial diagnosis of an innocent heart murmur seems to be a suitable approach.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital cardiopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>murmur</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>children</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Effects of high glucose concentrations on the endothelial function of the renal microcirculation of rabbits</s1>
</fA08>
<fA11 dir="011000">
<s1>Filipe de Souza Affonso</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Solange Cailleaux</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Leonardo Felipe Corrêa Pinto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marília de Brito Gomes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eduardo Tibiriçá</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UERJ Hospital Universitário Pedro Ernesto </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Instituto Oswaldo Cruz, FIOCRUZ Departamento de Fisiologia e Farmacodinâmica Laboratório de Farmacologia Neuro-Cardiovascular</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>161-165</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>45</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the acute effects of high glucose concentrations on vascular reactivity in the isolated non diabetic rabbit kidney. METHODS: Rabbits were anaesthetized for isolation of the kidneys. Renal arteries and veins were cannulated for perfusion with Krebs-Henselleit solution and measurement of perfusion pressure. After 3 hours of perfusion with glucose 5,5 mM (control ) and 15 mM, the circulation was submitted to sub maximal precontraction (80% of maximal response) trough continuous infusion of noradrenaline 10 mM. Vascular reactivity was then assessed trough dose-responses curves with endothelium-dependent (acetylcholine) and independent (sodium nitroprusside) vasodilators. The influence of hyperosmolarity was analyzed with perfusion with mannitol 15mM. RESULTS: A significant reduction in the endothelium-dependent vasodilation in glucose 15mM group was observed compared to that in control, but there was no difference in endothelium-independent vasodilation. After perfusion with mannitol 15 mM, a less expressive reduction in endothelium-dependent vasodilation was observed, only reaching significance in regard to the greatest dose of acetylcholine. CONCLUSION: High levels of glucose similar to those found in diabetic patients in the postprandial period can cause significant acute changes in renal vascular reactivity rabbits. In diabetic patients these effects may also occur and contribute to diabetes vascular disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endothelial dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hyperglycemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>renal circulation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Impact of cerebral cardiopulmonary resuscitation maneuvers in a general hospital: prognostic factors and outcomes</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo Bartholomay</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernando Suparregui Dias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fábio Alves Torres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Pedro Jacobson</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Afonso Mariante</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rodrigo Wainstein</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Renato Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luiz Carlos Bodanese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica do Rio Grande do Sul Hospital São Lucas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>189-195</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess survival of patients undergoing cerebral cardiopulmonary resuscitation maneuvers and to identify prognostic factors for short-term survival. METHODS: Prospective study with patients undergoing cardiopulmonary resuscitation maneuvers. RESULTS: The study included 150 patients. Spontaneous circulation was re-established in 88 (58%) patients, and 42 (28%) were discharged from the hospital. The necessary number of patients treated to save 1 life in 12 months was 3.4. The presence of ventricular fibrillation or tachycardia (VF/VT) as the initial rhythm, shorter times of cardiopulmonary resuscitation maneuvers and cardiopulmonary arrest, and greater values of mean blood pressure (BP) prior to cardiopulmonary arrest were independent variables for re-establishment of spontaneous circulation and hospital discharge. The odds ratios for hospital discharge were as follows: 6.1 (95% confidence interval [CI] = 2.7-13.6), when the initial rhythm was VF/VT; 9.4 (95% CI = 4.1-21.3), when the time of cerebral cardiopulmonary resuscitation was &lt; 15 min; 9.2 (95% CI = 3.9-21.3), when the time of cardiopulmonary arrest was &lt; 20 min; and 5.7 (95% CI = 2.4-13.7), when BP was &gt; 70 mmHg. CONCLUSION: The presence of VF/VT as the initial rhythm, shorter times of cerebral cardiopulmonary resuscitation and of cardiopulmonary arrest, and a greater value of BP prior to cardiopulmonary arrest were independent variables of better prognosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiopulmonary arrest</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiopulmonary resuscitation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>in-hospital</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Anomalous origin of the left coronary artery from the pulmonary trunk in a 45-year-old woman</s1>
</fA08>
<fA11 dir="011000">
<s1>José Luiz Balthazar Jacob</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernando Vilela Salis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Moléstias Cardiovasculares  </s1>
<s2>São José do Rio Preto </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>199-201</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report a rare case of anomalous origin of the left coronary artery from the pulmonary trunk in a 45-year-old woman. The approach and technique used for selective catheterization of an anomalous left coronary artery arising from the pulmonary trunk are described. Six years after diagnosis, echocardiography showed left ventricular disfunction, and surgical treatment was indicated again. The origin of the left coronary artery from the pulmonary trunk was closed, and the postoperative period was uneventful, with recovery of left ventricular function and disappearance of ischemic features on stress myocardial perfusion imaging with 99m Tc-sestamibi, performed 4 weeks after surgery.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Left atrial myxoma as the cause of syncope in an adolescent</s1>
</fA08>
<fA11 dir="011000">
<s1>Danilo Castellani Nogueira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Delio Bontempo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Carlos Menardi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Walter Vilella de A. Vicente</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo José de Freitas Ribeiro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paulo Roberto Barbosa Evora</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Ribeirão Preto Heart Hospital  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>UNAERP  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>206-209</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>08</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>A case of left atrial myxoma is reported in a 14-year-old female patient with recurrent episodes of syncope. The patient was immediately referred to the cardiologist after an inconclusive neurological investigation. Syncope is a symptom thoroughly described as being associated with heart myxomas, but its specific association with adolescence is extremely rare. The authors discuss the clinical manifestations of the disease, emphasizing the diagnostic difficulties on the basis of the unspecific symptoms. As part of the analysis a Brazilian literature review was carried out. Also, the authors experience in the surgical treatment of the heart tumors is briefly presented.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="en">
<s1>Correlation between turbidimetric and nephelometric methods of measuring C-reactive protein in patients with unstable angina or non-ST elevation acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Luis C. L. Correia</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José C. Lima</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gary Gerstenblith</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luis P. Magalhães</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Agnaluce Moreira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Octávio Barbosa Jr.</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Juliana Dumet</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luiz Carlos S. Passos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Argemiro D'Oliveira Júnior</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="101000">
<s1>José Péricles Esteves</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Federal University of Bahia School of Medicine Cardiology Division</s1>
<s2>Salvador BA</s2>
<s3>Brazil</s3>
</fA14>
<fA14 dir="020000">
<s1>Johns Hopkins Hospital Cardiology Division </s1>
<s2>Baltimore MD</s2>
<s3>USA</s3>
</fA14>
<fA20 dir="000000">
<s1>133-136</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the performance of the turbidimetric method of C-reactive protein (CRP) as a measure of low-grade inflammation in patients admitted with non-ST elevation acute coronary syndromes (ACS). METHODS: Serum samples obtained at hospital arrival from 68 patients (66±11 years, 40 men), admitted with unstable angina or non-ST elevation acute myocardial infarction were used to measure CRP by the methods of nephelometry and turbidimetry. RESULTS: The medians of C-reactive protein by the turbidimetric and nephelometric methods were 0.5 mg/dL and 0.47 mg/dL, respectively. A strong linear association existed between the 2 methods, according to the regression coefficient (b=0.75; 95% C.I.=0.70-0.80) and correlation coefficient (r=0.96; P&lt;0.001). The mean difference between the nephelometric and turbidimetric CRP was 0.02 ± 0.91 mg/dL, and 100% agreement between the methods in the detection of high CRP was observed. CONCLUSION: In patients with non-ST elevation ACS, CRP values obtained by turbidimetry show a strong linear association with the method of nephelometry and perfect agreement in the detection of high CRP.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>C-reactive protein</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>turbidimetric method</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute coronary syndromes</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Doenças coronarianas</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>5-43</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiopatias congênitas</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>44-47</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100002</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Doenças valvulares</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>48-49</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100003</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Doenças vasculares extra-cardíaca</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>50-53</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100004</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diversos</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>54-56</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100005</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Enfermagem</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>57-58</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100006</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretriz de indicações do ultra-som intracoronariano na prática clínica</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alexandre Abizaid</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Constantino Costantine</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luis Alberto Mattos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Adriano Caixeta</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Newton Stadler</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ibraim Pinto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Roselei Graebin</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Gilvan Dourado</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Claudia Alves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Andre Labrunie</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Marcelo Freitas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Jamil Abdalla Saad</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-10</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Doença coronariana no grande idoso: conduta conservadora ou agressiva?</s1>
</fA08>
<fA11 dir="011000">
<s1>Mauricio Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sergio Almeida Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>219-220</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Behavior of cardiac variables in animals exposed to cigarette smoke</s1>
</fA08>
<fA11 dir="011000">
<s1>Sergio Alberto Rupp de Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leonardo Antonio Mamede Zornoff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marina Politi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Katashi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Carlos Cicogna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Alvaro Oscar Campana</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual Paulista Faculdade de Medicina de Botucatu </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>225-228</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the behavior of cardiac variables in animals exposed to cigarette smoke. METHODS: Two groups of Wistar rats were studied as follows: control group (C), comprising 28 animals; and smoking group (S), comprising 23 animals exposed to cigarette smoke for 30 days. Left ventricular cardiac function was assessed in vivo with transthoracic echocardiography, and myocardial performance was analyzed in vitro in preparations of isolated left ventricular papillary muscle. The cardiac muscle was assessed in isometric contractions with an extracellular calcium concentration of 2.5 mmol/L. RESULTS: No statistical difference was observed in the values of the body variables of the rats and in the mechanical data obtained from the papillary muscle between the control and smoking groups. The values of left ventricular systolic diameter were significantly greater in the smoking animals than in the control animals (C= 3.39 ± 0.4 mm and S= 3.71 ± 0.51 mm, P=0.02). A significant reduction was observed in systolic shortening fraction (C= 56.7 ± 4.2% and S= 53.5 ± 5.3%, P=0.02) and in ejection fraction (C= 0.92 ± 0.02 and S= 0.89 ± 0.04, P=0.01). CONCLUSION: The rats exposed to cigarette smoke had a reduction in left ventricular systolic function, although their myocardial function was preserved.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>smoking</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular junction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cigarette</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Coronary heart disease clinical manifestation and risk factors in Japanese immigrants and their descendents in the city of São Paulo</s1>
</fA08>
<fA11 dir="011000">
<s1>Reynaldo Vicente Amato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Antonio Machado César</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio de Pádua Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Whady Armindo Hueb</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Renato Martines Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Caio de Brito Vianna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>234-238</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess whether a difference exists in coronary heart disease clinical manifestations and the prevalence of risk factors between Japanese immigrants and their descendents in the city of São Paulo. METHODS: Retrospective analysis of coronary artery disease clinical manifestations and the prevalence of risk factors, comparing 128 Japanese immigrants (Japanese group) with 304 Japanese descendents (Nisei group). RESULTS: The initial manifestation of the disease was earlier in the Nisei group (mean = 53 years), a difference of 12 years when compared with that in the Japanese group (mean = 65 years) (P&lt;0.001). Myocardial infarction was the first manifestation in both groups (P = 0.83). The following parameters were independently associated with early coronary events: smoking (OR = 2.25; 95% CI = 1.35-3.77; P&lt;0.002); Nisei group (OR = 10.22; 95% CI = 5.64-18.5; P&lt;0.001); and female sex (OR = 5.04; 95% CI = 2.66-9.52; P&lt;0.001). CONCLUSION: The clinical presentation of coronary heart disease in the Japanese and their descendents in the city of São Paulo was similar, but coronary heart disease onset occurred approximately 12 years earlier in the Nisei group than in the Japanese group.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diabetes mellitus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypercholesterolemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertriglyceridemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>systemic arterial hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>ProBNP for stratifying patients with heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Pereira-Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mucio Tavares de Oliveira Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fabio Gazellato Franco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Célia Cassaro-Strunz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>244-248</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To verify whether the serum levels of N-Terminal ProBNP fraction (ProBNP) allow us to identify with accuracy the clinical functional status of patients with heart failure (HF), because the clinical diagnosis of this syndrome is based basically on clinical data when the complementary tests have lower specificity. METHODS: Sixty-nine patients with a history of HF were studied. Their mean age of was 53.5 years and 78.3% were males. All underwent clinical and echocardiographic evaluations and a test to determine the serum dosage of ProBNP. According to clinical manifestation, patients were in the following functional classes (FC), 14% FC I, 40.6% FC II, 28.1% FC III, and 23.4% FC IV. The mean ejection fraction (EF) was 0.28. RESULTS: ProBNP did not differ according to age, sex, and cause of cardiopathy. No correlation existed between EF and the ProBNP serum level. ProBNP levels were significantly lower in patients in FC I than those in FC II (42 vs 326.7 pmol/L; P=0.0001), and in FC II than those in FC III (P=0.01). ProBNP levels did not differ statically between FC III and IV patients (888.1 vs 1082.8 pmol/L; P=0.25). ProBNP values greater than 100 pmol/L identify patients with decompensated HF with a sensitivity of 98%. CONCLUSION: ProBNP values over 100 pmol/L were indicative of HF, and patients with advanced HF had values over 270 pmol/L. A ProBNP dosage test was an excellent auxiliary in the clinical characterization of patients with HF.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart Failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ProBNP</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>decompensation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Prevalence of dyslipidemia and risk factors in Campos dos Goytacazes, in the Brazilian State of Rio de Janeiro</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz José de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João Tadeu Damian Souto Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Thiago Ferreira de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Aldo Franklin Ferreira Reis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Carlos Gicovate Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Diogo Assed Bastos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Vitor Azevedo Côrtes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Félix Elias Barros Chalita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Cláudio Luiz Teixeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de Campos Hospital Escola Álvaro Alvim </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>257-264</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>60</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the prevalence of dyslipidemias in adults in the city of Campos dos Goytacazes, in the Brazilian state of Rio de Janeiro, and to identify its relation to risk factors. METHODS: Cross-sectional, population-based, observational study with sampling through conglomerates and stratified according to socioeconomic levels, sex, and age, with 1,039 individuals. Risk factors, familial history, blood pressure, anthropometric measurements, glucose, triglycerides and cholesterol were determined. RESULTS: The following prevalences were observed: of dyslipidemias 24.2%; of hypercholesterolemia, 4.2%; of elevated LDL-C, 3.5%; of low HDL-C, 18.3%; and of hypertriglyceridemia, 17.1%. The following mean levels were observed: cholesterol, 187.6± 33.7 mg/dL; LDL-C, 108.7±26.8 mg/dL; HDL-C, 48.5±7.7 mg/dL; and triglycerides, 150.1±109.8 mg/dL. The following variables showed a positive correlation with dyslipidemia: increased age (P&lt;0.001), male sex (P&lt;0.001), low familial income (P&lt;0.001), familial history (P&lt;0.01), overweight/obesity (P&lt;0.001), waist measure (P&lt;0.001), high blood pressure (P&lt;0.001), and diabetes mellitus (P&lt;0.001). The following variables had no influence on dyslipidemias: ethnicity, educational level, smoking habits, and sedentary lifestyle. CONCLUSION: The frequency of lipid changes in the population studied was high, suggesting that measures for the early diagnosis should be taken, in association with implementation of programs for primary and secondary prevention of atherosclerosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dyslipidemias</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prevalence</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypercholesterolemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertriglyceridemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hyperlipidemia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Kawasaki disease: involution of giant coronary aneurysms after prolonged anti-inflammatory treatment</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Foronda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz Narcio P. Bustamante</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>269-272</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>The patient is a 5-year-old male with Kawasaki disease, whose involution of giant aneurysms of the left coronary arteries was surprising after a prolonged period of treatment, which lasted 80 uninterrupted days and comprised anti-inflammatory drugs associated with anticoagulation agents. The distal diameters of the anterior interventricular, the diagonal, and the circumflex arteries normalized by the end of the treatment. A residual giant aneurysm localized at the beginning of the anterior interventricular artery did not cause ischemia. Continuation of the medication for a prolonged period was recommended.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Aneurysmal dilation of the reimplant segment of the visceral vessels after thoracoabdominal aneurysm correction</s1>
</fA08>
<fA11 dir="011000">
<s1>Ricardo R. Dias</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Joseph S. Coselli</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Noedir A. G. Stolf</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Altamiro R. Dias</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Charles Mady</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sérgio A. Oliveira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3>Brazil</s3>
</fA14>
<fA14 dir="020000">
<s1>Methodist Hospital  </s1>
<s2> TX</s2>
<s3>USA</s3>
</fA14>
<fA20 dir="000000">
<s1>276-278</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We present a case of aneurysmal dilation of the aortic residual segment, involving abdominal vessels in corrective surgeries for thoracoabdominal aortic aneurysm, through the identification of risk groups for recurrent dilation, aiming at using a specific operative technique with a branched graft, to prevent aneurysm relapse.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Behavior of inflammatory markers of myocardial injury in cardiac surgery: laboratory correlation with the clinical picture of postpericardiotomy syndrome</s1>
</fA08>
<fA11 dir="011000">
<s1>Ilmar Köhler</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo J. Saraiva</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Orlando B. Wender</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alcides J. Zago</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital de Clínicas de Porto Alegre  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>UFRG Faculdade Farmácia/Bioquímica </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>285-290</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To verify the association of serum markers of myocardial injury, such as troponin I, creatinine kinase, and creatinine kinase isoenzyme MB, and inflammatory markers, such as tumor necrosis factor alpha (TNF-alpha), C-reactive protein, and the erythrocyte sedimentation rate in the perioperative period of cardiac surgery, with the occurrence of possible postpericardiotomy syndrome. METHODS: This was a cohort study with 96 patients undergoing cardiac surgery assessed at the following 4 different time periods: the day before surgery (D0); the 3rd postoperative day (D3); between the 7th and 10th postoperative days (D7-10); and the 30th postoperative day (D30). During each period, we evaluated demographic variables (sex and age), surgical variables (type and duration , extracorporeal circulation), and serum dosages of the markers of myocardial injury and inflammatory response. RESULTS: Of all patients, 12 (12.5%) met the clinical criteria for a diagnosis of postpericardiotomy syndrome, and their mean age was 10.3 years lower than the age of the others (P=0.02). The results of the serum markers for tissue injury and inflammatory response were not significantly different between the 2 assessed groups. No significant difference existed regarding either surgery duration or extracorporeal circulation. CONCLUSION: The patients who met the clinical criteria for postpericardiotomy syndrome were significantly younger than the others were. Serum markers for tissue injury and inflammatory response were not different in the clinically affected group, and did not correlate with the different types and duration of surgery or with extracorporeal circulation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>inflammatory markers</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>injury markers</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>postpericardiotomy syndrome</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Assessment of cardiovascular risk factors in a rural community in the Brazilian state of Bahia</s1>
</fA08>
<fA11 dir="011000">
<s1>André Costa Matos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ana Marice Ladeia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia Faculdade de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>297-302</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the frequency of cardiovascular risk factors in the rural community of Cavunge, in the Brazilian state of Bahia. METHODS: A cross-sectional study was carried out with 160 individuals (age &gt; 19 years) randomly drawn from those listed in the population census of the Cavunge Project. The following parameters were studied: arterial hypertension, dyslipidemia, diabetes, obesity, smoking, waist-hip ratio (WHR), physical activity, and overall cardiovascular risk classified according to the Framingham score. The assessing parameters used were those established by the III Brazilian Consensus on Hypertension and the II Brazilian Consensus on Dyslipidemia. RESULTS: Of the randomly drawn individuals, 126 with a mean age of 46.6 + 19.7 years were included in the study, 43.7% of whom were males. The frequency of arterial hypertension was 36.5%; 20.4% of the individuals had cholesterol levels &gt;240 mg/dL; 31.1% of the individuals had LDL-C levels &gt; 130 mg/dL; 4% were diabetic; and 39.7% had a high-risk Framingham score. Abdominal obesity was observed in 41.3% of the population and in 57.7% of the females. High caloric-expenditure (HCE) physical activities were performed by 56.5% of the individuals. The HCE group had a greater frequency of normal triglyceride levels (63% vs 44%; P=0.05), no diabetes, and WHR tending towards normal (46% vs 27%, P=0.08) as compared with those in the low caloric-expenditure group. CONCLUSION: Cardiovascular risk factors, such as hypertension and hypercholesterolemia, are frequently found in rural communities. The greatest frequency of normal triglyceride levels and normal WHR in the HCE group reinforces the association between greater caloric expenditure and a better risk profile.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rural community</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Demographic characteristics of the population undergoing cine coronary angiography at the Instituto do Coração of the Medical School of USP from 1986 to 1995</s1>
</fA08>
<fA11 dir="011000">
<s1>Bruno Caramelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luciana Savoy Fornari</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maristela Monachini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Dália Ballas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Nilson Roberto Fachini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antônio de Pádua Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Antônio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Medical School Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>306-308</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100310</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To obtain information about the profile and behavior of a population with ischemic heart disease undergoing cine coronary angiography and to determine disease severity. METHODS: Retrospective study assessing patients hospitalized at InCor from 1986 to 1995, in which the variables age, sex, and number of major coronary arteries with obstruction degree &gt; 40% were analyzed. RESULTS: We studied 18,221 patients and observed a significant increase in the number of females (22.8% to 25.2%, P=0.001) and an increase in age (57.1±29.3 to 60.4±10.7 years, P=0.0001). A significant increase in the incidence of multivessel disease was observed, which was more frequent among males (69.2% and 64.5%) and among the older patients (59.8±9.8 and 56.8±10.7 years, P=0.0001). A reduction in the incidence of single-vessel disease was also observed (66.2% vs 69.2% and 33.8% vs 30.5%, respectively, P&lt;0.0001). CONCLUSION: A change in the profile of the population studied was observed as follows: patients undergoing cine coronary angiography at InCor were older, had a greater number of impaired major coronary arteries, and the number of females affected increased, leading to indices suggestive of a poorer prognosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cine coronary angiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 9/2003 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>318-318</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100312</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Caracterização ultra-sônica tecidual miocárdica</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Pazin-Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>André Schmidt</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Oswaldo C. Almeida-Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José A. Marin-Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Benedito C. Maciel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>319-325</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100313</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Errata</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>326-327</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100314</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="en">
<s1>Ligation of the thoracic duct for the treatment of chylothorax in heart diseases</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo M. Pêgo-Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fábio B. Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Clayton Cesar Tokunaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Danielle Tiemi Simão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ricardo Beirutty</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Eliza Rumiko Iwahashi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>314-317</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100311</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>In children, chylothorax occurs mainly after cardiac and thoracic surgeries. One of the recommended postsurgery treatments is ligation of the thoracic tract, when all other conservative treatments have failed. We report 4 cases of chylothorax in patients who were successfully treated with this approach, which resulted in a decrease in pleural drainage without recurrent chylothorax.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Medical care and deaths due to coronary artery disease in Brazil, 1980-1999</s1>
</fA08>
<fA11 dir="011000">
<s1>Ines Lessa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia Instituto de Saúde Coletiva </s1>
<s2>Salvador BA</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>336-342</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To estimate the frequency of medical care preceding deaths due to coronary artery diseases (CAD) in different Brazilian regions and capitals and to describe trends in medical care from 1980 to 1999. METHODS: Information on medical care preceding deaths due to coronary artery diseases/acute myocardial infarction in adults &gt; 20 years from 1980 to 1999 was collected in the DATASUS, the databank of the Brazilian Health Ministry. Sex, states, and capitals selected for 1999 were analyzed in the study. Medical care was stratified as follows: with, without, and ignored medical care. The descriptive analysis comprised frequencies, ratios of frequency, test for proportions, and increments or reductions in frequencies. RESULTS: Acute myocardial infarction (AMI) represented 75 to 85% of the CAD in the period; the frequency of deaths with medical care ranged from 48.9 to 63%, and that of ignored medical care ranged from 27.2 to 41.5%. The frequency of other CAD with medical care ranged from 56 to 76%. The frequency of deaths preceded by medical care decreased by 17.8%, and that with ignored medical care increased by 36.5% (RF=2). The values for the other CAD were -20.2% and +64.6% (RF=44.4). Deaths preceded by medical care were more frequent in females at all ages and in all Brazilian regions. CONCLUSION: The results show a high frequency of sudden death and suggest errors in diagnosis or codification and overestimation of the statistics about mortality. Validation of the death certificate diagnosis and frequent surveillance are required.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>medical care</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>deaths</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Morphometric and topographic study of coronary ostia</s1>
</fA08>
<fA11 dir="011000">
<s1>Jennecy Sales Cavalcanti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Natália Corrêa Vieira de Melo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Renata Simões de Vasconcelos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Pernambuco  </s1>
<s2>Recife PE</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>359-362</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To investigate the morphometric and topographic aspects of coronary ostia, correlating them with the aortic leaflets. METHODS: Fifty-one hearts with the great vessels attached were analyzed in this study. The ascending aorta was transversally sectioned 1 cm above the commissures of the aortic leaflets. The right and left coronary ostia were analyzed, as were the distances from these ostia to the bottom of the aortic sinuses and to the commissures of the aortic leaflets. RESULTS: The left coronary ostium was located below the intercommissural line in 42% of cases, above that line in 40% of cases, and at the level of that line in 18% of cases. The mean distance from the left coronary ostium to the bottom of the corresponding sinus was 12.6±2.61 mm. The right coronary ostium was located below the intercommissural line in 60% of cases, above that line in 28% of cases, and at the level of that line in 12% of cases. The mean distance from the right coronary ostium to the bottom of the corresponding aortic sinus was 13.2±2.64 mm. The mean diameters of the left and right coronary ostia were 4.75±0.93 mm and 3.46±0.94 mm, respectively. The mean diameters of the juxtamural portion of the left and right coronary arteries were 3.75±0.79 mm and 2.9±0.73 mm, respectively. In one case, both ostia were located in the left coronary sinus. CONCLUSION: The left coronary ostium may be located either above or below the intercommissural line. The right coronary ostium is predominantly located below the intercommissural line. The coronary ostia have reduced diameters as compared with the juxtamural diameters of their respective coronary arteries.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic valve</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Secular trends in a population with ischemic heart disease admitted to the Instituto do Coração in São Paulo</s1>
</fA08>
<fA11 dir="011000">
<s1>Bruno Caramelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luciana Savoy Fornari</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maristela Monachini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Dália Ballas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Nilson Roberto Fachini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antônio de Pádua Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Antônio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto do Coração do Hospital das Clínicas FMUSP </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>369-374</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the clinical and demographic characteristics of a population with ischemic heart disease admitted in the final decades of the 20th century. METHODS: This study retrospectively assessed patients hospitalized with ischemic heart disease divided into the following 2 groups: acute group - 11.181 patients with acute myocardial infarction admitted from 1/1/82 to 12/31/94; and chronic group - 4.166 patients undergoing coronary artery bypass graft surgery from 1/1/84 to 12/31/94. RESULTS: In the acute group, an increase in the percentage of females (from 22.7% to 27.7%, P&lt;0.001) and diabetic individuals (from 12.4% to 17.5%, P&lt;0.001) was observed, as was an increase in age (from 57.4±11.5 to 59.9±12.1 years, P&lt;0.05). In-hospital mortality was greater among females (27.8% and 15.7%, P=0.001), among diabetic individuals (24.2% and 17.8%, P=0.001), and among the elderly (60.9±15.2 and 57.7±11.8 years, P=0.0001). In the chronic group, an increase in the percentage of females (from 17.5% to 27.2%, P=0.001) was observed, as was an increase in age (from 56.3±8.6 to 60.5±9.6 years, P=0.0001). In-hospital mortality was greater among females (8.3% and 5.8%, P&lt;0.05) and among the elderly (58.1±9.1 and 62.1±7.9 years, P=0.0001). CONCLUSION: The characteristics of the population studied with ischemic heart disease point towards a worse prognosis, due to the greater percentages of females, older patients, and diabetic patients, groups known to have greater in-hospital mortality.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemic heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery bypass graft surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Prevalence of systemic hypertension in students aged 7 to 14 years in the municipality of Barbacena, in the State of Minas Gerais, in 1999</s1>
</fA08>
<fA11 dir="011000">
<s1>Dilermando Fazito de Rezende</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo Augusto Baêta Scarpelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Guenael Freire de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Orleans da Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Adelaide Maria Baêta Scarpelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paulo Antônio Scarpelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Guilherme Bahia de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Hélius Moreira D'Agostini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Josuela Cabral Pedrosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de Barbacena  </s1>
<s2> MG</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>381-386</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To detect the prevalence of systemic hypertension in children and to establish the relation between blood pressure levels and sex, age, ethnicity, weight, and height. METHODS: The prevalence of systemic hypertension and its relation to sex, age, ethnicity, weight, and height were studied in 611 students aged 7 to 14 years out of 19.928 students classified according to age, ethnicity, and sex, who underwent anthropometric evaluation and blood pressure measurement. Hypertensive individuals were considered those whose blood pressure level was &gt; the 95th percentile for age and sex, confirmed on 3 examinations. RESULTS: The prevalence of hypertension was 16.6% in the first evaluation, and 4.6% and 2.5% in the subsequent evaluations. The mean blood pressure levels increased with age. Weight was important, not only to determine blood pressure in healthy children, but also to determine systemic hypertension in children, which was not observed with height despite the different studies. The prevalence of systemic hypertension in the different ethnic groups and the mean blood pressure levels according to sex were similar. CONCLUSION: In addition to routine physical examinations, age, weight, and appropriate cuff size should be considered when assessing blood pressure in children to prevent hypertension, morbidity and mortality, and to avoid placing a financial burden on health care providers.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>children</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results</s1>
</fA08>
<fA11 dir="011000">
<s1>Auristela I. O. Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rui F. Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Dorival J. D. Togna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antoninho S. Arnoni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rodolfo Staico</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Mercedes M. Galo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Zilda M. Meneghelo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>393-398</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the short- and long-term results of the use of streptokinase (SK) for the treatment of thromboses in cardiac valvular prostheses. METHODS: Seventeen patients with cardiac prosthetic thrombosis diagnosed by clinical, echocardiographic, and radioscopic findings underwent fibrinolytic treatment with a streptokinase bolus of 250,000 U followed by 100.000 U/hour. Short- and long-term results were assessed by radioscopy and echocardiography. RESULTS: Of the 17 patients, 12 had mechanical double-disk prostheses (4 aortic, 6 mitral, 2 tricuspid), 4 had single-disk prostheses (2 aortic, 1 mitral, and 1 tricuspid), and 1 had a tricuspid bioprosthesis. The success rate was 64.8%, the partial success rate was 17.6%, and the nonsuccess rate was 17.6%. All patients with a double-disk prosthesis responded, completely or partially, to the treatment. None of the patients with a single-disk prosthesis had complete resolution of the thrombosis. The time of streptokinase infusion ranged from 6 to 80 hours (mean of 56 h). The mortality rate due to the use of streptokinase was 5.8% and was secondary to cerebral bleeding. During streptokinase infusion, 3 (17.6%) embolic episodes occurred as follows: 1 cerebral, 1 peripheral, and 1 coronary. The rethrombosis index was 33% in a mean follow-up of 42 months. CONCLUSION: The use of fibrinolytic agents was effective and relatively safe in patients with primary thrombosis of a double-disk prosthesis. A fatal hemorrhagic complication occurred in 1 (5.8%) patient, and embolic complications occurred in 3 (17.6%) patients. In a mean 42-month follow-up, 67% of the patients were free from rethrombosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fibrinolytic therapy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thrombosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>streptokinase</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac valvular prostheses</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Cerebral infarction in autopsies of chagasic patients with heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Roque Aras</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Alberto M. da Matta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gildo Mota</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Irênio Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ailton Melo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia  </s1>
<s2>Salvador BA</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>414-416</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the frequency of encephalic infarction and its contribution to lethality in patients with Chagas' disease and heart failure. METHODS: Medical records and autopsy reports of patients with Chagas' disease complicated by heart failure, who died at the Professor Edgar Santos Hospital of the Federal University of Bahia in the past 45 years were retrospectively analyzed. Data comprised information regarding the clinical history on hospital admission, complementary and anatomicopathological examinations, including the presence of encephalic infarction, the impaired region, and the cause of death. RESULTS: Of the 5,447 autopsies performed, 524 were in patients with heart failure due to Chagas' disease. The mean age was 45.7 years, and 51 (63%) patients were of the male sex. The frequency of encephalic infarction was 17.5%, corresponding to 92 events in 92 individuals, 82 (15.8%) of which involved the brain, 8 (1.5%) involved the cerebellum, and 2 (0.4%) involved the hypophysis. CONCLUSION: Cerebral infarction has been a frequent finding in autopsies of chagasic patients with heart failure, and it has been an important cause of death in our region. The presence of cerebral infarction and its complications have been associated with death in 52% of the cases studied.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cerebral infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>frequency</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>autopsies</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Aspergillus infection in the ascending aorta of a patient with aortic and mitral valve prostheses</s1>
</fA08>
<fA11 dir="011000">
<s1>Auristela de Oliveira Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Amira Rose Costa Medeiros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Paredes Paulista</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cely Saad Abboud</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Zilda Machado Meneghelo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>419-420</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>We report the case of implantation of metallic mitral and aortic valve prostheses 6 months earlier, with subsequent multiple embolic episodes. The anatomicopathological examination of the thrombus of the third embolic episode was compatible with Aspergillus sp, which was treated with amphotericin B, followed by oral itraconazole. On the fourth embolism, vegetations were visualized in the ascending aorta on echocardiography and resonance imaging, and the patient underwent replacement of the aortic segment by a Haemashield tube and exploration of the aortic prosthesis, which was preserved, because no signs of endocarditis were found. Four months later, the patient died due to cardiogenic shock secondary to acute myocardial infarction caused by probable coronary embolism and partial dysfunction of the aortic prosthesis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 5/03 - paciente de 68 anos, sexo feminino, tabagista crônica, com tosse há 20 anos e dispnéia ao repouso há dois meses (Faculdade de Medicina da Pontifícia Universidade Católica, Campinas, SP)</s1>
</fA08>
<fA11 dir="011000">
<s1>Tiago Pugliese Branco</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>André Fernando Gemente Larrubia</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Josiane Mendes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Osvaldo Teixeira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria Aparecida Barone Teixeira</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>421-426</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 10/2003 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>427-427</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Três décadas de MAPA - monitorização ambulatorial da pressão arterial de 24 horas: mudanças de paradigmas no diagnóstico e tratamento da hipertensão arterial</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Nobre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eduardo Barbosa Coelho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina de Ribeirão Preto </s1>
<s2>Ribeirão Preto SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>428-434</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100412</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>The influence of patient's consciousness regarding high blood pressure and patient's attitude in face of disease controlling medicine intake</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Aparecida A Moura Strelec</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Angela M. G. Pierin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Décio Mion Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Nursing and MedicalSchools </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>349-354</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the relation between blood pressure control and the following: the Morisky-Green test, the patient's consciousness regarding high blood pressure, the patient's attitude in face of medicine intake, the patient's attendance at medical consultations, and the subjective physician's judgment. METHODS: We studied 130 hypertensive patients with the following characteristics: 73% females, 60±11 years, 58% married, 70% white, 45% retired, 45% with incomplete elementary schooling, 64% had a familial income of 1 to 3 minimum wages, body mass index of 30±7 kg/m², consciousness regarding the disease for a mean period of 11±9.5 years, and mean treatment duration of 8 ±7 years. RESULTS: Only 35% of the hypertensive individuals had blood pressure under control and a longer duration of treatment (10±7 vs 7±6.5 years; P&lt;0.05). The retiree predominated. The result of the Morisky-Green test did not relate to blood pressure control. In evaluating the attitude in face of medicine intake, the controlled patients achieved significantly higher scores than did the noncontrolled patients (8±1.9 vs 7 ±2, P&lt;0.05). The hypertensive patients had higher levels of consciousness regarding their disease and its treatment, and most (70%) patients attended 3 or 4 medical consultations, which did not influence blood pressure control. The physicians attributed significantly higher scores regarding adherence to treatment to controlled patients (6±0.8 vs 5±1.2; P&lt;0.05). CONCLUSION: Consciousness regarding the disease, the Morisky-Green test, and attendance to medical consultations did not influence blood pressure control.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>control</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adherence</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treatment</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="en">
<s1>Intrauterine ductus arteriosus constriction: analysis of a historic cohort of 20 cases</s1>
</fA08>
<fA11 dir="011000">
<s1>Stelamaris Luchese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João L. Mânica</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Cardiologia do Rio Grande do Sul Fundação Universitária de Cardiologia </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>405-410</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To describe the relative incidence, presentation, and evolvement of fetuses with early ductus constriction. METHODS: Twenty fetal echocardiograms indicating ductus constriction were reviewed in a population of 7000 pregnants. RESULTS: The cases were divided into group A (related to maternal use of cyclooxygenase inhibitors [n=7] and group B (idiopathics [n=13]). Mean gestational age was 32.5±3.1 (27-38) weeks and maternal age was 28.2±8.5 (17-42) years. Mean systolic velocity in the ductus was 2.22±0.34 (1.66-2.81) m/s, diastolic velocity 0.79±0.28 (0.45-1.5) m/s, and pulsatility index 1.33±0.36 (0.52-1.83). Two cases of ductal occlusion were noted. In 65% of the cases, an increase occurred in the right cavities; in 90% of the cases, tricuspid or pulmonary regurgitation, or both, occurred, with functional pulmonary atresia in 1 case. Diastolic velocity was greater in group A (1.13±0.33) than in group B (0.68±0.15) (P=0.008). The other data were similar in the 2 groups. The evolvement was not favorable in 4 patients from group B, including 1 death and 2 cases of persistent pulmonary hypertension. CONCLUSION: The high incidence of idiopathic constriction of the ductus arteriosus suggests that its diagnosis is underestimated and that many cases of persistence of fetal circulation in newborns may be related to constriction of the ductus arteriosus not diagnosed during intrauterine life. Group B had a lower severity but a risk of an unfavorable evolvement, suggesting a distinct alteration.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetal cardiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>gestation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Clinical significance of transient left ventricular dilation assessed during myocardial Tc-99m sestamibi scintigraphy</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Schiavom Duarte</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paola Emanuela Smanio</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Alberto Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Roberto Martins</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz Eduardo Mastrocolla</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Julio César Pereira</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>479-482</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the clinical significance of transient ischemic dilation of the left ventricle during myocardial perfusion scintigraphy with stress/rest sestamibi. METHODS: The study retrospectively analyzed 378 patients who underwent myocardial perfusion scintigraphy with stress/rest sestamibi, 340 of whom had a low probability of having ischemia and 38 had significant transient defects. Transient ischemic dilation was automatically calculated using Autoquant software. Sensitivity, specificity, and the positive and negative predictive values were established for each value of transient ischemic dilation. RESULTS: The values of transient ischemic dilation for the groups of low probability and significant transient defects were, respectively, 1.01 ± 0.13 and 1.18 ± 0.17. The values of transient ischemic dilation for the group with significant transient defects were significantly greater than those obtained for the group with a low probability (P&lt;0.001). The greatest positive predictive values, around 50%, were obtained for the values of transient ischemic dilation above 1.25. CONCLUSION: The results suggest that transient ischemic dilation assessed using the stress/rest sestamibi protocol may be useful to separate patients with extensive myocardial ischemia from those without ischemia.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>transient left ventricular dilation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial ischemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sestamibi scintigraphy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Noninvasive cardiac assessment in children of women with systemic lupus erythematosus</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria de Fátima Monteitro Pereira Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roger Aaron Levy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Mônica Scott Borges</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eduardo Correa Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Ginefra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paulo Roberto Barbosa Benchimol</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Nadia Barreto Tenório Aoun</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luiz Alberto Christiani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Francisco Manes Albanesi Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual do Rio de Janeiro Hospital Universitário Pedro Ernesto </s1>
<s2>Rio de Janeiro RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>489-493</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: Noninvasive cardiac assessment of newborns and infants of women with systemic lupus erythematosus. The children had no congenital total atrioventricular block and were compared with the children of healthy women. METHODS: We prospectively assessed 13 newborns and infants aged 1 to 60 days, children of women with systemic lupus erythematosus and without congenital total atrioventricular block. These children were compared with 30 children of women who had no lupus or anti-Ro/SSA antibodies, and no risk factors for congenital heart disease either. Their age groups matched. The following examinations were performed: cardiological physical examination, electrocardiography, echocardiography, and signal-averaged electrocardiography. RESULTS: The statistical analysis showed no significant difference in ventricular function or in the cardiac conduction system between the groups. CONCLUSION: In regard to the conduction system and ventricular function in the absence of total atrioventricular block, no statistically significant difference was observed between the children of women with systemic lupus erythematosus and children of healthy women.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>total atrioventricular block</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>neonatal lupus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital arrhythmia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Espondilodiscite como manifestação clínica de endocardite infecciosa</s1>
</fA08>
<fA11 dir="011000">
<s1>Daniela Calderaro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Tatiana F.G. Galvão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Renato Scotti Bagnatori</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Bruno Caramelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>526-527</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 11/2003 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>InCor  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>528-528</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Peptídeo natriurético tipo-B e doenças cardiovasculares</s1>
</fA08>
<fA11 dir="011000">
<s1>Luís Beck da Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos A. Ferreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Celso Blacher</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Leães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Haissam Haddad</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>529-534</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>39</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Errata</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-1</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100512</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Initial experience in Brazil with the Helex septal occluder for percutaneous occlusion of atrial septal defects</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos A.C. Pedra</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Simone F. Pedra</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>César A. Esteves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Francisco Chamiê</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sérgio Ramos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sérgio C. Pontes Jr</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>João Carlos Tress</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Sérgio L. N. Braga</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Larry A. Latson</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Valmir F. Fontes</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>444-452</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>45</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the initial clinical experience with the Helex septal occluder for percutaneous closure of atrial septal defects. METHODS: Ten patients underwent the procedure, 7 patients with ostium secundum atrial septal defects (ASD) with hemodynamic repercussions and 3 patients with pervious foramen ovale (PFO) and a history of stroke. Mean age was 33.8 years and mean weight was 55.4 kg. Mean diameter by transesophageal echocardiography and mean stretched ASD diameter were 11.33 ± 3.3mm, and 15.2 ± 3.8mm, respectively. The Qp/Qs ratio was 1.9 ± 0.3 in patients with ASD. RESULTS: Eleven occluders were placed because a patient with 2 holes needed 2 devices. It was necessary to retrieve and replace 4 devices in 3 patients. We observed immediate residual shunt (&lt; 2mm) in 4 patients with ASD, and in those with patent foramen ovale total occlusion of the defect occurred. No complications were noted, and all patients were discharged on the following day. After 1 month, 2 patients with ASD experienced trivial residual shunts (1mm). In 1 patient, we observed mild prolapse in the proximal disk in the right atrium, without consequences. CONCLUSION: The Helex septal occluder was safe and effective for occluding small to moderate atrial septal defects. Because the implantation technique is demanding, it requires specific training of the operator. Even so, small technical failures may occur in the beginning of the learning curve, but they do not involve patient safety.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial septal defect</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous occlusion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Helex septal occluder</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Female alcoholics: electrocardiographic changes and associated metabolic and electrolytic disorders</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Borini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Henrique Imaca Terrazas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Arlindo Ferreira Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Romeu Cardoso Guimarães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sabrina Bicalho Borini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Espírita de Marília  </s1>
<s2>Marília SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>512-517</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>46</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To identify the electrocardiographic changes and their associations with metabolic and electrolytic changes in female alcoholics. METHODS: The study comprised 44 female alcoholics with no apparent physical disorder. They underwent the following examinations: conventional electrocardiography; serologic tests for syphilis, Chagas' disease, and hepatitis B and C viruses; urinary pregnancy testing; hematimetric analysis; biochemical measurements of albumin, fibrinogen, fasting and postprandial glycemias, lipids, hepatic enzymes, and markers for tissue necrosis and inflammation. RESULTS: Some type of electrocardiographic change was identified in 33 (75%) patients. In 17 (38.6%) patients, more than one of the following changes were present: prolonged QTc interval in 24 (54.5%), change in ventricular repolarization in 11(25%), left ventricular hypertrophy in 6 (13.6%), sinus bradycardia in 4 (9.1%), sinus tachycardia in 3 (6.8%), and conduction disorder in 3 (6.8%). The patients had elevated mean serum levels of creatine phosphokinase, aspartate aminotransferases, and gamma glutamyl transferase, as well as hypocalcemia and low levels of total cholesterol and LDL-cholesterol. The patients with altered electrocardiograms had a more elevated age, a lower alcohol consumption, hypopotassemia, and significantly elevated levels of triglycerides, postprandial glucose, sodium and gamma glutamyl transferase than those with normal electrocardiograms. The opposite occurred with fasting glycemia, magnesium, and alanine aminotransferase. CONCLUSION: The electrocardiographic changes found were prolonged QTc interval, change in ventricular repolarization, and left ventricular hypertrophy. Patients with normal and abnormal electrocardiograms had different metabolic and electrolytic changes.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>alcoholism</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>females</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrocardiographic changes</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>A change in the treatment of abdominal aortic aneurysms</s1>
</fA08>
<fA11 dir="011000">
<s1>José Honório Palma</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Abner Moreira Sampaio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fausto Miranda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Claudia Maria Rodrigues Alves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Augusto de Marcondes Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Enio Buffolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>São Paulo Federal University  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>522-525</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: One of the most exciting potential applications of percutaneous therapy is the treatment of abdominal aneurysms. METHODS: Of 230 patients treated with a self-expanding polyester-lined stent-graft for different aortic pathologies at our institution, we selected 80 abdominal aneurysm cases undergoing treatment (from May 1997 to December 2002). The stent was introduced through the femoral artery, in the hemodynamic laboratory, with the patient under general anesthesia, with systemic heparinization, and induced hypotension. RESULTS: The procedure was successful in 70 (92.9%) cases; 10 patients with exclusion of abdominal aortic aneurysms were documented immediately within the hemodynamic room and 5 patients persisted with a residual leak. Two surgical conversions were necessary. Additional stent-grafts had to be inserted in 3 (3.7%) cases. In the follow-up, 91.4% of patients were alive at a mean follow-up of 15.8 months. CONCLUSION: We believe that stent-grafts are an important tool in improving the treatment of abdominal aneurysms, and this new policy may change the conventional medical management of these patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>abdominal aneurysm</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>self-expanding stent-graft</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Right ventricular structure and function as possible determinants of surgical outcome 30 years after repair of tetralogy of Fallot</s1>
</fA08>
<fA11 dir="011000">
<s1>Sonia F. Mesquita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Raquel Snitcowsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Augusto Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>458-461</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To identify the variables that may be involved in the persistence of symptoms (functional class II, III, or IV vs. I) in patients being followed up for 30 years after surgical repair of tetralogy of Fallot. METHODS: Fifty-three patients (27 women), who underwent corrective surgery for tetralogy of Fallot between 1960 and 1970, were studied. Their ages ranged from 7 months to 26 years. At the end of follow-up, 13 patients were asymptomatic and the remaining were in functional class II (N=24), III (N=15), and IV (N=1). To differentiate asymptomatic from symptomatic patients, the following variables were analyzed: age at surgery, need for widening the pulmonary ring and trunk, need for a second (2nd OP) or 3rd operation, residual defect of the interventricular septum, residual regurgitation of the pulmonary valve, systolic gradient through the right ventricular outflow tract, right ventricular dilation or hypertrophy (RVH), cardiothoracic index (CTI), right and left ventricular ejection fraction (RVEF/LVEF), and arrhythmias. RESULTS: The univariate analysis showed an association between the presence of symptoms and the 2nd OP (P=0.03), an increase in the CTI (P=0.0001), moderate to severe RVH (P=0.002), and dilation (P=0.0003). In the logistic regression model, the combination of the 2nd OP (P=0.008), the RVH (P=0.002), and the reduction in RVEF (P=0.01) determined the presence of symptoms. CONCLUSION: Despite the surgical treatment, right ventricular remodeling and performance were the major determinants in the late follow-up of tetralogy of Fallot.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tetralogy of Fallot</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>right ventricular structure</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Comparison of immediate results and follow-up of patients with single-vessel and multivessel coronary artery disease younger than 50 years of age undergoing coronary stent implantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre L. Anello</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Isaac Moscoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ricardo J. Tófano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Adnan A. Salman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Salvador A. B. Cristóvão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maria Fernanda Z. Mauro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>João Batista de O. Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>José A. Mangione</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Beneficência Portuguesa de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>500-505</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the in-hospital results and clinical follow-up of young patients (&lt; 50 years) with multivessel coronary artery disease undergoing stent implantation in native coronary arteries and to compare their results with those of patients with single-vessel coronary artery disease. METHODS: We retrospectively studied 462 patients undergoing coronary stent implantation. Patients were divided into 2 groups: group I (G-I) - 388 (84%) patients with single-vessel coronary artery disease; and group II (G-II) - 74 (16%) patients with multivessel coronary artery disease. RESULTS: The mean age of the patients was 45±4.9 years, and the clinical findings at presentation and demographic data were similar in both groups. The rate of clinical success was 95% in G-I and 95.8% in G-II (P=0.96), with no difference in regard to in-hospital evolution between the groups. Death, acute myocardial infarction, and the need for myocardial revascularization during clinical follow-up occurred in 10.1% and 11.2% (P=0.92) in G-I and G-II, respectively. By the end of 24 months, the actuarial analysis showed an event-free survival of 84.6 % in G-I and 81.1% in G-II (P=0.57). CONCLUSION: Percutaneous treatment with coronary stent implantation in young patients with multivessel disease may be safe with a high rate of clinical success, a low incidence of in-hospital complications, and a favorable evolution in clinical follow-up.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>multivessel</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stent percutaneous</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angioplasty</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="en">
<s1>Williams-Beuren syndrome: cardiovascular abnormalities in 20 patients diagnosed with fluorescence in situ hybridization</s1>
</fA08>
<fA11 dir="011000">
<s1>Sofia Mizuho Miura Sugayama</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Regina Lúcia Moisés</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Jaqueline Wagënfur</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Nana Miura Ikari</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Kikue Terada Abe</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cláudio Leone</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Clóvis Artur Almeida da Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Maria de Lourdes Lopes Ferrari Chauffaille</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Ae Kim Chong</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>468-473</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the cardiovascular findings and clinical follow-up of patients with Williams-Beuren syndrome. METHODS: We studied 20 patients (11 males, mean age at diagnosis: 5.9 years old), assessed for cardiovascular abnormalities with electrocardiography and Doppler echocardiography. Fluorescence in situ hybridization (FISH) was used to confirm the diagnosis of the syndrome. RESULTS: Elastin gene locus microdeletion was detected in 17 patients (85%) (positive FISH), and in 3 patients deletion was not detected (negative FISH). Sixteen patients with a positive FISH (94%) had congenital cardiovascular disease (mean age at diagnosis: 2,3 years old). We observed isolated (2/16) supravalvular aortic stenosis and supravalvular aortic stenosis associated (11/16) with pulmonary artery stenosis (4/11); mitral valve prolapse (3/11); bicuspid aortic valve (3/11); aortic coarctation (2/11), thickened pulmonary valve (2/11); pulmonary valvular stenosis (1/11); supravalvular pulmonary stenosis (1/11); valvular aortic stenosis (1/11); fixed subaortic stenosis (1/11); pulmonary artery stenosis (2/16) associated with pulmonary valvar stenosis (1/2) and with mitral valve prolapse (1/2); and isolated mitral valve prolapse (1/16). Four patients with severe supravalvular aortic stenosis underwent surgery (mean age: 5.7 years old), and 2 patients had normal pressure gradients (mean follow-up: 8.4 years). CONCLUSION: A detailed cardiac evaluation must be performed in all patients with Williams-Beuren syndrome due to the high frequency of cardiovascular abnormalities.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Williams-Beuren</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elastin</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>in situ hybridization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>supravalvular aortic stenosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretriz para realização de exames diagnósticos e terapêuticos em hemodinâmica</s1>
</fA08>
<fA11 dir="011000">
<s1>Jamil Abdalla Saad</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Carlos de Faria Garcia</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-6</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Normatização dos Equipamentos e Técnicas de Exame para Realização de Exames Ecocardiográficos</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Eduardo Suaide Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rogério Tasca</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz Henrique Weitzel</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Valdir Ambrósio Moisés</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz Darcy Cortez Ferreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Glaucia Maria Penha Tavares</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Luiz Barros Pena</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Juarez Ortiz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Caio C. J. Medeiros</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Claudia Gianini Monaco</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Luciana Braz Peixoto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-10</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretriz para Indicações e Utilização da Ecocardiografia na Prática Clínica</s1>
</fA08>
<fA11 dir="011000">
<s1>Orlando Campos Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Zielinsky</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Juarez Ortiz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Benedito Carlos Maciel</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Lazaro Andrade</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Wilson Mathias Jr.</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Djair Falcão Brindeiro Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Jorge Eduardo Assef</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Carlos T. Oliveira Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Márcia de Melo Barbosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Valdir Ambrósio Moisés</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Samira Mohry Borges</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Sérgio Cunha Pontes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Rogério Tasca</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Vera Márcia Gimenez</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>Iran Castro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>Manuel Adan Gil</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>Adelaide Arruda-Olson</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>Jeane Mike Tsu-Tsui</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="201000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>11-34</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200002</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Frequency of hypertension in chronic Chagas' disease: retrospective clinical study</s1>
</fA08>
<fA08 dir="pt">
<s1>Freqüência da hipertensão arterial na doença de Chagas crônica: estudo clínico retrospectivo</s1>
</fA08>
<fA11 dir="011000">
<s1>Cristina Brandt Friedrich Martin Gurgel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Armando Miguel Junior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Clayde Regina Mendes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carolina Okada Zerbini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Thiago Mussato Carcioni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica de Campinas Faculdade de Medicina </s1>
<s2> SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>545-548</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the frequency of hypertension in chagasic patients, as well as its clinical behavior and cardiologic findings. METHODS: We carried out a retrospective study with 225 patients with chronic Chagas' disease and hypertension (104 males), mean age of 55.1 ± 11.8. These patients were being followed up in the outpatient care clinics from 1984 to 2000. The study assessed the clinical, electrocardiographic, and radiological viewpoints. RESULTS: Of the 225 hypertensive patients (prevalence = 33.3%), 78 (34.7%) had mild hypertension, 108 (48%) had moderate hypertension, and 39 (17.3%) had severe hypertension. The association of left anterosuperior divisional block and right bundle-branch block occurred in 39 cases (17.3%), and enlargement of the cardiac area on radiological examination occurred in 93 (44.9%) of the 207 cases studied. The undetermined form of Chagas' disease was the most prevalent, 30.2% of the cases, followed by the form associated with conduction disorders in 27.1%, and the isolated form of conduction disorders in 21.3%. CONCLUSION: Chagasic patients had a frequency of hypertension similar to that of the general population, and the clinical profile of the hypertensive chagasic patients seemed not to differ a lot from that of the chagasic patients.</s0>
</fC01>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar a freqüência da hipertensão arterial sistêmica em chagásicos e seu comportamento clínico e os achados cardiológicos. MÉTODOS: Estudo retrospectivo em 225 portadores de doença chagásica crônica e hipertensão arterial sistêmica (104 homens), idade média de 55,1±11,8 anos, acompanhados em ambulatório entre os anos de 1984 e 2000, avaliado do ponto de vista clínico, eletrocardiográfico e radiológico. RESULTADOS: Nos 225 hipertensos (prevalência = 33,3%) a hipertensão arterial sistêmica leve ocorreu em 78 casos (34,7%), a moderada em 108 (48%) e a grave em 39 (17,3%). A associação do bloqueio divisional ântero-superior do ramo esquerdo do feixe de His com o bloqueio do ramo direito do feixe de His ocorreu em 39 casos (17,3%) e observou-se aumento da área cardíaca ao exame radiológico de 93 casos (44,9%) dos seus 207 estudados. A forma indeterminada da doença de Chagas foi a mais prevalente, 30,2% dos casos, seguida da forma dromopática associada em 27,1%, e dromopática isolada em 21,3%. CONCLUSÃO: Os chagásicos apresentaram freqüência de hipertensão arterial sistêmica semelhante a população geral e o perfil clínico dos chagásicos hipertensos parece não diferir muito do perfil dos chagásicos.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença de Chagas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Follow-up study of morphology and cardiac function in rats undergoing induction of supravalvular aortic stenosis</s1>
</fA08>
<fA08 dir="pt">
<s1>Estudo evolutivo da morfologia e função cardíaca em ratos submetidos a estenose aórtica supravalvar</s1>
</fA08>
<fA11 dir="011000">
<s1>Henrique Barbosa Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Katashi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Carlos Cicogna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edson Antonio Bregagnollo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria Aparecida Marchesan Rodrigues</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Carlos Roberto Padovani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Flávio Ferrari Aragon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Elenize Jamas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Marina Politi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNESP Faculdade de Medicina de Botucatu </s1>
<s2>Botucatu SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>569-575</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>40</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To characterize the follow-up of an experimental model of left ventricular hypertrophy (LVH) induced by supravalvular ascending aortic stenosis in young rats. METHODS: Wistar rats were submitted to thoracotomy and aortic stenosis was created by placing a clip on the ascending aorta (AoS group, n=12). Age-matched control animals underwent a sham operation (C group, n=12). Cardiac function was analysed by echocardiograms performed 6, 12, and 21 weeks after aortic banding. Myocardial morphological features and myocardial hydroxyproline concentration (HOP) were evaluated 2, 6, 12, and 21 weeks after surgery in additional animals. RESULTS: Aortic banding promoted early concentric LVH and a progressive increase in HOP. Under light microscopy, we observed myocyte hypertrophy and wall thickening of the intramural branches of the coronary arteries due to medial hypertrophy. Cardiac function was supranormal after 6 weeks (percentage of fractional shortening - EAo6: 70.3±10.8; C6: 61.3±5.4; p&lt;0.05), and depressed in the last period. Diastolic dysfunction was detected after 12 weeks (ratio of early-to-late filling velocity - EAo12: 4.20±3.25; C12: 1.61±0.16; p&lt;0.05). CONCLUSION: Ascending aortic stenosis promotes concentric LVH with myocardial fibrosis and minimal histological changes. According to the period of evaluation, cardiac function may be improved, normal, or depressed. The model is suitable and useful for studies on pathophysiology and treatment of the different phases of cardiac hypertrophy.</s0>
</fC01>
<fC01 dir="pt">
<s0>OBJETIVO: Caracterizar, evolutivamente, o modelo experimental de hipertrofia ventricular esquerda (HVE) por indução de estenose aórtica supravalvar em ratos jovens. MÉTODOS: Ratos Wistar foram submetidos a toracotomia para colocação de clipe ao redor da aorta torácica (grupo EAo, n=12). Animais controle foram submetidos à mesma cirurgia, porém sem a colocação do clipe (grupo C, n=12). A função cardíaca foi analisada por ecocardiogramas seriados após 6, 12 e 21 semanas. Outros grupos foram utilizados para avaliação histológica e quantificação da hidroxiprolina miocárdica (HOP: 2, 6, 12 e 21 semanas). RESULTADOS: A EAo promoveu precocemente HVE concêntrica e aumento progressivo da concentração de HOP. À microscopia óptica, observou-se hipertrofia dos miócitos e da camada média dos ramos intramurais das artérias coronárias. A função sistólica foi supranormal no período 6 semanas (porcentagem de encurtamento - EAo6:70,3±10,8; C6: 61,3±5,4; p&lt;0,05), apresentando-se reduzida apenas no último período. A partir de 12 semanas, verificou-se disfunção diastólica (E/A - EAo12: 4,20± 3,25; C12: 1,61±0,16; p&lt;0,05). CONCLUSÃO: A indução de EAo promove HVE concêntrica e fibrose miocárdica. A função cardíaca, dependendo do período de análise, encontra-se melhorada, normal ou deprimida. O modelo é adequado e potencialmente útil para estudos sobre a fisiopatologia e tratamento nas diferentes fases evolutivas da hipertrofia cardíaca.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic stenosis and rats</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose aórtica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ratos</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Influence of skeletal muscle mass on ventilatory and hemodynamic variables during exercise in patients with chronic heart failure</s1>
</fA08>
<fA08 dir="pt">
<s1>Influência da massa muscular esquelética sobre as variáveis ventilatórias e hemodinâmicas ao exercício em pacientes com insuficiência cardíaca crônica</s1>
</fA08>
<fA11 dir="011000">
<s1>Ricardo Vivacqua Cardoso Costa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Claudio Lucas da Nóbrega</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Salvador Manoel Serra</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Salete Rego</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mauricio Wajngarten</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clinicas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital Pró-Cardíaco  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>581-585</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the influence of skeletal muscle mass on ventilatory and hemodynamic variables during exercise in patients with chronic heart failure (CHF). METHODS: Twenty-five male patients underwent maximum cardiopulmonary exercise testing on a treadmill with a ramp protocol and measurement of the skeletal muscle mass of their thighs by using magnetic resonance imaging. The clinically stable, noncachectic patients were assessed and compared with 14 healthy individuals (S) paired by age and body mass index, who underwent the same examinations. RESULTS: Similar values of skeletal muscle mass were found in both groups (CHF group: 3863 ± 874 g; S group: 3743 ± 540 g; p = 0.32). Significant correlations of oxygen consumption in the anaerobic threshold (CHF: r = 0.39; P= 0.02 and S: r = 0.14; P = 0.31) and of oxygen pulse also in the anaerobic threshold (CHF: r = 0.49; P = 0.01 and S: r =0.12; P = 0.36) were found only in the group of patients with chronic heart failure. CONCLUSION: The results obtained indicate that skeletal muscle mass may influence the capacity of patients with CHF to withstand submaximal effort, due to limitations in their physical condition, even maintaining a value similar to that of healthy individuals. This suggests qualitative changes in the musculature.</s0>
</fC01>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a influência da massa muscular esquelética sobre as variáveis ventilatórias e hemodinâmicas ao exercício em portadores de insuficiência cardíaca crônica (ICC). MÉTODOS: Foram realizados testes ergoespirométricos máximos, com protocolo de rampa em esteira rolante e medidas da massa muscular esquelética de coxas pela ressonância magnética em 25 homens, clinicamente estáveis, não caquéticos, avaliados e comparados com 14 indivíduos sadios (S), pareados por faixa etária e índice de massa corporal, submetidos aos mesmos exames. RESULTADOS: Verificaram-se valores semelhantes da massa muscular em ambos os grupos (ICC: 3863 ± 874g; S: 3743 ± 540g; p = 0,32) e suas correlações significativas com o consumo de oxigênio no limiar anaeróbico (ICC: r= 0,39 p = 0,02; S: r = -0,14; p = 0,31), e com o pulso de oxigênio também no limiar anaeróbio (ICC: r = 0,49 p=0,01; S: r =0,12; p = 0,36), apenas nos pacientes com insuficiência cardíaca. CONCLUSÃO: Os resultados obtidos indicam que a massa muscular esquelética pode influenciar a capacidade desses pacientes em sustentar esforços submáximos, relacionando-se à limitação da condição física, mesmo mantendo valor semelhante a dos indivíduos normais, sugerindo alterações qualitativas dessa musculatura.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>skeletal muscle</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chronic heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiopulmonary exercise test</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>músculo esquelético</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca crônica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ergoespirometria</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Comparative study of smokers, ex-smokers, and nonsmokers who have experienced myocardial infarction</s1>
</fA08>
<fA08 dir="pt">
<s1>Estudo comparativo entre pacientes infartados fumantes, ex-fumantes e não-fumantes</s1>
</fA08>
<fA11 dir="011000">
<s1>Diogo Nozawa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Alexandre Franken</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Karina de Cássia Braga Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Afonso Celso Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sandra Regina Schwarzwälder Sprovieri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Valdir Golin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa de Misericórdia de São Paulo  </s1>
<s2> SP</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>589-591</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the impact of smoking on in-hospital morbidity and mortality in patients who have experienced acute myocardial infarction and to assess the association between smoking and other cardiovascular risk factors and clinical data. METHODS: A prospective cohort study analyzed 121 patients, including 54 smokers, 35 ex-smokers, and 32 nonsmokers. RESULTS: Using the chi-square test (P&lt;0.05), an association between smoking and the risk factors sex, age, and diabetes was documented. Among the morbidity and mortality variables, only acute pulmonary edema showed a statistically significant difference (OR=9.5; 95% CI), which was greater in the ex-smoker group than in the nonsmoker group. CONCLUSION: An association between smoking and some cardiovascular risk factors was observed, but no statistical difference in morbidity and mortality was observed in the groups studied, except for the variable acute pulmonary edema.</s0>
</fC01>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o impacto do tabagismo sobre a morbimortalidade intrahospitalar dos pacientes vítimas de infarto agudo do miocárdio e verificar sua associação a outros fatores de risco cardiovasculares e dados clínicos. MÉTODOS: Foram analisados, por meio de um estudo prospectivo de coortes, 121 pacientes, 54 fumantes, 35 ex-fumantes e 32 não fumantes. RESULTADOS: Houve associação pelo teste do qui-quadrado (p&lt;0,05) entre tabagismo e os fatores de risco sexo, idade, diabetes. Entre as variáveis de morbimortalidade, houve apenas diferença estatiticamente significante (OR=9,5; IC de 95%) de edema agudo de pulmão, maior no grupo ex-fumante do que no grupo não fumante. CONCLUSÃO: Houve associação entre o tabagismo e alguns fatores de risco cardiovasculares, mas, não houve diferenças estatísticas de morbimortalidade entre os grupos estudados, exceto na variável edema agudo de pulmão.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>smoking</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tabagismo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>miocárdio</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Lipid profile and cardiovascular risk in two Amazonian populations</s1>
</fA08>
<fA08 dir="pt">
<s1>Perfil lipídico e risco cardiovascular em amazônidas</s1>
</fA08>
<fA11 dir="011000">
<s1>Claudine Maria Alves Feio</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Francisco A. H. Fonseca</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Simone S. Rego</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Max N. B. Feio</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria C. Elias</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Eduardo A. S. Costa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Maria C. O. Izar</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Ângelo A. V. Paola</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Antonio C. C. Carvalho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Pará  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>596-599</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To compare the lipid profiles and coronary heart disease risks of 2 Brazilian Amazonian populations as follows: a riverside population (village of Vigia) and an urban population (city of Belém in the state of Pará). METHODS: Fifty individuals controlled for age and sex were assessed in each region, and the major risk factors for coronary heart disease were analyzed. RESULTS: According to the National Cholesterol Education Program (NCEP III) and using the Framingham score, both populations had the same absolute risk of events (Vigia = 5.4 ± 1 vs Belém = 5.7 ± 1), although the population of Vigia had a lower consumption of saturated fat (P&lt;0.0001), a greater consumption of mono- and polyunsaturated fat (P&lt;0.03), in addition to lower values for body mass index (25.4± 0.6 vs 27.6 ± 0.7 kg/m², P&lt;0.02), of biceps skin fold (18.6 ± 1.1 vs 27.5 ± 1.3 mm, P&lt;0.0001), of triceps skin fold (28.7 ± 1.2 vs 37.3 ± 1.7 mm, P&lt;0.002), and of total cholesterol (205 ± 5 vs 223 ± 6 mg/dL, P&lt; 0.03) and triglycerides (119 ± 9 vs 177 ± 18 mg/dL, P&lt;0.005). Both populations did not differ in regard to HDL-C (46 ± 1 vs 46 ± 1 mg/dL), LDL-C (135 ± 4 vs 144 ± 5 mg/dL) and blood pressure (SBP 124 ± 3 vs 128 ± 3 mmHg; DBP 80 ± 2 vs 82 ± 2 mmHg). CONCLUSION: The riverside and urban populations of Amazonia had similar cardiovascular risks. However, the marked difference in the variables studied suggests that different strategies of prevention should be applied.</s0>
</fC01>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar o perfil lipídico e risco coronariano de uma população ribeirinha (Vigia) ao de uma população urbana (Belém). MÉTODOS: Foram avaliados 50 indivíduos de cada região, controlados por idade e sexo, examinando-se os principais fatores de risco para a doença coronariana. RESULTADOS: Segundo o Programa Nacional de Educação sobre o Colesterol (NCEP III) e determinando-se o escore de Framingham, ambas as populações expressaram o mesmo risco absoluto de eventos (Vigia 5,4 ± 1 vs. Belém 5,7 ± 1), a despeito da população de Vigia apresentar menor consumo de gordura saturada (p&lt;0,0001), maior de mono e poliinsaturada (p&lt;0,03), além de menores valores do índice de massa corpórea (25,4±0,6 vs. 27,6±0,7kg/m², p&lt;0,02), da prega biceptal (18,6±1,1 vs. 27,5±1,3mm, p&lt;0,0001) e triceptal (28,7±1,2 vs. 37,3±1,7mm, p&lt;0,002), de colesterol total (205±5 vs. 223±6mg/dL, p&lt; 0,03) e triglicérides (119 ± 9 vs. 177±18mg/dL, p&lt;0,005), não diferindo no HDL-c (46±1 vs. 46±1mg/dL), LDL-c (135 ± 4 vs. 144 ± 5mg/dL) e pressão arterial (PAS 124 ± 3 vs. 128 ± 3mmHg; PAD 80 ± 2 vs. 82 ± 2mmHg). CONCLUSÃO: A população ribeirinha e urbana da Amazônia apresentaram risco cardiovascular semelhante. Entretanto, a marcante diferença entre as variáveis estudadas sugere que devam ser aplicadas diferentes estratégias de prevenção.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipids</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nutrition</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lípides</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>nutrição</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Pulmonary vein pulsatility in fetuses of diabetic mothers: prenatal Doppler echocardiographic study</s1>
</fA08>
<fA08 dir="pt">
<s1>Pulsatilidade venosa pulmonar em fetos de mães diabéticas: estudo doppler-ecocardiográfico pré-natal</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio L. Piccoli Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Lucas Teixeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eduardo I. Gus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>João L. Mânica</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fabíola Satler</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Humberto Vaz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luiz H. Nicoloso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Stelamaris Luchese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Marlui Sheid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Silvana Marcantonio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Domingos Hatém</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>604-607</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To verify the hypothesis that the pulmonary vein pulsatility index is higher in fetuses of diabetic mothers than it is in normal fetuses of nondiabetic mothers. METHODS: Twenty-four fetuses of mothers with either gestational or previous diabetes (cases), and 25 normal fetuses of mothers without systemic disease (control) were examined. Fetuses were examined through prenatal Doppler and color flow mapping. The pulmonary vein pulsatility index was obtained by placing the pulsed Doppler sample volume over the right superior pulmonary vein and applying the formula (systolic velocity - presystolic velocity)/mean velocity. RESULTS: The mean gestational age of the study fetuses was 30.3±2.7 weeks, and gestational age of the controls was 29±3.3 weeks, with no significant difference in gestational age between groups (p=0.14). Fetuses of diabetic mothers had a mean pulmonary vein pulsatility index of 1.6±1, and those of the control group had an index of 0.86±0.27. CONCLUSION: Fetuses of diabetic mothers had pulmonary vein pulsatility indexes (parameter easily obtained through Doppler echocardiography that may be related to fetal diastolic function) higher than those in fetuses of mothers with normal glycemia.</s0>
</fC01>
<fC01 dir="pt">
<s0>OBJETIVO: Testar a hipótese de que o índice de pulsatilidade da veia pulmonar é maior em fetos de mães diabéticas do que em fetos normais. MÉTODOS: Examinados 24 fetos de mães com diabetes prévio ou gestacional (casos) e 25 fetos normais de mães sem doença sistêmica (controles). Os fetos foram examinados pela ecocardiografia pré-natal com Doppler e mapeamento de fluxo em cores. O índice de pulsatilidade da veia pulmonar foi obtido colocando-se a amostra volume do Doppler pulsado sobre a veia pulmonar superior direita e aplicando-se a fórmula (velocidade sistólica-velocidade pré-sistólica)/velocidade média. RESULTADOS: Os casos apresentaram idade gestacional média de 30,3 ± 2,7 semanas, e os controles, de 29, ± 3,3 semanas, sem diferença significativa entre as idades gestacionais nos dois grupos (p = 0,14). Os fetos de mães diabéticas apresentaram índice de pulsatilidade da veia pulmonar médio de 1,6 ± 1 e os fetos do grupo controle 0,86 ± 0,27. CONCLUSÃO: Fetos de mães diabéticas apresentam índice de pulsatilidade da veia pulmonar (parâmetro Doppler-ecocardiográfico de fácil obtenção, que pode estar relacionado com a função diastólica fetal) maior do que os de mães com glicemia normal.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetal echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetal diastolic function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetal pulmonary venous flow</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diabetes</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary vein pulsatility index</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia fetal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função diastólica fetal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fluxo venoso pulmonar fetal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>diabetes</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>índice de pulsatilidade da veia pulmonar</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Spontaneous rupture of a right atrial angiosarcoma and cardiac tamponade</s1>
</fA08>
<fA08 dir="pt">
<s1>Ruptura espontânea de angiossarcoma atrial direito e tamponamento cardíaco</s1>
</fA08>
<fA11 dir="011000">
<s1>Ricardo Barros Corso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nadja Kraychete</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sidnei Nardeli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rilson Moitinho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Cristiano Ourives</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rosenbert Mamedio da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ricardo Eloy Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa de Misericórdia Hospital Santa Izabel Serviço de Cardiologia Clínica Cardiointensiva</s1>
<s2>Salvador BA</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>611-613</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>Primary cardiac angiosarcoma is a rare disease of difficult diagnosis and poor prognosis frequently associated with recurring hemopericardium. We report the case of a 30-year-old female with a right atrial angiosarcoma and spontaneous rupture to the pericardial cavity, who was diagnosed during an emergency exploratory thoracotomy, whose indication was cardiac tamponade. This is the 8th case reported in the literature. Clinical findings are discussed and a literature review is provided.</s0>
</fC01>
<fC01 dir="pt">
<s0>O angiossarcoma primário do coração é uma doença rara, de diagnóstico difícil e de prognóstico reservado, freqüentemente associado ao hemopericárdio recidivante. Relatamos um caso de uma mulher de 30 anos, portadora de angiossarcoma atrial direito, com ruptura espontânea para a cavidade pericárdica, diagnosticada à toracotomia exploradora de urgência, indicada por tamponamento cardíaco. Trata-se do 8º caso descrito na literatura. São discutidos detalhes clínicos e revisão bibliográfica.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 6/2003 - Homem de 54 anos, com insuficiência cardíaca progressiva e refratária, infarto do miocárdio, aterosclerose coronariana e ponte miocárdica (Faculdade de Ciências Médicas da Universidade de Campinas - UNICAMP)</s1>
</fA08>
<fA11 dir="011000">
<s1>Luís Felipe Bachur</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eros Antonio de Almeida</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luís Antônio K. Bittencourt</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Márcio Jansen O. Figueiredo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eduardo Arantes Nogueira</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>614-619</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 12/2003 - instituto do coração do hospital das clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>620-620</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="en">
<s1>Quantifying the risk of coronary artery disease in a community: The Bambuí Project</s1>
</fA08>
<fA08 dir="pt">
<s1>Quantificando o risco de doença coronariana na comunidade: Projeto Bambuí</s1>
</fA08>
<fA11 dir="011000">
<s1>Sandhi Maria Barreto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Valéria Maria Azeredo Passos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alisson Renê Aquino Cardoso</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Fernanda Lima-Costa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFMG Faculdade de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Fundação Oswaldo Cruz Centro de Pesquisas René Rachou </s1>
<s2>Belo Horizonte MG</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>556-561</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>en</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the coronary risk profile in adults and elderly in a community. METHODS: The study comprised a sample of adults (30-59 years, n=547) and the entire elderly population (60-74 years, n=1165) residing in Bambuí town, Brazil. The Framingham score based on sex, age, smoking, diabetes mellitus, systolic and diastolic blood pressure, total cholesterol, and HDL-C was used. The score based on age and sex was defined as &quot;expected&quot; and compared with the mean score obtained by the sum of all risk factors in each age group and sex (score &quot;observed&quot;). RESULTS: The difference between the scores &quot;observed&quot; and &quot;expected&quot; increased with aging in both sexes. Smoking increased the difference from 30 years of age onwards, in both sexes, and hypertension was important in men above the age of 30 years and in women above the age of 50 years. Diabetes and elevated total cholesterol increased the risk of the disease above the age of 50 years in both sexes. A higher level of HDL-C reduced the risk among men above the age of 30 years, with no significant difference among women. Less schooling (&lt; 4 years versus &amp;sup3; 4 years) was associated with a higher score in adults of both sexes, but not among the elderly. CONCLUSION: Based on these results, in the community studied, the risk of coronary artery disease may be reduced up to 44% in men and 38% in women.</s0>
</fC01>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar o risco de adultos e idosos de uma comunidade desenvolverem doença arterial coronariana em 10 anos. MÉTODOS: Participaram do estudo uma amostra probabilística simples de adultos (30-59a, n=547) e toda a população idosa (60-74a, n=1165) residentes em Bambuí, MG. Utilizou-se o escore proposto pelo estudo de Framingham, com a inclusão dos fatores: sexo, idade, fumo, diabete, pressão sistólica e diastólica, colesterol total e HDLc. O escore baseado na idade e sexo foi definido como esperado e comparado ao escore médio global em cada faixa etária e sexo (observado). RESULTADOS: A diferença entre o escore observado e o esperado aumentou com o envelhecimento em ambos os sexos. O tabagismo aumentou a diferença desde os 30 anos, em ambos os sexos, e a hipertensão foi importante nos homens após 30 anos e nas mulheres após 50 anos. O diabetes e o colesterol total aumentaram o risco da doença após 50 anos nos dois sexos. Um maior nível de HDLc reduziu o risco entre os homens após 30 anos, sem diferença significativa entre as mulheres. Uma menor escolaridade (&lt;4 anos x&lt;FONT FACE=Symbol&gt;&amp;sup3;&lt;/FONT&gt; 4 anos) foi associada a um maior escore entre os adultos de ambos os sexos, mas não entre idosos. CONCLUSÃO: Os resultados alertam para a contribuição de medidas preventivas e terapêuticas na diminuição do risco de doença coronariana. Seu risco na comunidade estudada pode ser reduzido em até 44% entre os homens e 38% entre as mulheres.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk score</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>population-based study</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>escore de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estudo de base populacional</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Passado, Presente e Futuro</s1>
</fA08>
<fA11 dir="011000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Eduardo Suaide Silva</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>109-110</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Raça e lesão de órgãos-alvo da hipertensão arterial em pacientes atendidos em um ambulatório universitário de referência na cidade de Salvador</s1>
</fA08>
<fA08 dir="en">
<s1>Race and hypertensive target-organ damage in patients from an university-affiliated outpatient care referral clinic in the city of Salvador</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Beisl Noblat</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo Barreto Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Alberto Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia Hospital Universitário Professor Edgard Santos </s1>
<s2>Salvador BA</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>111-115</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>44</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar se a raça do paciente estaria associada à presença de hipertrofia ventricular esquerda, acidente vascular cerebral e insuficiência renal crônica em hipertensos atendidos em ambulatório de referência em Salvador-BA. MÉTODOS: Analisados dados de 622 pacientes com o primeiro atendimento em ambulatório de hipertensão, entre 1982 e 1986, e identificados os com história prévia ou seqüela de acidente vascular cerebral, hipertrofia ventricular esquerda ou insuficiência renal (creatinina sérica &gt; 1,4 mg/dL). Modelos de regressão logística foram utilizados para estimar odds ratio (OR) da associação entre raça (mulatos ou negros vs brancos) e lesão de órgãos-alvo de hipertensão, ajustadas para sexo e idade. RESULTADOS: A média de idade dos pacientes foi 53,8±14,3 anos, 74,1% mulheres. Quanto à raça, 15,1% eram brancos, 65,9% mulatos e 19,0% negros. Acidente vascular cerebral foi significantemente mais freqüente em negros ou mulatos do que em brancos (odds ratio ajustada (ORa)=3,44; intervalo de confiança (IC) 95%=1,23-9,67). Quanto às associações envolvendo raça com os eventos hipertrofia ventricular esquerda e insuficiência renal as ORa não foram estatisticamente significantes, mas foram consistentes com maior prevalência de hipertrofia ventricular esquerda e insuficiência renal em negros e mulatos. CONCLUSÃO: Negros e mulatos hipertensos têm maior risco de lesão de órgão alvo do que brancos, com diferença racial maior para acidente vascular cerebral não fatal. Deve ser avaliada se diferenças raciais em mortalidade relacionada a complicações da hipertensão influenciam as associações observadas entre raça e lesão de órgãos-alvo.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess whether a patient's race is associated with the presence of left ventricular hypertrophy, stroke, and renal failure in hypertensive patients from an outpatient care referral clinic in the city of Salvador in the state of Bahia. METHODS: We assessed the data of 622 patients collected during their first visit to the hypertension outpatient care clinic between 1982 and 1986, identifying those with a previous history or sequela of stroke, left ventricular hypertrophy, or renal failure (serum creatinine &gt; 1.4 mg/dL). Logistic regression models were used to estimate the odds ratio (OR) of the association between race (mulattos or black vs white individuals) and hypertensive target-organ damage adjusted for sex and age. RESULTS: The mean age of the patients was 53.8±14.3 years, and 74.1% were women. In regard to race, 15.1% were white, 65.9% mulatto, and 19.0% black. Stroke was significantly more frequent in blacks or mulattos than in white individuals [adjusted odds ratio (aOR) = 3.44; 95% confidence interval (CI) = (1.23-9.67). In regard to the associations involving race and the events of left ventricular hypertrophy and renal failure, the aORs were not statistically significant but were consistent with a greater prevalence of left ventricular hypertrophy and renal failure in blacks and mulattos. CONCLUSION: Hypertensive mulattos and blacks have a greater risk of target-organ damage than white individuals do, with a greater racial difference for nonfatal stroke. Whether racial differences in mortality related to hypertensive complications influence the associations observed between race and target-organ damage should be assessed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>raça</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>negro</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>race</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blacks</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Epidemiologia da insuficiência cardíaca descompensada em Niterói: Projeto EPICA - Niterói</s1>
</fA08>
<fA08 dir="en">
<s1>Epidemiology of decompensated heart failure in the city of Niterói: EPICA - Niterói Project</s1>
</fA08>
<fA11 dir="011000">
<s1>Leandro Reis Tavares</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Heraldo Victer</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Maurício Linhares</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Clovis Monteiro de Barros</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marcus Vinicius Oliveira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luis Carlos Pacheco</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Cenésio Henrique Viana</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Sabrina Bernardez Pereira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Gisele Pinto da Silva</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Universitário Antonio Pedro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital de Clínicas de Niterói  </s1>
<s2>Niterói RJ</s2>
<s3>Brazil</s3>
</fA14>
<fA20 dir="000000">
<s1>121-124</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar entre os hospitais públicos e privados de Niterói o perfil epidemiológico, sócio-econômico, aspectos clínicos, etiologia, tempo de internação e a mortalidade dos pacientes internados por insuficiência cardíaca descompensada. MÉTODOS: Estudo transversal prospectivo e multicêntrico (julho a setembro/ 2001), incluindo todos os pacientes internados com diagnóstico primário de insuficiência cardíaca, maiores de 18 anos, e com pontuação 8 ou superior pelos critérios de Boston. RESULTADOS: Incluídos 203 pacientes: 98 públicos, 50% eram homens, média de idade de 61,1± 11,3 anos, 65% negros, 57% recebiam até 1 salário mínimo, 56% eram analfabetos, 66% tinham cardiopatia isquêmica; tempo médio de internação de 12,6 dias e a taxa de mortalidade ajustada para a idade de 5,23; 105 privados, 49% eram homens, média de idade de 72 ± 12,7 anos, 20% negros, 58% recebiam mais de 6 salários mínimos, 11% eram analfabetos, 62% eram isquêmicos; o tempo médio de internação hospitalar de 8 dias e a taxa de mortalidade ajustada para idade de 2,94. A distribuição das co-morbidades e fatores de risco similar entre os pacientes, à exceção do tabagismo, mais freqüente no serviço público. CONCLUSÃO: Além de assimetrias sócio-econômicas, o tempo de internação hospitalar e a taxa mortalidade ajustada para idade foram maiores no serviço público de saúde.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare the epidemiological and socioeconomic profiles, clinical features, etiology, length of hospitalization, and mortality of patients with decompensated heart failure admitted to public and private hospitals in the city of Niterói. METHODS: We carried out a prospective, multicenter study (from July to September 2001) comprising all patients older than 18 years with the primary diagnosis of heart failure and admitted to hospitals in the city of Niterói, whose scores according to the Boston criteria were 8 or above. Proportions were compared using the chi-square and Fisher exact tests. RESULTS: The sample comprised 203 patients as follows: 1) 98 patients from public hospitals: 50% were men, their mean age was 61.1±11.3 years, 65% were black, 57% had an income of 1 minimum wage or less, 56% were illiterate, 66% had ischemic heart disease, their mean length of hospitalization was 12.6 days, and the mortality rate adjusted for age was 5.23; 2) 105 patients from private hospitals: 49% were men, their mean age was 72±12.7 years, 20% were black, 58% had an income greater than 6 minimum wages, 11% were illiterate, 62% had ischemic heart disease, their mean length of hospitalization was 8 days, and the mortality rate adjusted for age was 2.94. The distribution of comorbidities and risk factors was similar among the patients of the 2 hospital systems, except for the smoking habit, which was more frequent among patients from public hospitals. CONCLUSION: In addition to the socioeconomic asymmetries, the hospitalization length and the mortality rate adjusted for age were greater in patients in the public health system.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>epidemiologia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Niterói</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Niterói</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Lipoma de ventrículo esquerdo: relato de caso</s1>
</fA08>
<fA08 dir="en">
<s1>Left ventricular lipoma</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Manuel Pêgo-Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Alfredo Batagello</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fábio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fabio Biscegli Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sérgio Almeida Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>188-190</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Mulher de 21 anos encaminhada com piora dos sintomas que vinha apresentando há anos: tontura ao levantar-se, sem sintomas vertiginosos, sem queixas de síncope ou alterações neurológicas, melhora em decúbito dorsal e repouso, após poucos minutos. O ecocardiograma transtorácico mostrava presença de massa hiperecogênica na região médio-apical da parede posterior do ventrículo esquerdo e pericárdio normal. A ressonância nuclear magnética cardíaca permitiu o diagnóstico de tumor de ventrículo esquerdo sugestivo de lipoma. Realizado tratamento cirúrgico e ressecado o tumor, a paciente apresentou boa recuperação e mantém-se assintomática.</s0>
</fC01>
<fC01 dir="en">
<s0>We report the case of a 21-year-old female referred to our institution complaining of dizziness when standing up, which improved in the dorsal decubitus position and at rest, after a few minutes. The symptom, which had lasted for years, was not accompanied by vertigo, syncope, or neurological changes, but was gradually getting worse. Transthoracic echocardiogram showed a hyperechoic mass in the middle-apical region of the left ventricular posterior wall and normal pericardium. The cardiac nuclear magnetic resonance allowed the diagnosis of the left ventricular tumor suggestive of lipoma. Surgery was performed and the tumor was resected. The patient recovered well and is currently asymptomatic.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 1/2004 - Onda Q anormal no ECG após troca valvar mitral em jovem do sexo feminino com 20 anos de idade</s1>
</fA08>
<fA11 dir="011000">
<s1>Roberto Chaim Berber</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marith Gândara Graciano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Osvaldo Teixeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Aparecida Barone Teixeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica Hospital e Maternidade Celso Pierro Grupo de Estudo em Correlação Anatomoclínica</s1>
<s2>Campinas SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>194-197</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200212</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 2/2004 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>InCor  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>198-198</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200213</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Monitorização hemodinâmica em cirurgia cardíaca pediátrica</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Antibas Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>199-208</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200214</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Níveis de hormônios tireoideanos em pacientes com dissecção aórtica: comparação com controles e correlação com a porcentagem de área da camada média composta por depósitos mixóides</s1>
</fA08>
<fA08 dir="en">
<s1>Thyroid hormone levels in patients with aortic dissection: comparison with controls and correlation with the percentage of the aortic media composed of myxoid deposits</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Sampaio Gutierrez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Adelaide Albergaria Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Regina Célia Martins Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Noedir Antonio Groppo Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria de Lourdes Higuchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>129-133</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Pesquisar a ocorrência de disfunção clínica ou subclínica da tireóide em portadores de dissecção aórtica e analisar se há correlação entre os níveis séricos de hormônios relacionados à função tireoideana e ao conteúdo de material mixóide da média aórtica. MÉTODOS: Níveis séricos de triiodotironina (T3), tiroxina (T4) e hormônio estimulador da tireóide (TSH) foram dosados por métodos convencionais em 28 pacientes em pós-operatório de correção de dissecção aórtica; T4 livre foi medido em 20 deles. Os mesmos hormônios foram quantificados em 20 pacientes-controle pareados por sexo e idade. Os resultados foram comparados pelo teste de Mann-Whitney. A porcentagem da camada média da aorta ocupada por material mixóide foi medida em espécimes cirúrgicos de 25 pacientes e correlacionada aos níveis séricos de hormônios através do teste de Pearson. Estabeleceu-se o nível de significância como p&lt;0,05. RESULTADOS: Nos 20 pares nos quais as quantidades de hormônios foram comparadas, os valores médios de T3, T4, T4 livre e TSH foram 1,22ng/ml, 9,89mcg/dl, 1,18ng/dl e 5,45microUi/ml nos casos e 1,15ng/ml, 8,57mcg/dl, 1,32ng/dl e 2,15microUi/ml nos controles. Nem tais diferenças nem a correlação entre a percentagem de conteúdo mixóide (média= 30%) e os valores de T3, T4, T4 livre e TSH (médias- 1,22ng/ml, 9,44mcg/dl, 1,20ng/dl e 5,08 micro Ui/ml; n=25) foram significantes. CONCLUSÃO: Nossos dados sugerem que a dissecção da aorta; não têm relação com os níveis séricos de hormônios tireoideanos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Deposits of myxoid material, similar to myxedema related to thyroid disease, are described in the medial layer of aortas with dissection. We analyzed the clinical or subclinical thyroid dysfunction of patients with this disease and analyzed whether a correlation exists between serum levels of thyroid-related hormones and the myxoid content of the aortic media. METHODS: We measured, with standard methods, serum levels of triiodothyronine (T3), thyroxine (T4), and thyroid stimulating hormone (TSH) in 28 patients who underwent aortic dissection and free T4 in 20 of them. The same hormones were quantified in 20 control patients matched by sex and age. Results were compared by using the Mann-Whitney test. We also measured the percentage of the aortic media occupied by myxoid material in the surgical specimens of 25 of the patients with aortic dissection and analyzed its correlation with hormone levels by using the Pearson test. RESULTS: In the 20 pairs in which the amount of hormones was compared, the mean values for T3, T4, free T4, and TSH were 1.22ng/mL, 9.89mcg/dL, 1.18ng/dL, and 5.45 microIU/mL in study patients and 1.15ng/mL, 8.57mcg/dL, 1.32ng/dL, and 2.15 microIU/mL in controls. Neither these differences nor the correlation between the percentage of myxoid content (mean=30%) and the values for T3, T4, free T4, and TSH (mean 1.22ng/mL, 9.44mcg/dL, 1.20ng/dL, and 5.08 microIU/mL, respectively; n= 25) were significant. CONCLUSION: Our data suggest that serum levels of thyroid hormones have no relation with the myxoid content in the aortic media in cases of aortic dissection.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aneurismas dissecantes</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aorta</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hormônios tireóideos</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aorta</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aneurysms</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dissecting</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thyroid hormones</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Comparação do perfil lipídico, pressão arterial e aspectos nutricionais em adolescentes, filhos de hipertensos e de normotensos</s1>
</fA08>
<fA08 dir="en">
<s1>Comparison of the lipid profile, blood pressure, and dietary habits of adolescents and children descended from hypertensive and normotensive individuals</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Cristina Elias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Max Samuel Mattos Bolívar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Francisco Antonio Helfenstein Fonseca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Tania Leme da Rocha Martinez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Japy Angelini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Celso Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Nelson Kasinski</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Angelo Amato Vincenzo de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Antonio Carlos Camargo Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>139-142</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar a pressão arterial, o perfil lipídico, o consumo alimentar e dados antropométricos em adolescentes com ou sem antecedente familiar de hipertensão arterial. MÉTODOS: Foram avaliados 43 adolescentes de ambos os sexos, na faixa etária entre 11 a 18 anos, sendo 20 filhos de hipertensos e 23 de normotensos e examinados: a pressão arterial, o consumo alimentar, dados antropométricos, o perfil lipídico e o resultado da orientação dietética (American Heart Association). RESULTADOS: Os filhos dos hipertensos mostraram maiores valores basais de pressão arterial sistólica (109 ± 3 vs. 99 ± 2 mm Hg, p=0,01) e diastólica (68 ± 2 vs. 62 ± 2 mm Hg, p=0,04), da relação CT/HDL-c (4,1 ± 0,3 vs. 3,2 ± 0,2, p&lt;0.01) e de LDL-c/HDL-c (2,7 ± 0,2 vs. 1,9 ± 0,1, p&lt;0,01) e menores valores de HDL-c (43 ± 2 vs. 53 ± 2 mg/dL, p&lt;0,005). O consumo alimentar e medidas antropométricas analisadas não diferiram entre os grupos. A intervenção dietética, embora tenha resultado em reduções no índice de massa corpórea (21,0± 1,2 vs. 20,1 ± 1,1 kg/m², p&lt;0,01), não modificou a dislipidemia presente nos filhos de hipertensos. CONCLUSÃO: Encontraram-se maiores níveis de pressão arterial e perfil lipídico mais desfavorável entre filhos de hipertensos, onde os níveis baixos de HDL-c foram o achado mais relevante e independente de variáveis antropométricas ou nutricionais.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare blood pressure, lipid profile, food intake, and anthropometric data of adolescents with or without a familial history of hypertension. METHODS: Forty-three adolescents from both sexes were assessed, with ages ranging from 11 to 18 years old. Twenty had hypertensive parents, and 23 had normotensive parents. The following variables were examined: blood pressure, food intake, anthropometric data, lipid profile, and the results of following dietary guidelines (American Heart Association). RESULTS: The offspring of hypertensive parents had greater baseline systolic blood pressure (109 ± 3 vs. 99 ± 2 mm Hg, P=0.01), diastolic blood pressure (68 ± 2 vs. 62 ± 2 mm Hg, p=0.04), greater TC/HDL-C ratio (4.1 ± 0.3 vs. 3.2 ± 0.2, P&lt;0.01), and greater LDL/HDL-C (2.7 ± 0.2 vs. 1.9 ± 0.1, P&lt;0.01), and smaller values of HDL-C (43 ± 2 vs.53 ± 2 mg/dL, P&lt;0.005). Dietary intake and anthropometric measures assessed did not differ between the groups. Even though dietary intervention resulted in reductions in body mass index (21.0± 1.2 vs. 20.1 ± 1.1 kg/m², P&lt;0.01), it did not change dyslipidemia present in the offspring of hypertensive individuals. CONCLUSION: Increased blood pressure levels and less favorable lipid profiles are found among offspring of hypertensive parents, where low levels of HDL-C were the most relevant finding regardless of anthropometric or nutritional variables.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>adolescência</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>pressão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hábitos alimentares</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lipídios</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adolescence</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dietary habits</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipids</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>O teste ergométrico é útil, seguro e eficaz, mesmo em indivíduos muito idosos, com 75 anos ou mais</s1>
</fA08>
<fA08 dir="en">
<s1>Exercise stress testing is useful, safe, and efficient even in patients aged 75 years or older</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciano Janussi Vacanti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luciano B H Sespedes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maíra de Oliveira Sarpi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNILUS Faculdade de Medicina Hospital Guilherme Álvaro</s1>
<s2>Santos SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>147-150</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Descrever as variáveis clínicas e hemodinâmicas obtidas pelo teste ergométrico em idosos &gt;75 anos. MÉTODOS: Estudados 100 indivíduos de 75-94 anos (80±4 anos), submetidos a teste ergométrico sintoma limitante, sendo 65% assintomáticos, 25% com dor torácica não anginosa e 10% com precordialgia típica, 32% eram homens, 50% hipertensos, 36% dislipidêmicos, 14% diabéticos e 9% com doença arterial coronariana prévia. O protocolo utilizado foi uma adaptação para rampa, do protocolo de Bruce, acrescido de 1min de aquecimento com velocidade de 1,0mph sem inclinação. RESULTADOS: Não houve complicações e 92% dos testes foram eficazes. Os pacientes atingiram em média 95% da freqüência cardíaca máxima prevista. A duração do exame e os equivalentes metabólicos alcançados foram, em média, respectivamente: 6,8 ±2min e 6,6 ±2,3 METs. Apresentaram resposta inotrópica hiperreativa 11 dos pacientes e observadas arritmias ventriculares e supraventriculares não complexas em 37% da amostra. Foram positivos para isquemia miocárdica 18% dos testes. Os pacientes com precordialgia típica apresentaram mais respostas isquêmicas do que os com dor torácica não anginosa e assintomáticos: 70% vs 16% (p&lt;0,001) e 70% vs 10% (p&lt;0,01), respectivamente. CONCLUSÃO: O teste ergométrico sintoma limitante é útil, seguro e eficaz para analisar as respostas isquêmicas e hemodinâmicas, mesmo no indivíduo muito idoso.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To describe the clinical and hemodynamic variables obtained with exercise testing in elderly patients SW &gt;75 years. METHODS: This study assessed 100 patients aged 75-94 years (80±4 years) undergoing symptom-limited exercise testing, 65% of whom were asymptomatic, 25% had nonanginal chest pain, and 10% had typical precordialgia. Of the 100 patients, 32% were males, 50% were hypertensive, 36% were dyslipidemic, 14% were diabetic, and 9% had had previous coronary artery disease. A ramp-adaptation of the Bruce protocol (ramped Bruce protocol) was used, preceded by a 1-minute warm-up with no treadmill incline and a velocity of 1.0 mph. RESULTS: No complications were observed, and 92% of the tests were efficient. On average, the patients reached 95% of the maximum heart rate predicted. The mean duration of the test and the mean metabolic equivalent reached were, respectively, 6.8 ±2 minutes and 6.6 ±2.3 METs. Eleven patients had a hyperreactive inotropic response, and 37% of the sample had noncomplex ventricular and supraventricular arrhythmias. Eighteen percent of the tests were positive for myocardial ischemia. The patients with typical precordialgia had more ischemic responses than did those with nonanginal chest pain or those who were asymptomatic: 70% vs 16% (P&lt;0.001) and 70% vs 10% (P&lt;0.01), respectively. CONCLUSION: The symptom-limited exercise test is useful, safe, and efficient for analyzing ischemic and hemodynamic responses, even in very elderly individuals.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste ergométrico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>idoso</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Isolamento das veias pulmonares para tratamento da fibrilação atrial paroxística: resultados clínicos após um único procedimento</s1>
</fA08>
<fA08 dir="en">
<s1>Pulmonary veins isolation to treat patients with refractory paroxysmal atrial fibrillation: clinical results after a single procedure</s1>
</fA08>
<fA11 dir="011000">
<s1>Mauricio Scanavacca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Raul Sartini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando Tondato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>André d'Ávila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Denise Hachul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Francisco Darrieux</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Sissy Lara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Eduardo Sosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>155-159</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a evolução clínica dos pacientes com fibrilação atrial paroxística submetidos a um único procedimento de isolamento das veias pulmonares. MÉTODOS: Estudados 49 pacientes consecutivos (36 homens; idade média de 53±10 anos) com episódios freqüentes e sintomáticos de fibrilação atrial paroxística de difícil controle clínico. Para mapeamento da junção do átrio esquerdo com as veias pulmonares, foi utilizado o cateter decapolar circular Lasso e para ablação 30 watts e 50ºC, um cateter com ponta deflectível e eletrodo distal de 4mm. RESULTADOS: Em seguimento médio de 12±5 meses, 25 (51%) pacientes não apresentaram recorrência de fibrilação atrial e 24 (49%) apresentaram pelo menos uma recorrência. Em 20 (83%), a 1ª crise ocorreu antes do 1º mês e em 4, após 2 a 9 meses. Após a introdução de drogas antiarrítmicas, 15 (63%) pacientes apresentaram melhora importante, 10 tornaram-se assintomáticos, 5 referiam crises raras, auto-limitadas e de curta duração e 9 (37%) permaneceram com as manifestações clínicas inalteradas, apesar das drogas antiarrítmicas e foram encaminhados à nova intervenção. No final do seguimento, 35 (71%) pacientes permaneciam em ritmo sinusal estável sem recorrência de fibrilação atrial, após um único procedimento, 50% dos quais sem drogas antiarrítmicas. CONCLUSÃO: A maioria dos pacientes com fibrilação atrial paroxística sintomática, não controlados com medicação antiarrítmica, obtém controle clínico após um único procedimento de isolamento das veias pulmonares.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: The purpose of this study was to access the clinical outcome of patients submitted to a single procedure of radiofrequency pulmonary veins (PV) isolation to treat refractory paroxysmal atrial fibrillation (AF). METHODS: This study included 49 consecutive patients (36 male; mean age 54±10 years old) who had frequent symptomatic paroxysmal AF refractory to at least three antiarrhythmic drugs. We used a circular decapolar catheter for mapping PVs - left atrial connections and a 4-mm distal tip catheter for ablation (30 W and 50 C), aiming to achieve electrical isolation of 3 -4 PVs. RESULTS: Twenty-five patients (51%) did not present any AF recurrence in a mean follow-up of 12±5 months. Twenty-four (49%) had at least one recurrence during outcome; twenty (83%) of them within the first month after the procedure and four after two to nine months. After introducing antiarrhythmic drugs 15 (63%) patients were under control, 10 were asymptomatic and five complained of sporadic short duration AF episodes. Nine (37%) patients remained very symptomatic despite the use of antiarrhythmic drugs and were referred to a new procedure of PV isolation. No patient presented major complications. At the end of the follow-up, 35 (71%) patients remained in stable sinus rhythm with no AF recurrences after a single procedure, 50% of them without antiarrhythmic drugs. CONCLUSION: Most patients who present symptomatic paroxysmal AF refractory to antiarrhythmic drugs obtain a good clinical control after a single PV isolation procedure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fibrilação atrial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ablação por cateter</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>radiofreqüência</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>veias pulmonares</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>radiofrequency catheter ablation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary veins</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Insuficiência respiratória persistente secundária a insuficiência cardíaca diastólica</s1>
</fA08>
<fA08 dir="en">
<s1>Persistent respiratory insufficiency secondary to diastolic heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>José Acylino de Lima Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Claudio Buarque Benchimol</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ricardo Segadas Acylino de Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital São Vicente de Paulo Serviço de Pneumologia </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>165-169</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Foram estudados 2 pacientes de 85 anos de idade com diagnóstico de insuficiência cardíaca diastólica e insuficiência respiratória persistente, caracterizada por distúrbio ventilatório obstrutivo grave e alterações das trocas gasosas. A possibilidade de que esse comprometimento respiratório decorresse de doença pulmonar primária foi excluída. Sinais radiológicos de edema pulmonar leve foram observados em um dos doentes nos 4 anos anteriores à primeira internação. O quadro respiratório foi atribuído a lesões pulmonares condicionadas à presença de edema pulmonar crônico. A incidência da doença em pacientes muito idosos pode dar origem a uma enfermidade que poderia ser denominada doença pulmonar congestiva.</s0>
</fC01>
<fC01 dir="en">
<s0>This study assessed two 85-year-old patients diagnosed with diastolic heart failure and persistent respiratory insufficiency characterized by severe obstructive ventilatory disorder and gas exchange alterations. The possibility that the respiratory impairment was consequent to primary pulmonary disease was excluded. Radiological signs of mild pulmonary edema had been observed in 1 of the patients during the 4 years preceding the first hospitalization. The respiratory findings were attributed to pulmonary lesions conditioned to the presence of chronic pulmonary edema. The incidence of the disease in very elderly patients may create an illness that can be called congestive pulmonary disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Crise de feocromocitoma simulando um infarto agudo do miocárdio em paciente com artérias coronárias normais</s1>
</fA08>
<fA08 dir="en">
<s1>Pheochromocytoma-induced segmental myocardial dysfunction mimicking an acute myocardial infarction in a patient with normal coronary arteries</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo S. Darzé</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto L. Von Sohsten</s1>
<afiliation>A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>John F. Kennedy Medical Center Atlantis Cardiology Division </s1>
<s2> FL</s2>
<s3>USA</s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital Aliança Serviço de Cardiologia/Ecocardiografia </s1>
<s2>Salvador BA</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>175-177</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Relatamos o caso de um paciente com alterações eletrocardiográficas e disfunção miocárdica segmentar induzidas por feocromocitoma, simulando infarto agudo do miocárdio. A angiografia coronariana foi normal e houve normalização completa do eletrocardiograma e ecocardiograma, após terapia com um bloqueador alfa-adrenérgico e ressecção do tumor. Espasmo coronariano foi o provável mecanismo envolvido na produção dessas alterações, ilustrando a importância de manter um alto grau de suspeição clínica em pacientes com evento miocárdico inesperado em meio a uma crise hipertensiva.</s0>
</fC01>
<fC01 dir="en">
<s0>We report a case of pheochromocytoma-induced segmental myocardial dysfunction and electrocardiographic abnormalities mimicking an acute anterior myocardial infarction, probably due to coronary spasm. Coronary angiography showed normal coronaries, and the electrocardiographic and echocardiographic changes resolved completely after therapy with an alpha-adrenergic blocker and tumor removal. Our case illustrates the importance of maintaining a high index of suspicion in patients presenting with an unexpected myocardial event and a hypertensive crisis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Transplante de células de medula óssea para o miocárdio em paciente com insuficiência cardíaca secundária á doença de Chagas</s1>
</fA08>
<fA08 dir="en">
<s1>Bone marrow cell transplantation to the myocardium of a patient with heart failure due to Chagas' disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Fábio Vilas-Boas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gilson Soares Feitosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Milena B. P. Soares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Joel Alves Pinho-Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Augusto Mota</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Augusto José Gonçalves Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Cristiane Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Heitor Ghissoni de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Adriano Dourado de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Ricardo Ribeiro dos Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FIOCRUZ/BA Centro de Pesquisas Gonçalo Moniz Hospital Santa Izabel</s1>
<s2>Salvador BA</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>181-184</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Apresentado o primeiro caso de transplante de célula de medula óssea para o miocárdio de um portador de insuficiência cardíaca de etiologia chagásica. Homem, 52 anos, portador de insuficiência cardíaca crônica, em classe funcional III da NYHA, apesar de terapêutica clínica otimizada. Como procedimento, foi aspirado 50 ml de medula óssea através de punção da crista ilíaca, seguidos de filtragem, separação das células mononucleares, ressuspensão e injeção intracoronariana. A fração de ejeção do ventrículo esquerdo em repouso, medida pela ventriculografia radioisotópica com hemácias marcadas, antes do transplante, era de 24% e, após 30 dias, aumentou para 32% sem alterar o esquema medicamentoso. Foram avaliados, antes e 30 dias após o procedimento, respectivamente, o diâmetro diastólico final do ventrículo esquerdo (82 mm; 76 mm); escore de qualidade de vida de Minnesota (55; 06); distância caminhada no teste de 6min (513 m; 683 m). Achados demonstraram ser possível realizar a injeção intracoronariana de célula de medula óssea, sugerindo que este procedimento é potencialmente seguro e efetivo em pacientes com insuficiência cardíaca chagásica.</s0>
</fC01>
<fC01 dir="en">
<s0>We report the first case of bone marrow cell transplantation to the myocardium of a patient with heart failure due to chagas' disease. The patient is a 52-year-old man with chronic heart failure, NYHA functional class III, despite the optimized clinical therapy. The procedure consisted of aspiration of 50 mL of bone marrow through puncture of the iliac crest, followed by filtration, separation of the mononuclear cells, resuspension, and intracoronary injection. The left ventricular ejection fraction at rest, measured using radionuclide ventriculography with labeled red blood cells prior to transplantation, was 24%, and, after 30 days, it increased to 32% with no change in the medicamentous schedule. The following measurements were assessed before and 30 days after transplantation: left ventricular end diastolic diameter (82 mm and 76 mm, respectively); Minnesota living with heart failure questionaire score (55 and 06, respectively); and distance walked in the 6-minute walking test (513 m and 683 m, respectively). Our findings show that intracoronary injection of bone marrow cells may be performed, suggesting that this is a potentially safe and effective procedure in patients with due to Chagas' disease heart failure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>A redução do ventrículo esquerdo não apenas diminui a pós-carga</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo J. F. Tucci</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rosemeire M. Kanashiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP Escola Paulista de Medicina Departamento de Fisiologia</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>209-211</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Anomalia de Ebstein: resultados com a reconstrução cônica da valva tricúspide</s1>
</fA08>
<fA08 dir="en">
<s1>Ebstein's anomaly: results of the conic reconstruction of the tricuspid valve</s1>
</fA08>
<fA11 dir="011000">
<s1>José Pedro da Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Francisco Baumgratz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luciana da Fonseca</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jorge Yussef Afiune</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sônia Meiken Franchi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Lílian Maria Lopes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Daniel Marcelo Silva Magalhães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>José Henrique Andrade Vila</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>212-216</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar os resultados de uma modificação técnica de plastia da valva tricúspide na anomalia de Ebstein. MÉTODOS: De novembro/1993 a agosto/2002, 21 pacientes com anomalia de Ebstein da valva tricúspide, com idades variando de 20 meses a 37 (média: 23) anos, foram submetidos a uma nova técnica de plastia da valva tricúspide, onde o megafolheto anterior tricúspide é desinserido da parede ventricular e do anel valvar, total, ou quase totalmente, transformando-o num cone, cujo vértice permanece fixo na ponta do ventrículo direito e cuja base é suturada ao verdadeiro anel tricúspide, inclusive na região septal, após o ajuste, com uma plicatura do anel, ao tamanho da base do cone. RESULTADOS: Houve um (4,7%), óbito hospitalar, causado por baixo débito cardíaco em portador de miocardiopatia causada pela hipóxia crônica. O tempo médio de seguimento foi de 4 anos e os ecocardiogramas recentes mostraram boa morfologia do ventrículo direito e valva tricúspide com discreta ou mínima insuficiência em 18 pacientes e moderada em 2. Em dois dos três portadores de feixe anômalo foi possível localizá-los e seccioná-los no ato cirúrgico. Não ocorreu bloqueio atrioventricular em nenhum dos pacientes. CONCLUSÃO: A técnica utilizada foi eficiente para a correção da insuficiência tricúspide e a restauração da morfologia do ventrículo direito, e aplicável para todos os tipos anatômicos de Ebstein, exceto o tipo D da classificação de Carpentier.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the results of a technical modification of tricuspid valvuloplasty in Ebstein's anomaly. METHODS: From November 1993 to August 2002, 21 patients with Ebstein's anomaly of the tricuspid valve, with ages ranging from 20 months to 37 years (mean, 23 years), underwent a new technique of tricuspid valvuloplasty. This technique consisted of total or almost total detachment of the anterior tricuspid megaleaflet from the ventricular wall and valvular ring, transforming it into a cone, whose vertex remained fixed in the right ventricular tip, and the base was sutured to the tricuspid ring, after its plication, adjusting it to the size of the base of the cone (tricuspid ring), including the septal region. RESULTS: One (4.7%) patient with cardiomyopathy caused by chronic hypoxia died in the hospital due to low cardiac output. The mean follow-up lasted 4 years, and the recent echocardiograms showed good morphology of the right ventricle and tricuspid valve with mild or minimal insufficiency in 18 patients and moderate insufficiency in 2 patients. In 2 of the 3 patients with an anomalous bundle, it could be located and sectioned during surgery. No atrioventricular block occurred. CONCLUSION: The technique used was efficient in repairing tricuspid insufficiency and restoring right ventricular morphology, being applicable to all anatomic types of Ebstein's anomaly, except for Carpentier classification type D.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença de Ebstein</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência da valva tricúspide</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>plastia valvar tricúspide</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Ebstein's anomaly</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tricuspid insufficiency</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tricuspid valvuloplasty</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Associação entre evolução da função cognitiva e mortalidade após a alta hospitalar em pacientes idosos com insuficiência cardíaca avançada</s1>
</fA08>
<fA08 dir="en">
<s1>Correlation between evolution of the cognitive function and mortality after hospital discharge in elderly patients with advanced heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo E. Ochiai</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luciano L.S. Franco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Otávio C.E. Gebara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Amit Nussbacher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>João B. Serro-Azul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Humberto Pierri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Jairo Rays</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Antonio C.P. Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Mauricio Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>251-254</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a associação entre a evolução do desempenho cognitivo e o prognóstico de idosos após compensação de insuficiência cardíaca avançada. MÉTODOS: Selecionados, consecutivamente, 31 pacientes internados com insuficiência cardíaca classe IV da New York Heart Association, com idade &gt; 64 anos (68 ±7) e fração de ejeção &lt; 0,45 (0,38 ± 0,06). Submetidos a testes cognitivos (digit span, digit symbol, letter cancellation, trail making A e B) e teste de caminhada de 6min, 4 dias antes da alta (T1) e 6 semanas após (T2), cujos desempenhos foram comparados pelo teste T. O valor prognóstico dos escores dos testes cognitivos foram analisados pela regressão logística e o valor de maior acurácia dos testes associado com o prognóstico determinado pela ROC curve. RESULTADOS: Após 24,7 meses, 17 (55%) pacientes faleceram. Os desempenhos ao teste de caminhada e maioria dos testes cognitivos melhoraram entre T1 e T2. O escore do digit span entre os sobreviventes variou de 3,9 para 5,2 (p=0,003), permanecendo inalterado entre os que faleceram (4,1para 3,9; p=0,496). Melhora &lt; 0,75 pontos no escore foi associada à mortalidade (risco relativo de 8,1; p=0,011). CONCLUSÃO: Em idosos, após a compensação de insuficiência cardíaca avançada, a ausência de melhora evolutiva do desempenho cognitivo foi associada a pior prognóstico.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the relation between the evolution of cognitive performance and the prognosis of elderly patients after compensation of advanced heart failure. METHODS: Thirty-one patients older than 64 (68 ± 7) years and admitted with New York Heart Association class IV heart failure and ejection fraction = 0.45 (0.38 ± 0.06) were consecutively selected. They underwent cognitive tests (digit span, digit symbol, letter cancellation, trail making A and B) and the 6-minute walking test 4 days before (T1) and 6 weeks after (T2) hospital discharge, and their performances were compared using the t test. The prognostic value of the scores of the cognitive tests was analyzed with logistic regression, and the value of greatest accuracy of the tests was associated with the prognosis determined by the ROC curve. RESULTS: After 24.7 months, 17 (55%) patients had died. The performances in the 6-minute walking test and most cognitive tests improved between T1 and T2. The digit span score of the survivors ranged from 3.9 to 5.2 (P=0.003) and remained unaltered among those who died (4.1 to 3.9; P=0.496). An improvement &lt; 0.75 points in the score was associated with mortality (relative risk of 8.1; P=0.011). CONCLUSION: In the elderly, after compensation of advanced heart failure, the lack of evolutionary improvement in cognitive performance was associated with a worse prognosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca congestiva prognóstica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>envelhecimento</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure, prognosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aging</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Condições para o sucesso das instituições médicas</s1>
</fA08>
<fA11 dir="011000">
<s1>Protásio Lemos da Luz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>277-280</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Infecção de prótese vascular em cirurgia da aorta torácica: revisão da experiência e relato de caso tratado por técnica não convencional</s1>
</fA08>
<fA08 dir="en">
<s1>Vascular prosthesis infection in thoracic aorta surgery: review of the experience and a case report illustrating treatment with an unconventional technique</s1>
</fA08>
<fA11 dir="011000">
<s1>Ronaldo Ducceschi Fontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Noedir Antônio Groppo Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Júlio Cesar Marino</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>David Pamplona</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luis Francisco Ávila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sérgio Almeida Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>287-290</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200310</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Relatamos o caso de uma paciente de 37 anos de idade, que há cinco anos havia sido submetida à operação de Bental-de Bono em nosso serviço e retornou com dor de forte intensidade no toráx, sendo diagnosticada dissecção aguda de aorta do tipo III e tratada clinicamente. Um ano após esse episódio houve expansão dessa dissecção e a paciente foi submetida à cirurgia com interposição de prótese de dacron em aorta descendente. No pós-operatório imediato houve broncopneumonia esquerda e a paciente recebeu alta em boas condições e afebril. Após um mês da alta, retornou com febre e toxemia. Com diagnóstico de empiema pleural, foi submetida à toracotomia exploradora que não confirmou esse diagnóstico, havendo apenas intenso espessamento pleural. Quatro meses após a toracotomia exploradora, foram isolados Klebsiella pneumoniae e Enterobacter sp na hemocultura. A ressonância magnética revelou imagens compatíveis com infecção peri-prótese. Com esse quadro clínico e laboratorial foi indicada a remoção do enxerto e derivação axilo-bifemoral. A operação foi realizada com sucesso, a paciente recebeu alta em boas condições e continua fazendo controle ambulatorial e, atualmente, encontra-se com 57 meses de evolução sem complicações. São discutidos os métodos empregados para o diagnóstico e tratamento da infecção de prótese na cirurgia da aorta torácica.</s0>
</fC01>
<fC01 dir="en">
<s0>We report the case of a 37-year-old-female patient who had undergone a Bentall procedure at our service and returned with intense chest pain and acute aortic dissection type III, which was diagnosed and clinically treated. One year after this episode, this dissection expanded, and the patient underwent surgery with interposition of a Dacron graft in the descending aorta. In the immediate postoperative period, the patient experienced left bronchopneumonia and was discharged afebrile and in good condition. One month after discharge, she returned with fever and toxemia. Pleural empyema was diagnosed, and she underwent an exploratory thoracotomy that did not confirm this diagnosis, but revealed intense effusion thickening. Four months after the exploratory thoracotomy, Klebsiella pneumoniae and Enterobacter sp were isolated in a blood culture. Magnetic resonance imaging revealed shapes compatible with perigraft infection. With this clinical and laboratory picture, graft removal was indicated as was axillo-bifemoral grafting. Surgery was successfully performed, the patient was discharged in good condition, and remains well after a 57-month follow-up without complications. The methods used for diagnosis and treatment of prosthesis infection in thoracic aorta surgery are discussed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Radioterapia mediastínica e lesão ostial de tronco de coronária esquerda</s1>
</fA08>
<fA11 dir="011000">
<s1>Edgar Guimarães Victor</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Giordano Bruno de Oliveira Parente</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Pernambuco Hospital das Clínicas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>295-297</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200311</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Doença cardíaca isquêmica é uma complicação rara e, só recentemente reconhecida, de irradiação mediastínica para tratamento de tumores nesta região. É relatado caso de uma mulher de 51 anos com angina do peito, rapidamente progressiva, em que o achado angiográfico foi representado por lesão suboclusiva ostial de tronco de coronária esquerda. A história pregressa era marcada por uso de radioterapia para tratamento de linfoma Hodgkin mediastínico, com íntima relação com ventrículo direito, ressecado cirurgicamente e tratado em seqüência com irradiação e quimioterapia, dois anos antes. A indução de estenoses coronarianas nesses pacientes pode ser dependente ou não de aterosclerose focal e é mediada, principalmente, por espessamento intimal decorrente de fibrose tissular, sem que haja alteração na camada média e com predileção pelas porções proximais (ostiais) das artérias principais. O reconhecimento desta condição (radioterapia torácica), como fator isolado e independente para doença coronariana, deve ser considerada na programação de medidas para prevenção, detecção e tratamento precoce.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 3/2004 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>301-301</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200312</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>O ensino de cardiologia na graduação médica: desafios atuais</s1>
</fA08>
<fA11 dir="011000">
<s1>José A. Maia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP Centro de Desenvolvimento do Ensino em Saúde </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>302-306</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200313</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Resultados imediatos e tardios da valvoplastia percutânea com balão na estenose valvar pulmonar</s1>
</fA08>
<fA08 dir="en">
<s1>Short- and long- term results of percutaneous balloon valvuloplasty in pulmonary valve stenosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Domingos M. Hatem</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Iran Castro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Carlos Haertel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Raul I. Rossi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Flávio C. Leboute</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Nara Pomar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Maristela Winckler</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Rogério N. Kersten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Carlos Roberto Cardoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Carlos A.M. Gottschall</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia </s1>
<s2> RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>221-227</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>37</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar os resultados em longo prazo da valvoplastia percutânea por balão em uma instituição isolada. MÉTODOS: Estudados 189 pacientes com estenose valvar pulmonar submetidos a valvoplastia percutânea por balão, entre 1984-1996, com idade média de 7,97±9,25 anos, classificando-se como bem sucedida, a redução do gradiente VD-AP em níveis &lt; 36mmHg e reestenose gradientes &gt; 36mmHg após procedimento eficaz. RESULTADOS: Após o término do procedimento, o gradiente pico a pico transvalvar reduziu-se de 70,12±30,06 para 25,11±20,23 mmHg (p&lt;0,001). Obtiveram sucesso imediato 148 (78,72%) pacientes. Houve redução posterior do gradiente para valores &lt; 36mmHg em outros 24 pacientes categorizados sem sucesso no grupo. Assim a valvoplastia percutânea por balão foi considerada efetiva em 172 (91,01%) pacientes. A efetividade aumentou para 93,53% (159/170) nos casos de morfologia típica. O tempo de seguimento foi de 4,39±3anos até o período máximo de 13,01 anos. Observou-se reestenose em 24 (13,95%). A presença de regurgitação pulmonar foi detectada em 95,1% dos pacientes, sendo que em 29,5% com grau maior do que leve. A probabilidade de se manter um resultado adequado, até qualquer ponto no tempo, sem a ocorrência de reestenose, foi de 92,29% em 2 anos, de 87,38 % em 5 anos, de 82,46% em 8 anos e de 64,48% em 10 anos. CONCLUSÃO: A valvoplastia percutânea por balão foi efetiva e segura no tratamento da estenose valvar pulmonar com excelentes resultados imediatos e a longo prazo.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the long-term results of percutaneous balloon valvuloplasty at a single institution. METHODS: This study comprised 189 patients with pulmonary valve stenosis undergoing percutaneous balloon valvuloplasty from 1984 to 1996, whose mean age was 7.97±9.25 years. The procedure was classified as successful when the RV-PA gradient was reduced to levels &lt; 36 mmHg; restenosis was indicated by RV-PA gradients &gt; 36 mmHg after an effective procedure. RESULTS: After the procedure, the peak-to-peak transvalvular gradient decreased from 70.12±30.06 to 25.11 ±20.23 mmHg (P&lt;0.001). Immediate success was obtained in 148 (78.72%) patients. A later reduction in the gradient to values &lt; 36 mmHg was obtained in 24 other patients previously categorized as unsuccessful. Therefore, percutaneous balloon valvuloplasty was considered effective in 172 (91.01%) patients. Effectiveness increased to 93.53% (159/170) in the cases of typical morphology. Follow-up ranged from 4.39±3 years to 13.01 years. Restenosis was observed in 24 (13.95%) patients. Pulmonary regurgitation was detected in 95.1% of the patients, being more intense than mild in 29.5% of the patients. The probability of maintaining an appropriate result, at any time point, with no restenosis was 92.29% in 2 years, 87.38% in 5 years, 82.46% in 8 years, and 64.48% in 10 years. CONCLUSION: Percutaneous balloon valvuloplasty was effective and safe for the treatment of pulmonary valve stenosis with excellent short- and long-term results.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvoplastia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose da valva pulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>resultados</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>valvuloplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary valve stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>results</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Troca valvar com preservação de cordas e plástica na cirurgia da insuficiência mitral crônica</s1>
</fA08>
<fA08 dir="en">
<s1>Valve replacement with chordal preservation and valvuloplasty for chronic mitral insufficiency</s1>
</fA08>
<fA11 dir="011000">
<s1>José Luiz Dancini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Pablo Maria Alberto Pomerantzeff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Guilherme Sobreira Spina</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Mírian Magalhães Pardi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria Clementina Pinto Giorgi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Roney Orismar Sampaio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>235-242</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar, clinica e laboratorialmente, três grupos de pacientes submetidos ao tratamento cirúrgico da insuficiência mitral crônica isolada; um grupo submetido à plástica valvar e dois à troca da valva mitral com diferentes técnicas de preservação das cordas. MÉTODOS: Operados 28 pacientes com idade média de 54,1 anos, sem doença coronariana, multivalvar ou reoperações: 9 tiveram plástica valvar, 10 troca valvar mitral com preservação das cordas de ambas as cúspides, e 9 apenas da cúspide posterior. Avaliações clínicas, ecodopplercardiográfica e radioisotópica foram realizadas até o 6º mês de seguimento. RESULTADOS: Ao final, 88,8% encontravam-se em classe funcional I. Um faleceu por hemorragia intracraniana durante tratamento anticoagulante. Houve queda no diâmetro diastólico (p&lt;0,0001) e volume diastólico final do ventrículo esquerdo (p&lt;0,0001) nos três grupos. Apenas os pacientes submetidos à plástica tiveram queda no diâmetro sistólico (p=0,0003) e no volume sistólico final (p=0,0040), sem alterações na fração de ejeção (p=0,5586). Os submetidos à troca valvar mitral tiveram queda similar na fração de ejeção (p=0,0001 e p=0,0296). CONCLUSÃO: Houve melhora clínica com as três técnicas empregadas. Os pacientes submetidos à plástica valvar tiveram melhor preservação da função ventricular. Não houve diferença significativa no desempenho cardíaco entre os dois grupos submetidos à troca valvar mitral com preservação das cordas até o 6º mês de seguimento.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare, from the clinical and laboratory points of view, 3 groups of patients undergoing surgical treatment for isolated chronic mitral insufficiency. One group underwent valvuloplasty, and the other 2 groups underwent mitral valve replacement with different techniques for chordal preservation. METHODS: Twenty-eight patients with a mean age of 54.1 years, no coronary or multivalvular disease, and no reoperation, underwent surgery as follows: 9 underwent valvuloplasty; 10 underwent mitral valve replacement with chordal preservation in both leaflets; and 9 underwent mitral valve replacement with chordal preservation only in the posterior leaflet. Clinical, Doppler echocardiographic, and radionuclide ventriculographic assessments were performed until the 6th month of follow-up. RESULTS: At the end, 88.8% of the patients were in functional class I. One died due to intracranial hemorrhage during anticoagulant treatment. The left ventricular diastolic diameter (P&lt;0.0001) and end-diastolic volume (P&lt;0.0001) decreased in the 3 groups. Only the patients undergoing valvuloplasty had a decrease in systolic diameter (P=0.0003) and in end-systolic volume (P=0.0040), with no change in the ejection fraction (P=0.5586). The patients undergoing mitral valve replacement had a similar drop in ejection fraction (P=0.0001 and P=0.0296). CONCLUSION: The 3 surgical techniques used provided clinical improvement. Patients undergoing valvuloplasty had better preservation of ventricular function. No significant difference was observed in cardiac performance between the 2 groups undergoing mitral valve replacement with chordal preservation within a 6-month follow-up.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência da valva mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>implante de prótese de valva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cordas tendinosas</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valve insufficiency</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>valvular prosthesis implantation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>methods</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chordae tendineae</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Drenagem anômala total das veias pulmonares: terapêutica cirúrgica dos tipos anatômicos infracardíaco e misto</s1>
</fA08>
<fA08 dir="en">
<s1>Total anomalous pulmonary venous drainage: surgical therapy for the infradiaphragmatic and mixed anatomical types</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Antibas Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Patricia Egusquiza Irun</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Miguel Barbero-Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>259-263</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar a evolução hospitalar em portadores de drenagem anômala total de veias pulmonares (DATVP), nas formas infracardíaca e mista, submetidos a tratamento cirúrgico. MÉTODOS: De 65 pacientes operados com o diagnóstico isolado de DATVP, de dezembro/1993 a março/2002, foram selecionados, retrospectivamente, 7 (10,8%) pacientes das formas mista e infradiafragmática, sendo 5 (71,4%) do sexo masculino, idades variando de 5 dias a 19 (média de 7) meses, com diagnóstico clínico feito pelo ecocardiograma bidimensional. Quatro (57,1%) pacientes apresentavam formas mistas, em um, obstrutiva intrínseca, com estenose discreta da veia inferior esquerda. Os restantes três (42,9%) apresentavam a forma infradiafragmática obstrutiva, extrínseca ao nível do diafragma. Todas as operações foram realizadas através de esternotomia mediana, sob circulação extracorpórea hipotérmica com parada circulatória total em 2 casos. RESULTADOS: Óbito hospitalar ocorreu em 1 paciente com DATVP infradiafragmática com conexão da veia vertical inferior com a veia porta. A causa mortis foi relacionada à falência de múltiplos órgãos e sistemas. O pós-operatório foi caracterizado pela presença de baixo débito cardíaco e hipertensão pulmonar em 4 (57,1%) pacientes. CONCLUSÃO: O resultado da correção cirúrgica desta anomalia está associado à morbidade e mortalidade aceitáveis, na dependência do encaminhamento e tratamento cirúrgico precoces, sem progressão do quadro de hipertensão vascular pulmonar.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study the in-hospital evolution of patients with the infradiaphragmatic and mixed types of total anomalous pulmonary venous drainage (TAPVD), who underwent surgical therapy. METHODS: Of the 65 patients diagnosed with isolated TAPVD and operated on from December 1993 to March 2002, 7 (10.8%) patients with the mixed and infradiaphragmatic forms were retrospectively selected. Their ages ranged from 5 days to 19 months (mean of 7 months), 5 (71.4%) were males, and their clinical diagnosis was established with 2-dimensional echocardiography. Four (57.1%) patients had the mixed form, which was intrinsic obstructive in 1 patient, with mild stenosis of the left inferior vein. The remaining 3 (42.9%) patients had the obstructive infradiaphragmatic form, extrinsic at the level of the diaphragm. All surgeries were performed through median sternotomy with hypothermic extracorporeal circulation, and total circulatory arrest was required in 2 patients. RESULTS: In-hospital death occurred in 1 patient with infradiaphragmatic TAPVD with connection of the inferior vertical vein with the portal vein. The cause of death was related to multisystem organ failure. In 4 (57.1%) patients, the postoperative period was characterized by the presence of low cardiac output and pulmonary hypertension. CONCLUSION: The result of the surgical correction of this anomaly is associated with acceptable morbidity and mortality, depending on early referral and surgery, without progression of the pulmonary vascular hypertension findings.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>drenagem anômala total de veias pulmonares</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatias congênitas com hiperfluxo pulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>veias pulmonares</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>total anomalous pulmonary venous drainage</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart defect with increased pulmonary blood flow</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary veins</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>O suco de berinjela (Solanum melongena) não modifica os níveis séricos de lípides</s1>
</fA08>
<fA08 dir="en">
<s1>Eggplant (Solanum melongena) extract does not alter serum lipid levels</s1>
</fA08>
<fA11 dir="011000">
<s1>Juliana Marchiori Praça</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Andréa Thomaz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Bruno Caramelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>269-272</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o efeito do suco de berinjela sobre os lípides plasmáticos em comparação à lovastatina. MÉTODOS: Estudados 21 indivíduos de ambos os sexos, com colesterol total (CT) &gt; 200 mg/dl, sem diabetes, ou contra-indicação para o uso de estatinas ou em uso de drogas hipocolesterolêmicas, divididos em 3 grupos: o grupo berinjela (B), um copo de suco de berinjela com laranja pela manhã, em jejum; grupo estatina (E), 20 mg de lovastatina pela manhã; grupo controle (C) nenhum tratamento. Foram feitas três dosagens de CT, frações (HDL, LDL) e triglicérides, com intervalos de três semanas. RESULTADOS: Os três grupos possuíam níveis lipídicos basais semelhantes. Após 6 semanas ocorreu uma diminuição significativa do CT (245,29 ± 41,69 para 205,71 ± 46,45, p=0,02) e do LDL-colesterol (170,83 ± 41,76 para 121,29 ± 44,90, p=0,008) no grupo E. No grupo B, o colesterol total (230,60 ± 19,30 para 240,20 ± 16,22, p=0,27) e o LDL-colesterol (139,60 ± 21,49 para 154,40 ± 9,66, p=0,06) não apresentaram variação significativa, como ocorrido no grupo C. Não houve variação significativa, em nenhum dos três grupos, nos valores de HDL-colesterol e triglicérides ao longo do estudo. CONCLUSÃO: O suco de berinjela com laranja não pode ser considerado uma alternativa às estatinas na redução dos níveis séricos de colesterol.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare the effect of eggplant extract on serum lipid levels with that of lovastatin. METHODS: The study included 21 individuals of both sexes, with total cholesterol (TC) levels &gt; 200 mg/dL, no diabetes, no contraindication for the use of statins, and no use of cholesterol-lowering drugs, divided into the following 3 groups: 1) the eggplant group (B), in which the patients drank 1 glass of eggplant extract with orange juice before breakfast each morning; 2) the statin group (E), in which the patients received 20 mg of lovastatin in the evening after dinner; 3) control group (C), in which the patients received no treatment. Total cholesterol and fractions (HDL, LDL), and triglycerides were measured 3 times at 3-week intervals. RESULTS: The baseline lipid levels were similar in the 3 groups. After 6 weeks, a significant reduction in TC levels (from 245.29 ± 41.69 to 205.71 ± 46.45; P=0.02) and in LDL-cholesterol levels (from 170.83 ± 41.76 to 121.29 ± 44.90; P=0.008) was observed in group E. In group B, total cholesterol (from 230.60 ± 19.30 to 240.20 ± 16.22; P=0.27) and LDL-cholesterol (from 139.60 ± 21.49 to 154.40 ± 9.66; P=0.06) showed no statistically significant variation, as in group C. No significant variation was observed in the HDL-cholesterol and triglyceride levels in the 3 groups throughout the study. CONCLUSION: The eggplant extract with orange juice is not to be considered an alternative to statins in reducing serum levels of cholesterol.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença isquêmica do coração</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dislipidemia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>berinjela</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemic heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dyslipidemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>eggplant</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Mixoma de átrio esquerdo: avaliação ecocardiográfica tridimensional</s1>
</fA08>
<fA08 dir="en">
<s1>Left atrial myxoma: three-dimensional echocardiographic assessment</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo L.C. Vieira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Bárbara M. Ianni</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Charles Mady</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Javier Encinas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Pablo M. A. Pommerantzeff</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paulo P. Fernandes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Samira B. Leal</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Wilson Mathias Jr</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>José L. Andrade</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>José A. F. Ramires</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>281-283</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>8</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Mulher de 70 anos, com antecedentes de diabetes mellitus e hipertensão arterial sistêmica, em acompanhamento ambulatorial por anemia crônica após cirurgia corretiva de angiodisplasia de jejuno proximal, apresentou imagem de mixoma em átrio esquerdo em exame ecocardiográfico transtorácico de rotina. Foi submetida a investigação ecocardiográfica transesofágica multiplanar e a estudo ecocardiográfico tridimensional. O ecocardiograma tridimensional propiciou melhor detalhamento anatômico da tumoração. A paciente foi submetida a exérese da massa, com confirmação anatomopatológica. O ecocardiograma tridimensional mostrou ser técnica que apresenta contribuição adicional à investigação diagnóstica das cardiopatias estruturais.</s0>
</fC01>
<fC01 dir="en">
<s0>The patient was a 70-year-old female with antecedents of diabetes mellitus and hypertension, being followed up in the outpatient care clinic due to chronic anemia after corrective surgery for angiodysplasia of the proximal jejunum, in whom an image suggestive of left atrial myxoma was found on routine transthoracic echocardiography. Then multiplanar transesophageal echocardiography and 3-dimensional echocardiography were performed, showing the latter better anatomical details of the tumor. The patient underwent exeresis of the mass with anatomicopathological confirmation of the tumor. Three-dimensional echocardiography proved to be a technique that can provide additional contributions to the diagnostic investigation of structural heart diseases.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Normatização para a concessão e revalidação do título de especialista em cardiologia e de área de atuação dentro da especialidade</s1>
</fA08>
<fA11 dir="011000">
<s1>Miguel Antonio Moretti</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Benedito Carlos Maciel</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcos Vinicius Bolivar Malachias</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Roberto Pozzan</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Dalton Bertolim Precoma</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antônio Silveira Sbissa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Sergio Zimmermann</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Walter Geraldo da Silveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Gil Eduardo Perini</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Frederico Augusto  Lima e Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>João David de Sousa Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Brivaldo Markmann Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Sadi de Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Aristoteles Conte de Alencar Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-10</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200002</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Carta do Editor</s1>
</fA08>
<fA11 dir="011000">
<s1>Miguel Antonio Moretti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>SBC  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>3-3</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>IV Diretrizes Brasileiras de Hipertensão Arterial</s1>
</fA08>
<fA08 dir="en">
<s1>IV Brazilian Guidelines on Arterial Hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>Decio Mion Jr.</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Alberto Machado</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marco Antonio Mota Gomes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fernando Nobre</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Osvaldo Kohlmann Jr.</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Celso Amodeo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Nery Praxedes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Istenio Pascoal</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Lucélia C. Magalhães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-1</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Apresentação</s1>
</fA08>
<fA08 dir="en">
<s1>Presentation</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>4-4</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200002</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>IV Diretrizes Brasileiras de Hipertensão Arterial Grupos de trabalho</s1>
</fA08>
<fA08 dir="en">
<s1>IV Brazilian Guidelines on Arterial Hypertension Work groups</s1>
</fA08>
<fA11 dir="011000">
<s1>Marco Antonio Mota Gomes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Angela Maria Geraldo Pierin</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Silveira Sbissa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Armando da Rocha Nogueira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ayrton Pires Brandão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cibeli I. Saad Rodrigues</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Edgar Pessoa de Mello</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>José Xavier de Mello Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Luiz Carlos Bodanese</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Paulo Toscano</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Sebastião Ferreira Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Fernando Nobre</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Agostinho Tavares</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Antonio Carlos Lopes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Jorge Pinto Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>José Carlos Aydar Ayoub</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>José Márcio Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>Luiz Introcaso</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>Marcelo Corrêa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="201000">
<s1>Mario Maranhão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="211000">
<s1>Pedro Jabur</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="221000">
<s1>Raimundo Marques Nascimento</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="231000">
<s1>Roberto de Sá Cunha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="241000">
<s1>Rogério Andrade Mulinari</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="251000">
<s1>Carlos Alberto Machado</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="261000">
<s1>Adriana Avila</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="271000">
<s1>Clóvis Oliveira Andrade</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="281000">
<s1>João Carlos Rocha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="291000">
<s1>Margarida Maria Veríssimo Lopes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="301000">
<s1>Maria Cecília G. Marinho Arruda</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="311000">
<s1>Maria Fátima Azevedo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="321000">
<s1>Maria Helena C. Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="331000">
<s1>Marilda Novaes Lipp</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="341000">
<s1>Nárcia Elisa B. Kohlmann</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="351000">
<s1>Neide de Jesus</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="361000">
<s1>Paulo César da Veiga Jardim</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="371000">
<s1>Celso Amodeo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="381000">
<s1>Carlos Eduardo Negrão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="391000">
<s1>Celso Ferreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="401000">
<s1>Cláudio Pereira da Cunha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="411000">
<s1>Eli Toscano</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="421000">
<s1>Eliuden Galvão de Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="431000">
<s1>Estelamaris Tronco Monego</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="441000">
<s1>Fátima Lúcia Machado Braga</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="451000">
<s1>Hilton de Castro Chaves Jr.</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="461000">
<s1>Joel Heiman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="471000">
<s1>Tales de Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="481000">
<s1>Osvaldo Kohlmann Jr.</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="491000">
<s1>Alvaro Avezum</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="501000">
<s1>Artur Beltrame Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="511000">
<s1>Carlos Alberto Gomes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="521000">
<s1>Dante Marcelo Artigas Giorgi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="531000">
<s1>Gilson Feitosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="541000">
<s1>Harue Ohashi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="551000">
<s1>José Antonio Franchini Ramirez</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="561000">
<s1>Marcelo Marcondes Machado</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="571000">
<s1>Natalino Salgado Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="581000">
<s1>Rafael Leite Luna</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="591000">
<s1>Roberto Jorge da Silva Franco</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="601000">
<s1>Robson Augusto dos Santos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="611000">
<s1>Wille Oigman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="621000">
<s1>Istênio Fernandes Pascoal</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="631000">
<s1>Airton Massaro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="641000">
<s1>Álvaro Nagib Atallah</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="651000">
<s1>Andréa Brandão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="661000">
<s1>Elizabete Viana de Freitas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="671000">
<s1>Ivan Cordovil</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="681000">
<s1>José Egídio Paulo de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="691000">
<s1>José Geraldo L. Ramos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="701000">
<s1>Maria Teresa Zanella</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="711000">
<s1>Maurício Wajngarten</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="721000">
<s1>Roberto Dischinger Miranda</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="731000">
<s1>Soubihe Kahhale</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="741000">
<s1>Vera Koch</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="751000">
<s1>Décio Mion Jr.</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="761000">
<s1>Armênio C. Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="771000">
<s1>Catia Sueli Palmeira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="781000">
<s1>Claudia Lucia de Moraes Forjaz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="791000">
<s1>Eduardo B. Coelho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="801000">
<s1>Fernando Antonio Almeida</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="811000">
<s1>Isabel Cristina Estefano Pellizari</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="821000">
<s1>Marcos Ausenka Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="831000">
<s1>Michel Batlouni</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="841000">
<s1>Paulo Lotufo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="851000">
<s1>Regina Teresa Capelari</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="861000">
<s1>Lucélia C. Magalhães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="871000">
<s1>Abrahão Afiune Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="881000">
<s1>Abrão Cury</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="891000">
<s1>Alci Moreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="901000">
<s1>Ana Luisa de Souza</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="911000">
<s1>Flavio Danni Fuchs</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="921000">
<s1>Ines Lessa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="931000">
<s1>Marcus V. Bolívar Malachias</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="941000">
<s1>Romero Bezerra</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="951000">
<s1>Sandra Fuchs</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="961000">
<s1>José Nery Praxedes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="971000">
<s1>Antonio Cambara</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="981000">
<s1>Antonio Marmo Lucon</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="991000">
<s1>Berenice Mendonça</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="001000">
<s1>Flavio Borelli</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="011000">
<s1>Helio B. Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>João Egidio Romão Jr.</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Gastão Rocha Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Luiz Santello</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz Bortolotto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luis Celso Matavelli</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Maria Eliete Pinheiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Valéria Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>5-5</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200003</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>IV Diretrizes Brasileiras de Hipertensão Arterial</s1>
</fA08>
<fA08 dir="en">
<s1>IV Brazilian Guidelines on Hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>Décio Mion Jr.</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marco Antônio Mota Gomes</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando Nobre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Celso Amodeo</s1>
<afiliation>A03</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Osvaldo Kohlmann Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Nery Praxedes</s1>
<afiliation>A03</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Carlos Alberto Machado</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Carlos Alberto Machado</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Istênio Pascoal</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Lucélia C. Magalhães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Sociedade Brasileira de Hipertensão  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Sociedade Brasileira de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Sociedade Brasileira de Nefrologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>7-14</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200004</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretrizes da cirúrgia de revascularização miocárdica valvopatias e doenças da aorta</s1>
</fA08>
<fA11 dir="011000">
<s1>Ricardo de Carvalho Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luis Fernando Kubrusly</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Carlos de Sales Nery</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Bruno Botelho Pinheiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alexandre Visconti Brick</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Domingos Sávio Ramos de Souza</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Domingos Marcolino Braile</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Enio Buffolo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Fernando Antonio Lucchese</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Frederico Pires de Vasconcelos Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>João Nelson Branco</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>José Glauco Lobo Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>José Teles de Mendonça</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>José Wanderley Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Jorge Augusto Nunes Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>Marcius Vinícius M. Maranhão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>Maria do Socorro Duarte Leite</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>Mario Gesteira Costa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>Maurílio Onofre Deininger</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="201000">
<s1>Mauro Barbosa Arruda</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="211000">
<s1>Mauro Arruda Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="221000">
<s1>Mozart Augusto Soares de Escobar</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="231000">
<s1>Nilson Augusto Mendes Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="241000">
<s1>Paulo Slud Brofman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="251000">
<s1>Pedro Rafael Salerno</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="261000">
<s1>Sérgio Tavares Montenegro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="271000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-20</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretrizes de cirurgia nas valvopatias</s1>
</fA08>
<fA11 dir="011000">
<s1>Pablo Maria Pomerantzeff</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gilberto Venossi Barbosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Basílio Serrano de Sousa Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Manuel de Almeida Brandão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Edison José Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Francisco Diniz Affonso Costa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Francisco Gregori Junior</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Jayro Thadeu Paiva de Vasconcelos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>José Carlos Haertel</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Luiz Carlos Schimin</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Luiz Daniel da Fraga Torres</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Marcelo Gentil Almeida Guedes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Marcos Ramos Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Max Grinberg</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Raul Correa Rabelo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>Renato Abdala Karam Kalil</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>Ricardo Eloy Pereira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>Waldemiro Carvalho Junior</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>22-33</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200002</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretrizes para a cirurgia das doenças da aorta</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciano Cabral Albuquerque</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Honório Palma</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Domingo Braile</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Walter Gomes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>35-50</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200003</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Aplicando protocolos na doença cardiovascular</s1>
</fA08>
<fA11 dir="011000">
<s1>Carisi Anne Polanczyk</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Faculdade de Medicina Hospital de Clínicas de Porto Alegre</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>307-307</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Entendo &amp; aceito &amp; faço: estratégia pró-adesão à anticoagulação oral</s1>
</fA08>
<fA11 dir="011000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>309-312</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Rastreamento populacional de anormalidades cardíacas fetais por ecocardiografia pré-natal em gestações de baixo risco no município de Porto Alegre</s1>
</fA08>
<fA11 dir="011000">
<s1>Lauro L. Hagemann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>313-319</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>55</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar as anormalidades morfo-funcionais do sistema cardiovascular fetal detectáveis por ultra-sonografia. MÉTODOS: Foram submetidos 3.980 fetos de gestantes sem risco obstétrico ou cardiológico, do município de Porto Alegre, de julho/1996 a novembro/2000, ao ecocardiograma de rastreamento para malformações cardiovasculares através dos cortes de quatro câmaras e vias de saída dos ventrículos direito e esquerdo. RESULTADOS: Houve 103 diagnósticos de anormalidades cardiovasculares fetais, correspondendo a 2,5% (103/3.980) da população estudada, ou 25,8/1000, sendo que 47 referiam-se a alterações morfo-funcionais do coração fetal, prevalência global de 11,8/1000 (47/3.980), e 56 exibiam alterações na refringência (golf ball). Três falso-negativos e nenhum falso-positivo elevaram a prevalência global para 12.5/1000 (50/3.980), ou 26,6/1000 (106/3.980), quando incluídas também as alterações de refringência. CONCLUSÃO: A detecção das malformações cardiovasculares ainda no período intra-uterino, visando planejamento perinatal é possível, confirmando a experiência internacional. É sugerida implantação do rastreamento de malformações cardiovasculares, aninhada em rede de atenção rotineira de ultra-sonografia obstétrica.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>anormalidades cardíacas fetais</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia pré-natal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>gestações</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mortalidade neonatal</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Isolamento das veias pulmonares em pacientes com fibrilação atrial permanente secundária a valvopatia mitral</s1>
</fA08>
<fA08 dir="en">
<s1>Isolation of the pulmonary veins in patients with permanent atrial fibrillation secondary to mitral valve disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Gustavo G. Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Renato A.K. Kalil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Tiago L.L. Leiria</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Gustavo F. Vanni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marcelo H. Miglioransa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Daniel L. Faria-Corrêa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Domingos Hatem</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Rogério Abrahão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>João R. Sant'Anna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Paulo Prates</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Ivo A. Nesralla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>337-341</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar a eficácia do isolamento cirúrgico das veias pulmonares para restabelecer ritmo sinusal em pacientes com fibrilação atrial secundária à doença mitral. MÉTODOS: 33 pacientes com indicação de correção cirúrgica da valva mitral e com fibrilação atrial permanente, foram submetidos ao isolamento cirúrgico das veias pulmonares, sendo 67% mulheres. Média de idade de 56,3±10 anos, classe funcional NYHA pré-operatória de 3,2±0,6, tamanho de átrio esquerdo de 5,5± 0,9 cm, fração de ejeção de 61,3±13%. A técnica cirúrgica consistiu de incisão circunferencial ao redor das 4 veias pulmonares, excisão do apêndice atrial esquerdo e de incisão perpendicular desde a borda inferior da incisão, isolando as veias pulmonares, até o ânulo da valva mitral. Arritmias precoces foram tratadas, agressivamente, com cardioversão. RESULTADOS: O seguimento médio foi de 23,9±17 meses e ocorreram 3 óbitos no pós-operatório. Dez pacientes necessitaram de cardioversão elétrica no pós-operatório; 87% apresentavam ritmo sinusal na última consulta e 33% estavam em uso de amiodarona. CONCLUSÃO: Isolamento das veias pulmonares associado à cirurgia da valva mitral é uma técnica efetiva e segura na manutenção de ritmo sinusal em pacientes com fribilação atrial permanente.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the efficacy of surgical isolation of the pulmonary veins for re-establishing sinus rhythm in patients with atrial fibrillation secondary to mitral valve disease. METHODS: Thirty-three (67% were women) patients with permanent atrial fibrillation and indication for surgical correction of the mitral valve underwent surgical isolation of the pulmonary veins. Their mean age was 56.3±10 years, preoperative NYHA functional class was 3.2±0.6, left atrial size was 5.5±0.9 cm, and ejection fraction was 61.3±13%. The surgical technique consisted of a circumferential incision surrounding the 4 pulmonary veins, excision of the left atrial appendage, and a perpendicular incision originating in the inferior margin of the circumferential incision isolating the pulmonary veins down to the mitral valve. Early arrhythmias were aggressively treated with cardioversion. RESULTS: The mean follow-up was 23.9±17 months, and 3 patients died in the postoperative period. Ten patients required electrical cardioversion in the postoperative period; 87% had sinus rhythm in the last medical visit, and 33% were using amiodarone. CONCLUSION: Isolation of the pulmonary veins associated with mitral valve surgery is an effective and safe technique for maintaining sinus rhythm in patients with permanent atrial fibrillation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>arritmia cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia do labirinto</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fibrilação atrial</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac arrhythmia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>maze procedure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Trombose de prótese biológica mitral: importância do ecocardiograma transesofágico no diagnóstico e acompanhamento pós-tratamento</s1>
</fA08>
<fA08 dir="en">
<s1>Bioprosthetic mitral valve thrombosis: importance of transesophageal echocardiography in the diagnosis and follow-up after treatment</s1>
</fA08>
<fA11 dir="011000">
<s1>Adelino Parro Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marta Lancia Carramona</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Caio Augusto Ferreira Amaral</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Luiz Balthazar Jacob</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Carlos Nicolau</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Moléstias Cardiovasculares  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>346-352</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>50</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Descrever os achados clínicos e ecocardiográficos de trombose em prótese biológica mitral e o valor do ecocardiograma transesofágico (ETE) no diagnóstico e monitoração da lise do trombo. MÉTODOS: Foram estudados ao ETE 111 pacientes com prótese biológica mitral, e incluídos 4 de 7 com suspeita de trombo nestas próteses (idade média = 60,2±10,2 anos; 2 homens). O diagnóstico pôde ser confirmado pela realização seriada do ETE e pela evolução clínica. Investigaram-se os aspectos morfológicos dos folhetos da prótese, e presença e característica das massas ecogênicas anexas. Foram obtidos o gradiente médio pela prótese e a área valvar. RESULTADOS: O diagnóstico de trombo em prótese biológica mitral foi realizado 48,7±55,2 meses após a cirurgia. Dois pacientes apresentaram acidente vascular encefálico isquêmico no pós-operatório imediato. O gradiente médio global estava elevado (11,4±3 mmHg) e a área valvar reduzida (1,24±0,3cm²). Ao ETE, em todos foram evidenciadas massas ecogênicas em face ventricular esquerda da prótese biológica mitral, sugestivas de trombo. No ETE seriado (136±233 dias), houve desaparecimento do trombo em dois casos e redução do trombo nos outros dois, após tratamento. O gradiente médio reduziu para 6,2±3 mmHg (p=0,004; IC 95%), e a área valvar aumentou para 2,07±0,4 (p=ns). CONCLUSÃO: O ETE mostrou-se útil na detecção de trombo em prótese biológica mitral e eficaz na monitoração do tratamento, em todos casos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To report the clinical and echocardiographic findings of bioprosthetic mitral valve thrombosis and the value of transesophageal echocardiography (TEE) in its diagnosis and monitoring of thrombolysis. METHODS: One hundred and eleven patients with mitral bioprostheses underwent TEE, and 4 out of 7 suspected of having a thrombus on these prostheses were included in the study (mean age = 60.2±10.2 years; 2 men). The diagnosis was confirmed with serial TEE and clinical evolution. The morphologic features of the prosthetic leaflets, as well as the presence and characteristics of attached echogenic masses were investigated. The mean gradient through the prosthesis and the valvular area were obtained. RESULTS: The diagnosis of bioprosthetic mitral valve thrombosis was established 48.7±55.2 months after surgery. Two patients had ischemic stroke in the early postoperative period. The mean overall gradient was high (11.4±3 mmHg) and the valvular area reduced (1.24±0.3 cm²). On TEE, echogenic masses on the left ventricular face of the mitral bioprosthesis suggestive of thrombus were evidenced in all patients. On serial TEE (136±233 days), in 2 patients the thrombus had disappeared and in 2 others it was smaller after treatment, the mean gradient dropped to 6.2±3 mmHg (P = 0.004; 95% CI), and the valvular area increased to 2.07±0.4 (P = NS). CONCLUSION: TEE proved to be useful for detecting bioprosthetic mitral valve thrombosis and was effective in monitoring the treatment in all patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>trombose</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>bioprótese</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma transesofágico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thrombosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>bioprosthesis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>transesophageal echocardiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Pericardite: série de 84 casos consecutivos</s1>
</fA08>
<fA08 dir="en">
<s1>Pericarditis: series of 84 consecutive cases</s1>
</fA08>
<fA11 dir="011000">
<s1>Marco Tulio Zanettini</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João Otavio Zanettini</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Jacira Pisani Zanettini</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Eletrocor Laboratório Cárdio Diagnóstico  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade de Caxias do Sul  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>360-364</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Identificar características clínicas, laboratoriais e ecocardiográficas diferenciais em indivíduos com diagnóstico de pericardite secundária e idiopática. MÉTODOS: De janeiro/1999 a dezembro/2001, foram identificados 84 pacientes com diagnóstico clínico e ecocardiográfico de pericardite em clínica de cardiologia. Foram estudados, retrospectivamente, quanto à idade, sexo, características antropométricas, hábitos, pressão arterial casual, causas potenciais, comorbidades, sinais e sintomas, medicação e complicações. Os indivíduos foram divididos em 2 grupos: grupo A constituído de 61 pacientes com causas potenciais conhecidas e grupo B com 23 casos considerados idiopáticos. Os grupos foram comparados, utilizando-se o teste do Qui-quadrado, considerando-se estatisticamente significativas as associações com p &lt; 0,05. RESULTADOS: Os dois grupos foram semelhantes quanto à idade, sexo, medidas antropométricas, hábitos e pressão arterial casual. No grupo B, 23 (100%) casos foram diagnosticados entre os meses de abril e agosto contra 24 (39,4%) no mesmo período no grupo A (p&lt;0,01). No grupo B, 23 (100%) pacientes receberam vacina antiinfluenza previamente contra nenhum no grupo A. Dispnéia (p=0,02) e edema (p=0,01) foram mais freqüentes no grupo A, enquanto fadiga foi mais referida no grupo B (p=0,01). No manejo terapêutico, administrou-se antiinflamatórios não esteróides (AINE) em 5 (8,2%) pacientes do grupo A e em 19 (82,6%) do grupo B (p=0.01). CONCLUSÃO: Os pacientes com pericardite idiopática receberam aplicação prévia de vacina antiinfluenza, apresentaram-se com distribuição sazonal, tiveram menor prevalência de comorbidades, sintomatologia menos exuberante e foram tratados principalmente com AINE.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To identify differential clinical, laboratory, and echocardiographic characteristics in persons with diagnosed idiopathic and secondary pericarditis. METHODS: From January 1999 to December 2001, 84 patients with clinically and echocardiographically diagnosed pericarditis were identified in a heart clinic. These patients were analyzed according to age, sex, anthropometric measurements, body habitus, casual blood pressure (BP), signs and symptoms, morbid history, medicines and complications. The individuals were divided into 2 groups: group A comprised 61 patients with known causes of pericarditis and group B comprised 23 patients with idiopathic causes. The groups were compared with chi-square test. P&lt;0.05 was considered statistically significant. RESULTS: The population of these 2 groups was similar in age, sex, anthropometric measures, body habitus, and casual BP. In group B (idiopathic), 23 (100%) cases were diagnosed between April and August versus 24 (39.4%) in the same period for group A (P&lt;0.01). Twenty-three (100%) group B patients received anti-influenza vaccine versus none in group A. Breathlessness (P=0.02) and swelling (P=0.01) were more frequent in group A, but fatigue was more common in group B (P=0.01). For treatment, non-steroidal anti-inflammatory drugs (NSAID) were prescribed to 5 (8.2%) patients in group A and 19 (82.6%) in group B (P=0.01). CONCLUSION: In this series, patients labeled as having idiopathic pericarditis who had previously taken the influenza vaccine had seasonal distribution, a lower prevalence of previous disease, less exuberant signs and symptoms, and clinical regression with NSAID use.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>pericardite</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>pericardite idiopática</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>vacina antiinfluenza</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pericarditis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>idiopathic pericarditis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>influenza</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>anti-influenza vaccine</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Redução da mortalidade após implementação de condutas consensuais em pacientes com infarto agudo do miocárdio</s1>
</fA08>
<fA08 dir="en">
<s1>Mortality decline after implementation of standard protocols for treating patients with acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Juliana G. Bordon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sérgio A. R. Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz S. Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Roberto M. T. Inoue</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mirna Matsui</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Ana Lúcia Gut</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ana Lúcia A. Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Leonardo A. M. Zornoff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNESP Faculdade de Medicina de Botucatu </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>370-373</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar a mortalidade em 30 dias com a utilização de determinados grupos de medicamentos por pacientes, entre 1992-1997, quando não se dispunham de condutas consensuais para tratamento do infarto agudo do miocárdio, e de 2000-2002, após a padronização dessas condutas em nosso serviço. MÉTODOS: Avaliados, retrospectivamente, no 1º e 2º períodos, 172 e 143 pacientes respectivamente, admitidos com diagnóstico de infarto agudo do miocárdio: foram realizados os testes estatísticos: c² para comparar proporções, teste t de Student e o de Mann-Whitney para comparação de médias ou medianas. RESULTADOS: A análise não mostrou diferença em relação aos homens, brancos e a idade média de 61 anos, nos dois períodos. Com relação aos fatores de risco clássicos, foi observada diferença apenas na incidência de dislipidemia (17 e 29%) e, quanto à estratégia terapêutica, aumento significativo do uso de: trombolíticos (39 e 61,5%), ácido acetilsalicílico (70,9 e 96,5%), betabloqueadores (34,8 e 67,8%), inibidor da enzima conversora da angiotensina (45,9 e 74,8%), nitratos (61 e 85,3%) e a redução significativa de bloqueadores de cálcio (16,8 e 5,3%), antiarrítmicos (29,1 e 9,7%) e diuréticos (50,6 e 26,6%). O uso de inotrópicos não diferiu entre os períodos (29,6 e 32,1%). A mortalidade em 30 dias apresentou redução estatisticamente significante de 22,7 para 10,5%. CONCLUSÃO: A implementação das condutas consensuais para o tratamento do infarto agudo do miocárdio foi acompanhada por significante redução da taxa de mortalidade em 30 dias.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare 30-day mortality in patients receiving different types of medication from 1992 to 1997, when no consensual treatment for acute myocardial infarction was available, versus 30-day mortality in patients being treated between 2000 and 2002 after standardization of that treatment was obtained in our service. METHODS: In the first and second study periods, 172 and 143 patients, respectively, admitted with the diagnosis of acute myocardial infarction were retrospectively assessed. Their diagnoses were confirmed, and the following statistical tests were performed: the chi-square test for comparing proportions and the Student t test and the Mann-Whitney test for comparing the means or medians. RESULTS: The analysis showed no difference in regard to white men with a mean age of 61 years in the 2 study periods. In regard to the traditional risk factors, a difference was observed only in the incidence of dyslipidemia (17 and 29%). In regard to the therapeutic strategy adopted, the following was observed: 1) a significant increase in the use of thrombolytic agents (39 and 61.5%), acetylsalicylic acid (70.9 and 96.5%), beta-blockers (34.8 and 67.8%), angiotensin-converting enzyme inhibitors (45.9 and 74.8%), and nitrates (61 and 85.3%); and 2) a significant reduction in the use of calcium channel blockers (16.8 and 5.3%), antiarrhythmics (29.1 and 9.7%), and diuretics (50.6 and 26.6%). The use of inotropic agents did not differ between the study periods (29.6 and 32.1%). The 30-day mortality showed a statistically significant reduction from 22.7 to 10.5%. CONCLUSION: The implementation of standard protocols for the treatment of acute myocardial infarction was accompanied by a significant reduction in the 30-day mortality rate.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mortalidade</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tratamento</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treatment</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Endocardite de Libmann-Sacks e anticoagulação oral</s1>
</fA08>
<fA08 dir="en">
<s1>Libman-Sacks endocarditis and oral anticoagulation</s1>
</fA08>
<fA11 dir="011000">
<s1>Fabiano Almeida Brito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Magali LMC Tófani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fábio Ávila Tófani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Adriana Maria Kakehasi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Cristina Costa Duarte Lanna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marco Antonio Parreiras Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFMG Hospital das Clínicas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>378-380</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Paciente de 34 anos, com lúpus eritematoso sistêmico e síndrome de anticorpo antifosfolípide secundária, evoluiu com crises convulsivas, parcialmente controladas com anticonvulsivante, e ausculta de sopro cardíaco, cuja propedêutica mostrou a presença de vegetação em valva mitral. Diante do diagnóstico de endocardite de Libman-Sacks foi iniciada terapia com warfarina sódica, e após seis meses de anticoagulação oral, a paciente apresentava controle total das crises convulsivas e desaparecimento da vegetação valvar ao ecocardiograma. São discutidas a ocorrência da endocardite de Libman-Sacks no lúpus eritematoso sistêmico, sua associação com a síndrome de anticorpo antifosfolípide e a terapêutica anticoagulante, e feita uma revisão da literatura.</s0>
</fC01>
<fC01 dir="en">
<s0>The patient is a 34-year-old female with systemic lupus erythematosus and secondary antiphospholipid antibody syndrome, who evolved with convulsive crises, partially controlled with an anticonvulsant, and auscultation of a cardiac murmur, whose investigation showed the presence of a mitral valve vegetation. Once the diagnosis of Libman-Sacks endocarditis was established, therapy with warfarin sodium was initiated, and, after 6 months of oral anticoagulation, the patient had total control of the convulsive crises and the valvular vegetation disappeared on echocardiography. This study discusses the occurrence of Libman-Sacks endocarditis in systemic lupus erythematosus, its association with antiphospholipid antibody syndrome, and the anticoagulant therapy. A literature review is also provided.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Quilopericárdio isolado após cirurgia cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Isolated chylopericardium after cardiac surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Ranieli Pitol</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Renato Pederiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando Pasin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Domingos Vitola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia RS </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>384-386</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Quilopericárdio como complicação de cirurgia cardíaca é raro. Pode ser causado por lesão no ducto torácico, de tributárias do ducto ou pela trombose da confluência das veias jugular e subclávia esquerda, obstruindo a drenagem do ducto torácico. O tratamento pode ser conservador ou cirúrgico, dependendo da duração e do volume drenado. Apresentamos o caso de uma mulher de 24 anos que no pós-operatório tardio de troca da valva mitral (bioprótese) foi internada com quadro de tamponamento cardíaco devido à presença de quilopericárdio. São comentados os aspectos clínicos e o tratamento instituído.</s0>
</fC01>
<fC01 dir="en">
<s0>Chylopericardium is a rare complication of cardiac surgery. It may be caused by a lesion in the thoracic duct or its tributaries or by thrombosis in the confluence of the jugular and left subclavian veins, obstructing the drainage of the thoracic duct. The treatment may be conservative or surgical, depending on the duration and on the volume of the effusion. We report the case of a 24-year-old female, who, in the late postoperative period of mitral valve replacement (bioprosthesis), was hospitalized with cardiac tamponade due to the presence of chylopericardium. The clinical findings and treatment performed are discussed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Anomalia de Ebstein detectada in utero e síndrome de Down: diagnóstico pré-natal de uma combinação rara</s1>
</fA08>
<fA08 dir="en">
<s1>Intrauterine detection of Ebstein's anomaly and Down's syndrome: prenatal diagnosis of a rare combination</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria de Fátima M.P. Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto B. Gianisella</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul Unidade de Cardiologia Fetal</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>390-392</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>A anomalia de Ebstein é uma doença rara, embora seja a malformação mais comum da valva tricúspide. A associação com outras síndromes e anomalias extracardíacas é muito incomum e matéria de poucos relatos de caso. Apresenta-se um caso de diagnóstico pré-natal de anomalia de Ebstein em um paciente com síndrome de Down.</s0>
</fC01>
<fC01 dir="en">
<s0>Ebstein's anomaly, although the most common malformation of the tricuspid valve, is a rare disease. Its association with other syndromes and extracardiac anomalies is very rare and has been reported in only a few cases. A case of prenatal diagnosis of Ebstein's anomaly in a patient with Down's syndrome is reported.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiomiopatia hipertrófica em gêmeos monozigóticos</s1>
</fA08>
<fA08 dir="en">
<s1>Hypertrophic cardiomyopathy in monozygotic twins</s1>
</fA08>
<fA11 dir="011000">
<s1>Aloir Q. Araujo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto do Coração do Hospital das Clínicas  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>396-397</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200412</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 2/2004 - Dor torácica seguida de parada cardíaca com atividade cardíaca sem pulso, em homem de 34 anos portador de hipertensão pulmonar secundária à persistência do canal arterial</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciano Ferreira Drager</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Alberto Benvenuti</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>400-400</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200413</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 4/2004 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>406-406</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200414</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Errata</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>0-0</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200415</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>A ecocardiografia com contraste no diagnóstico de dilatações vasculares intrapulmonares em candidatos ao transplante hepático</s1>
</fA08>
<fA08 dir="en">
<s1>Contrast echocardiography in the diagnosis of intrapulmonary vascular dilations in patients eligible for liver transplantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Roberto Pavarino</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Hélio Augusto do Reis Corbucci</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Henrique de Marchi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paula Fernanda da   Mata</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Moacir Fernandes de Godoy</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital de Base  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Faculdade de Medicina de São José do Rio Preto  </s1>
<s2> SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>327-331</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a importância da ecocardiografia com contraste no diagnóstico de dilatações vasculares intrapulmonares (DVP) em portadores de doenças hepáticas crônicas, candidatos ao transplante. MÉTODOS: O ecocardiograma transtorácico (ETT) com imagem em segunda harmônica foi realizado em 76 pacientes, dos quais, 32 foram submetidos consecutivamente ao estudo transesofágico (ETE). O contraste ecocardiográfco foi obtido por microbolhas geradas pela injeção de solução salina agitada, em acesso venoso periférico. Considerou-se como positivo quando detectada a presença anormal de contraste em câmaras cardíacas esquerdas, com um atraso de 4 a 6 ciclos cardíacos, após opacificação inicial das câmaras direitas. RESULTADOS: O diagnóstico de DVP foi realizado em 53,9% dos pacientes (41/76). A sensibilidade, especificidade, valor preditivo positivo, valor preditivo negativo e acurácia do ETT em relação ao ETE foi respectivamente de 75%, 100%, 100%, 80% e 87,5%. O ecocardiograma foi positivo em 37 (55,2%) dos 67 pacientes não hipoxêmicos e em 4 (44,4%) dos 9 hipoxêmicos. Não foi observada qualquer repercussão hemodinâmica cardiológica decorrente do shunt intrapulmonar. CONCLUSÃO: A ecocardiografia com contraste mostrou-se eficaz, de utilização fácil e segura para o rastreamento e identificação de alterações vasculares intrapulmonares em candidatos ao transplante hepático.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the importance of contrast echocardiography in the diagnosis of intrapulmonary vascular dilations (PVD) in patients with severe hepatic diseases, eligible for transplantation. METHODS: Transthoracic ecocardiography (TTE) with second harmonic imaging was performed in 76 patients, among them 32 patients were consecutively undergone to a transesophageal study (ETE). Echocardiographic contrast was obtained from microbubbles derived from the injection of agitated saline solution, in venous peripheral access. Abnormal presence of contrast in the left cardiac chambers was considered positive, with a delay of 4 to 6 cardiac cycles , after initial opacicification of the right cardiac chambers. RESULTS: PVD diagnosis was performed in 53.9% of the patients (41/76). Sensibility, specificity, positive predictive value, negative predictive value, and accuracy of the TTE in relation to the ETE was 75%, 100%, 100%, 80% e 87.5%, respectively. Echocardiography was positive in 37 (55.2%) of 67 nonhypoxemic patients, and in 4 (44.4%) hypoxemic ones. No cardiologic hemodynamic repercussions from intrapulmonar shunt were observed. CONCLUSION: The contrast echocardiography is efficient, easy to be used, and safe in the search for and identification of intrapulmonary vascular alterations in patients eligible for hepatic transplantation</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia com contraste</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dilatações vasculares intrapulmonares</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>transplante hepático</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>contraste chocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>intrapulmonary vascular dilations</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hepatic transplantation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Prevalência dos fatores de risco para doença cardiovascular em funcionários do Centro de Pesquisas da Petrobras</s1>
</fA08>
<fA08 dir="en">
<s1>Prevalence of risk factors for cardiovascular disease in employees of the Research Center at Petrobras</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria de Fátima Duarte Matos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nelson Albuquerque Souza e Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Armando Jorge Marques Pimenta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio José Ledo Alves da Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio de Janeiro Faculdade de Medicina </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-4</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a prevalência de fatores de risco para doença cardiovascular em funcionários do Centro de Pesquisas da Petrobras. MÉTODOS: Em estudo descritivo transversal, foram avaliados clínica e laboratorialmente, de março de 2000 e fevereiro de 2001, empregados do Centro de Pesquisas da Petrobras, tendo sido excluídos os que não compareceram à realização do exame médico periódico anual de 2000. Calculados o percentual da ocorrência dos fatores de risco e a média e o desvio padrão das variáveis bioquímicas, da pressão arterial e do índice de massa corpórea. RESULTADOS: De um total de 1.191 empregados, foram estudados 970, sendo 75,4% homens e 24,6% mulheres, com idade média de 42,2 anos. A prevalência de fatores de risco foi o sedentarismo (67,3%), o colesterol &gt; 200 mg/dl (56,6%), o sobrepeso (42%), a obesidade (17%), a hipertensão arterial (18,2%), o tabagismo (12,4%) e o diabetes mellitus (2,5%). CONCLUSÃO: A elevada prevalência de fatores de risco para doença cardiovascular, em indivíduos jovens, alerta para a necessidade de adoção de programas de promoção de saúde e prevenção de doenças no ambiente de trabalho.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the prevalence of risk factors for cardiovascular diseases in employees of the research center at Petrobras. METHODS: In a cross-sectional study, employees of the research center at Petrobras were assessed clinically and by laboratory testing from March 2000 and February 2001. Those who did not attend the periodical annual medical examination of 2000 were excluded from the study. The percentage of risk factor occurrence and the mean standard deviation of the biochemical variables, blood pressure, and body mass index were calculated. RESULTS: Of 1,911 employees, 970 were studied, 75.4% were men and 24.6% were women with a mean age of 42.2 years old. The risk factors were lack of exercise (67.3%), cholesterol &gt; 200 mg/dL (56.6%), overweight (42%), obesity (17%), blood hypertension (18.2%), smoking (12.4%), and diabetes mellitus (2.5%). CONCLUSION: The high prevalence of risk factors for cardiovascular disease in young individuals draws attention to the need for the adoption of workplace programs to encourage healthy lifestyles and to prevent diseases.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença aterosclerótica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ambiente de trabalho</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerotic disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>work place</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Efetividade do metoprolol na prevenção de fibrilação e flutter atrial no pós-operatório de cirurgia de revascularização miocárdica</s1>
</fA08>
<fA08 dir="en">
<s1>Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Eraldo de Azevedo Lúcio</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Adriana Flores</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Celso Blacher</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo E. Leães</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fernando A. Lucchese</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Jorge Pinto Ribeiro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa de Misericórdia de Porto Alegre Hospital São Francisco </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal do Rio Grande do Sul  </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>37-41</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a efetividade do metoprolol na prevenção de fibrilação e flutter atrial clinicamente detectáveis após cirurgia de revascularização miocárdica. MÉTODOS: Ensaio clínico, randomizado e aberto, para tratar 200 pacientes submetidos à cirurgia de revascularização miocárdica isolada com circulação extracorpórea, randomizados para receber metoprolol, por via oral, ou para não receber a medicação no pós-operatório. Os desfechos de interesse eram a detecção de fibrilação e flutter atrial sustentados, sintomáticos ou que requeressem tratamento. Excluídos do estudo os pacientes com fração de ejeção basal do ventrículo esquerdo &lt; 35%, fibrilação atrial prévia, história de broncoespasmo, bloqueios atrioventriculares de 2º e 3º grau, baixo débito cardíaco e insuficiência cardíaca. RESULTADOS: Arritmias ocorreram em 11 de 100 pacientes do grupo metoprolol e em 24 de 100 pacientes do grupo controle (p=0,02). O risco relativo (RR) foi 0,46 (IC de 95%= 0,24-0,88) e o número necessário para tratar (NNT) e evitar o desfecho foi de 8 pacientes. A fibrilação atrial foi a arritmia mais freqüentemente observada (30/35). Em 38 pacientes com idade &gt; 70 anos, as arritmias ocorreram em 2 de 19 pacientes do grupo metoprolol e em 10 de 19 do grupo controle (c2 Yates: p=0,01). O risco relativo foi 0,20 (IC de 95%= 0,05-0,79) e o número necessário para tratar foi de 2 pacientes. CONCLUSÃO: O metoprolol é efetivo na prevenção de fibrilação e flutter atrial no PO de cirurgia de revascularização miocárdica, sendo esse efeito mais marcante no grupo de pacientes idosos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effectiveness of metoprolol in preventing clinically detectable atrial fibrillation (AF) and flutter after coronary artery bypass graft (CABG) surgery . METHODS: An open, randomized study was carried out to treat 200 patients who had undergone isolated CABG surgery with extracorporeal circulation. The patients were randomized to either receive metoprolol orally or not to receive the medication in the postoperative period. The outcomes were the detection of sustained atrial AF and flutter, which were symptomatic or required treatment. The patients with the following characteristics were excluded from the study: baseline left ventricular ejection fraction &lt; 35%; previous AF; history of bronchospasm; second- and third-degree atrioventricular blocks, low cardiac output, and heart failure. RESULTS: Arrhythmias occurred in 11 out of 100 patients in the metoprolol group and in 24 out of 100 patients in the control group (P=0.02). The relative risk (RR) was 0.46 (95% CI = 0.24-0.88), and the number necessary to treat (NNT) and avoid the outcome was 8 patients. AF was the arrhythmia most frequently observed (30/35). In 38 patients aged 70 years or more, the arrhythmias occurred in 2 out of 19 patients in the metoprolol group and in 10 out of 19 patients in the control group (c2 Yates: P=0.01). The relative risk was 0.20 (95% CI = 0.05-0.79) and the number necessary to treat was 2 patients. CONCLUSION: Metoprolol is effective in preventing AF and flutter in the postoperative period of CABG surgery, and this effect was more evident in the group of elderly patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>metoprolol</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fibrilação atrial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia de revascularização miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>metoprolol</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery bypass graft surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeitos da associação propafenona - propofol na contratilidade miocárdica, freqüência cardíaca, fluxo coronariano e incidência de arritmia em corações isolados de ratos</s1>
</fA08>
<fA08 dir="en">
<s1>Effects of propafenone associated with propofol on myocardial contractility, heart rate, coronary flow, and the incidence of arrhythmia in isolated hearts of rats</s1>
</fA08>
<fA11 dir="011000">
<s1>Nilcéa Leal de Moraes Assis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Otoni Moreira Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Silvério Leonardo Macedo Garcia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Guilherme Gustavo do Valle</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Cardiovascular São Francisco de Assis Serviço do Coração </s1>
<s2>Belo Horizonte MG</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>82-87</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>48</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar a influência da propafenona associada ao propofol na contratilidade miocárdica (dP/dt e freqüência cardíaca), fluxo coronariano e incidência de arritmia em corações isolados de ratos. MÉTODOS: Estudados 40 corações de ratos albinos anestesiados com éter sulfúrico, adaptados a sistema de perfusão, tipo Langendorff modificado, nutridos com solução de Krebs-Henseleit (K-H), (95% de O2, 5% de CO2, pH de 7,4±0,1, pressão de perfusão entre 90 e 100cm de água e temperatura de 37±0,5º C), obtidos registros de controle após período de estabilização e distribuídos em quatro grupos: I (controle), II (propafenona, na dose de 100mcg), III (propofol, na dose de 25mcg) e IV (propafenona-propofol). RESULTADOS: Verificou-se diminuição (p&lt;0,05) da freqüência cardíaca nos grupos II e IV, com maior queda no grupo II. Na relação dP/dt, houve queda (p&lt; 0,05) nos grupos II e IV, em todos os períodos, sendo que o grupo III apresentou depressão do 1º ao 3º minuto. O fluxo coronariano apresentou diminuição (p&lt;0,05) em todos os grupos, em relação ao controle, principalmente no grupo IV com queda de 14 para 11ml/min. O efeito arritmogênico da propafenona (pró-arritmia) foi constatado em 50% no grupo II. Na associação com propofol (grupo IV), não houve diferença significativa, sendo observadas arritmias (efeito pró-arrítmico) em 40% dos corações. CONCLUSÃO: A associação propafenona-propofol não foi mais nociva do que o uso da propafenona isoladamente, quanto aos efeitos na contratilidade miocárdica, no fluxo coronariano e na incidência de arritmia.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study the influence of propafenone associated with propofol on myocardial contractility (dP/dt and heart rate), coronary flow, and the incidence of arrhythmia in isolated rat hearts. METHODS: Forty albino rats were anesthetized with sulfuric ether, a modified Langendorff method was performed, and the rats were fed with Krebs-Henseleit (K-H) solution, (95% O2, 5% CO2, pH 7.4±0.1, perfusion pressure between 90 and 100cm of water, and temperature 37± 0.5ºC). Control records were obtained after a stabilization period and rats were distributed into the following 4 groups: I (control), II (100mcg propafenone), III (25mcg propofol), and IV (propafenone-propofol). RESULTS: A decrease (P&lt;0.05) in the heart rate in groups II and IV was observed, with a greater decrease in group II. A decrease was noted in the dP/dt ratio (P&lt; 0.05) in groups II and IV, during all periods. Group III experienced depression from the 1st to the 3rd minute. Coronary flow had a decrease (P&lt;0.05) in all groups, compared with the control group, especially in group IV with a decrease from 14mL/min to 11mL/min. Arrhythmogenic effects of propafenone (pro-arrhythmia) were verified in 50% of group II. In the association with propofol (group IV), no significant difference occurred, and arrhythmias (pro-arrhythmic effect) were observed in 40% of the hearts. CONCLUSION: The association propafenone-propofol was not harmful to the use of propafenone solely, regarding the effects observed in myocardial contractility, coronary flow, and in the incidence of arrhythmias.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>contratilidade miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>propafenona</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>propofol</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial contractility</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>propafenone</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>propofol</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Valvoplastia aórtica percutânea em adolescente gestante</s1>
</fA08>
<fA08 dir="en">
<s1>Percutaneous balloon aortic valvuloplasty in a pregnant adolescent</s1>
</fA08>
<fA11 dir="011000">
<s1>Rogério T. Tumelero</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Norberto T. Duda</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alexandre P. Tognon</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Iselso Sartori</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Silvane Giongo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de Passo Fundo Faculdade de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital São Vicente de Paulo  </s1>
<s2>Passo Fundo RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>94-97</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Relatamos um caso em que a valvoplastia aórtica percutânea foi utilizada como primeira escolha, em procedimento de urgência, para o tratamento de estenose aórtica grave em paciente gestante de 16 anos, com congestão pulmonar sem controle clínico. Descrevem-se o quadro clínico, a fisiopatologia, os aspectos diagnósticos e indicações do tratamento percutâneo. A estenose valvar aórtica congênita, quando grave, é rara em crianças e jovens. A valva aórtica bicúspide ocorre em 3% a 6% com doença cardíaca congênita e, quando relacionada com fusão comissural, pode haver estenose importante já na infância. A associação de estenose aórtica congênita grave com gestação é de difícil controle clínico e alto risco de mortalidade materna e fetal, principalmente quando se manifesta com sintomas de congestão pulmonar1,².</s0>
</fC01>
<fC01 dir="en">
<s0>We report the case of a 16-year-old pregnant patient with severe aortic stenosis and pulmonary congestion clinically uncontrolled, in whom percutaneous balloon aortic valvuloplasty was used as the first choice of treatment in an emergency procedure. The clinical findings, pathophysiology, diagnostic features, and indications for percutaneous treatment are reported. Severe congenital aortic stenosis is rare in children and young individuals. Bicuspid aortic valve occurs in 3% to 6% of patients with congenital heart disease; when associated with commissural fusion, significant stenosis may be present in childhood. The association of severe congenital aortic stenosis and pregnancy is difficult to control clinically, carrying a high risk of maternal and fetal mortality, mainly when manifested with symptoms of pulmonary congestion 1,2.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 1/2004 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>102-102</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Repolarização precoce no eletrocardiograma do atleta: bases iônicas e modelo vetorial</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo Corrêa Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Roberto Benchimol Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alfredo de Souza Bomfim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Plínio José da Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Ginefra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>103-107</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200111</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo pré-natal da hiper-refringência endocárdica fetal e sua relação com toxoplasmose materna</s1>
</fA08>
<fA08 dir="en">
<s1>Prenatal study of fetal endocardial hyperrefringence and its relation to maternal toxoplasmosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Henrique Soares Nicoloso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Tiene Zingano Henke</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>27-31</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar, comparativamente, um grupo de fetos de mães com toxoplasmose aguda ou recente e um grupo sem doença sistêmica, analisando-se a presença de alterações da refringência endocárdica. MÉTODOS: Avaliados 91 fetos cujas mães tinham diagnóstico de toxoplasmose aguda ou recente, detectados por soroconversão ou presença de títulos elevados de IgM e IgG, confirmados através do teste de captura e comparados com um grupo controle constituído de 182 fetos, selecionados a partir de uma população de baixo risco, participante de um programa de rastreamento de cardiopatias pré-natais. RESULTADOS: Não houve diferença significativa entre as idades médias gestacionais (29,2±4,6 semanas; 29,2±4,6 semanas) e maternas (25,7±6,7 anos; 26±5,4 anos) nos dois grupos. Áreas de hiperecogenicidade endocárdica observadas em 69 fetos com toxoplasmose materna (75,8%) e em apenas 6 fetos do grupo controle (3,3%) (p&lt;0,001). Em 52 dos casos do grupo de estudo (75,4%) a hiper-refringência endocárdica era difusa e em 17 (24,3%), focal. No grupo controle, uma distribuição focal foi observada em 5 fetos (83,3%). CONCLUSÃO: A imagem ecocardiográfica pré-natal de hiper-refringência endocárdica focal ou difusa é mais prevalente em gestações com toxoplasmose materna do que naquelas normais, existindo associação entre a presença de hiperecogenicidade endocárdica fetal e doença materna.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare a group of fetuses whose mothers had acute or recent toxoplasmosis with a group of fetuses whose mothers had no systemic disease, analyzing the presence of changes in endocardial refringence. METHODS: This study assessed 91 fetuses of mothers diagnosed with acute or recent toxoplasmosis, detected by seroconversion or the presence of elevated IgM and IgG titers, confirmed through the IgM-capture ELISA. They were compared with a control group comprising 182 fetuses selected from a low-risk population participating in a prenatal screening program for heart diseases. RESULTS: No significant difference was observed between the mean gestational (29.2±4.6 weeks; 29.2±4.6 weeks) and maternal (25.7±6.7 years; 26±5.4 years) ages in the 2 groups. Areas of endocardial hyperechogenicity were observed in 69 fetuses whose mothers had toxoplasmosis (75.8%) and in only 6 fetuses of the control group (3.3%) (P&lt;0.001). In 52 patients of the group studied (75.4%), endocardial hyperrefringence was diffuse, and, in 17 (24.3%), it was focal. In the control group, focal distribution was observed in 5 fetuses (83.3%). CONCLUSION: The prenatal echocardiographic image of focal or diffuse endocardial hyperrefringence is more prevalent in pregnancies with maternal toxoplasmosis than in the healthy ones, and an association between fetal endocardial hyperechogenicity and maternal disease exists.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coração fetal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>toxoplasmose congênita</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fibroelastose endocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>diagnóstico por imagem</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetal heart</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital toxoplasmosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endocardial fibroelastosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>imaging diagnosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Associação entre o efeito de contraste espontâneo na aorta torácica e eventos isquêmicos encefálicos recentes. Estudo através do ecocardiograma transesofágico</s1>
</fA08>
<fA08 dir="en">
<s1>Association between the effect of spontaneous contrast in the thoracic aorta and recent ischemic stroke determined by transesophageal echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Flavio José Petersen Velho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernanda Dotta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Leonora Scherer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eduardo Bartholomay</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Daniela Augusta da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Jefferson Gomes Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Marco Antonio Rodrigues Torres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica do Rio Grande do Sul Hospital São Lucas Centro de Diagnóstico por Imagem</s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>47-51</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a existência de associação independente entre a presença de efeito de contraste espontâneo na aorta e eventos isquêmicos encefálicos recentes. MÉTODOS: Estudados com ecocardiograma transesofágico 224 indivíduos com diagnóstico de eventos isquêmicos encefálicos recente 5 e 85 controles que realizaram o exame por diversas doenças cardíacas presentes/suspeitas, sendo pesquisado a presença do efeito de contraste na aorta e de outras potenciais fontes emboligênicas cardíacas associadas. Um questionário sobre os fatores de risco clínicos para eventos isquêmicos encefálicos foi coletado no momento do exame. RESULTADOS: O efeito de contraste na aorta apresentou associação com eventos isquêmicos encefálicos (RC=2,83; IC 95%, 1,65-4,46; P&lt;0,001), na análise bivariada. Na análise multivariada, permaneceu associado a eventos isquêmicos encefálicos recentes (RC=2,05; IC 90%, 1,10-3,85 ; P=0,06). A idade &gt; 60 anos, história de hipertensão arterial sistêmica, história de tabagismo e de dislipidemia foram fatores de risco associados independentemente ao efeito de contraste na aorta. A presença de efeito de contraste espontâneo no átrio esquerdo e a de excrescências de Lambl foram fatores ecocardiográficos associados independentemente ao efeito de contraste na aorta. CONCLUSÃO: O efeito de contraste na aorta esteve associado, de forma independente, aos eventos isquêmicos encefálicos recentes, bem como seus fatores de risco clínicos. Estes resultados vêm reforçar a hipótese de que o fenômeno é um marcador de múltiplos fatores de risco.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the independent association between the presence of spontaneous echo contrast in the aorta and recent stroke events. METHODS: Two hundred and twenty-four individuals with a diagnosis of recent stroke and 85 control individuals who were examined due to various present/suspected heart diseases were studied through transesophageal echocardiography. The effects of spontaneous contrast in the aorta and the presence of other potential sources of cardiac embolism associated with them were researched and a questionnaire was completed about patients' clinical risk factors at the time of examination. RESULTS: The effects of contrast in the aorta was associated with stroke (OR=2.83; CI = 95%, 1.65-4.46; P&lt;0.001) in the bivariate analysis. In the multivariate analysis, it remained associated with recent stroke (OR=2.05; CI = 90%, 1.10-3.85; P=0.06). Age &gt; 60 years, a history of systemic blood hypertension and smoking, and dyslipidemia were risk factors independently associated with the effects of contrast in the aorta. The presence of a spontaneous contrast effect in the left atrium and Lambl's excrescences were echocardiographic factors independently associated with the effects of contrast in the aorta. CONCLUSION: The effect of contrast in the aorta was independently associated with recent stroke and with its clinical risk factors. These results reinforce the hypothesis that the phenomenon is a predictor of several risk factors.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma transesofágico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>efeito de contraste espontâneo aorta</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>acidente vascular encefálico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>transesophageal echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>spontaneous contrast effects on the aorta</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stroke</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Monitorização ambulatorial da pressão arterial em indivíduos normotensos submetidos a duas sessões únicas de exercícios: resistido e aeróbio</s1>
</fA08>
<fA08 dir="en">
<s1>Ambulatory blood pressure monitoring in normotensive individuals undergoing two single exercise sessions: resistive exercise training and aerobic exercise training</s1>
</fA08>
<fA11 dir="011000">
<s1>Ambrosina Maria Lignani de Miranda Bermudes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dalton Valentim Vassallo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Elisardo Corral Vasquez</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eliudem Galvão Lima</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>57-64</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>62</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Investigar a influência de duas sessões únicas de exercício resistido (circuito com pesos) e aeróbio sobre as alterações pressóricas, em indivíduos sedentários e normotensos. MÉTODOS: Foram avaliados pela monitorização numa situação controle, sem realização de exercícios (MAPA 1) 25 indivíduos, após exercício resistido (MAPA 2) e após exercício aeróbio (MAPA 3). Os exercícios resistidos foram realizados sob forma de circuito com pesos, com intensidade de 40% da força máxima individual e os exercícios aeróbicos em cicloergômetro, com intensidade entre 60% e 70% da freqüência cardíaca (FC) máxima alcançada no teste ergométrico. RESULTADOS: A pressão arterial sistólica (PAS) de 24h e sub-períodos vigília e sono não apresentaram variações estatisticamente significantes quando comparada à MAPA2 e MAPA3 e MAPA2 e MAPA3 entre si. A pressão arterial diastólica (PAD) de 24h e diurna apresentaram reduções significantes (P&lt;0,05). A média da freqüência cardíaca de 24h e no período vigília apresentou aumentos significativos (P&lt;0,05) quando comparada a MAPA2 à MAPA3. CONCLUSÃO: Uma sessão única de exercício resistido em indivíduos normotensos foi suficiente para promover reduções significativas dos níveis tensionais, no período de sono após o exercício, e a de exercício aeróbio nesses mesmos indivíduos, foi mais eficaz em promover reduções significativas dos níveis pressóricos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the influence of 2 single exercise sessions on blood pressure in sedentary normotensive individuals: one of resistive exercise training (circuit weight training) and the other of aerobic exercise training. METHODS: Using ambulatory blood pressure monitoring, this study assessed 25 individuals as follows: in a controlled situation at rest (ABPM 1); after resistive exercise training (ABPM 2); and after aerobic exercise training (ABPM 3). Resistive exercise training was performed as circuit weight training with an intensity of 40% of each individual's maximum strength. The aerobic exercise training was performed on a cycloergometer with intensity between 60% and 70% of the maximum heart rate (HR) reached during previous exercise testing. RESULTS: Systolic blood pressure (SBP) values during 24 hours and during subperiods of wakefulness and sleep showed no statistically significant variations when the results obtained at rest were compared with those of ABPM2 and ABPM3, and when the results of ABPM2 were compared with those of ABPM3. The mean heart rate during 24 hours and in the wakefulness period showed significant increases (P&lt;0.05), when ABPM2 was compared with ABPM3. CONCLUSION: A single session of resistive exercise training in normotensive individuals was sufficient to cause significant reductions in blood pressure levels after exercise in the period of sleep. The session of aerobic exercise training in these same individuals was more effective in significantly reducing blood pressure levels.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>MAPA</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>exercícios resistidos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>exercícios aeróbicos</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ABPM</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>resistive exercise</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aerobic exercise</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Correlação entre o consumo de oxigênio obtido pelo método de Fick e pela calorimetria indireta no paciente grave</s1>
</fA08>
<fA08 dir="en">
<s1>Correlation between oxygen consumption calculated using Fick's method and measured with indirect calorimetry in critically ill patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Flávio Marson</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Auxiliadora Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Francisco Antonio Coletto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Dorival Campos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Anibal Basile-Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto </s1>
<s2>Ribeirão Preto SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>72-76</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Correlacionar o índice de consumo de oxigênio medido através da calorimetria indireta (VO2I DELTA) às medidas calculadas pela equação reversa de Fick (VO2I FICK) em pacientes graves, vítimas de trauma ou sepse. MÉTODOS: Analisados 14 pacientes vítimas de trauma (n=5) ou sepse (n=9), com média de idade de 39,4 ± 5,4 anos, sendo 10 homens e 4 mulheres, APACHE II de 21,3±1,8, ISS de 24,8±6, Sepsis Score de 19,6±2,3, com risco de óbito calculado pelo APACHE II de 41,9±7,1%, submetidos à ventilação mecânica e monitorização hemodinâmica invasiva com cateter de Swan-Ganz e realizadas, pelos dois métodos, 4 séries de medidas do VO2I (T1 a T4). RESULTADOS: Houve uma boa correlação entre os dois métodos (r = 0,77), para a média das quatro medidas seriadas. Não houve diferença estatisticamente significativa entre os dois métodos nos tempos T1 (VO2I DELTA = 138±28 e VO2I FICK = 159±38 mL.min-1.m-2, p = 0,10) e T3 (VO2I DELTA = 144±26 e VO2I FICK = 158±35 mL.min-1.m-2, p = 0,14). Houve diferença significativa nos tempos T2 (VO2I DELTA = 141±27 e VO2I FICK = 155±26 mL.min-1.m-2, p = 0,03) e T4 (VO2I DELTA = 145±24 e VO2I FICK = 162±26 mL.min-1.m-2, p = 0,01). CONCLUSÃO: A calorimetria indireta é um método não invasivo, isento de complicações, que pode ser usado para avaliação do consumo de oxigênio no paciente grave de forma tão eficaz quanto à equação reversa de Fick.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare the oxygen consumption index measured by using indirect calorimetry (VO2I Delta) with a portable metabolic cart and calculated according to Fick's principle (VO2 I Fick) in critically ill patients. METHODS: Fourteen patients (10 men and 4 women, mean age 39.4 ± 5.4 years) were analyzed, 5 of them trauma victims and 9 sepsis victims. The following mean scores were obtained for these patients: APACHE II = 21.3±1.8, ISS = 24.8±6, and sepsis score = 19.6±2.3. The mortality risk (odds ratio), calculated from APACHE II, was 41.9±7.1%. All patients underwent mechanical ventilation and invasive hemodynamic monitoring with a Swan-Ganz catheter. VO2 was obtained using the 2 methods (VO2I Delta and VO2I Fick) at 4 different times (T1-T4). RESULTS: A good correlation was found between the 2 methods (r=0.77) for the mean of the 4 serial measurements. No statistically significant differences were observed between indirect calorimetry and Fick's equation at T1 (VO2I Delta = 138±28 and VO2I Fick = 59±38 mL.min-2.m-2, P=0.10) and T3 (VO2I Delta = 144±26 and VO2I Fick = 158±35 mL.min-2.m-2, P=0.14), but a significant difference was observed at T2 (VO2I Delta = 141±27 and VO2I Fick = 155±26 mL.min-2.m-2, P=0.03) and T4 (VO2I Delta = 145±24 and VO2I Fick = 162±26 mL.min-2.m-2, P=0.01). CONCLUSION: We may state that indirect calorimetry can be used for oxygen consumption analysis in critically ill patients and is as efficient as Fick's reverse equation, with the benefit of being a noninvasive and risk-free procedure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>consumo de oxigênio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>trauma</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sepse</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>oxygen consumption</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>trauma</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sepsis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Tratamento cirúrgico da coarctação de aorta pela aortoplastia trapezoidal</s1>
</fA08>
<fA08 dir="en">
<s1>Surgical treatment of coarctation of the aorta using trapezoidal aortoplasty</s1>
</fA08>
<fA11 dir="011000">
<s1>Jarbas Jakson Dinkhuysen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Tarcisio Luiz Valle de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ibraim Masciarelli Francisco Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Carlos Bento de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>9-17</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: A aortoplastia trapezoidal é uma variante técnica da anastomose término-terminal que, amparada em elementos da geometria, objetiva aumentar o diâmetro da aorta ao nível da sutura reduzida e, consequentemente, a manutenção de gradientes pressóricos residuais ou recorrentes indesejáveis a curto e a longo prazo. MÉTODOS: Após a ressecção da área coarctada e tecido ductal, são confeccionados em cada coto aórtico 3 trapezóides que, ao serem confrontados, criam linha de sutura com aspecto sinusoidal (zigue-zague). Foram operados por esta técnica 33 pacientes, a maioria homens, com idades variando de 3 meses a 36 anos (m 9,5 ± 9,7). RESULTADOS: Não ocorreu mortalidade imediata ou tardia e o tempo de evolução a longo prazo foi de 1,1 a 7,6 anos (m 3,6 ± 3,4). A maioria dos pacientes ficou assintomática com níveis normais de pressão arterial, possibilitando a descontinuação da terapêutica antihipertensiva (p&lt;0,0001). Constatou-se importante redução dos gradientes pressóricos observados ao ecodopplercardiograma e ao cateterismo cardíaco (p&lt;0,001). A análise das imagens das aortografias mostrou boa continuidade anatômica na região da anastomose e o estudo morfométrico da aorta revelou efeitos benéficos do método traduzidos pelo aumento do calibre da aorta no segmento distal do arco, istmo e porção descendente. CONCLUSÃO: A aortoplastia trapezoidal mostrou resultados clínicos satisfatórios que autorizam sua aplicação em todos os casos de anastomose término-terminal indicados.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Trapezoidal aortoplasty is a technical variant of end-to-end anastomosis, which, based on elements of geometry, aims at increasing the diameter of the aorta at the level of the suture, therefore reducing the occurrence of residual or recurrent pressure gradients in the short and long run. METHODS: After resecting the coarcted area and ductal tissue, 3 trapezoids are confected in each aortic stump, which, when confronted, create a suture line with a sinusoidal aspect (zigzag). Thirty-three patients underwent surgery with this technique, 22 (66.7%) males, with ages ranging from 3 months to 36 years (mean of 9.84 ± 9.69). RESULTS: No immediate or late deaths occurred. Follow-up ranged from 1.1 to 7.6 years (mean of 3.6 ± 3.4). Most patients became asymptomatic with normal blood pressure levels, enabling the discontinuation of antihypertensive therapy (P&lt;0.0001). A significant reduction in the pressure gradients was observed on Doppler echocardiography and during cardiac catheterization (P&lt;0.001). The analysis of the images of aortography showed good anatomical continuity in the region of the anastomosis, and the morphometric study of the aorta revealed the beneficial effects of the technique indicated by the increase in the caliber of the aorta in the distal segment of the arch, isthmus, and descending portion. CONCLUSION: Trapezoidal aortoplasty showed satisfactory clinical results that allow its application in all cases indicated for end-to-end anastomosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coarctação aórtica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>anastomose cirúrgica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>métodos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>evolução clínica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coarctation of the aorta</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgical anastomosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>methods</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>clinical evolution</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Normatização dos equipamentos e das técnicas para a realização de exames de ultra-sonografia vascular</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciano Herman Juaçaba Belem</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Carlos Santos Nogueira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Claudio Domenico Schettino</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcio Vinicius Lins Barros</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Monica Luiza de Alcantara</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paulo Cesar de Carvalho Studart</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Paula Pimentel de Araújo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Salomon Israel do Amaral</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Simone Barretto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-14</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Apresentação</s1>
</fA08>
<fA11 dir="011000">
<s1>Martino Martinelli Filho</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-1</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretriz de fibrilação atrial</s1>
</fA08>
<fA11 dir="011000">
<s1>Martino Martinelli Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dalmo A. Ribeiro Moreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Adalberto M Lorga</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eduardo Sosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Jacob Atié</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>João Pimenta</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Carlos S. de Andrade</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Márcio Luis A. Fagundes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Ricardo Ryoshim Kuniyoshi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Adalberto Lorga Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Adalberto Menezes Lorga</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Alberto Nicodemus G Lopes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Ângelo A. V. de Paola</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Álvaro Barros da Costa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Ayrton Klier Péres</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>César J. Grupi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>Cídio Halperin</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>Dalmo A. Ribeiro Moreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>Eduardo A. Sousa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="201000">
<s1>Eduardo Sternick</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="211000">
<s1>Fernando Eugênio S. Cruz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="221000">
<s1>Francisco Carlos C. Darrieux</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="231000">
<s1>Gustavo Glotz Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="241000">
<s1>Jacob Atié</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="251000">
<s1>José Carlos Moura Jorge</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="261000">
<s1>José Carlos S. de Andrade</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="271000">
<s1>José Carlos Pachón Mateos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="281000">
<s1>João Pimenta</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="291000">
<s1>Júlio Cesar de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="301000">
<s1>Leandro I. Zimerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="311000">
<s1>Márcio Luis A. Fagundes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="321000">
<s1>Martino Martinelli Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="331000">
<s1>Maurício I. Scanavacca</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="341000">
<s1>Paulo de Tarso J. Medeiros</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="351000">
<s1>Reynaldo Castro Miranda</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="361000">
<s1>Roberto Costa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="371000">
<s1>Ricardo Ryoshim Kunyioshi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="381000">
<s1>Sérgio Gabriel Rassi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="391000">
<s1>Silas S Galvão Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="401000">
<s1>Tamer N. Seixas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="411000">
<s1>Thiago da Rocha Rodrigues</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="421000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>2-24</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100002</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretriz de patologia clínica/medicina laboratorial da cardiologia</s1>
</fA08>
<fA11 dir="011000">
<s1>José Carlos Carneiro Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Agnaluce Moreira Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ana Paula Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlor Alberto Franco Balarrati</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eduardo Sá</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Carlos Carneiro Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Luciana Estrella Souza</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Rafael Padovani</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Wilson Shcolnik</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-4</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Resumos temas livres</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>6-26</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100002</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Distribuição dos escores de cálcio coronariano determinados pela tomografia ultra-rápida em 2.253 homens brancos assintomáticos</s1>
</fA08>
<fA08 dir="en">
<s1>Distribution of coronary artery calcium scores determined by ultrafast computed tomography in 2.253 asymptomatic white men</s1>
</fA08>
<fA11 dir="011000">
<s1>Romeu S. Meneghelo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Raul D. Santos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Breno Almeida</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jairo Hidal</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Tania Martinez</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Renato Moron</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Antonio F. Ramires</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Fabio Nasri</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Israelita Albert Einstein  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Faculdade de Medicina da Universidade de São Paulo Instituto do Coração do Hospital das Clínicas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>27-31</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100003</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Descrever a distribuição dos escores de cálcio coronariano numa população de homens brasileiros brancos assintomáticos submetidos à avaliação pela tomografia ultra-rápida. MÉTODOS: Foram avaliados 2.253 homens de 22-88 anos, submetidos a exame tomográfico num aparelho ImatronR C150 para detecção do cálcio coronariano. Os dados foram separados em 7 faixas etárias: &lt; 40 anos, 40-44 anos, 45-49 anos, 50-54 anos, 55-59 anos, 60-64 anos e &gt;65 anos. RESULTADOS: A média e o desvio padrão da idade foram de 50,0 ± 9,7 anos. Em 48,8% dos casos ocorreu incidência de escore de cálcio coronário &gt; zero, que apresentou distribuição não Gaussiana e mostrou grande variação para a mesma faixa etária. Houve correlação direta entre a idade e o escores de cálcio coronariano (r=0,4, p&lt;0,01). Exceto na comparação entre os indivíduos nas faixas etárias 60-64 anos e, abaixo 55-60 anos e acima de 65 anos, quanto maior a faixa etária maiores as medianas dos escores de cálcio coronariano (p&lt;0,0001). Os escores de cálcio coronariano estão relatados de acordo com os percentis 25,50,75 e 90 para as faixas etárias. CONCLUSÃO: Este estudo, primeiro a relatar a distribuição dos escores de cálcio coronariano em uma amostra de homens brasileiros brancos, pode ser útil para estratificação do risco de eventos coronarianos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJETIVE: To describe the distribution of coronary artery calcium scores in a population of asymptomatic white Brazilian men undergoing assessment with ultrafast computed tomography. METHODS: The study assessed 2.253 men aged 22 to 88 years undergoing computed tomography in an ImatronR C150 device for detecting coronary calcium. Data were divided based on the patient's age into 7 groups: &lt; 40 years, 40-44 years, 45-49 years, 50-54 years, 55-59 years, 60-64 years, and &gt;65 years. RESULTS: The mean and standard deviation of age were 50.0 ± 9.7 years. In 48.8% of the cases, the coronary artery calcium score was &gt; zero, with a non-Gaussian distribution and a large variation for the same age group. A direct correlation between age and the coronary artery calcium score was observed (r=0.4, P&lt;0.01). Except for the comparison of individuals in the age groups 60-64 years, below 55-60 years, and above 65 years, the older the age group, the greater the medians of the coronary artery calcium scores (P&lt;0.0001). Coronary artery calcium scores were reported according to the 25th, 50th, 75th, and 90th percentiles for the age groups. CONCLUSION: This study, the first to report the distribution of the coronary artery calcium scores in a sample of white Brazilian men, may be useful for stratifying the risk of coronary events.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tomografia computadorizada por feixe de elétrons</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coronariopatia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>diagnóstico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electron beam computed tomography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diagnosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>81</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretriz de apoio ao suporte avançado de vida em cardiologia - Código Azul - Registro de ressuscitação normatização do carro de emergência</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sergio Timerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Germano Emilio Conceição Souza</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ana Paula Quilici</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria Margarita Castro Gonzalez</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>André Guanaes Gomes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Adriana M. Garcia</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>André Schmidt</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Antonio P Mansur</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Caio de Brito Vianna</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Dario Ferreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Edison Paiva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Fátima Gil</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Flávio Marques</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>Frederico Arnaud</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>Hugo Tannus</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>Jose Antonio F Ramires</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>Luis Hargreaves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="201000">
<s1>Marcello Markus Paulista</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="211000">
<s1>Manuel F. Canesin</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="221000">
<s1>Marcia Martins</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="231000">
<s1>Paulo Miranda</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="241000">
<s1>Ricardo Tavares de Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="251000">
<s1>Roberto Kalil Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="261000">
<s1>Silvia Regina Rios Vieira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="271000">
<s1>Tião Viana</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Sociedade Brasileira de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>3-14</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2003</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(03)08100001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>A legislação e o fumo</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco Manes Albanesi Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>407-408</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>A pós graduação no Instituto do Coração da Faculdade de Medicina da Universidade de São Paulo</s1>
</fA08>
<fA11 dir="011000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Neusa Rodrigues Dini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Antônio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina Instituto do Coração do Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>409-410</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Intervenção coronariana percutânea de resgate após fibrinolise</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Adriano M. Caixeta</s1>
<afiliation>A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Fundação Zerbini Instituto do Coração </s1>
<s2>Brasília DF</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>411-412</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Características morfológicas angiográficas na atresia pulmonar com septo interventricular íntegro</s1>
</fA08>
<fA08 dir="en">
<s1>Angiographic morphologic characteristics in pulmonary atresia with intact ventricular septum</s1>
</fA08>
<fA11 dir="011000">
<s1>Marco Aurélio Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vitor Manuel Pereira Azevedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Nacional de Cardiologia Laranjeiras  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>413-419</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>65</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar as alterações morfofuncionais do ventrículo direito na atresia pulmonar com septo íntegro (APSI) para uma avaliação de candidatos aos diversos procedimentos terapêuticos atualmente disponíveis. MÉTODOS: Submetidos ao estudo cineangiocardiográfico utilizando-se projeções axiais, 31 pacientes com idades variando de 1 a 50 dias (x=9,6), sendo que 28 foram estudados no 1º mês de vida. Na análise estatística foram empregados o X² e calculado o intervalo de confiança de 95% (IC95), o teste de Kruskal-Wallis para a média e desvio padrão e a regressão múltipla. Considerado significativo quando alfa &lt; 0,05. RESULTADOS: Os pacientes foram divididos em 3 grupos de acordo com a morfologia angiográfica do ventrículo direito (VD): grupo A - VD tripartide (n=16); grupo B - VD bipartide (n=9) e grupo C - VD unipartide (n=6). O diâmetro da válvula tricúspide foi de 10,28 ± 2,67 mm (A); 7,82 ± 3,41 (B) e 5,27 ± 0,57 (C) (p=0,0005). A atresia pulmonar foi da válvula em todos do grupo A e infundibular em todos do grupo C (p&lt;0,0001). As conexões coronário-cavitárias foram infreqüentes (2/16) no grupo A e em todos do grupo C (p=0,0006), com opacificação retrógrada da aorta (fluxo do VD para a aorta) em 2 pacientes do grupo A e em todos os do grupo C (p=0,0003). Em 3 pacientes (2 do grupo C e 1 do grupo A) observou-se circulação coronariana VD dependente. A regurgitação tricúspide moderada/grave isolada teve tendência de ser mais freqüente no grupo A (p=0,0525). O ângulo que o ductus arteriosus faz com a aorta descendente foi: 104,06 ± 8,98 no grupo A; 79,17 ± 33,08 no grupo B e 39,0 ± 6,52 no grupo C (p=0,0016). A correlação entre o diâmetro da válvula tricúspide e o ângulo entre o ductus arteriosus com a aorta descendente foi 0,6568 (p=0,0002). CONCLUSÃO: Em função da heterogeneidade da morfologia do VD nos pacientes com atresia pulmonar com septo íntegro, torna-se necessário o conhecimento de todas essas informações na seleção de candidatos aos diversos procedimentos terapêuticos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the morphological and functional changes in the right ventricle in pulmonary atresia with intact ventricular septum (PAIVS) for assessing the candidates for the different therapeutic procedures currently available. METHODS: Thirty-one patients underwent cineangiocardiographic study with axial projections. Their ages ranged from 1 to 50 days (x = 9.6), and 28 of them were studied during the first month of life. The statistical analysis comprised the following: chi-square test, Kruskal-Wallis test for the mean and standard deviation, multiple regression, and the 95% confidence interval (95%CI) was calculated. The significance level adopted was alpha &lt; 0.05. RESULTS: The patients were divided into 3 groups according to the angiographic morphology of the right ventricle (RV): group A - tripartite RV (n=16); group B - bipartite RV (n=9); and group C - unipartite RV (n=6). The diameter of the tricuspid valve was 10.28 ± 2.67 mm (A); 7.82 ± 3.41 (B); and 5.27 ± 0.57 (C) (P=0.0005). Pulmonary atresia was of the valvular type in all group A patients and of the infundibular type in all group C patients (P&lt;0.0001). Coronary-cavitary connections were rare (2/16) in group A patients, but occurred in all group C patients (P=0.0006), with retrograde opacity of the aorta (flow from the RV to the aorta) in 2 group A patients and in all group C patients (P=0.0003). Three patients (2 in group C and 1 in group A) had right-ventricular-dependent coronary circulation. Isolated moderate/severe tricuspid regurgitation showed a tendency towards being more frequent in group A (P=0.0525). The angle of the ductus arteriosus with the descending aorta was as follows: 104.06 ± 8.98 in group A; 79.17 ± 33.08 in group B; and 39.0 ± 6.52 in group C (P=0.0016). The correlation between the diameter of the tricuspid valve and the angle of the ductus arteriosus with the descending aorta was 0.6568 (P=0.0002). CONCLUSION: Because of the heterogeneity of the morphology of the RV in patients with pulmonary atresia with intact ventricular septum, knowledge about all these data is required for selecting candidates for the different therapeutic procedures.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>atresia pulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ductus arteriosus</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatia congênita</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores prognósticos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvulotomia pulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary atresia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ductus arteriosus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognostic factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary valvotomy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação das pressões sistólica, diastólica e pressão de pulso como fator de risco para doença aterosclerótica coronariana grave em mulheres com angina instável ou infarto agudo do miocárdio sem supradesnivelamento do segmento ST</s1>
</fA08>
<fA08 dir="en">
<s1>Evaluation of systolic, diastolic, and pulse pressure as risk factors for severe coronary arteriosclerotic disease in women with unstable angina non-ST-elevation acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>José Marconi Almeida de Sousa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João L. V. Hermann</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>João B. Guimarães</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Pedro Paulo O. Menezes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Carlos Camargo Carvalho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital Santa Marcelina  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>426-429</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar se as pressões, medidas na raiz da aorta, são fatores de risco para doença aterosclerótica coronariana grave em mulheres com angina instável ou infarto agudo do miocárdio sem supradesnivelamento do segmento ST (AI/IAMSS). MÉTODO:As pressões, assim como os fatores de risco para doença arterial coronariana (DAC) foram prospectivamente coletados de março/1993 a agosto/2001 em 593 mulheres com diagnóstico de AI/IAMSS submetidas à cinecoronariografia. Lesões coronarianas definidas como graves estenoses &gt; 70%. RESULTADOS: Idade média de 59,2±11,2 anos, significantemente mais alta nas pacientes com DAC: 61,9 ± 10,8 anos vs 56.4 ± 10,8 anos; tabagismo, diabetes e climatério foram mais freqüentes nas pacientes com DAC. As médias das pressões sistólica e arterial média foram iguais nos dois grupos, entretanto as médias das pressões diastólicas do ventrículo esquerdo (17.6 ± 8.7 x 15.1 ± 8.1, p=0.001) e da pressão de pulso aórtica foram significantemente maiores nas pacientes com DAC (75.5 ± 22 x 70 ± 19, p=0.002), enquanto a média da pressão diastólica aórtica foi significantemente mais alta nas pacientes sem DAC (75.3 ± 17.5 x 79.8 ± 16, p=0.003). Na análise multivariada a pressão de pulso &gt; 80 mmHg e pressão sistólica &gt; 165 foram independentemente associadas a DAC com razão de chance de 2.12 e 2.09, p&lt;0.05, respectivamente. CONCLUSÃO: A doença arterial coronariana está associada à pressão de pulso mais elevada e pressão diastólica mais baixa em mulheres com AI/IAMSS. Embora a média da pressão sistólica não tenha se associado com DAC, valores dicotomisados de pressão de pulso &gt; 80 mmHg e pressão sistólica &gt; 165 mmHg determinaram risco duas vezes maior de lesão coronariana grave.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate pressures assessed at the aortic root as risk factors for severe atherosclerotic coronary heart disease in women with unstable angina/compatible clinical history associated with increase in cardiac enzymes (total CPK and CK-MB) 2 times greater than the standard value used in the hospital, with the absence of new Q waves on the electrocardiogram (UA/NSTEMI). METHODS: Five hundred and ninety-three female patients with clinical diagnosis of UA/NSTEMI underwent cinecoronariography from March 1993 to August 2001, and the risk factors for CHD were studied. During examination the pressures, at the aortic root, and coronary obstructions were visually assessed by 2 interventional cardiologists, and those stenosis over 70% were considered severe. RESULTS: Eight-one per cent of the population was white and 18.3% was black. Mean age was 59.2±11.2 years, and it was significantly higher in patients with severe coronary lesions: 61.9 ± 10.8 years versus 56.4 ± 10.8 years; smoking, diabetes mellitus and climacteric were more frequent in patients with CHD. The average mean arterial pressure and mean systolic blood pressure was the same in both groups, however, average left ventricle diastolic pressure (17.6 ± 8.7 x 15.1 ± 8.1, p=0.001), and aortic pulse pressure were significantly greater in patients with CHD (75.5 ± 22 x 70 ± 19, p=0.002), while average aortic diastolic pressure was significantly greater in patients without CHD (79.8 ± 16 x 75.3 ± 17.5, p=0.003). In the multivariated analysis, pulse pressure &gt; 80 mmHg and systolic blood pressure &gt; 165 were independently associated with severe CHD with odds ratio of 2.12 and 2.09, p&lt;0.05, respectively. CONCLUSION: CHD is associated with increased pulse pressure and lower diastolic blood pressure in women with UA/NSTEMI. Although average systolic blood pressure has not been associated with CHD in this population, dichotomized values of pulse pressure &gt; 80 mmHg and systolic blood pressure &gt; 165 mmHG determined risk two times greater of severe coronary disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença aterosclerótica coronariana grave</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angina instável</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto agudo do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary arterioscherotic disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>unstable angina</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Uma comparação entre a intervenção coronariana percutânea de resgate e primária realizadas no infarto agudo do miocárdio: relato multicêntrico de 9.371 pacientes</s1>
</fA08>
<fA08 dir="en">
<s1>A comparison of rescue and primary percutaneous coronary interventions for acute myocardial infarction: a multicenter registry report of 9,371 patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Alberto Mattos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Amanda G.M.R. Sousa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ibraim M.F. Pinto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Expedito R. Silva</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Klauber Carneiro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>J. Eduardo Sousa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Armando Mangione</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Paulo Caramori</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Valter Lima</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Ronaldo L. Bueno</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista  </s1>
<s2>São Paulo SP</s2>
<s3>Brasil</s3>
</fA14>
<fA20 dir="000000">
<s1>434-439</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Análise comparativa dos resultados hospitalares em pacientes infartados reperfundidos por meio de uma intervenção coronariana percutânea de resgate ou primária. MÉTODOS: Selecionados pacientes consecutivos, submetidos a uma intervenção percutânea no infarto do miocárdio (&lt; 24h), entre 1997 e 2000, incluídos no registro nacional multicêntrico CENIC, comparando os resultados hospitalares, entre aqueles submetidos ao procedimento de resgate (n=840) ou primário (n=8.531). RESULTADOS: Os pacientes que realizaram intervenção de resgate eram significativamente mais jovens, com infarto anterior, associado à presença de disfunção ventricular, porém com menor porcentual de doença coronariana multiarterial, comparados aos primários. As taxas de implante de stents foram similares (56,9% vs. 54,9%; p=0,283), mas o sucesso do procedimento foi menor nos casos de resgate (88,1% vs. 91,2%; p&lt;0,001), cursando com maior mortalidade (7,4% vs. 5,6%; p=0,034), comparado à intervenção primária; nova revascularização (&lt; 0,5%), cirurgia de emergência (&lt; 0,3%) e reinfarto (&lt; 2,6%) foram similares. A análise multivariada identificou o procedimento de resgate como preditor de mortalidade ao final da fase hospitalar [RC (IC=95%) = 1,60 (1,17-2,19); p=0,003]. CONCLUSÃO: Neste registro nacional, a intervenção de resgate apresentou uma maior mortalidade hospitalar, comparada ao procedimento primário.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To perform a comparative analysis of in-hospital results obtained from AMI patients who underwent rescue or primary PTCA. METHODS: From the Brazilian Interventional National Registry (CENIC), we selected all consecutive patients who underwent a percutaneous coronary intervention for myocardial infarction (&lt; 24 hours), between 1997 and 2000, analyzing those undergoing a rescue (n=840) or a primary (n=8,531) procedure, and comparing their in-hospital results. RESULTS: Rescue patients were significantly younger males with anterior wall infarctions, associated with left ventricular dysfunction, but had less multivessel disease, compared with those treated with primary intervention. Coronary stents were implanted in at similar rates (56.9% vs. 54.9%; P=0.283). Procedural success were lower for rescue cases (88.1% vs. 91.2%; P&lt;0.001), with higher mortality (7.4% vs. 5.6%; P=0.034), compared with the primary intervention group; target vessel revascularization (&lt; 0.5%), emergency bypass surgery (&lt; 0.3%) and reinfarction (&lt; 2.6%) rates were similar for both strategies. Multivariate analysis identified the rescue procedure as a predictor of in-hospital death [OR(CI=95%) = 1.60 (1.17-2.19); P=0.003]. CONCLUSION: Patients who underwent a rescue coronary intervention had higher in-hospital death rates compared with those who underwent a primary coronary intervention.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angioplastia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>reperfusão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>trombólise</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>stent</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>antiplaquetários</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>reperfusion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thrombolysis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stent</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>platelet inhibitors</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Tratamento cirúrgico para claudicação intermitente em pacientes que não melhoram com o tratamento clínico</s1>
</fA08>
<fA08 dir="en">
<s1>Surgical treatment for intermittent claudication in patients who do not improve with clinical treatment</s1>
</fA08>
<fA11 dir="011000">
<s1>Nelson Wolosker</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marco Antonio S. Munia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ruben Rosoky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ronald J. Fidelis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Livio Nakano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paulo Kauffman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Pedro Puech-Leão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>445-449</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar prospectivamente os resultados obtidos com o tratamento cirúrgico de portadores de claudicação intermitente que não obtiveram melhora clínica com o tratamento conservador, acompanhados, em média, por 6 anos. MÉTODOS: De janeiro/1992 a janeiro/2002 foram acompanhados 26 pacientes tratados cirurgicamente de um grupo de 1380 portadores de claudicação intermitente, admitidos num ambulatório de doença arterial obstrutiva periférica e claudicação intermitente, representando 1,88% do total. RESULTADOS: Não referiam limitação para deambular após a cirurgia 16 pacientes. Experimentaram melhora nove, porém com algum grau de limitação, e dois, pequena melhora na distância máxima de marcha. Não houve mortalidade intra-operatória. Três pacientes apresentaram trombose da artéria tratada 6,48 e 60 meses após o procedimento e passaram a apresentar claudicação intermitente para as distâncias prévias à cirurgia. Durante o seguimento a longo prazo observamos uma mortalidade de 23,0% devido a infarto agudo do miocárdio (4 casos), insuficiência renal (um) e acidente vascular cerebral (um). Dois pacientes foram submetidos a revascularização do miocárdio 2 e 4 anos após a reconstrução arterial e um ainda necessitou angioplastia coronariana com 3 anos de seguimento. O tempo de seguimento médio foi de 73 meses. CONCLUSÃO: O tratamento cirúrgico diminuiu sintomas isquêmicos da claudicação intermitente em muitos pacientes, com excelente taxa de patência (88,4%) dos enxertos, tornando-se em pacientes que não apresentam melhora com tratamento clínico, boa alternativa com baixas taxas de complicações e bons resultados a longo prazo.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study the results obtained with surgical treatment of patients with intermittent claudication (IC) who did not clinically improve with conservative treatment, accompanied by a long follow-up (average 6 years). METHODS: From January 1992 to January 2002, 26 patients treated surgically in a group of 1380 IC patient, representing 1.88% of the total. RESULTS: Sixteen patients did not experience walking limitations after the surgery. Nine patients improved, however, with some degree of limitation. No intraoperative mortalities occurred. Three patients experienced thrombosis of the treated artery 6, 48, and 60 months after the procedure and started to suffer IC with onset at the same distances as before the surgery. During the long-term follow-up, we observed a mortality rate of 23.0% due to myocardial infarctions (4 patients), renal insufficiency (1 patient), and cerebral infarction (1 patient). Two patients underwent coronary bypasses 2 and 4 years after the vascular surgery, and one underwent coronary angioplasty after 3 years of follow-up. The mean follow-up was 73 months. CONCLUSION: In our study, the results from surgical treatment of IC brought about a lasting regression of the ischemic conditions in a significant number of patients, with excellent patency rates (88.4%). We conclude that this is a good alternative for select patients, with low rates of complications and positive long-term results.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tratamento cirúrgico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>claudicação</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tratamento clínico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgical treatment</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>claudication</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>clinical treatment</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Os ramos ventriculares posteriores das artérias coronárias no homem</s1>
</fA08>
<fA08 dir="en">
<s1>The posterior ventricular branches of the coronary arteries in the human heart</s1>
</fA08>
<fA11 dir="011000">
<s1>José Roberto Ortale</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luisa Carolina Borges Keiralla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luciana Sacilotto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica de Campinas  </s1>
<s2>Campinas SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>463-467</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Descrever os ramos ventriculares posteriores no tecido adiposo epicárdico e propor um novo critério de análise da distribuição desses ramos, conforme a classificação tradicional, a fim de determinar a predominância ou o equilíbrio entre as artérias coronárias no suprimento arterial do coração. MÉTODOS: Dissecados 40 corações obtidos de necroscopias de adultos, fixados em solução de formol e a face posterior de cada ventrículo dividida em oito áreas, aproximadamente iguais, para a classificação morfológica da circulação coronariana. Foram considerados os três tipos tradicionais: A) dominância da direita, B) tipo balanceado e C) dominância da esquerda e analisados o número, o diâmetro e as áreas de terminação dos ramos ventriculares posteriores no epicárdio. RESULTADOS: Os ramos verificados e sua freqüência foram: ramo marginal esquerdo - 100%; ramos posteriores do ventrículo esquerdo: lateral - 75%, intermédio - 82,5% e medial - 87,5%; ramo interventricular posterior - 95%; ramos posteriores do ventrículo direito: medial - 40%, intermédio - 32,5% e lateral - 40%; ramo diagonal posterior do ventrículo direito - 17,5%; ramo marginal direito - 95%. Foram encontrados 62,5% de dominância da artéria coronária direita, 25% de tipo balanceado e 12,5% de dominância da coronária esquerda. CONCLUSÃO: O método adotado permitiu-nos uma classificação mais precisa dos casos analisados nos tipos de distribuição coronariana. O tipo de dominância da artéria coronária direita foi o prevalente, seguido do equilíbrio e da dominância esquerda.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To describe the trajectory of the posterior ventricular branches of the coronary arteries in the epicardial adipose tissue, and to propose a new criterion for analyzing the distribution of these branches, according to the traditional classification, to determine the predominance or balance of the coronary arteries in the arterial supply to the heart. METHODS: Forty hearts obtained from autopsies of adults were dissected and fixed in a formol solution. The posterior face of each ventricle was divided into 8 approximately equal areas for the morphological classification of the coronary circulation. The following 3 traditional types were considered: A) right dominance, B) balanced, and C) left dominance. The number, diameter, and terminal areas of the posterior ventricular branches in the epicardium were analyzed. RESULTS: The following branches and respective frequencies were found: left marginal branch - 100%; posterior left ventricular branches: lateral - 75%, intermediate - 82.5%, and medial - 87.5%; interventricular posterior branch - 95%; posterior right ventricular branch: medial - 40%, intermediate - 32.5%, and lateral - 40%; posterior diagonal branch of the right ventricle - 17.5%; right marginal branch - 95%. In regard to dominance, the following values were found: dominance of the right coronary artery - 62.5%; balanced type - 25%; and dominance of the left coronary artery - 12.5%. CONCLUSION: The method adopted allowed a more precise classification of the types of coronary artery distribution found. The right coronary artery dominance type was the most prevalent, followed by the balanced type and the left coronary artery dominance.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>circulação coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coração</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>anatomia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary circulation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>anatomy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>O papel da ultra-sonografia vascular com Doppler colorido na avaliação da hipertensão reno-vascular: acurácia da técnica direta de avaliação das artérias renais</s1>
</fA08>
<fA08 dir="en">
<s1>Vascular color Doppler ultrasound for assessing renovascular hypertension: accuracy of the direct technique for assessing the renal arteries</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Alberto Engelhorn</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ana Luiza Engelhorn</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Renata Pullig</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica Núcleo Vascular Periférico </s1>
<s2>Curitiba PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>473-476</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a acurácia da ultra-sonografia vascular com Doppler colorido em relação à arteriografia digital por subtração de imagens, na identificação das estenoses hemodinamicamente significativas, nas artérias renais. MÉTODOS: Estudados, prospectivamente, pelo exame ultra-sonográfico, 137 artérias renais de 69 pacientes adultos, com suspeita de hipertensão arterial reno-vascular. Os resultados obtidos foram comparados, de maneira duplo-cega, ao estudo arteriográfico digital por subtração de imagens, e calculados a sensibilidade, especificidade, valor preditivo positivo, valor preditivo negativo e acurácia geral do exame para critérios previamente definidos. RESULTADOS: Na comparação entre os métodos, excluindo-se os laudos inconclusivos (7 artérias), das 130 artérias restantes, 116 (89,2%) artérias tiveram laudos concordantes e 14 (10,8%) discordantes. Os valores de sensibilidade, especificidade, valor preditivo positivo, valor preditivo negativo e acurácia geral da ultra-sonografia vascular com Doppler colorido foram respectivamente 95,33%, 88,14%, 89,86%, 94,55% e 91,94%. CONCLUSÃO: Existiu boa correlação entre os dois exames na avaliação das estenoses hemodinamicamente significativas das artérias renais, tornando-se a ultra-sonografia vascular com Doppler colorido método não invasivo útil na seleção de pacientes com suspeita de hipertensão reno-vascular.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the accuracy of vascular color Doppler ultrasound as compared with digital subtraction arteriography for identifying hemodynamically significant renal artery stenoses. METHODS: One hundred and thirty-seven renal arteries from 69 adult patients suspected of having renovascular arterial hypertension were prospectively studied with ultrasound. The results obtained were compared in a double-blind manner with those obtained on digital subtraction arteriography, and the following parameters were calculated according to previously defined criteria: sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy. RESULTS: The inconclusive results (7 arteries) were excluded. The comparison of the 2 methods in regard to the 130 remaining arteries showed concordant results for 116 (89.2%) arteries and discordant results for 14 (10.8%) arteries. The sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy of vascular color Doppler ultrasound were, respectively, 95.33%, 88.14%, 89.86%, 94.55%, and 91.94%. CONCLUSION: A good correlation between the 2 examinations was observed in the evaluation of the hemodynamically significant renal artery stenoses, making vascular color Doppler ultrasound a noninvasive method useful for selecting patients with suspected renovascular hypertension.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>artéria renal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ultra-som</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>renal artery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ultrasound</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Dor torácica por compressão atrial direita por timolipoma</s1>
</fA08>
<fA08 dir="en">
<s1>Chest pain due to right atrial compression caused by a thymolipoma</s1>
</fA08>
<fA11 dir="011000">
<s1>José Ramos Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo F. Melo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcelo de Macedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Antônio Fiorelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alexandre Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Roberto B. Isolatto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade São Francisco  </s1>
<s2>Atibaia SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>481-483</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiomiopatia mitocôndrica hipertrófica associada à síndrome de Wolff-Parkinson-White</s1>
</fA08>
<fA08 dir="en">
<s1>Mitochondrial hypertrophic cardiomyopathy associated with Wolff-Parkinson-White syndrome</s1>
</fA08>
<fA11 dir="011000">
<s1>Elsa Silva-Oropeza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Esperanza García Reyes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Lydia Rodríguez Hernández</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luisa Beirana Palencia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Mexicano del Seguro Social Centro Médico Nacional Siglo XXI </s1>
<s2> </s2>
<s3>México</s3>
</fA14>
<fA20 dir="000000">
<s1>487-489</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200512</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 5/2004 - Adolescente de 16 anos com anomalia de Ebstein Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>InCor  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>493-493</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200513</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Insuficiência cardíaca com função sistólica preservada</s1>
</fA08>
<fA11 dir="011000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jaderson Socrates</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Salvador Rassi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Humberto Villacorta</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Charles Mady</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>494-500</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200514</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Concordância do sistema de pontos para controle de colesterol e gordura no sangue</s1>
</fA08>
<fA08 dir="en">
<s1>Concordance of the scoring system for controlling the serum levels of cholesterol and fat</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcia de Araujo Leite Nacif</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Edeli Simioni de Abreu</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Elizabeth Aparecida Ferraz da Silva Torres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>455-458</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a compreensão do sistema de pontos para controle de colesterol e gordura no sangue, como instrumento de intervenção dietética para pacientes hipercolesterolêmicos. MÉTODOS: Estudados 153 indivíduos de ambos os sexos, com idades entre 20 e 65 anos, atendidos em um hospital e uma unidade básica de saúde, divididos em três grupos: hipercolesterolêmicos; sem diagnóstico de hipercolesterolemia e profissionais da área de saúde. Aplicado recordatório de 24h em cada indivíduo, que fazia a pontuação de índice de colesterol e gordura saturada de sua dieta, consultando o sistema de pontos, e a pesquisadora confirmava os cálculos de cada participante, sendo esta considerada o padrão de referência. O entendimento do sistema foi avaliado pela comparação entre a medida de referência e os dados obtidos pelos entrevistados, utilizando-se o coeficiente de correlação intraclasse. RESULTADOS: Os pacientes sem diagnóstico obtiveram alta correlação em todas as refeições. O café da manhã, a merenda e a ceia foram as refeições que obtiveram maior correlação (r=1). Nos hipercolesterolêmicos, a ceia foi a refeição que mais concordou com a pontuação de referência (r=1) e quanto aos profissionais de saúde obteve-se coeficiente de correlação de 1 em todas as refeições, exceto o almoço (r=0,99). CONCLUSÃO: O sistema de pontos mostrou-se rápido, simples e fácil de ser compreendido e aceito pela população estudada.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the comprehension of the scoring system for controlling the serum levels of cholesterol and fat as an instrument of dietary intervention for hypercholesterolemic patients. METHODS: The study comprised 153 individuals of both sexes, with ages ranging from 20 to 65 years, who sought medical care in a hospital or in a basic health unit. They were divided into the following 3 groups: hypercholesterolemic individuals, individuals with no diagnosis of hypercholesterolemia, and health care professionals. A 24-hour recall was used with each individual, who applied the cholesterol/saturated-fat index to their diets, consulting the scoring system. The researcher confirmed the calculation of each participant, considering her calculation as the a reference pattern. Understanding of the system was assessed through comparison between the reference pattern and the data obtained by the interviewees, using the intraclass correlation coefficient. RESULTS: The patients without a diagnosis of hypercholesterolemia obtained a high correlation in all meals. The morning and afternoon snacks and supper were the meals with the greatest correlation (r=1). In hypercholesterolemic individuals, supper was the meal with the greatest concordance with the reference score (r=1), and the health care professionals obtained a correlation coefficient of 1 in all meals, except lunch (r=0.99). CONCLUSION: The scoring system was fast, simple, and easy to be understood and accepted by the population studied.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>índice de colesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lipídios</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sistema de pontos</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cholesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipids</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>score system</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiomiopatia dilatada em crianças: existe um preditor ecocardiográfico de prognóstico?</s1>
</fA08>
<fA11 dir="011000">
<s1>Samira Saady Morhy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Incor</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>501-502</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>O cardiologista deve suspeitar mais das disfunções tireoidianas!</s1>
</fA08>
<fA11 dir="011000">
<s1>Angelo V. A. de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cláudio Cirenza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rui M. B. Maciel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>503-504</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>A ecocardiografia com contraste no diagnóstico de dilatações vasculares intrapulmonares em candidatos ao transplante hepático</s1>
</fA08>
<fA08 dir="en">
<s1>Contrast echocardiography in the diagnosis of intrapulmonary vascular dilations in candidates for liver transplantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Roberto Pavarino</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Hélio Augusto dos Reis Corbucci</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Henrique de Marchi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paula Fernanda da Mata</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Moacir Fernandes de Godoy</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital de Base de São José do Rio Preto  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Faculdade de Medicina de São José do Rio Preto - SP  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>515-518</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a importância da ecocardiografia com contraste no diagnóstico de dilatações vasculares intrapulmonares em portadores de doenças hepáticas graves, candidatos a transplante. MÉTODOS: Estudados 76 pacientes com doenças hepáticas crônicas, sem evidências de doenças intrínsecas pulmonares, insuficiência cardíaca ou cardiopatias congênitas com comunicações intracardíacas, submetidos ao ecocardiograma transtorácico, sendo que em 32 realizou-se, consecutivamente, o estudo transesofágico. O resultado da ecocardiografia com contraste foi positivo quando detectada a presença de contraste em câmaras cardíacas esquerdas, 4 a 6 ciclos cardíacos, após opacificação das câmaras cardíacas direitas. RESULTADOS: A prevalência de dilatações vasculares intrapulmonares foi de 53,9% (41/76 pacientes). A sensibilidade, especificidade, valor preditivo positivo, valor preditivo negativo e acurácia do ecocardiograma transtorácico em relação ao transesofágico, na confirmação de anormalidades vasculares pulmonares em hepatopatas foi, respectivamente, de 75%, 100%, 100%, 80% e 87,5%. O grau de oxigenação arterial não apresentou qualquer correlação com a ocorrência de estudo ecocardiográfico positivo. CONCLUSÃO: A ecocardiografia com contraste mostrou-se eficaz, de utilização fácil e segura em candidatos ao transplante hepático. O ecocardiograma transtorácico pode ser empregado na rotina diagnóstica das dilatações vasculares intrapulmonares, reservando-se o estudo transesofágico para os casos inconclusivos com suspeita clínica.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the importance of contrast echocardiography in the diagnosis of intrapulmonary vascular dilations in patients with severe liver disease, who are candidates for liver transplantation. METHODS: The study comprised 76 patients with chronic liver disease and no evidence of intrinsic pulmonary disease, heart failure, or congenital heart disease with intracardiac communications, who underwent transthoracic echocardiography with second harmonic imaging. Thirty-two of them underwent consecutive transesophageal study. The result of contrast echocardiography was considered positive when the presence of contrast was detected in the left cardiac chambers with a delay of 4 to 6 cardiac cycles after initial opacification of the right cardiac chambers. RESULTS: The prevalence of intrapulmonary vascular dilations was 53.9% (41/76 patients). The sensitivity, specificity, positive and negative predictive values, and accuracy of transthoracic echocardiography as compared with those of transesophageal echocardiography for confirming pulmonary vascular abnormalities in patients with liver disease were, respectively, 75%, 100%, 100%, 80%, and 87.5%. The degree of arterial oxygenation showed no correlation with the occurrence of a positive echocardiographic study. Arterial hypoxemia (PaO2 &lt; 70 mm Hg) was observed in 9 (15.9%) of the 76 patients. The echocardiographic study was positive in 37 (55.2%) of the 67 nonhypoxemic patients and in 4 (44.4%) of the 9 hypoxemic ones. CONCLUSION: Contrast echocardiography proved to be effective, easy, and safe to use in candidates for liver transplantation. Transthoracic echocardiography may be used in the diagnostic routine of intrapulmonary vascular dilations, the transesophageal study being reserved for inconclusive cases with clinical suspicion.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia com contraste</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dilatações vasculares intrapulmonares</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>transplante hepático</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>contrast echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>intrapulmonary vascular dilations</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>liver transplantation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Doenças cardiovasculares na população idosa: análise do comportamento da mortalidade em município da região Sul do Brasil no período de 1979 a 1998</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiovascular diseases in the elderly: analysis of the behavior of mortality in a municipality in the Southern Region of Brazil from 1979 to 1998</s1>
</fA08>
<fA11 dir="011000">
<s1>Thais Aidar de Freitas Mathias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Helena Prado de Mello Jorge</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ruy Laurenti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Maringá Departamento de Enfermagem </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>533-541</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>40</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Conhecer o comportamento da mortalidade por doenças cardiovasculares em idosos residentes em Maringá-PR. MÉTODOS: Foram analisadas as causas de morte num período de 20 anos, segundo sexo, idade e agrupamentos da Classificação Internacional de Doenças, 9ª e 10ª Revisões, utilizando-se banco de dados de mortalidade do Ministério da Saúde. RESULTADOS: Em relação ao total de óbitos em idosos, a mortalidade proporcional por doenças cerebrovasculares e doença isquêmica do coração diminuiu 42,5% e 34,4% e aumentou de 119% para a hipertensão que passou de 2,1% para 4,6%. Houve queda do risco de morte por doença cerebrovascular, doença isquêmica do coração e outras formas de doenças do coração de 51,2%, 44,6% e de 12,5%, respectivamente. Para a doença cerebrovascular e doença isquêmica do coração, a queda na estimativa do risco de morte foi maior para as mulheres e, para as outras formas de doenças do coração, a queda foi maior para os homens. Em relação às faixas etárias observou-se que os riscos de óbito são crescentes à medida que avança a idade para cada uma das doenças cardiovasculares, em ambos os sexos. CONCLUSÃO: As doenças cardiovasculares continuam sendo importantes na morbimortalidade da população idosa, exigindo ainda maiores esforços dos serviços de saúde para sua prevenção e tratamento.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To know the behavior of mortality due to cardiovascular diseases in the elderly living in the municipality of Maringá, in the Brazilian state of Paraná. METHODS: The causes of death over 20 years were studied according to sex, age, and groupings of the International Classification of Diseases, 9th and 10th Revisions, using the mortality database of the Ministry of Health. RESULTS: In regard to total deaths in the elderly, the proportional mortality due to cerebrovascular disease and ischemic heart disease decreased 42.5% and 34.4%, respectively, while that due to hypertension increased 119%, increasing from 2.1% to 4.6%. A 51.2%, 44.6%, and 12.5% decrease occurred, respectively, in the risk of death due to cerebrovascular disease, ischemic heart disease, and other forms of heart disease. For cerebrovascular disease and ischemic heart disease, the decrease in the estimate of the risk of death was greater among women, while for the other forms of heart disease, the decrease was greater among men. In regard to age groups, the risk of death increases as age advances for each cardiovascular disease in both sexes. CONCLUSION: Cardiovascular diseases continue to play an important role in morbidity and mortality in the elderly population, requiring even greater effort from health care providers for their prevention and treatment.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doenças cardiovasculares</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>idosos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mortalidade</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mortality</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Hipovolemia grave como causa de insuficiência mitral aguda</s1>
</fA08>
<fA08 dir="en">
<s1>Severe volume depletion leading to mitral insufficiency</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre C. Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Arley Arrais Peter</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Simon Chakko</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Howard Willens</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eduardo de Marchena</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de Miami Centro Cardiovascular Divisão de Cardiologia</s1>
<s2>Miami </s2>
<s3>EUA</s3>
</fA14>
<fA20 dir="000000">
<s1>559-560</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 6/2004 - lactente de 14 meses com tetralogia de Fallot e com discreto hiperfluxo pulmonar. Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>567-567</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Como o ecocardiograma pode ser útil em predizer a morte em crianças com cardiomiopatia dilatada idiopática?</s1>
</fA08>
<fA08 dir="en">
<s1>How can the echocardiogram be useful for predicting death in children with idiopathic dilated cardiomyopathy?</s1>
</fA08>
<fA11 dir="011000">
<s1>Vitor Manuel Pereira Azevedo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Francisco Manes Albanesi Fº</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marco Aurélio Santos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Márcia Bueno Castier</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Bernardo Rangel Tura</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Nacional de Cardiologia Laranjeiras  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>505-509</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar os fatores preditores ecocardiográficos de morte em crianças com cardiomiopatia dilatada idiopática. MÉTODOS: Estudo retrospectivo de 148 crianças com cardiomiopatia dilatada idiopática diagnosticadas entre setembro/1979 a março/2003. Critérios para inclusão: insuficiência cardíaca e redução da contratilidade no ecocardiograma, na ausência de cardiopatia congênita ou secundária. Foram analisados 470 exames, durante 244,8 meses de evolução. Parâmetros analisados: dimensão do átrio esquerdo (DAE), relação átrio esquerdo/aorta (DAE/Ao), dimensão sistólica (DSVE) e diastólica (DDVE) do VE, massa do VE (massa), dimensão do ventrículo direito (DVD), fração de ejeção do VE (FE), percentagem de encurtamento do VE (%EC), gravidade da insuficiência das valvas atrioventriculares e da valva pulmonar e medida da pressão sistólica (PsVD) e diastólica (PdVD) do VD. Foi considerado significativo erro alfa &lt;0,05. RESULTADOS: Idade média de 2,37 anos, ocorridos 35 óbitos (23,7% - IC95=17,1% a 31,2%). ANOVA demonstrou: DAE (p&lt;0,0001), DAE/Ao (p&lt;0,0001), DSVE (p=0,0061), DDVE (p=0,0086), massa (p&lt;0,0001), FE (p=0,0074), %EC (p=0,0072) e DVD (p&lt;0,0001). O agravamento da insuficiência mitral (IM) (p=0,0113) e tricúspide (IT) (p=0,0044) foram marcadores de óbito e a presença de IM, IT e insuficiência pulmonar moderada/grave foram deletérias à sobrevida. A análise de Cox demonstrou como preditores independentes da morte: DAE/Ao (p=0,0487), FE (&lt;0,0001) e presença de IM moderada/grave (p=0,0419). CONCLUSÃO: Os pacientes com aumento progressivo da DAE/Ao, redução da FE e agravamento progressivo da IM, a despeito do tratamento clínico, devem ser considerados precocemente em programa de transplante cardíaco.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the echocardiographic predicting factors of death in children with idiopathic dilated cardiomyopathy. METHODS: A retrospective study of 148 children with idiopathic dilated cardiomyopathy diagnosed between September 1979 and March 2003 was carried out. The inclusion criteria were as follows: heart failure and a reduction in contractility on the echocardiogram in the absence of congenital or secondary heart disease. Four hundred and seventy examinations during a period of 244.8 months of evolution were analyzed. The following parameters were assessed: left atrial dimension (LAD); left atrium/aorta ratio (LAD/Ao); left ventricular systolic (LVSD) and diastolic (LVDD) dimensions; left ventricular mass (LVmass); right ventricular dimension (RVD); left ventricular ejection fraction (LVEF); left ventricular shortening fraction (% SH); severity of the insufficiency of the atrioventricular and pulmonary valves; and right ventricular systolic (RVSP) and diastolic (RVDP) pressures. The significance level adopted was alpha &lt; 0.05. RESULTS: The mean age was 2.37 years, and 35 patients died (23.7% - 95 CI = 17.1% to 31.2%). The analysis of variance showed the following: LAD (p&lt;0.0001); LAD/Ao (p&lt;0.0001); LVSD (p=0.0061); LVDD (p=0.0086); LVmass (p&lt;0.0001); LVEF (p=0.0074); %SH (p=0.0072); and RVD (p&lt;0.0001). Worsening of mitral (MI) (p=0.0113) and tricuspid (TI) insufficiencies (p=0.0044) were markers of death, and the presence of MI, TI, and moderate/severe pulmonary insufficiency were deleterious to survival. The Cox proportional hazards regression model showed the following independent predictors of death: LAD/Ao (p=0.0487); LVEF (&lt;0.0001); and the presence of moderate/severe MI (p=0.0419). CONCLUSION: Patients with a progressive increase in LAD/Ao, a reduction in LVEF, and progressive worsening of MI, regardless of the clinical treatment, should be considered for early heart transplantation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiomiopatia dilatada idiopática</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>preditores de morte</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>criança</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>idiopathic dilated cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>predictors of death</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>children</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Disfunção tireoidiana e conduta dos cardiologistas em pacientes usando amiodarona</s1>
</fA08>
<fA08 dir="en">
<s1>Thyroid dysfunction and cardiological management in patients receiving amiodarone</s1>
</fA08>
<fA11 dir="011000">
<s1>Anna Gabriela Fuks</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mário Vaisman</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alexandru Buescu</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFRJ Hospital Universitário Clementino Fraga Filho </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital de Cardiologia de Laranjeiras  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>523-527</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>48</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a prevalência de disfunção tireoidiana em pacientes usando amiodarona e os possíveis fatores associados. Verificar através de questionário aplicado a cardiologistas, a importância do fármaco causar alterações na função tireoidiana. MÉTODO: Avaliados 56 pacientes em uso crônico (&gt; 3 meses) de amiodarona com dosagens séricas de TSH, T4 livre, T3 total e Anti-TPO e definidos como portadores de disfunção tireoidiana (DT) pacientes com TSH alterado. RESULTADOS: A prevalência de disfunção tireoidiana foi de 33,9%. Não houve diferença entre este grupo e os pacientes sem disfunção, exceto em relação à prevalência de anti-TPO positivo maior nos pacientes com DT (p=0,02). Hipotireoidismo subclínico foi diagnosticado em 10 (17,9%) pacientes e hipotireoidismo clínico em 6 (10,7%). A prevalência de hipertireoidismo subclínico foi de 3,6% e de hipertireoidismo clínico de 1,8%. Anticorpos anti-TPO foram positivos em 5 (8%) pacientes (dos quais 4 apresentavam disfunção). Quando comparados aos doentes sem anti-TPO positivo este grupo teve maior prevalência de disfunção (80% vs 29,4%; p=0,04). Verificado que apenas 49,2% dos cardiologistas faziam acompanhamento da função tireoidiana rotineiramente e a prevalência de disfunção referida na experiência da maioria era de 1 a 10%. CONCLUSÃO: A prevalência de disfunção tireoidiana na nossa população foi elevada, mostrando a necessidade de implementação de uma rotina laboratorial. Houve grande divergência entre os cardiologistas em relação ao tipo de acompanhamento utilizado nos pacientes em uso de amiodarona.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the prevalence of thyroid dysfunction in patients receiving amiodarone, and the possible associated factors. The study also aimed at assessing the effect of amiodarone on thyroid function through the application of a questionnaire to cardiologists. METHOD: Fifty-six patients chronically (&gt; 3 months) receiving amiodarone were assessed by measurement of their serum levels of TSH, free T4, total T3, and anti-TPO antibodies. Patients with changes in TSH levels were defined as having thyroid dysfunction (TD). RESULTS: The prevalence of thyroid dysfunction was 33.9%. No difference was observed between this group and that of patients with no dysfunction, except for the greater prevalence of anti-TPO positivity in patients with TD (P=0.02). Subclinical hypothyroidism was diagnosed in 10 (17.9%) patients and clinical hypothyroidism in 6 (10.7%). The prevalence of subclinical hyperthyroidism was 3.6% and that of clinical hyperthyroidism was 1.8%. Anti-TPO antibodies were positive in 5 (8%) patients (of whom, 4 had thyroid dysfunction). When compared with patients negative for anti-TPO antibodies, that group had a greater prevalence of dysfunction (80% vs 29.4%; P=0.04). Only 49.2% of the cardiologists routinely treated their patients' thyroid function, and the prevalence of the referred dysfunction for most of them ranged from 1 to 10%. CONCLUSION: The prevalence of thyroid dysfunction in our population was high, showing the need for implementing a laboratory routine. The cardiologists disagreed greatly in regard to the type of follow-up required for patients using amiodarone.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>amiodarona</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>disfunção tireoidiana</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipotireoidismo</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>amiodarone</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thyroid dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypothyroidism</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Estratégia para individualizar uma dose eficiente de betabloqueador em pacientes idosos com isquemia miocárdica e função ventricular esquerda preservada</s1>
</fA08>
<fA08 dir="en">
<s1>Strategy for identifying an efficient dosage of beta-blocker for elderly patients with myocardial ischemia and preserved left ventricular function</s1>
</fA08>
<fA11 dir="011000">
<s1>João Batista Serro-Azul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mauricio Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Amit Nussbacher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria C. Giorgi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José C. Meneghetti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marco A. de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Rubens Abe</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Creusa Dal Bó</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Humberto Pierri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Otávio Gebara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>551-554</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar estratégia de titulação para prescrever uma dose de propranolol que seria eficiente em reduzir isquemia do miocárdio em idosos. MÉTODOS: Foram estudados 14 homens idosos (73,6 ± 5,3 anos), portadores de doença coronariana estável, documentada pela cinecoronariografia, com resposta isquêmica ao teste ergométrico e função ventricular esquerda preservada. O propranolol foi titulado a fim de atingir redução de 15% na freqüência cardíaca, ao final da carga de 50 W (correspondente às atividades diárias normais de idosos), em testes ergométricos semanais e feito estudo cintilográfico sincronizado das câmaras cardíacas, em repouso e durante exercício, antes e após seu uso. RESULTADOS: As reduções da freqüência cardíaca na carga de 50 W e em repouso foram semelhantes (21% vs 20%; p=0,5100). O propranolol melhorou a duração do exercício (12,2 ± 2,0 min vs 13,1 ± 1,8 min; p=0,0313) e aboliu as alterações do segmento ST induzidas pelo exercício em 8 (57%) pacientes. Em repouso, a fração de ejeção não foi modificada pelo betabloqueador. Durante o exercício máximo, o propranolol reduziu o índice de volume sistólico final e aumentou a fração de ejeção. CONCLUSÃO: A estratégia de empregar betabloqueadores para reduzir a freqüência cardíaca em 15% na carga de 50 W é segura e benéfica nos idosos com isquemia miocárdica e função ventricular preservada. A dose utilizada reduziu a isquemia miocárdica e melhorou a tolerância ao exercício, sem prejudicar o desempenho ventricular durante exercício máximo.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the strategy of titration for prescribing an efficient dosage of propranolol to reduce myocardial ischemia in the elderly. METHODS: The study comprised 14 elderly men (73.6 ± 5.3 years) with stable coronary heart disease documented on coronary cineangiography, ischemic response to exercise testing, and preserved left ventricular function. Titration was performed to identify the dosage of propranolol that would cause a 15% reduction in heart rate at the end of a 50 W load (corresponding to normal daily activities in the elderly) in weekly exercise tests. Synchronous scintigraphic study of the cardiac chambers was performed at rest and during exercise prior to and after propranolol use. RESULTS: The reductions in heart rate with the 50 W load and at rest were similar (21% vs 20%; P=0.5100). Propranolol improved the duration of exercise (12.2 ± 2.0 min vs 13.1 ± 1.8 min; P=0.0313) and abolished the changes in the ST segment induced by exercise in 8 (57%) patients. At rest, the ejection fraction was not modified by the beta-blocker. During maximum exercise, propranolol reduced the end-systolic volume index and increased ejection fraction. CONCLUSION: The strategy of using beta-blockers to reduce heart rate by 15% with a 50 W load is safe and beneficial in the elderly patient with myocardial ischemia and preserved ventricular function. The dose of beta-blocker used reduced myocardial ischemia and improved tolerance to exercise without hampering ventricular performance during maximum exercise.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>betabloqueador</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>idoso</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>isquemia miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>beta-blocker</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial ischemia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>82</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 2/2004 - Febre, dor torácica, dispnéia e edema em homem de 42 anos. (Instituto do Coração HC-FMUSP, São Paulo)</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Eduardo Pereira Pesaro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Sampaio Gutierrez</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>563-566</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08200609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>XXVIII Olimpíadas, Atenas. O cardiologista está preparado?</s1>
</fA08>
<fA11 dir="011000">
<s1>Renata Rodrigues Teixeira de Castro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Claudio Lucas da Nóbrega</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Eduardo Henrique De Rose</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense Depto de Fisiologia e Farmacologia Laboratório de Ciências do Exercício</s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-3</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Significado clínico das dissecções coronarianas não complicadas após o implante de &quot;stents&quot;</s1>
</fA08>
<fA08 dir="en">
<s1>Clinical meaning of uncomplicated coronary dissections after stent implantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre Schaan de Quadros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos A. M. Gottschall</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rogério Sarmento-Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Lenise Valler</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>André Bussmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3>Brasil</s3>
</fA14>
<fA20 dir="000000">
<s1>4-10</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar a influência de dissecções coronarianas não complicadas na incidência de revascularização do vaso alvo e eventos cardiovasculares maiores, em um ano. MÉTODO: Pacientes tratados de junho/1996 a dezembro/2000, sendo os dados coletados, prospectivamente, e comparadas dissecções não complicadas (G1, n=36) às sem dissecções (G2, n=871). Os dados foram analisados com programa estatístico SPSS 8,0, os desfechos comparados com curvas de Kaplan-Meier e o nível de significância avaliado pelo teste do log rank. RESULTADOS: As características clínicas foram semelhantes nos dois grupos: O G1 apresentou diâmetro de referência médio menor (p&lt;0,0001), mais pacientes com lesões tipo C (p=0,01), menores diâmetros luminais ao final do procedimento (p=0,003) e maiores relações balão/artéria (p&lt;0,0001). Por análise multivariada, somente diâmetro de referência e relação balão-artéria foram independentemente associados à presença de dissecções residuais. Não houve diferença estatisticamente significativa nas incidências de revascularização do vaso alvo e eventos cardiovasculares maiores, no seguimento clínico em um ano, entre os grupos de pacientes com ou sem dissecções. Os preditores de eventos clínicos adversos em um ano foram diâmetro de referência, extensão da lesão e estenose residual, mas não a presença de dissecção residual. CONCLUSÃO: Dissecções residuais não complicadas após o implante de &quot;stents&quot; coronarianos estão associadas a artérias de menor calibre e maiores relações balão/artéria, mas não com piores desfechos no seguimento clínico em um ano.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the influence of uncomplicated coronary dissections in the incidence of target vessel revascularization and cardiovascular events after 1 year. METHODS: Patients treated from June 1996 to December 2000, with data prospectively collected and uncomplicated dissections (G1, n=36), were compared with those patients without dissections (G2, n=871). Data were assessed with SPSS 8.0 statistical software, the outcomes were compared with the Kaplan-Meier curve, and the significance level was assessed using the log-rank test. RESULTS: Clinical features were similar in both groups: G1 had lower mean reference diameters (P&lt;0.0001), a greater number of patients with type C lesions (P=0.01), a lower final lumen diameter at the end of the procedure (P=0.003), and a greater balloon/artery ratio (P&lt;0.0001). In the multivariate analysis, only the reference diameter and the artery/balloon ratio were independently associated with the presence of residual dissections. No statistically significant difference existed in the incidence of revascularization of the target vessel and major cardiovascular events, at 1-year clinical follow-up, between the 2 groups of patients. Predictors of adverse clinical events at 1 year were the reference diameter, lesion extension, and residual stenosis, rather than the presence of residual dissection. CONCLUSION: Uncomplicated residual dissections after coronary stents are associated with narrower vessels and a higher balloon/artery ratio. Residual dissections are not associated with worse outcomes at 1-year clinical follow-up.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hemodinâmica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>stents</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dissecção</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hemodynamic</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stents</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dissection</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Redução do período de internação e de despesas no atendimento de portadores de cardiopatias congênitas submetidos à intervenção cirúrgica cardíaca no protocolo da via rápida</s1>
</fA08>
<fA08 dir="en">
<s1>The reduction in hospital stay and costs in the care of patients with congenital heart diseases undergoing fast-track cardiac surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Alfredo Manoel da Silva Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alfredo José Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luis Fernando Canêo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Domingos Dias Lourenço</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marilde Albuquerque Piccioni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sonia Mieken Franchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Cristina Machado C. Afiune</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Jorge Wiliam Gadioli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Sérgio de Almeida Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>18-26</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o atendimento de cardiopatas congênitos e cardiopatas isquêmicos submetidos à cirurgia cardíaca no protocolo de atendimento na via rápida (fast-track recovery) em relação ao convencional. MÉTODOS: Avaliada a movimentação de 175 pacientes, 107 (61%) homens e 68 (39%) mulheres, idades entre 0,3-81 anos nas diferentes unidades hospitalares. RESULTADOS: A taxa de alta das diferentes unidades hospitalares por unidade de tempo, dos cardiopatas congênitos atendidos no protocolo da via rápida em relação ao convencional foi: a) 11,3 vezes a taxa de alta quando assistidos no protocolo da via convencional, quanto ao tempo de permanência no centro cirúrgico; b) 6,3 vezes quanto à duração da intervenção cirúrgica; c) 6,8 vezes quanto à duração da anestesia; d) 1,5 vezes quanto à duração da perfusão; e) 2,8 vezes quanto à permanência na unidade de recuperação pós-operatória I; f) 6,7 vezes quanto à permanência no hospital (período de tempo entre a data da internação e a data da alta); g) 2,8 vezes quanto à permanência na unidade de internação pré-operatória; h) 2,1 vezes quanto à permanência na unidade de internação após a alta da recuperação pós-operatória; i) associada com redução de despesas pré e pós-operatórias. A diferença não foi significativa nos portadores de cardiopatia isquêmica. CONCLUSÃO: Verificou-se redução do período de internação e de despesas no atendimento dos pacientes submetidos à intervenção cirúrgica cardíaca no protocolo da via rápida.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the care provided to patients with congenital heart diseases and ischemic heart diseases undergoing cardiac surgery according to the fast-track recovery protocol compared with those undergoing the conventional procedure. METHODS: The transfer of patients from one hospital unit to another was assessed for 175 patients, 107 (61%) men and 68 (39%) women, with ages ranging from 0.3 to 81 years. RESULTS: The discharge rate from the different hospital units per unit of time of the patients with congenital heart diseases treated according to the fast-track recovery protocol compared with that of patients conventionally treated was as follows: a) 11.3 times faster than the discharge rate of patients treated according to the conventional protocol, in regard to the time spent in the operating room; b) 6.3 times faster in regard to the duration of the surgical intervention; c) 6.8 times faster in regard to the duration of anesthesia; d) 1.5 times faster in regard to the duration of perfusion; e) 2.8 times faster in regard to the stay in the postoperative recovery I unit; f) 6.7 times faster in regard to hospital stay (time period between hospital admission and hospital discharge); g) 2.8 times faster in regard to the stay in the preoperative unit; h) 2.1 times faster in regard to the stay in the admission unit after discharge from postoperative recovery; i) associated with reduced costs. The difference was not significant for patients with ischemic heart disease. CONCLUSION: A reduction in the length of hospital stay and costs for the care of patients undergoing cardiac surgery according to the fast-track protocol was observed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>relação custo-benefício</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatias congênitas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tratamento</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cost-benefit ratio</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treatment</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Estresse ortostático ativo e arritmia sinusal respiratória em chagásicos com função sistólica global do ventrículo esquerdo preservada</s1>
</fA08>
<fA08 dir="en">
<s1>Active orthostatic stress and respiratory sinus arrhythmia in patients with Chagas' disease with preserved left ventricular global systolic function</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Luiz P. Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Lídia Magda Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Enilce de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo C. F. Cruzeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rosália Moraes Torres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Manoel Otávio Costa Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Minas Gerais  </s1>
<s2>Belo Horizonte MG</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>35-39</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>37</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a utilização do teste de estresse ostostático ativo na detecção de disfunção vagal em chagásicos com função sistólica global preservada, comparando-o ao teste da arritmia sinusal respiratória. MÉTODO: Foram selecionados 61 chagásicos (Ch) e 38 não-chagásicos (NCh) sem evidências significativas de cardiopatia ou doenças sistêmicas, submetidos ao ecodopplercardiograma e às provas autonômicas. O teste da arritmia sinusal respiratória foi realizado através do registro eletrocardiográfico enquanto o paciente respirava profundamente, a 6 irpm, calculando-se a razão E:I (média das razões entre os maiores intervalos RR expiratórios e os menores RR inspiratórios a cada ciclo). O eletrocardiograma foi registrado enquanto o paciente se levantava e nos 30s seguintes (teste do estresse ortostático ativo), calculando-se a razão RR máx./RR min (maior e menor intervalo RR logo após a mudança postural). Os índices foram ajustados para covariáveis significativas. RESULTADOS: A razão RR max:min (NCh: 1,52 [1,44-1,74] x Ch: 1,43 [1,33-1,51], p &lt; 0,001) e a razão E:I (NCh: 1,38&amp;plusmn;0,02 x Ch: 1,25&amp;plusmn;0,02, p&lt;0,001) foram menores entre os chagásicos. Houve elevada correlação entre a razão RR max:min e a razão E:I ajustadas (r = 0,628, p &lt; 0,001), mas ambas não se correlacionaram significativamente com a fração de ejeção do ventrículo esquerdo. CONCLUSÃO: Chagásicos com função sistólica global do ventrículo esquerdo preservada apresentam redução significativa de índices vagais obtidos por provas curtas, quando comparados a controles normais. O teste de estresse ortostático ativo apresentou boa correlação com a manobra de arritmia sinusal respiratória, constituindo-se opção válida na avaliação ambulatorial do controle vagal.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the use of the active orthostatic stress test for detecting vagal dysfunction in patients with Chagas' disease with preserved overall systolic function, and to compare it with the respiratory sinus arrhythmia test. METHODS: Sixty-one chagasic patients (Ch) and 38 nonchagasic (NCh) patients with no significant evidence of heart disease or systemic diseases underwent Doppler echocardiography and autonomic function tests. The respiratory sinus arrhythmia test was performed through electrocardiographic recording during deep breathing, at 6 ripm, calculating the E:I ratio (mean ratio between the longest expiratory RR interval and the shortest inspiratory RR interval at each cycle). The electrocardiogram was recorded during the act of standing and during the following 30 seconds (active orthostatic stress test), and the max RR/min RR ratio (the longest and shortest RR intervals right after change in posture) was calculated. The indices were adjusted for significant covariables. RESULTS: The max RR/min RR ratio (NCh: 1.52 [1.44-1.74] x Ch: 1.43 [1.33-1.51], P &lt; 0.001) and the E:I ratio (NCh: 1.38&amp;plusmn;0.02 x Ch: 1.25&amp;plusmn;0.02, P&lt;0.001) were lower among chagasic patients. A high correlation was observed between the adjusted max RR/min RR ratio and E:I ratio (r = 0.628, P &lt; 0.001), but neither significantly correlated with left ventricular ejection fraction. CONCLUSION: Chagasic patients with preserved left ventricular overall systolic function showed a significant reduction in the vagal indices obtained on short-lasting tests, as compared with normal controls. The active orthostatic stress test that, showed a good correlation with the respiratory sinus arrhythmia maneuver, constituted a valid option for the outpatient care assessment of vagal control.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença de Chagas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sistema nervoso autônomo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ortostatismo</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>autonomous nervous system</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>orthostatism</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Fluxo no ducto venoso e hipertrofia miocárdica em fetos de mães diabéticas</s1>
</fA08>
<fA08 dir="en">
<s1>Ductus venosus flow and myocardial hypertrophy in fetuses of diabetic mothers</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Silvana Marcantonio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz Henrique Nicoloso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Stelamaris Luchese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Domingos Hatem</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marlui Scheid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>João Luiz Mânica</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Eduardo Ioschpe Gus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Fabíola Satler</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Antônio L. Piccoli Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul</s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>45-50</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Testar a hipótese de que o índice de pulsatilidade do ducto venoso (IPDV) é maior nos fetos de mães diabéticas (FMD) com hipertrofia miocárdica (HM) do que em FMD sem HM e em fetos controles de mães não diabéticas (FMND) comparando os resultados com os picos de velocidade dos fluxos diastólicos nas valvas mitral e tricúspide. MÉTODOS: Estudo transversal incluindo fetos com idade gestacional entre 20 semanas até o termo, divididos em 3 grupos: 56 FMD com HM (grupo I), 36 FMD sem HM (grupo II) e 53 FMND (grupo III, controle). O Doppler-ecocardiograma avaliou o IPDV através da razão (velocidade sistólica - velocidade pré-sistólica)/velocidade média. As ondas E e A dos fluxos mitral e tricúspide foram também avaliadas. RESULTADOS: A média do IPDV no grupo I foi de 1,13 &amp;plusmn; 0,64, no grupo II, de 0,84 &amp;plusmn; 0,38 e no grupo III de 0,61&amp;plusmn;0,17. Aplicando-se a ANOVA e o teste de Tukey, houve diferença estatisticamente significativa entre os 3 grupos (p= 0,015 entre os grupos I e II, p &lt; 0,001 entre os grupos I e III e p = 0,017 entre os grupos II e III). A média da onda E mitral foi significativamente maior no grupo I (0,39 &amp;plusmn; 0,12 m/s) do que nos grupos II (0,32 &amp;plusmn; 0,08 m/s) (p=0,024) e III (0,32 &amp;plusmn; 0,08 m/s) (p=0,023). A média da onda E tricúspide foi também maior no grupo I (0,43 &amp;plusmn; 0,1 m/s) do que no grupo III (0,35 &amp;plusmn; 0,10 m/s) (p= 0,031). CONCLUSÃO: O IPDV é significativamente maior em FMD com HM do que em FMD sem HM e do que em FMND. Como o IPDV pode representar modificações na complacência ventricular, este índice pode ser um parâmetro mais sensível para a avaliação da função diastólica fetal.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To test the hypothesis that the pulsatility index of ductus venosus (PIDV) is greater in the fetuses of diabetic mothers (FDM) with myocardial hypertrophy (MH) than in the FDM with no MH and in the control fetuses of nondiabetic mothers (FNDM). Comparing the results with mitral and tricuspid diastolic peak flows. METHODS: The cross-sectional study included fetuses with gestational ages ranging from 20 weeks to term, divided into the following 3 groups: 56 FDM with MH (group I), 36 FDM with no MH (group II), and 53 FNDM (group III, control). The Doppler echocardiogram assessed the PIDV through the ratio (systolic velocity - presystolic velocity)/mean velocity. The mitral and tricuspid E and A waves were also assessed. RESULTS: The mean PIDV in groups I, II, and III were 1.13 &amp;plusmn; 0.64, 0.84 &amp;plusmn; 0.38, and 0.61&amp;plusmn;0.17, respectively. Using ANOVA and the Tukey test, a statistically significant difference was found in the 3 groups (P = 0.015 between groups I and II; P &lt; 0.001 between groups I and III; and P = 0.017 between groups II and III). The mean mitral E wave was significantly greater in group I (0.39 &amp;plusmn; 0.12 m/s) than in groups II (0.32 &amp;plusmn; 0.08 m/s) (P = 0.024) and III (0.32 &amp;plusmn; 0.08 m/s) (P = 0.023). The mean tricuspid E wave was also greater in group I (0.43 &amp;plusmn; 0.1 m/s) than in group III (0.35 &amp;plusmn; 0.10 m/s) (P = 0.031). CONCLUSION: The PIDV is significantly greater in FDM with MH than in FDM with no MH and in FNDM. Because the PIDV may represent modifications in ventricular compliance, this index may be a more sensitive parameter for assessing fetal diastolic function.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>diabetes materno</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia miocárdica fetal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ducto venoso</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função diastólica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>maternal diabetes</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetal myocardial hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ductus venosus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diastolic function</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Braquiterapia intracoronariana. Tratamento da reestenose intra-stent com o sistema Beta-Cath: experiência inicial na América Latina</s1>
</fA08>
<fA08 dir="en">
<s1>Intracoronary brachytherapy. Treatment of in-stent restenosis with the Beta-Cath system: initial experience in Latin America</s1>
</fA08>
<fA11 dir="011000">
<s1>Juan Simon Muñoz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fausto Feres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alexandre C. Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz A. Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rodolfo Staico</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marinella Centemero</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Luiz F. Tanajura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Ibraim Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Amanda G.M.R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>J. Eduardo Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>57-62</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>39</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a segurança e eficácia da braquiterapia intracoronariana usando o sistema Beta-CathTM na prevenção da recorrência de restenose intra-stent (RIS), por meio da análise dos resultados clínicos, angiográficos e pelo ultra-som intracoronariano (USIC). MÉTODO: Foram submetidos à angioplastia com cateter-balão, seguida de beta-radiação intracoronariana com o sistema Beta-CathTM (90Sr/Y) 30 pacientes com RIS em artérias coronárias nativas e, posteriormente, avaliados. RESULTADOS: Incluíram-se lesões reestenóticas complexas (77% do tipo difuso-proliferativo) com extensão elevada (18,66±4,15 mm). O sucesso da braquiterapia foi de 100%. A dose média utilizada foi de 20,7±2,3 Gy, liberada em um período médio de 3,8±2,1 min. No seguimento tardio, o diâmetro luminal mínimo (DLM) intra-stent diminuiu discretamente (1,98±0,30mm para 1,84±0,39 aos 6 meses, p=0,13), com uma perda tardia de 0,14±0,18 mm. O DLM intra-segmentar foi significativamente menor do que o intra-stent (1,55±0,40mm vs.1,84±0,39mm, p=0,008), associando-se à perda tardia (0,40±0,29mm vs. 0,14±0,18mm; p=0,0001). No USIC, observou-se discreto incremento do tecido neointimal em 6,8±14,3 mm³ aos 6 meses (p=0,19) e a percentagem de obstrução volumétrica aumentou em 4,7±7,5%. A reestenose binária e a revascularização do vaso-alvo recorreram em 17% dos casos; houve 1 caso (3%) de oclusão tardia, associada a infarto do miocárdio. A sobrevida livre de eventos foi de 80%. CONCLUSÃO: O manejo da reestenose intra-stent com a beta-radiação intracoronariana mostrou-se procedimento seguro e eficaz, com alta taxa de sucesso imediato, representando uma opção terapêutica para a inibição da hiperplasia neointimal.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the safety and efficacy of intracoronary brachytherapy using the Beta-Cath systemTM for preventing recurrence of in-stent restenosis (ISR), by analyzing clinical, angiographic, and intracoronary ultrasound (ICUS) results. METHODS: This study assessed 30 patients with ISR in native coronary arteries who underwent balloon catheter angioplasty followed by intracoronary beta radiation with the Beta-Cath systemTM (90Sr/Y). RESULTS: The study comprised complex, extensive (18.66±4.15 mm) restenotic lesions, 77% of which were of the diffuse-proliferative type. Brachytherapy was successful in 100% of the cases. The mean radiation dose used was 20.7±2.3 Gy, released for a mean period of 3.8±2.1 minutes. On late follow-up, the in-stent minimum luminal diameter (MLD) slightly decreased (from 1.98±0.30 mm to 1.84±0.39 mm at 6 months; P=0.13), with a late loss of 0.14±0.18 mm. The intrasegmentary MLD was significantly smaller than the in-stent diameter (1.55±0.40 mm vs 1.84±0.39 mm; P=0.008), and was associated with a more significant late loss (0.40±0.29 mm vs 0.14±0.18 mm; P=0.0001). On ICUS, a mild increase of 6.8±14.3 mm³ in the neointimal tissue was observed at 6 months (P=0.19), and the percentage of volumetric obstruction increased by 4.7±7.5%. Binary restenosis and revascularization of the target vessel recurred in 17% of the cases; late occlusion associated with myocardial infarction occurred in 1 case (3%). Event-free survival was 80%. CONCLUSION: The management of in-stent restenosis with intracoronary beta radiation proved to be a safe and effective procedure, with a high rate of immediate success, representing a therapeutic option for inhibiting neointimal hyperplasia.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>reestenose intra-stent</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>braquiterapia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sistema Beta-CathTM</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>in-stent restenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>brachytherapy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Beta-Cath system</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Infarto miocárdico inferior e choque associado a obstrução da via de saída do ventrículo esquerdo</s1>
</fA08>
<fA08 dir="en">
<s1>Inferior myocardial infarction and shock associated with left ventricular outflow tract obstruction</s1>
</fA08>
<fA11 dir="011000">
<s1>Bráulio Muzzi Ribeiro de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Frank Nunes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Denise Ulhoa Dani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>João Batista Gusmão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Luiz Barros Pena</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Felício Rocho  </s1>
<s2>Belo Horizonte MG</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>69-72</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Tratamento cirúrgico da embolização de coil para artéria pulmonar após tentativa de fechamento percutâneo do canal arterial</s1>
</fA08>
<fA08 dir="en">
<s1>Surgical treatment of coil embolization to the pulmonary artery after an attempt at percutaneous closure of patent ductus arteriosus</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Antibas Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fabio Biscegli Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Henrique N. Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Miguel Barbero-Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>77-79</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Adenoma de Conn: uma causa de hipertensão e hipocalemia</s1>
</fA08>
<fA08 dir="en">
<s1>Conn's adenoma: a cause of hypertension and hypokalemia</s1>
</fA08>
<fA11 dir="011000">
<s1>José Fernando Vilela Martin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Adriano Roberto Tarifa Vicente</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Patrícia Maluf Cury</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jorge Adas Dib</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Paulo Cipullo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de São José do Rio Preto  </s1>
<s2>São José do Rio Preto SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>83-86</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Conheço&amp;Aplico&amp;Comporto-me identidade bioética do cardiologista</s1>
</fA08>
<fA11 dir="011000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Incor do Hospital das Clínicas</s1>
<s2> SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>91-95</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 6/2004 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>96-96</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300111</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Considerações sobre o processo de revisão pelos pares nos arquivos</s1>
</fA08>
<fA11 dir="011000">
<s1>Cicero Piva de Albuquerque</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>97-98</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Fatores de risco e morbimortalidade associados à fibrilação atrial no pós-operatório de cirurgia cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Risk factors, morbidity, and mortality associated with atrial fibrillation in the postoperative period of cardiac surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Rogério Gomes da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gustavo Glotz de Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Andréia Laranjeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Altamiro Reis da Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Edemar Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rubem Rodrigues</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>99-104</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a incidência de fibrilação atrial no pós-operatório de cirurgia cardíaca, seu impacto sobre a morbimortalidade e o tempo de internação hospitalar e analisar os fatores de risco presentes no pré, trans e pós-operatório. MÉTODO: Estudo de coorte contemporâneo com 158 pacientes adultos submetidos à cirurgia cardíaca, sendo excluídos aqueles com fibrilação atrial no pré-operatório. Os pacientes foram avaliados por monitorização cardíaca contínua e eletrocardiogramas diários e a fibrilação atrial considerada como qualquer episódio de ritmo irregular, com presença de ondas f de morfologia e amplitude variáveis. RESULTADOS: A incidência de fibrilação atrial foi de 28,5%, sendo 21,6% para os pacientes revascularizados e 44,3% para os submetidos à correção valvar. Fatores independentemente associados à fibrilação atrial foram insuficiência cardíaca esquerda no pré-operatório (p=0,05; RC=2,2), balanço hídrico total (p=0,01; RC=1,0), tempo de cirurgia (p=0,03; RC=1,01) e outros fatores associados: idade &gt; 70 anos, doença valvar aórtica, agitação psicomotora, tempo de permanência de drenos, congestão pulmonar e insuficiência respiratória no pós-operatório. O uso de betabloqueadores (p=0,01; RC=0,3) foi um fator de proteção. Fibrilação atrial pós-operatória associou-se a aumento do tempo de internação hospitalar (16,9 ± 12,3 dias vs 9,2 ± 4,0 dias, p&lt;0,001) e a maior incidência de acidente vascular cerebral ou óbito pós-operatório, (p=0,02). CONCLUSÃO: A incidência de fibrilação atrial no pós-operatório de cirurgia cardíaca foi elevada e ocasionou significativo aumento de morbimortalidade e tempo de internação hospitalar. Entre os fatores de risco independentes destaca-se o balanço hídrico excessivo e, como fator protetor, uso de betabloqueadores.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the incidence of atrial fibrillation in the postoperative period of cardiac surgery, its impact on morbidity, mortality, and hospital stay, and to analyze the risk factors in the pre, trans, and postoperative periods. METHOD: Contemporary cohort study with 158 adult patients undergoing cardiac surgery, of whom those with atrial fibrillation in the preoperative period were excluded. The patients were assessed with continuous cardiac monitoring and daily electrocardiograms. Any episode of irregular rhythm with the presence of f waves of variable morphology and amplitude was considered atrial fibrillation. RESULTS: The general incidence of atrial fibrillation was 28.5%, being 21.6% for revascularized patients and 44.3% for those undergoing valvular repair. Factors independently associated with atrial fibrillation were left heart failure in the preoperative period (p=0.05; RC=2.2), total fluid balance (p=0.01; RC=1.0), duration of surgery (p=0.03; RC=1.01) [and other associated factors, age &gt; 70 years, aortic valvular disease, psychomotor agitation, length of installation of the drains, pulmonary congestion and respiratory insufficiency in the postoperative period]. The use of beta-blockers (p=0.01; RC=0.3) was a protective factor. Atrial fibrillation in the postoperative period was associated with an increase in the length of hospital stay (16.9±12.3 days versus 9.2±4.0 days, p&lt;0.001) and a greater incidence of stroke or postoperative death (p=0.02). CONCLUSION: The incidence of atrial fibrillation in the postoperative period of cardiac surgery was high and caused a significant increase in morbidity, mortality, and the length of hospital stay. Among the independent risk factors, excessive fluid balance is significant. The use of beta-blockers was identified as a protective factor.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fibrilação atrial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>arritmias</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cuidados pós-operatório</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arrhythmias</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>postoperative care</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Quantificação da massa infartada do ventrículo esquerdo pela ressonância magnética cardíaca: comparação entre a planimetria e o método de escore visual semi-quantitativo</s1>
</fA08>
<fA08 dir="en">
<s1>Quantification of left ventricular infarcted mass on cardiac magnetic resonance imaging: comparison between planimetry and the semiquantitative visual scoring method</s1>
</fA08>
<fA11 dir="011000">
<s1>Clerio Francisco de Azevedo Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo Hadlich</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>João Luiz Fernandes Petriz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luís Antonio Mendonça</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Jorge Neval Moll Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Carlos Eduardo Rochitte</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>111-117</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Validar um novo método de escore visual semi-quantitativo contra a planimetria digital quantitativa para a determinação da massa infartada do ventrículo esquerdo pela ressonância magnética cardíaca com técnica de realce tardio. MÉTODO: Estudados 77 pacientes com infarto miocárdico prévio em aparelho de ressonância magnética de 1,5T utilizando técnica de realce tardio para avaliação da viabilidade miocárdica e cálculo da massa infartada. Para avaliação da função ventricular esquerda pelo método de Simpson utilizamos técnica de cine-ressonância. O cálculo da massa infartada foi realizado nas imagens de realce tardio de duas formas: planimetria e método de escore. Utilizamos métodos de regressão linear simples, correlação e concordância entre métodos e observadores segundo a análise de Bland-Altman. RESULTADOS: Em todos os 77 pacientes as áreas de infarto foram detectadas pela ressonância magnética cardíaca utilizando a técnica de realce tardio. O tamanho do infarto medido pela planimetria foi semelhante ao obtido pelo método de escore, com a média das diferenças entres as medidas de apenas 1,03% da massa do ventrículo esquerdo. As variabilidades inter (0,41%) e intra-observador (0,34%) evidenciaram excelente reprodutibilidade do método de escore. A massa infartada apresentou boa correlação com a fração de ejeção e volumes distólico e sistólico finais indexados, r=-0,76, r=0,63 e r=0,67, respectivamente. CONCLUSÃO: A avaliação de pacientes com infarto agudo do miocárdio prévio pela ressonância magnética cardíaca, utilizando a técnica de realce tardio, permite a determinação reprodutível do tamanho do infarto, tanto pelo método de planimetria, quanto pelo modelo semi-quantitativo de escore.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare a new semiquantitative visual scoring method with quantitative digital planimetry for determining left ventricular infarcted mass by use of cardiac delayed contrast-enhanced magnetic resonance imaging. METHOD: Seventy-seven patients with previous myocardial infarction underwent delayed contrast-enhanced magnetic resonance imaging using a 1.5T device for assessing myocardial viability and calculating the infarcted mass. Cine magnetic resonance imaging was used for assessing left ventricular function with the Simpson method. The infarcted mass was calculated on the delayed contrast-enhanced images according to the following 2 methods: planimetry and the scoring method. Simple linear regression and correlation and agreement between the methods and observers according to the Bland-Altman plot were used. RESULTS: The infarcted areas in all 77 patients were detected by use of cardiac delayed contrast-enhanced magnetic resonance imaging. The size of the infarction measured by planimetry was similar to that obtained with the scoring method, with a mean difference between measurements of only 1.03% of the left ventricular mass. Inter- (0.41%) and intraobserver (0.34%) variabilities indicated an excellent reproducibility of the scoring method. Infarcted mass showed a good correlation with ejection fraction and indexed end-diastolic and end-systolic volumes, r=-0.76, r=0.63, and r=0.67, respectively. CONCLUSION: In patients with previous myocardial infarction, delayed-enhanced magnetic resonance imaging provides accurate infarct size quantification by planimetry and by semiquantitative score.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ressonância magnética</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>viabilidade miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>magnetic resonance imaging</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial viability</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Perfil de crise hipertensiva: prevalência e apresentação clínica</s1>
</fA08>
<fA08 dir="en">
<s1>Hypertensive crisis profile: prevalence and clinical presentation</s1>
</fA08>
<fA11 dir="011000">
<s1>José Fernando Vilela Martin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Érika Higashiama</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Evandro Garcia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Murilo Rizzatti Luizon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Paulo Cipullo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de São José do Rio Preto Departamento de Medicina </s1>
<s2> SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>125-130</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a prevalência, o quadro clínico e as lesões orgânicas envolvidas em uma crise hipertensiva. MÉTODO: Estudo retrospectivo de análise de prontuários médicos de pacientes com elevação dos níveis de pressão arterial diastólica &gt; 120 mmHg e sintomáticos, atendidos em setor de emergência de hospital universitário durante 12 meses. Urgência foi caracterizada como elevação sintomática da pressão arterial sem evidências de lesão em órgão-alvo e, emergência hipertensiva, como elevação sintomática da pressão arterial com evidências de lesão aguda ou em evolução de órgão-alvo. RESULTADOS: Incluídos 452 pacientes com crise hipertensiva, representando 0,5% de todas as emergências clínico-cirúrgicas, sendo 273 (60,4%) de urgência e 179 (39,6%) de emergência hipertensiva. Não conheciam ser hipertensos 18%. Tabagismo e diabetes foram fatores de risco associados ao desenvolvimento de crise hipertensiva em 1/4 e 1/5 dos pacientes, respectivamente. Pacientes com emergência apresentaram maior idade (59,6 ± 14,8 vs 49,9 ± 18,6 anos, p &lt; 0,001) e maior pressão arterial diastólica (129,1 ± 12 vs 126,6 ± 14,4 mmHg, p &lt; 0,05) do que aqueles com urgência hipertensiva. Acidente vascular encefálico isquêmico e edema agudo de pulmão foram as emergências hipertensivas mais comuns, compatíveis com as manifestações clínicas mais freqüentemente encontradas de déficit neurológico e dispnéia. CONCLUSÃO: Crise hipertensiva respondeu por 0,5% de todos os atendimentos de emergência do estudo e a 1,7% das emergências clínicas, sendo a urgência mais comum que a emergência hipertensiva. Acidente vascular encefálico isquêmico e edema agudo de pulmão foram as lesões em órgãos-alvo mais freqüentes nas emergências hipertensivas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the prevalence of hypertensive crisis, related clinical findings, and the organic lesions involved. METHOD: This retrospective study comprised the analysis of the medical records of symptomatic patients with an elevation in diastolic blood pressure levels &gt; 120 mmHg, who sought the emergency unit of a university-affiliated hospital over 12 months. Hypertensive urgency was characterized as the symptomatic elevation of blood pressure levels with no evidence of target-organ lesions, and hypertensive emergency was characterized as the symptomatic elevation of blood pressure levels with evidence of acute or ongoing target-organ lesion. RESULTS: This study comprised 452 patients with hypertensive crisis, accounting for 0.5% of all clinicosurgical emergencies, of which, 273 (60.4%) were hypertensive urgencies and 179 (39.6%) were hypertensive emergencies. Eighteen percent of the patients ignored their hypertensive condition. Smoking and diabetes were risk factors associated with the development of a hypertensive crisis in 1/4 and 1/5 of the patients, respectively. The patients with a hypertensive emergency were older (59.6±14.8 versus 49.9±18.6 years, p &lt; 0.001) and had greater diastolic blood pressure (129.1±12 versus 126.6±14.4 mmHg, p &lt; 0.05) than those with hypertensive urgencies. Ischemic stroke and acute pulmonary edema were the most common hypertensive emergencies, being in accordance with the most frequently found clinical manifestations of neurologic deficit and dyspnea. CONCLUSION: Hypertensive crises accounted for 0.5% of all emergency cases studied and for 1.7% of all clinical emergencies, hypertensive urgency being more common than hypertensive emergency. Ischemic stroke and acute pulmonary edema were the most frequent target-organ lesions in hypertensive emergencies.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>crise hipertensiva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prevalência</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>emergência hipertensiva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>urgência hipertensiva</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertensive crisis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prevalence</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertensive emergency</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertensive urgency</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Anticorpos contra beta2-glicoproteína I como fatores de risco para infarto agudo do miocárdio</s1>
</fA08>
<fA08 dir="en">
<s1>Anti-beta2-glycoprotein I antibodies as risk factors for acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Aline Ranzolin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jussara Marilú Bohn</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gary L. Norman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Euler Manenti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luis Carlos Bodanese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Carlos Alberto von Mühlen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Henrique Luiz Staub</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica do Rio Grande do Sul Hospital São Lucas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>137-140</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar se títulos elevados de anticorpos contra o cofator fosfolipídico beta2-glicoproteína I (beta2-gpI) se associam a risco aumentado de infarto agudo do miocárdio. MÉTODOS: Incluídos 82 pacientes com infarto agudo do miocárdio e 82 controles, avaliados quanto à idade, sexo, raça, hipertensão, tabagismo, cardiopatia prévia, história de diabetes mellitus e hipercolesterolemia. Anticorpos anticardiolipina e antibeta2-gpI IgA, IgG e IgM foram detectados por imunoensaio. Odds ratios (OR) ajustados para fatores de risco foram obtidos através de regressão logística. RESULTADOS: A média de idade para casos e controles foi, respectivamente, de 57,7 e 51,1 anos (P=0,003), predominando homens (P=0.005) e a raça branca em ambos os grupos (P = 0.798). Entre os fatores de risco, história de diabetes (OR 5,3; IC95% 1,9 a 14,9; P=0,001) e cardiopatia prévia (OR 4,7; IC95% 2,0 a 10,7; P&lt;0,001) foram as associações mais consistentes com o infarto do miocárdio. A freqüência de anticorpos anticardiolipina IgG, IgM e IgA não diferiu em casos e controles (P=1,000). Anticorpos IgA contra beta2-gpI IgA foram mais freqüentes em casos do que em controles (P=0.054). O OR ajustado para anticorpos IgA anti-beta2-gpI IgA foi 3,4 (IC95% 1,3 a 9,1; P = 0,015). CONCLUSÃO: Anticorpos IgA antibeta2-gpI, mas não anticardiolipina, parecem se comportar como fatores de risco independentes para o infarto, o que pode representar um elo entre autoimunidade e aterosclerose em pacientes com infarto agudo do miocárdio.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine whether high levels of antibodies against the phospholipid beta2-glycoprotein I (beta2-gpI) cofactor are associated with an increase in the risk of acute myocardial infarction. METHODS: The study comprised 82 patients with acute myocardial infarction and 82 controls, who were assessed in regard to age, sex, race, hypertension, smoking, previous heart disease, history of diabetes mellitus, and hypercholesterolemia. The following antibodies were detected using immunoassay: anticardiolipin and anti-beta2-gpI IgA, IgG, and IgM. Adjusted odds ratios (OR) for risk factors were obtained through logistic regression. RESULTS: The mean ages of the cases and controls were, respectively, 57.7 and 51.1 years (P=0.003). Men (P=0.005) and the white race predominated in both groups (P=0.798). Of the risk factors, a history of diabetes (OR=5.3; 95% CI: 1.9 to 14.9; P=0.001) and previous heart disease (OR=4.7; 95% CI: 2.0 to 10.7; P&lt;0.001) were the most consistent associations with myocardial infarction. The frequency of anticardiolipin IgG, IgM, and IgA antibodies did not differ between cases and controls (P=1.000). Anti-beta2-gpI IgA antibodies were more frequent in cases than in controls (P=0.054). The adjusted OR for anti-beta2-gpI IgA antibodies was 3.4 (95% CI: 1.3 to 9.1; P=0.015). CONCLUSION: Anti-beta2-gpI IgA antibodies, but not anticardiolipin antibodies, seemed to behave as independent risk factors for myocardial infarction, which may represent a link between autoimmunity and atherosclerosis in patients with acute myocardial infarction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>anticorpos antifosfolípides</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>anticorpos antibeta2-glicoproteína I</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto agudo do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>antiphospholipid antibodies</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>anti-beta2-glycoprotein I antibodies</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Insuficiência renal aguda após cirurgia de revascularização miocárdica com circulação extracorpórea: incidência, fatores de risco e mortalidade</s1>
</fA08>
<fA08 dir="en">
<s1>Acute renal failure after coronary artery bypass surgery with extracorporeal circulation: incidence, risk factors, and mortality</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Oliveira Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marco Antonio Silveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Roberto Barreto Maia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcelo Dantas Cerqueira Monteiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Reinaldo Martinelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Santa Isabel  </s1>
<s2>Salvador </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>145-149</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Identificar a incidência, fatores de risco e mortalidade de insuficiência renal aguda (IRA), em pacientes submetidos à cirurgia para revascularização miocárdica com circulação extracorpórea. MÉTODOS: Estudados prospectivamente todos os pacientes submetidos a cirurgia de revascularização miocárdica e as variáveis clínicas e laboratoriais analisadas através de métodos uni e multivariado (regressão logística). RESULTADOS: Insuficiência renal aguda ocorreu em 16,1% dos 223 pacientes estudados, diálise foi necessária em 4,9% dos pacientes. Os fatores de risco associados à IRA na análise univariada foram: idade &gt; 63 anos OR 3,6 (95% IC=1,6 a 8,3), creatinina sérica pré-operatória &gt; 1,2 mg/dl OR 5,9 (95% IC=2,4 a 14,6), duração da circulação extracorpórea &gt; 90 min OR 2,1 (95% IC=1,0 a 4,4), uso de balão intra-aórtico OR 2,6 (95% IC=1,2 a 5,5); necessidade de drogas inotrópicas OR 4,4 (95% IC=1,9 a 10,2) e, na análise multivariada, foram fatores independentes associados à IRA idade &gt; 63 anos OR 3,0 (95% IC=1,3 a 7,2), creatinina sérica pré-operatória &gt; 1,2 mg/dl OR 4,3 (95% IC=1,6 a 11,4), necessidade de drogas inotrópicas OR 3,2 (95% IC=1,3 a 8,0). A mortalidade nos pacientes com IRA foi de 25,0 % em comparação com 1,1% entre os sem IRA e 63,6% entre os que necessitaram de diálise. CONCLUSÃO: Insuficiência renal aguda em cirurgia de revascularização miocárdica é uma complicação freqüente e está associada à alta mortalidade. Sendo fatores de risco independentes: idade, insuficiência renal prévia e necessidade de drogas inotrópicas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To identify the incidence, risk factors, and mortality of acute renal failure (ARF) in patients undergoing myocardial coronary artery bypass surgery with extracorporeal circulation. METHODS: All patients undergoing myocardial coronary artery bypass surgery were prospectively studied, and their clinical and laboratory variables were assessed using uni- and multivariate analysis (logistic regression). RESULTS: Acute renal failure occurred in 16.1% of the 223 patients studied; 4.9% of patients required dialysis. Risk factors associated with ARF in the univariate analysis were age &gt; 63 years, OR 3.6 (95% CI=1.6 to 8.3); preoperative serum creatinine &gt; 1.2 mg/dL, OR 5.9 (95% CI=2.4 to 14.6); duration of extracorporeal circulation &gt; 90 min, OR 2.1 (95% CI=1.0 to 4.4); use of intraaortic balloon, OR 2.6 (95% CI=1.2 to 5.5); need for inotropic drugs, OR 4.4 (95% CI=1.9 to 10.2). In the multivariate analysis, independent factors associated with ARF were: age &gt; 63 years, OR 3.0 (95% CI=1.3 to 7.2); preoperative serum creatinine &gt; 1.2 mg/dL, OR 4.3 (95% CI=1.6 to 11.4); need for inotropic drugs, OR 3.2 (95% CI=1.3 to 8.0). Mortality in the patients with ARF was 25.0% compared with 1.1% in those without ARF and 63.6% in those who required dialysis. CONCLUSION: Acute renal failure after myocardial coronary artery bypass surgery is a frequent complication associated with a high mortality rate. The independent risk factors are age, previous renal failure, and the need for inotropic drugs.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência renal aguda</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia de revascularização miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>circulação extracorpórea</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute renal failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery bypass surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>extracorporeal circulation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Validação do teste de exercício de 4 segundos em posição ortostática</s1>
</fA08>
<fA08 dir="en">
<s1>Validation of the 4-second exercise test in the orthostatic position</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcos Bezerra de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Djalma Rabelo Ricardo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Claudio Gil Soares de Araújo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Gama Filho  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>155-159</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Testar a viabilidade operacional e validar um protocolo do teste de exercício de 4s (T4s) realizado em posição ortostática (ORTO). MÉTODOS: O ORTO, similar ao protocolo convencional (CICLO), ou seja, exercício súbito do 4º ao 8º segundo de uma apnéia inspiratória máxima de 12s, ao invés da pedalada rápida (sem carga), em caminhada estacionária acelerada (flexão alternada dos quadris). Índice vagal cardíaco (IVC), adimensional, calculado pela razão entre as durações dos intervalo RRs imediatamente antes do exercício (RRB) e o mais curto durante o exercício (RRC), medido em traçado de eletrocardiograma a uma resolução de 10ms. Avaliados 47 indivíduos (40±17 anos, 169±9 cm, 72±14 kg) de ambos os sexos, saudáveis ou não, que realizaram randomicamente três repetições consecutivas nos dois protocolos, sendo a primeira utilizada apenas para familiarização dos procedimentos. RESULTADOS: Embora tenha havido diferenças no IVC para os dois protocolos (1,48±0,04 vs 1,42±0,04; p&lt;0,001), não houve relevância fisiológica. Em 5 (11%) casos observou-se diferença clinicamente relevante entre ORTO e CICLO para o IVC. Os resultados de RRB, RRC e IVC nos dois protocolos foram fortemente correlacionados, respectivamente, 0,84; 0,85 e 0,93, (p&lt;0,001). CONCLUSÃO: O T4s realizado em posição ortostática demonstrou ser uma opção válida para avaliação do tônus vagal cardíaco nos laboratórios que não dispõem de cicloergômetro, sem prejuízo da interpretação clínica, além da simplicidade e aplicabilidade do procedimento, de baixo custo operacional.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To test the operational viability of and validate the 4-second exercise test (4sET) protocol in the orthostatic position (ORTHO). METHODS: The ORTHO protocol, an alternative to the conventional protocol (CYCLO), was used. The ORTHO protocol consists of performing sudden exercise in the orthostatic position - accelerated stationary walking (alternate upward flexion of the thighs) - from the fourth to the eighth second of a 12-second maximum inspiratory apnea, instead of rapid cycling without load. The adimensional cardiac vagal index (CVI) was calculated using the ratio between the longest RR interval (RRB) - the one immediately before, or the first during exercise - and the shortest RR interval during exercise - usually the last (RRC) - measured on electrocardiographic tracings at a 10-ms resolution. Forty-seven individuals (40±17 years, 169±9 cm, 72±14 kg) of both sexes, healthy or unhealthy, randomly underwent 3 consecutive repetitions of the 2 protocols, the first being performed only to acquaint patients with the procedure. RESULTS: Although differences in the CVI were found in both protocols (1.48±0.04 vs 1.42±0.04; P&lt;0.001), no physiological relevance was observed. In 5 (11%) cases, a clinically significant difference between the ORTHO and CYCLO protocols was observed for CVI. The results of RRB, RRC, and CVI in the 2 protocols were strongly correlated, being 0.84, 0.85, and 0.93, respectively (P&lt;0.001). CONCLUSION: The 4sET performed in the orthostatic position proved to be a valid option for assessing the vagal cardiac tonus in laboratories lacking a cycloergometer, without jeopardizing clinical interpretation. In addition to simplicity and applicability, the procedure also provides low operational costs.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste de exercício de 4 segundos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>posição ortostática</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>exercício</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>vagal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>freqüência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>4-second exercise test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>orthostatic position</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>vagal</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart rate</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Análise da variabilidade da freqüência cardíaca em pacientes hipertensos, antes e depois do tratamento com inibidores da enzima conversora da angiotensina II</s1>
</fA08>
<fA08 dir="en">
<s1>Analysis of heart rate variability in hypertensive patients before and after treatment with angiotensin II-converting enzyme inhibitors</s1>
</fA08>
<fA11 dir="011000">
<s1>Antônio da Silva Menezes Júnior</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Humberto Graner Moreira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Murilo Tavares Daher</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Goiás  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital São Francisco de Assis  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>165-168</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>37</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar a variabilidade de freqüência cardíaca em indivíduos normotensos e hipertensos e observar o comportamento do sistema nervoso autônomo após terapia com inibidores da enzima conversora de angiotensina II. MÉTODO: Estudados 286 pacientes com diagnóstico de hipertensão arterial, pela 1ª vez, e divididos em 4 grupos, conforme a pressão arterial diastólica (PAD): grupo A - PAD&lt;90 mmHg; grupo B - PAD 90-99 mmHg; grupo C - PAD 100-109 mmHg; grupo D - PAD&gt;110 mmHg. Os pacientes do grupo A (normais) e do grupo C (HA moderada), somando 110 e 79 pacientes, respectivamente, submeteram-se ao Holter-ECG 24h com análise de variabilidade de freqüência cardíaca no domínio do tempo (DT) e no domínio da freqüência (DF). O grupo C foi tratado com inibidores da ECA durante 3 meses, e após esse período novamente avaliado com Holter-ECG 24h e variabilidade da freqüência cardíaca, e os valores comparados com os normotensos. RESULTADOS: Os parâmetros SDNN, PNN50 (DT) e o espectro LF (DF) foram significativamente diferentes para os dois grupos, com valores notadamente diminuídos em hipertensos (p&lt;0,05). Pacientes do grupo C, após tratamento com IECA, mostraram-se recuperados em todas as variáveis da variabilidade da freqüência cardíaca, apresentando valores próximos aos dos normotensos. CONCLUSÃO: A variabilidade da freqüência cardíaca mostrou-se reduzida em hipertensos quando comparados aos normotensos, apontando para uma queda no reflexo baroceptor. Observou-se ainda a presença de um ajuste autonômico funcional após terapia anti-hipertensiva com IECA, indicando recuperação do tônus parassimpático.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare heart rate variability in normotensive and hypertensive individuals and to observe the behavior of the autonomic nervous system after treatment with angiotensin II-converting enzyme inhibitors. METHOD: The study comprised 286 patients diagnosed with arterial hypertension (AH) for the first time and divided into 4 groups according to diastolic blood pressure (DBP) levels: group A - DBP&lt;90 mmHg; group B - DBP 90-99 mmHg; group C - DBP 100-109 mmHg; group D - DBP&gt;110 mmHg. Group A (110 healthy individuals) and group C (79 patients with moderate AH) underwent 24-hour Holter-ECG with analysis of heart rate variability in time domain (TD) and frequency domain (FD). The group C patients were treated with ACE inhibitors for 3 months, and, after this period, they underwent a new 24-hour Holter-ECG study for assessing heart rate variability, the values being compared with those of normotensive individuals. RESULTS: The SDNN and PNN50 parameters (TD), and the LF spectrum (FD) were significantly different in the 2 groups, with clearly reduced values in hypertensive individuals (P&lt;0.05). Group C patients, after treatment with ACE inhibitors, showed a recovery in all variables of heart rate variability, achieving values close to those of normotensive individuals. CONCLUSION: Heart rate variability was reduced in hypertensive patients when compared with that in normotensive individuals, indicating a decrease in the baroreceptor reflex. A functional autonomic adjustment after the antihypertensive treatment with ACEI was observed, indicating recovery of parasympathetic tonus.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>inibidores da ECA</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sistema nervoso autônomo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>variabilidade da freqüência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ACE inhibitors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>autonomic nervous system</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart rate variability</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Edema generalizado e circulação hiperdinâmica: um possível caso de beribéri</s1>
</fA08>
<fA08 dir="en">
<s1>Generalized edema and hyperdynamic circulation: a possible case of beriberi</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcos F. Minicucci</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leonardo A. M. Zornoff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Mirna Matsue</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Roberto M. T. Inoue</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz S. Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marina P. Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Katashi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Álvaro O. Campana</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Sergio A. R. Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual Paulista Faculdade de Medicina de Botucatu </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>173-175</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Qual a diretriz de hipertensão arterial os médicos brasileiros devem seguir? Análise comparativa das diretrizes brasileiras, européias e norte-americanas (JNC VII)</s1>
</fA08>
<fA11 dir="011000">
<s1>Giovanio Vieira da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Décio Mion Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marco Antônio Mota Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Alberto Machado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Nery Praxedes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Celso Amodeo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Fernando Nobre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Oswaldo Kohlmann Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>179-181</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 4/2004 - Morte súbita em mulher de 24 anos portadora de arterite de Takayasu (Instituto do Coração do Hospital das Clínicas - FMUSP, São Paulo)</s1>
</fA08>
<fA11 dir="011000">
<s1>Sandra Falcão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dante Marcelo Artigas Giorgi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Desidério Favarato</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Bortolotto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Sampaio Gutierrez</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>182-186</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Otimização do tratamento medicamentoso na doença arterial coronariana: tarefa para o subespecialista?</s1>
</fA08>
<fA11 dir="011000">
<s1>Anis Rassi Jr.</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>187-188</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Endocardite infecciosa: perfil clínico em evolução</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcia M. Barbosa</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>189-190</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Achados ecocardiográficos em pacientes com suspeita diagnóstica de endocardite infecciosa</s1>
</fA08>
<fA08 dir="en">
<s1>Echocardiographic findings in patients with suspected infective endocarditis</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo Luiz Campos Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Pablo M. A. Pomerantzeff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José L. de Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alfredo J. Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>191-196</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar os achados ecocardiográficos em pacientes com suspeita diagnóstica de endocardite infecciosa. MÉTODOS: Foram submetidos à investigação ecocardiográfica transtorácica e transesofágica 262 pacientes com suspeita diagnóstica de endocardite infecciosa. Analisadas imagens de vegetações, abscessos valvares e insuficiência periprotética aguda e avaliada a correlação com dados clínicos, laboratoriais, categoria diagnóstica e a evolução hospitalar. RESULTADOS: O diagnóstico de endocardite foi categorizado como definido em 127 (47,8%) episódios, possível em 81 (30,4%) e rejeitado em 58 (21,8%). Nos pacientes com o diagnóstico definido, foram identificadas 135 imagens de vegetações, 37 de abscesso e 6 de insuficiência periprotética. Vegetações foram mais freqüentes em pacientes com endocardite por estreptococos do grupo viridans e enterococos (p=0,02) e com duração dos sintomas &lt; 10 dias (p= 0,001); abscesso mais freqüente em pacientes com duração dos sintomas &lt; 10 dias (p= 0,001) e insuficiência periprotética associada à maior necessidade de tratamento cirúrgico (p=0,001). Nos pacientes com o diagnóstico possível de endocardite, foram identificadas 8 imagens ecocardiográficas consideradas compatíveis com vegetações e, nos pacientes com diagnóstico de endocardite rejeitado, não foram demonstradas vegetações, abscessos valvares e insuficiência periprotética. CONCLUSÃO: Nossos achados ecocardiográficos variaram de acordo com a categoria diagnóstica. A contribuição tanto para o diagnóstico quanto para a avaliação prognóstica deve levar em consideração a probabilidade pré-teste do diagnóstico de endocardite infecciosa.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the echocardiographic findings in patients with suspected infective endocarditis. METHODS: Two hundred sixty-two patients with suspected infective endocarditis underwent transthoracic and transesophageal echocardiographic investigation. Images of vegetations, valvular abscesses, and acute periprosthetic insufficiency were analyzed, and the correlation with clinical and laboratory data, diagnostic category, and hospital evolution was assessed. RESULTS: The diagnosis of endocarditis was categorized as defined in 127 (47.8%) episodes, possible in 81 (30.4%), and rejected in 58 (21.8%). In patients with the defined diagnosis, the following images were identified: 135 vegetations, 37 abscesses, and 6 periprosthetic insufficiencies. Vegetations were more frequent in patients with endocarditis due to streptococci of the viridans group and enterococci (P=0.02), and with symptom duration &lt; 10 days (P=0.001). Abscesses were more frequent in patients with symptom duration &lt; 10 days (P=0.001). Periprosthetic insufficiency was associated with a greater need for surgical treatment (P=0.001). In patients with the possible diagnosis of endocarditis, 8 echocardiographic images considered compatible with vegetations were identified. In patients whose diagnosis of endocarditis was rejected, no vegetations, valvular abscesses, or periprosthetic insufficiencies were demonstrated. CONCLUSION: Our echocardiographic findings varied according to the diagnostic category. The contribution to both the diagnosis and prognostic evaluation should consider the pretest probability of the diagnosis of infective endocarditis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Endocardite infecciosa</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>infective endocarditis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Tratamento cirúrgico da fibrilação atrial por isolamento da parede posterior do átrio esquerdo em doentes com valvopatia mitral reumática crônica: um estudo randomizado com grupo controle</s1>
</fA08>
<fA08 dir="en">
<s1>Surgical treatment of atrial fibrillation through isolation of the left atrial posterior wall in patients with chronic rheumatic mitral valve disease: a randomized study with control group</s1>
</fA08>
<fA11 dir="011000">
<s1>José Tarcísio Medeiros de Vasconcelos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maurício Ibrahim Scanavacca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Roney Orismar Sampaio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eduardo Argentino Sosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sergio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>203-210</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>42</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a efetividade do isolamento cirúrgico da parede posterior do átrio esquerdo envolvendo os óstios das veias pulmonares, no tratamento da fibrilação atrial de etiologia reumática. MÉTODOS: Estudo prospectivo e randomizado envolvendo portadores de valvopatia mitral reumática, fibrilação atrial persistente com duração &gt; a 6 meses, idade &lt; a 60 anos e diâmetro atrial esquerdo &lt; a 65 mm. Os pacientes foram distribuídos aleatoriamente em dois grupos: tratamento cirúrgico valvar (grupo controle) e tratamento cirúrgico valvar associado ao isolamento da parede posterior do átrio esquerdo mediante técnica de &quot;corte e sutura&quot; (grupo tratado). RESULTADOS: Foram operados 29 indivíduos, sendo que 27 (13 do grupo controle e 14 do grupo tratado), foram acompanhados regularmente. Os pacientes dos dois grupos não diferiram em relação às suas características basais. O tempo de seguimento médio foi de 11,5 meses no grupo controle e de 10,3 meses no grupo tratado. As freqüências cumulativas de pacientes livres de fibrilação atrial foram significativamente maiores no grupo tratado tanto na fase peri-operatória (p= 0,0035) quanto na fase tardia (p= 0,0430). CONCLUSÃO: O isolamento cirúrgico da parede posterior do átrio esquerdo envolvendo os óstios das veias pulmonares é uma forma efetiva de tratamento da fibrilação atrial na valvopatia mitral reumática.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the effectiveness of surgical isolation of the left atrial posterior wall encompassing the ostia of the pulmonary veins for the treatment of atrial fibrillation of rheumatic etiology. METHODS: Prospective and randomized study of patients with rheumatic mitral valve disease, persistent atrial fibrillation for 6 months or longer, age &lt; 60 years, and left atrial diameter &lt; 65 mm. The patients were randomly distributed into 2 groups as follows: surgical valvular treatment (control group) and surgical valvular treatment associated with isolation of the left atrial posterior wall according to the &quot;cut-and-sew&quot; technique (treated group). RESULTS: Twenty-nine individuals were operated upon, 27 of whom (13 in the control group and 14 in the treated group) were regularly followed up. The patients of both groups did not differ in regard to their basal characteristics. The mean follow-up time was 11.5 months in the control group and 10.3 months in the treated group. The cumulative frequencies of the patients without atrial fibrillation were significantly greater in the treated group both in the perioperative (P=0.0035) and late (P=0.0430) phases. CONCLUSION: Surgical isolation of the left atrial posterior wall encompassing the ostia of the pulmonary veins is an effective form of treating atrial fibrillation in rheumatic mitral valve disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tratamento cirúrgico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fibrilação atrial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>isolamento da parede posterior do átrio esquerdo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvopatia mitral reumática</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgical treatment</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>isolation of the left atrial posterior wall</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rheumatic mitral valve disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Variabilidade entre cardiologistas na abordagem aos pacientes em prevenção secundária da cardiopatia isquêmica</s1>
</fA08>
<fA08 dir="en">
<s1>Variability among cardiologists in the management of patients under secondary prevention of ischemic heart disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Ricardo Stein</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Caroline Alboim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Candice Campos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Renato Bandeira de Mello</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Guido Aranha Rosito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Carisi Anne Polanczyk</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital de Clínicas de Porto Alegre Ambulatório Especializado em Cardiopatia Isquêmica </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>219-222</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar o manejo dos pacientes com cardiopatia isquêmica, atendidos por cardiologistas em ambulatório geral de cardiologia, com aquele realizado em ambulatório específico de cardiopatia isquêmica, dando ênfase à solicitação do perfil lipídico e ao tratamento farmacológico prescrito. MÉTODOS: Dados obtidos de prontuário médico de 52 pacientes consecutivos atendidos no ambulatório de cardiopatia isquêmica (grupo I) e de 43 acompanhados no ambulatório de cardiologia geral (grupo II), sendo o diagnóstico anatômico de cardiopatia isquêmica, condição básica para sua inclusão. Considerou-se critério para dislipidemia, colesterol total &gt; 200mg/dl e/ou LDL colesterol &gt; 100 mg/dl em pacientes em uso ou não de hipolipemiantes e o uso de drogas hipolipemiantes, mesmo quando os níveis de colesterol total e/ou LDL colesterol eram &lt; a 200 mg/dl e 100 mg/dl, respectivamente. Usou-se teste exato de Fischer para comparação de variáveis, aceitando como significativo p bicaudal &lt; 0,05. RESULTADOS: Características demográficas, fatores de risco observados para cardiopatia isquêmica, prevalência de infarto do miocárdio prévio e procedimentos de revascularização prévios não apresentaram diferenças significativas entre os pacientes do grupo I e II. Observou-se que os pacientes do grupo I receberam aspirina em 98% dos casos, enquanto que no grupo II, sua prescrição foi de 83% (p=0,02). Em relação a drogas hipolipemiantes, as prevalências foram de 60% no grupo I e de 19% no grupo II (p=0,001). Exames de perfil lipídico foram solicitados para 98% dos indivíduos do grupo I e 79% do grupo II (p=0,003). CONCLUSÃO: Houve maior fidedignidade de condutas no ambulatório específico de cardiopatia isquêmica em relação às novas evidências médicas, principalmente no que tange à prescrição de aspirina e de drogas hipolipemiantes.</s0>
</fC01>
<fC01 dir="en">
<s0>OBECTIVE: To compare the management of patients with ischemic heart disease being followed up in a general cardiology outpatient clinic with that of patients being followed up in an outpatient clinic specific for ischemic heart disease, emphasizing the lipid profile and the pharmacological treatment prescribed. METHODS: Data were collected from the medical records of 52 patients consecutively treated in the outpatient clinic for ischemic heart disease (group I) and of 43 patients treated in the general cardiology outpatient clinic (group II), the anatomical diagnosis of ischemic heart disease being the basic condition for their inclusion in the study. The criteria for dyslipidemia were as follows: total cholesterol &gt; 200 mg/dL or LDL-cholesterol &gt; 100 mg/dL, or both, in patients using or not lipid-lowering drugs, and the use of lipid-lowering drugs, even when the total cholesterol or LDL-cholesterol levels were &lt; 200 mg/dL and 100 mg/dL, respectively, or both. The Fisher exact test was used for comparing the variables, and a 2-tailed p &lt; 0.05 was accepted as significant. RESULTS: Demographic characteristics, risk factors for ischemic heart disease, prevalence of previous myocardial infarction, and previous revascularization procedures showed no significant differences between the patients in groups I and II. In group I, 98% of the patients received aspirin, while, in group II, 83% of the patients received that drug (p=0.02). In regard to the use of lipid-lowering drugs, the prevalences were 60% in group I and 19% in group II (p=0.001). The lipid profile examination was requested for 98% of group I individuals and 79% of group II individuals (p=0.003). CONCLUSION: In regard to new medical evidence, mainly prescription of aspirin and lipid-lowering drugs, the management was more reliable in the outpatient clinic specifically aimed at treating ischemic heart disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatia isquêmica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prevenção secundária</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coorte ambulatorial</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemic heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>secondary prevention</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>outpatient care cohort</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Massa ventricular esquerda em portadores de insuficiência cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Left ventricular mass in patients with heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcello Ricardo Paulista Markus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Humberto Felício Gonçalves de Freitas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Roberto Chizzola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Gisela Tunes da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Carlos Pedroso de Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Alfredo José Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>227-231</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a massa ventricular esquerda em pacientes com insuficiência cardíaca, as correlações com outras variáveis clínicas e com o prognóstico. MÉTODOS: Foram estudados 587 pacientes com idades entre 13,8 anos e 68,9 anos, 461 (78,5%) homens e 126 (21,5%) mulheres. A massa ventricular esquerda foi estimada com o uso do ecocardiograma no modo M e indexada pela altura. RESULTADOS: O índice da massa ventricular esquerda variou de 35,3 g/m a 333,5 g/m e aumentou conforme a idade. O índice da massa ventricular esquerda foi maior nos homens (média 175,7 g/m) do que nas mulheres (média 165,7 g/m). O índice da massa ventricular esquerda foi maior nos portadores de cardiomiopatia hipertensiva (média 188,1 g/m), de cardiomiopatia dilatada idiopática (média 177,7 g/m) e de cardiomiopatias de outras etiologias (média 175,1 g/m) do que nos portadores de cardiomiopatia chagásica (média 164,3 g/m) e isquêmica (média 162 g/m). O índice da massa ventricular esquerda de portadores de insuficiência cardíaca demonstrou associação com a idade, o sexo, a etiologia e o diâmetro do átrio esquerdo. A correlação com a fração de ejeção do ventrículo esquerdo foi negativa - o aumento do índice da massa ventricular esquerda associou-se à redução da fração de ejeção. O risco relativo de óbito foi 1,22 para cada acréscimo de 50 g/m no índice da massa ventricular esquerda. CONCLUSÕES: A estimação da massa ventricular esquerda pode contribuir para a avaliação prognóstica de portadores de insuficiência cardíaca.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess left ventricular mass in patients with heart failure and its correlations with other clinical variables and prognosis. METHODS: The study comprised 587 patients aged from 13.8 years to 68.9 years, 461 (78.5%) being males and 126 (21.5%) females. Left ventricular mass was estimated by using M-mode echocardiography and was indexed by height. RESULTS: The left ventricular mass index ranged from 35.3 g/m to 333.5 g/m and increased with age. The left ventricular mass index was greater in males (mean, 175.7 g/m) than in females (mean, 165.7 g/m). The left ventricular mass index was greater in patients with hypertensive cardiomyopathy (mean of 188.1 g/m), with idiopathic dilated cardiomyopathy (mean, 177.7 g/m) and with cardiomyopathies of other etiologies (mean, 175.1 g/m) than in patients with chagasic (mean, 164.3 g/m) or ischemic (mean, 162 g/m) cardiomyopathy. The left ventricular mass index in patients with heart failure showed a correlation with age, sex, etiology, and left atrial diameter. The correlation with left ventricular ejection fraction was negative: the increase in the left ventricular mass index was associated with a reduction in ejection fraction. The relative risk of death was 1.22 for each 50-g/m increase in the left ventricular mass index. CONCLUSIONS: The estimate of left ventricular mass may contribute to the prognostic assessment of patients with heart failure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>massa ventricular esquerda</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia ventricular esquerda</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prognóstico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular mass</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Implante direto de stent através de cateter guia 5F por técnica transradial</s1>
</fA08>
<fA08 dir="en">
<s1>Direct stent implantation using a 5F guiding catheter and transradial approach</s1>
</fA08>
<fA11 dir="011000">
<s1>Wilson Miguel Cecim Coelho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Luiz Balthazar Jacob</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Dalmo de Araujo Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sumaira Faitarone Frederico</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ivone Eduarda Campos Cabbaz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Moléstias Cardiovasculares Sociedade Portuguesa de Beneficência </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>237-239</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o implante de stents sem dilatação prévia com cateter balão convencional para o tratamento das obstruções coronarianas, utilizando-se cateteres guias de baixo perfil através da técnica radial. MÉTODOS: A técnica radial é atraente pela possibilidade de se evitar o trauma provocado pelo balão, menor tempo para sua realização, exposição reduzida à radiação e consumo de contraste em quantidades inferiores às habitualmente usadas neste tipo de procedimento. RESULTADOS: Analisada a experiência inicial de implante direto de stents, através de cateteres de baixo perfil por via radial, em 45 pacientes, com idade média de 65 anos. Em todos os casos houve sucesso no procedimento sem complicações maiores na fase hospitalar. CONCLUSÃO: Os resultados com a população estudada demonstraram ser a técnica radial segura, eficaz e com muito baixo risco de complicações.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess stent implantation without previous dilation with a conventional balloon catheter to treat coronary artery obstructions, by using low profile guiding catheters and the transradial approach. METHODS: The transradial approach is attractive due to the possibility of avoiding the trauma caused by the balloon, its shorter time of performance, reduced exposure to radiation, and the use of lower quantities of contrast medium than those usually required in this type of procedure. RESULTS: The initial experience of direct stent implantation with low profile guiding catheters and the transradial approach was analyzed in 45 patients, whose mean age was 65 years. All procedures were successful, with no major complications in the in-hospital phase. CONCLUSION: The results obtained with the population studied proved that the transradial approach is safe, effective, and has very few risks of complications.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>implante direto stent</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cateter</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>transradial</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>direct stent implantation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>catheter</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>transradial</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Comparação entre comissurotomia e valvoplastia por cateter-balão na estenose mitral: cinco anos de acompanhamento</s1>
</fA08>
<fA08 dir="en">
<s1>Comparison of open commissurotomy and balloon valvuloplasty in mitral stenosis: a five-year follow-up</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Francisco Cardoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Pablo Maria Alberto Pomerantzeff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Miguel Antonio Neves Rati</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Caio Cesar Jorge Medeiros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marcelo Luiz Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Luiz Virgen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Flávio Tarasoutchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>243-247</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar dados clínicos-laboratoriais em portadores de estenose mitral submetidos à comissurotomia ou valvoplastia por cateter-balão, obtidos ao longo de 5 anos de acompanhamento. MÉTODOS: Foram acompanhados, prospectivamente, 81 pacientes no pré (PRÉ), imediatamente após o procedimento (POI), e ao longo de cinco anos (PO12M, PO24M,..., PO60M) e randomizados em dois grupos: GC: 37 pacientes (32,4 &amp;plusmn; 7,2 anos e 89,2% mulheres) e GV: 44 pacientes (32,9 &amp;plusmn; 9,5 anos e 90,9% mulheres). A avaliação compreendeu: classe funcional, ocorrência de eventos, eletrocardiograma e ecodopplercardiograma. RESULTADOS: Houve melhora expressiva da classe funcional na maioria dos pacientes, três casos do GC e do GV estavam em classe funcional III no PO60M. Não houve diferença em relação ao gradiente mitral entre os grupos. Houve diferença das médias de área valvar mitral entre os grupos durante toda avaliação. Não ocorreram óbitos. No POI do GC observamos 3 casos com insuficiência mitral (IM) moderada, 3 com sangramento (1 reoperado) e, no GV, 4 casos com IM moderada, 1 com IM importante, 2 com tamponamento cardíaco, 1 caso necessitou cirurgia por IM importante. Ao longo de 60 meses, no GV, 9 casos evoluiram com IM moderada ou importante e no GC, 6 casos evoluiram com IM moderada ou importante e outros dois necessitaram cirurgia por dupla disfunção mitral. CONCLUSÃO: Ambos os métodos obtiveram 100% de sucesso com baixa taxa de complicações. No seguimento, houve elevação discreta do gradiente mitral e queda de área valvar mitral em ambos os grupos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare clinical and laboratory data in patients with mitral stenosis undergoing open commissurotomy or balloon valvuloplasty, who were followed up for 5 years. METHODS: Eighty-one patients were prospectively assessed prior to the procedure (PRE) and immediately after the procedure, in the immediate postoperative period (IPO), and followed up yearly for 5 years (PO12M, PO24M, PO36M, PO48M, and PO60M). They were randomized into the following 2 groups: GC (group undergoing open commissurotomy): 37 patients (32.4 &amp;plusmn; 7.2 years; 89.2% females); and GV (group undergoing balloon valvuloplasty): 44 patients (32.9 &amp;plusmn; 9.5 years; 90.9% females). The patients' assessment comprised the following items: functional class, occurrence of events, electrocardiography, and Doppler echocardiography. RESULTS: A significant improvement in functional class occurred in most patients. Three patients in GC and in GV were in functional class III in PO60M. No difference in the mitral gradient was observed between the groups. A difference in the mean mitral valve areas was observed between the groups during the entire evaluation. No patients died. In regard to the IPO of GC, 3 patients had moderate mitral insufficiency (MI), and 3 had bleeding (1 was reoperated upon). In the IPO of GV, 4 patients had moderate MI, 1 had severe MI, 2 had cardiac tamponade, and 1 patient required surgery due to severe MI. Over 60 months, 9 GV patients evolved to moderate or severe MI, while 6 GC patients evolved to moderate or severe MI, and 2 other GC patients required surgery due to double mitral dysfunction. CONCLUSION: The rate of success in open mitral commissurotomy and balloon mitral valvuloplasty was 100%, and the rate of complications was low. During follow-up, a mild elevation in mitral gradient and a drop in mitral valve area were observed in both groups.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose da valva mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>febre reumática</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>comissurotomia mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvoplastia mitral por cateter-balão</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valve stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rheumatic fever</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral commissurotomy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>balloon mitral valvuloplasty</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Estenose mitral grave como evolução a longo prazo de miotomia/miectomia septal cirúrgica</s1>
</fA08>
<fA08 dir="en">
<s1>Severe mitral stenosis in the long-term evolution of myotomy-myectomy-septal resection</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre de Matos Soeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Juliana Ascenção de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Vicente Serrano Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Alberto Benvenuti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Reynaldo Castro Miranda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Carlos Nicolau</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Antônio F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>253-257</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 8/2004: criança de 10 anos de idade com comunicação interventricular subarterial e insuficiência valvar aórtica - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>263-263</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300310</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Vastatinas na prevenção da doença aterosclerótica: dados atuais</s1>
</fA08>
<fA11 dir="011000">
<s1>Neusa Forti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jayme Diament</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>264-271</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300311</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Errata</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>242-242</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300312</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Pesquisa básica na terapia celular: luxo ou necessidade?</s1>
</fA08>
<fA11 dir="011000">
<s1>Hans Fernando Rocha Dohmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardiaco  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>275-277</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Tétrade de Fallot: qual o real benefício da correção operatória na idade adulta?</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernando Antibas Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>278-279</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Homoenxerto aórtico criopreservado no tratamento cirúrgico das lesões da valva aórtica: resultados imediatos</s1>
</fA08>
<fA08 dir="en">
<s1>Cryopreserved aortic homograft for aortic valve replacement: immediate results</s1>
</fA08>
<fA11 dir="011000">
<s1>Luís Roberto Gerola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Wesley Araújo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Hyong C. Kin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Gabriela E. F. Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Armindo Pereira Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Guilherme Flora Vargas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Enio Buffolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina Disciplina de Cirurgia Cardiovascular</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>280-283</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar os resultados imediatos, clínicos e ecocardiográficos, com o uso do homoenxerto aórtico criopreservado no tratamento cirúrgico da valva aórtica. MATERIAL: Dezoito pacientes com lesão na valva aórtica receberam homoenxerto aórtico criopreservado, sendo 15 homens, 10 com insuficiência aórtica e oito, estenose aórtica. A idade variou de 18 a 65 (média de 44,5 ± 18,14) anos. Quatro pacientes apresentavam endocardite bacteriana em atividade, 12 estavam em classe funcional II, seis em classe funcional III (NYHA). A função ventricular esquerda era normal em 15 pacientes. RESULTADOS: A mortalidade hospitalar foi de 5,5% (um paciente), por insuficiência respiratória, os demais receberam alta hospitalar entre o 5° e 8° dia de pós-operatório em classe funcional I. O gradiente transvalvar aórtico máximo, ao ecocardiograma, variou de zero a 30 mmhg, com média de 10,9 ± 9,2 mmhg. Cinco pacientes não apresentavam nenhum grau de refluxo pelo homoenxerto, 11 (61,1%) tinham refluxo mínimo e dois apresentavam refluxo leve. O tempo de circulação extracorpórea variou de 130 a 220 (média de 183,9 ± 36,7) minutos. O tempo de pinçamento da aorta variou de 102 a 168 (média de 139,14 ± 25,10) minutos. O sangramento no pós-operatório variou 210 a 1220 ml, com média de 511,4 ± 335,1 ml e não houve reoperações. O tempo de intubação orotraqueal variou de 2h e 50min a 17 h com média de 9,14 ± 3,6 h. CONCLUSÃO: O homoenxerto aórtico criopreservado pode ser utilizado rotineiramente com baixa morbi-mortalidade hospitalar.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess immediate clinical and echocardiographic results of the use of cryopreserved aortic homografts for aortic valve replacement. METHODS: Eighteen patients with aortic valve disease underwent aortic valve replacement, receiving a cryopreserved aortic homograft, 15 were male, 10 had aortic regurgitation, and 8 had aortic stenosis. Age ranged from 18 to 65 years (mean, 44.5 ± 18.14 years). Four patients had infective endocarditis, 12 patients were in functional class II, and 6 patients were in functional class III (NYHA). Left ventricular function was normal in 15 patients. RESULTS: Hospital mortality was 5.5% (1 patient) due to respiratory distress; the other patients were discharged from the hospital between the fifth and eighth postoperative days in functional class I. Maximal aortic transvalvular gradient, on echocardiography, ranged from 0 to 30 mmHg, with a mean of 10.9 ± 9.2 mmHg. Five patients did not have any degree of regurgitation through the aortic homograft, 11 patients (61.1%) had minimal regurgitation, and 2 had mild regurgitation. Duration of extracorporeal circulation ranged from 130 to 220 minutes (mean, 183.9 ± 36.7 minutes). Duration of aortic clamping ranged from 102 to 168 minutes (mean, 139.14 ± 25.10 minutes). Bleeding in the postoperative period ranged from 210 to 1220 mL, with a mean of 511.4 ± 335.1 mL. Reoperations were not necessary. Duration of orotracheal intubation ranged from 2 hours 50 minutes to 17 hours with a mean of 9.14 ± 3.6 hours. CONCLUSION: Cryopreserved aortic homografts may be routinely used with low hospital morbidity and mortality.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>homoenxerto aórtico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>troca valvar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvopatia aórtica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic homograft</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>valve replacement</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic valve disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>O transplante em conjunto de células mioblásticas esqueléticas e mesenquimais (cocultivadas) na disfunção ventricular pós-infarto do miocárdio</s1>
</fA08>
<fA08 dir="en">
<s1>Combined transplantation of skeletal myoblasts and mesenchymal cells (cocultivation) in ventricular dysfunction after myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Cesar Guarita Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Katherine Athayde Teixeira de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carmen Rebelatto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alessandra Senegaglia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marcus Furuta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Nelson Miyague</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Paula Hansen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Julio C Francisco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Paulo Roberto Slud Brofman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica do Paraná  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>288-293</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: A terapia celular no miocárdio tem sido realizada fundamentalmente com dois tipos celulares: as células mioblásticas esqueléticas (miogênicas) e as mesenquimais (angiogênicas) com resultados satisfatórios. Foi analisado o resultado do transplante em conjunto destas células (CEM) em ratos infartados. MÉTODOS: Foram induzidos ao infarto do miocárdio, por meio de ligadura da coronária esquerda 26 ratos Wistar. Após uma semana, os animais foram submetidos à ecocardiografia para avaliação da fração de ejeção (FE,%) e dos volumes diastólico e sistólico finais do ventrículo esquerdo (VDF, VSF,ml). Após dois dias os animais foram reoperados e divididos em dois grupos: 1) controle (n=10) que recebeu 0,15 ml de meio de cultura e 2) CEM (n=16) que recebeu 7.5x106 células mioblásticas esqueléticas e mesenquimais, heterólogas, na região do infarto. As células foram obtidas a partir da punção da crista ilíaca e da biópsia do músculo esquelético, ambas submetidas à cultura celular in vitro. Após um mês, os animais foram submetidos a nova ecocardiografia. RESULTADOS: Não houve diferença significativa entre os dois grupos quanto a FE, VDF e VSF nos valores ecocardiográficos de base. Um mês após o transplante, foram observados diminuição da FE no grupo controle (29.31 &amp;plusmn; 5.6% para 23.54 &amp;plusmn; 6.51% p=0.048) e acréscimo da FE no grupo CEM (24.03 &amp;plusmn; 8.68% para 31.77 &amp;plusmn; 9.06%, p=0.011). Identificou-se a presença de neovasos e fibras musculares, nas regiões de fibrose miocárdica no grupo CEM. CONCLUSÃO: O cocultivo das células mioblásticas esqueléticas e das células mesenquimais é funcionalmente efetivo.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Cell therapy in the myocardium has been mainly performed with satisfactory results using 2 cell types: skeletal myoblasts (myogenic) and mesenchymal cells (angiogenic). This study assessed the combined transplantation of those 2 cell types (SMM) into infarcted rats. METHODS: Myocardial infarction was induced by ligature of the left coronary artery in 26 Wistar rats. After one week, the animals underwent echocardiography for assessing ejection fraction (EF%) and left ventricular end-diastolic and systolic volumes (EDV, ESV, mL). After 2 days, the animals were reoperated on and divided into 2 groups: 1) control (n=10), which received 0.15 mL of culture medium; and 2) SMM (n=16), which received 7.5x10(6) heterologous skeletal myoblasts and mesenchymal cells in the infarcted region. The cells were obtained from puncture of the iliac crest and biopsy of skeletal muscle, and were cultured in vitro. After one month, the animals underwent a new echocardiography. RESULTS: No significant difference in EF, EDV, and ESV was observed between the 2 groups on baseline echocardiographic values. One month after transplantation, the following was observed: a reduction in EF in the control group (29.31 ± 5.6% to 23.54 ± 6.51%; P=0.048); and an increase in EF in the SMM group (24.03 ± 8.68% to 31.77 ± 9.06%; P=0.011). The presence of neovascularization and muscle fibers was identified in the regions of myocardial fibrosis in the SMM group. CONCLUSION: Cocultivation of skeletal myoblasts and mesenchymal cells is functionally effective.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Transplante</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>células mioblásticas esqueléticas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>células mesenquimais</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>disfunção ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Transplantation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>skeletal myoblasts</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mesenchymal cells</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>A mobilidade do Septum primum não depende do diâmetro do forame oval em fetos normais</s1>
</fA08>
<fA08 dir="en">
<s1>Mobility of the Septum primum does not depend on the foramen ovale diameter in normal fetuses</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo Sallum</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fabíola Satler</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eduardo Ioschpe Gus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz Henrique Nicoloso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>João Luiz Mânica</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antônio Luiz Piccoli Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>300-303</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Testar a hipótese de que existe correlação entre o diâmetro máximo diastólico do forame oval e o índice de excursão do septum primum em fetos normais. MÉTODOS: Foram examinados, por ecocardiografia, 102 fetos normais de gestantes com idades gestacionais entre 20 e 40 semanas. O diâmetro do forame oval e a excursão máxima do septum primum foram medidos num corte de 4 câmaras. Na análise dos dados utilizou-se o coeficiente de correlação de Pearson. RESULTADOS: A média do forame oval foi de 5,06 ± 1,29 mm; a da excursão máxima do septum primum de 5,42 ± 1,41 mm; a do átrio esquerdo 11,47 ± 2,76 mm e a do índice de excursão 0,48 ± 0,09. A relação média FO/IE foi de 11,35 ± 3,94 mm. Não houve correlação FO/IE (r = -0,03) e observou-se correlação fraca do forame oval com o átrio esquerdo (r = 0,031) e com a excursão do septum primum (r = 0,21). CONCLUSÃO: A mobilidade do septum primum não depende do diâmetro do forame oval em fetos normais, sugerindo que as modificações da sua excursão diastólica não decorram do grau de abertura interatrial.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To test the hypothesis that a correlation exists between the maximum foramen ovale diastolic diameter and the excursion index (EI) of the septum primum in normal fetuses. METHODS: One hundred and two normal fetuses with gestational ages ranging from 20 to 40 weeks were submitted to echocardiography. The foramen ovale diameter and the &quot;maximal excursion&quot; of the septum primum were measured in a 4-chamber view. The data were analyzed by Pearson's correlation coefficient. RESULTS: The mean foramen ovale (FO) diameter was 5.06 ± 1.29 mm; the maximal excursion of the septum primum was 5.42 ± 1.41 mm; the left atrium diameter 11.47 ± 2.76 mm; the septum primum &quot;excursion index&quot; was 0.48 ± 0.09. Mean FO/EI ratio was 11.35 ± 3.94 mm. No FO/EI correlation (r = -0.03) existed, and a weak foramen ovale/left atrium correlation (r = 0.31) was observed, as well as a weak foramen ovale/excursion of septum primum correlation (r = 0.21). CONCLUSION: Septum primum mobility does not depend on the foramen ovale diameter in normal fetuses, suggesting that the modifications of its diastolic displacement is not influenced by the size of the interatrial opening.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Ecocardiografia fetal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>forame oval</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>septum primum</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função diastólica ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetal echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>foramen ovale</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>septum primum</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular diastolic function</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Complicações da hipertensão arterial em homens e mulheres atendidos em um ambulatório de referência</s1>
</fA08>
<fA08 dir="en">
<s1>Complications of hypertension in men and women seen in a referral outpatient care unit</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Beisl Noblat</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo Barreto Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gildete Barreto Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Alberto Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>308-313</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar se o sexo se associa à hipertrofia ventricular esquerda, ao acidente vascular cerebral e à insuficiência renal em hipertensos atendidos em ambulatório de referência. MÉTODOS: Dados de 622 hipertensos, admitidos com diagnóstico de hipertrofia ventricular esquerda baseado no eletrocardiograma, de insuficiência renal, na creatinina &gt; 1,4 mg/dl, e de acidente vascular cerebral em história pregressa e exame físico. Regressão logística foi utilizada para estimar odds ratio da associação entre sexo e lesão de órgãos-alvo da hipertensão, ajustadas para raça, idade e sua duração. RESULTADOS: A média das idades foi 48,4&amp;plusmn;13,8 anos, 74,1% eram mulheres, 84,9% mulatos ou negros. Quase a metade dos homens e mais de 40% das mulheres apresentavam pelo menos um evento definido com lesão órgão-alvo. Insuficiência renal foi maior nos homens, OR ajustada (ORa) = 2,73; (p=0,002). Nos pacientes brancos, a freqüência de acidente vascular cerebral foi significantemente (p=0,017) maior nos homens (4/33) do que nas mulheres (0/56) e, na análise para idade &gt; 49 anos, a prevalência de hipertrofia ventricular esquerda foi significantemente maior em homens, ORa = 1,99; (p=0,024). CONCLUSÃO: Os dados obtidos sugerem maior prevalência de insuficiência renal em homens do que em mulheres, de acidente vascular cerebral em homens brancos do que em mulheres brancas, e de hipertrofia ventricular esquerda em homens do que em mulheres com idade &gt; 49 anos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the association between sex and left ventricular hypertrophy, stroke, and renal failure in hypertensive patients in a referral outpatient care unit. METHODS: This study assessed 622 hypertensive patients diagnosed with left ventricular hypertrophy based on electrocardiography, renal failure based on serum creatinine level &gt; 1.4 mg/dL, and stroke based on a previous history and physical examination. Logistic regression was used to estimate the odds ratio of the association between sex and target-organ lesions in hypertension adjusted for race, age, and duration of the disease. RESULTS: The mean age of the patients was 48.4&amp;plusmn;13.8 years; 74.1% were women, and 84.9% were mulattos or blacks. Almost half of the men and more than 40% of the women had had at least 1 definite event involving a target-organ lesion. The incidence of renal failure was greater among men [adjusted OR (ORa) = 2.73, P= 0.002]. In white patients, the incidence of stroke was significantly (P= 0.017) greater among men (4/33) than among women (0/56), and, in the age group &gt; 49 years, the prevalence of left ventricular hypertrophy was significantly greater among men (ORa = 1.99, P= 0.024). CONCLUSION: The data obtained suggest a greater prevalence of renal failure in men than in women, of stroke in white men than in white women, and of left ventricular hypertrophy in men than in women aged 49 years and above.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sexo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sex</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Análise da função ventricular de pacientes com doença pulmonar obstrutiva crônica avançada pela ressonância magnética</s1>
</fA08>
<fA08 dir="en">
<s1>Assessment of the ventricular function of patients with advanced chronic obstructive pulmonary disease by using magnetic resonance imaging</s1>
</fA08>
<fA11 dir="011000">
<s1>Nazareth de Novaes Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rafael Stelmach</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alberto Cukier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Rodrigues Parga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz Francisco Ávila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Márcia Caldas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Paula Buck</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>320-325</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>45</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar os possíveis mecanismos envolvidos na evolução da disfunção ventricular direita e esquerda em pacientes com doença pulmonar obstrutiva crônica (DPOC). MÉTODOS: A ressonância magnética foi aplicada em 27 pacientes com DPOC divididos em grupos, DPOCc e DPOCs, de acordo com a presença ou ausência de disfunção ventricular direita, respectivamente, e 11 controles (grupo C). O exame Doppler ecocardiográfico foi empregado para análise do grau de hipertensão pulmonar. RESULTADOS: O diâmetro do ventrículo direito foi similar nos 3 grupos, DPOCs, DPOCc e C, 29±8 mm vs 31±7 mm vs 30±6 mm; p NS, respectivamente. Foram observados hipertrofia ventricular direita somente nos grupos DPOC (8±2 mm e 9±3 mm vs 5±1 mm; p&lt;0,01), percentual de espessamento sistólico da parede lateral do ventrículo direito similar (%RVLWT) (86±82% vs 41±35% vs 86±89%; p NS) e diferentes frações de ejeção ventricular esquerda entre os 3 grupos (69±9% vs 55±16% vs 76±6%; p&lt;0,01); correlação linear positiva e significante entre o diâmetro diastólico do ventrículo esquerdo (VE) e o débito sistólico do VE (r=0,72, p &lt; 0,01). Não houve correlação entre os volumes pulmonares e a gasometria arterial com a função ventricular. CONCLUSÃO: Não houve correlação entre a gravidade da função pulmonar e o grau de comprometimento da função ventricular. Fica a ser elucidado se um preservado %RVLWT significa a possibilidade de reversibilidade da função ventricular direita. No entanto, confirmamos a presença do fenômeno da interdependência ventricular.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the mechanisms that may be involved in the evolution of right and left ventricular dysfunction in patients with chronic obstructive pulmonary disease (COPD). METHODS: Magnetic resonance imaging was used in 11 control patients (group C) and 27 patients with COPD, who were divided into 2 groups, COPDc and COPDs, according to the presence or absence of right ventricular dysfunction, respectively. Doppler echocardiography was used for assessing the degree of pulmonary hypertension. RESULTS: The right ventricular diameter was similar in the 3 groups, COPDs, COPDc and C (29±8 mm; 31±7 mm; and 30±6 mm; respectively, P=NS). Right ventricular hypertrophy was observed only in the COPD groups (8±2 mm and 9±3 mm vs 5±1 mm; P&lt;0.01). The percentage of systolic right ventricular lateral wall thickening (%RVLWT) in the 3 groups were as follows: 86±82% vs 41±35% vs 86±89%; P=NS). Different left ventricular ejection fractions were observed in the groups as follows: 69±9% vs 55±16% vs 76±6%; P &lt; 0.01. A positive and significant linear correlation was observed between the left ventricular (LV) diastolic diameter and the LV systolic volume (r = 0.72; P &lt; 0.01). No correlation was observed between the pulmonary volumes, arterial blood gas analysis, and ventricular function. CONCLUSION: No correlation was observed between the severity of pulmonary function and the degree of ventricular function impairment. Whether a preserved %RVLWT means the possibility of reversibility of right ventricular function remains to be elucidated. However, the presence of the phenomenon of ventricular interdependence was confirmed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença pulmonar obstrutiva crônica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ressonância magnética</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chronic obstructive pulmonary disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>magnetic resonance imaging</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>A cirurgia de revascularização do miocárdio sem circulação extracorpórea minimiza o sangramento pós-operatório e a necessidade transfusional</s1>
</fA08>
<fA08 dir="en">
<s1>Myocardial revascularization surgery without extracorporeal circulation minimizes postoperative bleeding and the need for transfusion</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Antibas Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leonardo Augusto Miana</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fábio B. Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Otávio C. Auler Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração do Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>332-337</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparando a revascularização do miocárdio (RM) com e sem circulação extracorpórea (CEC), com o sangramento no pós-operatório e a necessidade de transfusão de sangue e hemoderivados. MÉTODOS: De novembro/2001 a fevereiro/2002, foram analisados 186 pacientes submetidos a revascularização miocárdica, excluindo-se procedimentos associados, divididos em grupo A de 116 pacientes submetidos a RM com CEC e grupo B de 69 pacientes a RM sem CEC. Os dois grupos foram comparáveis em relação a características pré e intra-operatórias, exceto pelo maior número de anastomoses distais (p=0,0004) no grupo A, e maior atividade de protrombina (p=0,04) e RNI (p=0,03) no grupo B. Para evitar discrepâncias entre os grupos, foram selecionados 140 pacientes com características estatisticamente similares. RESULTADOS: Estudando os grupos pareados, tanto o volume total de sangramento em 24h (p=0,001), quanto aquele indexado para a superfície corpórea (p=0,004) foram respectivamente maiores no grupo A (609,6 &amp;plusmn; 395,8 ml; 331,8 &amp;plusmn; 225,8 ml/m²) em relação ao grupo B (437,2 &amp;plusmn; 315 ml; 241 &amp;plusmn; 173,9 ml/m²). Embora a necessidade de transfusão não fosse significativamente diferente entre os grupos (p=0,1), a quantidade transfundida de concentrado de hemáceas foi maior no grupo A (p=0,01). Não houve diferença estatística em relação à transfusão dos outros hemocomponentes e à necessidade de revisão cirúrgica de hemostasia. CONCLUSÃO: A RM sem CEC apresentou vantagens sobre a RM com CEC, em relação ao menor sangramento no pós-operatório e menor transfusão de concentrado de hemáceas. As repercussões deste achado podem ser inúmeras, principalmente em relação a minimização de fatores mórbidos e de custos hospitalares.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare myocardial revascularization (MR) with and without extracorporeal circulation (ECC) in regard to postoperative bleeding and the need for blood and hemoderivate transfusion. METHODS: From November 2001 to February 2002, 186 patients undergoing myocardial revascularization were assessed, excluding those who underwent associated procedures. The patients were divided into 2 groups as follows: group A - comprising 116 patients undergoing MR with ECC; and group B - comprising 69 patients undergoing MR without ECC. Both groups were comparable in regard to pre- and intraoperative characteristics, except for the greater number of distal anastomoses (P=0.0004) in group A, and greater prothrombin activity (P=0.04) and INR (P=0.03) in group B. To avoid discrepancies between the groups, 140 patients with statistically similar characteristics were selected. RESULTS: Studying the paired groups, both the total bleeding volume in 24 hours (P=0.001) and the bleeding volume indexed for body surface (P=0.004) were greater in group A (609.6 &amp;plusmn; 395.8 mL; 331.8 &amp;plusmn; 225.8 mL/m², respectively) than in group B (437.2 &amp;plusmn; 315 mL; 241 &amp;plusmn; 173.9 mL/m², respectively). Although the need for transfusion was not significantly different between the groups (P=0.1), the amount of erythrocyte concentrate transfused was greater in group A (P=0.01). No statistical difference was observed in regard to transfusion of other hemocomponents and the need for surgical review of hemostasis. CONCLUSION: Myocardial revascularization without ECC was more advantageous than MR with ECC in regard to smaller postoperative blood loss and a lesser need for transfusion of erythrocyte concentrate. The repercussions of this finding may be innumerable, particularly in regard to minimization of morbid factors and hospital costs.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>revascularização do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>circulação extracorpórea</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sangramento mediastinal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>transfusão de sangue</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>extracorporeal circulation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mediastinal bleeding</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood transfusion</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Miocardite aguda secundaria a feocromocitoma</s1>
</fA08>
<fA08 dir="en">
<s1>Acute myocarditis secondary to pheochromocytoma</s1>
</fA08>
<fA11 dir="011000">
<s1>Lucélia Cunha Magalhães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eduardo S. Darze</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antônio Ximenes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Oto Santana</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Jorge Bastos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Armênio Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>343-345</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Terapia de células-tronco no infarto agudo do miocárdio, através de perfusão coronariana retrógrada: uma nova técnica</s1>
</fA08>
<fA08 dir="en">
<s1>Stem cell therapy with retrograde coronary perfusion in acute myocardial infarction: a new technique</s1>
</fA08>
<fA11 dir="011000">
<s1>Stans Murad-Netto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rogério Moura</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz José Martins Romeo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antônio Manoel Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Neison Duarte</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fernando Barreto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>André Jensen</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Roberto Fernandez Viña</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Francisco Vraslovik</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Andrin Oberdan</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Frederico Benetti</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Jorge Saslavsky</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Marcelo Fernandez Viña</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>José Geraldo Amino</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>349-351</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiologia baseada em evidência</s1>
</fA08>
<fA11 dir="011000">
<s1>Edgar Guimarães Victor</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>André de Marco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFPE Pós-graduação de Medicina Interna </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>355-356</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiologia baseada em evidências: alguns esclarecimentos são necessários!</s1>
</fA08>
<fA11 dir="011000">
<s1>Otávio Berwanger</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Álvaro Avezum</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alexandre Biasi Cavalcante</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>357-359</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300412</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 05/2004 - Morte súbita precedida por dispnéia intensa em mulher de 70 anos portadora de hipertensão e doença coronariana</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Eduardo Batista de Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Alberto Benvenuti</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>360-364</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300413</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Errata</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>364-364</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300414</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Importância da correlação clínico-radiográfica na aproximação diagnóstica das cardiopatias congênitas</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>365-367</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Reabilitação não supervisionada ou semi-supervisionada: uma alternativa prática</s1>
</fA08>
<fA11 dir="011000">
<s1>Japy Angelini Oliveira Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Xiomara Miranda Salvetti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>368-370</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Polimorfismos em genes relacionados ao sistema renina-angiotensina-aldosterona, associação com a doença arterial coronariana e suas características anatômicas</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco Antonio Helfenstein Fonseca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Cristina de Oliveira Izar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Setor de Lípides, Aterosclerose e Biologia Vascular </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>371-372</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Biópsia endomiocárdica prediz a recuperação da função ventricular após cirurgia de revascularização do miocárdio</s1>
</fA08>
<fA08 dir="en">
<s1>Endomyocardial biopsy foretells ventricular function recovery after coronary artery bypass grafting</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo L. Moreno</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Orlando B. Wender</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marinez Barra</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Lucia C. Pellanda</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz E. Rohde</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Nadine Clausell</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Cardiologia do RS  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Fundação Universitária de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Fundação Federal de Ciências Médicas de Porto Alegre  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="040000">
<s1>Hospital de Clínicas de Porto Alegre  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>373-378</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Pacientes com insuficiência cardíaca isquêmica podem ser beneficiados com a cirurgia de revascularização do miocárdio. Foram estudadas as variáveis histopatológicas que estariam associadas à melhora da fração de ejeção seis meses após a cirurgia. MÉTODOS: Em 24 pacientes estudados com indicação de cirurgia de revascularização do miocárdio, fração de ejeção &lt; 35%, classe funcional de insuficiência cardíaca II-IV e idades entre 59 &amp;plusmn; 9 anos, foram realizadas biópsias endomiocárdicas no transoperatório e seis meses após. Extensão de fibrose, número de células apresentando miocitólise e hipertrofia da fibra muscular foram quantificados por um sistema analisador de imagem. Revisão clínica e funcional foi repetida em seis meses. RESULTADOS: Houve melhora significativa da classe funcional de insuficiência cardíaca em 16 pacientes após os seis meses de acompanhamento (classe NYHA 2,8&amp;plusmn; 0,7 para 1,7&amp;plusmn;0,6; p &lt;0,001), enquanto a fração de ejeção não se alterou (25 &amp;plusmn; 6% vs. 26 &amp;plusmn; 10%). Hipertrofia da fibra muscular foi similar nos espécimes biopsiados no pré e no pós operatório (21&amp;plusmn;4 vs. 22&amp;plusmn;4 &amp;micro;m), enquanto que a extensão de fibrose (8&amp;plusmn;8 vs. 21&amp;plusmn;15% área) e células apresentando miocitólise (9&amp;plusmn;11 vs. 21&amp;plusmn;15% cel) aumentaram significativamente. No entanto, a composição de um escore histológico, combinando as três variáveis, indicou maior incremento na função ventricular naqueles que apresentavam menor grau de alterações histopatológicas no pré-operatório. CONCLUSÃO: Portadores de miocardiopatia isquêmica, submetidos à revascularização do miocárdio, apresentaram melhora da função ventricular quando as alterações histopatológicas adversas do pré-operatório foram de menor grau.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Patients with ischemic heart failure may benefit from coronary artery bypass grafting. The histopathological variables associated with improvement in ejection fraction 6 months after surgery were assessed. METHODS: This study comprised 24 patients indicated for coronary artery bypass grafting, ejection fraction &lt; 35%, functional class II-IV heart failure, and mean age 59 &amp;plusmn; 9 years. Endomyocardial biopsies were performed during and 6 months after surgery. Extension of the fibrosis, number of cells with myocytolysis, and hypertrophy of the muscle fiber were quantified by using a system of image analysis. Clinical and functional review was repeated within 6 months. RESULTS: A significant improvement in heart failure functional class was observed in 16 patients after 6 months of follow-up (from NYHA functional class 2.8&amp;plusmn;0.7 to 1.7&amp;plusmn;0.6; P &lt;0.001), but the ejection fraction did not change (25&amp;plusmn;6 % vs. 26&amp;plusmn;10%). Hypertrophy of the muscle fiber was similar in the specimens biopsied in the pre- and postoperative periods (21&amp;plusmn;4 vs. 22&amp;plusmn; 4 &amp;micro;m), but the extension of fibrosis (8&amp;plusmn;8 vs. 21&amp;plusmn;15% area) and the number of cells with myocytolysis (9&amp;plusmn;11 vs. 21&amp;plusmn;15% cell) significantly increased. However, the composition of a histological score combining those 3 variables indicated a greater increase in the ventricular function of those with a lower degree of preoperative histopathological alterations. CONCLUSION: Patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting improved their ventricular function when the preoperative adverse histopathological alterations were of a lower degree.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatia isquêmica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>biópsia endomiocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>revascularização</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemic cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endomyocardial biopsy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery bypass grafting</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeitos agudos dos estrogênios associados a progestogênios sobre a trigliceridemia e reatividade vascular pós-prandial</s1>
</fA08>
<fA08 dir="en">
<s1>Acute effects of the use of estrogens in association with progestogens on postprandial triglyceridemia and vascular reactivity</s1>
</fA08>
<fA11 dir="011000">
<s1>Silvio C.M. Santos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jaime Augusto Canashiro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Otavio C.E. Gebara</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Mendes Aldrighi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Nubia Vieira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Amit Nussbacher</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Humberto Pierri</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>João Serro-Azul</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Maurício Wajngarten</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Giuseppe Rosano</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Jose A. F. Ramires</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Instituto San Raffaele  </s1>
<s2>Roma Itália</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>385-390</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>41</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar se a terapia de reposição hormonal com estrogênios e progestogênios, em mulheres hipertensas na pós-menopausa, modifica a trigliceridemia e a reatividade vascular pós-prandial. MÉTODOS: Estudo controlado, duplo cego, cruzado contra placebo em 15 mulheres na pós-menopausa (idade de 50 a 70, média = 61,6 &amp;plusmn; 6 anos), sorteadas para 2 semanas de placebo ou ingestão oral de 0,625 mg de estrogênios conjugados eqüinos e 2,5 mg de medroxiprogesterona e alimentadas com refeição rica em gorduras (897 calorias; 50,1% de gorduras). Foi medida a reatividade vascular (RV - % de variação dos diâmetros do vaso entre o jejum e 2h após a alimentação), usando-se método ultra-sonográfico automatizado. Foram também determinados o perfil lipídico e a glicose, em jejum e 2h após a alimentação rica em gorduras. RESULTADOS: Com o placebo, a reatividade vascular (RV) diminuiu de 3,20 &amp;plusmn; 17% em jejum para -2,1 &amp;plusmn; 30%, 2h após a alimentação (p = 0,041), e com terapia de reposição hormonal, a reatividade vascular diminuiu de 6,14 &amp;plusmn; 27% em jejum para -0,05&amp;plusmn;18%, 2h após a alimentação (p=NS). A trigliceridemia pós-prandial aumentou, 35 &amp;plusmn; 25% com o placebo, e 12 &amp;plusmn; 10% com a terapia de reposição hormonal (P &lt; 0,05). CONCLUSÃO: Em mulheres hipertensas, na pós-menopausa, 2 semanas de reposição hormonal com uma associação de estrogênios e progestogênios, diminuiu a hipertrigliceridemia após uma refeição com alto teor de gorduras, efeito que pode melhorar a disfunção endotelial existente no período pós-prandial.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess whether hormone replacement therapy with estrogens in association with progestogens in postmenopausal hypertensive women alters postprandial triglyceridemia and vascular reactivity. METHODS: A double-blind, placebo-controlled, crossover study was carried out with 15 postmenopausal women (age range: 50 to 70 years, mean = 61.6 &amp;plusmn; 6 years) randomly assigned to 2 weeks of placebo or oral ingestion of 0.625 mg of equine conjugated estrogens and 2.5 mg of medroxyprogesterone, fed a high-fat diet (897 calories; 50.1% fat). Vascular reactivity (VR - % of vessel diameter variation in the fasting period and 2 hours after meals) was measured by using the automated ultrasound method. Lipid profile and glycemia during the fasting period and 2 hours after a high-fat meal were measured. RESULTS: With placebo, vascular reactivity (VR) decreased from 3.20 &amp;plusmn; 17% during the fasting period to -2.1 &amp;plusmn; 30% 2 hours after the meal (P=0.041). With the hormone replacement therapy, vascular reactivity decreased from 6.14 &amp;plusmn; 27% during the fasting period to - 0.05 &amp;plusmn; 18% 2 hours after the meal (P=NS). Postprandial triglyceridemia increased as follows: 35 &amp;plusmn; 25% with placebo; and 12 &amp;plusmn; 10% with hormone replacement therapy (P &lt; 0.05). CONCLUSION: In postmenopausal hypertensive women, 2 weeks of hormone replacement with an association of estrogens and progestogens decreased hypertriglyceridemia after a high-fat meal, an effect that may reduce the endothelial dysfunction occurring in the postprandial period.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>terapia de reposição hormonal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>trigliceridemia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>endotélio vascular</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hormone replacement therapy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>triglyceridemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>vascular endothelium</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Guia de endereços eletrônicos para o estudo de cardiologia</s1>
</fA08>
<fA08 dir="en">
<s1>Guide of internet sites for the study of cardiology</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciana Aikawa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Denise Cássia Moreira Zornoff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Beatriz Bojikian Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNESP Faculdade de Medicina de Botucatu </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>396-399</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Ampliar os recursos didáticos para estudantes de medicina, médicos e profissionais da área da saúde, estimulando o uso da Internet para fins acadêmicos ou de reciclagem em cardiologia. MÉTODO: Pesquisados e selecionados endereços eletrônicos com conteúdo acadêmico nas áreas da anatomia, biofísica, fisiologia, semiologia, eletrocardiografia e diagnóstico por imagem, com critérios de seleção, incluíndo relevância do conteúdo, clareza na apresentação e riqueza em recursos de animação e, os sites obtidos, classificados quanto ao conteúdo e nível acadêmico. RESULTADOS: Obtidos 5 sites de anatomia e anatomia patológica, 1 de biofísica, 3 de fisiologia, 8 de semiologia, 7 de diagnóstico por imagem e 2 de eletrocardiografia. Como alternativa de acesso, os sites também foram organizados de acordo com o nível acadêmico. O conjunto de endereços resultou em um guia simplificado e hierarquizado de conteúdos para o estudo da morfologia cardíaca e do diagnóstico por imagem em cardiologia. CONCLUSÃO: O roteiro obtido é um exemplo do potencial da Internet como instrumento de aprendizagem, a ser utilizado em associação com outros métodos pedagógicos convencionais.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To increase the offer of didactic resources for medical students, physicians, and health care professionals, stimulating the use of the Internet for academic purposes or cardiological updating. METHOD: Electronic addresses with academic content in the areas of anatomy, biophysics, physiology, semiology, electrocardiography, and image diagnosis were researched and selected. The selection criteria included the following: relevance of the content, neatness of presentation, and richness of animation resources. The sites obtained were classified in regard to their contents and academic level. RESULTS: The sites obtained were as follows: 5 sites of anatomy and anatomical pathology, one of biophysics, 3 of physiology, 8 of semiology, 7 of image diagnosis, and 2 of electrocardiography. The sites were also organized according to academic level to provide an alternative access. The set of addresses resulted in a simplified and hierarchic guide of contents for the study of cardiac morphology and image diagnosis in cardiology. CONCLUSION: The resulting list of sites is an example of the potential of the Internet as a learning instrument to be used in association with other conventional pedagogical methods.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>educação médica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>educação em saúde</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiologia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>informática médica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Internet</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>medical education</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>health education</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>medical informatics</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Internet</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>O polimorfismo A1166C do receptor tipo 1 da angiotensina II no infarto agudo do miocárdio</s1>
</fA08>
<fA08 dir="en">
<s1>The A1166C polymorphism of the angiotensin II type-1 receptor in acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Messias Antônio de Araújo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Bruno Soares Menezes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Clauber Lourenço</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Elisângela Rosa Cordeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Renata Rispoli Gatti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luiz Ricardo Goulart</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Uberlândia Instituto do Coração do Triângulo Mineiro </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>404-408</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>RESUMO OBJETIVO:Avaliar a associação do polimorfismo A1166C do gene do receptor AT1 da angiotensina II (AT1R) com o infarto agudo do miocárdio e a severidade da doença arterial coronariana. MÉTODOS: Estudo prospectivo, transversal de 110 pacientes com infarto agudo do miocárdio submetidos à angiografia coronariana com lesão significante (&gt; 50%) avaliada por três critérios de severidade: número de vasos lesados, morfologia da placa aterosclerótica e escore de risco coronariano. Sem lesões coronarianas 104 indivíduos controles. O polimorfismo A1166C do gene do AT1R foi determinado pela reação em cadeia da polimerase no DNA dos leucócitos do sangue periférico. Os fatores de risco coronariano clássicos foram analisados em todos os indivíduos. RESULTADOS: Na estratificação dos genótipos em relação aos fatores de risco apenas o tabagismo teve predominância nos heterozigotos AC (p = 0,02). A freqüência dos genótipos nos pacientes infartados foi de AA = 54,5%; AC = 35,5% e CC = 10%, sendo similar e não significativa em relação aos controles (p = 0,83). Não houve aumento do risco de infarto agudo do miocárdio nas comparações dos genótipos CC vs AA (OR = 1,35; IC-95% = 0,50 - 3,59), AC vs AA (OR = 1,03; IC-95% = 0,58 - 1,84 e AA+AC vs AA (OR = 1,33; IC-95% = 0,51 - 3,45). Nenhum dos critérios de severidade teve associação significativa com os genótipos. CONCLUSÃO: Os nossos resultados indicam não haver associação do polimorfismo A1166C do AT1R com o infarto agudo do miocárdio e nem com a severidade da doença arterial coronariana segundo nossos resultados.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the association of the A1166C polymorphism of the angiotensin II type-1 receptor (AT1R) gene with acute myocardial infarction and also with the severity of coronary artery disease. METHODS: A prospective, cross-sectional study was carried out with 110 patients with acute myocardial infarction, who, on coronary angiography, had significant lesions (&gt; 50%) assessed according to 3 criteria of severity: number of vessels affected, morphology of the atherosclerotic plaque, and coronary risk score. The control group comprised 104 individuals with no coronary lesions. The A1166C polymorphism of AT1R gene was determined by polymerase chain reaction in the DNA of leukocytes in peripheral blood. The classic coronary risk factors were analyzed in all individuals. RESULTS: When stratifying the genotypes in regard to risk factors, only smoking predominated in the AC heterozygous patients (P = 0.02). The genotypic frequency in the infarcted patients was as follows: AA = 54.5%; AC = 35.5%; and CC = 10%, which was similar and nonsignificant in regard to that in the control group (P = 0.83). No risk increase occurred for acute myocardial infarction when comparing the genotypes as follows: CC vs AA (OR = 1.35; 95% CI = 0.50 - 3.59); AC vs AA (OR = 1.03; 95% CI = 0.58 - 1.84); and AA+AC vs AA (OR = 1.33; 95% CI = 0.51 - 3.45). None of the severity criteria showed a significant correlation with the genotypes. CONCLUSION: According to our results, no correlation exists between the A1166C polymorphism of the angiotensin II type-1 receptor (AT1R) gene and acute myocardial infarction or the severity of coronary artery disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>polimorfismo A1166C</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angiotensina II</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto agudo do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença arterial coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>A1166C polymorphism</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angiotensin II</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Ecocardiografia de contraste miocárdico em pacientes com doença arterial coronariana suspeita ou conhecida: comparação com a cintilografia miocárdica com radioisótopos</s1>
</fA08>
<fA08 dir="en">
<s1>Myocardial contrast echocardiography in patients with suspected or known coronary artery disease: comparison with myocardial nuclear scintigraphy</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcia Carrinho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alvaro Moraes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando Morcerf</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Caio Medeiros</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Márcia Castier</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luis José Martins Romeo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>ECOR Ecocardiografia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal Fluminense  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>414-418</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar a ecocardiografia de contraste miocárdico (ECM) usando PESDA e adenosina em bolus (ADN) com a cintilografia miocárdica com radioisótopos (CM) em pacientes (pts) submetidos a investigação e alta probabilidade de doença arterial coronariana. MÉTODOS: Foram estudados 125 pts, 58,4 &amp;plusmn; 10,6 anos, 85 homens, com ECM e CM, realizados com intervalo máximo de 4 semanas. ECM foi realizada com PESDA em infusão contínua em repouso e após ADN. As paredes do VE foram divididas em 3 territórios relacionados às artérias coronarianas, totalizando 375 territórios. ECM foi normal quando houve aumento da intensidade do contraste após ADN. Diminuição da intensidade do contraste em repouso ou após ADN foi definida como ECM anormal. CM foi realizada usando protocolos clássicos. Comparados por pacientes, foram considerados concordantes quando ambos exames eram normais ou anormais independente de localização. A comparação por território foi considerada concordante quando havia ou não déficit perfusional num mesmo território. A significância da concordância foi feita pelo teste do qui-quadrado. RESULTADOS: Em 106/125 pts ECM e CM foram concordantes (84,8% - p&lt;0,001). Houve concordância em 342/375 territórios (91,2% - p&lt;0,001). Para o território de DA a concordância foi de 87,2%, para CD 93,6% e para CX 92,8% (p&lt;0,001). CONCLUSÃO: Existe uma ótima concordância entre ECM e CM nos pts em investigação para doença arterial coronariana, podendo a ECM representar uma alternativa à avaliação da perfusão miocárdica.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare myocardial contrast echocardiography (MCE) using PESDA and adenosine in bolus (ADN) with myocardial nuclear scintigraphy (NS) in patients (pts) undergoing routine investigation with a high probability of having coronary artery disease. METHODS: This study comprised 125 pts (85 men) with 58.4 &amp;plusmn; 10.6 years, who underwent MCE and NS within 4 weeks. MCE was performed with PESDA in a continuous infusion at rest and after administration of an adenosine bolus. The LV walls was divided into 3 territories related to the coronary arteries, in a total of 375 territories. MCE was normal when an increase in contrast intensity occurred after ADN. The reduction in contrast intensity at rest or after ADN was defined as an abnormal MCE result. NS was performed according to classical protocols. When compared per patient, both examinations were considered concordant when they were normal or abnormal, independent of its location. The comparison by territory was considered concordant when perfusion defects existed or not in the same territory. The chi-square test was used to determine the significance of concordance. RESULTS: In 106/125 pts, MCE and NS were concordant (84.8% - P &lt; 0.001). Concordance occurred in 342/375 territories (91.2% - P &lt; 0.001). For the LAD territory, concordance was 87.2%; for the RCA, 93.6%; and for the CX, 92.8% (P &lt; 0.001). CONCLUSION: An excellent concordance exists between MCE and NS in assessing pts for coronary artery disease; therefore, MCE may represent a good alternative for assessing myocardial perfusion.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>perfusão miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>contraste ecocardiográfico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença arterial coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>adenosina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cintilografia miocárdica com radioisótopos</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial perfusion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiographic contrast medium</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adenosine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial nuclear scintigraphy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Prevalência, reconhecimento e controle da hipertensão arterial sistêmica no estado do Rio Grande do Sul</s1>
</fA08>
<fA08 dir="en">
<s1>Prevalence, awareness, and control of systemic arterial hypertension in the state of Rio Grande do Sul</s1>
</fA08>
<fA11 dir="011000">
<s1>Iseu Gus</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Erno Harzheim</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cláudio Zaslavsky</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cláudio Medina</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Miguel Gus</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Cardiologia do Rio Grande do Sul  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Fundação Universitária de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>424-428</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Descrever a prevalência dos fatores de risco das doenças cardiovasculares, em particular, a hipertensão arterial sistêmica na população adulta do RS, seu nível de reconhecimento e controle, além dos fatores associados. MÉTODOS: Estudo transversal, de base populacional, com amostragem aleatória por conglomerado, em 918 adultos &gt;20 anos, realizada de 1999-2000, tendo hipertensão arterial sistêmica definida como pressão arterial &gt;140/90 ou uso atual de anti-hipertensivos. RESULTADOS: A prevalência de hipertensão arterial sistêmica foi de 33,7% (n=309), sendo que 49,2% desconheciam ser hipertensos; 10,4% tinham conhecimento de ser hipertensos, mas não seguiam o tratamento; 30,1% seguiam o tratamento, mas não apresentavam controle adequado e 10,4% seguiam tratamento anti-hipertensivo com bom controle. Após análise multivariada, as características associadas significativamente com a presença de hipertensão arterial sistêmica foram: idade (OR=1,06), obesidade (OR=3,03) e baixa escolaridade (OR=1,82); as mesmas características foram associadas à falta de reconhecimento da hipertensão: idade (OR=1,05), obesidade (OR=2,46) e baixa escolaridade (OR=2,17). CONCLUSÃO: A prevalência de hipertensão arterial sistêmica no RS manteve-se em níveis constantes nas últimas décadas, e seu grau de reconhecimento apresentou discreta melhora. Entretanto, o nível de controle da hipertensão arterial sistêmica não apresentou crescimento. Este estudo permitiu definir um grupo-alvo - pessoas de maior idade, obesas e de baixa escolaridade - tanto para campanhas diagnósticas, como para a obtenção de maior controle de níveis pressóricos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To report the prevalence of cardiovascular risk factors, particularly of systemic arterial hypertension, in the adult population of the Brazilian state of Rio Grande do Sul, in addition to the public's level of awareness, hypertensive control, and associated factors. METHODS: A cross-sectional, population-based study with random sampling from a population pool was carried out with 918 patients older than 20 years from 1999 to 2000. Systemic arterial hypertension was defined as blood pressure &gt; 140/90 or current use of antihypertensive drugs. RESULTS: The prevalence of systemic arterial hypertension was 33.7% (n=309), and 49.2% of the individuals were unaware of their hypertensive condition; 10.4% knew they were hypertensive, but did not undergo treatment; 30.1% underwent antihypertensive treatment, but did not have adequate control; and 10.4% underwent antihypertensive treatment with adequate control. Based on multivariate analysis, the following variables were found to be significantly associated with the presence of systemic arterial hypertension: age (OR=1.06), obesity (OR=3.03), and low educational level (OR=1.82). These same variables were associated with unawareness of the hypertensive condition: age (OR=1.05), obesity (OR=2.46), and low educational level (OR=2.17). CONCLUSION: Prevalence of systemic arterial hypertension in the state of Rio Grande do Sul has been remained at constant levels for the past decades, and the population's level of awareness of it has improved slightly. However, the control level of systemic arterial hypertension has not increased. This study allowed the definition of a target group - elderly, obese individuals with low educational level - for both diagnostic campaigns and better control of blood pressure levels.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>epidemiologia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doenças cardiovasculares</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Síncope e bloqueio atrioventricular total relacionado a tromboembolismo pulmonar</s1>
</fA08>
<fA08 dir="en">
<s1>Syncope and complete atrioventricular block related to pulmonary thromboembolism</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Elias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo Kuniyoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Bruno Moulin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fabíola Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eduardo Castro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Alfredo Nunes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Vitor Barreto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Alaôr Queiroz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Felipe Moysés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Unimed Coração  </s1>
<s2>Vitória </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>434-438</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Implante de stent em estenose crítica no tronco celíaco: expandindo as fronteiras da intervenção vascular percutânea</s1>
</fA08>
<fA08 dir="en">
<s1>Stent implantation in critical stenosis of the celiac trunk: enlarging the frontiers of percutaneous vascular intervention</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre Schaan de Quadros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rogério Sarmento-Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cláudio Vasquez Moraes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luis Maria Yordi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Mãe de Deus Centro de Terapia Endovascular </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital Moinhos de Vento  </s1>
<s2>Porto Alegre </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>442-444</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Normatização dos equipamentos e técnicas da reabilitação cardiovascular supervisionada</s1>
</fA08>
<fA11 dir="011000">
<s1>Claudio Gil Soares de Araújo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Tales de Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Claudia Lúcia Barros de Castro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ricardo Vivácqua Costa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ruy Silveira Moraes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Japy Angelini Oliveira Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>448-452</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300512</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>III Diretriz sobre tratamento do infarto agudo do miocárdio</s1>
</fA08>
<fA11 dir="011000">
<s1>Leopoldo S. Piegas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ari Timerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Carlos Nicolau</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Alberto Mattos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>João Manoel Rossi Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Gilson S. Feitosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Álvaro Avezum</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Antonio Carlos C. Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Antonio de Pádua Mansur</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Ari Timerman</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Armênio Costa Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Augusto Elias Z. Bozza</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Brivaldo Markman F.</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Carisi A. Polanczyk</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Carlos Vicente Serrano</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>César Cardoso de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>Claudia M. Rodrigues Alves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>Dalton Bertolim Précoma</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>Denílson Campos de Albuquerque</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="201000">
<s1>Edson Renato Romano</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="211000">
<s1>Edson Stefanini</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="221000">
<s1>Elias Knobel</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="231000">
<s1>Elisabete S. Santos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="241000">
<s1>Epotamenides M. Good God</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="251000">
<s1>Expedito E. Ribeiro da Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="261000">
<s1>Fábio Sandoli de Brito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="271000">
<s1>Gilmar Reis</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="281000">
<s1>Gilson S. Feitosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="291000">
<s1>Gustavo Glotz de Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="301000">
<s1>Jacob Atie</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="311000">
<s1>João Manoel Rossi Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="321000">
<s1>José Antonio Marin Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="331000">
<s1>José Carlos Nicolau</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="341000">
<s1>José Francisco Kerr Saraiva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="351000">
<s1>José Geraldo de Castro Amino</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="361000">
<s1>Leopoldo S. Piegas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="371000">
<s1>Lilia Nigro Maia</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="381000">
<s1>Luis Felipe Moreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="391000">
<s1>Luiz Alberto Mattos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="401000">
<s1>Magaly Arraes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="411000">
<s1>Mário Coutinho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="421000">
<s1>Oscar Dutra</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="431000">
<s1>Otávio Rizzi Coelho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="441000">
<s1>Paulo Ernesto Leães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="451000">
<s1>Paulo Roberto Ferreira Rossi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="461000">
<s1>Pedro Albuquerque</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="471000">
<s1>Roberto Bassan</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="481000">
<s1>Roberto Esporcatte</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="491000">
<s1>Roberto Rocha Giraldez</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="501000">
<s1>Romeu Sérgio Meneghelo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="511000">
<s1>Rui Fernando Ramos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="521000">
<s1>Valéria Bezerra de Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="531000">
<s1>Wilson Mathias</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="541000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-86</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>spe</s2>
</fA06>
<fA08 dir="pt">
<s1>Instituto Dante Pazzanese de Cardiologia: assistência, ensino e pesquisa</s1>
</fA08>
<fA11 dir="011000">
<s1>Amanda G.M.R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>J. Eduardo M.R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Leopoldo S. Piegas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-1</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>spe</s2>
</fA06>
<fA08 dir="pt">
<s1>O uso do ultra-som intracoronariano na tomada de decisão para o tratamento das lesões coronarianas moderadas</s1>
</fA08>
<fA08 dir="en">
<s1>The use of intravascular ultrasound in deciding on the treatment of moderate coronary lesions</s1>
</fA08>
<fA11 dir="011000">
<s1>Andrea Claudia Leão de Sousa Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leopoldo Soares Piegas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alexandre Antonio Cunha Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Fernando Leite Tanajura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Aurea Jacob Chaves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marinella Patrizia Centemero</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ana Cristina C. Seixas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luiz Alberto Piva Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Ibraim Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Amanda Guerra Morais Rego Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>J. Eduardo Morais Rego Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>3-6</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300002</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Investigar o critério ultra-sonográfico de área mínima da luz (AML), com valor de corte igual a 4,0 mm² na tentativa de diferençar as lesões que devem ou não ser tratadas. MÉTODOS: Incluímos 173 pacientes consecutivos com lesões angiograficamente moderadas (porcentual de estenose entre 40 e 70) submetidos à realização de ultra-som, divididos em 2 grupos: grupo 1 clínico (AML &gt; 4,0 mm²) e grupo 2 revascularização (AML &lt; 4,0 mm²), que foram acompanhados para determinar as taxas de eventos cardíacos maiores (ECM) em dois anos, a necessidade de revascularização da lesão-alvo e identificar os preditores clínicos, angiográficos e ultra-sonográficos dos eventos. RESULTADOS: Apresentaram AML &gt; 4,0 mm² 75 (43%) pacientes, mantidos clinicamente e 98 (57%) pacientes AML &lt; 4,0 mm², tratados com stents coronarianos. Pela angiografia coronariana quantitativa não houve diferença significante entre o porcentual de estenose do vaso [grupo 1: 48% vs grupo 2: 53%; p=0,06]. Ao contrário das mensurações ultra-sonográficas, pois a AML mostrou-se significativamente maior no grupo 1 quando comparada ao grupo 2 [4,54 mm² vs 2,45 mm²; p&lt;0,001)]. O impacto clínico da tomada de decisão foi favorável, não verificando-se diferença na ocorrência de eventos cardíacos maiores: [grupo 1: 5 (7%) vs grupo 2: 14 (15%); p= 0,09]. A necessidade de revascularização da lesão-alvo também não diferiu (grupo 1: 3 (4%) vs grupo 2: 11 (12%); p=0,07). As variáveis preditoras para os ECM foram: diabetes, angina CFIII pré-hospitalização e a AML avaliada pelo ultra-som. CONCLUSÃO: A estratégia de decisão de tratamento assegura baixas taxas de ECM em ambos os grupos no seguimento de 24 meses, garantindo reduzidas taxas de revascularização, sendo as variáveis preditoras de eventos cardíacos maiores: diabetes melito, angina classe funcional III e a AML ao ultra-som intracoronariano.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To investigate the ultrasound criterion of minimum luminal area (MLA) with a cutoff value of 4.0 mm² in an attempt to differentiate the lesions that should be treated from those that should not. METHODS: The study comprised 173 consecutive patients with moderate angiographic lesions (percentage of stenosis between 40 and 70) who underwent ultrasound imaging. They were divided into 2 groups as follows: group 1 or clinical group (MLA &gt; 4.0 mm²); and group 2 or revascularization group (MLA &lt; 4.0 mm²). The patients were followed up to determine the rate of major cardiac events (MCE) in 2 years, the need for revascularization of the target lesion, and to identify the clinical, angiographic, and ultrasound predictors of events. RESULTS: Seventy-five (43%) patients had MLA &gt; 4.0 mm² and were clinically treated; 98 (57%) patients had MLA &lt; 4.0 mm² and were treated with coronary stents. On quantitative coronary angiography, no significant difference was observed between the percentage of vessel stenosis [group 1: 48% vs group 2: 53%; P=0.06]. By the other hard ultrasound measurements, as MLA was significantly greater in group 1 compared with that in group 2 [4.54 mm² vs 2.45 mm²; P &lt; 0.001)]. The clinical impact of the decision was favorable, and no difference was observed in regard to the occurrence of major cardiac events: [group 1: 5 (7%) vs group 2: 14 (15%); P = 0.09]. The need for revascularization of the target lesion also did not differ (group 1: 3 (4%) vs group 2: 11 (12%); P = 0.07). The predictive variables for MCE were diabetes, functional class III (FC III) angina before hospitalization, and MLA assessed on ultrasound. CONCLUSION: This strategy for deciding on appropriate treatment guarantees low rates of MCE in both groups in the 24-month follow-up, with reduced revascularization rates. The predictive variables of major cardiac events were as follows: diabetes mellitus, FC III angina, and MLA on intravascular ultrasound.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ultra-som intracoronariano</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lesão coronariana moderada</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença arterial coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>intravascular ultrasound</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>moderate coronary lesion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>spe</s2>
</fA06>
<fA08 dir="pt">
<s1>Efetividade clínica e segurança do tratamento percutâneo da comunicação interatrial tipo ostium secundum, com a prótese Amplatzer®</s1>
</fA08>
<fA08 dir="en">
<s1>Clinical efficacy and safety of the percutaneous treatment of secundum atrial septal defect with the Amplatzer occluder</s1>
</fA08>
<fA11 dir="011000">
<s1>Sérgio Luiz Navarro Braga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Amanda Guerra de Moraes Rego Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Augusto Cardoso Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>César Augusto Esteves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Simone Rolim Fernandes Fontes Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Valmir Fernandes Fontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>7-13</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300003</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVOS: Analisar a eficácia clínica e segurança da prótese Amplatzer® na oclusão percutânea da comunicação interatrial tipo ostium secundum. MÉTODOS: Foram submetidos ao procedimento orientados pela ecocardiografia transesofágica (ETE) e sob anestesia geral 49 pacientes e acompanhados clinicamente por um período de 12 meses. RESULTADOS: O defeito apresentou-se como orifício único em 91,8% dos casos. As médias dos diâmetros longitudinal e transverso corresponderam a 14,3 &amp;plusmn; 5,0 mm e 14,4 &amp;plusmn; 4,9 mm. A média dos diâmetros estirados foi de 19,3 &amp;plusmn; 5,1 mm e das próteses de 20,3 &amp;plusmn; 4,9 mm. Houve sucesso técnico em 97,9% dos casos. Observou-se fluxo residual imediato em 54,1% sendo 45,8% mínimos ou pequenos e 8,3% moderados caindo para 25% após 24h (p = 0,0002). Ao final de 13,1 &amp;plusmn; 1,3 meses a incidência do fluxo residual global reduziu-se para 14,6% sendo apenas 4,1% moderados. Houve significante redução do diâmetro diastólico do ventrículo direito nas diversas fases do seguimento clínico (p &lt; 0,001). CONCLUSÃO: O procedimento com a prótese Amplatzer® mostrou-se eficaz e seguro constituindo-se numa opção para o tratamento da comunicação interatrial tipo ostium secundum em casos selecionados.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the clinical efficacy and safety of the Amplatzer occluder for percutaneous closure of secundum atrial septal defect. METHODS: Forty-nine patients underwent the procedure guided by transesophageal echocardiography (TEE) while under general anesthesia, afterwards being clinically followed up for 12 months. RESULTS: The defect presented as a single orifice in 91.8% of the cases. The means of the longitudinal and transverse diameters were 14.3±5.0 mm and 14.4±4.9 mm, respectively. The means of the stretched diameters and prostheses were 19.3±5.1 mm and 20.3±4.9 mm, respectively. Technical success occurred in 97.9% of the cases. Immediate residual flow was observed in 54.1% of the patients, being minimum or small in 45.8% and moderate in 8.3%. After 24 hours, residual flow was observed in 25% of the patients (P = 0.0002). At the end of 13.1±1.3 months, the incidence of the overall residual flow decreased to 14.6%, only 4.1% being moderate. A significant reduction in the right ventricular diastolic diameter was observed in the different phases of clinical follow-up (P &lt; 0.001). CONCLUSION: Implantation of the Amplatzer prosthesis proved to be effective and safe, constituting an option for the treatment of the secundum atrial septal defect in selected cases.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatias congênitas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>comunicação interatrial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cateterismo intervencionista</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prótese Amplatzer®</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial septal defect</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>interventional catheterization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Amplatzer occluder</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>spe</s2>
</fA06>
<fA08 dir="pt">
<s1>Resultados imediatos da cirurgia de revascularização miocárdica: comparação entre homens e mulheres</s1>
</fA08>
<fA08 dir="en">
<s1>Immediate results of myocardial revascularization: comparison between men and women</s1>
</fA08>
<fA11 dir="011000">
<s1>Vivian Lerner Amato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ari Timerman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ângela T. Paes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Valéria T. Baltar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Pedro S. Farsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Jorge A. Farran</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Carlos Gun</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Paulo Paredes Paulista</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Leopoldo S. Piegas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>J. Eduardo M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>14-20</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>44</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300004</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a morbimortalidade de homens e mulheres submetidos à cirurgia de revascularização miocárdica isolada e os fatores relacionados às diferenças eventualmente encontradas. MÉTODOS: Análise comparativa de 2032 pacientes, 1402 (69%) homens e 630 (31%) mulheres submetidos consecutivamente à cirurgia, de janeiro 1999 a dezembro 2002. RESULTADOS: As mulheres apresentaram idade média mais elevada, maior número de fatores de risco e taxas de angina instável. Enxertos com artéria torácica interna foram mais freqüentemente usados nos homens, 85,6% vs. 78,3%, p&lt;0,001. Não houve diferenças nas taxas de complicações pós operatórias, exceto as infecções, mais freqüentes nas mulheres. A mortalidade hospitalar foi de 4,1% e 6,3%, para homens e mulheres respectivamente, p=0,026. Na análise multivariada o sexo feminino não foi identificado como fator prognóstico independente para óbito, assim como o uso de enxertos com artéria torácica não foi também isoladamente identificado como fator protetor, porém a interação sexo-artéria torácica interna foi significativa; foram ainda selecionados, idade (OR 1,03; [IC] 95% 1,01 a 1,06; p=0,004), insuficiência renal no pré-operatório (OR 1.82; [IC] 95% 1,07 a 3,11; p=0,028) e cirurgia de urgência/emergência (OR 2,85; [IC] 95% 1,32 a 6,14; p=0,008). CONCLUSÃO: O sexo feminino apresentou maior mortalidade operatória porém não se mostrou fator prognóstico independente para óbito; o uso de enxertos com artéria torácica mostrou-se protetor; pacientes mais idosos, com insuficiência renal e em situação emergencial apresentaram maiores índices de óbito hospitalar.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess morbidity and mortality in men and women undergoing isolated myocardial revascularization and to analyze the factors related to differences occasionally found. METHODS: Comparative analysis of 2032 patients, 1402 (69%) men and 630 (31%) women, who consecutively underwent surgery from January 1999 to December 2002. RESULTS: Women had a greater mean age, more risk factors, and a greater incidence of unstable angina. Internal thoracic artery grafts were more frequently used in men, 85.6% vs 78.3%, P &lt; 0.001. No differences in the postoperative complication rates were observed, except for infections, more frequent in women. In-hospital mortality rates were 4.1% and 6.3% for men and women, respectively (P = 0.026). On multivariate analysis, neither the female sex was identified as an independent prognostic factor for death nor was the use of thoracic artery grafts identified as an isolated protective factor. However, sex-internal thoracic artery graft interaction was significant. The following variables were also selected: age (OR = 1.03; 95% CI = 1.01 to 1.06; P = 0.004), preoperative renal failure (OR = 1.82; 95% CI = 1.07 to 3.11; P = 0.028) and urgent/emergency surgery (OR = 2.85; 95% CI = 1.32 to 6.14; P = 0.008). CONCLUSION: The female sex had a greater surgical mortality; this, however, was not an independent prognostic factor for death. The use of thoracic artery grafts proved to be protective. Older patients with renal failure in an emergency situation had greater indices of in-hospital death.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia de revascularização miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>homens</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mulheres</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>men</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>women</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>spe</s2>
</fA06>
<fA08 dir="pt">
<s1>Sensibilidade e especificidade do hormônio natriurético do tipo B para identificar doentes com insuficiência mitral grave sintomáticos e assintomáticos</s1>
</fA08>
<fA08 dir="en">
<s1>Sensitivity and specificity of B-type natriuretic peptide for identifying symptomatic and asymptomatic patients with severe mitral regurgitation</s1>
</fA08>
<fA11 dir="011000">
<s1>Zilda Machado Meneghelo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Hélio M. Magalhães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Auristela I. O. Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jorge Eduardo Assef</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Davi Costa Le Bihau</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Nivia A. de Campos Salvarani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Angela Tavares Paes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Romeu S. Meneghelo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>21-25</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300005</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar a sensibilidade e a especificidade do hormônio natriurético do tipo B (BNP) para identificar pacientes ambulatoriais, com insuficiência mitral crônica grave, sintomáticos e assintomáticos. MÉTODOS: Um grupo de pacientes com insuficiência mitral foi examinado e submetido à eletrocardiografia, telerradiografia de tórax, coletas de sangue venoso e ecocardiograma transtorácico. Por meio da análise de variáveis ecocardiográficas, 62 pacientes apresentavam refluxo mitral discreto e moderado (G I) e 34 refluxo mitral grave (G II). A capacidade discriminante do BNP em detectar pacientes com insuficiência mitral grave foi avaliada pela construção de curvas ROC. RESULTADOS: Entre os 96 doentes, 71 (73%) eram mulheres e as idades variaram entre 15 e 63 (média de 31,7) anos. Os valores de BNP variaram de 0,00 pg/ml a 193 pg/ml. Os doentes do G I tiveram um valor médio de BNP de 18,10 &amp;plusmn; 0,74 pg/ml e os do G II de 50,54 &amp;plusmn; 1,46 pg/ml, (p=0,001). O valor de corte para identificar insuficiência mitral grave foi de 15,40 pg/ml, para o melhor balanço entre a sensibilidade e a especificidade, respectivamente de 0,73 e 0,74. O valor de corte para identificar pacientes sintomáticos e com insuficiência mitral grave foi de 28,40 pg/ml, para o melhor balanço entre a sensibilidade e a especificidade, respectivamente de 0,78 e 0,83. CONCLUSÃO: Os valores de BNP capazes de indentificar doentes com insuficiência mitral grave assintomáticos e sintomáticos são menores do que os 100 pg/ml considerados para o diagnóstico de insuficiência cardíaca.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the sensitivity and specificity of B-type natriuretic peptide (BNP) for identifying symptomatic and asymptomatic patients with severe chronic mitral regurgitation followed up on an outpatient care basis. METHODS: A group of patients with mitral regurgitation underwent electrocardiography, chest teleradiography, venous blood withdrawal, and transthoracic echocardiography. Based on an analysis of the echocardiographic variables, 62 patients had mild and moderate mitral regurgitation (GI) and 34 had severe mitral regurgitation (GII). The discriminating capacity of the BNP for detecting patients with severe mitral regurgitation was assessed by use of ROC curves. RESULTS: The patients' ages ranged from 15 to 63 (mean, 31.7) years, and of the 96 patients, 71 (73%) were females. The BNP values ranged from 0.00 pg/mL to 193 pg/mL. The mean BNP values in GI and GII patients were 18.10 ± 0.74 pg/mL and 50.54 ± 1.46 pg/mL, respectively (P=0.001). The cutoff point for identifying severe mitral regurgitation was 15.40 pg/mL for the best balance between sensitivity and specificity, which were 0.73 and 0.74, respectively. The cutoff point for identifying symptomatic patients with severe mitral regurgitation was 28.40 pg/mL for the best balance between sensitivity and specificity, which were 0.78 and 0.83, respectively. CONCLUSION: The BNP values capable of identifying asymptomatic and symptomatic patients with severe mitral regurgitation are lower than 100 pg/mL, which is considered for the diagnosis of heart failure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Insuficiência mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hormônios natriuréticos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>BNP</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral regurgitation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>natriuretic peptides</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>BNP</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>spe</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeitos da estimulação com corrente elétrica contínua pulsátil sobre as propriedades eletrofisiológicas atriais: estudo experimental da fibrilação atrial em cães</s1>
</fA08>
<fA08 dir="en">
<s1>Effects of stimulation with pulsatile continuous electrical current on atrial electrophysiological properties: experimental study of atrial fibrillation in dogs</s1>
</fA08>
<fA11 dir="011000">
<s1>Dalmo Antonio Ribeiro Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Amanda Guerra Moraes Rego Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Valente</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Elizabete Hosri Leone</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>26-33</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300006</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar se a estimulação atrial com corrente elétrica contínua pulsátil induz fibrilação atrial e os seus efeitos sobre as propriedades eletrofisiológicas atriais e as alterações histológicas atriais. MÉTODOS: Foram submetidos à toracotomia lateral direita 22 cães e implantados eletrodos de marcapasso no sulcus terminalis (ST), apêndice atrial direito (ADb) e na região póstero-inferior do átrio esquerdo (AE); um par de eletrodos foi suturado na auriculeta direita para estimulação com bateria alcalina de 9 Volts conectada a uma sistema (LM 555) que transforma a energia contínua linear da bateria em corrente contínua pulsátil, durante 60 min. A biópsia epicárdica atrial foi realizada antes e após a estimulação atrial. RESULTADOS: Não foram observadas diferenças nas durações dos períodos refratários efetivos atriais. Os tempos de condução intra-atrial, interatrial, bem como dos extra-estímulos atriais também prolongaram-se. A duração dos eletrogramas atriais prolongou-se durante ritmo sinusal e estimulação atrial programada; em 68% dos cães a fibrilação atrial foi induzida e sustentou-se. Foram observados edema intersticial e bandas de contração celular no subepicárdio à microscopia óptica, e intensa desorganização miofibrilar e aumento do tamanho das mitocôndrias à microscopia eletrônica. CONCLUSÃO: Esta técnica de estimulação atrial induz fibrilação atrial e provoca modificações atriais que aumentam sua vulnerabilidade para o surgimento de fibrilação atrial.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess whether atrial stimulation with pulsatile continuous electrical current induces atrial fibrillation and to evaluate its effects on atrial electrophysiological properties as well as the atrial histological alterations. METHODS: Twenty-two dogs underwent right lateral thoracotomy and implantation of pacemaker electrodes in the sulcus terminalis (ST), in the right atrial appendix (RAb), and in the posteroinferior region of the left atrium (LA). A pair of electrodes was sutured to the right atrial appendix for stimulation with a 9-volt alkaline battery connected to a system (LM 555) that transforms the linear continuous energy of the battery into a pulsatile continuous current for 60 minutes. Atrial epicardial biopsy was performed before and after atrial stimulation. RESULTS: No differences were observed in the durations of the effective atrial refractory periods. The times of intra-atrial and interatrial conduction, as well as that of atrial extrastimuli, were prolonged. The duration of atrial electrograms was prolonged during sinus rhythm and programmed atrial stimulation; in 68% of the dogs, atrial fibrillation was induced and was sustained. Interstitial edema and bands of cellular contraction were observed in the subepicardium on optical microscopy, as were intense myofibrillar disorganization and an increase in the size of the mitochondria on electron microscopy. CONCLUSION: That technique of atrial stimulation induces atrial fibrillation and causes atrial changes that increase atrial vulnerability to the appearance of atrial fibrillation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>arritmia cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fibrilação atrial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>eletrofisiologia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac arrhythmia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atrial fibrillation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrophysiology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>spe</s2>
</fA06>
<fA08 dir="pt">
<s1>Contribuição para o diagnóstico e o tratamento das fístulas arteriovenosas pulmonares após a operação de Glenn bidirecional</s1>
</fA08>
<fA08 dir="en">
<s1>Contribution to the diagnosis and treatment of pulmonary arteriovenous fistulae after a bidirectional Glenn operation</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Virgínia Tavares Santana</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Paredes Paulista</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sérgio Cunha Pontes Junior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>César Augusto Esteves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Valmir Fernandes Fontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Eduardo Moraes Rego Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>34-42</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>46</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300007</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a incidência de fístulas arteriovenosas pulmonares (FAVPs) pós-operação de Glenn bidirecional; as possíveis variáveis independentes que poderiam influenciar no seu aparecimento; comprovar o uso do ecocardiograma contrastado com microbolhas na sua detecção; e testar a sensibilidade e especificidade da angiografia pulmonar. MÉTODOS: Operados 59 pacientes, entre março 1990 e dezembro 1995, com idades entre 2 e 132 meses (média 32,7&amp;plusmn;33,6). Todos submetidos a exames clínico, laboratorial, ecocardiograma contrastado com microbolhas e cateterismo cardíaco. RESULTADOS: Nos 54 pacientes sobreviventes as FAVPs ocorreram em 20 (37,0%). A idade desses pacientes variou de 2 a 132 meses (média 29,6&amp;plusmn; 29,7). A atresia tricúspide em 10 (50,0%) e o coração univentricular em 8 (40,0%), foram as cardiopatias prevalentes. Em 13 (65%) a operação de Glenn bidirecional foi realizada à direita, em 2 (10,%), à esquerda e em 5 (25%) foi bicaval. O tempo de seguimento dos pacientes FAVPs, variou de 4 a 84 meses (média 32,4&amp;plusmn;21,65), e nos sem fístulas de 1 a 77 meses (média de 23,4&amp;plusmn;18,8), com valor de p=0,04, com significância estatística. O diagnóstico de FAVPs foi feito pelo ecocardiograma contrastado com microbolhas nos 20 casos, sendo considerado positivo, ao se detectar retorno de microbolhas pelas veias pulmonares. A angiografia pulmonar mostrou alterações compatíveis com FAVPs em 16, demonstrando sensibilidade de 80%. CONCLUSÃO: A incidência de FAVPs pós-operação de Glenn bidirecional foi alta (37%), e o intervalo de tempo decorrido após a operação de Glenn bidirecional, foi a única variável independente que se correlacionou de forma significativa com o aparecimento das FAVPs (p=0,04); o ecocardiograma com microbolhas foi o método padrão de diagnóstico; a angiografia pulmonar se revelou um método com sensibilidade de 80,0%.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the incidence of pulmonary arteriovenous fistulae (PAVFs) after the bidirectional Glenn operation and the possible independent variables that could influence their appearance; to confirm the use of microbubble contrast echocardiography for the detection of PAVFs; and to test the sensitivity and specificity of pulmonary angiography. METHODS: From March 1990 to December 1995, 59 patients were operated upon. Their ages ranged from 2 to 132 months (mean, 32.7± 33.6). All underwent clinical and laboratory examinations, microbubble contrast echocardiography, and cardiac catheterization. RESULTS: Of the 54 survivors, 20 (37.0%) had PAVFs. The ages ranged from 2 to 132 months (mean, 29.6±29.7). In 13 (65%) patients, the bidirectional Glenn operation was performed on the right-hand side; in 2 (10.0%) patients, on the left-hand side; and in 5 (25%) patients, it was bicaval. The follow-up of the patients with PAVFs ranged from 4 to 84 months (mean, 32.4±21.65), and that of the patients without fistulae ranged from 1 to 77 months (mean, 23.4±18.8), with statistical significance (P=0.04). The PAVFs were diagnosed by use of microbubble contrast echocardiography in 20 cases; the examination was considered positive when return of microbubbles through the pulmonary veins was detected. PAVFs were observed in the right lung in 9 (45%) patients, in the left lung in 3 (15%) patients, and in both lungs in 8 (40%) patients. The pulmonary angiography showed alterations compatible with PAVFs in 16 patients, with a sensitivity of 80%. CONCLUSION: The incidence of PAVFs after the bidirectional Glenn operation was high (37%). The time interval elapsed after the bidirectional Glenn operation was the only independent variable that significantly correlated with the appearance of PAVFs (P=0.04). Microbubble contrast echocardiography was the standard diagnostic method. The pulmonary angiography showed a sensitivity of 80.0%.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fístulas arteriovenosas pulmonares</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>operação de Glenn bidirecional</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma com microbolhas</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary arteriovenous fistulae</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>bidirectional Glenn operation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>microbubble contrast echocardiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>spe</s2>
</fA06>
<fA08 dir="pt">
<s1>A utilização de retalho composto de pele e tecido mamário na reparação de área cruenta resultante da deiscência de esternotomia em cirurgia cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Use of a flap composed of skin and breast tissue for repairing a recalcitrant wound resulting from dehiscence of sternotomy in cardiac surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Jaime Anger</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Pedro Silvio Farsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vivian Lerner Amato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cely Saad Abboud</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Flávio Sanches de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Renato T. Arnoni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Jarbas Jackson Dinkhuysen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Paulo P. Paulista</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>43-45</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300008</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Descrever nova técnica para a reparação de áreas cruentas resultantes de infecção e deiscência de esternotomia na cirurgia cardíaca em seis mulheres que, além de área cruenta extensa na região esternal, haviam sido submetidas a uma primeira reintervenção com recidiva. MÉTODOS: É descrita a técnica cirúrgica utilizada baseada em retalho triangular composto de pele e tecido mamário com base no sulco inframamário inferior, transposto para a área cruenta a fim fornecer uma cobertura de tecido bem vascularizado. RESULTADOS: São discutidos os diversos tratamentos da fase aguda e também de reconstrução nas deiscências de região esternal. CONCLUSÃO: Este retalho preenche as necessidades em relação às dimensões da perda de tecido da área cruenta além de fornecer uma maior proteção contra infecção a uma área que, pela deiscência ocorrida, permaneceu por certo tempo exposta.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To describe a new technique for repairing recalcitrant wounds resulting from infection and dehiscence in sternotomy of cardiac surgery in 6 women, who had an extensive raw area in the sternal region and had undergone a previous reintervention with relapse. METHODS: The surgical technique used was based on a triangular flap composed of skin and breast tissue with a base in the inframammary crease, which was transposed to the raw area to provide coverage with vascularized tissue. RESULTS: The several treatments of the acute phase are discussed, as are the techniques for reconstructing dehiscences of the sternal region. CONCLUSION: That flap composed of skin and breast tissue fulfills the needs regarding the dimensions of tissue loss in the raw area, in addition to providing greater protection against infection to an area that, due to the dehiscence, remained exposed for a longer period.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>esternotomia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>complicações</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>retalho</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mama</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>plastic surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dehiscence</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>spe</s2>
</fA06>
<fA08 dir="pt">
<s1>Incidência de trombo intracardíaco e de tromboembolismo nos três primeiros meses após o implante de bioprótese valvar</s1>
</fA08>
<fA08 dir="en">
<s1>Incidence of intracardiac thrombus and thromboembolism in the first three months after bioprosthetic valve implantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Auristela Isabel de Oliveira Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Helio Maximiano de Magalhães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Mercedes Maldonado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Dorival Júlio Della Togna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Zilda Machado Meneghelo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antoninho Sanfins Arnoni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Lucia Machado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Nisia Lyra Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Paulo Paredes Paulista</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>46-52</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300009</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a incidência de trombo intracardíaco e de tromboembolismo nos três primeiros meses após a troca valvar por bioprótese e identificar fatores de risco para a formação de trombo. MÉTODO:Incluídos 184 pacientes, entre 15 e 75 anos de idade, submetidos a implante de bioprótese e realizados ecocardiogramas transtorácico e transesofágico (ETE) na fase hospitalar, média 8,4&amp;plusmn;3 dias, e três meses após, média 97,4&amp;plusmn;21,7 dias. RESULTADOS: Incidência de trombo foi significativamente mais elevada nos pacientes com prótese em posição mitral ou mitroaórtica (21,0%) do que em posição aórtica (2,8%), p&lt;0,001. A análise de regressão logística multivariada identificou a prótese em posição mitral ou mitroaórtica como a única variável independente para a formação de trombo. No seguimento de três meses o ETE evidenciou trombo em 35 (20,7%) dos 169 pacientes com evolução ecocardiográfica, 31,7% nos mitrais e 3,1% nos aórticos, p&lt;0,001. No 3&amp;ordm; mês a análise de regressão logística multivariada também identificou a prótese em posição mitral ou mitroaórtica como a única variável independente para a formação de trombo. Durante os três meses de seguimento, três (1,6%) pacientes faleceram e oito (4,3%) apresentaram fenômeno embólico, todos para território cerebral. CONCLUSÃO: A incidência de trombo nos três primeiros meses, após o implante da bioprótese foi 14,1% nos 10 primeiros dias e 20,7% em três meses; a prótese em posição mitral ou mitroaórtica foi identificada como fator de risco para a formação de trombo; a incidência de fenômenos embólicos diagnosticados clinicamente foi inferior à proporção de trombo atrial documentado pelo ecocardiograma.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the incidence of intracardiac thrombus and thromboembolism in the first 3 months after bioprosthetic valve replacement and to identify the risk factors for thrombus formation. METHODS: The study comprised 184 patients, aged between 15 and 75 years, who underwent bioprosthetic valve implantation. Transthoracic and transesophageal (TEE) echocardiographies were performed in the in-hospital phase (mean, 8.4&amp;plusmn;3 days) and after 3 months (mean, 97.4&amp;plusmn;21.7 days). RESULTS: The incidence of thrombus was significantly greater in patients with a prosthesis in the mitral or mitroaortic position (21.0%) than in those with a prosthesis in the aortic position (2.8%), P&lt;0.001. The multiple logistic regression identified the prosthesis in the mitral or mitroaortic position as the only independent variable for thrombus formation. On the 3-month follow-up, TEE showed a thrombus in 35 (20.7%) of the 169 patients on echocardiographic assessment, 31.7% in mitral patients and 3.1% in aortic patients, P&lt;0.001. In the third month, the multiple logistic regression also identified the prosthesis in the mitral or mitroaortic position as the only independent variable for thrombus formation. During the 3-month follow-up, 3 (1.6%) patients died and 8 (4.3%) experienced embolic phenomena, all in the cerebral territory. CONCLUSION: The incidence of thrombi in the first 3 months after bioprosthetic valve implantation was 14.1% in the first 10 days and 20.7% in 3 months. A prosthesis in the mitral or mitroaortic position was identified as a risk factor for thrombus formation. The incidence of embolic phenomena clinically diagnosed was lower than the proportion of atrial thrombi documented on echocardiography.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>bioprótese valvar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tromboembolismo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>trombose valvar</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>bioprosthetic valve</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thromboembolism</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>valvular thrombosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>spe</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação comparativa do valor prognóstico de quatro marcadores bioquímicos de lesão miocárdica pós intervenções percutâneas utilizando stents coronarianos</s1>
</fA08>
<fA08 dir="en">
<s1>Comparative assessment of the prognostic value of four biochemical markers of myocardial damage after percutaneous coronary stenting</s1>
</fA08>
<fA11 dir="011000">
<s1>Marinella Centemero</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Amanda Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rodolfo Staico</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alexandre Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fausto Feres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luiz Fernando Tanajura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Luiz Alberto Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Áurea Chaves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Ibraim Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Camila Sarteschi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Angela Paes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>J. Eduardo Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>53-58</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300010</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar o efeito prognóstico das alterações de quatro marcadores de lesão miocárdica (CKMB atividade/massa e troponinas T e I) pós- stent em relação à ocorrência de morte, infarto e novos procedimentos de revascularização em um ano e determinar a incidência e as variáveis preditoras de suas elevações. MÉTODOS: Em 199 pacientes tratados por stents em artérias naturais foram mensurados os quatro marcadores em três períodos: pré-procedimento, 6-8h e 14-18h pós-stent. Curvas de sobrevivência e a regressão logística de Cox determinaram o impacto prognóstico das alterações na ocorrência de eventos cardíacos em um ano. RESULTADOS: A incidência das alterações dos 4 marcadores pós-stent é relativamente freqüente (6,1% a 32,8%), associa-se à maior complexidade das lesões tratadas (longas e angulações &gt;45&amp;ordm;) e ao desenvolvimento de intercorrências durante o procedimento (oclusão de ramos secundários, presença de angina e alterações eletrocardiográficas). A sobrevivência livre de infarto e nova revascularização foi significativamente menor somente nos pacientes com elevação da CKMB atividade pós-procedimento em comparação àqueles sem esta alteração (60% x 85,08%, p=0,025). Influenciaram a sobrevivência livre de eventos o diabetes mellitus (OR: 2,27, p=0,0256), pré-dilatação com balão (OR: 3,16, p=0,0082) e elevação da CKMB atividade pós-procedimento (OR: 3,64, p=0,0162). CONCLUSÃO: A recomendação da monitoração sistemática da CKMB atividade pós-stent coronário baseia-se na compreensão do seu comportamento clínico e laboratorial, nos resultados dos estudos que relacionam a elevação de seus níveis pós-procedimento à pior evolução tardia e ao baixo custo do exame.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the prognostic effect of the changes in the levels of 4 biochemical markers of myocardial damage (CK-MB activity/mass and troponins T and I) after stent implantation in regard to the occurrence of death, infarction, and new myocardial revascularization procedures in a one-year period. The study also aimed at determining the incidence of their elevations and the existence of predictive variables. METHODS: Those 4 markers were measured in 199 patients treated with stent implantation in native arteries in the following 3 periods: before the procedure, 6-8 hours after the procedure, and 14-18 hours after the procedure. Survival curves and Cox logistic regression were used to determine the prognostic impact of the changes on the occurrence of cardiac events in one year. RESULTS: Changes in the levels of the 4 markers after stent implantation are relatively frequent (6.1% to 32.8%), are associated with the degree of complexity of the lesions treated (long lesions and angulations &gt; 45&amp;ordm;) and with the development of problems during the procedure (occlusion of the secondary branches, presence of angina, and electrocardiographic changes). The infarction-free survival rate and the need for a new revascularization were significantly lower only in the patients with an elevation in the CK-MB activity after the procedure as compared with those in patients without that alteration (60% x 85.08%; P=0.025). The following variables influenced the event-free survival rate: diabetes mellitus (OR: 2.27; P=0.0256), balloon predilation (OR: 3.16; P=0.0082), and an elevation in the CK-MB activity after the procedure (OR: 3.64; P=0.0162). CONCLUSION: Systematic monitoring of CK-MB activity after coronary stenting is justified due to its clinical and laboratory behavior reported in studies relating its elevation after the procedure to a worse late outcome, and due to its low cost.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Stent</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>marcadores bioquímicos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prognóstico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stent</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>biochemical markers</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>spe</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo prospectivo e randomizado de pacientes tratados com e sem stents revestidos com carbeto de silício amorfo para a prevenção da reestenose coronariana. Avaliação ultra-sonográfica</s1>
</fA08>
<fA08 dir="en">
<s1>Randomized intravascular ultrasound comparison between endoprostheses with and without amorphous silicon-carbide</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Fernando Leite Tanajura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>J. Eduardo M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Amanda G. M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alexandre Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>João Eduardo T. Paula</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Mariano Albertal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Fausto Feres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luiz Alberto P. Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Rodolfo Staico</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Ibraim M.F. Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>59-63</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300011</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: A reestenose intra-stent é a maior limitação das intervenções coronárias percutâneas. O carbeto de silício amorfo (SiC-a), substância antitrombótica e antiinflamatória capaz de reduzir a deposição de fibrina, plaquetas e leucócitos sobre o stent, apresenta potencial de prevenir a hiperplasia neo-intimal e a reestenose. MÉTODOS: Estudo prospectivo, randomizado e tipo rótulo aberto comparando pacientes com doença coronariana tratados com e sem stents revestidos com o SiC-a, utilizando a angiografia quantitativa e o ultra-som intracoronário. Foram incluídos 100 pacientes (50 em cada grupo) a fim de mensurar o volume de hiperplasia neo-intimal intra-stent/extremidades. Como os stents comparados apresentavam extensões diferentes, o volume de hiperplasia foi analisado em valores absolutos (por paciente) e relativos (por milímetro de extensão do stent). Avaliaram-se ainda os eventos cardíacos maiores e os resultados da angiografia quantitativa. RESULTADOS: Os grupos apresentaram características de base semelhantes. Todos os pacientes foram tratados com sucesso. No 6&amp;deg; mês de evolução foram reestudados 94% dos casos dos dois grupos, obtendo-se ultra-som em 92%. O volume de hiperplasia neo-intimal absoluto foi significativamente maior nos tratados com os stents revestidos (51.2 DP 18.8 mm³ vs 41.9 DP 16.4 mm³; p=0.014), porém o relativo foi semelhante (2.9 DP 1.0 mm³/mm stent vs 2.5 DP 0.9 mm³/mm stent; p=0.108). A obstrução volumétrica da luz também foi similar (36.4 DP 11.1% vs 37.9 DP 10.9%; p=0.505). O diâmetro mínimo da luz (1.9 DP 0.7 mm vs 1.8 DO 0.6 mm; p=0.552), a reestenose (19.1% vs 17%; p&gt;0.999) e a revascularização do vaso-alvo (16% vs 14%; p&gt;0.999) não diferiram. CONCLUSÃO: Os stents revestidos apresentaram resultados clínicos, angiográficos e ultra-sonográficos similares aos controles.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: In-stent restenosis remains a major limitation following coronary stent implantation. Amorphous silicon-carbide (a-SiC) coating has been shown to improve stent biocompatibility, therefore, reducing local inflammation and thrombus generation. Due to the latter, a-SiC coating might have an impact on the prevention of neointimal hyperplasia (NIH) and restenosis. METHODS: This prospective, randomized, open-label trial compared a-SiC-coated (group A) versus uncoated (group B) stent implantation in de novo lesions. We included 100 patients (50 patients in each group) and the primary end-point was in-stent volume of NIH measured by intravascular ultrasound. RESULTS: All patients underwent successful stent deployment. Although absolute NIH volume was greater in A (51.2 mm³ SD 18.8 mm³ versus 41.9 mm³ SD 16.4 mm³; P = 0.014), relative (divided per mm of stent length) NIH volume was similar (2.9 mm³/mm stent SD 1.0 mm³/mm stent versus 2.5 mm³/mm stent SD 0.9 mm³/mm stent; P = 0.108). Late loss, restenosis, and major adverse cardiac events (MACE) were similar. CONCLUSION: A-SiC-coated stents did not reduce either NIH or MACE at long-term follow-up.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Reestenose</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença arterial coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angioplastia coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>restenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous coronary intervention</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>spe</s2>
</fA06>
<fA08 dir="pt">
<s1>Variáveis Doppler-ecocardiográficas e o tipo de cirurgia a ser realizada na regurgitação valvar mitral reumática</s1>
</fA08>
<fA08 dir="en">
<s1>Doppler echocardiographic variables and the type of surgery to be performed in rheumatic mitral valve regurgitation</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Eduardo Assef</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leopoldo Soares Piegas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sérgio Cunha Pontes Junior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rodrigo Bellio de Mattos Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mercedes Maldonado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Mohamed Hassam Saleh</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>David Le Bihan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Vera Marcia Lopes Gimenes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Zilda Machado Meneghelo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Paulo Paredes Paulista</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>64-70</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300012</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Identificar variáveis Doppler-ecocardiográficas associadas ao tipo de cirurgia realizada na regurgitação mitral reumática e determinar a relação entre essas variáveis e resultados da plastia em médio prazo. MÉTODOS: Analisaram-se variáveis Doppler-ecocardiográficas em 68 pacientes com regurgitação mitral reumática grave no dia prévio à cirurgia, que foram divididos, segundo a cirurgia realizada, em grupo-plastia e grupo-troca. Grupo-plastia submeteu-se também a Doppler-ecocardiograma antes da alta hospitalar e seis meses após. Compararam-se variáveis Doppler-ecocardiográficas do exame pré-operatório ao tipo de cirurgia e grau de regurgitação detectado seis meses após. RESULTADOS: Os grupos foram iguais nas características demográficas e função ventricular. O grupo-troca apresentou área mitral menor (p = 0.001). Na análise univariada as variáveis associadas à troca foram restrição da mobilidade dos folhetos anterior (p = 0.01) e posterior (p = 0.01), calcificação do folheto anterior (p = 0.01) e fusão de cordoalha (p = 0.018). Restrição da mobilidade do folheto anterior e área permaneceram como determinantes independentes de implante protético pós-análise multivariada. Dos 7 pacientes com regurgitação mitral maior que discreta, detectada 6 meses após plastia, 6 mostraram antes da cirurgia restrição da mobilidade do folheto anterior e 4, fusão de cordoalha. CONCLUSÃO: Probabilidade de troca valvar é 3,8 vezes maior quando presente restrição da mobilidade do folheto anterior da valva mitral e 2,2 vezes maior para cada 0,5 cm² de redução da área mitral. Restrição da mobilidade do folheto anterior e fusão de cordoalha estão associadas à regurgitação maior que discreta, observada 6 meses após plastia.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To identify the Doppler echocardiographic variables associated with the type of surgery performed in rheumatic mitral valve regurgitation and to determine the relation between those variables and the medium-term results of valvuloplasty. METHODS: Doppler echocardiographic variables were assessed in 68 patients with severe rheumatic mitral valve regurgitation on the day preceding surgery. The patients were divided, according to the surgery performed, into 2 groups: 1) valvuloplasty group; and 2) valve replacement group. The valvuloplasty group also underwent Doppler echocardiography before hospital discharge and 6 months after that. The Doppler echocardiographic variables of the preoperative period were assessed considering the type of surgery performed and the degree of regurgitation detected 6 months later. RESULTS: The groups did not differ in regard to their demographic characteristics and ventricular function. The valve replacement group had a smaller mitral area (P=0.001). In univariate analysis, the variables related to valve replacement were as follows: restricted mobility of the anterior (P=0.01) and posterior (P=0.01) leaflets; calcification of the anterior leaflet (P=0.01); and fusion of the chordae tendineae (P=0.018). Restricted mobility of the anterior leaflet and area remained as independent determining factors of the prosthetic implantation after multivariate analysis. Of the 7 patients with mitral regurgitation greater than mild detected 6 months after valvuloplasty, 6 had, before surgery, restricted mobility of the anterior leaflet and 4 had fusion of the chordae tendineae. CONCLUSION: The chance of valve replacement is 3.8 times greater when restricted mobility of the mitral valve anterior leaflet exists and 2.2 times greater for each 0.5 cm² reduction in the mitral valve area. Restricted mobility of the anterior leaflet and fusion of the chordae tendineae are associated with regurgitation greater than mild, observed 6 months after valvuloplasty.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Doppler-ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>regurgitação mitral reumática</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Doppler echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rheumatic mitral valve regurgitation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretriz de Embolia Pulmonar</s1>
</fA08>
<fA11 dir="011000">
<s1>André Volschan</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Bruno Caramelli</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Antônio Mascia Gottschall</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Celso Blacher</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Enio Leite Casagrande</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Eraldo de Azevedo Lucio</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Euler Roberto Fernandes Manente</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Luiz Carlos Bodanese</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Mario Seixas Rocha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-8</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Diretrizes de doença coronariana crônica angina estável</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Antonio Machado César</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio de Pádua Mansur</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Dikran Armaganijan</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Geraldo Amino</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antônio Carlos Sousa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antonio Felipe Simão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Augusto Xavier de Brito</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Bruno Caramelli</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Caio de Brito Vianna</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Carlos Alberto Pastore</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Carlos Eduardo Rochitte</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>César Cardoso de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Cláudio Meneghetti</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Daniella Calderaro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Denilson Campos de Albuquerque</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>Edson Stefanini</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>Eulógio E. Martinez Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>Fausto Feres</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>Hans Fernando Rocha Dohmann</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="201000">
<s1>Humberto Pierri</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="211000">
<s1>Jamil Cherem Schneider</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="221000">
<s1>Jamil Ribeiro Cade</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="231000">
<s1>Jeane Mike Tsutsui</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="241000">
<s1>João Fernando Monteiro Ferreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="251000">
<s1>Kerginaldo Torres</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="261000">
<s1>Luciano Atanes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="271000">
<s1>Luis Alberto Dallan</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="281000">
<s1>Luiz Felipe Simão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="291000">
<s1>Luiz Henrique Goldwak</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="301000">
<s1>Miguel Antonio Moretti</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="311000">
<s1>Otavio Rizzi Coelho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="321000">
<s1>Pedro Ferreira de Albuquerque</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="331000">
<s1>Pedro Puech Leão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="341000">
<s1>Raul D. Santos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="351000">
<s1>Roberto Luiz Marino</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="361000">
<s1>Romeu Meneghello</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="371000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="381000">
<s1>Sérgio Montenegro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="391000">
<s1>Vinicius Daher Vaz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="401000">
<s1>Whady Armindo Hueb</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="411000">
<s1>Wilson Mathias Junior</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="421000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>2-43</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Saúde cardiovascular na era tecnológica</s1>
</fA08>
<fA11 dir="011000">
<s1>Nelson Albuquerque de Souza e Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio de Janeiro Faculdade de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>453-455</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Movimento de consolidação da ciência cardiovascular nacional</s1>
</fA08>
<fA11 dir="011000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Eduardo Suaide Silva</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>456-457</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Programa de pós-graduação em cardiologia e ciências cardiovasculares da Faculdade de Medicina da Universidade Federal do Rio Grande do Sul</s1>
</fA08>
<fA11 dir="011000">
<s1>Nadine Clausell</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Flávio D. Fuchs</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Waldomiro C. Manfroi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jorge Pinto Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Faculdade de Medicina Programa de Pós-graduação em Cardiologia e Ciências Cardiovasculares</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>458-460</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Variações de parâmetros da função diastólica do ventrículo esquerdo de acordo com a idade através da ecocardiografia com Doppler tissular</s1>
</fA08>
<fA08 dir="en">
<s1>Changes in the parameters of left ventricular diastolic function according to age on tissue Doppler imaging</s1>
</fA08>
<fA11 dir="011000">
<s1>Márcia Duarte Pedone</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Iran Castro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Domingos Hatem</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Carlos Haertel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Flávia Feier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fernando Pandolfo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do RS </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>461-465</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a correlação entre as velocidades diastólicas do Doppler tissular com a idade em amostra de adultos saudáveis, e correlacionar a idade com as velocidades do fluxo transmitral e de veias pulmonares. MÉTODOS: Estudados, através da ecocardiografia, 51 indivíduos saudáveis, com idades entre 21 e 69 anos e registradas as velocidades miocárdicas diastólicas ao Doppler tissular e determinadas as velocidades dos fluxos transmitral e venoso pulmonar. RESULTADOS: As velocidades miocárdicas diastólicas iniciais septal basal e lateral basal apresentaram correlação inversa com a idade, com r = - 0,40 (p = 0,004) e r = - 0,60 (p = 0,0001) respectivamente. As velocidades atriogênicas do Doppler tissular foram diretamente correlacionadas com a idade, sendo no segmento septal basal r = 0,56 (p = 0,0001) e no segmento lateral basal r = 0,50 (p = 0,0001). As velocidades do fluxo transmitral e do fluxo venoso pulmonar também mostraram correlação com a idade. CONCLUSÃO: Existe correlação entre a idade e as velocidades miocárdicas diastólicas do Doppler tissular e com as velocidades do fluxo transmitral e fluxo venoso pulmonar, demonstrando em indivíduos saudáveis uma variação de parâmetros da função diastólica do ventrículo esquerdo com a evolução natural da idade.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the correlation between diastolic velocities on tissue Doppler imaging and age in a sample of healthy adults and to correlate age with the velocities of transmitral and pulmonary vein flows. METHODS: Echocardiographic assessment of 51 healthy individuals, whose ages ranged from 21 to 69 years. The diastolic myocardial velocities were recorded on tissue Doppler imaging. The velocities of the transmitral and pulmonary vein flows were also determined. RESULTS: The initial basal septal and basal lateral diastolic myocardial velocities showed an inverse correlation with age [r = - 0.40 (P = 0.004), and r = - 0.60 (P = 0.0001), respectively]. The atriogenic velocities of tissue Doppler imaging correlated directly with age [r = 0.56 (P = 0.0001) in the basal septal segment, and r = 0.50 (P = 0.0001) in the basal lateral segment]. The velocities of transmitral and pulmonary vein flows also correlated with age. CONCLUSION: Age correlates with the tissue Doppler diastolic myocardial velocities and with the velocities of transmitral and pulmonary vein flows. In healthy individuals, the parameters of left ventricular diastolic function vary with the natural evolution of age.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Doppler tissular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função diastólica ventricular esquerda</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tissue Doppler imaging</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular diastolic function</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo do encurtamento global do átrio esquerdo em fetos de mães diabéticas</s1>
</fA08>
<fA08 dir="en">
<s1>Study of global left atrial shortening in fetuses of diabetic mothers</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Zielinsky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fabíola Satler</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Stelamaris Luchese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz Henrique Nicoloso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio L. Piccoli Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Eduardo I. Gus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>João Luiz Manica</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Marlui Scheid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Silvana Marcantonio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Domingos Hatem</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do RS </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>470-472</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Testar a hipótese de que a fração de encurtamento atrial esquerda seja menor nos fetos de mães diabéticas do que em fetos de mães sem doenças sistêmicas. MÉTODOS: Foram examinados, por ecocardiografia, 42 fetos de mães com diabetes prévio ou gestacional e 39 fetos normais de mães sem doença sistêmica (controles), com idades gestacionais a partir da 25ª semana até o termo. A fração de encurtamento atrial esquerda foi obtida pelo quociente diâmetro máximo do átrio esquerdo (AE) - diâmetro mínimo AE/diâmetro máximo AE. Os dados foram comparados pelo teste t de Student, com um alfa crítico de 0,05. RESULTADOS: Os filhos de mães diabéticas apresentaram fração de encurtamento atrial esquerda média de 0,39 &amp;plusmn; 0,15 e os fetos do grupo controle de 0,51 &amp;plusmn; 0,11. Esta diferença foi significativa, com p &lt; 0,001. CONCLUSÃO: A dinâmica atrial esquerda, com diminuição do seu encurtamento global, está acentuada nos filhos de mães diabéticas. Especulamos que este parâmetro possa ser útil na avaliação da função diastólica ventricular esquerda fetal.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To test the hypothesis that left atrial shortening fraction is lower in fetuses of diabetic mothers than in fetuses of mothers with no systemic disease. METHODS: Forty-two fetuses of mothers with previous diabetes or gestational diabetes and 39 healthy fetuses of mothers with no systemic disease (controls) underwent echocardiographic examination. Their gestational ages ranged from 25 weeks to term. The left atrial shortening fraction was obtained with the following formula: (left atrial maximum diameter - left atrial minimum diameter)/left atrial maximum diameter. Data were compared using the Student t test, with an alpha level of 0.05. RESULTS: Mean left atrial shortening fractions in fetuses of diabetic mothers and in those in the control group were 0.39&amp;plusmn;0.15 and 0.51&amp;plusmn;0.11, respectively. This difference was significant with P &lt; 0.001. CONCLUSION: Left atrial dynamics, with a reduction in global left atrial shortening, is increased in fetuses of diabetic mothers. We speculate that this parameter may be useful in assessing fetal left ventricular diastolic function.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia fetal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função diastólica fetal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fração de encurtamento global do átrio esquerdo</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetal echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetal diastolic function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>global left atrial shortening fraction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação da dosagem direta do colesterol-LDL em amostras de sangue de 10.664 pacientes em comparação com o uso da fórmula de Friedewald</s1>
</fA08>
<fA08 dir="en">
<s1>Comparison of LDL-cholesterol direct measurement with the estimate using the Friedewald formula in a sample of 10,664 patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Caio Maurício Mendes de Cordova</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Rudi Schneider</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Iara Deise Juttel</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maurício Mendes de Cordova</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FURB Departamento de Ciências Farmacêuticas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Laboratório Santa Isabel de Análises Clínicas  </s1>
<s2>Blumenau SC</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>476-481</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a dosagem direta do colesterol LDL (LDL-C) por um método homogêneo, em comparação com a estimativa pela fórmula de Friedewald, em uma grande população heterogênea. MÉTODOS: As dosagens do colesterol total (ColT) e dos triglicerídeos (Trig) foram realizadas por métodos enzimáticos tradicionais. As dosagens do HDL-C e do LDL-C foram realizadas por métodos diretos, sem precipitação, e a estimativa da fração LDL-C calculada pela fórmula de Friedewald. RESULTADOS: Por análise de regressão linear, os dois métodos apresentaram coeficientes de correlação extremamente significativos (p&lt;0,001). Entretanto, a fórmula de Friedewald apresentou um bias positivo em relação ao método direto, mais pronunciado com níveis de ColT &gt; 201 mg/dL. Este bias positivo também ocorreu com relação a níveis de Trig &lt; 150 mg/dL. Com níveis de Trig entre 151-200 mg/dL e entre 201-300 mg/dL, não foi observado bias entre os dois métodos. Por outro lado, com níveis de Trig entre 301-400 mg/dL, este bias da fórmula de Friedewald tornou-se negativo. CONCLUSÃO: Foi possível demonstrar que a fórmula de Friedewald não apresenta um desempenho homogêneo para a estimativa do LDL-C em amostras com diferentes níveis de Trig, em comparação com o método direto, podendo causar dúvidas na classificação quanto ao risco de desenvolver doença arterial coronariana.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare direct measurement of LDL-cholesterol (LDL-C) determined by a homogeneous method with LDL-cholesterol estimation determined by the Friedewald formula in a large heterogeneous population. METHODS: The measurements of total cholesterol (TC) and triglycerides (TG) were performed using traditional enzymatic methods. The measurements of HDL-C and LDL-C were performed using direct methods with no precipitation, and the estimation of the LDL-C fraction was calculated using the Friedewald formula. RESULTS: On linear regression analysis, the 2 methods had extremely significant correlation coefficients (P &lt; 0.001). However, the Friedewald formula had a positive bias in regard to the direct method, more pronounced with TC levels &gt; 201 mg/dL. This positive bias also occurred in regard to TG levels &lt; 150 mg/dL. No bias was observed between the methods for TG levels ranging from 151 to 200 mg/dL and from 201 to 300 mg/dL. On the other hand, for TG levels ranging from 301 to 400 mg/dL, this bias of the Friedewald formula became negative. CONCLUSION: The Friedewald formula did not have a homogeneous performance for estimating LDL-C levels in samples with different TG levels as compared with that of the direct method, what could launch doubts on patients classification on the risk of developing coronary artery disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>colesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>LDL-C</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>LDL direto</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fórmula de Friedewald</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cholesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>LDL-C</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>direct LDL</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Friedewald formula</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeitos da lipoproteína LDL-oxidada sobre a proliferação e a motilidade espontânea in vitro de células endoteliais de artérias coronárias humanas</s1>
</fA08>
<fA08 dir="en">
<s1>Effects of oxidized LDL on in vitro proliferation and spontaneous motility of human coronary artery endothelial cells</s1>
</fA08>
<fA11 dir="011000">
<s1>Hermes Toros Xavier</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dulcinéia Saes Parra Abdalla</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Tania Leme da Rocha Martinez</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Ricardo de Toledo Gagliardi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>USP Faculdade de Ciências Farmacêuticas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>488-492</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Investigar os efeitos de baixas concentrações de LDL oxidada (LDL-ox) sobre a proliferação e a motilidade espontânea de células endoteliais de artérias coronárias humanas (CEACH) em cultura. MÉTODOS: Culturas de CEACH foram tratadas com baixas concentrações de LDL nativa (LDLn), isolada de plasma humano, e com LDL minimamente oxidada por diferentes métodos químicos, e os efeitos, comparados entre si. RESULTADOS: LDLn não apresentou efeitos deletérios sobre o endotélio em proliferação e na motilidade in vitro de CEACH, porém na mais alta concentração e por tempo mais prolongado inibiu a proliferação celular. As LDL-ox, quimicamente, pela espermina nonoato (ENO) e 3-morfolinosidnonimina (SIN-1) expressaram efeitos inibitórios significativos sobre a proliferação e a motilidade in vitro de CEACH proporcionais às maiores concentrações e graus de oxidação das LDL. CONCLUSÃO: LDL-ox apresenta efeito citotóxico, inibindo a proliferação e a motilidade espontânea de células endoteliais de artérias coronárias humanas em cultura, proporcionalmente à concentração e ao grau de oxidação da LDL, enquanto, LDL nativa é relativamente inócua.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To investigate the effects of low concentrations of oxidized LDL (oxLDL) on the proliferation and spontaneous motility of human coronary artery endothelial cells (HCAEC) in culture. METHODS: Cultures of HCAEC were treated with low concentrations of native LDL (nLDL) isolated from human plasma and with LDL minimally oxidized through different chemical methods; the effects were compared. RESULTS: Native LDL had no deleterious effects on in vitro proliferation and motility of HCAEC; however, at its highest concentration and for a longer exposure, nLDL inhibited cell proliferation. The LDL chemically oxidized by spermine nonoate (SNO) and 3-morpholinylsydnonimine (SYN-1) had significant inhibiting effects on in vitro proliferation and motility of HCAEC, which were proportional to the greatest concentrations and degrees of oxidation of LDL. CONCLUSION: OxLDL has a cytotoxic effect, inhibiting the proliferation and spontaneous motility of HCAEC in culture. This effect is proportional to the concentration and degree of oxidation of LDL; native LDL is relatively innocuous.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>LDL-oxidada</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>células endoteliais de artérias coronárias humanas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença aterosclerótica cardiovascular</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>oxidized LDL</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery endothelial cells</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular atherosclerotic disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Origem anômala de uma artéria pulmonar da aorta ascendente: resolução da hipertensão arterial pulmonar com a correção cirúrgica</s1>
</fA08>
<fA08 dir="en">
<s1>Anomalous origin of one pulmonary artery from the ascending aorta: surgical repair resolving pulmonary arterial hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>Marco Aurélio Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vitor Manuel Pereira Azevedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Nacional de Cardiologia Laranjeiras  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>498-502</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Enfatizar a possibilidade diagnóstica da origem anômala de uma artéria pulmonar da aorta ascendente, em lactentes com quadro de insuficiência cardíaca clinicamente intratável e sem defeito estrutural intracardíaco. MÉTODOS: Estudo retrospectivo em quatro lactentes com insuficiência cardíaca intratável, submetidos a estudo ecocardiográfico bidimensional com cortes subcostal, supraesternal e paraesternal, e a estudo hemodinâmico e angiocardiográfico na projeção ântero-posterior. RESULTADOS: Três dos quatro lactentes tinham a artéria pulmonar direita originando-se da aorta ascendente, como diagnóstico principal. No quarto paciente a artéria pulmonar esquerda originava-se da aorta ascendente associada à ampla comunicação interventricular. Os lactentes tinham pressão em ambas artérias pulmonares em nível sistêmico. Todos foram submetidos a tratamento cirúrgico que consistiu na translocação da artéria pulmonar anômala da aorta. Não houve óbitos cardíacos imediatos ou tardios. CONCLUSÃO: Uma vez estabelecido o diagnóstico de origem anômala de artéria pulmonar da aorta ascendente, na forma isolada, a correção cirúrgica deverá ser prontamente realizada, não só pelo desenvolvimento de doença vascular pulmonar, como pelos excelentes resultados cirúrgicos atualmente obtidos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To emphasize the diagnostic possibility of the anomalous origin of one pulmonary artery from the ascending aorta in infants with clinically refractory heart failure and no intracardiac structural defect. METHODS: Retrospective study of 4 infants with refractory heart failure undergoing 2-dimensional echocardiographic study with subcostal, suprasternal, and parasternal views, and hemodynamic and angiocardiographic study in the anteroposterior projection. RESULTS: Three of the 4 infants had their right pulmonary artery originating from the ascending aorta as their major diagnosis. In the fourth patient, the left pulmonary artery originated from the ascending aorta in association with a large interventricular septal defect. The pressure level in both pulmonary arteries in all infants was that of the systemic level. All patients underwent surgery, which consisted of translocation of the anomalous pulmonary artery from the aorta. Neither immediate nor late cardiac deaths occurred. CONCLUSION: Once the diagnosis of anomalous origin of the pulmonary artery from the ascending aorta in the isolated form is established, the surgical correction should be immediately performed, not only because of the risk of developing pulmonary vascular disease, but also because of the excellent surgical results currently obtained.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>artéria pulmonar anômala</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença vascular pulmonar obstrutiva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatia congênita acianótica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hiperfluxo sistêmico pulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>anomalous pulmonary artery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>obstructive pulmonary vascular disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acyanotic congenital heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>increased systemic pulmonary flow</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Ausência de efeito do captopril no metabolismo de uma emulsão lipídica artificial semelhante aos quilomícrons em pacientes hipertensos e hipercolesterolêmicos</s1>
</fA08>
<fA08 dir="en">
<s1>Lack of effect of captopril on the metabolism of an artificial lipid emulsion similar to chylomicrons in hypertensive hypercholesterolemic patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Renato J. Alves</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jayme Diament</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rosângela F. Amâncio</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Neusa Forti</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Raul C. Maranhão</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina InCor</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>USP Faculdade de Ciências Farmacêuticas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>508-511</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o efeito do captopril, sobre o metabolismo dos quilomícrons e de seus remanescentes e as possíveis alterações nas concentrações dos lípides plasmáticos em hipertensos e hipercolesterolêmicos. MÉTODOS: O metabolismo dos quilomícrons foi testado pelo método da emulsão lipídica artificial de quilomícrons marcada com 3H-oleato de colesterol, foi injetada intravenosamente em 10 pacientes com hipertensão arterial leve-moderada antes e após 45 dias de tratamento com captopril (50 mg/dia). Após injeção, foram coletadas amostras de sangue durante 60min em intervalos de tempo pré-estabelecidos para determinar a curva de decaimento e a taxa fracional de remoção (TFR em min-1), bem como o tempo de residência no plasma, da emulsão lipídica artificial, por análise compartimental. As concentrações dos lípides do plasma também foram avaliadas antes e após o tratamento. RESULTADOS: A taxa fracional de remoção (em min-1) da emulsão lipídica antes e após o tratamento com captopril (0,012&amp;plusmn;0,003 e 0,011&amp;plusmn;0,003, respectivamente; p=0,85, n.s.) ou o tempo de permanência da emulsão no plasma (83,3&amp;plusmn;20,8 e 90,9&amp;plusmn; 22,5 min, n.s.) não se alteraram, mas os níveis de colesterol total e de LDL-c reduziram-se em 7% e 10% respectivamente (p=0,02). As concentrações de HDL-c, triglicérides, Lp(a) e apolipoproteínas AI e B não se modificaram. CONCLUSÃO: O tratamento com captopril, avaliado pelo método da emulsão lipídica artificial, não provoca alterações deletérias no metabolismo dos quilomícrons e seus remanescentes.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effect of captopril, an angiotensin-converting enzyme inhibitor, on the metabolism of chylomicrons and their remnants and the possible alterations in the concentrations of plasma lipids caused by the drug in hypertensive hypercholesterolemic individuals. METHODS: The metabolism of chylomicrons was tested with the method of artificial lipid emulsion of chylomicrons labeled with ³H-cholesteryl oleate. The emulsion was injected intravenously in 10 patients with mild-moderate arterial hypertension before and 45 days after treatment with captopril (50 mg/day). After injection, blood samples were collected during 60 minutes at pre-established time intervals for determining the decay curve, the fractional catabolic rate (FCR in min-1), and the plasma residence time of the artificial lipid emulsion by analyzing different compartments. The plasma concentrations of the lipids were also assessed before and after treatment. RESULTS: The fractional catabolic rate (min-1) of the lipid emulsion before and after treatment with captopril (0.012&amp;plusmn;0.003 and 0.011&amp;plusmn;0.003, respectively; p=0.85, n.s.) and the plasma residence time of the emulsion (83.3&amp;plusmn;20.8 and 90.9&amp;plusmn;22.5 min, n.s.) did not change, but the total cholesterol and LDL-C levels decreased by 7% and 10%, respectively (p=0.02). The concentrations of HDL-C, triglycerides, Lp(a), and apolipoproteins AI and B did not change. CONCLUSION: Treatment with captopril, evaluated with the artificial lipid emulsion method, does not cause deleterious changes in the metabolism of chylomicrons and their remnants.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>captopril</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>quilomícrons</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lipoproteínas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>metabolismo</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>captopril</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chylomicrons</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipoproteins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>metabolism</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Correção cirúrgica da origem anômala de artéria pulmonar direita em aorta ascendente</s1>
</fA08>
<fA08 dir="en">
<s1>Surgical repair of the anomalous origin of the right pulmonary artery from the ascending aorta</s1>
</fA08>
<fA11 dir="011000">
<s1>Miguel Arboleda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Iván Niño de Guzman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Eva Ticona</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Gabriela Morales</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Edgard Gloria</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Plinio Obregon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Alfredo Lora</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>María Ganiku</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Manuel Adrianzen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Liana Falcon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Nacional del Corazón  </s1>
<s2>Lima </s2>
<s3>Peru</s3>
</fA14>
<fA20 dir="000000">
<s1>516-518</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>A origem anômala da artéria pulmonar direita em aorta ascendente é uma malformação congênita rara. Descrevemos o caso de uma criança submetida à correção cirúrgica com anastomose direta entre a artéria pulmonar direita e o tronco pulmonar. Após 18 meses a paciente permanece assintomática sem apresentar estenose residual significativa na angioressonância.</s0>
</fC01>
<fC01 dir="en">
<s0>The anomalous origin of the right pulmonary artery (AORPA) from the ascending aorta is a rare congenital malformation. We describe an infant who underwent a surgical correction with direct anastomosis between the right pulmonary artery and the pulmonary trunk. Eighteen months later, the patient remains asymptomatic, and no significant residual stenosis was detected on angioresonance.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Abordagem endovascular na oclusão ilíaca com sofrimento isquêmico agudo do membro inferior: procedimento simples e efetivo em pacientes de alto risco</s1>
</fA08>
<fA11 dir="011000">
<s1>Rogério Sarmento-Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nilo Mandelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Mario Frederico C. Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos A.M. Gottschall</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>522-522</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300611</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 06/2004 - Morte súbita em muher de 69 anos no terceiro dia de pós-opertório de cirurgia de revascularização miocárdica realizada na fase aguda de infarto do miocádio: Instituto do Coração (InCor) HC-FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Felipe Kumamoto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sandrigo Mangini</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vera Demarchi Aiello</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>523-526</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300612</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 10/2004 - Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>527-527</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300613</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Estenose de carótida extracraniana</s1>
</fA08>
<fA11 dir="011000">
<s1>Bruno Augusto Goulart Campos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Wilson Coelho Pereira Filho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Juiz de Fora Faculdade de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Santa Casa de Misericórdia de Juiz de Fora  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>528-532</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300614</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>83</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Errata</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-1</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2004</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(04)08300615</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Atenção integral ao paciente chagásico: uma proposta para o cuidar</s1>
</fA08>
<fA11 dir="011000">
<s1>Wilson de Oliveira Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UPE Hospital Universitário Oswaldo Cruz </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-2</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação do suprimento sangüíneo vascular pulmonar nos portadores de atresia pulmonar com comunicação interventricular e artérias colaterais sistêmico-pulmonares</s1>
</fA08>
<fA08 dir="en">
<s1>Assessment of the pulmonary vascular blood supply in patients with pulmonary atresia, ventricular septal defect, and aortopulmonary collateral arteries</s1>
</fA08>
<fA11 dir="011000">
<s1>Ulisses Alexandre Croti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Miguel Lorenzo Barbero Marcial</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carla Tanamati</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcelo Biscegli Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Domingo Marcolino Braile</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sergio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Instituto do Coração do Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>3-9</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar as características morfométricas das artérias pulmonares centrais e artérias colaterais sistêmico-pulmonares, avaliando a morfologia do suprimento sangüíneo vascular pulmonar, procurando estabelecer suas implicações no tratamento cirúrgico. MÉTODO: Entre janeiro/1990 e junho/2001, foram estudados 40 pacientes, incluíndo-se os que apresentavam estudo cineangiocardiográfico completo e prévio à primeira intervenção cirúrgica. Analisaram-se as características morfométricas das artérias pulmonares centrais e artérias colaterais sistêmico-pulmonares, assim como a distribuição da irrigação sangüínea nos pulmões. Calcularam-se os índices arterial pulmonar (IAAPP), arterial colateral sistêmico-pulmonar (IACSP) e arterial neopulmonar total (IANPT = IAAPP + IACSP). O tratamento cirúrgico foi considerado paliativo (TP), paliativo definitivo (TPD) e definitivo (TD). RESULTADOS: O TP foi predominante. Não houve diferenças estatisticamente significantes entre os pacientes com TP, TPD e TD, em relação ao IAAPP, IACSP e IANPT. Comparando o IAAPP e o IACSP, não houve diferença entre os índices para o TD (p=0,4309), o IACSP foi maior que o IAAPP para o TP (p=0,0176) e descritivamente também maior para o TPD. O IANPT dos pacientes em TD foi maior que os em TP (p=0,0959). Foram identificados cinco subgrupos morfologicamente semelhantes, denominados: B1, B2, B3, B4 e B5. A mortalidade total foi de 17,5%. CONCLUSÃO: A morfologia do suprimento sangüíneo vascular pulmonar das artérias pulmonares centrais e artérias colaterais sistêmico-pulmonares mostrou-se soberana na orientação do tratamento cirúrgico. Independentemente da divisão didática em subgrupos, o TP foi predominante. A mortalidade não apresentou correlação com as características morfométricas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study the morphometric characteristics of the central pulmonary arteries and aortopulmonary collateral arteries by assessing the morphology of the pulmonary vascular blood supply, to determine their significance in surgical treatment. METHOD: From January 1990 to June 2001, 40 patients were studied. Those who had the complete cineangiocardiographic study prior to the first surgical intervention were included in the study. The morphometric characteristics of the central pulmonary arteries (PPAA) and aortopulmonary collateral arteries (APCA) were analyzed, as was the distribution of blood irrigation to the lungs. The following indices were calculated: pulmonary arterial index (PPAAI), aortopulmonary collateral arterial index (APCAI), and total neopulmonary arterial index (TNPAI = PPAAI + APCAI). The surgical treatment was considered palliative (PT), palliative definitive (PDT), and definitive (DT). RESULTS: The palliative treatment predominated. No statistically significant differences were observed in the patients undergoing PT, PDT, and DT, in regard to PPAAI, APCAI, and TNPAI. Comparing PPAAI and APCAI, no difference was observed for DT (P=0.4309); APCAI was greater than PPAAI for PT (P=0.0176); and APCAI was descriptively greater for PDT. The TNPAI of patients undergoing DT was greater than that of patients undergoing PT (P=0.0959). Five morphologically similar subgroups were identified and designated as B1, B2, B3, B4, and B5. Overall mortality was 17.5%. CONCLUSION: The morphometric characteristics are important, but the morphology of the pulmonary vascular blood supply of the PPAA and APCA proved to be better for guiding the surgical treatment. Independently of the didactical division into subgroups, PT predominated. Mortality was not correlated with the morphometric characteristics.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>atresia pulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>comunicação interventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>artérias colaterais sistêmico-pulmonares</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary atresia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular septal defect</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortopulmonary collateral arteries</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Remodelação miocárdica após infarto agudo do miocárdio experimental em ratos: efeito do bloqueio do sistema renina angiotensina aldosterona</s1>
</fA08>
<fA08 dir="en">
<s1>Myocardial remodeling after experimental acute myocardial infarction in rats: effect of renin-angiotensin-aldosterone system blockade</s1>
</fA08>
<fA11 dir="011000">
<s1>Hindalis Ballesteros Epifanio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leonardo Antonio Mamede Zornoff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Beatriz Bojikian Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sergio Alberto Rupp de Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Roberto Minoru Tani Inoue</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luiz Shiguero Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNESP Faculdade de Medicina de Botucatu </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>10-14</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar a ação do lisinopril e do losartan sobre a remodelação miocárdica no infarto experimental em ratos. MÉTODOS: Ratos machos Wistar foram submetidos a infarto e tratados com lisinopril 20 mg/kg/dia (LIS, n=13) ou losartan 20 mg/kg/dia (LOS, n=11), ou mantidos sem tratamento (NT, n=11), por três meses e os resultados comparados com grupo controle (CONT, n=11) de ratos sem infarto. Após a eutanásia, o ventrículo esquerdo foi separado e pesado. Foram medidas a área seccional dos miócitos (AC), fração de colágeno intersticial (CVF) e a hidroxiprolina (HOP) miocárdica. As variáveis foram comparadas pela ANOVA de uma via, para nível de significância de p&lt;0,05. RESULTADOS: O infarto agudo promoveu a hipertrofia do ventrículo esquerdo e os tratamentos com lisinopril e losartam preveniram a hipertrofia quantificada pelo peso do ventrículo esquerdo (LOS=1,06&amp;plusmn; 0,12g, LIS=0,97&amp;plusmn;0,18g, NT=1,26&amp;plusmn;0,17g, CONT=1,02&amp;plusmn; 0,09g; p&lt;0,05), pelo peso de ventrículo esquerdo corrigido pelo peso corporal VE/PC (LOS=2,37&amp;plusmn;0,21mg/g, LIS=2,41&amp;plusmn; 0,38mg/g,NT=2,82&amp;plusmn;0,37mg/g, CONT=2,27&amp;plusmn; 0,15mg/g) e pela medida da AC do ventrículo esquerdo (LOS=210&amp;plusmn;39&amp;micro;², LIS=217&amp;plusmn;35&amp;micro;², NT=256&amp;plusmn;35&amp;micro;², CONT= 158&amp;plusmn;06 &amp;micro;²; p&lt;0,05). O CVF foi significantemente maior no ventrículo esquerdo do grupo infartado e houve prevenção do aumento com os tratamentos (LOS=1,16&amp;plusmn;0,4%, LIS=1,27&amp;plusmn; 0,5%, NT=1,8&amp;plusmn; 0,4%, CONT=0,7&amp;plusmn;0,5%). A HOP foi maior no grupo infartado (NT=6,91&amp;plusmn;2,98mg/g vs. CONT=2,81&amp;plusmn;1,21mg/g) e não alterou com o tratamento. CONCLUSÃO: A remodelação miocárdica pós-infarto é caracterizada por aumento da massa ventricular remanescente e aumento de colágeno intersticial. O bloqueador da enzima conversora da angiotensina e o antagonista seletivo AT1 da angiotensina II previnem a hipertrofia do miócito e a fibrose intersticial.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effect of lisinopril and losartan on myocardial remodeling in experimental infarction in rats. METHODS: Male Wistar rats underwent myocardial infarction and were either treated with lisinopril [20 mg/kg/day (LIS, n=13)] or losartan [20 mg/kg/day (LOS, n=11)], or kept without any treatment (NT, n=11) for 3 months. Their results were compared with those of a control group (CONT, n=11) comprising noninfarcted rats. After euthanasia, the left ventricle was isolated and weighed. The following measurements were taken: the sectional area of myocytes (AC), interstitial collagen fraction (CVF), and myocardial hydroxyproline (HOP). The variables were compared by using 1-way ANOVA, with a significance level of P&lt;0.05. RESULTS: Acute myocardial infarction caused left ventricular hypertrophy. The treatments with lisinopril or losartan could prevent hypertrophy, which was quantified by use of left ventricular weight (LOS=1.06&amp;plusmn;0.12g, LIS=0.97&amp;plusmn;0.18g, NT=1.26&amp;plusmn;0.17g, CONT=1.02&amp;plusmn;0.09g; P&lt;0.05), of left ventricular weight-to-body weight ratio LV/BW (LOS=2.37&amp;plusmn; 0.21mg/g, LIS=2.41&amp;plusmn;0.38mg/g, NT=2.82&amp;plusmn;0.37mg/g, CONT=2.27&amp;plusmn; 0.15mg/g), and of left ventricular AC measure-ment (LOS=210&amp;plusmn;39&amp;micro;², LIS=217&amp;plusmn;35&amp;micro;², NT=256&amp;plusmn;35&amp;micro;², CONT=158&amp;plusmn;06 &amp;micro;²; P&lt;0.05). The CVF was significantly greater in the left ventricle of the infarcted group, and its increase was prevented with treatment (LOS=1.16&amp;plusmn;0.4%, LIS=1.27&amp;plusmn;0.5%, NT=1.8&amp;plusmn; 0.4%, CONT=0.7&amp;plusmn;0.5%). Myocardial hydroxyproline was greater in the infarcted group (NT=6.91&amp;plusmn;2.98mg/g vs. CONT=2.81&amp;plusmn; 1.21mg/g) and did not change with treatment. CONCLUSION: Myocardial remodeling after infarction is characterized by an increase in the remaining ventricular mass and in interstitial collagen. The angiotensin-converting-enzyme blockers and the selective angiotensin II AT1 antagonist prevent hypertrophy of the myocyte and interstitial fibrosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>remodelação miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto agudo do miocárdio experimental</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sistema renina angiotensina aldosterona</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial remodeling</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>experimental acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>renin-angiotensin-aldosterone system</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeito do estradiol sobre as respostas cardiopulmonar e metabólica em mulheres normotensas após a menopausa submetidas à cicloergoespirometria</s1>
</fA08>
<fA08 dir="en">
<s1>Effect of estradiol on cardiopulmonary and metabolic responses of postmenopausal normotensive women undergoing cardiopulmonary exercise testing</s1>
</fA08>
<fA11 dir="011000">
<s1>Roberto Calvoso Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Mendes Aldrighi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Eduardo Negrão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ivani Credidio Trombetta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Antonio F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>15-19</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar pela cicloergoespirometria as respostas cardiopulmonar e metabólica, em 30 usuárias de estrogênio após a menopausa, durante exercício físico máximo, sendo que 25 completaram o estudo. MÉTODOS: Em estudo prospectivo, duplo-cego, randomizado, controlado por placebo foram avaliados dois grupos de mulheres: um, constituído por 14 mulheres (57,6&amp;plusmn;4,8 anos) após a menopausa, usuárias de estradiol na dose de 2 mg/dia por via oral durante 90 dias, e, outro, por 11 mulheres (55,8&amp;plusmn;6,7 anos) usuárias de placebo no mesmo período. Ambos os grupos foram submetidos a testes cicloergoespirométricos e analisadas as variáveis: volume de oxigênio consumido por kg/min no pico do exercício (VO2 pico), limiar anaeróbio (LA), volume de oxigênio consumido por Kg/min no limiar anaeróbio (VO2 no LA), ponto de descompensação respiratória (PDR), tempo de exercício (TE), carga máxima atingida (CM), freqüência cardíaca máxima (FC), pressão arterial sistólica (PAS), pressão arterial diastólica (PAD), antes e após administração dos medicamentos. RESULTADOS: Constataram-se reduções estatisticamente significantes em VO2 pico (p=0,002), LA (p=0,01), VO2 no LA (p=0,001) e TE (p=0,05) somente no grupo de usuárias de estradiol. As outras variáveis não sofreram alterações. CONCLUSÃO: O estradiol não promoveu melhora nas respostas cardiopulmonar e metabólica, quando comparado ao placebo.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the cardiopulmonary and metabolic responses of 30 postmenopausal women using estrogen during maximum physical activity during cardiopulmonary exercise testing. Twenty-five women completed the test. METHODS: A prospective, double-blind, randomized, placebo-controlled study was carried out to assess 2 groups of women: estradiol group - comprising 14 postmenopausal women (57.6&amp;plusmn;4.8 years) receiving oral estradiol at the dosage of 2 mg/day for 90 days; and placebo group - comprising 11 women (55.8&amp;plusmn;6.7 years) receiving placebo during the same period. Both groups underwent cardiopulmonary exercise testing on a cycloergometer, during which the following variables were assessed: volume of oxygen consumption per kilogram per minute during peak exercise (VO2peak); anaerobic threshold (AT); volume of oxygen consumption per kilogram per minute in the anaerobic threshold (VO2 in AT); point of respiratory decompensation (PRD); duration of exercise (DE); maximum load achieved (ML); maximum heart rate (HR); systolic blood pressure (SBP); and diastolic blood pressure (DBP) before and after drug administration. RESULTS: The following variables showed statistically significant reductions only in the group of women receiving estradiol: VO2peak (P=0.002); AT (P=0.01); VO2 in AT (P=0.001); and DE (P=0.05). The other variables did not change. CONCLUSION: Estradiol did not improve the cardiopulmonary and metabolic responses when compared with placebo.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>pós-menopausa</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>terapia de reposição de estrógenos estradiol</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>placebo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>exercício</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>postmenopausal</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>estrogen replacement therapy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>estradiol</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>placebo</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeitos do estado e especificidade do treinamento aeróbio na relação %VO2max versus %FCmax durante o ciclismo</s1>
</fA08>
<fA08 dir="en">
<s1>Effects of the state and specificity of aerobic training on the %VO2max versus %HRmax ratio during cycling</s1>
</fA08>
<fA11 dir="011000">
<s1>Fabrizio Caputo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Camila Coelho Greco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Benedito Sérgio Denadai</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNESP Laboratório de Avaliação da Performance Humana </s1>
<s2>Rio Claro </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>20-23</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar os efeitos do estado e especificidade de treinamento aeróbio na relação entre o percentual do consumo máximo de oxigênio (%VO2max) e o percentual da frequência cardíaca máxima (%FCmax) durante o exercício incremental realizado no cicloergômetro. MÉTODOS: Sete corredores, 9 ciclistas, 11 triatletas e 12 sedentários, todos do sexo masculino e aparentemente saudáveis, foram submetidos a um teste incremental até a exaustão no cicloergômetro. Regressões lineares entre %VO2max e %FCmax foram determinadas para cada indivíduo. Com base nessas regressões, foram calculados %FCmax correspondentes a determinados %VO2max (50, 60, 70, 80 e 90%) de cada participante. RESULTADOS: Não foram encontradas diferenças significantes entre todos os grupos nos %FCmax para cada um dos %VO2max avaliados. Analisando-se os voluntários como um único grupo, as médias dos %FCmax correspondentes a 50, 60, 70, 80 e 90% %VO2max foram 67, 73, 80, 87, e 93%, respectivamente. CONCLUSÃO: Nos grupos analisados, a relação entre o %VO2max e %FCmax durante o exercício incremental no ciclismo não é dependente do estado e especificidade do treinamento aeróbio.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the effects of the status and specificity of exercise training in the ratio between maximum oxygen consumption (%VO2max) and the percentage of maximal heart rate (%HRmax) during incremental exercise on a cycle ergometer. METHODS: Seven runners, 9 cyclists, 11 triathletes, and 12 sedentary individuals, all male and apparently healthy, underwent exhaustive incremental exercise on cycle ergometers. Linear regressions between %VO2max x %HRmax were determined for each individual. Based on these regressions, %HRmax was assessed corresponding to a determined %VO2max (50, 60, 70, 80, and 90%) from each participant. RESULTS: Significant differences were not found between the groups in %HRmax for each of the %VO2max assessed. Analyzing the volunteers as a single group, the average of the corresponding %HRmax to 50, 60, 70, 80, and 90% %VO2max were 67, 73, 80, 87, and 93%, respectively. CONCLUSION: The ratio between %VO2max and %HRmax in the groups assessed during incremental exercise on the bicycle is not dependent on the status and specificity of aerobic exercise training.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Consumo de oxigênio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>freqüência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prescrição do exercício</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estado de treinamento</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ciclismo</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>oxygen consumption</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart rate</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise prescription</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>training status</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cycling</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Síndromes coronarianas agudas na ausência de doença arterial coronariana significativa</s1>
</fA08>
<fA08 dir="en">
<s1>Acute coronary syndromes in the absence of significant coronary artery disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria das Graças Viana Pinheiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alvaro Rabelo Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rogerio Santos de Jesus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luciana Cunha Nascimento</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ursula Maria Moreira Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundaçao Bahiana de Cardiologia Unidade de Cardiologia e Cirurgia Cardiovascular </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>24-28</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar as características clínicas, a evolução e as complicações intra-hospitalares de pacientes com síndromes coronarianas agudas (SCA) na ausência de doença arterial coronariana (DAC) obstrutiva significativa. MÉTODOS: Estudo transversal envolvendo pacientes internados, de agosto/96 a março/02, com síndromes coronarianas agudas, com e sem supradesnivelamento ST, analisando as características clinicas, demográficas e complicações intra-hospitalares nos casos com (&gt;50%) e sem (&lt; 50%) estenose coronariana significativa. RESULTADOS: Dos 1351 pacientes admitidos com síndrome coronariana aguda, 28% apresentavam supradesnivelamento ST e 72% não o demonstravam. Os pacientes com a síndrome coronariana aguda sem supradesnivelamento do segmento ST, na ausência de obstrução coronariana significativa, eram mais jovens, predominantemente mulheres, e apresentavam menor freqüência de dislipidemia, doença arterial coronariana prévia, diabetes mellitus, tabagismo e hipertensão arterial sistêmica, quando comparados àqueles com lesão obstrutiva significativa. Entre os indivíduos com síndrome coronariana aguda e supradesnivelamento ST, tabagismo foi o fator de risco com maior prevalência nos pacientes com lesão obstrutiva não significativa. Quanto às complicações, houve menor freqüência de isquemia recorrente, insuficiência cardíaca congestiva e arritmias em pacientes com síndrome coronariana aguda sem supradesnivelamento ST na ausência de lesão coronariana obstrutiva significativa. CONCLUSÃO: Pacientes com síndrome coronariana aguda sem supradesnivelamento ST com lesões coronarianas obstrutivas não significativas são mais jovens, predominantemente mulheres, com menor freqüência de fatores de risco para doença arterial coronariana e menor incidência de complicações, em relação aos pacientes com lesão coronariana obstrutiva significativa.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the clinical characteristics, evolution, and in-hospital complications of patients with acute coronary syndromes (ACS) in the absence of significant obstructive coronary artery disease (CAD). METHODS: Cross-sectional study of patients hospitalized from August 1996 to March 2002 with acute coronary syndrome, with or without an elevation in the ST segment, and with (= 50%) or without (&lt;50%) significant coronary stenosis. Their clinical and demographic characteristics and their in-hospital complications were analyzed. RESULTS: Of the 1351 patients admitted with acute coronary syndrome, 28% had an elevation in the ST segment and 72% had no elevation. The patients with acute coronary syndrome with no elevation in the ST segment and no significant coronary obstruction were younger, predominantly females, and had a lower frequency of dyslipidemia, previous coronary arterial disease, diabetes mellitus, smoking, and systemic arterial hypertension, when compared with those with significant obstructive lesion. Among the individuals with acute coronary syndrome and an elevation in the ST segment, smoking was the most prevalent risk factor in patients with nonsignificant obstructive lesion. In regard to complications, recurring ischemia, congestive heart failure, and arrhythmias were more frequent in patients with acute coronary syndrome with no elevation in the ST segment and no significant obstructive coronary lesion. CONCLUSION: Patients with acute coronary syndrome with no elevation in the ST segment and with nonsignificant obstructive coronary lesions are younger, predominantly females, have a greater frequency of risk factors for coronary arterial disease, and a lower incidence of complications as compared with patients with significant obstructive coronary lesion.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença arterial coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>características clínicas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary arterial disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>clinical characteristics</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary stenosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Prevalência de excesso de peso e hipertensão arterial, em população urbana de baixa renda</s1>
</fA08>
<fA08 dir="en">
<s1>Prevalence of excessive weight and hypertension in a low-income urban population</s1>
</fA08>
<fA11 dir="011000">
<s1>Adelina Maria Melo Feijão</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Francisco Vieira Gadelha</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Alberto Bezerra</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Maurício de Oliveira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria do Socorro Sombra Silva</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Wellington de Oliveira Lima</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Nacional de Saúde  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Estadual do Ceará  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>29-33</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar a relação entre massa corporal e pressão arterial em população urbana de baixa renda. MÉTODOS: Estudo transversal desenvolvido em amostra representativa de uma comunidade urbana de baixa renda, no período de julho a dezembro/1998. De um total de 224 quadras, 67(30%) quadras foram selecionadas com indivíduos de ambos os sexos, com idade &gt; 30 anos. A pressão arterial, o peso e a altura foram medidos, e através de questionário, obtidas informações sobre sexo, idade, renda familiar, escolaridade e ocupação. Foi calculado o índice de massa corporal (IMC), dividindo-se o peso (quilograma) pela altura (metro) elevada ao quadrado e considerado normal IMC&lt;25; como sobrepeso 25 &lt;IMC &lt; 30; como obesidade IMC&gt; 30. Adicionalmente, excesso de peso foi definido como IMC&gt; 25, hipertensão arterial foi definida como uma pressão sistólica &gt; 140 mm Hg e diastólica &gt; 90 mm Hg. RESULTADOS: Em 1078 domicílios, residiam 1.137 indivíduos elegíveis, e foram obtidas informações completas de 1.032 (91%) pessoas. A prevalência de hipertensão arterial e de excesso de peso foi 22,58% e 51,26% respectivamente. Antes de ajustar, o OR de hipertensão arterial foi 1,85 (IC 95%: 1,52-2,25) para os indivíduos com sobrepeso e 3,7 (IC 95%: 3,04-4,50) para os indivíduos obesos e, depois, respectivamente, 2,04 (IC 95%: 1,65-2,54) e 4,08 (IC 95%:3,30-5,08) CONCLUSÃO: Existe uma forte associação entre massa corporal e pressão arterial, que é independente do sexo, idade, renda familiar, escolaridade e ocupação.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study the relation between body mass and blood pressure in a low-income urban population. METHODS: From July to December 1998, a cross-sectional study was carried out in a representative sample of a low-income urban community with individuals of both sexes, aged &gt; 30 years and living in 67 (30%) blocks selected out of 224. Blood pressure, weight, and height were measured, and completion of a questionnaire provided information on sex, age, familial income, educational level, and occupation. Body mass index was obtained by dividing weight (kilogram) by height squared (square meter), and the following values were considered: BMI &lt; 25, normal; 25 &gt; BMI &lt; 30, overweight; BMI &gt; 30, obesity. In addition, excessive weight was defined as BMI &gt; 25, and arterial hypertension was defined as systolic blood pressure &gt; 140 mm Hg and diastolic blood pressure &gt; 90 mm Hg. RESULTS: In 1078 dwellings, 1137 eligible individuals resided, and complete information was obtained from 1032 (91%) individuals. The prevalences of arterial hypertension and excessive weight were 22.58% and 51.26%, respectively. Before adjustment, the OR for arterial hypertension for overweight individuals was 1.85 (95% CI: 1.52-2.25) and, for obese individuals, 3.7 (95% CI: 3.04-4.50); after adjustment, the ORs were 2.04 (95% CI: 1.65-2.54) and 4.08 (95% CI: 3.30-5.08), respectively. CONCLUSION: A strong association between body mass and blood pressure exists, independently of sex, age, familial income, educational level, and occupation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prevalência</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>excesso de peso</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>excessive weight</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>body mass index</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Revascularização do miocárdio sem circulação extracorpórea em pacientes acima de 75 anos: análise dos resultados imediatos</s1>
</fA08>
<fA08 dir="en">
<s1>Myocardial revascularization without extracorporeal circulation in patients over 75 years of age: analysis of immediate results</s1>
</fA08>
<fA11 dir="011000">
<s1>Rodrigo Milani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Brofman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alexandre Varela</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jose Augusto Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maximiliano Guimarães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rafael Pantarolli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Alexandre Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Laura Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Thaise Sandri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Luiz Gustavo Emed</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Fernanda Ceccon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Francisco Maia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica do Paraná Serviço de Cirurgia Cardiovascular da Aliança Saúde </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>34-37</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar os resultados imediatos da operação para revascularização do miocárdio sem circulação extracorpórea em pacientes acima de 75 anos. MÉTODOS: De janeiro 2001 a dezembro 2003, 193 pacientes com idade variando de 75 a 94 anos, correspondendo a 100% das operações coronarianas realizadas em pacientes acima de 75 anos, sendo 121 homens e 72 mulheres, foram submetidos a operação para revascularização do miocárdio sem circulação extracorpórea e analisados, retrospectivamente, os dados de internação dos pacientes. RESULTADOS: A hipertensão arterial esteve presente em 174 (90%), seguida de dislipidemia em 115 (59%), tabagismo em 89 (46%) e diabetes em 57 (29%), e 96 (49,7%) com antecedente de infarto do miocárdio. Destes, 53 (27,4%) tinham apresentado evento isquêmico agudo em um período &lt; 30 dias da data da operação. Tinham lesões obstrutivas críticas em três ou mais vasos coronarianos 156 (80,95%) pacientes, enquanto 30 (15%) apresentavam obstrução do tronco da coronária esquerda e 30 (15%) apresentavam fração de ejeção &lt; 30%. A pontuação obtida através do EUROSCORE variou de 3 a 18, com uma mortalidade esperada para o grupo de 7,54&amp;plusmn;2,69%. O número total de anastomoses distais foi de 639. Houve 7 (3,62%) óbitos, três por broncopneumonia, um por mediastinite, um por causas metabólicas, uma morte súbita após refixação de deiscência de esterno e um choque cardiogênico. Reoperação por sangramento, reintubação orotraqueal e ventilação mecânica prolongada foram fatores associados com aumento da mortalidade. CONCLUSÃO: A operação adotada para revascularização do miocárdio sem circulação extracorpórea foi associada à baixa mortalidade, baixo índice de complicações e curto período de hospitalização.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the immediate results of myocardial revascularization surgery without extracorporeal circulation in a group of patients over 75 years of age. METHODS: From January 2001 to December 2003, 193 (121 men and 72 women) patients with ages ranging from 75 to 94 years, corresponding to 100% of the coronary surgeries performed in patients over the age of 75 years, underwent myocardial revascularization without extracorporeal circulation. Their hospitalization data were retrospectively analyzed. RESULTS: Arterial hypertension was present in 174 (90%), dyslipidemia in 115 (59%), smoking in 89 (46%), and diabetes in 57 (29%). Ninety-six (49.7%) patients had had a previous myocardial infarction, 53 of whom (27.4%) had experienced an acute ischemic event in a period &lt; 30 days after surgery. Critical obstructive lesions in 3 or more coronary vessels were present in 156 (80.95%) patients, while 30 (15%) patients had an important obstruction of the left main coronary artery, and 30 (15%) patients had an ejection fraction &lt; 30%. The score obtained according to the EUROSCORE ranged from 3 to 18, with an expected mortality rate for the group of 7.54&amp;plusmn;2.69%. The total number of distal anastomoses was 639. Seven (3.62%) patients died, 3 due to bronchopneumonia, 1 due to mediastinitis, 1 due to metabolic causes, 1 due to cardiogenic shock, and another died suddenly after refixation of a sternal dehiscence. Reoperation due to bleeding, orotracheal reintubation, and prolonged mechanical ventilation were factors associated with an increase in mortality. CONCLUSION: The surgery adopted for myocardial revascularization was associated with a low mortality rate, a low complication index, and a short length of stay at the hospital.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>revascularização do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>circulação extracorpórea</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>idoso</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>extracorporeal circulation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>A depressão miocárdica pós-isquemia/reperfusão não altera a resposta cardíaca à elevação da freqüência de contrações</s1>
</fA08>
<fA08 dir="en">
<s1>Postischemic stunned myocardium does not alter cardiac response to an elevation in contractile frequency</s1>
</fA08>
<fA11 dir="011000">
<s1>Orlando Sant'Ana Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto J. Nogueira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Neif Murad</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Carlos Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo J. F. Tucci</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina Fisiologia Cardiovascular</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>38-43</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar a influência da depressão miocárdica pós-isquemia/reperfusão (DMPIR) sobre os efeitos inotrópico e lusitrópico promovidos pela freqüência cardíaca (FC). MÉTODOS: Nove preparações de coração isolado de cães nutrido pelo sangue arterial de um outro cão e contraindo isovolumetricamente tiveram a freqüência cardíaca elevada de 60 bpm a 200 bpm, em etapas de 20 bpm. Foram avaliadas as variáveis antes (C) e depois (D) da isquemia (15 min) e reperfusão (30 min): a pressão desenvolvida durante a contração (PD), sua 1ª derivada positiva (+dP/dt) e negativa (-dP/dt), o tempo de pressão máxima (TPM), a pressão de repouso (Pr) e o tempo para a pressão desenvolvida regredir em 90% de seu valor máximo (TR90%). RESULTADOS: Os efeitos estimulantes da elevação da FC sobre o inotropismo e o relaxamento foram semelhantes em C e em D: houve aumento dos valores da +dP/dt, redução do TPM, acentuação da -dP/dt e diminuição do TR90%. A PD não sofreu alteração e a Pr se elevou. CONCLUSÃO: Os resultados confirmaram o efeito inotrópico positivo da elevação da FC (efeito Bowditch) e a ação depressora da isquemia/reperfusão. Evidenciaram ainda que a DMPIR não altera a ação estimulante do efeito Bowditch. Os resultados se adequam ao conceito vigente de que a DMPIR não compromete a cinética miocárdica do cálcio, favorecendo, a hipótese prevalente de que o decaimento da capacidade contrátil pós-isquemia/reperfusão depende de redução da responsividade dos miofilamentos ao cálcio.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE:To assess the influence of the postischemia/reperfusion stunned myocardium (PIRSM) on the inotropic and lusitropic effects of heart rate (HR). METHODS: Nine preparations of isolated dog hearts in isovolumic contraction and nourished by the arterial blood of another dog underwent heart rate elevation from 60 bpm to 200 bpm, in 20-bpm stages. The following variables were assessed before (B) and after (A) ischemia (15 min) and reperfusion (30 min): the pressure developed during contraction (PD), its first positive (+dP/dt) and negative (-dP/dt) derivative, the time of maximum pressure (TMP), the pressure at rest (Pr), and the time necessary for the developed pressure to decrease by 90% of its maximum value (time for relaxation - TR90%). RESULTS: The stimulating effects of HR elevation on inotropism and relaxation were similar before and after ischemia/reperfusion as follows: +dP/dt values increased, TMP decreased, -dP/dt values were intensified, and TR90% decreased. The values of PD did not change, and Pr increased. CONCLUSION: The results confirmed the positive inotropic effect of HR elevation (Bowditch effect) and the depressive action of ischemia/reperfusion. They also evidenced that PIRSM does not alter the stimulating action of the Bowditch effect, in accordance with the current concept that PIRSM does not impair calcium myocardial kinetics, favoring the prevalent hypothesis that the decrease in the contractile capacity after ischemia/reperfusion depends on the reduction of the myofilament responsiveness to calcium.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>depressão miocárdica pós-isquemia/reperfusão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>efeito Bowditch</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>freqüência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função sistólica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função diastólica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>postischemia/reperfusion stunned myocardium</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Bowditch effect</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart rate</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>systolic function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diastolic function</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Anticoagulação, gravidez e cardiopatia: uma tríade, três domínios e cinco momentos</s1>
</fA08>
<fA11 dir="011000">
<s1>Walkiria Samuel Avila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>44-48</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Transplante cardíaco em portadora de endomiocardiofibrose</s1>
</fA08>
<fA08 dir="en">
<s1>Heart transplantation in a patient with endomyocardial fibrosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Humberto F.G. de Freitas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Pedro Paulo Neves de Castro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Roberto Chizzola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edimar Alcides Bocchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM HC</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>49-50</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400111</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>A endomiocardiofibrose é uma doença comum em países tropicais, particularmente Uganda e Nigéria, e pode acometer tanto o ventrículo esquerdo como direito, gerando uma insuficiência cardíaca restritiva que, além dos sintomas clássicos, manifesta-se por ascite desproporcional ao edema periférico. Apresentamos o caso de uma portadora de endomiocardiofibrose refratária ao tratamento clínico, submetida ao tratamento cirúrgico com melhora clínica por curto período, voltando a apresentar sintomas incapacitantes três meses após a cirurgia de ressecção de fibrose endomiocárdica e plastia tricúspide. A paciente foi então submetida a transplante cardíaco ortotópico bicaval, com boa evolução clínica. É o primeiro caso de transplante cardíaco nesta doença, mostrando-se uma alternativa de tratamento promissora.</s0>
</fC01>
<fC01 dir="en">
<s0>Endomyocardial fibrosis is a common disease in tropical countries, particularly Uganda and Nigeria. It may affect the right and left ventricles, creating restrictive heart failure, which, in addition to the classical symptoms, manifests as ascites disproportional to peripheral edema. We report the case of a female patient with endomyocardial fibrosis refractory to clinical treatment, who underwent surgical treatment with clinical improvement for a short period. Three months after the surgery for resection of the endomyocardial fibrosis and tricuspid valvuloplasty, the disabling symptoms reappeared. Then the patient underwent bicaval orthotopic heart transplantation, which had a good clinical outcome. This was the first case of heart transplantation for the treatment of endomyocardial fibrosis, which proved to be a promising alternative.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Infarto agudo do miocárdio e morte súbita documentada</s1>
</fA08>
<fA08 dir="en">
<s1>Acute myocardial infarction and documented sudden death</s1>
</fA08>
<fA11 dir="011000">
<s1>Gustavo Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maurício de Nassau Machado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Lília Nigro Maia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de São José do Rio Preto  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>51-54</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400112</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Homem, sexagenário, deu entrada na emergência com dor torácica duvidosa e lipotímia. Investigado e estratificado, teve eletrocardiogramas e marcadores séricos de injúria miocárdica seriados negativos para isquemia miocárdica, e teste ergométrico sem critérios para isquemia miocárdica. Contudo, apresentou morte súbita presenciada dentro do hospital enquanto fazia uso da monitorização eletrocardiográfica contínua com o holter, que evidenciou, em seus traçados, infarto agudo do miocárdico complicado com arritmia ventricular complexa (taquicardia e fibrilação ventricular), que culminou em morte refratária às manobras de reanimação cardio-respiratória.</s0>
</fC01>
<fC01 dir="en">
<s0>A sexagenarian man sought the emergency unit complaining of dubious chest pain and lipothymia. He was investigated and stratified. His serial electrocardiograms and serum markers for myocardial injury were negative for myocardial ischemia, as was his exercise test. However, the patient died suddenly inside the hospital while under continuous electrocardiographic Holter monitoring, which evidenced acute myocardial infarction complicated by complex ventricular arrhythmia (ventricular tachycardia and fibrillation), which culminated in death refractory to the cardiopulmonary resuscitation maneuvers.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Artéria coronária única submetida a angioplastia com implante de Stent</s1>
</fA08>
<fA08 dir="en">
<s1>Single coronary artery: angioplasty with stent implantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Ian C. D. Teixeira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alexandre X. Brant</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alexandre Ares</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Bruno Sarbi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Isaac Moscoso</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Adnan A. Salman</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Salvador A. B. Cristóvão</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>João B. Oliveira Neto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Maria Fernanda Z. Mauro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="101000">
<s1>José A. Mangione</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Beneficência Portuguesa de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Faculdade de Medicina de Mogi das Cruzes Disciplina de Cardiologia </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>55-58</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400113</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Relatamos caso de rara anomalia de artéria coronária direita saindo do terço médio da artéria descendente anterior com lesão obstrutiva ateromatosa proximal, imediatamente antes da emergência da coronária direita. O paciente foi submetido a angioplastia com implante de Stent na descendente anterior com sucesso. Há relatos de apenas 7 casos desta anomalia de distribuição na literatura, porém nenhum com tratamento de revascularização percutânea.</s0>
</fC01>
<fC01 dir="en">
<s0>We report the case of a rare anomaly of the right coronary artery originated from the middle third of the left anterior descending (LAD) coronary artery with a proximal atheromatous obstructive lesion immediately before the emergence of the right coronary artery (RCA). The patient underwent successful angioplasty with stent implantation in the left anterior descending coronary artery. Only 7 cases of this anomaly of distribution have been reported in the literature, but none of them was treated with percutaneous revascularization.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="">
<s1></s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>60-99</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400114</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Criança de 5 anos de idade com atresia tricúspide e operação de Blalock-Taussig modificada: Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>100-100</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400115</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Índice valvar &amp; escore valvar: uma nova forma de comunicação do continuum da história natural da valvopatia</s1>
</fA08>
<fA08 dir="en">
<s1>Valvular index and valvular score: a new approach for the follow-up of the natural history of valvular heart disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Guilherme Sobreira Spina</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>101-102</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Estenose subaórtica associada a comunicação interventricular perimembranosa: acompanhamento clínico de 36 pacientes</s1>
</fA08>
<fA08 dir="en">
<s1>Subaortic stenosis associated with perimembranous ventricular septal defect: clinical follow-up of 36 patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria da Gloria Cruvinel Horta</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Alberto Franco Faria</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Dilermando Fazito Rezende</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Tereza Lucia Masci</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Cathia Costa C. Rabelo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Tamara Katina</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Marly de Oliveira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luciana Paulino Oliveira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFMG Faculdade de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Santa Casa de Misericórdia de Belo Horizonte  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>103-107</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>42</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar o comportamento clínico da estenose subaórtica associada a comunicação interventricular perimembranosa. MÉTODOS: Foram acompanhadas, de janeiro 1979 a junho 2000, quanto às características anatômicas, caráter evolutivo e eventos clínicos, 36 crianças com comunicação interventricular perimembranosa e estenose subaórtica fixa. RESULTADOS: A idade de diagnóstico da estenose subaórtica fixa variou de seis meses a 170 meses, sendo abaixo de 1 ano apenas em duas crianças. Quanto ao sexo a distribuição foi de 2:1 com grande predomínio do masculino. A comunicação interventricular era de tamanho pequeno em 61,00% dos casos, médio em 30,56% e grande em 8,40%, apresentando diminuição do tamanho da comunicação durante o acompanhamento em 30,56% (11 casos). Em todos os pacientes a estenose subaórtica era fixa, em membrana. Durante o tempo de acompanhamento, 23 pacientes apresentaram progressão da estenose. Foi realizado tratamento cirúrgico em 21 casos, sendo um paciente reoperado por reestenose. Endocardite bacteriana ocorreu em dois casos, um deles faleceu. CONCLUSÃO: A estenose subaórtica ocorre na história natural da comunicação interventricular geralmente após o 1º ano de vida, apresentando caráter progressivo e necessitando de cirurgia na maioria dos casos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study the clinical pattern of subaortic stenosis associated with perimembranous ventricular septal defect. METHODS: From January 1979 to June 2000, 36 children with perimembranous ventricular septal defect and fixed subaortic stenosis were followed-up regarding anatomic characteristics, evolvement, and clinical events. RESULTS: Age at diagnosis of subaortic stenosis ranged from 6 months to 170 months, and it was less than 1 year in only 2 children. Regarding sex, the distribution was 2:1 with a greater predominance of males. Ventricular septal defect was small in 61.0% of cases, medium in 30.56%, and large in 8.40%; the size of the septal defect decreased during follow-up in 30.56% (11 cases). In all patients, subaortic stenosis was membranous and fixed. During follow-up, 23 patients experienced evolvement of the stenosis. Surgical treatment was performed in 21 cases, and one patient underwent surgery for restenosis. Infectious endocarditis occurred in 2 patients; one of the patients died. CONCLUSION: Subaortic stenosis occurs in the natural history of ventricular septal defect usually after the first year of life, and it is progressive and requires surgery in most cases.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>comunicação interventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose subaórtica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatia congênita</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>endocardite</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular septal defect</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>subaortic stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endocarditis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Prevalência da doença arterial coronariana em diabéticos tipo 1 candidatos a transplante duplo (rim e pâncreas)</s1>
</fA08>
<fA08 dir="en">
<s1>Prevalence of coronary artery disease in type I diabetic candidates for double transplantation (kidney and pancreas)</s1>
</fA08>
<fA11 dir="011000">
<s1>Dinaldo C. Oliveira</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Glauco Gusmão Filho</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alysson Nakamoto</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Francival L. Souza</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="051000">
<s1>João Roberto de Sá</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José O. Medina Pestana</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Valter C. Lima</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital do Rim e Hipertensão  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>UNIFESP  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>108-110</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a prevalência da doença arterial coronariana (DAC) em população de pacientes diabéticos tipo 1, nefropatas, em programa de diálise e candidatos a transplante duplo (rim e pâncreas). MÉTODOS: De janeiro/2000 a julho/2002, foram submetidos a cinecoronariografia, como protocolo de avaliação para transplante duplo, 58 pacientes diabéticos tipo 1. Doença arterial coronariana foi definida como qualquer irregularidade nas artérias coronárias, e classificada, de acordo com a grau de estenose luminal, em leve (&lt;30%), moderada (&gt;30 a 70%) e grave (&gt;70%). RESULTADOS: A idade dos pacientes foi 34 ± 12 anos, sendo que 32 (55%) eram homens. Nenhum paciente tinha história de angina ou infarto agudo do miocárdio. Os principais fatores de risco para a doença foram hipertensão arterial sistêmica em 93%, dislipidemia em 38%, historia familiar em 25% e tabagismo 20%. O tempo médio de duração do diabetes foi 20,8 ± 9 anos, o tempo de diálise de 26 ± 9 meses. A coronariografia revelou doença arterial coronariana em 42 (72%) pacientes, sendo 20 (34%) discreta, 9 (16%) moderada e 13 (22%) grave. CONCLUSÃO: Pacientes diabéticos tipo 1 em programa de diálise e candidatos a transplante duplo têm elevada prevalência de doença arterial coronariana, tornando-se marcante a observação de que esses pacientes não apresentavam sintomas da doença.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the prevalence of coronary artery disease (CAD) in a population of type I diabetic, nephropathic patients in a dialysis program and candidates for double transplantation (kidney and pancreas). METHODS: From January 2000 to July 2002, 58 type I diabetic patients underwent coronary cineangiography as part of an assessment protocol for double transplantation. Coronary artery disease was defined as any irregularity in the coronary arteries and was classified according to the degree of luminal stenosis as mild (&lt; 30%), moderate (&gt; 30 to 70%), and severe (&gt; 70%). RESULTS: The mean age of the patients was 34 ± 12 years, and 32 (55%) were men. No patient had a history of angina or acute myocardial infarction. The major risk factors for the disease were systemic arterial hypertension in 93% of the patients, dyslipidemia in 38%, familial history in 25%, and smoking in 20%. The mean duration of diabetes was 20.8 ± 9 years, and the duration of dialysis was 26 ± 9 months. Coronary angiography revealed coronary artery disease in 42 (72%) patients, which was mild in 20 (34%) patients, moderate in 9 (16%), and severe in 13 (22%). CONCLUSION: Patients with type I diabetes in a dialysis program and candidates for double transplantation had an elevated prevalence of coronary artery disease. It is worth noting that those patients had no symptoms of the disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aterosclerose</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>diabetes mellitus tipo 1</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>transplante duplo</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>type I diabetes mellitus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>double transplantation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Características clínicas demográficas em 99 episódios de febre reumática no Acre, Amazônia Brasileira</s1>
</fA08>
<fA08 dir="en">
<s1>Clinical and demographic characteristics of 99 episodes of rheumatic fever in Acre, the Brazilian Amazon</s1>
</fA08>
<fA11 dir="011000">
<s1>Fátima Borges</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Luiza A. Barbosa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Renata Beyruth Borges</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Olívia C. Pinheiro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Carlos Cardoso</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Claudilson Bastos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Roque Aras</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Hospitalar do Acre  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>UFB  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>111-114</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Relatar as manifestações clínicas e características demográficas de pacientes com febre reumática atendidos em serviço público no Estado do Acre. MÉTODOS: Estudo de corte transversal em pacientes atendidos consecutivamente no Ambulatório de Cardiologia da FUNDHACRE, avaliados através de questionário contendo dados demográficos, clínicos e laboratoriais. O diagnóstico de febre reumática foi realizado através da aplicação dos critérios de Jones, em associação com dados laboratoriais, eletrocardiograma, radiografia de tórax e ecocardiograma bidimensional. Excluídos portadores com outras cardiopatias, diabetes, obesidade, doenças inflamatórias, processos infecciosos, tabagismo, gestantes, uso de drogas anti-inflamatórias ou reposição hormonal. RESULTADOS: De julho/2003 a fevereiro/2004, foram avaliados 99 pacientes com febre reumática aguda (idade média de 11 anos, dp= ± 10,18) com predominância feminina (59,6%) e fenótipo racial mestiço de índio (60,6%). Excluídos 3 indivíduos, por não preencherem os critérios diagnósticos. A idade média de início foi de 9,1 anos, sendo que em 30,4% dos pacientes a doença foi diagnosticada no primeiro episódio de atividade reumática. As manifestações clínicas mais freqüentes foram cardite (69,7%), artrite (21,4%) e coréia (6,1%) e a regurgitação mitral (36,4%) a lesão mais comum seguida da associação de regurgitação mitral com aórtica (9,1%). CONCLUSÃO: Cardite reumática foi a manifestação mais freqüente de febre reumática, predominando no grupo racial mestiço de índio (60,6%), A baixa aderência à antibioticoprofilaxia contribuiu para recorrências e seqüelas cardíacas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To report clinical manifestations and demographic characteristics of patients with rheumatic fever treated in a public hospital in the state of Acre. METHODS: A cross-sectional study was conducted of patients consecutively seen in the Cardiology Ward at FUNDHACRE Demographic, clinical and laboratory data were assessed through a questionnaire. The diagnosis of rheumatic fever was made based on Jones' criteria, associated with laboratory data, electrocardiography, chest X-ray, and bi-dimensional echocardiography. Patients with other heart diseases, diabetes, obesity, inflammatory disease, and infections were excluded. Those who smoked, were pregnant, or used anti-inflammatory medication or hormone therapy were also excluded. RESULTS: From July 2003 to February 2004, 99 patients with rheumatic fever were assessed (mean age, 11 years, SD= ± 10.18) with a predominance of females (59.6%), and a racial phenotype of a mixture of Caucasian and Indian (60.6%). Three individuals were excluded because they did not meet the diagnostic criteria. Mean age was 9.1 years old, and in 30.4% of the patients, the disease was diagnosed at the first episode of rheumatic fever. The most frequent clinical manifestations were carditis (69.7%), arthritis (21.4%), and chorea (6.1%). Mitral regurgitation was the most common lesion (36.4%) followed by the association of mitral regurgitation and aortic regurgitation (9.1%). CONCLUSION: Rheumatic carditis was the most common manifestation of rheumatic fever, predominant in the group with a racial mixture of Caucasian and Indian (60.6%). Low compliance with antibiotic therapy contributed to the recurrence of the disease and to cardiac sequelae.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>febre reumática</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardite</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coréia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rheumatic fever</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>carditis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chorea</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>A administração precoce de hormônio de crescimento resulta em efeitos deletérios na remodelação ventricular após o infarto agudo do miocárdio</s1>
</fA08>
<fA08 dir="en">
<s1>The early administration of growth hormone results in deleterious effects on ventricular remodeling after acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>José G. Mill</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leonardo A. M. Zornoff</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marina P. Okoshi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Katashi Okoshi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Carlos R. Padovani</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Mário Sugisaki</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Cláudia M. Leite</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Antônio C. Cicogna</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Vitória  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Faculdade de Medicina de Botucatu  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>115-121</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar a ação do hormônio de crescimento (GH) sobre a remodelação miocárdica em ratos infartados. MÉTODOS: Ratos Wistar foram submetidos ao infarto e tratados com GH (IAM-GH; n=8), ou com o veículo (IAM; n=8). Ratos controles foram submetidos ao infarto simulado (C; n=8). Após 30 dias, os animais foram submetidos ao estudo funcional por meio de ecocardiograma e as alterações da contratilidade miocárdica estudadas no músculo papilar isolado do ventrículo esquerdo (VE). RESULTADOS: O ecocardiograma identificou aumento nos diâmetros (mm) diastólico (C=7,32±0,49; IAM=8,50±0,73; IAM-GH= 9,34± 0,73; P&lt;0,05) e sistólico (C=3,38±0,47, IAM= 5,16±1,24; IAM-GH=5,96±1,54; P&lt;0,05) no VE dos animais com infarto. Os animais do grupo IAM-GH apresentaram menor fração (%) de ejeção (C=0,9±0,03; IAM=0,76±0,12; IAM-GH=0,72±0,14; P&lt;0,05 para C vs IAM-GH) em relação aos controles. O estudo do músculo papilar isolado do ventrículo esquerdo mostrou que o grupo IAM-GH apresentou alterações (C=1,50±0,59; IAM= 1,28±0,38; IAM-GH=1,98±0,41; P&lt;0,05 para C vs IAM-GH) somente na tensão de repouso (TR - g/mm²) e no delta do tempo para a tensão desenvolvida decrescer 50% (TR50, ms) após estimulação com cálcio (C=23,75±9,16; IAM=-16,56±14,82; IAM-GH=-4,69±8,39; P&lt;0,05 para C vs IAM-GH) e no delta da tensão desenvolvida (TD, g/mm²) após estimulação com isoproterenol (C=0,99±0,17; IAM=0,54±0,62; IAM-GH= 0,08±0,75; P&lt;0,05 para C vs IAM-GH), em relação aos animais controle. CONCLUSÃO: A administração precoce do GH no modelo de infarto experimental em ratos pode resultar em efeitos adversos no processo de remodelação ventricular.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effect of growth hormone (GH) on myocardial remodeling in infarcted rats. METHODS: This study comprised 24 Wistar rats divided into 3 groups as follows: 1) AMI-GH group - comprising 8 rats that underwent infarction and were treated with GH; 2) AMI group - comprising 8 rats that underwent infarction and received only the diluent of the GH solution; and 3) control group (C group) - comprising 8 rats that underwent simulated infarction. After 30 days, the animals underwent functional study through echocardiography, and the changes in myocardial contractility of the isolated left ventricular (LV) papillary muscle were studied. RESULTS:The echocardiography identified an increase in the diastolic (C=7.32±0.49; AMI=8.50±0.73; AMI-GH=9.34±0.73; P&lt;0.05) and systolic (C=3.38±0.47, AMI=5.16±1.24; AMI-GH=5.96±1.54; P&lt;0.05) diameters (mm) in the LV of the infarcted animals. The AMI-GH group animals had a lower ejection fraction (%) (C=0.9±0.03; AMI=0.76±0.12; AMI-GH= 0.72± 0.14; P&lt;0.05 for C vs AMI-GH) compared with those in controls. The study of the isolated left ventricular papillary muscle showed that the AMI-GH group had changes (C= 1.50±0.59; AMI= 1.28±0.38; AMI-GH=1.98±0.41; P&lt;0.05 for C vs AMI-GH) only in the tension at rest (TR - g/mm²) and in the time delta for a 50% decrease in the tension developed (TR50, ms) after stimulation with calcium (C=23.75±9.16; AMI=-16.56±14.82; AMI-GH=-4.69±8.39; P&lt;0.05 for C vs AMI-GH) and in the delta of tension developed (TD, g/mm²) after stimulation with isoproterenol (C=0.99±0.17; AMI=0.54±0.62; AMI-GH=0.08±0.75; P&lt;0.05 for C vs AMI-GH) compared with those in control animals. CONCLUSION: The early administration of GH in the experimental infarction model in rats may result in adverse effects on the process of ventricular remodeling.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>músculo papilar</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>papillary muscle</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Perfil inflamatório, metabólico e lipídico na síndrome isquêmica aguda: relação com eventos intra e pós-hospitalares</s1>
</fA08>
<fA08 dir="en">
<s1>Inflammatory, lipid, and metabolic profile in acute ischemic syndrome: correlation with hospital and posthospital events</s1>
</fA08>
<fA11 dir="011000">
<s1>Elizabeth da Rosa Duarte</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Lucia Campos Pellanda</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vera Lúcia Portal</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Cardiologia do Rio Grande do Sul  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Fundação Universitária de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>122-129</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>70</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Associar o perfil lipídico, inflamatório (proteína C reativa ultra sensível - PCR us - e fibrinogênio) e metabólico (glicose) com eventos intra e pós-hospitalares de pacientes com síndrome isquêmica aguda (SIA) e descrever preditores de mortalidade nesta população. MÉTODOS: Estudo de coorte com 199 pacientes com SIA (angina instável, infarto agudo do miocárdio com ou sem supradesnivelamento de ST) internados na unidade de terapia intensiva (UTI) de uma instituição de referência cardiológica, no período de março a novembro de 2002. Foram registrados as doenças prévias, as medicações em uso e os fatores de risco coronarianos. Os eventos clínicos intra-hospitalares considerados foram Re-IAM, angina, insuficiência cardíaca (IC), fibrilação ventricular e óbito e os pós-hospitalares (30 dias após a alta) foram Re-IAM, angina, IC, óbito e re-internação para procedimentos percutâneos (ACTP) ou de revascularização (CRM). RESULTADOS: A PCR us e a glicemia alterada associaram-se, significativamente, com os eventos intra-hospitalares (p=0,03 e p&lt;0,01, respectivamente), mas não com os eventos pós-hospitalares (p=0,19 e p=0,61, respectivamente). O perfil lipídico e o fibrinogênio não mostraram associação estatisticamente significativa em nenhum dos momentos avaliados. Após regressão logística múltipla, idade (p=0,04), IAM prévio (p=0,04), infarto do miocárdio com supra ST (p=0,008) ou sem supra de ST (p=0,048) e glicemia alterada (p=0,002) foram preditores de mortalidade hospitalar. CONCLUSÃO: A PCR us elevada e a glicemia alterada associaram-se a maior incidência de eventos intra-hospitalares enquanto a idade, IAM prévio, IAM com ou sem supra de ST e glicemia alterada foram preditores de mortalidade hospitalar.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To associate the markers lipid profile, inflammatory profile (high-sensitivity C-reactive protein HSCRP and fibrinogen), and metabolic profile (glucose determination) with hospital and posthospital events in patients with acute ischemic syndrome (AIS) and to describe the predictors of mortality in this population. METHODS: A cohort study with 199 patients with AIS (unstable angina, acute myocardial infarction (AMI) with or without ST segment elevation) admitted to the intensive care unit (ICU) of a university cardiology Hospital, from March to November 2002. The previous diseases, the medication in use, and the coronary risk factors were recorded. The clinical events considered in the hospital were reinfarction, angina, heart failure (HF), ventricular fibrillation, and death; the posthospital events considered (30 days after hospital discharge) were reinfarction, angina, HF, death, and admittance for percutaneous procedures (PTCA) or for revascularization (MRS). RESULTS: HSCRP and altered glycemia were significantly associated with hospital events (P = 0.03 and P &lt; 0.01, respectively); however, they were not associated with posthospital events (P = 0.19 and P = 0.61, respectively). Lipid profile and fibrinogen did not have a statistically significant association in any of the times assessed. Using multiple logistic regression, age (P = 0.04), previous AMI (P = 0.04), myocardial infarction with ST segment elevation (P = 0.008) or without ST segment elevation (P = 0.048), and altered glycemia (P = 0.002) were predictors of hospital mortality. CONCLUSION: Increased HSCRP and altered glycemia were associated with a greater number of hospital events, whereas age, previous AMI, AMI with or without ST segment elevation, and altered glycemia were predictors of hospital mortality.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>síndrome isquêmica aguda</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>perfil lipídico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>marcadores inflamatórios</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute ischemic syndrome</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipid profile</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>inflammatory markers</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo angiográfico da circulação pulmonar na tetralogia de Fallot com atresia pulmonar</s1>
</fA08>
<fA08 dir="en">
<s1>Angiographic study of pulmonary circulation in tetralogy of Fallot with pulmonary atresia</s1>
</fA08>
<fA11 dir="011000">
<s1>Marco Aurélio Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vitor Manuel Pereira Azevedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Nacional de Cardiologia Laranjeiras  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>130-136</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Identificar os tipos de suprimento sangüíneo vascular pulmonar na tetralogia de Fallot com atresia pulmonar por meio de estudo hemodinâmico. MÉTODOS: Foram submetidos a estudo cineangiocardiográfico 56 pacientes portadores de tetralogia de Fallot com atresia pulmonar com idade de 20 dias a 4 anos e efetuadas injeções de contraste nas seguintes estruturas vasculares: 1) veia pulmonar encunhada, 2) colaterais aortopulmonares, 3) aorta torácica e 4) ductus arteriosus e/ou shunt sistêmico pulmonar. RESULTADOS: Dos 56 pacientes, 15 tinham o suprimento sangüíneo pulmonar através de colaterais aortopulmonares, em 36 o suprimento sangüíneo pulmonar era feito isoladamente pelo ductus arteriosus e em 5 pelo ductus arteriosus e colaterais aortopulmonares. Conforme a presença ou ausência de estruturas vasculares que compõem a circulação pulmonar na tetralogia de Fallot com atresia pulmonar e do tipo de perfusão vascular pulmonar, os doentes foram classificados em 6 tipos. CONCLUSÃO: Em função da grande complexidade e extrema variabilidade do suprimento sangüíneo pulmonar na tetralogia de Fallot com atresia pulmonar torna-se possível, com este tipo de abordagem, a obtenção de informações, suficientemente necessárias, para o correto manuseio clínico-cirúrgico.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To identify the types of pulmonary vascular blood supply in tetralogy of Fallot with pulmonary atresia by use of hemodynamic study. METHODS: Fifty-six patients with tetralogy of Fallot and pulmonary atresia, and ages ranging from 20 days to 4 years, underwent cineangiocardiographic study with contrast medium injections in the following vascular structures: 1) wedged pulmonary vein; 2) aortopulmonary collaterals; 3) thoracic aorta; and 4) ductus arteriosus or systemic-pulmonary shunt. RESULTS: In the 56 patients studied, pulmonary blood was supplied as follows: in 15, by aortopulmonary collaterals; in 36, only by the ductus arteriosus; and in 5, by the ductus arteriosus and aortopulmonary collaterals. The patients were classified into 6 types depending on the type of pulmonary vascular perfusion and the presence or absence of vascular structures that compose the pulmonary circulation in tetralogy of Fallot with pulmonary atresia. CONCLUSION: This type of approach enables the obtainment of information necessary for the correct clinicosurgical management of patients, due to the great complexity and extreme variability of the pulmonary blood supply in tetralogy of Fallot with pulmonary atresia.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>atresia pulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tetralogia de Fallot</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>colaterais aortopulmonares</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angiocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pulmonary atresia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tetralogy of Fallot</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortopulmonary collaterals</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angiocardiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Determinação do peptídeo natriurético cerebral humano em portadores da doença de Chagas</s1>
</fA08>
<fA08 dir="en">
<s1>Measurement of human brain natriuretic peptide in patients with Chagas' disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Railton Bezerra de Melo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Giordano Bruno de Oliveira Parente</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Edgar Guimarães Victor</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFP  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>137-140</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>7</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar os níveis séricos do peptídeo natriurético cerebral (PNB) em pacientes com cardiopatia chagásica crônica e em indivíduos com sorologia positiva para doença de Chagas sem comprometimento cardíaco, e correlacionar os níveis de PNB com o grau de comprometimento cardíaco, dimensões cardíacas, presença de marcapasso e fração de ejeção. MÉTODOS: Concentrações séricas de PNB foram determinadas através do Triage® - BNP Test, produzido pela BIOSITE®. Foi avaliado o PNB sérico de 25 indivíduos do ambulatório de doença de Chagas do Hospital Universitário Oswaldo Cruz, distribuídos em 2 grupos, um, G1; composto por 13 portadores de sorologia positiva para doença de Chagas, assintomáticos e sem cardiopatia detectável pelo eletrocardiograma, radiografia do tórax e ecocardiograma, o outro, G2; por 12 portadores da doença de Chagas com comprometimento cardíaco. RESULTADOS: Níveis significativamente mais elevados de PNB foram detectados nos pacientes chagásicos com comprometimento cardíaco: (G1=4,4±4,4 pg/ml, G2=293,0±460,2 pg/ml) p&lt;0,01. Nos 2 grupos não houve correlação dos níveis séricos de PNB com a idade e o sexo. Os níveis foram diretamente proporcionais à classe funcional e à área cardíaca no estudo radiológico do tórax. Apesar de demonstrar uma tendência de elevação no comprometimento da função sistólica, não houve correlação linear com a fração de ejeção ao ecocardiograma. Presença de marcapasso definitivo e alterações eletrocardiográficas não modificaram os níveis séricos de PNB. CONCLUSÃO: Os indivíduos com sorologia positiva para doença de Chagas, assintomáticos e sem evidência de disfunção ventricular, possuem níveis séricos de PNB semelhantes aos da população em geral.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To measure the serum levels of brain natriuretic peptide (BNP) in patients with chronic chagasic heart disease and in individuals with positive serology for Chagas' disease and no heart impairment, and to correlate the serum BNP levels with the degree of cardiac impairment, cardiac dimensions, presence of a pacemaker, and ejection fraction. METHODS: Serum BNP concentrations were determined by use of the Triage - BNP Test produced by BIOSITE. Serum BNP was assessed in 25 patients from the Chagas' disease outpatient clinic of the Hospital Universitário Oswaldo Cruz, who were divided into 2 groups as follows: 1) G1 - comprising 13 assymptomatic patients with positive serology for Chagas' disease and no heart disease detectable on electrocardiography, chest X-ray, and echocardiography; and 2) G2 - comprising 12 patients with Chagas' disease and heart impairment. RESULTS: Significantly more elevated BNP levels were detected in the chagasic patients with cardiac impairment: (G1=4.4 ±4.4 pg/ml, G2=293.0±460.2 pg/ml); (P&lt;0.01). In the 2 groups, the serum levels of BNP correlated neither with age nor with sex. The levels were directly proportional to functional class and cardiac area on chest X-ray. Although a trend towards an increment in systolic function impairment was observed, no linear correlation with the ejection fraction on echocardiography occurred. The presence of definitive pacemaker and electrocardiographic alterations did not change the serum BNP levels. CONCLUSION: Asymptomatic individuals with a positive serology for Chagas' disease and no evidence of ventricular dysfunction have serum BNP levels similar to those of the general population.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença de Chagas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>peptídeos natriuréticos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>peptídeo natriu rético cerebral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca congestiva</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>natriuretic peptides</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cerebral natriuretic peptide</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congestive heart failure</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Características clínicas associadas à evolução desfavorável na miocardiopatia periparto</s1>
</fA08>
<fA08 dir="en">
<s1>Clinical characteristics associated with unfavorable outcomes in peripartum myocardiopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>Caroline da Costa Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Silméia Garcia Zanati</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vera Therezinha Borges Medeiros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cláudia Guimarães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Elaine Farah Simões</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Beatriz Bojikian Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Unesp Faculdade de Medicina de Botucatu </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>141-146</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVOS: Avaliar as características clínicas de mulheres com diagnóstico prévio de miocardiopatia periparto e verificar as características associadas à evolução desfavorável. MÉTODOS: Variáveis clínicas, obstétricas e ecocardiográficas foram estudadas em 12 pacientes com miocardiopatia periparto, avaliadas no momento do diagnóstico e em consulta atual, quando foram divididas em dois grupos: GF (n= 6, sem alterações cardíacas) e GD (n= 6, com cardiomegalia e disfunção ventricular persistentes). As comparações foram feitas com o teste &quot;t&quot; de Student e exato de Fisher (p&lt;0,05). RESULTADOS: No diagnóstico, a idade média das pacientes (8 brancas e 4 negras/pardas) foi de 24±7,4 anos; todas em classe funcional IV (NYHA) e 8 relataram hipertensão gestacional ou pré-eclâmpsia. A mediana do tempo de seguimento foi de 25 meses. Dez pacientes evoluíram para classe funcional I/II. A comparação entre os grupos mostrou GD com menor fração de ejeção do ventrículo esquerdo (0,30±0,05 vs. 0,58±0,09; p&lt;0,001) e maior diâmetro sistólico do VE (58±5mm vs. 46±3mm; p&lt;0,001), no momento do diagnóstico. A evolução desfavorável foi mais frequente entre as pardas (p=0,01). Na avaliação atual o GD apresentou menor espessura relativa da parede (0,13±0,02 vs. 0,17±0,02; p&lt; 0,05) e maior massa do VE (283±90g vs. 186±41g; p&lt;0,05). CONCLUSÃO: Pacientes com miocardiopatia periparto prévia apresentam evolução desfavorável associada à raça negra e alterações cardíacas iniciais mais acentuadas e a evolução favorável está associada à redução da massa miocárdica e aumento da espessura relativa da parede ventricular.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the clinical characteristics of women with a previous diagnosis of peripartum myocardiopathy and to study the characteristics associated with unfavorable outcomes. METHODS: Clinical, obstetric, and echocardiographic variables were studied in 12 patients with peripartum myocardiopathy, assessed at diagnosis and at a current appointment, when they were divided into 2 groups: FG (n = 6, without cardiac alterations) and UG (n = 6, with cardiomegaly and persistent ventricular dysfunction). The comparisons were made using the Student t test and Fisher's exact test (P &lt; 0.05). RESULTS: At diagnosis, mean age of the patients (8 Caucasian and 4 black/non-Caucasian) was 24±7.4 years, all in Functional Class IV (NYHA) and 8 reporting gestational hypertension or preeclampsia. Mean follow-up time was 25 months. Ten patients developed Functional Class I/II. Comparison between the groups demonstrated that UG had lower left ventricular ejection fractions (0.30±0.05 vs. 0.58±0.09; P &lt; 0.001) and greater LV systolic diameter (58±5mm vs. 46±3mm; P &lt; 0.001) at diagnosis. An unfavorable outcome was more frequent among non-Caucasian women (P = 0.01). In the current evaluation, UG had lower relative wall thickness (0.13±0.02 vs. 0.17±0.02; P &lt; 0.05) and greater LV mass (283±90g vs. 186±41g; P &lt; 0.05). CONCLUSION: Patients with previous peripartum myocardiopathy had unfavorable outcomes associated with black race, and stronger initial cardiac alterations; a favorable outcome was associated with a reduction in myocardial mass and an increase in relative ventricular wall thickness.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>gestação</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>gestation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Perfil ambulatorial em cardiologia pediátrica na cidade de Ribeirão Preto, SP</s1>
</fA08>
<fA08 dir="en">
<s1>Profile of pediatric outpatient in cardiology clinics in the city of Ribeirão Preto</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Amaral</s1>
<afiliation>A01 A02 A03 A04 A05</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João A. Granzotti</s1>
<afiliation>A01 A02 A03 A04 A05</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Bruno G. Dantas</s1>
<afiliation>A01 A02 A03 A04 A05</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Diogo C. Balestra</s1>
<afiliation>A01 A02 A03 A04 A05</afiliation>
</fA11>
<fA14 dir="010000">
<s1>SUS Ambulatório Regional de Especialidades </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>UNAERP Faculdade de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Hospital do Coração de Ribeirão Preto  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="040000">
<s1>Fundação Waldemar B. Pessoa  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="050000">
<s1>USP Faculdade de Medicina de Ribeirão Preto </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>147-151</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar em casuísticas ambulatoriais na rede pública de saúde, em hospital terciário e na clínica privada, as características do atendimento, em cardiopatia pediátrica enfatizando o motivo de encaminhamento, o diagnóstico definitivo e a conduta adotada. MÉTODOS: Um total de 1.365 pacientes consecutivos, com idades entre 1 mês a 14 anos foram atendidos, em 1996, em 3 locais distintos: G1 (n = 562), ambulatório de referência da rede pública, oriundo de Ribeirão Preto (RP) (78%) e região (22%); G2 (n = 420), clínica privada, oriundo de RP (67%), região (25%) e outras regiões/estados (8%); G3 (n = 383), ambulatório de referência do Hospital das Clínicas da FMRP - USP, procedente de RP (26%), região (43,5%) e outras regiões/estados (30,5%). RESULTADOS: Motivo de encaminhamento: G1: sopro (71%), arritmia (8%), dor precordial (7%), dispnéia (6,5%) e motivos variados (7,5%); G2: sopro (70%), dor precordial (7%), arritmia (7%), dispnéia (4%), pós-operatório (4%) e motivos variados (8%); G3: sopro (56%), pós-operatório (24%), arritmia (4%) e motivos variados (16%). Abandono de tratamento: G1: 31%, G2: 17% e G3: 3%. Diagnóstico definitivo: G1: 346 (89%) normais e 43 (11%) anormais; G2: 268 (76%) normais e 82 (24%) anormais; G3: 22 (6%) normais e 351 (94%) anormais. Conduta: G1: alta (89%) e seguimento (11%); G2: alta (76%) e seguimento (24%); G3: alta (6%) e seguimento (94%). CONCLUSÃO: Perfil clínico diferenciado entre os três grupo. Há necessidade de intervenção nas unidades básicas de saúde para verificar condições de atendimento e oferecer treinamento cardiológico pediátrico aos pediatras. Importante determinar causas do índice de abandono no G1 e há necessidade de investir na natureza estrutural e de recursos humanos para o atendimento no ambulatório do G3.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To verify the pediatric cardiology outpatient clinic characteristics in Ribeirão Preto (RP) city, emphasizing reasons for referral, definitive diagnosis and outcome through analysis of patients seen in 3 distinct settings. METHODS: In 1996, 1,365 consecutive patients, aged 1 month to 14 years were seen: G1 (n = 562), public pediatric cardiology outpatient clinic; G2 (n = 420), private practice; G3 (n = 383) pediatric cardiology outpatient clinic at Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto. Origin of the patients: G1: RP (78%) and region (22%); G2: RP (67%), region (25%), and other regions/states (8%); G3: RP (26%), region (43.5%), and other regions/states (30.5%). RESULTS: Reasons for referral: G1: murmur (71%), arrhythmia (8%), chest pain (7%), breathlessness (6.5%), other reasons (7.5%). G2: murmur (70%), chest pain (7%), arrhythmia (7%), breathlessness (4%), postoperative follow-up (4%), other reasons (8%). G3: murmur (56%), postoperative follow-up (24%), arrhythmia (4%), other reasons (16%). Patients lost to follow-up: G1: 31%, G2: 17%, G3: 3%. Final diagnosis: G1: 346 (89%) normal and 43 (11%) abnormal patients; G2: 268 (76%) normal and 82 (24%) abnormal patients; G3: 22 (6%) normal and 351 (94%) abnormal patients. Outcome: G1: discharge (89%), follow-up (11%); G2: discharge (76%), follow-up (24%); G3: discharge (6%), follow-up (94%). CONCLUSION: Clinical profile is different among the 3 groups (G1 and G2 are similar). Intervention in the Basic Health Units seems to be necessary to verify structural facilities and to offer basic pediatric cardiology training to pediatricians. It is important to verify the high index of patients lost to follow-up, particularly in G1. Structural and human resources are needed if adequate assistance is to be expected for the highly complex cases seen in G3. The pediatric cardiology public outpatient clinic should be maintained until resolution of cases by the pediatricians in the Basic Health Units improves.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiologia pediátrica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sopro cardíaco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ambulatório</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pediatric cardiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pediatric outpatient</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart murmur</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Capacidade funcional máxima, fração de ejeção e classe funcional na cardiomiopatia chagásica: existe relação entre estes índices?</s1>
</fA08>
<fA08 dir="en">
<s1>Maximal functional capacity, ejection fraction, and functional class in Chagas cardiomyopathy: are these indices related?</s1>
</fA08>
<fA11 dir="011000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vera Maria Cury Salemi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Barbara Maria Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Felix José Alvarez Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>152-155</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>40</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a potencial associação entre a capacidade funcional máxima (VO2max), fração de ejeção do ventrículo esquerdo (FEVE) e a classe funcional (CF) pela NYHA em pacientes com cardiomiopatia chagásica. MÉTODOS: Foram estudados 104 homens, com idade média de 40.3± 9.0 anos (variação: de 18 a 65), com diagnóstico estabelecido de cardiomiopatia chagásica. A FEVE e VO2max foram classificadas em três categorias: FEVE &lt;0.30, 0.30&lt; FEVE &lt;0.50, e FEVE &gt; 0.50 e VO2max &lt;10, 10&lt;VO2max &lt;20, e VO2max &gt;20 ml.kg-1.min-1, respectivamente. RESULTADOS: Do total, 31 (29.8%) pacientes estavam em CF II, 41 (39.4%) em classe funcional III, e 32 (30.8%) em CF IV. Os valores correspondentes do VO2max e da FEVE para CF II, III e IV foram 21.5±4.0 ml.kg-1.min-1, 18.3±5.8 ml.kg-1.min-1 e 14.7±4.9 ml.kg-1.min-1 e 0.50±0.6, 0.35±0.9 e 0.29±0.7, respectivamente. FEVE &lt;0.30 e VO2max &lt;10 ml.kg-1.min-1 foram encontradas na grande maioria dos pacientes em CF IV. Inversamente, pacientes em CF II foram relacionados com FEVE &gt;0.50 como também VO2max &gt;20 ml.kg-1.min-1. CONCLUSÃO: Existe uma boa associação entre a classe funcional, a capacidade funcional máxima e a fração de ejeção do ventrículo esquerdo em pacientes com cardiomiopatia chagásica. Dados que podem ser úteis no manuseio da insuficiência cardíaca, em chagásicos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Left ventricular ejection fraction (LVEF) and maximal functional capacity (VO2max) have both been shown to be related to a poor long-term survival in Chagas' disease patients. The aim of this study was to estimate the potential association of VO2max, LVEF, and NYHA functional class in patients with Chagas' disease cardiomyopathy. METHODS: One hundred four male patients, aged 40.3±9.0 years (range, 18 to 65), with a definite diagnosis of Chagas disease cardiomyopathy were studied. LVEF and VO2max were both classified into 3 degrees: LVEF &lt;0.30, 0.30&lt; LVEF &lt;0.50, and LVEF &gt; 0.50 and VO2max &lt;10, 10&lt;VO2max &lt;20, and VO2max &gt;20 ml.kg-1.min-1, respectively. RESULTS: Thirty-one patients (29.8%) were in NYHA functional class II, 41 (39.4%) in functional class III, and 32 (30.8%) in functional class IV. The corresponding values of VO2max and LVEF for functional classes II, III, and IV were 21.5±4.0 ml.kg-1.min-1, 18.3±5.8 ml.kg-1.min-1, and 14.7±4.9 ml.kg-1.min-1 and 0.50±0.6, 0.35± 0.9, and 0.29±0.7, respectively. LVEF= &lt;0.30 and VO2max = &lt;10 ml.kg-1.min-1 were found in the majority of patients in NYHA functional class IV. Conversely, patients in functional class II were mostly those with LVEF &gt;0.50 as well as VO2max &gt;20 ml.kg-1.min-1. CONCLUSION: A convincingly good association exists between NYHA functional class, functional capacity and LVEF in patients with Chagas' disease cardiomyopathy. These data may be helpful in the management of heart failure in Chagas' disease patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>capacidade funcional máxima</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fração de ejeção</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>classe funcional</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiomiopatia chagásica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>maximal functional capacity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ejection fraction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>functional class in Chagas cardiomyopathy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Doença cardiovascular e fatores de risco cardiovascular em candidatos a transplante renal</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiovascular disease and risk factors in candidates for renal transplantation</s1>
</fA08>
<fA11 dir="011000">
<s1>Luís Henrique Wolff Gowdak</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Flávio Jota de Paula</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Dante Marcelo Artigas Giorgi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcelo Luís Campos Vieira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eduardo Moacyr Krieger</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Jayme Galvão De Lima</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Incor  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>156-160</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400212</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a prevalência de doença cardiovascular (DCV) e de fatores de risco tradicionais em portadores de insuficiência renal crônica em avaliação para inclusão em lista para transplante renal. MÉTODOS: Foram submetidos à avaliação clínica e exames complementares 195 pacientes com insuficiência renal crônica dialítica e comparados a grupo de 334 hipertensos pareados por idade. As equações de Framingham foram usadas para o cálculo do risco absoluto (RA); o risco relativo (RR) foi calculado tendo como referência o risco absoluto da coorte de baixo risco de Framingham. RESULTADOS: Do total, 37% apresentaram algum tipo de doença cardiovascular na avaliação inicial, sendo que arteriopatia obstrutiva (23%) foi a mais prevalente. Excluídos os pacientes com doença cardiovascular, em relação aos fatores de risco tradicionais, houve diferença significativa quanto à pressão arterial sistólica e colesterol total (maiores no grupo de hipertensos) e às prevalências de homens, diabetes e tabagismo, maiores no grupo de insuficiência renal crônica, que apresentou maior grau de hipertrofia ventricular esquerda, menor pressão arterial diastólica e menor prevalência de história familiar de doença cardiovascular e obesidade. O risco relativo para doença cardiovascular dos pacientes com insuficiência renal crônica foi mais elevado em relação à população controle de Framingham porém não diferiu da observada no grupo de hipertensos. CONCLUSÃO: Em candidatos a transplante renal é significativa a prevalência de doença cardiovascular e de fatores de risco tradicionais; as equações de Framingham não quantificam adequadamente o risco cardiovascular real e outros fatores de risco específicos desta população devem contribuir para o maior risco cardiovascular.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the prevalence of cardiovascular disease (CVD) and traditional risk factors in patients with chronic renal failure undergoing evaluation for inclusion on the renal transplantation list. METHODS: One hundred ninety-five patients with dialytic chronic renal failure underwent clinical evaluation and complementary tests and were compared with a group of 334 hypertensive patients paired for age. The Framingham equations were used for calculating the absolute risk (AR). The relative risk (RR) was calculated based on the absolute risk of the low-risk Framingham cohort. RESULTS: Thirty-seven percent of the patients had some sort of cardiovascular disease on the initial evaluation, peripheral vascular disease (23%) being the most prevalent. Patients with cardiovascular disease were excluded. Regarding traditional risk factors, a significant difference was observed in systolic blood pressure and total cholesterol (greater in the hypertensive group), and in the prevalence of men, diabetes, and smoking, which were greater in the chronic renal failure group. The latter had a greater degree of left ventricular hypertrophy, lower diastolic blood pressure, and a lower prevalence of familial history of cardiovascular disease and obesity. The relative risk for cardiovascular disease in patients with chronic renal failure was greater compared with that in the Framingham control population, but it did not differ from that observed in the group of hypertensive individuals. CONCLUSION: The prevalence of cardiovascular disease and traditional risk factors is high among candidates for renal transplantation; the Framingham equations do not adequately quantify the real cardiovascular risk, and other risk factors specific for that population should contribute for their greater cardiovascular risk.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença cardiovascular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>transplante renal</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>renal transplantation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Principais características clínicas de pacientes que sobrevivem 24 meses ou mais após uma hospitalização devido a descompensação cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Major clinical characteristics of patients surviving 24 months or more after hospitalization due to decompensated heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Mucio Tavares de Oliveira Jr</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Manoel Fernandes Canesin</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Robson Tadeu Munhoz</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Henrique Del Carlo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Airton Scipioni</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto do Coração  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>USP FM HC</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>161-166</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400213</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar as principais características clínicas dos pacientes com insuficiência cardíaca sobreviventes há mais de 24 meses após hospitalização para compensação. MÉTODOS: Estudados 126 pacientes com insuficiência cardíaca, em classe funcional III ou IV, com idade média de 51,7 anos, a maioria homens (73%), com fração de ejeção (FE) média de 0,36 e diâmetro diastólico (DD) do VE de 7,13 cm. Avaliaram-se as principais características clínicas e laboratoriais e no seguimento identificaram-se 25 (19.8%) pacientes que sobreviveram mais de 24 meses após a alta hospitalar. Compararam-se os dados dos sobreviventes (G1) aos dos que faleceram (G2) antes de 24 meses. RESULTADOS: No G1 encontraram-se níveis mais elevados do sódio sérico (138,3±3,4 vs 134,5±5,8 mEq/l; p=0,001), da pressão arterial (120,0 vs 96,7 mmHg; p=0,003) e da FE do VE (0,40±0,08 vs 0,34±0,09; p=0,004) e valores menores da uréia (59,8 vs 76,3 mg/dl; p=0,007), do tempo de protrombina (12,9 vs 14,8s; p=0,001), do DDVE (6,78±0,55 vs 7,22±0,91; p=0,003) e do diâmetro do AE (4,77 vs 4,99cm; p=0,0003). Houve mais sobreviventes entre os portadores de cardiomiopatia idiopática e hipertensiva do que entre os chagásicos e doença coronariana. Na análise multivariada permaneceram como variáveis preditoras independentes da mortalidade o DDVE &gt; 7,8 cm (HR 1,95), o Na &lt; 132 mEq/l (HR 2,30) e o tempo de protrombina &gt; 14 seg (HR 1,69). CONCLUSÃO: O estudo permite predizer quais os pacientes com insuficiência cardíaca que poderão apresentar uma boa sobrevida após a alta e os com maior possibilidade de longa sobrevivência após a alta.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study the major clinical characteristics of patients with heart failure who survived more than 24 months after hospitalization for compensation. METHODS: The study comprised 126 patients with heart failure in functional class III or IV, with a mean age of 51.7 years. Most patients were men (73%), had a mean ejection fraction (EF) of 0.36 and left ventricular diastolic diameter (DD) of 7.13 cm. The major clinical and laboratory characteristics were assessed, and, on follow-up, 25 (19.8%) patients, who survived more than 24 months after hospital discharge, were identified. Data of survivors (G1) were compared with those of patients who died (G2) before 24 months. RESULTS: In G1, the following levels were greater: serum sodium (138.3±3.4 vs 134.5±5.8 mEq/L; P=0.001); blood pressure levels (120.0 vs 96.7 mm Hg; P=0.003); and LVEF levels (0.40±0.08 vs 0.34±0.09; P=0.004); and the following levels were lower: urea (59.8 vs 76.3 mg/dL; P=0.007); prothrombin time (12.9 vs 14.8 seconds; P=0.001); LVDD (6.78±0.55 vs 7.22±0.91; P=0.003); and LA diameter (4.77 vs 4.99cm; P=0.0003). More survivors were found among patients with idiopathic cardiomyopathy and arterial hypertension than among patients with Chagas' disease and coronary artery disease. In multivariate analysis, the following variables remained as independent predictors of mortality: LVDD &gt; 7.8 cm (HR 1.95); Na &lt; 132 mEq/L (HR 2.30); and prothrombin time &gt; 14 seconds (HR 1.69). CONCLUSION: The study allowed predicting which patients with heart failure will have a good survival after hospital discharge and those with a greater chance of a long survival after discharge.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca avançada</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>disfunção sistólica ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sobrevida</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hiponatremia e choque</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>advanced heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular systolic dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>survival</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hyponatremia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>shock</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Insuficiência renal aguda após uso de imunoglobulina intravenosa para tratamento de miocardite</s1>
</fA08>
<fA08 dir="en">
<s1>Acute renal failure after intravenous use of immunoglobulin to treat myocarditis</s1>
</fA08>
<fA11 dir="011000">
<s1>Vitor Pordeus</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Andréa Tostes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cláudio Tinoco Mesquita</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Charles Mady</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>167-169</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400214</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Mulher de 60 anos com quadro de insuficiência cardíaca classe funcional III/IV (NYHA) de etiologia imuno-mediada (miocardite autoimune). Após tentativas terapêuticas sem sucesso, foi utilizada imunoglobulina intravenosa, deteriorando a função renal, complicação rara desta terapia. Após hemodiálise a paciente recuperou a função renal e ocorreu melhora da insuficiência cardíaca crônica para classe funcional I.</s0>
</fC01>
<fC01 dir="en">
<s0>The patient is a 60-year-old female with functional class III/IV (NYHA) heart failure of an immunomediated etiology (autoimmune myocarditis). After unsuccessful therapeutic attempts, intravenous immunoglobulin was used, leading to deterioration in renal function, a rare complication of that therapy. After hemodialysis, the patient's renal function was restored, and the chronic heart failure improved to functional class I.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Síndrome de Wolff-Parkinson-White associada a comunicação interatrial tipo seio venoso</s1>
</fA08>
<fA08 dir="en">
<s1>Wolff-Parkinson-White syndrome and the sinus venosus atrial septal defect association</s1>
</fA08>
<fA11 dir="011000">
<s1>Patrícia Lopes Moraes</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luíz Márcio Gerken</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Bayard Gontijo Filho</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Walter Villela de Andrade Vicente</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Roberto Barbosa Evora</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>CECORP  </s1>
<s2>Ribeirão Preto </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>BIOCOR  </s1>
<s2>Belo Horizonte </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>USP Faculdade de Medicina de Ribeirão Preto </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>170-172</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>5</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400215</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>A associação de comunicação interatrial (CIA) tipo seio venoso com síndrome de Wolff Parkinson White (WPW) é muito rara e ainda não descrita na literatura médica especializada. Descreve-se o caso de uma jovem portadora dessa associação de patologias tratada com ablação da via acessória por radiofreqüência, seguida de correção cirúrgica do defeito do septo interatrial.</s0>
</fC01>
<fC01 dir="en">
<s0>The Wolff-Parkinson-White syndrome (WPW) and sinus venosus atrial septal defect (ASD) association is very rare and not yet reported in the literature. It is the main basis for this case report.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Divertículo ventricular congênito associado à taquicardia ventricular</s1>
</fA08>
<fA08 dir="en">
<s1>Congenital ventricular diverticulum associated with ventricular tachycardia</s1>
</fA08>
<fA11 dir="011000">
<s1>Ranieli Pitol</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cristiano de Oliveira Cardoso</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Roberto Cardoso</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marne de Freitas Gomes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Schvartzman</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Cardiologia do Rio Grande do Sul  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Fundação Universitária de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>173-175</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400216</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Divertículos ventriculares congênitos são raros. Clinicamente, podem ser assintomáticos ou causa de embolização sistêmica, insuficiência cardíaca, insuficiência valvar, ruptura ventricular, arritmia ventricular ou morte súbita. Apresentamos caso de uma mulher de 56 anos com taquicardia ventricular sustentada, na qual, durante a investigação, foi diagnosticada a presença de um divertículo na posição ínfero-basal do ventrículo esquerdo. Comentam-se as características clínicas e o tratamento desta doença infreqüente.</s0>
</fC01>
<fC01 dir="en">
<s0>Congenital ventricular diverticula are rare. Clinically, they may be asymptomatic or cause systemic embolization, heart failure, valvular regurgitation, ventricular rupture, ventricular arrhythmia, or sudden death. We report the case of a 56-year-old woman with sustained ventricular tachycardia, who, during investigation, was diagnosed with a diverticulum in the inferobasal portion of the left ventricle. The clinical characteristics and treatment of this rare disease are discussed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Sildenafil melhora a função ventricular direita no receptor de transplante cardíaco</s1>
</fA08>
<fA08 dir="en">
<s1>Sildenafil improves right ventricular function in a cardiac transplant recipient</s1>
</fA08>
<fA11 dir="011000">
<s1>Rodrigo Pereira Paez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Wesley Ferreira Araujo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Nelson Americo Hossne Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ana Lucia Neves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Guilherme Flora Vargas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luciano de Figueiredo Aguiar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>João Nelson Rodrigues Branco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Roberto Catani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Enio Buffolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>176-178</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400217</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Relatamos caso de um paciente submetido a transplante cardíaco ortotópico, onde se utilizou um doador marginal pela piora clínica do receptor, que apresentava choque cardiogênico por disfunção de ventrículo direito secundária a hipertensão pulmonar associado à vasoplegia. Obtivemos recuperação hemodinâmica do paciente, com redução da resistência vascular pulmonar, retirada de drogas vasoativas e recuperação da função do ventrículo direito após a introdução de sildenafil.</s0>
</fC01>
<fC01 dir="en">
<s0>We report the case of a male patient who underwent orthotopic cardiac transplantation. A marginal donor was used, because the recipient's clinical condition was critical. He experienced cardiogenic shock due to right ventricular dysfunction secondary to pulmonary hypertension associated with vasoplegia. After the introduction of sildenafil, the patient recovered hemodynamically, his pulmonary vascular resistance decreased, the vasoactive drugs were withdrawn, and his right ventricular function improved.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Cintilografia com MIBI-dipiridamol negativa em doença coronariana grave no pré-operatório de correção de aneurisma de aorta abdominal</s1>
</fA08>
<fA08 dir="en">
<s1>Negative sestamibi-dipyridamole perfusion imaging in severe coronary artery disease in the preoperative period of correction of abdominal aortic aneurysm</s1>
</fA08>
<fA11 dir="011000">
<s1>Helio Halpern</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Erika Miyoshi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Eduardo P. Pesaro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos V. Serrano Jr</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Nelson Wolosker</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Israelita Albert Einstein  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>179-181</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400218</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Descreve-se o caso de um paciente de 73 anos, candidato à correção de aneurisma de aorta abdominal, sem anormalidades na primeira avaliação cardiológica. A cirurgia foi postergada para tratamento de epididimite. Duas semanas após, o paciente retornou ao hospital com dor torácica e a angiografia mostrou obstruções de duas coronárias, tratadas com sucesso por angioplastia transluminal percutânea com implante de stent. Após 45 dias, o paciente foi submetido à cirurgia para correção do aneurisma de aorta abdominal sob anestesia peridural e geral, evoluindo sem complicações.</s0>
</fC01>
<fC01 dir="en">
<s0>We report the case of a 73-year-old male patient who was a candidate for correction of an abdominal aortic aneurysm without abnormalities in his first cardiological evaluation. The surgery was postponed because of the need for treatment of epididymitis. Two weeks later, the patient returned to the hospital with thoracic pain, when the angiography showed obstructions in 2 coronary arteries, which were successfully treated with percutaneous transluminal angioplasty and stent implantation. After 45 days, the patient underwent surgery for correction of the abdominal aortic aneurysm under peridural and general anesthesia. The patient evolved without complications.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Troponina T positiva em paciente chagásico com taquicardia ventricular sustentada e cinecoronariografia sem lesões obstrutivas</s1>
</fA08>
<fA08 dir="en">
<s1>Positive troponin T in a chagasic patient with sustained ventricular tachycardia and no obstructive lesions on cine coronary angiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Maurício de Nassau Machado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fábio Augusto Suzuki</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Osana Costa C. Mouco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Mauro Esteves Hernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria Angélica B.T. Lemos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Lilia Nigro Maia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de São José do Rio Preto  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>182-184</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400219</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>A avaliação e estratificação de pacientes com dor torácica na sala de emergência pode nos direcionar a terapêutica adequada a cada paciente baseada na probabilidade da presença de doença coronariana aguda e no risco de eventos cardíacos maiores desta coronariopatia. Esta avaliação é baseada no tripé: quadro clínico, achados eletrocardiográficos e nos marcadores de lesão miocárdica. Relatamos o caso de um paciente chagásico de 58 anos de idade admitido na unidade de emergência por dor torácica e palpitações, com eletrocardiograma mostrando uma taquicardia ventricular sustentada e com dosagem de troponina positiva (0,99 ng/ml), submetido a cinecoronariografia, que não evidenciou doença coronariana obstrutiva.</s0>
</fC01>
<fC01 dir="en">
<s0>The assessment and stratification of patients with chest pain in the emergency unit may indicate the appropriate therapy for each patient based on the probability of the presence of acute coronary artery disease and on the risk of its major cardiac events. That assessment is based on the triplet: clinical setting, electrocardiographic findings, and markers of myocardial lesion. We report the case of a 58-year-old male chagasic patient admitted to the emergency unit due to chest pain and palpitations, with an electrocardiogram showing sustained ventricular tachycardia and positive troponin measurement (0.99 ng/mL). The patient underwent cine coronary angiography, which evidenced no obstructive coronary artery disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Ablação de taquicardia ventricular idiopática com morfologia de bloqueio de ramo esquerdo localizada no tronco da artéria pulmonar</s1>
</fA08>
<fA08 dir="en">
<s1>Ablation of idiopathic ventricular tachycardia with left bundle-branch block morphology located in the pulmonary trunk</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Roberto Leite</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José R. Barreto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Roberval Melo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edmur C. Araujo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luciano Nogueira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Lucas A. Fonseca</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Edson D'Ávila</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>César Gonzáles</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Fernando Cruz</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Angelo A. V. de Paola</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Santa Luzia  </s1>
<s2>Brasília </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>UFSP Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>185-187</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400220</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Paciente de 26 anos, sem cardiopatia estrutural, apresentando palpitações e pré-síncopes devido à taquicardia ventricular não sustentada, foi submetida a estudo eletrofisiológico para tentativa de ablação do foco arritmogênico, usando-se como local, os critérios de mapeamento. Sem obter êxito com o mapeamento da via de saída do ventrículo direito, posicionou-se o cateter dentro da artéria pulmonar com mapeamento de foco satisfatório, eliminando a taquicardia tão logo iniciada a radiofreqüência. Durante seguimento de 14 meses, a paciente permanece assintomática, sem arritmia ao Holter e não nessecitando de drogas antiarrítmicas.</s0>
</fC01>
<fC01 dir="en">
<s0>We report the case of a 26-year-old female patient with palpitations and presyncopes due to nonsustained ventricular tachycardia, who had no structural heart disease. The patient underwent electrophysiological study in an attempt to ablate the arrhythmogenic focus, whose location was determined by using mapping criteria. Because mapping of the right ventricular outflow tract was not successful, the catheter was placed inside the pulmonary artery with satisfactory mapping of the arrhythmogenic focus, and tachycardia was eliminated as soon as radiofrequency was initiated. The patient has remained asymptomatic for 14 months, with no treatment with antiarrhythmic drugs, and no arrhythmias on serial 24-hour Holter.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Reflexões sobre o relacionamento entre o médico acadêmico, a sociedade em geral e empresas produtoras de medicamentos e equipamentos em particular</s1>
</fA08>
<fA11 dir="011000">
<s1>José Antonio Marin-Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Benedito Carlos Maciel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Medicina de Ribeirão Preto Departamento de Clínica Médica</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>188-191</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400221</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Eletrocardiogramas distintos em gêmeos univitelinos com prolapso valvar mitral</s1>
</fA08>
<fA11 dir="011000">
<s1>Lurildo R. Saraiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ana Elizabete M. Batista</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Thiago B. Saraiva Leão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFPE Hospital das Clínicas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>192-192</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400222</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Ecocardiografia tridimensional em tempo real da valva mitral em paciente com estenose valvar submetido a valvoplastia com cateter balão</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo L. C. Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José L. Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Wilson Mathias Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Samira S. Morhy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luis F. Cardoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luis J. Kajita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José A. F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>193-194</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400223</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 01/2005 - Óbito em mulher de 59 anos com história de angina de peito e insuficiência cardíaca, após episódios repetitivos de dor precordial</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcos Bianchini Cardoso</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Chain Berber</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando Bianchini Cardoso</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Osvaldo Teixeira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria Aparecida Barone Teixeira</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>195-197</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400224</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 12/2004: Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>198-198</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400225</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>O prognóstico da insuficiência cardíaca no Brasil: a busca de dados confiáveis e representativos</s1>
</fA08>
<fA08 dir="en">
<s1>The prognosis of heart failure in Brazil: the search for reliable and representative data</s1>
</fA08>
<fA11 dir="011000">
<s1>Luis E. Rohde</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>281-282</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Miocardiopatia adrenérgica: o estresse pode causar uma cardiopatia aguda?</s1>
</fA08>
<fA08 dir="en">
<s1>Adrenergic cardiomyopathy: can stress cause acute heart disease?</s1>
</fA08>
<fA11 dir="011000">
<s1>Cláudio Tinoco Mesquita</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Claudio Lucas da Nóbrega</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal Fluminense  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>283-284</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação da contratilidade segmentar na doença de Chagas utilizando a integral do gradiente intramiocárdico de velocidade (strain miocárdico) obtida pela ecocardiografia com Doppler tecidual</s1>
</fA08>
<fA08 dir="en">
<s1>Evaluation of segmentary contractility in Chagas' disease by using the integral of the myocardial velocity gradient (myocardial strain) obtained through tissue Doppler echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Eduardo Suaide Silva</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Darcy Cortez Ferreira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luciana Braz Peixoto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Claudia Gianini Monaco</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Manuel Adán Gil</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Juarez Ortiz</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Bárbara Maria Ianni</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>José Lázaro Andrade</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Wilson Mathias Júnior</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Antônio Carlos Pereira Barretto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>OMNI-CCNI Medicina Diagnóstica  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>285-291</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Quantificar o percentual de contratilidade dos diversos segmentos miocárdicos, em portadores de doença de Chagas, através da medida do strain miocárdico e verificar diferenças na função contrátil radial e longitudinal ventricular entre as formas indeterminada e dilatada da miocardiopatia chagásica crônica quando comparadas a um grupo de indivíduos normais. MÉTODOS: Foram estudados 39 indivíduos, 20 (51,3%) do sexo masculino divididos em quatro grupos: Nl: 17 (43,6%) indivíduos normais; Ind: 7 (17,9%) portadores de doença de Chagas forma indeterminada; C1, 7 (17,9%) portadores de doença de Chagas forma crônica com fração de ejeção &lt; 50% e C2: 8 (20,5%) portadores de doença de Chagas forma crônica com fração de ejeção &gt; 50%. Após realização de ecocardiograma basal foram registradas as imagem em Doppler tecidual para a medida do strain miocárdico nos diversos segmentos aos cortes paraesternais, longitudinal e transversal, e apicais, de duas e quatro câmaras. RESULTADOS E CONCLUSÃO: O percentual de contração dos diversos segmentos miocárdicos, tanto em seu componente radial quanto longitudinal é maior nos indivíduos normais do que em portadores da forma crônica da doença de Chagas e naqueles com a forma indeterminada da doença quando comparado com chagásicos crônicos com FE &lt; 50%. A contratilidade radial do ventrículo esquerdo é maior que a longitudinal nos três grupos (Nl, Ind e Crônico). Os dados apresentados nos permitem propor um caráter progressivo do acometimento miocárdico em portadores da doença de Chagas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To quantify the percentage of contractility of different myocardial segments in patients with Chagas' disease by measuring myocardial strain and to assess the differences in the radial and longitudinal ventricular contractile function in the undetermined and dilated forms of chronic chagasic cardiomyopathy as compared with those in a group of healthy individuals. METHODS: The study comprised 39 individuals [20 (51.3%) of the male sex] divided into the following 4 groups: 1) Nl: 17 (43.6%) healthy individuals; 2) Und: 7 (17.9%) patients with the undetermined form of Chagas' disease; 3) C1: 7 (17.9%) patients with the chronic form of Chagas' disease with ejection fraction &lt; 50%; and 4) C2: 8 (20.5%) patients with the chronic form of Chagas' disease with ejection fraction &gt; 50%. After performing baseline echocardiography, Doppler tissue images were recorded to measure myocardial strain in different segments on longitudinal and transversal parasternal, and apical 2- and 4-chamber views. RESULTS AND CONCLUSION: The percentage of contractility in the different myocardial segments, both the radial and longitudinal components, is greater in healthy individuals than in patients with the chronic form of Chagas' disease, and in those with the undetermined form of the disease as compared with that of chronic chagasic patients with EF &lt; 50%. Left ventricular radial contractility is greater than left ventricular longitudinal contractility in all groups (Nl, Und, and Chronic). The data presented allow us to propose a progressive character of myocardial impairment in patients with Chagas' disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença de Chagas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doppler tecidual</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>strain miocárdico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tissue Doppler</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial strain</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo prospectivo da morbi-mortalidade precoce e tardia da cirurgia do aneurisma da aorta abdominal</s1>
</fA08>
<fA08 dir="en">
<s1>Prospective study of early and late morbidity and mortality in the abdominal aortic aneurysm surgical repair</s1>
</fA08>
<fA11 dir="011000">
<s1>Francine C. de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Veridiana Porto Maggioli da Rocha Brito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Elisângela Campaner Tribulatto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Bonno van Bellen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Beneficência Portuguesa de São Paulo Serviço de Cirurgia Vascular e Angiologia </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>292-296</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar, prospectivamente, a morbidade e mortalidade precoce e tardia de pacientes submetidos a correção cirúrgica eletiva de aneurisma de aorta abdominal infra-renal e determinar os preditores independentes de eventos cardiológicos. MÉTODOS: Estudados 130 pacientes durante seis anos consecutivos, submetidos a rotina de avaliação pré-operatória padronizada e cirúrgica, sempre pela mesma equipe clínica, cirúrgica e anestesiológica. RESULTADOS: A mortalidade hospitalar foi de 3,1% (4 pacientes), sendo a principal causa de óbito isquemia mesentérica, ocorrida em três pacientes. Houve 48 (37%) complicações não-operatórias, 8,5% consistiram em complicações cardíacas e 28,5% em complicações não cardíacas. As complicações pulmonares foram as mais comuns, ocorridas em 14 (10,8%) pacientes. A sobrevida no 1º, 3º e 6º ano pós-operatório foi, respectivamente, de 95%, 87% e 76%. As variáveis que se correlacionaram significativamente com a morbimortalidade foram preditor clínico, idade média de 70,5 anos, presença de insuficiência cardíaca e insuficiência renal crônica. Não foi identificado nenhum preditor de morbimortalidade tardia. CONCLUSÃO: Apesar de ser uma cirurgia considerada de alta complexidade, a mortalidade é baixa, as complicações cardíacas são de pequena monta e os pacientes apresentam boa evolução a longo prazo.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To prospectively assess early and late morbidity and mortality of patients undergoing elective surgical repair of abdominal infrarenal aortic aneurysms and to determine the independent predictors of cardiac events. METHODS: For 6 consecutive years, this study analyzed 130 patients, who underwent routine standardized preoperative assessment always with the same clinical, surgical, and anesthesia teams. RESULTS: In-hospital mortality was 3.1% (4 patients), and the major cause of death was mesenteric ischemia, which occurred in 3 patients. Forty-eight (37%) nonsurgical complications occurred as follows: 8.5% were cardiac complications and 28.5% were noncardiac complications. The most common complications were the pulmonary ones, which occurred in 14 (10.8%) patients. Survivals in the first, third, and sixth postoperative years were 95%, 87%, and 76%, respectively. The variables that significantly correlated with morbidity and mortality were clinical predictors, mean age of 70.5 years, and presence of heart failure and chronic renal failure. No predictor of late morbidity and mortality was identified. CONCLUSION: Although this is considered a highly complex surgery, mortality is low, the cardiac complications are not very significant, and the patients have a good long-term evolution.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aorta abdominal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aneurisma</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>abdominal aorta</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aneurysm</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Correção dos aneurismas da aorta torácica e toracoabdominal: técnica de canulação central</s1>
</fA08>
<fA08 dir="en">
<s1>Correction of thoracic and thoracoabdominal aortic aneurysms: central cannulation technique</s1>
</fA08>
<fA11 dir="011000">
<s1>Salomón Soriano Ordinola Rojas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Viviane Cordeiro Veiga</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Januário Manoel de Souza</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcos Fassheber Berlinck</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Dante Fanganiello Senra</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Reinaldo Wilson Vieira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Luiz Alberto Magna</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Domingo Marcolino Braile</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>297-303</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Demonstrar a viabilidade do uso da circulação extracorpórea estabelecida entre o átrio esquerdo e a aorta ascendente para indução da hipotermia profunda na correção de aneurismas torácicos e toracoabdominais. MÉTODOS: De janeiro 1994 a julho 2001, foram operados 38 pacientes, com média de idade de 54,6&amp;plusmn;12,7 anos. Foram submetidos a correção de aneurisma toracoabdominal 12 (31,6%) pacientes e 26 a aneurismas torácicos descendentes. Os pacientes foram induzidos a hipotermia profunda por meio de circulação extracorpórea, com temperatura faríngea variando entre 15 e 25ºC (média de 20,6&amp;plusmn;3,2ºC). RESULTADOS: Dentre as complicações neurológicas, a paraplegia ocorreu em dois (5,3%) casos. Um paciente evoluiu com paraparesia de membros inferiores e um com quadro de convulsão. As complicações respiratórias estiveram presentes em 12 (31,6%) pacientes, com mortalidade de 16,7% (dois pacientes). Dois pacientes foram operados em caráter de urgência e vieram a falecer. A mortalidade total foi de 18,4% (7 pacientes). CONCLUSÃO: A correção dos aneurismas da aorta torácica descendente e toracoabdominal, com emprego da hipotermia profunda pela circulação extracorpórea estabelecida entre o átrio esquerdo e a aorta ascendente, demonstrou ser um método viável na correção desses aneurismas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To demonstrate the viability of the use of extracorporeal circulation established between the left atrium and ascending aorta to induce deep hypothermia for correcting thoracic and thoracoabdominal aortic aneurysms. METHODS: From January 1994 to July 2001, 38 patients (mean age, 54.6 &amp;plusmn; 12.7 years) were operated on as follows: 12 (31.6%) patients underwent repair of thoracoabdominal aortic aneurysm, and 26 patients underwent repair of descending thoracic aneurysms. Deep hypothermia was induced by use of extracorporeal circulation, with pharyngeal temperature ranging from 15 to 25ºC (20.6 &amp;plusmn; 3.2ºC). RESULTS: Of the neurological complications, paraplegia occurred in 2 (5.3%) patients. One patient developed paraparesis, and another evolved with convulsion. Twelve (31.6%) patients had respiratory complications, and 2 (16.7%) patients died. Two other patients were operated on on an emergency basis and ended up dying. Total mortality was 18.4% (7 patients). CONCLUSION: Repair of descending thoracic and thoracoabdominal aortic aneurysms with deep hypothermia by use of extracorporeal circulation established between the left atrium and ascending aorta proved to be a viable method for correcting those aneurysms.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aneurismas torácicos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aneurismas toracoabdominais</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipotermia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thoracic aortic aneurysms</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thoracoabdominal aortic aneurysms</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypothermia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>O bloqueio do sistema renina-angiotensina atenua a remodelação cardíaca de ratos submetidos a estenose aórtica</s1>
</fA08>
<fA08 dir="en">
<s1>Blockade of renin-angiotensin system attenuates cardiac remodeling in rats undergoing aortic stenosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Giancarlo Gonçalves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leonardo A. M. Zornoff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Henrique B. Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marina P. Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fernando R. S. Cordaro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Katashi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Carlos R. Padovani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Flávio F. Aragon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Antonio C. Cicogna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual Paulista Faculdade de Medicina de Botucatu </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>304-308</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o papel do bloqueador dos receptores AT1 e do inibidor da enzima conversora da angiotensina na remodelação cardíaca induzida por estenose aórtica em ratos. MÉTODOS: Ratos Wistar foram divididos em 4 grupos: controle (C, n=13), estenose aórtica (EAo, n=11), EAo com lisinopril, 20 mg/kg/dia (LIS, n=11) e EAo com losartan, 40 mg/kg/dia (LOS, n=9). Os tratamentos foram iniciados 3 dias antes da cirurgia. Após 6 semanas, os animais foram submetidos ao estudo ecocardiográfico, quantificação da concentração de hidroxiprolina e da área seccional (CSA) miocitária do ventrículo esquerdo (VE). RESULTADOS: A EAo induziu aumento da espessura da parede do VE. Os animais LIS e LOS não apresentaram diferença em relação aos animais controles. Os ratos EAo e LIS apresentaram maiores diâmetros do átrio esquerdo que os ratos controles, enquanto nos animais LOS não houve diferença. Os animais com EAo apresentaram maiores valores da porcentagem de encurtamento que os controle. Esse fato não foi modificado com LIS ou LOS. A CSA dos animais do grupo EAo foi maior que a dos controle. Entretanto, o tratamento com LOS e com LIS atenuou o aumento da área induzida pela EAo. A EAo resultou em aumento na concentração de HOP, enquanto o grupo LOS não apresentou diferença em relação ao grupo controle. CONCLUSÃO: O bloqueio do sistema renina-angiotensina, com bloqueador AT1 e com IECA, pode atenuar o desenvolvimento de hipertrofia cardíaca, porém só o bloqueio dos receptores AT1 atenua a fibrose intersticial do VE.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the role of the AT1 receptor blocker and the angiotensin-converting enzyme inhibitor in cardiac remodeling induced by aortic stenosis in rats. METHODS: Wistar rats were divided into the following 4 groups: 1) C - control (n=13); 2) AoS - aortic stenosis (n=11); 3) LIS - AoS treated with lisinopril, 20 mg/kg/day (n=11); and 4) LOS - AoS treated with losartan, 40 mg/kg/day (n=9). The treatments were initiated 3 days before surgery. After 6 weeks, the animals underwent echocardiographic study, and quantification of the hydroxyproline (HOP) concentration and the left ventricular (LV) myocyte cross-sectional area (CSA). RESULTS: Aortic stenosis induced an increase in left ventricular wall thickness. The LIS and LOS groups showed no difference as compared with the control group. The AoS and LIS rats had greater left atrial diameters than the control rats did, while no difference was observed in the LOS animals. The AoS animals had greater values of shortening percentage than control animals did. This fact was modified with neither LIS nor LOS. The cross-sectional area of the animals in the AoS group was greater than that in the control group. However, treatment with LOS and LIS attenuated the AoS-induced increase in area. Aortic stenosis caused an increase in HOP concentration, while the LOS group showed no difference as compared with the control group. CONCLUSION: Blockade of the renin-angiotensin system with AT1 blocker and ACEI may attenuate the development of heart hypertrophy, but only the blockade of AT1 receptors attenuates left ventricular interstitial fibrosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fibrose</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fibrosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Sobrevida e fatores prognósticos na insuficiência cardíaca sistólica com início recente dos sintomas</s1>
</fA08>
<fA08 dir="en">
<s1>Survival and prognostic factors in systolic heart failure with recent symptom onset</s1>
</fA08>
<fA11 dir="011000">
<s1>Salvador Rassi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antônio Carlos Pereira Barretto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Celmo Celeno Porto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Crésio Romeu Pereira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Bárbara Wosjunk Calaça</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Daniela C. Rassi</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>309-313</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar a sobrevida e fatores prognósticos associados à mortalidade em pacientes com insuficiência cardíaca sistólica acompanhados desde o início de seus sintomas. MÉTODOS: Coorte de 204 pacientes consecutivos com insuficiência cardíaca sistólica, identificada com início dos sintomas até seis semanas do primeiro atendimento e seguida por 46 meses. As variáveis prognósticas analisadas foram coletadas à inclusão e correlacionadas com a mortalidade cardiovascular. A Fração de Ejeção (FE) &lt; 40% ao ecocardiograma caracterizava a disfunção sistólica ventricular. RESULTADOS: A taxa geral de sobrevida pela técnica de Kaplan-Meier foi de 98,0%, 90,6% e de 70,2% aos três, 12 e 48 meses de seguimento, respectivamente. A análise multivariada identificou o efeito independente de seis variáveis sobre o risco de morte cardiovascular. As classes funcionais III e IV aumentou em 2,7 vezes o risco em relação à classe II; incrementos de 10 mmHg na pressão arterial sistólica reduziram em 25% o risco de morte; cada aumento de 10 bpm na freqüência cardíaca elevava o risco de morte em 1,6 vezes e cada incremento de 0,25 mg/dL na creatinina sérica acarretava um aumento de risco de 60%. A presença de 3ª bulha aumentou em 3,0 vezes o risco de morte e a etiologia chagásica também se associou à mortalidade cardiovascular (P&lt;0,0001). CONCLUSÃO: Estas evidências mostram que a mortalidade na fase inicial não é elevada e que a etiologia, classe funcional avançada, hipotensão arterial, taquicardia, presença de 3ª bulha e creatinina sérica elevada, conferem um pior prognóstico.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study survival and prognostic factors associated with mortality in patients with systolic heart failure followed up since symptom onset. METHODS: We carried out a study with a cohort of 204 consecutive patients with systolic heart failure, whose symptom onset occurred within the 6 weeks preceding the first medical visit. They were followed up for 46 months. The prognostic variables analyzed were collected when the patients were included in the study and were correlated with cardiovascular mortality. An EF &lt; 40% on echocardiography characterized systolic ventricular dysfunction. RESULTS: The overall survival rates according to the Kaplan-Meier technique were 98.0%, 90.6%, and 70.2% at 3, 12, and 48 months of follow-up, respectively. The multivariate analysis identified the independent effect of 6 variables on the risk of cardiovascular death. Functional classes III and IV increased risk 2.7 times as compared with class II; 10-mmHg increments in systolic blood pressure reduced the risk of death by 25%; each 10-bpm increase in heart rate increased the risk of death 1.6 times; and each 0.25-mg/dL increment in serum creatinine caused a 60% increase in risk. The presence of the third cardiac sound caused a 3-fold increase in the risk of death, and chagasic etiology was also associated with cardiovascular mortality (P&lt;0.0001). CONCLUSION: Evidence shows that mortality in the initial phase is not elevated, and that etiology, advanced functional class, arterial hypotension, tachycardia, presence of the third cardiac sound, and elevated serum creatinine lead to a worse prognosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>epidemiologia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prognóstico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>análise de sobrevida</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>analysis of survival</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeitos da atorvastatina, fluvastatina, pravastatina e simvastatina sobre a função endotelial, a peroxidação lipídica e a aterosclerose aórtica em coelhos hipercolesterolêmicos</s1>
</fA08>
<fA08 dir="en">
<s1>Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Afonso Ribeiro Jorge</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eros Antonio de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Michiko R. Ozaki</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Mariana Jorge</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Adriano Carneiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de Campinas Faculdade de Ciências Médicas </s1>
<s2>Campinas </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>314-319</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>56</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar os efeitos da atorvastatina, fluvastatina, pravastatina e simvastatina sobre a função endotelial, a aterosclerose aórtica e o teor de malonodialdeído (MDA) nas LDL nativas, oxidadas e na parede arterial de coelhos hipercolesterolêmicos, depois que as doses destas estatinas foram ajustadas para reduzir o colesterol total plasmático a valores similares. MÉTODOS: Coelhos machos, foram separados em grupos de 10 animais (n=10), chamados hipercolesterolêmico (controle), atorvastatina, fluvastatina, pravastatina e normal. A exceção do grupo normal, os animais foram alimentados com ração padrão acrescida de colesterol a 0,5% e óleo de coco a 2% durante 45 dias. As drogas foram administradas a partir do 15º dia do início do experimento e no 30º dia, as doses foram ajustadas, através do controle do colesterol plasmático, para obter valores semelhantes em cada grupo. Ao final do experimento foi dosado o colesterol plasmático e as lipoproteinas e retirado um segmento de aorta torácica para estudo da função endotelial, da peroxidação lipídica e exame histológico para medida da aterosclerose aórtica. RESULTADOS: As estatinas reduziram significantemente o colesterol total plasmático, as LDL-colesterol e a aterosclerose aórtica. O teor de MDA também foi significantemente reduzido nas LDL nativas e oxidadas, assim como na parede arterial. O relaxamento-dependente do endotélio foi significantemente maior no grupo tratado em comparação ao hipercolesterolêmico. CONCLUSÃO: As estatinas, em doses ajustadas, tiveram efeito significante e similar em reduzir a peroxidação lipídica nas LDL e na parede arterial, na regressão da aterosclerose aórtica e na reversão da disfunção endotelial.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare the effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, aortic atherosclerosis, and the content of malondialdehyde (MDA) in native and oxidized LDL and in the arterial wall of hypercholesterolemic rabbits after adjusting the dosages of those statins to reduce total serum cholesterol levels to similar values. METHODS: Male rabbits were divided into the following 6 groups of 10 animals (n=10): 1) GH (control) - hypercholesterolemic animals; 2) GA - atorvastatin; 3) GF - fluvastatin; 4) GP - pravastatin; 5) GS - simvastatin; and 6) GN - normal. The animals were fed a standard food preparation enriched with 0.5% cholesterol and 2% coconut oil for 45 days. Fifteen days after beginning the experiment, atorvastatin, fluvastatin, pravastatin and simvastatin were administered for 15 days through gavage, and the dosages were adjusted to obtain similar cholesterol values in each group. At the end of the experiment, a blood sample was withdrawn for determining total cholesterol and separating the lipoproteins, and a segment of the thoracic aorta was removed to be used for studying endothelial function and lipid peroxidation, and for measuring aortic atherosclerosis in histological sections. RESULTS: The statins significantly reduced total serum cholesterol levels, LDL-cholesterol levels, and aortic atherosclerosis. The MDA content was also significantly reduced in native and oxidized LDL, as well as in the arterial wall. Endothelium-dependent relaxation was significantly greater in the treated group compared with that in the hypercholesterolemic group. CONCLUSION: The statins, at dosages adjusted, had a significant and similar effect in reducing lipid peroxidation in native and oxidized LDL-C and in arterial walls, in decreasing aortic atherosclerosis, and in reverting endothelial dysfunction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>inibidores da HMGCoA-redutase</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aterosclerose aórtica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>peroxidação lipídica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>HMG-CoA reductase inhibitors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipid peroxidation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>A exposição crônica à fumaça do cigarro resulta em remodelação cardíaca e prejuízo da função ventricular em ratos</s1>
</fA08>
<fA08 dir="en">
<s1>Chronic cigarette smoke exposure results in cardiac remodeling and impaired ventricular function in rats</s1>
</fA08>
<fA11 dir="011000">
<s1>Édson Castardeli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sergio A. R. Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Beatriz B. Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz S. Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marcos F. Minicucci</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paula S. Azevedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Álvaro O. Campana</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Leonardo A. M. Zornoff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual Paulista Faculdade de Medicina de Botucatu </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>320-324</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar as alterações cardíacas estruturais e funcionais causadas pela exposição à fumaça do cigarro em ratos. MÉTODOS: Os animais foram aleatoriamente distribuídos em dois grupos: fumante (F), composto por 10 animais, expostos à fumaça do cigarro, na taxa de 40 cigarros/dia e controle (C), constituído por 10 animais não submetidos à exposição. Após 4 meses, os animais foram submetidos a estudo morfológico e funcional por meio do ecocardiograma. As variáveis estudadas foram analisadas pelo teste t ou pelo teste de Mann-Whitney. RESULTADOS: Os ratos fumantes apresentaram maior átrio esquerdo (F=4,2&amp;plusmn; 0,7mm; C=3,5&amp;plusmn;0,6mm; p&lt;0,05), maiores diâmetros diastólicos (F=7,9&amp;plusmn;0,7mm; C=7,2&amp;plusmn;0,5mm; p&lt;0,05) e sistólicos (F=4,1 &amp;plusmn;0,5; C=3,4&amp;plusmn;0,5; p&lt;0,05) do ventrículo esquerdo (VE). O índice de massa do VE foi maior nos animais fumantes (F=1,5 mg/kg&amp;plusmn; 0,2; C=1,3 mg/kg&amp;plusmn;0,2; p&lt;0,05), e a fração de ejeção (F=0,85&amp;plusmn;0,03; C=0,89&amp;plusmn;0,03; p&lt;0,05) e a fração de encurtamento (F=47,8 %&amp;plusmn;3,7; C=52,7%&amp;plusmn;4,6; p&lt;0,05) maiores no grupo controle. Não foram identificadas diferenças nas variáveis de fluxo diastólico (onda E, na onda A e na relação E/A) transmitral. CONCLUSÃO: A exposição crônica à fumaça do cigarro resulta em remodelação cardíaca, com diminuição da capacidade funcional ventricular.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the cardiac structural and functional alterations caused by cigarette smoke exposure in rats. METHODS: The animals were randomly distributed into the following 2 groups: 1) smokers (S), comprising 10 animals exposed to cigarette smoke at a rate of 40 cigarettes/day; and 2) control (C), comprising 10 animals not exposed to cigarette smoke. After 4 months, the animals underwent morphological and functional study with echocardiography. The variables studied were analyzed by use of the t test or the Mann-Whitney test. RESULTS: The smoking rats had a greater left atrium (S=4.2&amp;plusmn;0.7mm; C=3.5&amp;plusmn;0.6mm; P&lt;0.05), and greater left ventricular diastolic (S=7.9&amp;plusmn;0.7mm; C=7.2&amp;plusmn;0.5mm; P&lt;0.05) and systolic (S=4.1&amp;plusmn;0.5; C=3.4&amp;plusmn;0.5; P&lt;0.05) diameters. The left ventricular mass index was greater in the smoking animals (S=1.5mg/kg&amp;plusmn;0.2; C=1.3mg/kg&amp;plusmn;0.2; P&lt;0.05), and the ejection fraction (S=0.85&amp;plusmn;0.03; C=0.89&amp;plusmn;0.03; P&lt;0.05) and the shortening fraction (S=47.8%&amp;plusmn;3.7; C=52.7%&amp;plusmn;4.6; P&lt;0.05) were greater in the control group. No differences were observed in the diastolic transmitral flow variables (E wave, A wave, and E/A ratio). CONCLUSION: Chronic cigarette smoke exposure results in cardiac remodeling with a decrease in ventricular functional capacity.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dilatação ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular dilation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Perfil nutricional e lipídico de mulheres na pós-menopausa com doença arterial coronariana</s1>
</fA08>
<fA08 dir="en">
<s1>Nutritional status and lipid profile of postmenopausal women with coronary heart disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Aparecida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jorge Mancini Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>325-329</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o estado nutricional e perfil lipídico de mulheres na pós-menopausa com doença arterial coronariana. MÉTODOS: Estudo transversal retrospectivo de dados obtidos do prontuário médico de 217 mulheres, na ocasião da 1º consulta no Ambulatório de Nutrição do InCor, referentes ao estado nutricional, pelo índice de massa corpórea, uso de medicamentos hipolipemiantes e lípides plasmáticos (colesterol e frações). RESULTADOS: A média de idade foi 60,98 &amp;plusmn; 9,23 anos com prevalência de obesidade em 56%. O uso de medicamentos hipolipemiantes foi observado em 73% da população. Quanto ao perfil lipídico, 56% apresentavam níveis plasmáticos adequados de HDL-c. O estado nutricional esteve inadequado devido à prevalência de obesidade, o que implica no surgimento de outras doenças crônicas, como as dislipidemias. Embora não se tenha verificado a dosagem utilizada, o emprego de hipolipemiantes pela população estudada não pareceu ser favorável, pois foram observados níveis elevados de colesterol total e LDL-c, que nessa condição, encontram-se fortemente relacionados à ocorrência de doenças cardiovasculares. CONCLUSÃO: Faz-se necessária a ação multidisciplinar em programas de Saúde da Mulher, abrangendo aspectos preventivos relacionados à doença arterial coronariana para, assim, melhorar a qualidade de vida nessa população.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the nutritional status and lipid profile of postmenopausal women with coronary heart disease. METHODS: A retrospective cross-sectional study was conducted with information obtained from the medical records of 217 women on the occasion of their first visit to the InCor Nutrition Outpatient Care Clinic. The data referred to the patients' nutritional status, body mass index, use of lipid-lowering medication, and serum lipid levels (cholesterol and fractions). RESULTS: The mean age was 60.98 &amp;plusmn; 9.23 years, and obesity prevailed in 56% of the patients. The use of lipid-lowering drugs was observed in 73% of the population. In regard to lipid profile, 56% had adequate serum levels of HDL-C. The nutritional status was inadequate due to the prevalence of obesity, which results in the appearance of other chronic diseases, such as dyslipidemias. Although the dosages of the lipid-lowering drugs used were not assessed, their use by the population studied did not seem to be favorable, because high levels of total cholesterol and LDL-C were observed, and those high levels in that condition are strongly related to the occurrence of cardiovascular diseases. CONCLUSION: Multidisciplinary action in the form of programs to promote women's health is required, comprising preventive aspects related to coronary heart disease, to improve the quality of life in that population.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dislipidemia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>menopausa</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença arterial coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dyslipidemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>menopause</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary heart disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Distrofia miotônica e cardiopatia: comportamento dos eventos arrítmicos e dos distúrbios da condução</s1>
</fA08>
<fA08 dir="en">
<s1>Myotonic dystrophy and heart disease: behavior of arrhythmic events and conduction disturbances</s1>
</fA08>
<fA11 dir="011000">
<s1>Silvana Angelina D'Orio Nishioka</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Martino Martinelli Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Suely Marie</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Mayana Zatz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Roberto Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Coração do Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>330-336</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar a prevalência e a evolução natural dos eventos arrítmicos e distúrbios da condução, correlacionar o defeito genético com achados cardiovasculares, avaliar a mortalidade cardíaca, freqüência e fatores preditivos de morte súbita, correlacionar a gravidade do envolvimento neuromuscular e cardíaco e definir o papel do estudo eletrofisiológico (EEF), na distrofia miotônica. MÉTODOS: Realizados periodicamente avaliação clínica e exames complementares, exame genético, eletrocardiograma, ecocardiograma e Holter (exceto exame genético) em 83 pacientes consecutivos com tempo médio de seguimento de 42&amp;plusmn;30,63 meses, sendo o estudo eletrofisiológico realizado em 59 casos. RESULTADOS: Taquiarritmia atrial foi observada em 10 (12%) pacientes, taquicardia ventricular não sustentada (TVNS) em 14 (17%), bloqueio átrio-ventricular (BAV) 1º grau em 24 (29%), bloqueio de ramo esquerdo (BRE) em 19 (23%), bloqueio de ramo direito (BRD) em 13 (16%). Sintomas, aumento do intervalo PR, alargamento do QRS, fração de ejeção do ventrículo esquerdo (FEVE) &lt;60% e idade foram preditivos de óbito. Ocorreram 9 mortes (4 súbitas; 2 insuficiência cardíaca; 3 outras). EEF: HV&gt;70ms em 34% e &gt;100ms em 11% (pós-procainamida). CONCLUSÃO: A prevalência dos eventos arrítmicos e distúrbios da condução foi de 50% a 80% após 6 anos, não se correlacionando ao defeito genético, sendo o flutter atrial, a arritmia sustentada mais freqüente. O envolvimento cardíaco aumentou com a piora da doença neuromuscular, mas essa progressão foi mais rápida que a neuromuscular. A mortalidade total foi baixa (11%) e morte súbita ocorreu em metade dos casos. EEF identificou grupo de risco para implante de marcapasso.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study the prevalence and natural evolution of arrhythmic events and conduction disturbances in myotonic dystrophy; to correlate the genetic defect with cardiovascular findings; to assess cardiac mortality, frequency, and predictive factors of sudden death; to correlate the severity of the neuromuscular and cardiac involvement; and to define the role of the electrophysiological study (EPS), in myotonic dystrophy. METHODS: Periodic clinical assessment and the following tests were performed in 83 consecutive patients with a mean follow-up of 42&amp;plusmn;30.63 months: complementary examinations, genetic tests, electrocardiography, echocardiography, and Holter; electrophysiological study was performed in 59 cases. RESULTS: Atrial tachyarrhythmia was observed in 10 (12%) patients, NSVT in 14 (17%), first-degree AVB in 24 (29%), LBBB in 19 (23%), and RBBB in 13 (16%). Symptoms, an increase in the PR interval, QRS enlargement, LVEF &lt; 60%, and age were predictive factors of death. Nine patients died (4 sudden deaths; 2 due to heart failure; 3 due to other causes). Electrophysiological study: H-V interval &gt;70 ms in 34% and &gt; 100 ms in 11% (postprocainamide). CONCLUSION: The prevalence of arrhythmic events and conduction disturbances ranged from 50% to 80% after 6 years, and did not correlate with the genetic defect. Atrial flutter was the most common sustained arrhythmia. Cardiac involvement increased as the neuromuscular disease became aggravated, but progression of the cardiac involvement was more rapid than that of the neuromuscular disease. Overall mortality was low (11%) and sudden death occurred in half of the cases. The EPS identified a group at risk for pacemaker implantation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>distrofia miotônica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>arritmias</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sistema de condução cardíaco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mortalidade</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myotonic dystrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arrhythmias</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac conduction system</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mortality</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Angioplastia transluminal coronariana em portador de púrpura trombocitopênica idiopática</s1>
</fA08>
<fA08 dir="en">
<s1>Percutaneous transluminal coronary angioplasty in a patient with idiopathic thrombocytopenic purpura</s1>
</fA08>
<fA11 dir="011000">
<s1>Luis Gustavo M. Marques</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Murillo Kenji Furukawa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Thenyson Pereira Leitão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Luis A. Quiñones</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fernando César de Queiroz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rogerio Felippe Tiossi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Virgílio Ribeiro Franco Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Carlos Eduardo M. Domingues</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Decio Salvadori Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Real e Benemérita Associação Portuguesa de Beneficência  </s1>
<s2>São Paulo </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>337-339</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>5</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400412</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>A associação entre a doença arterial coronariana e a púrpura trombocitopênica é rara e implica em algumas dificuldades quando a revascularização se faz necessária. Relatamos um caso dessa associação, com importante comprometimento coronariano, tratado percutaneamente com o implante de stent.</s0>
</fC01>
<fC01 dir="en">
<s0>The association between coronary heart disease and thrombocytopenic purpura is rare and poses some difficulties when myocardial revascularization is necessary. We report a case with this association and significant coronary impairment, which was percutaneously treated with stent implantation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Síndrome da disfunção apical reversível (Takotsubo)</s1>
</fA08>
<fA08 dir="en">
<s1>Transient ventricular dysfunction (Takotsubo cardiomyopathy)</s1>
</fA08>
<fA11 dir="011000">
<s1>José Marconi Almeida de Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcos Knobel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gustavo Buchelle</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Augusto M. de Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Cláudio H. Fisher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Daniel Born</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Nelson Akamine</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Elias Knobel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Israelita Albert Einstein  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>340-342</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400413</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Homem portador de miastenia gravis, internado por descompensação da doença de base, em insuficiência respiratória aguda. Na evolução, apresentou quadro sugestivo de infarto agudo do miocárdio, com alterações eletrocardiográficas e enzimáticas compatíveis com o diagnóstico. Submetido a coronariografia de urgência, não evidenciou obstrução coronariana grave, entretanto o ventrículo esquerdo apresentava disfunção sistólica importante, com alteração característica pela ventriculografia da síndrome descrita como disfunção ventricular transitória ou síndrome de Takotsubo. Na evolução, houve completa recuperação das alterações eletrocardiográficas e da função ventricular sistólica avaliada pelo ecocardiograma, confirmando a síndrome.</s0>
</fC01>
<fC01 dir="en">
<s0>The patient was a male with myasthenia gravis, hospitalized with acute respiratory failure due to decompensation of the underlying disease. He evolved with findings suggestive of acute myocardial infarction, with electrocardiographic and enzymatic alterations compatible with that diagnosis. The patient underwent emergency coronary angiography, which showed no severe coronary obstruction, although his left ventricle had significant systolic dysfunction with characteristic alterations, on ventriculography, of the syndrome described as transient ventricular dysfunction or Takotsubo syndrome. On evolution, complete recovery of the electrocardiographic alterations and systolic ventricular function assessed on echocardiography occurred, confirming the syndrome.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Hematoma intramural da aorta descendente</s1>
</fA08>
<fA08 dir="en">
<s1>Intramural haematoma of the descending aorta</s1>
</fA08>
<fA11 dir="011000">
<s1>Bruno Botelho Pinheiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Walter Vosgrau Fagundes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rafael Haddad</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Cardoso Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Santa Genoveva  </s1>
<s2>Goiânia GO</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>343-344</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400414</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 2/2005 - Choque em homem de 103 anos com história de insuficiência cardíaca de longa duração após infarto do miocárdio há 10 anos (Instituto do Coração do Hospital das Clínicas - FMUSP, São Paulo)</s1>
</fA08>
<fA08 dir="en">
<s1>Circulatory shock in a 103 year-old man with a history of long lasting heart failure following acute myocardial infarction ten years before</s1>
</fA08>
<fA11 dir="011000">
<s1>Thiago Marchini Naves</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Tarso Augusto D. Accorsi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Sampaio Gutierrez</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>345-349</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400415</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 1/2005 - Lactente com 4 meses de idade, portador de comunicação interventricular. Instituto do Coração do Hospital das Clínicas da FMUSP</s1>
</fA08>
<fA08 dir="en">
<s1>Four-month-old infant with ventricular septal defect</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>350-350</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400416</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Determinação de parâmetros hemodinâmicos através do ecocardiograma bidimensional com Doppler: ferramenta para busca de otimização terapêutica em pacientes ambulatoriais com insuficiência cardíaca congestiva</s1>
</fA08>
<fA08 dir="en">
<s1>Determination of hemodynamic parameters using Doppler two-dimensional echocardiography: a searching tool for therapeutic optimization in patients with congestive heart failure on an outpatient care follow-up</s1>
</fA08>
<fA11 dir="011000">
<s1>Dora V. Palombini</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luis E. Rohde</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Leticia Crestana</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Lívia Goldraich</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marta Pereira Lima</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Candice Campos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Nadine Clausell</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>351-356</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400417</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Terapia celular: uma nova perspectiva no tratamento da insuficiência cardíaca de causa isquêmica</s1>
</fA08>
<fA08 dir="en">
<s1>Stem cell therapy: a new perspective for the treatment of ischemic heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Domingo Marcolino Braile</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Moacir F. de Godoy</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>357-359</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Melhora sintomática e da capacidade de exercício após o transplante autólogo, transendocárdico, de células mononucleares da medula óssea em pacientes com cardiopatia isquêmica grave, sustentada até o sexto mês de evolução</s1>
</fA08>
<fA08 dir="en">
<s1>Sustained improvement in symptoms and exercise capacity up to six months after autologous transendocardial transplantation of bone marrow mononuclear cells in patients with severe ischemic heart disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Hans Fernando R. Dohmann</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Emerson C. Perin</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Radovan Borojevic</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Suzana A. Silva</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Andre L. S. Souza</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Guilherme V. Silva</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="071000">
<s1>João A. R. Assad</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Maria I. D. Rossi</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Claudio T. Mesquita</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Hans J. Dohmann</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Texas Heart Institute  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>360-366</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>58</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Este estudo tem por objetivo avaliar os efeitos, no seguimento de 6 meses, do transplante autólogo, transendocárdico, de células mononucleares da medula óssea (TACMMO), sobre os sintomas, capacidade de exercício, perfusão e contratilidade miocárdica nos portadores de cardiopatia isquêmica grave. MÉTODOS: Vinte e um pacientes foram incluídos neste estudo prospectivo (os 14 primeiros pacientes, grupo tratado; os 7 últimos pacientes, grupo controle). Inicialmente todos os indivíduos foram submetidos à avaliação clínica e laboratorial, teste ergométrico, ecocardiograma, cintilografia miocárdica e Holter de 24 horas. As CMMO foram isoladas, lavadas e diluídas em salina 0,9% para injeção transendocárdica em áreas de miocárdio viável no grupo tratado, (15 injeções de 0,2 ml). Todos os pacientes foram reavaliados ao final de 2 e 6 meses de acompanhamento. RESULTADOS: Os dados demográficos e demais características não diferiram significativamente entre os grupos na avaliação inicial. Não foram observados eventos adversos maiores relacionados ao TACMMO. Ao final de 6 meses, houve redução da área isquêmica na imagem de perfusão nuclear (p=0,05) e melhora significativa dos sintomas, da capacidade funcional e da função global do ventrículo esquerdo. CONCLUSÃO: Este estudo demonstra a segurança da realização de injeções transendocárdicas de CMMO em humanos com cardiopatia isquêmica associada a grave disfunção ventricular. Os efeitos observados em curto prazo foram mantidos até 6 meses de acompanhamento.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: This study aimed at assessing the effects of autologous transendocardial transplantation of bone marrow mononuclear cells (ATTBMMC) on symptoms, exercise capacity, myocardial perfusion and contractility in patients with severe ischemic heart disease during a 6-month follow-up period. METHODS: This prospective study comprised 21 patients as follows: the first 14 patients forming the treated group, and the last 7 patients forming the control group. Initially, all patients underwent clinical and laboratory assessment, treadmill testing, echocardiography, myocardial scintigraphy, and 24-hour Holter. The bone marrow mononuclear cells (BMMC) were isolated, washed, and diluted in 0.9% saline solution for transendocardial injection in areas of viable myocardium in the treated group, (15 0.2-mL injections). All patients were reassessed in the end of 2 and 6 months of follow-up. RESULTS: The demographic data and other characteristics did not significantly differ between the groups in the initial evaluation. No major adverse events related to the ATTBMMC were observed. In the end of 6 months, a reduction in the ischemic area was observed on nuclear perfusion imaging (P=0.05), as was a significant improvement in symptoms, functional capacity, and left ventricular overall function. CONCLUSION: This study showed that transendocardial injections of BMMC are safe in human beings with ischemic heart disease associated with severe ventricular dysfunction. The effects observed in the short run were maintained up to the sixth month of follow-up.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>células</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>isquemia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>revascularização</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>terapia gênica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cells</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>revascularization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>gene therapy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação do monitor de medida de pressão arterial 0mron 705-CP para uso em adolescentes e adultos jovens</s1>
</fA08>
<fA08 dir="en">
<s1>Evaluation of the Omron 705-CP blood pressure measuring device for use in adolescents and young adults</s1>
</fA08>
<fA11 dir="011000">
<s1>Erika Arai Furusawa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Franqueline Osório Ruiz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Ignês Saito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Vera Hermina Koch</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Instituto da Criança do Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>367-370</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o monitor OMRON 705-CP de medida de pressão arterial em adolescentes e adultos jovens. MÉTODOS: De acordo com o protocolo da British Hypertension Society e da Association for the Advancement of Medical Instrumentation, realizamos a validação do aparelho em 60 adolescentes. O monitor foi conectado em Y com a coluna de mercúrio e foram realizadas 4 medidas consecutivas e simultâneas, analisadas as independentes e calculadas as diferenças médias entre as pressões e o desvio padrão dessas diferenças. Os resultados foram analisados de acordo com o sistema de grau do protocolo utilizado. RESULTADOS: Foram avaliadas 240 medidas. A idade média dos pacientes foi 16,3 anos. Quando comparada a medida realizada pela coluna de mercúrio com o aparelho houve uma diferença &lt; 15 mmHg em 97,9% das medidas sistólicas e 98,8% das diastólicas; uma diferença &lt; 10 mmHg em 86,3% das medidas sistólicas e 90,4% das diastólicas, classificada como grau A; uma diferença &lt; 5 mmHg em 59,1% das medidas sistólicas e 67% das medidas diastólicas, considerada pela classificação entre A/B. A diferença média e o desvio padrão dessa diferença na pressão sistólica foi de 2,91±6,42 mmHg e para a diastólica de 1,16±5,79 mmHg. CONCLUSÃO: O monitor OMRON 705-CP mostrou-se válido para medidas de pressão arterial de adolescentes segundo o protocolo empregado.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the Omron 705-CP monitor for measuring blood pressure in adolescents and young adults. METHODS: According to the protocols of the British Hypertension Society and the Association for the Advancement of Medical Instrumentation, we performed validation of the device in 60 adolescents. The Omron monitor was connected in Y to a mercury column. Four consecutive and simultaneous measurements were taken with the mercury column sphygmomanometer and the test device, were independently analyzed, and the mean differences between the blood pressure measurements and the standard deviations of those differences were calculated. The results were analyzed according to the grading system of the protocol used. RESULTS: Two hundred and forty measurements were evaluated. The mean age of the patients was 16.3 years. When the measurement performed with the mercury column sphygmomanometer was compared with that taken with the device, a difference &lt; 15 mmHg was observed in 97.9% of the systolic and 98.8% of the diastolic blood pressure measurements; a difference &lt; 10 mmHg was observed in 86.3% of the systolic and 90.4% of the diastolic blood pressure measurements, which was classified as grade A; a difference &lt; 5 mmHg was observed in 59.1% of the systolic and 67% of the diastolic blood pressure measurements, and was classified as grade A/B. The mean difference and the standard deviation of that difference for the systolic blood pressure was 2.91±6.42 mmHg, and, for the diastolic blood pressure, it was 1.16±5.79 mmHg. CONCLUSION: The Omron 705-CP monitor proved to be useful for measuring blood pressure in adolescents according to the protocol used.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Omron 705-CP</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>medida residencial da pressão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>adolescentes</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Omron 705-CP</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>home blood pressure measurement</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adolescents</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Troca de valva com a prótese valvar modelo Omnicarbon: seguimento clínico de 10 anos</s1>
</fA08>
<fA08 dir="en">
<s1>Valve replacement with the Omnicarbon valve prosthesis: a 10-year follow-up</s1>
</fA08>
<fA11 dir="011000">
<s1>Santiago Florez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Salvatore Di Stefano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Yolanda Carrascal</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Juan Bustamante</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Enrique Fulquet</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Ramón Echevarria</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Casquero Elena</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Javier Gualis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Luis Fiz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Universitario de Valladolid Servicio de Cirugía Cardíaca Instituto de Ciencias del Corazon (ICICOR)</s1>
<s2> </s2>
<s3>Spain</s3>
</fA14>
<fA20 dir="000000">
<s1>371-375</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar retrospectivamente os resultados de 264 pacientes submetidos à implementação cirúrgica de válvula modelo Omnicarbon entre abril 1985 e maio 1995. MÉTODOS: No momento da cirurgia, a média de idade dos pacientes que receberam essa prótese mecânica era de 57±11 anos. As válvulas modelo Omnicarbon foram colocadas em posição aórtica em 36% dos casos, na posição mitral em 44% dos casos, e nas duas posições em 20% dos casos. O seguimento clínico foi feito cuidadosamente, com a maioria dos pacientes submetidos ao exame físico em nossa clínica. Levando em conta o histórico do caso, os cardiologistas faziam perguntas aos pacientes sobre as complicações relacionadas à válvula. RESULTADOS: O seguimento acumulado dos pacientes foi de 1291 anos, com média de seguimento de 5,4 anos. A sobrevida após 10 anos foi de 79,4±3,9%, incluindo todas as causas de morte e os casos de mortalidade precoce. As complicações relatadas durante os 11 anos de estudo incluem: tromboembolismo (0,1 %), hemorragia (0,4%), endocardite (0,2%), e insuficiência não-estrutural (1,2%). Não foram detectadas anemia hemolítica, trombose valvar, ou insuficiência estrutural durante esse longo período de estudo. A capacidade funcional desses pacientes foi avaliada subjetivamente pelo sistema de classificação da NYHA. Com o tempo de seguimento maior do que 5 anos em média, nossos pacientes que receberam a válvula modelo Omnicarbon se encontram na classe I ou II da NYHA. CONCLUSÃO: As próteses mecânicas modelo Omnicarbon apresentam um bom desempenho clínico por até 10 anos, tanto em posição aórtica quanto mitral. Os resultados indicam uma baixa incidência de tromboembolismo e complicações hemorrágicas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: We retrospectively examined the outcomes of 264 patients who underwent consecutive Omnicarbon valve implantation surgery between April 1985 and May 1995. METHODS: At the time of surgery, patients who received this mechanical prosthesis averaged 57±11 years of age. Omnicarbon valves were placed in the aortic position in 36% of the cases, in the mitral position in 44%, and in both positions in 20%. Follow-up was carefully performed, with most patients undergoing physical examination at our clinic. While taking the case history, cardiac physicians specifically questioned the patient about valve-related complications. RESULTS: Accumulated total patient-years is 1291, with a mean follow-up time of 5.4 years. Survival at 10 years is 79.4±3.9%, including all causes of death and early mortality. Complications recorded during the 11-year study include: thromboembolism (0.1%), hemorrhage (0.4%), endocarditis (0.2%), and nonstructural failure (1.2%). No hemolytic anemia, valve thrombosis, or structural failure was detected during this long-term experience. Functional capability of these patients was subjectively assessed by the NYHA classification system. With follow-up time averaging over 5 years, 97% of our Omnicarbon valve patients are in NYHA I or II. CONCLUSION: The Omnicarbon mechanical prosthesis provides a good clinical performance for up to 10 years in both the aortic and mitral positions. Results indicated a low incidence of thromboembolism and of hemorrhagic complications.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>válvula cardíaca mecânica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>morbidade</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sobrevida</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tromboembolismo</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mechanical heart valve</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>morbidity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>survival</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thromboembolism</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Potenciação pós-extra-sistólica na cardiopatia chagásica crônica: estudo com ventriculografia de contraste radiológico</s1>
</fA08>
<fA08 dir="en">
<s1>Post-extrasystolic potentiation in chronic Chagas' heart disease: a radiologic contrast ventriculography study</s1>
</fA08>
<fA11 dir="011000">
<s1>José Mário M. Brandão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Andrea Miziara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Geraldo Luiz de Figueiredo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Moysés O. Lima-Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Elias M. Ayres-Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Antonio Marin-Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>376-380</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a existência e freqüência do fenômeno da potenciação pós-extra-sistólica em áreas miocárdicas discinérgicas de pacientes com cardiopatia chagásica crônica estudados por ventriculografia de contraste radiológico. MÉTODOS: Análise retrospectiva semiquantitativa da ventriculografia de contraste radiológico em pacientes com cardiopatia chagásica crônica, consecutivamente estudados para avaliação de mecanismos de taquicardia ventricular. RESULTADOS: De 72 pacientes inicialmente incluídos, apenas em 20 o ventriculograma foi analisável para os propósitos do estudo. O fenômeno da potenciação pós-extra-sistólica foi verificado em 11 (55%) desses pacientes, obtendo-se melhora de 15,31% no escore de contração, da situação basal para a de pós-extra-sístole (p= 0,0001). Sua ocorrência verificou-se mesmo em segmentos ventriculares com déficit intenso de contratilidade. CONCLUSÃO: O fenômeno da potenciação pós-extra-sistólica é verificável em proporção significante de pacientes com cardiopatia chagásica crônica em que, angiograficamente, foi possível analisar o fenômeno, indicando a existência de reserva contrátil, potencialmente recrutável, em regiões ventriculares, exibindo discinergia acentuada. Estudos adicionais para se entender os mecanismos subjacentes são requeridos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the existence and frequency of the phenomenon of post-extrasystolic potentiation in dysynergic myocardial areas of patients with chronic Chagas' heart disease studied by use of radiologic contrast ventriculography. METHODS: This study is a semiquantitative retrospective analysis of radiologic contrast ventriculography in patients with chronic Chagas' disease, who were consecutively studied to assess the mechanisms of ventricular tachycardia. RESULTS: Of the 72 patients initially included, in only 20 patients was possible the ventriculographic analysis for the purposes of this study. The phenomenon of post-extrasystolic potentiation was observed in 11 (55%) of these patients, and a 15.31% improvement was observed in the contractility score from the baseline to the post-extrasystole condition (P=0.0001). That phenomenon occurred even in ventricular segments with an intense deficit in contractility. CONCLUSION: The phenomenon of post-extrasystolic potentiation is observed in a significant proportion of patients with chronic Chagas' heart disease, in whom the phenomenon could be angiographically analyzed, indicating the existence of potentially recruitable contractile reserve in ventricular regions, showing marked dysynergy. Additional studies for clarifying the underlying mechanisms are required.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatia chagásica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>potenciação pós-extra-sistólica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ventriculografia de contraste</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>post-extrasystolic potentiation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>contrast ventriculography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>O papel do ecocardiograma como método isolado na indicação cirúrgica de pacientes portadores de cardiopatia congênita</s1>
</fA08>
<fA08 dir="en">
<s1>The role of echocardiography as an isolated method for indicating surgery in patients with congenital heart disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Lilian Maria Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ana Paula Damiano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gláucia Neusa Oliveira Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Terezinha J. F. Azevedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Célia Toshie Nagamatsu</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Gláucia Maria Penha Tavares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Victor Coimbra Guerra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>José Pedro da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Gláucio Furlanetto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>André Bavaresco Cristóvão Salvador</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Beneficência Portuguesa de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>381-386</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a acurácia diagnóstica do ecocardiograma, analisando prospectivamente, o valor do método na indicação cirúrgica sem cateterismo em portadores de cardiopatia congênita, através da comparação do diagnóstico ecocardiográfico com os achados intra-operatórios e/ou do estudo invasivo. MÉTODOS: De fevereiro/2000 a janeiro/2001, foram acompanhados 493 pacientes cardiopatas congênitos com indicação cirúrgica, submetidos a ecocardiograma com mapeamento de fluxo em cores para decisão terapêutica. Os resultados foram comparados aos achados cirúrgicos e/ou de cateterismo quando realizado para complementação diagnóstica. RESULTADOS: Dos pacientes estudados, 94,3% (465 casos) foram submetidos à correção da cardiopatia congênita apenas com o ecocardiograma e sem cateterismo diagnóstico. O estudo invasivo foi realizado para complementação diagnóstica em 28 (5,6%) casos, o tratamento cirúrgico realizado em mais de 95% dos casos e o cateterismo terapêutico em 3,6%. Os achados do ecocardiograma se confirmaram em 464 (94,1%) dos casos, demonstrando uma alta acurácia do método. Ocorreram 8 (1,6%) casos de falso positivos e 39 (7,9%) casos de falso negativos. Segundo os cirurgiões, nenhum dos erros diagnósticos levaram a complicações ou afetaram os resultados cirúrgicos adversamente. CONCLUSÃO: O ecocardiograma se mostrou método sensível e seguro para indicação cirúrgica, dispensando, muitas vezes, a realização de estudo invasivo, ficando este, restrito aos casos de complementação diagnóstica ou terapêutica.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the diagnostic accuracy of echocardiography for indicating surgery without catheterization in patients with congenital heart disease through a prospective analysis and comparison of the echocardiographic diagnosis with the intraoperative findings, or invasive study, or both. METHODS: From February 2000 to January 2001, 493 patients with congenital heart diseases indicated for surgery were followed up. They underwent echocardiography with color-flow mapping for a therapeutic decision. The results were compared with the findings of surgery or catheterization, or both, when the latter were performed for diagnostic reasons. RESULTS: Of the patients studied, 94.3% (465 cases) underwent congenital heart disease correction based only on echocardiographic findings, without a diagnostic catheterization. The invasive study was performed for diagnostic reasons in 28 (5.6%) patients, the surgical treatment was performed in more than 95% of the patients, and therapeutic catheterization was performed in 3.6%. The echocardiographic findings were confirmed in 464 (94.1%) patients, which showed the high accuracy of the method. False-positive findings occurred in 8 (1.6%) patients, and false-negative findings in 39 (7.9%). According to surgeons, no diagnostic error led to complications or adversely affected the surgical results. CONCLUSION: Echocardiography proved to be a sensitive and safe method for indicating surgery, making catheterization, often, unnecessary. The invasive study was restricted to diagnostic or therapeutic uses.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>diagnóstico não invasivo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatia congênita</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>noninvasive diagnosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Prevalência de fatores de risco cardiovascular em crianças e adolescentes da rede de ensino da cidade de Maceió</s1>
</fA08>
<fA08 dir="en">
<s1>Prevalence of cardiovascular risk factors in child and adolescent students in the city of Maceió</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Alayde Mendonça da Silva</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ivan Romero Rivera</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Roseane Mendonça Tenório Ferraz</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Aluísio José Tavares Pinheiro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sheyla Waleska dos Santos Alves</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Adriana Ávila Moura</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antonio Carlos Camargo Carvalho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Alagoas  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal de São Paulo Escola Paulista de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>387-392</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>67</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estabelecer a prevalência de hipertensão arterial sistêmica (HAS), do &quot;risco de sobrepeso&quot;, sobrepeso, sedentarismo e tabagismo em crianças e adolescentes, de 7 a 17 anos, de ambos os sexos, da rede pública e privada de ensino de Maceió, AL. MÉTODOS: Estudo epidemiológico transversal. Amostragem por conglomerados em escolas de nível fundamental e médio. Cálculo da amostra baseado na menor prevalência esperada das variáveis estudadas. Protocolo de avaliação: questionário estruturado, antropometria e medidas da pressão arterial. Análise de associação das variáveis realizada pelo método do qui-quadrado. RESULTADOS: Em 2001 foram avaliados 1253 estudantes (547 do sexo masculino, média de idade 12,4±2,9 anos), demonstrando-se que 1172 não praticavam atividade física de moderada a intensa; &quot;risco de sobrepeso&quot; e sobrepeso presentes em 116 e 56 indivíduos, respectivamente; pressão arterial no percentil &gt; de 95 identificada em 97 estudantes e apenas 30 admitiram fumar regularmente. Observou-se associação significante do &quot;risco sobrepeso&quot; e do sobrepeso com estudantes de escolas particulares (*p=0,0001) e do sedentarismo com o sexo feminino (*p=0,0001). CONCLUSÃO: A prevalência de sedentarismo, &quot;risco de sobrepeso&quot;, sobrepeso, hipertensão arterial sistêmica e tabagismo na população estudada foi de 93,5%; 9,3%; 4,5%; 7,7% e 2,4%, respectivamente.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the prevalence of systemic arterial hypertension (SAH), &quot;risk of overweight,&quot; overweight, sedentary lifestyle, and smoking in children and adolescents from 7 to 17 years of age, of both sexes, in public and private schools in the city of Maceió, in the state of Alagoas. METHODS: A cross-sectional epidemiological study with sampling from a population pool was carried out. It comprised elementary and middle schools, randomly selected. The sample was calculated based on the expected lower prevalence of the variables studied. The assessment protocol comprised a structured questionnaire, anthropometry, and blood pressure measurements. The chi-square test was used to analyze the association among variables. RESULTS: In 2001, 1,253 students (547 of the male sex; mean age, 12.4±2.9 years) were assessed. The results were as follows: 1.172 students participated in no moderate to intense physical activity; &quot;risk of overweight&quot; and overweight were present in 116 and 56 individuals, respectively; blood pressure in the &gt; 95th percentile was identified in 97 students; and only 30 students admitted smoking regularly. The following significant associations were observed: &quot;risk of overweight&quot; and overweight in private school students (*P=0.0001) and sedentary lifestyle in the female sex (*P=0.0001). CONCLUSION: The prevalence of a sedentary lifestyle, &quot;risk of overweight,&quot; overweight, systemic arterial hypertension, and smoking in the population studied was 93.5%, 9.3%, 4.5%, 7.7%, and 2.4%, respectively.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fator de risco cardiovascular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>crianças e adolescentes</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prevalência</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular risk factor</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>children and adolescents</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prevalence</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliar a correlação entre a concentração da hemoglobina e a medida ecográfica do diâmetro biventricular externo em fetos anêmicos de gestantes isoimunizadas</s1>
</fA08>
<fA08 dir="en">
<s1>Assessment of the correlation between hemoglobin concentration and the echographic measurement of biventricular outer diameter in anemic fetuses of isoimmunized women</s1>
</fA08>
<fA11 dir="011000">
<s1>Rosangela Lopes Miranda Rodrigues</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alamanda Kfoury Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcos Roberto Taveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Isabela Gomes de Melo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Gabriel Costa Osanan</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antônio Carlos Vieira Cabral</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Centro de Medicina Fetal Hospital das Clínicas da UFMG </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>393-396</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar se existe correlação significativa entre a medida ecográfica do diâmetro biventricular externo e a concentração sérica da hemoglobina fetal pré-transfusional e se essa medida ecográfica poderá vir a ser utilizada como marcador não invasivo da anemia fetal. MÉTODOS: Estudo transversal prospectivo, no qual foram selecionadas 65 cordocenteses realizadas em 36 fetos anêmicos de mães portadoras de isoimunização pelo fator Rh. Obteve-se a medida do diâmetro biventricular externo (DBVE), por meio do modo M, utilizando-se aparelho de ultra-som convencional. Anterior à transfusão foi obtida amostra de 0,5ml de sangue fetal, para dosagem da hemoglobina, sendo a medida imediatamente realizada através de espectrofotometria, no equipamento Hemocue®. Como análise estatística foi utilizada a regressão dos mínimos quadrados, aceitando-se p&lt;0,05 e análise multivariada. RESULTADOS: Foram observadas correlação inversa entre a concentração da hemoglobina no sangue fetal no momento prévio à transfusão e a medida do DBVE e correlação direta entre a medida do DBVE e a idade gestacional, e, também, através da análise multivariada que, à medida que a concentração de hemoglobina fetal cai, o DBVE aumenta, independentemente da influência da idade gestacional nesse parâmetro. CONCLUSÃO: Existe correlação inversa entre a concentração da hemoglobina no sangue fetal e a medida do DBVE, independente da idade gestacional. Os achados sugerem que o DBVE poderá vir a ser um marcador ecográfico de predição do nível de hemoglobina de fetos de gestantes isoimunizadas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess whether a significant correlation exists between the echographic measurement of biventricular outer diameter and the pretransfusional serum concentration of fetal hemoglobin and whether that echographic measurement can be used as a noninvasive marker of fetal anemia. METHODS: A prospective cross-sectional study was carried out comprising 65 cordocenteses performed in 36 anemic fetuses of mothers with isoimmunization to the Rh antigen. The biventricular outer diameter (BOD) was obtained by M-mode evaluation. Previous to the transfusion, a 0.5-mL fetal blood sample was obtained for hemoglobin measurement with spectrophotometry in the Hemocue device. The minimum square regression was used with p &lt; 0.05 and multivariate analysis were used as statistical analysis. RESULTS: An inverse correlation was observed between the fetal hemoglobin concentration before transfusion and the BOD measurement, and a direct correlation was observed between the BOD measurement and gestational age. In addition, multivariate analysis showed that fetal hemoglobin concentration decreases as BOD increases, independently of the influence of gestational age on that parameter. CONCLUSION: An inverse correlation exists between fetal hemoglobin concentration and BOD measurement, regardless of gestational age. The findings suggest that BOD may become an echographic predictor of the hemoglobin level of fetuses of isoimmunized pregnant women.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>anemia fetal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hemoglobina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>isoimunização gestacional</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ecocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fetal anemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hemoglobin</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>isoimmunized pregnant women</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Valvoplastia mitral percutânea por balão: evolução a longo prazo e análise dos fatores de risco para óbito e eventos maiores</s1>
</fA08>
<fA08 dir="en">
<s1>Percutaneous mitral balloon valvotomy: long-term outcome and assessment of risk factors for death and major events</s1>
</fA08>
<fA11 dir="011000">
<s1>Ivana Picone Borges</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Edison Carvalho Sandoval Peixoto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rodrigo Trajano Sandoval Peixoto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Sergio de Oliveira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mario Salles Netto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Pierre Labrunie</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Marta Labrunie</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Ricardo Trajano Sandoval Peixoto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Ronaldo de Amorim Villela</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Cinecor 4º Centenario  </s1>
<s2>Rio de Janeiro </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal Fuminense  </s1>
<s2>Niterói Rio de Janeiro</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>397-404</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>67</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Identificar os fatores, que predizem óbito e eventos combinados de óbito, nova valvoplastia mitral por balão ou cirurgia valvar mitral a longo prazo, nos pacientes submetidos à valvoplastia mitral percutânea por balão. MÉTODOS: O período de seguimento foi de 49,0±31,0 (1 a 122) meses. Foram usadas as técnicas do balão único (84,4%), do balão de Inoue (13,8%) e do duplo balão (1,7%). RESULTADOS: Acompanhados 289 pacientes com idade de 38,0±12,6 (13 a 83) anos, no pré-procedimento, 244 apresentavam escore ecocardiográfico &lt; 8 e 45 escore &gt; 8, 85% eram do sexo feminino e 84% estavam em ritmo sinusal. No seguimento, a sobrevida do grupo total, do grupo de escore &lt; 8 e do grupo de escore &gt; 8 foi de 95,5%, 98,0% e 82,2% respectivamente (p&lt;0,0001), enquanto que a sobrevida livre de eventos combinados foi respectivamente 83,4%, 86,1% e 68,9% (p&lt;0,0001). Na análise multivariada, os fatores, que predisseram óbito a longo prazo foram o escore ecocardiográfico &gt; 8 pré-procedimento e a presença de insuficiência valvar mitral grave per-procedimento, e os que predisseram eventos combinados, foram a história prévia de comissurotomia valvar mitral e de fibrilação atrial e a presença de insuficiência valvar mitral grave per-procedimento e de área valvar mitral &lt; 1,5 m² (insucesso) pós-procedimento. CONCLUSÃO: A valvoplastia mitral percutânea por balão é um procedimento efetivo, sendo que mais de dois terços dos pacientes estavam livres de eventos ao final do seguimento. A sobrevida no grupo total foi elevada, maior no grupo com menor escore ecocardiográfico.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To identify the factors that predict death and combined events, (death, new mitral balloon valvotomy, or mitral valve surgery) in long-term follow-up of patients undergoing percutaneous mitral balloon valvotomy. METHODS: Follow-up was 49.0±31.0 (1 to 122) months. Techniques used were the single-balloon (84.4%), Inoue-balloon (13.8%), and double-balloon techniques (1.7%). RESULTS: Included in the study were 289 patients 38.0±12.6 years of age (range, 13 to 83). Before the procedure, 244 patients had echocardiographic score &lt; 8, and 45 patients had score &gt; 8. Females comprised 85%, and 84% patients were in sinus rhythm. During follow-up, survival of the total group was 95.5%, that of the group with &lt; 8 was 98.0%, finally that of the group with scores &gt; 8 was 82.2% (P&lt;0.0001), whereas combined event-free survival was 83.4%, 86.1%, and 68.9%, respectively (P&lt;0.0001). In the multivariate analysis, the factors that predicted long-term death were a preprocedure echocardiographic score &gt; 8 and the presence of severe valvular mitral regurgitation during the procedure. The events that predicted combined events were a previous history of mitral valvular commissurotomy and atrial fibrillation and the presence of severe mitral valvular regurgitation during the procedure, and postprocedure mitral valvular area &lt; 1.5 m² (failure). CONCLUSION: Percutaneous mitral balloon valvotomy is an effective procedure, and over 2/3 of the patients were event-free at the end of follow-up. Survival in the group was high, even higher in the group with lower echocardiographic scores.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose valvar mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvoplastia mitral por balão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>febre reumática</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valvular stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral balloon valvotomy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rheumatic fever</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Perfil lipídico de indivíduos sem cardiopatia com sobrepeso e obesidade</s1>
</fA08>
<fA08 dir="en">
<s1>Lipidic profile of individuals without cardiopathy with overweight and obesity</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Araújo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alice T. Yamada</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marinalva V. M. Araújo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria do Rosário D. O. Latorre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alfredo J. Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>405-409</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o perfil lipídico de indivíduos com sobrepeso e obesidade submetidos à avaliação cardiológica e que não mostraram evidências de cardiopatia. MÉTODOS: Amostra com 684 indivíduos, 389 (56,9%) mulheres e 295 (43,1%) homens, com idade de 14 a 74 (média 40,6) anos, sem evidências de cardiopatia após avaliação clínica e análise do eletrocardiograma, radiografia do tórax, teste ergométrico em esteira e ecocardiograma bidimensional com Doppler. Foi estudado o perfil sérico de lípides e glicose quanto ao sexo e faixas do índice de massa corpórea (IMC) - eutróficos até 24,9 Kg/m², sobrepeso 25-29,9 Kg/m² e obesos &gt; 30 Kg/m². RESULTADOS: Apresentaram diferença estatisticamente significativa entre os sexos (médias): glicose (mg/dL) de mulheres 90,21±23,13 e homens 95,28±28,64 (p&lt;0.001); triglicérides (mg/dL) de mulheres 97,27±55,24 e homens 141,47±57,06 (p&lt;0,001) e HDL-C (mg/dL) de mulheres 52,63±13,92 e homens 43±10,88 (p&lt;0,001). O IMC médio das mulheres foi 26,15 e dos homens 26,33 (p=ns). Na análise por faixas de IMC houve diferença significativa entre os sexos (p=0,037). Na faixa de sobrepeso e obesidade, apenas as médias de triglicérides das mulheres mostraram diferença estatisticamente significativa: mulheres com sobrepeso 102,25±60,68 mg/dL e obesas 121,64±63,57 mg/dL (p=0,034). CONCLUSÃO: Mulheres sem cardiopatia apresentaram níveis séricos de glicose, triglicérides e HDL-colesterol inferiores aos homens. Em ambos os sexos, as médias são menores na comparação entre eutróficos e com excesso de peso, e apenas as médias dos triglicérides das mulheres com sobrepeso e obesidade apresentou diferença significativamente estatística.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the lipidic profile of overweight and obese individuals submitted to cardiologic assessment and who did not show evidences of cardiopathy. METHODS: Sample with 684 individuals, 389 (56.9%) women and 295 (43.1%) men, with age ranging from 14 to 74 (average of 40.6) years old, without evidences of cardiopathy after clinical assessment and analysis of electrocardiogram, thorax radiography, ergometric test on treadmill and two-dimensional Doppler echocardiogram. The serum profile of lipids and glucose regarding sex and ranges of body mass index (BMI) - eutrophic up to 24.9 Kg/m², overweight 25-29.9 Kg/m² and obese &gt; 30 Kg/m², was studied. RESULTS: The following means showed a significant statistic difference between the sexes: glucose (mg/dL) in women 90.21±23.13 and men 95.28±28.64 (p&lt;0.001); triglycerides (mg/dL) in women 97.27±55.24 and men 141.47±57.06 (p&lt;0.001) and HDL-C (mg/dL) in women 52.63±13.92 and men 43±10.88 (p&lt;0.001). The average BMI in women was 26.15 and in men 26.33 (p=ns). In the analysis through BMI ranges there was a significant difference between the sexes (p=0.037). In the categories of overweight and obesity, only the means of triglycerides in women showed a significant statistic difference: overweight women with 102.25±60.68 mg/dL and obese 121.64±63.57 mg/dL (p=0.034). CONCLUSION: Women without cardiopathy showed serum levels of glucose, triglycerides and HDL-cholesterol lower than men's. In both sexes, the means are lower in the comparison with eutrophic and overweight, and only the triglycerides average of women with overweight and obesity showed significant statistic difference.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lípides, obesidade</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sobrepeso</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>epidemiologia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>índice de massa corpórea</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipids</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>obesity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>overweight</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>body mass index</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Textura de bioprótese mitral, função ventricular esquerda e formação de trombo: análise por ecocardiografia transesofágica e aplicação de bioescore</s1>
</fA08>
<fA08 dir="en">
<s1>Texture of mitral bioprosthesis, ventricular function and formation of thrombus: analysis through transesophageal echocardiography and use of bioscore</s1>
</fA08>
<fA11 dir="011000">
<s1>Henry Abensur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José A. F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>410-415</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>52</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Diante da hipótese da participação do estresse mecânico como causa de disfunção de bioprótese mitral, decidimos avaliar a relação da preservação da textura dos folhetos da bioprótese mitral com a função ventricular esquerda, adicionalmente à eventual formação de trombo em átrio esquerdo nos pacientes com disfunção ventricular esquerda desde o implante da bioprótese mitral. MÉTODOS: Estudados 40 pacientes com bioprótese mitral por ecocardiograma transesofágico multiplanar, que foram divididos em dois grupos: com disfunção ventricular esquerda (FE=0,40±0.09) desde o implante da bioprótese (20 pacientes: idade 47,75±11,10 anos e tempo de cirurgia 5,3±2,6 anos) e com função ventricular esquerda normal (FE=0,73±0.06) desde o implante (20 pacientes: idade 49,75±13,59 anos e tempo de cirurgia 5,7±3 anos). A textura dos folhetos da bioprótese foi analisada através de um escore ecocardiográfico transesofágico (Bioescore FACIME): 1) fusão de folhetos (escore 1 a 3); 2) aposição de tecidos (escore 1 a 3); 3) cálcio em folhetos (escore 1 a 5); 4) integridade dos folhetos (escore 1 a 3); 5) mobilidade dos folhetos (escore 1 a 4) e 6) Espessura dos folhetos (escore 1 a 3). A presença de trombos em átrio esquerdo foi avaliada pela varredura multiplanar do átrio e apêndice atrial esquerdos no estudo transesofágico. RESULTADOS: Não houve diferença significativa na textura dos folhetos da bioprótese mitral entre os dois grupos, tanto para o escore total (8,7±2,4 vs 7,9±2,1, p=0,259), quanto para cada item analisado. Maior incidência de trombos encontrada em átrio e apêndice atrial esquerdos nos pacientes com disfunção ventricular (65% vs 20%, p=0,004). CONCLUSÃO: A disfunção ventricular esquerda não foi fator protetor da textura dos folhetos da bioprótese em posição mitral no período pós-operatório tardio. Os pacientes com disfunção ventricular esquerda apresentam um ambiente mais propício à formação de trombos em átrio esquerdo.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Facing the hypothesis of participation of mechanical stress as a cause of mitral bioprosthesis dysfunction, we decided to assess the relation of preservation of the texture of the mitral bioprosthesis leaflets with left ventricular function, in addition to the casual formation of thrombus in left atrium in patients with left ventricular dysfunction from the implant of mitral bioprosthesis. METHODS: Forty 40 patients with mitral bioprosthesis through multiplane transesophageal echocardiogram were studied and divided in two groups: with left ventricular dysfunction (FE=0.40±0.09) since the bioprosthesis implant (20 patients: age 47.75±11.10 years old and surgery time 5.3±2.6 years) and with normal left ventricular function (FE=0.73±0.06) since the implant (20 patients: age 49.75±13.59 years old and surgery time 5.7±3 years). The texture of bioprosthesis leaflets was analyzed through a transesophageal echocardiographic score (FACIMT Bioscore): 1) Fusion of leaflets (score 1 to 3); 2) Apposition of tissues (score 1 to 3); 3) Calcium in leaflets (score 1 to 5); 4) Integrity of leaflets (score 1 to 3); 5) Motility of leaflets (score 1 to 4) and 6) Thickness of leaflets (score 1 to 3). The presence of thrombi in left atrium was assessed through multiplane scanning of the left atrium and left atrial appendage in the transesophageal study. RESULTS: There was no significant difference in the texture of bioprosthesis mitral position between the groups, for the total score (8.7±2.4 vs. 7.9±2.1, p=0.259), and for each analyzed item. A greater incidence of thrombi in left atrium and left atrial appendage was detected in patients with ventricular dysfunction (65% vs. 20%, p=0.004). CONCLUSION: The left ventricular dysfunction was not a protecting factor of the texture of bioprosthesis leaflets in mitral position in the tardive post-surgery period. The patients with left ventricular dysfunction showed a more favorable environment for the formation of thrombi in left atrium.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>bioprótese mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função ventricular esquerda</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia transesofágica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>formação de trombos</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral bioprosthesis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>transesophageal echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>formation of thrombi</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Tendência temporal de letalidade hospitalar por infarto agudo do miocárdio: 1994-2003</s1>
</fA08>
<fA08 dir="en">
<s1>Temporal tendency of in-hospital lethality due to acute myocardial infarction: 1994-2003</s1>
</fA08>
<fA11 dir="011000">
<s1>Marco Antonio de Mattos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Daniele Gusmão Toledo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Eduardo de Mattos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Bernardo Rangel Tura</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Diego Neri Benevides Gadelha</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Aristarco Gonçalves de Siqueira Filho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Nacional de Cardiologia Laranjeiras  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal do Rio de Janeiro  </s1>
<s2>Rio de Janeiro </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>416-421</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>54</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400512</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar a tendência temporal de letalidade atribuída ao infarto agudo do miocárdio (IAM) e se a mudança de conduta interferiu diretamente nesta letalidade. MÉTODOS: Avaliaram-se 1055 pacientes não selecionados internados em unidade coronariana de 1994-2003. Foram analisadas variáveis relacionadas ao perfil clínico e terapêutico. A análise estatística utilizou o amortecimento exponencial de séries temporais e outras técnicas como a regressão linear logística. RESULTADOS: A letalidade média foi de 10,8%, sendo 12% em 1994 e 7% em 2002 (p=0,000), uma redução relativa de 58%. Não houve variação significativa do perfil de risco dos pacientes. Eram 67,4% homens e 32,4% mulheres, com idade média de 60,93 e 64,84 anos, respectivamente e observou-se aumento significativo no percentual de cateterismos cardíacos (de 14% para 51%), na angioplastia realizada após 24 horas do infarto (de 2% para 33%), na cirurgia de revascularização miocárdica (de 4% para 7%) e na angioplastia primária (de 4% para 11%) com p=0,000, p=0,021, p=0,000 e p=0,000, respectivamente, para tendência linear. Nas primeiras 24 horas houve aumento do uso de aspirina e betabloqueadores, de 78% para 100% e, de 33% para 76% (p=0,003 e p=0,004, respectivamente) ao longo dos anos. Após a análise, persistiram como determinantes de letalidade a terapia de reperfusão miocárdica, a utilização de aspirina e de betabloqueador nas primeiras 24 horas do IAM (p=0,010, p=0,024 e p=0,035, respectivamente). CONCLUSÃO: Houve queda da letalidade e a mudança de conduta no tratamento do IAM ao longo dos anos foi responsável pela redução da letalidade nesta série temporal.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the temporal tendency of lethality due to acute myocardial infarction (AMI) and if the change in behavior directly interfered in such lethality. METHODS: 1055 non-selected patients, who were hospitalized in coronary unit from 1994 to 2003, were assessed. Clinical and therapeutic profile-related variables were analyzed. The statistic analysis used the exponential damping of temporal series and other techniques, such as the logistic linear regression. RESULTS: The average lethality was 10.8%, being 12% in 1994 and 7% in 2002 (p=0.000), a relative reduction of 58%. There was no significant variation in the risk profile of the patients. There were 67.4% of men and 32.4% of women, with an average age of 60.93 and 64.84 years old, respectively. It was observed a significant increase in the percentage of cardiac catheterization (from 14% to 51%), in the angioplasty carried out 24 hours after the infarction (from 2% to 33%), in the surgery for myocardial revascularization (from 4% to 7%) and in the primary angioplasty (from 4% to 11%) with p=0.000, p=0.021, p=0.000 and p=0.000, respectively, for linear tendency. In the first 24 hours there was an increase of the use of aspirin and beta-blockers, from 78% to 100% and, from 33% to 76% (p=0.003 and p=0.004, respectively) along the years. After the analysis, the myocardial reperfusion therapy, the use of aspirin and beta-blocker in the first 24 hours of the AMI (p=0.010, p=0.024 and p=0.035, respectively) kept on being lethality determiners. CONCLUSION: There was a decrease in lethality and the change of behavior in the treatment of AMI along the years was responsible for the reduction of lethality in that temporal series.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tendência temporal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>letalidade hospitalar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto agudo do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>temporal tendency</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>in-hospital lethality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Custo da insuficiência cardíaca no Sistema Único de Saúde</s1>
</fA08>
<fA08 dir="en">
<s1>Cost of heart failure in the Unified Health System</s1>
</fA08>
<fA11 dir="011000">
<s1>Denizar Vianna Araujo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leandro Reis Tavares</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Renata Veríssimo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcos Bosi Ferraz</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Escola Paulista de Medicina  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal Fluminense  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>422-427</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400513</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Descrever custo direto e indireto do tratamento ambulatorial e hospitalar da insuficiência cardíaca, durante 2002, no Hospital Universitário Antônio Pedro, Niterói. MÉTODOS: Estudo transversal, retrospectivo sobre utilização e valoração de recursos em 70 pacientes, selecionados de forma consecutiva, em tratamento ambulatorial e hospitalar. Foram utilizados questionários e prontuários dos pacientes para coleta dos dados. Os recursos utilizados foram valorados em reais (ano 2002). O ponto de vista do estudo foi a perspectiva da sociedade. Os dados foram analisados no programa EPINFO, versão 2002. RESULTADOS: A população estudada constou de 70 pacientes (39 mulheres), idade média de 60,3 anos. Ocorreram 465 diárias hospitalares (28,5% dos pacientes). Houve 386 internações em enfermaria e 79 em unidade de tratamento intensivo. O custo com consulta ambulatorial foi de R$ 14,40. O gasto com medicamentos ambulatoriais totalizou R$ 83.430,00 (custo por paciente/ano de R$ 1.191,86). O custo por paciente internado foi de R$ 4.033,62. O custo com exames complementares totalizou R$ 39.009,50 (custo por paciente/ ano de R$ 557,28). Foram aposentados pela insuficiência cardíaca 20 pacientes, representando perda de produtividade de R$ 182.000,00. O custo total foi de R$ 444.445,20. Hospitalização representou 39,7% e a utilização de medicamentos 38,3% do custo direto. CONCLUSÃO: O custo com hospitalização e os gastos com medicamentos representaram os principais componentes do custo direto. Os custos indiretos representaram impactos econômicos semelhantes aos custos diretos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To describe the direct and indirect costs of ambulatory and in-patient treatments of heart failure during 2002, in the University Hospital Antônio Pedro, Niterói. METHODS: A cross-sectional and retrospective study on utilization and valuation of resources in 70 patients, consecutively selected, under ambulatory and in-patient treatment. Questionnaires and records of the patients were used for data collection. The resources used were valuated in Brazilian Reais (2002). The study's point of view was the perspective from society. The data were analyzed in the EPINFO program, 2002 version. RESULTS: The studied population consisted of 70 patients (39 women), with average age of 60.3 years old. 465 in-patients days (28.5% of the patients) took place. There were 386 ward hospitalizations and 79 in ICUs. The cost with ambulatory appointments was R$ 14.40. The expenses with ambulatory medications amounted R$ 83,430.00 (R$ 1,191.86/patient/year). The cost per hospitalized patient was R$ 4,033.62. The cost with complementary examinations totaled R$ 39,009.50 (R$ 557.28/patient/year). Twenty patients retired due to heart failure, which represented a loss in productivity of R$ 182,000.00. The total cost was R$ 444,445.20. Hospitalization represented 39.7% and the use of medications 38.3% from direct costs. CONCLUSION: The hospitalization cost and the expenses with medications represented the main components of direct costs. Indirect costs represented economic impacts similar to direct costs.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>custo da doença</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>economia da saúde</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cost of disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>health economy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Ressonância magnética em paciente portadora de marcapasso</s1>
</fA08>
<fA08 dir="en">
<s1>Magnetic resonance imaging in a patient with pacemaker</s1>
</fA08>
<fA11 dir="011000">
<s1>Jaime Giovany Arnez Maldonado</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Euda Pereira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Karina Rabelo de Albuquerque</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jorge Pires</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Santa Julia Serviço de Eletrofisiologia e Marcapasso </s1>
<s2>Manaus </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital Universitário Dona Francisca Mendes  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>428-430</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400514</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Mulher de 24 anos, portadora de marcapasso dupla câmara, com hipertensão intracraniana e perda visual progressiva, e vários exames de tomografia de crânio inconclusivos. Foi submetida à Ressonância Magnética, mesmo sendo este método diagnóstico uma contra-indicação absoluta em portadores de marcapasso.</s0>
</fC01>
<fC01 dir="en">
<s0>The patient is a 24-year-old female with a dual-chamber pacemaker, who had intracranial hypertension, progressive visual loss, and several inconclusive cranial tomographies. She underwent magnetic resonance imaging, even though that diagnostic method is absolutely contraindicated in patients with pacemakers.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Diretriz de Reabilitação Cardíaca</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>431-440</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400515</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Correção</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>0-0</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400516</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>&quot;Tempo é vida&quot;: um dever de conscientização da morte súbita</s1>
</fA08>
<fA08 dir="en">
<s1>&quot;Time is life&quot;: a duty of awareness on sudden death</s1>
</fA08>
<fA11 dir="011000">
<s1>Manoel Fernandes Canesin</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sergio Timermam</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Flávio Rocha Brito Marques</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Dario Ferreira</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Irani Ribeiro de Moura</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Londrina  </s1>
<s2>Londrina PR</s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Ministério da Saúde  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>441-442</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Chlamydia pneumoniae e Mycoplasma pneumoniae nos nódulos de calcificação da estenose da valva aórtica</s1>
</fA08>
<fA08 dir="en">
<s1>Chlamydia pneumoniae and Mycoplasma pneumoniae in calcified nodes of stenosed aortic valves</s1>
</fA08>
<fA11 dir="011000">
<s1>Marilia Harumi Higuchi-dos-Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Humberto Pierri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria de Lourdes Higuchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Amit Nussbacher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sueli Palomino</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Nadia Vieira Sambiase</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Maurício Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>443-448</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Investigar se chlamydia pneumoniae (CP) ou mycoplasma pneumoniae (MP) estão presentes na estenose da valva aórtica (EA). MÉTODOS: Imuno-histoquímica foi utilizada para identificar os antígenos de CP (Ag-CP), a hibridização in situ para identificar o DNA de MP, e microscopia eletrônica para avaliação dos dois agentes, nos grupos: normal - 11 valvas normais de autópsia; aterosclerose - 10 valvas de pacientes com aterosclerose sistêmica de autópsia e sem EA; e EA - 14 espécimes cirúrgicos provenientes de pacientes com EA analisados em 3 sub-regiões: EA-preservada - regiões mais preservadas na periferia da valva; EA-fibrose - tecido fibrótico peri-calcificação; e EA-calcificação - nódulos calcificados. RESULTADOS: As medianas da fração de área positiva para Ag-CP foram 0,09; 0,30; 0,18; 1,33; e 3,3 nos grupos acima descritos, respectivamente. A densidade de CP foi significativamente maior nos grupos aterosclerose e EA-calcificação em relação ao normal (p&lt;0,05). Dentro do grupo EA, a quantidade de CP foi maior nas regiões de fibrose e calcificação (p&lt;0,05). As frações de área positivas para MP-DNA (medianas) foram 0,12; 0,44; 0,07; 0,36; e 1,52 nos grupos acima descritos, respectivamente. A quantidade de MP-DNA foi maior na EA-calcificação em relação ao normal (p&lt;0,05). Dentro do grupo EA, maior quantidade de MP-DNA foi encontrada nas regiões de calcificação e fibrose (p&lt;0,05). CONCLUSÃO: Os nódulos de calcificação da EA tinham maior concentração de CP e MP sugerindo que essas bactérias possam estar associadas ao desenvolvimento de calcificação e inflamação, apontando novas semelhanças entre os processos de EA e aterosclerose, que podem ter mecanismos infecciosos envolvidos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: We investigated whether Chlamydia pneumoniae (CP) and Mycoplasma pneumoniae (MP) are present in aortic valve stenosis (AS). METHODS: Immunohistochemistry was utilized to identify CP antigens, in situ hybridization to identify MP DNA, and electron microscopy was used to evaluate the following three groups: Normal - 11 normal autopsy valves; Atherosclerosis - 10 autopsy valves from patients with systemic atherosclerosis and no AS; and AS - 14 surgical specimens of AS analyzed in 3 sub-regions: AS-Preserved - peripheral, preserved regions; AS-Fibrosis - peri-calcified fibrotic tissue; and AS-Calcification - calcified nodules. RESULTS: The positive area fraction of CP antigen median values were 0.09, 0.30, 0.18, 1.33, and 3.3 in groups Normal, Atherosclerosis, AS-Preserved, AS-Fibrosis, and AS-Calcification, respectively. CP density was significantly greater in Atherosclerosis and AS-Calcification than in Normal (P&lt;0.05). Within the AS group, the amount of CP was greater in the Calcification and Fibrosis regions (P&lt;0.05). MP-DNA positive area fraction (median values) were 0.12, 0.44, 0.07, 0.36, and 1.52 in groups Normal, Atherosclerosis, AS-Preserved, AS-Fibrosis, and AS-Calcification, respectively. The amount of MP-DNA was greater in AS-Calcification than in Normal (P&lt;0.05). Within the AS group, MP-DNA was in larger quantity in the Calcification and Fibrosis regions (P&lt;0.05). CONCLUSION: AS Calcified nodes present higher concentration of CP and MP suggesting that these bacteria may be associated with the development of calcification and inflammation. This adds novel similarities between AS and the atherosclerosis process, which may have infection mechanisms involved.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mycoplasma pneumoniae</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>chlamydia pneumoniae</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose da valva aórtica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aterosclerose</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>idoso</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Mycoplasma pneumoniae</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chlamydia pneumoniae</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Aortic Valve Stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Elderly</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Análise do atendimento intra-hospitalar de eventos simulados de fibrilação ventricular/taquicardia ventricular</s1>
</fA08>
<fA08 dir="en">
<s1>Analysis of the intra-hospital attending of ventricular fibrilation/ventricular taquicardia simulated events</s1>
</fA08>
<fA11 dir="011000">
<s1>Miguel Antônio Moretti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>André Moreira Bento</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ana Paula Quilici</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Márcia Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luís Francisco Cardoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sérgio Timerman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>449-451</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar os intervalos de tempo entre o início da Fibrilação Ventricular/Taquicardia Ventricular (FV/TV) e os principais procedimentos realizados. MÉTODOS: Foram realizadas e filmadas 20 simulações de FV/TV em ambiente hospitalar, utilizando-se manequim estático, ocorridas em dia e hora aleatórios. Todas as equipes tinham o mesmo nível de habilidades. Foram analisados os tempos (em s) relativos ao suporte básico de vida (SBV) - chegada da equipe (TC) confirmação da parada (TCP) início da RCP (TI) e os tempos relativos ao suporte avançado de vida (SAV) - 1º desfibrilação (TD) 1º dose de adrenalina (TA) e intubação orotraqueal (TIOT). As variáveis foram analisadas e comparadas em dois grupos: unidade de cuidados intensivos (UCI) e enfermarias com telemetria (ETL). RESULTADOS: ETL x UCI respectivamente - TC (70,2+38,7 x 38,6+49,2); TCP (89,4+57,1 x 71+63,9); TI (166,8+81,1 x 142+66,2); TD (282,5+142,8 x 108,4+52,5); TA (401,4+161,7 x 263,3+122,8) e TIOT (470,3+150,6 x 278,8+98,8). Apresenta a comparação das médias de tempos entre os dois grupos. CONCLUSÃO: As diferenças observadas em relação a TD, TA e TIOT favoráveis à UCI estão associadas às facilidades de realização das manobras de SAV nesse ambiente. Os tempos relacionados ao SBV foram semelhantes nos dois grupos, reforçando a necessidade do uso de desfibriladores semi-automáticos mesmo em ambiente hospitalar.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the time intervals between the beginning of the Ventricular Fibrilation/Ventricular Taquicardia (VF/VT) and the main procedures made. METHODS: Twenty VF/VT simulations were performed and filmed in a hospital environment, using a static mannequin, on random days at random times. All teams had the same level of skills. The times (in sec.) related to basic life support (BLS) - arrival of the team (AT), confirmation of the arrest (CAT), beginning of the CPR (IT) and the times related to the advanced life support (ALS) - 1st defibrillation (DT), 1st dose of adrenalin (AT) and orotracheal intubation (OTIT). The variables were analyzed and compared in two groups: intensive care unit (ICU) and wards with telemetry (TLW). RESULTS:The results in both groups was in that order (GW x ICU ) - AT (70.2+38.7 x 38.6+49.2); CCA (89.4+57.1 x 71+63.9); SC (166.8+81.1 x 142+66.2); FD (282.5+142.8 x 108.4+52.5); FE (401.4+161.7 x 263.3+122.8) e OI (470.3+150.6x278.8+98.8). Shows the comparison of the average times between the two groups. CONCLUSION: The differences noted in relation to DT, AT and OTIT favorable to ICU are associated to the facility of performance of the ALS maneuvers in such environment. The BLS-related times were similar in both groups, which reinforce the need for the use of semi-automatic defibrillators, even in a hospital environment.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>atendimento intra-hospitalar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>eventos simulados</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>FV/TV</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>intra-hospital attending</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>simulated events</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>VF/VT</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Função do átrio esquerdo na miocardiopatia chagásica</s1>
</fA08>
<fA08 dir="en">
<s1>Function of the left atrium in the Chagas' cardiomyopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria do Carmo Pereira Nunes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Márcia de Melo Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Édson Siqueira da Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Manoel Otávio da Costa Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Minas Gerais Serviço de Ecocardiografia Ecocenter Hospital Socor</s1>
<s2>Belo Horizonte MG</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>452-456</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar a função do átrio esquerdo em portadores de miocardiopatia dilatada de etiologia chagásica e correlacioná-la à função diastólica e à classe funcional. MÉTODOS: Estudados 75 portadores de miocardiopatia chagásica de julho de 1999 a maio de 2001, submetidos a exame clínico, eletrocardiograma e ecocardiograma transesofágico. A função do átrio esquerdo foi avaliada por meio das velocidades no apêndice atrial esquerdo e do reverso atrial na veia pulmonar. O grupo controle constou de 20 pacientes normais. RESULTADOS: A idade foi de 48±13 anos e 69% eram homens. A maioria dos pacientes estava em classe funcional I e II (88%), em tratamento convencional para insuficiência cardíaca. A fração de ejeção do ventrículo esquerdo foi de 39±13%. Os indicadores de função diastólica associaram-se aos de função sistólica e à classe funcional. Os portadores de padrão pseudonormal ou restritivo de disfunção diastólica apresentavam maior diâmetro do átrio esquerdo, menores velocidades do fluxo no apêndice atrial esquerdo, e maior duração do reverso atrial. Não houve diferença entre os pacientes com padrão normal e relaxamento diastólico anormal em relação ao grupo controle. CONCLUSÃO: A função atrial esquerda constitui um importante parâmetro na avaliação dos pacientes com miocardiopatia chagásica, e relaciona-se às funções sistólica e diastólica do ventrículo esquerdo.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study the function of the left atrium in carriers of dilated cardiomyopathy of chagasic etiology and relate it to the diastolic function and to the functional class. METHODS: We studied 75 chagasic with cardiomyopathy patients from July to 1999 to May to 2001, submitted to clinical exams, electrocardiogram and transesophageal echocardiogram. The left atrium function was assessed by means of the velocities in the left atrial appendix and the atrial reverse in the pulmonary vein. The control group consisted of 20 normal patients. RESULTS: The age was 48±13 years old and 69% were men. Most of patients (88%) were in functional classes I and II, under a conventional treatment for cardiac insufficiency. The fraction of ejection of the left ventricle was 39±13%. The indicators of diastolic function associate to those of systolic function and the functional class. Patients with pseudonormal or restrictive pattern of diastolic dysfunction presented a larger diameter of the left atrium, lower flow velocities in the left atrial appendix and a longer duration of the atrial reverse. There was no difference among the patients with normal pattern and abnormal diastolic relaxation in relation to the control group. CONCLUSION: The left atrial function is an important parameter in the assessment of patients with chagasic myocardiopathy and it is related to the systolic and diastolic functions of the left ventricle.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença de Chagas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>miocardiopatia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>átrio esquerdo e ecocardiograma transesofágico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chagas' disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left atrium and transesophageal echocardiogram</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação funcional do apêndice atrial esquerdo ao ecocardiograma transesofágico antes e após valvotomia percutânea na estenose mitral</s1>
</fA08>
<fA08 dir="en">
<s1>Functional assessment of the left atrial appendage at transesophageal echocardiography before and after percutaneous valvotomy in the mitral stenosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Solange Bernardes Tatani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Orlando Campos Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Claudio Henrique Fischer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Valdir Ambrósio Moisés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Augusto Marcondes de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cláudia Maria Rodrigues Alves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Angelo Amato Vincenzo de Paola</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Antonio Carlos C. Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo - UNIFESP  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>457-460</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar os efeitos da abertura efetiva da valva mitral estenótica através da valvotomia percutânea por cateter balão na função do apêndice atrial esquerdo. MÉTODOS: Foram estudados 12 pacientes com estenose mitral sintomática, em ritmo sinusal, submetidos ao ecocardiograma transesofágico antes e após valvotomia percutânea por cateter balão efetiva. Em relação ao apêndice atrial esquerdo, foram analisadas ao Doppler pulsátil as velocidades máximas e respectivas integrais dos fluxos anterógrado e retrógrado, além da fração de ejeção calculada pela planimetria da área desta estrutura. RESULTADOS: Houve aumento significante das velocidades de fluxo anterógrado do apêndice atrial esquerdo após valvotomia percutânea por cateter balão (pré: média de 0,30 m/s; pós: média de 0,47 m/s; p&lt;0,05) e de suas respectivas integrais. O mesmo ocorreu com as velocidades de fluxo retrógrado (pré: média de 0,35 m/s, pós: média de 0,53 m/s; p&lt;0,05). Houve tendência de aumento da fração de ejeção do apêndice atrial esquerdo após o procedimento (pré: média de 20%, pós: média de 31%; p=0,08). CONCLUSÃO: A abertura efetiva do orifício mitral estenosado decorrente da valvotomia percutânea por cateter balão determinou melhora do padrão de fluxo do apêndice atrial esquerdo, o que potencialmente pode contribuir para redução do risco embólico.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effects of the relief of the mitral stenosis by percutaneous ballon valvotomy in the function of the left atrial appendage. METHODS: Twelve patients with symptomatic mitral stenosis, in sinus rhythm, were studied. They were submitted to the transesophageal echocardiogram before and after effective percutaneous ballon valvotomy. Concerning the left atrial appendage, the peak flow velocities and the respective integral of the anterograde and retrograde flow, in addition to the ejection fraction calculated through the planimetry of the area of that structure, were analyzed at the pulsatile Doppler. RESULTS: There was a significant increase of the anterograde flow velocity of the left atrial appendage after percutaneous ballon valvotomy (pre: mean of 0.30 m/s; post: mean of 0.47 m/s; p&lt;0.05) and their respective integrals. The same happened with the retrograde flow velocity (pre: mean of 0.35 m/s, post: mean of 0.53 m/s; p&lt;0.05). There was a tendency of increase of the ejection fraction of the left atrial appendage after the procedure (pre: mean of 20%, post: mean of 31%; p=0.08). CONCLUSION: The effective opening of the stenosed mitral orifice resulting from the percutaneous ballon valvotomy determined an improvement of the flow pattern of the left atrial appendage, which can potentially contribute for the reduction of the embolic risk.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma transesofágico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>apêndice atrial esquerdo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvotomia percutânea por cateter balão</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>transesophageal echocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left atrial appendage</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous ballon valvotomy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Disfunção diastólica em pacientes diabéticos normotensos, independente da presença de microangiopatia</s1>
</fA08>
<fA08 dir="en">
<s1>Diastolic dysfunction in diabetic normotensive patients, regardless of the presence of microangiopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>João Carlos Ferreira Braga</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fábio Villaça Guimarães Filho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Roberto Padovani</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Beatriz B. Matsubara</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade Estadual de Medicina de Marília  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Faculdade de Medicina de Botucatu Marília  </s1>
<s2>Botucatu SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>461-466</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar as alterações Doppler-ecocardiográficas de pacientes normotensos, com diabetes mellitus tipo II, na presença ou ausência de sinais de microangiopatia. MÉTODOS: Pacientes com diabetes mellitus tipo II foram submetidos a exames de fundo de olho contrastado com fluoresceína e dosagem de microalbuminúria para diagnóstico de microangiopatia, e divididos em dois grupos: DMII (pacientes sem microangiopatia, n=19) e DM+A (pacientes com microangiopatia, n=13). Todos foram submetidos a Doppler-ecocardiografia e os resultados comparados com normotensos de mesmo sexo e idade (grupo C, n=20), aplicando-se a ANOVA, seguida de teste de Tukey. Em todas as comparações, adotou-se como nível de significância p&lt;0,05. RESULTADOS: Não houve diferenças entre os grupos quanto aos indicadores de função sistólica ou massa do ventrículo esquerdo. Foram observadas diferenças compatíveis com disfunção diastólica nos dois grupos de diabéticos, independente da presença de microangiopatia, que exibiram valores significativamente maiores dos tempos de relaxamento isovolumétrico do ventrículo esquerdo (TRIVE, ms): (DMII=97±22,2; DM+A=107±28,2 e C=80±10,7; p&lt;0,05), e menores das velocidades máximas da onda de enchimento ventricular rápido (E, cm/s): (DMII=69±17,5; DM+A=75±19,7 e C=84±14,5, p&lt;0,05 entre DMII e C). Sem diferença entre os grupos quanto à razão E/A. CONCLUSÃO: Pacientes normotensos com diabetes mellitus tipo II e sem sinais clínicos de comprometimento cardiovascular, apresentaram sinais de disfunção diastólica não associados à presença de microangiopatia.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the Doppler-echocardiographic changes in normotensive patients with type II diabetes mellitus, in the presence or absence of signs of microangiopathy. METHODS: Patients with type II diabetes mellitus were submitted to funduscopy contrasted with fluorescein and dosage of microalbuminuria for diagnose of microangiopathy and divided into two groups: DMII (patients without microangiopathy, n=19) and DM+A (patients with microangiopathy, n=13). All of them were submitted to a Doppler-echocardiography and the results were compared with normotensive patients of same sex and age (group C, n=20), by using the ANOVA, followed by the test of Tukey. In all comparisons the significance level p&lt;0.05 was adopted. RESULTS: There were no differences among the groups regarding the systolic function indicators or left ventricular mass. Differences compatible with diastolic dysfunction in the two groups of diabetic were observed, regardless of the presence of microangiopathy, which showed significantly higher values of the times of isovolumetric relaxation of the left ventricle (TIRLV, ms): (DMII= 97±22.2; DM+A= 107±28.2 and C= 80±10.7; p&lt;0.05), and lower values of the maximum speeds of the wave of fast ventricular filling (E, cm/s): (DMII= 69±17.5; DM+A= 75±19.7 and C= 84±14.5, p&lt;0.05 between DMII and C). There was no difference among the groups concerning the E/A rate. CONCLUSION: Normotensive patients with type II diabetes mellitus and without clinical signs of cardiovascular compromising showed signs of diastolic dysfunction, non-associated to the presence of microangiopathy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ventrículo esquerdo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiomiopatia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>diabetes mellitus</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricle</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiomiopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diabetes mellitus</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Pesquisa de marcadores para os genes da cadeia pesada da beta-miosina cardíaca e da proteína C de ligação à miosina em familiares de pacientes com cardiomiopatia hipertrófica</s1>
</fA08>
<fA08 dir="en">
<s1>Research of markers for the genes of the heavy chain of cardiac beta-myosin and myosin binding protein C in relatives of patients with hypertrophic cardiomyopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>Adriana Paula Tirone</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alexandre da Costa Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Eduardo Krieger</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paula de Cássia Buck</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Barbara Maria Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>467-472</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>43</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar os marcadores moleculares para os genes da cadeia pesada da beta-miosina cardíaca e da proteína-C de ligação à miosina em familiares de portadores de cardiomiopatia hipertrófica. MÉTODOS: Foram estudadas 12 famílias que realizaram anamnese, exame físico, eletrocardiograma, ecocardiograma e coleta de sangue para o estudo genético através da reação em cadeia da polimerasse. RESULTADOS: Dos 227 familiares 25% eram acometidos, sendo 51% do sexo masculino com idade média de 35±19 (2 a 95) anos. A análise genética mostrou ligação com o gene da b-miosina cardíaca em uma família e, em outra, ligação com o gene da proteína C de ligação à miosina. Em cinco famílias foram excluídas ligações com os dois genes; em duas, a ligação com o gene da proteína C de ligação à miosina, porém para o gene da b-miosina os resultados foram inconclusivos; em duas famílias os resultados foram inconclusivos para os dois genes e em uma foi excluída ligação para o gene da b-miosina mas ficou inconclusivo para o gene da proteína C de ligação à miosina. CONCLUSÃO: Em nosso meio, talvez predominem outros genes que não aqueles descritos na literatura, ou que existam outras diferenças genéticas relacionadas com a origem de nossa população e/ou fatores ambientais.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study the molecular markers for the genes of the heavy chain of cardiac beta-myosin and the myosin binding protein C in relatives of carriers of hypertrophic cardiomyopathy. METHODS: Twelve families who had anamnesis, physical exam, electrocardiogram, echocardiogram and blood collection for the genetic study through the chain reaction of polymerase. RESULTS: From the 227 relatives, 25% were ill-taken, with 51% men, with an average age of 35±19 (2 to 95) years old. The genetic analysis showed a connection with the gene of the cardiac b-myosin in a family and, in another, a connection with the gene of the myosin-binding protein C. In five families, the connections with the two genes were excluded; in two, the connection with the gene of the myosin-binding protein C, but for the b-myosin gene the results were non-conclusive; in two families, the results were non-conclusive for both genes and in one the connection for the b-myosin gene was excluded. The results were non-conclusive for the gene of the myosin-binding protein C. CONCLUSION: In our environment, other genes, different from those described in the literature, may prevail, or there are other genetic differences related to the origin of our population and/or environmental factors.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiomiopatia hipertrófica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mutação</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>beta-miosina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>gene da proteína C de ligação à miosina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>genética</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertrophic cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mutation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>beta-myosin</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>gene of the myosin-binding protein C</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>genetics</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Programa domiciliar de exercícios: efeitos de curto prazo sobre a aptidão física e pressão arterial de indivíduos hipertensos</s1>
</fA08>
<fA08 dir="en">
<s1>Home exercise program: short term effects on physical aptitude and blood pressure in hypertensive individuals</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo de Tarso Veras Farinatti</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo Brandão de Oliveira</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vivian Liane Mattos Pinto</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Walace David Monteiro</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Emílio Francischetti</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Grupo Amil Total-Care </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Universidade Gama Filho  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>473-479</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>41</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Observar a influência de quatro meses de um programa domiciliar não-supervisionado de exercícios sobre a pressão arterial (PA) e aptidão física em hipertensos. MÉTODOS: Foram observados um grupo experimental com 26 homens e 52 mulheres e um grupo controle, com 9 homens e 7 mulheres, com idades entre 25 e 77 anos. O grupo experimental submeteu-se a um programa domiciliar de exercícios, com atividades aeróbias (60-80% da FC máxima para a idade, 30min de caminhadas no mínimo três vezes por semana), exercícios de flexibilidade. Orientações sobre a ficha de controle e o treinamento eram dadas a cada reavaliação. Foram acompanhados por quatro meses, com reavaliações a cada dois meses, observando-se: PA em repouso; peso corporal, relação cintura-quadril (RCQ), percentual de gordura (%G), somatório de dobras cutâneas (SOMD) e relação central e periférica de dobras (P/C); flexibilidade de tronco (FX); relação entre freqüência cardíaca e carga de trabalho durante teste submáximo em ciclo-ergômetro (FC/W), traduzida pela inclinação da curva de regressão entre ambas (a). RESULTADOS: O grupo experimental exibiu alterações significativas para o peso (-3,7 kg), RCQ (-0,03), SOMD (-12 mm), %G (-4,4%), FX (+2,3 cm), FC/W (-0,02) e PA (-6 e -9 mmHg para pressão sistólica e diastólica, respectivamente). O grupo controle teve pequenas alterações no peso (+1,3 Kg) e %G (+1,7%). CONCLUSÃO: Programas domiciliares não supervisionados de exercícios, podem exercer efeito positivo sobre a PA e aptidão física de hipertensos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To observe the influence of a four-month-unsupervised-exercise program performed at home on the blood pressure (BP) and physical performance in hypertensive adults. METHODS: A target group with 26 men and 52 women, and a control group with 9 men and 7 women were observed, with ages ranging from 25 to 77 years old. The target group underwent a home exercise program, basically with aerobic activity (60-80% of the estimated maximum heart rate for the age, 30min of walking at least 3 times a week), in addition to the flexibility exercises. Guidelines on the control chart and variables that could influence the treatment were given at each assessment. Patients were followed-up for four months, with assessments every 2 months observing: BP at rest; body weight, waist-hip ratio (W/HR), body fat percentage (%F), sum of skinfold measurements (SM) and central-peripheral skinfold ratio (C/P); trunk flexibility (TF); heart rate and workload ratio during submaximal test in cycle ergometer (HR/W), represented by the regression curve inclination between both (a). RESULTS: The target group demonstrated significant alterations in weight (-3.7 kg), WHR (-0.03), SM (-12 mm), %F (-4.4%), TF (+2.3 cm), HR/W (-0.02) and BP (-6 and -9 mmHg for systolic and diastolic pressure respectively). The control group presented small weight alterations (+1.3 Kg) and %F (+1.7%). CONCLUSION: Unsupervised exercise home programs, even in short term, may present positive effects on the blood pressure and physical performance in hypertensive individuals.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Saúde</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>adesão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença cardiovascular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>atividade física</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Health</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>physical activity</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Repercussão nutricional na insuficiência cardíaca avançada e seu valor na avaliação prognóstica</s1>
</fA08>
<fA08 dir="en">
<s1>Nutritional repercussion in advanced heart failure and its value in prognostic assessment</s1>
</fA08>
<fA11 dir="011000">
<s1>Luís Guilherme Veloso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mucio Tavares de Oliveira Junior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Robson Tadeu Munhoz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Cesar Morgado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>480-485</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar a repercussão nutricional na insuficiência cardíaca e suas relações com a disfunção ventricular esquerda e a mortalidade. MÉTODOS: Estudou-se uma série de parâmetros nutricionais num grupo de 95 pacientes com insuficiência cardíaca crônica avançada decorrente de cardiomiopatia dilatada e idade &lt; 65 anos, sem evidências de doenças concomitantes. Foram verificados a duração dos sintomas, o diâmetro diastólico final e a fração de ejeção do ventrículo esquerdo. A avaliação nutricional incluiu a percentagem ideal do peso, a espessura da prega tricipital, os percentis da circunferência da massa muscular do braço, os níveis séricos de albumina e a contagem global dos linfócitos. RESULTADOS: A situação nutricional esteve alterada em 45,3% a 94,7% dos pacientes conforme o parâmetro da avaliação empregado. Não houve correlação entre os parâmetros nutricionais e a duração dos sintomas, nem com o grau de disfunção ventricular. Este grupo de pacientes teve uma evolução homogênea e 75,8% dos pacientes faleceram num tempo médio de 21,86 semanas. O diâmetro diastólico e a fração de ejeção do ventrículo esquerdo não permitiram predizer a sobrevida. Uma massa corpórea diminuída identificou um grupo com maior risco de morte. A percentagem ideal do peso corpóreo foi preditiva da sobrevida (p=0,0352), os pacientes com menos de 80% do peso ideal tiveram um risco relativo maior de morte de 1,99 (1,12-3,02) (p=0,0132). CONCLUSÃO: A desnutrição é freqüente nos pacientes com insuficiência cardíaca avançada e cardiomiopatia dilatada. A massa corpórea reduzida foi melhor preditor de sobrevida do que a fração de ejeção do ventrículo esquerdo, nos pacientes em fase avançada de comprometimento miocárdico.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the nutritional repercussion in heart failure and its relations with left ventricular dysfunction and mortality. METHODS: A series of nutritional parameters in a group of 95 patients with advanced chronic heart failure, arising out of dilated cardiomyopathy and age &lt; 65 years old, without concomitant diseases was studied. The duration of symptons, final diastolic diameter and left ventricular ejection fraction were verified. The nutritional assessment, included the ideal percentage of weight the triceps skin fold thickness, percentiles of circumference of muscular mass of the arm, the albumin serum levels and the lymphocytes global count. RESULTS: The nutritional situation was alterated in 45.3% to 94.7% of the patients in accordance to the assessment parameter used. There was neither correlation between the nutritional parameters and the length of symptoms, nor with the ventricular dysfunction level. That group of patients had a homogenous evolution, and 75.8% of them died in an average time of 21.86 weeks. The left ventricular diastolic diameter and ejection fraction did not allow for the prediction of survival. A diminished body mass identified a group with higher risk of death. The ideal percentage of the body mass was predictive of survival (p=0.0352), the patients with less than 80% of ideal weight had a higher relative risk of death of 1.99 (1.12-3.02) (p=0.0132). CONCLUSION: Malnutrition is frequent in patients with advanced heart failure and dilated cardiomyopathy. The reduced body mass was a better predictor of survival than the left ventricular ejection fraction in patients under advanced stage of myocardial compromising.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>desnutrição</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiomiopatia dilatada e insuficiência cardíaca avançada</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>malnutrition</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dilated cardiomyopathy and advanced heart failure</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Dispnéia por compressão de estruturas mediastinais por cisto pericárdico</s1>
</fA08>
<fA08 dir="en">
<s1>Dyspnea through compression of mediastinal structures due to pericardial cyst</s1>
</fA08>
<fA11 dir="011000">
<s1>Jeanine Eggers Caramori</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luciane Miozzo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maurice Formigheri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cristiano Barcellos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Muriel Grando</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Tiago Trentin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital São Vicente de Paulo  </s1>
<s2>Passo Fundo RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>486-487</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>06</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Caso de uma paciente com 65 anos, apresentando dispnéia aos esforços e dor torácica lateral direita como principais sintomas de um cisto no pericárdio, de aproximadamente 8 cm. Os exames físico, bioquímico e eletrocardiográfico não evidenciaram alterações. O resultado dos exames de radiografia de tórax, tomografia computadorizada e ecocardiograma foi sugestivo de cisto pericádico. Com base nessas evidências clínicas a paciente foi submetida à toracotomia em região torácica lateral direita e realizada excisão completa da massa mediastinal com remissão total dos sintomas.</s0>
</fC01>
<fC01 dir="en">
<s0>A case of a 65-year-old patient, showing dyspnea to strains and right side pain as main symptoms of an approximately 8 cm cyst in the pericardium. The physical, biochemical and electrocardiographic examinations did not evince any changes. The results from the thoracic radiography, CT scan and echocardiogram suggested pericardial cyst. Based on those clinical evidences, the patient was submitted to a thoracotomy in the right side thoracic region and a complete excision of the mediastinal mass was performed, with complete remission of the symptoms.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Pseudoaneurisma de ventrículo esquerdo associado a insuficiência mitral grave complicando infarto agudo do miocárdio ínfero-látero-dorsal</s1>
</fA08>
<fA08 dir="en">
<s1>Left ventricular pseudoaneurysm associated to severe mitral insufficiency, complicating inferolaterodorsal acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>João Luiz de A. A. Falcão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sandra Nívea R. S. Falcão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Fernanda M. A. Garcia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ana Lúcia M. Arruda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alexadre C. Hueb</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fábio B. Jatene</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Paulo S. Gutierrez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>José Carlos Nicolau</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>José Antônio F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Roberto Rocha C. V. Giraldez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>488-491</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400611</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Descrevemos um caso de pseudoaneurisma de ventrículo esquerdo associado a grave regurgitação mitral, complicando um infarto ínfero-látero-dorsal. A lesão foi descoberta em ecocardiograma de rotina durante o seguimento ambulatorial. Destacam-se a estratégia cirúrgica bem sucedida, e a boa evolução clínica da paciente.</s0>
</fC01>
<fC01 dir="en">
<s0>We described a case of left ventricular pseudoaneurysm associated to a severe mitral regurgitation, complicating a inferolaterodorsal acute myocardial infarction. The lesion was found in a routine echocardiogram during the in-hospital follow-up. The well-succeeded surgical strategy and the good clinical evolution of the patient were distinguished.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 3/2005 - Parada cardíaca em atividade elétrica sem pulso, em homem de 49 anos, no 23º dia após infarto agudo</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiac arrest in pulseless electric activity in a 49 year-old man in the 23th day post acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Desidério Favarato</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Sampaio Gutierrez</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>492-494</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400612</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Ampliando a utilização da terapia de reperfusão: do GISSI ao DANAMI</s1>
</fA08>
<fA08 dir="en">
<s1>Expanding the use of reperfusion therapy: from GISSI to DANAMI</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Luiz da Silva Brasileiro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Nacional de Cardiologia Laranjeiras  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital Barra D'Or  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>495-499</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400613</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Os bloqueadores dos receptores da angiotensina II (BRA-II) aumentam a incidência de infarto do miocárdio?</s1>
</fA08>
<fA08 dir="en">
<s1>Do angiotensin II receptor blockers (ARB-II) increase the incidence of myocardial infarction?</s1>
</fA08>
<fA11 dir="011000">
<s1>Mário Sérgio Soares de Azeredo Coutinho</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>500-500</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400614</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Os bloqueadores da angiotensina II aumentam a incidência de infarto do miocárdio?</s1>
</fA08>
<fA08 dir="en">
<s1>Do angiotesin II blockers increase the incidence of myocardial infarction?</s1>
</fA08>
<fA11 dir="011000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>501-502</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400615</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação ecocardiográfica da terapia de ressincronização cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Echocardiographic assessment of cardiac resynchronization therapy</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Eduardo Suaide Silva</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Diagnósticos da América OMNI-CCNI Medicina Diagnóstica </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>503-507</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400616</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Fatores de risco cardiovascular no Brasil: os próximos 50 anos!</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiovascular risk factors in Brazil: the next 50 years!</s1>
</fA08>
<fA11 dir="011000">
<s1>Carisi Anne Polanczyk</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>199-201</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Revascularização miocárdica em multiarteriais</s1>
</fA08>
<fA08 dir="en">
<s1>Myocardial revascularization in patients with multivessel disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre A. C. Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dimytri Alexandre Siqueira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>202-205</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Fatores de risco associados com infarto agudo do miocárdio na região metropolitana de São Paulo: uma região desenvolvida em um país em desenvolvimento</s1>
</fA08>
<fA08 dir="en">
<s1>Risk factors associated with acute myocardial infarction in the São Paulo metropolitan region: a developed region in a developing country</s1>
</fA08>
<fA11 dir="011000">
<s1>Álvaro Avezum</s1>
<afiliation>A01 A02 A03 A04 A05 A06 A07 A08 A09 A10 A11</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leopoldo Soares Piegas</s1>
<afiliation>A01 A02 A03 A04 A05 A06 A07 A08 A09 A10 A11</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Júlio César R. Pereira</s1>
<afiliation>A01 A02 A03 A04 A05 A06 A07 A08 A09 A10 A11</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital do Coração da Associação do Sanatório Sírio  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Hospital São Luís  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="040000">
<s1>Hospital São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="050000">
<s1>Hospital do Servidor Público Municipal  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="060000">
<s1>Hospital Santa Marcelina  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="070000">
<s1>Hospital Santa Casa de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="080000">
<s1>Hospital Municipal de Santo André  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="090000">
<s1>Hospital e Maternidade Brasil  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="100000">
<s1>Hospital Santa Paula  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="110000">
<s1>Hospital Wladimir Arruda  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>206-213</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>42</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Identificar os fatores de risco, associados com infarto agudo do miocárdio (IAM), com as respectivas forças de associação, na região metropolitana de São Paulo. MÉTODOS: Os casos eram pacientes com diagnóstico de primeiro IAM com elevação do segmento ST e os controles eram indivíduos sem doença cardiovascular conhecida. Foram incluídos 271 casos e 282 controles provenientes de 12 hospitais. Os fatores avaliados: raça, escolaridade, estado civil, renda familiar, história familiar de insuficiência coronariana, antecedentes de hipertensão arterial e de diabetes mellitus, reposição hormonal em mulheres, tabagismo, atividade física, consumo de álcool, colesterol total, LDL-colesterol, HDL-colesterol, triglicérides e glicose, índice de massa corporal e relação cintura-quadril. RESULTADOS: Os seguintes fatores de risco apresentaram associação independente com IAM: tabagismo (razão de chances [OR]=5,86; intervalo de confiança [IC] 95% 3,25-10,57; p&lt;0,00001), relação cintura-quadril [tercil superior vs. inferior] (OR=4,27; IC 95% 2,28-8,00; p&lt;0,00001), antecedentes de hipertensão arterial (OR=3,26; IC 95% 1,95-5,46; p&lt;0,00001), relação cintura-quadril [tercil intermediário vs. inferior] (OR=3,07; IC95% 1,66-5,66; p=0,0003), nível sérico de LDL-colesterol (OR=2,75; IC 95% 1,45-5,19; p=0,0018), antecedentes de diabetes mellitus (OR=2,51; IC 95% 1,45-5,19; p=0,023), história familiar de insuficiência coronariana (OR=2,33; IC 95% 1,44-3,75; p=0,0005) e HDL-colesterol (OR=0,53; IC 95% 0,32-0,87; p=0,011). CONCLUSÃO: Tabagismo, relação cintura-quadril, antecedentes de hipertensão arterial e de diabetes, história familiar de insuficiência coronariana, níveis séricos de LDL-colesterol e de HDL-colesterol encontram-se independentemente associados com IAM na região metropolitana de São Paulo.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To identify the risk factors associated with acute myocardial infarction (AMI) and their respective powers of association in the São Paulo metropolitan region. METHODS: The cases comprised patients diagnosed with first AMI with an ST segment elevation. The controls were individuals with no known cardiovascular disease. The study comprised 271 cases and 282 controls from 12 hospitals. Risk factors were as follows: ethnic group; educational level; marital status; family income; family history of coronary artery disease; antecedents of arterial hypertension and of diabetes mellitus; hormonal replacement in women; smoking; physical activity; alcohol consumption; total cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride, and glucose levels; body mass index; and waist-hip ratio (WHR). RESULTS: The following risk factors showed and independent association with AMI: smoking [odds ratio (OR)=5.86; 95% confidence interval (CI) 3.25-10.57; P &lt; 0.00001); waist-hip ratio (first vs. third tertile) (OR=4.27; 95% CI 2.28-8.00; P&lt;0.00001); antecedents of arterial hypertension (OR=3.26; 95% CI 1.95-5.46; P&lt; 0.00001); waist-hip ratio (first vs second tertile) (OR=3.07; 95% CI 1.66-5.66; P=0.0003); LDL-cholesterol level (OR=2.75; 95% CI 1.45-5.19; P=0.0018); antecedents of diabetes mellitus (OR= 2.51; 95% CI 1.45-5.19; P=0.023); family history of coronary artery disease (OR=2.33; 95% CI 1.44-3.75; P=0.0005); and HDL-cholesterol level (OR=0.53; 95% CI 0.32-0.87; P=0.011). CONCLUSION: Smoking, waist-hip ratio, antecedents of arterial hypertension and of diabetes mellitus, family history of coronary artery disease, and LDL-cholesterol and HDL-cholesterol levels showed to be independently associated with AMI within the São Paulo metropolitan region.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto agudo do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estudo de caso-controle</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>case-control study</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo comparativo dos resultados da intervenção cirúrgica e da angioplastia na revascularização do miocárdio em portadores de comprometimento multiarterial equivalente</s1>
</fA08>
<fA08 dir="en">
<s1>Comparative study of the results of coronary artery bypass grafting and angioplasty for myocardial revascularization in patients with equivalent multivessel disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Roberto Dutra da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Whady Armindo Hueb</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz Antônio Machado César</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Antônio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>214-221</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>46</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Investigar a relativa eficácia de estratégias terapêuticas em pacientes com doença coronariana multiarterial sintomática, com função ventricular preservada. Os objetivos primários foram definidos com a combinação de: morte por origem cardíaca, infarto agudo do miocárdio (IAM) ou angina refratária que necessitasse de revascularização e, os secundários, estado anginoso e isquemia esforço-induzida. MÉTODOS: De 20.769 pacientes avaliados por cineangiocoronariografia no InCor, 210 foram escolhidos para o estudo e randomizados para revascularização miocárdica (RCM) (n=105) e angioplastia transluminal coronariana (ATC) (n=105). RESULTADOS: Média de 3,2&amp;plusmn;0,8 vasos receberam anastomoses e 2,1&amp;plusmn;0,8 foram dilatados com sucesso nos grupos RCM e ATC, respectivamente. Em cinco anos de seguimento as respectivas taxas de eventos para RCM e ATC foram: 9,52% e 12,38% para mortalidade, 2,85% e 8,57% (p=0,0668) para IAM, 2,85% e 24,76% (p&lt; 0,001) para uma intervenção adicional; a taxa de sobrevivência de 88,39% para RCM e de 84,93% para ATC; os respectivos porcentuais livres de IAM, 84,40 e 77,40%. Os pacientes estavam livres de angina em 62% do RCM e 60% do grupo ATC e os testes de esforço foram considerados não-isquêmicos em 62,5% e 62,1%, nos grupos cirúrgico e angioplastia. CONCLUSÃO: Comparada com a angioplastia para pacientes multivasculares, a revascularização miocárdica foi associada a uma baixa incidência de eventos a longo prazo e reduzida necessidade de novas intervenções (p=0,001).</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To investigate the relative efficacy of different therapeutic strategies in patients with symptomatic multivessel coronary artery disease with preserved ventricular function. The primary objectives were defined as a combination of death of cardiac origin, acute myocardial infarction (AMI), and refractory angina that required revascularization, and the secondary objectives were defined as anginal state and exercise-induced ischemia. METHODS: Of the 20,769 patients assessed on cine coronary angiography at InCor, 210 were chosen for this study and were randomized either for coronary artery bypass grafting (CABG, n=105) or transluminal coronary angioplasty (TCA, n=105). RESULTS: A mean of 3.2&amp;plusmn;0.8 vessels received anastomoses and 2.1&amp;plusmn;0.8 were successfully dilated in the CABG and TCA groups, respectively. In a 5-year follow-up, the rates of events in the CABG and TCA groups were, respectively: mortality, 9.52% and 12.38%; acute myocardial infarction, 2.85% and 8.57% (P = 0.0668); and additional intervention, 2.85% and 24.76% (P &lt; 0.001). The survival rate was 88.39% for CABG and 84.93% for TCA; the respective AMI-free percentages were 84.40% and 77.40%. In the CABG and TCA groups, 62% and 60% of the patients had no angina, respectively. The exercise tests were considered nonischemic in 62.5% and 62.1% of the patients in the CABG and TCA groups, respectively. CONCLUSION: In multivessel patients, compared with angioplasty, coronary artery bypass grafting was associated with a lower incidence of long-term events and a reduced need for new interventions (P=0.001).</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angioplastia transluminal percutânea coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>revascularização miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coronariopatias</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>transluminal coronary angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery bypass grafting</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Relação do tamanho do átrio esquerdo com a capacidade de exercício na endomiocardiofibrose</s1>
</fA08>
<fA08 dir="en">
<s1>Relation between left atrial dimension and exercise capacity in endomyocardial fibrosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vera Maria Cury Salemi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Barbara Maria Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fábio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>222-224</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar se a capacidade de exercício está relacionada à dimensão atrial esquerda (DAE) em pacientes com endomiocardiofibrose biventricular. MÉTODOS: Estudaram-se 38 pacientes sendo 25 mulheres, com idade média 37,5 &amp;plusmn; 11,5 anos (variação de 11 a 59 anos), todos em ritmo sinusal, divididos nos grupos A (12 pacientes) e B (26 pacientes) de acordo com a classe funcional da NYHA na internação. Todos os pacientes foram submetidos à ergoespirometria para a obtenção do consumo máximo de oxigênio (VO2 max) e tiveram a dimensão atrial esquerda determinada pela ecocardiografia. RESULTADOS: VO2 max de 21,8&amp;plusmn;4,8 ml.kg-1.min-1 e 13,7&amp;plusmn;3,5 ml.kg.-1. min-1, e dimensão atrial esquerda de 3,7&amp;plusmn;0,7cm e 4,4&amp;plusmn; 0,7cm para os grupos A e B, respectivamente. Foi encontrada correlação significativa e inversa entre VO2max e a DAE nos grupos estudados. CONCLUSÃO: O aumento da dimensão do átrio esquerdo acha-se associado ao comprometimento da capacidade de exercício em pacientes com endomiocardiofibrose. Nossos achados levam a permitir a utilização da dimensão atrial esquerda para estimar um índice de capacidade funcional, mais complexo e difícil de avaliar, como o VO2max.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess whether exercise capacity is related to left atrial dimension (LAD) in patients with biventricular endomyocardial fibrosis. METHODS: This study comprised 38 patients in sinus rhythm, with a mean age of 37.5 &amp;plusmn; 11.5 years (range, 11 to 59 years), 25 of whom were women. They were divided into 2 groups according to the NYHA functional class on hospital admission as follows: group A (12 patients) and group B (26 patients). All patients underwent cardiopulmonary exercise testing to determine their maximum oxygen consumption (VO2 max), and their left atrial dimension was determined on echocardiography. RESULTS: The VO2max values for groups A and B were 21.8 &amp;plusmn; 4.8 mL.kg-1.min-1 and 13.7 &amp;plusmn; 3.5 mL.kg-1.min-1, respectively, and the left atrial dimensions were 3.7&amp;plusmn;0.7cm and 4.4&amp;plusmn;0.7cm for groups A and B, respectively. A significant and inverse correlation was found between VO2max and LAD in the groups studied. CONCLUSION: The increase in left atrial dimension is associated with impairment in exercise capacity in patients with endomyocardial fibrosis. Our findings support the use of left atrial dimension to estimate a more complex and difficult to assess index of functional capacity, such as VO2max.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tamanho do átrio esquerdo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>capacidade de exercício</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>endomiocardiofibrose</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left atrial dimension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise capacity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endomyocardial fibrosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeitos da inibição prolongada da enzima de conversão da angiotensina sobre as características morfológicas e funcionais da hipertrofia ventricular esquerda em ratos com sobrecarga pressórica persistente</s1>
</fA08>
<fA08 dir="en">
<s1>Effects of the prolonged inhibition of the angiotensin-converting enzyme on the morphological and functional characteristics of left ventricular hypertrophy in rats with persistent pressure overload</s1>
</fA08>
<fA11 dir="011000">
<s1>Edson Antonio Bregagnollo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Katashi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Isamara Fernanda Bregagnollo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Roberto Padovani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marina P. Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antonio Carlos Cicogna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual Paulista Faculdade de Medicina de Botucatu </s1>
<s2>Botucatu SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>225-232</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>50</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar os efeitos do lisinopril (L) sobre as taxas de mortes (M), insuficiência cardíaca (ICC), características da remodelação miocárdica, geométrica e funcional do ventrículo esquerdo (VE), em ratos com estenose aórtica supravalvar (EAS). MÉTODOS: Ratos foram submetidos a EAS ou cirurgia simulada (GC:n=10). Randomizados após 6 semanas para receber L (GL:n=30) ou nenhum tratamento (GE:n=73) sendo avaliados 6s e 21s por estudos ecocardiográfico, hemodinâmico e morfológico concomitantes. RESULTADOS: As taxas de M (GE: 53,9% vs GL: 16,7% e ICC GE: 44,8% vs GL: 20% p&lt;0,05). No final do experimento, os valores da pressão sistólica do VE dos grupos GE e GL foram equivalentes e significantemente mais elevados do que no grupo GC; (p&lt;0,05) não diferindo dos observados 6 semanas após os procedimentos cirúrgicos. Os valores da pressão diastólica do VE no grupo GE foram maiores do que os do grupo GL (p&lt;0,05) sendo ambos maiores do que os do grupo GC (4 &amp;plusmn; 2 mmHg, p&lt;0,05). O mesmo comportamento foi observado com as variáveis: razão E/A; índice de massa, área seccional dos miócitos e conteúdo de hidroxiprolina do VE. A porcentagem de encurtamento do VE foi semelhante nos grupos GC e GL (p&gt;0,05) sendo ambos maiores que os verificados no grupo GE. Comportamento semelhante foram obtidos com os valores da primeira derivada positiva e negativa da pressão do VE. CONCLUSÃO: Em ratos com EAS o L reduziu as taxas de M e ICC e exerceu efeitos benéficos sobre a remodelação e a função do VE.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the effects of lisinopril (L) on mortality (M) rate and congestive heart failure (CHF), and the characteristics of geometrical myocardial remodeling and left ventricular function in rats with supravalvular aortic stenosis (SAS). METHODS: Some Wistar rats underwent SAS or the simulated surgery (CG, n=10). After 6 weeks, the animals were randomized to receive lisinopril (LG, n=30) or no treatment (SG, n=73) for 15 weeks. Cardiac remodeling was assessed in the sixth and 21st weeks after the surgical procedures through concomitant echocardiographic, hemodynamic, and morphological studies. RESULTS: The M were 53.9% and 16.7% in SG and LG, respectively; the incidence of CHF was 44.8% and 20%, in SG and LG, respectively, (P&lt;0.05). At the end of the experiment, the values of LV systolic pressure in SG and LG were equivalent and significantly greater than those in CG;(P&lt;0.05) and did not differ from those observed 6 weeks after the surgical procedures. The values of LV diastolic pressure in SG were greater than those in LG;(P&lt;0.05), and both were greater than those in CG;(P&lt;0.05). The same behavior was observed with the following variables: E/A ratio; mass index; sectional area of the myocytes; and LV hydroxyproline content. Left ventricular shortening percentage was similar in CG and LG;(P&gt;0.05), and both were greater than those in SG;(P&lt;0.05). Similar results were obtained with the values of the positive and negative first derivate of LV pressure. CONCLUSION: In rats with SAS, the treatment with L reduced M rate and ICC and had beneficial effects on geometrical myocardial remodeling and left ventricular function.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>inibidores da enzima conversora de angiotensina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lisinopril</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>angiotensin-converting enzyme inhibitors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lisinopril</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular function</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Análise inicial do uso de enxerto tubular orgânico L-D-Hydro - (Eato L-D-Hydro) para realização de Blalock-Taussig modificado nas cardiopatias congênitas com hipofluxo pulmonar</s1>
</fA08>
<fA08 dir="en">
<s1>Initial analysis of the use of the L-D-Hydro (Eato L-D-Hydro) organic tubular graft for performing the modified Blalock-Taussig procedure in congenital heart diseases with decreased pulmonary blood flow</s1>
</fA08>
<fA11 dir="011000">
<s1>Wilson Luiz da Silveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mirna de Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernanda A. Oliveira Peixoto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rogério Souza Lobo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mailza A. Costa Rios</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Carlos César Elias de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Fabiana A. Penachi Bosco Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Lincoln Henrique Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>João Alberto Pansanni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Adélio Ferreira Leite</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Santa Genoveva Grupo CentroCardio </s1>
<s2>Goiânia GO</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>233-236</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar os resultados iniciais da utilização do enxerto tubular orgânico, utilizados para anastomoses sistêmico-pulmonares. MÉTODOS: De março/2002 a abril/2003, 10 pacientes foram submetidos à realização de shunt sistêmico pulmonar tipo Blalock-Taussig modificado utilizando um novo tipo de enxerto biológico originado da artéria mesentérica bovina tratada com poliglicol denominado L-D-Hydro. A idade variou de 3 dias a 7 anos e 60% dos pacientes eram do sexo masculino. O diagnóstico das cardiopatias foi determinado pela ecocardiografia, todos apresentando sinais clínicos de hipóxia severa (cianose). As cardiopatias foram: tetralogia de Fallot (40%), atresia tricúspide (50%), defeito do septo atrioventricular (10%). RESULTADOS: Em 10 pacientes, ocorreu um óbito por sepse e em nove houve melhora imediata na saturação de O2 ao oxímetro de pulso e da pressão parcial de oxigênio à gasometria arterial. Nenhum paciente apresentou obstrução do shunt no pós-operatório imediato ou qualquer outra complicação. Todos os pacientes mostraram shunt pérvio ao exame ecocardiográfico no pós-operatório imediato e tardio, realizado no 3º mês de pós-operatório. Nenhum paciente apresentou sangramento no intra e pós-operatório. CONCLUSÃO: O enxerto tubular L-D-HYDRO demonstrou ser promissor para a realização de shunt sistêmico pulmonar, como alternativa para produtos inorgânicos existentes no mercado, entretanto, temos de ter maior número de implantes e acompanhamento tardio para uma avaliação definitiva.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the initial results of the use of an organic tubular graft for systemic-pulmonary anastomoses. METHODS: From March 2002 to April 2003, 10 patients underwent systemic-pulmonary shunt of the modified Blalock-Taussig type, using a new type of biological graft originating from the bovine mesenteric artery treated with polyglycol, the so-called L-D-Hydro. The patients' ages ranged from 3 days to 7 years, and 60% of them were of the male sex. The diagnoses of heart disease were determined on echocardiography. All patients had clinical signs of severe hypoxia (cyanosis). The heart diseases were as follows: tetralogy of Fallot (40%), tricuspid atresia (50%), and atrioventricular septal defect (10%). RESULTS: One patient died due to sepsis and 9 had an immediate improvement in O2 saturation on pulse oximetry and in the partial oxygen pressure on arterial blood gas analysis. The intensive care unit length of stay ranged from 2 to 6 days. No patient had obstruction of the shunt on the immediate postoperative period or any other complication. All patients had a patent shunt on the echocardiographic studies performed in the immediate postoperative period and later, in the third postoperative month. No bleeding occurred during surgery or in the postoperative period. CONCLUSION: The tubular L-D-Hydro graft proved to be promising for performing systemic-pulmonary shunt as an alternative for the inorganic products available in the market, however, we need a greater number of implantations and late follow-up for definitive assessment.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>anastomose sistêmico-pulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Blalock-Taussig modificado</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>systemic-pulmonary anastomosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>modified Blalock-Taussig</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Anemia como fator prognóstico em uma população hospitalizada por insuficiência cardíaca descompensada</s1>
</fA08>
<fA08 dir="en">
<s1>Anemia as a prognostic factor in a population hospitalized due to decompensated heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Ana Luíza F. Sales</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Humberto Villacorta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Leandro Reis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>237-240</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>12</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar a prevalência e o valor prognóstico da anemia em uma população hospitalizada por insuficiência cardíaca descompensada. MÉTODOS: De julho a setembro de 2001, 204 pacientes foram incluídos em um registro hospitalar multicêntrico de insuficiência cardíaca (Estudo EPICA-Niterói). Os 142 que tinham dados sobre hematócrito e hemoglobina coletados na admissão hospitalar compuseram esta análise retrospectiva. A idade média foi de 69,5&amp;plusmn;13,3 anos e 72 (50,7%) eram do sexo masculino. Considerou-se como anemia uma hemoglobina &lt; 13,5 g/dL para os homens e &lt; 12 g/dL para as mulheres. Avaliou-se através de análise uni e multivariada por regressão logística a relação da anemia com a mortalidade hospitalar. RESULTADOS: Anemia foi observada em 89 (62,6%) pacientes, sendo 52 (58%) homens e 37 (42%) mulheres. A mortalidade foi de 16,8% nos pacientes anêmicos contra 8% nos não anêmicos (p=0,11). Em ambos os sexos, as taxas de mortalidade nos anêmicos e não anêmicos foram, respectivamente, 19,2% vs 0% (p=0,034) e 13,5% vs 12,2% (p=0,86). Através de análise multivariada, as variáveis que se relacionaram de modo independente com a mortalidade hospitalar foram, hiponatremia (RR=7,0, intervalo de confiança de 95% [IC 95%] 6,1 a 8,7, p=0,0001), anemia (RR=3,1, IC 95%=2,4 a 4,3, p=0,024) e presença de classe funcional IV da NYHA (RR=1,9, IC 95%=1,3 a 2,6, p=0,04). CONCLUSÃO: Na população estudada com insuficiência cardíaca descompensada, a presença de anemia foi um marcador independente de mortalidade hospitalar. A mortalidade no grupo com anemia foi significativamente alta nos homens.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study the prevalence and prognostic value of anemia in a population hospitalized due to decompensated heart failure. METHOD: From July to September, 2001, 204 patients were included in a multicenter hospital registry of heart failure (EPICA Study _ Niterói). This retrospective analysis comprised 142 patients with data about hematocrit and hemoglobin levels collected on hospital admission. The mean age was 69.5&amp;plusmn;13.3 years, and 72 (50.7%) patients were men. Hemoglobin levels &lt; 13.5 g/dL for men and &lt; 12 g/dL for women were considered anemia. The relation between anemia and in-hospital mortality was assessed through univariate and multivariate analysis with logistic regression. RESULTS: Anemia was observed in 89 (62.6%) patients, 52 (58%) men and 37 (42%) women. Mortality in anemic patients was 16.8% and, in nonanemic, it was 8% (P=0.11). In both sexes, the mortality rates in anemic and nonanemic patients were, respectively, 19.2% vs 0% (P=0.034) and 13.5% vs 12.2% (P=0.86). Through multivariate analysis, the following variables were found to be independently related to in-hospital mortality: hyponatremia [RR=7.0; 95% confidence interval (95% CI)=6.1 to 8.7; P=0.0001], anemia (RR=3.1, 95% CI=2.4 to 4.3; P=0.024), and presence of NYHA functional class IV (RR=1.9; 95% CI=1.3 to 2.6; P=0.04). CONCLUSION: In the population studied with decompensated heart failure, the presence of anemia was an independent marker of in-hospital mortality. Mortality in the group with anemia was significantly high among men.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>anemia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prognóstico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>anemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação quantitativa da movimentação parietal regional do ventrículo esquerdo na endomiocardiofibrose</s1>
</fA08>
<fA08 dir="en">
<s1>Quantitative assessment of left ventricular regional wall motion in endomyocardial fibrosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vera Maria Cury Salemi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Barbara Maria Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Edmundo Arteaga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fábio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Felix J A Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>241-244</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar a movimentação parietal regional do ventrículo esquerdo (VE) em pacientes com endomiocardiofibrose (EMF). MÉTODOS: Estudados 88 pacientes, 59 do sexo feminino, com idade média de 39&amp;plusmn;13 anos (variação de 9 a 65) com evidência ecocardiográfica e angiográfica de EMF do VE. A intensidade da deposição de tecido fibroso na cineventriculografia contrastada foi classificada como discreta, moderada ou importante. A fração de ejeção global do ventrículo esquerdo (FEVE) foi determinada pelo método área-comprimento por meio da ventriculografia. O movimento foi medido em 100 cordas eqüidistantes e perpendiculares à linha média desenhada no meio dos contornos diastólico e sistólico finais e normalizadas para o tamanho cardíaco. Analisaram-se cinco segmentos do VE: A - apical; AL - ântero-lateral; AB - ântero-basal; IA - ínfero-apical; IB - ínfero-basal. A anormalidade foi expressa em unidades de desvio padrão do movimento médio em uma população de referência normal, composta por 103 pacientes com VE normal, conforme dados de clínica, eletrocardiograma e padrões angiográficos. RESULTADOS: A FEVE média foi de 0,47&amp;plusmn;0,12. O envolvimento de tecido fibroso do VE foi discreto em 12 pacientes, moderado em 40 e importante em 36. As regiões com pior movimentação parietal foram A (-1,4&amp;plusmn;1,6 desvio-padrão/cordas) e IA (-1,6&amp;plusmn;1,8 desvio-padrão/cordas) comparadas com AB (-0,3&amp;plusmn;1,9 desvio-padrão /cordas), AL (-0,5&amp;plusmn;1,8 desvio-padrão/cordas) e IB (-0,9&amp;plusmn;1,3 desvio-padrão/cordas). Não se observou relação entre a intensidade de envolvimento do tecido fibroso e a manutenção parietal regional. CONCLUSÃO : Existe alteração da movimentação parietal regional na EMF e é independente da intensidade de deposição de tecido fibroso avaliada qualitativamente. O envolvimento não uniforme do VE deve ser levado em conta no planejamento cirúrgico dessa doença.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze left ventricular (LV) regional wall motion in patients with endomyocardial fibrosis (EMF). METHODS: The study comprised 88 patients, 59 of the female sex, with a mean age of 39&amp;plusmn;13 years (range, 9 to 65) and with echocardiographic and angiographic evidence of left ventricular EMF. The intensity of fibrous tissue buildup on contrast cineventriculography was classified as mild, moderate, or severe. The overall left ventricular ejection fraction (LVEF) was determined by using the area-length method on ventriculography. The motion was measured in 100 equidistant chords perpendicular to the centerline drawn in the middle of the final diastolic and systolic contours and normalized to cardiac size. Five left ventricular segments were analyzed: A - apical; AL - anterolateral; AB - anterobasal; IA - inferoapical; IB - inferobasal. Abnormality was expressed in units of standard deviation of the mean motion in a normal population of reference, comprised of 103 patients with normal LV according to clinical and electrocardiographic data, and angiographic standards. RESULTS: Mean LVEF was 0.47&amp;plusmn;0.12. Fibrous tissue buildup in the left ventricle was mild in 12 patients, moderate in 40, and severe in 36. The regions with the poorest ventricular wall motion were A (-1.4&amp;plusmn;1.6 standard deviation/chords) and IA (-1.6&amp;plusmn;1.8 standard deviation/chords) compared with that in AB (-0.3&amp;plusmn;1.9 standard deviation/chords), AL (-0.5&amp;plusmn;1.8 standard deviation/chords) and IB (-0.9&amp;plusmn;1.3 standard deviation/chords). No relation was observed between the intensity of fibrous tissue buildup and regional ventricular wall motion. CONCLUSION: A change in LV regional wall motion exists in EMF, and it is independent of the intensity of fibrous tissue buildup qualitatively assessed. Nonuniform involvement of the LV should be considered when planning surgery for this disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>contratilidade regional</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>envolvimento fibroso</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>endomiocardiofibrose</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>regional contractility</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fibrous involvement</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endomyocardial fibrosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Monitoração ecocardiográfica da atriosseptostomia com balão</s1>
</fA08>
<fA08 dir="en">
<s1>Echocardiographic monitoring of balloon atrial septostomy</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos Henrique de Marchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Moacir Fernandes de Godoy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Márcio Antônio dos Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Airton Camacho Moscardini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sírio Hassen Sobrinho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Ulisses Alexandre Croti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de São José do Rio Preto  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>245-250</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400310</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a atriosseptostomia com balão monitorada pela ecocardiografia. MÉTODOS: Entre agosto de 1997 e janeiro de 2004, 31 crianças portadoras de cardiopatias congênitas com indicação de atriosseptostomia com balão foram submetidas ao procedimento sob monitoração ecocardiográfica exclusiva. Admitiu-se sucesso quando da obtenção de comunicação interatrial com diâmetro &gt; 4 mm e com ampla mobilidade das suas margens. RESULTADOS: Predominou o sexo masculino (83,9%). A idade mediana foi de 5 dias (1-150) e o peso teve mediana de 3.300g (1.800-7.500). Transposição das grandes artérias ocorreu em 80,6%, atresia tricúspide em 12,9%, drenagem anômala total de veias pulmonares em 3,2% e atresia pulmonar com septo íntegro em 3,2%. O procedimento foi bem sucedido em todos os casos. O tamanho da comunicação interatrial aumentou de 1,8&amp;plusmn;0,8 mm para 5,8&amp;plusmn;1,3 mm (P&lt;0,0001) e a saturação arterial de oxigênio de 64,5&amp;plusmn; 18,9% para 85,1&amp;plusmn;9,2% (P&lt;0,0001). Complicações ocorridas: três rupturas de balão, uma lesão de veia femoral direita, uma taquicardia supraventricular e um flutter atrial. CONCLUSÃO: Atriosseptostomia com balão monitorada pela ecocardiografia é método seguro e eficaz. Possibilita a realização do procedimento à beira do leito, evitando o transporte da criança, identificando o posicionamento do cateter, reduzindo complicações graves e avaliando o resultado imediato do procedimento.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess balloon atrial septostomy monitored with echocardiography. METHODS: From August 1997 to January 2004, 31 infants with congenital heart diseases indicated for balloon atrial septostomy underwent the procedure with exclusive echocardiographic monitoring. Success was defined as the obtainment of an atrial septal defect diameter &gt; 4 mm and ample mobility of its margins. RESULTS: The male sex predominated (83.9%). The median age was 5 days (1 - 150), and the median weight was 3,300 g (1,800 - 7,500). Transposition of the great arteries occurred in 80.6% of the patients, tricuspid valve atresia in 12.9%, total anomalous pulmonary venous drainage in 3.2%, and pulmonary atresia with intact septum in 3.2%. The procedure was successful in all patients. The size of the atrial septal defect increased from 1.8 &amp;plusmn; 0.8 mm to 5.8 &amp;plusmn; 1.3 mm (P &lt; 0.0001) and oxygen arterial saturation from 64.5 &amp;plusmn; 18.9% to 85.1 &amp;plusmn; 9.2% (P &lt; 0.0001). The following complications occurred: 3 balloon ruptures, one lesion of the right femoral vein, one supraventricular tachycardia, and one atrial flutter. CONCLUSION: Balloon atrial septostomy monitored with echocardiography is a safe and effective procedure. It may be performed at bedside, avoiding transporting of the patient, identifies the catheter location, reduces the occurrence of severe complications, and assesses the immediate result of the procedure.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatia congênita</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>atriosseptostomia com balão</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>balloon atrial septostomy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Amiodarona causa vasodilatação dependente do endotélio em artérias coronárias caninas</s1>
</fA08>
<fA08 dir="en">
<s1>Amiodarone causes endothelium-dependent vasodilation in canine coronary arteries</s1>
</fA08>
<fA11 dir="011000">
<s1>Alfredo José Rodrigues</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Roberto Barbosa Evora</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ayako Maruo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Hartzell V. Schaff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>251-255</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400311</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar os efeitos vasodilatadores da amiodarona em artérias coronárias caninas empregando soluções de amiodarona dissolvida em polisorbato 80 ou em água. MÉTODOS: Anéis de artéria coronária, com e sem o endotélio íntegro, foram imersos em solução de krebs e conectadas a um transdutor para aferição de força isométrica promovida por contração vascular. As artérias foram expostas a concentrações crescentes de polisorbato 80, amiodarona dissolvida em água, amiodarona dissolvida em polisorbato 80 e uma apresentação comercial da amiodarona (Cordarone®). Os experimentos foram conduzidos na presença e na ausência dos seguintes bloqueadores enzimáticos: apenas indometacina, Nômega-nitro-L-arginina associada à indometacina e apenas Nômega-nitro-L-arginina. RESULTADOS: O polisorbato 80 causou pequeno relaxamento não dependente do endotélio. O Cordarone®, a amiodarona dissolvida em água e em polisorbato 80 promoveram relaxamento dependente do endotélio, que foi de maior magnitude para a amiodarona dissolvida em polisorbato e para o Cordarone®. Apenas a associação de indometacina com a Nômega-nitro-L-arginina foi capaz de abolir o relaxamento dependente do endotélio provocado pela amiodarona dissolvida em polisorbato 80. CONCLUSÃO: Os resultados obtidos indicam que a vasodilatação promovida pela amiodarona em artérias coronárias caninas é causada principalmente pela estimulação da liberação de óxido nítrico e fatores endoteliais relaxantes dependentes das ciclo-oxigenases.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the vasodilating effects of amiodarone on canine coronary arteries by using solutions of amiodarone dissolved in polysorbate 80 or water. METHODS: Rings of coronary arteries, with or without intact endothelium, were immersed in Krebs solution and connected to a transducer for measuring the isometric force promoted by a vascular contraction. The arteries were exposed to increasing concentrations of polysorbate 80, amiodarone dissolved in water, amiodarone dissolved in polysorbate 80, and a commercial presentation of amiodarone (Cordarone). The experiments were conducted in the presence of the following enzymatic blockers: only indomethacin, Nw-nitro-L-arginine associated with indomethacin, and only Nw-nitro-L-arginine. RESULTS: Polysorbate 80 caused a small degree of nonendothelium-dependent relaxation. Cordarone, amiodarone dissolved in water, and amiodarone dissolved in polysorbate 80 caused endothelium-dependent relaxation, which was greater for amiodarone dissolved in polysorbate and for Cordarone. Only the association of indomethacin and Nw-nitro-L-arginine could eliminate the endothelium-dependent relaxation caused by amiodarone dissolved in polysorbate 80. CONCLUSION: The results obtained indicate that vasodilation promoted by amiodarone in canine coronary arteries is mainly caused by stimulation of the release of nitric oxide and cyclooxygenase-dependent relaxing endothelial factors.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>endotélio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>amiodarona</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>óxido nítrico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ciclo-oxygenase</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>circulação coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>endothelium</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>amiodarone</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nitric oxide</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cyclooxygenase</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary circulation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Implante de stent eluído com batimastat para o tratamento da doença arterial coronariana: resultados do estudo piloto brasileiro</s1>
</fA08>
<fA08 dir="en">
<s1>Batimastat-eluting stent implantation for the treatment of coronary artery disease: results of the Brazilian pilot study</s1>
</fA08>
<fA11 dir="011000">
<s1>Cristiana Marques de Araujo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gustavo Adolfo B. Rando</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Fernanda Z. Mauro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Salvador A. B. Cristóvão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Isaac S. Moscoso Sanchez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Adnan Ali Salman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>João B. de Oliveira Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>José Armando Mangione</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Beneficência Portuguesa de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>256-260</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400312</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Os excelentes resultados obtidos com os stents eluídos com sirolimus (rapamicina) na prevenção da reestenose motivaram a avaliação de outras substâncias que também apresentassem esta propriedade. O batimastat é um bloqueador de alta eficácia da enzima metaloproteinase, com potencial para reduzir a degradação da matriz extracelular e inibir a migração das células musculares lisas, com conseqüente capacidade de controlar a reestenose coronariana. MÉTODOS: De outubro/2001 a abril/2002, foram selecionados prospectivamente, 34 pacientes com lesões &quot;de novo&quot;, em artéria coronária nativa, &gt;50% e &lt; 100%, passíveis de tratamento com stents de 3 a 4 mm de diâmetro e de 18 mm de comprimento. O desfecho primário do estudo foi verificar a ocorrência de eventos cardiovasculares maiores (morte de origem cardíaca, infarto agudo do miocárdio e necessidade de revascularização do vaso alvo) aos 30 dias e aos 4 meses e o secundário avaliar a taxa de reestenose coronariana após 4 meses do implante e de trombose subaguda aos 30 dias. RESULTADOS: A taxa de sucesso do procedimento foi de 97,1%. O desfecho primário ocorreu em 2,9% e 27,2% dos pacientes aos 30 dias e aos 4 meses respectivamente. A taxa de reestenose binária ao estudo angiográfico foi de 39,3%. Não houve episódio de trombose subaguda. A análise comparativa entre os grupos que apresentaram ou não reestenose não mostrou diferenças significativas entre ambos, exceto na perda luminal tardia, maior no G-I. CONCLUSÃO: Os stents eluídos com batimastat apresentaram bom perfil de segurança, entretanto, não se mostraram efetivos no controle da reestenose coronariana.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: The excellent results obtained with sirolimus (rapamicin)-eluting stents for preventing restenosis have motivated the evaluation of other substances with that property. Batimastat is a highly effective metalloproteinase enzyme blocker, with the potential to reduce the degradation of extracellular matrix and to inhibit the migration of smooth muscle cells, with the consequent capacity to control coronary restenosis. METHODS: From October 2001 to April 2002, 34 patients were prospectively selected with de novo lesions in a native coronary artery &gt;50% and &lt; 100%, which could be treated with stents of 3 to 4 mm in diameter and 18 mm in length. The primary outcome of the study was to assess the occurrence of major cardiovascular events (death of cardiac origin, acute myocardial infarction, and the need for revascularizing the target vessel) by the 30th day and fourth month; the secondary outcome of the study was to assess the rate of coronary restenosis 4 months after implantation and subacute thrombosis by the 30th day. RESULTS: The success rate of the procedure was 97.1%. The primary outcome occurred in 2.9% and 27.2% of the patients by the 30th day and fourth month, respectively. The binary restenosis rate on angiography was 39.3%. No episode of subacute thrombosis occurred. The comparative analysis between groups with and without restenosis showed no significant difference between both, except for late luminal loss, which was greater in G-I. CONCLUSION: Batimastat-eluting stents had a good safety profile; however, they were not effective in controlling coronary restenosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>reestenose</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>stent coronariano</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angioplastia coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>restenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary stent</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angioplasty</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Feocromocitoma em criança</s1>
</fA08>
<fA08 dir="en">
<s1>Pheochromocytoma in childhood</s1>
</fA08>
<fA11 dir="011000">
<s1>Gesmar Volga Haddad Herdy</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Cecília Olivaes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vânia Glória Silami Lopes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Adriano Gazanego Pontes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>João Batista Ormond Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Eliene C. Fonseca</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>267-269</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400314</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Feocromocitoma é uma neoplasia de células cromafins que causa sintomas e sinais decorrentes da libertação de catecolminas e é muito rara em crianças. Relatamos um caso feocromocitoma em criança, com difícil manejo clínico, confirmado também pela anatomia-patológica e curado após a ressecção cirúrgica.</s0>
</fC01>
<fC01 dir="en">
<s0>Pheochromocytoma is a neoplasia of chromaffin cells that is very rare in children. Its signs and symptoms result from the release of catecholamines. We report the case of a child with pheochromocytoma of difficult clinical management, confirmed on the anatomicopathological study, and cured after surgical resection.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Volumosas fístulas de ambas coronárias para a artéria pulmonar: embolização percutânea com micro-molas e balões destacáveis</s1>
</fA08>
<fA08 dir="en">
<s1>Large coronary-pulmonary artery fistulae: percutaneous embolization with microcoils and disposable balloons</s1>
</fA08>
<fA11 dir="011000">
<s1>Antenor Portela</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Benjamim Pessoa Vale</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Raldir Bastos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>João Francisco de Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Itamar Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Jayro Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital São Marcos Serviço de Cardiologia Intervencionista </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>270-272</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400315</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Mulher de 43 anos, sintomática (dispnéia e palpitações), apresentava múltiplas fístulas de alto débito de ambas coronárias para a artéria pulmonar, embolizadas percutaneamente com micro-molas de liberação controlada e balões destacáveis, com sucesso.</s0>
</fC01>
<fC01 dir="en">
<s0>A 43-year-old symptomatic woman (dyspnea and palpitation) had multiple coronary-pulmonary artery fistulae with high output; percutaneous embolization was successfully performed using controlled-release microcoils and disposable balloons.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Diretrizes para Habilitação de Centros de Treinamento e para Obtenção de Certificação em Hemodinâmica e Cardiologia Intervencionista</s1>
</fA08>
<fA11 dir="011000">
<s1>Eulógio Emílio Martinez Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Alberto Piva Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo R. A. Caramori</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Adriano Mendes Caixeta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ari Mandil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cláudia M. Rodrigues Alves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Cesar A. Esteves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Fábio Sândoli de Brito Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Fausto Feres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>José Klauber Roger Carneiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Newton Fernando Stlader de Souza Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Sociedade Brasileira de Cardiologia Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>273-277</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400316</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Ondas T anômalas em bloqueio completo de ramo esquerdo, na cardiomiopatia não compactada do ventrículo esquerdo</s1>
</fA08>
<fA08 dir="en">
<s1>Anomalous T waves in the complete left bundle branch block in the non-compaction cardiomyopathy of the left ventricle</s1>
</fA08>
<fA11 dir="011000">
<s1>Lurildo R. Saraiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo Loureiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Djair Brindeiro Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Pernambuco Hospital das Clínicas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>278-278</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400317</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Embolia múltipla simultânea das artérias coronárias direita e esquerda</s1>
</fA08>
<fA08 dir="en">
<s1>Multiple simultaneous embolisms of right and left coronary arteries</s1>
</fA08>
<fA11 dir="011000">
<s1>Moacir Fernandes Godoy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Thiago Augustus Portes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Leandro Alves Bernardo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Flávio Correa Pivatelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de São José do Rio Preto  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>279-280</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400318</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Análise comparativa dos fluxos da artéria torácica interna esquerda dissecada na forma pediculada versus a forma esqueletizada em cirurgia de revascularização do miocárdio</s1>
</fA08>
<fA08 dir="en">
<s1>Comparative analysis of the flows of left internal thoracic artery grafts dissected in the pedicled versus skeletonized manner for myocardial revascularization surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Gustavo Peressoni Castro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Hospital de Clínicas Serviço de Cirurgia Cardiovascular</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>261-266</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>43</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400313</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar os fluxos livres, os calibres e os comprimentos da artéria torácica interna esquerda (ATIE) pediculada (P) e esqueletizada (E) no transoperatório antes e depois da aplicação do vasodilatador tópico (VT). MÉTODOS: Em ensaio clínico randomizado e cego foram estudados 50 pacientes submetidos a cirurgia de revascularização miocárdica eletivas quanto ao emprego da ATIE in situ nas formas P ou E. Dos 25 pacientes no grupo pediculada (GP), 16 eram do sexo masculino, apresentando angina classe II e III (NYHA) e fração de ejeção (FE) de 50,8 &amp;plusmn; 9,2%. No grupo esqueletizada (GE), 19 pacientes eram do sexo masculino, possuindo angina classe II e FE de 46,8 &amp;plusmn; 9,3%. As medidas foram realizadas pré-circulação extracorpórea e divididas em duas fases: fase 1 (antes) e fase 2 (após 15 min da aplicação da papaverina tópica a 2,5 mg/ml a 37ºC). Durante as aferições, eram monitoradas a pressão arterial média, pressão venosa central e freqüência cardíaca. RESULTADOS: O GP apresentou fluxo de 46&amp;plusmn;16 e 77&amp;plusmn;28 ml/min e calibre de 1,4&amp;plusmn;0,1 e 1,7&amp;plusmn;0,1 mm nas fases 1 e 2, e o GE, 57&amp;plusmn;27 e 97&amp;plusmn;35 ml/min de fluxo e 1,4&amp;plusmn;0,1 e 1,8&amp;plusmn;0,2 mm de calibre, respectivamente, não havendo diferenças significativas no desfecho comprimento. CONCLUSÃO: ATIE E demonstrou um aumento significativo no fluxo e calibre, após o uso de VT com p=0,03 e p=0,01 respectivamente, comparados com a ATIE P.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare the free blood flow, caliber, and length of the left internal thoracic artery (LITA), dissected in the pedicled (P) and skeletonized (S) manners, during surgery before and after topical vasodilator (TV) application. METHODS: A randomized, blind, clinical trial was carried out with 50 patients undergoing elective myocardial revascularization to assess the use of the LITA in situ in its pedicled or skeletonized form. The 25 patients in the pedicled group (GP) had NYHA class II or III angina, ejection fraction (EF) of 50.8&amp;plusmn;9.2%, and 16 were of the male sex. The patients in the skeletonized group (SG) had NYHA class II angina, EF of 46.8&amp;plusmn;9.3%, and 19 were of the male sex. The measurements were performed before extracorporeal circulation and divided into 2 phases: phase 1 (before topical papaverine application) and phase 2 (15 min after topical application of papaverine, 2.5 mg/mL, at 37ºC). During the measurements, mean blood pressure, central venous pressure, and heart rate were monitored. RESULTS: The phase 1 and 2 results are as follows: 1) PG: blood flow, 46&amp;plusmn;16 and 77&amp;plusmn;28 mL/min; caliber, 1.4&amp;plusmn;0.1 and 1.7&amp;plusmn;0.1 mm, respectively; 2) SG: blood flow, 57&amp;plusmn;27 and 97&amp;plusmn;35 mL/min; and caliber, 1.4&amp;plusmn;0.1 and 1.8&amp;plusmn;0.2 mm, respectively. No significant differences were observed in length. CONCLUSION: The LITA in SG had a significant increase in blood flow and caliber after the use of TV compared with blood flow and caliber in PG (P=0.03 and P=0.01, respectively).</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>artéria torácica interna esquerda</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>revascularização miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>esqueletizada</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left internal thoracic artery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery bypass grafting</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>skeletonized</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>I Diretriz Latino-Americana para avaliação e conduta na insuficiência cardíaca descompensada</s1>
</fA08>
<fA08 dir="en">
<s1>I Latin American Guidelines for the assessment and management of decompensated heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Edimar Alcides Bocchi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fábio Vilas-Boas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sergio Perrone</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Angel G Caamaño</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Nadine Clausell</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maria da Consolação V Moreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Jorge Thierer</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Hugo Omar Grancelli</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Carlos Vicente Serrano Junior</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Denilson Albuquerque</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Dirceu Almeida</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Fernando Bacal</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Luís Felipe Moreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Adonay Mendonza</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Antonio Magaña</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>Arturo Tejeda</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>Daniel Chafes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>Efraim Gomez</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>Erick Bogantes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="201000">
<s1>Estela Azeka</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="211000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="221000">
<s1>Francisco José Farias B Reis</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="231000">
<s1>Hector Mora</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="241000">
<s1>Humberto Vilacorta</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="251000">
<s1>Jesus Sanches</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="261000">
<s1>David de Souza Neto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="271000">
<s1>José Luís Vuksovic</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="281000">
<s1>Juan Paes Moreno</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="291000">
<s1>Júlio Aspe y Rosas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="301000">
<s1>Lidia Zytynski Moura</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="311000">
<s1>Luís Antonio de Almeida Campos</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="321000">
<s1>Luis Eduardo Rohde</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="331000">
<s1>Marcos Parioma Javier</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="341000">
<s1>Martin Garrido Garduño</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="351000">
<s1>Múcio Tavares</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="361000">
<s1>Pablo Castro Gálvez</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="371000">
<s1>Raul Spinoza</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="381000">
<s1>Reynaldo Castro de Miranda</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="391000">
<s1>Ricardo Mourilhe Rocha</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="401000">
<s1>Roberto Paganini</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="411000">
<s1>Rodolfo Castano Guerra</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="421000">
<s1>Salvador Rassi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="431000">
<s1>Sofia Lagudis</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="441000">
<s1>Solange Bordignon</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="451000">
<s1>Solon Navarette</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="461000">
<s1>Waldo Fernandes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="471000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="481000">
<s1>Victor Issa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="491000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-48</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Impacto econômico do tratamento da cardiopatia isquêmica crônica no Brasil: o desafio da incorporação de novas tecnologias cardiovasculares</s1>
</fA08>
<fA08 dir="en">
<s1>Economic impact of chronic ischemic cardiopathy treatment in Brazil: the challenge of new cardiovascular technology inclusion</s1>
</fA08>
<fA11 dir="011000">
<s1>Denizar Vianna Araujo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcos Bosi Ferraz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-2</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Custo anual do manejo da cardiopatia isquêmica crônica no Brasil: perspectiva pública e privada</s1>
</fA08>
<fA08 dir="en">
<s1>Annual cost of ischemic heart disease in Brazil: public and private perspective</s1>
</fA08>
<fA11 dir="011000">
<s1>Rodrigo A. Ribeiro</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Renato G. B. Mello</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Raquel Melchior</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Juliana C. Dill</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Clarissa B. Hohmann</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Angélica M. Lucchese</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ricardo Stein</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Jorge Pinto Ribeiro</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Carisi A. Polanczyk</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital das Clínicas de Porto Alegre  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital Moinhos de Vento  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Universidade Federal do Rio Grande do Sul  </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>3-8</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>08</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estimar o custo anual do manejo da doença arterial coronária (DAC) em valores do SUS e convênios. MÉTODOS: Estudo de coorte, incluindo pacientes ambulatoriais com DAC comprovada. Considerou-se para estimar custos diretos: consultas, exames, procedimentos, internações e medicamentos. Valores de consultas e exames foram obtidos da tabela SUS e da Lista de Procedimentos Médicos (LPM). Valores de eventos cardiovasculares foram obtidos de internações em hospital público e privado com estas classificações diagnósticas em 2002. O preço dos fármacos utilizado foi o de menor custo no mercado. RESULTADOS: Os 147 pacientes (65&amp;plusmn;12 anos, 63% homens, 69% hipertensos, 35% diabéticos e 59% com IAM prévio) tiveram acompanhamento médio de 24&amp;plusmn;8 meses. O custo anual médio estimado por paciente foi de R$ 2.733,00, pelo SUS, e R$ 6.788,00, para convênios. O gasto com medicamentos ($ 1.154,00) representou 80% e 55% dos custos ambulatoriais, e 41% e 17% dos gastos totais, pelo SUS e para convênios, respectivamente. A ocorrência de evento cardiovascular teve grande impacto (R$ 4.626,00 vs. R$ 1.312,00, pelo SUS, e R$ 13.453,00 vs. R$ 1.789,00, para convênios, p&lt;0,01). CONCLUSÃO: O custo médio anual do manejo da DAC foi elevado, sendo o tratamento farmacológico o principal determinante dos custos públicos. Essas estimativas podem subsidiar análises econômicas nesta área, sendo úteis para nortear políticas de saúde pública.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To estimate the annual cost of coronary artery disease (CAD) management in Public Health Care System (SUS) and HMOs values in Brazil. METHODS: Cohort study, including ambulatory patients with proven CAD. Clinic visits, exams, procedures, hospitalizations and medications were considered to estimate direct costs. Values of appointments and exams were obtained from the SUS and the Medical Procedure List (LPM 1999) reimbursement tables. Costs of cardiovascular events were obtained from admissions in public and private hospitals with similar diagnoses-related group classifications in 2002. The price of medications used was the lowest found in the market. RESULTS: The 147 patients (65&amp;plusmn;12 years old, 63% men, 69% hypertensive, 35% diabetic and 59% with previous AMI) had an average follow-up of 24&amp;plusmn;8 months. The average estimated annual cost per patient was R$ 2,733.00, for the public sector, and R$ 6,788.00, for private and fee-for-service plans. Expenses with medications (R$ 1,154.00) represented 80% and 55% of outpatient costs, and 41% and 17% of total expenses, in public and non-public sectors, respectively. The occurrence of cardiovascular event had a great impact (R$ 4,626.00 vs. R$ 1,312.00, in SUS, and R$ 13,453.00 vs. R$ 1,789.00, for HMOs, p&lt;0.01) on the results. CONCLUSION: The average annual cost of CAD management was high, being the pharmacological treatment the main determinant of public costs. Such estimates may subsidize economical analyses in this area, and foster related healthcare policies.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>custo da doença</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>análise econômica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença arterial coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coorte</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cost of illness</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>economical analysis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cohort</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Análise de custos do tratamento de episódios de descompensação aguda de insuficiência cardíaca: levosimendan versus dobutamina</s1>
</fA08>
<fA08 dir="en">
<s1>Cost analysis of the treatment of acute decompensated heart failure: levosimendan versus dobutamine</s1>
</fA08>
<fA11 dir="011000">
<s1>Mucio Tavares Oliveira Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Wilson Follador</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Lucia Orlandi Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Roberta Canaviera</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rosana Lima Garcia Tsuji</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Airton Scipioni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>9-14</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar se o tratamento com levosimendan seria mais dispendioso que o usual com dobutamina, uma vez que o preço dos medicamentos não representa a maior despesa no tratamento da descompensação cardíaca. MÉTODOS: Comparou-se o custo do tratamento de 18 pacientes hospitalizados devido a descompensação cardíaca, 9 tratados com dobutamina (grupo dobuta) e 9 com levosimendan (grupo levo). Os grupos foram semelhantes quanto à idade, sexo, classe funcional e função cardíaca. RESULTADOS: O custo do tratamento foi semelhante para os dois grupos. No grupo levo as despesas com medicamentos foram maiores, mas as relativas ao período de terapia intensiva e do material empregado foram menores. Levo - medicamentos: R$ 5.414,00; materiais: R$ 399,90; diárias hospitalares: R$ 5.061,20; serviços profissionais: R$ 3.241,80; final: R$ 14.117,00. Dobuta - medicamentos: R$ 2.320,10; materiais: R$ 1.665,70; diárias hospitalares: R$ 6.261,90; serviços profissionais: R$ 3.894,30; final: R$ 14.142,00. CONCLUSÃO: Apesar do preço mais elevado da droga, o custo global do tratamento foi semelhante para os pacientes tratados com dobutamina ou levosimendan. O paciente tratado com levosimendan permaneceu menos tempo em terapia intensiva.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess whether the treatment with levosimendan is more expensive than the usual one with dobutamine, since price of medications does not usually represent the greatest expense in the treatment of cardiac decompensation. METHODS: The cost of treatment of 18 inpatients with cardiac decompensation, 9 of which treated with dobutamine (dobuta group) and 9 with levosimendan (levo group), was compared. Groups were similar concerning age, sex, functional class and cardiac function. RESULTS: Treatment costs were similar for both groups. In the levo group, the costs with the drug were higher than in the dobuta group, but those related to the length of stay in intensive care unit and to the material used during admission were lower. Levo - drug: R$ 5,414.00; material: R$ 399.90; hospital daily rates: R$ 5,061.20; professional honorarium: R$ 3,241.80; total costs: R$ 14,117.00. Dobuta - drug: R$ 2,320.10; materials: R$ 1,665.70; hospital daily rates: R$ 6,261.90; professional honorarium: R$ 3,894.30; total costs: R$ 14,142.00. CONCLUSION: Despite the higher price of levosimendan, the global cost of the treatment was similar for patients who were treated either with dobutamine or levosimendan. Patients who were treated with levosimendan had a shorter length of stay in intensive care unit.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca descompensada</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>inotrópicos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>levosimendan</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dobutamina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>farmacoeconomia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>decompensated heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>inotropics</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>levosimendan</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dobutamine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pharmacoeconomics</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Lipemia pós-prandial: influência do envelhecimento</s1>
</fA08>
<fA08 dir="en">
<s1>Postprandial lipemia: influence of aging</s1>
</fA08>
<fA11 dir="011000">
<s1>Jaqueline Scholz Issa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jayme Diament</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Neusa Forti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>15-19</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Investigar o comportamento da lipemia pós-prandial, avaliada por meio de medidas repetidas de triglicérides, em indivíduos saudáveis de 20 a 50 anos de idade, distribuídos em faixas etárias: GI - 20 a 30; GII - 31 a 40; GIII - 41 a 50 anos. MÉTODOS: Os triglicérides foram determinados em 3 condições: após jejum de 12 h, 2 h e 6 h após refeição padronizada contendo 40 g de gordura. RESULTADOS: A análise de medidas repetidas dos triglicérides demonstrou comportamento distinto dos grupos etários ao longo das 6 h. Os participantes mais jovens (GI) apresentavam redução dos valores de triglicérides na 6ª hora; os da faixa etária (GIII) mais idosa, valores ascendentes na 6ª hora, e os da faixa etária intermediária (GII), manutenção dos triglicérides, comparando a 2ª com a 6ª hora de coleta. As diferenças de comportamento foram significantes (p=0,01). CONCLUSÃO: Em amostra populacional adulta saudável, o envelhecimento exerce influência sobre o comportamento da lipemia pós-prandial.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To investigate the behavior of postprandial lipemia assessed by means of repeated measurements of triglyceride levels in healthy individuals aged from 20 to 50 years, divided into the following 3 age groups: GI - from 20 to 30 years; GII - from 31 to 40 years; and GIII - from 41 to 50 years. METHODS: Triglyceride levels were measured in 3 conditions: after a 12-hour fast, and 2 and 6 hours after a standard meal containing 40 g of fat. RESULTS: The repeated-measures analysis of triglyceride levels showed a distinct behavior of the age groups throughout the 6 hours. The younger participants (GI) had a reduction in the triglyceride levels in the sixth hour; the elderly (GIII) had increasing values in the sixth hour; and those in the intermediate age group (GII) maintained their triglyceride levels, when comparing the second and sixth hours of blood collection. The differences in behavior were significant (P=0.01). CONCLUSION: In a healthy adult population sample, aging influences the postprandial lipemia behavior.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lipemia pós-prandial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>envelhecimento</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>metabolismo lipídico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>postprandial lipemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aging</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipid metabolism</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Fatores de risco cardiovascular e mortalidade: seguimento em longo prazo (até 20 anos) em programa preventivo realizado pela medicina ocupacional</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiovascular risk factors and mortality: long-term follow-up (up to 20 years) in a preventive program carried out by occupational medicine</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Alberto de Souza Ciorlia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Moacir Fernandes de Godoy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de São José do Rio Preto  </s1>
<s2>São José do Rio Preto SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>20-25</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>51</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: A queda da mortalidade por doenças cardiovasculares (DCV) está sendo conseguida nos Estados Unidos e o mesmo declínio está ocorrendo em países em desenvolvimento, graças a mudanças favoráveis alcançadas no estilo de vida e nos fatores de risco. Apesar dessa consideração, o volume de informações de que se dispõe sobre a distribuição e comportamento desse tipo de doença e seus fatores de risco no Brasil ainda é pequeno. MÉTODOS: Foi realizada avaliação das alterações do colesterol total (CT), níveis de pressão arterial (PA), índice de massa corporal (IMC) e tabagismo, além da ocorrência de eventos cardiovasculares fatais (F) e não fatais (NF), sob intervenção dietética e comportamental e seguimento em longo prazo (até 20 anos) em um grupo fechado, composto por 621 eletricitários de ambos os sexos, com idade média de 29,1&amp;plusmn;7,1 anos, variando de 15 a 59 anos. Foram construídas curvas atuariais para analisar os eventos cardiovasculares F e NF. RESULTADOS: A média do CT apresentou redução significativa por efeito da orientação dietética. O hábito de fumar diminuiu significativamente com mudanças comportamentais. A média das PAs diminuiu significativamente com uma melhor detecção e medidas higiênicas, e a adesão dos hipertensos definitivos ao tratamento mostrou um índice de 56,6%. Por outro lado, o IMC apresentou um aumento expressivo e gradativo. A probabilidade de os indivíduos continuarem livres de qualquer evento cardiovascular foi de 98,1%, enquanto que para os eventos fatais foi de 99,2%. CONCLUSÃO: Esses resultados comprovam que iniciativas voltadas para a prevenção devem ser prioritárias, com a intenção de se modificar as taxas de morbimortalidade das DCV.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: The decrease in mortality due to cardiovascular diseases (CVD) has been achieved in the United States and the same decrease has been happening in developing countries, thanks to favorable changes in lifestyle and risk factors. Despite such consideration, the volume of information available on the distribution and behavior of that type of disease and its risk factors in Brazil is still little. METHODS: The assessment of changes in total cholesterol (TC), levels of blood pressure (BP), body mass index (BMI) and smoking was carried out, besides the occurrence of fatal (F) and non-fatal (NF) cardiovascular events, under dietary and behavioral intervention and long-term follow-up (up to 20 years) in a closed group, consisting of 621 electric power company workers of both sexes, with average age of 29.1&amp;plusmn;7.1 years old, varying from 15 to 59 years old. Actuarial curves were obtained to analyze the F and NF cardiovascular events. RESULTS: The TC mean showed significant reduction due to dietary guidance. The smoking habit decreased significantly with behavioral changes. The mean of the BPs decreased significantly with a better detection and hygienic measures, and the adhesion by definite hypertensive people to the treatment showed an index of 56.6%. On the other hand, the BMI showed an expressive and gradual increase. The probability for the individuals to remain free of any cardiovascular event was of 98.1%, whereas for the fatal events, it was 99.2%. CONCLUSION: Those results prove that initiatives directed towards the prevention must be priorities, aiming at modifying the morbimortatility rates of CVD.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>risco cardiovascular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>medicina preventiva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>medicina ocupacional</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular risk</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>preventive medicine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>occupational medicine</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Indicadores antropométricos de obesidade como instrumento de triagem para risco coronariano elevado em adultos na cidade de Salvador - Bahia</s1>
</fA08>
<fA08 dir="en">
<s1>Anthropometric indexes of obesity as an instrument of screening for high coronary risk in adults in the city of Salvador - Bahia</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco José Gondim Pitanga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ines Lessa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia  </s1>
<s2>Salvador BA</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>26-31</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar vários indicadores antropométricos de obesidade e identificar dentre eles qual melhor discrimina o risco coronariano elevado (RCE). MÉTODOS: Estudo de corte transversal, com amostra composta por 968 adultos de 30 a 74 anos de idade, sendo 391 (40,4%) do sexo masculino. Foram construídas diversas curvas Receiver Operating Characteristic (ROC) e comparadas às áreas sob as mesmas entre o índice de conicidade (índice C), índice de massa corporal (IMC), razão circunferência cintura-quadril (RCCQ), circunferência de cintura (CC) e RCE. Verificou-se também a sensibilidade e especificidade para identificar e comparar o melhor ponto de corte entre os diversos indicadores de obesidade para discriminar o RCE. Foi utilizado intervalo de confiança a 95%. RESULTADOS: A maior área sob a curva ROC foi encontrada entre o índice C e RCE, em indivíduos do sexo masculino, 0,80 (0,74-0,85), diferindo significativamente dos demais indicadores de obesidade. Em mulheres, a maior área sob a curva ROC encontrada foi de 0,76 (0,71-0,81), sendo iguais entre índice C, RCCQ e RCE. CONCLUSÃO: Esses resultados demonstram que o índice C e RCCQ são os melhores indicadores de obesidade para discriminar RCE. A CC tem intermediário poder discriminatório e o IMC foi o indicador antropométrico de obesidade menos adequado para discriminar RCE. Estes dados sugerem que os indicadores de obesidade abdominal são melhores para discriminar RCE que os indicadores de obesidade generalizada.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare some anthropometric indexes of obesity and identify among them which one best discriminates the high coronary risk (HCR). METHODS: A cross-section study, with sample consisting of 968 adults, between 30 and 74 years old, being 391 (40.4%) men. Many Receiver Operating Characteristic (ROC) curves were obtained and compared to areas under them among the conicity index (C index), body mass index (BMI), waist-hip circumference ratio (WHCR), waist circumference (WC) and HCR. The sensitivity and specificity to identify and compare the best cut-off point among the many indexes of obesity to discriminate the HCR were also identified. A confidence interval of 95% was used. RESULTS: The largest area under ROC curve was found between the C index and the HCR, in individuals of male sex, 0.80 (0.74-0.85), significantly differing from the other indexes of obesity. In women, the largest area found under the ROC curve was 0.76 (0.71-0.81), being equal between C, WHCR and HCR indexes. CONCLUSION: Those results show that C and WHCR indexes are the best indexes of obesity to discriminate HCR. WC has intermediate discriminatory power and the BMI was the least suitable anthropometric index of obesity to discriminate HCR. Those data suggest that the indexes of abdominal obesity are better to discriminate HCR than the indexes of general obesity.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>indicadores antropométricos de obesidade</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>risco coronariano</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>obesidade abdominal</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>anthropometric indexes of obesity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary risk</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>abdominal obesity</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Desmame da ventilação mecânica utilizando pressão de suporte ou tubo T: comparação entre pacientes cardiopatas e não cardiopatas</s1>
</fA08>
<fA08 dir="en">
<s1>Weaning from mechanical ventilation by using pressure support or T-tube ventilation: comparison between patients with and without heart disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre Doval da Costa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo de Mello Rieder</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Silvia Regina Rios Vieira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital de Clínicas de Porto Alegre  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal do Rio Grande do Sul  </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>32-38</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar variáveis cardiorrespiratórias durante o desmame com as técnicas tubo T e pressão de suporte e compará-las em grupos de cardiopatas e não cardiopatas. MÉTODOS: Avaliados 20 pacientes (57&amp;plusmn;15 anos) quanto à: oxigenação, eliminação de CO2, freqüência respiratória e cardíaca, volume corrente e volume minuto, freqüência cardíaca, pressão arterial e alterações eletrocardiográficas. Os dados foram registrados, em ambas as técnicas, aos zero, 15 e 30 min, com intervalo de 30 min. Os pacientes foram divididos em cardiopatas (n=11) e não cardiopatas (n=9) e comparados. RESULTADOS: Comparando-se pressão de suporte com tubo T demonstraram-se: valores de oxigenação e eliminação de CO2 significativamente mais elevados e freqüência respiratória reduzidos. Não houve diferença quanto à pressão arterial e freqüência cardíaca. Comparando-se cardiopatas versus não cardiopatas, foram verificadas, respectivamente, alterações de segmento ST em 7 (64%) versus 2 (22%), arritmias em 3 (27%) versus 1 (11%) e menor ocorrência de taquicardia. CONCLUSÃO: Na comparação de pressão de suporte com tubo T uma melhor resposta foi observada nas medidas de parâmetros respiratórios e de oxigenação com o uso de pressão de suporte, não havendo diferenças significativas nas medidas de parâmetros cardiovasculares. Houve menor ocorrência de taquicardia, maior ocorrência de alterações de segmento ST e tendência à maior ocorrência de arritmias nos cardiopatas, em ambos os modos de desmame.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess cardiorespiratory variables during weaning from mechanical ventilation by using the T-tube and pressure support techniques, and to compare them in groups of patients with and without heart disease. METHODS: To assess the following parameters of 20 patients (57&amp;plusmn;15 years) undergoing weaning from mechanical ventilation: oxygenation; CO2 elimination; respiratory and heart rates; tidal and minute volumes; blood pressure; and electrocardiographic alterations. Data were recorded by using both techniques at the following times: zero, 15, and 30 minutes, and after a 30-minute interval. The patients were divided into 2 groups, with heart disease (n=11) and without heart disease (n=9), and then compared. RESULTS: The pressure support ventilation showed significantly more elevated oxygenation and CO2 elimination values, and reduced respiratory rate as compared with those of the T-tube ventilation. No difference was found in regard to blood pressure and heart rate. More patients with heart disease had alterations in the ST segment [7 (64%) patients versus 2 (22%)] and arrhythmias [3 (27%) versus 1 (11%)], as compared with patients without heart disease. A lower frequency of tachycardia was observed in those with heart disease. CONCLUSION: When comparing pressure support ventilation with T-tube ventilation, a better response was observed in the measurements of the respiratory and oxygenation parameters when using pressure support ventilation. No significant difference was observed in the measurements of cardiovascular parameters. In both weaning techniques, patients with heart disease had tachycardia less frequently, more alterations in the ST segment, and a greater tendency towards the occurrence of arrhythmias.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ventilação mecânica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>isquemia miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>desmame</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mechanical ventilation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial ischemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>weaning</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Estratégia cirúrgica na transposição das grandes artérias com septo interventricular intacto após o período neonatal</s1>
</fA08>
<fA08 dir="en">
<s1>Surgical strategy for transposition of the great arteries with intact ventricular septum after the neonatal period</s1>
</fA08>
<fA11 dir="011000">
<s1>Bayard Gontijo Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fernando A. Fantini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cristiane Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Roberto Max Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Roberto de S. Thiago Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sonia Maria Rabelo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Eliana Heyden</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Érika Vrandecic</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Mario O. Vrandecic</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Biocor Instituto  </s1>
<s2>Belo Horizonte MG</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>39-44</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar o resultado cirúrgico em portadores de transposição das grandes artérias com septo interventricular intacto, operados após o período neonatal. MÉTODOS: Entre janeiro de 1998 e março de 2004 foram atendidas 121 crianças com transposição das grandes artérias com septo interventricular intacto, sendo 29 (24%) após o período neonatal. A seleção para tratamento cirúrgico foi baseada na avaliação ecocardiográfica pelo cálculo da massa do ventrículo esquerdo e da configuração do septo interventricular. Das 29 crianças, 12 foram selecionadas para correção anatômica primária, 12 para correção em dois estágios, após preparo cirúrgico do ventrículo esquerdo e 5 submetidas a correção atrial. RESULTADOS: No grupo submetido à correção anatômica primária houve 1 (8,3%) óbito hospitalar por sepsis. No grupo de correção em dois estágios, 5 pacientes foram submetidos ao preparo lento, com correção 3-6 meses após o 1º estágio, ocorrendo 4 óbitos após o 1º estágio. Este fato determinou mudança no nosso protocolo, adotando-se a técnica de preparo rápido nos outros 7 pacientes, tendo todos atingido o 2º estágio. Das 8 crianças submetidas ao 2º estágio houve 1 óbito hospitalar e outro óbito tardio. A evolução clínica tardia das crianças de ambos os grupos é excelente. CONCLUSÃO: A seleção ecocardiográfica adequada da transposição de grandes artérias com septo interventricular intacto quando abordada após o período neonatal, permitiu uma orientação segura da escolha da melhor abordagem cirúrgica nestes pacientes.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the surgical results in patients with transposition of the great arteries and intact ventricular septum undergoing surgery after the neonatal period. METHODS: From January 1998 to March 2004, 121 children with transposition of the great arteries with intact ventricular septum were treated, 29 (24%) of whom after the neonatal period. Selection for surgical treatment was based on echocardiographic assessment by use of the calculation of left ventricular mass and configuration of the ventricular septum. Of the 29 children, 12 were selected for primary anatomic correction, 12 for 2-stage correction after surgical preparation of the left ventricle, and 5 underwent atrial correction. RESULTS: In the group undergoing primary anatomic correction, one (8.3%) patient died at the hospital due to sepsis. In the group undergoing 2-stage correction, 5 patients underwent slow preparation with correction 3-6 months after the first stage, 4 of whom died after the first stage. This fact caused a change in our protocol, with adoption of the rapid preparation technique in the other 7 patients, of whom all achieved the second stage. Of the 8 children undergoing the second stage, one died at the hospital and another died later. Late clinical evolution of the children in both groups is excellent. CONCLUSION: The echocardiographic selection allowed a safe choice of the best surgical approach for patients with transposition of the great arteries and intact ventricular septum after the neonatal period.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>transposição das grandes artérias</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>septo interventricular intacto</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>correção anatômica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>preparo ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>transposition of the great arteries</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>intact ventricular septum</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>anatomic correction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular preparation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Freqüência cardíaca máxima em testes de exercício em esteira rolante e em cicloergômetro de membros inferiores</s1>
</fA08>
<fA08 dir="en">
<s1>Maximal heart rate in exercise tests on treadmill and in a cycloergometer of lower limbs</s1>
</fA08>
<fA11 dir="011000">
<s1>Claudio Gil Soares de Araújo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vivian Liane Mattos Pinto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Clínica de Medicina do Exercício  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Gama Filho  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>45-50</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>32</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar, retrospectivamente, os valores de freqüência cardíaca máxima (FCM) e o descenso da freqüência cardíaca no primeiro minuto da recuperação (dFC), obtidos em teste de exercício (TE) realizados em dois ergômetros e momentos distintos. MÉTODOS: Sessenta indivíduos (29 a 80 anos de idade), submetidos a TE cardiopulmonar em ciclo de membros inferiores (CMI) em nosso laboratório e que possuíam TE prévio (até 36 meses) em esteira (EST) em outros laboratórios, nas condições idênticas de medicações de ação cronotrópica negativa. RESULTADOS: FCM foi semelhante no CMI: 156&amp;plusmn;3 e EST: 154&amp;plusmn;2 bpm (p=0,125), enquanto o dFC foi maior em CMI: 33&amp;plusmn;2, EST: 26&amp;plusmn;3 bpm (média &amp;plusmn; erro padrão da média) (p&lt;0,001). Nas variáveis hemodinâmicas estudadas, a pressão arterial sistólica e o duplo produto foram maiores no TE-CMI (p&lt;0,001). O eletrocardiograma (ECG) foi semelhante nos dois TEs, exceto por arritmias supraventriculares mais freqüentes no CMI. CONCLUSÃO: a) É possível, com empenho do examinador e conhecimento prévio do resultado de FCM em um TE anterior, obter níveis altos de FCM em um TE-CMI; b) interromper o TE baseado em FCM prevista por equações tende a levar a esforços submáximos; c) o dFC difere nas recuperações ativa e passiva; d) novas formas de analisar o comportamento da FC no exercício, que não apenas o valor da FCM, são necessárias para caracterizar um TE como máximo.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare, retrospectively, the values of maximum heart rate (MHR) and the decrease of the heart rate at the first minute of recovery, which were obtained in an exercise test (ET) performed in two different ergometers and at different moments. METHODS: Sixty individuals (from 29 to 80 years old), submitted to cardiopulmonary ET in a cycle of lower limbs (CLL) in our laboratory and who had previous ET (up to 36 months) in a treadmill (TRM) in other laboratories, under identical conditions of medications of negative chronotropic action. RESULTS: MHR was similar in CLL: 156&amp;plusmn;3 and TRM: 154&amp;plusmn;2 bpm (p=0.125), whereas dHR was higher in CLL: 33&amp;plusmn;2, EST: 26&amp;plusmn;3 bpm (mean &amp;plusmn; standard error of the mean) (p&lt;0.001). In hemodynamic variables studied, the systolic blood pressure and the double product were higher in the ET-CLL (p&lt;0.001). The electrocardiogram (ECG) was similar in both ETs, except due to more frequent supraventricular arrhythmias in CLL. CONCLUSION: a) With some diligence from the examiner and previous knowledge of MHR in a previous ET it is possible to obtain high levels of MHR in an ET-CLL; b) interrupting the MHR-based ET forecast through equations tends to lead to sub-maximum efforts; c) dHR differs in active and passive recoveries; d) new ways to analyze the HR behavior under exercise, which is not only the value of MHR, are necessary to characterize an ET as maximum.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>freqüência cardíaca máxima</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste de exercício</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ergômetro</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>freqüência cardíaca de recuperação</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>maximal heart rate</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ergometer</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart rate recovery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Coartação de aorta em crianças até um ano: análise de 20 anos de experiência</s1>
</fA08>
<fA08 dir="en">
<s1>Coarctation of the aorta in infants under one year of age: an analysis of 20 years of experience</s1>
</fA08>
<fA11 dir="011000">
<s1>Gabriel Lorier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Orlando Wender</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Renato A.K. Kalil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Javier Gonzalez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Gustavo Hoppen</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Christiano Barcellos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Abud Homsi-Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Paulo R. Prates</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>João R.M. Sant'Anna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Ivo A. Nesralla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>51-56</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>38</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Revisão da experiência com diversas técnicas de correção empregadas, nos últimos 20 anos, em crianças menores de um ano de idade. MÉTODOS: No período de 1978 a 1998, foram operados 148 pacientes (pc) consecutivos com coartação de aorta (CoAo) com até um ano de idade, com ou sem defeitos intracardíacos associados. A idade apresentou mediana de 50 dias, 92 pc do sexo feminino (62,1%). O peso foi de 4.367&amp;plusmn;1.897 gramas. O seguimento foi em média de 1.152&amp;plusmn;1.462 dias. A população foi dividida em 3 grupos: Grupo I, CoAo isolada: 74 pc (50%); Grupo II, CoAo e comunicação interventricular (CIV): 41 pacientes (27,7%) e Grupo III, CoAo com malformações complexas: 33 pc (22,3%). RESULTADOS: Mortalidade total foi 43 pc (29%): com menos de 30 dias, foi 53%, p=0,009, OR=4,5, entre 31 e 90 dias, foi 14,7%, p=0,69, e acima de 91 dias, 15%, p=0,004. A probabilidade de sobrevida atuarial de toda a população foi de 67% aos 5 e 10 anos. Trinta e seis pacientes (24,3%) recoartaram, dos quais 18 pacientes (50%) tinham menos de 30 dias, OR=6,35. A incidência de recoartação foi com a técnica de Waldhausen em 4 pacientes (10%) e com a término-terminal clássica em 19 pacientes (26%) p=0.03, e a istmoplastia em 6 pacientes (37,5%). A probabilidade de sobrevida atuarial livre de recoartação aos 5 e 10 anos foi de 69% com a técnica de Waldhausen e 63% com a técnica término-terminal clássica. CONCLUSÃO: Pacientes com menos de 30 dias apresentaram risco aumentado de mortalidade e recoartação. A técnica de Waldhausen em pacientes com mais de 30 dias mostrou-se efetiva. A técnica término-terminal clássica mostrou não ser uma boa opção em todas as faixas etárias, sendo imperativo executar variantes técnicas como término-terminal estendida.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: A review of experience with techniques of correction used, in the last 20 years, in children younger than one year old. METHODS: In the period from 1978 to 1998, 148 patients (pt) with coarctation of the aorta (CoAo), under one year of age, with or without associated intracardiac defects, were submitted to surgery. Median age 50 days, 92 female pt (62.1%). The average weight was 4,367&amp;plusmn; 1,897 gr. The average follow-up was 1,152&amp;plusmn;1,462 days. The population was divided in 3 groups: Group I, isolated CoAo: 74 pt (50%); Group II, CoAo and interventricular communication (IVC): 41 pt (27.7%) and Group III, CoAo with complex intracardiac malformations: 33 pt (22.3%). RESULTS: The total mortality was of 43 patients (29%). In patients younger than 30 days, the mortality was 53%, p=0.009, DR=4.5, between 31 and 90 days, 14.7%, p=0.69, and over 91 days, 15%, p=0.004. The probability of actuarial survival of the whole population was 67% at 5 and 10 years. Thirty-six patients (24.3%) had recoarctation, from which 18 patients (50%) were younger than 30 days, DR=6.,35. The incidence of recoarctation was with Waldhausen technique in 4 patients (10%) and with the classic termino-terminal technique in 19 patients (26%) p=0.03, and isthmusplastic operation in 6 patients (37.5%). The patients younger than 30 days showed a relative risk for recoarctation de DR=6.35. The probability of actuarial survival, free of coarctation repair, at 5 and 10 years was of 69% with Waldhausen's technique and 63% with the classic termino-terminal technique. CONCLUSION: Patients younger than 30 days showed increased mortality and recoarctation risk. Waldhausen's technique in patients older than 30 days showed effective. The classic termino-terminal technique did not show to be a good option in all age ranges, being imperative to carry out more radical technical variations, such as the extended termino-terminal.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coartação aórtica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>crianças</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic coarctation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>children</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Perfil lipídico e fatores de risco para doenças cardiovasculares em estudantes de medicina</s1>
</fA08>
<fA08 dir="en">
<s1>Lipid profile and risk factors for cardiovascular diseases in medicine students</s1>
</fA08>
<fA11 dir="011000">
<s1>Vanessa Gregorin Coelho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Loeni Fátima Caetano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Raphael Del Roio Liberatore Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Antônio Cordeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Dorotéia Rossi Silva Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de São José do Rio Preto  </s1>
<s2>São José do Rio Preto SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>57-62</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>36</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500111</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar o perfil lipídico e sua correlação com fatores de risco para doenças cardiovasculares (DCV) em estudantes de medicina. MÉTODOS: Foram avaliados 153 estudantes, independente do sexo, com idade entre 18 e 31 anos, submetidos à análise do perfil lipídico, incluindo níveis séricos de colesterol total (CT), fração de colesterol das lipoproteínas de baixa (LDLc), alta (HDLc) e muito baixa densidade (VLDLc) e triglicérides (TG), além de hábitos de vida e dados antropométricos. Aplicou-se análise estatística, incluindo teste de Mann Whitney, qui-quadrado, correlação de Pearson e análise multivariada, admitindo-se nível de significância para valor p&lt;0,05. RESULTADOS: Destacaram-se sedentarismo (43,1%) e antecedentes familiais para DCV, particularmente hipertensão arterial (74,5%). O perfil lipídico mostrou-se desejável, embora níveis alterados de CT, LDLc e TG foram detectados em 11,8%, 9,8% e 8,5% dos estudantes, respectivamente, e níveis reduzidos de HDLc em 12,4% deles. As mulheres apresentaram valores significativamente reduzidos para LDLc e elevados para HDLc comparado aos homens (p=0,031 e p&lt;0,0001, respectivamente). Houve associação significante entre perfil lipídico e, preferencialmente, índice de massa corpórea (IMC), sedentarismo, ingesta de álcool, uso de anticoncepcional, antecedentes familiais de acidente vascular cerebral e dislipidemia. CONCLUSÃO: Antecedentes familiais para DCV, sedentarismo e uso de anticoncepcional entre os estudantes de medicina mostram-se freqüentes e associados ao perfil lipídico, assim como ingesta de álcool e IMC. Embora com perfil lipídico desejável, independente do sexo, níveis mais elevados de LDLc e reduzidos de HDLc no sexo masculino conferem aos homens desvantagem comparado às mulheres.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the lipid profile and its correlation with risk factors for cardiovascular diseases (CVD) among medicine students. METHODS: We assessed 153 students, regardless of sex, with age between 18 and 31 years old, submitted to lipid profile analysis, including serum levels of total cholesterol (TC), fraction of cholesterol of low (LDLc), high (HDLc) and very low density (VLDLc) lipoproteins and triglycerides (TG), besides of life habits and anthropometric data. Statistic analysis was employed, including the test of Mann Whitney, chi-square test, Pearson's correlation and multivariate analysis, by adopting a significance level for a value of p&lt;0.05. RESULTS: Sedentary lifestyle (43.1%) and familial history for CVD, particularly hypertension (74.5%), were distinguished. The lipid profile showed desirable, although altered levels of TC, LDLc and TG were detected in 11.8%, 9.8% and 8.5% from the students, respectively, and reduced levels of HDLc in 12.4% of them. Women showed significantly reduced values for LDLc and high values for HDLc compared to men's (p=0.031 and p&lt;0.0001, respectively). There was a significant association between lipid profile and, preferably, body mass index (BMI), sedentary lifestyle, ingestion of alcohol, contraceptive use, familial antecedents of cerebrovascular accident and dyslipidemia. CONCLUSION: Familial history for CVD, sedentary lifestyle and contraceptive use among medicine students showed frequent and associated to the lipid profile, as well as ingestion of alcohol and BMI. Although with desirable lipid profile, regardless of sex, higher levels of LDLc and reduced levels of HDLc in male sex provide a disadvantage to men compared to women.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lipídio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estudantes de medicina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doenças cardiovasculares</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipid</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>medicine students</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular diseases</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Endocardite infecciosa causada por Eikenella corrodens</s1>
</fA08>
<fA08 dir="en">
<s1>Eikenella corrodens infective endocarditis</s1>
</fA08>
<fA11 dir="011000">
<s1>Juliano Novaes Cardoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo Eidi Ochiai</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Múcio T. Oliveira Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Morgado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Robinson Munhoz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fernanda E. Andretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Alfredo José Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>63-64</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>07</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500112</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Os microorganismos do grupo HACEK (Haemophilus spp, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens e Kingella kingae) são responsáveis por 3% dos casos de endocardites. Eles apresentam propriedades clínicas e microbiológicas semelhantes entre si: são bacilos gram-negativos, isolados mais facilmente em meios aeróbicos, suas culturas necessitam de tempo prolongado de incubação para crescimento (média 3,3 dias) e podem ser considerados como parte da flora normal do trato respiratório superior e da orofaringe1,2. Algumas características foram identificadas nas endocardites por esses agentes, como o quadro clínico insidioso¹, diagnóstico difícil pela natureza fastidiosa e culturas negativas3,4. A endocardite por Eikenella corrodens foi descrita pela primeira vez em 1972(5) e continua sendo um agente etiológico raro. Relatamos o caso de uma paciente com valva nativa que apresentou endocardite infecciosa causada por Eikenella corrodens.</s0>
</fC01>
<fC01 dir="en">
<s0>The HACEK microorganisms (Haemophilus spp, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kingella kingae) account for 3% of the cases of endocarditis. They have the following similar clinical and microbiological properties: are Gram-negative bacilli, more easily isolated in aerobic media; their cultures require prolonged incubation time for growing (mean, 3.3 days); and may be considered part of normal flora of upper respiratory tract and oropharynx1,2. The following characteristics have been identified in endocarditis caused by the HACEK microorganisms: insidious clinical findings¹; difficult diagnosis due to the fastidious nature of the microorganisms; and negative cultures3,4. The Eikenella corrodens endocarditis was first described in 1972(5). That microorganism continues to be a rare etiological agent. We report the case of a female patient with native valve, who had Eikenella corrodens infective endocarditis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Aneurisma do átrio direito associado à hidropisia fetal: diagnóstico por ecocardiografia fetal</s1>
</fA08>
<fA08 dir="en">
<s1>Right atrial aneurysm associated to fetal hydrops: diagnosis through fetal echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcia Ferreira Alves Barberato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Silvio Henrique Barberato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cláudio Correa Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sérgio Luis Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alfred Krawiec</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Centro de Medicina Materno-Fetal  </s1>
<s2>Curitiba PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>65-67</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500113</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Os aneurismas de átrio direito são entidades raramente relatadas na prática cardiológica, especialmente em vida intra-uterina, e podendo ser confundidos com derrame pericárdico e anomalia de Ebstein da valva tricúspide. Apresentamos revisão da literatura e ilustramos com caso de diagnóstico pré-natal de aneurisma de átrio direito cursando com sinais de hidropisia.</s0>
</fC01>
<fC01 dir="en">
<s0>Right atrium aneurysms are entities which are rarely reported in cardiologic practice, especially in intrauterine life, and may be mistaken with pericardial effusion and Ebstein's anomaly. We show a review of the literature and illustrate with a case of prenatal diagnosis of right atrium aneurysm running through with hydropsy signs.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Miocardiopatia preponderante de ventrículo direito por miocardite prévia ou por displasia arritmogênica?</s1>
</fA08>
<fA08 dir="en">
<s1>Prevailing right ventricular myocardiopathy for previous myocarditis or arrhythmogenic dysplasia?</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Eduardo Rochitte</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luis Francisco R. de Ávila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luiz J. Kajita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Renata Bacic Palhares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>68-71</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500114</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>É relatado o caso clínico de um paciente do sexo masculino com 10 anos de idade, cuja miocardiopatia dilatada e preponderante de ventrículo direito apresenta dificuldades diagnósticas entre a etiologia de miocardite prévia e a displasia arritmogênica. Como os elementos não são patognomônicos de uma ou de outra causa, a elevação de enzimas cardíacas na fase subaguda talvez incline para a suposição de miocardite prévia. Daí, o questionamento de que muitos casos rotulados como displasia arritmogênica poderem, verdadeiramente, corresponder à possibilidade de miocardite evolutiva. A controvertida conduta clínica é discutida.</s0>
</fC01>
<fC01 dir="en">
<s0>A clinical case of a 10-year-old male patient is reported. His dilated and prevailing right ventricular myocardiopathy shows diagnostic difficulties between previous myocarditis etiology and arrhythmogenic dysplasia. As the elements are not pathognomonic of one or other cause, the increase of cardiac enzymes in subacute stage maybe tends to the supposition of previous myocarditis. Hence, the questioning that many cases labeled as arrhythmogenic dysplasia can truly correspond to the possibility of evolutional myocarditis. The controversial clinic management is disputable.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Terapêutica na prática clínica cardiovascular: vivências e evidência</s1>
</fA08>
<fA08 dir="en">
<s1>Therapeutics in clinical cardiovascular practice: experiences and evidence</s1>
</fA08>
<fA11 dir="011000">
<s1>Flávio Danni Fuchs</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio Grande do Sul Faculdade de Medicina Hospital de Clínicas de Porto Alegre</s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>72-75</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500115</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Terapêutica trombolítica em trombose de prótese valvar</s1>
</fA08>
<fA08 dir="en">
<s1>Thrombolytic therapy in prosthetic valve thrombosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo Katz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Flavio Tarasoutchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>76-78</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500116</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Síndrome metabólica em crianças e adolescentes</s1>
</fA08>
<fA08 dir="en">
<s1>Metabolic syndrome in children and adolescents</s1>
</fA08>
<fA11 dir="011000">
<s1>Ayrton Pires Brandão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Andréa Araújo Brandão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gerald S. Berenson</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Valentin Fuster</s1>
<afiliation>A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Tulane Center for Cardiovascular Health The Bogalusa Heart Study </s1>
<s2>New Orleans LA</s2>
<s3>USA</s3>
</fA14>
<fA14 dir="030000">
<s1>World Heart Federation Mount Sinai School of Medicine </s1>
<s2>New York NY</s2>
<s3>USA</s3>
</fA14>
<fA20 dir="000000">
<s1>79-81</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Angioplastia coronariana e revascularização cirúrgica do miocárdio devem ser consideradas métodos eficientes para o controle da isquemia miocárdica na angina estável?</s1>
</fA08>
<fA08 dir="en">
<s1>Should percutaneous coronary intervention and coronary artery bypass graft surgery be considered effective methods to control myocardial ischemia in stable angina?</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Roberto Dutra da Silva</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Sérgio Cordeiro da Rocha</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Instituto Nacional de Cardiologia Laranjeiras  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>82-84</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Lípides séricos em crianças e adolescentes de Florianópolis, SC: Estudo Floripa saudável 2040</s1>
</fA08>
<fA08 dir="en">
<s1>Serum lipids in school kids and adolescents from Florianópolis, SC, Brazil: Healthy Floripa 2040 study</s1>
</fA08>
<fA11 dir="011000">
<s1>Isabela de Carlos Back Giuliano</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mário Sérgio Soares de Azeredo Coutinho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sérgio Fernando Torres de Freitas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Marlene de Souza Pires</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>João Nilson Zunino</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Robespierre Queiroz da Costa Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>85-91</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>72</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a distribuição dos lipídeos séricos em crianças e adolescentes de Florianópolis, SC. Determinar a associação entre colesterol não-desejável (&gt;170 mg/dL) e outros fatores de risco para aterosclerose. MÉTODOS: Amostra aleatória estratificada (por idade e tipo de escola) de alunos da rede escolar de Florianópolis. Dados sobre fatores de risco, antropometria, pressão arterial e concentração sérica de lípides foram coletados. RESULTADOS: Participaram 1.053 indivíduos com idade entre 7 e 18 anos. A concentração sérica do colesterol (média&amp;plusmn;DP) foi 162&amp;plusmn;28 mg/dL; dos triglicerídeos 93&amp;plusmn;47 mg/dL; do HDL-colesterol 53&amp;plusmn;10 mg/dL; do LDL-colesterol 92&amp;plusmn;24 mg/dL e do colesterol não-HDL 109&amp;plusmn; 26 mg/dL. As médias das relações CT/HDL e LDL/HDL foram, respectivamente, 3,1&amp;plusmn;0,6 e 1,8&amp;plusmn;0,5. Os lípides foram mais elevados nas crianças de escola privada, nos menores de 10 anos, no sexo feminino e nos de cor negra. O modelo de regressão logística que melhor previu os níveis de colesterol anormal incluía: obesidade, história familiar de acidente vascular cerebral ou infarto do miocárdio, sexo feminino, idade inferior a 10 anos e a imagem corporal definida pelo médico como sobrepeso/obesidade. CONCLUSÃO: As concentrações de lipídeos em crianças e adolescentes mostraram valores intermediários quando comparados a estudos semelhantes. Uma grande parcela dos indivíduos apresenta níveis de colesterol sérico classificados como não-desejáveis para idade. Pela significância da associação do colesterol com o excesso de peso, o controle deste fator na infância deve ser tomado como prioridade nos programas de prevenção primordial com o objetivo de reduzir a incidência das doenças relacionadas à aterosclerose na idade adulta.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the distribution of serum lipids in children and adolescents of Florianopolis, Santa Catarina State, Brazil. To determine the association between undesirable levels for total cholesterol (&gt;170 mg/dL) and others coronary heart disease risks factors. METHODS: A questionnaire, physical examination and blood analyses were collected from randomized sample from school kids aged range from 7 to 18 years old. RESULTS: 1,053 students participated, aged between 7 and 18 years old. They presented a total cholesterol mean of 162&amp;plusmn;28 mg/dl, triglyceride mean of 93&amp;plusmn;47 mg/dl, HDL-cholesterol mean of 53&amp;plusmn;10 mg/dl, LDL-cholesterol mean of 92&amp;plusmn;24 mg/dl and non-HDL cholesterol mean of 109&amp;plusmn;26 mg/dl. The TC/HDL and LDL/HDL mean rates were, respectively, 3.1&amp;plusmn;0.6 and 1.8&amp;plusmn;0.5. Findings showed that private school children, 10 years old or less, girls and black children had higher lipids values. Overall findings suggest that the best logistic regression model which explained abnormal total cholesterol levels included: obesity, stroke and heart attack familial history, feminine gender, age of 10 years old or less and overweight body image determined on inspection. CONCLUSION: In comparison to international literature, our results, showed intermediated total cholesterol, lower LDL-cholesterol and non-HDL-cholesterol and higher HDL-cholesterol. Therefore, primary prevention programs are needed to be carrying out, especially among overweight children and adolescents so to prevent ischemic heart disease as adulthood.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>criança</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>adolescente</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lípides</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aterosclerose</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>child</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adolescent</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipids</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo comparativo entre os efeitos terapêuticos da revascularização cirúrgica do miocárdio e angioplastia coronária em situações isquêmicas equivalentes: análise através da cintilografia do miocárdio com 99mTc-Sestamibi</s1>
</fA08>
<fA08 dir="en">
<s1>Comparative study between the therapeutic effects of surgical myocardial revascularization and coronary angioplasty in equivalent ischemic situations: analysis through myocardial scintigraphy with 99mTc-Sestamibi</s1>
</fA08>
<fA11 dir="011000">
<s1>Anellys E. L. C. Moreira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Whady A. Hueb</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo Rogério Soares</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Cláudio Meneghetti</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Maria Clementina P. Jorge</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>William A. Chalela</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Eulogio E. Martinez Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Fábio Biscegli Jatene</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>José Antônio Franchini Ramires</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>92-99</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>37</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a carga isquêmica do miocárdio prévia e ulterior à revascularização do miocárdio. MÉTODOS: Foram avaliados 96 pacientes randomizados, portadores de doença arterial coronariana multivascular, angina estável, função do ventrículo esquerdo preservada e isquemia miocárdica esforço-induzida tratados com revascularização cirúrgica (RCM) ou angioplastia coronariana (ATC). Cintilografia do miocárdio com 99mTc-Sestamibi foi realizada antes e 6 meses após a revascularização do miocárdio. RESULTADOS: A RCM determinou índice significantemente maior de revascularização completa (p=0,001), aumento no número de testes ergométricos máximos (p=0,001) e redução no número de testes ergométricos positivos com angina de esforço (p=0,018). Ambos os procedimentos ofereceram melhora importante na classe funcional da angina (p=0,001), aumento no valor médio do duplo produto de pico (p=0,009), e do tempo de tolerância ao esforço (p&lt;0,001), além de redução no valor médio da somatória do escore do esforço (p&lt;0,001) e da diferença da somatória dos escores (p&lt;0,001) nos dois grupos. CONCLUSÃO: ATC e RCM não diferiram significantemente quanto à redução da carga isquêmica do miocárdio 6 meses após o procedimento. A revascularização do miocárdio foi mais completa com a RCM do que com a ATC, mas não representou fator significante para redução da carga isquêmica do miocárdio.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the myocardial ischemic load to previous and after myocardial revascularization. METHODS: Ninety-six randomized patients, carriers of multivessel coronary artery disease, stable angina, preserved left ventricular function, and exercise-induced myocardial ischemia treated with revascularization (SMR) or coronary angioplasty (TCA). Myocardial scintigraphy with 99mTc-Sestamibi was performed prior to and 6 months after myocardial revascularization. RESULTS: The SMR determined a significant greater index of complete revascularization (p=0.001), an increase in the number of maximum ergometric tests (p=0.001) and reduction in the number of positive ergometric tests with exercise angina (p=0.018). Both procedures provided an important improvement in the functional class of angina (p=0.001), an increase in the average value of double peak product (p=0.009), and the time of exercise tolerance (p&lt;0.001), besides the reduction in the average value of the summed of exercise score (p&lt;0.001) and the difference of the summed of scores (p&lt;0.001) in both groups. CONCLUSION: TCA and SMR did not differ significantly concerning the reduction of myocardial ischemic load 6 months after the procedure. The myocardial revascularization was more complete with the SMR than the TCA, but it did not represent a significant factor for the reduction myocardial ischemic load.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>revascularização cirúrgica do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angioplastia coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cintilografia do miocárdio com 99mTecnécio-Sestamibi</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>isquemia miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgical myocardial revascularization</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial scintigraphy with 99mTechnetium-Sestamibi</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial ischemia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Tendência da mortalidade por doenças isquêmicas do coração na cidade de Curitiba - Brasil, de 1980 a 1998</s1>
</fA08>
<fA08 dir="en">
<s1>Mortality trend due to ischemic heart diseases in the city of Curitiba - Brazil, from 1980 to 1998</s1>
</fA08>
<fA11 dir="011000">
<s1>Edevar Daniel</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Helio Germiniani</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Eleusis Ronconi de Nazareno</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Simone Viana Braga</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Anderson Marcelo Winkler</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Claudio L. Pereira da Cunha</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>100-104</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>26</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar a tendência de mortalidade pelas doenças isquêmicas do coração, por sexo, e do infarto agudo do miocárdio, por sexo e faixa etária, de 1980 a 1998, na cidade de Curitiba. MÉTODOS: Utilizou-se os dados de óbitos por doença isquêmica do coração e infarto agudo do miocárdio do Sistema de Informação sobre Mortalidade do Ministério da Saúde, por sexo, faixa etária e local de residência em Curitiba. Os dados de população foram obtidos da Fundação Instituto Brasileiro de Geografia e Estatística. As taxas de mortalidade foram ajustadas por idade pelo método direto, utilizando como referência a população de Curitiba, em 1980. A análise de tendência foi calculada através da regressão linear simples, com um nível de significância de 5%. RESULTADOS: As taxas de mortalidade das doenças isquêmicas do coração apresentaram uma tendência de declínio em ambos os sexos. Nas faixas etárias do infarto agudo do miocárdio, o sexo masculino apresentou queda até os 79 anos; no sexo feminino, até os 59 anos, mantendo-se estáveis após estes períodos. No restante das doenças isquêmicas, o sexo feminino apresentou uma queda maior que o masculino. CONCLUSÃO: O estudo demonstra uma tendência de redução da mortalidade por doenças isquêmicas do coração, em ambos os sexos, na cidade de Curitiba, de 1980 a 1998. No infarto agudo do miocárdio, essa redução vem ocorrendo de forma mais pronunciada nos homens, mantendo-se estável, a partir dos 60 anos, nas mulheres. As razões para a tendência de redução diferenciada entre os sexos não são claras, permanecendo como importante questão para novas investigações.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess mortality trends due to ischemic heart diseases, per sex, and acute myocardial infarction, per sex and age range, from 1980 to 1998, in the city of Curitiba. METHODS: Data of death due to ischemic heart disease and acute myocardial infarction from Sistema de Informação sobre Mortalidade do Ministério da Saúde (Information System on Mortality of Ministry of Health), per sex, age range and domicile location in Curitiba were used. Population data were obtained from Fundação Instituto Brasileiro de Geografia e Estatística (Brazilian Institute of Geography and Statistics Foundation). Mortality rates were adjusted per age through direct method, by using the population of Curitiba, in 1980, as reference. The analysis of trend was calculated through simple linear regression, with a significance level of 5%. RESULTS: Mortality rates due to ischemic heart diseases showed a decrease trend among both sexes. In age ranges of acute myocardial infarction, male sex showed a decrease until 79 years of age, among female sex individuals, the decrease was until 59 years of age. They were shown stable after those periods. Among the remaining ischemic diseases, female sex individuals showed a greater decrease than male sex ones. CONCLUSION: The study demonstrates a trend of reduction of mortality due to ischemic heart diseases, in both sexes, in the city of Curitiba, from 1980 to 1998. In acute myocardial infarction, such reduction has been happening in a more pronounced way among men, achieving stability, from 60 years of age, among women. The reasons for differentiated reduction trend between sexes are not clear, remaining as na important matter for new investigations.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estudos de tendência</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mortalidade</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doenças isquêmicas do coração</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto agudo do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>trend studies</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemic heart diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Análise comparativa da captação de 18 fluordesoxiglicose por câmara de cintilação e sistema de coincidência e a ecocardiografia de estresse pela dobutamina na detecção de viabilidade miocárdica</s1>
</fA08>
<fA08 dir="en">
<s1>Comparative study of 18 F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera with dobutamine stress echocardiography for the assessment of myocardial viability</s1>
</fA08>
<fA11 dir="011000">
<s1>Pedro Silvio Farsky</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Leopoldo Soares Piegas</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Vera Marcia Gimenes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ana Claudia G. Petisco</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo S. Duarte</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luiz Roberto Martins</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Mario Issa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Paulo Paredes Paulista</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>José Eduardo Moraes Rego Sousa</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>105-109</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar a câmara de cintilação e sistema de coincidência (CC) com a ecocardiografia de estresse pela dobutamina (EED) na detecção de viabilidade miocárdica, utilizando-se a recuperação funcional como padrão de referência. MÉTODOS: Vinte e um pacientes com doença arterial coronária e disfunção grave do ventrículo esquerdo foram estudados prospectivamente, submetidos a EED e CC, antes da cirurgia de revascularização do miocárdio (RM), e a EED, três meses após. RESULTADOS: De 290 segmentos analisados, 83% encontravam-se acinéticos, 15%, hipocinéticos, e 2, discinéticos ao repouso. A EED identificou 68% destes segmentos como não-viáveis. A CC identificou 56% destes segmentos como normais (contratilidade alterada com metabolismo e perfusão preservada), 30% como viáveis (perfusão reduzida e metabolismo preservado) e 14%, como não-viáveis (ausência de metabolismo e perfusão). Entre os não-viáveis pela EED, a CC classificou 80% como normais ou viáveis e 19,9%, como não viáveis (p&lt;0,001). A sensibilidade e especificidade da EED foram de 48,3% e 78,1%, respectivamente. A sensibilidade e especificidade da CC de 92,2% e 20,0%, respectivamente. A CC identificou maior proporção de recuperação funcional nos segmentos classificados como normais do que os viáveis e não-viáveis. CONCLUSÃO: A CC classificou como normal ou viável a maior parte dos segmentos não-viáveis pela EED. Na avaliação da recuperação funcional, três meses após a RM, a CC demonstrou uma alta sensibilidade, porém reduzida especificidade.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare Dual-Head coincidence gamma camera (DCD-AC) with dobutamine stress echocardiography (DSE) in viability assessment, using functional recovery as the gold standard. METHODS: Twenty-one patients were prospectively studied, with coronary artery disease and severe left ventricular dysfunction undergoing DSE and DCD-AC at baseline and DSE three months after revascularization. RESULTS: Of the 290 segments analyzed, 83% were akinetic, 15% hypokinetic and 2% dyskinetic at rest. DSE identified 68% of these segments as non-viable. DCD-AC identified 56% of these segments as normal (dysfunctional segments with preserved metabolism and perfusion), 30% as viable (preserved metabolism and reduced perfusion) and 14% as non-viable (reduced perfusion and metabolism). Of the DSE non-viable segments, DCD-AC identified 80% as normal or viable and 19.9% as non-viable (p&lt;0.001). In hypokinetic segments viability and normal segments were detected in a higher proportion by both methods (p&lt;0.001). DSE sensibility and specificity were 48.3% and 78.1% respectively. DCD-AC sensibility and specificity was 92.2% and 20.0%. DCD-AC identifies a higher incidence of function improvement in normal segments than in viable and non-viable. CONCLUSION: DCD-AC classified as normal or viable most of the non-viable DSE segments. In assessment of functional recovery segments after three months, DCD-AC showed a high sensibility but low specificity.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>miocárdio atordoado</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fluordesoxiglicose F18</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>revascularização miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dobutamine echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dual-head gamma camera</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial viability</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fluorodeoxyglucose</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery bypass surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Idade e distúrbios psicológicos: variáveis associadas à disfunção sexual no período pós-infarto</s1>
</fA08>
<fA08 dir="en">
<s1>Age and psychologic disorders: variables associated to post-infarction sexual dysfunction</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciano Janussi Vacanti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Bruno Caramelli</s1>
<afiliation>A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Zerbini Instituto do Coração (InCor-DF) </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade de São Paulo Faculdade de Medicina Instituto do Coração (InCor)</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>110-114</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>52</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: As informações sobre a disfunção sexual (DS) após o infarto do miocárdio (IM) são esparsas, principalmente em nosso meio e em relação aos seus preditores. Avaliamos pacientes de ambos os sexos, com vida sexual ativa e sem disfunção sexual prévia ao IM, para estudar a incidência de DS após o IM, e identificar as possíveis variáveis associadas às mesmas. MÉTODOS: Estudamos consecutivamente 43 pacientes, utilizando questionários estruturados para diagnóstico das DS e dos distúrbios psicológicos (DP). Analisamos a influência dos fatores de risco clássicos para aterosclerose, dos DP e do uso de medicamentos na ocorrência de DS até o sexto mês após o IM. RESULTADOS: Após o IM, 91% dos pacientes reiniciaram a atividade sexual. Vinte e seis pacientes (60%) apresentaram disfunção sexual até o 6º mês da alta hospitalar (9 com ejaculação precoce, 15 com disfunção erétil e 20 com desejo sexual hipoativo). Os pacientes com DP apresentaram disfunção sexual em maior freqüência que aqueles sem DP (100%x47%, p=0,001). O grupo com disfunção sexual era significativamente mais velho que o grupo sem disfunção sexual: 53&amp;plusmn;8,9 anos versus 47&amp;plusmn;8,7 anos (p=0,04). CONCLUSÃO: Os pacientes apresentaram significativa redução da freqüência da atividade sexual e elevada incidência de DS após o infarto agudo do miocárdio. A presença de DP e a idade mais elevada estiveram associadas à maior incidência de DS após o infarto.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Data on sexual disfunction (SD) after myocardial infarction (MI) are sketchy, especially in our community and in regard to predictors. Both males and females, with active sexual life and no sexual dysfunction prior to MI were evaluated in order to investigate SD incidence after MI, as well as to identify the possible variables associated. METHODS: Forty-three patients were studied consecutively, through structured questionnaires for SD and psychological disorders (PD) diagnosis. The interference of classic risk factors was analysed for atherosclerosis, for PD and for the use of medications when SD was present up to month 6 after MI. RESULTS: After MI, 91% of patients resumed sexual activity. Twenty-six patients (60%) reported sexual dysfunction up to month 6 from hospital discharge (9 with precocious ejaculation (PE), 15 with erectile dysfunction (ED), and 20 with hypoactive sexual desire disorder (HSDD). PD patients reported sexual dysfunction at higher frequency as compared to those who did not report PD (100%x47%, p=0.001). The sexual dysfunction group was significantly older than the group not reporting sexual dysfunction: 53&amp;plusmn;8.9 years of age versus 47&amp;plusmn;8.7 years of age (p=0.04). CONCLUSION: Patients reported significant reduction of sexual activity frequency and high incidence of SD after acute myocardial infarction (AMI). PD and older age were shown to be associated to higher incidence of post-infarction SD.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>disfunção sexual</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto agudo do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>distúrbios psicológicos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>envelhecimento</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>sexual dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction (AMI)</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>psychological disorders</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ageing</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Hipertensão arterial sistêmica no setor de emergência: o uso de medicamentos sintomáticos como alternativa de tratamento</s1>
</fA08>
<fA08 dir="en">
<s1>Systemic hypertension at emergency units: the use of symptomatic drugs as choice for management</s1>
</fA08>
<fA11 dir="011000">
<s1>Sandro Gonçalves de Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luciana Simões do Nascimento</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cândido Nobre dos Santos Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria de Fátima P. Militão de Albuquerque</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Edgar Guimarães Victor</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Universitário Oswaldo Cruz  </s1>
<s2>Recife PE</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>115-123</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>56</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar a resposta terapêutica dos pacientes atendidos no Setor de Emergência com sintomas e pressão arterial (PA) elevada, ao tratamento com medicação sintomática ou anti-hipertensiva. MÉTODOS: Ensaio clínico randomizado, cego, envolvendo 100 pacientes atendidos na Emergência Cardiológica do Hospital Universitário Oswaldo Cruz com sintomas associados à pressão arterial sistólica (PAS) entre 180 e 200 mmHg e/ou pressão arterial diastólica (PAD) entre 110 e 120 mmHg. Os pacientes foram randomizados para tratamento com medicação sintomática (dipirona ou diazepam) ou anti-hipertensiva (captopril). Aqueles portadores de qualquer condição clínica associada, que necessitassem de tratamento imediato na Unidade de Emergência, foram excluídos do estudo. Atingiram o critério de alta os pacientes que, ao final do período de observação de noventa minutos, tornaram-se assintomáticos e tiveram seus níveis tensionais sistólicos reduzidos para abaixo de 180 mmHg e diastólicos para aquém de 110 mmHg. RESULTADOS: A idade média da população estudada foi 54,4 anos. A maioria dos pacientes era do sexo feminino, hipertensos crônicos em tratamento farmacológico irregular, com baixa taxa de aderência às medidas não farmacológicas e classificados quanto ao índice de massa corpórea (IMC), em sobrepeso e obesos grau I. Cefaléia, dor torácica tipo D (não anginosa) e dispnéia foram as queixas mais freqüentes. A proporção de pacientes tratados com medicação sintomática que atingiu o critério de alta foi semelhante àquela de pacientes medicados com anti-hipertensivo (p=0,165). Não foi encontrada associação entre o diagnóstico prévio de hipertensão arterial sistêmica (HAS) (p=0,192), tratamento farmacológico (p=0,687) e não-farmacológico e o critério de alta. CONCLUSÃO: Uma maior proporção (não significativa) de pacientes tratados com medicação sintomática obtiveram redução da PA aquém dos níveis estabelecidos no critério de alta e tornaram-se assintomáticos após o período de observação.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Compare the therapeutic response of symptomatic, hypertensive patients to symptomatic medication or anti-hypertensive drugs at the Emergency Unit. METHODS: A randomized, blind clinical trial involving 100 (one hundred) patients assisted at the Cardiology Emergency Unit at Oswaldo Cruz University Hospital (HUOC). All patients reported symptoms associated to systolic pressure (SBP) between 180 and 200 mmHg and/or diastolic pressure (DBP) between 110 and 120 mmHg. Patients were randomized for treatment with symptomatic (dipirone or diazepan) or anti-hipertensive drug (captopril). Those reporting any associated clinical condition and in need of immediate treatment at the Emergency Unit were excluded from the study. Patients reporting no symptoms, and systolic pressure reduced to levels under 180 mmHg and diastolic pressure under 110 mmHg after the 90-minute period were considered as having met discharge criteria. RESULTS: Mean age of population studied was 54.4 years old, most commonly females. Patients were chronic hypertensive, on irregular pharmacological treatment, with low compliance to non-pharmacologic actions, and classified as overweight and obese grade I. Headache, type D (non-angina) chest pain, and dyspnea were the most frequent complaints. The number of patients treated with symptomatic drug who reached discharge criteria was similar to that of patients treated with anti-hypertensive (p=0.165). No association was found between previous high blood pressure (HBP) diagnosis (p=0.192), pharmacological treatment (p=0.687), and non-pharmacological treatment and discharge criteria. CONCLUSION: Blood pressure (BP) was reduced below levels for discharge criteria for a (non-significant) higher rate of patients treated with symptomatic drug, who were turned into asymptomatic after the observation period.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>crise hipertensiva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>medicamentos sintomáticos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial sistêmica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tratamento emergência</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension crisis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>symptomatic drugs</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>systemic hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>emergency treatment</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Tratamento cirúrgico sem circulação extracorpórea de arteriopatia relacionada com arterite de Takayasu envolvendo aorta e vasos da base</s1>
</fA08>
<fA08 dir="en">
<s1>Surgical treatment without extracorporeal circulation of artery disease related to Takayasu's arteritis involving the aorta and great vessels</s1>
</fA08>
<fA11 dir="011000">
<s1>Rodrigo Milani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Brofman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Tayse Sandri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alexandre Varela</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Augusto Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luiz Gustavo Emed</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Stefan da Silveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Marcelo Dantas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Maximiliano Guimarães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Rafael Pontarolli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Francisco Maia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>PUC Santa Casa de Misericórdia </s1>
<s2>Curitiba PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>124-127</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Relatamos o caso de duas pacientes portadoras de arterite de Takayasu, encaminhadas ao nosso serviço onde as lesões acometiam a aorta torácica descendente e os vasos da base e, em uma delas, lesão obstrutiva crítica do óstio da coronária esquerda. Ambas as pacientes foram operadas sem circulação extracorpórea, com heparinização plena e auxílio de autotransfusão.</s0>
</fC01>
<fC01 dir="en">
<s0>We report the cases of 2 female patients with Takayasu's arteritis referred to our service with lesions affecting the descending thoracic aorta and great vessels. One of the patients had a critical obstructive lesion in the left coronary ostium. Both patients underwent surgery without extracorporeal circulation, with full heparinization and autotransfusion.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiomiopatia de Takotsubo: uma causa rara de choque cardiogênico simulando infarto agudo do miocárdio</s1>
</fA08>
<fA08 dir="en">
<s1>Takotsubo cardiomiopathy: a rare cause of cardiogenic shock simulating acute myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Jayro Thadeu Paiva de Vasconcelos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sebastião Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>João Francisco de Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antenor Portela</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital São Marcos  </s1>
<s2>Teresina PI</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>128-130</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Cardiomiopatia de Takotsubo é uma causa rara de aneurisma ventricular esquerdo agudo, na ausência de coronariopatia, só recentemente descrita na literatura mundial. Os sintomas podem assemelhar-se aos do infarto agudo do miocárdio com dor torácica típica. A imagem do balonamento ventricular sugestivo de haltere ou &quot;Takotsubo&quot; (dispositivo utilizado no Japão para prender Octopus) é característico desta nova síndrome e usualmente há desaparecimento do movimento discinético até o 18º dia do início dos sintomas, em média.</s0>
</fC01>
<fC01 dir="en">
<s0>Takotsubo Cardiomiopathy is a rare cause of acute left ventricular aneurysm, in the absence of coronariopathy, only recently described in world literature. Symptoms may be similar to those from acute myocardial infarction with typical thoracic pain. The image of dumbbell or Takotsubo (a device used in Japan to capture octopus) suggestive ventricular ballooning is characteristic of that new syndrome and there is usually the disappearing of dyskinetic movement up to the 18th day from the beginning of the symptoms, in average.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Angioedema relacionado ao uso de estreptoquinase</s1>
</fA08>
<fA08 dir="en">
<s1>Angioedema related to the use of streptokinase</s1>
</fA08>
<fA11 dir="011000">
<s1>Daniela Camargo de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Otávio Rizzi Coelho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Karen Paraschin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Natasha Rebouças Ferraroni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ricardo de Lima Zolner</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Ciências Médicas Hospital das Clínicas </s1>
<s2>Campinas SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>131-134</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>O angioedema é uma reação rara, aguda e potencialmente fatal, à estreptoquinase, devendo ser diagnosticada prontamente e tratada para garantir melhor prognóstico ao paciente. Descrevemos aqui o caso de um homem de 65 anos, que apresentou reação anafilática após o início de trombólise com estreptoquinase, sendo rapidamente tratado, permaneceu uma semana internado em Unidade de Terapia Intensiva.</s0>
</fC01>
<fC01 dir="en">
<s0>Angioedema is a rare reaction to streptokinase, acute and potentially fatal, which should be quickly diagnosed and treated to guarantee the best prognosis for the patient. We describe here the case of a 65-year-old man, who displayed an anaphylactic reaction after the beginning of thrombolysis with streptokinase, which was quickly treated, and remained hospitalized for one week in the Intensive Care Unit.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Doença aterosclerótica difusa desmascarada pela avaliação fisiológica invasiva da circulação coronária</s1>
</fA08>
<fA08 dir="en">
<s1>Diffuse atherosclerotic disease unmasked by invasive physiologic assessment of coronary flow</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Mendes Sant'Anna</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Expedito E. Ribeiro da Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Leonardo Alves Batista</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fábio Machado Ventura</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Carlos Alberto Mussel Barrozo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Nico H.J. Pijls</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>135-137</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>11</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500212</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Sabe-se que a aterosclerose coronária é um processo difuso, pouco visível à angiografia. Este artigo descreve um paciente com angina estável, três meses após infarto agudo do miocárdio (IAM), e uma lesão severa na artéria descendente anterior (ADA), evidenciada pela cinecoronariografia. A reserva de fluxo fracionada do miocárdio (FFR), obtida através de medidas pressóricas intracoronárias, foi 0,37 durante a hiperemia máxima, demonstrando claramente a existência de isquemia. Um stent foi implantado na ADA e, a despeito do excelente resultado angiográfico, a FFR pós-stent foi apenas 0,75, o limite mínimo abaixo do qual existe isquemia. Quando a corda guia pressórica (pressure wire - PW) foi lentamente recuada da porção distal da ADA para sua porção proximal, notou-se um aumento contínuo e gradativo na pressão intracoronária, o que indica claramente aterosclerose difusa e não estenose focal. Não se notava gradiente no local do stent. O paciente foi mantido em tratamento médico e permanece assintomático até o momento.</s0>
</fC01>
<fC01 dir="en">
<s0>It is known that coronary atherosclerosis is a diffuse process, very little visible at angiography. This article describes a stable angina patient, three months after acute myocardial infarction (AMI), and a severe lesion in anterior descending artery (ADA), evinced by coronariography. Myocardial fractional flow reserve (FFR), obtained through intracoronary pressure measurements, was 0.37 during maximum hyperemia, clearly showing the presence of ischemia. A stent was implanted in ADA and, despite the excellent angiographic result, post-stent FFR was only 0.75, the minimum limit, below which there is ischemia. When the pressure wire (PW) was slowly drawn back from the distal portion of ADA to its proximal portion, a continuous and gradual increase in intracoronary pressure was noted, which clearly indicates diffuse atherosclerosis and not focal stenosis. A gradient was not observed at the stent place. The patient was kept under medical treatment and has been asymptomatic so far.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Lactente de 40 dias com transposição das grandes artérias e comunicação interventricular</s1>
</fA08>
<fA08 dir="en">
<s1>Forty days old infant with transposition of the great arteries and ventricular septal defect</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>138-138</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500213</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Infarto fatal do miocárdio em mulher de 88 anos de idade</s1>
</fA08>
<fA08 dir="en">
<s1>Fatal myocardial infarction in a 88-year-old woman</s1>
</fA08>
<fA11 dir="011000">
<s1>Ariane Vieira Scarlatelli Macedo</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Jorge Moffa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cesar José Grupi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Eulógio Emílio Martinez Filho</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Petter Libby</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paulo Sampaio Gutierrez</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>139-146</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500214</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Hipertensão arterial pulmonar: fisiopatologia, aspectos genéticos e resposta ao uso crônico do sildenafil</s1>
</fA08>
<fA08 dir="en">
<s1>Pulmonary arterial hypertension: physiopathology, genetic aspects and response to the chronic use of sildenafil</s1>
</fA08>
<fA11 dir="011000">
<s1>Alessandra Costa Barreto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sônia Meiken Franchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alexandre C. Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Augusto Lopes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>147-154</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500215</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Correção</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>0-0</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500216</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>IV Diretriz para uso da Monitorização Ambulatorial da Pressão Arterial - II Diretriz para uso da Monitorização Residencial da Pressão Arterial IV MAPA / II MRPA</s1>
</fA08>
<fA08 dir="en">
<s1>IV Guideline for Ambulatory Blood Pressure Monitoring - II Guideline for Home Blood Pressure Monitoring IV ABPM / II HBPM</s1>
</fA08>
<fA11 dir="011000">
<s1>Alexandre Alessi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Andréa A. Brandão</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ângela Pierin</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="041000">
<s1>Audes Magalhães Feitosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="051000">
<s1>Carlos Alberto Machado</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cláudia Lúcia de Moraes Forjaz</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="071000">
<s1>Cristina S. Atie</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="081000">
<s1>Dante Marcelo Artigas Giorgi</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="091000">
<s1>Décio Mion Jr.</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="101000">
<s1>Eduardo Cantoni Rosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="111000">
<s1>Fernando Nobre</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="121000">
<s1>Giovânio Vieira Silva</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="131000">
<s1>Hilton Chaves Jr.</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="141000">
<s1>Istênio José Fernandes Pascoal</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="151000">
<s1>Jorge Ilha Guimarães</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="161000">
<s1>José Luis Santello</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="171000">
<s1>José Márcio Ribeiro</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="181000">
<s1>José Nery Praxedes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="191000">
<s1>Kátia Coelho Ortega</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="201000">
<s1>Lílian Soares da Costa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="211000">
<s1>Luis Aparecido Bortolotto</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="221000">
<s1>Marco Antonio Mota Gomes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="231000">
<s1>Maurício Wajngarten</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="241000">
<s1>Miguel Gus</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="251000">
<s1>Osvaldo Kohlmann Jr.</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="261000">
<s1>Paulo César Veiga Jardim</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="271000">
<s1>Tufik José Magalhães Geleilete</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="281000">
<s1>Vera Koch</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-18</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>O que vem ocorrendo com a insuficiência cardíaca no Brasil?</s1>
</fA08>
<fA08 dir="en">
<s1>What is the current scenario for heart failure in Brazil?</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco Manes Albanesi Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>155-156</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Relação entre a assiduidade às consultas ambulatoriais e o controle da pressão arterial em pacientes hipertensos</s1>
</fA08>
<fA08 dir="en">
<s1>Relationship between regular attendance to ambulatory appointments and blood pressure control among hypertensive patients</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo Barbosa Coelho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Miguel Moysés Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Raquel Palhares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Camila de Miranda Cardoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Tufik José Magalhães Geleilete</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fernando Nobre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto Hospital das Clínicas</s1>
<s2>Ribeirão Preto SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>157-161</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>18</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Nosso objetivo foi determinar a taxa de pacientes hipertensos com a pressão arterial (PA) controlada (&lt;140X90 mmHg) e estudar sua relação com a assiduidade às consultas ambulatórias. MÉTODOS: Foram analisados, de forma aleatória e retrospectiva, 245 prontuários de pacientes hipertensos seguidos na Unidade Clínica de Hipertensão Arterial do HCFMRP-USP no período de um ano. Os pacientes foram classificados como assíduos (A) e faltosos (F) definidos como atraso a consulta agendada em prazo maior que 30 dias. A média das três medidas anteriores a data do agendamento foi calculada para a determinação da taxa de pacientes com a PA controlada (&lt;140x90 mmHg). A observância ao tratamento proposto foi inferida através de questionário aplicado durante a pré-consulta pela equipe de enfermagem. RESULTADOS: Dos 245 pacientes analisados, 220 foram classificados como A (89,7%) e 25 (10,3%) como F. Os pacientes do grupo A mostraram uma maior taxa de controle da PA quando comparados com F (30% vs 8%, p=0,02, teste exato de Fischer). A aderência relatada pelos pacientes ao tratamento farmacológico foi maior nos pacientes A que F (91% vs 56%, p&lt;0,05) assim como para o tratamento não farmacológico (63% vs 44%, p&lt;0,05). CONCLUSÃO: Embora a taxa de controle da pressão arterial seja baixa na população estudada, observa-se pior aderência ao tratamento e controle da PA em indivíduos com hábito de faltar às consultas agendadas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Our objective was to determine the rate of hypertensive patients with controlled BP (BP &lt;140X90 mmHg) and to study its relationship with regular attendance to ambulatory appointments. METHODS: A total of 245 medical records from patients followed up at the Unidade Clínica de Hipertensão Arterial (Clinical Unit of Arterial Hypertension) HCFMRP-USP for a period of one year were randomly and retrospectively reviewed. The patients were classified as assiduous (A) and as regularly absent to scheduled appointments (F), with the second group being defined as those who failed to appear longer than 30 days after the scheduled appointment. The mean of three measurements prior to the date of the scheduled appointment was calculated to determine the rate of patients with controlled BP. Compliance with the treatment was inferred through a questionnaire applied by the nurse team before the appointment. RESULTS: From the 245 patients analyzed, 220 were classified as A (89.7%) and 25 (10.3%) as F. Group A patients showed a higher rate of BP control than F patients (30% vs. 8%, p=0.02, Fischer exact test). Compliance with pharmacological treatment was higher in A patients than in F patients (91% vs. 56 %, p&lt;0.05) as well as to non-pharmacological treatment (63% vs. 44%, p&lt;0.05). CONCLUSION: Although the rate of blood pressure control was low in the population studied, lower compliance with the treatment and BP control was observed in individuals who usually missed the scheduled appointments.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aderência</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tratamento</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>pressão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>compliance</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treatment</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>A baixa taxa de obtenção da meta do LDL-colesterol numa população de baixa renda</s1>
</fA08>
<fA08 dir="en">
<s1>Low rate of achieving LDL-cholesterol objective in a low income population</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciano J Vacanti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Silvio C. de Moraes Santos</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alessandro M Fujita</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>David S Lima</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alan F Lopes</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Rodrigo Vetorazi</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ana Sellera</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Nataly R Scarin</s1>
<afiliation>A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto do Coração do Distrito Federal  </s1>
<s2>Distrito Federal DF</s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Faculdade de Medicina de Santos  </s1>
<s2>Santos SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>162-165</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o percentual de pacientes adequados às metas preconizadas pelas III Diretrizes sobre Dislipidemias da Sociedade Brasileira de Cardiologia, numa população de baixa renda. Determinar se havia diferença deste percentual, nos pacientes de alto risco, conforme a idade (&lt;75 anos x &gt;75 anos). MÉTODOS: Analisamos consecutivamente 190 pacientes, divididos em dois grupos: 51 pacientes de baixo e médio risco (G I) e 139 de alto risco para doença arterial coronariana (G II). A amostra era caracterizada por pacientes de baixa renda (69% dos pacientes tinham uma renda familiar entre 1 e 2 salários mínimos), cuja terapêutica hipolipemiante era fornecida irregularmente pelo Estado. RESULTADOS: Os G I e G II apresentavam, respectivamente, 70,1&amp;plusmn;13,7 anos e 13,7% de homens e 68,5&amp;plusmn;10,6 anos e 62,6% de homens. Dentre os pacientes do G II, 30% apresentavam o LDL-colesterol dentro das metas preconizadas. Sendo que, a freqüência de pacientes adequados às metas foi, significativamente, menor em indivíduos com 75 anos ou mais que aqueles com menos de 75 anos (16% vs. 30%, p=0,04). CONCLUSÃO: Numa população, predominantemente, de baixa renda e sem assistência contínua do Estado para adquirir estatinas, a obtenção das metas preconizadas para o LDL- colesterol, pelas III Diretrizes sobre Dislipidemias da Sociedade Brasileira de Cardiologia, é baixa e ainda, significativamente, menor em pacientes muito idosos, com perfil de alto risco para aterosclerose.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the percentage of patients suitable to the objectives preconized by III Diretrizes sobre Dislipidemias da Sociedade Brasileira de Cardiologia (3rd Guidelines on Dyslipidemia of Brazilian Society of Cardiology), in a low income population. To determine whether there was a difference of that percentage in high risk patients, according to their age (&lt;75 years old vs. &gt;75 years old). METHODS: We analyzed, consecutively, 190 patients, divided in two groups: 51 low and middle risk patients (G I) and 139 high risk patients for coronaray artery disease (G II). The sample was characterized by low income patients (69% for the patients had a family income between 1 and 2 minimum salaries), whose hypolipidemic therapy was irregularly supplied by the State. RESULTS: G I and G II showed, respectively, 70.1&amp;plusmn;13.7 years old and 13.7% of men and 68.5&amp;plusmn;10.6 years old and 62.6% of men. Among patients from G II, 30% showed LDL-cholesterol within the preconized objectives. The frequency of patients suitable to the objectives was significantly lower in individuals with 75 years of age or older than among those younger than 75 years old (16% vs. 30%, p=0.04). CONCLUSION: In a predominantly low income population and without continuous assistance from the State to purchase statins, the achievement of preconized objectives for LDL-cholesterol, by 3rd Guidelines on Dyslipidemia of Brasilian Society of Cardiology, is low and also significantly lower among very old patients, with a high risk profile for atherosclerosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença arterial coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dislipidemia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>LDL-colesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>terapêutica hipolipemiante</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dyslipidemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>LDL-cholesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypolipidemic therapy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Hiper-homocisteinemia como fator de risco para doença aterosclerótica coronariana em idosos</s1>
</fA08>
<fA08 dir="en">
<s1>Hyperhomocysteinemia as a risk factor for coronary atherosclerotic diseases in the elderly</s1>
</fA08>
<fA11 dir="011000">
<s1>Claudia Felícia Gravina-Taddei</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Michel Batlouni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Camila Sarteschi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Valéria T Baltar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Nívea A.C Salvarini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Marcelo C Bertolami</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Eduardo M. R Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>166-173</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>58</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Investigar se a hiper-homocisteinemia é fator de risco independente para doença aterosclerótica coronariana em idosos. MÉTODOS: Estudo caso-controle com 172 idosos, 88 pertencentes ao grupo controle e 84 ao grupo caso, que apresentavam cineangiocoronariografia solicitada por indicações clínicas. Angiografia coronariana quantitativa foi realizada em 91% dos pacientes. Homocisteinemia foi avaliada sob forma contínua e categorizada, por análise univariada e multivariada. RESULTADOS: Quando analisada sob forma contínua, verificou-se que, na análise univariada, os idosos do grupo caso apresentaram média de níveis de homocisteinemia significativamente mais elevada que a dos idosos do grupo controle (14,33&amp;plusmn;4,59 µmol/l versus 11,99&amp;plusmn; 4,59 µmol/l , p=0,015). Na análise multivariada, a homocisteinemia sob forma contínua associou-se a razão de risco para doença arterial coronariana de 1,07 a cada aumento de 1 µmol/l de nível de homocisteína. Aumento de 5 µmol/l correspondeu a razão de risco de 1,40. Quando analisada sob forma categorizada, definiu-se como hiper-homocisteinemia os valores encontrados acima do percentil 75 do grupo controle (14 µmol/l ). Hiper-homocisteinemia foi encontrada em 34% dos idosos, sendo 37,3% no grupo controle e 62,7% no grupo caso (p=0,009). Na análise multivariada, a hiperhomocisteinemia constituiu fator de risco independente para doença aterosclerótica coronariana em idosos, com razão de risco para doença arterial coronariana de 2,03, intervalo de confiança 95%, 1,02-4,03. CONCLUSÃO: Hiper-homocisteinemia foi fator de risco independente para doença arterial coronariana em idosos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To investigate whether hyperhomocysteinemia is an independent risk factor for atherosclerotic disease in elderly individuals METHODS: A case-control study with 172 elderly individuals, 88 belonging to control group and 84 to case group, who showed coronary angiography requested for clinical indications. Quantitative coronary angiography was performed in 91% of the patients. Homocysteinemia was assessed in a continuous and categorized way, through univariate and multivariate analysis. RESULTS: When analyzed continuously, in univariate analysis, it was verified that case group elderly individuals showed an average homocysteinemia levels significantly higher than the control group individuals' (14.33&amp;plusmn;4.59 µmol/l against 11.99&amp;plusmn;4.59 µmol/l, p=0.015). In multivariate analysis, continuous homocysteinemia was associated to the risk rate for coronary artery disease of 1.07 for each 1 µmol/l increase of homocysteine level. Na increase of 5 µmol/l corresponded to the risk rate of 1.40. When analyzed in categorized way, the values found over percentile 75 of control group (14 µmol/l) were defined as hyperhomocysteinemia. Hyperhomocysteinemia was found in 34% of elderly individuals, being 37.3% in control group and 62.7% in case group (p= 0.009). In multivariate analysis, hyperhomocysteinemia constituted an independent risk factor for coronary atherosclerotic disease for elderly individuals, with a risk rate for coronary artery disease of 2.03, confidence interval 95%, 1.02-4.03. CONCLUSION: Hyperhomocysteinemia was an independent risk factor for coronary artery disease in elderly individuals.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hiper-homocisteinemia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>homocisteína</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>idoso</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>octogenário</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fator de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença arterial coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hyperhomocysteinemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>homocysteine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>elderly</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>octogenarian</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factor</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Oclusão percutânea das comunicações interventriculares: experiência inicial</s1>
</fA08>
<fA08 dir="en">
<s1>Interventricular septal defects percutaneous occlusion: initial experiment</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco José Araújo Chamié de Queiróz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Raul Ivo Rossi Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Sérgio Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>César Esteves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Daniel Silva Chamié de Queiróz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Paulo Renato Machado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>João Carlos Tress</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Stella Suzana Horowitz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Helder Paupério</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Rosaura Victer</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Cardiologia do Rio Grande do Sul Cardiologia Pediátrica e Fetal do Rio de Janeiro </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>174-179</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a experiência inicial com o fechamento percutâneo das comunicações interventriculares (CIV), em especial, das CIV perimembranosas (CIVPM) com a nova prótese de Amplatzer. MÉTODOS: Foram submetidos ao procedimento onze pacientes, seis com CIV perimembranosas (CIVPM) e cinco com CIV musculares (CIVM). Dois apresentavam infecções repetidas do trato respiratório e tinham baixo ganho ponderal. Um apresentou história prévia de endocardite infecciosa. Os demais eram assintomáticos e foram selecionados pela ecocardiografia transtorácica (ETT). RESULTADOS: No grupo das CIVM (n=5), um paciente tinha uma CIV apical, dois tinham defeitos médio-septais e dois pacientes apresentavam defeitos múltiplos. Neste grupo, foi utilizada uma prótese de comunicação interatrial (CIA) (Amplatzer Septal Occluder®) e cinco próteses para CIVM (Amplatzer VSD-MUSC Occluder®), sendo que uma mesma paciente recebeu dois dispositivos. Todos os implantes foram bem sucedidos e transcorreram sem complicações. No grupo das CIVPM (n=6), dois tinham aneurismas de septo membranoso. Em 5, identificamos dois pertuitos com angiografia seletiva. Utilizamos próteses de Amplatzer para canal arterial (PCA) (Amplatzer Duct Occluder®) em 1 paciente e próteses específicas para CIVPM nos demais (Amplatzer VSD-MEMB Occluder®). Um oclusor perimembranoso migrou imediatamente depois de liberado, sendo retirado da aorta descendente. Outro paciente apresentou bloqueio atrioventricular total (BAVT), que reverteu após corticoterapia. CONCLUSÃO: O procedimento é tecnicamente complexo e deve ser executado apenas em centros especializados. Apesar disso, mostrou-se seguro e eficaz nos casos selecionados, e pode ser oferecido como alternativa ao tratamento cirúrgico tradicional.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the initial experiment with percutaneous closure of interventricular septal defects (IVSD), especially perimembranous IVSD (PMIVSD) with the new Amplatzer prosthesis. METHODS: Eleven patients were submitted to the procedure. Six of them had perimembranous IVSD (PMIVSD) and five with muscular IVSD (MIVSD). Two showed repeated respiratory tract infections and had low ponderal gain. One of them showed a previous history of infectious endocarditis. The others were asymptomatic and were selected through transthoracic echocardiography (TTE). RESULTS: In MIVSD group (n=5), a patient had apical IVSD, two had medioseptal defects and two patients showed multiple defects. In this group, an interatrial septal defects (IASD) (Amplatzer Septal Occluder®) and five prostheses for MIVSD (Amplatzer VSD-MUSC Occluder®), and one patient received two devices. All implants were well-succeeded and went by without complications. In PMIVSD group (n=6), two patients had membranous septal aneurysms. In five, we identified two orifices with selective angiography. We used arterial canal Amplatzer prostheses (ACP) (Amplatzer Duct Occluder®) in 1 patient and specific prostheses for PMIVSD in the others (Amplatzer VSD-MEMB Occluder®). A perimembranous occluder migrated immediately after released, being removed from the descending aorta. Another patient showed total atrioventricular block (TAVB), which reversed after corticotherapy. CONCLUSION: The procedure is technically complex and must be performed only in specialized centers. Despite of that, it showed safe and efficient in the selected cases, and it can be provided as an alternative to traditional surgical treatment.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>comunicação interventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>oclusão percutânea</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatia congênita</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Amplatzer</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>interventricular septal defects</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous occlusion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital cardiopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Amplatzer</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Marcadores inflamatórios intracoronarianos após intervenções coronarianas percutâneas</s1>
</fA08>
<fA08 dir="en">
<s1>Intracoronary inflammatory markers after percutaneous coronary interventions</s1>
</fA08>
<fA11 dir="011000">
<s1>Wilson Salgado Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eulógio E Martinez Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Pedro Horta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Pedro A Lemos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Bruno C Migueletto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Carlos Vicente Serrano Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Tania Leme da Rocha Martinez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>180-185</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar a liberação intracoronariana de marcadores inflamatórios (MI) após intervenções coronarianas percutâneas (ICP) e comparar suas concentrações com relação ao tipo de ICP utilizada (rotablator vs angioplastia por balão). MÉTODOS: Foram randomizados 22 pacientes com média de idade de 60&amp;plusmn;11,9 anos, 12 do sexo masculino, portadores de síndromes coronarianas estáveis, submetidos ao tratamento eletivo de uma única lesão coronariana utilizando rotablator (N=11) ou pré-dilatação por balão (N=11) para implante de stents. As amostras foram colhidas na raiz da aorta e no seio coronariano, imediatamente antes e 15 minutos após as intervenções. Todas as dosagens foram feitas antes do implante do stent, sendo analisadas as citocinas TNF-a, IL-6 e IL-1 e as moléculas de adesão solúveis ICAM-1, E-selectina e P-selectina, utilizando o método ELISA. RESULTADOS: As concentrações de TNF-a e IL-6 aumentaram após as ICP, passando respectivamente de 9,5&amp;plusmn;1,5 pg/ml para 9,9&amp;plusmn;1,8 pg/ml (p=0,017) e de 6,0&amp;plusmn;2,4 pg/ml para 6,9&amp;plusmn;3,0 pg/ml (p&lt;0,001). Não houve mudança significativa na expressão de IL-1, ICAM-1 e P-selectina, observando-se diminuição nas concentrações de E-selectina após os procedimentos (52,0&amp;plusmn;17,5 ng/ml para 49,3&amp;plusmn;18,7 ng/ml; p=0,009). Não houve diferença significativa entre as concentrações dos MI após as ICP, com relação ao tipo de procedimento utilizado. CONCLUSÃO: No período precoce, pós-intervenções coronarianas percutâneas, observou-se aumento das concentrações intracoronárias de TNF-a e IL-6 e ausência de diferença significativa entre as concentrações dos marcadores inflamatórios liberados na circulação coronariana por rotablator e pela angioplastia com balão.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze intracoronary release of inflammatory markers (IM) after percutaneous coronary interventions (PCI) and compare their concentrations concerning the type of PCI used (rotablator vs. balloon angioplasty). METHODS: Twenty-two patients with average age of 60&amp;plusmn;11.9 years old, 12 of male sex, with stable coronary disease, submitted to elective treatment of a single coronary lesion, using rotablator (N=11) or balloon pre-dilatation (N=11) for stent implant were randomized. Samples were collected at aorta root and coronary sinus, immediately before and 15 minutes after intervention. All dosages were made before stent implant, and the cytokines TNF-a, IL-6 and IL-1 and the soluble adhesion molecules ICAM-1, E-selectin and P-selectin were analyzed by using ELISA method. RESULTS: TNF-a and IL-6 concentrations increased after PCI, respectively from 9.5&amp;plusmn;1.5 pg/ml to 9.9&amp;plusmn;1.8 pg/ml (p=0.017) and from 6.0&amp;plusmn;2.4 pg/ml to 6.9&amp;plusmn;3.0 pg/ml (p&lt;0.001). There was no significant changes in IL-1, ICAM-1 and P-selectin, and a decrease in E-selectin concentrations after the procedures (52.0&amp;plusmn;17.5 ng/ml to 49.3&amp;plusmn;18.7 ng/ml; p=0.009) was observed. There were no significant differences between IM concentrations after PCI, concerning the type of procedure used. CONCLUSION: At the early period, post-percutaneous coronary interventions, an increase of intracoronary concentrations of TNF-a and IL-6, and absence of significant difference between concentrations of inflammatory markers released in coronary flow through rotablator and balloon angioplasty were observed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>marcadores inflamatórios</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>intervenções coronarianas percutâneas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>síndromes coronarianas estáveis</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>inflammatory markers</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous coronary interventions</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stable coronary syndromes</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Hipertrofia ventricular esquerda do atleta: resposta adaptativa fisiológica do coração</s1>
</fA08>
<fA08 dir="en">
<s1>Left ventricular hypertrophy of athletes: adaptative physiologic response of the heart</s1>
</fA08>
<fA11 dir="011000">
<s1>Nabil Ghorayeb</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Michel Batlouni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ibraim M. F Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Giuseppe S Dioguardi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>191-197</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>42</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar se a hipertrofia ventricular esquerda (HVE) de atletas competitivos de resistência (maratonistas) representa processo adaptativo, puramente fisiológico, ou se pode envolver aspectos patológicos em suas características anatômicas e funcionais. MÉTODOS: De novembro de 1999 a dezembro de 2000, foram separados consecutivamente de 30 maratonistas em atividade esportiva plena, idade inferior a 50 anos, com HVE, previamente documentada, e sem cardiopatia subjacente. Foram submetidos aos exames: clínico, eletrocardiograma, ecodopplercardiograma, e teste ergométrico (TE). Quinze foram sorteados para realizar, também, teste ergoespirométrico e ressonância magnética (RM) do coração. RESULTADOS: Nos TE, todos apresentavam boa capacidade física cardiopulmonar, sem evidências de resposta isquêmica ao exercício, sintomas ou arritmias. No ecodopplercardiograma, os valores do diâmetro e espessura diastólica da parede posterior do ventrículo esquerdo (VE), do septo interventricular, massa do VE e diâmetro do átrio esquerdo, foram significativamente maiores que os do grupo de não atletas, com idades e medidas antropométricas semelhantes. A média da massa do VE dos atletas indexada à superfície corpórea (126 g/m2) foi significativamente maior que a do grupo controle (70 g/m2) (p&lt;0,001). A RM mostrou que não havia prejuízo da força contrátil ou da performance ventricular esquerda e valores de volume diastólico final, volume sistólico final e fração de ejeção dentro dos limites da normalidade. Por outro lado, a massa do VE média, 162,93&amp;plusmn;17,90 g, e a espessura parietal ventricular, 13,67&amp;plusmn;2,13 mm, ao final da diástole no grupo atleta, diferiu significativamente do controle: 110&amp;plusmn;14,2 g (p=0,0001) e 8&amp;plusmn;0,9 mm, respectivamente (p=0,0001). O mesmo ocorreu na média da espessura ao final da sístole, que foi 18,87&amp;plusmn;3,40 mm (controle: 10&amp;plusmn; 1,80 mm, p=0,0001). CONCLUSÃO: Os resultados permitiram concluir que a HVE de maratonistas em período de atividade esportiva plena, avaliada por métodos não invasivos, representa resposta adaptativa ao treinamento físico intensivo e prolongado, com características fisiológicas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To verify whether left ventricular hypertrophy (LVH) of elite competition athletes (marathoners) represents a purely physiological, adaptative process, or it may involve pathological aspects in its anatomical and functional characteristics. METHODS: From November 1999 to December 2000, consecutive samples from 30 under 50-year-old marathoners in full sportive activity, with previously documented LVH and absence of cardiopathy were selected. They were submitted to clinical exams, electrocardiogram, color Doppler echocardiogram and exercise treadmill test (ETT). Fifteen were assorted to be also submitted to ergoespirometric test and heart magnetic resonance imaging (MRI). RESULTS: In ETT, all of them showed good physical pulmonary capacity, with no evidences of ischemic response to exercise, symptoms or arrhythmias. In Doppler echocardiogram, values of diameter and diastolic thickness of LV posterior wall, interventricular septum, LV mass and left atrium diameter, were significantly higher when compared to non-athlete control group, with similar ages and anthropometric measurements. The mean of LV mass of athletes indexed to body surface (126 g/m2) was significantly greater than the one in control group (70 g/m2) (p&lt;0.001). Magnetic resonance imaging (MRI) showed there was not impairment of contractile strength or LV performance, and values of end diastolic volume, end systolic volume and EF within limits of normality. On the other hand, average ventricular parietal mass, 162.93&amp;plusmn;17.90 g, and LV parietal thickness, 13.67&amp;plusmn;2.13 mm, at the end of diastole in athlete group, differed significantly from control group: 110&amp;plusmn;14.2 g (p=0.0001) and 8&amp;plusmn;0.9 mm, respectively (p=0.0001). The same happened to the thickness at the end of systole, which was 18.87&amp;plusmn;3.40 mm (control group: 10&amp;plusmn;1.80 mm, p=0.0001). CONCLUSION: Results allowed for concluding that LVH in marathoners in full sportive activity period, assessed by non-invasive methods, represents an adaptative response to intensive and prolonged physical training, with purely physiological characteristics.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coração de atleta</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiomegalia do atleta</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac hypertrophy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>athletic heart</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>athletic cardiomegaly</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Segurança e exeqüibilidade do ecocardiograma sob estresse com dobutamina e atropina em pacientes octogenários</s1>
</fA08>
<fA08 dir="en">
<s1>Safety and feasibility of dobutamine-atropine stress echocardiography in octogenarian patients</s1>
</fA08>
<fA11 dir="011000">
<s1>José Sebastião de Abreu</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Tereza Cristina Pinheiro Diógenes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ana Gardenia Liberato Ponte Farias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>José Maria Bonfim de Morais</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Nogueira Paes Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Prontocárdio de Fortaleza  </s1>
<s2>CE </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>198-204</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>44</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar a exeqüibilidade e segurança do ecocardiograma sob estresse com dobutamina e atropina (EED) em octogenários. MÉTODOS: Avaliaram-se 5.467 EED, distribuídos entre grupo dos octogenários (GI=203) e grupo controle (GII=5.264). A idade média no GI=83&amp;plusmn;3 (80-95) e no GII=59&amp;plusmn;11 (17-79) anos. Os parâmetros resultantes do EED, coletados prospectivamente, foram comparados e analisados. RESULTADOS: O percentual de pacientes que atingiram freqüência cardíaca máxima foi em GI=63,5% e GII=41% (GI vs. GII; p&lt;0,001), e o GI necessitou de menos atropina (GI=47% vs. GII=78%; p&lt;0,001). A ocorrência de dor não foi significativamente diferente (GI=13% vs. GII=15,6%; p=0,429), nem o percentual de EED positivo para isquemia miocárdica (GI=20,7% vs. GII=16,9%; p=0,296), mas a concomitância entre EED positivo e ausência de dor (GI=17% vs. GII=11%; p=0,029) foi maior no grupo I. A ocorrência de extra-sistolia (GI=47,8% vs GII=27,6%; p&lt;0,001) e taquiarritmia supraventricular (GI=5,9% vs. GII=1,9%; p=0,001) foi maior no grupo I. Das 11 taquiarritmias supraventriculares do grupo I, 9 reverteram espontaneamente. Não houve óbito, infarto ou prevalência de taquicardia ventricular. Só ocorreu fibrilação ventricular (2 casos; 0,03%) no GII. CONCLUSÃO: Apesar do menor uso de atropina para concluir o EED, os octogenários atingiram mais a freqüência cardíaca máxima. Houve uma maior correlação entre EED positivo para isquemia miocárdica e a ausência de dor. Apresentaram mais distúrbios do ritmo, todavia a resolução, em geral, foi espontânea. Em nosso estudo, o EED mostrou ser um método exeqüível e seguro para os octogenários.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the feasibility and safety of dobutamine-atropine stress echocardiography (DASE) in octogenarians. METHODS: We evaluated 5,467 DASE which were distributed in two groups: group I (GI) with 203 DASE performed in octogenarians, and group II (GII), the control group, with 5,264 DASE. The mean age of GI and GII was 83&amp;plusmn;3 (80-95) and 59&amp;plusmn;11 (17-79) years, respectively. DASE parameters that were prospectively collected, were compared and analyzed. RESULTS: The percentage of patients that achieved maximum heart rate was 63.5% in GI and 41% in GII (p&lt;0.001), and GI patients required less atropine compared to GII (GI=47%, GII=78%, p&lt;0.001).The presence of chest pain (GI=13%, GII=15.6%, p=0.429) and DASE positive for myocardial ischemia (GI=20.7%, GII=16.9%, p=0.296) were not statistically different between the two groups. However, concomitant positive DASE and absence of chest pain (GI=17%, GII=11%, p=0.029) was higher in GI. The incidence of premature beats in GI was higher than in GII (GI=47.8%, GII=27.6%, p&lt;0.001), and there were more supraventricular tachyarrhythmias (ST) in GI than in GII (GI=5.9%, GII=1.9%, p=0.001). Out of 11 ST that happened in GI, 9 reverted spontaneously. There weren't either deaths or acute myocardial infarction. Ventricular fibrillation only happened in GII (2 cases, 0.03%). CONCLUSION: In the present study, octogenarians achieved maximum heart rate more frequently despite the lesser amount of atropine that they required for DASE completion. Moreover, in this elderly population, there was a higher correlation between positive DASE and absence of chest pain. Although octogenarians did present more heart rhythm disturbs, they usually resolved spontaneously. In our study, DASE proved to be feasible and safe in octogenarians.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dobutamina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>octogenários</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dobutamine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>octogenarian</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Fibroelastoma papilífero: experiência de uma instituição</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiac papillary fibroelastoma: experience of an institution</s1>
</fA08>
<fA11 dir="011000">
<s1>Suzelle F. de M Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo Ribeiro Dias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fábio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Noedir A. G. Stolf</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>205-207</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500310</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Os tumores cardíacos primários do coração são raros, com uma prevalência entre 0,0017% e 0,19% dos estudos de autópsia não selecionados. Cerca de 75% são tumores benignos e quase a metade são mixomas. Os restantes se dividem entre rabdomiomas, lipomas e fibroelastomas. Os mixomas são os tumores cardíacos mais comuns na idade adulta e os rabdomiomas, os mais comuns da população pediátrica. O fibroelastoma papilífero (FEP) é um tumor benigno do coração, relativamente raro, correspondendo a aproximadamente 8% dos tumores cardíacos. São os que mais comumente acometem as valvas cardíacas¹. No passado, consistiam de achados de necropsia ou eram encontrados em procedimentos cirúrgicos ao acaso. O diagnóstico in vivo era esporádico². Com o aprimoramento das técnicas de ecocardiografia, o FEP tem sido diagnosticado com maior freqüência. São, geralmente, descritos como uma massa móvel, pedunculada, bem delimitada e com predileção pelo endocárdio valvar. A proposta terapêutica, quando pedunculados, é a ressecção cirúrgica, visando a prevenção de fenômenos embólicos cerebrais, pulmonares, coronarianos ou periféricos1,3. Serão apresentados cinco casos diagnosticados em nossa instituição, no período de agosto de 1995 a junho de 2004.</s0>
</fC01>
<fC01 dir="en">
<s0>Primary intracardiac tumors are rare, with prevalence between 0.0017% and 0.19% from non-selected autopsy studies. Approximately 75% are benign and almost half of them are myxomas. The remaining tumors are divided among rabdomyomas, lipomas and fibroelastomas. Myxomas are the most common intracardiac tumors in adult age and rabdomyomas the most common among pediatric population. Papillary fibroelastoma (PFE) is a relative rare benign heart tumor, corresponding to approximately 8% of intracardiac tumors. They most commonly manifested in cardiac valves¹. In the past, they either consisted of necropsy findings or were found in surgical procedures at random. In vivo diagnosis was sporadic². With the improvement of echocardiography techniques, PFE has been more frequently diagnosed. They are usually described as a movable, pedunculate, well-delimited mass and with predilection for valve endocardium. Therapeutic proposal, when they are pedunculate, is surgical resection, preventing cerebral, pulmonary, coronary or peripheral embolic phenomena1,3. Five cases diagnosed in our institution, in the period from August 1995 to June 2004, will be presented</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Qual o melhor determinante do prognóstico pela monitorização ambulatorial da pressão arterial: ausência de descenso da pressão durante o sono ou elevação rápida da pressão pela manhã?</s1>
</fA08>
<fA08 dir="en">
<s1>What is the best prognostic determinant for ambulatory blood pressure monitoring: nondipping or morning surge in blood pressure?</s1>
</fA08>
<fA11 dir="011000">
<s1>Katia Coelho Ortega</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Décio Mion Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>208-209</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500311</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Quantos dias, quais horários e quantas medidas por dia devem ser recomendadas na monitorização residencial da pressão arterial?</s1>
</fA08>
<fA08 dir="en">
<s1>How many days, which period of the day and how many measurements per day are recommended in home blood pressure monitoring?</s1>
</fA08>
<fA11 dir="011000">
<s1>Audes Diógenes de Magalhães Feitosa</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marco Antônio Mota Gomes</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Décio Mion Júnior</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>210-211</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500312</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Que valores devem ser adotados como limites de normalidade na monitorização ambulatorial de pressão arterial e na monitorização residencial de pressão arterial?</s1>
</fA08>
<fA08 dir="en">
<s1>Which threshold values should be recommended in ambulatory blood pressure monitoring and self blood pressure monitoring?</s1>
</fA08>
<fA11 dir="011000">
<s1>Miguel Gus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital de Clínicas de Porto Alegre  </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>212-214</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500313</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>A MAPA é indicada para todo hipertenso e normotenso?: Existem evidências para tanto?</s1>
</fA08>
<fA08 dir="en">
<s1>Is ABPM indicated for all hypertensives and normotensives?: Is supportive evidence available?</s1>
</fA08>
<fA11 dir="011000">
<s1>Giovânio Vieira da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Décio Mion Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>215-217</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500314</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Projeto Corações do Brasil</s1>
</fA08>
<fA08 dir="en">
<s1>Hearts of Brazil Project</s1>
</fA08>
<fA11 dir="011000">
<s1>Raimundo Marques do Nascimento Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Eduardo Krieger</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>George L Machado-Coelho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alexandre da Costa Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Investigadores do Projeto Corações do Brasil  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>218-221</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500315</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Eventos cardiovasculares: um efeito de classe dos inibidores de COX-2</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiovascular events: a class effect by COX-2 inhibitors</s1>
</fA08>
<fA11 dir="011000">
<s1>Leila Fernandes Araujo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alexandre de Matos Soeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Juliano de Lara Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Vicente Serrano Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo Faculdade de Medicina Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>222-229</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500316</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Professor Edson Saad</s1>
</fA08>
<fA11 dir="011000">
<s1>Charles Mady</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="021000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation></afiliation>
</fA11>
<fA11 dir="031000">
<s1>Whady A Hueb</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>230-230</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500317</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Volume ventricular esquerdo crítico na estenose aórtica no primeiro ano de vida: sua importância na seleção de pacientes candidatos à correção univentricular pós-valvotomia</s1>
</fA08>
<fA08 dir="en">
<s1>Critical left ventricular volume in aortic stenosis in first year of life: its importance in patients selection candidates to univentricular surgical correction pos-valvotomy</s1>
</fA08>
<fA11 dir="011000">
<s1>Marco Aurélio Santos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vitor Manuel Pereira Azevedo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria Ourinda Mesquita da Cunha</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Nacional de Cardiologia Laranjeiras  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Instituto Nacional do Câncer  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>186-190</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Análise do volume diastólico final ventricular esquerdo crítico, definido como o menor volume aceitável para a manutenção do débito cardíaco, na seleção de pacientes com estenose aórtica pós-valvotomia, candidatos à correção univentricular. MÉTODOS: Estudo retrospectivo em 21 pacientes com estenose aórtica, durante o primeiro ano de vida, e 232 compilados da literatura. Arbitraram-se como normais os valores do volume diastólico final (VDF) de 20 a 60 ml/m2. Foi comparado o VDF dos grupos que foram ao óbito com aqueles que sobreviveram. Procurou-se, também, estabelecer uma correlação da idade e volume ventricular, na época da valvotomia, entre os grupos. Por fim, determinou-se o VDF esquerdo crítico, obtido através de uma relação teórica entre o VDF esquerdo e freqüência cardíaca para diferentes frações de ejeção e determinados índices cardíacos (IC): 2.000 e 2.500 ml/min/m2. RESULTADOS: Para valores do VDF &lt;20ml/m2 e &gt;60 ml/m2, houve significância estatística entre os mortos e os sobreviventes (p&lt;0,0001). Entretanto, na faixa entre 20 e 60 ml/m2, esta significância foi menor (p=0,0309). Também ocorreu uma maior incidência de óbito naqueles, com apresentação na primeira semana de vida. Para um IC de 2.500 ml/min/m2 e uma freqüência cardíaca de 140 bpm, o VDF crítico será de 26 ml/m2 se a fração de ejeção (FE) do ventrículo esquerdo for de 0,70 e de 44,5 ml/m2, se a FE for de 0,40. CONCLUSÃO: A análise do volume ventricular esquerdo crítico pode adicionar mais um parâmetro na indicação da correção univentricular em pacientes com estenose aórtica pós-valvotomia, durante o primeiro ano de vida.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Analysis of critical end diastolic left ventricular volume (EDLVV), defined as the lowest acceptable volume to keep cardiac output, in the selection of patients with post-valvotomy aortic stenosis, candidates to univentricular correction. METHODS: A retrospective study in 21 patients with aortic stenosis, during the first year of life, and 232 patients compiled from literature. Values of end diastolic volume (EDLVV), from 20 to 60 ml/m2 were determined as normal. The EDLVV of deceased patients was compared to that from survival patients. A correlation between the age and EDLVV was carried out at the time of valvotomy, between the groups. Finally, the critical EDLVV through the theoretical relationship between the EDLVV and heart rate for different ejection fractions and designated cardiac indexes (CI): 2,000 and 2,500 20-60 ml/min/m2 was determined. RESULTS: For EDLVV values &lt;20ml/m2 and &gt;60 ml/m2, there was statistical significance between deceased and survival patients (p&lt; 0.0001). However, in the range between 20 and 60 ml/m2, that significance was lower (p=0.0309). A greater incidence of death took place among those who showed it in the first week of life. For a CI of 2,500 ml/min/m2 and a heart rate (HR) of 140 bpm, critical EDLVV will be 26 ml/m2 if left ventricular ejection fraction (LVEF) is 0.70, and 44.5 ml/m2, if LVFE is 0.40. CONCLUSION: The analysis of critical end diastolic left ventricular volume (EDLVV) can add another parameter in the indication of univentricular correction in patients with post-valvotomy aortic stenosis, during the first year of life.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose aórtica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>volume ventricular esquerdo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prognóstico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>correção univentricular</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left ventricular volume</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognostic</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>univentricular correction</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>84</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>3-28</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08400001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>O significado da Sociedade Sul-Americana de Cardiologia</s1>
</fA08>
<fA08 dir="en">
<s1>The meaning of the South American Society of Cardiology</s1>
</fA08>
<fA11 dir="011000">
<s1>Gilson Soares Feitosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa de Misericórdia da Bahia Hospital Santa Izabel Escola Bahiana de Medicina</s1>
<s2>Salvador BA</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>231-232</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo cardiológico longitudinal em crianças expostas ao vírus da imunodeficiência humana tipo 1 por via perinatal</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiac longitudinal study of children perinatally exposed to human immunodeficiency virus type 1</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Suely Bezerra Diógenes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Regina Célia de Menezes Succi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Daisy M. Machado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Valdir Ambrósio Moisés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Neil Ferreira Novo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>233-240</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>64</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinação da freqüência das alterações cardíacas e sua evolução nas crianças expostas ao HIV-1 por via perinatal. MÉTODOS: Realizada avaliação seqüencial clínico-cardiológica, eletrocardiográfica e ecocardiográfica Doppler em 84 crianças expostas ao HIV-1. RESULTADOS: Grupo I (sororreversão) 43 crianças (51,2%). Ausência de alterações clínicas. ECG: distúrbio de condução de ramo direito 5 casos. ECO: CIA (1 caso) e CIV (1 caso). Grupo II 41 infectados (48,8%) com 51,2% de alterações cardiológicas. Crianças assintomáticas ou com sintomas leves, sem imunossupressão: alterações clínico-ecocardiográficas ausentes; ECG: distúrbio de condução de ramo direito (2 casos). Crianças com comprometimento clínico-imunológico moderado e severo: Alterações encontradas: 1) Clínicas (31,7%): taquicardia isolada (1 caso), ICC (12 casos). 2) Eletrocardiográficas (43,9%): taquicardia sinusal associada a outras alterações (10 casos), distúrbio de condução de ramo direito (5 casos), BDAS (1 caso), HBAD (1 caso), alterações da repolarização ventricular (11 casos), SVD (2 casos), SVE (1 caso), desvio do AQRS para direita (1 caso), arritmias (3 casos). 3) Ecocardiográficas (26,8%): miocardiopatia dilatada (5 casos), derrame pericárdico com tamponamento (2 casos), hipertensão pulmonar (2 casos) e prolapso da valva mitral (1 caso). CONCLUSÃO: O envolvimento cardíaco foi uma característica do grupo infectado. Houve maior prevalência de alterações nas crianças pertencentes à categoria clínico-imunológica mais avançada. Os achados clínicos, eletrocardiográficos e ecocardiográficos mais freqüentes foram, respectivamente, ICC, alterações da repolarização ventricular e miocardiopatia dilatada. Esta foi reversível em um caso. As alterações eletrocardiográficas foram significantemente mais freqüentes que as clínicas e ecocardiográficas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the frequency of cardiac abnormalities and its natural history in children perinatally exposed to HIV-1. METHODS: Eighty-four children exposed to HIV-1 were evaluated by serial clinical, electrocardiographic (ECG), and Doppler-echocardiographic (ECHO) examinations. RESULTS: Group I - (seroreversion) - 43 children (51.2%). Absence of clinical abnormalities. ECG: incomplete right bundle branch block (RBBB) 5 cases. ECHO: atrial septal defect (ASD) and ventricular septal defect (VSD) - 1 case each. Group II - 41 HIV-infected children (48.8%), of whom 51.2% were found to have cardiac abnormalities. Asymptomatic or mildly symptomatic children without immunosuppression: no clinical and echocardiographic abnormalities; ECG: incomplete right bundle branch block (RBBB) - (2 cases). Children with moderate and severe symptoms and immunological impairment: the following abnormalities were found: 1) clinical (31.7%)-isolated tachycardia (1 case), congestive heart failure (12 cases). 2) electrocardiographic (43.9%)- sinus tachycardia associated with other abnormalities (10 cases), incomplete right bundle branch block (5 cases), left anterior hemiblock (1 case), right anterior hemiblock (1 case), changes in ventricular repolarization (11 cases), right ventricular overload (2 cases), left ventricular overload (1 case), right QRS axis deviation (1 case), and arrhythmias (3 cases). 3) echocardiographic (26.8%)- dilated cardiomyopathy (5 cases), pericardial effusion with tamponade (2 cases), pulmonary hypertension (2 cases), and mitral valve prolapse (1 case). CONCLUSION: Cardiac involvement was a characteristic of the HIV-infected group. Higher prevalence of abnormalities was found among children belonging to the most advanced clinical and immunological category. The most commonly observed clinical, electrocardiographic and echocardiographic findings were congestive heart failure (CHF), changes in ventricular repolarization, and dilated cardiomyopathy, respectively. The latter was reversible in one case. Electrocardiogram changes were significantly more frequent than clinical and echocardiographic changes.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>HIV</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>transmissão vertical</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>eletrocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>HIV</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>vertical transmission</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiogram</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Disfunção erétil: um marcador para alterações da perfusão miocárdica?</s1>
</fA08>
<fA08 dir="en">
<s1>Erectile dysfunction: a marker for myocardial perfusion impairment?</s1>
</fA08>
<fA11 dir="011000">
<s1>Juarez Ortiz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sergio Tranchesi Ortiz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Claudia Gianini Monaco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cristina Harumi Yamashita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Miriam Cássia Mendes Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Carlos Alberto F. Monaco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>CCNI Medicina Diagnóstica OMNI </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>241-246</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Investigar a correlação entre alterações da perfusão miocárdica e a presença de disfunção erétil (DE) em homens com suspeita clínica ou diagnóstico já estabelecido de insuficiência coronariana crônica. MÉTODOS: Estudo prospectivo com 287 pacientes que, após responderem o questionário IIEF-5 para diagnóstico e avaliação do grau de DE, foram submetidos a avaliação clínico-cardiológica e a estudo cintilográfico da perfusão miocárdica (tecnécio - 99m sestamibi - gated SPECT), antes e após estresse físico ou farmacológico. RESULTADOS: Em 137 pacientes (47,8%) foi detectado algum grau de disfunção erétil (grupo DE+) e nestes, a idade (60,60±9,84 vs 50,67±9,94 - p&lt;0,001)) foi significativamente maior do que naqueles sem disfunção (grupo DE-). No grupo DE+ houve maior prevalência de hipertensão arterial, diabetes, infarto do miocárdio e coronarioplastia prévios. Independentemente do fator idade, o grupo DE+ teve maior prevalência de alterações da perfusão miocárdica (necrose e/ou isquemia) e de diminuição da mobilidade e do grau de espessamento sistólico do miocárdio ventricular. CONCLUSÃO: Pacientes com DE tem maior probabilidade de apresentar alterações da perfusão e do desempenho miocárdico segmentar, independentemente do fator idade. Na presente amostra, a DE foi considerada não só como um marcador da doença isquêmica do coração, mas também fortemente relacionada à ocorrência de eventos coronarianos maiores como infarto do miocárdio e necessidade de coronarioplastia.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study the correlation between erectile dysfunction (ED) and myocardial perfusion impairment in men with suspected or diagnosed coronary artery disease (CAD). METHODS: In this prospective study a self-administered IIEF-5 questionnaire was answered by 287 patients that underwent myocardial perfusion imaging under both resting and stress condition with technetium-99m sestamibi, through gated SPECT nuclear scintigraphy technique, before and after physical or pharmacological stress. RESULTS: Some degree of erectile dysfunction (group ED+) was found in 137 (47.8%) patients and in these, age was significantly higher (60.60±9.84 vs 50.67±9.94 - p&lt;0.001)) than in those without erectile dysfunction (group ED-). In the ED+ group, it was observed a higher prevalence of hypertension, diabetes, myocardial infarction (MI) and percutaneous coronary angioplasty (PCTA). Regardless of the age factor, ED+ patients also presented higher occurrence of myocardial perfusion impairment (necrosis and/or ischemia) and left ventricular systolic wall motion and thickening abnormalities. CONCLUSION: Patients with ED have higher estimated probability of presenting segmental myocardial perfusion and functional contraction impairment and, therefore, CAD, independent of the aging factor. The authors conclude that ED may be considered not only a marker for CAD but also a condition related to the occurrence of major coronary events such as MI and PCTA.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>disfunção erétil</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença arterial coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>medicina nuclear</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>perfusão miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>erectile dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nuclear medicine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial perfusion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>atherosclerosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Terapia da insuficiência cardíaca avançada ajustada por objetivos hemodinâmicos obtidos pela monitorização invasiva</s1>
</fA08>
<fA08 dir="en">
<s1>Advanced heart failure therapy adapted to hemodynamic objectives acquired from invasive hemodynamic monitoring</s1>
</fA08>
<fA11 dir="011000">
<s1>Gustavo Luiz Gouvêa de Almeida Júnior</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Esporcatte</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando Oswaldo Dias Rangel</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ricardo Mourilhe Rocha</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Gustavo de Miranda Gouvêa e Silva</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Bernardo Rangel Tura</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Kezen Camilo Jorge</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luiz Eduardo Fonseca Drumond</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Francisco Manes Albanesi Filho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro Hospital Pró-Cardíaco </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Casa de Saúde São José  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>247-253</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o tratamento da insuficiência cardíaca (IC) avançada em relação à redução das pressões de enchimento ventricular, com a utilização de doses maiores de vasodilatadores, através da monitorização hemodinâmica invasiva. MÉTODOS: Foram estudados 19 pacientes com IC avançada, nos quais foi instalado o cateter de Swan-Ganz para guiar a administração de diurético intravenoso (IV) e nitroprussiato de sódio, com o objetivo de se reduzir de forma significativa as pressões de enchimento ventricular. Depois de alcançado esse objetivo ou 48 horas, foram introduzidas drogas orais até serem retirados os fármacos venosos, mantendo o benefício hemodinâmico. RESULTADOS: Dos 19 pacientes estudados, 16 (84%) eram do sexo masculino. A idade média foi de 66 ± 11,4 anos; a fração de ejeção média foi de 26 ± 6,3%; 2 pacientes (10,5%) apresentavam classe funcional (CF) III e 17 (89,5%), CF IV. Houve queda da pressão de oclusão da artéria pulmonar de 23 ± 11,50 mmHg para 16 ± 4,05 mmHg (p=0,008), do índice de resistência vascular sistêmica de 3.023 ± 1.153,71 dynes/s/cm-5/m² para 1.834 ± 719,34 dynes/s/cm-5/m² (p=0,0001) e aumento do índice cardíaco de 2,1 ± 0,56 l/min/m² para 2,8 ± 0,73 l/min/m² (p=0,0003). Um subgrupo com hipovolemia foi identificado. CONCLUSÃO: Foi possível reduzir as pressões de enchimento ventricular para valores significativamente menores, obtendo melhora significativa do índice cardíaco, do índice de resistência vascular sistêmica e da pressão média da artéria pulmonar, utilizando-se doses significativamente maiores de vasodilatadores.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess advanced heart failure (HF) treatment in relation to reduction of ventricular filling pressures, with the use of greater doses of vasodilators, through invasive hemodynamic monitoring. METHODS: Nineteen advanced HF patients were studied, in whom Swan-Ganz catheter was inserted to direct administration of diuretic intravenously (IV) and sodium nitroprusside, with the aim of significantly reduce ventricular filling pressures. After achieving such objective or 48 hours, oral drugs were introduced until venous medicines were removed, keeping hemodynamic benefit. RESULTS: From 19 patients studied, 16 (84%) were of male sex. The average age was 66 ± 11.4 years old; average ejection fraction was 26 ± 6.3%; 2 patients (10.5%) showed functional class (FC) III and 17 (89.5%), FC IV. There was a decrease of pulmonary artery occlusion pressure from 23 ± 11.50 mmHg to 16 ± 4.05 mmHg (p = 0.008), of systemic vascular resistance index from 3,023 ± 1,153.71 dynes/s/cm-5/m² to 1,834 ± 719.34 dynes/s/cm-5/m² (p = 0.0001) and an increase of cardiac index from 2.1 ± 0.56 l/min/m² to 2.8 ± 0.73 l/min/m² (p = 0.0003). A subgroup with hypovolemia was identified. CONCLUSION: It was possible to reduce ventricular filling pressures to significantly lower values, obtaining a significant improvement of cardiac index, systemic vascular resistance index and pulmonary artery mean pressure, by using significantly higher doses of vasodilators.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>monitorização hemodinâmica invasiva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>terapia ajustada</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tratamento</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>invasive hemodynamic monitoring</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adjusted therapy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treatment</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Análise prospectiva de risco em pacientes submetidos à cirurgia de revascularização miocárdica</s1>
</fA08>
<fA08 dir="en">
<s1>Prospective risk analysis in patients submitted to myocardial revascularization surgery</s1>
</fA08>
<fA11 dir="011000">
<s1>Antonio Carlos Mugayar Bianco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ari Timerman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ângela Tavares Paes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Gun</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rui Fernando Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Ronald Brewer Pereira Freire</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>César Nicolas Conde Vela</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Antonio Aurélio de Paiva Fagundes Junior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Luís Cláudio Behrmann Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Leopoldo Soares Piegas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>254-261</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>46</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Análise estratificada de risco em Cirurgia de Revascularização Miocárdica (CRVM). MÉTODOS: Estudou-se, de forma prospectiva, 814 pacientes, aplicando-se dois índices prognósticos (IP): Parsonnet e Higgins Modificado. O IP Higgins foi Modificado por substituição da variável &quot;valor do índice cardíaco&quot; por &quot;síndrome de baixo débito cardíaco&quot;, na admissão à Unidade de Terapia Intensiva (UTI). A capacidade discriminatória para morbimortalidade de ambos foi analisada através de curva ROC (receiver operating characteristic). Identificou-se, através de regressão logística, os fatores associados, de forma independente aos eventos. RESULTADOS: A taxa de mortalidade foi de 5,9% e a de morbidade, 35,5%. O IP Higgins Modificado, que analisa variáveis pré, intra-operatórias e variáveis fisiológicas na admissão à UTI, demonstrou áreas sob a curva ROC de 77% para mortalidade e de 67%, para morbidade. Por sua vez, o IP Parsonnet, que analisa somente variáveis pré-operatórias, demonstrou áreas de 62,2% e 62,4%, respectivamente. Doze variáveis caracterizaram-se como fatores prognósticos independentes: idade, diabete melito, baixa superfície corpórea, creatinina (&gt;1,5 mg/dl), hipoalbuminemia, cirurgia não-eletiva, tempo prolongado de circulação extracorpórea (CEC), necessidade de balão intra-aórtico pós-CEC, síndrome de baixo débito cardíaco na admissão do paciente à UTI, freqüência cardíaca elevada, queda do bicarbonato sérico e alargamento do gradiente alvéolo-arterial de oxigênio nesse período. CONCLUSÃO: O IP Higgins Modificado mostrou-se superior ao IP Parsonnet na estratificação de risco cirúrgico, salientando a importância da análise de eventos intra-operatórios e variáveis fisiológicas na admissão do paciente à UTI, quando da definição prognóstica.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To perform a stratified risk analysis in Myocardial Revascularization Surgery (MRS). METHODS: 814 patients were prospectively studied by applying two prognostic indexes (PI): Parsonnet and Modified Higgins. The Higgins PI was modified by substituting the variable &quot;cardiac index value&quot; by &quot;low cardiac output syndrome&quot; at the Intensive Care Unit (ICU) admission. The discriminatory capacity for morbimortality of both indexes was analyzed by ROC (receiver operating characteristic) curve. Logistic reaction identified the associated factors, independently from the events. RESULTS: Mortality and morbidity rates were 5.9% and 35.5%, respectively. The Modified Higgins PI, which analyzes pre- and intra-operative and physiological variables at the ICU admission showed areas under the ROC curve of 77% for mortality and 67% for morbidity. The Parsonnet PI, which only analyzes pre-operative variables, showed areas of 62.2% and 62.4%, respectively. Twelve variables were characterized as independent prognostic factors: age, diabetes mellitus, low body surface, creatinine levels (&gt;1.5 mg/dL), hypoalbuminemia, non-elective surgery, prolonged time of extracorporeal circulation (ECC), necessity of post-ECC intra-aortic balloon, low cardiac output syndrome at the ICU admission, elevated cardiac frequency, decrease in serum bicarbonate concentrations and increase of the alveolar-arterial oxygen gradient within this period. CONCLUSION:The Modified Higgins PI showed to be superior to the Parsonnet PI at the surgical risk stratification, showing the importance of the analysis of intraoperative events and physiological variables at the patient's ICU admission, when prognostic definition is achieved.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia de revascularização miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>índices prognósticos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>morbidade e mortalidade</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognostic indexes</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>morbidity and mortality</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Fatores prognósticos de sobrevida pós-reanimação cardiorrespiratória cerebral em hospital geral</s1>
</fA08>
<fA08 dir="en">
<s1>In-hospital post-cardiopulmonary-cerebral resuscitation survival prognostic factors</s1>
</fA08>
<fA11 dir="011000">
<s1>André Mansur de Carvalho Guanaes Gomes</s1>
<afiliation>A01 A02 A03 A04 A05 A06</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ari Timerman</s1>
<afiliation>A01 A02 A03 A04 A05 A06</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Alfredo Marcílio de Souza</s1>
<afiliation>A01 A02 A03 A04 A05 A06</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Maurício Cardeal Mendes</s1>
<afiliation>A01 A02 A03 A04 A05 A06</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Heitor Portella Póvoas Filho</s1>
<afiliation>A01 A02 A03 A04 A05 A06</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Adriano Martins de Oliveira</s1>
<afiliation>A01 A02 A03 A04 A05 A06</afiliation>
</fA11>
<fA11 dir="071000">
<s1>José Antonio de Almeida Souza</s1>
<afiliation>A01 A02 A03 A04 A05 A06</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Hospital da Cidade  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA14 dir="040000">
<s1>Escola Bahiana de Medicina e Saúde Pública  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="050000">
<s1>Universidade Federal da Bahia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="060000">
<s1>Instituto Sócrates Guanaes  </s1>
<s2>Salvador BA</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>262-271</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>43</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar as características clínicas e demográficas dos pacientes que receberam reanimação cardiorrespiratória e detectar fatores prognósticos de sobrevivência a curto e longo prazo. MÉTODOS: Analisamos, prospectivamente, 452 pacientes que receberam reanimação em hospitais gerais de Salvador. Utilizou-se análise uni, bivariada e estratificada nas associações entre as variáveis e a curva de sobrevida de Kaplan-Meier e a regressão de Cox para análise de nove anos de evolução. RESULTADOS: A idade variou de 14 a 93 anos, media de 54,11 anos; predominou o sexo masculino; metade dos pacientes tinha ao menos uma doença de base, enfermidade cardiovascular foi etiologia responsável em metade dos casos. Parada cardíaca foi testemunhada em 77% dos casos e em apenas 69% dos pacientes foi iniciada imediatamente a reanimação. O ritmo cardíaco inicial não foi diagnosticado em 59% dos pacientes. Assistolia foi o ritmo mais freqüente (42%), seguida de arritmia ventricular (35%). A sobrevida imediata foi de 24% e sobrevida à alta hospitalar de 5%. Foram identificados como fatores prognósticos em curto prazo: etiologia da parada; diagnóstico do ritmo cardíaco inicial; fibrilação ou taquicardia ventricular como mecanismo de parada; tempo estimado préreanimação menor ou igual a 5 minutos e, tempo de reanimação menor ou igual a 15 minutos. Os fatores prognósticos de sobrevivência em nove anos de evolução foram: não ter recebido epinefrina; ser reanimado em hospital privado e tempo de reanimação menor ou igual a 15 minutos. CONCLUSÃO: Os dados observados podem servir de subsídios para os profissionais de saúde decidir quando iniciar ou parar uma reanimação no ambiente hospitalar.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess clinical and demographic characteristics of patients who had cardiopulmonary resuscitation and identify short- and long-term survival prognostic factors. METHODS: Four hundred and fifty-two (452) resuscitated patients in general hospitals from Salvador were prospectively assessed through bivariate and stratified analysis in associations between variables and survival curve for a nine-year evolution assessment. RESULTS: Age ranged from 14 to 93 years old, mean of 54.11 years old. Male gender patients prevailed and half of them had at least a base disease. Cardiovascular disease was the responsible etiology in 50% of cases. Cardiac arrest was observed in 77% of cases and only 69% of patients were immediately resuscitated. Initial cardiac rhythm was not diagnosed in 59% of patients. Asystole was the most frequent rhythm (42%), followed by ventricular arrhythmia (35%). Immediate survival was 24% and hospital discharge survival 5%. Cardiac arrest etiology, initial cardiac rhythm diagnosis, ventricular fibrillation or tachycardia as arrest mechanism, pre-resuscitation estimated time lower than or equal to 15 minutes and resuscitation time lower than or equal to 5 minutes were recognized as short-term prognostic factors. Non-administration of epinephrine, being resuscitated in private hospital and resuscitation time lower than or equal to 15 minutes were nine-year evolution survival prognostic factors. CONCLUSION: Data may help healthcare professionals decide when start or stop in-hospital resuscitation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ressuscitação cardiopulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>parada cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prognóstico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hospitais gerais</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiopulmonary resuscitation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac arrest</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>general hospitals</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Estado da arte do procedimento percutâneo: paciente octogenário submetido com sucesso, em apenas uma sessão, a valvotomia pulmonar, implante de stent coronário e implante de marcapasso definitivo</s1>
</fA08>
<fA08 dir="en">
<s1>State of the art percutaneous procedure: octogenarian patient successfully submitted, in a single session, to a pulmonary valvotomy, coronary stent implant and permanent pacemaker implant</s1>
</fA08>
<fA11 dir="011000">
<s1>Wilson Albino Pimentel Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Milton de Macedo Soares Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gil Vicente Cividanis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rubens Vaz Feijó Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto de Cardiologia de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>272-274</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>É relatado caso de paciente de 82 anos, portador de insuficiência renal leve, estenose valvar pulmonar (EVP) severa, estenose severa de artéria descendente anterior e bloqueio atrioventricular total, submetido a angioplastia coronária com implante de stent coronário, valvotomia pulmonar e implante de marcapasso definitivo no mesmo procedimento, com sucesso.</s0>
</fC01>
<fC01 dir="en">
<s0>This report describes a case involving an 82 year old patient with mild renal insufficiency, severe pulmonary valve stenosis (PVS), severe anterior descending artery stenosis and complete atrioventricular block, who successfully underwent, in a single session, coronary angioplasty and a stent implant, pulmonary valvotomy and a permanent pacemaker implant.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Endomiocardiofibrose biventricular associada à amiloidose renal</s1>
</fA08>
<fA08 dir="en">
<s1>Biventricular endomyocardiofibrosis associated with renal amyloidosis</s1>
</fA08>
<fA11 dir="011000">
<s1>José Ramos Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Alberto Fontes de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Enzo Magrini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcelo de Macedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Roberto Bauab Isolato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade São Francisco  </s1>
<s2>Bragança Paulista SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>275-278</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>A endomiocardiofibrose (EMF) é uma cardiomiopatia restritiva, caracterizada por envolvimento fibrótico do endocárdio e miocárdio adjacente, e disfunção diastólica, causada por alteração da distensibilidade, dificultando o enchimento ventricular adequado, estando a função sistólica preservada. Clinicamente, apresenta-se como insuficiência cardíaca, mas, para o diagnóstico etiológico correto, são necessárias perspicácia semiológica, suspeita e investigação clínica. Relatamos o caso de uma paciente portadora de endomiocardiofibrose biventricular associada à amiloidose renal.</s0>
</fC01>
<fC01 dir="en">
<s0>Endomyocardiofibrosis is a restrictive cardiomyopathy characterized by fibrotic involvement of the endocardium and adjacent myocardium, and by diastolic dysfunction caused by changes in distensibility making ventricular filling inadequate while preserving the systolic function. Clinically, it appears as heart failure, but etiological symptomatic discernment, suspicion and a clinical examination would be necessary in order to make a correct etiological diagnosis. The case of a patient with biventricular endomyocardial fibrosis associated with renal amyloidosis is presented.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Tratamento percutâneo da úlcera penetrante de aorta</s1>
</fA08>
<fA08 dir="en">
<s1>Percutaneous management of penetrating aortic ulcer</s1>
</fA08>
<fA11 dir="011000">
<s1>Gustavo Carvalho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maurício de Nassau Machado</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Robson B. de Carvalho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antônio Carvalho Leme Neto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de São José do Rio Preto  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Santa Casa de Misericórdia de Goiânia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>279-282</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>A úlcera penetrante de aorta é uma variante da dissecção aórtica clássica, que apresenta características histopatológicas peculiares e, quando não tratada adequadamente, evolui com taxas de morbimortalidade tão elevadas quanto as da dissecção clássica, merecendo, desta forma, atenção especial com diagnóstico e tratamento precisos. Há a preferência para o tratamento percutâneo com o uso de endopróteses, pois estes pacientes são idosos e apresentam co-morbidades, as quais elevariam as taxas de complicações da cirurgia convencional. Mulher de 78 anos, admitida com queixa de dor torácica com irradiação para região interescapular e lombar à esquerda, com evolução de quatro meses. Na investigação diagnóstica, foi encontrada uma úlcera penetrante de aorta, que foi tratada de forma percutânea, com o implante de stent, com sucesso, estando a paciente em acompanhamento ambulatorial, assintomática.</s0>
</fC01>
<fC01 dir="en">
<s0>Penetrating aortic ulcer is a variant of classic aortic dissection having distinct histopathological characteristics. If not appropriately treated, it evolves to combined morbidity and mortality rates as high as those of classic dissection. This condition, therefore, warrants special attention with accurate diagnosis and treatment. Percutaneous management using endoprosthesis is the method of choice, since the patients are usually elderly and have comorbidities that would increase the complication rates of traditional surgery. A 78-year-old woman complaining of thoracic pain was admitted to the hospital; her pain had been radiating to the interscapular and left lumbar regions for four months. Upon diagnostic investigation, a penetrating aortic ulcer was found, and after being successfully treated percutaneously with stent implantation, the patient became asymptomatic and is under outpatient follow-up.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Proíbo, logo assisto</s1>
</fA08>
<fA08 dir="en">
<s1>I forbid, therefore I assist</s1>
</fA08>
<fA11 dir="011000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>283-286</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Revascularização do miocárdio sem circulação extracorpórea</s1>
</fA08>
<fA08 dir="en">
<s1>Myocardial revascularization without extracorporeal circulation</s1>
</fA08>
<fA11 dir="011000">
<s1>Enio Buffolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>287-288</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Embolia pulmonar gordurosa durante cirurgia ortopédica monitorada por ecocardiograma transesofágico</s1>
</fA08>
<fA08 dir="en">
<s1>Fat pulmonary embolism during orthopedic surgery monitored through transesophageal echocardiogram</s1>
</fA08>
<fA11 dir="011000">
<s1>João Mansur Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gustavo Luiz Gouvêa de Almeida Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Kezen Camilo Jorge</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Serafin Gomes Sá Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>João Renato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Alcino Affonseca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Samaritano  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>289-289</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500412</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Homem de 88 anos de idade com edema agudo dos pulmões, choque cardiogêncio e novo sopro holossistólico de aparecimento recente</s1>
</fA08>
<fA08 dir="en">
<s1>A 88 year-old man with acute pulmonary edema, cardiogenic schock and holosystolic murmur of recent onset</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Eduardo Cordeiro Barreto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jussara Bianchi Castelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>290-294</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500413</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Ablação por cateter da fibrilação atrial: técnicas e resultados</s1>
</fA08>
<fA08 dir="en">
<s1>Catheter ablation of atrial fibrillation: techniques and results</s1>
</fA08>
<fA11 dir="011000">
<s1>Mauricio Ibrahim Scanavacca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eduardo Sosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>295-301</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500414</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Correção</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>302-302</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500415</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Indicadores de saúde no Brasil</s1>
</fA08>
<fA08 dir="en">
<s1>Health indicators in Brazil</s1>
</fA08>
<fA11 dir="011000">
<s1>Aloyzio Cechella Achutti</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Academia Sul-Rio-Grandense de Medicina  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital Moinhos de Vento Instituto de Educação e Pesquisa </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>303-304</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Mortalidade compensada por doenças cardiovasculares no período de 1980 a 1999 - Brasil</s1>
</fA08>
<fA08 dir="en">
<s1>Balanced cardiovascular disease mortality from 1980 to 1999 - Brazil</s1>
</fA08>
<fA11 dir="011000">
<s1>Gláucia Maria Moraes Oliveira</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nelson Albuquerque Souza e Silva</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Henrique Klein</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Escola Nacional de Saúde Pública  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Secretaria de Estado de Saúde do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>305-313</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>34</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar comparativamente a evolução das mortalidades por doenças do aparelho circulatório (DAC), doenças isquêmicas do coração (DIC) e cerebrovasculares (DCBV), no estados do Rio de Janeiro (RJ), São Paulo (SP) e Rio Grande do Sul (RS), e suas capitais, no período 1980-1999. MÉTODOS: Os dados relativos a óbitos por DAC provieram do Datasus, e os das populações, do IBGE. Calcularam-se taxas de mortalidade brutas e ajustadas, por sexo e idade, pelo método direto (população padrão: maiores de vinte anos do Estado do RJ, em 2000). Em razão do crescimento relevante da mortalidade por causas mal definidas no município e no Estado do RJ, a partir de 1990, procedeu-se à compensação dos óbitos preliminares aos ajustamentos. As tendências foram analisadas com regressões lineares. RESULTADOS: Os declínios anuais da mortalidade, compensados e ajustados, variaram de -11,3 óbitos por DAC, por cem mil habitantes, no município e no Estado do RJ, até -7,4 no município de SP. As DIC foram semelhantes no Estado e município do RJ e em Porto Alegre, sendo menores no município de SP (-2,5 óbitos por cem mil habitantes). Nas DCBV, a variação observada foi de -6,0 a -2,8 óbitos por cem mil habitantes, no Estado do RJ e em Porto Alegre, respectivamente. CONCLUSÃO: Observaram-se declínios das taxas de mortalidade compensadas e ajustadas por DAC, DIC e DCBV, no período 1980-1999, nos três estados e capitais. No RJ, Estado e município, os declínios das DIC foram nítidos a partir de 1990, enquanto as DCBV mostraram quedas em todo o período.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare trends in mortality rates from cardiovascular diseases (CVD), ischemic heart diseases (IHD) and cerebrovascular diseases (CBVD) in the States of Rio de Janeiro (RJ), São Paulo (SP) and Rio Grande do Sul (RS) and respective capitals from 1980 to 1999. METHODS: Data regarding CVD deaths were obtained from Datasus, and those regarding populations were obtained from IBGE. Crude and sex and age-adjusted mortality rates were calculated using the direct method (standard population: State of Rio de Janeiro's population twenty years of age or older in 2000). Because of the relevant increase in mortality from ill-defined causes in the city and State of RJ as of 1990, the deaths were balanced prior to adjustments. The trends were analyzed using linear regressions. RESULTS: Annual declines of balanced and adjusted mortality ranged from -11.3 CVD deaths/100,000 inhabitants in the city and State of RJ to -7.4 in the city of SP. IHD mortality rates were similar in the State and city of RJ and in Porto Alegre, and lower in the city of SP (-2.5 deaths/100,000 inhabitants). CBVD mortality rates ranged from -6.0 to -2.8 deaths/100,000 inhabitants in the State of RJ and in Porto Alegre, respectively. CONCLUSION: A decline in balanced and adjusted CVD, IHD and CBVD mortality rates was observed from 1980 to 1999 in the three States and capitals. In the State and city of RJ declines in IHD were clear as of 1990, whereas declines in CBVD occurred throughout the period studied.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tendência</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mortalidade</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doenças cardiovasculares</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>trend</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular diseases</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação clínico-cardiológica e ecocardiográfica, seqüencial, em crianças portadoras da síndrome de Marfan</s1>
</fA08>
<fA08 dir="en">
<s1>Serial clinical and echocardiographic evaluation in children with Marfan syndrome</s1>
</fA08>
<fA11 dir="011000">
<s1>Victor Manuel Oporto Lopez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ana Beatriz Alvarez Perez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Valdir Ambrósio Moisés</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Lourdes Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Patricia da Silveira Pedreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Célia C. Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Orlando Campos Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Antônio Carlos C. Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>314-318</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Descrever a apresentação clínica cardiológica e a evolução temporal, estimar a incidência de ectasia ânulo-aórtica e de prolapso da valva mitral, e avaliar a tolerância e a efetividade dos betabloqueadores em crianças com síndrome de Marfan. MÉTODOS: Foram submetidas a exame clínico e ecocardiográfico seriado, durante um ano, 21 crianças com síndrome de Marfan. No ecocardiograma foram analisados: presença de prolapso mitral, diâmetro da raiz aórtica, refluxos das valvas mitral e aórtica, e o crescimento dos diâmetros aórticos na vigência de betabloqueadores. Em 11 pacientes foi possível obter duas medidas da raiz aórtica no intervalo de um ano. RESULTADOS: Durante o estudo as crianças não apresentaram sintomas. Prolapso mitral foi encontrado em 11 (52%) crianças. Ectasia ânulo-aórtica ocorreu em 16 (76%) pacientes, sendo de grau discreto em 42,8%, moderado em 9,5%, e importante em 23,8%. Um desses pacientes foi submetido com sucesso à cirurgia de Bentall DeBono. Com o uso de betabloqueador a freqüência cardíaca diminuiu 13,6% (de 85 para 73 bpm; p &lt; 0,009), mas houve um crescimento da raiz aórtica de 1,4 mm/ano (p &lt; 0,02). Uma criança não pôde receber betabloqueador em razão de asma brônquica, e não foram observados efeitos colaterais significativos nas outras crianças, incluindo uma com asma brônquica. CONCLUSÃO: Os resultados obtidos sugerem que, no período observado, as crianças permaneceram assintomáticas, o uso de betabloqueadores diminuiu significativamente a freqüência cardíaca e não se acompanhou de efeitos adversos significativos. Ao contrário da literatura, a incidência de ectasia ânulo-aórtica foi elevada e maior do que a de prolapso valvar mitral, tendo crescimento mesmo na vigência de uso eficaz de betabloqueador.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To describe the clinical cardiac manifestations and temporal evolution of Marfan syndrome in children; to estimate the incidence of annuloaortic ectasia and mitral valve prolapse; and to evaluate tolerability and efficacy of beta-blockers in these patients. METHODS: During one year, 21children with Marfan syndrome underwent serial clinical and echocardiographic examinations. Echocardiograms assessed: the presence of mitral valve prolapse, aortic root diameter, mitral and aortic valves regurgitation, and aortic enlargement during beta-blocker therapy. Eleven patients had two measurements of the aortic root taken one year apart. RESULTS: The children were asymptomatic throughout the study. Mitral prolapse was found in 11 (52%) children. Annuloaortic ectasia occurred in 16 (76%) patients and found to be mild in 42.8%, moderate in 9.5%, and severe in 23.8%. One of these patients underwent aortic valve replacement and repair of the ascending aorta by the Bentall-De Bono technique, with good results. Heart rate decreased by 13.6% (from 85 to 73 bpm; p &lt; 0.009) with the use of beta-blockers; however, aortic root diameter increased by 1.4 mm/year (p&lt;0.02). One child could not be given beta-blockers due to bronchial asthma, and no significant side effects were observed in the remaining children, including one who also had bronchial asthma. CONCLUSION: The children remained asymptomatic throughout the study, the use of beta-blockers led to a significant decrease in heart rate, and no significant adverse effects were observed. Contrary to the literature, incidence of annuloaortic ectasia was high among the study population, greater than that of mitral valve prolapse, even during beta-blocker therapy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>síndrome de Marfan</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aneurisma de aorta torácica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prolapso da valva mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia com Doppler</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Marfan syndrome</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thoracic aortic aneurysm</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral valve prolapse</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Doppler echocardiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Depressão e síndromes isquêmicas miocárdicas instáveis: diferenças entre homens e mulheres</s1>
</fA08>
<fA08 dir="en">
<s1>Depression and acute coronary syndromes: gender-related differences</s1>
</fA08>
<fA11 dir="011000">
<s1>Glória Heloise Perez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Carlos Nicolau</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Bellkiss Wilma Romano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ronaldo Laranjeira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Instituto do Coração do Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>319-326</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Investigar, em portadores de Síndromes Isquêmicas Miocárdicas Instáveis (SIMI) estratificados por sexo, se características sociodemográficas, diagnóstico clínico, tabagismo, consumo de álcool e ansiedade estão associados com depressão. MÉTODOS: Foram entrevistados 345 pacientes consecutivos com SIMI (206 com infarto agudo do miocárdio e 139 com angina instável). As entrevistas incluíram questões sobre características sociodemográficas, tabagismo, avaliação de depressão (Prime MD e BDI), de ansiedade traço e ansiedade estado (IDATE), e de consumo de álcool (AUDIT). RESULTADOS: O diagnóstico de depressão se correlacionou, significativamente, com sexo feminino, idade inferior a 50 anos e escores médios mais elevados de ansiedade traço e ansiedade estado. Os homens (245) com depressão eram freqüentemente mais jovens que 50 anos, fumantes, e apresentavam escore médio de ansiedade traço e ansiedade estado mais elevado que os não deprimidos. A análise multivariada aponta que, no sexo masculino, idade está negativamente associada (OR 0,9519, 95% IC 0,9261 - 0,9784) e escores mais altos de ansiedade traço estão positivamente associados (OR 1,0691 95% IC 1,0375 - 1,1017) com depressão. Na amostra feminina (100), mulheres com depressão diferenciam-se das sem depressão por apresentarem escore médio mais alto de ansiedade traço e de ansiedade estado. Na análise multivariada da amostra feminina, escore mais alto de ansiedade traço associou-se de forma independente à depressão (OR 1,1267 95% IC 1,0632-1,1940). CONCLUSÃO: Conclui-se que, em pacientes hospitalizados com SIMI, as mulheres, os homens com menos de 50 anos e os ansiosos têm mais chance de apresentarem depressão.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Investigate whether social and demographic characteristics, clinical diagnosis, smoking status, alcohol consumption, and anxiety are associated with depression in patients with Acute Coronary Syndromes (ACS) stratified by gender. METHODS: Three hundred forty-five consecutive patients with unstable myocardial ischemic syndrome (206 with myocardial infarction and 139 with unstable angina) were interviewed. The interviews included questions about sociodemographics, smoking status, screening for depression (Prime MD e BDI), trait and state anxiety, (IDATE), and alcohol consumption (AUDIT). RESULTS: Diagnosis of depression has significantly correlated with female gender, age under 50 years, and higher average scores on trait anxiety and state anxiety. Depressed men (245) were usually younger than 50 years of age, smokers and had higher average score on trait anxiety and state anxiety than those non-depressed. The multivariate analysis highlights that age is negatively associated with depression (OR 0.9519 95% CI 0.9261 - 0.9784) and that higher scores on trait anxiety are positively associated (OR 1.0691 95% CI 1.0375 - 1.1017) with depression in the male gender. In the female sample (100), depressed women differ from non-depressed women in that they have a higher average score on trait anxiety and state anxiety. In the multivariate analysis of the female sample, a higher score on trait anxiety was independently associated with depression (OR 1.1267 95% CI 1.0632 - 1.1940). CONCLUSION: It was concluded that, among hospitalized patients with ACS, women, as well as men under 50 years and who suffer from anxiety are more likely to experience depression.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>depressão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angina instável</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ansiedade</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>depression</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>unstable angina</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>anxiety</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Tendência da mortalidade por insuficiência cardíaca em Salvador, Bahia, Brasil</s1>
</fA08>
<fA08 dir="en">
<s1>Heart failure mortality trend in Salvador, Bahia, Brazil</s1>
</fA08>
<fA11 dir="011000">
<s1>Adriana Lopes Latado</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Carlos Santana Passos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rodrigo Guedes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alessandra B. Santos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marianna Andrade</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Simone Moura</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Secretaria de Saúde da Bahia  </s1>
<s2>Salvador BA</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>327-332</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a tendência da mortalidade por insuficiência cardíaca (IC) em Salvador - Bahia, no período de 1979-1995. MÉTODOS: A IC foi definida pelas notações da 9ª Revisão do Código Internacional de Doenças (CID9) 428.0, 428.1 e 428.9. Dados de óbitos por IC e populacionais (região metropolitana de Salvador) foram obtidos por meio da Secretaria de Saúde da Bahia e do Instituto Brasileiro de Geografia e Estatística. As taxas de mortalidade (/100.000) foram totais ou por gênero e idade, e brutas ou ajustadas por idade (padronização direta). RESULTADOS: As taxas de mortalidade por IC sofreram redução progressiva no período de tempo avaliado, para ambos os gêneros, especialmente até o ano de 1992. A partir daí e até 1995, ocorreu uma aparente estabilização das curvas. A taxa de mortalidade bruta passou de 25,0/10(5), em 1979, para 16,4/10(5) habitantes, em 1995 (queda de 34,4%). A redução foi de 34,0% (23,3/10(5), em 1979, para 15,4/10(5) habitantes, em 1995) para o sexo masculino e de 35,2% (26,7/10(5), em 1979, para 17,3/10(5) habitantes, em 1995), para o sexo feminino. A mesma tendência ocorreu nas diversas faixas etárias, inclusive para a população &gt; 40 anos, de maior risco para IC. Após o ajuste por idade (população padrão de 1979), observa-se que as reduções relativas nas taxas foram ainda maiores. CONCLUSÃO: A mortalidade por IC, em Salvador-Bahia, declinou de 1979 a 1992, estabilizando-se a partir de então até 1995.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess mortality trend due to heart failure (HF) in Salvador - Bahia, from 1979 to 1995. METHODS: HF was defined by notations from the 9th Review of International Disease Code (IDC9) 428.0, 428.1 and 428.9. HF death and population data (metropolitan area of Salvador) were obtained by means of Secretaria de Saúde da Bahia (Bahia State Health Secretariat) and Instituto Brasileiro de Geografia e Estatística (Brazilian Institute of Geography and Statistics). Mortality rates (/100,000) were total or per gender and age, and gross or adapted per age (straight standardization). RESULTS: Mortality rates due to HF had a progressive reduction in the period of time assessed, for both genders, especially up to 1992. From then and up to 1995, there was an apparent stabilization of the curves. Gross mortality rate went from 25.0/10(5), in 1979, to 16.4/10(5) inhabitants, in 1995 (a decrease of 34.4%). The reduction was 34.0% (23.3/10(5), in 1979, to 15.4/10(5) inhabitants, in 1995) for male sex and 35.2% (26.7/10(5), in 1979, to 17.3/10(5) inhabitants, in 1995), for female sex. The same trend took place in several age ranges, including the population &gt; 40 years old, which has a greater risk for HF. After adaptation per age (standard population of 1979), it is observed that relative reductions in the rates were even greater. CONCLUSION: Mortality due to HF, in Salvador-Bahia, decreased from 1979 to 1992, becoming stable from then to 1995.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mortalidade</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>epidemiologia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mortality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Demonstração do mecanismo da terapia de ressincronização ventricular com ecocardiografia tridimensional em tempo real em paciente com insuficiência cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Mechanism of cardiac resynchronization therapy by real-time three-dimensional echocardiography in patients with heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo Luiz Campos Vieira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Prasad V. Maddukuri</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Robert S. Phang</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Natesa G. Pandian</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Wilson Mathias Júnior</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José A. F. Ramires</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Instituto do Coração do Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Tufts University New England Medical Center </s1>
<s2>Boston MA</s2>
<s3>EUA</s3>
</fA14>
<fA20 dir="000000">
<s1>333-336</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>8</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Relatamos caso de homem de 66 anos de idade portador de insuficiência cardíaca classe funcional (NYHA) IV que foi submetido a terapia de ressincronização cardíaca por implante de marcapasso biventricular. O paciente foi avaliado antes e 48 horas após o implante do marcapasso com o emprego da ecocardiografia tridimensional transtorácica em tempo real. A utilização da ecocardiografia tridimensional contribuiu para o entendimento do mecanismo envolvido na ressincronização cardíaca através da demonstração da melhor sincronização dos segmentos cardíacos, o que resultou em melhora clínica do paciente.</s0>
</fC01>
<fC01 dir="en">
<s0>We report the case of a 66-year-old man with heart failure NYHA class IV treated with biventricular pacing for cardiac resynchronization. The patient was evaluated by real-time three-dimensional transthoracic echocardiography before and 48 hours after pacemaker implantation. The use of three-dimensional echocardiography contributed to understanding the underlying mechanism involved in cardiac resynchronization therapy by demonstrating enhanced synchrony of myocardial segments, which resulted in the patient's clinical improvement.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Fístula de enxerto coronariano da artéria torácica interna esquerda para artéria pulmonar esquerda após cirurgia de revascularização miocárdica: causa rara de isquemia miocárdica</s1>
</fA08>
<fA08 dir="en">
<s1>Left internal thoracic artery to left pulmonary artery fistula after coronary artery bypass graft surgery: a rare cause of myocardial ischemia</s1>
</fA08>
<fA11 dir="011000">
<s1>Gustavo Luiz Gouvêa de Almeida Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Kezen Camilo Jorge</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Augusto César de Araújo Neno</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fernanda Beloni dos Santos Nogueira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Bruno Hellmuth</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Roberto Hugo da Costa Lins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Renato Vilella</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Valdo José Carreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Ivo Thadeu</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>José Pedro da Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Casa de Saúde São José  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>337-339</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>6</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Descrevemos o caso de um paciente que, seis anos após cirurgia de revascularização do miocárdio, desenvolveu dispnéia aos pequenos esforços. Foi documentada isquemia miocárdica por método de medicina nuclear e a cineangiocoronariografia mostrou todos os enxertos patentes com grande fístula da artéria torácica interna esquerda para artéria pulmonar esquerda. O paciente foi tratado com fechamento cirúrgico da fístula, tendo ótima evolução pós-operatória.</s0>
</fC01>
<fC01 dir="en">
<s0>We report a patient who developed dyspnea on mild exertion six years after coronary artery bypass graft surgery (CABG). Myocardial ischemia was documented by radionuclide imaging, and coronary angiography showed patency of all grafts and a large fistula between the left internal thoracic artery (LITA) and the left pulmonary artery (LPA). The patient was submitted to surgical closure of the fistula and made an excellent recovery.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Aneurisma de artéria coronária um ano e cinco meses pós-implante de stent com eluição de sirolimus</s1>
</fA08>
<fA08 dir="en">
<s1>Coronary artery aneurysm one year and five months after sirolimus-eluting stent placement</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciano Abreu</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>George César Ximenes Meireles</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Artur Forte</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcos Sumita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Jorge Hayashi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>José Solano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Stella Maris Departamento de Cardiologia </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>340-342</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Paciente de 52 anos de idade, do sexo masculino, com diagnóstico de angina instável pós-infarto. A angiografia coronariana revelou obstrução luminal de 90% no terço médio da artéria coronária direita e de 90% no ramo marginal da artéria circunflexa. Após o uso de clopidogrel 300 mg associado ao ácido acetilsalicílico, o paciente foi submetido a implante de stent com eluição de sirolimus (CYPHER; Johnson&amp;Johnson-Cordis) 2,5 x 18 mm, na lesão do ramo marginal esquerdo. Após um ano e cinco meses do implante do stent CYPHER, foi observada em nova angiografia a presença de aneurisma coronariano intra-stent, no ramo marginal esquerdo. O presente relato sugere que o implante de stent coronariano revestido com sirolimus pode ocasionar, tardiamente, a formação de aneurisma da artéria coronária.</s0>
</fC01>
<fC01 dir="en">
<s0>A 52-year-old man with diagnosis of post-infarction unstable angina. Coronary angiography revealed 90% luminal obstruction in the middle third of the right coronary artery and 90% in the marginal branch of the circumflex artery. After the administration of clopidogrel 300 mg associated with acetylsalicylic acid, the patient underwent the implantation of a sirolimus-eluting stent (CYPHER; Johnson &amp; Johnson Cordis) 2.5 x 1.8 mm in the lesion located at the left marginal branch. One year and five months after the CYPHER stent implantation, a new angiography showed intrastent coronary aneurysm at the left marginal branch. This case report suggests that the implantation of a sirolimus-coated coronary stent may cause late formation of coronary artery aneurysm.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Pseudo-aneurisma femoral micótico após onze anos de cateterismo</s1>
</fA08>
<fA08 dir="en">
<s1>Mycotic femoral pseudoaneurysm after 11 years of catheterism</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcello Barbosa Barros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Arturo Almazán</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Francisco S. Lozano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de Salamanca Hospital Universitário de Salamanca Unidade de Cirurgia Vascular</s1>
<s2>Salamanca </s2>
<s3>Espanha</s3>
</fA14>
<fA20 dir="000000">
<s1>343-345</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Relatamos o caso incomum de um alpinista de 52 anos que apresentava dor e edema em sua coxa direita, o que revelou ser um pseudoaneurisma micótico roto, sem histórico de trauma recente ou outra causa aparente. O paciente relatou uma história de infarto do miocárdio onze anos antes, com a realização de dois cateterismos femorais para cineangiocoronariografia. Ele negou qualquer episódio de febre ou diagnóstico de bacteremia naquele momento ou mais tarde, como também outra queixa durante esses onze anos. A raridade do caso, a aparência dessa complicação extremamente tardia, juntamente com o tipo de atividade esportiva do paciente sugeriram-nos publicar o caso.</s0>
</fC01>
<fC01 dir="en">
<s0>The authors report the unusual case of a 52-year-old mountain climber that presented with pain and swelling in his right thigh which revealed to be a ruptured mycotic pseudoaneurysm with no history of recent trauma or other apparent cause. The patient reported a past history of myocardial infarction 11 years before, with the performing of two femoral catheterisms for coronary angiography. He denied any episode of fever or diagnosis of bacteraemia at that time or later, nor any other complaint during these 11 years. The rarity of the case, the appearance of this extremely late complication together with the patient's kind of sportive activity prompted us to publish the case.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Fístula aorta-ventrículo direito: uma complicação inesperada da endocardite bacteriana</s1>
</fA08>
<fA08 dir="en">
<s1>Aorta-right ventricle fistula: an unexpected complication of bacterial endocarditis</s1>
</fA08>
<fA11 dir="011000">
<s1>Gustavo Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Reinaldo B. Bestetti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Moacir Godoy</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Patrícia Cury</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antônio C. Leme Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de São José do Rio Preto Hospital de Base </s1>
<s2>São José do Rio Preto SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>346-347</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Cuidando da hipertensão no consultório</s1>
</fA08>
<fA08 dir="en">
<s1>Treating hypertension in the doctor's office</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo César B. Veiga Jardim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Goiás Faculdade de Medicina </s1>
<s2>Goiânia GO</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>348-349</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Visita à imunologia</s1>
</fA08>
<fA08 dir="en">
<s1>Visiting immunology</s1>
</fA08>
<fA11 dir="011000">
<s1>Nelson Monteiro Vaz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Vitor Pordeus</s1>
<afiliation>A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFMG ICB Departamento de Bioquímica e Imunologia</s1>
<s2>Belo Horizonte MG</s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Centro de Ensino e Pesquisa do Hospital Pró-Cardíaco  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>350-362</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500512</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Manifestações cardiovasculares em pacientes com infecção pelo vírus da imunodeficiência humana</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiovascular manifestations in patients infected with the human immunodeficiency virus</s1>
</fA08>
<fA11 dir="011000">
<s1>Ludhmila Abrahão Hajjar</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Daniela Calderaro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Pai Ching Yu</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Isabela Giuliano</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Enéas Martins de Oliveira Lima</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Giuseppe Barbaro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Bruno Caramelli</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Instituto do Coração do Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>University La Sapienza Department of Medical Pathophysiology </s1>
<s2>Roma </s2>
<s3>Itália</s3>
</fA14>
<fA20 dir="000000">
<s1>363-377</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500513</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Introdução</s1>
</fA08>
<fA11 dir="011000">
<s1>Dikran Armaganijan</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>0-0</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Pré-congresso - Temas livres - 17/09/05</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-8</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500002</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Temas livres - 18/09/05</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>9-46</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500003</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Temas livres - 19/09/05</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>47-90</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500004</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Temas livres - 20/09/05</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>91-134</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500005</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Temas livres - 21/09/05</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>135-162</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500006</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Enfermagem - oral - 18/09/05</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>163-163</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500007</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Enfermagem - oral - 19/09/05</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>164-165</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500008</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Enfermagem - mural - 19/09/05</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>166-170</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500009</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Nutrição - 18 e 19/09/05</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>171-173</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500010</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Fisioterapia - oral - 20/09/05</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>174-176</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500011</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Psicologia - oral - 20/09/05</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>177-177</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500012</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Fisioterapia - oral - 21/09/05</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>178-178</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500013</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Editorial</s1>
</fA08>
<fA11 dir="011000">
<s1>Hermes Toros Xavier</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>4-4</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Periodicidade e escolha de exames laboratoriais na terapia hipolipemiante</s1>
</fA08>
<fA08 dir="en">
<s1>Special recommendations for lipid-lowering treatment: efficacy and safety</s1>
</fA08>
<fA11 dir="011000">
<s1>Tania Leme da Rocha Martinez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Helena Maria do Nascimento</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP HCFM Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>6-8</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>16</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500002</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Intervenções farmacológicas com hipolipemiantes devem ser monitoradas periodicamente para avaliar eficácia e parâmetros de segurança. As estatinas são drogas normalmente bem toleradas e os seus principais efeitos colaterais incluem aumento das enzimas hepáticas (AST e ALT) e muscular (CK). O tratamento deve ser interrompido ou diminuído no caso de um aumento significativo das AST ou ALT (&gt; 3x LSN), ou CK (&gt; 10x LSN). Outros agentes hipolipemiantes também podem produzir hepatotoxicidade ou miosite, fibratos e ácido nicotínico, especialmente em associação com as estatinas ou na presença de anormalidades metabólicas (tireoidite, hepatopatia e nefropatia). Ácido nicotínico pode também aumentar os níveis plasmáticos de glicose e ácido úrico. Testes laboratoriais podem ser utilizados no seguimento da terapia hipolipemiante e devem ser repetidos a cada três meses durante o primeiro ano e então em intervalos de seis meses. Intervalos menores são recomendados para casos especiais.</s0>
</fC01>
<fC01 dir="en">
<s0>Pharmacologic lipid-lowering interventions should be monitored periodically to assess efficacy and safety parameters. Statins are usually well-tolerated drugs and major side effects include increased serum liver and muscle enzymes (AST, ALT, CK). Treatment should be stopped or diminished in case of significant increase of AST or ALT (&gt; 3x ULN), or CK (&gt; 10x ULN). Other lipid lowering agents may also produce hepatotoxicity or myositis, especially in association with statins (fibrates and nicotinic acid) or in presence of metabolic abnormalities (thyroid, liver or renal disorders). Nicotinic acid can also increase glucose and uric acid plasma levels. Laboratory tests might be performed prior to hypolipidemic drug treatment and should be repeated every three months during the first year and then at 6-mo intervals. Shorter intervals should be recommended in individual cases.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Estatinas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>segurança</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hepatotoxicidade</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Statins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>safety</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hepatotoxicity</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Farmacocinética das estatinas</s1>
</fA08>
<fA08 dir="en">
<s1>Pharmacokinetics of statins</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco Antonio Helfenstein Fonseca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP EPM Setor de Lípides, Aterosclerose e Biologia Vascular</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>9-14</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500003</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>As estatinas são agentes hipolipemiantes que exercem os seus efeitos através da inibição da HMG-CoA redutase, enzima fundamental na síntese do colesterol, levando a uma redução do colesterol tecidual e um conseqüente aumento na expressão dos receptores de LDL. Existem consideráveis diferenças entre as estatinas, no que tange às propriedades farmacocinéticas, bem como ao coeficiente de hidrofilicidade, via hepática de metabolização (especialmente, do citocromo P450 e isoenzimas), meia-vida plasmática e eficácia na redução lipídica. As estatinas também podem diferir na capacidade de interação com outras drogas que utilizam a mesma via de metabolização. Recentemente, muitos efeitos pleiotrópicos têm sido relatados com estas drogas, bem como propriedades antiinflamatórias, melhora na função endotelial e benefícios na hemostasia.</s0>
</fC01>
<fC01 dir="en">
<s0>Statins are lipid lowering agents that promote their effects on plasma lipids through the inhibition of HMG-CoA reductase, a crucial enzyme in the cascade of cholesterol synthesis, leading to reduction of tissue cholesterol pool and consequently, to an upregulation of the LDL receptor expression. There are considerable differences among statins regarding some pharmacokinetic properties, such as the coefficient of hydrophilicity, via liver metabolism (especially regarding P450 cytochrome and isoenzymes), plasma half-life and efficacy of serum lipid changes. They may also differ regarding interactions with other drugs that share the same pathway of metabolism. Recently, many pleiotropic effects have been reported with these drugs, such as anti-inflammatory properties, improvement in endothelial function and benefits on hemostasis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Estatinas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>farmacocinéticas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>interação com drogas</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Statins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pharmacokinetics</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>drug interactions</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Farmacologia do fibratos</s1>
</fA08>
<fA08 dir="en">
<s1>Pharmacology of fibrates</s1>
</fA08>
<fA11 dir="011000">
<s1>Hermes Toros Xavier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNILUS Faculdade de Ciências Médicas de Santos Divisão de Moléstias Cardiovasculares</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>15-16</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500004</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Os fibratos são as drogas de escolha nas hipertrigliceridemias. Após sua absorção, os fibratos são metabolizados pelo fígado, utilizando isoenzimas P450 não compartilhadas pelas estatinas. Entretanto, para alguns fibratos, como o genfibrozil, uma interação com estatinas pode ocorrer durante a sua glucuronidação, ou pelo deslocamento de frações livres de estatina ligadas às proteínas plasmáticas. A vida-média plasmática é variável entre os fibratos (2-80 h). Recentemente, foi demonstrado que os fibratos promovem suas ações lipídicas pelo estímulo dos PPAR-alfa. Através dessa ação, existe um incremento na transcrição de alguns genes relacionados com o metabolismo lipídico, como a LLP, APOAI, APOAII, ABCA-1, bem como uma diminuição na expressão da APOCIII, e muitas outras ações.</s0>
</fC01>
<fC01 dir="en">
<s0>Fibrates are drugs commonly used in hypertriglyceridemias. After their absorption, fibrates are metabolized by the liver, using P450 isoenzymes not shared by statins. However, for some fibrates, such as genfibrozil, an interaction with statins can occur during their liver glucuronidation, or by displacement of free fraction of statins linked to proteins in plasma. Plasma half-life is variable among fibrates (2-80 h). Recently it has been shown that fibrates produce plasma lipid changes mainly by stimulating peroxisome-proliferation activation receptors alpha. Through this action, there is an increase in the transcription of some genes related to lipid metabolism, such as LLP, APOAI, APOAII, ABCA-1, as well as decrease in the expression of APOCIII, and many other actions.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Fibratos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>farmacologia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>metabolismo lipídico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Fibrates</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pharmacology</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipid metabolism</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Farmacologia da niacina ou ácido nicotínico</s1>
</fA08>
<fA08 dir="en">
<s1>Pharmacology of niacin or nicotinic acid</s1>
</fA08>
<fA11 dir="011000">
<s1>Raul D. Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP HCFM InCor</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>17-19</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500005</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Niacina ou ácido nicotínico é uma vitamina solúvel com propriedades hipolipemiantes. Niacina reduz triglicérides (20% - 50%), LDL (5% - 25%), e aumenta HDL (15% - 35%). O estudo Coronary Drug Project mostrou que o uso de niacina foi associado com redução de eventos coronários e mortalidade total, e mais recentemente, foi demonstrado que niacina combinada com outras drogas hipolipemiantes pode atenuar a progressão da aterosclerose coronária. A niacina parece reduzir a mobilização de ácidos graxos livres dos adipócitos, agindo em receptores específicos, diminuindo a formação de lipoproteínas ricas em triglicérides pelo fígado. Existem duas formas de niacina, uma de absorção rápida (cristalina), mais comumente associada com flushing, e outra de liberação extendida, recentemente referida como de melhor tolerabilidade. O uso de niacina pode associar-se com dispepsia, aumento dos níveis plasmáticos de enzimas hepáticas e também com modestas elevações na glicose e ácido úrico, ao menos na utilização de doses até 2g / dia da forma de liberação prolongada.</s0>
</fC01>
<fC01 dir="en">
<s0>Niacin or nicotinic acid is a soluble vitamin with hypolipidemic properties. Niacin reduces triglycerides (20 50%), LDL-c (5-25%), and raises HDL c (15-35%). The Coronary Drug Project study showed that the use of niacin was associated with reduction on coronary events and total mortality, and more recently it has been demonstrated that niacin combined with other hypolipidemic drugs can attenuate the progression of coronary atherosclerosis. Niacin appears to reduce the mobilization of free fatty acids from the adipocytes, acting on specific receptors, diminishing the liver formation of triglyceride-rich lipoproteins. There are two forms of niacin, one of rapid absorption (crystalline), more commonly associated with flushing, and another of extended release, recently reported to be better tolerated. The use of niacin can be associated with dyspepsia, increased plasma levels of liver enzymes and also with a modest elevation in glucose and uric acid plasma levels, at least using the extended-release preparation up to 2g/d.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Niacina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ácido nicotínico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dislipidemia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Niacin</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nicotinic acid</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dyslipidemia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Ezetimiba: farmacocinética e terapêutica</s1>
</fA08>
<fA08 dir="en">
<s1>Ezetimibe: pharmacokinetics and therapeutics</s1>
</fA08>
<fA11 dir="011000">
<s1>Renata G. Araújo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio Casella Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Antonio Carlos P. Chagas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP HCFM Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>20-24</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>52</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500006</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Ezetimiba é um inibidor da absorção do colesterol que é glucuronidado no fígado após sua rápida absorção nos enterócitos, onde juntamente com os seus metabólitos, exerce as suas ações hipolipidêmicas, reduzindo a absorção do colesterol através da inibição do transporte do colesterol por enzimas transportadoras específicas. Esta droga pode ser utilizada uma vez ao dia, em função de sua meia-vida plasmática prolongada e normalmente é muito bem tolerada. A eliminação da ezetimiba e de seus metabólitos é feita principalmente pela excreção fecal. Em geral, o uso da ezetimiba isolada promove modestos efeitos no LDL plasmático, entretanto, quando combinada às estatinas, importantes mudanças no perfil lipídico podem ser observadas.</s0>
</fC01>
<fC01 dir="en">
<s0>Ezetimibe is an inhibitor of cholesterol absorption that is liver glucuronized after its rapid absorption, and is mobilized to the enterocytes, where together with its metabolites it exerts hypolipidemic effects, avoiding the absorption of cholesterol, through the reduction of specific cholesterol-transporter enzymes in the gut. This drug can be given once daily due to its prolonged plasma half-life, and is usually very well-tolerated. Elimination of ezetimibe and its metabolites is mainly via fecal excretion. In general, the use of ezetimibe alone promotes modest effects on plasma LDL-c, however, when combined with statins, a remarkable change in the lipid profile can be observed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Ezetimiba</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>matabolismo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estatina</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Ezetimibe</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>metabolism</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>statin</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Mecanismos de hepatotoxicidade</s1>
</fA08>
<fA08 dir="en">
<s1>Mechanisms of hepatotoxicity</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo Chiara Bertolami</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia Secretaria de Estado da Saúde de São Paulo </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>25-27</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500007</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Hepatopatia relacionada ao uso de drogas hipolipemiantes tem sido definida como um dano celular (aumento das enzimas AST e ALT) sem alterações colestáticas (aumento de bilirrubinas e/ou fosfatase alcalina). Seis mecanismos são propostos para a hepatopatia: 1. Reações de alta energia no citocromo P450 comprometendo a homeostase do cálcio com a ruptura de fibrilas intracelulares e lise de hepatócitos. 2. Disfunção de proteínas transportadoras relacionadas com o fluxo de ácidos biliares (mecanismo proposto para a toxicidade hepática dos fibratos). 3. Reações imunes geradas pela formação de metabólitos das drogas hipolipemiantes formados no fígado. 4. Hepatoxicidade promovida por células T com inflamação adicional mediada por neutrófilos. 5. Apoptose mediada por TNF e Fas (imune-mediada). 6. Estresse oxidativo gerado por dano a organelas intracelulares. Ainda, idade avançada, consumo excessivo de álcool, altas doses de drogas hipolipemiantes, interação com outros fármacos, e doença hepática ativa prévia podem aumentar a hepatotoxidade.</s0>
</fC01>
<fC01 dir="en">
<s0>Liver disease following the use of hypolipidemic drugs has been reported as a cellular damage (increases in AST or ALT enzymes) without cholestatic alterations (bilirubin and or alkaline phosphatase increases). Six mechanisms were proposed for hepatotoxicity : 1. High energy reactions on P450 cytochrome impairing calcium homestasis with rupture of intracellular fibrils and hepatocyte lysis. 2. Impairment of transporter proteins related to the bile acids flux (mechanism proposed for fibrate liver toxicity). 3. Immune reactions due to the formation of metabolites linked to enzymes following liver metabolism of hypolipidemic drugs. 4. Hepatotoxicity by T cells with additional inflammation mediated by neutrophils. 5. Apoptosis mediated by TNF and Fas (immune mediated). 6. Oxidative stress due to damage of intracellular organelles. In addition, advanced age, alcohol in excess, high doses of hypolipidemic drugs, interaction with other drugs, and previous active liver disease might increase liver toxicity.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Hepatotoxidade</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>metabolismo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tratamento com drogas</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Hepatotoxicity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>metabolism</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>drug treatment</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Terapia hipolipemiante em situações especiais: hipotireoidismo e hepatopatias</s1>
</fA08>
<fA08 dir="en">
<s1>Hypolipidemic therapy in special situations: hypothyroidism and liver disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando H. Y. Cesena</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Hermes Toros Xavier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Protásio L. da Luz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP HCFM Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>28-33</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>45</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500008</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>O hipotireoidismo é comum entre pessoas idosas, especialmente entre as mulheres. A suspeita diagnóstica deve se basear na presença de sinais e sintomas clássicos e a detecção pode ser feita pela elevação dos níveis do hormônio tireo-estimulante (TSH). Anormalidades lipídicas na presença de hipotireoidismo sub-clínico são de menor impacto. Entretanto, a reposição específica de hormônio tireoideano é tão mais importante quanto a magnitude do distúrbio glandular. Na vigência de doença hepática, alguns agentes hipolipemiantes podem levar a um agravamento do quadro, entretanto, estudos recentes têm mostrado que as estatinas podem ser utilizadas na presença de esteatose hepática. Terapia hipolipemiante combinada pode induzir aumentos de enzimas hepáticas e o monitoramento cuidadoso é recomendado nestes pacientes.</s0>
</fC01>
<fC01 dir="en">
<s0>Hypothiroidism is common in the elderly, especially among women. It should be suspected in the presence of classic signals and symptoms, and can be detected by an elevation of serum thyroid stimulating hormone (TSH). Lipid abnormalities in the presence of subclinical hypothiroidsm are of minor importance. However, the importance of specific treatment (hormone replacement) increases with the magnitude of thyroid disturbance. Some hypolipidemic agents can aggravate prior liver disease, however, recent studies have shown that statins might be useful in the presence of steatohepatitis. Some associations of hypolipidemic drugs can increase liver enzymes, and careful monitoring is recommended.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipotireoidismo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hepatopias</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estatina</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypothyroidism</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>liver disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>statins</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Associação de medicamentos: estatinas e fibratos</s1>
</fA08>
<fA08 dir="en">
<s1>Combination of drugs: statins and fibrates</s1>
</fA08>
<fA11 dir="011000">
<s1>Hermes Toros Xavier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNILUS Faculdade de Ciências Médicas de Santos Divisão de Moléstias Cardiovasculares</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>34-35</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>4</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500009</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Monoterapia para o tratamento das dislipidemias é frequentemente insuficiente para o alcance das metas recomendadas pelas diretrizes. Entretanto, nos últimos anos, o uso de terapia combinada tem se apresentado como uma nova opção em muitos casos. Uma revisão de 36 estudos envolvendo a combinação de estatinas com fibratos apresentou 29 casos de rabdomiólise e uma prevalência geral de miopatia de 0,12%. A combinação de estatinas com o genfibrozil parece causar mais rabdomiólise que com os fibratos de nova geração (especialmente quando comparado com fenofibrato ou bezafibrato). Idade avançada, diabetes, mulheres, medicações concomitantes, disfunção renal, consumo excessivo de álcool, exercícios, traumatismos e cirurgias estão também associados com maior risco de efeitos adversos.</s0>
</fC01>
<fC01 dir="en">
<s0>Monotherapy for the treatment of dyslipidemias is commonly insufficient to achieve all lipid targets recommended by current guidelines. Therefore, the use of combined treatment has emerged as a new option in many cases in the last few years. A review of 36 studies in which the combination of statins with fibrates was used revealed 29 cases of rhabdomyolysis with a prevalence of 0,12% in the risk of myopathy. Combination of a statin with genfibrozil appeared to cause more rhabdomyolysis than with newest fibrates (especially when compared with fenofibrate or bezafibrate). Advanced age, diabetes, females, concomitant medications, renal insufficiency, excess in alcohol intake, exercises, trauma and surgery were all associated with higher rates of adverse effects.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Estatinas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fibratos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>rabdomiólise</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Statins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fibrates</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rhabdomyolysis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Combinação de fármacos na abordagem das dislipidemias: associação entre estatinas e niacina</s1>
</fA08>
<fA08 dir="en">
<s1>Combination of drugs: statins and niacin</s1>
</fA08>
<fA11 dir="011000">
<s1>Jairo Lins Borges</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia de São Paulo Seção clínica de Cardiogeriatria </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>36-41</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500010</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>A combinação de estatinas com niacina se apresenta como uma atraente associação, na presença de dislipidemia mista com níveis de HDL baixo, quando monoterapia é insuficiente para o alcance das metas lipídicas. Benefícios clínicos foram observados com a combinação de estatinas com niacina nos estudos FATS, HATS e ARBITER 2, mostrando atenuação no desenvolvimento da aterosclerose e/ou redução de eventos coronários, acompanhados de alterações lipídicas favoráveis. Em geral, esta combinação é bem tolerada. Recomenda-se monitoração adequada das enzimas hepáticas e muscular e, ainda, titulação cuidadosa de cada uma das drogas combinadas.</s0>
</fC01>
<fC01 dir="en">
<s0>Combination of statins with niacin appears to be an attractive association, in the presence of mixed dyslipidemia with low HDL-c levels, when monotherapy is insufficient to achieve target lipid levels. Clinical benefits were observed by the combination of statins with niacin in the FATS, HATS and ARBITER 2 trials, showing attenuation of atherosclerosis development and/or reduction in coronary events following favorable lipid changes. In general, this combination can be well-tolerated. Recommendations for appropriate monitoring of liver and muscle enzymes are important to reduce the rate of side effects. In addition, careful titration of each drug is recommended.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Estatinas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>niacina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dislipidemia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Statins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>niacin</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dyslipidemia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Mecanismos de rabdomiólise com as estatinas</s1>
</fA08>
<fA08 dir="en">
<s1>Mechanisms of rhabdomyolysis with statins</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Eliane Campos Magalhães</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro Hospital Universitário Pedro Ernesto Setor de Hipertensão Arterial e Lípides</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>42-44</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>14</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500011</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>A rabdomiólise é incomum, mas é o efeito adverso mais sério observado na terapia hipolipemiante com estatinas. A ocorrência de rabdomiólise fatal reportada nos Estados Unidos desde a introdução das estatinas no mercado, na década de 1980, foi muito rara (0,15 casos por milhão de pacientes tratados por ano). Entretanto, a miopatia, definida como: sintomas musculares associados com elevações da CK; é muito mais comum (1%-5%). Os mecanismos de miopatia mediada por estatinas não estão totalmente compreendidos. Várias hipóteses têm sido propostas: diminuição dos níveis celulares de isoprenóides e ubiquinona, incremento de apoptose, mudanças nos canais de cloro diminuindo a hiperpolarização da membrana celular e alterações da permeabilidade da membrana celular. Interação com outras drogas, e alterações metabólicas pré-existentes podem predispor a miopatia.</s0>
</fC01>
<fC01 dir="en">
<s0>Rhabdomyolysis is uncommon, but is a serious side-effect observed following statin use. The occurrence of fatal rhabdomyolysis reported in the USA since the introduction of statins in the market in the late eighties was very rare (0,15 cases per million patients treated per year). However, myopathy, defined as muscle symptoms associated with CK elevation is much more common (1-5%). Mechanism of statin-induced myopathy is not fully understood. Several hypotheses have been proposed: decreased cellular levels of isoprenoids and ubiquinone, increased rates of apoptosis, changes in chloride channels impairing cell-membrane hyperpolarization, and changes in the cell-membrane permeability. Interactions with other drugs, and preexisting metabolic alterations may predispose to myopathy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Rabdomiólise</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estatinas</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Rhabdomyolysis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>statins</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Estatinas na doença renal crônica</s1>
</fA08>
<fA08 dir="en">
<s1>Statins in chronic renal disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Soraia R. C. Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Aloísio M. Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Francisco K. Saraiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>PUC de Campinas Faculdade de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>45-49</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500012</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Hipertrigliceridemia e o HDL baixo são aspectos comuns em pacientes com insuficiência renal crônica. A mortalidade cardiovascular está substancialmente aumentada na presença de doença renal crônica (10-20 vezes maior). Existem evidências de estudos clínicos com estatinas sugerindo uma ação protetora dessas drogas na progressão da doença renal. Além disso, pacientes pós-transplante renal recebendo fluvastatina, experimentaram redução na incidência de infartos não fatais e de mortalidade cardíaca. Entretanto, um estudo recente com atorvastatina não demonstrou reduções na morbi-mortalidade cardiovascular entre pacientes diabéticos em hemodiálise. Estudos em andamento definirão o preciso papel das estatinas neste grupo especial de pacientes.</s0>
</fC01>
<fC01 dir="en">
<s0>Hypertriglyceridemia and low HDL-c are common features in patients with chronic renal failure. Cardiovascular mortality is substantially increased in the presence of chronic renal disease (10-20 times higher). There is evidence from clinical trials with statins suggesting their protective role in the progression of renal disease. In addition, reduced rates of non-fatal myocardial infarction and cardiac mortality were seen after renal transplant in patients receiving fluvastatin. However, a recent study with atorvastatin failed to demonstrate reduction in cardiovascular morbidity and mortality among diabetic patients on hemodyalisis therapy. Ongoing trials will define the precise role of statins in this subset of patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Estatina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença renal crônica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dislipidemia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Statins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>end stage renal disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dyslipidemia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Tratamento hipolipemiante em situações especiais: pós-transplante e/ou terapia imunossupressora</s1>
</fA08>
<fA08 dir="en">
<s1>Hypolipidemic treatment under special conditions: posttransplant and/or immunosupressive therapy</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Cristina de Oliveira Izar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNIFESP EPM Setor de Lípides, Aterosclerose e Biologia Vascular</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>50-57</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>42</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500013</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Existem dados limitados sobre o uso concomitante de agentes hipolipemiantes e drogas imunosupressoras. As melhores evidências provêm do uso de estatinas e ciclosporina. Em termos farmacodinâmicos, estas duas drogas têm substratos diferentes. No tocante a farmacocinética, as estatinas não modificam as concentrações plasmáticas de ciclosporina. Entretanto, quando combinada a qualquer estatina, um controle rigoroso dos níveis de ciclosporina é recomendado, levando-se em conta o seu estreito intervalo terapêutico. Ciclosporina afeta a área sob a curva de muitas estatinas, pela inibição do CYP450 3A4, aumentando a exposição sistêmica dessas drogas. Pravastatina se apresenta como o composto de maior segurança, uma vez que é glucuronidado. A área sob a curva para as outras estatinas (sinvastatina, lovastatina, atorvastatina, cerivastatina e rosuvastatina) pode aumentar em graus variáveis de acordo com o seu sítio de metabolização, extração hepática pelo OATP-transportador, secreção biliar, excreção renal, e extrusão da droga pelo sistema MDR.</s0>
</fC01>
<fC01 dir="en">
<s0>There are limited data regarding the use of hypolipidemic agents concomitantly with immunosuppressive drugs. Best evidence is provided for the use of statins and cyclosporine. In terms of pharmacodynamics, these two drugs have different substrates. In respect to pharmacokinetics, statins usually do not modify serum concentrations of cyclosporine, however when combined with any statin a careful monitoring of cyclosporine levels is recommended, due to a narrow therapeutic window of the immunosupressive agent. Conversely, cyclosporine does affect the area under the curve for many statins, by inhibiting the CYP450 3A4, thus increasing systemic exposure to statins. Pravastatin appears to be the safest compound, once it is glucuronized. The area under the curve for the other statins (simvastatin, lovastatin, atorvastatin, cerivastatin, and rosuvastatin) can be increased in variable degrees according to the site of metabolization, liver extraction by OATP-C transporter, biliary secretion, renal excretion, and drug extrusion by the MDR system.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Transplante renal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>terapia imunosupressora</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estatinas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ciclosporina</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Renal transplantation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>immunosuppressive therapy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>statins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cyclosporine</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>Terapia hipolipemiante em situações especiais: síndrome de imunodeficiência adquirida</s1>
</fA08>
<fA08 dir="en">
<s1>Hypolipidemic therapy under special conditions: acquired immune deficiency syndrome</s1>
</fA08>
<fA11 dir="011000">
<s1>Pai Ching Yu</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Daniela Calderaro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Enéas M. O. Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Bruno Caramelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP HCFM Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>58-61</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>43</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500014</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Dislipidemias podem ser observadas precocemente entre pacientes com AIDS. Frequentemente, estas anormalidades lipídicas incluem HDL baixo e moderado aumento dos triglicérides sanguíneos. A terapia anti-retroviral combinada (HAART) pode agravar a dislipidemia nestes pacientes, com importante aumento nos triglicérides e no LDL. Vários mecanismos são propostos para explicar a dislipidemia mista observada nestes indivíduos, incluindo diferentes etapas do metabolismo lipídico. A importância do tratamento desses distúrbios lipídicos tem se tornado evidente com o aumento da expectativa de vida e os relatos de complicações cardiovasculares nestes pacientes. Existe um estado de resistência à insulina nos pacientes com AIDS em tratamento com HAART,que apresentam lipodistrofia, hipertrigliceridemia e baixos níveis de HDL. Drogas retro-antivirais são metabolizadas pelo CYP P450 3A4 e interações com algumas estatinas, especialmente com sinvastatina podem ocorrer. O tratamento com agentes hipolipemiantes deve ser baseado no perfil lipídico e no risco de coronariopatia. Para hipertrigliceridemias, fibratos (principalmente fenofibrato ou bezafibrato) devem ser as drogas de escolha, bem como as estatinas (principalmente pravastatina). Terapia combinada usando estatinas mais fibratos é recomendada para dislipidemias mistas graves e sempre sob rigoroso monitoramento de efeitos adversos.</s0>
</fC01>
<fC01 dir="en">
<s0>Lipid alterations can be observed early among patients with AIDS disease. Commonly, these lipid abnormalities include low HDL-C and modest increase in triglyceride plasma levels. Highly Active Anti-Retroviral Therapy (HAART) in these patients may aggravate the dyslipidemia, with notable increases in triglycerides as well as in LDL-C. There are several mechanisms proposed to explain the mixed hyperlipidemia observed in these subjects, including different steps in lipid metabolism. The importance of the treatment of dyslipidemia became evident with the increased life expectancy and reports of cardiovascular complications in these individuals. There is an insulin resistance state in patients with AIDS disease under treatment with HAART, who present with lypodistrophy, hypertriglyceridemia, low levels of HDL-C. Antiretroviral drugs are metabolized by CYP P450 3A4 and interactions with some statins, especially with simvastatin are expected to occur. Treatment with lipid-lowering agents should be based on lipid profile and coronary risk. For hypertriglyceridemias, fibrates (mainly fenofibrate or bezafibrate) should be the drugs of choice, as well as statins (mainly pravastatin). Combined treatment using fibrates plus statins are recommended for severe mixed hyperlipidemias under very close monitoring for adverse effects.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>AIDS</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>HAART</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dislipidemia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>AIDS</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>HAART</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dyslipidemia</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2></s2>
</fA06>
<fA08 dir="pt">
<s1>I Diretriz de Prevenção da Aterosclerose na Infância e na Adolescência</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>3-36</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500001</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Como era gostoso o meu caldo de cana...</s1>
</fA08>
<fA08 dir="en">
<s1>The sugarcane juice was delicious, but...</s1>
</fA08>
<fA11 dir="011000">
<s1>Barbara Maria Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>379-381</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>A cardiologia no século XXI: o uso do PDA é indispensável?</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiology in the 21st century: is PDA an indispensable tool for the practice?</s1>
</fA08>
<fA11 dir="011000">
<s1>João Manoel Rossi Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>382-384</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Trinta anos de pós-graduação em cardiologia</s1>
</fA08>
<fA08 dir="en">
<s1>Thirty years of postgraduation in cardiology</s1>
</fA08>
<fA11 dir="011000">
<s1>Whady Hueb</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José A. F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>385-387</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação da função autonômica na cardiomiopatia hipertrófica</s1>
</fA08>
<fA08 dir="en">
<s1>Assessing autonomic function in hypertrophic cardiomyopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo Imbroinise Bittencourt</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Roberto Benchimol Barbosa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cantídio Drumond Neto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ricardo Bedirian</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eduardo Corrêa Barbosa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Flavia Brasil</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Alfredo de Souza Bomfim</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Francisco Manes Albanesi Filho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Santa Casa de Misericórdia do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>388-396</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a função autonômica na cardiomiopatia hipertrófica (CMH) através da variabilidade da freqüência cardíaca (VFC) e correlacioná-la com dados ecocardiográficos. MÉTODOS: Foram estudados 2 grupos pareados por sexo, idade e freqüência cardíaca: A) 10 pacientes com CMH septal (70% não obstrutiva); B) 10 voluntários saudáveis. A VFC foi analisada durante quatro estágios sucessivos: repouso, respiração controlada, teste de inclinação e respiração controlada associada ao teste de inclinação. Compararam-se as médias das variáveis entre os grupos, intragrupos durante os estágios, e no grupo A, correlacionando com as medidas ecocardiográficas (septo interventricular e diâmetro atrial esquerdo). RESULTADOS: Não observamos diferença na VFC entre os grupos nos 3 primeiros estágios. No 4º estágio, constatamos que medidas de atividade vagal apresentaram valores maiores no grupo A [logaritmo da raiz média quadrática das diferenças entre intervalos RR (LogRMSSD) - 1,35&amp;plusmn;0,14 vs 1,17&amp;plusmn;0,16; p=0,019; logaritmo do componente alta freqüência (LogAF)-4,89&amp;plusmn;0,22 vs 4,62&amp;plusmn;0,26; p=0,032]. Durante os estágios, também verificamos que medidas vagais [proporção de pares de intervalos RR consecutivos cuja diferença &gt; 50ms (pNN50) e LogAF] apresentaram menor redução durante o 3º estágio no grupo A, e o LogAF, um aumento no último estágio (p=0,027), indicando marcante atividade parassimpática neste grupo. A análise da VFC do grupo A não revelou diferença entre pacientes com maior hipertrofia ou diâmetro atrial. CONCLUSÃO: 1) ocorreu predomínio parassimpático durante estimulação autonômica nos pacientes com CMH; 2) não encontramos correlação entre VFC e as medidas ecocardiográficas analisadas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Assess the autonomic function in hypertrophic cardiomyopathy (HCM) through heart rate variability (HRV) and to correlate it to echocardiographic data. METHODS: Two groups were studied, and compared for gender, age and HR:A) Ten (10) patients reporting septal HCM (70% non-obstructive); B) ten (10) healthy volunteers. HRV was analyzed along four successive stages: at rest, under controlled breathing, while bending, and controlled breathing associated to bending. Variables means were compared between groups and intra-groups in the different stages; in Group A, variables means were correlated to echocardiographic measurements (interventricular septum and left atrial diameter). RESULTS: No HRV difference was reported among groups in the first 3 stages. In the fourth stage vagal activity was shown to be higher in Group A [quadratic mean log between RR intervals (RMSSD) - 1.35&amp;plusmn;0.14 vs 1.17&amp;plusmn;0.16; p=0.019; high frequency component logarithm (LogHF)- 4.89&amp;plusmn;0.22 vs 4.62&amp;plusmn;0.26; p=0.032]. Along the stages, vagal measurements [rate of pairs of consecutive RR intervals whose difference is &gt; 50ms (pNN50) and LogHF] also showed lower reduction in the third stage in Group A, while LogHF showed some increase in last stage (p=0.027), thus indicating marked parasympathetic activity in that group. Group A HRV analysis showed no difference among patients reporting larger hypertrophy or atrial diameter. CONCLUSION: 1) parasympathetic prevalence was shown during autonomic stimulation in HCM patients; 2) no correlation was found between HRV and echocardiographic measurements under analysis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sistema nervoso autônomo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiomiopatia hipertrófica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>freqüência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>autonomic ner vous system (ANS)</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertrophic cardiomyopathy (HCM)</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart rate (HR)</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Viabilidade miocárdica na lesão uniarterial: papel da ecocardiografia de estresse com dobutamina</s1>
</fA08>
<fA08 dir="en">
<s1>Myocardial viability in a single-vessel disease: the role of a dobutamine stress echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Márcia Bueno Castier</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Raul Alves Carrinho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Márcia Alves Carrinho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Francisco Manes Albanesi Filho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Álvaro Villela de Moraes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Fernando Portugal Morcerf</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro ECOR Serviço de Ecocardiografia </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>ECOR Serviço de Ecocardiografia  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>397-402</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar um grupo de pacientes com lesão significativa em apenas uma artéria coronária e demonstrar se a ecocardiografia de estresse com dobutamina (EED) tem boa sensibilidade e especificidade na avaliação de viabilidade miocárdica nesse grupo de pacientes. MÉTODOS: Foram estudados 20 pacientes submetidos a angioplastia coronariana transluminal percutânea (ATC). Esse grupo foi avaliado 2 a 7 (3,65 &amp;plusmn; 1,69) dias antes do procedimento, e 2 a 5 (4 &amp;plusmn; 0,80) dias depois, realizando-se EED. Para a determinação de viabilidade miocárdica foi utilizado ecocardiograma bidimensional três meses após o procedimento. Doze pacientes foram submetidos a ATC de artéria descendente anterior (DA), 7 de artéria coronária direita (CD) e 1 de circunflexa (CX). Apenas um procedimento (CD) não obteve pleno êxito. RESULTADOS: Dos 340 segmentos estudados, 99 (29,18%) demonstraram alterações contráteis, sendo 63 hipocinéticos (63,4%), 28 acinéticos (28,28%) e 8 discinéticos (8,08%). Quanto aos segmentos envolvidos, obtivemos sensibilidade de 92,59%, especificidade de 84,45%, acurácia de 88,88% para o exame EED. O único caso de ATC de CX demonstrou sensibilidade de 100%; para DA, sensibilidade de 88,58%, especificidade de 95% e acurácia de 90,91%. Para segmentos da CD, sensibilidade de 91,30%, especificidade de 83,33% e acurácia de 88,71%. Todos os segmentos discinéticos eram inviáveis. Dos 63 hipocinéticos, a EED previu recuperação em 91,48%. CONCLUSÃO: A EED é útil na avaliação de viabilidade miocárdica em pacientes com lesão significativa de apenas uma artéria.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To investigate a group of patients that have a significant lesion in a single-vessel and to demonstrate whether or not the sensitivity and specificity of a dobutamine stress echocardiography (DSE) was valuable in the evaluation of myocardial viability for these patients. METHODS: Twenty patients who had undergone percutaneous transluminal coronary angioplasty (PTCA) were studied. This group was evaluated 2 to 7 days (3.65 &amp;plusmn; 1.69) before the procedure and 2 to 5 days (4 &amp;plusmn; 0.80) after the procedure with a DSE. Myocardial viability was assessed three months after the procedure using a two dimensional echocardiogram. Twelve patients underwent PTCA on the left anterior descending artery (LAD), 7 on the right coronary artery (RC) and 1 on the circumflex artery (CX). Only one right coronary artery procedure was not 100% successful. RESULTS: From the 340 segments that were studied, 99 (29.18%) demonstrated contractile alterations of which 63 were hypokinetic (63.4%), 28 akinetic (28.28%) and 8 dyskinetic (8.08%). In reference to the segments involved, we obtained a sensitivity of 92.59%, specificity of 84.45%, and accuracy of 88.88% for the DSE. The solitary case of PTCA for the circumflex artery demonstrated 100% sensitivity. The LAD demonstrated a sensitivity of 88.58%, specificity of 95% and accuracy of 90.91%. For the RC segments, sensitivity was 91.30%, specificity 83.33% and accuracy 88.71%. All dyskinetic segments were unviable. The DSE predicted a 91.48% recovery rate for the 63 hypokinetic segments. CONCLUSION: The DSE is an effective test for evaluating myocardial viability in patients with a significant single-vessel disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma de estresse</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>viabilidade miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lesão uniarterial</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stress echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial viability</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>single-vessel disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação cardiológica tardia de crianças com insuficiência mitral reumática, submetidas a cirurgia reconstrutora com anel de Gregori</s1>
</fA08>
<fA08 dir="en">
<s1>Late heart evaluation of children with rheumatic mitral regurgitation submitted to reconstructive surgery with implantation of Gregori's ring</s1>
</fA08>
<fA11 dir="011000">
<s1>Vitor Hugo Soares Machado</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Francisco Gregori Júnior</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Londrina  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital Evangélico de Londrina  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Santa Casa de Londrina  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="040000">
<s1>Hospital João de Freitas de Arapongas  </s1>
<s2>Londrina PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>403-411</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>52</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar crianças com insuficiência mitral reumática (IMR) submetidas a cirurgia reconstrutora na valva mitral com implante do anel de Gregori (CRVM), de 1987 a 2003. MÉTODOS: Quarenta e três crianças com IMR, submetidas a CRVM, com idades variando de cinco a doze anos, média de 9,7 &amp;plusmn; 2,2 anos, sendo 25 (58,1%) pacientes do sexo feminino. Os pacientes foram avaliados mediante parâmetros clínicos: classe funcional de insuficiência cardíaca, ausculta cardíaca, eletrocardiograma, radiografia de tórax e parâmetros ecocardiográficos. RESULTADOS: Quarenta e três pacientes foram avaliados no préoperatório e, no pós, 31, em virtude de seis óbitos e seis trocas valvares. O seguimento foi de 100%. A classe funcional da insuficiência cardíaca, sopro sistólico mitral, área cardíaca pela radiografia de tórax, sobrecarga ventricular esquerda no eletrocardiograma e o grau de insuficiência mitral pelo ecocardiograma diminuíram significativamente. Após 188 meses a taxa de sobrevida foi de 82% e a de mortalidade anual de 0,38%. Estavam livres de reoperação 31 (72,6%) pacientes, e a taxa de reoperação anual foi de 0,51%. CONCLUSÃO: A CRVM apresenta resultados eficazes no tratamento da IMR em crianças, com melhora significativa na classe funcional, sopro sistólico mitral e grau de insuficiência mitral pelo ecocardiograma.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Assess late cardiological evolution of children with rheumatic mitral regurgitation (RMR) who underwent mitral valve reconstructive surgery with implantation of Gregori's ring (MVR), from 1987 to 2003. METHODS: A study was conducted to analyze a series of cases of 43 children with RMR who underwent MVR with ages ranged from five to twelve years (mean age 9.7 &amp;plusmn; 2.2 years); 25 of the patients were females (58.1%). Patients were evaluated as per the following clinical parameters: functional class of heart failure, heart auscultation, electrocardiogram, chest X-ray and echocardiographic findings. RESULTS: Forty-three patients underwent preoperative evaluation during the postoperative period, the number of patients evaluated decreased to 31 due to the fact that 6 patients had died and 6 others underwent valve replacement surgery. Follow-up was carried out for 100% of the patients. A significant reduction of heart failure functional class was observed. Mitral systolic murmur became lesss intense during the postoperative period. The cardiac area on chest X-ray and the presence of left ventricular overload on electrocardiogram were reduced, as well as the mitral regurgitation level on echocardiographic study. After 188 months, the survival rate was 82%, and the annual mortality rate, 0.38%. Thirty-one (72.6%) patients did not require reoperation and the annual rate of patients who required further surgery was 0.51%. CONCLUSION: MVR is an effective procedure for treating RMR in children, resulting in a significant improvement of functional class, mitral systolic murmur and level of mitral regurgitation, as shown on Doppler echocardiogram.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência mitral reumática</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>crianças</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>anuloplastia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rheumatic mitral regurgitation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>children</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>annuloplasty</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Procedimento combinado entre operação de revascularização do miocárdio e endarterectomia de carótida: análise dos resultados</s1>
</fA08>
<fA08 dir="en">
<s1>Combined carotid endarterectomy and coronary artery bypass grafting: analysis of the results</s1>
</fA08>
<fA11 dir="011000">
<s1>Márcio Luís Lucas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Telmo Pedro Bonamigo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Elton Luiz Schmidt Weber</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Fernando Antônio Lucchese</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa de Porto Alegre  </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>412-420</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>54</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar os resultados da cirurgia combinada (endarterectomia carotídea e cirurgia de revascularização do miocárdio) em pacientes com doença carotídea e coronária concomitante. MÉTODOS: Os autores revisam 49 trabalhos que descrevem vários aspectos sobre a cirurgia combinada em um total de 4.788 pacientes, analisando eventos precoces no período peri-operatório. RESULTADOS: As taxas globais de acidente vascular cerebral (AVC), infarto agudo do miocárdio (IAM) e mortalidade foram, respectivamente, de 4,3%; 2,2%; e 4,2%. Para os trabalhos mais recentes (entre 1990-2000), a ocorrência de AVC foi significativamente inferior àquela obtida por trabalhos publicados anteriormente (entre 1972-1989) (4,1% x 10,2%; p &lt; 0,05). Neste mesmo levantamento, os índices de AVC pós-operatórios foram maiores nos artigos que continham uma amostra pequena (n &lt; 50) que naqueles trabalhos com uma população maior (n &gt; 100) (7,2% x 3,9%; p &lt; 0,05), denotando o impacto da experiência dos cirurgiões sobre os resultados pós-operatórios. CONCLUSÃO: Em suma, acreditamos que a cirurgia combinada é um procedimento seguro e eficaz quando realizado por cirurgiões experientes e qualificados.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the results of combined surgery (carotid endarterectomy and coronary artery bypass grafting) in patients with concomitant carotid and coronary artery disease. METHODS: The authors reviewed 49 different reports describing several aspects of the combined surgery in 4788 patients to analyze early events in the perioperative period. RESULTS: Overall stroke, acute myocardial infarction (AMI), and mortality rates were 4.3%, 2.2%, and 4.2%, respectively. Most recent papers (1990 to 2000) show significant lower incidence of strokes compared to those published earlier (1972 to 1989) (4.1% x 10.2%; p &lt; 0.05). In this same survey, the incidence of postoperative stroke was higher in the series with a small sample (n &lt; 50) than in those with a larger population (n &gt; 100) (7.2% x 3.9%; p &lt; 0.05), denoting the impact of surgeons' experience on postoperative results. CONCLUSION: In sum, we believe that combined carotid endarterectomy and coronary artery bypass grafting is a safe and effective procedure when performed by experienced and qualified surgeons.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>endarterectomia carotídea</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>revascularização coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>revisão</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>carotid endarterectomy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery bypass grafting</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>review</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Hiperplasia supra-renal congênita por deficiência de 11-ß-hidroxilase</s1>
</fA08>
<fA08 dir="en">
<s1>Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency</s1>
</fA08>
<fA11 dir="011000">
<s1>Ramires Tosatti Júnior</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Haroldo Silva de Souza</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alexandre Tosatti</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Geral de Goiânia  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital São Bernardo  </s1>
<s2>Aparecida de Goiânia GO</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>421-424</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Este artigo tem o objetivo de relatar o diagnóstico e a evolução clínica de um paciente de 15 anos portador de uma disfunção congênita da esteroideogênese adrenal, que pode apresentar-se como hipertensão arterial de diagnóstico muitas vezes tardio (adolescência), virilização ou formas perdedoras de sal (nascimento e infância).</s0>
</fC01>
<fC01 dir="en">
<s0>The objective of this article is to relate the diagnostic and clinical evolution of a 15 year old patient with a congenital adrenal steroidogenesis dysfunction that can present as hypertension diagnosed later in life (adolescence), virilization or salt wasting (birth and childhood).</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiomiopatia restritiva por cisticercose miocárdica</s1>
</fA08>
<fA08 dir="en">
<s1>Restrictive cardiomyopathy due to myocardial cysticercosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Rodrigo Morel Vieira de Melo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Almiro Vieira de Melo Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luís Cláudio L. Corrêa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Almiro Vieira de Melo Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia  </s1>
<s2>Salvador BA</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>425-427</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0>9</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Não há descrição na literatura de comprometimento da função cardíaca associado à cisticercose. Os autores relatam o caso de uma mulher de 46 anos, portadora de cisticercose e insuficiência cardíaca, cujo ecocardiograma é compatível com cardiomiopatia restritiva e o aspecto miocárdico é de microcalcificações, sugerindo infiltração cardíaca pela doença.</s0>
</fC01>
<fC01 dir="en">
<s0>There is no description of cysticercosis affecting heart function. In the present report, the authors describe the case of a 46-year-old woman with cardiac cysticercosis and heart failure, presenting with echocardiographic findings suggestive of restrictive cardiomyopahy and myocardial microcalcifications suggestive of cardiac infiltration by the disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Algumas considerações sobre a pirâmide invertida da formação médica brasileira e suas conseqüências para o treinamento em cardiologia</s1>
</fA08>
<fA08 dir="en">
<s1>Some comments on the inverted pyramid of medical qualification in Brazil and how it affects training in cardiology</s1>
</fA08>
<fA11 dir="011000">
<s1>Pedro José Negreiros de Andrade</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFC Hospital Universitário Walter Cantídio </s1>
<s2>Fortaleza CE</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>428-431</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>A doença renal como fator de risco cardiovascular</s1>
</fA08>
<fA08 dir="en">
<s1>Renal disease as a cardiovascular risk factor</s1>
</fA08>
<fA11 dir="011000">
<s1>Luis Cuadrado Martin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Jorge da Silva Franco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UNESP Faculdade de Medicina de Botucatu </s1>
<s2>Botucatu SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>432-436</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500611</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 06/2005: insuficiência cardíaca progressiva em paciente de 65 anos de idade portador de marcapasso cardíaco artificial</s1>
</fA08>
<fA08 dir="en">
<s1>Case 06/2005: progressive heart failure in a 65 year-old man with permanent cardiac pacemaker</s1>
</fA08>
<fA11 dir="011000">
<s1>Abrão Abuhad</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Alexandre W. Segre</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Lea Maria Macruz Ferreira Demarchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Vera Demarchi Aiello</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>437-443</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500612</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>85</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 03/2005: homem de 26 anos com defeito parcial do septo atrioventricular, com estenose pulmonar moderada</s1>
</fA08>
<fA08 dir="en">
<s1>Case 03/2005: 26-year-old male with partial atrioventricular septal defect with moderate pulmonary stenosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>444-445</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2005</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(05)08500613</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>O professor Jairo Ramos: editor fundador</s1>
</fA08>
<fA08 dir="en">
<s1>Professor Jairo Ramos: founding editor</s1>
</fA08>
<fA11 dir="011000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>1-2</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600101</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Cintilografia do miocárdio com tecnécio 99m-MIBI e administração de adenosina em portadores de doença arterial coronária: correlação dos resultados com a angiografia coronária e o ultra-som intracoronário</s1>
</fA08>
<fA08 dir="en">
<s1>Adenosine myocardial perfusion SPECT with Tc-99m-MIBI in patients with obstructive coronary artery disease: correlation between quantitative coronary angiography and intravascular ultrasound measurements</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Eduardo Mastrocolla</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Amanda G. M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paola E. P. Smanio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rodolfo Staico</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ibraim F. M. Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Romeu S. Meneghelo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Andreia C. Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Roselei Graebin</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Vinicius D. Vaz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Angela Paes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Daniela S. Martins</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="121000">
<s1>José Eduardo M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>3-13</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>62</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600102</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estabelecer a correlação da cintilografia de perfusão do miocárdio (CPM) com Tecnécio 99m-MIBI (MIBI) e injeção de adenosina, empregando a angiografia coronária quantitativa (ACQ) e o ultra-som intracoronário (UIC) como comparação. MÉTODOS: Estudo de 70 pacientes com doença arterial coronária (DAC), encaminhados à CPM com MIBI e adenosina. As manifestações clínicas, do eletrocardiograma (ECG) e os resultados das imagens foram correlacionadas às variáveis da análise visual e quantitativa da angiografia, bem como ao UIC. RESULTADOS: A média de idades foi de 60,6 anos, com 39 pacientes do sexo masculino. A angiografia coronária evidenciou estenose do diâmetro da luz (E%) de 49,94% em 105 artérias, com reavaliação à ACQ em 83 artérias (79%) e média de 44,20%, p&lt;0,05. Infradesnível de ST durante adenosina associou-se a maiores graus de E% (55,0% vs 47,8%), p&lt;0,05). A isquemia cintilográfica correlacionou-se a maior área porcentual de obstrução da luz pelo UIC (AO%). Os achados clínicos, do ECG e das imagens foram considerados em conjunto e expressos como respostas globais isquêmicas versus não-isquêmicas . A isquemia associou-se a menores valores do diâmetro mínimo da luz (DML) e da área mínima da luz (AML), obtidos à ACQ e ao UIC. CONCLUSÃO: A cintilografia do miocárdio com 99mTc-MIBI e adenosina correlaciona-se à AO% ao UIC, considerando-se as imagens de perfusão. Na avaliação dos resultados globais da prova observa-se associação com os diâmetros e as áreas da luz nos locais de obstrução, obtidos à ACQ e ao UIC.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To correlate myocardial perfusion scintigraphy (MPS) with Tc-99m-MIBI and adenosine infusion using quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS). METHODS: Seventy patients with coronary artery disease (CAD) referred for myocardial perfusion scintigraphy (MPS) with MIBI and adenosine were studied. Clinical, electrocardiographic (ECG), and scintigraphic findings were correlated with variables of visual and quantitative angiographic analysis, as well as to those of IVUS. RESULTS: The mean age of patients was 60.6 years, and 39 were male. Coronary angiography showed percentage of diameter stenosis (% DS) of 49.94% in 105 arteries, 83 of which were re-evaluated by QCA (79%), mean of 44.20%, p&lt;0.05. ST-segment depression during adenosine infusion was associated with higher degrees of % DS (55.0% vs. 47.8%), p&lt;0.05). Scintigraphic ischemia was correlated with greater cross-sectional area of lumen obstruction by IVUS (% CSA). Clinical, ECG, and IVUS findings were considered together and expressed as global ischemic versus non-ischemic responses. Ischemia was associated with lower values of minimal lumen diameter (MLD) and minimal lumen area (MLA) determined by QCA and IVUS. CONCLUSION: Tc-99m-MIBI and adenosine myocardial SPECT is correlated with % CSA on IVUS, perfusion images considered. Global results assessment showed association between lumen diameter and area at obstructed sites as determined by QCA and IVUS.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cintilografia do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença arterial coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angiografia coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>isquemia miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tecnécio 99m - MIBI</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>decisão clínica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial scintigraphy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial ischemia</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>technetium- 99m-MIBI</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>clinical decision</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Respostas cardiopulmonares ao exercício em pacientes com insuficiência cardíaca congestiva de diferentes faixas etárias</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiopulmonary responses to exercise in patients of different age group with congestive heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo de Castro César</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fábio Tadeu Montesano</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rosiane Vieira Zuza Diniz</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Dirceu Rodrigues Almeida</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Sérgio Tebexreni</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Turíbio Leite de Barros</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Metodista de PiracicabaPaulo  </s1>
<s2>Piracicaba SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>14-18</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600103</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVOS: Comparar a capacidade funcional cardiorrespiratória no exercício, representada pelos índices de limitação funcional, consumo máximo de oxigênio (VO2máx) e limiar anaeróbico, em pacientes com insuficiência cardíaca congestiva (ICC) de diferentes faixas etárias, e comparar as respostas cardiopulmonares ao exercício máximo. MÉTODOS: Foram avaliados 54 pacientes com ICC, agrupados por faixa etária, como segue: grupo I - idade entre trinta e 39 anos (n = 12); grupo II - idade entre quarenta e 49 anos (n = 18); grupo III - idade entre cinqüenta e 59 anos (n = 17); grupo IV - idade igual ou maior que sessenta anos (n = 7). Os pacientes foram submetidos a um teste cardiopulmonar máximo, em esteira rolante. Para a comparação entre os diferentes grupos etários foi realizada uma análise de variância com um fator. RESULTADOS: Não houve diferença significante dos valores obtidos de consumo máximo de oxigênio e de limiar anaeróbico entre os grupos etários, bem como dos valores máximos das variáveis produção de dióxido de carbono, pulso de oxigênio, razão de trocas gasosas, ventilação pulmonar, equivalentes ventilatórios para o oxigênio e para o dióxido de carbono. CONCLUSÕES: Os resultados obtidos sugerem que a capacidade funcional cardiorrespiratória no exercício de pacientes com ICC, assim como as variáveis cardiopulmonares obtidas no exercício máximo podem ser afetadas de forma semelhante pela doença cardíaca em todas as faixas etárias estudadas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVES: This paper aims at comparing cardiorespiratory functional capacity during exercise - represented by indicators of functional limitation, maximal oxygen uptake (VO2max), and anaerobic threshold - plus cardiopulmonary responses to maximal exercise in congestive heart failure (CHF) patients belonging to different age groups. METHODS: Fifty-four CHF patients, stratified by age group, were evaluated as follows: group I - 30 to 39 years (n = 12); group II - 40 to 49 years (n = 18); group III - 50 to 59 years (n = 17); and group IV - 60 years and above (n = 7). All patients underwent maximal cardiopulmonary exercise testing (CPET) on treadmills. A single-factor analysis of variance (ANOVA) was performed to compare different age groups. RESULTS: No significant differences were found in maximal oxygen uptake and anaerobic threshold among the age groups, nor in maximal values for carbon dioxide production, oxygen pulse, respiratory exchange ratio, pulmonary ventilation, and ventilatory equivalents for oxygen and carbon dioxide. CONCLUSIONS: These findings suggest that cardiorespiratory functional capacity during exercise in patients with CHF, as well as cardiopulmonary variables at maximal exercise, may be similarly affected by the heart disease in all studied age groups.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>exercício</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca congestiva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>idade</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congestive heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>age</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudos eletrofisiológicos seriados do sistema éxcito-condutor do coração de pacientes com cardiopatia chagásica crônica</s1>
</fA08>
<fA08 dir="en">
<s1>Serial electrophysiological studies of the heart's excito conductor system in patients with chronic chagasic cardiopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>Ney Valente</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João Pimenta</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Angelo Amato Vincenzo de Paola</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital do Servidor Público Estadual  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>19-25</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>41</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600104</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVOS:Estudar a evolução das lesões do sistema de condução do coração, por meio de estudos eletrofisiológicos (EEF) invasivos, o impacto dessas alterações nos eventos cardiovasculares (ECV) e a freqüência desses eventos em pacientes com cardiopatia chagásica crônica. MÉTODOS: Estudo prospectivo iniciado em 1979, com seguimento clínico até 2000, com participação de 28 pacientes chagásicos crônicos, com idade entre 18 e 65 anos, portadores de bloqueios de ramo e/ou bloqueios atrioventriculares (AV). Os pacientes foram submetidos a dois EEF, com intervalo de tempo mínimo de 4 anos, sendo estudados 5 parâmetros eletrofisiológicos, que foram correlacionados com ECV. Holter de 24 horas e ecocardiograma foram realizados. RESULTADOS: O tempo médio de seguimento após o 1º EEF foi de 154,5 meses, enquanto o intervalo entre os EEF foi de 107,5 meses. A idade variou entre 25 e 65 anos. Vinte e sete pacientes apresentavam bloqueio completo de ramo direito, associado ou não a bloqueio divisional ântero-superior esquerdo. O ecocardiograma foi alterado em 12 pacientes. Ao Holter de 24 horas e à estimulação ventricular, apenas um paciente apresentou TVS. Nove apresentaram ECV e somente o intervalo HV &gt;70 ms apresentou relação estatisticamente significante com esses eventos. CONCLUSÕES: a) A forma crônica da doença de Chagas apresenta diferentes porcentagens de anormalidades evolutivas nas variáveis eletrofisiológicas, sendo a mais freqüente a alteração no PW. b) Entre os achados eletrofisiológicos, somente o intervalo HV &gt; 70 ms relacionou-se com ECV. c) A incidência de ECV foi de 31,1% seguimento médio de 154,5 meses.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVES: To study the evolution of lesions in conduction system using invasive electrophysiological studies (EPS), the impact of these alterations on cardiovascular events (CVE), and the frequency of these events in chronic chagasic patients. METHODS: Prospective study, initiated in 1979 with clinical follow-up until 2000, with the participation of 28 chronic chagasic patients that were 18 to 65 years old, with bundle branch and/or atrioventricular blocks. The patients were submitted to two EPS with a minimum interval of four years between the studies in order to assess five electrophysiologis parameters that were correlated with CVE. A 24-hour Holter and echocardiogram were performed. RESULTS: The average follow-up time after the first EPS was 154.5 months while the interval between EPS was 107.5 months. Ages ranged from 25 to 65 years. Twenty seven patients presented complete right bundle branch block associated with a left anterior hemiblock. The echocardiogram showed alteration in twelve patients. During the 24-hour Holter and ventricular stimulation, only one patient presented sustained ventricular tachycardia (SVT). Nine presented CVE during the study and only the HV interval &gt; 70ms presented a significant statistical relationship with CVE. CONCLUSIONS: a) The chronic form of Chagas disease presents different progressive abnormality percentages for the electrophysiological variables and WP alterations are the most common. b) Among the electrophysiological findings, only the HV interval &gt; 70ms was associated with CVE. c) The incidence of CVE was 31.1% during the average follow-up period of 154.5 months.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estudo eletrofisiológico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>eventos cardiovasculares</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença de Chagas</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>electrophysiological studies</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular events</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Valores de pressão arterial e suas associações com fatores de risco cardiovasculares em servidores da Universidade de Brasília</s1>
</fA08>
<fA08 dir="en">
<s1>Blood pressure levels and their association with cardiovascular risk factors among employees of the University of Brasília, a Brazilian public university</s1>
</fA08>
<fA11 dir="011000">
<s1>Tatiana Valverde da Conceição</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fabiano Alves Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Pedro Luiz Tauil</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Tânia Torres Rosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de Brasília Faculdade de Medicina </s1>
<s2>Brasília DF</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>26-31</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600105</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar e classificar, de acordo com o JNC 7, os níveis de pressão arterial dos servidores acima de quarenta anos da Universidade de Brasília, e estimar a prevalência de fatores de risco cardiovasculares presentes em tal população. MÉTODOS: Foi realizado um estudo transversal na Universidade de Brasília, onde os servidores acima de quarenta anos responderam a um questionário e tiveram pressão arterial, peso e altura medidos. Os níveis de pressão arterial foram classificados de acordo com o JNC 7 e os dados demográficos dos indivíduos de cada categoria foram analisados. A porcentagem dos fatores de risco foi calculada. A análise estatística foi feita através do teste ANOVA e do teste qui-quadrado, quando aplicável. RESULTADOS: Setecentos e quatro servidores participaram do estudo, incluindo 438 homens e 266 mulheres. A mediana de idade foi 47 anos. Segundo o JNC 7, 139 (19,8%) pessoas foram classificadas como normotensas; 298 (42,3%) como pré-hipertensas e 267 (37,9%) como hipertensas. Os fatores de risco avaliados foram sobrepeso/obesidade (56,8%), tabagismo (19,5%), consumo de bebidas alcoólicas (53,6%), sedentarismo (48,4%) e hipertensão (37,9%). CONCLUSÃO: A alta freqüência de níveis pressóricos elevados e fatores de risco cardiovasculares apontam para a necessidade de medidas preventivas e terapêuticas de doenças cardiovasculares direcionadas aos servidores da universidade.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To verify and classify, according to the JNC 7, the blood pressure levels (BPL) of the employees of University of Brasilia, a public university in Brazil, who are older than 40 years of age, and to estimate the prevalence of cardiovascular risk factors in this population. METHODS: A cross-sectional study was conducted at the University of Brasilia, with employees over 40 years of age. They answered a questionnaire and had their blood pressure, weight and height measured. The BPLs were classified according to the JNC 7 classification and the demographic data of the subjects in each category were analyzed. The percentage of risk factors was calculated. The statistical analysis was carried out using the ANOVA test and the chi-square test, where applicable. RESULTS: Seven hundred and four subjects participated in the study, 438 male and 266 female. The median age was 47. According to the JNC 7, 139 (19.8%) subjects were classified as normotensive; 298 (42.3%) as prehypertensive and 267 (37.9%) as hypertensive. The risk factors assessed were overweight/obesity (56.8%), smoking habit (19.5%), alcohol consumption (53.6%), sedentary lifestyle (48.4%) and hypertension (37.9%). CONCLUSION: The high frequency of elevated blood pressure levels and cardiovascular risk factors among the employees indicates the need for preventive and therapeutic measures for cardiovascular disease targeted at the university's employees.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>pressão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fator de risco cardiovascular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular risk factor</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hypertension</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo comparativo das avaliações clínica e ecocardiográfica Doppler na evolução das lesões valvares em crianças e adolescentes portadores de febre reumática</s1>
</fA08>
<fA08 dir="en">
<s1>Comparative study of clinical and Doppler echocardiographic evaluations of the progression of valve diseases in children and adolescents with rheumatic fever</s1>
</fA08>
<fA11 dir="011000">
<s1>Zilda Maria Alves Meira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eugênio Marcos Andrade Goulart</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cleonice de Carvalho Coelho Mota</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Minas Gerais Faculdade de Medicina </s1>
<s2>Belo Horizonte MG</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>32-38</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600106</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar os exames clínico e ecocardiográfico Doppler na avaliação das lesões valvares em crianças e adolescentes com febre reumática, bem como investigar a evolução da doença segundo essas avaliações. MÉTODOS: Trata-se de estudo observacional longitudinal que englobou 258 crianças e adolescentes com diagnóstico de febre reumática, baseado nos critérios de Jones. Os pacientes foram acompanhados durante o período de 2 a 15 anos. A presença e a quantificação das lesões valvares nas fases aguda e crônica foram determinadas pelas avaliações clínica e ecocardiográfica Doppler. Utilizou-se a estatística de Kappa para estimar a concordância entre as avaliações, e as evoluções clínica e ecocardiográfica Doppler da cardite e valvite, respectivamente, foram comparadas pelo teste do qui-quadrado ou de Fisher, p &lt; 0,05. RESULTADOS: Dos 109 pacientes submetidos à avaliação ecocardiográfica Doppler na fase aguda, 31 não apresentavam clínica de cardite, mas 17 (54,8%) deles mostravam lesão valvar ao ecocardiograma Doppler (valvite subclínica). Na fase crônica, 153 dos 258 tinham exame cardiovascular normal, mas 85 (55,5%) desses mostravam lesão valvar ao ecocardiograma Doppler (valvopatia crônica subclínica). A involução das lesões valvares segundo a avaliação ecocardiográfica Doppler foi menos freqüente, ocorrendo em 10 (25,0%) dos pacientes com valvite leve e em apenas 1 (2,5%) daqueles com valvite moderada, e em nenhum com valvite grave. CONCLUSÃO: A identificação de lesões valvares na febre reumática é maior se a avaliação clínica for acrescida do exame ecocardiográfico Doppler, que também mostra menor índice de regressão das lesões valvares. O diagnóstico de valvite e valvopatia subclínicas tem implicação quanto às profilaxias secundária da febre reumática e da endocardite.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Compare clinical and Doppler echocardiographic evaluations in assessing valvular diseases in children and adolescents with rheumatic fever, as well as assess the progression of the disease in light of these assessments. METHODS: This is a longitudinal study of 258 children and adolescents diagnosed with rheumatic fever according to Jones' criteria. The follow-up period ranged from 2-15 years. The presence and quantification of valve diseases were determined by means of clinical and Doppler echocardiographic evaluations performed during the acute and chronic phases. The Kappa statististics method was used to estimate the degree of agreement between clinical and Doppler echocardiographic evaluations. Comparisons between clinical and Doppler echocardiographic findings on the progress of carditis and valvulitis, respectively, were made using chi-square test or Fisher's exact test, p&lt; 0.05. RESULTS: Of the 109 patients who underwent Doppler echocardiographic evaluation during the acute phase, 31 did not present clinical evidence of carditis, but the Doppler echocardiograms of 17 (54.8%) of them showed valve lesions (subclinical valvulitis). During the chronic phase, 153 of the 258 patients had normal cardiovascular examination results; however, Doppler echocardiograms showed that 81 of them (52.9%) had valve lesions (subclinical chronic valvular diseases). Involution of the valvular lesions, as shown by Doppler echocardiographic evaluations, was less frequent and occurred in 10 (25.0%) patients with mild valvulitis, in only one (2.5%) patient with moderate valvulitis, and in none of the patients with severe valvulitis. CONCLUSION: The identification of rheumatic fever valve lesions can be enhanced when clinical evaluations are supplemented by Doppler echocardiographic examinations; also, clinical examinations are not as suitable to detect valvular lesion regression as the echocardiography. The diagnosis of subclinical valvulitis and valvulopathy influences the secondary prophylaxis of rheumatic fever and endocarditis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>febre reumática</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia Doppler</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvite</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvopatia reumática</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rheumatic fever</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Doppler echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>valvulitis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rheumatic valvulopathy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo &quot;LOTHAR&quot;: avaliação de eficácia e tolerabilidade da combinação fixa de anlodipino e losartana no tratamento da hipertensão arterial primária</s1>
</fA08>
<fA08 dir="en">
<s1>The &quot;LOTHAR&quot; study: evaluation of efficacy and tolerability of the fixed combination of amlodipine and losartan in the treatment of essential hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>Osvaldo Kohlmann Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Wille Oigman</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Décio Mion Jr.</s1>
<afiliation>A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>João Carlos Rocha</s1>
<afiliation>A04</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marco Antonio Mota Gomes</s1>
<afiliation>A05</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Natalino Salgado</s1>
<afiliation>A06</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Gilson Soares Feitosa</s1>
<afiliation>A07</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Ernesto Dallaverde</s1>
<afiliation>A08</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Artur Beltrame Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Minas Gerais  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Universidade de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="040000">
<s1>Universidade Estadual de Campinas  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="050000">
<s1>Escola de Ciências Médicas de Alagoas  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="060000">
<s1>Universidade Federal do Maranhão  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="070000">
<s1>Escola Bahiana de Medicina e Saúde Pública  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="080000">
<s1>Biosintética Farmacêutica Departamento Médico </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>39-51</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600107</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: O estudo LOTHAR avaliou a eficácia, tolerabilidade e os efeitos metabólicos em médio e longo prazo (um ano) da combinação fixa de anlodipino e losartana versus anlodipino e losartana isoladamente. MÉTODOS: Estudo multicêntrico brasileiro, randomizado, duplo-cego e comparativo realizado com 198 pacientes com hipertensão arterial primária em estágios 1 e 2. RESULTADOS: A combinação fixa apresenta alta eficácia anti-hipertensiva que se mantém em longo prazo com percentual reduzido de escape do controle pressórico, inferior a dos dois regimes monoterápicos de comparação. Em longo prazo, mais de 60% dos pacientes tratados com a combinação fixa permaneceram com níveis da PAD &lt; 85 mmHg e o efeito anti-hipertensivo quando avaliado pela MAPA persistiu nas 24 horas com relação vale-pico de 76,7%. A freqüência de eventos adversos foi bastante reduzida neste grupo sendo a incidência em longo prazo de edema de membros inferiores cerca de quatro vezes menor que a observada com o anlodipino isolado. A combinação fixa não alterou os metabolismos da glicose e dos lípides tanto em médio quanto em longo prazos. CONCLUSÃO: Estes resultados nos permitem afirmar que a combinação de anlodipino e losartana, a primeira combinação fixa de um antagonista dos canais de cálcio e um bloqueador do receptor da angiotensina II disponível no mercado farmacêutico constitui-se em excelente opção para o tratamento da hipertensão arterial em larga gama de pacientes hipertensos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: The LOTHAR study evaluated medium and long term (one year) efficacy, tolerability and metabolic effects of the fixed combination of amlodipine and losartan compared to amlodipine or losartan alone. METHODS: Brazilian multicenter, randomized, double-blind and comparative trial performed with 198 patients in stage 1 and 2 essential hypertension. RESULTS: The fixed combination has a high antihypertensive efficacy that is sustained in the long term with very low percentage of loss of blood pressure control. This percentage is incidentally lower than that of the two monotherapy comparative regimens. In the long term, more than 60% of the patients treated with the fixed combination remained with DBP &lt; 85 mmHg, and the antihypertensive effect, when assessed by ABPM persisted for 24 hours with a trough-to-peak ratio of 76.7%. The frequency of adverse events was quite low in this group, and the long-term incidence of leg edema was approximately four-fold lower than that observed with amlodipine alone. The fixed combination did not change glucose and lipid metabolism in the medium or in the long term. CONCLUSION: Based on these results, we can say that the combination of amlodipine and losartan - the first fixed combination of a calcium channel blocker and an angiotensin II receptor blocker available in the pharmaceutical market, is an excellent option for the treatment of a wide range of hypertensive patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>combinação fixa de antihipertensivos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>anlodipino</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>losartana</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>eficácia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tolerabilidade</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>metabolismo da glicose e lípides</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>fixed-combination of antihypertensive drugs</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>amlodipine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>losartan</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>efficacy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tolerability</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>glucose and lipids metabolism</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Segurança do transplante autólogo, intra-arterial, de células mononucleares da medula óssea na fase aguda do acidente vascular cerebral isquêmico</s1>
</fA08>
<fA08 dir="en">
<s1>Intra-arterial autologous bone marrow mononuclear cell transplantation for acute ischemic stroke</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Lúcia Furtado de Mendonça</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Gabriel R. de Freitas</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Suzana Alves da Silva</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Aquiles Manfrim</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Carlos Henrique Eiras Falcão</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Constantino Gonzáles</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Charles André</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Hans Fernando Rocha Dohmann</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Radovan Borojevic</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Rosália Mendez Otero</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Instituto do Milênio de Bioengenharia Tecidual  </s1>
<s2>Rio deJaneiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>52-55</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>10</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600108</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>O acidente vascular cerebral (AVC) é a terceira causa de óbito e a principal causa de incapacidade em indivíduos adultos. Embora a mortalidade do AVC esteja diminuindo em alguns países, a morbidade tem aumentado em razão do envelhecimento da população e do aumento da sobrevida dos pacientes¹. O tratamento com ativador do plasminogênio tissular recombinante (rt-PA) é eficaz quando instituído em até 3 horas após o início dos sintomas², porém seu uso está limitado a cerca de 5% dos pacientes na fase aguda do AVC isquêmico. Além disso, nenhum agente para neuroproteção teve sua eficácia comprovada em estudos clínicos em humanos. Portanto, outras estratégias terapêuticas precisam ser desenvolvidas. Em modelos animais, o uso de células-tronco correlacionou-se com melhora funcional após o AVC³. Publicações recentes têm demonstrado a segurança do tratamento com células mononucleares da medula óssea (CMMO) injetadas via intracoronária em pacientes portadores de cardiopatia isquêmica aguda ou crônica4,5. Baseado nesses dados iniciais, há crescente interesse no estudo do transplante com CMMO na fase aguda do AVC. Relatamos o primeiro caso de transplante autólogo de CMMO via intra-arterial na fase aguda do AVC isquêmico.</s0>
</fC01>
<fC01 dir="en">
<s0>Stroke is the third cause of death and the leading cause of disability in adult subjects. Although stroke mortality has been declining in some countries, stroke morbidity has been increasing due to the aging of population and patients improved survival.¹ Treatment with recombinant tissue plasminogen activator (rtPA) is successful provided it is administered within 3 hours of symptoms onset,² but its use is limited to about 5% of the patients with acute ischemic stroke. Furthermore, no neuroprotective agent has yet been proven effective in human clinical trials. The development of other therapeutic strategies is, therefore, warranted. The use of stem cells in animal models has led to functional improvement following stroke.³ Recent publications have shown that bone marrow mononuclear cells (BM-MNC) therapy through intracoronary injection is a safe procedure in patients with acute or chronic ischemic heart disease.4,5 Based on these preliminary data, there has been growing interest in the study of BM-MNC transplantation for acute ischemic stroke. We report the first case of intra-arterial autologous BM-MNC transplantation for acute ischemic stroke.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardiologia baseada em evidências: onde buscar evidências?</s1>
</fA08>
<fA08 dir="en">
<s1>Evidence-based cardiology: where to find evidence</s1>
</fA08>
<fA11 dir="011000">
<s1>Otávio Berwanger</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Álvaro Avezum</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Hélio Penna Guimarães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>56-60</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600109</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Atividade sexual e coração</s1>
</fA08>
<fA08 dir="en">
<s1>Sexual activity and heart</s1>
</fA08>
<fA11 dir="011000">
<s1>Ricardo Stein</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Clarissa Barlem Hohmann</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital de Clínicas de Porto Alegre  </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>61-67</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600110</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>1</s2>
</fA06>
<fA08 dir="pt">
<s1>Diretriz de reabilitação cardiopulmonar e metabólica: aspectos práticos e responsabilidades</s1>
</fA08>
<fA11 dir="011000">
<s1>Tales de Carvalho</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>74-82</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600111</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Hiper-homocisteinemia como fator de risco para doença aterosclerótica coronariana em idosos</s1>
</fA08>
<fA08 dir="en">
<s1>Hyperhomocysteinemia as a risk factor for coronary atherosclerotic disease in the elderly</s1>
</fA08>
<fA11 dir="011000">
<s1>Armênio Costa Guimarães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFBA Faculdade de Medicina </s1>
<s2>Salvador BA</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>83-84</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600201</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Terapia celular para acidente vascular cerebral isquêmico: esperança ou panacéia?</s1>
</fA08>
<fA08 dir="en">
<s1>Stem cells for ischemic stroke: hope or panacea?</s1>
</fA08>
<fA11 dir="011000">
<s1>Hans Fernando Rocha Dohmann</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jamary Oliveira Filho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio de Janeiro Hospital Pró-Cardíaco </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Instituto do Milênio de Bioengenharia Tecidual  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>85-86</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600202</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>O papel da ecocardiografia no tratamento percutâneo dos defeitos septais</s1>
</fA08>
<fA08 dir="en">
<s1>The role of echocardiography in the percutaneous treatment of septal defects</s1>
</fA08>
<fA11 dir="011000">
<s1>Simone Rolim F. Fontes Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Sérgio Cunha Pontes Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Renata de Sá Cassar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Carlos Augusto Cardoso Pedra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sérgio Luiz Navarro Braga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>César Augusto Esteves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Maria Virgínia Tavares Santana</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Valmir Fernandes Fontes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>87-96</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600203</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>O uso do balão intra-aórtico no pré-operatório de cirurgia de revascularização miocárdica, associada à disfunção ventricular grave</s1>
</fA08>
<fA08 dir="en">
<s1>The use of preoperative intra-aortic balloon in myocardial revascularization surgery associated to severe ventricular dysfunction</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo Kern</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João Ricardo M. Santanna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>97-104</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600204</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a efetividade do Balão Intra-Aórtico (BIAo) profilático em cirurgia de revascularização miocárdica (CRM) eletiva, para prevenir o infarto trans ou pós-operatório e para reduzir a mortalidade intra-hospitalar nos pacientes com baixa fração de ejeção ventricular esquerda. MÉTODOS: Em modelo de estudo de coorte, foram analisados 239 pacientes com fração de ejeção do ventrículo esquerdo inferior ou igual a 40%, submetidos à CRM eletiva com circulação extracorpórea (CEC), no período compreendido entre março de 1995 a fevereiro de 2001. RESULTADOS: Destes, 58 pacientes receberam BIAo pré-operatório e os demais foram operados sem assistência circulatória (grupo controle). Os dois grupos de pacientes tinham características semelhantes quanto a fatores associados aos desfechos em questão. Ocorreram 5 (8,6%) óbitos no grupo com BIAo e 21 (11,6%), no grupo controle (diferença não-signifícativa). Ocorreram 2 (3,4%) infartos no grupo com BIAo e 28 (15,5%), no grupo controle BIAo (p &lt; 0,05), risco relativo de 0,22 com intervalo de confiança de 95% de 0,05 a 0,85. CONCLUSÃO: O BIAo, em uso pré-operatório, pode reduzir de forma significativa o risco de infarto agudo do miocárdio (IAM) trans ou pós-operatório, em pacientes com função sistólica diminuída, sem incremento de complicações vasculares. Nesta mesma situação, o BIAo não diminui de forma significativa a mortalidade. Estudos randomizados devem ser conduzidos para se ter conclusões mais precisas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the effectiveness of prophylactic intra-aortic balloon (IAB) in elective myocardial revascularization surgery (MRS), to prevent trans or post-operative infarction and reduce intra-hospital mortality in patients with low left ventricular ejection fraction. METHODS: Using a cohort study model, 239 patients with left ventricular ejection fraction &lt;40%, submitted to elective MRS with extracorporeal circulation (ECC) were evaluated from March 1995 to February 2001. RESULTS: Of these, 58 patients received preoperative IAB and the remainder underwent surgery without circulatory assistance (control group). The two groups of patients had similar characteristics regarding factors associated to the pertaining outcomes. There were five demises (8.6%) in the group with IAB and 21 (11.6%) in the control group (non-significant difference). There were 2 (3.4%) infarctions in the IAB group and 28 (15.5%) in the control group (p&lt; 0.05), relative risk of 0.22 with an interval of confidence of 95% from 0.05 to 0.85 CONCLUSION: The use of pre-operative IAB can significantly reduce the risk of trans or post-operative acute myocardial infarction (AMI) in patients with decreased systolic function, without increasing vascular complications. In this same situation, the IAB does not significantly decrease mortality. Randomized studies are necessary to establish more precise conclusions.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>balão intra-aórtico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>disfunção ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>revascularização miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>intra-aortic balloon</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial revascularization</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>A função mecânica do miocárdio remanescente a um infarto do miocárdio é normal durante o período de cicatrização, embora exista insuficiência cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Mechanical function is normal in remanent myocardium during the healing period of myocardial infarction - despite congestive heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Alessandra P. O. N. Peron</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto M Saraiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ednei L. Antonio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo José Ferreira Tucci</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>105-112</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600205</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: A relação temporal entre disfunção ventricular (DV) após infarto do miocárdio (IM) e função mecânica do miocárdio remanescente não está estabelecida. O trabalho analisou, por ecodopplercardiograma (ECO), a função ventricular de ratos com IM de grandes dimensões e a função mecânica de músculos papilares (MP) no término do período de cicatrização. MÉTODOS: Estudados ECO e MP de 9 ratos Wistar (IM), três semanas após IM e 9 controles (C). Determinaram-se: tensão desenvolvida (TD) e sua primeira derivada positiva e negativa, tempo de pico de tensão, tensão de repouso e tempo de relaxamento a 50% de TD em concentrações de cálcio (em mM) de 0,5, 1,0, 1,5, 2,0 e 2,5. Após rianodina, foram promovidas contrações tetânicas em concentrações de cálcio de 1,5, 2,5 e 5,0. RESULTADOS: O ECO caracterizou DV com marcada anormalidade do volume diastólico e da fração de ejeção do VE, além de nítido padrão restritivo do fluxo sangüíneo pela valva mitral. Não foi identificada diferença significante entre os dados de mecânica miocárdica dos ratos IM e C. CONCLUSÃO: A insuficiência cardíaca (IC) que ocorre em ratos com IM &gt; 40% do VE, no final do período de cicatrização, não depende de disfunção miocárdica. As modificações estruturais da câmara e a menor população de miócitos devem fundamentar a DV e a IC.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: The temporal relation between ventricular dysfunction (VD) after myocardial infarction (MI) and remanent myocardium mechanics is not yet clear. The present work investigated - through Doppler echocardiography (ECHO) - ventricular function in rats with extensive MI, as well as the mechanical function of papillary muscles (PM) at the end of the healing period. METHODS: ECHO and PM of 9 Wistar rats (MI) were studied against 9 controls (C) three weeks after LV myocardial infarction. The following were determined: developed tension (DT) and its first negative and positive derivative, time-to-peak tension (TPT), resting tension (RT), and relaxation time at 50% of DT at 0.5, 1.0, 1.5, 2.0 and 2.5 calcium concentrations (mM). Tetanic contractions were carried out after ryanodine administration at 1.5, 2.5 and 5.0 calcium concentrations. RESULTS: VD was characterized by ECHO, with marked abnormality of diastolic volume and LV and ejection fraction in addition to clear restrictive pattern of blood flow through the mitral valve. No significant difference was found in myocardial mechanics data either for MI or for C rats. CONCLUSION: The heart failure (HF) reported by MI rats with &gt; 40% MI at the end of the healing period is not myocardial function dependent. Chamber structural changes and lower population of myocites should base VD and HF.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>músculo papilar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>disfunção ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>período de cicatrização</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ratos</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>papillary muscle</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>healing period</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rats</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Transplante cardíaco e neoplasias: experiência na Escola Paulista de Medicina da Universidade Federal de São Paulo</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiac transplantation and neoplasms: experiences at Escola Paulista de Medicina of the Federal University of São Paulo</s1>
</fA08>
<fA11 dir="011000">
<s1>Walter Teixeira de Mello Junior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João Nelson R. Branco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Roberto Catani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luciano de Figueiredo Aguiar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rodrigo Pereira Paez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Enio Buffolo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>113-119</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>52</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600206</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVOS: Analisar ocorrência e tipos de neoplasias que se desenvolveram em pacientes submetidos a transplante cardíaco ortotópico, no Programa de Transplante Cardíaco da Escola de Paulista de Medicina da Universidade Federal de São Paulo. MÉTODOS: O presente estudo apresenta uma análise observacional de 106 pacientes submetidos a transplante cardíaco ortotópico, no período de novembro de 1986 a setembro de 2002, que sobreviveram por período superior a trinta dias após o procedimento. O regime de imunossupressão consistiu de terapia tríplice com ciclosporina A, azatioprina e corticosteróide. Apenas dois pacientes receberam, além da terapia tríplice, a adição de ortoclone OKT-3. O período médio de acompanhamento foi de 61,4 meses. (variação de dois meses a 192 meses). RESULTADOS: Vinte e três pacientes (21,3%) desenvolveram neoplasias, dos quais 56,5% apresentaram neoplasia de pele, 30,1% apresentaram tumores sólidos e 13,4%, doença linfoproliferativa pós-transplante (DLPT). O intervalo médio entre o transplante e o diagnóstico de neoplasia foi: pele - 54,9 meses, tumores sólidos - 24,8 meses e DLPT - 70,3 meses. CONCLUSÕES: A ocorrência de neoplasias malignas foi relativamente comum na população analisada. O câncer de pele prevaleceu em relação às demais neoplasias e os tumores sólidos foram mais diagnosticados do que as doenças linfoproliferativas nessa série de pacientes.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study the occurrence and types of neoplasms developed by patients who underwent an orthotopic cardiac transplantation under the Program of Cardiac Transplantation of Escola Paulista de Medicina, Federal University of São Paulo. METHODS: This is an observational study of 106 patients who underwent orthotopic cardiac transplantation from November 1986 to September 2002 and survived at least thirty days following the procedure. The triple immunosuppressive regimen given included cyclosporin A, azathioprine and a corticosteroid agent. Only two patients received OKT3 in addition to the regimen established. Mean follow-up was 61.4 months (ranging from two months to 192 months). RESULTS: Twenty-three patients (21.3%) developed neoplasms - 56.5% of these were skin neoplasm, 30.1%, solid tumors, and 13.4% of post-transplant lymphoproliferative disease (PTLD). Mean interval between transplantation and diagnosis of neoplasm was: 54.9 months for skin neoplasm; 24.8 months for solid tumors and 70.3 months for PTLD. CONCLUSION: Malignant neoplasms are relatively common in the population studied. Skin cancer was the most common type compared to the other types of neoplasms. Solid tumors were more frequently diagnosed than the lymphoproliferative diseases in the population examined.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Transplante cardíaco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>neoplasias</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cirurgia cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac transplantation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>neoplasms</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>surgery</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Valor prognóstico do teste de caminhada de seis minutos na insuficiência cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Prognostic value of the six-minute walk test in heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Valéria Siqueira Martins Rubim</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Cantídio Drumond Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Luiz Martins Romeo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcelo Westerlund Montera</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Santa Casa da Misericórdia do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>120-125</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600207</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVOS: Este estudo objetivou avaliar a utilidade do teste de caminhada de seis minutos como indicador prognóstico e sua contribuição na prática clínica diária de pacientes com insuficiência cardíaca. MÉTODOS: O teste de caminhada de seis minutos foi administrado a 179 pacientes (120 homens, 59 mulheres; idade média de 58,32 ± 12,7 anos), portadores insuficiência cardíaca nas classes II e III da New York Heart Association (NYHA), com fração de ejeção do ventrículo esquerdo de 34,91 ± 12,4%. Os pacientes realizaram o teste de caminhada de seis minutos e, 4 horas depois, o teste ergométrico convencional sob o Protocolo de Naughton limitado por sintomas, e foram acompanhados por um período médio de dezoito meses. RESULTADOS: A distância média percorrida no teste de caminhada seis minutos foi de 521,11 ± 76,1 metros. Durante o acompanhamento, 66 pacientes (36,9%) morreram. Houve uma correlação significativa entre a distância percorrida no teste de caminhada de seis minutos e a mortalidade (p &lt; 0,0001). O modelo de regressão logística identificou a distância percorrida durante o teste de caminhada de seis minutos como o mais forte indicador independente de mortalidade (p = 0,0001). A distância caminhada menor que 520 metros identificou os pacientes com maior probabilidade de óbito. O número de equivalentes metabólicos alcançados no teste ergométrico convencional também correlacionou-se significativamente com a mortalidade (p = 0,0001). CONCLUSÃO: O teste de caminhada de seis minutos é um método simples, seguro e potente de avaliação prognóstica de portadores de insuficiência cardíaca nas classes II e III da NYHA. É um exame objetivo, que pode substituir o teste ergométrico convencional na avaliação prognóstica desses pacientes.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: This study aimed to assess the true usefulness of the Six-Minute Walk Test as a prognostic indicator and its contribution to clinical practice with heart failure patients. METHODS: In order to investigate the actual value of the Six-Minute Walk Test as an objective measure of mortality probability in patients with heart failure, the test was applied to 179 stable patients (120 men and 59 women, mean age 58.32 ± 12.7 years, with NYHA class II and III heart failure and an ejection fraction (LVEF) of 34.91 ± 12.4%). Patients were instructed to walk for 6 minutes and then, four hours later, underwent a conventional exercise stress test (as per Naughton Protocol). Patients were followed for an average of eighteen months. RESULTS: The average distance walked was 521.11 ± 76.1 meters. During the follow-up period, 66 patients (36.9%) died. There was a significant correlation between the distance walked during the test and mortality (p &lt; 0.0001). The logistic regression model identified the distance walked during the test as the most important independent predictor of mortality (p = 0.0001). A distance shorter than 520 meters identified the patients with an increased probability of death. There was a significant correlation between the number of metabolic equivalents (METs) measured during the conventional exercise stress testing and mortality rate (p = 0.0001). CONCLUSION: The Six-Minute Walk test is a simple, safe and powerful method to assess the prognosis of patients with NYHA class II and III heart failure. It is an objective examination that may replace the conventional ergometric test for the prognostic evaluation of these patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste de caminhada de seis minutos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prognóstico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Six-Minute Walk test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Remodelação miocárdica na sobrecarga crônica de pressão ou de volume no coração de ratos</s1>
</fA08>
<fA08 dir="en">
<s1>Myocardial remodeling in chronic pressure or volume overload in the rat heart</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Shiguero Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Silvia Narikawa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ana Lucia dos Anjos Ferreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sergio Alberto Rupp de Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Leonardo Mamede Zornoff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Beatriz Bojikian Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Unesp Faculdade de Medicina de Botucatu Departamento de Clínica Médica</s1>
<s2>Botucatu SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>126-130</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600208</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar as alterações estruturais cardíacas em modelos experimentais de sobrecarga de pressão e de volume. MÉTODOS: Foram analisados ratos com hipertensão renovascular (HRV, n = 8), normotensos com sobrecarga de volume por fístula aortocava (FAV, n = 10) e animais controles (CONT, n = 8). Após quatro semanas, registrou-se a pressão arterial caudal (PAS) e obtiveram-se os pesos dos ventrículos direito (PVD) e esquerdo (PVE). Em cortes histológicos, foram medidas as áreas seccionais dos miócitos (AM), a espessura da parede do VE (E), o diâmetro da cavidade (DVE), a relação E/DVE, e a fração de colágeno (CVF). As comparações foram feitas pela ANOVA e teste de Tukey para nível de significância de 5%. RESULTADOS: A PAS (mmHg) foi maior no grupo HRV (HRV = 187 ± 22; CONT = 125 ± 10; FAV = 122 ± 6, p &lt; 0,05). A hipertrofia do VE foi observada nos grupos HRV e FAV. O grupo FAV apresentou aumento significante do DVE, comparado ao CONT e HRV. As espessuras absoluta e normalizada da parede ventricular foram semelhantes entre os grupos. Houve aumento significante do CVF no grupo HRV em relação aos grupos CONT e FAV. CONCLUSÃO: A sobrecarga de volume causa padrão distinto de remodelação cardíaca, quando comparada com aquela decorrente da hipertensão arterial, sugerindo que as implicações funcionais de cada padrão não são intercambiáveis.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare cardiac structural changes in experimental pressure and volume overload models. METHODS: The study analysis included renovascular hypertensive rats (RVH, n=8), normotensive rats with volume overload caused by an aortocaval fistula (ACF, n=10) and control rats (CONT, n=8). After four weeks, tail cuff blood pressure (SBP) was recorded. Rats were killed, the hearts were excised and the right and left ventricles (RV&amp;LV) were weighed (RVW&amp;LVW). Using histological sections, myocyte cross sectional areas (MA). LV wall thickness (LVWT) LV cavity diameter (LVD), normalized LVWT (LVWT/LVD) and collagen volume fraction (CVF) were measured. The comparisons were made using the ANOVA and Tukey test for a significance level of 5%. RESULTS: Tail cuff blood pressure (mmHg) was higher in the RVH group (RVH = 187 ± 22; CONT = 125 ± 10; ACF = 122 ± 6, p&lt;0.05). LV hypertrophy was observed in the RVH and ACF groups. The ACF group presented a significant increase in size of LVD, compared to CONT and RVH. The absolute and normalized ventricular wall thickness were similar among the groups. The RVH group presented a significant increase in CVF compared to CONT group and ACF group. CONCLUSION: Cardiac remodeling patterns following volume or pressure overload are distinct, suggesting that their implications on ventricular dysfunction are not interchangeable.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão renovascular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fístula artocava</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>colágeno</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Renovascular hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortocaval fistula</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>collagen</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular hypertrophy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Letalidade por doenças isquêmicas do coração no Estado do Rio de Janeiro no período de 1999 a 2003</s1>
</fA08>
<fA08 dir="en">
<s1>Ischemic heart disease lethalities in the state of Rio de Janeiro between 1999 and 2003</s1>
</fA08>
<fA11 dir="011000">
<s1>Gláucia Maria Moraes de Oliveira</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Henrique Klein</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Nelson Albuquerque de Souza e Silva</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Henrique Godoy</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Tânia Maria Peixoto Fonseca</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio de Janeiro Faculdade de Medicina </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Fiocruz Escola Nacional de Saúde Pública </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Secretaria de Estado de Saúde do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>131-137</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600209</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estimar a letalidade nos procedimentos de doenças isquêmicas do coração (DIC) aguda e crônica e por revascularização miocárdica (RVM) e angioplastia coronariana (AC) nos hospitais cadastrados no SIH/SUS (Sistema de Informações Hospitalares/Sistema Único de Saúde) no Estado do Rio de Janeiro (ERJ), de 1999 a 2003. MÉTODOS: Os procedimentos considerados de RVM e de AC provieram do Datasus. As taxas foram padronizadas por sexo, idade e gravidade de doença, tendo como padrão todos os procedimentos de alta complexidade cardiovascular, realizados no ERJ em 2000. Os grupos de DIC são: angina, infarto agudo do miocárdio, outras DIC agudas e DIC crônicas. RESULTADOS: As letalidades por angina, IAM, outras DIC agudas e DIC crônicas foram de 2,8%, 16,2%, 2,9% e 3,9%, respectivamente, no ERJ. As taxas de letalidade, ajustadas por idade, sexo e grupo diagnóstico, nas RVM e AC foram elevadas, variando entre 1,9% e 12,8% nas RVM, e atingindo 3,2% nas AC, e de 2,3% e 11,1%, quando o tratamento clínico era realizado. CONCLUSÃO: As RVM e AC no tratamento das DIC no ERJ vêm aumentando progressivamente. A letalidade esteve acima do desejável, principalmente nas internações por DIC crônicas (5,4% e 1,7%, respectivamente). O tratamento clínico otimizado parece boa opção terapêutica, reservando-se as RVM e AC para os casos de pior prognóstico. A letalidade no IAM com tratamento clínico foi semelhante à existente quando não se utilizam trombolíticos (16,7%).</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To estimate the lethality rate of acute and chronic ischemic heart disease (IHD) procedures, coronary artery bypass graft (CABG) procedures and percutaneous transluminal coronary angioplasty (PTCA) procedures in the hospitals that are registered as service providers for the Hospital Information System / Single Healthcare System (SIH/SUS) plan in the state of Rio de Janeiro (RJ) between 1999 and 2003. METHODS: The procedures considered as CABGs and PTCAs were provided by Datasus (SUS databank). The rates were standardized in accordance with gender, age, and disease severity. The common factors among these procedures are that they are highly complex cardiovascular procedures performed in RJ in the year 2000. The IHD groups are: angina, acute myocardial infarction, other acute IHDs and chronic IHDs. RESULTS: Lethality rates for angina, acute myocardial infarction (AMI), other acute and chronic IHDs were 2.8%, 16.2%, 2.9% and 3.9%, respectively, in the RJ. The lethality rates for CABG and PTCA, adjusted by age, sex and diagnostic groups, were elevated ranging from 1.9% to 12.8% for CABG procedures and as high as 3.2% for PTCA. When medical therapy was performed the rates were 2.3% for CABG and 11.1% for PTCA. CONCLUSION: There has been a progressive increase in the number of CABG and PTCA procedures to treat IHDs in the RJ. Lethality rates were above the desirable level, mainly for chronic IHD hospital admissions (5.4% and 1.7%, respectively). Optimized medical therapy appears to be a worthwhile therapeutic option, reserving CABG and PTCA procedures for the cases with the worst prognoses. Lethality rates for AMI with medical therapy was comparable to current rates when thrombolytics were not used (16.7%).</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doenças isquêmicas do coração</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>letalidade hospitalar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>revascularização do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angioplastia coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ischemic heart diseases</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hospital lethality</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery bypass graft</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>percutaneous transluminal coronary angioplasty</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Duplo produto elevado como preditor de ausência de coronariopatia obstrutiva de grau importante em pacientes com teste ergométrico positivo</s1>
</fA08>
<fA08 dir="en">
<s1>Increased rate-pressure product as predictor for the absence of significant obstructive coronary artery disease in patients with positive exercise test</s1>
</fA08>
<fA11 dir="011000">
<s1>Luis Domingos Fornitano</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Moacir Fernandes de Godoy</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Faculdade de Medicina de São José do Rio Preto  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Fundação Faculdade Regional de Medicina Hospital de Base </s1>
<s2>São José do Rio Preto SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>138-144</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600210</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Correlacionar valores do duplo produto acima de 30.000 mmHg.bpm, com presença ou não de coronariopatia obstrutiva importante, em pacientes com teste ergométrico positivo. MÉTODOS: Análise retrospectiva de 246 pacientes que haviam sido submetidos a teste ergométrico no máximo trinta dias antes de estudo cineangiocoronariográfico, por suspeita de coronariopatia obstrutiva, dos quais 165 pacientes tinham teste ergométrico positivo. O critério único para positividade foi a presença de infradesnivelamento do segmento ST de pelo menos 1,0 mm, de morfologia horizontal ou descendente, persistindo 0,08 seg. após o ponto J. RESULTADOS: Dentre os 165 pacientes, 50 (30,3%) alcançaram duplo produto &gt; 30.000 mmHg.bpm; desses, 38 (76%) eram angiograficamente normais ou tinham coronariopatia obstrutiva leve e 12 (24%) tinham coronariopatia importante. Entre os outros 115 pacientes com teste ergométrico positivo, mas duplo produto &lt; 30.000 mmHg.bpm, 59 (51,3%) eram normais ou com coronariopatia obstrutiva leve, e 56 (48,7%) apresentavam coronariopatia obstrutiva importante (Odds Ratio = 0,3327 IC 95% = 0,1579 a 0,7009; P = 0,0034). CONCLUSÃO: Com base nos dados obtidos dessa investigação, demonstrou-se que o duplo produto elevado constituiu-se em uma variável importante para prever a ausência de coronariopatia obstrutiva significante em indivíduos com teste ergométrico positivo, podendo tornar-se ferramenta útil na tomada de decisão clínica.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To correlate values of rate-pressure product (RPP) above 30,000 mmHg.bpm with or without significant obstructive coronary artery disease (CAD) in patients with positive exercise test. METHODS: A retrospective analysus of 246 patients that had been submitted to Exercise Treadmill Test (ETT) up to 30 days before coronary angiography on suspicion of obstructive disease. The 165 patients in which the ETT was positive were analyzed considering as positive the presence of horizontal or descending depression of the ST segment for at least 1 mm, 0.08 seconds after J point. RESULTS: Among the 165 appraised patients, 50 (30.3%) reached RPP &gt; 30,000 mmHg.bpm, of which 38 (76%) had normal coronary vessel angiography or low degree obstructive coronary artery disease and 12 (24%) had significant. Among the remaining 115 appraised patients with positive ETT and RPP &lt; 30,000 mmHg.bpm, 59 (51.3%) were normal or with low significance obstructive coronary artery disease, and 56 (48.7%) had significant disease. (Odds Ratio = 0.3327 CI 95% = 0.1579 to 0.7009; P=0.0034). CONCLUSION: Based on data collected in the present investigation, it has been demonstrated that RPP above 30,000 mmHg.bpm stands as a relevant variable to predict the absence of significant obstructive coronariopathy in individuals with positive ET and as a useful tool in making clinical decisions.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste ergométrico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>duplo produto</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coronariopatia obstrutiva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>método disgnóstico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rate-pressure product</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>obstructive coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diagnostic methods</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Valvopatia aórtica crônica grave sintomática: estudo comparado da ressonância magnética cardíaca e ecocardiografia</s1>
</fA08>
<fA08 dir="en">
<s1>Symptomatic severe chronic aortic valve disease: a comparative study of cardiac magnetic resonance imaging and echocardiography</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo Nigri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Carlos Eduardo Rochitte</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Flávio Tarasoutchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Guilherme S Spina</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Rodrigues Parga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luiz Francisco Ávila</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Roney Orismar Sampaio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>José Antonio Franchini Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Max Grinberg</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>145-149</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600211</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Mostrar o real valor da ressonância magnética cardíaca (RMC) na avaliação dos portadores de valvopatia aórtica crônica sintomática. MÉTODOS: Foram estudados 70 pacientes, 35 com estenose aórtica (EAo) e 35 com insuficiência aórtica (IAo), com indicação cirúrgica, que realizaram ecocardiograma (ECO) e RMC pré-operatórios para avaliação da função ventricular, volumes e índice de massa ventricular esquerda por meio da cinerressonância. RESULTADOS: Quando comparadas as variáveis do ECO e da RMC, nos grupos da EAo e da IAo não houve diferença estatística entre os dois métodos. Quando comparadas com o tipo de sintoma, as variáveis pelo ECO e pela RMC apresentam o mesmo comportamento. CONCLUSÃO: A RMC apresentou concordância com o ECO na avaliação do volume ventricular esquerdo e fração de ejeção e com a clínica dos pacientes com valvopatia aórtica crônica.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To show the real value of cardiac magnetic resonance imaging (CMRI) in the evaluation of patients with symptomatic chronic aortic valve disease. METHODS: Seventy patients - 35 with aortic stenosis (AoS) and 35 with aortic regurgitation (AoR) with surgical indication, who underwent preoperative echocardiogram (ECHO) and CMRI to assess ventricular function, volumes, and left ventricular mass index using cine magnetic resonance imaging, were studied. RESULTS: No statistically significant difference was observed between the AoS and AoR groups when ECHO and CMRI variables were compared. When compared with the type of symptom, ECHO and CMRI variables showed the same pattern. CONCLUSION: CMRI data were in agreement with ECHO data regarding the assessment of left ventricular volume and ejection fraction, and with the clinical presentation of patients with chronic aortic valve disease.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvopatia aórtica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ressonância magnética cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>classe funcional</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>chronic aortic valve disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac magnetic resonance imaging</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>functional class</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Comparação da coronariografia de mulheres diabéticas e não-diabéticas com síndrome coronariana aguda sem supradesnivelamento de ST</s1>
</fA08>
<fA08 dir="en">
<s1>Comparison of coronary angiography findings in diabetic and non-diabetic women with non-ST-segment-elevation acute coronary syndrome</s1>
</fA08>
<fA11 dir="011000">
<s1>José Marconi Almeida de Sousa</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>João L. V. Herrman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marco Teodoro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Sergio Diogo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Bernardino Bandeira Terceiro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Angelo Amato Vincenzo de Paola</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antonio Carlos Camargo Carvalho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital Santa Marcelina  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>150-155</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600212</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar o padrão hemodinâmico, angiográfico e a morfologia da lesão aterosclerótica em diabéticas e não-diabéticas com angina instável ou infarto agudo do miocárdio sem supradesnivelamento do segmento ST (AI/IAMSS). MÉTODOS: Dois hemodinamicistas determinaram a presença de lesão aterosclerótica grave, definida como &gt; 70%, a morfologia da placa, de acordo com a classificação da American Heart Association, a presença de circulação colateral e as pressões ventriculares e aórticas. A fração de ejeção foi calculada pela angiografia ou pelo ecocardiograma. RESULTADOS: Em oito anos e meio, foram realizados 645 coronariografias em mulheres com AI/IAMSS. Foram analisadas 593 pacientes (215 diabéticas - 36%). Este grupo diferiu das não-diabéticas nos seguintes aspectos: idade mais alta (61 ± 10,6 x 58,1 ± 11,4), prevalência maior de mulheres pós-menopausa e menor prevalência de tabagismo. Lesão grave em três vasos foi significativamente mais freqüente nas pacientes diabéticas (28% x 10%), assim como vasos totalmente ocluídos: 51 (23%) x 54 (14.3%), p &lt; 0.005.Fração de ejeção &lt; 50% foi mais comum nas diabéticas. CONCLUSÃO: Estes achados confirmam o acometimento difuso da doença aterosclerótica em pacientes diabéticas, assim como maior deterioração da função ventricular, que pode estar relacionada ao pior prognóstico dessa população em curto e em longo prazo.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Compare hemodynamic and angiographic patterns, as well as atherosclerotic lesion morphology, in diabetic and non-diabetic females with unstable angina or non-ST-segment-elevation myocardial infarction (UA/NSTEMI). METHODS: Two interventional cardiologists determined the presence of severe atherosclerotic lesion, defined as those &gt; 70%; plaque morphology, according to the American Heart Association classification; collateral circulation; plus ventricular and aortic pressures. Ejection fraction was calculated by angiography or echocardiography. RESULTS: During eight and a half years, 645 coronary angiographies were performed in women with UA/NSTEMI. In the present study, 593 female patients were assessed (215 diabetic - 36%). This group differed from the non-diabetic in the following aspects: older age (61 ± 10.6 x 58.1 ± 11.4), higher prevalence of postmenopausal women and lower prevalence of the smoking habit. Severe three-vessel disease was significantly more frequent in diabetic patients (28% x 10%), as well as totally occluded vessels: 51 (23%) x 54 (14.3%), p &lt; 0.005. Additionally, ejection fraction &lt; 50% was more common in diabetic patients. CONCLUSION: These findings confirm the diffuse pattern of atherosclerotic disease in diabetic patients, as well a greater deterioration of ventricular function, which may be associated to the poorer prognosis seen in this population both in the short- and long-term.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>diabete melito</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>mulher</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>angina instável</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>coronariografia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diabetes mellitus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>women</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>unstable angina</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary angiography</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 01/2006: insuficiência cardíaca progressiva em homem de 44 anos de idade</s1>
</fA08>
<fA08 dir="en">
<s1>Case 01/2006: progressive heart failure in a 44-year old man</s1>
</fA08>
<fA11 dir="011000">
<s1>Tiago Senra Garcia dos Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ariane Vieira Scarlatelli Macedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo J Moffa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Clementina Giorgi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Léa Maria Macruz Ferreira Demarchi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Jussara Bianchi Castelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>156-164</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600213</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>2</s2>
</fA06>
<fA08 dir="pt">
<s1>Correção</s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>0-0</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600214</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Uma tarefa desafiadora</s1>
</fA08>
<fA08 dir="en">
<s1>A challenging assignment</s1>
</fA08>
<fA11 dir="011000">
<s1>Fábio Vilas-Boas</s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>165-165</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600301</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Perfil da pressão arterial ao longo da árvore arterial e genética da hipertensão</s1>
</fA08>
<fA08 dir="en">
<s1>Blood pressure profile along the arterial tree and genetics of hypertension</s1>
</fA08>
<fA11 dir="011000">
<s1>Luiz Aparecido Bortolotto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Michel E. Safar</s1>
<afiliation>A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Diagnosis Center Hotel-Dieu Hospital </s1>
<s2>Paris France</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>191-197</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600302</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Evolução da função renal na fase aguda do infarto do miocárdio como fator prognóstico de eventos na fase intra-hospitalar e em um ano de seguimento</s1>
</fA08>
<fA08 dir="en">
<s1>Renal function outcome in acute myocardial infarction as a prognostic factor of in-hospital events and at one-year follow-up</s1>
</fA08>
<fA11 dir="011000">
<s1>Eduardo Pimenta</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rui Fernando Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Gun</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Elizabeth S. Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ari Timerman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Leopoldo S. Piegas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>170-174</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>25</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600303</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar o papel da disfunção renal na internação ou durante a evolução nos pacientes com infarto agudo do miocárdio (IAM). MÉTODOS: Foram avaliados 274 pacientes com IAM, entre janeiro de 2000 e dezembro de 2001. A função renal foi monitorada com a dosagem de creatinina (Cr) na internação e o valor pico durante a hospitalização. O clearance de creatinina (ClCr) foi calculado pela fórmula de Cockcroft &amp; Gault. Foi avaliada a morbidade e mortalidade intra-hospitalar e após um ano do evento. RESULTADOS: A média de idade foi 62,2 ± 13,5 anos e 73% eram do sexo masculino. A função renal esteve mais reduzida nos homens, em pacientes com hipertensão arterial sistêmica e cirurgia de revascularização prévia. A análise multivariada revelou aumento da mortalidade intra-hospitalar relacionada com a elevação nos níveis pico de Cr (OR:1,18 95% IC:1,18-2,77 p = 0,006), com o decréscimo no ClCr inicial (OR:0,96 95% IC:0,93-0,99 p = 0,025) e no ClCr pico (OR:0,96 95% IC:0,92-0,99 p = 0,023). A diferença percentual entre o ClCr inicial e o menor ClCr atingido também indicou maior mortalidade (OR:1,04 95% IC:1,00-1,07 p = 0,033). A piora da função renal não alterou a morbidade e mortalidade em um ano. CONCLUSÃO: Disfunção renal na internação, e sua deterioração durante a hospitalização, mostrou ser um importante marcador prognóstico de pior evolução imediata.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the role of renal dysfunction at admission or during hospitalization in patients with acute myocardial infarction (AMI). METHODS: Two hundred and seventy-four patients with AMI were assessed between January 2000 and December 2001. Renal function was monitored by serum creatinine (Cr) measurement at admission and peak level during hospitalization. Creatinine clearance (CrCl) was estimated by the Cockcroft-Gault formula. In-hospital and one-year morbidity and mortality were evaluated. RESULTS: Mean age of the population studied was 62.2 ± 13.5, and 73% of the patients were male. Renal function was more reduced in male patients and in those with systemic arterial hypertension and prior CABG. Multivariate analysis showed higher hospital mortality rates associated with increased peak serum Cr levels (OR: 1.18 95% CI:1.18-2.77 p = 0.006), decreased baseline CrCl (OR:0.96 95% CI:0.93-0.99 p = 0.025) and peak CrCl (OR:0.96 95% CI:0.92-0.99 p = 0.023). Percent difference between baseline CrCl and the lowest CrCl obtained during hospitalization also indicated higher mortality rates (OR: 1.04 95% CI: 1.00-1.07 p = 0.033). No change was observed in the one-year morbidity and mortality from worsening of renal function. CONCLUSION: Renal dysfunction at admission and its deterioration during hospitalization have proved to be a major prognostic marker for immediate poor outcome.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Infarto do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência renal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doenças cardiovasculares</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>renal insufficiency</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular diseases</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Dosagem dos níveis de NT pro-BNP nas afecções pericárdicas e sua utilidade como método complementar de avaliação de restrição diastólica. Experiência inicial de 25 casos: 25 cases</s1>
</fA08>
<fA08 dir="en">
<s1>NT Pro-BNP levels in pericardial diseases and how they are used as complementary evaluation method of diastolic restriction. Inititial experience</s1>
</fA08>
<fA11 dir="011000">
<s1>Fábio Fernandes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Izabel José de Almeida</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Félix J. A. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paula C. Buck</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Vera M. C. Salemi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Bárbara M. Ianni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Rogério Rabelo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Charles Mady</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital das Clínicas Instituto do Coração </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>175-180</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>19</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600304</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar se os níveis de NT pro-BNP encontram-se elevados em pacientes com afecções pericárdicas e avaliar a sua relação com medidas ecocardiográficas de disfunção diastólica. MÉTODOS: Vinte e cinco pacientes foram divididos em dois grupos: 1) derrame pericárdico (DP), 15 pacientes; 2) pericardite constritiva (PC), 10 pacientes. Foi constituído um grupo controle de 30 indivíduos sem doença cardíaca. O grau de derrame pericárdico foi avaliado pelo ecocardiograma bidimensional e a restrição avaliada pelo Doppler pulsátil do fluxo mitral. O diagnóstico de PC foi confirmado por meio da ressonância magnética. Os níveis de NT pro-BNP foram medidos por imunoensaio com detecção por eletroquimioluminescência. RESULTADOS: Dos 15 pacientes com DP, 14 apresentavam DP importante e apenas 1, moderado. Log NT pro-BNP esteve aumentado no DP (p &lt;0,05), com média de log 2,31 pg/ml e PC (p &lt;0,05), com média de log 2,67 pg/ml, quando comparados ao grupo controle, média de log 1,32 pg/ml. Não houve diferença entre DP e PC (p = 0,149). O log NT pro-BNP correlacionou-se com o pico de velocidade da onda E (r = 0,845; p = 0,001) e com a relação E/A (r=0,717; p= 0,003). CONCLUSÃO: O NT pro-BNP encontra-se aumentado nas afecções pericárdicas e apresenta relação com o grau de disfunção diastólica, podendo servir como método adicional na quantificação de restrição.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine whether NT pro-BNP levels are high in patients reporting pericardial diseases, as well as to investigate how they relate to diastolic dysfunction echocardiographic measures. METHODS: Twenty-five patients were split into two groups: 1) pericardial effusion (PE): 15 patients; 2) constrictive pericaditis (CP): 10 patients. A control group was made up with 30 individuals reporting no heart disease. Pericadial effusion was evaluated by bidimensional echocardiogram, with restriction evaluated by pulsed Doppler of mitral flow. CP diagnosis was confirmed by MRI. NT pro-BNP levels were measured by immunoassay and detected by electrochemiluminescence. RESULTS: From the 15 PD patients, 14 reported relevant PD, and only 1, moderate PD. Log NT pro-BNP was shown to be higher in PD (p &lt;0.05), with log mean of 2.31 pg/ml and CP (p &lt;0.05), with log mean of 2.67 pg/ml, when compared to control group, log mean of 1.32 pg/ml. No difference was reported between PD and CP (p = 0.149). The NT pro-BNP log showed to be correlated to peak velocity of the E wave (r = 0.845; p = 0.001) and with E/A (r=0.717; p= 0.003). CONCLUSION: NT pro-BNP is shown to have increased in pericardial diseases, and is associated to diastolic dysfunction. It may serve as an additional method in quantifying restriction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Derrame pericárdico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>pericardite constritiva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>NT pro-BNP</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Pericardial effusion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>constrictive pericaditis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>NT pro-BNP</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Influência do diabete melito nos resultados imediatos do implante de stent coronário: uma análise dos dados da Central Nacional de Intervenções Cardiovasculares (CENIC)</s1>
</fA08>
<fA08 dir="en">
<s1>Influence of Diabetes Mellitus on immediate results of coronary stent: National Center for Cardiovascular Interventions (CENIC) data analysis</s1>
</fA08>
<fA11 dir="011000">
<s1>Isaac Moscoso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Lázaro Claudiovino Garcia</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gilvan Oliveira Dourado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maria Fernanda Z. Mauro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paulo Caramori</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Wilson Coelho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Valter Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Ronaldo Bueno</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>José A. Mangione</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Central Nacional de Intervenções Cardiovasculares Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>181-190</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>39</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600305</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a influência do diabete melito (DM) nos resultados imediatos do implante de stent coronário (SC), de acordo com o quadro clínico de apresentação. MÉTODOS: Entre janeiro/1997 e dezembro/2003, segundo a Central Nacional de Intervenções Cardiovasculares (CENIC), 11.874 pacientes diabéticos foram submetidos a implante de SC: 7.386 (62,3%) com insuficiência coronária crônica (ICO), 3.142 (26,4%), em síndrome isquêmica instável sem elevação ST (SIASEST) e 1.346 (11,3%), com infarto agudo do miocárdio (IAM) com supradesnivelamento de ST. Estes grupos foram comparados com 48.103 não-diabéticos: 30.980 (64,5%) com ICO, 10.938 (22,7%) em SIASEST e 6.185 (12,8%) com IAM. RESULTADOS: Os diabéticos apresentaram características clínicas e angiográficas de maior risco. Os diabéticos com ICO apresentaram taxa de eventos adversos semelhantes aos não-diabéticos (0,98% x 0,91%, p=0,5971), porém, os diabéticos em SIASEST e IAM apresentaram maior incidência de eventos: 2,76% x 1,46% (p&lt;0,0001) e 7,87% x 4,1% (p&lt;0,0001), respectivamente. A análise multivariada mostrou o DM como preditor independente de risco para eventos adversos maiores na SIASEST (OR: 1,92 IC: 1,46-2,52 p&lt;0,0001) e no IAM (OR: 2,0 IC: 1,57-2,54 p&lt;=0,0001) e não na ICO (OR: 1,08 IC: 0,83-1,42 p=0,5470). CONCLUSÃO: Os pacientes diabéticos portadores de ICO apresentaram evolução hospitalar semelhante aos não diabéticos, porém, os com SIASEST e IAM demonstraram maior taxa de eventos cardíacos adversos comparados com a população não-diabética.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: This study sought to investigate the influence of Diabetes Mellitus (DM) on immediate results after coronary stenting implantation (CSI) according to clinical presentation. METHODS: Between January, 1997 and December, 2003, 11,874 diabetic patients underwent CSI, as recorded by CENIC database: 7,386 (62.3%) had chronic coronary disease (CCD); 3,142 (26.4%) acute coronary syndrome with non-ST segment elevation (ACSNST); and 1,346 (11.3%), reported acute myocardial infarction (AMI), with ST Segment elevation. Those groups were compared with 48,103 non-diabetics: 30,980 (64.5%) with CCD; 10,938 (22.7%), with non-elevated ST segments and unstable angina; and 6,185 (12.8%), with AMI. RESULTS: Diabetic patients presented worse clinical and angiographic characteristics. Diabetics with CCD showed similar incidence of MACE as compared to non-diabetics (0.98% x 0.91%, p=0.5971); however, diabetics with ACSNST and AMI reported higher incidence of events: 2.76% x 1.46% (p&lt;0.0001) and 7.87% x 4.1% (p&lt;0.0001), respectively. Multivariate analysis showed DM to act as independent risk predictor for larger adverse events under non-elevated ST segment and unstable angina (ACSNST) (OR: 1.92 CI: 1.46-2.52 p&lt;0.0001) and with AMI (OR: 2.0 CI: 1.57-2.54 p&lt;=0.0001) and no influence for CCD (OR: 1.08 CI: 0.83-1.42 p=0.5470 CONCLUSION: Diabetic patients with CCD reported similar outcome as compared to the non-diabetics; however, those with ACSNST and AMI presented higher incidence of major adverse cardiac events during hospital stay.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Diabete melito</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>stents</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>aterosclerose coronária</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Diabetes Mellitus</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>stenting</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary atherosclerosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Cardioversão elétrica e lesão miocárdica: avaliação pelos novos marcadores de injúria cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Electrical cardioversion and myocardial injury: evaluation by new cardiac injury markers</s1>
</fA08>
<fA11 dir="011000">
<s1>Elizabete Silva dos Santos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcos Paulo Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz Minuzzo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Dalmo A. R. Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rui Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Álvaro Avezum</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Ari Timerman</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Leopoldo S. Piegas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>191-197</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600306</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar, através da evolução dos novos marcadores bioquímicos de injúria cardíaca, se a cardioversão elétrica (CVE) causa lesão miocárdica. MÉTODOS: Foram avaliados 76 pacientes (P) submetidos a CVE eletiva de fibrilação atrial ou flutter atrial. Medidas de creatinafosfoquinase (CPK), CKMB-atividade e dosagem de CKMB-massa (M), mioglobina e troponina I cardíaca (cTnI) foram determinadas antes e após 6 e 24 horas da CVE. RESULTADOS: A CVE resultou um sucesso em 58 P (76,3%). A carga cumulativa (CC) foi de até 350 joules (J) em 36 P, de 500 a 650 J em 20 P e de 900 a 960 J em 20 P, com energia média aplicada de 493 J (± 309). A cTnI permaneceu dentro da normalidade nos 76 P. Com o aumento da CC, ocorreu elevação de CPK (&gt; valor de p = 0,007), CKMB-atividade (&gt; valor de p = 0,002), CKMB-M (&gt; valor de p = 0,03) e mioglobina (&gt; valor de p = 0,015). Correlação positiva foi observada entre a CC e picos de CPK (r = 0,660; p &lt; 0,001), CKMB-atividade (r = 0,429; p &lt; 0,0001), CKMB-M (r = 0,265; p = 0,02) e mioglobina (r = 0,684; p &lt; 0,0001). Correlação também positiva ocorreu entre o número de choques e picos de CPK (r = 0,770; p &lt; 0,001), CKMB-atividade (r = 0,642; p &lt; 0,0001), CKMB-M (r = 0,430; p &lt; 0,0001) e mioglobina (r = 0,745; p &lt; 0,0001). CONCLUSÃO: A CVE não causa lesão miocárdica detectável pela dosagem da cTnI. Elevações de CPK, CKMB-atividade, CKMB-M e mioglobina são decorrentes de lesão do músculo esquelético, estando correlacionadas positivamente com a CC aplicada ou com o número de choques.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Evaluate, based on the evolution of new biochemical markers of cardiac damage, if electrical cardioversion (ECV) causes myocardial injury. METHODS: Seventy-six patients (P) submitted to elective ECV for atrial fibrillation or atrial flutter were evaluated. Creatine phosphokinase (CPK), CK-MB activity, CK-MB mass, myoglobin and cardiac troponin I (cTnI) were measured before, and 6 and 24 hours after ECV. RESULTS: ECV was successful in 58 P (76.3%). Cumulative energy (CE) was up to 350 joules (J) in 36 P, from 500 to 650 J in 20 P and from 900 to 960 J in 20 P; the mean energy delivered being 493 J (± 309). The levels of cTnI remained within normal limits in all 76 P. The increase of cumulative energy led to an elevation of CPK levels (&gt; p value = 0.007), CK-MB activity (&gt; p value = 0.002), CK-MB mass (&gt; p value = 0.03), and myoglobin (&gt; p value = 0.015). A positive correlation between the cumulative energy and CPK peaks was observed (r = 0.660; p &lt; 0.001), CK-MB activity (r = 0.429; p &lt; 0.0001), CK-MB mass (r = 0.265; p = 0.02), and myoglobin (r = 0.684; p &lt; 0.0001), as well as between the number of shocks and the CPK peaks (r = 0.770; p &lt; 0.001), CK-MB activity (r = 0.642; p &lt; 0.0001), CK-MB mass (r = 0.430; p &lt; 0,0001), and myoglobin (r = 0.745; p &lt; 0.0001). CONCLUSION: ECV does not cause myocardial injury detectable by cTnI measurement. Elevations of CPK, CK-MB activity, CK-MB mass and myoglobin result from skeletal muscle injury and are positively correlated with the CE delivered or with the number of shocks.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Cardioversão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>injúria cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>troponina I cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Cardioversion</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial injury</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac troponin I.</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Diferentes padronizações do teste da caminhada de seis minutos como método para mensuração da capacidade de exercício de idosos com e sem cardiopatia clinicamente evidente</s1>
</fA08>
<fA08 dir="en">
<s1>Different patterns for the 6-minute walk test as a test to measure exercise ability in elderly with and without clinically evident cardiopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>Clênia Oliveira Araújo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Márcia R.P. Makdisse</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Paulo A.T. Peres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antônio Sérgio Tebexreni</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luis R. Ramos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Andréa M. Matsushita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Antônio C. Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>198-205</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>30</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600307</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVOS: Avaliar a correlação do consumo de oxigênio pico (VO2pico), no teste cardiopulmonar, com a distância percorrida no teste da caminhada de seis minutos (TC6) em idosos saudáveis e com infarto do miocárdio (IM). MÉTODOS: Avaliados 30 indivíduos, idade entre 65 e 87 anos (76,03 ± 4,75), divididos em 2 grupos: Grupo I - 14 com doença cardíaca clinicamente evidente (DCCE) Grupo II - 16 sem DCCE. Foram submetidos ao teste cardiopulmonar (TCP) e a 2 tipos de TC6. As variáveis mensuradas foram: a freqüência cardíaca (FC) e respiratória (FR), pressão arterial (PA), distância percorrida (DP), e a percepção subjetiva de esforço de BORG. RESULTADOS: O estudo mostrou uma forte correlação das distâncias percorridas, em ambas as formas do (TC6), com o VO2pico obtido no TCP, em todos idosos incluídos neste estudo. Na comparação entre os TC6, quando aplicado com acompanhamento (TC6ac) e sem acompanhamento (TC6s), foi observada diferença estatisticamente significante, com maiores valores médios da DP, da FC e FR, e da percepção subjetiva de esforço no TC6ac, em ambos os grupos. Além disso, a FC atingida ao final do esforço, no TC6ac, foi semelhante à obtida no TCP máximo (p &lt;0,05), sugerindo que esta forma de padronização do TC6 estimula a um maior desempenho cardiovascular. CONCLUSÃO: O TC6s, por ser submáximo, impõe uma sobrecarga cardiovascular menor do que TC6ac, sendo provavelmente mais seguro em idosos cardiopatas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVES: Evaluate the correlation between peak oxygen consumption (VO2peak), from cardiopulmonary test with the distance covered in the six-minute walk test (6MWT) in healthy elderly and with myocardial infarction (MI). METHODS: Thirty individuals were studied, with age range 65 - 87 years (76, 03± 4,75), divided into 2 groups: Group I - 14 with clinically evident coronary heart disease (CHD) and Group II - 16 without clinically evident CHD. They were submitted to cardiopulmonary test (CPT) and 2 types of 6MWT, standard test 6MWTs. Variables measure at rest and exertion were heart rate (HR) and respiratory rate (RR), blood pressure (BP), distance covered (DC), and Borg's rate subjective perceived exertion (RPE). RESULTS: The study showed significant, strong correlation between distances covered for both 6MWT, and (VO2peak) obtained from cardiopulmonary test (CPT) for all elderly included in the study. When comparing the 6MWT with physiotherapist support (6MWTphy) and without support (6MWTw), statistically significant difference was observed, with higher average values of the DC, of the RH and RR and Borg's RPE in the 6MWTphy, both of the groups. Addtionally, the RH reached at final the exertion in 6MWTphy was similar to that obtained in CPT (p&lt;0,05) suggesting that the 6MWT stimulates higher cardiovascular performance. CONCLUSION: 6MWTw, adopted a worldwide, by being submaximal imposes lower cardiovascular overburden as compared to 6MWTphy and is probably safer for elderly who are cardiopaths.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Idosos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste da caminhada</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste cardiopulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Elderly</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>walk test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiopulmonary test</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Resposta cronotrópica ao teste cardiopulmonar após o uso de cimetidina</s1>
</fA08>
<fA08 dir="en">
<s1>Effects of cimetidine on chronotropic response to cardiopulmonary exercise t esting</s1>
</fA08>
<fA11 dir="011000">
<s1>Gicela Risso Rocha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ricardo Stein</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Márcio R. Guimarães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jorge Pinto Ribeiro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>UFRGS Hospital de Clínicas de Porto Alegre Hospital Ernesto Dornelles</s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>206-210</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600308</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Testar a hipótese, por meio de ensaio clínico randomizado, de que a administração de cimetidina altera a resposta cronotrópica ao exercício. MÉTODOS: Foram selecionados 24 indivíduos saudáveis, com idade entre 20 e 68 anos, não-atletas, os quais concordaram em ser submetidos a testes cardiopulmonares, após uso de placebo e de cimetidina, 400 mg, duas vezes ao dia, durante uma semana. Os testes foram realizados em esteira rolante, com protocolo de rampa com análises diretas dos gases expirados. Foi avaliada freqüência cardíaca máxima atingida, além da freqüência cardíaca de repouso e do limiar anaeróbico. RESULTADOS: Os indivíduos estudados foram igualmente distribuídos por sexo, com idade média (± desvio padrão) de 43 ±11 anos. Os exames com placebo e com cimetidina tiveram igual duração (578±90 seg vs 603±131 seg) e igual VO2 pico (35±8 ml/kg.min vs 35±8 ml/kg.min). A administração de cimetidina não apresentou efeito significativo na freqüência cardíaca de repouso (75±10 vs 74±8 bpm), no pico do esforço (176±12 vs 176±11 bpm) e, da mesma forma, também não houve diferença entre as variações das freqüências cardíacas (pico - repouso), nos dois estudos (101±14 vs 101±13 bpm). CONCLUSÃO: A administração de cimetidina por sete dias não altera a resposta cronotrópica ao exercício.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To test the hypothesis that the administration of cimetidine will modify the chronotropic response to exercise testing through a random clinical trial. METHODS: The study selected 24 eligible healthy subjects, ages between 20 and 68 years, not athletes, who agreed to undergo cardiopulmonary exercise testing after the administration of placebo and 400 mg of cimetidine twice a day for one week. The tests were performed on a treadmill using a ramp protocol and direct analysis of the expired gases. Peak, resting and anaerobic threshold heart rate were recorded. RESULTS: The twenty subjects studied were equally distributed across sex with mean (± SD) age 43 ± 11 years. Tests on placebo and on cimetidine presented similar duration (578 ± 90 sec vs 603 ± 131 sec) and similar peak oxygen uptake (35 ± 8 ml/kg.min vs 35 ± 8 ml/kg.min). Cimetidine administration had no significant effect on resting heart rate (75 ± 10 bpm vs 74 ± 8 bpm), heart rate at peak exercise (176 ± 12 bpm vs 176 ± 11 bpm), and on the difference between the peak and the resting heart rates - delta HR (101 ± 14 bpm vs 101 ± 13 bpm). CONCLUSION: The administration of cimetidine for 7 days has no significant effect on the chronotropic response to exercise testing.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Resposta cronotrópica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste cardiopulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cimetidina</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>receptores H1 e H2</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>histamina</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chronotropic response</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiopulmonary exercise testing</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cimetidine</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>H1 and H2 receptors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>histamine</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Influência do sexo na evolução imediata e a médio prazo após a intervenção coronariana percutânea primária e análise dos fatores independentes de risco para óbito ou eventos</s1>
</fA08>
<fA08 dir="en">
<s1>Gender influence on the immediate and medium-term progression after primary percutaneous coronary intervention and analysis of independent risk factors for death or events</s1>
</fA08>
<fA11 dir="011000">
<s1>Rodrigo Trajano Sandoval Peixoto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Edison Carvalho Sandoval Peixoto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcello Augustus Sena</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Angelo Leone Tedeschi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Ivana Picone Borges</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Maurício Bastos Freitas Rachid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal Fluminense Hospital Procordis </s1>
<s2>Niterói RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>211-218</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>33</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600309</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar os fatores de risco para óbito e eventos e a influência do sexo na evolução intra-hospitalar e aos seis meses, de pacientes internados nas 12 horas iniciais do infarto agudo do miocárdio (IAM) com supradesnivelamento de ST, tratados com intervenção coronariana percutânea primária. MÉTODOS: Foram considerados 199 pacientes consecutivos, entre 07/1998 e 12/2000, com IAM e sem choque cardiogênico, sendo avaliada a evolução intra-hospitalar e em seis meses. RESULTADOS: As características clínicas eram semelhantes entre os grupos, exceto que as mulheres, que eram mais idosas que os homens (67,04 ± 11,53 x 59,70 ± 10,88, p &lt; 0,0001). A mortalidade intra-hospitalar foi maior no sexo feminino (9,1% x 1,5%, p = 0,0171), assim como a incidência de eventos maiores (12,1% x 3,0%, p = 0,0026). A diferença de mortalidade persistia em seis meses (12,1% x 1,5%, p = 0,0026). Na análise multivariada predisseram óbito: sexo feminino e octogenários e eventos e/ou angina estável: doença multiarterial e disfunção ventricular grave. CONCLUSÃO: Sexo feminino e octogenários foram fatores independentes relacionados à mortalidade seis meses após a intervenção coronariana percutânea primária.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Determine gender-related differences and risk factors for death and events, both in-hospital and at six-month evolution, of patients admitted within the first twelve hours of ST-segment elevation acute myocardial infarction and who underwent primary percutaneous coronary intervention. METHODS: Between July 1998 and December 2000, 199 consecutive patients were enrolled in the study, with elevation myocardial infarction and without cardiogenic shock, outcome, in-hospital and six-month progression were studied. RESULTS: Clinical characteristics were similar in both groups, except that women were older than men (67.04 ± 11.53 x 59.70 ± 10.88, p &lt; 0.0001). In-hospital mortality was higher among women (9.1% x 1.5%, p = 0.0171), as was the incidence of major events (12.1% x 3.0%, p = 0.0026). The difference in mortality rates remained the same at six months (12.1% x 1.5%, p = 0.0026). The multivariate analysis predicted death: female gender and an age over eighty years, and major events and/or stable angina multivessel: disease and severe ventricular dysfunction. CONCLUSION: Female gender and an age over eighty years were independent predictors of mortality, six months of patients who had undergone primary percutaneous intervention.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Angioplastia coronária primária</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto agudo do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sexo</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Primary coronary angioplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>gender</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo de prevalência e multiplicidade de fatores de risco cardiovascular em hipertensos do Município de Brusque, SC</s1>
</fA08>
<fA08 dir="en">
<s1>Study of the prevalence and multiplicity of cardiovascular risk factors in hypertensive individuals from the city of Brusque, SC, Brazil</s1>
</fA08>
<fA11 dir="011000">
<s1>Nilton Rosini</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcos José Machado</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Hermes Toros Xavier</s1>
<afiliation>A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Secretaria Municipal da Saúde de Brusque  </s1>
<s2>Brusque SC</s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal de Santa Catarina  </s1>
<s2>Florianópolis SC</s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Faculdade de Ciências Médicas de Santos  </s1>
<s2>Santos SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>219-222</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>17</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600310</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Investigar a prevalência e a multiplicidade de fatores de risco (FR) adicionais em uma amostra populacional de indivíduos hipertensos e tabagistas, diagnosticados e inscritos no Programa Hipertensos e Diabéticos do MS (HIPERDIA/Ministério da Saúde), no Município de Brusque, SC, Brasil. MÉTODOS: Determinação de parâmetros antropométricos e variáveis laboratoriais reconhecidas como fatores de risco cardiovascular. RESULTADO: Elevada prevalência de FR adicionais à hipertensão arterial (HAS) e ao tabagismo, configurando a multiplicidade que concorre com uma elevação acentuada do risco de eventos cardiovasculares nessa amostra populacional. CONCLUSÃO: Em populações de hipertensos, medidas de prevenção, identificação e controle de FR devem ser implementadas e programas informatizados, como o Hiperdia/MS, podem auxiliar no seguimento dos pacientes, possibilitando uma abordagem multidisciplinar mais criteriosa, sobretudo na análise do alcance das metas de tratamento e conseqüente redução de risco cardiovascular.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To investigate the prevalence and multiplicity of additional risk factors (RF) in a population sample of hypertensive smokers, diagnosed and enrolled at the Hiperdia Program of the Ministry of Health, in the city of Brusque, SC, Brazil. METHODS: Determination of the anthropometrical parameters and laboratory variables recognized as cardiovascular risk factors. RESULTS: Elevated prevalence of RF in addition to systemic arterial hypertension (SAH) and smoking, configuring the multiplicity that concurs with a marked elevation of the risk of cardiovascular events in this population sample. CONCLUSION: In hypertensive populations, the prevention, identification and RF control measures must be implemented; computerized programs such as the Hiperdia/MS can help in patients' follow-up, allowing a more stringent multidisciplinary approach, especially regarding the analysis of the attainment of treatment goals and the subsequent decrease of cardiovascular risk.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Fatores de risco cardiovascular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertensão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tabagismo</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Cardiovascular risk factors</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>arterial hypertension</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>smoking</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Correlação entre marcadores bioquímicos e a cineangiocoronariografia em portadores de síndromes isquêmicas agudas sem supradesnivelamento de segmento ST</s1>
</fA08>
<fA08 dir="en">
<s1>Correlation between biochemical markers and coronary angiography in patients with non-ST elevation acute coronary syndromes</s1>
</fA08>
<fA11 dir="011000">
<s1>Cynthia Karla Magalhães</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Aristarco Gonçalves de Siqueira Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>José Geraldo de Castro Amino</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Mônica Nolasco</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal do Rio de Janeiro Cardiobarra Clínicas </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>223-231</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>31</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600311</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Investigar associação entre marcadores bioquí­micos (TN-I, PCRt e fibrinogênio) e achados cineangiocoronariográficos em portadores de síndrome isquêmica aguda sem supradesnivelamento de segmento ST (SIA sem supra ST). MÉTODOS: Obtida amostra sangüínea única para dosagem dos marcadores, e cineangiocoronariografia (CINE) realizada até 72 horas da internação. Análise univariada para investigar relação dos três marcadores com os achados na CINE, no grupo com artéria responsável pela isquemia (ARI) identificada, e análise multivariada para investigar relação desses marcadores com a presença de lesão aterosclerótica instável, apenas no grupo com obstrução coronariana &gt;50%. RESULTADOS: Estudo prospectivo, com 84 pacientes, 65,5% do sexo masculino. No grupo onde identificou-se a ARI, os valores séricos dos três marcadores foram superiores, quando comparados aos grupos sem ARI identificada ou com coronárias normais. No grupo com ARI identificada, houve correlação entre fluxo TIMI e TN-I (p = 0,006), lesão aterosclerótica instável e TN-I e fibrinogênio (p = 0,02 e p = 0,01, respectivamente) e doença multiarterial e PCRt (p = 0,0005). Na análise multivariada, os três marcadores foram preditores independentes da presença de lesão aterosclerótica instável (p = 0,002, p = 0,003 e p = 0,007, respectivamente, para PCR, fibrinogênio e TN-I). CONCLUSÃO: Em portadores de SIA sem supra ST, a dosagem sérica de TN-I, PCR e fibrinogênio nas primeiras dez horas da internação se correlacionou a achados angiográficos.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Investigate the correlation between biochemical markers (TNI, CRP and fibrinogen) and anatomical coronary angiographic findings in patients with non-ST elevation acute coronary syndromes (NSTE-ACS). METHODS: One blood sample was obtained to test for markers, and coronary angiography was performed within the first 72 hours after hospitalization. Univariate analysis was used to search for correlations between the 3 markers and the angiographic findings in the group of patients with an identified ischemia-related artery (IRA), and multivariate analysis was performed to investigate the correlation between these markers and the presence of unstable atherosclerotic lesions solely in the group with a coronary obstruction &gt;50%. RESULTS: Prospective study conducted with 84 patients, 65.5% of whom were men. In the IRA-identified group, blood levels of the three markers were higher than in the groups with no IRA-identified or with normal coronary arteries. The analysis used to evaluate the IRA-identified group showed significant correlations between TIMI flow and TN-I (p = 0.006), unstable atherosclerotic lesions and TN-I and fibrinogen (p = 0.02 and p = 0.01, respectively), and multivessel disease and CRP (p = 0.0005). The multivariate analysis showed that CRP, fibrinogen and TN-I were independent predictors of unstable atherosclerotic lesions (p = 0.002; p = 0.003 and p = 0.007, respectively). CONCLUSION: In NSTE-ACS patients, TN-I, CRP and fibrinogen blood levels within the first 10 hours after hospitalization correlated with coronary angiographic findings.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Síndromes isquêmicas agudas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>inflamação</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>trombose</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>injúria miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Acute coronary syndromes</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>inflammation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>thrombosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial injury</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Estudo comparativo entre a pressão positiva intermitente (Reanimador de Müller) e contínua no pós-operatório de cirurgia de revascularização do miocárdio</s1>
</fA08>
<fA08 dir="en">
<s1>Comparative study between intermittent (Müller Reanimator) and continuous positive airway pressure in the postoperative period of coronary artery bypass grafting</s1>
</fA08>
<fA11 dir="011000">
<s1>Andréa Pires Müller</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Márcia Olandoski</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Rafael Macedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Constantino Costantini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz César Guarita-Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica do Paraná Hospital Costantini </s1>
<s2>Curitiba PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>232-239</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>24</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600312</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Comparar o efeito da aplicação da pressão positiva intermitente e contínua em pacientes no pós-operatório de cirurgia de revascularização do miocárdio. MÉTODOS: Neste estudo foram considerados quarenta pacientes, divididos em dois grupos: um submetido a pressão positiva contínua (Grupo CPAP), e outro submetido a pressão intermitente (Grupo Reanimador de Müller). Os pacientes foram avaliados nos momentos: pré-operatório, 3ª, 24ª e 48ª horas, em relação às diversas variáveis do estudo. RESULTADOS: Os grupos de pacientes eram homogêneos em relação a diversas variáveis demográficas e clínicas. Os valores gasométricos de PO2, PCO2 e SO2 estiveram dentro dos parâmetros de normalidade e não foram encontradas diferenças significantes entre os grupos. Na ventilometria os grupos apresentaram diferenças significativas no volume corrente e freqüência respiratória no pós-operatório de 48 horas. A dispnéia e a participação da musculatura acessória, nas avaliações do pós-operatório, foram encontradas com freqüência significativamente maior nos pacientes submetidos ao CPAP. Pacientes submetidos ao Reanimador de Müller apresentaram radiografia de tórax normal com maior freqüência do que pacientes submetidos ao CPAP. CONCLUSÃO: Observou-se que ambos os recursos foram capazes de manter valores de PO2, PCO2 e SO2 dentro da normalidade. Porém, quando se busca a reexpansão pulmonar, com menor carga de trabalho imposta, o Reanimador de Müller foi mais efetivo pela forma mais rápida de ação e, conseqüentemente, apresentou menores índices de dispnéia, freqüência respiratória (FR) e atividade de musculatura acessória.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To compare the effect of the use of intermittent and continuous positive airway pressure in postoperative patients undergoing coronary artery bypass grafting. METHODS: This study included forty patients divided into two groups: one undergoing continuous positive airway pressure (CPAP Group), and the other undergoing intermittent pressure (Müller Resuscitator Group). The patients were evaluated in relation to the several study variables at the following time points: preoperative, 3rd, 24th, and 48th hours. RESULTS: The patient groups were homogeneous in relation to the several demographic and clinical variables. The values of pO2, pCO2 and sO2 were within normal limits and no significant differences were found between the groups. Regarding respirometry, the groups showed significant differences in the tidal volume and respiratory rate at the 48th postoperative hour. Dyspnea and use of accessory muscle in postoperative assessments were found with a significantly higher frequency in patients undergoing CPAP. Patients undergoing Müller Resuscitator had a normal chest radiograph more frequently than did patients undergoing CPAP. CONCLUSION: Both devices were shown to be able to keep pO2, pCO2, and sO2 values within normal limits. However, when the objective was pulmonary reexpansion with less imposed workload, the Müller Resuscitator was more effective because of its prompter action and consequently lower levels of dyspnea, respiratory rate (RR) and use of accessory muscle were observed.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>IPPB</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>pressão positiva contínua nas vias aéreas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fisioterapia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>IPPB</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>continuous positive airway pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>physical therapy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>3</s2>
</fA06>
<fA08 dir="pt">
<s1>Monocitose é um marcador de risco independente para a doença arterial coronariana</s1>
</fA08>
<fA08 dir="en">
<s1>Monocytosis is an independent risk marker for coronary artery disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Abrahão Afiune Neto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Antonio de Pádua Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Solange Desirée Avakian</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Everly P. S. G. Gomes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Antonio F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>240-244</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600313</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVOS: Inflamação e ativação das células do sistema imunológico têm participação importante na patogênese da aterosclerose. Este estudo analisa o leucograma que incluiu neutrófilos, eosinófilos, linfócitos, monócitos e basófilos dos pacientes com doença arterial coronariana (DAC) crônica e no infarto agudo do miocárdio (IAM). MÉTODOS: Analisamos o leucograma de 232 pacientes não-diabéticos, com idade entre 15 e 88 anos. A DAC estava presente em 142 pacientes (57 com DAC estável e 85 com IAM), diagnosticada angiograficamente, comparada a 90 indivíduos-controle. Os grupos controle e DAC foram comparáveis para a idade, índice de massa corpórea, antecedentes familiares, tabagismo, hipertensão, HDL e LDL (todas variáveis com p &gt; 0,25). RESULTADOS: A análise univariada mostrou maior prevalência de leucocitose na DAC, sendo maior nos pacientes com IAM quando comparados com a DAC estável. O mesmo comportamento foi observado para os monócitos. Porém, a distribuição foi semelhante para as demais células do hemograma. A análise multivariada pelo método da regressão logística, utilizando-se os modelos stepwise (todas variáveis) e backward (p &lt; 0,25), mostrou que a monocitose foi variável independente para DAC e para o IAM. CONCLUSÃO: O número de monócitos, um dos mais importantes componentes do processo inflamatório na placa aterosclerótica, foi um marcador de risco independente para a DAC e para o IAM.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVES: Inflammation and activation of immune system cells play an important role in the pathogenesis of atherosclerosis. This study analyzes the white blood count, including neutrophils, eosinophils, lymphocytes, monocytes and basophils, of patients with chronic coronary artery disease (CAD) and acute myocardial infarction (AMI). METHODS: The white blood cell count was analyzed in 232 patients without diabetes between the ages of 15 and 88. One hundred and forty-two patients were angiographically diagnosed with CAD (57 with stable CAD and 85 with AMI) and compared to 90 control individuals. The control and CAD groups were similar in respect to age, body mass index, family history, smoking habits, hypertension, HDL and LDL (all variables with p &gt; 0.25). RESULTS: The univariate analysis revealed a higher prevalence of leukocytosis in the CAD group, which in turn was higher in the AMI patients than the stable CAD patients. The same trend was observed for monocytes. However, the distribution of all other cells in the complete blood count (CBC) was similar. Multivariate analysis using the logistic regression method with the stepwise (all variables) and backward models (p &lt; 0.25), showed that monocytosis was an independent variable for CAD and AMI. CONCLUSION: The number of monocytes, one of the most important components of the inflammatory process in the atherosclerosis plaque was an independent risk marker for CAD and AMI.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Aterosclerose</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença arterial coronariana</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>infarto agudo do miocárdio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hemograma, leucocitose</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>monocitose</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>inflamação</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Atherosclerosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary artery disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>acute myocardial infarction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>hemograma, leukocytosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>monocytosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>inflammation</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Stents com eluição de sirolimus para tratamento de estenose em artérias coronárias de pequeno calibre: o que aprendemos?</s1>
</fA08>
<fA08 dir="en">
<s1>Sirolimus-eluting stents for the treatment of stenoses in small coronary arteries: what have we learned?</s1>
</fA08>
<fA11 dir="011000">
<s1>Ricardo A. Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Alexandra J. Lansky</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Columbia University Medical Center Cardiovascular Research Foundation </s1>
<s2>Nova York NY</s2>
<s3>USA</s3>
</fA14>
<fA20 dir="000000">
<s1>245-248</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600401</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Predição de duração de tratamento e recorrência em pacientes portadores de síncope vasovagal: há luz no fim do túnel?</s1>
</fA08>
<fA08 dir="en">
<s1>Predicting therapy duration and recurrence in patients with vasovagal syncope: is there light at the end of the tunnel?</s1>
</fA08>
<fA11 dir="011000">
<s1>Carlos A. Morillo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>McMaster University Departamento de Medicina Unidade de Síncope e Distúrbios Autonômicos</s1>
<s2>Hamilton ON</s2>
<s3>Canada</s3>
</fA14>
<fA20 dir="000000">
<s1>249-250</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600402</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Aplicações clínicas do peptídeo natriurético do tipo B</s1>
</fA08>
<fA08 dir="en">
<s1>Clinical applications of B-type natriuretic peptide assays</s1>
</fA08>
<fA11 dir="011000">
<s1>Humberto Villacorta Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>251-255</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600403</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Evolução clínica de pacientes com síncope neurocardiogênica (SNC) após suspensão da terapia específica</s1>
</fA08>
<fA08 dir="en">
<s1>Clinical outcome of patients with neurocardiogenic syncope (NCS) after therapy interruption</s1>
</fA08>
<fA11 dir="011000">
<s1>Silvana Bastos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Mauricio Scanavacca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Francisco Darrieux</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Ana Cristina Ludovice</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Eduardo Sosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Denise Tessariol Hachul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>256-260</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>35</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600404</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a evolução clínica de pacientes com SNC após a suspensão do tratamento farmacológico e investigar as possíveis variáveis clínicas preditivas de recidiva. MÉTODOS: Trinta e sete pacientes (média de idade de 31 &amp;plusmn; 16 anos) com SNC recidivante refratária, dos quais 19 eram mulheres, foram estudados prospectivamente. Todos os pacientes estavam assintomáticos e apresentaram teste de inclinação ortostática (TI) negativo após a introdução da terapia farmacológica. Um novo TI foi realizado um mês após a suspensão do tratamento. A probabilidade livre de sintomas foi analisada de acordo com sexo, idade, número de síncopes prévias ao tratamento, tempo de história clínica, tempo de tratamento, resultado do TI após interrupção do tratamento e período sem medicação. RESULTADOS: Vinte e dois pacientes (59%) apresentaram recidiva durante um acompanhamento médio de 21 &amp;plusmn; 19,7 meses. As variáveis relacionadas com maior recidiva foram número de síncopes anteriores (p = 0,0248), TI positivo após a suspensão da terapia (p = 0,0002) e sexo feminino (p = 0,0131). CONCLUSÕES: A maior parte dos pacientes altamente sintomáticos com SNC apresenta recidiva após a supressão do tratamento. A realização do TI após a suspensão do tratamento pode identificar os pacientes com maior risco de recidiva, sobretudo durante o primeiro ano de acompanhamento.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the outcome of patients with NCS after interruption of pharmacological therapy and to investigate the possible clinical variables predicting recurrence. METHODS: Thirty-seven patients (age 31&amp;plusmn;16 years) with refractory recurrent NCS being 19 females where prospectively studied. All patients became asymptomatic and had a negative tilt table test (TT) after pharmacological therapy. The treatment was interrupted and one month later, a new TT with no medication was carried out. The probability free of symptoms recurrence was analyzed according to sex, age, number of syncope episodes previously to the treatment, clinical history time, treatment time, drug free from treatment time and TT result. RESULTS: Twenty-two patients (59%) presented recurrence during a mean follow-up of 21&amp;plusmn;19.7 months. The variables related to greater recurrence were number of previous syncope (p=0.0248), positive TT after interruption of the therapy (p=0.0002) and female gender (p= 0.0131). CONCLUSIONS: Most of the very symptomatic patients with NCS present recurrence after the suppression of a specific therapy. A TT carried out after treatment discontinuation can identify patients with higher risk of recurrence, specially in the first year of follow-up.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Síncope neurocardiogênica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>teste de inclinação</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tratamento</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Vasovagal syncope</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tilt -table test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>treatment</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Aspectos técnicos da cateterização do seio coronariano baseada no componente atrial do eletrograma intracavitário e anatomia radiológica durante o procedimento de implante de marcapasso biventricular</s1>
</fA08>
<fA08 dir="en">
<s1>Technical aspects of coronary sinus catheterization based on the atrial component of the intracavitary electrogram and radiological anatomy during the implantation procedure of a biventricular pacemaker</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Sérgio Oliva de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Nicola Luciano Mortati</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Domingo Marcolino Braile</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Reinaldo Wilson Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Salomon Ordinola Rojas</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Alessandre Caputo Rabelo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Januário Manuel de Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Sérgio Almeida de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de Campinas Real e Benemérita Sociedade Portuguesa de Beneficência </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>261-267</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>23</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600405</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Apresentar uma proposição técnica baseada na experiência de 130 implantes utilizando técnica simplificada para cateterização do seio coronariano, baseada no componente atrial do eletrograma intracavi-tário e anatomia radiológica. MÉTODOS: De outubro de 2001 a outubro de 2004 foram realiza-dos 130 implantes de marcapasso biventricular, utilizando-se anatomia radiológica e observação de eletrograma intracavitário, com prioridade ao componente atrial. RESULTADOS: O implante do sistema, utilizando-se a estimulação do ventrículo esquerdo via seio coronariano, não foi possível em 8 pacientes. Em 12 pacientes foram observadas dificuldades na canulação do óstio coronário e em 15 pacientes observaram-se dificuldades de progressão do eletrodo através do seio coronariano. O tempo médio de utilização de radioscopia foi de 18,69 min. CONCLUSÃO: A técnica de implante, utilizando a morfologia do componente atrial do eletrograma intracavitário e anatomia radiológica, demonstrou ser pouco trabalhosa, segura e eficaz para canulação do óstio do seio coronariano, necessitando de reduzido tempo de radioscopia.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To present a technical proposal based on the experience of 130 implantations using a simplified technique for coronary sinus catheterization, based on the atrial component of the intracavitary electrogram and radiological anatomy. METHODS: From October, 2001 to October, 2004, 130 biventricular pacemaker implantations were performed, using radiological anatomy and observation of the intracavitary electrogram, focusing on the atrial component. RESULTS: The implantation of the system using left ventricular pacing via coronary sinus was not possible in 8 patients. Difficulties on the cannulation of the coronary ostium were felt in 12 patients and difficulties of lead advancement through the coronary sinus were felt in 15 patients. The mean time of radioscopy utilization was 18.69 min. CONCLUSION: The implantation technique, using the atrial component morphology of the intracavitary electrogram and radiological anatomy showed to be workless, safe and effective for the cannulation of the coronary sinus ostium requesting reduced time of radioscopy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Insuficiência cardíaca congestiva</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>miocardiopatia dilatada</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>marcapasso artificial</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Congestive heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dilated cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>pacemaker</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>A exposição à fumaça de cigarro intensifica a remodelação ventricular após o infarto agudo do miocárdio</s1>
</fA08>
<fA08 dir="en">
<s1>Cigarette smoke exposure intensifies ventricular remodeling process following myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Leonardo A. M. Zornoff</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Beatriz B. Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz S. Matsubara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcos F. Minicucci</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Paula S. Azevedo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Álvaro O. Camapanha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Sergio A. R. Paiva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Unesp Faculdade de Medicina de Botucatu </s1>
<s2>Botucatu SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>276-282</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>28</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600407</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar os efeitos da exposição à fumaça de cigarro (EFC) na remodelação ventricular após o infarto agudo do miocárdio (IAM). MÉTODOS: Ratos foram infartados e distribuídos em dois grupos: C (controle, n = 31) e F (EFC: 40 cigarros/dia, n = 22). Após seis meses, foi realizado ecocardiograma, estudo funcional com coração isolado e morfometria. Para comparação, foi utilizado o teste t (com média &amp;plusmn; desvio padrão) ou teste de Mann-Whitney (com mediana e percentis 25 e 75). RESULTADOS: Os animais EFC apresentaram tendência a maiores áreas ventriculares diastólicas (C = 1,5 &amp;plusmn; 0,4 mm², F = 1,9 &amp;plusmn; 0,4 mm²; p = 0,08) e sistólicas (C = 1,05 &amp;plusmn; 0,3 mm², F = 1,32 &amp;plusmn; 0,4 mm²; p = 0,08) do VE. A função sistólica do VE, avaliada pela fração de variação de área, tendeu a ser menor nos animais EFC (C = 31,9 &amp;plusmn; 9,3 %, F = 25,5 &amp;plusmn; 7,6 %; p = 0,08). Os valores da - dp/dt dos animais EFC foram estatisticamente inferiores (C = 1474 &amp;plusmn; 397 mmHg, F = 916 &amp;plusmn; 261 mmHg; p = 0,02) aos animais-controle. Os animais EFC apresentaram maior peso do VD, ajustado ao peso corporal (C = 0,8 &amp;plusmn; 0,3 mg/g, F = 1,3 &amp;plusmn; 0,4 mg/g; p = 0,01), maior teor de água nos pulmões (C = 4,8 (4,3-4,8)%, F = 5,4 (5,1-5,5); p = 0,03) e maior área seccional do miócito do VE (C = 239,8 &amp;plusmn; 5,8 &amp;micro;m², F = 253,9 &amp;plusmn; 7,9 &amp;micro;m²; p = 0,01). CONCLUSÃO: A exposição à fumaça de cigarro intensifica a remodelação ventricular após IAM.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the role of cigarette smoke exposure (CSE) on ventricular remodeling following acute myocardial infarction (AMI). METHODS: Rats were submitted to myocardial infarction and divided into two groups: C (control, n = 31) and F (CSE: 40 cigarettes/day, n = 22). After 6 months, the survivors were submitted to echocardiogram, functional study with isolated heart, and morphometric analysis. For comparison purposes, we used the t test (mean &amp;plusmn; standard deviation) or the Mann-Whitney test (with median and 25th and 75th percentiles). RESULTS: The CSE animals tended to have larger diastolic (C = 1.5 &amp;plusmn; 0.4 mm², F = 1.9 &amp;plusmn; 0.4 mm²; p = 0.08) and systolic (C = 1.05 &amp;plusmn; 0.3 mm², F = 1.32 &amp;plusmn; 0.4 mm²; p = 0.08) left ventricular(LV) areas. The systolic function of the LV, assessed according to the fractional area change, tended to be impaired in CSE animals (C = 31.9 &amp;plusmn; 9.3%, F = 25.5 &amp;plusmn; 7.6%; p = 0.08). The - dp/dt values for CSE animals were statistically lower (C = 1474 &amp;plusmn; 397 mmHg, F = 916 &amp;plusmn; 261 mmHg; p = 0.02) than for control animals. The CSE animals presented higher right ventricle (RV) weight adjusted for body weight (C = 0.8 &amp;plusmn; 0.3 mg/g, F = 1.3 &amp;plusmn; 0.4 mg/g; p = 0.01), higher content of water in lungs (C = 4.8 (4.3-4.8)%, F = 5.4 (5.1-5.5); p = 0.03), and larger LV myocyte cross-sectional areas (C = 239.8 &amp;plusmn; 5.8 &amp;micro;m², F = 253.9 &amp;plusmn; 7.9 &amp;micro;m²; p = 0.01). CONCLUSION: Cigarette smoke exposure intensifies ventricular remodeling following acute myocardial infarction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Função ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dilatação ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>hipertrofia ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Ventricular function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular dilatation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular hypertrophy</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Correlação e concordância entre medidas ecocardiográficas obtidas durante o exame no ecocardiógrafo com medidas de imagens digitalizadas: estudo transversal</s1>
</fA08>
<fA08 dir="en">
<s1>Correlation and concordance between echocardiographic measurements obtained during echocardiography and digitized image measurements: transversal study</s1>
</fA08>
<fA11 dir="011000">
<s1>Maria Amélia Bulhões Hatem</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Iran Castro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Domingos M. Hatem</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Marcos Zuccolotto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Adalberto Schuck Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Lucia C. Pellanda</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Fernanda Pandolfo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Flávia Feier</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Fundação Universitária de Cardiologia Instituto de Cardiologia do Rio Grande do Sul </s1>
<s2>Porto Alegre RS</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>283-288</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>21</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600408</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a correlação e concordância entre medidas ecocardiográficas das dimensões cardíacas, obtidas através do aplicativo Echo off-line (programa para obtenção de medidas de imagens digitalizadas em estação de trabalho dedicada), com as realizadas convencionalmente. MÉTODOS: Estudo transversal, contemporâneo, sendo randomizados 56 pacientes. Através do programa Echo off-line foram mensuradas as medidas ao modo M e 2D ao nível dos ventrículos, do átrio esquerdo e da aorta. Estas medidas foram comparadas às realizadas por outro profissional, através do teste de correlação de Pearson (r), com alfa crítico de 0,05 e pela análise de concordância (Bland e Altman). RESULTADOS: As mensurações realizadas no sistema Echo off-line demonstraram r de 0,85 a 0,98. A análise de concordância mostrou que, para a maioria das medidas, a diferença média entre os métodos foi aproximadamente zero. A variação de valores absolutos não apresentou, em média, significância clínica. O aplicativo Echo off-line permite uma redução de, aproximadamente, 30% no tempo para realização das medidas. CONCLUSÃO: Este trabalho demonstrou a acurácia do programa Echo off-line para mensurar as dimensões cardíacas em estação de trabalho dedicada, podendo ser utilizado rotineiramente nos laboratórios de ecocardiografia.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the correlation and concordance between the measurements of echocardiographic analysis of cardiac dimensions obtained through the Echo off-line applicative (software for obtaining digitized image measurements in a dedicated workstation) available to public domain, and those obtained through the conventional method. METHOD: Transversal contemporary study, of 56 randomized patients whose images were obtained during examina-tions. The measurements of the M mode and 2D, were done in the ventricles, left atrium, and aorta by the Echo off-line program. These measurements were compared to those obtained by another professional, through Pearson's correlation test (r), alpha = 0.05 and by concordance analysis (Bland and Altman). RESULT: The measurements carried out by the Echo off-line system showed r that varied from 0.85 to 0.98. The analysis of concordance showed that for most measu-rements, the mean difference between the methods was approximately zero. The variation of absolute values did not show, in average, a clinical significance. The Echo off-line applicative allows a reduction of approximately 30% in the time spent to obtain the measurements. CONCLUSION: This study demonstrated the accuracy of the Echo off-line program to measure cardiac dimensions in a dedicated workstation, showing that it can be routinely used in echocardiography labs.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Interpretação de imagem guiada por computação</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>programa de domínio público</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Interpretation of image guided by computer</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>public domain program</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeitos de um programa de exercício físico não-supervisionado e acompanhado a distância, via internet, sobre a pressão arterial e composição corporal em indivíduos normotensos e pré-hipertensos</s1>
</fA08>
<fA08 dir="en">
<s1>The effects of nonsupervised exercise program, via internet, on blood pressure and body composition in normotensive and pré-hipertensive individuals</s1>
</fA08>
<fA11 dir="011000">
<s1>Ana Paula de Oliveira Barbosa Nunes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Aline Cristina dos Santos Rios</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Gisela Arsa da Cunha</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Carlos Pereira Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Carlos Eduardo Negrão</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Escola de Educação Física e Esporte da Universidade de São Paulo Secretaria Municipal de Saúde</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>289-296</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>41</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600409</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Verificar os efeitos de um programa de condicionamento físico não-supervisionado e acompanhado via internet, por um período de seis meses, na pressão arterial e composição corporal em indivíduos normotensos e pré-hipertensos. MÉTODOS: Participaram 135 indivíduos divididos em dois grupos: 1) normotenso (n = 57), 43 &amp;plusmn; 1 anos, pressão arterial sistólica (PAS) &lt; 120 e diastólica (PAD) &lt; 80 mmHg (GI); e 2) pré-hipertenso (n = 78), 46 &amp;plusmn; 1 anos, PAS de 120 a 139 e PAD de 80 a 89 mmHg (GII). RESULTADOS: Após três e seis meses de condicionamento físico, os indivíduos GII apresentaram redução significativa na PAS (-3,6 &amp;plusmn; 0,94 e -10 &amp;plusmn; 0,94 mmHg, p &lt; 0,05, respectivamente) e PAD (-6,5 &amp;plusmn; 1 e -7,1 &amp;plusmn; 0,9 mmHg, p &lt; 0,05, respectivamente), peso corporal (-1,12 &amp;plusmn; 0,26 e -1,25 &amp;plusmn; 0,31 kg, p &lt; 0,05, respectivamente), IMC (-0,79 &amp;plusmn; 0,4 e -0,84 &amp;plusmn; 0,41 kg/m2, p &lt; 0,05, respectivamente) e circunferência da cintura (-1,12 &amp;plusmn; 0,53 e -1,84 &amp;plusmn; 0,56 cm, p &lt; 0,05, respectivamente). No GI, o condicionamento físico diminuiu a circunferência da cintura no sexto mês (-1,6 &amp;plusmn; 0,63 cm, p &lt; 0,05). CONCLUSÃO: Este programa diminui a pressão arterial, peso corporal, IMC e circunferência da cintura em indivíduos pré-hipertensos, constituindo-se, portanto, numa estratégia segura e de baixo custo na prevenção de doenças cardiovasculares e melhoria da condição de saúde da população.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To verify the effects of a six-month non-supervised physical training program followed via the Internet on blood pressure and body composition in normotensive and borderline hypertensive individuals. METHODS: One hundred and thirty five individuals were divided into two groups: 1) normotensive individual (n = 57), 43 &amp;plusmn; 1 years of age, systolic blood pressure (SBP) &lt; 120 and diastolic blood pressure (DBP) &lt; 80 mmHg (GI); and 2) borderline hypertensive individual (n = 78), 46 &amp;plusmn; 1 years of age, SBP 120 to 139 and DBP 80 to 89 mmHg (GII). RESULTS: After a three and six-month physical training, GII individuals showed a significant reduction in SBP (-3.6 &amp;plusmn; 0.94 and -10 &amp;plusmn; 0.94 mmHg, p &lt; 0.05, respectively) and PAD (-6.5 &amp;plusmn; 1 and -7.1 &amp;plusmn; 0.9 mmHg, p &lt; 0.05, respectively), body weight (-1.12 &amp;plusmn; 0.26 and -1.25 &amp;plusmn; 0.31 kg, p &lt; 0.05, respectively), BMI (-0.79 &amp;plusmn; 0.4 and -0.84 &amp;plusmn; 0.41 kg/m², p &lt; 0.05, respectively) and waist circumference (-1.12 &amp;plusmn; 0.53 and -1.84 &amp;plusmn; 0.56 cm, p &lt; 0.05, respectively). In the GI group, the physical training led to a decrease in waist circumference at the sixth month (-1.6 &amp;plusmn; 0.63 cm, p &lt; 0.05). CONCLUSION: This program decreases blood pressure, body weight, BMI, and waist circumference in borderline hypertensive individuals, and is therefore a safe and low-cost strategy in the prevention of cardiovascular diseases and improvement of health status of the population.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Condicionamento físico não-supervisionado</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>pressão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>composição corporal</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Non-supervised physical training</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>body composition</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Aspectos clínicos e terapêuticos da insuficiência cardíaca por doença de Chagas</s1>
</fA08>
<fA08 dir="en">
<s1>Clinical and therapeutics aspects of heart failure due to Chagas disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Julio Cesar Vieira Braga</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Francisco Reis</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Roque Aras</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Nei Dantas Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Claudilson Bastos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Renata Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Alana Soares</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Ademir Moura Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Silvana Ásfora</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Adriana Lopes Latado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal da Bahia  </s1>
<s2>Salvador BA</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>297-302</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600410</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Descrever as características clínicas e terapêuticas de pacientes com insuficiência cardíaca (IC) secundária a miocardiopatia chagásica crônica, bem como avaliar se estas são diferentes nas demais etiologias. MÉTODOS: Foram analisados prospectivamente pacientes atendidos no período de agosto de 2003 a junho de 2004, em um ambulatório de referência para IC. RESULTADOS: Foram incluídos 356 pacientes com o diagnóstico de IC. Miocardiopatia chagásica foi a etiologia mais freqüente, (48% dos casos). Outras etiologias foram miocardiopatia hipertensiva em 19%, dilatada idiopática em 11%, e isquêmica em 9%. Pacientes com IC secundária a miocardiopatia chagásica tinham com maior freqüência etnia não-branca (88 x 75%; p = 0,002), história familiar de doença de Chagas (57 x 21%; p = 0,001), maior tempo de doença (71 x 56 meses; p = 0,034), menor escolaridade (4,4 &amp;plusmn; 4,1 x 5,7 &amp;plusmn; 4,2 anos de estudo; p = 0,004), menor freqüência cardíaca (69 &amp;plusmn; 12 x 73 &amp;plusmn; 13; p = 0,03) e pressão arterial sistólica (121 &amp;plusmn; 25 x 129 &amp;plusmn; 28 mmHg; p = 0,006). Utilizavam com maior freqüência amiodarona (22 x 13%; p = 0,036) marcapassos artificiais (15 x 1%; p = 0,001) e com menor freqüência drogas betabloqueadoras (39 x 59%; p = 0,001). CONCLUSÃO: Nessa amostra de pacientes ambulatoriais com IC, em um estado com alta prevalência de doença de Chagas, miocardiopatia chagásica foi a etiologia mais freqüente, apresentando algumas características clínicas e terapêuticas diferentes dos demais pacientes.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: Describe the clinical and therapeutic characteristics of patients with heart failure (HF) secondary to chronic chagasic cardiomyopathy and evaluate if these characteristics are different from those found in other etiologies. METHODS: A prospective analysis of the patients treated between August 2003 and June 2004 at a HF referral outpatient clinic was conducted. RESULTS: Three hundred and fifty six patients diagnosed with HF were included in the study. Chagasic cardiomyopathy was the most common etiology (48% of the cases). Other etiologies included hypertensive cardiomyopathy in 19% of the patients, idiopathic dilated in 11% and ischemic in 9%. Patients with HF secondary to chagasic cardiomyopathy were more frequently from non-white ethnic groups (88 vs. 75%; p = 0.002), had a family history of Chagas disease (57 vs. 21%; p = 0.001), had the disease for a longer length of time (71 vs. 56 months; p = 0.034), had lower levels of education (4.4 &amp;plusmn; 4.1 vs. 5.7 &amp;plusmn; 4.2 years of study; p = 0.004), had a lower heart rate (69 &amp;plusmn; 12 vs. 73 &amp;plusmn; 13; p = 0.03) and a lower systolic blood pressure (121 &amp;plusmn; 25 vs. 129 &amp;plusmn; 28 mmHg; p = 0.006). There was also a higher incidence of the use of amiodarone (22 vs. 13%; p = 0.036) and artificial pacemakers (15 vs. 1%; p = 0.001). There was a lower usage of beta-blockers (39 vs. 59%; p = 0.001). CONCLUSION: In this sample of HF outpatients, in a state with a high prevalence of Chagas disease, chagasic cardiomyopathy was the most common etiology and they presented some unique clinical and therapeutic characteristics in comparison to other heart failure patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Miocardiopatia chagásica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>epidemiologia</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagasic cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>epidemiology</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Pseudo-aneurisma iatrogênico de artéria axilar</s1>
</fA08>
<fA08 dir="en">
<s1>Atrogenic pseudoaneurysm of axillary artery</s1>
</fA08>
<fA11 dir="011000">
<s1>Amélia Cristina Seidel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Fausto Miranda Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Leandro V. Fregadolli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo Universidade Estadual de Maringá </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>303-305</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600411</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Ecocardiografia tridimensional em tempo real em paciente portador de cardiomiopatia hipertrófica</s1>
</fA08>
<fA08 dir="en">
<s1>Real time tridimensional echocardiography in a patient with hypertrophic cardiomyopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo Luiz Campos Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Prasad Maddukuri</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Natesa G. Pandian</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Wilson Mathias Jr.</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José A. F. Ramires</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Tufts University New England Medical Center </s1>
<s2>Boston MA</s2>
<s3>USA</s3>
</fA14>
<fA20 dir="000000">
<s1>306-307</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600412</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Dissecção espontânea de artéria coronária causando síndrome coronariana aguda</s1>
</fA08>
<fA08 dir="en">
<s1>Spontaneous coronary artery dissection causing acute coronary syndrome</s1>
</fA08>
<fA11 dir="011000">
<s1>Francisco Juarez C. Vasconcelos Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Erirtônio F. Barreto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Raimundo Barbosa Barros</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Imara C. L. Queiroz</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rômulo Ronkaly G. Lima</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital de Messejana  </s1>
<s2>Fortaleza CE</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>308-309</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600413</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 2/06 - insuficiência cardíaca na evolução tardia depois de infarto do miocárdio em mulher de 33 anos de idade</s1>
</fA08>
<fA08 dir="en">
<s1>Case 2/06 - heart failure in a 33 year-old woman in the late follow-up after myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Otavio Celeste Mangili</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo J. Moffa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Luiz Alberto Benvenuti</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Instituto do Coração do Hospital das Clínicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>310-316</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600414</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>4</s2>
</fA06>
<fA08 dir="pt">
<s1>Análise comparativa da hiperplasia intimal após o implante de stents com e sem sirolimus em artérias coronárias de pequeno calibre</s1>
</fA08>
<fA08 dir="en">
<s1>Comparative analysis of intimal hyperplasia after sirolimus-eluting stent and thin-strut bare-metal stent implantation in small coronary arteries</s1>
</fA08>
<fA11 dir="011000">
<s1>Fernando Stuchi Devito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Amanda G. M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fausto Feres</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alexandre Antonio Cunha Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Rodolfo Staico</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Luis Alberto Piva Mattos</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Luis Fernando Leite Tanajura</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Andréa C. L. S. Abizaid</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Áurea Jacob Chaves</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>J. Eduardo M. R. Sousa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>268-275</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600406</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a redução do volume de hiperplasia intimal após angioplastia com stents com sirolimus (Cypher®) comparados com os stents não-recobertos de estrutura metálica fina (Pixel®) em pacientes com vasos pequenos. MÉTODOS: Oitenta pacientes com doença arterial coronariana foram prospectivamente incluídos em duas séries consecutivas de tratamento, sendo a primeira empregando stents com sirolimus (50) e a segunda stents não-recobertos de estrutura metálica fina (30). RESULTADOS: Os resultados foram: menor porcentual de obstrução da prótese através do ultra-som intracoronário [5,0% (EP = 0,77) x 39,0% (EP = 4,72), p &lt; 0,001], menor perda tardia intra-stent [0,25 mm (EP = 0,03) x 1,11 mm (EP = 0,13), p &lt; 0,001] e no segmento do vaso [0,30 mm (EP = 0,04) x 0,83 mm (EP = 0,11), p &lt; 0,001], e também menor reestenose intra-stent (0% x 33,3%, p &lt; 0,001) e no segmento do vaso (4% x 36,7%, p &lt; 0,001) com os stents com sirolimus. A sobrevivência livre de eventos foi de 96% com os stents com sirolimus x 86,7% com os stents não-recobertos (p = 0,190). CONCLUSÃO: Os pacientes com vasos de pequeno calibre após o implante de stents com sirolimus evoluem com menor hiperplasia intimal (menor porcentual de obstrução intra-stent e menor perda tardia) do que quando são utilizados stents não-recobertos de estrutura metálica fina. Isto resultou em redução significativa da reestenose angiográfica aos oito meses de evolução.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: This study aimed at evaluating reduction in intimal hyperplasia volume following angioplasty using sirolimus-eluting stents (Cypher&amp;trade;) compared with thin-strut bare-metal stents (Pixel&amp;trade;) in patients with small vessels. METHODS: Eighty patients with coronary artery disease were prospectively included in two consecutive series, the first using sirolimus-eluting stents (50) and the second using bare-metal stents (30). RESULTS: The use of sirolimus-eluting stents reduced: in-stent net volume obstruction [5.0% (SE = 0.77) x 39.0% (SE = 4.72), p &lt; 0.001], in-stent late loss [0.25 mm (SE = 0.03) x 1,11 mm (SE = 0.13), p &lt; 0,001], in-segment late loss [0.30 mm (SE = 0.04) x 0.83 mm (SE = 0.11), p &lt; 0.001], in-stent restenosis (0% x 33.3%, p &lt; 0.001) and in-segment restenosis (4% x 36.7%, p &lt; 0.001). The event-free survival rate was 96% in the sirolimus-eluting stent group versus 86.7% in the bare-metal stent group (BMS) (p = 0.190). CONCLUSION: Sirolimus-eluting stents are superior to thin-strut bare-metal stents in reducing intimal hyperplasia (less in-stent obstruction and less late lumen loss) in patients with small vessels. The use of these stents significantly reduced angiographic restenosis at eight months.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Stent</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>reestenose</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>vaso pequeno</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Stent</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>restenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>small vessels</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Angiografia coronariana minimamente invasiva através de tomografia com múltiplos detectores</s1>
</fA08>
<fA08 dir="en">
<s1>Minimally invasive coronary angiography using a multidetector CT</s1>
</fA08>
<fA11 dir="011000">
<s1>André Ricardo Vale Rodrigues</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maurício Rezende Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcelo Sá Vieira de Brito</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Luciana Costa Silva</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Fernando Santana Machado</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>ECOAR Medicina Diagnóstica  </s1>
<s2>Belo Horizonte MG</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>323-330</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600501</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Impacto clínico da Tomografia por Emissão de Pósitrons realizada pelo sistema de coincidência com FDG-18F, na conduta terapêutica de pacientes com cardiopatia isquêmica pós-infarto do miocárdio</s1>
</fA08>
<fA08 dir="en">
<s1>Clinical impact of Positron Emission Tomography by coincidence system with 18F-FDG on therapeutic decision-making of patients with ischemic cardiomyopathy after myocardial infarction</s1>
</fA08>
<fA11 dir="011000">
<s1>Renata Christian Martins Felix</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Patrícia Lavatori Correa</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Jader Cunha de Azevedo</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Hans Fernando da Rocha Dohmann</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Evandro Tinoco Mesquita</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cláudio Tinoco Mesquita</s1>
<afiliation>A01 A02 A03</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Pró-Cardíaco Serviço de Medicina Nuclear </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Hospital Pró-Cardíaco  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Universidade Federal Fluminense  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>337-345</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>43</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600503</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar a influência da PET por Sistema de Coincidência, na tomada de decisão terapêutica, em pacientes com cardiopatia isquêmica e disfunção ventricular. MÉTODOS: Trinta e um pacientes realizaram PET com FDG-18F por Sistema de Coincidência entre setembro de 2003 e novembro de 2004. Os médicos assistentes responderam a um questionário sobre a proposta terapêutica do paciente antes da PET e após seu resultado. RESULTADOS: Vinte e sete (87%) pacientes apresentaram viabilidade miocárdica. Vinte e um (68%) médicos concordaram em que a PET modificou a terapêutica proposta para o paciente e 27 (87%) acharam que a PET contribuiu diretamente para a conduta tomada, mesmo quando não modificada. O tratamento atual proposto para o paciente (clínico ou revascularização) correlacionou-se com o achado de viabilidade (p=0,006). CONCLUSÕES: A PET pelo Sistema de Coincidência demonstra ser útil por auxiliar o médico na tomada de decisão quanto ao melhor tratamento de pacientes com cardiopatia isquêmica. A sintomatologia, o eletrocardiograma, a fração de ejeção e a área de fibrose miocárdica não se correlacionam com a viabilidade e, portanto, não servem como guia para indicação ou não da realização da PET.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the influence of the myocardium viability study by coincidence imaging using 18F-FDG in the clinical decision-making of patients with ischemic cardiomyopathy and left ventricular dysfunction. METHODS: Thirty-one patients were submitted to myocardial viability study with 18F-FDG by coincidence imaging between September 2003 and November 2004. The physician answered a questionnaire about the choice of therapeutic procedure before and after PET. RESULTS: Twenty-seven patients (87%) had myocardial viability. Twenty-one (68%) physicians thought that PET changed the therapeutic procedure for their patients and 27(87%) considered that PET added to the therapeutic decision. The current treatment decision (clinical or revascularization) correlated with myocardial viability (p=0.006). CONCLUSIONS: Coincidence imaging is a useful tool to help physicians in a difficult decision about the best treatment for patients with ischemic cardiomyopathy. Symptoms, electrocardiogram, ejection fraction and myocardial fibrosis area did not correlate with myocardium viability, so they should not be used to decide whether to perform a myocardial viability study or not.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Cardiopatia isquêmica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>viabilidade miocárdica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>PET</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sistema de coincidência</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Ischemic cardiomyopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardial viability</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>PET</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coincidence system</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Teste ergométrico: valor prognóstico em pacientes idosos com doença aterosclerótica coronariana estável</s1>
</fA08>
<fA08 dir="en">
<s1>Exercise stress test: prognostic value for elderly patients with stable coronary atherosclerosis</s1>
</fA08>
<fA11 dir="011000">
<s1>Marcelo Eidi Ochiai</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Otávio C. E. Gebara</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>João Batista Serro-Azul</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Lígia B. Pinto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Amit Nussbacher</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Humberto Pierri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Mauricio Wajngarten</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>346-352</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600504</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar o valor prognóstico das variáveis do teste ergométrico em pacientes idosos com doença aterosclerótica coronariana e isquemia induzida pelo esforço. MÉTODOS: Foram estudados 64 pacientes idosos (61 homens, idade de 73 &amp;plusmn; 5 anos) com doença aterosclerótica coronariana, comprovada por coronariografia, clinicamente estável, fração de ejeção de ventrículo esquerdo maior ou igual a 0,40 e isquemia miocárdica durante o teste ergométrico. A cada seis meses, os pacientes foram avaliados para eventos cardíacos (morte, infarto do miocárdio, angina instável, angioplastia e revascularização do miocárdio). RESULTADOS: Após seguimento médio de 48 meses, 23 (36%) pacientes sofreram eventos cardíacos. Não houve diferença clínica e angiográfica entre os pacientes que sofreram o evento e os que não o sofreram. Pela análise multivariada, a presença de dor precordial durante o teste ergométrico (risco relativo de 2,668 e p = 0,031) e a freqüência cardíaca no início da isquemia (risco relativo de 0,966 e p = 0,009) foram associadas a eventos cardíacos. CONCLUSÃO: Nessa população idosa, a presença de dor precordial durante o teste ergométrico e a freqüência cardíaca no início da isquemia foram associadas a eventos cardíacos. Essas variáveis podem ser úteis para avaliação do risco de pacientes com doença aterosclerótica coronariana estável.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study the prognostic value of exercise stress test variables in elderly patients with coronary atherosclerosis and exercise-induced ischemia. METHODS: Sixty-four elderly patients (61 men, 73 &amp;plusmn; 5 years old) with coronary atherosclerosis, verified by cardiac catheterization, that were clinically stable, had a left ventricle ejection fraction greater than or equal to 0.40 and developed myocardial ischemia during the exercise stress test were studied. The patients were evaluated every six months for cardiac events (death, myocardial infarction, unstable angina, angioplasty and myocardial revascularization). RESULTS: After a mean follow-up period of 48 months, 23 (36%) patients suffered cardiac events. There was no clinical or angiographical differences among the patients that suffered cardiac events and those that did not. Using multivariate analysis, the presence of chest pain during the exercise stress test (relative risk 2.668, p = 0.031) and the heart rate at the onset of ischemia (relative risk 0.966, p = 0.009) were associated with cardiac events. CONCLUSION: In this elderly population, the presence of chest pain during the exercise stress test and the heart rate at the onset of ischemia were associated with cardiac events. These variables could be useful for risk evaluation in patients with stable coronary atherosclerosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Idoso</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença coronariana aterosclerótica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prognóstico</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Aged</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>coronary disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Perfil de saúde cardiovascular de uma população adulta da região metropolitana de São Paulo</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiovascular health profile of an adult population from the metropolitan region of São Paulo</s1>
</fA08>
<fA11 dir="011000">
<s1>Renata Furlan Viebig</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Pastor Valero</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Fernando Araújo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alice Tatsuko Yamada</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Alfredo José Mansur</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP Faculdade de Saúde Pública </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>USP FM Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>353-360</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>40</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600505</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Descrever o perfil de saúde cardiovascular de uma população adulta da região metropolitana de São Paulo, segundo critérios da Sociedade Européia de Cardiologia (SEC). MÉTODOS: Foram estudados 200 indivíduos, homens e mulheres, voluntários, participantes do projeto &quot;Avaliação Cardiológica&quot; de um ambulatório geral. Foram coletadas informações sobre nível socioeconômico, tabagismo, consumo de álcool, medidas antropométricas, dieta, atividade física, lipídeos séricos, glicemia e pressão arterial. A ingestão média de colesterol dietético e de lipídeos totais foi estimada a partir de recordatórios de 24 horas. Avaliou-se o nível de atividade física por meio da aplicação do Questionário Internacional de Atividade Física (IPAQ-8) e de testes de esforço. RESULTADOS: A amostra foi composta por 61,5% de indivíduos do sexo feminino e 38,5%, do sexo masculino, com idades médias de 41,7 anos (mediana = 42,6) e 41,0 anos (mediana = 43,0). A prevalência de tabagismo (22%) e de consumo diário de álcool (14% dos homens; nenhuma mulher) foi baixa. A prevalência de sobrepeso foi de 47% (12% de obesos), além de níveis séricos elevados de colesterol total (&gt; 190 mg/dl) em 56% dos indivíduos e de LDL-colesterol (&gt; 115 mg/dl) em 61% dos participantes. Os resultados da aplicação do IPAQ-8 mostraram 6% de sedentários. CONCLUSÃO: A população de estudo apresentou maior risco de doenças cardiovasculares, segundo critérios da SEC, especialmente devido à elevada prevalência de indivíduos com sobrepeso e hipercolesterolemia.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To describe the cardiovascular health profile of an adult population from the metropolitan region of São Paulo, according to the European Society of Cardiology (ESC) criteria. METHODS: Two hundred volunteers of both sexes enrolled in the &quot;Cardiac Evaluation&quot; project of a general outpatient clinic were studied. Data collected included socioeconomic status, cigarette smoking, alcohol consumption, anthropometric measurements, diet, physical activity, serum lipids, blood glucose and blood pressure. Average intake of dietary cholesterol and total lipids was estimated from a 24-hour dietary recall. Physical activity level was assessed using the International Physical Activity Questionnaire (IPAQ-8) and exercise stress tests. RESULTS: Sample population composition was 61.5% female and 38.5% male, mean age 41.7 (median = 42.6) and 41.0 (median = 43.0%). Prevalence of smoking (22%) and daily alcohol consumption (14% males; no females) was low. The overweight prevalence was 47% (12% being obese), in addition to high levels of serum total cholesterol (&gt; 190 mg/dl) in 56% and LDL-cholesterol (&gt; 115 mg/dl) in 61%. The IPAQ-8 results showed that 6% were sedentary. CONCLUSION: The study population showed greater risk of cardiovascular diseases, according to ESC criteria, due especially to the high prevalence of overweight and hypercholesterolemia.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Saúde cardiovascular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>adultos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>fatores de risco</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Cardiovascular health</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adults</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>risk factors</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Perfil lipídico e efeitos da orientação nutricional em adolescentes com história familiar de doença arterial coronariana prematura</s1>
</fA08>
<fA08 dir="en">
<s1>Lipid profile and nutrition counseling effects in adolescents with family history of premature coronary artery disease</s1>
</fA08>
<fA11 dir="011000">
<s1>Gislaine A. Mendes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Tania L. Martinez</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Maria C. Izar</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Olga M. Amancio</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Neil F. Novo</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Simone C. Matheus</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Marcelo C. Bertolami</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Francisco Antonio Helfenstein Fonseca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Instituto Dante Pazzanese de Cardiologia  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>361-365</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600506</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Examinar o perfil lipídico e parâmetros nutricionais de adolescentes com história familiar de doença arterial coronariana (DAC) prematura e avaliar os efeitos da orientação nutricional. MÉTODOS: O estudo incluiu 48 adolescentes de ambos os sexos e idades entre 10 e 19 anos (grupo caso, n=18; grupo controle, n=30). RESULTADOS: Os filhos de coronarianos jovens apresentaram valores mais elevados de colesterol total (189 &amp;plusmn; 30 vs. 167 &amp;plusmn; 26 mg/dl, p&lt;0,01), LDL-C (144 &amp;plusmn; 20 vs. 100 &amp;plusmn; 27 mg/dl, p&lt;0,001) e Apo B (80 &amp;plusmn; 15 vs. 61 &amp;plusmn; 18 mg/dl, p=0,001) e valores mais baixos de HDL-C (45 &amp;plusmn; 9 vs. 51 &amp;plusmn; 13 mg/dl, p&lt;0,02) que os jovens controles. Não se observaram diferenças para os triglicérides e Apo A-I. Com a orientação dietoterápica obteve-se redução no consumo alimentar de ácidos graxos saturados (pré: 15,5 &amp;plusmn; 4,7% vs. pós: 6,6 &amp;plusmn; 3,7%, p=0,003) e melhora no perfil lipídico: CT (-8%, p=0,033), LDL-C (-18,2%, p=0,001), TG (-53%, p=0,002) nos filhos de pacientes com DAC prematura que apresentavam hiperlipidemia. CONCLUSÃO: A presença de dislipidemia foi mais prevalente em adolescentes filhos de portadores de DAC prematura, mas foi responsiva à intervenção nutricional.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess lipid profile and nutritional parameters from adolescents with family history of premature coronary artery disease (CAD) and assess the effects of nutritional counseling. METHODS: The study included 48 adolescents of both gender and with ages ranging from 10 and 19 years old (case group, n=18; control group, n=30). RESULTS: Offspring of young individuals with coronary artery disease showed higher values of total cholesterol (189 &amp;plusmn; 30 vs. 167 &amp;plusmn; 26 mg/dl, p &lt; 0.01), LDL-C (144 &amp;plusmn; 20 vs. 100 &amp;plusmn; 27 mg/dl, p &lt; 0.001) and apoB (80 &amp;plusmn; 15 vs. 61 &amp;plusmn; 18 mg/dl, p = 0.001) and lower values of HDL-C (45 &amp;plusmn; 9 vs. 51 &amp;plusmn; 13 mg/dl, p &lt; 0.02) than control young individuals. Differences were not found for triglycerides and apoA-I. With a dietotherapeutic counseling, we obtained a reduction in alimentary consumption of saturated fatty acids (pre: 15.5 &amp;plusmn; 4.7% vs. post: 6.6 &amp;plusmn; 3.7%, p = 0.003) and an improvement in lipid profile: TC (-8%, p = 0.033), LDL-C (-18.2%, p = 0.001), TG (-53%, p = 0.002) rates in offspring of premature CAD patients who showed hyperlipidemia. CONCLUSION: The presence of dyslipidemia was more prevalent among offspring adolescents of premature CAD patients, but it was responsive to nutritional intervention.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Saúde do adolescente</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>dieta</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lipídeos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lipoproteínas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>apolipoproteínas</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Teen health</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>diet</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipids</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>lipoproteins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>apolipoproteins</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Efeitos da rosiglitazona sobre a função endotelial em indivíduos não-diabéticos com síndrome metabólica</s1>
</fA08>
<fA08 dir="en">
<s1>Effects of rosiglitazone on endothelial function in non-diabetic subjects with metabolic syndrome</s1>
</fA08>
<fA11 dir="011000">
<s1>Luciana Bahia</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Luiz Guilherme K. Aguiar</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Nivaldo Villela</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Daniel Bottino</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Amélio F. Godoy-Matos</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Eliete Bouskela</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro Laboratório de Pesquisas em Microcirculação </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade do Estado do Rio de Janeiro Policlínica Piquet Carneiro </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>366-373</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>52</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600507</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar os efeitos de um sensibilizador de insulina - rosiglitazona (ROSI) sobre a função endotelial e marcadores de ativação endotelial em um grupo de indivíduos com síndrome metabólica não-diabéticos. MÉTODOS: O grupo foi composto de dezoito indivíduos (doze mulheres, seis homens), com 41,2 &amp;plusmn; 9,7 anos e IMC de 37,8 &amp;plusmn; 6,1 kg/m². A dose de ROSI utilizada foi 8 mg/dia durante doze semanas. Um grupo de nove indivíduos saudáveis, com 26,1 &amp;plusmn; 4,4 anos e IMC de 21,7 &amp;plusmn; 1,7 kg/m², foi estudado no estado basal para comparação da resposta vasodilatadora. A função endotelial foi avaliada através da pletismografia de oclusão venosa com infusão intra-arterial de acetilcolina (Ach) e nitroprussiato de sódio (SNP). Foram dosados: glicose, insulina, lipídeos, fibrinogênio e proteína C reativa ultra-sensível (PCR). Os índices HOMA e Quicki foram calculados para quantificar a resistência insulínica (RI). RESULTADOS: Houve melhora nos índices de RI com diminuição do HOMA-R e aumento do Quicki, além de diminuição da PCR e do fibrinogênio. A vasodilatação endotélio-dependente melhorou, com aumento no porcentual de incremento do fluxo sangüíneo após Ach e aumento no porcentual de decremento da resistência vascular. Não foi observada diferença na vasodilatação endotélio-independente. CONCLUSÃO: O uso de ROSI induziu uma redução da RI, do fibrinogênio e da PCR e melhorou a função endotelial em indivíduos com SM não-diabéticos. Esses dados sugerem o papel dessa substância na regulação da função endotelial em indivíduos com alto risco cardiovascular.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the effects of rosiglitazone (ROSI), an insulin-sensitizer, on endothelial function and endothelial activation markers in a group of non-diabetic subjects with metabolic syndrome. METHODS: A group of eighteen subjects (12 women, 6 men), mean age 41.2 &amp;plusmn; 9.7 and BMI 37.8 &amp;plusmn; 6.1 Kg/m², was treated with rosiglitazone 8 mg/day for 12 weeks. Another group of nine healthy subjects, mean age 26.1 &amp;plusmn; 4.4 and BMI 21.7 &amp;plusmn; 1.7 Kg/m², was studied at baseline to compare vasodilator response. Endothelial function was evaluated by venous occlusion plethysmography after intra-arterial infusions of acetylcholine (Ach) and sodium nitroprusside (SNP). The following were measured: glucose, insulin, lipids, fibrinogen, and high-sensitivity C-reactive protein (CRP). HOMA and Quicki indexes were calculated to quantify insulin resistance (IR). RESULTS: There was an improvement in insulin resistance, as evidenced by lower HOMA-R and higher QUICKI index, as well as a decrease in CRP and fibrinogen levels. Endothelium-dependent vasodilation also improved, as evidenced by greater increment in blood flow after Ach and greater decrement in vascular resistance. No difference in endothelium-independent vasodilation was noted. CONCLUSION: Rosiglitazone treatment reduced insulin resistance, fibrinogen, and CRP levels and improved endothelial function in non-diabetic subjects with metabolic syndrome. These data suggest that rosiglitazone plays a role in the regulation of endothelial function in patients at high cardiovascular risk.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Endotélio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>síndrome metabólica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>rosiglitazona</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Endothelium</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>metabolic syndrome</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rosiglitazone</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Morfometria do miocárdio humano em indivíduos senis</s1>
</fA08>
<fA08 dir="en">
<s1>Morphometry of human myocardium in senile individuals</s1>
</fA08>
<fA11 dir="011000">
<s1>José Antonio Cardoso</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ana Elisa Toscano</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Tetsuo Tashiro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Cláudio Antonio Ferraz de Carvalho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sílvia Regina Arruda de Moraes</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de Pernambuco  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>USP Instituto de Ciências Biomédicas </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>374-377</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>27</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600508</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Realizar uma avaliação quantitativa nas células do miocárdio humano de indivíduos senis, nas regiões ventriculares direita, esquerda e septal. MÉTODOS: Foram utilizados cinco corações de cadáveres de indivíduos sem enfermidades cardíacas, de ambos os sexos, com idade entre 67 e 87 anos. Foram avaliados os seguintes parâmetros: área da secção transversa unitária do miócito (a o mioc); comprimento do perímetro unitário do miócito (l o mioc); volume unitário do miócito (v o mioc); densidade volumétrica dos miócitos (Vv mioc); número de miócitos por unidade de volume (Nmm &amp;#094;³mio). Na análise estatística utilizou-se o teste &quot;t&quot; de Student. RESULTADOS: A análise das diferenças (p&lt;0,05) entre as regiões ventriculares direita (VD), esquerda (VE) e septal (S) do coração humano revelou que os valores da a o mioc mostraram-se menores no VD (1,51 &amp;plusmn; 0,10 &amp;micro;m²) e no S (1,55 &amp;plusmn; 0,07 &amp;micro;m²) em relação ao VE (1,84 &amp;plusmn; 0,24 &amp;micro;m²). Os valores do l o mioc também se apresentaram menores no S (5,11 &amp;plusmn; 0,46 &amp;micro;m) em relação VE (6,2 &amp;plusmn; 0,97 &amp;micro;m). Do mesmo modo, o v o mioc e a Vv mioc apresentaram valores menores no VD (88,75 &amp;plusmn; 25,37 &amp;micro;m ³; 0,39 &amp;plusmn; 0,03%) em relação ao VE (122,41 &amp;plusmn; 16,31 &amp;micro;m ³; 0,41 &amp;plusmn; 0,01%). CONCLUSÃO: Os resultados obtidos mostram que podem ocorrer modificações nas dimensões da miocélula da parede ventricular esquerda durante a fase senescente, entretanto, essas diferenças são sutis e parecem significar a adaptação do tecido às mudanças funcionais que se instalam no decorrer da vida.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To carry out a quantitative assessment in human myocardium cells of senile individuals, in right, left and septal ventricular regions. METHODS: Five hearts from corpses of individuals without heart diseases, of both sexes, with age between 67 and 87 years old were used. The following parameters were assessed: myocyte unit cross section area (myoc. a o); myocyte unit perimeter length (myoc. l o); myocyte unit volume (myoc. v o); myocyte volumetric density (myoc. Vv); number of myocytes per volume unit (Nmm &amp;#094;³myoc.). The t-test of Student was used in statistic analysis. RESULTS: The analysis of differences (p &lt; 0.05) among right (RV), left (LV) and septal (S) ventricular regions of human heart showed that myoc. a o values were lower in RV (1.51 &amp;plusmn; 0.10 &amp;micro;m²) and in S (1.55 &amp;plusmn; 0.07 &amp;micro;m²) in relation to LV (1.84 &amp;plusmn; 0.24 &amp;micro;m²). Values of myoc. l o were also shown lower in S (5.11 &amp;plusmn; 0.46 &amp;micro;m) comparing to LV (6.2 &amp;plusmn; 0.97 &amp;micro;m). Likewise, myoc. v o and myoc. Vv showed lower values in RV (88.75 &amp;plusmn; 25.37 &amp;micro;m ³; 0.39 &amp;plusmn; 0.03%) in relation to LV (122.41 &amp;plusmn; 16.31 &amp;micro;m ³; 0.41 &amp;plusmn; 0.01%). CONCLUSION: Results obtained show that there may be changes in dimensions of left ventricular wall myocyte cell during senescent stage. However, those differences are subtle and seem to mean the adjustment of tissue to functional changes that install along life.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Miócitos cardíacos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>envelhecimento</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>miocardio</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Myocytes</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiac</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aging</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>myocardium</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Estenose pulmonar valvar discreta: a possível cura espontânea na evolução natural do defeito</s1>
</fA08>
<fA08 dir="en">
<s1>Mild pulmonary valve stenosis: the possible spontaneous cure in the natural history of the defect</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Clínica Dr. Edmar Atik  </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>378-381</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>13</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600509</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar a evolução natural, a longo prazo, de pacientes com estenose pulmonar valvar discreta. MÉTODOS: No período evolutivo de 24 anos (1980 a 2004), foram avaliados 83 pacientes com estenose pulmonar valvar, sendo 29 destes em grau discreto. Destes 29, foram acompanhados, a longo prazo, 13 pacientes. A idade média na primeira e na última consulta correspondeu a 34 meses (1 mês a 15 anos) e 10,5 anos (3 a 24 anos), respectivamente. Avaliaram-se, como elementos evolutivos, os referentes à clínica, os aspectos eletrocardiográficos e os ecocardiográficos. RESULTADOS: Todos os pacientes mantiveram-se assintomáticos. Quanto ao gradiente de pressão valvar pulmonar, em 5 (38,4%) houve diminuição, manutenção em 3 (23%), eliminação em 4 (30,7%) e acentuação para grau moderado em 1 (7,6%). O gradiente médio inicial e final foi de 24,2 mmHg (15 a 30) e de 13,6 mmHg (0-54). Os gradientes iniciais dos 4 pacientes que obtiveram a cura espontânea eram de 30, 19, 30 e 20 mmHg. O sopro sistólico e a sobrecarga ventricular direita guardaram relação com o grau do gradiente de pressão, subdividido a cada 10 mmHg. CONCLUSÃO: A cura espontânea da estenose pulmonar valvar discreta é possível, de igual modo que ocorre em outras anomalias acianogênicas.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the long-term natural history of patients with mild pulmonary valve stenosis METHODS: Throughout a 24-year evolutive period (1980 a 2004), 83 patients with pulmonary valve stenosis were evaluated, with 29 of them presenting a mild form of the defect. Of these 29, 13 patients had a long-term follow up. The mean age at the first and last follow-up visits was 34 months (1 month to 15 years) and 10.5 years (3 to 24 years), respectively. In addition to evolutive elements, those regarding clinical, electrocardiographic and echocardiographic aspects were also assessed. RESULTS: All patients remained assymptomatic throughout the study. Regarding the pulmonary valve pressure gradient, 5 (38.4%) presented a decrease, 3 (23%) remained unchanged, 4 (30.7%) presented elimination and 1 (7.6%) presented accentuation to a moderate degree of involvement. The mean initial and final gradient was 24.2 mmHg (15-30) and 13.6 mmHg (0-54), respectively. The initial gradients of the 4 patients who achieved spontaneous cure were 30, 19, 30 and 20 mmHg. The systolic murmur and right ventricular overload had a direct correlation to the gradient pressure degree, subdivided at each 10 mmHg. CONCLUSION: The spontaneous cure of the mild pulmonary valve stenosis is possible to achieve, similarly to other acyanogenic anomalies.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Estenose da valva pulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>cardiopatias congênitas</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Pulmonary valve stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>congenital cardiopathy</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>natural history</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Resultados da valvoplastia por balão do grupo submetido a plastia mitral percutânea ou cirúrgica prévias com o tratado pela primeira vez: evolução do grupo com plastia prévia</s1>
</fA08>
<fA08 dir="en">
<s1>Balloon valvuloplasty outcome of a group previously submitted to mitral percutaneous or surgical valve repair versus first-time valvuloplasty patients: evolution of the group previously submitted to valve repair procedures</s1>
</fA08>
<fA11 dir="011000">
<s1>Edison Carvalho S. Peixoto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Rodrigo Trajano S. Peixoto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ivana Picone Borges</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Paulo Sergio de Oliveira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Mario Salles Netto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Ronaldo Amorim Villela</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Marta Labrunie</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Pierre Labrunie</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Ricardo Trajano S. Peixoto</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital 4º Centenário  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal Fluminense  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>382-387</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>56</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600510</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar 501 procedimentos de valvoplastia mitral e as diferenças entre um grupo já submetido a plastia valvar prévia por balão ou cirúrgica, com 59 procedimentos e um grupo sem intervenção prévia, com 442 procedimentos. MÉTODOS: Foi utilizado balão único em 406 procedimentos, balão de Inoue em 89, e duplo balão em seis, não havendo diferença entre os balões utilizados nos dois grupos (p=0,6610). Estudou-se a evolução a longo prazo dos pacientes com plastia prévia. RESULTADOS: O grupo submetido a plastia valvar prévia era mais velho, com maior escore ecocardiográfico, maior porcentual de pacientes em fibrilação atrial, e dos seus 59 pacientes, 48 tinham sido submetidos à comissurotomia cirúrgica, oito a valvoplastia com balão e três à comissurotomia cirúrgica e à valvoplastia com balão. Os grupos da valvoplastia com plastia valvar prévia e da valvoplastia sem intervenção prévia apresentaram pré-valvoplastia: área valvar mitral ecocardiográfica de 0,99&amp;plusmn;0,21 e 0,94&amp;plusmn;0,21 cm² (p=0,0802) e área valvar mitral (Gorlin) 0,94&amp;plusmn;0,18 e 0,91&amp;plusmn;0,21 cm² (p=0,2518) e área valvar mitral pós-valvoplastia mitral de 1,95&amp;plusmn;0,44 e 2,05&amp;plusmn;0,42 cm² (p=0,1059). CONCLUSÕES: O grupo com plastia valvar prévia apresentou o mesmo resultado imediato do grupo sem intervenção prévia. O subgrupo com plastia prévia seguido a longo prazo, apresentou evolução satisfatória.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate 501 procedures of mitral balloon valvuloplasty and the differences among the group already submitted the prior surgical or balloon valvuloplasty, with 59 procedures and the group without previous intervention, with 442 procedures. METHODS: It was used the single balloon in 403, Inoue balloon in 89 and a double balloon in six, with no difference between the 2 groups (p=0.6610). RESULTS: The prior surgical or balloon valvuloplasty group was older, with higher echo score and higher atrial fibrillation rate and of its 59 patients, 48 had been submitted only to mitral surgical commissurotomy, 8 only to mitral balloon valvuloplasty and 3 to surgical commissurotomy and after submitted to balloon valvuloplasty because of restenosis. In prior surgical or balloon valvuloplasty and mitral balloon valvuloplasty without previous intervention groups pre valvuloplasty there were respectively: echo mitral valve area 0.99&amp;plusmn;0.21 and 0.94&amp;plusmn;0.21 cm² (p=0.0802) and mitral valve area (Gorlin) 0.94&amp;plusmn;0.18 and 0.91&amp;plusmn;0.21 cm² (p=0.2518) and post mitral valvuloplasty 1.95&amp;plusmn;0.44 and 2.05&amp;plusmn;0.42 cm² (p=0.1059). CONCLUSIONS: The hemodynamic and angiographic outcome of the prior surgical or balloon valvuloplasty group were similar to the group without previous intervention. The evolution was satisfactory in the prior valvuloplasty subgroup with long-term follow-up.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Valvoplastia mitral percutânea por balão</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>comissurotomia cirúrgica prévia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>valvoplastia por balão prévia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose mitral</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Percutaneous mitral balloon valvuloplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>previous commissurotomy surgery</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>previous balloon valvuloplasty</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>mitral stenosis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Terapia celular na cardiomiopatia dilatada</s1>
</fA08>
<fA08 dir="en">
<s1>Cell therapy in dilated cardiomyopathy</s1>
</fA08>
<fA11 dir="011000">
<s1>Helena Furtado Martino</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo Sérgio Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Edmilson Assunção</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Rita Villela</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Miriam Gaze</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Patrícia C. dos Santos Costa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Fernando César Castro Souza</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Luiz Henrique Weitzel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Ana Paula R. Velloso</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Amarino Oliveira Júnior</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="111000">
<s1>Antônio C. Campos de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Instituto Nacional de Cardiologia Laranjeiras Hospital Prócardíaco </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>390-392</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>09</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600512</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Homem de 41 anos em insuficiência cardíaca sistólica, CF III NYHA, estágio clínico C, por cardiomiopatia dilatada, foi submetido ao transplante autólogo da fração mononuclear da medula óssea, via sistema arterial coronariano, através de cateterismo cardíaco. Dois meses após o procedimento, houve diminuição do BNP plasmático, diminuição da área cardíaca ao estudo radiológico do tórax e à ressonância nuclear magnética. O ecocardiograma demonstrou diminuição do fluxo regurgitante secundário a dilatação do anel mitral. Na ergoespirometria houve melhor desempenho, com aumento do consumo máximo de oxigênio, sendo possível redução da terapêutica medicamentosa. A ausência de eventos adversos caracterizados por: instabilidade clínica/hemodinâmica, alteração enzimática ou eletrocardiográfica apontam para segurança e exeqüibilidade deste procedimento realizado e descrito com pioneirismo na cardiomiopatia dilatada.</s0>
</fC01>
<fC01 dir="en">
<s0>A forty-one-year-old male with systolic heart failure, FC-III NYHA, clinical stage C due to dilated cardiomyopathy was submitted to an autologous transplant of the mononuclear fraction of bone marrow via coronary artery system through heart catheterism. Two months after the procedure, there was a decrease in plasma BNP and cardiac area reduction at the thorax X-ray and nuclear magnetic resonance. The echocardiogram showed decrease of the secondary regurgitation and mitral ring dilatation. There was a better performance at the ergospirometry, with increase of the maximum oxygen consumption and consequent reduction in drug therapy. The absence of adverse events characterized by clinical/hemodynamic instability, enzymatic alteration or electrocardiogram demonstrate the safety and feasibility of this procedure carried out and described with pioneering spirit in dilated cardiomyopathy.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Caso 1/2006 - lactente de oito meses com atresia pulmonar e comunicação interventricular e hiperfluxo pulmonar</s1>
</fA08>
<fA08 dir="en">
<s1>Case 1/2006 - eight-month-old infant with pulmonary atresia and ventricular septal defect and increased pulmonary blood flow</s1>
</fA08>
<fA11 dir="011000">
<s1>Edmar Atik</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>393-394</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600513</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação da recidiva da fibrilação atrial após ablação da veia pulmonar por radiofreqüência baseada em sintomas: esta é uma estratégia confiável?</s1>
</fA08>
<fA08 dir="en">
<s1>Symptoms-guided assessment of atrial fibrillation recurrence after radiofrequency pulmonary vein ablation: is it a reliable strategy?</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Roberto Benchimol Barbosa</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA11 dir="021000">
<s1>José Barbosa Filho</s1>
<afiliation>A01 A02 A03 A04</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Hospital Central Aristarcho Pessoa  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Corpo de Bombeiros Militar do Estado do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Corpo de Bombeiros Militar do Estado do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="040000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="050000">
<s1>Universidade Gama Filho  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>395-395</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600514</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Avaliação da recidiva da fibrilação atrial após ablação da veia pulmonar por radiofreqüência baseada em sintomas: esta é uma estratégia confiável?</s1>
</fA08>
<fA08 dir="en">
<s1>Symptoms-guided assessment of atrial fibrillation recurrence after radiofrequency pulmonary vein ablation: is it a reliable strategy?</s1>
</fA08>
<fA11 dir="011000">
<s1>Mauricio Scanavacca</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Eduardo Sosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>396-396</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600515</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="">
<s1></s1>
</fA08>
<fA11 dir="011000">
<s1> </s1>
<afiliation></afiliation>
</fA11>
<fA14 dir="010000">
<s1>  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>397-397</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600516</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Síndrome da classe econômica após longas viagens de ônibus</s1>
</fA08>
<fA08 dir="en">
<s1>Economy class syndrome after long duration bus travel</s1>
</fA08>
<fA11 dir="011000">
<s1>Múcio Tavares de Oliveira Jr</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo de Faveri</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Cíntia Mara Rodrigues Farias</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Alfredo José Mansur</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Antonio Carlos Pereira-Barretto</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>USP FM Hospital das Clínicas</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>388-389</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>15</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600511</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>Homem de 65 anos com insuficiência cardíaca causada por hipertensão e cardiopatia isquêmica foi internado com dispnéia, escarro sanguinolento e dor pleurítica após uma viagem de ônibus com duração de 52 horas. A avaliação clínica e laboratorial incluiu tomografia helicoidal do tórax, que demonstrou um defeito de enchimento do principal ramo da artéria pulmonar direita e uma opacidade periférica regular de formato triangular no lobo inferior da parte inferior do pulmão. Após o diagnóstico de tromboembolia pulmonar, foi instituída terapia com heparina, seguida por varfarina. O paciente recebeu alta hospitalar. O diagnóstico de embolia pulmonar deve ser levado em consideração em pacientes com sintomas semelhantes aos deste paciente após longa viagem de ônibus.</s0>
</fC01>
<fC01 dir="en">
<s0>A 65 year-old man with heart failure due to hypertensive and ischemic heart disease was admitted to the hospital with dyspnea, bloody sputum and pleuritic chest pain after a 52-hour bus trip. Clinical and laboratory evaluation included chest helical tomography that demonstrated a filling defect of the right main branch of the pulmonary artery and a regular peripheral opacity of triangular shape in the inferior lobe of the lower lung. The diagnosis of pulmonary thromboembolism was made and therapy with heparin, followed by warfarin was introduced. The patient was discharged from the hospital. The diagnosis of pulmonary embolism should be considered in patients with complaints like this patient after long-distance bus travel.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>5</s2>
</fA06>
<fA08 dir="pt">
<s1>Ablação por cateter com radiofreqüência de vias acessórias esquerdas por abordagem transeptal</s1>
</fA08>
<fA08 dir="en">
<s1>Radiofrequency catheter ablation of left accessory pathways by transeptal approach</s1>
</fA08>
<fA11 dir="011000">
<s1>Márcio Augusto Silva</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Elenir Nadalin</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Alessandro Kraemmer</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Gel Roberto Marmitt Berardi</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Carlos Moura Jorge</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Cláudio L. Pereira da Cunha</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Pontifícia Universidade Católica do Paraná Hospital Universitário Cajuru </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal do Paraná Hospital de Clínicas </s1>
<s2>Curitiba PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>331-336</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>20</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600502</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Estudar uma série de pacientes submetidos a ablação por cateter, com radiofreqüência (RF) de vias acessórias (VA) esquerdas mediante abordagem transeptal (TS), comparando-os aos pacientes submetidos ao mesmo tipo de procedimento por abordagem arterial retrógrada (AR) convencional. MÉTODOS: Cem pacientes consecutivos (56 masculinos; 34,3 &amp;plusmn; 11 anos de idade), portadores de 100 VA esquerdas (62 manifestas e 38 ocultas) foram submetidos a ablação por cateter por via TS (50 pacientes) e por via AR (50 pacientes), de forma alternada. A análise foi baseada na intenção de tratar. RESULTADOS: A punção transeptal foi realizada com sucesso em 48 (96%) pacientes. Por esse acesso foi obtido sucesso primário na ablação em todos os pacientes e nenhuma complicação foi observada. Ao compararmos com o grupo AR não verificamos diferença em relação ao sucesso primário (p = 0,2), taxa de recorrências (p = 1,0), tempos de fluoroscopia (p = 0,63) e total (p = 0,47). No grupo AR um paciente apresentou complicação vascular. A abordagem TS proporcionou um menor tempo de ablação (p = 0,01) e número de aplicações de RF (p = 0,003) em relação à abordagem AR convencional. As recorrências e insucessos da primeira sessão de cada grupo foram submetidos a novo procedimento pela técnica oposta (cross-over), obtendo-se assim um sucesso final na ablação de 100%. CONCLUSÃO: As abordagens TS e AR apresentam eficácia e segurança semelhantes para ablação de vias acessórias esquerdas. O tempo de ablação e o número de aplicações de RF foram menores com a abordagem TS. Quando as técnicas foram utilizadas de forma complementar, aumentaram a eficácia final da ablação.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To study a series of patients submitted to radiofrequency catheter ablation (RFA) of left accessory pathways (AP) using the transeptal approach (TSA) as compared to the conventional retrograde arterial approach (RAA). METHODS: One hundred consecutive patients (56 male; mean age of 34.3 &amp;plusmn; 11 years) with 100 left APs (62 overt and 38 concealed) underwent catheter ablation using the TS method (50 patients) and the RA method (50 patients) in an alternate fashion. The analysis was performed according to the intention-to-treat principle. RESULTS: The transeptal puncture was successfully performed in 48 patients (96%). This access allowed primary success in the ablation in all the patients without any complication. When we compared this approach with the RAA there was no difference as regards the primary success (p = 0.2), recurrence rate (p = 1.0), fluoroscopy time (p = 0.63) and total time (p = 0.47). One patient in the RAA group presented a vascular complication. The TSA allowed shorter ablation times (p=0.01) and smaller number of radiofrequency applications (p = 0.003) as compared to the conventional RAA. The patients who had recurrence and unsuccessful ablation in the first session in each approach underwent another session with the opposite technique (cross-over), with a final ablation success rate of 100%. CONCLUSION: The TS and RA approaches showed similar efficacy and safety for the ablation of left accessory pathways. The TSA allowed shorter ablation times and smaller number of radiofrequency applications. When the techniques were used in a complementary fashion, they increased the final efficacy of the ablation.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Ablação por cateter</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>septo cardíaco</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>taquicardia supraventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ondas de radio</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Catheter ablation</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart septum</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>tachycardia supraventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>radio waves</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Alterações cardiovasculares na síndrome da apnéia obstrutiva do sono</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiovascular comorbidities and obstructive sleep apnea</s1>
</fA08>
<fA11 dir="011000">
<s1>Fátima Dumas Cintra</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Dalva Poyares</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Christian Guilleminault</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Carlos Carvalho</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Sergio Tufik</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Angelo A. V. de Paola</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Stanford University  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>399-407</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>103</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600601</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>A síndrome da apnéia obstrutiva do sono (SAHOS) é uma condição prevalente na população, associada a maior risco cardiovascular, freqüentemente não-diagnosticada. O reconhecimento da síndrome requer alto grau de suspeita clínica, especialmente por cardiologistas, e pode ser confirmada por meio da polissonografia. O tratamento da síndrome com o uso de CPAP (pressão positiva na via aérea superior) é altamente eficaz, melhorando o padrão respiratório durante o sono, instituindo o sono reparador e, dessa forma, otimizando a qualidade de vida desses pacientes, além de atenuar ou reverter muitas das complicações cardiovasculares relacionadas a SAHOS. Este artigo aborda a fisiopatologia e os aspectos clínicos das comorbidades cardiovasculares associadas à síndrome.</s0>
</fC01>
<fC01 dir="en">
<s0>Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a prevalent condition in the general population. It is associated with increased cardiovascular risk and often goes unrecognized. Its diagnose requires a high degree of clinical suspicion, particularly on the part of cardiologists, and it may be confirmed by polysomnography. Continuous positive airway pressure (CPAP) therapy is highly effective, since it improves sleep breathing pattern, promotes restful sleep and thus enhances the quality of life of these patients, in addition to attenuating or reversing many cardiovascular complications related to OSAHS. This paper addresses the pathophysiology and clinical features of cardiovascular comorbidities associated with the syndrome.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Fatores adicionais de risco cardiovascular associados ao excesso de peso em crianças e adolescentes: o estudo do coração de Belo Horizonte</s1>
</fA08>
<fA08 dir="en">
<s1>Additional cardiovascular risk factors associated with excess weigth in children and adolescents: the Belo Horizonte heart study</s1>
</fA08>
<fA11 dir="011000">
<s1>Robespierre Q. C. Ribeiro</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Paulo A. Lotufo</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Joel A. Lamounier</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Reynaldo G. Oliveira</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="051000">
<s1>José Francisco Soares</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Denise Aparecida Botter</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal de Minas Gerais  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>408-418</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>40</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600602</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Examinar a associação de sobrepeso e obesidade com perfis de atividade física, pressão arterial (PA) e lípides séricos. MÉTODOS: Inquérito epidemiológico com 1.450 estudantes - seis a dezoito anos, em Belo Horizonte-MG. Dados: peso, altura, PA, espessura de pregas cutâneas, circunferência das cinturas, atividade física, colesterol total (CT), LDL-c, HDL-c, e hábitos alimentares. RESULTADOS:Prevalências de sobrepeso e obesidade foram 8,4% e 3,1%. Em relação aos estudantes situados no quartil inferior (Q1) da distribuição da prega subescapular, os estudantes do quartil superior (Q4) apresentaram um risco (odds ratio) 3,7 vezes maior de ter um CT aumentado. Os estudantes com sobrepeso e obesos tiveram 3,6 vezes mais risco de apresentar PA sistólica aumentada, e 2,7 vezes para PA diastólica aumentada, em relação aos estudantes com peso normal. Os estudantes menos ativos, no Q1 da distribuição de MET, apresentaram 3,8 vezes mais riscos de terem CT aumentado comparados com os mais ativos (Q4). CONCLUSÃO: Estudantes com sobrepeso ou obesos ou nos quartis superiores para outras variáveis de adiposidade, assim como os estudantes com baixos níveis de atividade física ou sedentários apresentaram níveis mais elevados de PA e perfil lipídico de risco aumentado para o desenvolvimento de aterosclerose.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To examine the association of overweight and obesity with physical activity, blood pressure (BP) and serum lipid profiles. METHODS: Epidemiologic investigation of 1,450 students, between the ages of 6 and 18, in the city of Belo Horizonte, MG. Data: weight, height, BP, skinfold thickness, waist circumference, physical activity, total cholesterol (TC), LDL-c, HDL-c, and dietary habits. RESULTS: The prevalence rates for overweight and obesity were 8.4% and 3.1%, respectively. In relation to the students in the lower quartile (Q1) of the distribution of subscapular skinfold, the students in the upper quartile (Q4) presented a 3.7 times higher risk (odds ratio) of having elevated TC levels. Overweight and obese students had a 3.6 times higher risk of having elevated systolic blood pressure, and a 2.7 times higher risk of elevated diastolic blood pressure when compared to normal weight students. The less active students in the Q1 of distribution of MET presented a 3.8 times higher risk of having elevated TC levels compared to those who were more active (Q4). CONCLUSION: Students who were overweight, obese or in the upper quartiles for other adiposity variables, as well as students with low levels of physical activity or a sedentary lifestyle presented higher blood pressure levels and a lipid profile indicative of an increased risk of developing atherosclerosis.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Obesidade</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>pressão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>atividade física</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>nutrição</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>criança</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>adolescente</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Obesity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>blood pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>motor activity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>nutrition</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>child</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>adolescent</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Concentração sérica de lípides e apolipoproteína B em recém-nascidos</s1>
</fA08>
<fA08 dir="en">
<s1>Concentration of serum lipids and apolipoprotein B in newborns</s1>
</fA08>
<fA11 dir="011000">
<s1>Sirlei Donegá</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Jane Oba</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Raul C. Maranhão</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade de São Paulo FMUSP Hospital das Clínicas de São Paulo</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>Universidade Federal de Londrina  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>419-424</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>40</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600603</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Determinar numa população de recém-nascidos de uma cidade do sul do Brasil as concentrações de lípides séricos e apolipoproteína B (apo-B) em neonatos normais a termo e pré-termo, analisando-se a influência da idade gestacional e do peso ao nascimento. MÉTODOS: Foram estudados 212 neonatos de ambos os sexos, deles, 142 a termo (&gt;37 semanas de gestação) e 70 neonatos pré-termo (&lt;37 semanas). Os neonatos a termo e pré-termo foram classificados pelo peso de nascimento em pequeno para a idade gestacional ou adequado para a idade gestacional. Utilizou-se o sangue do cordão umbilical para as análises bioquímicas. RESULTADOS: Os valores de colesterol total, LDL-C, HDL-C e de apo-B foram maiores nos neonatos pré-termo (79&amp;plusmn;34, 26&amp;plusmn;6, 45&amp;plusmn;15 e 36&amp;plusmn;14 mg/dL, respectivamente) do que nos neonatos a termo (58&amp;plusmn;19, 20&amp;plusmn;10, 31&amp;plusmn;14 e 28&amp;plusmn;7 mg/dL, respectivamente; p &lt; 0,0001). Inversamente, os valores de triglicérides foram menores nos neonatos pré-termo (36&amp;plusmn;14 mg/dL) do que nos neonatos a termo (43&amp;plusmn;25 mg/dL; p &lt; 0,0018). O sexo e o fato de o neonato ser pequeno ou adequado para a idade gestacional não influenciaram os valores de colesterol total e frações, de triglicérides e apo-B. CONCLUSÃO: As concentrações de lípides plasmáticos e de apo-B dos neonatos da população estudada são semelhantes às dos neonatos de outros países de continentes diversos reportados na literatura e, como esperado, é acentuadamente menor do que os valores referidos na literatura para as de crianças acima de dois anos. A maturidade fetal influencia a concentração de lípides dos neonatos, mas o peso de nascimento não tem efeito nesses parâmetros.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To determine the concentrations of serum lipids and apolipoprotein B (apo-B) in a population of normal full-term and preterm newborns in a city in Southern Brazil, and assess the impact of gestational age and birth weight on these values. METHODS: Two hundred and twelve newborns of both genders were studied, 142 of whom were full-term (&gt;37 weeks of gestation) and 70 preterm (&lt;37 weeks of gestation). According to their birth weights, the full-term and preterm newborns were classified as small for gestational age or appropriate for gestational age. Umbilical cord blood was collected for biochemical analysis. RESULTS: The total cholesterol, LDL-C, HDL-C and apo-B values were higher in preterm newborns (79&amp;plusmn;34, 26&amp;plusmn;6, 45&amp;plusmn;15 and 36&amp;plusmn;14 mg/dL, respectively ) than in full-term newborns (58&amp;plusmn;19, 20&amp;plusmn;10, 31&amp;plusmn;14 and 28&amp;plusmn;7 mg/dL, respectively; p &lt; 0.0001). Inversely, triglyceride values were lower in preterm newborns (36&amp;plusmn;14 mg/dL) than in full-term newborns (43&amp;plusmn;25 mg/dL; p &lt; 0.0018). Gender and size at birth did not have any impact on the values of total cholesterol and fractions, triglycerides, and apo-B. CONCLUSION: Plasma concentrations of lipids and apo-B in the population of newborns studied are similar to those in newborns from other countries and continents reported in medical literature and, as expected, are markedly lower than the values mentioned in literature for infants over two years of age. Fetal maturity has an impact on the concentration of lipids in newborns, but birth weight does not have any effect on these parameters.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Recém-nascidos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>colesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>triglicérides</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lipoproteína de alta densidade</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lipoproteína de baixa densidade</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Newborns</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cholesterol</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>triglycerides</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>high-density lipoprotein</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>low-density lipoprotein</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Influência da redução da pré-carga sobre o índice de desempenho miocárdico (índice de Tei) e outros parâmetros Doppler ecocardiográficos da função ventricular esquerda</s1>
</fA08>
<fA08 dir="en">
<s1>Influence of preload reduction on Tei index and other Doppler echocardiographic parameters of left ventricular function</s1>
</fA08>
<fA11 dir="011000">
<s1>Silvio Henrique Barberato</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Roberto Pecoits Filho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Católica do Paraná Centro de Ciências Biológicas e da Saúde </s1>
<s2>Curitiba PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>425-431</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>46</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600604</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar os efeitos da redução da pré-carga induzida por uma sessão de hemodiálise sobre o índice de desempenho miocárdico (Tei) e outros parâmetros ecocardiográficos de função cardíaca. MÉTODOS: Estimamos o índice de Tei e parâmetros de função sistólica e diastólica do ventrículo esquerdo (VE), antes e depois de uma sessão de hemodiálise. Incluímos no estudo indivíduos em ritmo sinusal e sem antecedentes de insuficiência coronariana ou evidências de valvopatia e derrame pericárdico. RESULTADOS: 15 pacientes (8 homens, idade 53 &amp;plusmn; 14 anos) completaram o estudo. Após ultrafiltração de 2,2 &amp;plusmn; 1,1 litros, a onda E diminuiu (p &lt; 0,05) e a onda A permaneceu inalterada (p = ns), resultando em decréscimo de E/A (p &lt; 0,01). O índice de Tei aumentou (0,57 &amp;plusmn; 0,07 para 0,65 &amp;plusmn; 0,09, p &lt; 0,01) através do prolongamento do TRIV (101 &amp;plusmn; 14 para 113 &amp;plusmn; 17 ms, p &lt; 0,01) e encurtamento do TEJ (271 &amp;plusmn; 22 para 252 &amp;plusmn; 22 ms, p &lt; 0,05). O TCIV não variou (p = ns). Os parâmetros diastólicos ao Doppler tecidual não mudaram (p = ns), enquanto a velocidade sistólica (S) aumentou (p &lt; 0,05). CONCLUSÃO: O índice de Tei foi afetado pela alteração da pré-carga induzida pela hemodiálise, assim como outros parâmetros derivados do Doppler transvalvar mitral. Os parâmetros diastólicos do Doppler tecidual do anel mitral foram independentes da pré-carga, enquanto a velocidade sistólica sugeriu melhora na função sistólica do VE após o procedimento.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To assess the influence of preload reduction by hemodialysis on Doppler Tei Index of myocardial performance and other parameters of cardiac function. METHODS: The Tei index and left ventricular (LV) systolic and diastolic function parameters were estimated, before and after a single hemodialysis session. Only subjects who were in sinus rhythm, without history of coronary artery disease, and no evidence of cardiac valve disease and pericardial effusion were included in the study. RESULTS: Fifteen patients (8 men, mean age 53 &amp;plusmn; 14 years) completed the study. After an ultrafiltration of 2,2 &amp;plusmn; 1,1 liters, peak mitral E velocity decreased (p&lt; 0,05) and A velocity remained unchanged (p = ns), resulting in reduction of E/A ratio (p&lt; 0,01). The Tei index increased (from 0,57 &amp;plusmn; 0,07 to 0,65 &amp;plusmn; 0,09, p&lt; 0,01) because of significant prolongations in isovolumetric relaxation time (from 101 &amp;plusmn; 14 to 113 &amp;plusmn; 17 ms, p&lt; 0,01) and ejection time (from 271 &amp;plusmn; 22 to 252 &amp;plusmn; 22, p&lt; 0,05). The isovolumetric contraction time did not vary (p = ns). There was no change in diastolic tissue Doppler parameters, while systolic velocities increased (p&lt; 0,05). CONCLUSION: The Tei index was affected by hemodialysis-induced preload alterations, as well as other mitral inflow Doppler-derived parameters. The diastolic parameters of mitral annulus Doppler tissue were independent of preload, while systolic velocities suggested improved systolic function.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Diálise renal</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ecocardiografia</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>função ventricular esquerda</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Renal dialysis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>echocardiography</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Doppler</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular function</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>left</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Critérios ecocardiográficos para definição de graus de disfunção ventricular em ratos portadores de estenose aórtica</s1>
</fA08>
<fA08 dir="en">
<s1>Echocardiographic criteria for the definition of ventricular dysfunction severity in aortic banded rats</s1>
</fA08>
<fA11 dir="011000">
<s1>Vanessa Oliveira Moreira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Ana Valéria Barros de Castro</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Marcelle Yumi Yaegaschi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Antonio Carlos Cicogna</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marina Politi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Camila Alves Pereira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Flávio Ferrari Aragon</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Mário Batista Bruno</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Carlos Roberto Padovani</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Katashi Okoshi</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Unesp Faculdade de Medicina de Botucatu Instituto de Biociências de Botucatu</s1>
<s2>Botucatu SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>432-438</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>22</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600605</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: O objetivo deste estudo foi identificar variáveis ecocardiográficas que definam graus de disfunção cardíaca em ratos com estenose aórtica (EAo). MÉTODOS: Ratos Wistar (n = 23), machos (90-100 g), foram submetidos a cirurgia para indução de EAo. As variáveis ecocardiográficas analisadas foram: diâmetros diastólico do ventrículo esquerdo (DDVE) e sistólico do átrio esquerdo em valores absolutos e normalizados para o peso corporal; diâmetro sistólico do VE (DSVE); três índices de encurtamento do VE (% de encurtamento endocárdico, %Enc.Endo; % de encurtamento miocárdico, %Enc.Mio; e velocidade de encurtamento da parede posterior do VE, VEPP); e índice de massa do VE (IMVE). Essas variáveis foram utilizadas para a análise de agrupamento (&quot;cluster analysis&quot;). RESULTADOS: A análise de agrupamento possibilitou separar os ratos com EAo em dois grupos: disfunção leve (n = 13) e disfunção severa (n = 9). Os intervalos de confiança das seguintes variáveis não apresentaram superposição dos seus valores: DDVE, DSVE, %Enc.Endo, %Enc.Mio, IMVE e VEPP. CONCLUSÃO: A utilização conjunta dos intervalos de confiança dessas variáveis permite identificar dois grupos de ratos com estenose aórtica e diferentes graus de comprometimento cardíaco, possibilitando a realização de estudos longitudinais com grupos homogêneos de animais.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: The purpose of this study was to identify echocar-diographic parameters that allow distinguishing different levels of cardiac dysfunction in aortic banded rats. METHODS: Wistar male rats (90-100 g) were subjected to aortic banding (n=23) or a sham operation (n=12). The following echocardiographic parameters were evaluated and used to group rats into groups with similar characteristics using cluster analysis: absolute values and after normalization to body weight of left ventricular end-diastolic diameter (LVDD) and left atrial systolic diameter; left ventricular end-systolic diameter (LVSD); LV weight to body weight ratio (LVW/BW); three indexes of left ventricular shortening (endocardial fractional shortening, EFS; midwall FS, MFS; and posterior wall shortening velocity, (PWSV). RESULTS: The cluster analysis could group aortic banded rats into two groups: mild (n=13) and severe (n=9) stage of heart failure. There was no overlapping among the values of the 95% confidence interval of the following parameters between the two groups: LVDD, LVSD, EFS, MFS, LVW/BW, and PWSV. CONCLUSION: It is feasible to distinguish two groups of aortic banded rats according to the level of cardiac dysfunction using those echocardiographic parameters. This allows to perform longitudinal studies in homogeneous groups of rats with aortic banding and cardiac dysfunction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Ecocardiograma</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>estenose aórtica</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>disfunção ventricular</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>ratos</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>análise de agrupamento</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Echocardiogram</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>aortic stenosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>ventricular dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>rats</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cluster analysis</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Fatores de risco cardiovasculares em adolescentes: indicadores biológicos e comportamentais</s1>
</fA08>
<fA08 dir="en">
<s1>Cardiovascular risk factors in adolescents: biological and behavioral indicators</s1>
</fA08>
<fA11 dir="011000">
<s1>Dartagnan Pinto Guedes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Joana Elisabete Ribeiro Pinto Guedes</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Decio Sabbatini Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Jair Aparecido de Oliveira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Luiz Cláudio Reeberg Stanganelli</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Estadual de Londrina  </s1>
<s2>Londrina PR</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>439-450</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>71</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600606</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Oferecer informações descritivas e investigar a extensão com que os fatores de risco para doenças cardiovasculares de natureza comportamental estão associados aos fatores de risco biológicos na população jovem. MÉTODOS: Amostra de 452 adolescentes (246 moças e 206 rapazes) com idades entre 15 e 18 anos, selecionados de uma escola de ensino médio da cidade de Londrina, Paraná. Fatores de risco de natureza comportamental foram analisados mediante prática insuficiente de atividade física, ingestão excessiva de gorduras e de colesterol e uso de tabaco. Como indicadores dos fatores de risco biológicos recorreu-se ao sobrepeso, aos níveis elevados de pressão arterial e concentrações não-favoráveis de lipídios-lipoproteínas plasmáticas. RESULTADOS: Por volta de 20% das moças e 16% dos rapazes apresentaram pelo menos um fator de risco biológico para o desenvolvimento de doenças cardiovasculares. O sobrepeso se associou significativamente com a ingestão excessiva de gorduras, enquanto a pressão arterial elevada se relacionou com o estilo de vida sedentário e o uso de tabaco. A excessiva ingestão de gorduras e de colesterol indicou risco aumentado de concentrações indesejáveis de lipídios-lipoproteínas plasmáticas. Adolescentes fumantes tenderam a demonstrar risco de pressão arterial e de lipídios-lipoproteínas plasmáticas alterados duas vezes maior que não-fumantes. CONCLUSÃO: Os resultados reforçam a necessidade de que intervenções direcionadas à adoção de um estilo de vida saudável, incluindo prática regular de atividade física, padrões dietéticos adequados e abstenção ao uso de tabaco, deverão ser iniciadas em idades jovens.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To provide descriptive information and investigate to what extent behavioral risk factors for cardiovascular diseases are associated with biological risk factors in the young population. METHODS: The sample included 452 adolescents (246 girls and 206 boys) between 15 and 18 years of age selected in a high school in the city of Londrina, Paraná. Risk factors of a behavioral nature were analyzed as regards insufficient physical activity, excessive intake of fat and cholesterol and smoking. As biological risk factor indicators we used overweight, high arterial pressure levels, and adverse concentration of serum lipids and lipoproteins. RESULTS: Approximately 20% of the girls and 16% of the boys presented at least one biological risk factor for development of cardiovascular diseases. Overweight was significantly associated with excessive intake of fats, while elevated arterial pressure was related to sedentary lifestyle and smoking. Excessive intake of fat and cholesterol indicated increased risk of undesirable concentrations of serum lipids and lipoproteins. The risk associated with altered blood pressure and serum lipids and lipoprotein was increased two-fold in smokers when compared with nonsmokers. CONCLUSION: The results reinforce the need for interventions targeted at the adoption of a healthy lifestyle, including the regular practice of physical exercise, appropriate dietary patterns, and abstention from smoking as of an early age.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Pressão arterial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>lipídios-lipoproteínas plasmáticas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sobrepeso</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>atividade física</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>padrão dietético</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>tabaco</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Blood pressure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>serum lipids-lipoproteins</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>overweight</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>physical activity</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>dietary patterns</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>smoking</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Valor preditivo de variáveis ventilatórias e metabólicas para óbito em pacientes com insuficiência cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Predictive value of ventilatory and metabolic variables for risk of death in patients with cardiac failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Ana Maria F. Wanderley Braga</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Urbana P. B. Rondon</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Carlos Eduardo Negrão</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Maurício Wajngarten</s1>
<afiliation>A01 A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>USP Escola de Educação Física </s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>451-458</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>65</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600607</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o valor preditivo de variáveis respiratórias, metabólicas e hemodinâmicas, no teste de esforço cardiopulmonar, para óbito em pacientes com insuficiência cardíaca. MÉTODOS: Foram estudados 87 pacientes em classe funcional II e III da NYHA, faixa etária de 51&amp;plusmn;0,5 anos, dos quais 26 eram de etiologia chagásica, 30 isquêmica e 31 idiopática. O teste de esforço cardiopulmonar consistiu de protocolo em rampa com incremento de 5 a 15W/min, realizado em cicloergômetro, até a exaustão. RESULTADOS: A análise dos fatores de controle, realizada com regressão múltipla de Cox, mostrou que a idade, estatura, peso, superfície corporal e sexo não foram estatisticamente significativos. O consumo de oxigênio, o equivalente ventilatório de oxigênio, o equivalente ventilatório de dióxido de carbono, o pulso de oxigênio, a pressão parcial de dióxido de carbono ao final da expiração, no limiar anaeróbio, no ponto de compensação respiratória e no pico do exercício apresentaram-se como importantes preditores de óbito. A relação do aumento de dióxido de carbono como função da elevação da ventilação minuto e a relação do aumento do consumo de oxigênio e da elevação da carga de trabalho do início do exercício até o limiar anaeróbio apresentaram correlação estatisticamente significativa com óbito (p&lt;0,05). CONCLUSÃO: O teste de esforço cardiopulmonar possibilita a avaliação de variáveis ventilatórias, metabólicas e hemodinâmicas, que podem ser utilizadas como marcadores importantes do prognóstico de vida, nesses pacientes.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the predictive value of respiratory, metabolic, and hemodynamic variables obtained during the cardiopulmonary stress test for the risk of death in patients with heart failure. METHODS: Eighty-seven NYHA Functional Class II and III patients were analyzed, ages 51 &amp;plusmn; 0.5 years, 26 of them with Chagas' disease, 30 with coronary ischemia, and 31 with idiopathic etiology. The cardiopulmonary stress test consisted of a ramp-protocol with 5 to 15 W/min workload increments performed on a bicycle-ergonometer until exhaustion. RESULTS: In this study, the multiple Cox regression analysis of age, height, weight, body surface, and gender showed that these parameters were not statistically significant control factors. Oxygen uptake, ventilatory equivalent of oxygen, ventilatory equivalent of carbon dioxide production, oxygen pulse, and end-tidal partial pressure of carbon dioxide at the anaerobic threshold, respiratory compensation point, and peak exercise proved to be important death predictors in heart failure patients. The relationship between the increase in carbon dioxide output as a function of the increase in minute ventilation, and the association between the oxygen uptake increase and the elevation of the workload from the beginning of exercise to the anaerobic threshold were statistically significant predictors of death in heart failure patients (p&lt;0.05). CONCLUSION: The cardiopulmonary stress test makes it possible to evaluate ventilatory, metabolic, and hemodynamic variables that may be utilized as important markers of life prognosis in these patients.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Teste de esforço cardiopulmonar</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>prognóstico</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Cardiopulmonary stress test</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>prognosis</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Exercício resistido na avaliação da disfunção endotelial na insuficiência cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Resistive exercise in the evaluation of endothelial dysfunction in heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Ricardo Tavares de Carvalho</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Marcelo Luis Campos Vieira</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Ângela Romano</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Liliane Kopel</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Silvia G. Lage</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>FMUSP Hospital das Clínicas Instituto do Coração</s1>
<s2>São Paulo SP</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>459-465</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>29</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600608</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Avaliar o uso de exercício físico resistido no estudo da disfunção endotelial na insuficiência cardíaca comparativamente à hiperemia reativa (HR). MÉTODOS: Dezoito portadores de insuficiência cardíaca (IC) e 15 voluntários realizaram esforço físico manual de preensão intermitente em bolsa pneumática com intensidade correspondente a 75% da carga máxima previamente avaliada. Foram avaliados por ultra-sonografia vascular de alta resolução para análise dos diâmetros da artéria braquial e fluxos bem como determinação do débito cardíaco em repouso, após HR e após exercício. Foram calculados o índice de fluxo sistólico na artéria braquial e o índice cardíaco. RESULTADOS: Houve aumento do índice de fluxo sistólico na artéria braquial nas condições HR e exercício físico sendo maior nessa última. Houve aumento do índice cardíaco nas condições de estudo comparativamente ao repouso. CONCLUSÃO: O exercício físico resistido, na carga avaliada, aumenta o fluxo sanguíneo local de forma mais intensa que a HR, constituindo-se numa opção fisiológica à avaliação da disfunção endotelial na IC .</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To evaluate the use of resistive exercise in the study of endothelial dysfunction in heart failure (HF) comparatively to reactive hyperemia (RH). METHODS: Eighteen patients with heart failure and 15 normal volunteers were submitted to intermittent handgrip exercise in a pneumatic bag, at an intensity that corresponds to 75% of the previously assessed maximum load. Patients underwent high-resolution vascular ultrasonography for brachial artery diameter and flow evaluation as well as cardiac output determination at rest, RH and after exercise. The systolic flow index in the brachial artery and cardiac index were calculated. RESULTS: Systolic flow index increase in the brachial artery was observed after RH and physical exercise, with the latter presenting the highest increase. There was an increase in the cardiac index after the study conditions in comparison to resting conditions. CONCLUSION: Resistive exercise, performed at the assessed load, increases blood flow more intensively than RH, constituting a physiological option for the evaluation of endothelial function in HF.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Disfunção endotelial</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>insuficiência cardíaca</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>exercício</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Endothelial dysfunction</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>heart failure</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>exercise</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Disfunção endotelial venosa em pacientes com doença de Chagas sem insuficiência cardíaca</s1>
</fA08>
<fA08 dir="en">
<s1>Venous endothelial dysfunction in Chagas' disease patients without heart failure</s1>
</fA08>
<fA11 dir="011000">
<s1>Rodrigo Della Méa Plentz</s1>
<afiliation>A01 A04</afiliation>
</fA11>
<fA11 dir="021000">
<s1>Maria Claudia Irigoyen</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="031000">
<s1>Andreia Simone Muller</s1>
<afiliation>A01 A04</afiliation>
</fA11>
<fA11 dir="041000">
<s1>Dulce Elena Casarini</s1>
<afiliation>A01</afiliation>
</fA11>
<fA11 dir="051000">
<s1>Marcelo Custodio Rubira</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="061000">
<s1>Heitor Moreno Junior</s1>
<afiliation>A03</afiliation>
</fA11>
<fA11 dir="071000">
<s1>Charles Mady</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="081000">
<s1>Bárbara Maria Ianni</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="091000">
<s1>Eduardo Moacir Krieger</s1>
<afiliation>A02</afiliation>
</fA11>
<fA11 dir="101000">
<s1>Fernanda Consolim-Colombo</s1>
<afiliation>A02</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade Federal de São Paulo  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="020000">
<s1>FMUSP Hospital das Clínicas IIInstituto do Coração</s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="030000">
<s1>Universidade Estadual de Campinas  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA14 dir="040000">
<s1>Universidade de Cruz Alta  </s1>
<s2> </s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>466-471</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0>39</s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600609</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="pt">
<s0>OBJETIVO: Analisar a função endotelial venosa em pacientes chagásicos sem insuficiência cardíaca. MÉTODOS: O grupo Chagas (G1) foi composto por quatorze mulheres e dois homens com idade de 46 &amp;plusmn; 2,7 anos, e o grupo controle (G0), por sete mulheres e um homem, pareados em idade, peso, altura. A Técnica de Complacência da Veia Dorsal da Mão foi utilizada para avaliação da função endotelial venosa. Foram infundidas doses crescentes de fenilefrina para se obter pré-constrição de 70% do basal; a seguir, foram administradas acetilcolina e nitroprussiato de sódio para avaliar as respostas de venodilatação, respectivamente, dependentes e independentes do endotélio. RESULTADOS: Não houve variação entre os valores hemodinâmicos nos grupos durante o experimento. A dose média de fenilefrina necessária para pré-constrição da veia foi significativamente maior no G1 (1116 &amp;plusmn; 668,2 ng/ml), comparada à do G0 (103 &amp;plusmn; 28 ng/ml) p = 0,05. A resposta de venodilatação máxima dependente do endotélio foi significativamente menor no grupo G1 (65,5 &amp;plusmn; 8%), comparada à do G0 (137 &amp;plusmn; 20 %) p = 0,009. Não houve diferença nas respostas de venodilatação independente do endotélio entre os grupos. CONCLUSÃO: Pacientes com doença de Chagas sem insuficiência cardíaca apresentam disfunção endotelial venosa.</s0>
</fC01>
<fC01 dir="en">
<s0>OBJECTIVE: To analyze the venous endothelial function in Chagas' disease patients without heart failure. METHODS: The Chagas' disease Group (G1) was composed by 14 women and 2 men aged 46 &amp;plusmn; 2,7 and the Control Group (G0) by 7 women and 1 man matched by age, weight and height. Dorsal Hand Vein Compliance Technique was used to evaluate the venous endothelial function. Crescent doses of phenylephrine were infused to get a 70% pre-constriction of the vein; after that, acetylcholine and sodium nitroprusside were respectively administrated to analyze the endothelium-dependent and -independent venodilation. RESULTS: No significant systemic hemodynamic changes were observed in both groups during the experiment. The necessary phenylephrine dose to reach 70% pre-constriction of the vein was significantly higher in the G1 (1116 &amp;plusmn; 668,2 ng/ml) compared to G0 (103 &amp;plusmn; 28 ng/ml) p = 0,05. The endothelium-dependent venous dilation was significantly lower in G1 (65,5 &amp;plusmn; 8%) compared to G0 (137 &amp;plusmn; 20 %) p = 0,009. No difference was observed in the endothelium-independent venous dilatation between groups. CONCLUSION: Patients with Chagas' disease without heart failure presented venous endothelial dysfunction.</s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>Endotélio</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença de Chagas</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>sistema venoso</s0>
<s4></s4>
</fC03>
<fC03 dir="pt">
<s0>doença cardiovascular</s0>
<s4></s4>
</fC03>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Endothelium</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>Chagas' disease</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>system venous</s0>
<s4></s4>
</fC03>
<fC03 dir="en">
<s0>cardiovascular disease</s0>
<s4></s4>
</fC03>
</record>
<record label="">
<fA01 dir="011000">
<s0>0066-782X</s0>
</fA01>
<fA03 dir="001000">
<s0>Arq. Bras. Cardiol.</s0>
</fA03>
<fA05 dir="000000">
<s2>86</s2>
</fA05>
<fA06 dir="000000">
<s2>6</s2>
</fA06>
<fA08 dir="pt">
<s1>Letalidade por doenças isquêmicas do coração no Estado do Rio de Janeiro no período de 1999 a 2003</s1>
</fA08>
<fA08 dir="en">
<s1>Ischemic heart disease lethalities in the State of Rio de Janeiro between 1999 and 2003</s1>
</fA08>
<fA11 dir="011000">
<s1>Paulo Roberto Benchimol Barbosa</s1>
<afiliation>A01</afiliation>
</fA11>
<fA14 dir="010000">
<s1>Universidade do Estado do Rio de Janeiro  </s1>
<s2>Rio de Janeiro RJ</s2>
<s3></s3>
</fA14>
<fA20 dir="000000">
<s1>472-473</s1>
</fA20>
<fA21 dir="000000">
<s1></s1>
</fA21>
<fA23 dir="010000">
<s0>pt</s0>
</fA23>
<fA43 dir="010000">
<s1>0066-782X</s1>
<s2>2006</s2>
</fA43>
<fA45 dir="000000">
<s0></s0>
</fA45>
<fA47 dir="011000">
<s0>S0066-782X(06)08600610</s0>
</fA47>
<fA60 dir="000000">
<s1>P</s1>
</fA60>
<fA61 dir="000000">
<s0>A</s0>
</fA61>
<fA64 dir="011000">
<s0></s0>
</fA64>
<fA66 dir="010000">
<s0></s0>
</fA66>
<fC01 dir="">
<s0></s0>
</fC01>
<fC03 dir="">
<s0></s0>
<s4></s4>
</fC03>
</record>
</recordset>
